FN Clarivate Analytics Web of Science
VR 1.0
PT J
AU Hwang, D
   Yang, S
   Zhang, JL
   Koo, BK
AF Hwang, Doyeon
   Yang, Seokhun
   Zhang, Jinlong
   Koo, Bon-Kwon
TI Physiologic Assessment after Coronary Stent Implantation
SO KOREAN CIRCULATION JOURNAL
LA English
DT Review
DE Percutaneous coronary intervention; Fractional flow reserve;
   Non-hyperemic pressure ratio; Outcomes
ID FRACTIONAL FLOW RESERVE; DRUG-ELUTING STENT; WAVE-FREE RATIO; INCOMPLETE
   ANGIOGRAPHIC REVASCULARIZATION; OPTICAL COHERENCE TOMOGRAPHY; OPTIMAL
   MEDICAL THERAPY; CLINICAL-OUTCOMES; PROGNOSTIC VALUE; INTRAVASCULAR
   ULTRASOUND; PRESSURE MEASUREMENT
AB The presence of myocardial ischemia is a prerequisite for the benefit of coronary revascularization. In the cardiac catheterization laboratory, fractional flow reserve and non-hyperemic pressure ratios are used to define the ischemia-causing coronary stenosis, and several randomized studies showed the benefit of physiology-guided coronary revascularization. However, physiology-guided revascularization does not necessarily guarantee the relief of ischemia. Recent studies reported that residual ischemia might exist in up to 15-20% of cases after angiographically successful percutaneous coronary intervention (PCI). Therefore, post-PCI physiologic assessment is necessary for judging the appropriateness of PCI, detecting the lesions that may benefit from additional PCI, and risk stratification after PCI. This review will focus on the current evidence for post-PCI physiologic assessment, how to interpret these findings, and the future perspectives of physiologic assessment after PCI.
C1 [Hwang, Doyeon; Yang, Seokhun; Koo, Bon-Kwon] Seoul Natl Univ Hosp, Dept Internal Med, 101 Daehak Ro, Seoul 03080, South Korea.
   [Hwang, Doyeon; Yang, Seokhun; Koo, Bon-Kwon] Seoul Natl Univ Hosp, Cardiovasc Ctr, 101 Daehak Ro, Seoul 03080, South Korea.
   [Zhang, Jinlong] Zhejiang Univ, Affiliated Hosp 2, Sch Med, Dept Cardiol, Hangzhou, Peoples R China.
RP Koo, BK (corresponding author), Seoul Natl Univ Hosp, Dept Internal Med, 101 Daehak Ro, Seoul 03080, South Korea.; Koo, BK (corresponding author), Seoul Natl Univ Hosp, Cardiovasc Ctr, 101 Daehak Ro, Seoul 03080, South Korea.
EM bkkoo@snu.ac.kr
CR Agarwal SK, 2016, JACC-CARDIOVASC INTE, V9, P1022, DOI 10.1016/j.jcin.2016.01.046
   Azzalini L, 2019, J INVASIVE CARDIOL, V31, P229
   Bech GJW, 1999, CIRCULATION, V99, P883, DOI 10.1161/01.CIR.99.7.883
   Bertrand OF, 2004, INT J CARDIOVAS IMAG, V20, P279, DOI 10.1023/B:CAIM.0000041947.11384.93
   Biscaglia S, 2019, JACC-CARDIOVASC INTE, V12, P2079, DOI 10.1016/j.jcin.2019.06.003
   Boden WE, 2007, NEW ENGL J MED, V356, P1503, DOI 10.1056/NEJMoa070829
   Bom MJ, 2021, CATHETER CARDIO INTE, V97, P614, DOI 10.1002/ccd.29210
   Dai Neng, 2021, JACC Cardiovasc Interv, V14, P353, DOI 10.1016/j.jcin.2020.10.036
   De Bruyne B, 2008, HEART, V94, P949, DOI 10.1136/hrt.2007.122838
   Doh JH, 2015, J INVASIVE CARDIOL, V27, P346
   Douglas PS, 2015, EUR HEART J, V36, P3359, DOI 10.1093/eurheartj/ehv444
   Farooq V, 2013, CIRCULATION, V128, P141, DOI 10.1161/CIRCULATIONAHA.113.001803
   Farooq V, 2013, J AM COLL CARDIOL, V61, P282, DOI 10.1016/j.jacc.2012.10.017
   Frimerman A, 2019, JACC-CARDIOVASC INTE, V12, P692, DOI 10.1016/j.jcin.2018.12.037
   Hakeem A, 2019, JACC-CARDIOVASC INTE, V12, P2002, DOI 10.1016/j.jcin.2019.07.026
   Hamaya R, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.18162
   Hanekamp CEE, 1999, CIRCULATION, V99, P1015, DOI 10.1161/01.CIR.99.8.1015
   Hannan EL, 2006, CIRCULATION, V113, P2406, DOI 10.1161/CIRCULATIONAHA.106.612267
   Hoole SP, 2020, HEART, V106, P1380, DOI [10.1136/heartjnl-2019-316291, 10.1136/heartjnl-2019-315707]
   Hoshino M, 2019, EUROINTERVENTION, V15, pE779, DOI 10.4244/EIJ-D-18-01032
   Hwang D, 2020, JACC-CARDIOVASC INTE, V13, P1639, DOI 10.1016/j.jcin.2020.04.041
   Hwang D, 2019, EUROINTERVENTION, V15, P457, DOI 10.4244/EIJ-D-18-00913
   Im E, 2014, CIRC-CARDIOVASC INTE, V7, P88, DOI 10.1161/CIRCINTERVENTIONS.113.000797
   Ito T, 2014, INT J CARDIOL, V176, P399, DOI 10.1016/j.ijcard.2014.07.115
   Jeremias A, 2019, JACC-CARDIOVASC INTE, V12, P1991, DOI 10.1016/j.jcin.2019.05.054
   Jeremias A, 2014, J AM COLL CARDIOL, V63, P1253, DOI 10.1016/j.jacc.2013.09.060
   Johnson NP, 2014, J AM COLL CARDIOL, V64, P1641, DOI 10.1016/j.jacc.2014.07.973
   Kasula S, 2016, HEART, V102, P1988, DOI 10.1136/heartjnl-2016-309422
   Kawamori H, 2013, EUR HEART J-CARD IMG, V14, P865, DOI 10.1093/ehjci/jes299
   Kay FU, 2020, KOREAN CIRC J, V50, P185, DOI 10.4070/kcj.2019.0315
   Kikuta Y, 2018, JACC-CARDIOVASC INTE, V11, P757, DOI 10.1016/j.jcin.2018.03.005
   Kim J, 2020, KOREAN CIRC J, V50, P406, DOI 10.4070/kcj.2019.0319
   Kim KH, 2014, JACC-CARDIOVASC INTE, V7, P72, DOI 10.1016/j.jcin.2013.05.024
   Kogame N, 2019, JACC-CARDIOVASC INTE, V12, P2064, DOI 10.1016/j.jcin.2019.08.009
   Koo BK, 2011, J AM COLL CARDIOL, V58, P1989, DOI 10.1016/j.jacc.2011.06.066
   Lee CH, 2019, KOREAN CIRC J, V49, P771, DOI 10.4070/kcj.2019.0198
   Lee JM, 2019, CIRCULATION, V139, P889, DOI 10.1161/CIRCULATIONAHA.118.037021
   Lee JM, 2018, JACC-CARDIOVASC INTE, V11, P2099, DOI 10.1016/j.jcin.2018.07.031
   Lee SH, 2020, JACC-CARDIOVASC INTE, V13, P2670, DOI 10.1016/j.jcin.2020.06.062
   Leesar MA, 2011, EUROINTERVENTION, V7, P917, DOI 10.4244/EIJV7I8A145
   Li SJ, 2017, JACC-CARDIOVASC INTE, V10, P986, DOI 10.1016/j.jcin.2017.02.012
   Maron DJ, 2020, NEW ENGL J MED, V382, P1395, DOI 10.1056/NEJMoa1915922
   Matsuo A, 2021, CARDIOVASC INTERV TH, V36, P208, DOI 10.1007/s12928-020-00668-0
   Matsuo A, 2013, CARDIOVASC INTERV TH, V28, P170, DOI 10.1007/s12928-012-0147-7
   Min JK, 2012, JAMA-J AM MED ASSOC, V308, P1237, DOI 10.1001/2012.jama.11274
   Murai T, 2015, CATHETER CARDIO INTE, V85, P585, DOI 10.1002/ccd.25499
   Nagaoka H, 1998, JPN CIRC J, V62, P160, DOI 10.1253/jcj.62.160
   Nam CW, 2011, AM J CARDIOL, V107, P1763, DOI 10.1016/j.amjcard.2011.02.329
   Neumann FJ, 2019, EUR HEART J, V40, P79, DOI 10.1093/eurheartj/ehy855
   Norgaard BL, 2014, J AM COLL CARDIOL, V63, P1145, DOI 10.1016/j.jacc.2013.11.043
   Omori H, 2020, JACC-CARDIOVASC INTE, V13, P2688, DOI 10.1016/j.jcin.2020.06.060
   Petraco R, 2014, CIRC-CARDIOVASC INTE, V7, P492, DOI 10.1161/CIRCINTERVENTIONS.113.000926
   Pijls NHJ, 2002, CIRCULATION, V105, P2950, DOI 10.1161/01.CIR.0000020547.92091.76
   Piroth Z, 2017, CIRC CARDIOVASC INTE, V10
   Reith S, 2015, J INVASIVE CARDIOL, V27, P222
   Rimac G, 2017, AM HEART J, V183, P1, DOI 10.1016/j.ahj.2016.10.005
   Rodes-Cabau J, 2001, J NUCL MED, V42, P1768
   Rosner GF, 2012, CIRCULATION, V125, P2613, DOI 10.1161/CIRCULATIONAHA.111.069237
   Rubimbura V, 2020, CATHETER CARDIO INTE, V96, P1145, DOI 10.1002/ccd.28615
   Sen S, 2013, J AM COLL CARDIOL, V61, P1409, DOI 10.1016/j.jacc.2013.01.034
   Shaw LJ, 2008, CIRCULATION, V117, P1283, DOI 10.1161/CIRCULATIONAHA.107.743963
   Shin D, 2020, JACC-CARDIOVASC INTE, V13, P1920, DOI 10.1016/j.jcin.2020.05.042
   Svanerud J, 2018, EUROINTERVENTION, V14, P806, DOI 10.4244/EIJ-D-18-00342
   Takano Y, 2001, J AM COLL CARDIOL, V38, P1622, DOI 10.1016/S0735-1097(01)01618-7
   Tu SX, 2020, EUR HEART J, V41, P3271, DOI 10.1093/eurheartj/ehz918
   van Bommel RJ, 2019, CIRC-CARDIOVASC INTE, V12, DOI 10.1161/CIRCINTERVENTIONS.118.007428
   van't Veer M, 2017, J AM COLL CARDIOL, V70, P3088, DOI 10.1016/j.jacc.2017.10.066
   Volz S, 2020, J AM COLL CARDIOL, V75, P2785, DOI 10.1016/j.jacc.2020.04.018
   Wolfrum M, 2018, EUROINTERVENTION, V14, pE1324, DOI 10.4244/EIJ-D-18-00071
NR 69
TC 0
Z9 0
U1 1
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAR
PY 2021
VL 51
IS 3
BP 189
EP 201
DI 10.4070/kcj.2020.0548
PG 13
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA QQ1NI
UT WOS:000624292700001
PM 33655719
OA Green Published
DA 2021-04-22
ER

PT J
AU Kim, HK
   Tantry, US
   Park, HW
   Shin, ES
   Geisler, T
   Gorog, DA
   Gurbel, PA
   Jeong, YH
AF Kim, Hyun Kuk
   Tantry, Udaya S.
   Park, Hyun-Woong
   Shin, Eun-Seok
   Geisler, Tobias
   Gorog, Diana A.
   Gurbel, Paul A.
   Jeong, Young-Hoon
TI Ethnic Difference of Thrombogenicity in Patients with Cardiovascular
   Disease: a Pandora Box to Explain Prognostic Differences
SO KOREAN CIRCULATION JOURNAL
LA English
DT Review
DE Thrombogenicity; Coagulation; Inflammation; Race; Antithrombotic
   treatment
ID C-REACTIVE PROTEIN; PERCUTANEOUS CORONARY INTERVENTION; DUAL
   ANTIPLATELET THERAPY; EXPERT CONSENSUS STATEMENT; EAST-ASIAN PATIENTS;
   MYOCARDIAL-INFARCTION; PLATELET REACTIVITY; STENT THROMBOSIS; VENOUS
   THROMBOEMBOLISM; RACIAL-DIFFERENCES
AB Arterial and venous atherothrombotic events are finely regulated processes involving a complex interplay between vulnerable blood, vulnerable vessel, and blood stasis. Vulnerable blood ('thrombogenicity') comprises complex interactions between cellular components and plasma factors (inflammatory, procoagulant, anticoagulant, and fibrinolytic factors). The extent of thrombogenicity may determine the progression of atheroma and the clinical manifestation of atherothrombotic events, with the highest thrombogenicity in African Americans and lowest in East Asians. Inherent thrombogenicity may influence clinical efficacy and safety of specific antithrombotic treatments in high-risk patients, which may in part explain the observation that East Asian patients have reduced anti-ischemic benefits and elevated bleeding risk with antithrombotic therapy compared to Caucasian patients. In this review, we discuss available evidence regarding the racial differences in thrombogenicity and its impact on clinical outcomes among patients with atherosclerotic cardiovascular disease.
C1 [Kim, Hyun Kuk] Chosun Univ Hosp, Dept Cardiol, Gwangju, South Korea.
   [Tantry, Udaya S.; Gurbel, Paul A.] Sinai Hosp, Sinai Ctr Thrombosis Res, 2401 W Belvedere Ave, Baltimore, MD 21215 USA.
   [Park, Hyun-Woong; Jeong, Young-Hoon] Gyeongsang Natl Univ, Dept Internal Med, Sch Med, Jinju, South Korea.
   [Park, Hyun-Woong] Gyeongsang Natl Univ Hosp, Div Cardiol, Jinju, South Korea.
   [Shin, Eun-Seok] Univ Ulsan, Ulsan Univ Hosp, Div Cardiol, Coll Med, Ulsan, South Korea.
   [Geisler, Tobias] Univ Hosp Tubingen, Dept Cardiol & Angiol, Tubingen, Germany.
   [Gorog, Diana A.] Imperial Coll, Natl Heart & Lung Inst, London, England.
   [Gorog, Diana A.] Univ Hertfordshire, Postgrad Med Sch, Hatfield, Herts, England.
   [Jeong, Young-Hoon] Gyeongsang Natl Univ, Cardiovasc Ctr, Changwon Hosp, Chang Won, South Korea.
   [Jeong, Young-Hoon] Gyeongsang Natl Univ, Inst Hlth Sci, Jinju, South Korea.
RP Jeong, YH (corresponding author), Gyeongsang Natl Univ, Sch Med, Changwon Hosp, Dept Internal Med,Cardiovasc Ctr, 11 Samjeongja Ro, Chang Won 51472, South Korea.
EM goodoctor@naver.com
OI Gorog, Diana/0000-0002-9286-1451; Jeong, Young-Hoon/0000-0003-0403-3726
FU Basic Science Research Program through the National Research Foundation
   (NRF) of Korea - Ministry of Science, ICT and Future Planning
   [NRF-2015R1A5A2008833]
FX This study is supported by the Basic Science Research Program through
   the National Research Foundation (NRF) of Korea funded by the Ministry
   of Science, ICT and Future Planning (NRF-2015R1A5A2008833).
CR Albert MA, 2004, AM J CARDIOL, V93, P1238, DOI 10.1016/j.amjcard.2004.01.067
   Anand SS, 2000, LANCET, V356, P279, DOI 10.1016/S0140-6736(00)02502-2
   Ang L, 2013, J AM COLL CARDIOL, V61, P23, DOI 10.1016/j.jacc.2012.09.037
   Bae JS, 2018, CURR VASC PHARMACOL, V16, P459, DOI 10.2174/1570161116666180117103238
   Bagot CN, 2008, BRIT J HAEMATOL, V143, P180, DOI 10.1111/j.1365-2141.2008.07323.x
   Bang OY, 2016, J STROKE, V18, P169, DOI 10.5853/jos.2016.00052
   Bhatt DL, 2010, JAMA-J AM MED ASSOC, V304, P1350, DOI 10.1001/jama.2010.1322
   Bikdeli B, 2020, J AM COLL CARDIOL, V75, P2950, DOI 10.1016/j.jacc.2020.04.031
   Capodanno D, 2020, NAT REV CARDIOL, V17, P242, DOI 10.1038/s41569-019-0314-y
   Chao TF, 2019, EUR HEART J, V40, P1518, DOI 10.1093/eurheartj/ehy807
   Chaudhary Rahul, 2020, EClinicalMedicine, V29, P100647, DOI 10.1016/j.eclinm.2020.100647
   Chaudhary R, 2020, THROMB HAEMOSTASIS, V120, P1594, DOI 10.1055/s-0040-1714217
   Cho H, 2020, KOREAN CIRC J, V50, P645, DOI 10.4070/kcj.2020.0098
   Choudry FA, 2020, J AM COLL CARDIOL, V76, P1168, DOI 10.1016/j.jacc.2020.07.022
   Collins SD, 2010, CIRCULATION, V122, P1085, DOI 10.1161/CIRCULATIONAHA.109.907998
   Connors JM, 2020, BLOOD, V135, P2033, DOI 10.1182/blood.2020006000
   Daemen J, 2007, LANCET, V369, P667, DOI 10.1016/S0140-6736(07)60314-6
   Daneshjou R, 2016, MOL GENET GENOM MED, V4, P513, DOI 10.1002/mgg3.226
   Edelstein LC, 2014, BLOOD, V124, P3450, DOI 10.1182/blood-2014-04-572479
   Edelstein LC, 2013, NAT MED, V19, P1609, DOI 10.1038/nm.3385
   Festa A, 2003, CIRCULATION, V107, P2422, DOI 10.1161/01.CIR.0000066908.82782.3A
   Frydman GH, 2020, CLIN APPL THROMB-HEM, V26, DOI 10.1177/1076029620943671
   Gijsberts CM, 2015, GLOB HEART, V10, P301, DOI 10.1016/j.gheart.2014.11.004
   Golomb M, 2020, JACC-CARDIOVASC INTE, V13, P1586, DOI 10.1016/j.jcin.2020.04.020
   Gong LL, 2012, THROMB RES, V130, pE43, DOI 10.1016/j.thromres.2012.06.015
   Gorog DA, 2011, INT J CARDIOL, V152, P43, DOI 10.1016/j.ijcard.2010.07.002
   Gurbel PA, 2008, BLOOD COAGUL FIBRIN, V19, P268, DOI 10.1097/MBC.0b013e3282ff76ae
   Hahn JY, 2019, JAMA-J AM MED ASSOC, V321, P2428, DOI 10.1001/jama.2019.8146
   Horvei LD, 2016, J THROMB HAEMOST, V14, P1561, DOI 10.1111/jth.13369
   Huang GB, 2019, CLIN CARDIOL, DOI 10.1002/clc.23282
   Hulten E, 2013, AM J CARDIOL, V111, P479, DOI 10.1016/j.amjcard.2012.10.028
   Huo Y, 2019, SCI BULL, V64, P166, DOI 10.1016/j.scib.2018.12.020
   Infeld M, 2021, J THROMB THROMBOLYS, V51, P249, DOI 10.1007/s11239-020-02327-w
   Iso H, 2009, ATHEROSCLEROSIS, V207, P291, DOI 10.1016/j.atherosclerosis.2009.04.020
   Jafari Mohammadali, 2020, Acta Medica (Hradec Kralove), V63, P31, DOI 10.14712/18059694.2020.13
   Jan JY, 2018, EUR HEART J, V39
   Jee SH, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005025
   Jee SH, 2006, NEW ENGL J MED, V355, P779, DOI 10.1056/NEJMoa054017
   Jeong YH, 2012, CARDIOSOURCE INTERVE, V1, P38
   Jeong YH, 2021, J THROMB THROMBOLYS, V51, P454, DOI 10.1007/s11239-020-02240-2
   Jeong YH, 2014, THROMB HAEMOSTASIS, V111, P713, DOI 10.1160/TH13-08-0643
   Jeong YH, 2014, CURR CARDIOL REP, V16, DOI 10.1007/s11886-014-0485-4
   Jerrard-Dunne P, 2003, STROKE, V34, P1821, DOI 10.1161/01.STR.0000083049.65008.5F
   Kalkman DN, 2018, EUR HEART J, V39, P4101, DOI 10.1093/eurheartj/ehy633
   Kang J, 2019, THROMB HAEMOSTASIS, V119, P149, DOI 10.1055/s-0038-1676545
   Kang J, 2018, KOREAN CIRC J, V48, P537, DOI 10.4070/kcj.2018.0166
   Kang J, 2018, THROMB HAEMOSTASIS, V118, P591, DOI 10.1055/s-0038-1626697
   Kanji R, 2021, EUR J CLIN INVEST, V51, DOI 10.1111/eci.13471
   Kawashima H, 2020, JACC-CARDIOVASC INTE, V13, P2587, DOI 10.1016/j.jcin.2020.09.013
   Kelley-Hedgepeth A, 2008, CLIN CHEM, V54, P1027, DOI 10.1373/clinchem.2007.098996
   Kim BK, 2020, JAMA-J AM MED ASSOC, V323, P2407, DOI 10.1001/jama.2020.7580
   Kim HS, 2020, LANCET, V396, P1079, DOI 10.1016/S0140-6736(20)31791-8
   Kim HK, 2021, THROMB HAEMOSTASIS, V121, P422, DOI 10.1055/s-0040-1718729
   Kim HK, 2020, KOREAN CIRC J, V50, P845, DOI 10.4070/kcj.2020.0196
   Kim HK, 2020, KOREAN CIRC J, V50, P817, DOI 10.4070/kcj.2020.0287
   Kim HK, 2015, INT J CARDIOL, V193, P20, DOI 10.1016/j.ijcard.2015.05.017
   Kim IC, 2020, KOREAN CIRC J, V50, P543, DOI 10.4070/kcj.2020.0205
   Kimura T, 2009, CIRCULATION, V119, P987, DOI 10.1161/CIRCULATIONAHA.108.808311
   Knuuti J, 2020, EUR HEART J, V41, P407, DOI 10.1093/eurheartj/ehz425
   Koupenova M, 2020, CIRC RES, V127, P1419, DOI 10.1161/CIRCRESAHA.120.318218
   Kumar RS, 2013, CIRCULATION, V127, P1395, DOI 10.1161/CIRCULATIONAHA.113.001437
   Lawler PR, 2021, EUR HEART J, V42, P113, DOI 10.1093/eurheartj/ehaa099
   Lev EI, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.114.001167
   Levine GN, 2014, NAT REV CARDIOL, V11, P597, DOI 10.1038/nrcardio.2014.104
   Liao S, 2014, J THROMB HAEMOST, V12, P214, DOI 10.1111/jth.12464
   Liu J, 2004, JAMA-J AM MED ASSOC, V291, P2591, DOI 10.1001/jama.291.21.2591
   Lutsey PL, 2006, J THROMB HAEMOST, V4, P2629, DOI 10.1111/j.1538-7836.2006.02237.x
   Mak KH, 2009, AM HEART J, V157, P658, DOI 10.1016/j.ahj.2008.08.031
   MEADE TW, 1986, LANCET, V2, P533, DOI 10.1016/S0140-6736(86)90111-X
   Meadows TA, 2011, MAYO CLIN PROC, V86, P960, DOI 10.4065/mcp.2011.0010
   Michels A, 2020, ARTERIOSCL THROM VAS, V40, P2860, DOI 10.1161/ATVBAHA.120.314690
   Nishimura K, 2014, J ATHEROSCLER THROMB, V21, P784, DOI 10.5551/jat.19356
   Park DW, 2019, CIRCULATION, V140, P1865, DOI 10.1161/CIRCULATIONAHA.119.041766
   Park DW, 2011, J AM COLL CARDIOL, V58, P2630, DOI 10.1016/j.jacc.2011.08.057
   Park DW, 2008, JACC-CARDIOVASC INTE, V1, P494, DOI 10.1016/j.jcin.2008.06.011
   Patti G, 2019, THROMB HAEMOSTASIS, V119, P1773, DOI 10.1055/s-0039-1694969
   Pendyala LK, 2013, AM HEART J, V166, P266, DOI 10.1016/j.ahj.2013.04.008
   Puri R, 2013, CIRCULATION, V128, P2395, DOI 10.1161/CIRCULATIONAHA.113.004243
   Ridker PM, 2018, J AM COLL CARDIOL, V72, P3320, DOI 10.1016/j.jacc.2018.06.082
   Ridker PM, 1997, JAMA-J AM MED ASSOC, V277, P1305, DOI 10.1001/jama.277.16.1305
   Roger VL, 2012, CIRCULATION, V125, pE2, DOI 10.1161/CIR.0b013e31823ac046
   Samad F, 2013, BLOOD, V122, P3415, DOI 10.1182/blood-2013-05-427708
   SAXENA S, 1987, AM J CLIN PATHOL, V88, P106, DOI 10.1093/ajcp/88.1.106
   Shah T, 2010, CIRC-CARDIOVASC GENE, V3, P436, DOI 10.1161/CIRCGENETICS.110.957431
   Suh JW, 2009, AM HEART J, V157, P908, DOI 10.1016/j.ahj.2009.02.001
   Sumaya W, 2018, EUR HEART J, V39, P1078, DOI 10.1093/eurheartj/ehy013
   Sun Y, 2019, ATHEROSCLEROSIS, V290, P52, DOI 10.1016/j.atherosclerosis.2019.09.011
   Sung KC, 2014, EUR HEART J, V35, P1809, DOI 10.1093/eurheartj/ehu059
   van der Meijden PEJ, 2019, NAT REV CARDIOL, V16, P166, DOI 10.1038/s41569-018-0110-0
   van Lammeren GW, 2014, CIRCULATION, V129, P2269, DOI 10.1161/CIRCULATIONAHA.113.007603
   Vilahur G, 2017, CARDIOVASC RES, V113, P1046, DOI 10.1093/cvr/cvx086
   Vinholt PJ, 2016, THROMB RES, V148, P136, DOI 10.1016/j.thromres.2016.08.012
   Violi F, 2020, THROMB HAEMOSTASIS, V120, P949, DOI 10.1055/s-0040-1710317
   Virani SS, 2020, CIRCULATION, V141, pE139, DOI 10.1161/CIR.0000000000000757
   Watanabe H, 2019, JAMA-J AM MED ASSOC, V321, P2414, DOI 10.1001/jama.2019.8145
   Wright FL, 2020, J AM COLL SURGEONS, V231, P193, DOI 10.1016/j.jamcollsurg.2020.05.007
   Yasuda S, 2019, NEW ENGL J MED, V381, P1103, DOI 10.1056/NEJMoa1904143
   Ye Z, 2006, LANCET, V367, P651, DOI 10.1016/S0140-6736(06)68263-9
   Zaid Y, 2020, CIRC RES, V127, P1404, DOI 10.1161/CIRCRESAHA.120.317703
   Zakai NA, 2011, J THROMB HAEMOST, V9, P1877, DOI 10.1111/j.1538-7836.2011.04443.x
   Zheng YL, 2010, CLIN RES CARDIOL, V99, P45, DOI 10.1007/s00392-009-0076-3
NR 101
TC 0
Z9 0
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAR
PY 2021
VL 51
IS 3
BP 202
EP 221
DI 10.4070/kcj.2020.0537
PG 20
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA QQ1NI
UT WOS:000624292700002
PM 33655720
OA Green Published
DA 2021-04-22
ER

PT J
AU Lee, YJ
   Lee, SJ
   Hong, SJ
   Shim, CY
   Ahn, CM
   Kim, JS
   Kim, BK
   Hong, GR
   Ko, YG
   Choi, D
   Jang, Y
   Hong, MK
AF Lee, Yong-Joon
   Lee, Seung-Jun
   Hong, Sung-Jin
   Shim, Chi-Young
   Ahn, Chul-Min
   Kim, Jung-Sun
   Kim, Byeong-Keuk
   Hong, Geu-Ru
   Ko, Young-Guk
   Choi, Donghoon
   Jang, Yangsoo
   Hong, Myeong-Ki
TI Comparison of Transcatheter Aortic Valve Replacement between
   Self-Expanding versus Balloon-Expandable Valves in Patients with Small
   Aortic Annulus
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Transcatheter aortic valve replacement; Aortic valve stenosis
ID STENOSIS; IMPLANTATION; HEMODYNAMICS
AB Background and Objectives: Transcatheter aortic valve replacement (TAVR) has been reported as a good alternative for surgical aortic valve replacement in patients with small aortic annulus. Head-to-head comparisons of different transcatheter aortic valves in these patients are insufficient. We compared the outcomes after TAVR between two different types of recent transcatheter aortic valves (self-expanding vs. balloon-expandable) in patients with small aortic annulus.
   Methods: A total of 70 patients with severe aortic stenosis and small annulus (mean diameter <= 23 mm or minimal diameter <= 21 mm on computed tomography) underwent TAVR with either a self-expanding valve with supra-annular location (n=45) or a balloon-expandable valve with intra-annular location (n=25). The echocardiographic hemodynamic parameters after TAVR and 1-year follow-up were compared.
   Results: Between the self-expanding and balloon-expandable valve-treated patients, the clinical outcomes including permanent pacemaker implantation (11.1% vs. 8.0%), acute kidney injury stage 2 or 3 (4.4% vs. 4.0%), and major vascular complication (4.4% vs. 0.0%) were similar without all-cause mortality, stroke, and life-threatening bleeding during 30-day follow-up. Compared with the balloon-expandable valve-treated patients, the self-expanding valve-treated patients presented larger effective orifice area (EOA) (1.46 +/- 0.28 vs. 1.75 +/- 0.42 cm(2), p=0.002) and indexed EOA (0.95 +/- 0.21 vs. 1.18 +/- 0.28 cm(2)/m(2), p=0.001), whereas mean aortic valve gradient (11.7 +/- 2.9 vs. 8.9 +/- 5.2 mmHg, P=0.005) and incidence of >= moderate prosthesis-patient mismatch (36.0% vs. 8.9%, p=0.009) were lower. These hemodynamic differences were maintained at 1-year follow-up.
   Conclusions: TAVR with self-expanding valves was associated with superior hemodynamic outcomes compared with balloon-expandable valves in patients with small aortic annulus.
C1 [Lee, Yong-Joon; Lee, Seung-Jun; Hong, Sung-Jin; Shim, Chi-Young; Ahn, Chul-Min; Kim, Jung-Sun; Kim, Byeong-Keuk; Hong, Geu-Ru; Ko, Young-Guk; Choi, Donghoon; Jang, Yangsoo; Hong, Myeong-Ki] Yonsei Univ Hlth Syst, Severance Cardiovasc Hosp, Dept Internal Med, Div Cardiol, Seoul 03722, South Korea.
RP Hong, MK (corresponding author), Yonsei Univ, Coll Med, Severance Cardiovasc Hosp, Div Cardiol,Dept Internal Med, 50-1 Yonsei Ro, Seoul 03722, South Korea.
EM mkhong61@yuhs.ac
RI Shim, Chi Young/AAK-1057-2021
OI Shim, Chi Young/0000-0002-6136-0136; Hong, Sung-Jin/0000-0003-4893-039X;
   Choi, Donghoon/0000-0002-2009-9760; Ahn, Chul-Min/0000-0002-7071-4370;
   Kim, Jung-Sun/0000-0003-2263-3274
FU Korea Health Technology Research & Development Project through the Korea
   Health Industry Development Institute - Ministry of Health & Welfare,
   Republic of Korea [HI17C0882, HI16C2211, HI15C2782]; Bio & Medical
   Technology Development Program of the National Research Foundation - the
   Korean government [2015M3A9C6031514]; Cardiovascular Research Center,
   Seoul, Korea
FX This work was supported by grants from the Korea Health Technology
   Research & Development Project through the Korea Health Industry
   Development Institute, funded by the Ministry of Health & Welfare,
   Republic of Korea (No. HI17C0882, HI16C2211, and HI15C2782), the Bio &
   Medical Technology Development Program of the National Research
   Foundation funded by the Korean government (No. 2015M3A9C6031514), and
   the Cardiovascular Research Center, Seoul, Korea.
CR Baumgartner H, 2017, EUR HEART J, V38, P2739, DOI 10.1093/eurheartj/ehx391
   Binder RK, 2013, JACC-CARDIOVASC INTE, V6, P293, DOI 10.1016/j.jcin.2012.09.019
   Du Bois D, 1916, ARCH INTERN MED, V17, P863, DOI 10.1001/archinte.1916.00080130010002
   Freitas-Ferraz AB, 2019, CIRCULATION, V139, P2685, DOI 10.1161/CIRCULATIONAHA.118.038408
   Hahn RT, 2019, JACC-CARDIOVASC IMAG, V12, P25, DOI 10.1016/j.jcmg.2018.04.010
   Hase H, 2020, CATHETER CARDIO INTE, DOI 10.1002/ccd.29259
   Herrmann HC, 2018, J AM COLL CARDIOL, V72, P2701, DOI 10.1016/j.jacc.2018.09.001
   Kalavrouziotis D, 2011, J AM COLL CARDIOL, V58, P1016, DOI 10.1016/j.jacc.2011.05.026
   Kappetein AP, 2013, J THORAC CARDIOV SUR, V145, P6, DOI 10.1016/j.jtcvs.2012.09.002
   Manoharan G, 2015, JACC-CARDIOVASC INTE, V8, P1359, DOI 10.1016/j.jcin.2015.05.015
   Mauri V, 2017, CIRC-CARDIOVASC INTE, V10, DOI 10.1161/CIRCINTERVENTIONS.117.005013
   Nishimura RA, 2014, J AM COLL CARDIOL, V63, P2438, DOI 10.1016/j.jacc.2014.02.537
   Pibarot P, 2014, J AM COLL CARDIOL, V64, P1323, DOI 10.1016/j.jacc.2014.06.1195
   Regazzoli D, 2020, JACC-CARDIOVASC INTE, V13, P196, DOI 10.1016/j.jcin.2019.08.041
   Rodes-Cabau J, 2014, CIRC-CARDIOVASC INTE, V7, P701, DOI 10.1161/CIRCINTERVENTIONS.114.001681
   Rogers T, 2017, AM J CARDIOL, V119, P900, DOI 10.1016/j.amjcard.2016.11.044
   Watanabe Y, 2014, CATHETER CARDIO INTE, V84, P272, DOI 10.1002/ccd.24970
   Yashima F, 2017, INT J CARDIOL, V240, P126, DOI 10.1016/j.ijcard.2017.01.076
NR 18
TC 1
Z9 1
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAR
PY 2021
VL 51
IS 3
BP 222
EP 231
DI 10.4070/kcj.2020.0409
PG 10
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA QQ1NI
UT WOS:000624292700003
PM 33655721
OA Green Published
DA 2021-04-22
ER

PT J
AU Lee, CW
   Sung, SH
AF Lee, Ching-Wei
   Sung, Shih-Hsien
TI The Lower, The Better? Think Beyond the Gradient after Transcatheter
   Aortic Valve Replacement for Small Annulus
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
ID RISK PATIENTS; STENOSIS
C1 [Lee, Ching-Wei; Sung, Shih-Hsien] Taipei Vet Gen Hosp, Div Cardiol, Dept Med, 201,Sect 2,Shih Pai Rd, Taipei 11217, Taiwan.
   [Lee, Ching-Wei] Taipei Vet Gen Hosp, Dept Med Affairs & Planning, Taipei, Taiwan.
   [Lee, Ching-Wei; Sung, Shih-Hsien] Natl Yang Ming Univ, Cardiovasc Res Ctr, Taipei, Taiwan.
RP Sung, SH (corresponding author), Taipei Vet Gen Hosp, Div Cardiol, Dept Med, 201,Sect 2,Shih Pai Rd, Taipei 11217, Taiwan.
EM mr.sungsh@gmail.com
CR Aalaei-Andabili SH, 2020, CARDIOL THER, V9, P201, DOI 10.1007/s40119-020-00161-y
   BAUMGARTNER H, 1990, CIRCULATION, V82, P1467, DOI 10.1161/01.CIR.82.4.1467
   Freitas-Ferraz AB, 2019, CIRCULATION, V139, P2685, DOI 10.1161/CIRCULATIONAHA.118.038408
   Hase H, 2020, CATHETER CARDIO INTE, DOI 10.1002/ccd.29259
   Kim SH, 2019, INTERACT CARDIOV TH, V28, P58, DOI 10.1093/icvts/ivy190
   Lee YJ, 2021, KOREAN CIRC J, V51, P222, DOI 10.4070/kcj.2020.0409
   Makkar RR, 2020, LANCET, V396, P669, DOI 10.1016/S0140-6736(20)31358-1
   Pibarot P, 2014, J AM COLL CARDIOL, V64, P1323, DOI 10.1016/j.jacc.2014.06.1195
   Thyregod HGH, 2019, CIRCULATION
NR 9
TC 0
Z9 0
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAR
PY 2021
VL 51
IS 3
BP 232
EP 234
DI 10.4070/kcj.2020.0547
PG 3
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA QQ1NI
UT WOS:000624292700004
PM 33655722
OA Green Published
DA 2021-04-22
ER

PT J
AU Kim, M
   Kim, TH
   Yu, HT
   Choi, EK
   Park, HS
   Park, J
   Lee, YS
   Kang, KW
   Shim, J
   Sung, JH
   Oh, IY
   Joung, B
AF Kim, Min
   Kim, Tae-Hoon
   Yu, Hee Tae
   Choi, Eue-Keun
   Park, Hyung-Seob
   Park, Junbeom
   Lee, Young Soo
   Kang, Ki-Woon
   Shim, Jaemin
   Sung, Jung-Hoon
   Oh, Il-Young
   Joung, Boyoung
CA AF-Pacemaker Study Grp
TI Prevalence and Predictors of Clinically Relevant Atrial High-Rate
   Episodes in Patients with Cardiac Implantable Electronic Devices
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Arrhythmia; Pacemaker; artificial; Sick sinus syndrome; Left atrium
ID FIBRILLATION; PACEMAKER; DURATION; STROKE; RISK; OUTCOMES
AB Background and Objectives: Atrial high-rate episodes (AHREs) can be continuously detected by cardiovascular implantable electronic devices (CIEDs); however, the predictors of clinically relevant AHREs are unclear.
   Methods: This prospective multicenter study monitored 816 patients (median age 73 years, 40.4% male) without atrial fibrillation (AF) from September 2017 to July 2020. AHREs was defined as a programmed atrial detection rate >220 beats/min. The reference values of 6 minutes and 6 hours were set to analyze clinical implication of AHREs based on previously published data that the 6 minutes excluded most episodes of oversensing.
   Results: During a median follow-up of 18 months (interquartile interval 9-26 months), AHREs with the longest durations of >15 seconds, >6 minutes, and >6 hours and clinically documented AF by electrocardiography were noted in 246 (30.1%), 112 (13.7%), 49 (6.0%), and 24 (2.9%) patients, respectively. Among patients developing AHREs >6 minutes, 102 (91.1%) of 112 patients were identified at the 6-month visit. Patients with AHREs >6 minutes had higher proportions of sick sinus syndrome, subjects with atrial premature beat >1% on Holter monitoring, and larger left atrium (LA) size than patients with AHREs <= 6 minutes. Multivariable logistic regression analysis showed that LA diameter >41 mm (odds ratio [OR], 2.08; 95% confidence interval [95% CI], 1.25-3.45), and sick sinus syndrome (OR, 3.22; 95% CI, 1.91-5.43) were associated with AHREs >6 minutes.
   Conclusions: In patients with LA diameter >41 mm, and sick sinus syndrome before CIEDs implantation is associated with risk of developing AHREs >6 minutes.
C1 [Kim, Min; Kim, Tae-Hoon; Yu, Hee Tae; Joung, Boyoung] Yonsei Univ Hlth Syst, Div Cardiol, Seoul, South Korea.
   [Choi, Eue-Keun] Seoul Natl Univ Bundang Hosp, Dept Cardiol, Seongnam, South Korea.
   [Park, Hyung-Seob] Seoul Natl Univ Hosp, Dept Cardiol, Seoul, South Korea.
   [Park, Junbeom] Keimyung Univ Hosp, Div Cardiol, Daegu, South Korea.
   [Lee, Young Soo] Ewha Womans Univ Hosp, Dept Cardiol, Seoul, South Korea.
   [Kang, Ki-Woon] Daegu Catholic Univ Hosp, Div Cardiol, Daegu, South Korea.
   [Shim, Jaemin] Eulji Univ Hosp, Div Cardiol, Daejeon, South Korea.
   [Sung, Jung-Hoon] Korea Univ Hosp, Dept Cardiol, Seoul, South Korea.
   [Oh, Il-Young] CHA Bundang Univ Hosp, Dept Cardiol, Seongnam, South Korea.
RP Joung, B (corresponding author), Yonsei Univ, Coll Med, Severance Cardiovasc Hosp, Div Cardiol,Dept Internal Med, 50-1 Yonsei Ro, Seoul 03722, South Korea.; Oh, IY (corresponding author), Seoul Natl Univ, Bundang Hosp, Dept Cardiol, Dept Internal Med, 82 Gumi Ro 173 Beon Gil, Seongnam 13620, South Korea.
EM ilyoung.oh@snubh.org; cby6908@yuhs.ac
RI Choi, Eue-Keun/J-5968-2014
OI Choi, Eue-Keun/0000-0002-0411-6372; Kim, Min/0000-0002-8132-9873; Shim,
   Jaemin/0000-0001-8251-1522; Kim, Tae-Hoon/0000-0003-4200-3456; Sung,
   Jung -Hoon/0000-0003-3515-5283
FU Korean Healthcare Technology R&D project - Ministry of Health Welfare
   [HI15C1200, HC19C0130]; Abbott Medical Korea Ltd.; MedtronicMedtronic;
   AbbottAbbott Laboratories
FX This study was supported by research grants from the Korean Healthcare
   Technology R&D project funded by the Ministry of Health & Welfare
   (HI15C1200, HC19C0130), and from the Abbott Medical Korea Ltd. Dr.
   Boyoung Joung has served as a speaker for Bayer, BMS/Pfizer, Medtronic,
   and DaiichiSankyo and received research funds from Medtronic and Abbott.
CR Belkin MN, 2018, CIRC-ARRHYTHMIA ELEC, V11, DOI 10.1161/CIRCEP.117.005393
   Brambatti M, 2014, CIRCULATION, V129, P2094, DOI 10.1161/CIRCULATIONAHA.113.007825
   Capucci A, 2005, J AM COLL CARDIOL, V46, P1913, DOI 10.1016/j.jacc.2005.07.044
   Cheung JW, 2006, J CARDIOVASC ELECTR, V17, P1323, DOI 10.1111/j.1540-8167.2006.00648.x
   Gillis AM, 2002, J CARDIOVASC ELECTR, V13, P542, DOI 10.1046/j.1540-8167.2002.00542.x
   Glotzer TV, 2009, CIRC-ARRHYTHMIA ELEC, V2, P474, DOI 10.1161/CIRCEP.109.849638
   Glotzer TV, 2003, CIRCULATION, V107, P1614, DOI 10.1161/01.CIR.0000057981.70380.45
   Gonzalez M, 2014, HEART RHYTHM, V11, P2214, DOI 10.1016/j.hrthm.2014.08.019
   Gorenek B, 2018, EUROPACE, V20, P658, DOI 10.1093/europace/eux339
   Healey JS, 2017, CIRCULATION, V136, P1276, DOI 10.1161/CIRCULATIONAHA.117.028845
   Healey JS, 2013, CAN J CARDIOL, V29, P224, DOI 10.1016/j.cjca.2012.08.019
   Healey JS, 2012, NEW ENGL J MED, V366, P120, DOI 10.1056/NEJMoa1105575
   January CT, 2014, CIRCULATION, V130, P2071, DOI [10.1161/CIR.0000000000000041, 10.1161/CIR.0000000000000040]
   Kaufman ES, 2012, HEART RHYTHM, V9, P1241, DOI 10.1016/j.hrthm.2012.03.017
   Kim D, 2018, AM HEART J, V202, P20, DOI 10.1016/j.ahj.2018.04.017
   Kirchhof P, 2016, EUR HEART J, V37, P2893, DOI 10.1093/eurheartj/ehw210
   Lopes RD, 2017, AM HEART J, V189, P137, DOI 10.1016/j.ahj.2017.04.008
   Mahajan R, 2018, EUR HEART J, V39, P1407, DOI 10.1093/eurheartj/ehx731
   Mittal S, 2008, AM J CARDIOL, V102, P450, DOI 10.1016/j.amjcard.2008.03.080
   Pedersen KB, 2018, J CARDIOVASC ELECTR, V29, P707, DOI 10.1111/jce.13470
   Tse HF, 2005, HEART, V91, P362, DOI 10.1136/hrt.2003.027219
   Van Gelder IC, 2017, EUR HEART J, V38, P1339, DOI 10.1093/eurheartj/ehx042
   Wong JA, 2018, J AM COLL CARDIOL, V71, P2603, DOI 10.1016/j.jacc.2018.03.519
   Ziegler PD, 2012, AM J CARDIOL, V110, P1309, DOI 10.1016/j.amjcard.2012.06.034
NR 24
TC 1
Z9 1
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAR
PY 2021
VL 51
IS 3
BP 235
EP 247
DI 10.4070/kcj.2020.0393
PG 13
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA QQ1NI
UT WOS:000624292700005
PM 33655723
OA Green Published
DA 2021-04-22
ER

PT J
AU Jang, SW
AF Jang, Sung-Won
TI Left Atrial Enlargement and Sick Sinus Syndrome for Pacemaker Indication
   Were Associated with Atrial High Rate Episodes
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
ID FIBRILLATION; TACHYCARDIA; RISK
C1 [Jang, Sung-Won] Catholic Univ Korea, Coll Med, Eunpyung St Marys Hosp, Div Cardiol,Dept Internal Med, 1021 Tongil Ro, Seoul 03312, South Korea.
RP Jang, SW (corresponding author), Catholic Univ Korea, Coll Med, Eunpyung St Marys Hosp, Div Cardiol,Dept Internal Med, 1021 Tongil Ro, Seoul 03312, South Korea.
EM sungwon.jang@catholic.ac.kr
OI Jang, Sung-Won/0000-0001-5272-0665
CR Dagres N, 2020, EUR HEART J, V2020
   Glotzer TV, 2003, CIRCULATION, V107, P1614, DOI 10.1161/01.CIR.0000057981.70380.45
   Healey JS, 2012, NEW ENGL J MED, V366, P120, DOI 10.1056/NEJMoa1105575
   Hwang J, 2019, KOREAN CIRC J, V49, P437, DOI 10.4070/kcj.2018.0323
   Joung B, 2018, KOREAN CIRC J, V48, P1033, DOI 10.4070/kcj.2018.0339
   Kaufman ES, 2012, HEART RHYTHM, V9, P1241, DOI 10.1016/j.hrthm.2012.03.017
   Kim M, 2021, KOREAN CIRC J, V51, P235, DOI 10.4070/kcj.2020.0393
   Lee SR, 2017, INT J CARDIOL, V236, P226, DOI 10.1016/j.ijcard.2017.02.039
   Mahajan R, 2018, EUR HEART J, V39, P1407, DOI 10.1093/eurheartj/ehx731
   Swiryn S, 2016, CIRCULATION, V134, P1130, DOI 10.1161/CIRCULATIONAHA.115.020252
NR 10
TC 0
Z9 0
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAR
PY 2021
VL 51
IS 3
BP 248
EP 250
DI 10.4070/kcj.2020.0515
PG 3
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA QQ1NI
UT WOS:000624292700006
PM 33655724
OA Green Published
DA 2021-04-22
ER

PT J
AU Lee, SY
   Lee, TW
   Park, GT
   Kim, JH
   Lee, HC
   Han, JH
   Yoon, A
   Yoon, D
   Kim, S
   Jung, SM
   Choi, JH
   Chon, MK
   Lee, SH
   Hwang, KW
   Kim, J
   Park, YH
   Kim, JH
   Chun, KJ
   Hur, J
AF Lee, Soo Yong
   Lee, Tae Wook
   Park, Gyu Tae
   Kim, Jae Ho
   Lee, Hyun-Chae
   Han, Jung-Hwa
   Yoon, Aeseon
   Yoon, Dahye
   Kim, Shukmann
   Jung, Soon Myung
   Choi, Jin Hee
   Chon, Min Ku
   Lee, Sang Hyun
   Hwang, Ki Won
   Kim, Jeongsu
   Park, Yong Hyun
   Kim, June Hong
   Chun, Kook Jin
   Hur, Jin
TI Sodium/glucose Co-Transporter 2 Inhibitor, Empagliflozin, Alleviated
   Transient Expression of SGLT2 after Myocardial Infarction
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Myocardial infarction; Sodium-glucose transporter 2; Sodium-glucose
   transporter 2 inhibitors; Metabolism
ID SUBSTRATE METABOLISM; GLUCOSE-TRANSPORTER
AB Background and Objectives: Large clinical studies of sodium/glucose cotransporter 2 (SGLT2) inhibitors have shown a significant beneficial effect on heart failure-associated hospitalization and cardiovascular events. As SGLT2 is known to be absent in heart cells, improved cardiovascular outcomes are thought to be accounted for by the indirect effects of the drug. We sought to confirm whether such benefits were mediated through SGLT2 expressed in the heart using myocardial infarction (MI) model.
   Methods: Mice pre-treated with empagliflozin (EMPA), an SGLT2 inhibitor, showed a significantly reduced infarct size compared with the vehicle group three days post-MI. Interestingly, we confirmed SGLT2 localized in the infarct zone. The sequential changes of SGLT2 expression after MI were also evaluated.
   Results: One day after MI, SGLT2 transiently appeared in the ischemic areas in the vehicle group and increased until 72 hours. The appearance of SGLT2 was delayed and less in amount compared with the vehicle group. Additionally, there was a significant difference in metabolites, including glucose and amino acids in the H-1 nuclear magnetic resonance analysis between groups.
   Conclusions: Our work demonstrates that SGLT2 is transiently expressed in heart tissue early after MI and EMPA may directly operate on SGLT2 to facilitate metabolic substrates shifts.
C1 [Lee, Soo Yong; Jung, Soon Myung; Choi, Jin Hee; Chon, Min Ku; Lee, Sang Hyun; Hwang, Ki Won; Kim, Jeongsu; Park, Yong Hyun; Kim, June Hong; Chun, Kook Jin] Pusan Natl Univ, Dept Internal Med, Div Cardiol, Yangsan Hosp, Yangsan, South Korea.
   [Lee, Soo Yong; Kim, Jae Ho] Pusan Natl Univ, Res Inst Convergence Biomed Sci & Technol, Yangsan Hosp, Yangsan, South Korea.
   [Lee, Tae Wook; Park, Gyu Tae; Kim, Jae Ho] Pusan Natl Univ, Sch Med, Dept Physiol, Yangsan, South Korea.
   [Lee, Hyun-Chae; Han, Jung-Hwa; Yoon, Aeseon; Hur, Jin] Pusan Natl Univ, Dept Convergence Med, Sch Med, 49 Busandaehak Ro, Yangsan 50612, South Korea.
   [Han, Jung-Hwa; Yoon, Aeseon; Hur, Jin] Pusan Natl Univ, Dept Chem, Sch Med, Ctr Proteome Biophys & Chem,Inst Funct Mat, Busan, South Korea.
   [Yoon, Dahye; Kim, Shukmann] Pusan Natl Univ, PNU GRAND Convergence Med Sci Educ Res Ctr, Dept Chem, Sch Med, Yangsan, South Korea.
RP Hur, J (corresponding author), Pusan Natl Univ, Dept Convergence Med, Sch Med, 49 Busandaehak Ro, Yangsan 50612, South Korea.
EM gene44@pusan.ac.kr
FU Research institute for Convergence of biomedical science and technology
   [30-2016-004]; Pusan National University Yangsan HospitalPusan National
   University
FX This study was supported by Research institute for Convergence of
   biomedical science and technology (30-2016-004), Pusan National
   University Yangsan Hospital.
CR Arnott C, 2020, J AM HEART ASSOC, V9, DOI 10.1161/JAHA.119.014908
   Banerjee SK, 2009, CARDIOVASC RES, V84, P111, DOI 10.1093/cvr/cvp190
   Chen Jian, 2010, Diabetes Ther, V1, P57, DOI 10.1007/s13300-010-0006-4
   Damman K, 2020, EUR J HEART FAIL, V22, P713, DOI 10.1002/ejhf.1713
   Di Franco A, 2017, INT J CARDIOL, V243, P86, DOI 10.1016/j.ijcard.2017.05.032
   Drake KJ, 2012, EXP BIOL MED, V237, P1369, DOI 10.1258/ebm.2012.012025
   Ferrannini E, 2016, DIABETES CARE, V39, P1108, DOI 10.2337/dc16-0330
   Ferrannini G, 2015, DIABETES CARE, V38, P1730, DOI 10.2337/dc15-0355
   Kashiwagi Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130605
   Lambert R, 2015, J AM HEART ASSOC, V4, DOI 10.1161/JAHA.115.002183
   McMurray JJV, 2019, NEW ENGL J MED, V381, P1995, DOI 10.1056/NEJMoa1911303
   Ndibalema AR, 2020, DIABET METAB SYND OB, V13, P1953, DOI 10.2147/DMSO.S243170
   Neal B, 2017, NEW ENGL J MED, V377, P644, DOI 10.1056/NEJMoa1611925
   Panchapakesan U, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054442
   Stanley WC, 2005, PHYSIOL REV, V85, P1093, DOI 10.1152/physrev.00006.2004
   Taegtmeyer H, 1994, Curr Probl Cardiol, V19, P59
   Taegtmeyer H, 1997, AM J CARDIOL, V80, pA3, DOI 10.1016/S0002-9149(97)00452-9
   Tazawa S, 2005, LIFE SCI, V76, P1039, DOI 10.1016/j.lfs.2004.10.016
   Uthman L, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.01575
   Vallon V, 2015, ANNU REV MED, V66, P255, DOI 10.1146/annurev-med-051013-110046
   Van Steenbergen A, 2017, SCI REP-UK, V7, DOI 10.1038/srep41166
   Vrhovac I, 2015, PFLUG ARCH EUR J PHY, V467, P1881, DOI 10.1007/s00424-014-1619-7
   Wiviott SD, 2019, NEW ENGL J MED, V380, P347, DOI 10.1056/NEJMoa1812389
   Wright EM, 2007, J INTERN MED, V261, P32, DOI 10.1111/j.1365-2796.2006.01746.x
   Yurista SR, 2019, EUR J HEART FAIL, V21, P862, DOI 10.1002/ejhf.1473
   Zapata-Morales JR, 2014, J BIOL CHEM, V289, P346, DOI 10.1074/jbc.M113.526814
   Zhou LB, 2003, J CELL BIOCHEM, V90, P339, DOI 10.1002/jcb.10631
   Zinman B, 2015, NEW ENGL J MED, V373, P2117, DOI 10.1056/NEJMoa1504720
NR 28
TC 1
Z9 1
U1 1
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAR
PY 2021
VL 51
IS 3
BP 251
EP 262
DI 10.4070/kcj.2020.0303
PG 12
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA QQ1NI
UT WOS:000624292700007
PM 33655725
OA Green Published
DA 2021-04-22
ER

PT J
AU Garcia, MVF
   Han, J
AF Garcia, Maria Victoria Faith
   Han, Jin
TI SGLT2 Inhibitors: the Gift that Keeps on Giving
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
C1 [Garcia, Maria Victoria Faith; Han, Jin] Inje Univ, Coll Med, Cardiovasc & Metab Dis Ctr, Dept Physiol,Smart Marine Therapeut Ctr, 75 Bokji Ro, Busan 47392, South Korea.
   [Garcia, Maria Victoria Faith; Han, Jin] Inje Univ, Grad Sch, Dept Hlth Sci & Technol, Busan, South Korea.
RP Han, J (corresponding author), Inje Univ, Coll Med, Cardiovasc & Metab Dis Ctr, Dept Physiol,Smart Marine Therapeut Ctr, 75 Bokji Ro, Busan 47392, South Korea.
EM phyhanj@inje.ac.kr
FU Basic Research Lab Program through the National Research Foundation of
   Korea - Ministry of Science and ICT, Korea [NRF2020R1A4A1018943]; Basic
   Science Research Program through the National Research Foundation of
   Korea - Ministry of Science and ICT, Korea [2018R1A2A3074998]
FX This research was supported by the Basic Research Lab Program
   (NRF2020R1A4A1018943) and the Basic Science Research Program
   (2018R1A2A3074998) through the National Research Foundation of Korea
   funded by the Ministry of Science and ICT, Korea
CR Cowie MR, 2020, NAT REV CARDIOL, V17, P761, DOI 10.1038/s41569-020-0406-8
   Hwang J, 2020, KOREAN CIRC J, V50, P458, DOI 10.4070/kcj.2020.0066
   Kim YS, 2019, KOREAN CIRC J, V49, P1196, DOI 10.4070/kcj.2019.0287
   Lee SY, 2021, KOREAN CIRC J, V51, P251, DOI 10.4070/kcj.2020.0303
   Lehrke M, 2019, J AM COLL CARDIOL, V73, P1945, DOI 10.1016/j.jacc.2019.02.023
   McMurray JJV, 2019, NEW ENGL J MED, V381, P1995, DOI 10.1056/NEJMoa1911303
   Neal B, 2017, NEW ENGL J MED, V377, P644, DOI 10.1056/NEJMoa1611925
   Wiviott SD, 2019, NEW ENGL J MED, V380, P347, DOI 10.1056/NEJMoa1812389
   Zelniker TA, 2019, LANCET, V393, P31, DOI 10.1016/S0140-6736(18)32590-X
   Zinman B, 2015, NEW ENGL J MED, V373, P2117, DOI 10.1056/NEJMoa1504720
NR 10
TC 0
Z9 0
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAR
PY 2021
VL 51
IS 3
BP 263
EP 266
DI 10.4070/kcj.2020.0512
PG 4
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA QQ1NI
UT WOS:000624292700008
PM 33655726
OA Green Published
DA 2021-04-22
ER

PT J
AU Kim, JJ
   Kim, HJ
   Yu, JJ
   Yun, SW
   Lee, KY
   Yoon, KL
   Kil, HR
   Kim, GB
   Han, MK
   Song, MS
   Lee, HD
   Jun, HO
   Ha, KS
   Hong, YM
   Jang, GY
   Lee, JK
AF Kim, Jae-Jung
   Kim, Hea-Ji
   Yu, Jeong Jin
   Yun, Sin Weon
   Lee, Kyung-Yil
   Yoon, Kyung Lim
   Kil, Hong-Ryang
   Kim, Gi Beom
   Han, Myung-Ki
   Song, Min Seob
   Lee, Hyoung Doo
   Jun, Hyun Ok
   Ha, Kee Soo
   Hong, Young Mi
   Jang, Gi Young
   Lee, Jong-Keuk
CA Korean Kawasaki Dis Genetics Conso
TI IgA Levels Are Associated with Coronary Artery Lesions in Kawasaki
   Disease
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Mucocutaneous lymph node syndrome; IgA; Coronary aneurysms
ID GENOME-WIDE ASSOCIATION; SUSCEPTIBILITY LOCI; RISK; CHILDREN; SERUM
AB Background and Objectives: Kawasaki disease (KD) is an acute systemic vasculitis that affects the coronary arteries. Abnormal immune reactions are thought to contribute to disease pathogenesis. The effect of immunoglobulin (Ig) isotype (IgG, IgA, IgM, and IgE) on inflammatory data and clinical outcomes of patients with KD was examined.
   Methods: Ig levels in 241 patients with KD were measured during the acute, subacute, convalescent, and normal phases of the disease.
   Results: Compared with reference Ig values, IgG, IgA, and IgM levels were significantly higher in the subacute phase, while IgE levels were elevated in 73.9% (178/241) of patients with KD in all clinical phases. However, high IgE levels were not associated with clinical outcomes, including intravenous immunoglobulin unresponsiveness and coronary artery lesions (CALs). Significantly more CALs were observed in the high IgA group than in the normal IgA group (44.7% vs. 20.8%, respectively; p<0.01). In addition, IgA levels in the acute phase (p=0.038) were 2.2-fold higher, and those in the subacute phase were 1.7-fold higher (p<0.001), in the CAL group than in the non-CAL group. IgA concentrations increased along with the size of the coronary artery aneurysm (p<0.001). Furthermore, there was a strong correlation between IgA levels and CAL size (r=0.435, p<0.001), with a high odds ratio of 2.58 (p=0.022).
   Conclusions: High IgA levels in patients with KD are prognostic for the risk of CALs.
C1 [Kim, Jae-Jung; Kim, Hea-Ji; Lee, Jong-Keuk] Univ Ulsan, Asan Inst Life Sci, Coll Med, 88,Olymp Ro 43 Gil, Seoul 05505, South Korea.
   [Yu, Jeong Jin] Univ Ulsan, Asan Med Ctr, Dept Pediat, Coll Med, Seoul, South Korea.
   [Yun, Sin Weon] Chung Ang Univ Hosp, Dept Pediat, Seoul, South Korea.
   [Lee, Kyung-Yil] Catholic Univ Korea, Dept Pediat, Daejeon St Marys Hosp, Daejeon, South Korea.
   [Yoon, Kyung Lim] Kyung Hee Univ Hosp Gangdong, Dept Pediat, Seoul, South Korea.
   [Kil, Hong-Ryang] Chungnam Natl Univ Hosp, Dept Pediat, Daejeon, South Korea.
   [Kim, Gi Beom] Seoul Natl Univ, Dept Pediat, Childrens Hosp, Seoul, South Korea.
   [Han, Myung-Ki] Univ Ulsan, Gangneung Asan Hosp, Dept Pediat, Kangnung, South Korea.
   [Song, Min Seob] Inje Univ, Dept Pediat, Paik Hosp, Busan, South Korea.
   [Lee, Hyoung Doo] Pusan Natl Univ Hosp, Dept Pediat, Busan, South Korea.
   [Jun, Hyun Ok] Myongji Hosp, Dept Pediat & Adolescent Med, Goyang, South Korea.
   [Ha, Kee Soo] Korea Univ, Dept Pediat, Guro Hosp, Seoul, South Korea.
   [Hong, Young Mi] Ewha Womans Univ Hosp, Dept Pediat, Seoul, South Korea.
   [Jang, Gi Young] Korea Univ, Dept Pediat, Ansan Hosp, Ansan, South Korea.
RP Lee, JK (corresponding author), Univ Ulsan, Asan Inst Life Sci, Coll Med, 88,Olymp Ro 43 Gil, Seoul 05505, South Korea.
EM cookie_jklee@hotmail.com
RI Kim, Gi Beom/AAK-3377-2021
OI Kim, Gi Beom/0000-0002-7880-280X
FU Ministry of Health AMP; Welfare of the Republic of Korea [HI15C1575];
   National Research Foundation of KoreaNational Research Foundation of
   Korea [2019R1F1A1061238]
FX This study was supported by the Ministry of Health & Welfare of the
   Republic of Korea (HI15C1575) and the National Research Foundation of
   Korea (2019R1F1A1061238).
CR Bayers S, 2013, J AM ACAD DERMATOL, V69, DOI 10.1016/j.jaad.2013.06.040
   Berndt SI, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10933
   Ding Y, 2015, BMC MUSCULOSKEL DIS, V16, DOI 10.1186/s12891-015-0744-6
   Farh KKH, 2015, NATURE, V518, P337, DOI 10.1038/nature13835
   Gregory GA, 2012, GREGORYS PEDIAT ANES, P1300
   Jonsson S, 2017, NAT GENET, V49, P1182, DOI 10.1038/ng.3897
   Kawasaki T, 1967, Arerugi, V16, P178
   Khor CC, 2011, NAT GENET, V43, P1241, DOI 10.1038/ng.981
   Kim JJ, 2017, J HUM GENET, V62, P1023, DOI 10.1038/jhg.2017.87
   Kuo HC, 2013, BMC PEDIATR, V13, DOI 10.1186/1471-2431-13-38
   KUSAKAWA S, 1976, PEDIATR RES, V10, P108, DOI 10.1203/00006450-197602000-00007
   Kwon YC, 2018, CIRC-GENOM PRECIS ME, V11, DOI 10.1161/CIRCGEN.117.002020
   Lee YC, 2012, NAT GENET, V44, P522, DOI 10.1038/ng.2227
   Liew WK, 2011, PEDIAT ALLERG IMM-UK, V22, P488, DOI 10.1111/j.1399-3038.2011.01149.x
   LINDBERG RE, 1986, J ALLERGY CLIN IMMUN, V78, P614, DOI 10.1016/0091-6749(86)90078-3
   Newburger JW, 2004, CIRCULATION, V110, P2747, DOI 10.1161/01.CIR.0000145143.19711.78
   Newburger JW, 2004, CURR OPIN PEDIATR, V16, P508, DOI 10.1097/01.mop.0000137796.23813.64
   Onouchi Y, 2018, INT J RHEUM DIS, V21, P26, DOI 10.1111/1756-185X.13218
   Onouchi Y, 2012, NAT GENET, V44, P517, DOI 10.1038/ng.2220
   Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795
   Rivas MN, 2019, IMMUNITY, V51, P508, DOI 10.1016/j.immuni.2019.05.021
   Rowley AH, 2000, J INFECT DIS, V182, P1183, DOI 10.1086/315832
   Rowley AH, 1997, J IMMUNOL, V159, P5946
   Sawaji Y, 1998, ACTA PAEDIATR JAPON, V40, P218
   Scuccimarri R, 2012, PEDIATR CLIN N AM, V59, P425, DOI 10.1016/j.pcl.2012.03.009
   Wei CC, 2014, ANN EPIDEMIOL, V24, P340, DOI 10.1016/j.annepidem.2014.02.003
   Wood CD, 2016, ELIFE, V5, DOI 10.7554/eLife.18270
   Yanagimoto K, 2014, INT ARCH ALLERGY IMM, V164, P83, DOI 10.1159/000363383
   구청모, 2013, [Journal of Rheumatic Diseases, 대한류마티스학회지], V20, P4
NR 29
TC 1
Z9 1
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAR
PY 2021
VL 51
IS 3
BP 267
EP 278
DI 10.4070/kcj.2020.0345
PG 12
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA QQ1NI
UT WOS:000624292700009
PM 33655727
OA Green Published
DA 2021-04-22
ER

PT J
AU Han, MY
AF Han, Mi Young
TI Could Immunoglobulin Level Be a Prognostic Factor for Coronary Artery
   Lesions in Kawasaki Diseases?
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
ID IGA
C1 [Han, Mi Young] Kyung Hee Univ Hosp, Dept Pediat, 23 Kyungheedae Ro, Seoul 02447, South Korea.
RP Han, MY (corresponding author), Kyung Hee Univ Hosp, Dept Pediat, 23 Kyungheedae Ro, Seoul 02447, South Korea.
EM myhan44@naver.com
CR Gupta M, 2002, CARDIOLOGY, V97, P180, DOI 10.1159/000063118
   Kim JJ, 2021, KOREAN CIRC J, V51, P267, DOI 10.4070/kcj.2020.0345
   LIN CY, 1987, ANN ALLERGY, V59, P291
   OHSHIO G, 1987, MICROBIOL IMMUNOL, V31, P891, DOI 10.1111/j.1348-0421.1987.tb03150.x
   Rivas MN, 2019, IMMUNITY, V51, P508, DOI 10.1016/j.immuni.2019.05.021
   Rowley AH, 2000, J INFECT DIS, V182, P1183, DOI 10.1086/315832
   Rowley AH, 1997, J IMMUNOL, V159, P5946
   Rowley AH, 2018, FRONT PEDIATR, V6, DOI 10.3389/fped.2018.00374
   Sawaji Y, 1998, ACTA PAEDIATR JAPON, V40, P218
   Yanagimoto K, 2014, INT ARCH ALLERGY IMM, V164, P83, DOI 10.1159/000363383
NR 10
TC 0
Z9 0
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAR
PY 2021
VL 51
IS 3
BP 279
EP 280
DI 10.4070/kcj.2021.0046
PG 2
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA QQ1NI
UT WOS:000624292700010
PM 33655728
OA Green Published
DA 2021-04-22
ER

PT J
AU Lee, D
   Kim, IJ
   Son, MJ
   Yoo, SM
   Lee, HY
   White, CS
AF Lee, Dongjun
   Kim, In Jai
   Son, Min Ji
   Yoo, Seung Min
   Lee, Hwa Yeon
   White, Charles S.
TI Prompt CT Diagnosis of Epicardial Coronary Abscess after Percutaneous
   Coronary Intervention Caused by Klebsiella Pneumoniae
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
C1 [Lee, Dongjun] Mil Serv Korean Army, Hongcheon, South Korea.
   [Kim, In Jai] CHA Univ, Dept Cardiol, Bundang Med Ctr, Seongnam, South Korea.
   [Son, Min Ji; Yoo, Seung Min] CHA Univ, Dept Radiol, Bundang Med Ctr, 11 Yatap Ro,65 Beon Gil, Seongnam 13496, South Korea.
   [Lee, Hwa Yeon] Smile Radiol Clin, Seoul, South Korea.
   [White, Charles S.] Univ Maryland, Dept Radiol, Baltimore, MD 21201 USA.
RP Yoo, SM (corresponding author), CHA Univ, Dept Radiol, Bundang Med Ctr, 11 Yatap Ro,65 Beon Gil, Seongnam 13496, South Korea.
EM smyoo@cha.ac.kr
OI Yoo, Seung Min/0000-0002-1990-8145
CR Del Trigo M, 2012, CIRCULATION, V125, P390, DOI 10.1161/CIRCULATIONAHA.111.051508
   Elieson M, 2012, TEX HEART I J, V39, P884
   Reddy K V C, 2018, J CARDIOL CASES, V19, P5
NR 3
TC 0
Z9 0
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAR
PY 2021
VL 51
IS 3
BP 281
EP 282
DI 10.4070/kcj.2020.0469
PG 2
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA QQ1NI
UT WOS:000624292700011
PM 33655729
OA Green Published
DA 2021-04-22
ER

PT J
AU Kadoya, Y
   Zen, K
   Fukai, K
   Matsubayashi, K
   Yamano, M
   Yamano, T
   Nakamura, T
   Matoba, S
AF Kadoya, Yoshito
   Zen, Kan
   Fukai, Kuniyoshi
   Matsubayashi, Keiji
   Yamano, Michiyo
   Yamano, Tetsuhiro
   Nakamura, Takeshi
   Matoba, Satoaki
TI Recurrent Infective Endocarditis Following Transcatheter Edge-to-Edge
   Mitral Valve Repair with MitraClip System
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
C1 [Kadoya, Yoshito; Zen, Kan; Yamano, Michiyo; Yamano, Tetsuhiro; Nakamura, Takeshi; Matoba, Satoaki] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Cardiovasc Med, Kyoto, Japan.
   [Fukai, Kuniyoshi] Omihachiman Community Med Ctr, Dept Cardiovasc Med, Omihachiman, Shiga, Japan.
   [Matsubayashi, Keiji] Omihachiman Community Med Ctr, Dept Cardiovasc Surg, Omihachiman, Shiga, Japan.
RP Kadoya, Y (corresponding author), Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Cardiovasc Med, Kamigyo Ku, 465 Kajii Cho, Kyoto 6028566, Japan.
EM m03020kdy@gmail.com
OI Kadoya, Yoshito/0000-0001-8333-2219
CR Asmarats L, 2018, CATHETER CARDIO INTE, V92, P583, DOI 10.1002/ccd.27632
   Weiss E, 2017, STRUCT HEART, V1, P293, DOI [10.1080/ 24748706.2017. 1372650, DOI 10.1080/24748706.2017.1372650]
NR 2
TC 0
Z9 0
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAR
PY 2021
VL 51
IS 3
BP 283
EP 285
DI 10.4070/kcj.2020.0502
PG 3
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA QQ1NI
UT WOS:000624292700012
PM 33655730
OA Green Published
DA 2021-04-22
ER

PT J
AU Lee, HY
   Lim, S
   Park, S
AF Lee, Hae-Young
   Lim, Soyeon
   Park, Sungha
TI Role of Inflammation in Arterial Calcification (vol 51, pg 114, 2021)
SO KOREAN CIRCULATION JOURNAL
LA English
DT Correction
C1 [Lee, Hae-Young] Seoul Natl Univ Hosp, Dept Internal Med, Seoul, South Korea.
   [Lee, Hae-Young] Seoul Natl Univ Hosp, Cardiovasc Ctr, Seoul, South Korea.
   [Lim, Soyeon] Catholic Kwandong Univ, Inst Biomed Convergence, Coll Med, Kangnung, South Korea.
   [Park, Sungha] Yonsei Univ, Coll Med, Severance Cardiovasc Hosp, Div Cardiol, Seoul, South Korea.
   [Park, Sungha] Yonsei Univ, Coll Med, Integrat Res Ctr Cerebrovasc & Cardiovasc Dis, Seoul, South Korea.
RP Lee, HY (corresponding author), Seoul Natl Univ Hosp, Dept Internal Med, Seoul, South Korea.; Lee, HY (corresponding author), Seoul Natl Univ Hosp, Cardiovasc Ctr, Seoul, South Korea.
OI Lee, Hae-Young/0000-0002-9521-4102
CR Lee HY, 2021, KOREAN CIRC J, V51, P286, DOI 10.4070/kcj.2021.0999
NR 1
TC 1
Z9 1
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAR
PY 2021
VL 51
IS 3
BP 286
EP 287
DI 10.4070/kcj.2021.0999
PG 2
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA QQ1NI
UT WOS:000624292700013
PM 33655731
OA Green Published
DA 2021-04-22
ER

PT J
AU Bui, TVA
   Hwang, JW
   Lee, JH
   Park, HJ
   Ban, K
AF Thi Van Anh Bui
   Hwang, Ji-Won
   Lee, Jung-Hoon
   Park, Hun-Jun
   Ban, Kiwon
TI Challenges and Limitations of Strategies to Promote Therapeutic
   Potential of Human Mesenchymal Stem Cells for Cell-Based Cardiac Repair
SO KOREAN CIRCULATION JOURNAL
LA English
DT Review
DE Heart failure; Human mesenchymal stem cells; Cell priming; Therapeutic
   potential
ID LEFT-VENTRICULAR FUNCTION; HEPATOCYTE GROWTH-FACTOR; IN-VITRO;
   ISCHEMIC-HEART; STROMAL CELLS; INDOLEAMINE 2,3-DIOXYGENASE;
   DIFFERENTIATION CAPACITY; MYOCARDIAL-INFARCTION; OXIDATIVE STRESS;
   MIGRATION
AB Mesenchymal stem cells (MSCs) represent a population of adult stem cells residing in many tissues, mainly bone marrow, adipose tissue, and umbilical cord. Due to the safety and availability of standard procedures and protocols for isolation, culturing, and characterization of these cells, MSCs have emerged as one of the most promising sources for cell-based cardiac regenerative therapy. Once transplanted into a damaged heart, MSCs release paracrine factors that nurture the injured area, prevent further adverse cardiac remodeling, and mediate tissue repair along with vasculature. Numerous preclinical studies applying MSCs have provided significant benefits following myocardial infarction. Despite promising results from preclinical studies using animal models, MSCs are not up to the mark for human clinical trials. As a result, various approaches have been considered to promote the therapeutic potency of MSCs, such as genetic engineering, physical treatments, growth factor, and pharmacological agents. Each strategy has targeted one or multi-potentials of MSCs. In this review, we will describe diverse approaches that have been developed to promote the therapeutic potential of MSCs for cardiac regenerative therapy. Particularly, we will discuss major characteristics of individual strategy to enhance therapeutic efficacy of MSCs including scientific principles, advantages, limitations, and improving factors. This article also will briefly introduce recent novel approaches that MSCs enhanced therapeutic potentials of other cells for cardiac repair.
C1 [Thi Van Anh Bui; Ban, Kiwon] City Univ Hong Kong, Dept Biomed Sci, Kowloon, 83 Tat Chee Ave, Hong Kong, Peoples R China.
   [Hwang, Ji-Won; Park, Hun-Jun] Catholic Univ Korea, Dept Biomed & Hlth Sci, Seoul, South Korea.
   [Hwang, Ji-Won; Park, Hun-Jun] Catholic Univ Korea, Dept Internal Med, Div Cardiol, Seoul St Marys Hosp, 222 Banpo Daero, Seoul 06591, South Korea.
   [Lee, Jung-Hoon] City Univ Hong Kong, Dept Chem, Hong Kong, Peoples R China.
   [Park, Hun-Jun] Catholic Univ Korea, Coll Med, Cell Death Dis Res Ctr, Seoul, South Korea.
RP Ban, K (corresponding author), City Univ Hong Kong, Dept Biomed Sci, Kowloon, 83 Tat Chee Ave, Hong Kong, Peoples R China.; Park, HJ (corresponding author), Catholic Univ Korea, Dept Internal Med, Div Cardiol, Seoul St Marys Hosp, 222 Banpo Daero, Seoul 06591, South Korea.
EM cardioman@catholic.ac.kr; kiwonban@cityu.edu.hk
OI BAN, KIWON/0000-0003-0805-5439; BUI, Thi Van Anh/0000-0002-4423-5990;
   Hwang, Ji-Won/0000-0001-9922-364X
FU Hong Kong Research Grants CouncilHong Kong Research Grants Council
   [21100818]; NRF - Ministry of Education [2017M3A9B3061954]
FX This paper was supported by the Hong Kong Research Grants Council
   (21100818 to K.B.). This paper was also supported by the NRF funded by
   the Ministry of Education (2017M3A9B3061954).
CR Anastasiadis K, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-12
   Bhatti FU, 2017, OSTEOARTHR CARTILAGE, V25, P321, DOI 10.1016/j.joca.2016.09.014
   Chacko SM, 2010, AM J PHYSIOL-CELL PH, V299, pC1562, DOI 10.1152/ajpcell.00221.2010
   Chamberlain G, 2007, STEM CELLS, V25, P2739, DOI 10.1634/stemcells.2007-0197
   Chen SL, 2004, AM J CARDIOL, V94, P92, DOI 10.1016/j.amjcard.2004.03.034
   Chinnadurai R, 2014, J IMMUNOL, V192, P1491, DOI 10.4049/jimmunol.1301828
   Ciocci M, 2018, INT J BIOL MACROMOL, V108, P960, DOI 10.1016/j.ijbiomac.2017.11.013
   Cunningham CJ, 2018, J CEREBR BLOOD F MET, V38, P1276, DOI 10.1177/0271678X18776802
   Davani S, 2003, CIRCULATION, V108, P253, DOI 10.1161/01.cir.0000089186.09692.fa
   De Becker A, 2016, WORLD J STEM CELLS, V8, P73, DOI 10.4252/wjsc.v8.i3.73
   Estrada JC, 2012, CELL DEATH DIFFER, V19, P743, DOI 10.1038/cdd.2011.172
   Fehrer C, 2007, AGING CELL, V6, P745, DOI 10.1111/j.1474-9726.2007.00336.x
   Fierro FA, 2015, FRONT CELL DEV BIOL, V3, DOI 10.3389/fcell.2015.00068
   Florea V, 2017, CIRC RES, V121, P1279, DOI 10.1161/CIRCRESAHA.117.311827
   Francois M, 2012, MOL THER, V20, P187, DOI 10.1038/mt.2011.189
   FRIEDENSTEIN AJ, 1976, EXP HEMATOL, V4, P267
   Fujisawa K, 2018, STEM CELLS, V36, P1226, DOI 10.1002/stem.2826
   Gauthaman K, 2010, STEM CELL REV REP, V6, P86, DOI [10.1007/s12015-010-9166-x, 10.1007/s12015-009-9107-8]
   Ghiroldi A, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19103194
   Gnecchi M, 2005, NAT MED, V11, P367, DOI 10.1038/nm0405-367
   Gonzalez YIR, 2016, CYTOTHERAPY, V18, P1114, DOI 10.1016/j.jcyt.2016.05.017
   Gorin C, 2016, STEM CELL TRANSL MED, V5, P392, DOI 10.5966/sctm.2015-0166
   Grayson WL, 2004, BIOTECHNOL PROGR, V20, P905, DOI 10.1021/bp034296z
   Guijarro D, 2016, INT J CARDIOL, V209, P258, DOI 10.1016/j.ijcard.2016.02.016
   Guo YJ, 2020, CELL DEATH DIS, V11, DOI 10.1038/s41419-020-2542-9
   Gyongyosi M, 2015, CIRC RES, V116, P1346, DOI 10.1161/CIRCRESAHA.116.304346
   Hafizi M, 2015, STEM CELL RES THER, V6, DOI 10.1186/s13287-015-0216-9
   Hahn JY, 2008, J AM COLL CARDIOL, V51, P933, DOI 10.1016/j.jacc.2007.11.040
   Han YS, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.310
   Herrmann JL, 2010, SHOCK, V33, P24, DOI 10.1097/SHK.0b013e3181b7d137
   Hu CX, 2018, J CELL MOL MED, V22, P1428, DOI 10.1111/jcmm.13492
   Hu XY, 2008, J THORAC CARDIOV SUR, V135, P799, DOI 10.1016/j.jtcvs.2007.07.071
   Hu XY, 2016, CIRC RES, V118, P970, DOI 10.1161/CIRCRESAHA.115.307516
   Hu XY, 2011, AM J PHYSIOL-CELL PH, V301, pC362, DOI 10.1152/ajpcell.00013.2010
   Huang J, 2010, CIRC RES, V106, P1753, DOI 10.1161/CIRCRESAHA.109.196030
   Jiang SJ, 2006, CIRC RES, V99, P776, DOI 10.1161/01.RES.0000244687.97719.4f
   Jiang YQ, 2018, MOL CELLS, V41, P613, DOI 10.14348/molcells.2018.0143
   Jiang YB, 2011, CHINESE MED J-PEKING, V124, P401, DOI 10.3760/cma.j.issn.0366-6999.2011.03.015
   Karantalis V, 2014, CIRC RES, V114, P1302, DOI 10.1161/CIRCRESAHA.114.303180
   Kim J, 2015, PHARMACOL THERAPEUT, V151, P8, DOI 10.1016/j.pharmthera.2015.02.003
   Kim KJ, 2015, INT J NANOMED, V10, P2261, DOI 10.2147/IJN.S71925
   Korf-Klingebiel M, 2008, EUR HEART J, V29, P2851, DOI 10.1093/eurheartj/ehn456
   Krampera M, 2006, STEM CELLS, V24, P386, DOI 10.1634/stemcells.2005-0008
   Laflamme MA, 2011, NATURE, V473, P326, DOI 10.1038/nature10147
   Lazar-Karsten P, 2011, VOX SANG, V101, P65, DOI 10.1111/j.1423-0410.2010.01453.x
   Lee J, 2016, NUTR RES, V36, P925, DOI 10.1016/j.nutres.2016.06.010
   Lee JW, 2014, J KOREAN MED SCI, V29, P23, DOI 10.3346/jkms.2014.29.1.23
   Li MC, 2012, EUR J PHARMACOL, V696, P203, DOI 10.1016/j.ejphar.2012.09.033
   Li WZ, 2007, STEM CELLS, V25, P2118, DOI 10.1634/stemcells.2006-0771
   Li XK, 2015, PROTEIN CELL, V6, P735, DOI 10.1007/s13238-015-0196-7
   Li ZD, 2017, CLIN HEMORHEOL MICRO, V67, P267, DOI 10.3233/CH-179208
   Liang TZ, 2017, FEBS OPEN BIO, V7, P1722, DOI 10.1002/2211-5463.12317
   Liao SY, 2019, STEM CELL RES THER, V10, DOI 10.1186/s13287-019-1183-3
   Liu LQ, 2013, CELL BIOL INT, V37, P551, DOI 10.1002/cbin.10097
   Liu XL, 2011, PROTEIN CELL, V2, P845, DOI 10.1007/s13238-011-1097-z
   Liu XB, 2014, STEM CELL RES THER, V5, DOI 10.1186/scrt446
   Maia FR, 2014, ACTA BIOMATER, V10, P3197, DOI 10.1016/j.actbio.2014.02.049
   Mangi AA, 2003, NAT MED, V9, P1195, DOI 10.1038/nm912
   Mathiasen AB, 2015, EUR HEART J, V36, P1744, DOI 10.1093/eurheartj/ehv136
   Matsui T, 2001, CIRCULATION, V104, P330
   Menasche P, 2016, CURR RES TRANSL MED, V64, P97, DOI 10.1016/j.retram.2016.04.003
   Mirotsou M, 2007, P NATL ACAD SCI USA, V104, P1643, DOI 10.1073/pnas.0610024104
   Miteva K, 2017, STEM CELL TRANSL MED, V6, P1249, DOI 10.1002/sctm.16-0353
   Miyagawa S, 2016, CURR GENE THER, V16, P5, DOI 10.2174/1566523216666160119094143
   Moloney TC, 2012, PROTEIN SCI, V21, P904, DOI 10.1002/pro.2077
   Morgan JE, 2003, INT J BIOCHEM CELL B, V35, P1151, DOI 10.1016/S1357-2725(03)00042-6
   Muller-Ehmsen J, 2002, J MOL CELL CARDIOL, V34, P107, DOI 10.1006/jmcc.2001.1491
   Noronha NCND, 2019, STEM CELL RES THER, V10, DOI 10.1186/s13287-019-1224-y
   Najafi R, 2013, EXPERT OPIN BIOL TH, V13, P959, DOI 10.1517/14712598.2013.782390
   Nakamura T, 2010, P JPN ACAD B-PHYS, V86, P588, DOI 10.2183/pjab.86.588
   Noiseux N, 2006, MOL THER, V14, P840, DOI 10.1016/j.ymthe.2006.05.016
   Noiseux N, 2012, ENDOCRINOLOGY, V153, P5361, DOI 10.1210/en.2012-1402
   Numasawa Y, 2011, STEM CELLS, V29, P1405, DOI 10.1002/stem.691
   Pandey AC, 2017, STEM CELLS INT, V2017, DOI 10.1155/2017/9640108
   Park BW, 2020, SCI ADV, V6, DOI 10.1126/sciadv.aay6994
   Park SJ, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11091-2
   Peyvandi A, 2018, CELL PROLIFERAT, V51, DOI 10.1111/cpr.12434
   Pittenger MF, 2004, CIRC RES, V95, P9, DOI 10.1161/01.RES.0000135902.99383.6f
   Quevedo HC, 2009, P NATL ACAD SCI USA, V106, P14022, DOI 10.1073/pnas.0903201106
   Redondo-Castro E, 2017, STEM CELL RES THER, V8, DOI 10.1186/s13287-017-0531-4
   Rosova I, 2008, STEM CELLS, V26, P2173, DOI 10.1634/stemcells.2007-1104
   Sart S, 2016, BIOTECHNOL J, V11, P43, DOI 10.1002/biot.201500191
   Shen DL, 2012, J CELL MOL MED, V16, P2112, DOI 10.1111/j.1582-4934.2011.01512.x
   Shujia J, 2008, CARDIOVASC RES, V77, P525, DOI 10.1093/cvr/cvm077
   Singec I, 2008, NAT CELL BIOL, V10, P503, DOI 10.1038/ncb0508-503
   Song LG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065422
   Song SW, 2009, STEM CELLS, V27, P1358, DOI 10.1002/stem.47
   Sun XJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090667
   Sunagawa G, 2016, EXPERT REV MED DEVIC, V13, P191, DOI 10.1586/17434440.2016.1136212
   Takamiya R, 2009, AM J RESP CELL MOL, V41, P129, DOI 10.1165/rcmb.2008-0331OC
   Tanai E, 2016, COMPR PHYSIOL, V6, P187, DOI 10.1002/cphy.c140055
   Tang YL, 2005, J AM COLL CARDIOL, V46, P1339, DOI 10.1016/j.jacc.2005.05.079
   Tsai AC, 2016, BIOCHEM ENG J, V108, P51, DOI 10.1016/j.bej.2015.09.002
   Tu ZD, 2010, STEM CELLS DEV, V19, P1803, DOI 10.1089/scd.2009.0418
   Urnukhsaikhan E, 2016, LIFE SCI, V151, P130, DOI 10.1016/j.lfs.2016.02.066
   Wahl EA, 2016, SCI REP-UK, V6, DOI 10.1038/srep36879
   Wang JC, 2013, J SURG RES, V183, P509, DOI 10.1016/j.jss.2013.02.051
   Wang Q, 2019, STEM CELL RES THER, V10, DOI 10.1186/s13287-019-1425-4
   Wang S, 2017, J TRANSL MED, V15, DOI 10.1186/s12967-017-1144-5
   Wang X, 2015, THERANOSTICS, V5, P995, DOI 10.7150/thno.11607
   Wang Y, 2009, CELL BIOL INT, V33, P1173, DOI 10.1016/j.cellbi.2009.08.004
   Wickham MQ, 2003, CLIN ORTHOP RELAT R, P196, DOI 10.1097/01.blo.0000072467.53786.ca
   Williams AR, 2011, CIRC RES, V109, P923, DOI 10.1161/CIRCRESAHA.111.243147
   Wisel S, 2009, J PHARMACOL EXP THER, V329, P543, DOI 10.1124/jpet.109.150839
   Wollert KC, 2004, LANCET, V364, P141, DOI 10.1016/S0140-6736(04)16626-9
   Wu L, 2012, TISSUE ENG PT A, V18, P1542, DOI [10.1089/ten.TEA.2011.0715, 10.1089/ten.tea.2011.0715]
   Xiao WT, 2017, INT HEART J, V58, P238, DOI 10.1536/ihj.16-328
   Xu RX, 2009, CLIN EXP PHARMACOL P, V36, P176, DOI 10.1111/j.1440-1681.2008.05041.x
   Yang Y, 2016, STEM CELL RES THER, V7, DOI 10.1186/s13287-016-0313-4
   Yin K, 2017, STEM CELLS DEV, V26, P762, DOI 10.1089/scd.2016.0332
   Yu B, 2015, INT J CARDIOL, V182, P349, DOI 10.1016/j.ijcard.2014.12.043
   Yu H, 2017, BRIT MED BULL, V121, P135, DOI 10.1093/bmb/ldw059
   Yu Y, 2012, STEROIDS, V77, P132, DOI 10.1016/j.steroids.2011.10.017
   Zhang LY, 2016, EXP THER MED, V11, P1853, DOI 10.3892/etm.2016.3120
   Zhao JJ, 2014, MOL MED REP, V10, P1448, DOI 10.3892/mmr.2014.2378
   Zhu ZL, 2015, BIOCHEM BIOPH RES CO, V468, P601, DOI 10.1016/j.bbrc.2015.10.157
NR 116
TC 0
Z9 0
U1 1
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD FEB
PY 2021
VL 51
IS 2
BP 97
EP 113
DI 10.4070/kcj.2020.0518
PG 17
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA QQ1NG
UT WOS:000624292500001
PM 33525065
OA Green Published
DA 2021-04-22
ER

PT J
AU Lee, HY
   Lim, S
   Park, S
AF Lee, Hae Young
   Lim, Soyeon
   Park, Sungha
TI Role of Inflammation in Arterial Calcification
SO KOREAN CIRCULATION JOURNAL
LA English
DT Review
DE Arterial calcification; Pathobiology; Therapeutic strategy; Clinical
   implication
ID ENDOTHELIAL-MESENCHYMAL TRANSITION; ACUTE MYOCARDIAL-INFARCTION;
   NECROSIS-FACTOR-ALPHA; SMOOTH-MUSCLE-CELLS; VASCULAR CALCIFICATION;
   CORONARY CALCIFICATION; ALKALINE-PHOSPHATASE; OXIDATIVE STRESS; STATIN
   THERAPY; ATHEROSCLEROSIS
AB Arterial calcification, characterized by calcium phosphate deposition in the arteries, can be divided into intimal calcification and medial calcification. The former is the predominant form of calcification in coronary artery plaques; the latter mostly affects peripheral arteries and aortas. Both forms of arterial calcification have strong correlations with adverse cardiovascular events. Intimal microcalcification is associated with increased risk of plaque disruption while the degree of burden of coronary calcification, measured by coronary calcium score, is a marker of overall plaque burden. Continuous research on vascular calcification has been performed during the past few decades, and several cellular and molecular mechanisms and therapeutic targets were identified. However, despite clinical trials to evaluate the efficacy of drug therapies to treat vascular calcification, none have been shown to have efficacy until the present. Therefore, more extensive research is necessary to develop appropriate therapeutic strategies based on a thorough understanding of vascular calcification. In this review, we mainly focus on intimal calcification, namely the pathobiology of arterial calcification, and its clinical implications.
C1 [Lee, Hae Young] Seoul Natl Univ Hosp, Dept Internal Med, Seoul, South Korea.
   [Lee, Hae Young] Seoul Natl Univ Hosp, Cardiovasc Ctr, Seoul, South Korea.
   [Lim, Soyeon] Catholic Kwandong Univ, Coll Med, Inst Biomed Convergence, Kangnung, South Korea.
   [Park, Sungha] Yonsei Univ, Severance Cardiovasc Hosp, Div Cardiol, Coll Med, Seoul 03722, South Korea.
   [Park, Sungha] Yonsei Univ, Integrat Res Ctr Cerebrovasc & Cardiovasc Dis, Coll Med, Seoul 03722, South Korea.
RP Park, S (corresponding author), Yonsei Univ, Severance Cardiovasc Hosp, Div Cardiol, Coll Med, Seoul 03722, South Korea.; Park, S (corresponding author), Yonsei Univ, Integrat Res Ctr Cerebrovasc & Cardiovasc Dis, Coll Med, Seoul 03722, South Korea.
EM shpark0530@yuhs.ac
OI Lee, Hae-Young/0000-0002-9521-4102
FU Basic Science Research Program through the National Research Foundation
   of Korea (NRF) [NRF-2020R1A2C1007103, 2018R1A1A1A05078230]
FX This work was supported by Basic Science Research Program through the
   National Research Foundation of Korea (NRF), grant number
   NRF-2020R1A2C1007103 (Park S) and 2018R1A1A1A05078230 (Lim S).
CR Abdelbaky A, 2013, CIRC-CARDIOVASC IMAG, V6, P747, DOI 10.1161/CIRCIMAGING.113.000382
   Aengevaeren VL, 2017, CIRCULATION, V136, P138, DOI 10.1161/CIRCULATIONAHA.117.027834
   Aikawa E, 2007, CIRCULATION, V116, P2841, DOI 10.1161/CIRCULATIONAHA.107.732867
   Alesutan I, 2016, CARDIOVASC RES, V110, P408, DOI 10.1093/cvr/cvw062
   Armstrong ZB, 2011, CARDIOVASC RES, V90, P165, DOI 10.1093/cvr/cvq391
   Arnson Y, 2017, AM J CARDIOL, V120, P2154, DOI 10.1016/j.amjcard.2017.09.001
   Atzler D, 2014, ARTERIOSCL THROM VAS, V34, P2501, DOI 10.1161/ATVBAHA.114.304398
   Barrett HE, 2019, J BIOMECH, V87, P1, DOI 10.1016/j.jbiomech.2019.03.005
   Belmokhtar K, 2019, NEPHROL DIAL TRANSPL, V34, P2018, DOI 10.1093/ndt/gfz012
   Blacher J, 2001, HYPERTENSION, V38, P938, DOI 10.1161/hy1001.096358
   Chen NX, 2015, CURR OSTEOPOROS REP, V13, P372, DOI 10.1007/s11914-015-0293-9
   Cho HJ, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001534
   COLLIN P, 1992, CALCIFIED TISSUE INT, V50, P175, DOI 10.1007/BF00298797
   Cozzolino M, 2019, TOXINS, V11, DOI 10.3390/toxins11040213
   Csiszar A, 2002, CIRC RES, V90, P1159, DOI 10.1161/01.RES.0000020401.61826.EA
   Demer LL, 2008, CIRCULATION, V117, P2938, DOI 10.1161/CIRCULATIONAHA.107.743161
   Demer LL, 2019, TRENDS ENDOCRIN MET, V30, P646, DOI 10.1016/j.tem.2019.06.001
   Demer LL, 2014, ARTERIOSCL THROM VAS, V34, P715, DOI 10.1161/ATVBAHA.113.302070
   Detrano R, 2008, NEW ENGL J MED, V358, P1336, DOI 10.1056/NEJMoa072100
   Donato AJ, 2007, CIRC RES, V100, P1659, DOI 10.1161/01.RES.0000269183.13937.e8
   Villa JKD, 2017, CRIT REV FOOD SCI, V57, P3959, DOI 10.1080/10408398.2016.1211616
   Durham AL, 2018, CARDIOVASC RES, V114, P590, DOI 10.1093/cvr/cvy010
   Ehara S, 2004, CIRCULATION, V110, P3424, DOI 10.1161/01.CIR.0000148131.41425.E9
   Goldberg RB, 2017, CIRCULATION, V136, P52, DOI 10.1161/CIRCULATIONAHA.116.025483
   Grundy SM, 2019, CIRCULATION, V139, pE1046, DOI 10.1161/CIR.0000000000000624
   Hecht E, 2016, NEPHROL DIAL TRANSPL, V31, P789, DOI 10.1093/ndt/gfv321
   Heiss A, 2003, J BIOL CHEM, V278, P13333, DOI 10.1074/jbc.M210868200
   Henaut L, 2018, ADV CHRONIC KIDNEY D, V25, P281, DOI 10.1053/j.ackd.2017.12.001
   Henein M, 2015, INT J CARDIOL, V184, P581, DOI 10.1016/j.ijcard.2015.02.072
   Heymes C, 1998, ENDOCRINOLOGY, V139, P2579, DOI 10.1210/en.139.5.2579
   Hruska KA, 2005, CIRC RES, V97, P105, DOI 10.1161/01.RES.00000175571.53833.6c
   Hutcheson JD, 2016, NAT MATER, V15, P335, DOI 10.1038/nmat4519
   Jeong HS, 2019, KOREAN CIRC J, V49, P434, DOI 10.4070/kcj.2019.0045
   Kanno Y, 2008, CARDIOVASC RES, V77, P221, DOI 10.1093/cvr/cvm049
   Kassimis G, 2020, ANGIOLOGY, V71, P677, DOI 10.1177/0003319720932455
   Kim I, 2019, KOREAN CIRC J, V49, P615, DOI 10.4070/kcj.2018.0379
   Kim NG, 2015, J CELL BIOL, V210, P503, DOI 10.1083/jcb.201501025
   Lee KY, 2019, KOREAN CIRC J, V49, P1115, DOI 10.4070/kcj.2019.0211
   Lee SJ, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21082685
   Leszczynska A, 2018, FRONT BIOENG BIOTECH, V6, DOI 10.3389/fbioe.2018.00010
   Libby P, 2017, J AM COLL CARDIOL, V70, P2278, DOI 10.1016/j.jacc.2017.09.028
   Lin X, 2019, AGING-US, V11, P523, DOI 10.18632/aging.101758
   Liu H, 2019, HUM GENOMICS, V13, DOI 10.1186/s40246-019-0245-z
   Lomashvili K, 2006, KIDNEY INT, V69, P1464, DOI 10.1038/sj.ki.5000297
   Lutgens E, 2006, CIRCULATION, V113, P98, DOI 10.1161/CIRCULATIONAHA.105.561449
   Ma WQ, 2019, MOL CELL ENDOCRINOL, V479, P39, DOI 10.1016/j.mce.2018.08.012
   Madhavan MV, 2014, J AM COLL CARDIOL, V63, P1703, DOI 10.1016/j.jacc.2014.01.017
   Medici D, 2011, BIOCHEM J, V437, P515, DOI 10.1042/BJ20101500
   Menini S, 2013, CARDIOVASC RES, V100, P472, DOI 10.1093/cvr/cvt206
   Min LJ, 2009, AGEING RES REV, V8, P113, DOI 10.1016/j.arr.2008.12.002
   Moali C, 1998, BIOCHEMISTRY-US, V37, P10453, DOI 10.1021/bi980742t
   Mori H, 2018, JACC-CARDIOVASC IMAG, V11, P127, DOI 10.1016/j.jcmg.2017.10.012
   Motro M, 2001, HYPERTENSION, V37, P1410, DOI 10.1161/01.HYP.37.6.1410
   Motro M, 2007, CARDIOLOGY, V107, P165, DOI 10.1159/000095308
   Nik AB, 2017, FRONT CARDIOVASC MED, V4, DOI 10.3389/fcvm.2017.00078
   Olauson H, 2014, SEMIN NEPHROL, V34, P586, DOI 10.1016/j.semnephrol.2014.09.005
   Orakzai SH, 2009, ATHEROSCLEROSIS, V202, P289, DOI 10.1016/j.atherosclerosis.2008.03.014
   Parhami F, 2002, CIRC RES, V91, P570, DOI 10.1161/01.RES.0000036607.05037.DA
   Puri R, 2015, J AM COLL CARDIOL, V65, P1273, DOI 10.1016/j.jacc.2015.01.036
   Rhee FJ, 2019, KOREAN J INTERN MED, V34, P723, DOI 10.3904/kjim.2019.188
   Riphagen IJ, 2017, NUTRIENTS, V9, DOI 10.3390/nu9121334
   Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207
   Sandberg WJ, 2006, ARTERIOSCL THROM VAS, V26, P857, DOI 10.1161/01.ATV.0000204334.48195.6a
   Sangiorgi G, 1998, J AM COLL CARDIOL, V31, P126, DOI 10.1016/S0735-1097(97)00443-9
   Sata M, 2002, NAT MED, V8, P403, DOI 10.1038/nm0402-403
   Schwartz Robert S, 2014, Mo Med, V111, P89
   Shantouf RS, 2010, AM J NEPHROL, V31, P419, DOI 10.1159/000294405
   Shimomura A, 2014, J AM SOC NEPHROL, V25, P1954, DOI 10.1681/ASN.2013090967
   Shioi A, 2002, CIRC RES, V91, P9, DOI 10.1161/01.RES.0000026421.61398.F2
   Sun Y, 2012, CIRC RES, V111, P543, DOI 10.1161/CIRCRESAHA.112.267237
   Tantisattamo E, 2015, ARTERIOSCL THROM VAS, V35, P237, DOI 10.1161/ATVBAHA.114.304392
   Tyson KL, 2003, ARTERIOSCL THROM VAS, V23, P489, DOI 10.1161/01.ATV.0000059406.92165.31
   Tzanakis IP, 2014, INT UROL NEPHROL, V46, P2199, DOI 10.1007/s11255-014-0751-9
   Van den Bergh G, 2019, TRENDS MOL MED, V25, P1133, DOI 10.1016/j.molmed.2019.08.006
   van der Loo B, 2000, J EXP MED, V192, P1731, DOI 10.1084/jem.192.12.1731
   Wang MY, 2010, CURR OPIN NEPHROL HY, V19, P201, DOI 10.1097/MNH.0b013e3283361c0b
   WATSON KE, 1994, J CLIN INVEST, V93, P2106, DOI 10.1172/JCI117205
   Yao JY, 2015, CIRC RES, V117, P758, DOI 10.1161/CIRCRESAHA.115.306751
   Yeoh J, 2019, CATHETER CARDIO INTE, V93, P1295, DOI 10.1002/ccd.28165
   Yin TT, 2000, CIRCULATION, V102, P2636, DOI 10.1161/01.cir.102.21.2636
   Zhang X, 2017, J LIPID RES, V58, P895, DOI 10.1194/jlr.M074112
   Zhu DM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018291
   Zieman SJ, 2005, ARTERIOSCL THROM VAS, V25, P932, DOI 10.1161/01.ATV.0000160548.78317.29
NR 83
TC 0
Z9 0
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD FEB
PY 2021
VL 51
IS 2
BP 114
EP 125
DI 10.4070/kcj.2020.0517
PG 12
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA QQ1NG
UT WOS:000624292500002
PM 33525066
OA Green Published
DA 2021-04-22
ER

PT J
AU Dai, N
   Hwang, D
   Lee, JM
   Zhang, J
   Tong, YL
   Jeon, KH
   Paeng, JC
   Cheon, GJ
   Koo, BK
   Ge, JB
AF Dai, Neng
   Hwang, Doyeon
   Lee, Joo Myung
   Zhang, Jinlong
   Tong, Yaliang
   Jeon, Ki-Hyun
   Paeng, Jin Chul
   Cheon, Gi Jeong
   Koo, Bon-Kwon
   Ge, Junbo
TI Association of Quantitative Flow Ratio with Lesion Severity and Its
   Ability to Discriminate Myocardial Ischemia
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Coronary artery disease; Myocardial ischemia; Positron emission
   tomography
ID INVASIVE PHYSIOLOGICAL INDEXES; CORONARY-ANGIOGRAPHY;
   DIAGNOSTIC-ACCURACY; STENOSIS SEVERITY; BLOOD-FLOW; RESERVE; VALIDATION;
   ANATOMY
AB Background and Objectives: Quantitative flow ratio (QFR) is an angiography-based technique for functional assessment of coronary artery stenosis. This study investigated the response of QFR to different degree of stenosis severity and its ability to predict the positron emission tomography (PET)-defined myocardial ischemia.
   Methods: From 109 patients with 185 vessels who underwent both N-13-ammonia PET and invasive physiological measurement, we compared QFR, fractional flow reserve (FFR) and instantaneous wave-free ratio (iFR) for the responses to the different degree of anatomical (percent diameter stenosis [%DS]) and hemodynamic (relative flow reserve [RFR], coronary flow reserve, hyperemic stenosis resistance, and stress myocardial flow) stenosis severity and diagnostic performance against PET-derived parameters.
   Results: QFR, FFR, and iFR showed similar responses to both anatomic and hemodynamic stenosis severity. Regarding RFR, the diagnostic accuracy of QFR was lower than FFR (76.2% vs. 83.2%, p=0.021) and iFR (76.2% vs. 84.3%, p=0.031). For coronary flow capacity (CFC), QFR showed a lower accuracy than iFR (74.1% vs. 82%, p=0.031) and lower discriminant function than FFR (area under curve: 0.74 vs. 0.79, p=0.044). Discordance between QFR and FFR or iFR was shown in 14.6% of cases and was driven by the difference in %DS and heterogeneous distribution of PET-derived RFR and stress myocardial blood flow.
   Conclusions: QFR demonstrated a similar response to different anatomic and hemodynamic stenosis severity as FFR or iFR. However, its diagnostic performance was inferior to FFR and iFR when PET-derived RFR and CFC were used as a reference.
C1 [Dai, Neng; Ge, Junbo] Fudan Univ, Zhongshan Hosp, Shanghai Inst Cardiovasc Dis, Dept Cardiol, Shanghai, Peoples R China.
   [Hwang, Doyeon; Zhang, Jinlong; Koo, Bon-Kwon] Seoul Natl Univ Hosp, Dept Internal Med, 101 Daehak Ro, Seoul 03080, South Korea.
   [Hwang, Doyeon; Zhang, Jinlong; Koo, Bon-Kwon] Seoul Natl Univ Hosp, Cardiovasc Ctr, 101 Daehak Ro, Seoul 03080, South Korea.
   [Lee, Joo Myung] Sungkyunkwan Univ, Samsung Med Ctr, Heart Vasc Stroke Inst, Dept Internal Med,Sch Med,Div Cardiol, Seoul, South Korea.
   [Tong, Yaliang] Jilin Univ, Dept Cardiol, China Japan Union Hosp, Jilin, Jilin, Peoples R China.
   [Jeon, Ki-Hyun] Sejong Gen Hosp, Dept Internal Med, Bucheon, Peoples R China.
   [Paeng, Jin Chul; Cheon, Gi Jeong] Seoul Natl Univ Hosp, Dept Nucl Med, Seoul, South Korea.
   [Koo, Bon-Kwon] Seoul Natl Univ, Inst Aging, Seoul, South Korea.
RP Koo, BK (corresponding author), Seoul Natl Univ Hosp, Dept Internal Med, 101 Daehak Ro, Seoul 03080, South Korea.; Koo, BK (corresponding author), Seoul Natl Univ Hosp, Cardiovasc Ctr, 101 Daehak Ro, Seoul 03080, South Korea.
EM bkkoo@snu.ac.kr
OI JEON, KI HYUN/0000-0002-6277-7697; Lee, Joo Myung/0000-0002-2178-4014
FU National Natural Science Foundation of ChinaNational Natural Science
   Foundation of China (NSFC) [81600279]; China Postdoctoral Science
   FoundationChina Postdoctoral Science Foundation [2019M650075]
FX Dr. Neng Dai acknowledges support by project 81600279 from the National
   Natural Science Foundation of China and project 2019M650075 from China
   Postdoctoral Science Foundation.
CR Adjedj J, 2017, CIRC-CARDIOVASC IMAG, V10, DOI 10.1161/CIRCIMAGING.117.006243
   Chu M, 2017, INT J CARDIOVAS IMAG, V33, P975, DOI 10.1007/s10554-017-1085-3
   Collet C, 2018, EUR HEART J, V39, P3314, DOI 10.1093/eurheartj/ehy445
   Dehmer GJ, 2012, J AM COLL CARDIOL, V60, P2017, DOI 10.1016/j.jacc.2012.08.966
   DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595
   Emori H, 2018, CORONARY ARTERY DIS, V29, P611, DOI 10.1097/MCA.0000000000000650
   Gould KL, 2013, J AM COLL CARDIOL, V62, P1639, DOI 10.1016/j.jacc.2013.07.076
   Hajjiri MM, 2009, JACC-CARDIOVASC IMAG, V2, P751, DOI 10.1016/j.jcmg.2009.04.004
   Hwang D, 2019, J AM HEART ASSOC, V8, DOI 10.1161/JAHA.118.011605
   Hwang D, 2017, JACC-CARDIOVASC INTE, V10, P751, DOI 10.1016/j.jcin.2016.12.015
   Johnson NP, 2018, JACC-CARDIOVASC INTE, V11, P1492, DOI 10.1016/j.jcin.2018.05.021
   Johnson NP, 2013, CIRC-CARDIOVASC IMAG, V6, P817, DOI 10.1161/CIRCIMAGING.113.000373
   Johnson NP, 2012, JACC-CARDIOVASC IMAG, V5, P430, DOI 10.1016/j.jcmg.2011.12.014
   Johnson NP, 2012, JACC-CARDIOVASC IMAG, V5, P193, DOI 10.1016/j.jcmg.2011.09.020
   Lee HS, 2019, CARDIOL J, V26, P215, DOI 10.5603/CJ.a2019.0054
   Lee Jae Meen, 2016, Korean J Spine, V13, P9, DOI 10.14245/kjs.2016.13.1.9
   Lee JM, 2017, CIRCULATION, V136, P1798, DOI 10.1161/CIRCULATIONAHA.117.029911
   Mejia-Renteria H, 2018, JACC-CARDIOVASC INTE, V11, P741, DOI 10.1016/j.jcin.2018.02.014
   Neumann FJ, 2019, EUR HEART J, V40, P79, DOI 10.1093/eurheartj/ehy855
   Sen S, 2012, J AM COLL CARDIOL, V59, P1392, DOI 10.1016/j.jacc.2011.11.003
   Stuijfzand WJ, 2015, CIRC-CARDIOVASC IMAG, V8, DOI 10.1161/CIRCIMAGING.114.002400
   Tahari AK, 2014, EUR J NUCL MED MOL I, V41, P126, DOI 10.1007/s00259-013-2537-1
   Toth G, 2014, EUR HEART J, V35, P2831, DOI 10.1093/eurheartj/ehu094
   Toth GG, 2014, CIRC-CARDIOVASC INTE, V7, P751, DOI 10.1161/CIRCINTERVENTIONS.114.001608
   Tu SX, 2016, JACC-CARDIOVASC INTE, V9, P2024, DOI 10.1016/j.jcin.2016.07.013
   Tu SX, 2014, JACC-CARDIOVASC INTE, V7, P768, DOI 10.1016/j.jcin.2014.03.004
   Westra J, 2018, J AM HEART ASSOC, V7, DOI 10.1161/JAHA.118.009603
   Westra J, 2018, CIRC-CARDIOVASC IMAG, V11, DOI 10.1161/CIRCIMAGING.117.007107
   Xu B, 2017, J AM COLL CARDIOL, V70, P3077, DOI 10.1016/j.jacc.2017.10.035
NR 29
TC 1
Z9 1
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD FEB
PY 2021
VL 51
IS 2
BP 126
EP 139
DI 10.4070/kcj.2020.0375
PG 14
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA QQ1NG
UT WOS:000624292500003
PM 33525067
OA Green Published
DA 2021-04-22
ER

PT J
AU Cho, YK
   Nam, CW
AF Cho, Yun-Kyeong
   Nam, Chang-Wook
TI Would a Noninvasive Coronary Physiology Become a Standard and Popular
   Approach?
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
ID FRACTIONAL FLOW RESERVE; DIAGNOSTIC-ACCURACY; ANGIOGRAPHY; RATIO
C1 [Cho, Yun-Kyeong; Nam, Chang-Wook] Keimyung Univ, Dongsan Hosp, Dept Cardiol, 1035 Dalgubeol Daero, Daegu 42601, South Korea.
RP Nam, CW (corresponding author), Keimyung Univ, Dongsan Hosp, Dept Cardiol, 1035 Dalgubeol Daero, Daegu 42601, South Korea.
EM ncwcv@dsmc.or.kr
OI Nam, Chang-Wook/0000-0002-3370-5774
CR Cho YK, 2018, KOREAN J INTERN MED, V33, P851, DOI 10.3904/kjim.2018.006
   Cho YK, 2015, EUROINTERVENTION, V11, P163, DOI 10.4244/EIJV11I2A30
   Dai N, 2021, KOREAN CIRC J, V51, P126, DOI 10.4070/kcj.2020.0375
   Gotberg M, 2017, NEW ENGL J MED, V376, P1813, DOI 10.1056/NEJMoa1616540
   Hwang D, 2017, JACC-CARDIOVASC INTE, V10, P751, DOI 10.1016/j.jcin.2016.12.015
   Kim JH, 2019, KOREAN CIRC J, V49, P1022, DOI 10.4070/kcj.2019.0074
   Lee JM, 2020, KOREAN CIRC J, V50, P890, DOI 10.4070/kcj.2020.0083
   Nam CW, 2010, JACC-CARDIOVASC INTE, V3, P812, DOI 10.1016/j.jcin.2010.04.016
   Tu SX, 2016, JACC-CARDIOVASC INTE, V9, P2024, DOI 10.1016/j.jcin.2016.07.013
   Xu B, 2017, J AM COLL CARDIOL, V70, P3077, DOI 10.1016/j.jacc.2017.10.035
NR 10
TC 0
Z9 0
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD FEB
PY 2021
VL 51
IS 2
BP 140
EP 142
DI 10.4070/kcj.2020.0511
PG 3
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA QQ1NG
UT WOS:000624292500004
PM 33525068
OA Green Published
DA 2021-04-22
ER

PT J
AU Do, U
   Kim, J
   Kim, M
   Cho, MS
   Nam, GB
   Choi, KJ
   Kim, YH
AF Do, Ungjeong
   Kim, Jun
   Kim, Minsoo
   Cho, Min Soo
   Nam, Gi-Byoung
   Choi, Kee-Joon
   Kim, You-Ho
TI Esophageal Thermal Injury after Catheter Ablation for Atrial
   Fibrillation with High-Power (50 Watts) Radiofrequency Energy
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Atrial fibrillation; Complications; Endoscopy; Esophagus; Radiofrequency
   catheter ablation
ID PULMONARY VEIN ISOLATION; SHORT-DURATION; OUTCOMES; RISK; SAFE
AB Background and Objectives: Data regarding the safety of atrial fibrillation (AF) ablation using high-power (50 W) radiofrequency (RF) energy in Asian populations are limited. This study was conducted to evaluate the incidence and pattern of esophageal injury after high-power AF ablation in an Asian cohort.
   Methods: We searched the prospective AF ablation registry to identify patients who underwent AF ablation with 50 W RF energy using the smart touch surround flow catheter (Biosense Webster, Diamond Bar, CA, USA). Visitag (TM) (Biosense Webster) was used for lesion annotation with predefined settings of catheter stability (3 mm for 5 seconds) and minimum contact force (50% of time >5 g). All patients underwent upper gastrointestinal endoscopy at 1 or 3 days after the ablation.
   Results: A total of 159 patients (mean age: 63 +/- 9 years, male: 69%, paroxysmal AF: 45.3%, persistent AF: 27.7%, long-standing persistent AF: 27.0%) were analyzed. Initially, 26 patients underwent pulmonary vein isolation with 50 W for 5 seconds at each point. The remaining 133 patients underwent prolonged RF duration (anterior 10 seconds and posterior 6 seconds). The incidence rates of esophageal erythema/erosion and superficial ulceration were 1.3% for each type of the lesion. Food stasis, a suggestive finding of gastroparesis, was observed in 25 (15.7%) patients. There were no cases of cardiac tamponade, stroke, or death.
   Conclusions: In Asian patients, AF ablations using 50 W resulted in very low rates of mild esophageal complications.
C1 [Do, Ungjeong; Kim, Jun; Kim, Minsoo; Cho, Min Soo; Nam, Gi-Byoung; Choi, Kee-Joon; Kim, You-Ho] Univ Ulsan, Asan Med Ctr, Div Cardiol, Coll Med, 88 Olymp Ro,43 Gil, Seoul 05505, South Korea.
RP Kim, J (corresponding author), Univ Ulsan, Asan Med Ctr, Div Cardiol, Coll Med, 88 Olymp Ro,43 Gil, Seoul 05505, South Korea.
EM mdjunkim@gmail.com
OI Cho, Min Soo/0000-0001-9867-4991; Do, Ungjeong/0000-0003-0222-0384
FU Boston Scientific CorporationBoston Scientific Funding Source: Medline
CR Bhaskaran A, 2017, EUROPACE, V19, P874, DOI 10.1093/europace/euw077
   Black-Maier E, 2017, HEART RHYTHM, V14, P1328, DOI 10.1016/j.hrthm.2017.04.024
   Bunch TJ, 2008, HEART RHYTHM, V5, P624, DOI 10.1016/j.hrthm.2007.11.007
   Bunch TJ, 2020, HEART RHYTHM, V17, P184, DOI 10.1016/j.hrthm.2019.08.001
   Calkins H, 2017, HEART RHYTHM, V14, pE275, DOI 10.1016/j.hrthm.2017.05.012
   Castrejon-Castrejon S, 2020, J INTERV CARD ELECTR, V57, P57, DOI 10.1007/s10840-019-00645-5
   Chen S, 2020, HEART RHYTHM
   Chen SJ, 2019, J CARDIOVASC ELECTR, DOI 10.1111/jce.14219
   Halbfass P, 2019, J CARDIOVASC ELECTR, V30, P2256, DOI 10.1111/jce.14193
   Halm U, 2010, AM J GASTROENTEROL, V105, P551, DOI 10.1038/ajg.2009.625
   Han HC, 2017, CIRC-ARRHYTHMIA ELEC, V10, DOI 10.1161/CIRCEP.117.005579
   Hocini M, 2005, CIRCULATION, V112, P3688, DOI 10.1161/CIRCULATIONAHA.105.541052
   Irastorza RM, 2018, J CARDIOVASC ELECTR, V29, P322, DOI 10.1111/jce.13363
   Jais P, 2004, CIRCULATION, V110, P2996, DOI 10.1161/01.CIR.0000146917.75041.58
   Jhuo SJ, 2016, HEART RHYTHM, V13, P1786, DOI 10.1016/j.hrthm.2016.05.020
   Kawaji T, 2017, INT J CARDIOL, V249, P204, DOI 10.1016/j.ijcard.2017.09.023
   Kim YG, 2018, J CARDIOVASC ELECTR, V29, P1343, DOI 10.1111/jce.13671
   Knopp H, 2014, HEART RHYTHM, V11, P574, DOI 10.1016/j.hrthm.2014.01.010
   Kumar Saurabh, 2017, JACC Clin Electrophysiol, V3, P1114, DOI 10.1016/j.jacep.2017.09.001
   Lee JH, 2018, MEDICINE, V97, DOI 10.1097/MD.0000000000013060
   Leite LR, 2011, CIRC-ARRHYTHMIA ELEC, V4, P149, DOI 10.1161/CIRCEP.110.960328
   Leshem E, 2018, JACC-CLIN ELECTROPHY, V4, P467, DOI 10.1016/j.jacep.2017.11.018
   Marrouche NF, 2007, J CARDIOVASC ELECTR, V18, P583, DOI 10.1111/j.1540-8167.2007.00879.x
   Martinek M, 2009, J CARDIOVASC ELECTR, V20, P726, DOI 10.1111/j.1540-8167.2008.01426.x
   Nilsson B, 2006, EUROPACE, V8, P962, DOI 10.1093/europace/eul100
   Schoene K, 2020, EUROPACE, V22, P1487, DOI 10.1093/europace/euaa209
   Winkle RA, 2019, HEART RHYTHM, V16, P165, DOI 10.1016/j.hrthm.2018.11.031
   Winkle RA, 2011, PACE, V34, P531, DOI 10.1111/j.1540-8159.2010.02990.x
   Yarlagadda B, 2019, HEART RHYTHM, V16, P204, DOI 10.1016/j.hrthm.2018.09.027
   Zhang P, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-59539-6
NR 30
TC 1
Z9 1
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD FEB
PY 2021
VL 51
IS 2
BP 143
EP 153
DI 10.4070/kcj.2020.0323
PG 11
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA QQ1NG
UT WOS:000624292500005
PM 33525069
OA Green Published
DA 2021-04-22
ER

PT J
AU Shin, DG
   Lim, HE
AF Shin, Dong Geum
   Lim, Hong Euy
TI Esophageal Endoscopy after High-power and Short-duration Ablation in
   Atrial Fibrillation Patients
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
C1 [Shin, Dong Geum] Hallym Univ, Coll Med, Kangnam Sacred Heart Hosp, Div Cardiol, Seoul, South Korea.
   [Lim, Hong Euy] Hallym Univ, Coll Med, Sacred Heart Hosp, Div Cardiol, 22 Gwanpyeong Ro,170 Beon Gil, Anyang 14068, South Korea.
RP Lim, HE (corresponding author), Hallym Univ, Coll Med, Sacred Heart Hosp, Div Cardiol, 22 Gwanpyeong Ro,170 Beon Gil, Anyang 14068, South Korea.
EM hongeuy1046@gmail.com
OI Lim, Hong Euy/0000-0001-8102-8352
CR Barkagan M, 2018, J CARDIOVASC ELECTR, V29, P1287, DOI 10.1111/jce.13651
   Bunch TJ, 2020, HEART RHYTHM, V17, P184, DOI 10.1016/j.hrthm.2019.08.001
   Calzolari Vittorio, 2017, JACC Clin Electrophysiol, V3, P1126, DOI 10.1016/j.jacep.2017.08.016
   Do U, 2021, KOREAN CIRC J, V51, P143, DOI 10.4070/kcj.2020.0323
   Joung B, 2019, KOREAN CIRC J, V49, P794, DOI 10.4070/kcj.2019.0212
   Joung B, 2018, KOREAN CIRC J, V48, P1033, DOI 10.4070/kcj.2018.0339
   Kaneshiro T, 2020, CIRC-ARRHYTHMIA ELEC, V13
   Kapur S, 2017, CIRCULATION, V136, P1247, DOI 10.1161/CIRCULATIONAHA.117.025827
   Reddy VY, 2019, JACC-CLIN ELECTROPHY, V5, P778, DOI 10.1016/j.jacep.2019.04.009
   Shin DG, 2020, EUROPACE, V22, P1495, DOI 10.1093/europace/euaa144
NR 10
TC 0
Z9 0
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD FEB
PY 2021
VL 51
IS 2
BP 154
EP 156
DI 10.4070/kcj.2020.0488
PG 3
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA QQ1NG
UT WOS:000624292500006
PM 33525070
OA Green Published
DA 2021-04-22
ER

PT J
AU Park, H
   Lim, S
   Lee, S
   Mun, D
   Kang, J
   Kim, H
   Park, H
   Kim, C
   Park, S
   Lim, YM
   Joung, B
AF Park, Hyewon
   Lim, Sangchul
   Lee, Seunghoon
   Mun, Dasom
   Kang, JiYoung
   Kim, Hyoeun
   Park, Hyelim
   Kim, Changsoo
   Park, Sunho
   Lim, Yeong-Min
   Joung, Boyoung
TI High Level of Real Urban Air Pollution Promotes Cardiac Arrhythmia in
   Healthy Mice
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Air pollution; Arrhythmia; Inflammation; Fibrosis
ID B-CRYSTALLIN PREVENTS; PARTICULATE MATTER; OXIDATIVE STRESS;
   ASSOCIATION; ACTIVATION; PARTICLES; RAT; INFLAMMATION; DYSFUNCTION;
   EXPOSURE
AB Background and Objectives: Ambient particulate matter (PM) in real urban air pollution (RUA) is an environmental health risk factor associated with increased cardiac events. This study investigated the threshold level to induce arrhythmia, as well as arrhythmogenic mechanism of RUA that mainly consisted of PM <2.5 mu m in aerodynamic diameter close to ultrafine particles.
   Methods: RUA was artificially produced by a lately developed pyrolysis based RUA generator. C57BL/6 mice were divided into 4 groups: a control group (control, n=12) and three groups with exposure to RUA with the concentration of 200 mu g/m(3) (n=12), 400 mu g/m(3) (n=12), and 800 mu g/m(3) (n=12). Mice were exposed to RUA at each concentration for 8 hr/day and 5 day/week to mimic ordinary human activity during 3 weeks.
   Results: The QRS and QTc intervals, as well as intracellular Ca2+ duration, apicobasal action potential duration (APD) gradient, fibrosis, and inflammation of left ventricle of mouse hearts were increased dose-dependently with the increase of RUA concentration, and significantly increased at RUA concentration of 400 mu g/m(3) compared to control (all p<0.001). In mice exposed to RUA concentration of 800 mu g/m(3), spontaneous ventricular arrhythmia was observed in 42%, with significant increase of inflammatory markers, phosphorylated Ca2+/calmodulin-dependent protein kinase II (CaMKII), and phospholamban (PLB) compared to control.
   Conclusions: RUA could induce electrophysiological changes such as APD and QT prolongation, fibrosis, and inflammation dose-dependently, with significant increase of ventricular arrhythmia at the concentration of 400 mu g/m(3). RUA concentration of 800 mu g/m(3) increased phosphorylation of CaMKII and PLB.
C1 [Park, Hyewon; Mun, Dasom; Kang, JiYoung; Kim, Hyoeun; Park, Hyelim; Joung, Boyoung] Yonsei Univ, Div Cardiol, Coll Med, 50-1 Yonsei Ro, Seoul 03722, South Korea.
   [Park, Hyewon] Ewha Womans Univ, Sch Med, Dept Cardiol, Seoul, South Korea.
   [Lim, Sangchul; Lee, Seunghoon; Park, Sunho] Dankook Univ, Dept Mech Engn, Yongin, South Korea.
   [Park, Hyelim] Inha Univ, Coll Med, Dept Otorhinolaryngol Head & Neck Surg, Incheon, South Korea.
   [Kim, Changsoo] Yonsei Univ, Coll Med, Dept Prevent Med, Seoul, South Korea.
   [Lim, Yeong-Min] CHA Univ, CHA Bundang Med Ctr, Dept Cardiol, Seongnam, South Korea.
   [Lim, Yeong-Min] St Carollo Hosp, Div Cardiol, Sunchon, South Korea.
RP Joung, B (corresponding author), Yonsei Univ, Div Cardiol, Coll Med, 50-1 Yonsei Ro, Seoul 03722, South Korea.; Lim, YM (corresponding author), St Carollo Hosp, Div Cardiol, Dept Internal Med, 221 Sungwang Ro, Sunchon 57931, South Korea.
EM perhapsluke@naver.com; cby6908@yuhs.ac
OI Kim, Changsoo/0000-0002-5940-5649
FU Korean Cardiac Research Foundation [201803-01]; Basic Science Research
   Program through the National Research Foundation of Korea - Ministry of
   Education, Science and Technology [NRF-2017R1A2B3003303]; Korean
   Healthcare Technology R&D project - Ministry of Health Welfare
   [HI16C0058]; Ewha Womans University
FX This study was supported by research grants from the Korean Cardiac
   Research Foundation (201803-01), the Basic Science Research Program
   through the National Research Foundation of Korea, funded by the
   Ministry of Education, Science and Technology (NRF-2017R1A2B3003303),
   and the Korean Healthcare Technology R&D project, which is funded by the
   Ministry of Health & Welfare (HI16C0058). The Hyewon Park was supported
   by RP-Grant 2020 of Ewha Womans University.
CR Antzelevitch C, 2007, EUROPACE, V9, P4, DOI 10.1093/europace/eum166
   Soares SRC, 2009, ATHEROSCLEROSIS, V207, P368, DOI 10.1016/j.atherosclerosis.2009.04.041
   Cho S, 2016, ENERG FUEL, V30, P6614, DOI 10.1021/acs.energyfuels.6b01346
   Chow JC, 2006, J AIR WASTE MANAGE, V56, P1368, DOI 10.1080/10473289.2006.10464545
   Cozzi E, 2006, AM J PHYSIOL-HEART C, V291, pH894, DOI 10.1152/ajpheart.01362.2005
   Dockery DW, 2005, ENVIRON HEALTH PERSP, V113, P670, DOI 10.1289/ehp.7767
   Erickson JR, 2008, CELL, V133, P462, DOI 10.1016/j.cell.2008.02.048
   Hoek G, 2001, EPIDEMIOLOGY, V12, P355, DOI 10.1097/00001648-200105000-00017
   Huang W, 2012, AM J EPIDEMIOL, V176, P117, DOI 10.1093/aje/kwr511
   Kim IS, 2017, INT J CARDIOL, V240, P214, DOI 10.1016/j.ijcard.2017.03.122
   Kim JB, 2012, TOXICOL APPL PHARM, V259, P66, DOI 10.1016/j.taap.2011.12.007
   Ljungman PLS, 2008, EUR HEART J, V29, P2894, DOI 10.1093/eurheartj/ehn463
   Lucking AJ, 2008, EUR HEART J, V29, P3043, DOI 10.1093/eurheartj/ehn464
   Nemmar A, 2002, CIRCULATION, V105, P411, DOI 10.1161/hc0402.104118
   Park H, 2018, HEART RHYTHM, V15, P770, DOI 10.1016/j.hrthm.2017.09.039
   Park H, 2013, TOXICOL APPL PHARM, V266, P267, DOI 10.1016/j.taap.2012.10.013
   Park H, 2015, INT J CARDIOL, V182, P399, DOI 10.1016/j.ijcard.2014.12.152
   Peters A, 2001, CIRCULATION, V103, P2810
   Pope CA, 2004, CIRCULATION, V109, P71, DOI 10.1161/01.CIR.0000108927.80044.7F
   Silbajoris R, 2000, INHAL TOXICOL, V12, P453
   Simkhovich BZ, 2008, J AM COLL CARDIOL, V52, P719, DOI 10.1016/j.jacc.2008.05.029
   Sivagangabalan G, 2011, J AM COLL CARDIOL, V57, P198, DOI 10.1016/j.jacc.2010.08.625
   Sohn J, 2016, ENVIRON SCI POLLUT R, V23, P19432, DOI 10.1007/s11356-016-7144-9
   Takenaka S, 2006, INHAL TOXICOL, V18, P733, DOI 10.1080/08958370600748281
   Tobias HJ, 2001, ENVIRON SCI TECHNOL, V35, P2233, DOI 10.1021/es0016654
   Tornqvist H, 2007, AM J RESP CRIT CARE, V176, P395, DOI 10.1164/rccm.200606-872OC
   Xie LH, 2009, CIRC RES, V104, P79, DOI 10.1161/CIRCRESAHA.108.183475
   Zhang R, 2005, NAT MED, V11, P409, DOI 10.1038/nm1215
   Zhu WZ, 2007, J BIOL CHEM, V282, P10833, DOI 10.1074/jbc.M611507200
NR 29
TC 1
Z9 1
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD FEB
PY 2021
VL 51
IS 2
BP 157
EP 170
DI 10.4070/kcj.2020.0255
PG 14
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA QQ1NG
UT WOS:000624292500007
PM 33525071
OA Green Published
DA 2021-04-22
ER

PT J
AU Ahn, J
AF Ahn, Jinhee
TI Fine Particulate Matter: a Threat to the Heart Rhythm
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
ID AIR-POLLUTION
C1 [Ahn, Jinhee] Pusan Natl Univ Hosp, Div Cardiol, Dept Internal Med, 179 Gudeok Ro, Busan 49241, South Korea.
   [Ahn, Jinhee] Pusan Natl Univ Hosp, Biomed Res Inst, Busan, South Korea.
RP Ahn, J (corresponding author), Pusan Natl Univ Hosp, Div Cardiol, Dept Internal Med, 179 Gudeok Ro, Busan 49241, South Korea.
EM reinee7@gmail.com
CR Burnett R, 2018, P NATL ACAD SCI USA, V115, P9592, DOI 10.1073/pnas.1803222115
   Du YX, 2016, J THORAC DIS, V8, pE8, DOI 10.3978/j.issn.2072-1439.2015.11.37
   Folino F, 2017, LANCET PLANET HEALTH, V1, pE58, DOI [10.1016/S2542-5196(17)30020-7, 10.1016/s2542-5196(17)30020-7]
   Hayes RB, 2020, INT J EPIDEMIOL, V49, P25, DOI 10.1093/ije/dyz114
   Joung B, 2019, KOREAN CIRC J, V49, P794, DOI 10.4070/kcj.2019.0212
   Kelly FJ, 2015, ENVIRON GEOCHEM HLTH, V37, P631, DOI 10.1007/s10653-015-9720-1
   Landrigan PJ, 2018, LANCET, V391, P462, DOI 10.1016/S0140-6736(17)32345-0
   OECD, 2020, EC CONS OUTD AIR POL
   Park H, 2021, KOREAN CIRC J, V51, P157, DOI 10.4070/kcj.2020.0255
   Rajagopalan S, 2018, J AM COLL CARDIOL, V72, P2054, DOI 10.1016/j.jacc.2018.07.099
NR 10
TC 0
Z9 0
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD FEB
PY 2021
VL 51
IS 2
BP 171
EP 173
DI 10.4070/kcj.2020.0501
PG 3
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA QQ1NG
UT WOS:000624292500008
PM 33525072
OA Green Published
DA 2021-04-22
ER

PT J
AU Du, MY
   Jiang, L
   Tang, XF
   Gao, Z
   Xu, B
   Yuan, JQ
AF Du, Mengyang
   Jiang, Lin
   Tang, Xiaofang
   Gao, Zhan
   Xu, Bo
   Yuan, Jinqing
TI Contrast Induced Nephropathy and 2-Year Outcomes of Iso-Osmolar Compared
   with Low-Osmolar Contrast Media after Elective Percutaneous Coronary
   Intervention
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Contrast media; Percutaneous coronary intervention; Coronary artery
   disease
ID RENAL SAFETY; RISK-FACTORS; METAANALYSIS; IODIXANOL; PATHOPHYSIOLOGY;
   PREVENTION
AB Background and Objectives: This study investigated the relative incidence of contrast induced nephropathy (CIN) and long-term outcomes between iso-osmolar contrast media (IOCM) and low-osmolar contrast media (LOCM) undergoing elective percutaneous coronary intervention (PCI).
   Methods: A total of 9,431 patients receiving elective PCI were enrolled in the cohort. The patients were divided into IOCM group and LOCM group. Propensity score matching (PSM) was applied to minimize the selection bias between groups.
   Results: The multivariate analysis showed that the use of IOCM compared with LOCM did not affect the CIN incidence (odds ratio [OR], 0.912; 95% confidence interval [CI], 0.576-1.446; p=0.696). After PSM, the incidence of CIN was 1.5% and 4.0% in IOCM group (n=979) and LOCM group (n=979), respectively, p=0.001. IOCM significantly reduced the incidence of CIN compared with LOCM (OR, 0.393; 95% CI, 0.214-0.722; p=0.003). After 2 years of follow-up, the all-cause mortality was higher in IOCM group than LOCM group (2.1% vs. 0.9%, p<0.001). Cox regression analysis showed IOCM was not independent risk factor of 2-years all-cause mortality (OR, 0.849; 95% CI, 0.510-1.412; p=0.528). After PSM, the difference of all-cause death between groups disappeared (1.7% vs. 1.9%, p=0.739). Cox regression analysis showed that the use of IOCM compared with LOCM did not affect the incidence of 2-year all-cause mortality (OR, 1.037; 95% CI, 0.534-2.014; p=0.915).
   Conclusions: Compared with LOCM, IOCM significantly reduced the incidence of CIN after elective PCI, but had no significant effect on 2-year all-cause mortality.
C1 [Du, Mengyang; Jiang, Lin; Tang, Xiaofang; Gao, Zhan; Xu, Bo; Yuan, Jinqing] Chinese Acad Med Sci & Peking Union Med Coll, Dept Cardiol, State Key Lab Cardiovasc Dis, Fuwai Hosp,Natl Ctr Cardiovasc Dis, 167 Beilishi Rd, Beijing 100037, Peoples R China.
RP Xu, B; Yuan, JQ (corresponding author), Chinese Acad Med Sci & Peking Union Med Coll, Dept Cardiol, State Key Lab Cardiovasc Dis, Fuwai Hosp,Natl Ctr Cardiovasc Dis, 167 Beilishi Rd, Beijing 100037, Peoples R China.
EM bxu@citmd.com; dr_jinqingyuan@sina.com
FU National Key Research and Development Program of China [2016YFC1031301]
FX This work was funded by the National Key Research and Development
   Program of China (2016YFC1031301).
CR Aspelin P, 2003, NEW ENGL J MED, V348, P491, DOI 10.1056/NEJMoa021833
   Azzalini L, 2018, INT J CARDIOL, V273, P69, DOI 10.1016/j.ijcard.2018.08.097
   Bucher A, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/931413
   Fahling M, 2017, NAT REV NEPHROL, V13, P169, DOI 10.1038/nrneph.2016.196
   From AM, 2010, CIRC-CARDIOVASC INTE, V3, P351, DOI 10.1161/CIRCINTERVENTIONS.109.917070
   Hossain MA, 2018, SAUDI J KIDNEY DIS T, V29, P1, DOI 10.4103/1319-2442.225199
   Jo SH, 2006, J AM COLL CARDIOL, V48, P924, DOI 10.1016/j.jacc.2006.06.047
   Jost G, 2011, EUR J RADIOL, V80, P373, DOI 10.1016/j.ejrad.2011.02.003
   Khwaja A, 2012, NEPHRON CLIN PRACT, V120, pC179, DOI 10.1159/000339789
   Levey AS, 2006, ANN INTERN MED, V145, P247, DOI 10.7326/0003-4819-145-4-200608150-00004
   McCullough PA, 2008, J AM COLL CARDIOL, V51, P1419, DOI 10.1016/j.jacc.2007.12.035
   McCullough PA, 2006, J AM COLL CARDIOL, V48, P692, DOI 10.1016/j.jacc.2006.02.073
   Mehran R, 2006, KIDNEY INT, V69, pS11, DOI 10.1038/sj.ki.5000368
   Mruk B, 2016, POL J RADIOL, V81, P157, DOI 10.12659/PJR.895406
   Newhouse JH, 2008, AM J ROENTGENOL, V191, P376, DOI 10.2214/AJR.07.3280
   Reed M, 2009, JACC-CARDIOVASC INTE, V2, P645, DOI 10.1016/j.jcin.2009.05.002
   Scharnweber T, 2017, MAGN RESON IMAGING C, V25, P743, DOI 10.1016/j.mric.2017.06.012
   Seeliger E, 2012, EUR HEART J, V33, P2007, DOI 10.1093/eurheartj/ehr494
   Stacul F, 2011, EUR RADIOL, V21, P2527, DOI 10.1007/s00330-011-2225-0
   Wang YC, 2016, AM J CARDIOL, V118, P985, DOI 10.1016/j.amjcard.2016.07.017
   Zhao F, 2019, CANCER IMAGING, V19, DOI 10.1186/s40644-019-0224-6
NR 21
TC 1
Z9 1
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD FEB
PY 2021
VL 51
IS 2
BP 174
EP 181
DI 10.4070/kcj.2020.0307
PG 8
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA QQ1NG
UT WOS:000624292500009
PM 33525073
OA Green Published, Other Gold
DA 2021-04-22
ER

PT J
AU Jo, SH
AF Jo, Sang-Ho
TI Iso-osmolar Iodixanol Is Better than Low-osmolar Contrast for CIN
   Prevention. And Then?
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
C1 [Jo, Sang-Ho] Hallym Univ, Sacred Heart Hosp, Dept Internal Med, Div Cardiol, 22,Gwanpyeong Ro 170Beon Gil, Anyang 14068, South Korea.
RP Jo, SH (corresponding author), Hallym Univ, Sacred Heart Hosp, Dept Internal Med, Div Cardiol, 22,Gwanpyeong Ro 170Beon Gil, Anyang 14068, South Korea.
EM sophi5neo@gmail.com
CR Almendarez M, 2019, JACC-CARDIOVASC INTE, V12, P1877, DOI 10.1016/j.jcin.2019.04.055
   Aspelin P, 2003, NEW ENGL J MED, V348, P491, DOI 10.1056/NEJMoa021833
   Du MY, 2021, KOREAN CIRC J, V51, P174, DOI 10.4070/kcj.2020.0307
   Jo SH, 2006, J AM COLL CARDIOL, V48, P924, DOI 10.1016/j.jacc.2006.06.047
   Jo SH, 2011, KOREAN CIRC J, V41, P695, DOI 10.4070/kcj.2011.41.12.695
   Maeder M, 2004, J AM COLL CARDIOL, V44, P1763, DOI 10.1016/j.jacc.2004.06.075
   Persson PB, 2005, KIDNEY INT, V68, P14, DOI 10.1111/j.1523-1755.2005.00377.x
   Seeliger E, 2007, J AM SOC NEPHROL, V18, P2912, DOI 10.1681/ASN.2006111216
   Weisbord SD, 2020, J AM COLL CARDIOL, V75, P1311, DOI 10.1016/j.jacc.2020.01.023
   Yun KH, 2014, KOREAN CIRC J, V44, P301, DOI 10.4070/kcj.2014.44.5.301
NR 10
TC 0
Z9 0
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD FEB
PY 2021
VL 51
IS 2
BP 182
EP 184
DI 10.4070/kcj.2021.0003
PG 3
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA QQ1NG
UT WOS:000624292500010
PM 33525074
OA Green Published
DA 2021-04-22
ER

PT J
AU Kaneko, U
   Hachinohe, D
   Kobayashi, K
   Fujita, T
AF Kaneko, Umihiko
   Hachinohe, Daisuke
   Kobayashi, Ken
   Fujita, Tsutomu
TI Snare-Assisted Valve Delivery to Overcome a Severely Calcified Aortic
   Arch during Transcatheter Aortic Valve Replacement
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
C1 [Kaneko, Umihiko; Hachinohe, Daisuke; Kobayashi, Ken; Fujita, Tsutomu] Sapporo Heart Ctr, Sapporo Cardio Vasc Clin, Dept Cardiovasc Med, North 49,East 16,8-1 Higashi Ward, Sapporo, Hokkaido 0070849, Japan.
RP Kaneko, U (corresponding author), Sapporo Heart Ctr, Sapporo Cardio Vasc Clin, Dept Cardiovasc Med, North 49,East 16,8-1 Higashi Ward, Sapporo, Hokkaido 0070849, Japan.
EM uk434471@gmail.com
CR Kaneko U, 2020, INT HEART J, V61, P1059, DOI 10.1536/ihj.20-120
   Szlapka M, 2019, EUR J CARDIO-THORAC, V56, P204, DOI 10.1093/ejcts/ezy424
NR 2
TC 0
Z9 0
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD FEB
PY 2021
VL 51
IS 2
BP 185
EP 186
DI 10.4070/kcj.2020.0384
PG 2
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA QQ1NG
UT WOS:000624292500011
PM 33525075
OA Green Published
DA 2021-04-22
ER

PT J
AU Hachinohe, D
   Shitan, H
   Kaneko, U
   Kobayashi, K
   Mitsube, K
   Kawamura, T
   Fujita, T
AF Hachinohe, Daisuke
   Shitan, Hidemasa
   Kaneko, Umihiko
   Kobayashi, Ken
   Mitsube, Keijiro
   Kawamura, Takeshi
   Fujita, Tsutomu
TI Controlled Valve Slide-Over Using a Buddy Balloon: "Shoehorn Technique"
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
C1 [Hachinohe, Daisuke; Shitan, Hidemasa; Kaneko, Umihiko; Kobayashi, Ken; Fujita, Tsutomu] Sapporo Cardio Vasc Clin, Sapporo Heart Ctr, Div Cardiovasc Med, Sapporo, Hokkaido, Japan.
   [Mitsube, Keijiro] Sapporo Cardio Vasc Clin, Sapporo Heart Ctr, Div Cardiovasc Surg, Sapporo, Hokkaido, Japan.
   [Kawamura, Takeshi] Sapporo Cardio Vasc Clin, Sapporo Heart Ctr, Div Anesthesiol, Sapporo, Hokkaido, Japan.
RP Hachinohe, D (corresponding author), Sapporo Cardio Vasc Clin, Sapporo Heart Ctr, Div Cardiovasc Med, Higashi Ku, 8-1,Kita 49 Higashi 16, Sapporo, Hokkaido 0070849, Japan.
EM heartbond.8@gmail.com
NR 0
TC 0
Z9 0
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD FEB
PY 2021
VL 51
IS 2
BP 187
EP 188
DI 10.4070/kcj.2020.0454
PG 2
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA QQ1NG
UT WOS:000624292500012
PM 33525076
OA Green Published
DA 2021-04-22
ER

PT J
AU Gianni, C
   Della Rocca, DG
   Natale, A
   Horton, RP
AF Gianni, Carola
   Della Rocca, Domenico G.
   Natale, Andrea
   Horton, Rodney P.
TI Interventional Treatment for Stroke Prevention
SO KOREAN CIRCULATION JOURNAL
LA English
DT Review
DE Left atrial appendage occlusion; Stroke
ID LEFT ATRIAL APPENDAGE; CLOSURE; FIBRILLATION; WARFARIN; DEVICE;
   MANAGEMENT; COLCHICINE; IMPACT
AB Closure of the left atrial appendage using percutaneous transcatheter occlusion devices is used for stroke prevention as an alternative for patients with a high risk or contraindications for long-term oral anticoagulation use. Herein, we will discuss the practical aspects of five among the available devices used for interventional left atrial appendage occlusion: Watchman, Amulet, WaveCrest, LAmbre, and and Lariat.
C1 [Gianni, Carola; Della Rocca, Domenico G.; Natale, Andrea; Horton, Rodney P.] St Davids Med Ctr, Texas Cardiac Arrhythmia Inst, 3000 N IH-35 Suite 720, Austin, TX 78705 USA.
   [Natale, Andrea] HCA Natl Med Director Cardiac Electrophysiol, Austin, TX USA.
   [Natale, Andrea] Scripps Clin, Intervent Electrophysiol, La Jolla, CA USA.
   [Natale, Andrea] Case Western Reserve Univ, Metrohlth Med Ctr, Sch Med, Cleveland, OH USA.
   [Horton, Rodney P.] Univ Texas Austin, Dept Biomed Engn, Austin, TX 78712 USA.
RP Horton, RP (corresponding author), St Davids Med Ctr, Texas Cardiac Arrhythmia Inst, 3000 N IH-35 Suite 720, Austin, TX 78705 USA.
EM rodney.horton@gmail.com
OI Della Rocca, Domenico/0000-0003-3837-3462; Natale,
   Andrea/0000-0002-5487-0728
CR Asmarats L, 2017, CIRC-CARDIOVASC INTE, V10, DOI 10.1161/CIRCINTERVENTIONS.117.005359
   BEAL JM, 1950, ANN SURG, V132, P517, DOI 10.1097/00000658-195009000-00016
   Chahar Praveen, 2012, J Pain Res, V5, P257, DOI 10.2147/JPR.S27894
   Della Rocca DG, 2020, JACC-CARDIOVASC INTE, V13, P306, DOI 10.1016/j.jcin.2019.10.022
   Doshi SK, 2020, HEART RHYTHM, V17, pS74
   Enomoto Y, 2017, HEART RHYTHM, V14, P19, DOI 10.1016/j.hrthm.2016.10.020
   Gianni C, 2020, J CARDIOVASC ELECTR, V31, P2179, DOI 10.1111/jce.14471
   Glikson M, 2020, EUROPACE, V22, DOI 10.1093/europace/euz258
   Gunda S, 2016, J CARDIOVASC ELECTR, V27, P60, DOI 10.1111/jce.12869
   Holmes DR, 2009, LANCET, V374, P534, DOI 10.1016/S0140-6736(09)61343-X
   Holmes DR, 2014, J AM COLL CARDIOL, V64, P1, DOI 10.1016/j.jacc.2014.04.029
   Huang H, 2017, JACC-CARDIOVASC INTE, V10, P2188, DOI 10.1016/j.jcin.2017.06.072
   Hur J, 2009, RADIOLOGY, V251, P683, DOI 10.1148/radiol.2513090794
   Imazio M, 2014, JAMA-J AM MED ASSOC, V312, P1016, DOI 10.1001/jama.2014.11026
   January CT, 2019, J AM COLL CARDIOL, V74, P104, DOI 10.1016/j.jacc.2019.01.011
   January CT, 2014, J AM COLL CARDIOL, V64, pE1, DOI 10.1016/j.jacc.2014.03.022
   Johnson WD, 2000, EUR J CARDIO-THORAC, V17, P718, DOI 10.1016/S1010-7940(00)00419-X
   Korsholm K, 2017, JACC-CARDIOVASC INTE, V10, P2198, DOI 10.1016/j.jcin.2017.06.057
   Landmesser U, 2018, EUROINTERVENTION, V14, P590, DOI 10.4244/EIJ-D-18-00344
   MADDEN JL, 1949, JAMA-J AM MED ASSOC, V140, P769, DOI 10.1001/jama.1949.02900440011003
   Nishimura RA, 2014, J AM COLL CARDIOL, V63, P2438, DOI 10.1016/j.jacc.2014.02.537
   Price MJ, 2014, J AM COLL CARDIOL, V64, P565, DOI 10.1016/j.jacc.2014.03.057
   Reddy VY, 2017, J AM COLL CARDIOL, V70, P2964, DOI 10.1016/j.jacc.2017.10.021
   Stone GW, 2017, WAVECREST DEVICE DES
   Viles-Gonzalez JF, 2012, J AM COLL CARDIOL, V59, P923, DOI 10.1016/j.jacc.2011.11.028
   WOLF PA, 1991, STROKE, V22, P983, DOI 10.1161/01.STR.22.8.983
NR 26
TC 0
Z9 0
U1 1
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JAN
PY 2021
VL 51
IS 1
BP 1
EP 14
DI 10.4070/kcj.2020.0416
PG 14
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA PN4VN
UT WOS:000604478600001
PM 33377326
OA Green Published
DA 2021-04-22
ER

PT J
AU Campbell, T
   Bennett, RG
   Kotake, Y
   Kumar, S
AF Campbell, Timothy
   Bennett, Richard G.
   Kotake, Yasuhito
   Kumar, Saurabh
TI Updates in Ventricular Tachycardia Ablation
SO KOREAN CIRCULATION JOURNAL
LA English
DT Review
DE Ventricular tachycardia; Ventricular arrhythmias; Radiofrequency
   ablation; Multimodal imaging; Sympathectomy
ID CARDIAC SYMPATHETIC DENERVATION; NONISCHEMIC CARDIOMYOPATHY
   IMPLICATIONS; RADIOFREQUENCY CATHETER ABLATION; LIMITED-SUBSTRATE
   ABLATION; OUTFLOW TRACT; CONTACT FORCE; ARRHYTHMOGENIC SUBSTRATE;
   BRUGADA SYNDROME; SINUS RHYTHM; FOLLOW-UP
AB Sudden cardiac death (SCD) due to recurrent ventricular tachycardia is an important clinical sequela in patients with structural heart disease. As a result, ventricular tachycardia (VT) has emerged as a major clinical and public health problem. The mechanism of VT is predominantly mediated by re-entry in the presence of arrhythmogenic substrate (scar), though focal mechanisms are also important. Catheter ablation for VT, when compared to standard medical therapy, has been shown to improve VT-free survival and burden of device therapies. Approaches to VT ablation are dependent on the underlying disease process, broadly classified into idiopathic (no structural heart disease) or structural heart disease (ischemic or non-ischemic heart disease). This update aims to review recent advances made for the treatment of VT ablation, with respect to current clinical trials, peri-procedure risk assessments, pre-procedural cardiac imaging, electro-anatomic mapping and advances in catheter and non-catheter based ablation techniques.
C1 [Campbell, Timothy; Bennett, Richard G.; Kotake, Yasuhito; Kumar, Saurabh] Westmead Hosp, Dept Cardiol, Sydney, NSW, Australia.
   [Campbell, Timothy; Bennett, Richard G.; Kotake, Yasuhito; Kumar, Saurabh] Univ Sydney, Westmead Appl Res Ctr, Sydney, NSW, Australia.
RP Kumar, S (corresponding author), Univ Sydney, Westmead Hosp, Westmead Appl Res Ctr, Dept Cardiol, Darcy Rd, Westmead, NSW 2145, Australia.
EM saurabh.kumar@sydney.edu.au
OI Campbell, Timothy/0000-0003-4793-7741; Kumar,
   Saurabh/0000-0002-5643-5076
FU NSW Early-Mid Career Fellowship
FX This work was supported in part from the NSW Early-Mid Career
   Fellowship. Kumar S has received research grants from Abbott Medical and
   Biotronik; he has received honoraria from Biosense Webster, Inc., Abbott
   Medical, Biotronik, and Sanofi Aventis. Campbell T has received speakers
   Honoria from Biosense Webster, Inc.
CR Al-Khatib SM, 2018, HEART RHYTHM, V15, pE190, DOI 10.1016/j.hrthm.2017.10.035
   Anderson RD, 2020, PACING CLIN ELECTROP, DOI [10.4070/kcj.2020.0436, DOI 10.4070/KCJ.2020.0436]
   Anderson RD, 2020, JACC-CLIN ELECTROPHY, V6, P56, DOI 10.1016/j.jacep.2019.09.013
   Anderson RD, 2019, J CARDIOVASC ELECTR, V30, P2353, DOI 10.1111/jce.14143
   Anderson RD, 2019, HEART RHYTHM, V16, P1484, DOI 10.1016/j.hrthm.2019.05.026
   Andreu D, 2015, EUROPACE, V17, P938, DOI 10.1093/europace/euu310
   Aras D, 2019, ANATOL J CARDIOL, V21, P187, DOI 10.14744/AnatolJCardiol.2018.58534
   Aziz Z, 2019, CIRCULATION, V140, P1383, DOI 10.1161/CIRCULATIONAHA.119.042423
   Barbhaiya CR, 2019, J INTERV CARD ELECTR, V54, P119, DOI 10.1007/s10840-018-0455-7
   Barkagan M, 2020, EUROPACE, V22, P440, DOI 10.1093/europace/euz364
   Bennett RG, 2019, HEART LUNG CIRC, V28, P164, DOI 10.1016/j.hlc.2018.10.013
   Berruezo A, 2015, CIRC-ARRHYTHMIA ELEC, V8, P326, DOI 10.1161/CIRCEP.114.002386
   Berruezo A, 2012, CIRC-ARRHYTHMIA ELEC, V5, P111, DOI 10.1161/CIRCEP.110.960740
   BHANDARI AK, 1984, CIRCULATION, V70, P1018, DOI 10.1161/01.CIR.70.6.1018
   Bokhari F, 2004, CIRCULATION, V110, P112, DOI 10.1161/01.CIR.0000134957.51747.6E
   Campbell T, 2020, J CARDIOVASC ELECTR, V31, P2909, DOI 10.1111/jce.14740
   Campbell T, 2020, J CARDIOVASC ELECTR, V31, P474, DOI 10.1111/jce.14351
   CHANG RJ, 1993, AM HEART J, V125, P1276, DOI 10.1016/0002-8703(93)90995-L
   Chung FP, 2019, J CARDIOVASC ELECTR, V30, P1508, DOI 10.1111/jce.14057
   Cronin EM, 2019, EUROPACE, V21, P1143, DOI 10.1093/europace/euz132
   Cuculich PS, 2017, NEW ENGL J MED, V377, P2325, DOI 10.1056/NEJMoa1613773
   Cuculich PS, 2011, J AM COLL CARDIOL, V58, P1893, DOI 10.1016/j.jacc.2011.07.029
   Cury RC, 2008, RADIOLOGY, V248, P466, DOI 10.1148/radiol.2482071478
   de Vries LJ, 2018, EUROPACE, V20, P22, DOI 10.1093/europace/euy004
   Della Bella P, 2020, HEART RHYTHM
   Deno DC, 2017, IEEE T BIO-MED ENG, V64, P1067, DOI 10.1109/TBME.2016.2589158
   Di Biase L, 2012, J AM COLL CARDIOL, V60, P132, DOI 10.1016/j.jacc.2012.03.044
   Dickfeld T, 2003, CIRCULATION, V108, P2407, DOI 10.1161/01.CIR.0000093191.05433.B0
   Dinov B, 2014, CIRCULATION, V129, P728, DOI 10.1161/CIRCULATIONAHA.113.003063
   Elbatran AI, 2020, J INTERV CARD ELECTR, DOI 10.1007/s10840-020-00756-4
   Elsokkari I, 2018, J INTERV CARD ELECTR, V53, P323, DOI 10.1007/s10840-018-0396-1
   Esposito A, 2016, JACC-CARDIOVASC IMAG, V9, P822, DOI 10.1016/j.jcmg.2015.10.024
   Futyma P, 2020, HEART RHYTHM, V17, P1519, DOI 10.1016/j.hrthm.2020.04.029
   Garcia FC, 2009, CIRCULATION, V120, P366, DOI 10.1161/CIRCULATIONAHA.108.834903
   Glashan CA, 2019, JACC-CLIN ELECTROPHY, V5, P1130, DOI 10.1016/j.jacep.2019.06.004
   Gokoglan Y, 2016, J AM COLL CARDIOL, V68, P1990, DOI 10.1016/j.jacc.2016.08.033
   Graham AJ, 2020, CIRC-ARRHYTHMIA ELEC, V13, DOI 10.1161/CIRCEP.119.007377
   Haissaguerre M, 2002, CIRCULATION, V106, P962, DOI 10.1161/01.CIR.0000027564.55739.B1
   Haissaguerre M, 2003, CIRCULATION, V108, P925, DOI 10.1161/01.CIR.0000088781.99943.95
   Haissaguerre M, 2020, JACC-CLIN ELECTROPHY, V6, P591, DOI 10.1016/j.jacep.2020.03.010
   Haldar SK, 2017, CIRC-ARRHYTHMIA ELEC, V10, DOI 10.1161/CIRCEP.117.005018
   Hawson J, 2020, JACC CLIN ELECTROPHY
   Hendriks AA, 2015, J CARDIOVASC ELECTR, V26, P1224, DOI 10.1111/jce.12762
   Igarashi M, 2020, HEART RHYTHM, V17, P1500, DOI 10.1016/j.hrthm.2020.04.028
   Irie T, 2015, CIRC-ARRHYTHMIA ELEC, V8, P390, DOI 10.1161/CIRCEP.114.002637
   Jackson N, 2015, CIRC-ARRHYTHMIA ELEC, V8, P1433, DOI 10.1161/CIRCEP.115.003083
   Jamil-Copley S, 2015, CIRC-ARRHYTHMIA ELEC, V8, P76, DOI 10.1161/CIRCEP.114.001827
   Jesel L, 2014, CIRC-ARRHYTHMIA ELEC, V7, P1168, DOI 10.1161/CIRCEP.113.001219
   Knecht S, 2009, J AM COLL CARDIOL, V54, P522, DOI 10.1016/j.jacc.2009.03.065
   Kumar S, 2016, HEART RHYTHM, V13, P1957, DOI 10.1016/j.hrthm.2016.07.001
   Kumar S, 2015, CIRC-ARRHYTHMIA ELEC, V8, P87, DOI 10.1161/CIRCEP.114.002145
   Leong KMW, 2018, J CARDIOVASC ELECTR, V29, P115, DOI 10.1111/jce.13375
   Leshem Eran, 2017, JACC Clin Electrophysiol, V3, P220, DOI 10.1016/j.jacep.2016.12.016
   Linton NWF, 2009, HEART RHYTHM, V6, P1754, DOI 10.1016/j.hrthm.2009.08.038
   Liu MH, 2019, J CARDIOVASC ELECTR, V30, P642, DOI 10.1111/jce.13856
   Loo BW, 2015, CIRC-ARRHYTHMIA ELEC, V8, P748, DOI 10.1161/CIRCEP.115.002765
   Luther V, 2016, CIRC-ARRHYTHMIA ELEC, V9, DOI 10.1161/CIRCEP.116.004072
   Magtibay K, 2017, J AM HEART ASSOC, V6, DOI 10.1161/JAHA.117.006447
   Mahida S, 2019, HEART RHYTHM, V16, P536, DOI 10.1016/j.hrthm.2018.10.016
   Mahida S, 2017, CIRCULATION, V136, P2491, DOI 10.1161/CIRCULATIONAHA.117.029349
   Maron BJ, 2006, CIRCULATION, V113, P1807, DOI 10.1161/CIRCULATIONAHA.106.174287
   Masse S, 2016, CIRC-ARRHYTHMIA ELEC, V9, DOI 10.1161/CIRCEP.116.004107
   Meng Lingjin, 2017, JACC Clin Electrophysiol, V3, P942, DOI 10.1016/j.jacep.2017.06.006
   Mizuno H, 2013, J CARDIOVASC ELECTR, V24, P519, DOI 10.1111/jce.12080
   Munkler P, 2020, J CARDIOVASC ELECTR, V31, P61, DOI 10.1111/jce.14269
   Murtaza G, 2020, PACE, V43, P828, DOI 10.1111/pace.13968
   Muser D, 2018, ARRHYTH ELECTROPHYSI, V7, P282, DOI 10.15420/aer.2018.36.3
   Muser D, 2016, CIRC-ARRHYTHMIA ELEC, V9, DOI 10.1161/CIRCEP.116.004333
   Nademanee K, 2019, CIRCULATION, V140, P1477, DOI 10.1161/CIRCULATIONAHA.118.039022
   Nademanee K, 2011, CIRCULATION, V123, P1270, DOI 10.1161/CIRCULATIONAHA.110.972612
   Nair K, 2011, CIRC-ARRHYTHMIA ELEC, V4, P692, DOI 10.1161/CIRCEP.110.961037
   Nakahara S, 2010, J AM COLL CARDIOL, V55, P2355, DOI 10.1016/j.jacc.2010.01.041
   Nakamura T, 2019, HEART RHYTHM, V16, P1021, DOI 10.1016/j.hrthm.2019.01.032
   Nash MP, 2006, CIRCULATION, V114, P536, DOI 10.1161/CIRCULATIONAHA.105.602870
   Neuwirth R, 2019, EUROPACE, V21, P1088, DOI 10.1093/europace/euz133
   Nguyen DT, 2018, JACC-CLIN ELECTROPHY, V4, P1176, DOI 10.1016/j.jacep.2018.06.021
   Nguyen Duy T, 2017, JACC Clin Electrophysiol, V3, P1103, DOI 10.1016/j.jacep.2017.03.006
   Nguyen DT, 2015, J CARDIOVASC ELECTR, V26, P792, DOI 10.1111/jce.12682
   Nogami A, 2015, J CARDIOVASC ELECTR, V26, P110, DOI 10.1111/jce.12547
   Okubo K, 2019, CIRC-ARRHYTHMIA ELEC, V12, DOI 10.1161/CIRCEP.119.007500
   Papageorgiou N, 2018, EUROPACE, V20, P682, DOI 10.1093/europace/eux077
   Pappone C, 2017, CIRC-ARRHYTHMIA ELEC, V10, DOI 10.1161/CIRCEP.117.005053
   Parkash R, 2018, CIRC-ARRHYTHMIA ELEC, V11, DOI 10.1161/CIRCEP.117.005663
   Penela D, 2019, HEART, V105, P378, DOI 10.1136/heartjnl-2018-313452
   Penela D, 2017, HEART RHYTHM, V14, P592, DOI 10.1016/j.hrthm.2017.01.019
   Piers SRD, 2013, CIRC-ARRHYTHMIA ELEC, V6, P875, DOI 10.1161/CIRCEP.113.000537
   Poole JE, 2008, NEW ENGL J MED, V359, P1009, DOI 10.1056/NEJMoa071098
   Porta-Sanchez A, 2019, EUROPACE, V21, P813, DOI 10.1093/europace/euy304
   Porta-Sanchez A, 2018, JACC-CLIN ELECTROPHY, V4, P307, DOI 10.1016/j.jacep.2017.12.005
   Price A, 2012, J INNOV CARDIAC RHYT, V3, P599
   Robinson CG, 2019, CIRCULATION, V139, P313, DOI 10.1161/CIRCULATIONAHA.118.038261
   Roca-Luque I, 2020, EUROPACE, V22, P598, DOI 10.1093/europace/euaa021
   Romero J, 2020, J CARDIOVASC ELECTR, V31, P2022, DOI 10.1111/jce.14593
   Romero J, 2018, JACC-CLIN ELECTROPHY, V4, P810, DOI 10.1016/j.jacep.2018.01.016
   Rudic B, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.116.004095
   Rudy Yoram, 2015, Card Electrophysiol Clin, V7, P17, DOI 10.1016/j.ccep.2014.11.013
   Sandhu A, 2020, J CARDIOVASC ELECTR, V31, P360, DOI 10.1111/jce.14317
   Santangeli P, 2017, J AM COLL CARDIOL, V69, P2105, DOI 10.1016/j.jacc.2017.02.044
   Sapp JL, 2004, PACE, V27, P594, DOI 10.1111/j.1540-8159.2004.00492.x
   Sapp JL, 2020, CIRC-ARRHYTHMIA ELEC, V13, DOI 10.1161/CIRCEP.120.008255
   Sapp JL, 2016, NEW ENGL J MED, V375, P111, DOI 10.1056/NEJMoa1513614
   Sapp JL, 2013, CIRCULATION, V128, P2289, DOI 10.1161/CIRCULATIONAHA.113.003423
   Schron EB, 2002, CIRCULATION, V105, P589, DOI 10.1161/hc0502.103330
   Shirai Y, 2019, CIRC-ARRHYTHMIA ELEC, V12, DOI 10.1161/CIRCEP.119.007249
   Soejima K, 2002, CIRCULATION, V106, P1678, DOI 10.1161/01.CIR.0000030187.39852.A7
   Solomon SB, 2003, J INTERV CARD ELECTR, V8, P27, DOI 10.1023/A:1022379612437
   Sroubek J, 2019, J CARDIOVASC ELECTR, V30, P749, DOI 10.1111/jce.13867
   St. Jude Medical Inc, 2016, INSTR US ENS PREC CA, DOI [10.4070/kcj.2020.0436, DOI 10.4070/KCJ.2020.0436]
   Steven D, 2010, HEART RHYTHM, V7, P323, DOI 10.1016/j.hrthm.2009.11.011
   Stevenson WG, 2019, J AM COLL CARDIOL, V73, P1413, DOI 10.1016/j.jacc.2018.12.070
   Strickberger SA, 2017, J CARDIOVASC ELECTR, V28, P416, DOI 10.1111/jce.13170
   Takigawa M, 2019, JACC-CLIN ELECTROPHY, V5, P66, DOI 10.1016/j.jacep.2018.08.022
   Tilz RR, 2014, EUROPACE, V16, P1387, DOI 10.1093/europace/eut430
   Ustunkaya T, 2019, JACC-CLIN ELECTROPHY, V5, P1158, DOI 10.1016/j.jacep.2019.06.017
   Ustunkaya T, 2019, HEART RHYTHM, V16, P588, DOI 10.1016/j.hrthm.2018.10.029
   van der Ree MH, 2020, HEART RHYTHM, V17, P1381, DOI 10.1016/j.hrthm.2020.03.013
   Vaseghi M, 2017, J AM COLL CARDIOL, V69, P3070, DOI 10.1016/j.jacc.2017.04.035
   Vaseghi M, 2014, HEART RHYTHM, V11, P360, DOI 10.1016/j.hrthm.2013.11.028
   Vergara P, 2018, CIRC-ARRHYTHMIA ELEC, V11, DOI 10.1161/CIRCEP.118.006730
   Viswanathan K, 2017, HEART RHYTHM, V14, P176, DOI 10.1016/j.hrthm.2016.11.018
   Wilde AAM, 2008, NEW ENGL J MED, V358, P2024, DOI 10.1056/NEJMoa0708006
   Yamada T, 2015, CIRC-ARRHYTHMIA ELEC, V8, P344, DOI 10.1161/CIRCEP.114.002259
   Yamashita S, 2017, HEART RHYTHM, V14, P155, DOI 10.1016/j.hrthm.2016.11.012
   Yamashita S, 2016, J CARDIOVASC ELECTR, V27, P699, DOI 10.1111/jce.12963
   Yang JD, 2019, HEART RHYTHM, V16, P863, DOI 10.1016/j.hrthm.2018.12.018
   Zhang JJ, 2015, CIRCULATION, V131, P1950, DOI 10.1161/CIRCULATIONAHA.114.013698
NR 126
TC 0
Z9 0
U1 1
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JAN
PY 2021
VL 51
IS 1
BP 15
EP 42
DI 10.4070/kcj.2020.0436
PG 28
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA PN4VN
UT WOS:000604478600002
PM 33377327
OA Green Published
DA 2021-04-22
ER

PT J
AU Kim, CJ
   Chang, K
   Kim, BK
   Park, CG
   Jang, Y
AF Kim, Chan Joon
   Chang, Kiyuk
   Kim, Byeong-Keuk
   Park, Chang Gyu
   Jang, Yangsoo
TI An Open-label, Single-arm, Multicenter Feasibility Study Evaluating the
   Safety of Catheter-based Renal Denervation with DENEX (TM) in Patients
   with Uncontrolled Hypertension on Standard Medical Therapy
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Hypertension; Drug resistance; Denervation; Catheter ablation
ID GLOBAL SYMPLICITY REGISTRY; SYMPATHETIC DENERVATION; RESISTANT
   HYPERTENSION; TRIAL
AB Background and Objectives: DENEX (TM) is a novel renal sympathetic denervation (RDN) system that is equipped with 3 electrodes that deliver radiofrequency energy to the renal nerves along renal arteries. The purpose of this study was to evaluate the safety and efficacy of RDN with DENEX (TM) in resistant hypertension.
   Methods: This was an open-label, single-arm, multicenter, first-in-man pilot study. Between November 2016 and May 2018, a total of 16 patients were enrolled at 4 centers in South Korea. The inclusion criteria were systolic blood pressure (SBP) >= 150 mmHg and use of 3 or more antihypertensive medications, including diuretics. The primary objective was the safety outcome of RDN with the DENEX (TM) system. The secondary objective was efficacy outcome based on changes of office, and 24-hour ambulatory SBP from baseline to 3 months. The patients underwent abdominal computed tomography (CT) or duplex ultrasonogram before and 6 months after RDN.
   Results: No major adverse events occurred after RDN for 6 month of follow-up period. There was no vascular complication either by CT or duplex ultrasonogram. The office SBP was significantly reduced from 164.6 +/- 11.6 mmHg at baseline to 142.0 +/- 20.4 mmHg (-24.4 +/- 24.4 mmHg, p=0.003) at 3 months. The ambulatory SBP was reduced from 151.44 +/- 12.85 mmHg at baseline to 140.0 +/- 16.5 mmHg (-13.1 +/- 18.9 mmHg, p=0.056) at 3 months.
   Conclusion: RDN with the DENEX (TM) system showed a favorable safety profile in resistant hypertension. A significant reduction in office SBP and a borderline reduction in ambulatory SBP were observed.
C1 [Kim, Chan Joon] Catholic Univ, Dept Internal Med, Div Cardiol, Uijeongbu St Marys Hosp,Korea Coll Med, Uijongbu, South Korea.
   [Chang, Kiyuk] Catholic Univ, Dept Cardiol, Korea Coll Med, Seoul St Marys Hosp, Seoul, South Korea.
   [Kim, Byeong-Keuk; Jang, Yangsoo] Yonsei Univ, Severance Cardiovasc Hosp, Coll Med, Seoul, South Korea.
   [Park, Chang Gyu] Korea Univ, Coll Med, Cardiovasc Ctr, Guro Hosp, Seoul, South Korea.
RP Jang, Y (corresponding author), Yonsei Univ, Coll Med, Severance Cardiovasc Hosp, Div Cardiol,Dept Internal Med, 50-1 Yonsei Ro, Seoul 03722, South Korea.
EM JANGYS1212@yuhs.ac
OI Kim, Chan Joon/0000-0003-2929-8325
FU Korea Health Technology R&D Project through the Korea Health Industry
   Development Institute - Ministry of Health & Welfare, Republic of Korea
   [HI16C0924, HI20C1566]; Handok Kalos Medical, Seoul, Korea
FX This research was supported by a grant from the Korea Health Technology
   R&D Project through the Korea Health Industry Development Institute,
   funded by the Ministry of Health & Welfare, Republic of Korea (grant No.
   HI16C0924, HI20C1566), and was funded by Handok Kalos Medical, Seoul,
   Korea.
CR Azizi M, 2018, LANCET, V391, P2335, DOI 10.1016/S0140-6736(18)31082-1
   Bhatt DL, 2014, NEW ENGL J MED, V370, P1393, DOI 10.1056/NEJMoa1402670
   Bohm M, 2017, KOREAN CIRC J, V47, P9, DOI 10.4070/kcj.2016.0231
   Bohm M, 2015, HYPERTENSION, V65, P766, DOI 10.1161/HYPERTENSIONAHA.114.05010
   Bohm M, 2020, LANCET, V395, P1444, DOI 10.1016/S0140-6736(20)30554-7
   Esler MD, 2010, LANCET, V376, P1903, DOI 10.1016/S0140-6736(10)62039-9
   Kandzari DE, 2018, LANCET, V391, P2346, DOI 10.1016/S0140-6736(18)30951-6
   Kandzari DE, 2015, EUR HEART J, V36, P219, DOI 10.1093/eurheartj/ehu441
   Kim BK, 2016, J HUM HYPERTENS, V30, P315, DOI 10.1038/jhh.2015.77
   Kim SS, 2020, KOREAN CIRC J, V50, P38, DOI 10.4070/kcj.2019.0106
   Krum H, 2009, LANCET, V373, P1275, DOI 10.1016/S0140-6736(09)60566-3
   Mason E, 2015, EUR HEART J, V36, P535
   Park S, 2019, KOREAN CIRC J, V49, P1002, DOI 10.4070/kcj.2019.0261
   Townsend RR, 2017, LANCET, V390, P2160, DOI 10.1016/S0140-6736(17)32281-X
   Tsioufis C, 2017, HELL J CARDIOL, V58, P320, DOI 10.1016/j.hjc.2017.09.012
   Tzafriri AR, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa3236
   Williams B, 2018, J HYPERTENS, V36, P1953, DOI [10.1097/HJH.0000000000001940, 10.1093/eurheartj/ehy339]
   Worthley SG, 2013, EUR HEART J, V34, P2132, DOI 10.1093/eurheartj/eht197
NR 18
TC 1
Z9 1
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JAN
PY 2021
VL 51
IS 1
BP 43
EP 55
DI 10.4070/kcj.2020.0391
PG 13
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA PN4VN
UT WOS:000604478600003
PM 33377328
OA Green Published
DA 2021-04-22
ER

PT J
AU Jo, SH
AF Jo, Sang-Ho
TI Renal Denervation, Come Back Time?
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
C1 [Jo, Sang-Ho] Hallym Univ, Sacred Heart Hosp, Dept Internal Med, Div Cardiol, 22 Gwanpyeong Ro 170Beon Gil, Anyang 14068, South Korea.
RP Jo, SH (corresponding author), Hallym Univ, Sacred Heart Hosp, Dept Internal Med, Div Cardiol, 22 Gwanpyeong Ro 170Beon Gil, Anyang 14068, South Korea.
EM sophi5neo@gmail.com
CR Bhatt DL, 2014, NEW ENGL J MED, V370, P1393, DOI 10.1056/NEJMoa1402670
   Bohm M, 2017, KOREAN CIRC J, V47, P9, DOI 10.4070/kcj.2016.0231
   Kandzari DE, 2018, LANCET, V391, P2346, DOI 10.1016/S0140-6736(18)30951-6
   Kim CJ, 2021, KOREAN CIRC J, V51, P43, DOI 10.4070/kcj.2020.0391
   Kim SS, 2020, KOREAN CIRC J, V50, P38, DOI 10.4070/kcj.2019.0106
   Lee YS, 2020, KOREAN CIRC J, V50, P50, DOI 10.4070/kcj.2019.0361
   Medtronic, 2020, SYMPL SPYT REN DEN S
   Sharp TE, 2018, J AM COLL CARDIOL, V72, P2609, DOI 10.1016/j.jacc.2018.08.2186
   Townsend RR, 2017, LANCET, V390, P2160, DOI 10.1016/S0140-6736(17)32281-X
   Zheng H, 2019, AM J PHYSIOL-HEART C, V317, pH958, DOI 10.1152/ajpheart.00299.2019
NR 10
TC 0
Z9 0
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JAN
PY 2021
VL 51
IS 1
BP 56
EP 57
DI 10.4070/kcj.2020.0479
PG 2
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA PN4VN
UT WOS:000604478600004
PM 33377329
OA Green Published
DA 2021-04-22
ER

PT J
AU Kim, SH
   Oh, YS
   Choi, Y
   Hwang, Y
   Kim, JY
   Kim, TS
   Kim, JH
   Jang, SW
   Lee, MY
   Joung, B
   Choi, KJ
AF Kim, Sung-Hwan
   Oh, Yong-Seog
   Choi, Young
   Hwang, Youmi
   Kim, Ju-Youn
   Kim, Tae-Seok
   Kim, Ji-Hoon
   Jang, Sung-Won
   Lee, Man Young
   Joung, Boyoung
   Choi, Kee-Joon
TI Long-Term Efficacy of Prophylactic Cavotricuspid Isthmus Ablation during
   Atrial Fibrillation Ablation in Patients Without Typical Atrial Flutter:
   a Prospective, Multicentre, Randomized Trial
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Atrial fibrillation; Atrial flutter; Catheter ablation
ID EXPERT CONSENSUS STATEMENT; PULMONARY VEIN ISOLATION; CATHETER ABLATION;
   SURGICAL ABLATION; FOLLOW-UP; MANAGEMENT; BLOCK
AB Background and Objectives: Cavotricuspid isthmus (CTI) block is easily achieved, and prophylactic ablation can be performed during atrial fibrillation (AF) ablation. However, the previous study was too small and short-term to clarify the efficacy of this block.
   Methods: Patients who underwent catheter ablation for paroxysmal AF were enrolled, and patients who had previous or induced atrial flutter (AFL) were excluded. We randomly assigned 366 patients to pulmonary vein isolation (PVI) only and prophylactic CTI ablation (PVI vs. PVI+CTI).
   Results: There was no significant difference in procedure time between the two groups because most CTI blocks were performed during the waiting time after the PVI (176.8 +/- 72.6 minutes in PVI vs. 174.2 +/- 76.5 minutes in PVI+CTI, p=0.75). All patients were followed up for at least 18 months, and the median follow-up was 3.4 years. The recurrence rate of AF or AFL was not different in the 2 groups (25.7% in PVI vs. 25.7% in PVI+CTI, p=0.92). The recurrence rate of any AFL was not significantly different in the 2 groups (3.3% in PVI vs. 1.6% in PVI+CTI, p=0.31). The recurrence rate of typical AFL also was not different (0.5%in PVI vs. 0.5% in PVI+CTI, p=0.99).
   Conclusions: In this large and long-term follow-up study, prophylactic CTI ablation had no benefit in patients with paroxysmal AF without typical AFL.
C1 [Kim, Sung-Hwan; Oh, Yong-Seog; Choi, Young] Catholic Univ Korea, Coll Med, Dept Internal Med, Div Cardiol,Seoul St Marys Hosp, Seoul, South Korea.
   [Hwang, Youmi; Kim, Ji-Hoon] Catholic Univ Korea, Coll Med, Dept Internal Med, Div Cardiol,St Vincents Hosp, Seoul, South Korea.
   [Kim, Ju-Youn] Catholic Univ Korea, Coll Med, Dept Internal Med, Div Cardiol,Uijeongbu St Marys Hosp, Seoul, South Korea.
   [Kim, Tae-Seok] Catholic Univ Korea, Coll Med, Dept Internal Med, Div Cardiol,Daejeon St Marys Hosp, Seoul, South Korea.
   [Jang, Sung-Won] Catholic Univ Korea, Coll Med, Dept Internal Med, Div Cardiol,Eunpyeong St Marys Hosp, Seoul, South Korea.
   [Lee, Man Young] Catholic Univ Korea, Coll Med, Dept Internal Med, Div Cardiol,Yeouido St Marys Hosp, Seoul, South Korea.
   [Joung, Boyoung] Yonsei Univ, Severance Cardiovasc Hosp, Dept Internal Med, Div Cardiol,Coll Med, Seoul, South Korea.
   [Choi, Kee-Joon] Univ Ulsan, Asan Med Ctr, Dept Cardiol, Coll Med, 88,Olymp Ro 43 Gil, Seoul 05505, South Korea.
RP Choi, KJ (corresponding author), Univ Ulsan, Asan Med Ctr, Dept Cardiol, Coll Med, 88,Olymp Ro 43 Gil, Seoul 05505, South Korea.; Joung, B (corresponding author), Yonsei Univ, Severance Cardiovasc Hosp, Dept Internal Med, Div Cardiol, 50-1 Yonseiro, Seoul 03722, South Korea.
EM cby6908@yuhs.ac; kjchoi@amc.seoul.kr
OI Hwang, You-mi/0000-0001-8385-6485; Kim, Sung-Hwan/0000-0001-6805-0416;
   Joung, Boyoung/0000-0001-9036-7225; Jang, Sung-Won/0000-0001-5272-0665;
   Kim, Tae-Seok/0000-0002-4230-7698
CR Calkins H, 2004, AM J CARDIOL, V94, P437, DOI 10.1016/j.amjcard.2004.04.058
   Calkins H, 2018, EUROPACE, V20, pE1, DOI 10.1093/europace/eux274
   Calkins H, 2012, EUROPACE, V14, P528, DOI 10.1093/europace/eus027
   Chen J, 1999, CIRCULATION, V100, P2507, DOI 10.1161/01.CIR.100.25.2507
   Feld G, 2004, J AM COLL CARDIOL, V43, P1466, DOI 10.1016/j.jacc.2003.11.036
   Hsieh MH, 2002, J INTERV CARD ELECTR, V7, P225, DOI 10.1023/A:1021392105994
   Kirchhof P, 2016, EUR HEART J, V37, P2893, DOI 10.1093/eurheartj/ehw210
   Kumagai K, 2001, JPN HEART J, V42, P79, DOI 10.1536/jhj.42.79
   Mesquita J, 2018, INT J CARDIOL, V259, P82, DOI 10.1016/j.ijcard.2018.01.025
   Oral H, 2005, HEART RHYTHM, V2, P1165, DOI 10.1016/j.hrthm.2005.08.003
   Pontoppidan J, 2009, HEART, V95, P994, DOI 10.1136/hrt.2008.153965
   Roithinger FX, 1997, CIRCULATION, V96, P3484
   Sawhney NS, 2009, CARDIOL CLIN, V27, P55, DOI 10.1016/j.ccl.2008.09.010
   Scharf C, 2004, J AM COLL CARDIOL, V43, P2057, DOI 10.1016/j.jacc.2003.11.063
   Verma A, 2015, NEW ENGL J MED, V372, P1812, DOI 10.1056/NEJMoa1408288
   Winter JB, 2000, J CARDIOVASC ELECTR, V11, P859, DOI 10.1111/j.1540-8167.2000.tb00064.x
NR 16
TC 1
Z9 1
U1 1
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JAN
PY 2021
VL 51
IS 1
BP 58
EP 64
DI 10.4070/kcj.2020.0174
PG 7
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA PN4VN
UT WOS:000604478600005
PM 33150753
OA Green Published
DA 2021-04-22
ER

PT J
AU Choi, EK
AF Choi, Eue-Keun
TI Prophylactic Cavotricuspid Isthmus Ablation in Patients without Typical
   Atrial Flutter: End of the Line
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
ID FIBRILLATION; IMPACT
C1 [Choi, Eue-Keun] Seoul Natl Univ Hosp, Dept Internal Med, Div Cardiol, 101 Daehak Ro, Seoul 03080, South Korea.
RP Choi, EK (corresponding author), Seoul Natl Univ Hosp, Dept Internal Med, Div Cardiol, 101 Daehak Ro, Seoul 03080, South Korea.
EM choiek17@snu.ac.kr
RI Choi, Eue-Keun/J-5968-2014
OI Choi, Eue-Keun/0000-0002-0411-6372
FU BayerBayer AG; BMS/PfizerPfizer; Biosense Webster; Chong Kun Dang;
   Daiichi-SankyoDaiichi Sankyo Company Limited; Samjinpharm;
   Sanofi-AventisSanofi-Aventis; Seers Technology; Skylabs; Yuhan
FX The author has received research grants from Bayer, BMS/Pfizer, Biosense
   Webster, Chong Kun Dang, Daiichi-Sankyo, Samjinpharm, Sanofi-Aventis,
   Seers Technology, Skylabs, and Yuhan.
CR Hwang TH, 2020, KOREAN CIRC J, V50, P346, DOI 10.4070/kcj.2019.0268
   Kim SH, 2021, KOREAN CIRC J, V51, P58, DOI 10.4070/kcj.2020.0174
   Koerber SM, 2019, PACE, V42, P493, DOI 10.1111/pace.13637
   Lee WC, 2019, PACE, V42, P1421, DOI 10.1111/pace.13799
   Mesquita J, 2018, INT J CARDIOL, V259, P82, DOI 10.1016/j.ijcard.2018.01.025
   Mohanty S, 2013, CIRCULATION, V127, P1853, DOI 10.1161/CIRCULATIONAHA.113.001855
   Perez FJ, 2009, CIRC-ARRHYTHMIA ELEC, V2, P393, DOI 10.1161/CIRCEP.109.871665
   Pontoppidan J, 2009, HEART, V95, P994, DOI 10.1136/hrt.2008.153965
   Romero J, 2020, J CARDIOVASC ELECTR, V31, P1987, DOI 10.1111/jce.14614
   Wazni O, 2003, CIRCULATION, V108, P2479, DOI 10.1161/01.CIR.0000101684.88679.AB
NR 10
TC 0
Z9 0
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JAN
PY 2021
VL 51
IS 1
BP 65
EP 67
DI 10.4070/kcj.2020.0417
PG 3
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA PN4VN
UT WOS:000604478600006
PM 33377330
OA Green Published
DA 2021-04-22
ER

PT J
AU Youk, H
   Kim, M
   Lee, CJ
   Oh, J
   Park, S
   Kang, SM
   Kim, JH
   Ann, SJ
   Lee, SH
AF Youk, Harin
   Kim, Miso
   Lee, Chan Joo
   Oh, Jaewon
   Park, Sungha
   Kang, Seok-Min
   Kim, Jeong-Ho
   Ann, Soo-jin
   Lee, Sang-Hak
TI Nlrp3, Csf3, and Edn1 in Macrophage Response to Saturated Fatty Acids
   and Modified Low-Density Lipoprotein
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Atherosclerosis; Metabolic syndrome; Immunity; Obesity
ID INFLAMMASOME; MECHANISM; TLR
AB Background and Objectives: The relationship between metabolic stress, inflammation, and cardiovascular disease is being studied steadily. The aim of this study was to evaluate the effect of palmitate (PA) and minimally modified low-density lipoprotein (mmLDL) on macrophages and to identify the associated pathways.
   Methods: J774 macrophages were incubated with PA or mmLDL and lipopolysaccharide (LPS). Secretion of inflammatory chemokines and the expression of corresponding genes were determined. The phosphorylation of extracellular signal-regulated kinase (ERK) mitogen-activated protein kinase was also assessed. RNA sequencing of macrophages was performed to identify the genes regulated by PA or mmLDL. Some of the genes regulated by the 2 agents were validated by knocking down the cells using small interfering RNA.
   Results: PA or mmLDL promoted the secretion of interleukin (IL)-6 and IL-1 beta in LPS-stimulated macrophages, and this was accompanied by higher phosphorylation of ERK. RNA sequencing revealed dozens of genes that were regulated in this process, such as Csf3and Edn1, which were affected by PA and mmLDL, respectively. These agents also increased NIrp3 expression. The effect of Csf3 or Edn1 silencing on inflammation was modest, whereas toll-like receptor (TLR) 4 inhibition reduced a large proportion of macrophage activation.
   Conclusions: We demonstrated that the proinflammatory milieu with high levels of PA or mmLDL promoted macrophage activation and the expression of associated genes such as NIrp3, 613, and Edn1. Although the TLR4 pathway appeared to be most relevant, additional role of other genes in this process provided insights regarding the potential targets for intervention.
C1 [Youk, Harin; Kim, Miso; Ann, Soo-jin] Yonsei Univ, Grad Program Sci Aging, Grad Sch, Seoul, South Korea.
   [Lee, Chan Joo; Oh, Jaewon; Park, Sungha; Kang, Seok-Min; Lee, Sang-Hak] Yonsei Univ, Severance Hosp, Dept Internal Med, Div Cardiol,Coll Med, 50-1 Yonsei Ro, Seoul 03722, South Korea.
   [Kim, Jeong-Ho] Yonsei Univ, Dept Lab Med, Coll Med, Seoul, South Korea.
RP Lee, SH (corresponding author), Yonsei Univ, Severance Hosp, Dept Internal Med, Div Cardiol,Coll Med, 50-1 Yonsei Ro, Seoul 03722, South Korea.; Ann, SJ (corresponding author), Yonsei Univ, Coll Med, Integrat Res Ctr Cerebrovasc & Cardiovasc Dis, 50-1 Yonsei Ro, Seoul 03722, South Korea.
EM hoppum@yuhs.ac; shl1106@yuhs.ac
OI Lee, Chan Joo/0000-0002-8756-409X; Kang, Seok-Min/0000-0001-9856-9227;
   Oh, Jaewon/0000-0002-4585-1488; Park, Sungha/0000-0001-5362-478X; Kim,
   Jeong-Ho/0000-0003-2479-0548
FU National Research Foundation of Korea - Korean governmentNational
   Research Foundation of KoreaKorean Government [20181D1A1B07043855,
   2019R1F1A1057952]
FX This study was supported by the National Research Foundation of Korea,
   funded by the Korean government (No. 20181D1A1B07043855 and
   2019R1F1A1057952).
CR Adlam D, 2019, J AM COLL CARDIOL, V73, P58, DOI 10.1016/j.jacc.2018.09.085
   Ali L, 2018, CURR OPIN LIPIDOL, V29, P475, DOI 10.1097/MOL.0000000000000550
   Ann SJ, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193649
   Bettencourt IA, 2017, J IMMUNOL, V198, P999, DOI 10.4049/jimmunol.1601318
   Buchheiser A, 2011, CARDIOVASC RES, V92, P338, DOI 10.1093/cvr/cvr218
   Camarena V, 2017, NUTR METAB CARDIOVAS, V27, P739, DOI 10.1016/j.numecd.2017.05.010
   Choi SH, 2017, BBA-MOL CELL BIOL L, V1862, P393, DOI 10.1016/j.bbalip.2016.06.020
   Choi SH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083145
   Chung JH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029100
   Denisenko E, 2019, BMC GENOMICS, V20, DOI 10.1186/s12864-019-5450-6
   Deotare U, 2015, BONE MARROW TRANSPL, V50, P1150, DOI 10.1038/bmt.2015.80
   Eguchi K, 2012, CELL METAB, V15, P518, DOI 10.1016/j.cmet.2012.01.023
   Grebe A, 2018, CIRC RES, V122, P1722, DOI 10.1161/CIRCRESAHA.118.311362
   Hathaway CK, 2015, P NATL ACAD SCI USA, V112, P5141, DOI 10.1073/pnas.1504557112
   Horseman MA, 2017, CURR CARDIOL REV, V13, P86, DOI 10.2174/1573403X12666160901145313
   Houben T, 2017, BBA-MOL CELL BIOL L, V1862, P416, DOI 10.1016/j.bbalip.2016.07.008
   Karagiannis GS, 2013, BMC CARDIOVASC DISOR, V13, DOI 10.1186/1471-2261-13-4
   Korbecki J, 2019, INFLAMM RES, V68, P915, DOI 10.1007/s00011-019-01273-5
   Miller YI, 2005, ARTERIOSCL THROM VAS, V25, P1213, DOI 10.1161/01.ATV.0000159891.73193.31
   Miller YI, 2017, TRENDS ENDOCRIN MET, V28, P143, DOI 10.1016/j.tem.2016.11.002
   Miller YI, 2012, BRIT J PHARMACOL, V167, P990, DOI 10.1111/j.1476-5381.2012.02097.x
   Palomer X, 2018, TRENDS ENDOCRIN MET, V29, P178, DOI 10.1016/j.tem.2017.11.009
   Petrie JR, 2018, CAN J CARDIOL, V34, P575, DOI 10.1016/j.cjca.2017.12.005
   Rhoads JP, 2017, J IMMUNOL, V198, P2105, DOI 10.4049/jimmunol.1601563
   Ridker PM, 2017, NEW ENGL J MED, V377, P1119, DOI 10.1056/NEJMoa1707914
   Rocha DM, 2016, ATHEROSCLEROSIS, V244, P211, DOI 10.1016/j.atherosclerosis.2015.11.015
   Schwartz EA, 2010, ARTERIOSCL THROM VAS, V30, P802, DOI 10.1161/ATVBAHA.109.201681
   Sharma M, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-62272-9
   Tolar P, 2019, NAT IMMUNOL, V20, P1422, DOI 10.1038/s41590-019-0523-x
   Wiesner P, 2010, CIRC RES, V107, P56, DOI 10.1161/CIRCRESAHA.110.218420
NR 30
TC 1
Z9 1
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JAN
PY 2021
VL 51
IS 1
BP 68
EP 80
DI 10.4070/kcj.2020.0117
PG 13
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA PN4VN
UT WOS:000604478600007
PM 32975056
OA Green Published
DA 2021-04-22
ER

PT J
AU Park, JS
   Bae, SH
AF Park, Jeong Su
   Bae, Soo Han
TI Interplay between Saturated Free Fatty Acids and mmLDL Induces
   Inflammation in LPS-stimulated Macrophages
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
C1 [Park, Jeong Su; Bae, Soo Han] Yonsei Univ, Coll Med, Severance Biomed Sci Inst, 50-1 Yonsei Ro, Seoul 03722, South Korea.
   [Bae, Soo Han] Yonsei Univ, Brain Korea 21 PLUS Project Med Sci, Seoul, South Korea.
RP Bae, SH (corresponding author), Yonsei Univ, Coll Med, Severance Biomed Sci Inst, 50-1 Yonsei Ro, Seoul 03722, South Korea.
EM soohanbae@yuhs.ac
OI Bae, Soo Han/0000-0002-8007-2906; Park, Jeong Su/0000-0003-4551-4294
CR Ann SJ, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193649
   Ding SJ, 2019, BIOMOLECULES, V9, DOI 10.3390/biom9120850
   Fusco R, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21124223
   He Y, 2016, TRENDS BIOCHEM SCI, V41, P1012, DOI 10.1016/j.tibs.2016.09.002
   Juliana C, 2012, J BIOL CHEM, V287, P36617, DOI 10.1074/jbc.M112.407130
   Kelley N, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20133328
   Lara-Guzman OJ, 2018, REDOX BIOL, V15, P1, DOI 10.1016/j.redox.2017.11.017
   Wang Y, 2019, MOL MED, V25, DOI 10.1186/s10020-019-0075-4
   Xu L, 2019, J MOL ENDOCRINOL, V62, P197, DOI 10.1530/JME-18-0214
   Youk H, 2021, KOREAN CIRC J, V51, P68, DOI 10.4070/kcj.2020.0117
NR 10
TC 0
Z9 0
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JAN
PY 2021
VL 51
IS 1
BP 81
EP 82
DI 10.4070/kcj.2020.0386
PG 2
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA PN4VN
UT WOS:000604478600008
PM 33150754
OA Green Published
DA 2021-04-22
ER

PT J
AU Cha, SG
   Baek, JS
   Yu, JJ
   Kim, YH
   Kwon, BS
   Choi, ES
   Park, CS
   Yun, TJ
AF Cha, Seul Gi
   Baek, Jae Suk
   Yu, Jeong Jin
   Kim, Young-Hwue
   Kwon, Bo Sang
   Choi, Eun Seok
   Park, Chun Soo
   Yun, Tae-Jin
TI Growth Pattern of the Neo-Aorta after Arterial Switch Operation during
   Childhood
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Aorta; Dilatation; Arterial switch operation
ID LONG-TERM OUTCOMES; GREAT-ARTERIES; ANATOMIC CORRECTION; RISK-FACTORS;
   TRANSPOSITION; ROOT; REGURGITATION; EXPERIENCE
AB Background and Objectives: Neo-aortic root dilatation (ARD) and annular dilatation (AAD) tend to develop after arterial switch operation (ASO). However, the trend of neo-aortic growth has not been well established. This paper aims to identify this trend, its associated factors, and predictors of neo-aortic dilatation after ASO.
   Methods: We analyzed the growth trend of the neo-aortic root, annulus, and sinotubular junction (STJ) z-scores using random coefficients model and the risk factors affecting neoaortic dilatation in 163 patients who underwent ASO from 2006 to 2015.
   Results: Among 163 patients, 41 had a ventricular septal defect, and 11 had Taussig-Bing (TB) anomaly. The median follow-up duration was 6.61 years. The increased in the neo-aortic root z-score was different between the trapdoor and non-trapdoor coronary artery transfer techniques (0.149/year, p<0.001 vs. 0.311/year, p<0.001). Moreover, the neo-aortic annulus and STJ z-score significantly increased over time after ASO (0.067/year, p<0.001; 0.309/year, p<0.001). Pulmonary artery banding (PAB) was rather a negative affecting factor. The probabilities of freedom from ARD, AAD, and neo-aortic STJ dilatation at 10 years after ASO were 33.4%, 53.9%, and 65.4%. Neo-aortic regurgitation within 1 year was the predictor of ARD, AAD, and neo-aortic STJ dilatation. TB anomaly, PAB, and native pulmonary sinus z-score were other predictors for ARD.
   Conclusion: The growth of neo-aortic root, annulus, and STJ after ASO was greater than somatic growth during childhood. The coronary artery transfer technique affected the growth pattern of the neo-aortic root.
C1 [Cha, Seul Gi; Baek, Jae Suk; Yu, Jeong Jin; Kim, Young-Hwue] Univ Ulsan, Asan Med Ctr, Div Pediat Cardiol, Coll Med, 88,Olymp Ro 43 Gil, Seoul 05505, South Korea.
   [Kwon, Bo Sang; Choi, Eun Seok; Park, Chun Soo; Yun, Tae-Jin] Univ Ulsan, Asan Med Ctr, Div Pediat Cardiac Surg, Coll Med, Seoul, South Korea.
RP Baek, JS (corresponding author), Univ Ulsan, Asan Med Ctr, Div Pediat Cardiol, Coll Med, 88,Olymp Ro 43 Gil, Seoul 05505, South Korea.
EM mdjsbaek@amc.seoul.kr
OI Cha, Seul Gi/0000-0001-7470-9774
CR Baruteau AE, 2016, INTERACT CARDIOV TH, V23, P240, DOI 10.1093/icvts/ivw102
   Bove T, 2008, ANN THORAC SURG, V85, P823, DOI 10.1016/j.athoracsur.2007.10.043
   Cantinotti M, 2017, J CARDIOL, V69, P208, DOI 10.1016/j.jjcc.2016.03.010
   Co-Vu JG, 2013, ANN THORAC SURG, V95, P1654, DOI 10.1016/j.athoracsur.2012.10.081
   HOURIHAN M, 1993, CIRCULATION, V88, P615, DOI 10.1161/01.CIR.88.2.615
   Hutter PA, 2001, EUR J CARDIO-THORAC, V20, P82, DOI 10.1016/S1010-7940(01)00752-7
   Hwang HY, 2006, EUR J CARDIO-THORAC, V29, P162, DOI 10.1016/j.ejcts.2005.11.027
   Jacobs JP, 2019, ANN THORAC SURG, V107, P691, DOI 10.1016/j.athoracsur.2018.12.016
   JATENE AD, 1976, J THORAC CARDIOV SUR, V72, P364
   Jhang WK, 2012, EUR J CARDIO-THORAC, V42, P794, DOI 10.1093/ejcts/ezs169
   Lalezari S, 2011, ANN THORAC SURG, V92, P973, DOI 10.1016/j.athoracsur.2011.04.086
   Losay J, 2006, J AM COLL CARDIOL, V47, P2057, DOI 10.1016/j.jacc.2005.12.061
   Marino BS, 2006, CARDIOL YOUNG, V16, P481, DOI 10.1017/S1047951106000953
   McMahon CJ, 2004, PEDIATR CARDIOL, V25, P329, DOI 10.1007/s00246-003-0483-6
   O'Byrne ML, 2018, CIRCULATION, V138, P2119, DOI 10.1161/CIRCULATIONAHA.118.036145
   Rudra HS, 2011, ANN THORAC SURG, V92, P1742, DOI 10.1016/j.athoracsur.2011.04.101
   Schwartz ML, 2004, CIRCULATION, V110, pII128, DOI 10.1161/01.CIR.0000138392.68841.d3
   SIEVERS HH, 1984, CIRCULATION, V70, P202, DOI 10.1161/01.CIR.70.2.202
   van der Palen RLF, 2019, HEART, V105, P1732, DOI 10.1136/heartjnl-2019-315157
   Vandekerckhove KDHM, 2009, EUR J CARDIO-THORAC, V35, P582, DOI 10.1016/j.ejcts.2008.12.034
   Villafane J, 2014, J AM COLL CARDIOL, V64, P498, DOI 10.1016/j.jacc.2014.06.1150
NR 21
TC 0
Z9 0
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JAN
PY 2021
VL 51
IS 1
BP 83
EP 93
DI 10.4070/kcj.2020.0249
PG 11
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA PN4VN
UT WOS:000604478600009
PM 33164353
OA Green Published
DA 2021-04-22
ER

PT J
AU Kim, H
AF Kim, Hyungtae
TI Growth Pattern of the Neo-Aorta after Arterial Switch Operation: What Is
   the Factor of Determination?
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
ID REGURGITATION; PREDICTORS; VALVE
C1 [Kim, Hyungtae] Pusan Natl Univ, Yangsan Hosp, Res Inst Convergence Biomed Sci & Technol, Dept Thorac & Cardiovasc Surg, Yangsan, South Korea.
RP Kim, H (corresponding author), Pusan Natl Univ, Yangsan Hosp, Dept Thorac & Cardiovasc Surg, 20 Geumo Ro, Yangsan 50612, South Korea.
EM 2719k@naver.com
OI Kim, Hyungtae/0000-0003-3972-456X
CR Cha SG, 2020, KOREAN CIRC J, V51, P83
   Formigari R, 2003, J THORAC CARDIOV SUR, V126, P1753, DOI 10.1016/S0022-5223(03)01325-4
   Jhang WK, 2012, EUR J CARDIO-THORAC, V42, P794, DOI 10.1093/ejcts/ezs169
   Lim HG, 2013, EUR J CARDIO-THORAC, V43, P325, DOI 10.1093/ejcts/ezs264
   Lo Rito M, 2015, J THORAC CARDIOV SUR, V149, P1089, DOI 10.1016/j.jtcvs.2014.11.075
   Marino BS, 2006, CARDIOL YOUNG, V16, P481, DOI 10.1017/S1047951106000953
   Mavroudis C, 2011, ANN THORAC SURG, V92, P1747, DOI 10.1016/j.athoracsur.2011.04.102
   Schwartz ML, 2004, CIRCULATION, V110, pII128, DOI 10.1161/01.CIR.0000138392.68841.d3
   Shin HJ, 2020, KOREAN CIRC J, V50, P677, DOI 10.4070/kcj.2019.0364
   van der Palen RLF, 2019, HEART, V105, P1732, DOI 10.1136/heartjnl-2019-315157
NR 10
TC 0
Z9 0
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JAN
PY 2021
VL 51
IS 1
BP 94
EP 96
DI 10.4070/kcj.2020.0494
PG 3
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA PN4VN
UT WOS:000604478600010
PM 33377331
OA Green Published
DA 2021-04-22
ER

PT J
AU Kwon, CH
AF Kwon, Chang Hee
TI Extensive Deep Vein Thrombosis after Electrophysiology Study
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
C1 [Kwon, Chang Hee] Konkuk Univ, Sch Med, Med Ctr, Div Cardiol,Dept Internal Med, 120-1 Neungdong Ro, Seoul 05030, South Korea.
RP Kwon, CH (corresponding author), Konkuk Univ, Sch Med, Med Ctr, Div Cardiol,Dept Internal Med, 120-1 Neungdong Ro, Seoul 05030, South Korea.
EM vertex_77@naver.com
OI Kwon, Chang Hee/0000-0001-8716-1146
NR 0
TC 0
Z9 0
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD DEC
PY 2020
VL 50
IS 12
BP 1129
EP 1130
DI 10.4070/kcj.2020.0337
PG 2
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA PA2SA
UT WOS:000595482400011
PM 33150755
OA Other Gold, Green Published
DA 2021-04-22
ER

PT J
AU Kang, DS
   Park, HJ
   Shim, CY
   Hong, GR
   Seo, J
AF Kang, Dong Seon
   Park, Hee Jun
   Shim, Chi Young
   Hong, Geu Ru
   Seo, Jiwon
TI Pulmonary Artery Obstruction Caused by Leiomyosarcoma
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
C1 [Kang, Dong Seon; Park, Hee Jun; Shim, Chi Young; Hong, Geu Ru; Seo, Jiwon] Yonsei Univ, Coll Med, Dept Internal Med, Div Cardiol, 50-1 Yonsei Ro, Seoul 03722, South Korea.
RP Seo, J (corresponding author), Yonsei Univ, Coll Med, Dept Internal Med, Div Cardiol, 50-1 Yonsei Ro, Seoul 03722, South Korea.
EM eprangiana@yuhs.ac
RI Shim, Chi Young/AAK-1057-2021
OI Shim, Chi Young/0000-0002-6136-0136
NR 0
TC 0
Z9 0
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD DEC
PY 2020
VL 50
IS 12
BP 1127
EP 1128
DI 10.4070/kcj.2020.0349
PG 2
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA PA2SA
UT WOS:000595482400010
PM 33258322
OA Green Published, Other Gold
DA 2021-04-22
ER

PT J
AU Kim, M
   Kim, TH
AF Kim, Min
   Kim, Tae-Hoon
TI Finding Cardiac Resynchronization Therapy Responders: Postprocedural
   QRS-T Morphologies Matter
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
ID IMPROVEMENT; WAVE
C1 [Kim, Min; Kim, Tae-Hoon] Yonsei Univ, Coll Med, Severance Cardiovasc Hosp, Div Cardiol,Dept Internal Med, 50-1 Yonsei Ro, Seoul 03722, South Korea.
RP Kim, TH (corresponding author), Yonsei Univ, Coll Med, Severance Cardiovasc Hosp, Div Cardiol,Dept Internal Med, 50-1 Yonsei Ro, Seoul 03722, South Korea.
EM thkimcardio@yuhs.ac
OI Kim, Tae-Hoon/0000-0003-4200-3456; Kim, Min/0000-0002-8132-9873
CR Bode WD, 2015, HEART RHYTHM, V12, P2141, DOI 10.1016/j.hrthm.2015.06.001
   Hsu JC, 2012, J AM COLL CARDIOL, V59, P2366, DOI 10.1016/j.jacc.2012.01.065
   Jing R, 2020, KOREAN CIRC J, V50, P1062, DOI 10.4070/kcj.2019.0420
   Lee JH, 2019, KOREAN CIRC J, V49, P841, DOI 10.4070/kcj.2018.0444
   MANDEL WJ, 1968, CIRCULATION, V38, P178, DOI 10.1161/01.CIR.38.1.178
   O'Brien T, 2019, KOREAN CIRC J, V49, P384, DOI 10.4070/kcj.2019.0114
   Ponikowski P, 2016, EUR HEART J, V37, P2129, DOI 10.1093/eurheartj/ehw128
   Rad MM, 2016, HEART RHYTHM, V13, P217, DOI 10.1016/j.hrthm.2015.07.033
   Rickard J, 2013, HEART RHYTHM, V10, P55, DOI 10.1016/j.hrthm.2012.09.018
   Zeb M, 2015, INT J CARDIOL, V195, P205, DOI 10.1016/j.ijcard.2015.05.082
NR 10
TC 0
Z9 0
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD DEC
PY 2020
VL 50
IS 12
BP 1074
EP 1076
DI 10.4070/kcj.2020.0434
PG 3
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA PA2SA
UT WOS:000595482400003
PM 33258316
OA Green Published, Other Gold
DA 2021-04-22
ER

PT J
AU Pyun, WB
AF Pyun, Wook Bum
TI Hypertension Control in Young Population: the Earlier, the Better
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
ID CARDIOVASCULAR-DISEASE; ASSOCIATION; ADULTS; RISK
C1 [Pyun, Wook Bum] Ewha Womans Univ, Coll Med, Dept Internal Med, 260 Gonghang Daero, Seoul 07804, South Korea.
RP Pyun, WB (corresponding author), Ewha Womans Univ, Coll Med, Dept Internal Med, 260 Gonghang Daero, Seoul 07804, South Korea.
EM pwb423@ewha.ac.kr
OI Pyun, Wook Bum/0000-0002-6377-0411
CR Jeon YW, 2020, KOREAN CIRC J, V50, P1077, DOI 10.4070/kcj.2020.0208
   Kang J, 2019, ATHEROSCLEROSIS, V282, P188, DOI 10.1016/j.atherosclerosis.2018.11.035
   Nwabuo CC, 2020, EUR J PREV CARDIOL, DOI 10.1177/2047487320915342
   Osei AD, 2020, ATHEROSCLEROSIS, V301, P65, DOI 10.1016/j.atherosclerosis.2020.04.006
   Satoh M, 2019, HYPERTENSION, V73, P52, DOI 10.1161/HYPERTENSIONAHA.118.11635
   Shin J, 2020, KOREAN CIRC J, V50, P476, DOI 10.4070/kcj.2019.0338
   Son JS, 2018, JAMA-J AM MED ASSOC, V320, P1783, DOI 10.1001/jama.2018.16501
   Suvila K, 2019, HYPERTENSION, V74, P305, DOI 10.1161/HYPERTENSIONAHA.119.13069
   Wang C, 2020, J AM COLL CARDIOL, V75, P2921, DOI 10.1016/j.jacc.2020.04.038
   Yano Y, 2017, JAMA CARDIOL, V2, P381, DOI 10.1001/jamacardio.2016.5678
NR 10
TC 0
Z9 0
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD DEC
PY 2020
VL 50
IS 12
BP 1092
EP 1094
DI 10.4070/kcj.2020.0427
PG 3
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA PA2SA
UT WOS:000595482400005
PM 33258317
OA Green Published, Other Gold
DA 2021-04-22
ER

PT J
AU Park, J
AF Park, Junbeom
TI Increased Hb Levels Are Associated with the Incidence of Atrial
   Fibrillation: But Is It Related to the Occurrence of Stroke?
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
ID SHEAR-STRESS
C1 [Park, Junbeom] Ewha Womans Univ, Coll Med, Dept Cardiol, 1071 Anyangcheon Ro, Seoul 07985, South Korea.
RP Park, J (corresponding author), Ewha Womans Univ, Coll Med, Dept Cardiol, 1071 Anyangcheon Ro, Seoul 07985, South Korea.
EM parkjb@ewha.ac.kr
CR Choe WS, 2019, KOREAN CIRC J, V49, P338, DOI 10.4070/kcj.2018.0161
   Fukumoto Y, 2008, J AM COLL CARDIOL, V51, P645, DOI 10.1016/j.jacc.2007.10.030
   Holsworth RE, 2014, PERFUSION-UK, V29, P102, DOI 10.1177/0267659113505637
   Joung B, 2019, KOREAN CIRC J, V49, P794, DOI 10.4070/kcj.2019.0212
   Kameneva MV, 2003, ADV EXP MED BIOL, V530, P689
   Kim IS, 2020, KOREAN CIRC J, V50, P1095, DOI 10.4070/kcj.2020.0412
   Kong KA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185024
   Lee JM, 2018, KOREAN CIRC J, V48, P519, DOI 10.4070/kcj.2017.0389
   Malek AM, 1999, JAMA-J AM MED ASSOC, V282, P2035, DOI 10.1001/jama.282.21.2035
   SULLIVAN JL, 1981, LANCET, V1, P1293
NR 10
TC 0
Z9 0
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD DEC
PY 2020
VL 50
IS 12
BP 1111
EP 1112
DI 10.4070/kcj.2020.0495
PG 2
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA PA2SA
UT WOS:000595482400007
PM 33258319
OA Other Gold, Green Published
DA 2021-04-22
ER

PT J
AU Oh, JH
AF Oh, Jin-Hee
TI Congenital Heart Disease in Premature Infants Less than 1,500 grams: It
   Takes a Delicate Touch from Many Multidisciplinary Experts
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
ID KOREA
C1 [Oh, Jin-Hee] Catholic Univ Korea, St Vincents Hosp, Coll Med, Dept Pediat, 93 Jungbu Daero, Suwon 16247, South Korea.
RP Oh, JH (corresponding author), Catholic Univ Korea, St Vincents Hosp, Coll Med, Dept Pediat, 93 Jungbu Daero, Suwon 16247, South Korea.
EM jeany@catholic.ac.kr
CR Bubberman JM, 2019, J PEDIATR SURG, V54, P1755, DOI 10.1016/j.jpedsurg.2018.11.012
   Chang YH, 2006, PEDIATR CARDIOL, V27, P594, DOI 10.1007/s00246-006-1038-4
   Cho Seon Young, 2012, Korean J Pediatr, V55, P232, DOI 10.3345/kjp.2012.55.7.232
   Day T G, 2019, J Neonatal Perinatal Med, V12, P9, DOI 10.3233/NPM-1861
   Lee JY, 2020, KOREAN CIRC J, V50, P691, DOI 10.4070/kcj.2020.0216
   Schulz A, 2020, THORAC CARDIOV SURG, V68, P30, DOI 10.1055/s-0038-1676617
   Shin HJ, 2020, KOREAN CIRC J, V50, P677, DOI 10.4070/kcj.2019.0364
   Song WS, 2020, KOREAN CIRC J, V50, P1113, DOI 10.4070/kcj.2020.0135
   Yoon Young Mi, 2020, Clin Exp Pediatr, V63, P395, DOI 10.3345/cep.2019.01522
NR 9
TC 0
Z9 0
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD DEC
PY 2020
VL 50
IS 12
BP 1124
EP 1126
DI 10.4070/kcj.2020.0426
PG 3
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA PA2SA
UT WOS:000595482400009
PM 33258321
OA Other Gold, Green Published
DA 2021-04-22
ER

PT J
AU Shim, CY
AF Shim, Chi Young
TI Heart Failure with Preserved Ejection Fraction: the Major Unmet Need in
   Cardiology
SO KOREAN CIRCULATION JOURNAL
LA English
DT Review
DE Heart failure with preserved ejection fraction; Syndrome;
   Pathophysiology; Diagnosis; Treatment
ID LONGITUDINAL FUNCTIONAL RESERVE; VENTRICULAR DIASTOLIC FUNCTION;
   GENDER-RELATED DIFFERENCE; OBSTRUCTIVE SLEEP-APNEA; DIABETES-MELLITUS;
   MYOCARDIAL DYSFUNCTION; CENTRAL HEMODYNAMICS; MECHANICAL FUNCTION;
   ARTERIAL STIFFNESS; FILLING PRESSURE
AB Heart failure with preserved ejection fraction (HFpEF) has recently been recognized as the single greatest unmet need in cardiovascular medicine. As the population ages and the comorbidity increases, the prevalence of HFpEF increases considerably. Even though there have been large numbers of studies on pathophysiology, diagnosis, and treatment of HFpEF for latest years, there are no current pharmacologic interventions that can reduce mortality. HFpEF is currently understood as a heterogeneous syndrome originated from the interplay of cardiac and extracardiac abnormalities recognized by systemic inflammation, endothelial and coronary microvascular dysfunction, cardiomyocyte dysfunction and skeletal muscle dysfunction. The difficult "jigsaw puzzle" called HFpEF has been filled with some pieces, but it is still not enough to meet clinical needs. Here, we review recent evidences and unsolved problems about HFpEF to improve our understanding of HFpEF. Finally, we hope to accelerate to completion of the problematic "jigsaw puzzle".
C1 [Shim, Chi Young] Yonsei Univ, Severance Cardiovasc Hosp, Div Cardiol, Coll Med, 50-1 Yonsei Ro, Seoul 03722, South Korea.
RP Shim, CY (corresponding author), Yonsei Univ, Severance Cardiovasc Hosp, Div Cardiol, Coll Med, 50-1 Yonsei Ro, Seoul 03722, South Korea.
EM cysprs@yuhs.ac
RI Shim, Chi Young/AAK-1057-2021
OI Shim, Chi Young/0000-0002-6136-0136
CR Bhatia RS, 2006, NEW ENGL J MED, V355, P260, DOI 10.1056/NEJMoa051530
   Chirinos JA, 2019, J AM COLL CARDIOL, V74, P1237, DOI 10.1016/j.jacc.2019.07.012
   Choi EY, 2008, J AM SOC ECHOCARDIOG, V21, P487, DOI 10.1016/j.echo.2007.08.041
   Choi EY, 2010, J AM SOC ECHOCARDIOG, V23, P523, DOI 10.1016/j.echo.2010.02.004
   de Groote P, 2004, EUR HEART J, V25, P656, DOI 10.1016/j.ehj.2004.01.010
   Dei Cas A, 2015, JACC-HEART FAIL, V3, P136, DOI 10.1016/j.jchf.2014.08.004
   Dunlay SM, 2017, NAT REV CARDIOL, V14, DOI 10.1038/nrcardio.2017.65
   Fung JWH, 2002, CHEST, V121, P422, DOI 10.1378/chest.121.2.422
   Ha JW, 2009, HEART, V95, P399, DOI 10.1136/hrt.2008.145441
   Ha JW, 2008, CIRC J, V72, P1443, DOI 10.1253/circj.CJ-07-1028
   Ha JW, 2007, HEART, V93, P1571, DOI 10.1136/hrt.2006.101667
   Ha JW, 2020, JACC-CARDIOVASC IMAG, V13, P272, DOI 10.1016/j.jcmg.2019.01.037
   Ha JW, 2005, J AM SOC ECHOCARDIOG, V18, P63, DOI 10.1016/j.echo.2004.08.033
   Heerspink HJL, 2016, CIRCULATION, V134, P752, DOI 10.1161/CIRCULATIONAHA.116.021887
   Henning RJ, 2020, WORLD J CARDIOL, V12, P7, DOI 10.4330/wjc.v12.i1.7
   Holland DJ, 2010, CIRC-CARDIOVASC IMAG, V3, P149, DOI 10.1161/CIRCIMAGING.109.908152
   Kass DA, 2005, HYPERTENSION, V46, P185, DOI 10.1161/01.HYP.0000168053.34306.d4
   Kenchaiah S, 2002, NEW ENGL J MED, V347, P305, DOI 10.1056/NEJMoa020245
   Kim D, 2019, J AM SOC ECHOCARDIOG, V32, P826, DOI 10.1016/j.echo.2019.03.020
   Kim Darae, 2017, Clin Hypertens, V23, P21, DOI 10.1186/s40885-017-0078-9
   Kim MS, 2019, KOREAN CIRC J, V49, P46, DOI 10.4070/kcj.2018.0351
   Kim SA, 2011, HEART, V97, P1233, DOI 10.1136/hrt.2010.219220
   LAUER MS, 1991, JAMA-J AM MED ASSOC, V266, P231, DOI 10.1001/jama.266.2.231
   Lee JS, 2013, CIRC J, V77, P697, DOI 10.1253/circj.CJ-12-1009
   Lee JH, 2019, KOREAN CIRC J, V49, P22, DOI 10.4070/kcj.2018.0349
   Lee JH, 2019, KOREAN CIRC J, V49, P1, DOI 10.4070/kcj.2018.0373
   Lee SG, 2020, KOREAN CIRC J, V50, P443, DOI 10.4070/kcj.2019.0296
   Lewis GA, 2017, J AM COLL CARDIOL, V70, P2186, DOI 10.1016/j.jacc.2017.09.006
   McHugh K, 2019, J AM COLL CARDIOL, V73, P602, DOI 10.1016/j.jacc.2018.11.033
   McNicholas WT, 2007, EUR RESPIR J, V29, P156, DOI 10.1183/09031936.00027406
   Mitchell GF, 2014, HYPERTENSION, V64, P210, DOI 10.1161/HYPERTENSIONAHA.114.03449
   Moon J, 2013, CIRC J, V77, P1742, DOI 10.1253/circj.CJ-12-1378
   Mottram PM, 2005, HEART, V91, P1551, DOI 10.1136/hrt.2004.046805
   Obokata M, 2017, CIRCULATION, V136, P6, DOI 10.1161/CIRCULATIONAHA.116.026807
   Obokata M, 2017, CIRCULATION, V135, P825, DOI 10.1161/CIRCULATIONAHA.116.024822
   Oh CM, 2019, KOREAN CIRC J, V49, P1183, DOI 10.4070/kcj.2019.0180
   Oktay AA, 2015, CURR CARDIOL REV, V11, P42, DOI 10.2174/1573403X09666131117131217
   Owan TE, 2006, NEW ENGL J MED, V355, P251, DOI 10.1056/NEJMoa052256
   Park S, 2008, HYPERTENSION, V51, P1163, DOI 10.1161/HYPERTENSIONAHA.107.106690
   Pfeffer MA, 2019, CIRC RES, V124, P1598, DOI 10.1161/CIRCRESAHA.119.313572
   Ponikowski P, 2016, EUR HEART J, V37, P2129, DOI 10.1093/eurheartj/ehw128
   Shah SJ, 2019, J AM SOC ECHOCARDIOG, V32, P1379, DOI 10.1016/j.echo.2019.08.002
   Shah SJ, 2016, CIRCULATION, V134, P73, DOI 10.1161/CIRCULATIONAHA.116.021884
   Shah SJ, 2015, CIRCULATION, V131, P269, DOI 10.1161/CIRCULATIONAHA.114.010637
   Shah SJ, 2014, HEART FAIL CLIN, V10, P407, DOI 10.1016/j.hfc.2014.04.008
   Shim CY, 2008, METABOLISM, V57, P448, DOI 10.1016/j.metabol.2007.11.003
   Shim CY, 2019, HEART FAIL CLIN, V15, P267, DOI 10.1016/j.hfc.2018.12.006
   Shim CY, 2018, EUR RESPIR J, V51, DOI 10.1183/13993003.01774-2017
   Shim CY, 2015, J HYPERTENS, V33, P612, DOI 10.1097/HJH.0000000000000431
   Shim CY, 2014, J DIABETES INVEST, V5, P362, DOI 10.1111/jdi.12153
   Shim Chi Young, 2011, J Cardiovasc Ultrasound, V19, P62, DOI 10.4250/jcu.2011.19.2.62
   Shim CY, 2013, J AM SOC HYPERTENS, V7, P198, DOI 10.1016/j.jash.2013.01.005
   Shim CY, 2011, AM J HYPERTENS, V24, P1136, DOI 10.1038/ajh.2011.121
   Shim CY, 2011, HEART, V97, P1417, DOI 10.1136/hrt.2010.220467
   Shim CY, 2011, J AM COLL CARDIOL, V57, P1226, DOI 10.1016/j.jacc.2010.09.067
   Silverman Daniel N, 2019, Curr Treat Options Cardiovasc Med, V21, P20, DOI 10.1007/s11936-019-0709-4
   Tadic M, 2019, HEART FAIL REV, V24, P379, DOI 10.1007/s10741-018-09766-x
   Tan YT, 2009, J AM COLL CARDIOL, V54, P36, DOI 10.1016/j.jacc.2009.03.037
   Weber T, 2018, EUR HEART J, V39, P3847, DOI 10.1093/eurheartj/ehy346
   Wiviott SD, 2019, NEW ENGL J MED, V380, P347, DOI 10.1056/NEJMoa1812389
   Wolfe BM, 2016, CIRC RES, V118, P1844, DOI 10.1161/CIRCRESAHA.116.307591
   Yancy CW, 2013, CIRCULATION, V128, P1810, DOI 10.1161/CIR.0b013e31829e8807
   Zile MR, 2004, NEW ENGL J MED, V350, P1953, DOI 10.1056/NEJMoa032566
   Zinman B, 2015, NEW ENGL J MED, V373, P2117, DOI 10.1056/NEJMoa1504720
NR 64
TC 0
Z9 0
U1 2
U2 2
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD DEC
PY 2020
VL 50
IS 12
BP 1051
EP 1061
DI 10.4070/kcj.2020.0338
PG 11
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA PA2SA
UT WOS:000595482400001
PM 33150751
OA Other Gold, Green Published
DA 2021-04-22
ER

PT J
AU Jing, R
   Jin, H
   Hua, W
   Yang, SW
   Hu, YR
   Zhang, S
AF Jing, Ran
   Jin, Han
   Hua, Wei
   Yang, Shengwen
   Hu, Yiran
   Zhang, Shu
TI Association Between Subcutaneous Implantable Cardioverter Defibrillator
   Preimplantation Screening and the Response to Cardiac Resynchronization
   Therapy
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Cardiac resynchronization therapy; Electrocardiography; Prognosis
ID SUPER-RESPONSE; PREDICTORS; ELIGIBILITY; SENSITIVITY; MORTALITY;
   OUTCOMES
AB Background and Objectives: Preimplantation QRS-T morphology screening (TMS) is a composite tool for selecting subcutaneous implantable cardioverter defibrillator (S-ICD) candidates. However, its role in predicting the patient's response to cardiac resynchronization therapy (CRT) is uncertain.
   Methods: A total of 55 consecutive de novo CRT candidates were enrolled between January 2016 and March 2017. Electrocardiogram (ECG) and TMS were performed before and soon after implantation. The ECG parameters were recorded, including QRS duration and morphology (such as Delta QRS_Index, QTc during biventricular pacing mode [BiV pacing QTc], and QRS/T ratio during biventricular pacing mode [BiV pacing QRS/T ratio]). TMS monitored three sensory vectors of the S-ICD. Six months after implantation, the responses to CRT were evaluated.
   Results: Thirty-nine patients (70.9%) passed the TMS during biventricular pacing mode. At the six-month follow-up, the number of responders and super-responders was significantly higher in the passing group than in the non-passing group (responders: 31/39 [79.5%] vs. 5/16 [31.3%], p<0.001; super-responders: 9/39 [23.1%] vs. 1/16 [6.3%], p=0.020). The super-response rate was higher among patients who passed all three vectors than among those who passed 1 or 2 vectors (3 vs. 2 vectors, p=0.018; 3 vs. 1 vector, p=0.003). A smaller left atrial diameter, vectors that passed TMS during biventricular pacing mode, and larger Delta QRS_Index values were independently associated with good CRT response.
   Conclusions: Our study demonstrated that patients on CRT who pass the TMS during biventricular pacing mode are more likely to respond and super-respond to CRT.
C1 [Jing, Ran; Hua, Wei; Yang, Shengwen; Hu, Yiran; Zhang, Shu] Chinese Acad Med Sci & Peking Union Med Coll, Fuwai Hosp, Cardiac Arrhythmia Ctr, 167 Beilishi Rd, Beijing 100037, Peoples R China.
   [Jin, Han] Peking Univ, Dept Cardiol, Hosp 1, Beijing, Peoples R China.
RP Hua, W (corresponding author), Chinese Acad Med Sci & Peking Union Med Coll, Fuwai Hosp, Cardiac Arrhythmia Ctr, 167 Beilishi Rd, Beijing 100037, Peoples R China.
EM drhuaweifw@sina.com
CR Antonio N, 2009, EUROPACE, V11, P343, DOI 10.1093/europace/eup038
   Bacharova L, 2014, CURR CARDIOL REV, V10, P257, DOI 10.2174/1573403X10666140514103220
   Brouwer TF, 2016, J AM COLL CARDIOL, V68, P2047, DOI 10.1016/j.jacc.2016.08.044
   Burke MC, 2015, J AM COLL CARDIOL, V65, P1605, DOI 10.1016/j.jacc.2015.02.047
   Burri H, 2014, EUROPACE, V16, P1865, DOI 10.1093/europace/euu152
   Cai C, 2014, J GERIATR CARDIOL, V11, P296, DOI 10.11909/j.issn.1671-5411.2014.04.004
   Chalil S, 2007, PACE, V30, P1201, DOI 10.1111/j.1540-8159.2007.00841.x
   Corbalan R, 2019, JAMA CARDIOL, V4, P526, DOI 10.1001/jamacardio.2018.4729
   Fontaine JM, 2015, J ELECTROCARDIOL, V48, P226, DOI 10.1016/j.jelectrocard.2014.12.011
   Fujinami M, 2018, J CARDIOL, V71, P299, DOI 10.1016/j.jjcc.2017.09.004
   Groh CA, 2014, HEART RHYTHM, V11, P1361, DOI 10.1016/j.hrthm.2014.04.025
   Guo J P, 2016, Zhonghua Xin Xue Guan Bing Za Zhi, V44, P483, DOI 10.3760/cma.j.issn.0253-3758.2016.06.006
   Hadjis A, 2019, PACE, V42, P431, DOI 10.1111/pace.13638
   Hiraiwa H, 2018, J CARDIOL, V71, P284, DOI 10.1016/j.jjcc.2017.09.002
   Hsu JC, 2012, J AM COLL CARDIOL, V59, P2366, DOI 10.1016/j.jacc.2012.01.065
   Ip JE, 2017, J CARDIOVASC ELECTR, V28, P544, DOI 10.1111/jce.13182
   Kawabata M, 2018, INT HEART J, V59, P951, DOI 10.1536/ihj.17-550
   Killu AM, 2014, J CARD FAIL, V20, P379, DOI 10.1016/j.cardfail.2014.03.001
   Kuperstein R, 2014, CIRC-HEART FAIL, V7, P154, DOI 10.1161/CIRCHEARTFAILURE.113.000748
   Lang RM, 2015, EUR HEART J-CARD IMG, V16, P233, DOI 10.1093/ehjci/jev014
   Nordkamp LRAO, 2014, J CARDIOVASC ELECTR, V25, P494, DOI 10.1111/jce.12343
   Ponikowski P, 2016, EUR HEART J, V37, P2129, DOI 10.1093/eurheartj/ehw128
   Randles DA, 2014, EUROPACE, V16, P1015, DOI 10.1093/europace/eut370
   Rickard J, 2013, HEART RHYTHM, V10, P55, DOI 10.1016/j.hrthm.2012.09.018
   van Stipdonk AMW, 2018, CIRC-ARRHYTHMIA ELEC, V11, DOI 10.1161/CIRCEP.118.006497
   [薛聪 Xue Cong], 2016, [中国循环杂志, Chinese Circulation Journal], V31, P250
   Yanagisawa S, 2014, PACE, V37, P1553, DOI 10.1111/pace.12506
   Zeb M, 2015, INT J CARDIOL, V195, P205, DOI 10.1016/j.ijcard.2015.05.082
   Ziacchi M, 2016, HEART LUNG CIRC, V25, P476, DOI 10.1016/j.hlc.2015.10.016
NR 29
TC 1
Z9 1
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD DEC
PY 2020
VL 50
IS 12
BP 1062
EP 1073
DI 10.4070/kcj.2019.0420
PG 12
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA PA2SA
UT WOS:000595482400002
PM 33150752
OA Green Published, Other Gold
DA 2021-04-22
ER

PT J
AU Jeon, YW
   Kim, HC
AF Jeon, Yong Woo
   Kim, Hyeon Chang
TI Factors Associated with Awareness, Treatment, and Control Rate of
   Hypertension among Korean Young Adults Aged 30-49 Years
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Young adult; Hypertension; Disease management; Epidemiologic factor
ID NATIONAL-HEALTH; PREVALENCE; BURDEN; CHINA
AB Background and objectives: Hypertension awareness, treatment, and control have been substantially improved in the last decades worldwide, but hypertension management in younger adults is still challenged. We analyzed a nationally representative sample of Korea to investigate factors affecting hypertension management among the young Korean population.
   Methods: Among 8,024 young adults aged 30-49 years from the 2014-2018 Korea National Health and Nutrition Examination Survey, 1,103 participants with hypertension were analyzed to identify factors associated with hypertension management status. Multiple logistic regression models were conducted separately by sex.
   Results: Young adults with hypertension showed a low rate of awareness (35.8%), treatment (30.9%), and control (23.0%). The older age (40-49 years), obese (body mass index >= 25.0 kg/m(2)), having diabetes mellitus (DM), and having past-history of cardiovascular disease were positively associated with awareness, and taking health examination in the past 2 years were positively associated with both treatment and control of hypertension among male. Young females who were older (40-49 years), rural residents, unemployed, not taking sodium over the recommended amount, having dyslipidemia, and having DM showed a higher likelihood of awareness. Young females who have not experienced unmet medical needs in the past year were more likely to be treated or controlled with hypertension.
   Conclusions: The factors associated with hypertension awareness, treatment, and control were different by sex and age group. Enhancing attention on hypertension among young hypertension and encouraging them to visit clinics would be key strategies to improve hypertension management among the young hypertensive population.
C1 [Jeon, Yong Woo; Kim, Hyeon Chang] Yonsei Univ, Dept Prevent Med, Coll Med, 50-1 Yonsei Ro, Seoul 03722, South Korea.
   [Kim, Hyeon Chang] Yonsei Univ, Cardiovasc & Metab Dis Etiol Res Ctr, Coll Med, Seoul, South Korea.
RP Kim, HC (corresponding author), Yonsei Univ, Dept Prevent Med, Coll Med, 50-1 Yonsei Ro, Seoul 03722, South Korea.
EM hckim@yuhs.ac
RI Kim, Hyeon Chang/F-8796-2019
OI Kim, Hyeon Chang/0000-0001-7867-1240
CR Cho Eunhee, 2013, [Journal of Korean Academy of Community Health Nursing, 지역사회간호학회지], V24, P419, DOI 10.12799/jkachn.2013.24.4.419
   Cho SMJ, 2020, KOREAN CIRC J, V50, P485, DOI 10.4070/kcj.2019.0347
   Choi HM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178334
   De Venecia T, 2016, POSTGRAD MED, V128, P201, DOI 10.1080/00325481.2016.1147927
   Everett B, 2015, BIODEMOGR SOC BIOL, V61, P1, DOI 10.1080/19485565.2014.929488
   Guo FJ, 2012, J AM COLL CARDIOL, V60, P599, DOI 10.1016/j.jacc.2012.04.026
   Hanyang University College of Medicine, 2014, REP QUAL CONTR ASS B
   Hanyang University College of Medicine, 2018, REP QUAL CONTR ASS B
   Johnson Heather M, 2017, BMC Res Notes, V10, P9, DOI 10.1186/s13104-016-2332-8
   Johnson HM, 2016, BMC FAM PRACT, V17, DOI 10.1186/s12875-016-0428-9
   Kang SH, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-46965-4
   Kim Hyeon Chang, 2019, Clin Hypertens, V25, P16, DOI 10.1186/s40885-019-0121-0
   Kjeldsen S, 2014, DRUGS, V74, P2033, DOI 10.1007/s40265-014-0306-5
   Korean Society Hypertension (KSH), 2018, Clin Hypertens, V24, P13, DOI 10.1186/s40885-018-0098-0
   Kweon S, 2014, INT J EPIDEMIOL, V43, P69, DOI 10.1093/ije/dyt228
   Lee MH, 2012, DIABETES METAB J, V36, P43, DOI 10.4093/dmj.2012.36.1.43
   Li DJ, 2015, INT J CARDIOL, V184, P637, DOI 10.1016/j.ijcard.2015.03.045
   Li TY, 2020, J HUM HYPERTENS, V34, P43, DOI 10.1038/s41371-019-0263-2
   Moon Jong Youn, 2013, J Prev Med Public Health, V46, P353, DOI 10.3961/jpmph.2013.46.6.353
   Olsen MH, 2016, LANCET, V388, P2665, DOI 10.1016/S0140-6736(16)31134-5
   Ostchega Y, 2008, AM J HYPERTENS, V21, P159, DOI 10.1038/ajh.2007.32
   Ostchega Y, 2018, AM J HYPERTENS, V31, P886, DOI 10.1093/ajh/hpy047
   Park JE, 2019, ASIA-PAC J PUBLIC HE, V31, P121, DOI 10.1177/1010539518825006
   Satoh A, 2017, J HYPERTENS, V35, P401, DOI 10.1097/HJH.0000000000001169
   Ueshima H, 2000, J HUM HYPERTENS, V14, P765, DOI 10.1038/sj.jhh.1001054
   World Health Organization, 2000, ASIA PACIFIC PERSPEC
   World Health Organization, 2007, PREV CARD DIS
   World Health Organization, 2010, GLOB REC PHYS ACT HL
   Wu Y, 2009, J HYPERTENS, V27, P190, DOI 10.1097/HJH.0b013e328317c8c3
   2019, LANCET, V394, P639
NR 30
TC 1
Z9 1
U1 1
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD DEC
PY 2020
VL 50
IS 12
BP 1077
EP 1091
DI 10.4070/kcj.2020.0208
PG 15
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA PA2SA
UT WOS:000595482400004
PM 32975054
OA Other Gold, Green Published
DA 2021-04-22
ER

PT J
AU Kim, IS
   Lee, BK
   Yang, PS
   Joung, B
   Kim, JY
AF Kim, In-Soo
   Lee, Byoung Kwon
   Yang, Pil-Sung
   Joung, Boyoung
   Kim, Jong-Youn
TI Sex-based Approach for the Clinical Impact of the Increased Hemoglobin
   on Incident AF in the General Population
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Hemoglobins; Polycythemia; Sex; Atrial fibrillation
ID ATRIAL-FIBRILLATION; SHEAR-STRESS; BLOOD; HEMATOCRIT; DISEASE; RISK;
   GUIDELINES; MORTALITY; STROKE; FLOW
AB Background and Objectives: Although the adverse cardiovascular effect of anemia has been well described, the effect of polycythemia on the incident atrial fibrillation (AF) remain unclear. The objective of this study is to identify the association between increased hemoglobin and incident AF.
   Methods: This was a retrospective-cohort study with 434,269 subjects who underwent national health examinations from the Korean National Sample Cohort. We estimated the risk of incident AF according to hemoglobin-based four-categories.
   Results: During 3.9-year of follow-up, polycythemia group showed higher incidences of AF (hazard ratio[HR] with 95% confidence interval[CI], 1.50 [1.28-1.76] and 1.69 [1.13-2.56); in men and women, respectively) than normal hemoglobin group (each p<0.001). In the normal hemoglobin and polycythemia groups, a 1 g/dL increase in hemoglobin level was associated with increased risks of incident AF (1.12 [1.07-1.17] and 1.18 [1.10-1.26] in men and women, each p<0.001). To investigate the specific hemoglobin concentration related to greater AF incidence, we analyzed the sensitivity/specificity of different hemoglobin levels: >= 16.0 g/dL in men and >= 14.5 g/dL in women showed the highest Youden's index, with c-indices of 0.83 and 0.82, respectively. Kaplan-Meier cumulative-event curves according to these specific hemoglobin levels (>= 16.0 g/dL in men and >= 14.5 g/dL in women) also showed consistent results in both sexes (each p<0.05).
   Conclusions: Even in the Korean general population, increased hemoglobin was significantly associated with higher rate of incident AF. Especially, subjects with hemoglobin levels >= 14.5 g/dL in women and >= 16.0 g/dL among men were associated with increased risk of incident AF.
C1 [Kim, In-Soo; Lee, Byoung Kwon; Kim, Jong-Youn] Yonsei Univ, Gangnam Severance Hosp, Dept Internal Med, Div Cardiol,Coll Med, 211 Eonju Ro, Seoul 06273, South Korea.
   [Yang, Pil-Sung] CHA Univ, CHA Bundang Med Ctr, Dept Cardiol, Seongnam, South Korea.
   [Joung, Boyoung] Yonsei Univ, Dept Internal Med, Div Cardiol, Coll Med, Seoul, South Korea.
RP Kim, JY (corresponding author), Yonsei Univ, Gangnam Severance Hosp, Dept Internal Med, Div Cardiol,Coll Med, 211 Eonju Ro, Seoul 06273, South Korea.
EM jykim0706@yuhs.ac
OI Kim, Jong-Youn/0000-0001-7040-8771; Joung, Boyoung/0000-0001-9036-7225;
   Yang, Pil-sung/0000-0002-6552-1742; Lee, Byoung Kwon/0000-0001-9259-2776
FU "Lee Kyu Suk" Faculty Research Assistance Program of Yonsei University
   College of Medicine [6-2014-0192]; "Lee Kyu Suk" Faculty Research
   Assistance Program of Gangnam Severance Hospital [DHHD000070]; Korean
   Healthcare Technology R&D project - Ministry of Health Welfare
   [HI15C1200, HC19C0130, 6-2020-0158]; Basic Science Research Program
   through the National Research Foundation of Korea - Ministry of
   Education, Science and Technology [NRF-2017R1A2B3003303]; Department of
   Internal Medicine, Yonsei University College of Medicine
   [2019-802080717-4323130]; faculty research grant of Yonsei University
   College of Medicine [2019-802080717-4323130]
FX This study was financially supported by the "Lee Kyu Suk" Faculty
   Research Assistance Program of Yonsei University College of Medicine for
   2014 (6-2014-0192), the "Lee Kyu Suk" Faculty Research Assistance
   Program of Gangnam Severance Hospital for 2020 (DHHD000070), and was
   supported by research grants from the Korean Healthcare Technology R&D
   project funded by the Ministry of Health & Welfare (HI15C1200,
   HC19C0130), a faculty research grant of Department of Internal Medicine,
   Yonsei University College of Medicine for 2019-802080717-4323130, a
   faculty research grant of Yonsei University College of Medicine for
   6-2020-0158, and a research grant from the Basic Science Research
   Program through the National Research Foundation of Korea funded by the
   Ministry of Education, Science and Technology (NRF-2017R1A2B3003303).
CR Barba C, 2004, LANCET, V363, P157, DOI 10.1016/s0140-6736(03)15268-3
   Cetin MS, 2016, KOREAN CIRC J, V46, P784, DOI 10.4070/kcj.2016.46.6.784
   Chao TF, 2015, J AM COLL CARDIOL, V66, P1339, DOI 10.1016/j.jacc.2015.07.026
   Diamond PT, 2003, ARCH PHYS MED REHAB, V84, P964, DOI 10.1016/S0003-9993(03)00009-1
   Fukumoto Y, 2008, J AM COLL CARDIOL, V51, P645, DOI 10.1016/j.jacc.2007.10.030
   Gotoh S, 2015, ATHEROSCLEROSIS, V242, P199, DOI 10.1016/j.atherosclerosis.2015.07.014
   Gotsadze M, 2019, Georgian Med News, P59
   Holsworth RE, 2014, PERFUSION-UK, V29, P102, DOI 10.1177/0267659113505637
   Kameneva MV, 2003, ADV EXP MED BIOL, V530, P689
   Kim BG, 2019, AM J CARDIOL, V124, P1319, DOI 10.1016/j.amjcard.2019.07.056
   Kim IS, 2020, J CARDIOL, V75, P549, DOI 10.1016/j.jjcc.2019.11.004
   Kim M, 2020, IJC HEART VASC, V27, DOI 10.1016/j.ijcha.2020.100507
   KU DN, 1985, ARTERIOSCLEROSIS, V5, P293, DOI 10.1161/01.ATV.5.3.293
   Kunnas T, 2009, PREV MED, V49, P45, DOI 10.1016/j.ypmed.2009.04.015
   LANGILLE BL, 1986, SCIENCE, V231, P405, DOI 10.1126/science.3941904
   Lee J, 2017, INT J EPIDEMIOL, V46, DOI 10.1093/ije/dyv319
   Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006
   Li HP, 2019, PACE, V42, P1197, DOI 10.1111/pace.13776
   Lim WH, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-63878-9
   Lippi G, 2019, WORLD J CARDIOL, V11, P292, DOI 10.4330/wjc.v11.i12.292
   Liu L, 2019, INT HEART J, V60, P1398, DOI 10.1536/ihj.19-131
   Malek AM, 1999, JAMA-J AM MED ASSOC, V282, P2035, DOI 10.1001/jama.282.21.2035
   McKechnie RS, 2004, CIRCULATION, V110, P271, DOI 10.1161/01.CIR.0000134964.01697.C7
   Ponikowski P, 2016, EUR HEART J, V37, P2129, DOI 10.1093/eurheartj/ehw128
   SULLIVAN JL, 1981, LANCET, V1, P1293
   Vaquez BYS, 2008, AM J RESP CELL MOL, V38, P135, DOI 10.1165/rcmb.2007-0081OC
   von Elm E, 2007, ANN INTERN MED, V147, P573, DOI 10.7326/0003-4819-147-8-200710160-00010
   WHO, 2011, HAEM CONC DIAGN AN A
   Wolters FJ, 2019, NEUROLOGY, V93, pE917, DOI 10.1212/WNL.0000000000008003
   YOUDEN WJ, 1950, CANCER, V3, P32, DOI 10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3
NR 30
TC 1
Z9 1
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD DEC
PY 2020
VL 50
IS 12
BP 1095
EP 1110
DI 10.4070/kcj.2020.0412
PG 16
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA PA2SA
UT WOS:000595482400006
PM 33258318
OA Other Gold, Green Published
DA 2021-04-22
ER

PT J
AU Song, WS
   Kim, CY
   Lee, BS
   Kim, EAR
   Kim, KS
   Jung, E
AF Song, Woo Sun
   Kim, Chae Young
   Lee, Byong Sop
   Kim, Ellen Ai-Rhan
   Kim, Ki-Soo
   Jung, Euiseok
TI Morbidity and Mortality of Very Low Birth Weight Infants with Congenital
   Heart Disease
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Congenital heart defect; Preterm infants; Very-low-birth-weight infant;
   Bronchopulmonary dysplasia; Necrotizing enterocolitis
ID PROLONGED MECHANICAL VENTILATION; EXTREMELY PRETERM INFANTS; NECROTIZING
   ENTEROCOLITIS; SURGICAL REPAIR; CARDIAC-SURGERY; RISK-FACTORS
AB Background and objectives: This study aimed to provide morbidity and mortality information on very low birth weight (VLBW) infants with congenital heart disease (CHD-VLBWs).
   Methods: The study used a 10-year cohort of VLBW infants from a single institution. CHD was classified according to International Classification of Diseases, Version 9, Clinical Modification. Mortality and neonatal outcomes were assessed by comparing the CHD-VLBWs with gestational age- and birth weight-matched controls.
   Results: The prevalence of CHD-VLBWs was 7.5% (79/1,050), mean gestational age was 31.1 +/- 3.2 weeks, and mean birth weight was 1,126.2 +/- 268.3 g; 50.6% of the infants were small for the gestational age. The CHD-VLBWs more commonly had bronchopulmonary dysplasia (BPD), and the longer they were exposed to oxygen, the more frequently they developed BPD. Those with cyanotic heart disease developed severe BPD more frequently. Necrotizing enterocolitis (NEC) occurred frequently in the CHD-VLBWs and was not associated with their feeding patterns. CHD-VLBWs had a higher mortality rate; prematurity-related diseases were the leading cause of death before surgery, while heart-related problems were the leading cause of death after surgery. We found no significant difference in mortality from prematurity-related disease between the CHD-VLBWs and controls. In the subgroup analysis of CHD, the cyanotic CHD group had a higher incidence of BPD and higher mortality rate than the acyanotic CHD group.
   Conclusions: CHD-VLBWs showed higher BPD, NEC, and mortality rates than those without CHD. There was also a higher incidence of BPD and mortality in VLBW infants with cyanotic CHD than in those with acyanotic CHD.
C1 [Song, Woo Sun] Univ Eulji, Dept Pediat, Coll Med, Daejeon, South Korea.
   [Kim, Chae Young] Kyung Hee Univ Hosp Gangdong, Dept Pediat, Seoul, South Korea.
   [Lee, Byong Sop; Kim, Ellen Ai-Rhan; Kim, Ki-Soo; Jung, Euiseok] Asan Med Ctr, Dept Pediat, Div Neonatol, Childrens Hosp, 88 Olymp Ro 43 Gil, Seoul 05505, South Korea.
RP Jung, E (corresponding author), Asan Med Ctr, Dept Pediat, Div Neonatol, Childrens Hosp, 88 Olymp Ro 43 Gil, Seoul 05505, South Korea.
EM euisjung@amc.seoul.kr
OI Jung, Euiseok/0000-0003-0693-5627
CR Alrddadi SM, 2019, SAUDI MED J, V40, P367, DOI 10.15537/smj.2019.4.23682
   Bain J, 2014, J PERINATOL, V34, P319, DOI 10.1038/jp.2013.174
   Battersby C, 2018, ARCH DIS CHILD-FETAL, V103, pF182, DOI 10.1136/archdischild-2017-313880
   D'Alto M, 2019, INT J CARDIOL, V290, P156, DOI 10.1016/j.ijcard.2019.05.010
   Dollat C, 2015, PEDIATR CARDIOL, V36, P1279, DOI 10.1007/s00246-015-1158-9
   Fenton TR, 2013, BMC PEDIATR, V13, DOI 10.1186/1471-2431-13-59
   Fisher JG, 2015, J AM COLL SURGEONS, V220, P1018, DOI 10.1016/j.jamcollsurg.2014.11.026
   GARNER A, 1984, ARCH OPHTHALMOL-CHIC, V102, P1130
   Giannone PJ, 2008, LIFE SCI, V82, P341, DOI 10.1016/j.lfs.2007.09.036
   Henderson G, 2009, ARCH DIS CHILD-FETAL, V94, pF120, DOI 10.1136/adc.2007.119560
   Jobe Alan H., 2001, American Journal of Respiratory and Critical Care Medicine, V163, P1723
   Kawahira Y, 2010, J THORAC CARDIOV SUR, V139, P1339, DOI 10.1016/j.jtcvs.2009.08.034
   Kecskes Z, 2002, ARCH DIS CHILD-FETAL, V87, pF31, DOI 10.1136/fn.87.1.F31
   Moons P, 2009, ACTA PAEDIATR, V98, P472, DOI 10.1111/j.1651-2227.2008.01152.x
   Nam HK, 2018, ANN PEDIATR ENDOCRIN, V23, P9, DOI 10.6065/apem.2018.23.1.9
   Neu J, 2011, NEW ENGL J MED, V364, P255, DOI 10.1056/NEJMra1005408
   Norman M, 2020, J AM HEART ASSOC, V9, DOI 10.1161/JAHA.119.015369
   PAPILE LA, 1978, J PEDIATR-US, V92, P529, DOI 10.1016/S0022-3476(78)80282-0
   Pappas A, 2012, PEDIATR CARDIOL, V33, P1415, DOI 10.1007/s00246-012-0375-8
   Polito A, 2013, INTENS CARE MED, V39, P1104, DOI 10.1007/s00134-013-2887-y
   Rios R, 2013, PEDIATR CARDIOL, V34, P1935, DOI 10.1007/s00246-012-0478-2
   Salas AA, 2017, NEONATOLOGY, V112, P211, DOI 10.1159/000472247
   Shi SS, 2008, CHEST, V134, P768, DOI 10.1378/chest.07-2573
   Shim SY, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06490-8
   Simpson C, 2002, PEDIATRICS, V110, P517, DOI 10.1542/peds.110.3.517
   Speer CP, 2006, J PERINATOL, V26, pS57, DOI 10.1038/sj.jp.7211476
   Tanner K, 2005, PEDIATRICS, V116, pE833, DOI 10.1542/peds.2005-0397
   Lopes SAVD, 2018, ARQ BRAS CARDIOL, V111, P666, DOI 10.5935/abc.20180175
   WALSH MC, 1986, PEDIATR CLIN N AM, V33, P179, DOI 10.1016/s0031-3955(16)34975-6
NR 29
TC 1
Z9 1
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD DEC
PY 2020
VL 50
IS 12
BP 1113
EP 1123
DI 10.4070/kcj.2020.0135
PG 11
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA PA2SA
UT WOS:000595482400008
PM 33258320
OA Green Published, Other Gold
DA 2021-04-22
ER

PT J
AU Sahayo, BJ
   Mishra, S
   Kim, SW
   Dambalkar, A
   Phan, QT
   Won, H
   Cho, JH
   Lee, WS
AF Sahayo, Bino John
   Mishra, Sundeep
   Kim, Sang-Wook
   Dambalkar, Arvind
   Quang Tan Phan
   Won, Hoyoun
   Cho, Jun Hwan
   Lee, Wang Soo
TI Rediscover a Missed Culprit Lesion with Optical Coherence Tomography in
   Acute Coronary Syndrome: a Simple Stationary Pullback Method
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
ID PLAQUE
C1 [Sahayo, Bino John; Kim, Sang-Wook; Dambalkar, Arvind; Won, Hoyoun; Cho, Jun Hwan; Lee, Wang Soo] Chung Ang Univ Hosp, Heart Res Inst, Coll Med, 102 Heukseok Ro, Seoul 06973, South Korea.
   [Mishra, Sundeep] All India Inst Med Sci, Dept Cardiol, 425 Mt Kailash Tower,2 East Kailash, New Delhi 110065, India.
   [Quang Tan Phan] Quang Nam Cent Gen Hosp, Intervent Ctr, Quang Nam, Vietnam.
RP Kim, SW (corresponding author), Chung Ang Univ Hosp, Heart Res Inst, Coll Med, 102 Heukseok Ro, Seoul 06973, South Korea.; Mishra, S (corresponding author), All India Inst Med Sci, Dept Cardiol, 425 Mt Kailash Tower,2 East Kailash, New Delhi 110065, India.
EM drsundeepmishra@hotmail.com; swkimcv@cau.ac.kr
OI Kim, Sang-Wook/0000-0002-7208-8596
FU ChungAng University
FX This research was supported by the ChungAng University Research Grants
   in 2019.
CR Jang IK, 2005, CIRCULATION, V111, P1551, DOI 10.1161/01.CIR.0000159354.43778.69
   Kubo T, 2007, J AM COLL CARDIOL, V50, P933, DOI 10.1016/j.jacc.2007.04.082
   Kwon JE, 2016, KOREAN CIRC J, V46, P499, DOI 10.4070/kcj.2016.46.4.499
NR 3
TC 0
Z9 0
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD NOV
PY 2020
VL 50
IS 11
BP 1043
EP 1044
DI 10.4070/kcj.2020.0081
PG 2
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA PA1RS
UT WOS:000595404500013
PM 32725999
OA Green Published
DA 2021-04-22
ER

PT J
AU Kim, S
   Lee, SY
   Kim, Y
   Lee, DI
   Lee, JH
   Bae, JW
   Hwang, KK
   Cho, MC
AF Kim, Sangmin
   Lee, Sang Yeub
   Kim, Yongcheol
   Lee, Dae In
   Lee, Ju-Hee
   Bae, Jang-Whan
   Hwang, Kyung-Kuk
   Cho, Myeong-Chan
TI ISOptical Coherent Tomographic (OCT) Finding of Radial Arterial
   Recanalization
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
C1 [Kim, Sangmin; Lee, Sang Yeub; Lee, Dae In; Lee, Ju-Hee; Bae, Jang-Whan; Hwang, Kyung-Kuk; Cho, Myeong-Chan] Chungbuk Natl Univ Hosp, Reg Cardiovasc Dis Ctr, Cheongju, South Korea.
   [Lee, Sang Yeub; Bae, Jang-Whan; Hwang, Kyung-Kuk; Cho, Myeong-Chan] Chungbuk Natl Univ, Coll Med, Dept Internal Med, Div Cardiol, 776,1Sunhwan Ro, Cheongju 28644, South Korea.
   [Kim, Yongcheol] Yonsei Univ, Coll Med, Dept Internal Med, Div Cardiol, Yongin, South Korea.
   [Kim, Yongcheol] Yongin Severance Hosp, Cardiovasc Ctr, Yongin, South Korea.
RP Lee, SY (corresponding author), Chungbuk Natl Univ, Coll Med, Dept Internal Med, Div Cardiol, 776,1Sunhwan Ro, Cheongju 28644, South Korea.
EM louisahj@gmail.com
OI Cho, Myeong-Chan/0000-0002-0047-0227; Kim, Sangmin/0000-0002-1300-6079;
   Lee, sang yeub/0000-0003-1386-349X; Hwang,
   Kyung-Kuk/0000-0003-3464-3023; Kim, Yongcheol/0000-0001-5568-4161
CR Bae DH, 2019, CARDIOL J, V26, P610, DOI 10.5603/CJ.2019.0102
   Kadowaki H, 2016, HEART VESSELS, V31, P124, DOI 10.1007/s00380-014-0567-7
   Kang SJ, 2012, JACC-CARDIOVASC IMAG, V5, P725, DOI 10.1016/j.jcmg.2012.03.012
   Kim Y, 2020, KOREAN J INTERN MED
   Kim Y, 2018, KOREAN CIRC J, V48, P532, DOI [10.4070/kcj.2018.0016, 10.4070/kcj.2018.0181]
NR 5
TC 0
Z9 0
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD NOV
PY 2020
VL 50
IS 11
BP 1045
EP 1047
DI 10.4070/kcj.2020.0110
PG 3
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA PA1RS
UT WOS:000595404500014
PM 32725994
OA Other Gold, Green Published
DA 2021-04-22
ER

PT J
AU Kaneko, U
   Kashima, Y
   Sugie, T
   Kanno, D
   Fujita, T
AF Kaneko, Umihiko
   Kashima, Yoshifumi
   Sugie, Takuro
   Kanno, Daitaro
   Fujita, Tsutomu
TI Rotablator Driveshaft Fracture Due to Significant Proximal Tortuosity
   and Enlargement Causing Massive Coronary Perforation
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
C1 [Kaneko, Umihiko; Kashima, Yoshifumi; Sugie, Takuro; Kanno, Daitaro; Fujita, Tsutomu] Sapporo Heart Ctr, Sapporo Cardio Vasc Clin, Dept Cardiovasc Med, North 49,East 16,8-1 Higashi Ward, Sapporo, Hokkaido 0070849, Japan.
RP Kaneko, U (corresponding author), Sapporo Heart Ctr, Sapporo Cardio Vasc Clin, Dept Cardiovasc Med, North 49,East 16,8-1 Higashi Ward, Sapporo, Hokkaido 0070849, Japan.
EM uk434471@gmail.com
OI Kanno, Daitaro/0000-0002-5216-3608; Sugie, Takuro/0000-0001-6660-1464;
   fujita, tsutomu/0000-0002-3651-6231
CR Latsios G, 2019, CARDIOVASC REVASCULA, V20, pS13, DOI 10.1016/j.carrev.2019.03.020
   Ogita M, 2018, CASE REP CARDIOL, V2018, DOI 10.1155/2018/5927161
NR 2
TC 1
Z9 1
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD NOV
PY 2020
VL 50
IS 11
BP 1048
EP 1050
DI 10.4070/kcj.2020.0136
PG 3
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA PA1RS
UT WOS:000595404500015
PM 32725997
OA Green Published
DA 2021-04-22
ER

PT J
AU Lee, HS
   Kang, J
AF Lee, Hak Seung
   Kang, Jeehoon
TI Renin-Angiotensin System Blockade in Acute Myocardial Infarction: Is
   There a Winner?
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
ID CAPTOPRIL; TRIAL
C1 [Kang, Jeehoon] Seoul Natl Univ Hosp, Dept Internal Med, Seoul, South Korea.
   Seoul Natl Univ Hosp, Cardiovasc Ctr, Seoul, South Korea.
RP Kang, J (corresponding author), Seoul Natl Univ Hosp, Dept Internal Med, Seoul, South Korea.
EM medikang@gmail.com
OI Lee, Hak Seung/0000-0002-2200-6601; Kang, Jeehoon/0000-0002-9078-2231
CR COLLINS R, 1995, LANCET, V345, P669
   Gayet JL, 2002, LANCET, V360, P1884, DOI 10.1016/S0140-6736(02)11745-4
   Hall AS, 2007, HEART, V93, P1011, DOI 10.1136/hrt.2006.107185
   Ibanez B, 2018, EUR HEART J, V39, P119, DOI 10.1093/eurheartj/ehx393
   Kim GS, 2020, KOREAN CIRC J, V50, P984, DOI 10.4070/kcj.2020.0057
   Kim I, 2019, KOREAN CIRC J, V49, P615, DOI 10.4070/kcj.2018.0379
   Mogensen UM, 2017, AM HEART J, V188, P35, DOI 10.1016/j.ahj.2017.02.034
   Pfeffer MA, 2003, NEW ENGL J MED, V349, P1893, DOI 10.1056/NEJMoa032292
   Strauss MH, 2006, CIRCULATION, V114, P838, DOI 10.1161/CIRCULATIONAHA.105.594986
   Won H, 2020, KOREAN CIRC J, V50, P499, DOI 10.4070/kcj.2019.0231
NR 10
TC 0
Z9 0
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD NOV
PY 2020
VL 50
IS 11
BP 995
EP 997
DI 10.4070/kcj.2020.0398
PG 3
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA PA1RS
UT WOS:000595404500004
PM 33118333
OA Green Published, Other Gold
DA 2021-04-22
ER

PT J
AU Shim, J
AF Shim, Jaemin
TI Management of Tachycarida-bradycardia Syndrome: To Pace or to Ablate,
   That Is the Question
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
ID SINUS NODE FUNCTION; ATRIAL-FIBRILLATION; CATHETER ABLATION
C1 [Shim, Jaemin] Korea Univ, Coll Med, Dept Internal Med, Div Cardiol, 73 Goryeodae Ro, Seoul 02841, South Korea.
   [Shim, Jaemin] Korea Univ, Med Ctr, 73 Goryeodae Ro, Seoul 02841, South Korea.
RP Shim, J (corresponding author), Korea Univ, Coll Med, Dept Internal Med, Div Cardiol, 73 Goryeodae Ro, Seoul 02841, South Korea.; Shim, J (corresponding author), Korea Univ, Med Ctr, 73 Goryeodae Ro, Seoul 02841, South Korea.
EM jaemins@korea.ac.kr
OI Shim, Jaemin/0000-0001-8251-1522
CR Andrade JG, 2012, PACE, V35, P106, DOI 10.1111/j.1540-8159.2011.03256.x
   Cho SC, 2020, KOREAN CIRC J, V50, P998, DOI 10.4070/kcj.2020.0065
   Elvan A, 1996, CIRCULATION, V94, P2953, DOI 10.1161/01.CIR.94.11.2953
   Gillis AM, 2002, J CARDIOVASC ELECTR, V13, P542, DOI 10.1046/j.1540-8167.2002.00542.x
   Go AS, 2018, JAMA CARDIOL, V3, P601, DOI 10.1001/jamacardio.2018.1176
   Hocini M, 2003, CIRCULATION, V108, P1172, DOI 10.1161/01.CIR.0000090685.13169.07
   Inada K, 2014, EUROPACE, V16, P208, DOI 10.1093/europace/eut159
   Jackson LR, 2016, CLIN CARDIOL, V39, P119, DOI 10.1002/clc.22504
   Kim DH, 2018, BMC CARDIOVASC DISOR, V18, DOI 10.1186/s12872-018-0834-0
   Lamas GA, 2002, NEW ENGL J MED, V346, P1854, DOI 10.1056/NEJMoa013040
NR 10
TC 0
Z9 0
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD NOV
PY 2020
VL 50
IS 11
BP 1010
EP 1012
DI 10.4070/kcj.2020.0363
PG 3
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA PA1RS
UT WOS:000595404500006
PM 33118334
OA Green Published, Other Gold
DA 2021-04-22
ER

PT J
AU Kim, SJ
AF Kim, Soo-Jin
TI Pediatric Acute Myocarditis: Current Approach to Diagnosis and Treatment
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
ID CARDIOVASCULAR MAGNETIC-RESONANCE
C1 [Kim, Soo-Jin] Yonsei Univ, Coll Med, Yongin Severance Hosp, Dept Pediat, 363 Dongbaekjukjeon Daero, Yongin 16995, South Korea.
RP Kim, SJ (corresponding author), Yonsei Univ, Coll Med, Yongin Severance Hosp, Dept Pediat, 363 Dongbaekjukjeon Daero, Yongin 16995, South Korea.
EM ksoojn@naver.com
CR Arola A, 2017, J AM HEART ASSOC, V6, DOI 10.1161/JAHA.116.005306
   Caforio ALP, 2015, HEART, V101, P1332, DOI 10.1136/heartjnl-2014-306363
   Cooper LT, 2007, CIRCULATION, V116, P2216, DOI 10.1161/CIRCULATIONAHA.107.186093
   Ferreira VM, 2018, J AM COLL CARDIOL, V72, P3158, DOI 10.1016/j.jacc.2018.09.072
   Friedrich MG, 2009, J AM COLL CARDIOL, V53, P1475, DOI 10.1016/j.jacc.2009.02.007
   Kim J, 2020, KOREAN CIRC J, V50, P1013, DOI 10.4070/kcj.2020.0108
   LIEBERMAN EB, 1991, J AM COLL CARDIOL, V18, P1617, DOI 10.1016/0735-1097(91)90493-S
   May LJ, 2011, CARDIOL YOUNG, V21, P241, DOI 10.1017/S1047951110001964
   Shin YR, 2019, KOREAN CIRC J, V49, P678, DOI 10.4070/kcj.2019.0163
NR 9
TC 0
Z9 0
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD NOV
PY 2020
VL 50
IS 11
BP 1023
EP 1025
DI 10.4070/kcj.2020.0389
PG 3
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA PA1RS
UT WOS:000595404500008
PM 33118335
OA Other Gold, Green Published
DA 2021-04-22
ER

PT J
AU Rha, SW
AF Rha, Seung-Woon
TI Is Hospital Percutaneous Coronary Intervention Volume-In-hospital
   Outcome Relation an Issue in Acute Myocardial Infarction?
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
ID OPERATOR; IMPACT
C1 [Rha, Seung-Woon] Korea Univ, Guro Hosp, Cardiovasc Ctr, 148 Gurodong Ro, Seoul 08308, South Korea.
RP Rha, SW (corresponding author), Korea Univ, Guro Hosp, Cardiovasc Ctr, 148 Gurodong Ro, Seoul 08308, South Korea.
EM swrha617@yahoo.co.kr
CR Badheka AO, 2014, CIRCULATION, V130, P1392, DOI 10.1161/CIRCULATIONAHA.114.009281
   Canto JG, 2000, NEW ENGL J MED, V342, P1573, DOI 10.1056/NEJM200005253422106
   Dawkins KD, 2005, HEART, V91, DOI 10.1136/hrt.2005.061457
   Harold JG, 2013, J AM COLL CARDIOL, V62, P357, DOI 10.1016/j.jacc.2013.05.002
   Inohara T, 2017, JACC-CARDIOVASC INTE, V10, P918, DOI 10.1016/j.jcin.2017.02.015
   Kim BK, 2020, KOREAN CIRC J, V50, P1026, DOI 10.4070/kcj.2020.0172
   Kim JH, 2019, KOREAN CIRC J, V49, P1022, DOI 10.4070/kcj.2019.0074
   Matsuzawa Y, 2020, CIRC J, V84, P1140, DOI 10.1253/circj.CJ-19-0869
   Shin DH, 2019, KOREAN CIRC J, V49, P1136, DOI 10.4070/kcj.2018.0413
   Windecker S, 2015, EUROINTERVENTION, V10, P1024, DOI 10.4244/EIJY14M09_01
NR 10
TC 0
Z9 0
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD NOV
PY 2020
VL 50
IS 11
BP 1037
EP 1039
DI 10.4070/kcj.2020.0383
PG 3
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA PA1RS
UT WOS:000595404500010
PM 33118337
OA Green Published, Other Gold
DA 2021-04-22
ER

PT J
AU Yeo, KK
   Wong, N
AF Yeo, Khung Keong
   Wong, Ningyan
TI Percutaneous Edge-to-Edge Mitral Valve Repair
SO KOREAN CIRCULATION JOURNAL
LA English
DT Review
DE Mitral regurgitation; Percutaneous mitral valve repair
ID VALVULAR HEART-DISEASE; 2014 AHA/ACC GUIDELINE; EXERCISE CAPACITY; RISK
   PATIENTS; TASK-FORCE; FOLLOW-UP; REGURGITATION; MANAGEMENT; OUTCOMES;
   THERAPY
AB Percutaneous edge-to-edge mitral valve repair, using the MitraClip device for severe mitral regurgitation (MR) was first introduced in 2003. Since then, more than 100,000 cases have been performed worldwide and it remains the most established percutaneous therapy available for the treatment of severe MR. Currently, it is indicated for severe, symptomatic functional MR in patients who continue to have significant symptoms despite optimal guideline directed medical therapy, as well as in symptomatic patients with severe degenerative MR who are deemed too high risk for conventional surgical therapy in the opinion of the heart team. In this paper, we discuss the evolution of the MitraClip device, the clinical studies supporting its use as well as the important concept of proportionate and disproportionate MR.
C1 [Yeo, Khung Keong; Wong, Ningyan] Natl Heart Ctr Singapore, 5 Hosp Dr, Singapore 169609, Singapore.
   [Yeo, Khung Keong; Wong, Ningyan] Duke NUS Med Sch, Singapore, Singapore.
RP Yeo, KK (corresponding author), Natl Heart Ctr Singapore, 5 Hosp Dr, Singapore 169609, Singapore.
EM yeo.khung.keong@singhealth.com.sg
OI Yeo, Khung Keong/0000-0002-5457-4881
CR Asch FM, 2019, J AM COLL CARDIOL, V74, P2969, DOI 10.1016/j.jacc.2019.09.017
   Baldus S, 2012, EUR J HEART FAIL, V14, P1050, DOI 10.1093/eurjhf/hfs079
   Baumgartner H, 2017, EUR HEART J, V38, P2739, DOI 10.1093/eurheartj/ehx391
   Condado JA, 2006, CATHETER CARDIO INTE, V67, P323, DOI 10.1002/ccd.20603
   Condado Jose Antonio, 2003, J Interv Cardiol, V16, P523, DOI 10.1046/j.1540-8183.2003.01052.x
   Duino V, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000000608
   Feldman T, 2005, J AM COLL CARDIOL, V46, P2134, DOI 10.1016/j.jacc.2005.07.065
   Feldman T, 2018, ANN CARDIOTHORAC SUR, V7, P755, DOI 10.21037/acs.2018.07.04
   Feldman T, 2011, NEW ENGL J MED, V364, P1395, DOI 10.1056/NEJMoa1009355
   Feldman T, 2009, J AM COLL CARDIOL, V54, P686, DOI 10.1016/j.jacc.2009.03.077
   Glower DD, 2014, J AM COLL CARDIOL, V64, P172, DOI 10.1016/j.jacc.2013.12.062
   Grayburn PA, 2019, JACC-CARDIOVASC IMAG, V12, P353, DOI 10.1016/j.jcmg.2018.11.006
   Grayburn PA, 2014, J AM COLL CARDIOL, V64, P2792, DOI 10.1016/j.jacc.2014.10.016
   Grayburn PA, 2012, CIRCULATION, V126, P2005, DOI 10.1161/CIRCULATIONAHA.112.121590
   Hayashida K, 2017, CIRC J, V81, P1116, DOI 10.1253/circj.CJ-17-0115
   Izumo M, 2011, EUR J ECHOCARDIOGR, V12, P54, DOI 10.1093/ejechocard/jeq105
   Lancellotti P, 2005, EUR HEART J, V26, P1528, DOI 10.1093/eurheartj/ehi189
   Lapu-Bula R, 2002, CIRCULATION, V106, P1342, DOI 10.1161/01.CIR.0000028812.98083.D9
   Lee CW, 2018, J CHIN MED ASSOC, V81, P305, DOI 10.1016/j.jcma.2017.11.006
   Lim DS, 2019, JACC-CARDIOVASC INTE, V12, P1369, DOI 10.1016/j.jcin.2019.04.034
   Lim DS, 2014, J AM COLL CARDIOL, V64, P182, DOI 10.1016/j.jacc.2013.10.021
   Mack MJ, 2018, AM HEART J, V205, P1, DOI 10.1016/j.ahj.2018.07.021
   Maisano F, 2013, J AM COLL CARDIOL, V62, P1052, DOI 10.1016/j.jacc.2013.02.094
   Masumoto A, 2019, JACC-CARDIOVASC INTE, V12, pE215, DOI 10.1016/j.jcin.2019.09.021
   Nickenig G, 2019, LANCET, V394, P2002, DOI 10.1016/S0140-6736(19)32600-5
   Nickenig G, 2014, J AM COLL CARDIOL, V64, P875, DOI 10.1016/j.jacc.2014.06.1166
   Nishimura RA, 2014, J AM COLL CARDIOL, V63, P2438, DOI 10.1016/j.jacc.2014.02.537
   Nishimura RA, 2014, CIRCULATION, V129, pE521, DOI 10.1161/CIR.0000000000000031
   Obadia JF, 2018, NEW ENGL J MED, V379, P2297, DOI 10.1056/NEJMoa1805374
   Obadia JF, 2015, EUROINTERVENTION, V10, P1354, DOI 10.4244/EIJV10I11A232
   Rogers JH, 2011, EUR HEART J, V32, P2350, DOI 10.1093/eurheartj/ehr101
   Schafer U, 2015, EUROINTERVENTION, V11, P942, DOI 10.4244/EIJY14M08_13
   Sorajja P, 2017, J AM COLL CARDIOL, V70, P2315, DOI 10.1016/j.jacc.2017.09.015
   Sorajja P, 2016, J AM COLL CARDIOL, V67, P2811, DOI 10.1016/j.jacc.2016.03.587
   Stone GW, 2018, NEW ENGL J MED, V379, P2307, DOI 10.1056/NEJMoa1806640
   Stone GW, 2019, NEW ENGL J MED, V380, P1980, DOI 10.1056/NEJMc1903982
   Szymanski C, 2011, AM J CARDIOL, V108, P1714, DOI 10.1016/j.amjcard.2011.07.045
   Taramasso M, 2019, JACC-CARDIOVASC INTE, V12, P155, DOI 10.1016/j.jcin.2018.10.022
   Tay E, 2016, CATHETER CARDIO INTE, V87, pE275, DOI 10.1002/ccd.26289
   Vahanian A, 2012, GUIDELINES MANAGEMEN, DOI [10.4070/kcj.2020.0308, DOI 10.4070/KCJ.2020.0308]
   Vahanian A, 2012, EUR J CARDIO-THORAC, V42, pS1, DOI 10.1093/ejcts/ezs455
   Wong N, 2018, EUR HEART J CASE REP, V2
   Yeo KK, 2014, EUROINTERVENTION, V10, P620, DOI 10.4244/EIJV10I5A107
   Zoghbi WA, 2003, J AM SOC ECHOCARDIOG, V16, P777, DOI 10.1016/S0894-7317(03)00335-3
NR 44
TC 0
Z9 0
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD NOV
PY 2020
VL 50
IS 11
BP 961
EP 973
DI 10.4070/kcj.2020.0308
PG 13
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA PA1RS
UT WOS:000595404500001
PM 32975055
OA Green Published, Other Gold
DA 2021-04-22
ER

PT J
AU Lee, KY
   Lee, BK
   Kim, WJ
   Kang, SH
   Park, TK
   Kim, SY
   Suh, JW
   Yoon, CH
   Yang, DH
   Ryu, SK
   Kim, SH
   Lee, SY
   Chae, IH
AF Lee, Kwan Yong
   Lee, Bong-Ki
   Kim, Won-Jang
   Kang, Se Hun
   Park, Taek Kyu
   Kim, Song-Yi
   Suh, Jung-Won
   Yoon, Chang-Hwan
   Yang, Dong Heon
   Ryu, Sung Kee
   Kim, Sang-Hyun
   Lee, Sung Yun
   Chae, In-Ho
CA Korean Soc Interventional Cardiolo
TI Consensus Statement on Coronary Intervention during the Coronavirus
   Disease 2019 (COVID-19) Pandemic: from the Korean Society of
   Interventional Cardiology (KSIC)
SO KOREAN CIRCULATION JOURNAL
LA English
DT Review
DE COVID-19; Cardiovascular diseases; Coronary angiography; Percutaneous
   coronary intervention; Practice guideline
AB Coronavirus disease 2019 (COVID-19) is a highly contagious disease caused by the novel virus severe acute respiratory syndrome coronavirus-2. The first case developed in December, 2019 in Wuhan, China; several months later, COVID-19 has become pandemic, and there is no end in sight. This disaster is also causing serious health problems in the area of cardiovascular intervention. In response, the Korean Society of Interventional Cardiology formed a COVID-19 task force to develop practice guidelines. This special article introduces clinical practice guidelines to prevent secondary transmission of COVID-19 within facilities; the guidelines were developed to protect patients and healthcare workers from this highly contagious virus. We hope these guidelines help healthcare workers and cardiovascular disease patients around the world cope with the COVID-19 pandemic.
C1 [Lee, Kwan Yong] Catholic Univ Korea, Dept Cardiol, Incheon St Marys Hosp, Incheon, South Korea.
   [Lee, Bong-Ki] Kangwon Natl Univ, Kangwon Natl Univ Hosp, Dept Internal Med, Div Cardiol,Sch Med, Chunchon, South Korea.
   [Kim, Won-Jang; Kang, Se Hun] CHA Univ, CHA Bundang Med Ctr, Dept Cardiol, Sch Med, Seongnam, South Korea.
   [Park, Taek Kyu] Sungkyunkwan Univ, Heart Vasc & Stroke Inst, Samsung Med Ctr, Div Cardiol,Dept Med,Sch Med, Seoul, South Korea.
   [Kim, Song-Yi] Jeju Natl Univ, Jeju Natl Univ Hosp, Dept Internal Med, Div Cardiol,Sch Med, Jeju, South Korea.
   [Suh, Jung-Won; Yoon, Chang-Hwan; Chae, In-Ho] Seoul Natl Univ, Cardiovasc Ctr, Bundang Hosp, 82 Gumi Ro 173 Beon Gil, Seongnam 13620, South Korea.
   [Yang, Dong Heon] Kyungpook Natl Univ Hosp, Sch Med, Dept Internal Med, Div Cardiol, Daegu, South Korea.
   [Ryu, Sung Kee] Eulji Univ, Nowon Eulji Med Ctr, Div Cardiol, Seoul, South Korea.
   [Kim, Sang-Hyun] Seoul Natl Univ, Seoul Boramae Hosp, Div Cardiol, Coll Med, Seoul, South Korea.
   [Lee, Sung Yun] Inje Univ, Cardiac & Vasc Ctr, Ilsan Paik Hosp, Goyang, South Korea.
RP Chae, IH (corresponding author), Seoul Natl Univ, Cardiovasc Ctr, Bundang Hosp, 82 Gumi Ro 173 Beon Gil, Seongnam 13620, South Korea.
EM ihchae@snu.ac.kr
OI Kim, Song-Yi/0000-0002-1170-8165; Lee, Kwan yong/0000-0002-0480-1046;
   Yoon, Chang-Hwan/0000-0001-6305-4442; RYU, SUNG KEE/0000-0003-1673-0166;
   Suh, Jung-Won/0000-0002-0397-6071; Kang, Se Hun/0000-0001-5876-1791
CR Armstrong PW, 2013, NEW ENGL J MED, V368, P1379, DOI 10.1056/NEJMoa1301092
   Campo G, 2020, EUR HEART J, V41, P1784, DOI 10.1093/eurheartj/ehaa308
   Choe PG, 2020, KOREAN J INTERN MED, V35, P765, DOI 10.3904/kjim.2020.159
   Danzi GB, 2020, EUR HEART J, V41, P1858, DOI 10.1093/eurheartj/ehaa254
   Deng Q, 2020, INT J CARDIOL, V311, P116, DOI 10.1016/j.ijcard.2020.03.087
   Galeazzi GL, 2020, KOREAN CIRC J, V50, P632, DOI 10.4070/kcj.2020.0166
   Klok FA, 2020, THROMB RES, V191, P145, DOI 10.1016/j.thromres.2020.04.013
   Kochi AN, 2020, J CARDIOVASC ELECTR, V31, P1003, DOI 10.1111/jce.14479
   Korea Centers for Disease Control and Prevention, 2020, 8 UPD COVID 19 RESP
   Korea Centers for Disease Control and Prevention, 2020, STEPS PUT TAK LEV D
   Lemkes JS, 2019, NEW ENGL J MED, V380, P1397, DOI 10.1056/NEJMoa1816897
   Rab T, 2015, J AM COLL CARDIOL, V66, P62, DOI 10.1016/j.jacc.2015.05.009
   Shah PB, 2020, JACC-CARDIOVASC INTE, V13, P1607, DOI 10.1016/j.jcin.2020.05.035
   Wang DW, 2020, JAMA-J AM MED ASSOC, V323, P1061, DOI 10.1001/jama.2020.1585
   Welt FGP, 2020, J AM COLL CARDIOL, V75, P2372, DOI 10.1016/j.jacc.2020.03.021
   Zeng JH, 2020, INFECTION, V48, P773, DOI 10.1007/s15010-020-01424-5
NR 16
TC 0
Z9 0
U1 1
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD NOV
PY 2020
VL 50
IS 11
BP 974
EP 983
DI 10.4070/kcj.2020.0283
PG 10
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA PA1RS
UT WOS:000595404500002
PM 33118332
OA Green Published
DA 2021-04-22
ER

PT J
AU Kim, GS
   Ko, YG
   Suh, Y
   Won, H
   Hong, SJ
   Ahn, CM
   Kim, JS
   Kim, BK
   Choi, D
   Hong, MK
   Jang, Y
AF Kim, Gwang Sil
   Ko, Young-Guk
   Suh, Yongsung
   Won, Hoyoun
   Hong, Sung-Jin
   Ahn, Chul-Min
   Kim, Jung-Sun
   Kim, Byeong-Keuk
   Choi, Donghoon
   Hong, Myeong-Ki
   Jang, Yangsoo
TI Impact of Angiotensin II Receptor Blockers on Clinical Outcomes after
   Percutaneous Coronary Intervention in Patients with Acute Myocardial
   Infarction Based on Data from the Korean National Health Insurance
   Database (2005-2014)
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Angiotensin type II receptor blockers; Angiotensin converting enzyme
   inhibitors; Myocardial infarction; Drug therapy
ID CONVERTING-ENZYME-INHIBITORS; VENTRICULAR SYSTOLIC DYSFUNCTION;
   ASSOCIATION TASK-FORCE; HEART-FAILURE; CARDIOVASCULAR-DISEASES;
   ALDOSTERONE SYSTEM; AMERICAN-COLLEGE; MORTALITY; EVENTS; RISK
AB Background and objectives: The effectiveness of angiotensin II receptor blockers (ARBs) compared with angiotensin converting enzyme inhibitors (ACEIs) in patients with acute myocardial infarction (AMI) has not been established. We investigated the effects of ARBs on clinical outcomes after percutaneous coronary intervention (PCI) in AMI patients.
   Methods: Patients receiving ACEIs or ARBs after AMI treated with PCI between January 2005 and December 2014 were selected from the Korean National Health Insurance Service database. The primary endpoint was major cardiovascular adverse event (MACE; all-cause death, myocardial infarct [MI], or stroke).
   Results: We included patients regularly taking ACEIs (n=22,331) or ARBs (n=28,533) (medication possession ratio k80%). Compared with the ACEI group, the ARB group contained more females (31% vs. 18%), were older (mean, 63 vs. 60 years), and had more comorbidities, including hypertension (62.8% vs. 44.8%), diabetes (33.9% vs. 26.4%), congestive heart failure (7.9% vs. 4.3%), chronic obstructive pulmonary disease (25.5% vs. 18.9%), and end-stage renal disease (1.3% vs. 0.4%) (p<0.001 for all). After propensity score-matching, ARBs were associated with a 23% lower risk of MACE (hazard ratio [HR], 0.774; 95% confidence interval [CI], 0.715-0.838; p<0.001) than ACEIs. ARB use was also associated with a significantly reduced risk of death (HR, 0.741; 95% CI, 0.659-0.834; p<0.001), MI (HR, 0.731; 95% CI, 0.638-0.837; p<0.001), and revascularization (HR, 0.816; 95% CI, 0.773-0.861; p<0.001).
   Conclusions: ARB use was associated with a lower risk of MACE, MI, and revascularization than ACEIs in our retrospective analysis of AMI patients who underwent PCI.
C1 [Kim, Gwang Sil] Inje Univ, Sanggye Paik Hosp, Dept Cardiol, Coll Med, Seoul, South Korea.
   [Ko, Young-Guk; Hong, Sung-Jin; Ahn, Chul-Min; Kim, Jung-Sun; Kim, Byeong-Keuk; Choi, Donghoon; Hong, Myeong-Ki; Jang, Yangsoo] Yonsei Univ Hlth Syst, Severance Cardiovasc Hosp, Div Cardiol, Seoul, South Korea.
   [Suh, Yongsung] Myeongji Hosp, Dept Cardiol, Goyang, South Korea.
   [Won, Hoyoun] Chung Ang Univ, Chung Ang Univ Hosp, Cardiovasc & Arrhythmia Ctr, Coll Med, Seoul, South Korea.
RP Ko, YG (corresponding author), Yonsei Univ, Div Cardiol, Severance Cardiovasc Hosp, Coll Med, 50-1 Yonsei Ro, Seoul 03122, South Korea.
EM ygko@yuhs.ac
OI Choi, Donghoon/0000-0002-2009-9760; Jang, Yangsoo/0000-0002-2169-3112;
   Hong, Sung-Jin/0000-0003-4893-039X; Hong, Myeong-Ki/0000-0002-2090-2031;
   Ahn, Chul-Min/0000-0002-7071-4370; Kim, Byeong-Keuk/0000-0003-2493-066X;
   Kim, Jung-Sun/0000-0003-2263-3274; Ko, Young-Guk/0000-0001-7748-5788
FU Korean Society of Cardiology [201605-03]
FX This study was supported by a grant from the Korean Society of
   Cardiology (201605-03). We thank J. Hwang, Professor of the Division of
   Mathematics and Big Data Science, Daegu University, Gyeongsan, Korea,
   for the support provided during the statistical analyses.
CR Amsterdam EA, 2014, CIRCULATION, V130, pE344, DOI 10.1161/CIR.0000000000000134
   Ann SH, 2020, INT J CARDIOL, V306, P35, DOI 10.1016/j.ijcard.2019.11.086
   BALL SG, 1993, LANCET, V342, P821
   Cheng J, 2014, JAMA INTERN MED, V174, P773, DOI 10.1001/jamainternmed.2014.348
   Choi IS, 2019, J CARDIOVASC PHARM T, V24, P120, DOI 10.1177/1074248418795897
   Dagenais GR, 2006, LANCET, V368, P581, DOI 10.1016/S0140-6736(06)69201-5
   Danchin N, 2006, ARCH INTERN MED, V166, P787, DOI 10.1001/archinte.166.7.787
   Dickstein K, 2002, LANCET, V360, P752, DOI 10.1016/S0140-6736(02)09895-1
   Ennezat P V, 2000, Curr Cardiol Rep, V2, P258, DOI 10.1007/s11886-000-0077-3
   Hara M, 2014, AM J CARDIOL, V114, P1, DOI 10.1016/j.amjcard.2014.03.055
   Kozma CM, 2013, PATIENT PREFER ADHER, V7, P509, DOI 10.2147/PPA.S40736
   Lang CC, 2013, NAT REV CARDIOL, V10, P125, DOI 10.1038/nrcardio.2012.196
   Lee JH, 2016, KOREAN J INTERN MED, V31, P267, DOI 10.3904/kjim.2014.268
   Ma TKW, 2010, BRIT J PHARMACOL, V160, P1273, DOI 10.1111/j.1476-5381.2010.00750.x
   McDowell SE, 2006, BMJ-BRIT MED J, V332, P1177, DOI 10.1136/bmj.38803.528113.55
   Morimoto T, 2004, J EVAL CLIN PRACT, V10, P499, DOI 10.1111/j.1365-2753.2003.00484.x
   Nehme A, 2017, HYPERTENS RES, V40, P903, DOI 10.1038/hr.2017.65
   O'Gara PT, 2013, J AM COLL CARDIOL, V61, pE78, DOI 10.1016/j.jacc.2012.11.019
   Ortolani P, 2015, EUR HEART J-CARD PHA, V1, P254, DOI 10.1093/ehjcvp/pvv028
   PFEFFER MA, 1992, NEW ENGL J MED, V327, P669, DOI 10.1056/NEJM199209033271001
   Pfeffer MA, 2003, NEW ENGL J MED, V349, P1893, DOI 10.1056/NEJMoa032292
   Ricci F, 2016, INT J CARDIOL, V217, P128, DOI 10.1016/j.ijcard.2016.04.132
   Roffi M, 2016, EUR HEART J, V37, P267, DOI 10.1093/eurheartj/ehv320
   Savarese G, 2013, J AM COLL CARDIOL, V61, P131, DOI 10.1016/j.jacc.2012.10.011
   Singh A, 2012, CURR OPIN CARDIOL, V27, P381, DOI 10.1097/HCO.0b013e328353bc68
   Steg PG, 2012, EUR HEART J, V33, P2569, DOI 10.1093/eurheartj/ehs215
   Strauss MH, 2006, CIRCULATION, V114, P838, DOI 10.1161/CIRCULATIONAHA.105.594986
   Yang JH, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g6650
   Yusuf S, 2000, NEW ENGL J MED, V342, P145
NR 29
TC 2
Z9 2
U1 2
U2 2
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD NOV
PY 2020
VL 50
IS 11
BP 984
EP 994
DI 10.4070/kcj.2020.0057
PG 11
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA PA1RS
UT WOS:000595404500003
PM 32725998
OA Green Published
DA 2021-04-22
ER

PT J
AU Cho, SC
   Jin, ES
   Om, SY
   Hwang, KW
   Choi, HO
   Kim, KH
   Kim, SH
   Park, KM
   Kim, J
   Choi, KJ
   Kim, YH
   Nam, GB
AF Cho, Sang Cheol
   Jin, Eun-Sun
   Om, Sang Yong
   Hwang, Ki Won
   Choi, Hyung Oh
   Kim, Ki-Hun
   Kim, Sung-Hwan
   Park, Kyoung-Min
   Kim, Jun
   Choi, Ki-Joon
   Kim, You-Ho
   Nam, Gi-Byoung
TI Long-term Clinical Outcomes of Radiofrequency Catheter Ablation versus
   Permanent Pacemaker Implantation in Patients with
   Tachycardia-Bradycardia Syndrome
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Atrial fibrillation; Catheter ablation; Pacemaker; artificial
ID PAROXYSMAL ATRIAL-FIBRILLATION; PULMONARY VEIN ISOLATION; GUIDELINES;
   THERAPY
AB Background and Objectives: Pacemaker (PM) implantation is a well-accepted treatment option for patients with paroxysmal atrial fibrillation (AF) and related tachycardiabradycardia syndrome (TBS). Data on the long-term clinical outcomes after radiofrequency catheter ablation (RFCA) or PM implantation are sparse.
   Methods: The medical records of 217 patients with TBS were retrospectively assessed. Outcomes in patients who underwent RFCA (n=108, 49.8%) were compared to those with PM implantation (n=109, 50.2%). The clinical outcomes were sinus rhythm maintenance, conversion to persistent AF, additional procedure or crossover, and the composite of cardiovascular hospitalization and death.
   Results: During the follow-up period (mean 35 +/- 2.0 years), the RFCA group, compared to the PM group, showed better sinus rhythm maintenance (adjusted hazard ratio [aHR], 0.27; 95% confidence interval [CI], 0.15-0.46; p=0.002) and less progression to persistent AF (aHR, 0.20; 95% CI, 0.06-0.63; p=0.006). Additional procedure or crossover did not differ significantly between the groups (aHR, 2.07; 95% CI, 0.71-6.06; p=0.185 and aHR, 0.69; 95% CI, 10.8-2.67; p=0.590, respectively). Most RFCA patients (92.6%) did not require pacemaker implantation during long term follow-up period (>3.5 years). The composite endpoint of cardiovascular rehospitalization and death was not significantly different between the groups (aHR, 0.92; 95% CI, 0.50-1.66; p=0.769).
   Conclusions: RFCA is an effective alternative to PM implantation in patients with TBS. In these patients, successful RF ablation of AF is related to a higher rate of sinus rhythm maintenance compared to PM implantation, and the composite outcome of cardiovascular rehospitalization and death is similar.
C1 [Cho, Sang Cheol; Om, Sang Yong; Kim, Jun; Choi, Ki-Joon; Kim, You-Ho; Nam, Gi-Byoung] Univ Ulsan, Asan Med Ctr, Dept Internal Med, Coll Med, Seoul, South Korea.
   [Jin, Eun-Sun] Kyung Hee Univ Hosp Gangdong, Cardiovasc Ctr, Seoul, South Korea.
   [Hwang, Ki Won] Pusan Natl Univ, Pusan Natl Univ Med, Dept Internal Med, Div Cardiol,Yangsan Hosp, Yangsan, South Korea.
   [Choi, Hyung Oh] Soonchunhyang Univ, Soonchunhyang Univ Hosp, Dept Internal Med, Div Cardiol,Coll Med, Bucheon, South Korea.
   [Kim, Ki-Hun] Inje Univ, Haeundae Paik Hosp, Dept Internal Med, Div Cardiol,Coll Med, Busan, South Korea.
   [Kim, Sung-Hwan] Catholic Univ Korea, Coll Med, Dept Internal Med, Div Cardiol, Seoul, South Korea.
   [Park, Kyoung-Min] Sungkyunkwan Univ, Samsung Med Ctr, Dept Internal Med, Div Cardiol, Seoul, South Korea.
RP Nam, GB (corresponding author), Univ Ulsan, Asan Med Ctr, Dept Cardiol, Coll Med, 88,Olymp Ro 43 Gil, Seoul 05505, South Korea.
EM gbnam@amc.seoul.kr
OI Jin, Eun-Sun/0000-0003-1182-8244; Cho, Sang-Cheol/0000-0001-7587-5037;
   Kim, Sung-Hwan/0000-0001-6805-0416; choe, hyeong-o/0000-0002-0837-8513;
   Park, Kyoung-Min/0000-0002-5416-9691
FU Korean Society of Circulation [201003-02]
FX This work was funded by Korean Society of Circulation (201003-02).
CR Berruezo A, 2007, EUR HEART J, V28, P836, DOI 10.1093/eurheartj/ehm027
   Brignole M, 2013, EUROPACE, V15, P1070, DOI 10.1093/europace/eut206
   Chen YW, 2014, PACE, V37, P403, DOI 10.1111/pace.12340
   Epstein AE, 2008, CIRCULATION, V117, P2820, DOI 10.1161/CIRCUALTIONAHA.108.189741
   FERRER MI, 1968, J AMER MED ASSOC, V206, P645, DOI 10.1001/jama.206.3.645
   Ganesan AN, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.112.004549
   Hada M, 2019, HEART VESSELS, V34, P503, DOI 10.1007/s00380-018-1256-8
   Inada K, 2014, EUROPACE, V16, P208, DOI 10.1093/europace/eut159
   Khaykin Y, 2004, J CARDIOVASC ELECTR, V15, P784, DOI 10.1046/j.1540-8167.2004.03279.x
   Kim DH, 2018, BMC CARDIOVASC DISOR, V18, DOI 10.1186/s12872-018-0834-0
   Miyanaga S, 2009, EUROPACE, V11, P576, DOI 10.1093/europace/eup082
   Nademanee K, 2008, J AM COLL CARDIOL, V51, P843, DOI 10.1016/j.jacc.2007.10.044
   Ohkubo K, 2007, INT HEART J, V48, P247, DOI 10.1536/ihj.48.247
   Pappone C, 2003, J AM COLL CARDIOL, V42, P185, DOI 10.1016/S0735-1097(03)00577-1
   Pokushalov E, 2011, J CARDIOVASC ELECTR, V22, P369, DOI 10.1111/j.1540-8167.2010.01923.x
   Rajappan K, 2009, HEART, V95, P334, DOI 10.1136/hrt.2008.156372
   Rajappan K, 2009, HEART, V95, P259, DOI 10.1136/hrt.2007.132753
   RASMUSSEN K, 1971, AM HEART J, V81, P38, DOI 10.1016/0002-8703(71)90052-4
   Sanders P, 2004, CIRCULATION, V109, P1514, DOI 10.1161/01.CIR.0000121734.47409.AA
   Weerasooriya R, 2011, J AM COLL CARDIOL, V57, P160, DOI 10.1016/j.jacc.2010.05.061
   Wilber DJ, 2010, JAMA-J AM MED ASSOC, V303, P333, DOI 10.1001/jama.2009.2029
   Wu JT, 2013, INTERNAL MED, V52, P2305, DOI 10.2169/internalmedicine.52.0982
NR 22
TC 1
Z9 1
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD NOV
PY 2020
VL 50
IS 11
BP 998
EP 1009
DI 10.4070/kcj.2020.0065
PG 12
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA PA1RS
UT WOS:000595404500005
PM 32812404
OA Green Published
DA 2021-04-22
ER

PT J
AU Kim, J
   Cho, MJ
AF Kim, Jinmi
   Cho, Min-Jung
TI Acute Myocarditis in Children: a 10-year Nationwide Study (2007-2016)
   based on the Health Insurance Review and Assessment Service Database in
   Korea
SO KOREAN CIRCULATION JOURNAL
LA English
DT Review
DE Myocarditis; Children; Korea; Epidemiology
ID FULMINANT MYOCARDITIS; PEDIATRIC MYOCARDITIS; CLINICAL PRESENTATION;
   OUTCOMES; GENDER
AB Background and Objectives: We performed a nationwide study to assess the incidence, treatment patterns, and outcomes of acute myocarditis in Korean children.
   Methods: The nationwide incidence, treatment patterns, and outcomes of acute myocarditis in Korean children were assessed using data between 2007 and 2016 from the Health Insurance Review and Assessment database.
   Results: We investigated 1,627 children during the study period. The overall incidence of acute myocarditis was 1.4 per 100,000 children in 2007 and 2.1 per 100,000 children in 2016, which indicates a significant increase in the trend over time. A bimodal age distribution was observed with a larger peak in infancy and a smaller peak in the mid-teenage years. No sex difference was observed in the incidence rate of acute myocarditis in children aged <= 5 years (373 boys vs. 366 girls); however, the incidence rate of acute myocarditis in adolescents aged >= 13 years showed significant male preponderance (482 boys vs. 152 girls). Acute fulminant myocarditis occurred in 371 children (22.8%) who needed extracorporeal membrane oxygenation and/or mechanical ventilator support. Of the 371 children with acute fulminant myocarditis, 258 (69.5%) survived. The survival rate of children with acute fulminant myocarditis remained nearly identical over the 10-year study period.
   Conclusions: This was the first nationwide epidemiological study to investigate acute myocarditis in Korean children. In our view, this study would help clinicians in decision-making and planning for optimal management of acute myocarditis in children.
C1 [Kim, Jinmi] Pusan Natl Univ Hosp, Biomed Res Inst, Busan, South Korea.
   [Cho, Min-Jung] Gyeongsang Natl Univ, Dept Pediat, Changwon Hosp, 11 Samjeongja Ro, Chang Won 51472, South Korea.
RP Cho, MJ (corresponding author), Gyeongsang Natl Univ, Dept Pediat, Changwon Hosp, 11 Samjeongja Ro, Chang Won 51472, South Korea.
EM mjchomd@gmail.com
OI kim, jinmi/0000-0002-6715-0447
FU Convergence Medical Institute of Technology RD project [CMIT2017-10];
   Pusan National University HospitalPusan National University
FX This work was supported by Convergence Medical Institute of Technology
   R&D project (CMIT2017-10), Pusan National University Hospital.
CR Anderson BR, 2014, AM J CARDIOL, V114, P1400, DOI 10.1016/j.amjcard.2014.07.074
   Arola A, 2017, J AM HEART ASSOC, V6, DOI 10.1161/JAHA.116.005306
   Cooper LT, 2009, NEW ENGL J MED, V360, P1526, DOI 10.1056/NEJMra0800028
   DRUCKER NA, 1994, CIRCULATION, V89, P252, DOI 10.1161/01.CIR.89.1.252
   Durani Y, 2009, AM J EMERG MED, V27, P942, DOI 10.1016/j.ajem.2008.07.032
   Fairweather D, 2013, CURR PROB CARDIOLOGY, V38, P7, DOI 10.1016/j.cpcardiol.2012.07.003
   Freedman SB, 2007, PEDIATRICS, V120, P1278, DOI 10.1542/peds.2007-1073
   Ghelani SJ, 2012, CIRC-CARDIOVASC QUAL, V5, P622, DOI 10.1161/CIRCOUTCOMES.112.965749
   Hia CPP, 2004, ARCH DIS CHILD, V89, P580, DOI 10.1136/adc.2003.034686
   Hsiao HJ, 2011, PEDIATR NEONATOL, V52, P135, DOI 10.1016/j.pedneo.2011.03.005
   Jung SY, 2016, INTERACT CARDIOV TH, V23, P247, DOI 10.1093/icvts/ivw114
   Klugman D, 2010, PEDIATR CARDIOL, V31, P222, DOI 10.1007/s00246-009-9589-9
   Kyto V, 2013, HEART, V99, P1681, DOI 10.1136/heartjnl-2013-304449
   LIEBERMAN EB, 1991, J AM COLL CARDIOL, V18, P1617, DOI 10.1016/0735-1097(91)90493-S
   Matsuura H, 2016, CIRC J, V80, P2362, DOI 10.1253/circj.CJ-16-0234
   McCarthy RE, 2000, NEW ENGL J MED, V342, P690, DOI 10.1056/NEJM200003093421003
   Miyake CY, 2014, AM J CARDIOL, V113, P535, DOI 10.1016/j.amjcard.2013.10.021
   Prasad AN, 2014, INDIAN PEDIATR, V51, P583, DOI 10.1007/s13312-014-0456-2
   Robinson J, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004370.pub3
   Saji T, 2012, CIRC J, V76, P1222, DOI 10.1253/circj.CJ-11-1032
   Sankar J, 2011, PEDIATR CARDIOL, V32, P885, DOI 10.1007/s00246-011-0007-8
   Vashist Sudhir, 2009, Curr Treat Options Cardiovasc Med, V11, P383
   Wu ET, 2006, HEART, V92, P1325, DOI 10.1136/hrt.2005.077511
   Wu HP, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/2510695
NR 24
TC 1
Z9 1
U1 1
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD NOV
PY 2020
VL 50
IS 11
BP 1013
EP 1022
DI 10.4070/kcj.2020.0108
PG 10
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA PA1RS
UT WOS:000595404500007
PM 32812406
OA Other Gold, Green Published
DA 2021-04-22
ER

PT J
AU Kim, BK
   Nah, DY
   Choi, KU
   Bae, JH
   Rhee, MY
   Jang, JS
   Moon, KW
   Lee, JH
   Kim, HY
   Kang, SH
   Song, WH
   Lee, SU
   Shim, BJ
   Chung, H
   Hyon, MS
AF Kim, Byong-Kyu
   Nah, Deuk-Young
   Choi, Kang Un
   Bae, Jun-Ho
   Rhee, Moo-Yong
   Jang, Jae-Sik
   Moon, Keon-Woong
   Lee, Jun-Hee
   Kim, Hee-Yeol
   Kang, Seung-Ho
   Song, Woo Hyuk
   Lee, Seung Uk
   Shim, Byung-Ju
   Chung, Hangjae
   Hyon, Min Su
TI Impact of Hospital volume of Percutaneous Coronary Intervention (PCI) on
   In-Hospital Outcomes in Patients with Acute Myocardial Infarction: Based
   on the 2014 Cohort of the Korean Percutaneous Coronary Intervention
   (K-PCI) Registry
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Myocardial infarction; Percutaneous coronary intervention; Low-volume
   hospitals; Treatment outcome
ID ACCF/AHA/SCAI GUIDELINE; PERFORMING ANGIOPLASTY; ESC/EACTS GUIDELINES;
   OPERATOR VOLUMES; CATHETERIZATION; RECOMMENDATIONS; ASSOCIATION;
   ANGIOGRAPHY; STATEMENT; UPDATE
AB Background and Objectives: The relationship between the hospital percutaneous coronary intervention (PCI) volumes and the in-hospital clinical outcomes of patients with acute myocardial infarction (AMI) remains the subject of debate. This study aimed to determine whether the in-hospital clinical outcomes of patients with AMI in Korea are significantly associated with hospital PCI volumes.
   Methods: We selected and analyzed 17,121 cases of AMI, that is, 8,839 cases of non-ST-segment elevation myocardial infarction and 8,282 cases of ST-segment elevation myocardial infarction, enrolled in the 2014 Korean percutaneous coronary intervention (K-PCI) registry. Patients were divided into 2 groups according to hospital annual PCI volume, that is, to a high-volume group (>= 400/year) or a low-volume group (<400/year). Major adverse cardiovascular and cerebrovascular events (MACCEs) were defined as composites of death, cardiac death, non-fatal myocardial infarction (MI), stent thrombosis, stroke, and need for urgent PCI during index admission after PCI.
   Results: Rates of MACCE and non-fatal MI were higher in the low-volume group than in the high-volume group (MACCE: 10.9%vs. 8.6%, p=0.001; non-fatal MI: 4.8% vs. 2.6%, p=0.001, respectively). Multivariate regression analysis showed PCI volume did not independently predict MACCE.
   Conclusions: Hospital PCI volume was not found to be an independent predictor of inhospital clinical outcomes in patients with AMI included in the 2014 K-PCI registry.
C1 [Kim, Byong-Kyu; Nah, Deuk-Young; Choi, Kang Un; Bae, Jun-Ho] Dongguk Univ, Gyeongju Hosp, Dept Internal Med, Div Cardiol,Coll Med, 87 Dongdae Ro, Gyeongju 38067, South Korea.
   [Rhee, Moo-Yong] Dongguk Univ, Coll Med, Cardiovasc Ctr, Dept Internal Med,Illsan Hosp, Goyang, South Korea.
   [Jang, Jae-Sik] Inje Univ, Coll Med, Div Cardiol, Busan Paik Hosp, Busan, South Korea.
   [Moon, Keon-Woong] Catholic Univ Korea, Dept Internal Med, Div Cardiol, St Vincents Hosp, Suwon, South Korea.
   [Lee, Jun-Hee] Hallym Univ, Kangdong Sacred Heart Hosp, Dept Internal Med, Div Cardiol,Coll Med, Seoul, South Korea.
   [Kim, Hee-Yeol] Catholic Univ Korea, Dept Internal Med, Div Cardiol, Bucheon St Marys Hosp, Bucheon, South Korea.
   [Kang, Seung-Ho] Cheju Halla Gen Hosp, Dept Internal Med, Div Cardiol, Jeju, South Korea.
   [Song, Woo Hyuk] Korea Univ, Dept Cardiol, Ansan Hosp, Ansan, South Korea.
   [Lee, Seung Uk] Kwangju Christian Hosp, Dept Internal Med, Div Cardiol, Gwangju, South Korea.
   [Shim, Byung-Ju] Pohang St Marys Hosp, Dept Internal Med, Pohang, South Korea.
   [Chung, Hangjae] Pohang Semyeong Christianity Hosp, Dept Internal Med, Div Cardiol, Pohang, South Korea.
   [Hyon, Min Su] Soonchunhyang Univ, Sch Med, Dept Internal Med, Div Cardiol,Seoul Hosp, Seoul, South Korea.
RP Nah, DY (corresponding author), Dongguk Univ, Gyeongju Hosp, Dept Internal Med, Div Cardiol,Coll Med, 87 Dongdae Ro, Gyeongju 38067, South Korea.
EM ptca@dongguk.ac.kr
OI CHOI, KANG-UN/0000-0002-3385-3152; Moon, Keon-Woong/0000-0003-2726-3209
CR Badheka AO, 2014, CIRCULATION, V130, P1392, DOI 10.1161/CIRCULATIONAHA.114.009281
   Banning AP, 2015, HEART, V101, P1, DOI 10.1136/heartjnl-2015-307821
   Canto JG, 2000, NEW ENGL J MED, V342, P1573, DOI 10.1056/NEJM200005253422106
   Darmoch F, 2020, J AM HEART ASSOC, V9, DOI 10.1161/JAHA.119.013678
   Dawkins KD, 2005, HEART, V91, DOI 10.1136/hrt.2005.061457
   Dehmer GJ, 2012, J AM COLL CARDIOL, V60, P2017, DOI 10.1016/j.jacc.2012.08.966
   Desai NR, 2015, JAMA-J AM MED ASSOC, V314, P2045, DOI 10.1001/jama.2015.13764
   Fanaroff AC, 2017, J AM COLL CARDIOL, V69, P2913, DOI 10.1016/j.jacc.2017.04.032
   Harold JG, 2013, J AM COLL CARDIOL, V62, P357, DOI 10.1016/j.jacc.2013.05.002
   Hirshfeld JW, 1998, J AM COLL CARDIOL, V31, P722
   Hong SL, 2020, JACC-CARDIOVASC INTE, V13, P62, DOI 10.1016/j.jcin.2019.09.033
   Inohara T, 2017, JACC-CARDIOVASC INTE, V10, P918, DOI 10.1016/j.jcin.2017.02.015
   Jang JS, 2017, KOREAN CIRC J, V47, P328, DOI 10.4070/kcj.2017.0071
   Kim YH, 2013, ANATOL J CARDIOL, V13, P237, DOI 10.5152/akd.2013.070
   Kumbhani DJ, 2009, JAMA-J AM MED ASSOC, V302, P2207, DOI 10.1001/jama.2009.1715
   Langabeer JR, 2017, QUAL MANAG HEALTH CA, V26, P160, DOI 10.1097/QMH.0000000000000142
   Lee JH, 2020, KOREAN CIRC J, V50, P133, DOI 10.4070/kcj.2019.0206
   Levine GN, 2016, J AM COLL CARDIOL, V67, P1235, DOI 10.1016/j.jacc.2015.10.005
   Levine GN, 2011, J AM COLL CARDIOL, V58, pE44, DOI 10.1016/j.jacc.2011.08.007
   Maroney J, 2013, CATHETER CARDIO INTE, V81, P34, DOI 10.1002/ccd.24366
   Milstein A, 2000, Eff Clin Pract, V3, P313
   Neumann FJ, 2019, EUR HEART J, V40, P79, DOI 10.1093/eurheartj/ehy855
   Pose PN, 2010, EUR HEART J, V31, P1985, DOI 10.1093/eurheartj/ehq151
   Shiraishi J, 2008, CIRC J, V72, P1041, DOI 10.1253/circj.72.1041
   Spaulding C, 2006, EUR HEART J, V27, P1054, DOI 10.1093/eurheartj/ehi843
   Thygesen K, 2012, J AM COLL CARDIOL, V60, P1581, DOI 10.1016/j.jacc.2012.08.001
   Tonino PAL, 2009, NEW ENGL J MED, V360, P213, DOI 10.1056/NEJMoa0807611
   Tsuchihashi M, 2004, CIRC J, V68, P887, DOI 10.1253/circj.68.887
   Vakili BA, 2001, CIRCULATION, V104, P2171, DOI 10.1161/hc3901.096668
   Windecker S, 2015, EUROINTERVENTION, V10, P1024, DOI 10.4244/EIJY14M09_01
NR 30
TC 2
Z9 2
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD NOV
PY 2020
VL 50
IS 11
BP 1026
EP 1036
DI 10.4070/kcj.2020.0172
PG 11
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA PA1RS
UT WOS:000595404500009
PM 33118336
OA Other Gold, Green Published
DA 2021-04-22
ER

PT J
AU Wiwanitkit, V
AF Wiwanitkit, Viroj
TI Heart Transplantation to Fulminant Myocarditis during COVID-19 Outbreak
SO KOREAN CIRCULATION JOURNAL
LA English
DT Letter
C1 [Wiwanitkit, Viroj] Dr DY Patil Univ, Dept Community Med, Pune 411018, Maharashtra, India.
RP Wiwanitkit, V (corresponding author), Dr DY Patil Univ, Dept Community Med, Pune 411018, Maharashtra, India.
EM wviroj@yahoo.com
CR Joob B, 2020, ANZ J SURG, V90, P1214, DOI 10.1111/ans.15971
   Kim IC, 2020, KOREAN CIRC J, V50, P634, DOI 10.4070/kcj.2020.0177
   Lee H, 2020, PEDIATR TRANSPLANT, V24, P1645, DOI 10.1111/petr.13780
   Lima B, 2020, TRANSPL INFECT DIS, V22, DOI 10.1111/tid.13382
NR 4
TC 0
Z9 0
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD NOV
PY 2020
VL 50
IS 11
BP 1040
EP 1040
DI 10.4070/kcj.2020.0357
PG 1
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA PA1RS
UT WOS:000595404500011
PM 33118339
OA Green Published
DA 2021-04-22
ER

PT J
AU Kim, IC
   Hwang, I
   Kim, YS
   Kim, JB
AF Kim, In-Cheol
   Hwang, Ilseon
   Kim, Yun Seok
   Kim, Jae-Bum
TI Author's Reply to Heart Transplantation to Fulminant Myocarditis during
   COVID-19 Outbreak
SO KOREAN CIRCULATION JOURNAL
LA English
DT Letter
C1 [Kim, In-Cheol] Keimyung Univ, Sch Med, Dongsan Hosp, Div Cardiol,Dept Internal Med,Cardiovasc Ctr, 1035 Dalgubeol Daero, Daegu 42601, South Korea.
   [Hwang, Ilseon] Keimyung Univ, Sch Med, Dongsan Hosp, Dept Pathol, Daegu, South Korea.
   [Kim, Yun Seok; Kim, Jae-Bum] Keimyung Univ, Sch Med, Dongsan Hosp, Dept Cardiothorac Surg, Daegu, South Korea.
RP Kim, IC (corresponding author), Keimyung Univ, Sch Med, Dongsan Hosp, Div Cardiol,Dept Internal Med,Cardiovasc Ctr, 1035 Dalgubeol Daero, Daegu 42601, South Korea.
EM kimic@dsmc.or.kr
OI Hwang, Ilseon/0000-0002-6122-4417; Kim, In-Cheol/0000-0002-5751-2328
CR Kim IC, 2020, KOREAN CIRC J, V50, P543, DOI 10.4070/kcj.2020.0205
   Kim IC, 2020, KOREAN CIRC J, V50, P634, DOI 10.4070/kcj.2020.0177
   Kim IC, 2018, KOREAN CIRC J, V48, P565, DOI 10.4070/kcj.2018.0189
NR 3
TC 0
Z9 0
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD NOV
PY 2020
VL 50
IS 11
BP 1041
EP 1042
DI 10.4070/kcj.2020.3571
PG 2
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA PA1RS
UT WOS:000595404500012
PM 33118338
OA Green Published
DA 2021-04-22
ER

PT J
AU Ahn, JM
AF Ahn, Jung-Min
TI Coronary Microvascular Dysfunction: Is It Distinct Clinical Entity or
   Common Physiologic Pathway?
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
C1 [Ahn, Jung-Min] Univ Ulsan, Coll Med, Asan Med Ctr, Heart Inst,Dept Cardiol, 88,Olymp Ro 43 Gil, Seoul 05505, South Korea.
RP Ahn, JM (corresponding author), Univ Ulsan, Coll Med, Asan Med Ctr, Heart Inst,Dept Cardiol, 88,Olymp Ro 43 Gil, Seoul 05505, South Korea.
EM drjmahn@gmail.com
CR Camici PG, 2007, NEW ENGL J MED, V356, P830, DOI 10.1056/NEJMra061889
   Crea F, 2014, EUR HEART J, V35, P1101, DOI 10.1093/eurheartj/eht513
   Fearon WF, 2017, CIRC-CARDIOVASC INTE, V10, DOI 10.1161/CIRCINTERVENTIONS.117.005361
   Herrmann J, 2012, EUR HEART J, V33, P2771, DOI 10.1093/eurheartj/ehs246
   Lee JM, 2020, KOREAN CIRC J, V50, P890, DOI 10.4070/kcj.2020.0083
   Lee JM, 2016, J AM COLL CARDIOL, V67, P1158, DOI 10.1016/j.jacc.2015.12.053
   Lim HS, 2018, KOREAN CIRC J, V48, P16, DOI 10.4070/kcj.2017.0177
NR 7
TC 1
Z9 1
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD OCT
PY 2020
VL 50
IS 10
BP 904
EP 906
DI 10.4070/kcj.2020.0352
PG 3
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA NV8KA
UT WOS:000574562000005
PM 32969207
OA Green Published
DA 2021-04-22
ER

PT J
AU Ko, YG
AF Ko, Young-Guk
TI Sapien 3 versus Sapien XT Balloon-expanding Valve for Transcatheter
   Aortic Valve Replacement: Improved Immediate and Late Outcomes at the
   Expense of Smaller Effective Orifice Area
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
ID PROSTHETIC VALVES; IMPLANTATION; MISMATCH
C1 [Ko, Young-Guk] Yonsei Univ, Coll Med, Div Cardiol, Severance Cardiovasc Hosp, 50-1 Yonsei Ro, Seoul 03722, South Korea.
RP Ko, YG (corresponding author), Yonsei Univ, Coll Med, Div Cardiol, Severance Cardiovasc Hosp, 50-1 Yonsei Ro, Seoul 03722, South Korea.
EM ygko@yuhs.ac
OI Ko, Young-Guk/0000-0001-7748-5788
CR Abdelghani M, 2018, JACC-CARDIOVASC INTE, V11, P2507, DOI 10.1016/j.jcin.2018.07.050
   Al-Azizi K, 2019, HEART, V105, pS6, DOI 10.1136/heartjnl-2018-313511
   Ando T, 2016, INT J CARDIOL, V220, P472, DOI 10.1016/j.ijcard.2016.06.159
   Head SJ, 2012, EUR HEART J, V33, P1518, DOI 10.1093/eurheartj/ehs003
   Kim C, 2019, KOREAN CIRC J, V49, P283, DOI 10.4070/kcj.2019.0044
   Kook H, 2020, KOREAN CIRC J, V50, P907, DOI 10.4070/kcj.2020.0061
   Ribeiro HB, 2014, PROG CARDIOVASC DIS, V56, P583, DOI 10.1016/j.pcad.2014.02.001
   Theron A, 2018, EUR HEART J-CARD IMG, V19, P225, DOI 10.1093/ehjci/jex019
   Tummala R, 2018, CATHETER CARDIO INTE, V92, pE149, DOI 10.1002/ccd.27398
   Yu CW, 2018, KOREAN CIRC J, V48, P382, DOI 10.4070/kcj.2018.0117
NR 10
TC 0
Z9 0
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD OCT
PY 2020
VL 50
IS 10
BP 923
EP 924
DI 10.4070/kcj.2020.0353
PG 2
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA NV8KA
UT WOS:000574562000007
PM 32969208
OA Green Published
DA 2021-04-22
ER

PT J
AU Cho, SW
AF Cho, Sung Woo
TI Subclinical and Tiny Myocardial Injury within Upper Reference Limit of
   Cardiac Troponin Should Not Be Ignored after Noncardiac Surgery
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
ID MORTALITY
C1 [Cho, Sung Woo] Inje Univ, Coll Med, Ilsan Paik Hosp, Div Cardiol,Dept Internal Med, 170 Juhwa Ro, Goyang 10380, South Korea.
RP Cho, SW (corresponding author), Inje Univ, Coll Med, Ilsan Paik Hosp, Div Cardiol,Dept Internal Med, 170 Juhwa Ro, Goyang 10380, South Korea.
EM drswcho@hanmail.net
CR Botto F, 2014, ANESTHESIOLOGY, V120, P564, DOI 10.1097/ALN.0000000000000113
   Devereaux PJ, 2018, LANCET, V391, P2325, DOI 10.1016/S0140-6736(18)30832-8
   Devereaux PJ, 2017, JAMA-J AM MED ASSOC, V317, P1642, DOI 10.1001/jama.2017.4360
   Devereaux PJ, 2015, NEW ENGL J MED, V373, P2258, DOI 10.1056/NEJMra1502824
   Devereaux PJ, 2011, ANN INTERN MED, V154, P523, DOI 10.7326/0003-4819-154-8-201104190-00003
   Devereaux PJ, 2019, EUR HEART J
   Park J, 2020, KOREAN CIRC J, V50, P925, DOI 10.4070/kcj.2020.0088
   Puelacher C, 2018, CIRCULATION, V137, P1221, DOI 10.1161/CIRCULATIONAHA.117.030114
   Thygesen K, 2018, CIRCULATION, V138, pE618, DOI 10.1161/CIR.0000000000000617
NR 9
TC 1
Z9 1
U1 1
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD OCT
PY 2020
VL 50
IS 10
BP 938
EP 939
DI 10.4070/kcj.2020.0327
PG 2
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA NV8KA
UT WOS:000574562000009
PM 32969209
OA Green Published, Other Gold
DA 2021-04-22
ER

PT J
AU Sung, J
AF Sung, Jidong
TI Lipid and Ischemic Heart Disease Revisited: Mendelian Randomization
   Analysis
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
C1 [Sung, Jidong] Sungkyunkwan Univ, Prevent & Rehabil Ctr, Heart Vasc & Stroke Inst, Div Cardiol,Dept Med,Samsung Med Ctr,Sch Med, 81 Irwon Ro, Seoul 06351, South Korea.
RP Sung, J (corresponding author), Sungkyunkwan Univ, Prevent & Rehabil Ctr, Heart Vasc & Stroke Inst, Div Cardiol,Dept Med,Samsung Med Ctr,Sch Med, 81 Irwon Ro, Seoul 06351, South Korea.
EM jdsung@skku.edu
CR Bowden J, 2015, INT J EPIDEMIOL, V44, P512, DOI 10.1093/ije/dyv080
   Chen L, 2008, PLOS MED, V5, DOI 10.1371/journal.pmed.0050052
   DAVIES NM, 2018, BMJ-BRIT MED J, V362, DOI DOI 10.1136/BMJ.K601
   Jun JE, 2001, KOREAN CIRC J, V31, P849
   Lee SH, 2020, KOREAN CIRC J, V50, P940, DOI 10.4070/kcj.2020.0131
   Pierce BL, 2013, AM J EPIDEMIOL, V178, P1177, DOI 10.1093/aje/kwt084
   Spiller W, 2020, KOREAN CIRC J, V50, P91, DOI 10.4070/kcj.2019.0293
   Sung J, 2020, KOREAN CIRC J, V50, P248, DOI 10.4070/kcj.2020.0020
NR 8
TC 0
Z9 0
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD OCT
PY 2020
VL 50
IS 10
BP 949
EP 950
DI 10.4070/kcj.2020.0328
PG 2
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA NV8KA
UT WOS:000574562000011
PM 32969210
OA Green Published, Other Gold
DA 2021-04-22
ER

PT J
AU Beom, JW
   Choi, JH
   Boo, KY
   Lee, JG
   Kim, SY
   Joo, SJ
AF Beom, Jong Wook
   Choi, Joon Hyouk
   Boo, Ki Yung
   Lee, Jae-Geun
   Kim, Song-Yi
   Joo, Seung-Jae
TI A Case of Anomalous Right Coronary Artery Infarction Mimicking
   ST-Segment Elevation Myocardial Infarction at the Left Anterior
   Descending Artery
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
C1 [Beom, Jong Wook; Choi, Joon Hyouk; Boo, Ki Yung; Lee, Jae-Geun; Kim, Song-Yi; Joo, Seung-Jae] Jeju Natl Univ, Jeju Natl Univ Hosp, Sch Med, Div Cardiol,Dept Internal Med, 15 Aran 13 Gil, Jeju 63241, South Korea.
RP Choi, JH (corresponding author), Jeju Natl Univ, Jeju Natl Univ Hosp, Sch Med, Div Cardiol,Dept Internal Med, 15 Aran 13 Gil, Jeju 63241, South Korea.
EM valgom@hanmail.net
OI Lee, Jae-Geun/0000-0003-4915-9584; Choi, Joon Hyouk/0000-0003-4245-1582;
   Kim, Song-Yi/0000-0002-1170-8165; Joo, Seung-Jae/0000-0002-4322-0703
CR Khan Usman Azhar, 2019, Eur Heart J Case Rep, V3, DOI 10.1093/ehjcr/ytz137
   TOPAZ O, 1992, INT J CARDIOL, V34, P129, DOI 10.1016/0167-5273(92)90148-V
   Villa RB, 2001, REV ESP CARDIOL, V54, P269
   YAMANAKA O, 1990, CATHETER CARDIO DIAG, V21, P28, DOI 10.1002/ccd.1810210110
NR 4
TC 0
Z9 0
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD OCT
PY 2020
VL 50
IS 10
BP 951
EP 954
DI 10.4070/kcj.2020.0115
PG 4
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA NV8KA
UT WOS:000574562000012
PM 32725987
OA Green Published, Other Gold
DA 2021-04-22
ER

PT J
AU Li, GY
   Chung, FP
AF Li, Guan-Yi
   Chung, Fa-Po
TI Primary Pericardial Angiosarcoma: an Insidious and Aggressive Malignant
   Tumor
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
C1 [Li, Guan-Yi] Taipei Vet Gen Hosp, Dept Med, Taipei, Taiwan.
   [Chung, Fa-Po] Taipei Vet Gen Hosp, Heart Rhythm Ctr, 201,Sect 2,Shih Pai Rd, Taipei 112, Taiwan.
   [Chung, Fa-Po] Taipei Vet Gen Hosp, Div Cardiol, Dept Med, 201,Sect 2,Shih Pai Rd, Taipei 112, Taiwan.
RP Chung, FP (corresponding author), Taipei Vet Gen Hosp, Heart Rhythm Ctr, 201,Sect 2,Shih Pai Rd, Taipei 112, Taiwan.; Chung, FP (corresponding author), Taipei Vet Gen Hosp, Div Cardiol, Dept Med, 201,Sect 2,Shih Pai Rd, Taipei 112, Taiwan.
EM marxtaiji@gmail.com
OI Chung, Fa-Po/0000-0001-8960-1301; Li, Guan-Yi/0000-0002-0550-8837
FU Center for Dynamical Biomarkers and Translational Medicine, Ministry of
   Science and Technology [107-2314-B-010-061-MY2, MOST
   106-2314-B-075-006-MY3, MOST 106-2314-B-010-046-MY3, MOST
   106-2314-B-075-073MY3]; Research Foundation of Cardiovascular Medicine;
   Taipei Veterans General HospitalTaipei Veterans General Hospital
   [V106C-158, V106C-104, V107B-014, V107C-060, V107C-054, V108C-107,
   V109C-113]; Szu-Yuan Research Foundation of Internal Medicine
FX This work was supported by the Center for Dynamical Biomarkers and
   Translational Medicine, Ministry of Science and Technology (grant nos.
   107-2314-B-010-061-MY2, MOST 106-2314-B-075-006-MY3, MOST
   106-2314-B-010-046-MY3, and MOST 106-2314-B-075-073MY3), Research
   Foundation of Cardiovascular Medicine, Szu-Yuan Research Foundation of
   Internal Medicine, and Taipei Veterans General Hospital (grant nos.
   V106C-158, V106C-104, V107B-014, V107C-060, V107C-054, V108C-107, and
   V109C-113).
CR Holtan SG, 2007, INT J CARDIOL, V115, pE8, DOI 10.1016/j.ijcard.2006.06.034
   Meng QY, 2002, INT J CARDIOL, V84, P69, DOI 10.1016/S0167-5273(02)00136-5
   Shi XM, 2017, CLIN NUCL MED, V42, P973, DOI 10.1097/RLU.0000000000001852
   Timoteo AT, 2010, KARDIOL POL, V68, P802
NR 4
TC 0
Z9 0
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD OCT
PY 2020
VL 50
IS 10
BP 955
EP 956
DI 10.4070/kcj.2020.0109
PG 2
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA NV8KA
UT WOS:000574562000013
PM 32725992
OA Green Published, Other Gold
DA 2021-04-22
ER

PT J
AU Agasthi, P
   Shipman, J
   DeValeria, P
   Mookadam, F
   Arsanjani, R
AF Agasthi, Pradyumna
   Shipman, Justin
   DeValeria, Patrick
   Mookadam, Farouk
   Arsanjani, Reza
TI Complex Aortic Root Abscess with Fistula Formation to Right Atrium and
   Ventricle
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
ID VALSALVA; SINUS
C1 [Agasthi, Pradyumna; Mookadam, Farouk; Arsanjani, Reza] Mayo Clin, Div Cardiovasc Med, 13400 East Shea Blvd, Scottsdale, AZ 85259 USA.
   [Shipman, Justin] Mayo Clin, Div Internal Med, Scottsdale, AZ USA.
   [DeValeria, Patrick] Mayo Clin, Div Cardiothorac Surg, Scottsdale, AZ USA.
RP Arsanjani, R (corresponding author), Mayo Clin, Div Cardiovasc Med, 13400 East Shea Blvd, Scottsdale, AZ 85259 USA.
EM Arsanjani.Reza@mayo.edu
OI Agasthi, Pradyumna/0000-0003-3067-6979; Shipman,
   Justin/0000-0002-0052-036X; Arsanjani, Reza/0000-0001-7081-4286
CR CHU SH, 1990, J THORAC CARDIOV SUR, V99, P288
   Takach TJ, 1999, ANN THORAC SURG, V68, P1573, DOI 10.1016/S0003-4975(99)01045-0
   VANSON JAM, 1994, CIRCULATION, V90, P20
NR 3
TC 0
Z9 0
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD OCT
PY 2020
VL 50
IS 10
BP 957
EP 959
DI 10.4070/kcj.2020.0126
PG 3
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA NV8KA
UT WOS:000574562000014
PM 32725993
OA Other Gold, Green Published
DA 2021-04-22
ER

PT J
AU Kim, HK
   Ahn, Y
   Chang, K
   Jeong, YH
   Hahn, JY
   Choo, EH
   Kim, MC
   Kim, HS
   Kim, W
   Cho, MC
   Jang, Y
   Kim, CJ
   Jeong, MH
   Chae, SC
AF Kim, Hyun Kuk
   Ahn, Youngkeun
   Chang, Kiyuk
   Jeong, Young-Hoon
   Hahn, Joo-Yong
   Choo, Eun Ho
   Kim, Min Chul
   Kim, Hyo-Soo
   Kim, Weon
   Cho, Myeong-Chan
   Jang, Yangsoo
   Kim, Chong Jin
   Jeong, Myung Ho
   Chae, Shung Chull
CA Korean Soc Myocardial Infarction K
TI 2020 Korean Society of Myocardial Infarction Expert Consensus Document
   on Pharmacotherapy for Acute Myocardial Infarction
SO KOREAN CIRCULATION JOURNAL
LA English
DT Review
DE Myocardial infarction; Drug therapy
ID ST-SEGMENT-ELEVATION; PERCUTANEOUS CORONARY INTERVENTION; DUAL
   ANTIPLATELET THERAPY; CONVERTING ENZYME-INHIBITORS; TYPE-1 RECEPTOR
   BLOCKERS; STATIN THERAPY; UNFRACTIONATED HEPARIN; CARDIOVASCULAR EVENTS;
   FIBRINOLYTIC THERAPY; PRIMARY ANGIOPLASTY
AB Clinical practice guidelines published by the European Society of Cardiology and the American College of Cardiology/American Heart Association summarize the available evidence and provide recommendations for health professionals to enable appropriate clinical decisions and improve clinical outcomes for patients with acute myocardial infarction (AMI). However, most current guidelines are based on studies in non-Asian populations in the pre-percutaneous coronary intervention (PCI) era. The Korea Acute Myocardial Infarction Registry is the first nationwide registry to document many aspects of AMI from baseline characteristics to treatment strategies. There are well-organized ongoing and published randomized control trials especially for antiplatelet therapy among Korean patients with AMI. Here, members of the Task Force of the Korean Society of Myocardial Infarction review recent published studies during the current PCI era, and have summarized the expert consensus for the pharmacotherapy of AMI.
C1 [Kim, Hyun Kuk] Chosun Univ, Dept Internal Med, Coll Med, Gwangju, South Korea.
   [Ahn, Youngkeun; Kim, Min Chul; Jeong, Myung Ho] Chonnam Natl Univ Hosp, Dept Cardiol, 42 Jebong Ro, Gwangju 61469, South Korea.
   [Chang, Kiyuk; Choo, Eun Ho] Catholic Univ Korea, Dept Internal Med, Div Cardiol, Seoul St Marys Hosp, Seoul, South Korea.
   [Jeong, Young-Hoon] Gyeongsang Natl Univ, Sch Med, Dept Internal Med, Chang Won, South Korea.
   [Jeong, Young-Hoon] Gyeongsang Natl Univ, Cardiovasc Ctr, Changwon Hosp, Chang Won, South Korea.
   [Hahn, Joo-Yong] Sungkyunkwan Univ, Samsung Med Ctr, Heart Vasc & Stroke Inst, Sch Med, Seoul, South Korea.
   [Kim, Hyo-Soo] Seoul Natl Univ Hosp, Dept Internal Med, Div Cardiol, Seoul, South Korea.
   [Kim, Hyo-Soo] Seoul Natl Univ Hosp, Cardiovasc Ctr, Seoul, South Korea.
   [Kim, Weon] Kyung Hee Univ, Kyung Hee Univ Hosp, Dept Internal Med, Div Cardiovasc, Seoul, South Korea.
   [Cho, Myeong-Chan] Chungbuk Natl Univ, Coll Med, Dept Internal Med, Cheongju, South Korea.
   [Jang, Yangsoo] Yonsei Univ, Cardiovasc Res Inst, Cardiol Div, Coll Med, Seoul, South Korea.
   [Kim, Chong Jin] Kyung Hee Univ Hosp Gangdong, Cardiovasc Ctr, Seoul, South Korea.
   [Chae, Shung Chull] Kyungpook Natl Univ Hosp, Dept Internal Med, 680 Gukchaebosang Ro, Daegu 41944, South Korea.
   [Chae, Shung Chull] Kyungpook Natl Univ, Sch Med, 680 Gukchaebosang Ro, Daegu 41944, South Korea.
RP Jeong, MH (corresponding author), Chonnam Natl Univ Hosp, Dept Cardiol, 42 Jebong Ro, Gwangju 61469, South Korea.; Chae, SC (corresponding author), Kyungpook Natl Univ Hosp, Dept Internal Med, 680 Gukchaebosang Ro, Daegu 41944, South Korea.; Chae, SC (corresponding author), Kyungpook Natl Univ, Sch Med, 680 Gukchaebosang Ro, Daegu 41944, South Korea.
EM myungho@chollian.net; scchae@knu.ac.kr
OI Kim, Min Chul/0000-0001-6026-1702; Jeong,
   Young-Hoon/0000-0003-0403-3726; Cho, Myeong-Chan/0000-0002-0047-0227;
   Hahn, Joo-Yong/0000-0002-4412-377X
CR Amsterdam EA, 2014, CIRCULATION, V130, pE344, DOI 10.1161/CIR.0000000000000134
   Andersen HR, 2003, NEW ENGL J MED, V349, P733, DOI 10.1056/NEJMoa025142
   [Anonymous], 1988, LANCET, V2, P349
   Antman EM, 2006, NEW ENGL J MED, V354, P1477, DOI 10.1056/NEJMoa060898
   Armstrong PW, 2013, NEW ENGL J MED, V368, P1379, DOI 10.1056/NEJMoa1301092
   Bae JS, 2018, CURR VASC PHARMACOL, V16, P459, DOI 10.2174/1570161116666180117103238
   Baigent C, 2010, LANCET, V376, P1670, DOI 10.1016/S0140-6736(10)61350-5
   Bonaca MP, 2015, NEW ENGL J MED, V372, P1791, DOI 10.1056/NEJMoa1500857
   Bonnefoy E, 2009, EUR HEART J, V30, P1598, DOI 10.1093/eurheartj/ehp156
   Byun JK, 2018, ATHEROSCLEROSIS, V277, P130, DOI 10.1016/j.atherosclerosis.2018.08.038
   Cannon CP, 2015, NEW ENGL J MED, V372, P2387, DOI 10.1056/NEJMoa1410489
   Cannon CP, 2004, NEW ENGL J MED, V350, P1495, DOI 10.1056/NEJMoa040583
   Chen KY, 2009, CIRCULATION, V119, P3207, DOI 10.1161/CIRCULATIONAHA.108.822791
   Chen ZM, 2005, LANCET, V366, P1622
   Chen ZM, 2005, LANCET, V366, P1607, DOI 10.1016/s0140-6736(05)67660-x
   Choi IS, 2019, J CARDIOVASC PHARM T, V24, P120, DOI 10.1177/1074248418795897
   Choi SY, 2017, INT J CARDIOL, V249, P48, DOI 10.1016/j.ijcard.2017.08.030
   Choo EH, 2014, HEART, V100, P492, DOI 10.1136/heartjnl-2013-305137
   Dargie HJ, 2001, LANCET, V357, P1385, DOI 10.1016/s0140-6736(00)04560-8
   Dondo TB, 2017, J AM COLL CARDIOL, V69, P2710, DOI 10.1016/j.jacc.2017.03.578
   Eikelboom JW, 2017, NEW ENGL J MED, V377, P1319, DOI 10.1056/NEJMoa1709118
   Grundy SM, 2019, J AM COLL CARDIOL, V73, P3168, DOI 10.1016/j.jacc.2018.11.002
   Hahn JY, 2019, JAMA-J AM MED ASSOC, V321, P2428, DOI 10.1001/jama.2019.8146
   Hahn JY, 2018, LANCET, V391, P1274, DOI 10.1016/S0140-6736(18)30493-8
   Huo Y, 2019, SCI BULL, V64, P166, DOI 10.1016/j.scib.2018.12.020
   Ibanez B, 2018, EUR HEART J, V39, P119, DOI 10.1093/eurheartj/ehx393
   Ibanez B, 2013, CIRCULATION, V128, P1495, DOI 10.1161/CIRCULATIONAHA.113.003653
   Jeong HC, 2014, INT J CARDIOL, V170, P291, DOI 10.1016/j.ijcard.2013.07.146
   Jeong YH, 2018, NEW ENGL J MED, V378, P396, DOI 10.1056/NEJMc1714934
   Jeong YH, 2015, NEW ENGL J MED, V373, P1273, DOI 10.1056/NEJMc1508692
   Ji MS, 2016, INT J CARDIOL, V225, P50, DOI 10.1016/j.ijcard.2016.09.082
   Kang J, 2019, THROMB HAEMOSTASIS, V119, P149, DOI 10.1055/s-0038-1676545
   Kang J, 2018, THROMB HAEMOSTASIS, V118, P591, DOI 10.1055/s-0038-1626697
   Keeley EC, 2003, LANCET, V361, P13, DOI 10.1016/S0140-6736(03)12113-7
   Kim BK, 2020, JAMA-J AM MED ASSOC, V323, P2407, DOI 10.1001/jama.2020.7580
   Kim MS, 2019, CLIN PHARMACOL THER, V106, P182, DOI 10.1002/cpt.1361
   Kim MC, 2019, KOREAN CIRC J, V49, P419, DOI 10.4070/kcj.2018.0341
   Kim RB, 2013, J KOREAN MED SCI, V28, P16, DOI 10.3346/jkms.2013.28.1.16
   Knuuti J, 2020, EUR HEART J, V41, P407, DOI 10.1093/eurheartj/ehz425
   Korhonen MJ, 2017, J AM COLL CARDIOL, V70, P1543, DOI 10.1016/j.jacc.2017.07.783
   Lee CW, 2014, CIRCULATION, V129, P304, DOI 10.1161/CIRCULATIONAHA.113.003303
   Lee JH, 2016, KOREAN J INTERN MED, V31, P267, DOI 10.3904/kjim.2014.268
   Lee JH, 2010, AM HEART J, V159, P1012, DOI 10.1016/j.ahj.2010.03.009
   Lee JM, 2015, TRIALS, V16, DOI 10.1186/s13063-015-0925-5
   Lee KH, 2011, J AM COLL CARDIOL, V58, P1664, DOI 10.1016/j.jacc.2011.05.057
   Lee SW, 2015, KOREAN CIRC J, V45, P202, DOI 10.4070/kcj.2015.45.3.202
   Lee SH, 2020, EUR HEART J CARDIOVA
   Mach F, 2020, EUR HEART J, V41, P111, DOI 10.1093/eurheartj/ehz455
   Mega JL, 2012, NEW ENGL J MED, V366, P9, DOI 10.1056/NEJMoa1112277
   Mehta RH, 2015, CIRCULATION, V131, P980, DOI 10.1161/CIRCULATIONAHA.114.013451
   Mo C, 2015, WORLD J GASTROENTERO, V21, P5382, DOI 10.3748/wjg.v21.i17.5382
   Motovska Z, 2016, CIRCULATION, V134, P1603, DOI 10.1161/CIRCULATIONAHA.116.024823
   Nabel EG, 2012, NEW ENGL J MED, V366, P54, DOI 10.1056/NEJMra1112570
   Neumann A, 2018, CIRC-CARDIOVASC QUAL, V11, DOI 10.1161/CIRCOUTCOMES.117.004356
   Neumann FJ, 2019, EUR HEART J, V40, P87, DOI 10.1093/eurheartj/ehy394
   O'Gara PT, 2013, J AM COLL CARDIOL, V61, pE78, DOI 10.1016/j.jacc.2012.11.019
   Park DW, 2019, CIRCULATION, V140, P1865, DOI 10.1161/CIRCULATIONAHA.119.041766
   Park J, 2018, J AM HEART ASSOC, V7, DOI 10.1161/JAHA.117.008055
   Park KH, 2018, J CARDIOL, V71, P36, DOI 10.1016/j.jjcc.2017.05.003
   Park KH, 2016, INT J CARDIOL, V215, P193, DOI 10.1016/j.ijcard.2016.04.044
   Park K, 2018, ESC HEART FAIL, V5, P354, DOI 10.1002/ehf2.12249
   Piao ZH, 2017, AM J CARDIOL, V120, P174, DOI 10.1016/j.amjcard.2017.04.003
   Pizarro G, 2014, J AM COLL CARDIOL, V63, P2356, DOI 10.1016/j.jacc.2014.03.014
   Ridker PM, 2008, NEW ENGL J MED, V359, P2195, DOI 10.1056/NEJMoa0807646
   Robinson JG, 2005, J AM COLL CARDIOL, V46, P1855, DOI 10.1016/j.jacc.2005.05.085
   Roffi M, 2016, EUR HEART J, V37, P267, DOI 10.1093/eurheartj/ehv320
   Roolvink V, 2016, J AM COLL CARDIOL, V67, P2705, DOI 10.1016/j.jacc.2016.03.522
   Sabatine MS, 2017, NEW ENGL J MED, V376, P1713, DOI 10.1056/NEJMoa1615664
   Sabatine MS, 2005, NEW ENGL J MED, V352, P1179, DOI 10.1056/NEJMoa050522
   Schupke S, 2019, NEW ENGL J MED, V381, P1524, DOI 10.1056/NEJMoa1908973
   Schwartz GG, 2018, NEW ENGL J MED, V379, P2097, DOI 10.1056/NEJMoa1801174
   Sim DS, 2020, J CARDIOL, V75, P66, DOI 10.1016/j.jjcc.2019.06.006
   Sim DS, 2016, CIRC-CARDIOVASC INTE, V9, DOI 10.1161/CIRCINTERVENTIONS.115.003508
   Sim DS, 2009, AM J CARDIOL, V103, P1333, DOI 10.1016/j.amjcard.2009.01.339
   Sinnaeve PR, 2014, CIRCULATION, V130, P1139, DOI 10.1161/CIRCULATIONAHA.114.009570
   Song PS, 2015, AM J CARDIOVASC DRUG, V15, P439, DOI 10.1007/s40256-015-0140-5
   Song PS, 2014, AM HEART J, V168, P346, DOI 10.1016/j.ahj.2014.04.019
   Sterling LH, 2017, INT J CARDIOL, V228, P295, DOI 10.1016/j.ijcard.2016.11.133
   Stone NJ, 2014, J AM COLL CARDIOL, V63, P2889, DOI 10.1016/j.jacc.2013.11.002
   Thrane PG, 2020, EUR HEART J, V41, P847, DOI 10.1093/eurheartj/ehz595
   TOPOL E, 1993, NEW ENGL J MED, V329, P673, DOI 10.1056/nejm199309023291001
   Valgimigli M, 2018, EUR HEART J, V39, P213, DOI 10.1093/eurheartj/ehx419
   Van de Werf F, 2001, LANCET, V358, P605
   Wang P, 2011, PHARMACOGENOMICS, V12, P1605, DOI [10.2217/PGS.11.98, 10.2217/pgs.11.98]
   Yang JH, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g6650
   Yang JH, 2014, JACC-CARDIOVASC INTE, V7, P592, DOI 10.1016/j.jcin.2013.12.206
   Yun JE, 2019, J AM HEART ASSOC, V8, DOI 10.1161/JAHA.119.012078
NR 87
TC 3
Z9 3
U1 3
U2 3
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD OCT
PY 2020
VL 50
IS 10
BP 845
EP 866
DI 10.4070/kcj.2020.0196
PG 22
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA NV8KA
UT WOS:000574562000001
PM 32969206
OA Other Gold, Green Published
DA 2021-04-22
ER

PT J
AU Dash, D
AF Dash, Debabrata
TI Iteration of Reverse Controlled Antegrade and Retrograde Tracking for
   Coronary Chronic Total Occlusion Intervention: a Current Appraisal
SO KOREAN CIRCULATION JOURNAL
LA English
DT Review
DE Percutaneous coronary intervention; Chronic total occlusion; Reverse
   controlled antegrade and retrograde tracking
ID RECANALIZATION; EXPERIENCE; OUTCOMES
AB Coronary chronic total occlusion (CTO) remains one of the most challenging subsets for percutaneous coronary intervention (PCI). The retrograde recanalization is one of the most significant amendments of the technique that remains critical to improved success of CTO PCI. Currently the reverse controlled antegrade and retrograde tracking (CART) is the most dominant retrograde technique. With emergence of new equipment and important iterations, this approach has become safer, faster and more successful. In this review, the author proposes the iteration and standardization of this technique which would further facilitates its adoption with more efficacy and safety.
C1 [Dash, Debabrata] Aster Hosp, Dept Cardiol, Kuwait Rd, Al Mankhool 119428, Dubai, U Arab Emirates.
RP Dash, D (corresponding author), Aster Hosp, Dept Cardiol, Kuwait Rd, Al Mankhool 119428, Dubai, U Arab Emirates.
EM dr_dash2003@yahoo.com
CR Brilakis ES, 2012, CATHETER CARDIO INTE, V79, P3, DOI 10.1002/ccd.23004
   Dash D., 2017, SL CLIN EXP CARDIOL, V1, P111
   DASH D, 2016, J INDIAN COLL CARDIO, V6, P152, DOI DOI 10.1016/J.JICC.2016.12.003
   Dash D, 2018, INDIAN HEART J, V70, pS446, DOI 10.1016/j.ihj.2018.08.011
   Dash D, 2015, CURR CARDIOL REV, V11, P323, DOI 10.2174/1573403X11666150909105827
   Dash Debabrata, 2016, Indian Heart J, V68, P584, DOI 10.1016/j.ihj.2016.05.008
   Dash Debabrata, 2016, Indian Heart J, V68, P410, DOI 10.1016/j.ihj.2016.02.019
   Dash D, 2015, CURR CARDIOL REV, V11, P291, DOI 10.2174/1573403X11666150909110300
   Dash D, 2016, J INTERV CARDIOL, V29, P70, DOI 10.1111/joic.12268
   Fung Raymond, 2017, J Cardiol Cases, V16, P205, DOI 10.1016/j.jccase.2017.08.005
   Hasegawa K, 2017, EUROINTERVENTION, V12, P1868, DOI 10.4244/EIJ-D-16-00557
   Hoye A, 2005, EUR HEART J, V26, P2630, DOI 10.1093/eurheartj/ehi498
   Karmpaliotis D, 2012, JACC-CARDIOVASC INTE, V5, P1273, DOI 10.1016/j.jcin.2012.06.025
   Kim U, 2011, CIRC J, V75, P861, DOI 10.1253/circj.CJ-10-0635
   Matsuno S, 2018, EUROINTERVENTION, V14, P94, DOI 10.4244/EIJ-D-17-00867
   Nguyen TN, 2013, PRACTICAL HDB ADV IN
   Rathore S, 2010, JACC-CARDIOVASC INTE, V3, P155, DOI 10.1016/j.jcin.2009.10.030
   RUOCCO NA, 1992, AM J CARDIOL, V69, P69, DOI 10.1016/0002-9149(92)90678-R
   Surmely Jean-Francois, 2006, J Invasive Cardiol, V18, P334
   Tsuchikane E, 2010, JACC-CARDIOVASC INTE, V3, P165, DOI 10.1016/j.jcin.2009.10.026
   Wu BE, 2018, ASIAINTERVENTION, V4, P98
   Wu Eugene B, 2009, J Invasive Cardiol, V21, pe113
NR 22
TC 1
Z9 1
U1 1
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD OCT
PY 2020
VL 50
IS 10
BP 867
EP 879
DI 10.4070/kcj.2020.0156
PG 13
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA NV8KA
UT WOS:000574562000002
PM 32725995
OA Green Published
DA 2021-04-22
ER

PT J
AU Lee, SY
   Mintz, GS
   Kim, JS
   Kim, BK
   Jang, Y
   Hong, MK
AF Lee, Seung-Yul
   Mintz, Gary S.
   Kim, Jung-Sun
   Kim, Byeong-Keuk
   Jang, Yangsoo
   Hong, Myeong-Ki
TI Long-term Clinical Outcomes of Drug-Eluting Stent Malapposition
SO KOREAN CIRCULATION JOURNAL
LA English
DT Review
DE Coronary artery disease; Percutaneous coronary intervention; Stents
ID OPTICAL COHERENCE TOMOGRAPHY; ELEVATION MYOCARDIAL-INFARCTION;
   INTRAVASCULAR ULTRASOUND ANALYSIS; CORONARY-THROMBOSIS; CONSENSUS
   DOCUMENT; FOLLOW-UP; IMPLANTATION; APPOSITION; IMPACT; MECHANISMS
AB Previous pathologic, intravascular imaging, and clinical studies have investigated the association between adverse cardiac events and stent malapposition, including acute stent malapposition (ASM, that is detected at index procedure) and late stent malapposition (LSM, that is detected during follow-up) that can be further classified into late-persistent stent malapposition (LPSM, ASM that remains at follow-up) or late-acquired stent malapposition (LASM, newly developed stent malapposition at follow-tip that was not present immediately after index stent implantation). ASM has not been associated with adverse cardiac events compared with non-ASM, even in lesions with large-sized malapposition. The clinical outcomes of LSM may depend on its subtype. The recent intravascular ultrasound studies with long-term follow-tip have consistently demonstrated that LASM steadily increased the risk of thrombotic events in patients with first-generation drug-eluting stents (DESs). This association has not yet been identified in LPSM. Accordingly, it is reasonable that approaches to stent malapposition should be based on its relationship with clinical outcomes. ASM may be tolerable after successful stent implantation, whereas prolonged anti-thrombotic medications and/or percutaneous interventions to modify LASM may be considered in selected patients with first-generation DESs. However, these treatments are still questionable due to lack of firm evidences.
C1 [Lee, Seung-Yul] Wonkwang Univ Hosp, Reg Cardiocerebrovasc Ctr, Iksan, South Korea.
   [Mintz, Gary S.] Cardiovasc Res Fdn, New York, NY USA.
   [Kim, Jung-Sun; Kim, Byeong-Keuk; Jang, Yangsoo; Hong, Myeong-Ki] Yonsei Univ Hlth Syst, Severance Cardiovasc Hosp, Div Cardiol, 50-1 Yonsei Ro, Seoul 03722, South Korea.
RP Hong, MK (corresponding author), Yonsei Univ Hlth Syst, Severance Cardiovasc Hosp, Div Cardiol, 50-1 Yonsei Ro, Seoul 03722, South Korea.
EM mkhong61@yuhs.ac
OI Jang, Yangsoo/0000-0002-2169-3112; Hong, Myeong-Ki/0000-0002-2090-2031;
   Kim, Jung-Sun/0000-0003-2263-3274; Kim, Byeong-Keuk/0000-0003-2493-066X;
   Lee, Seung-Yul/0000-0002-9039-9806
FU Korea Health Technology Research & Development Project through the Korea
   Health Industry Development Institute - Ministry of Health & Welfare,
   Republic of Korea [HI17C0882, HI16C2211, HI15C2782]; Bio & Medical
   Technology Development Program of the National Research Foundation -
   Korean government [2015M3A9C6031514]; Cardiovascular Research Center,
   Seoul, Korea; Wonkwang University
FX This work was supported by grants from the Korea Health Technology
   Research & Development Project through the Korea Health Industry
   Development Institute, funded by the Ministry of Health & Welfare,
   Republic of Korea (No. HI17C0882, HI16C2211, and HI15C2782); the Bio &
   Medical Technology Development Program of the National Research
   Foundation funded by the Korean government (No. 2015M3A9C6031514); the
   Cardiovascular Research Center, Seoul, Korea; and the Wonkwang
   University in 2020.
CR Adriaenssens T, 2017, CIRCULATION, V136, P1007, DOI 10.1161/CIRCULATIONAHA.117.026788
   Ali ZA, 2016, LANCET, V388, P2618, DOI 10.1016/S0140-6736(16)31922-5
   Attizzani GF, 2014, J AM COLL CARDIOL, V63, P1355, DOI 10.1016/j.jacc.2014.01.019
   Banning AP, 2019, EUROINTERVENTION, V15, P90, DOI 10.4244/EIJ-D-19-00144
   Bernelli C, 2016, CIRC J, V80, P895, DOI 10.1253/circj.CJ-15-1140
   Boden H, 2012, EUROINTERVENTION, V7, P1021, DOI 10.4244/EIJV7I9A164
   Cook S, 2012, EUR HEART J, V33, P1334, DOI 10.1093/eurheartj/ehr484
   Cook S, 2009, CIRCULATION, V120, P391, DOI 10.1161/CIRCULATIONAHA.109.854398
   Doi T, 2017, ARTERIOSCL THROM VAS, V37, P2350, DOI 10.1161/ATVBAHA.117.309683
   Guo N, 2010, CIRCULATION, V122, P1077, DOI 10.1161/CIRCULATIONAHA.109.906040
   Hoffmann R, 2008, HEART, V94, P322, DOI 10.1136/hrt.2007.120154
   Hong MK, 2006, CIRCULATION, V113, P414, DOI 10.1161/CIRCULATIONAHA.105.563403
   Hong MK, 2004, CIRCULATION, V109, P881, DOI 10.1161/01.CIR.0000116751.88818.10
   Hong MK, 2007, J AM COLL CARDIOL, V50, P1515, DOI 10.1016/j.jacc.2007.07.038
   Hong SJ, 2019, YONSEI MED J, V60, P824, DOI 10.3349/ymj.2019.60.9.824
   Hur SH, 2016, EUROINTERVENTION, V12, pE979, DOI 10.4244/EIJY15M09_12
   Im E, 2019, ATHEROSCLEROSIS, V288, P118, DOI 10.1016/j.atherosclerosis.2019.07.014
   Im E, 2019, J AM HEART ASSOC, V8, DOI 10.1161/JAHA.118.011817
   Im E, 2014, CIRC-CARDIOVASC INTE, V7, P88, DOI 10.1161/CIRCINTERVENTIONS.113.000797
   Karalis I, 2012, HEART, V98, P1529, DOI 10.1136/heartjnl-2011-301220
   Kawamori H, 2013, EUR HEART J-CARD IMG, V14, P865, DOI 10.1093/ehjci/jes299
   Kawsara A, 2018, JACC-CARDIOVASC INTE, V11, P1211, DOI 10.1016/j.jcin.2018.02.041
   Kolandaivelu K, 2011, CIRCULATION, V123, P1400, DOI 10.1161/CIRCULATIONAHA.110.003210
   Lee SY, 2020, ARTERIOSCL THROM VAS, V40, P288, DOI 10.1161/ATVBAHA.119.313602
   Lee SY, 2018, CIRC-CARDIOVASC INTE, V11, DOI 10.1161/CIRCINTERVENTIONS.118.007192
   Lee S, 2019, J AM HEART ASSOC, V8, DOI 10.1161/JAHA.118.011401
   Luscher TF, 2007, CIRCULATION, V115, P1051, DOI 10.1161/CIRCULATIONAHA.106.675934
   Mintz GS, 2001, J AM COLL CARDIOL, V37, P1478, DOI 10.1016/S0735-1097(01)01175-5
   Mintz GS, 2003, CIRCULATION, V107, P2660, DOI 10.1161/01.CIR.0000074778.46065.24
   Nakazawa G, 2011, J AM COLL CARDIOL, V57, P390, DOI 10.1016/j.jacc.2010.05.066
   Otsuka F, 2014, CIRCULATION, V129, P211, DOI 10.1161/CIRCULATIONAHA.113.001790
   Palmerini T, 2012, CIRC-CARDIOVASC INTE, V5, P357, DOI 10.1161/CIRCINTERVENTIONS.111.967083
   Prail F, 2015, JACC-CARDIOVASC IMAG, V8, P1297, DOI 10.1016/j.jcmg.2015.08.013
   Prati F, 2016, CIRC-CARDIOVASC INTE, V9, DOI 10.1161/CIRCINTERVENTIONS.115.003726
   Raber L, 2018, EUR HEART J, V39, P3281, DOI 10.1093/eurheartj/ehy285
   Rizas KD, 2016, CIRC-CARDIOVASC INTE, V9, DOI 10.1161/CIRCINTERVENTIONS.115.002943
   Romagnoli E, 2017, CATHETER CARDIO INTE, V90, P566, DOI 10.1002/ccd.26974
   Sawaya FJ, 2016, JACC-CARDIOVASC INTE, V9, P1861, DOI 10.1016/j.jcin.2016.06.056
   Shimamura K, 2015, EUR HEART J-CARD IMG, V16, P23, DOI 10.1093/ehjci/jeu174
   Siqueira DA, 2007, EUR HEART J, V28, P1304, DOI 10.1093/eurheartj/ehm114
   Soeda T, 2015, CIRCULATION, V132, P1020, DOI 10.1161/CIRCULATIONAHA.114.014704
   Souteyrand G, 2016, EUR HEART J, V37, P1208, DOI 10.1093/eurheartj/ehv711
   Steinberg DH, 2010, JACC-CARDIOVASC INTE, V3, P486, DOI 10.1016/j.jcin.2010.03.007
   Tanabe K, 2005, CIRCULATION, V111, P900, DOI 10.1161/01.CIR.0000155607.54922.16
   Taniwaki M, 2016, CIRCULATION, V133, P650, DOI 10.1161/CIRCULATIONAHA.115.019071
   Tearney GJ, 2012, J AM COLL CARDIOL, V59, P1058, DOI 10.1016/j.jacc.2011.09.079
   van der Hoeven BL, 2008, JACC-CARDIOVASC INTE, V1, P192, DOI 10.1016/j.jcin.2008.02.003
   Virmani R, 2004, CIRCULATION, V109, P701, DOI 10.1161/01.CIR.0000116202.41966.D4
   Wang B, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.116.004438
   Wilson GJ, 2009, CIRCULATION, V120, P141, DOI 10.1161/CIRCULATIONAHA.107.730010
NR 50
TC 0
Z9 0
U1 1
U2 2
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD OCT
PY 2020
VL 50
IS 10
BP 880
EP 889
DI 10.4070/kcj.2020.0198
PG 10
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA NV8KA
UT WOS:000574562000003
PM 32812407
OA Green Published
DA 2021-04-22
ER

PT J
AU Lee, JM
   Choi, KH
   Doh, JH
   Nam, CW
   Shin, ES
   Hoshino, M
   Murai, T
   Yonetsu, T
   Mejia-Renteria, H
   Kakuta, T
   Escaned, J
   Koo, BK
AF Lee, Joo Myung
   Choi, Ki Hong
   Doh, Joon-Hyung
   Nam, Chang-Wook
   Shin, Eun-Seok
   Hoshino, Masahiro
   Murai, Tadashi
   Yonetsu, Taishi
   Mejia-Renteria, Hernan
   Kakuta, Tsunekazu
   Escaned, Javier
   Koo, Bon-Kwon
TI Long-term Patient Prognostication by Coronary Flow Reserve and Index of
   Microcirculatory Resistance: International Registry of Comprehensive
   Physiologic Assessment
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Myocardial ischemia; Coronary artery disease; Fractional flow reserve;
   Coronary flow reserve; Index of microcirculatory resistance;
   Percutaneous coronary intervention
ID MICROVASCULAR DYSFUNCTION; HEMODYNAMIC DEPENDENCE;
   VELOCITY-MEASUREMENTS; ESC/EACTS GUIDELINES; BLOOD-FLOW;
   REPRODUCIBILITY; DISCORDANCE; TOMOGRAPHY; PRESSURE; STENOSES
AB Background and Objectives: Recent guideline recommends evaluation using of coronary flow reserve (CFR) and index of microcirculatory resistance (IMR) in patients with functionally insignificant stenosis. We evaluated clinical implications of CFR and IMR in patients with high fractional flow reserve (FFR) and deferred revascularization.
   Methods: A total of 867 patients (1,152 vessels) consigned to deferred revascularization who underwent comprehensive physiologic assessments were enrolled. Patients with high FFR (>0.80) were categorized by CFR (<= 2) and IMR (>= 23 U). Clinical outcome was assessed by patient-oriented composite outcome (POCO), a composite of any death, myocardial infarction (MI), and revascularization at 5 years.
   Results: Patients with low CFR (<= 2) showed significantly greater risk of POCO than those with high CFR (>2) in both high-FFR (p=0.024) and low-FFR (p=0.034) groups. In patients with high FFR, those with low CFR and high IMR (overt microvascular disease) displayed the greatest risk of POCO overall (p=0.015), surpassing those with high CFR and low IMR (HR, 2.873; 95% CI, 1.476-5.594; p=0.002) and showing significantly greater risk of cardiac death or MI (HR, 5.662; 95% CI, 1.984-16.154; p=0.001). Overt microvascular disease was independently associated with POCO in the high-FFR population (HR, 2.282; 95% CI, 1.176-4.429; p=0.015).
   Conclusion: Among patients with deferred revascularization, those with low CFR showed significantly greater risk of POCO than those with high CFR, regardless of FFR. In patients with high FFR, those with overt microvascular disease showed significantly greater risk of POCO and cardiac death or MI at 5-year, compared with the others.
C1 [Lee, Joo Myung; Choi, Ki Hong] Sungkyunkwan Univ, Samsung Med Ctr, Heart Vasc Stroke Inst, Dept Internal Med,Div Cardiol,Sch Med, Seoul, South Korea.
   [Doh, Joon-Hyung] Inje Univ, Dept Med, Ilsan Paik Hosp, Goyang, South Korea.
   [Nam, Chang-Wook] Keimyung Univ, Dept Med, Dongsan Med Ctr, Daegu, South Korea.
   [Shin, Eun-Seok] Ulsan Hosp, Div Cardiol, Ulsan, South Korea.
   [Shin, Eun-Seok] Univ Ulsan, Ulsan Univ Hosp, Dept Cardiol, Coll Med, Ulsan, South Korea.
   [Hoshino, Masahiro; Murai, Tadashi; Kakuta, Tsunekazu] Tsuchiura Kyodo Gen Hosp, Div Cardiovasc Med, Ibaraki, Japan.
   [Yonetsu, Taishi] Tokyo Med & Dent Univ, Dept Cardiovasc Med, Tokyo, Japan.
   [Mejia-Renteria, Hernan; Escaned, Javier] Hosp Clin San Carlos, Cardiovasc Inst, Madrid, Spain.
   [Escaned, Javier] Ctr Nacl Invest Cardiovasc Carlos III CNIC, Madrid, Spain.
   [Koo, Bon-Kwon] Seoul Natl Univ Hosp, Dept Internal Med, 101 Daehak Ro, Seoul 03080, South Korea.
   [Koo, Bon-Kwon] Seoul Natl Univ Hosp, Cardiovasc Ctr, 101 Daehak Ro, Seoul 03080, South Korea.
   [Koo, Bon-Kwon] Seoul Natl Univ, Inst Aging, Seoul, South Korea.
RP Koo, BK (corresponding author), Seoul Natl Univ Hosp, Dept Internal Med, 101 Daehak Ro, Seoul 03080, South Korea.; Koo, BK (corresponding author), Seoul Natl Univ Hosp, Cardiovasc Ctr, 101 Daehak Ro, Seoul 03080, South Korea.
EM bkkoo@snu.ac.kr
OI Yonetsu, Taishi/0000-0002-1798-5008; Lee, Joo Myung/0000-0002-2178-4014;
   Choi, Ki Hong/0000-0001-7511-9581; Nam, Chang-Wook/0000-0002-3370-5774;
   Doh, Joon Hyung/0000-0001-7966-9564; Mejia Renteria,
   Hernan/0000-0003-1030-1926
CR Ahn JM, 2017, CIRCULATION, V135, P2241, DOI 10.1161/CIRCULATIONAHA.116.024433
   Camici PG, 2012, J MOL CELL CARDIOL, V52, P857, DOI 10.1016/j.yjmcc.2011.08.028
   Crea F, 2014, EUR HEART J, V35, P1101, DOI 10.1093/eurheartj/eht513
   De Bruyne B, 2014, NEW ENGL J MED, V371, P1208, DOI 10.1056/NEJMoa1408758
   deBruyne B, 1996, CIRCULATION, V94, P1842, DOI 10.1161/01.CIR.94.8.1842
   Dhawan SS, 2012, ATHEROSCLEROSIS, V223, P384, DOI 10.1016/j.atherosclerosis.2012.05.034
   Echavarria-Pinto M, 2013, CIRCULATION, V128, P2557, DOI 10.1161/CIRCULATIONAHA.112.001345
   Forstermann U, 2012, EUR HEART J, V33, P829, DOI 10.1093/eurheartj/ehr304
   Hachamovitch R, 2002, CIRCULATION, V105, P823, DOI 10.1161/hc0702.103973
   Hamaya R, 2018, JACC-CARDIOVASC INTE, V11, P728, DOI 10.1016/j.jcin.2018.01.249
   Johnson NP, 2012, JACC-CARDIOVASC IMAG, V5, P430, DOI 10.1016/j.jcmg.2011.12.014
   Johnson NP, 2012, JACC-CARDIOVASC IMAG, V5, P193, DOI 10.1016/j.jcmg.2011.09.020
   Knuuti J, 2020, EUR HEART J, V41, P407, DOI 10.1093/eurheartj/ehz425
   Kolh P, 2014, EUR J CARDIO-THORAC, V46, P517, DOI [10.1093/eurheartj/ehu278, 10.1093/ejcts/ezu366]
   Lee JM, 2018, JACC-CARDIOVASC INTE, V11, P1423, DOI 10.1016/j.jcin.2018.05.005
   Lee JM, 2018, EUR HEART J, V39, P945, DOI 10.1093/eurheartj/ehx458
   Lee JM, 2016, J AM COLL CARDIOL, V67, P1158, DOI 10.1016/j.jacc.2015.12.053
   Lee JM, 2015, CIRC-CARDIOVASC INTE, V8, DOI 10.1161/CIRCINTERVENTIONS.115.002857
   Li J, 2013, EUR HEART J, V34, P1375, DOI 10.1093/eurheartj/eht005
   Mehran R, 2011, CIRCULATION, V123, P2736, DOI 10.1161/CIRCULATIONAHA.110.009449
   Mejia-Renteria H, 2018, JACC-CARDIOVASC INTE, V11, P741, DOI 10.1016/j.jcin.2018.02.014
   Meuwissen M, 2008, CATHETER CARDIO INTE, V71, P291, DOI 10.1002/ccd.21331
   Murthy VL, 2014, CIRCULATION, V129, P2518, DOI 10.1161/CIRCULATIONAHA.113.008507
   Neumann FJ, 2018, EUR HEART J, V39, P3759, DOI 10.1093/eurheartj/ehy658
   Ng MKC, 2006, CIRCULATION, V113, P2054, DOI 10.1161/CIRCULATIONAHA.105.603522
   Taqueti VR, 2013, JACC-CARDIOVASC IMAG, V6, P668, DOI 10.1016/j.jcmg.2013.02.005
   Usui E, 2018, JACC-CARDIOVASC INTE, V11, P2058, DOI 10.1016/j.jcin.2018.07.012
   van de Hoef TP, 2014, CIRC-CARDIOVASC INTE, V7, P301, DOI 10.1161/CIRCINTERVENTIONS.113.001049
   van de Hoef TP, 2013, CIRC-CARDIOVASC INTE, V6, P329, DOI 10.1161/CIRCINTERVENTIONS.113.000378
   Xaplanteris P, 2018, NEW ENGL J MED, V379, P250, DOI 10.1056/NEJMoa1803538
NR 30
TC 2
Z9 2
U1 3
U2 3
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD OCT
PY 2020
VL 50
IS 10
BP 890
EP 903
DI 10.4070/kcj.2020.0083
PG 14
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA NV8KA
UT WOS:000574562000004
PM 32725991
OA Other Gold, Green Published
DA 2021-04-22
ER

PT J
AU Kook, H
   Jang, DH
   Yang, KS
   Joo, HJ
   Park, JH
   Hong, SJ
   Lim, DS
   Choi, SH
   Choi, YJ
   Chang, K
   Yu, CW
AF Kook, Hyungdon
   Jang, Duck Hyun
   Yang, Kyung-Sook
   Joo, Hyung Joon
   Park, Jae Hyoung
   Hong, Soon Jun
   Lim, Do-Sun
   Choi, Seung-Hyuk
   Choi, Young Jin
   Chang, Kiyuk
   Yu, Cheol Woong
TI Comparing the Procedural and Clinical Outcomes of Sapien XT and Sapien 3
   Valves in Transcatheter Aortic Valve Replacement in Korean Patients
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Transcatheter aortic valve replacement; Aortic valve stenosis
ID HEART-VALVE; IMPLANTATION; PROSTHESIS; REGURGITATION; MISMATCH;
   STENOSIS; IMPACT
AB Background and Objectives: The Sapien 3 (S3) valve has not been compared to the Sapien XT (SXT) valve in Korea. We compared procedural and clinical outcomes between the 2 devices.
   Methods: A total of 189 patients who underwent transcatheter aortic valve replacement (TAVR) with S3 (n=95) or SXT (n=94) valve was analyzed. The primary endpoint was cardiovascular mortality at 1 year. The median follow-up duration was 438 days.
   Results: The Society of Thoracic Surgeons score was similar between the 2 groups. The device success rate (90.4% vs. 97.9%; p=0.028) was higher in the S3 than in the SXT. The S3 showed significantly fewer cases of moderate or severe paravalvular leakage (PVL) (16.7% vs. 0.0%; p=0.001) than the SXT. However, effective orifice area (EOA) (2.07 +/- 0.61 vs. 1.70 +/- 0.49 cm(2); p<0.001) was smaller in the S3. Multivariable Cox regression analysis showed the S3 was associated with significantly fewer cardiovascular mortality at 1 year compared to the SXT (5.4% vs. 1.1%; hazard ratio, 0.031; 95% confidence interval, 0.001-0.951; p=0.047). Periprocedural complication rates, composite of disabling stroke or all-cause mortality, all-cause mortality, and disabling stroke at 1 year were similar between the 2 groups.
   Conclusions: Cardiovascular mortality was lower in the S3 group than in the SXT group over 1 year of follow-up. The reduction in PVL was attributed to the higher device success rate of TAVR with the S3 valve. However, the benefit of S3 obtained at the expense of reduced EOA should be meticulously re-evaluated in larger studies during long-term follow-up.
C1 [Kook, Hyungdon; Joo, Hyung Joon; Park, Jae Hyoung; Hong, Soon Jun; Lim, Do-Sun; Yu, Cheol Woong] Korea Univ, Anam Hosp, Dept Internal Med, Div Cardiol,Coll Med, 73 Goryeodae Ro S, Seoul 02841, South Korea.
   [Jang, Duck Hyun] Yuseong Sun Hosp, Dept Internal Med, Div Cardiol, Daejeon, South Korea.
   [Yang, Kyung-Sook] Korea Univ, Dept Biostat, Coll Med, Seoul, South Korea.
   [Choi, Seung-Hyuk] Sungkyunkwan Univ, Samsung Med Ctr, Dept Internal Med, Div Cardiol,Coll Med, Seoul, South Korea.
   [Choi, Young Jin] Sejong Gen Hosp, Sejong Heart Inst, Dept Internal Med, Div Cardiol, Bucheon, South Korea.
   [Chang, Kiyuk] Catholic Univ Korea, Coll Med, Dept Internal Med, Div Cardiol,Seoul St Marys Hosp, 222 Banpo Daero, Seoul 06591, South Korea.
RP Yu, CW (corresponding author), Korea Univ, Anam Hosp, Dept Internal Med, Div Cardiol,Coll Med, 73 Goryeodae Ro S, Seoul 02841, South Korea.; Chang, K (corresponding author), Catholic Univ Korea, Coll Med, Dept Internal Med, Div Cardiol,Seoul St Marys Hosp, 222 Banpo Daero, Seoul 06591, South Korea.
EM kiyuk@catholic.ac.kr; ycw717@naver.com
CR Adams DH, 2014, NEW ENGL J MED, V370, P1790, DOI 10.1056/NEJMoa1400590
   Ahmad M, 2019, CUREUS, V11, DOI 10.7759/cureus.4370
   Baumgartner H, 2017, EUR HEART J, V38, P2739, DOI 10.1093/eurheartj/ehx391
   Bax JJ, 2014, EUR HEART J, V35, P2639, DOI 10.1093/eurheartj/ehu257
   Binder RK, 2015, CIRC-CARDIOVASC INTE, V8, DOI 10.1161/CIRCINTERVENTIONS.115.002653
   Dvir D, 2014, JAMA-J AM MED ASSOC, V312, P162, DOI 10.1001/jama.2014.7246
   Grube E, 2007, J AM COLL CARDIOL, V50, P69, DOI 10.1016/j.jacc.2007.04.047
   Kappetein AP, 2012, EUR HEART J, V33, P2403, DOI 10.1093/eurheartj/ehs255
   Kazuno Y, 2016, EUR HEART J-CARD IMG, V17, P1054, DOI 10.1093/ehjci/jew032
   Lefevre T, 2011, EUR HEART J, V32, P148, DOI 10.1093/eurheartj/ehq427
   Leipsic J, 2011, JACC-CARDIOVASC IMAG, V4, P416, DOI 10.1016/j.jcmg.2011.01.014
   Leon MB, 2016, NEW ENGL J MED, V374, P1609, DOI 10.1056/NEJMoa1514616
   Leon MB, 2010, NEW ENGL J MED, V363, P1597, DOI 10.1056/NEJMoa1008232
   Mack MJ, 2019, NEW ENGL J MED, V380, P1695, DOI 10.1056/NEJMoa1814052
   Nijhoff F, 2015, CIRC-CARDIOVASC INTE, V8, DOI 10.1161/CIRCINTERVENTIONS.115.002408
   Nishimura RA, 2017, J AM COLL CARDIOL, V70, P252, DOI 10.1016/j.jacc.2017.03.011
   Pibarot P, 2006, HEART, V92, P1022, DOI 10.1136/hrt.2005.067363
   Popma JJ, 2019, NEW ENGL J MED, V380, P1706, DOI 10.1056/NEJMoa1816885
   RAHIMTOOLA SH, 1978, CIRCULATION, V58, P20, DOI 10.1161/01.CIR.58.1.20
   Reardon MJ, 2017, NEW ENGL J MED, V376, P1321, DOI 10.1056/NEJMoa1700456
   Sawa Y, 2014, CIRC J, V78, P1083, DOI 10.1253/circj.CJ-14-0162
   Sinning JM, 2012, J AM COLL CARDIOL, V59, P1134, DOI 10.1016/j.jacc.2011.11.048
   Tamburino C, 2011, CIRCULATION, V123, P299, DOI 10.1161/CIRCULATIONAHA.110.946533
   Theron A, 2018, EUR HEART J-CARD IMG, V19, P225, DOI 10.1093/ehjci/jex019
   Tuzcu EM, 2018, J AM COLL CARDIOL, V72, P370, DOI 10.1016/j.jacc.2018.04.074
   Van Belle E, 2014, CIRCULATION, V129, P1415, DOI 10.1161/CIRCULATIONAHA.113.002677
   Vendrik J, 2018, AM J CARDIOL, V121, P856, DOI 10.1016/j.amjcard.2017.12.024
   Webb JG, 2019, J AM COLL CARDIOL, V73, P2647, DOI 10.1016/j.jacc.2019.03.483
   Yu CW, 2018, KOREAN CIRC J, V48, P382, DOI 10.4070/kcj.2018.0117
NR 29
TC 1
Z9 1
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD OCT
PY 2020
VL 50
IS 10
BP 907
EP 922
DI 10.4070/kcj.2020.0061
PG 16
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA NV8KA
UT WOS:000574562000006
PM 32812405
OA Green Published
DA 2021-04-22
ER

PT J
AU Park, J
   Hyeon, CW
   Lee, SH
   Kim, J
   Kwon, JH
   Yang, K
   Min, JJ
   Lee, JH
   Lee, SM
   Yang, JH
   Song, YB
   Hahn, JY
   Choi, JH
   Choi, SH
   Kim, K
   Ahn, J
   Gwon, HC
AF Park, Jungchan
   Hyeon, Cheol Won
   Lee, Seung-Hwa
   Kim, Jihoon
   Kwon, Ji-Hye
   Yang, Kwangmo
   Min, Jeong Jin
   Lee, Jong Hwan
   Lee, Sangmin Maria
   Yang, Jeong Hoon
   Song, Young Bin
   Hahn, Joo-Yong
   Choi, Jin-ho
   Choi, Seung-Hyuk
   Kim, Kyunga
   Ahn, Joonghyun
   Gwon, Hyeon-Cheol
TI Mildly Elevated Cardiac Troponin below the 99th-Percentile Upper
   Reference limit after Noncardiac Surgery
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Generalsurgery; Troponin; Mortality
ID MYOCARDIAL INJURY; MAGNETIC-RESONANCE; 30-DAY MORTALITY; ASSOCIATION;
   INFARCTION
AB Background and Objectives: In patients with perioperative cardiac troponin (cTn) I below the 99th-percentile upper range of limit (URL), mortality according to cTn I level has not been fully evaluated. This study evaluated the association between postoperative cTn I level above the lowest limit of detection but within the 99th-percentile URL and 30-day mortality after noncardiac surgery.
   Methods: Patients with cTn I values below the 99th-percentile URL during the perioperative period were divided into a no-elevation group with cTn I at the lowest limit of detection (6 ng/L) and a minor elevation group with cTn I elevation below the 99th percentile URL (6 ng/L < cTn I < 40 ng/L). The primary outcome was 30-day mortality.
   Results: Of the 5,312 study participants, 2,582 (48.6%) were included in the no-elevation group and 2,730 (51.4%) were included in the minor elevation group. After propensity score-matching, the minor elevation group showed significantly increased 30-day mortality (0.5% vs. 2.3%; hazard ratio, 4.30; 95% confidence interval, 2.23-8.29; p<0.001). The estimated cutoff value of cTn Ito predict 30-day mortality was 6 ng/L with the area under the receiver operating characteristic curve 0.657.
   Conclusions: A mild elevation of cTn I within the 99th-percentile URL after noncardiac surgery was significantly associated with increased 30-day mortality as compared with the lowest limit of detection.
C1 [Park, Jungchan; Kwon, Ji-Hye; Min, Jeong Jin; Lee, Jong Hwan; Lee, Sangmin Maria] Sungkyunkwan Univ, Samsung Med Ctr, Dept Anesthesiol & Pain Med, Sch Med, Seoul, South Korea.
   [Hyeon, Cheol Won; Lee, Seung-Hwa; Kim, Jihoon; Yang, Jeong Hoon; Song, Young Bin; Hahn, Joo-Yong; Choi, Jin-ho; Choi, Seung-Hyuk; Gwon, Hyeon-Cheol] Sungkyunkwan Univ, Samsung Med Ctr, Heart Vasc Stroke Inst, Div Cardiol,Dept Med,Sch Med, 81 Irwon Ro, Seoul 06351, South Korea.
   [Yang, Kwangmo] Sungkyunkwan Univ, Ctr Hlth Promot, Samsung Med Ctr, Sch Med, Seoul, South Korea.
   [Choi, Jin-ho] Sungkyunkwan Univ, Samsung Med Ctr, Dept Emergency Med, Sch Med, Seoul, South Korea.
   [Kim, Kyunga; Ahn, Joonghyun] Samsung Med Ctr, Stat & Data Ctr, Res Inst Future Med, Seoul, South Korea.
   [Kim, Kyunga] Sungkyunkwan Univ, Samsung Adv Inst Hlth Sci & Technol SAIHST, Dept Digital Hlth, Seoul, South Korea.
RP Lee, SH (corresponding author), Sungkyunkwan Univ, Samsung Med Ctr, Heart Vasc Stroke Inst, Div Cardiol,Dept Med,Sch Med, 81 Irwon Ro, Seoul 06351, South Korea.
EM shuaaa.lee@samsung.com
OI Kim, Jihoon/0000-0002-6919-446X; Lee, Seung Hwa/0000-0001-5508-7519;
   Yang, Kwangmo/0000-0002-7176-4935; bag, jeongchan/0000-0002-7794-3547;
   Hyeon, Cheol Won/0000-0003-3992-6364; Yang, Jeong
   Hoon/0000-0001-8138-1367; Min, Jeong Jin/0000-0002-7584-2670
CR Beckman JA, 2013, CIRCULATION, V127, P2253, DOI 10.1161/CIRCULATIONAHA.113.003195
   Devereaux PJ, 2017, JAMA-J AM MED ASSOC, V317, P1642, DOI 10.1001/jama.2017.4360
   Devereaux PJ, 2012, JAMA-J AM MED ASSOC, V307, P2295, DOI 10.1001/jama.2012.5502
   Devereaux PJ, 2019, EUR HEART J
   Ford I, 2016, J AM COLL CARDIOL, V68, P2719, DOI 10.1016/j.jacc.2016.10.020
   Giannitsis E, 2008, J AM COLL CARDIOL, V51, P307, DOI 10.1016/j.jacc.2007.09.041
   Gillmann HJ, 2014, CRIT CARE MED, V42, P1498, DOI 10.1097/CCM.0000000000000249
   Haider DG, 2017, INT J CARDIOL, V228, P779, DOI 10.1016/j.ijcard.2016.10.043
   Keller T, 2019, NAT REV CARDIOL, V16, P135, DOI 10.1038/s41569-018-0122-9
   Kristensen SD, 2014, EUR HEART J, V35, P2344, DOI 10.1093/eurheartj/ehu285
   Latouche A, 2004, STAT MED, V23, P3263, DOI 10.1002/sim.1915
   Lee AYY, 2015, JAMA-J AM MED ASSOC, V314, P677, DOI 10.1001/jama.2015.9243
   Lonborg J, 2013, EUR HEART J-CARD IMG, V14, P387, DOI 10.1093/ehjci/jes271
   Machado MN, 2014, REV BRAS CIR CARDIOV, V29, P299, DOI 10.5935/1678-9741.20140049
   Mariathas M, 2019, BMJ-BRIT MED J, V364, DOI 10.1136/bmj.l729
   Niizuma S, 2017, FRONT CARDIOVASC MED, V4, DOI 10.3389/fcvm.2017.00010
   Omland T, 2009, NEW ENGL J MED, V361, P2538, DOI 10.1056/NEJMoa0805299
   Park J, 2018, TRANSPLANTATION, V102, pE236, DOI 10.1097/TP.0000000000002068
   Puelacher C, 2018, CIRCULATION, V137, P1221, DOI 10.1161/CIRCULATIONAHA.117.030114
   Ribbing J, 2007, J PHARMACOKINET PHAR, V34, P485, DOI 10.1007/s10928-007-9057-1
   Sandoval Y, 2016, AM J MED, V129, P354, DOI 10.1016/j.amjmed.2015.12.005
   Sessler DI, 2016, ANESTH ANALG, V123, P359, DOI 10.1213/ANE.0000000000001450
   Smilowitz NR, 2019, CARDIOL REV, V27, P267, DOI 10.1097/CRD.0000000000000254
   Thygesen K, 2019, EUR HEART J, V40, P237, DOI [10.1016/j.jacc.2018.08.1038, 10.1093/eurheartj/ehy462]
   Twerenbold R, 2018, CIRCULATION, V137, P436, DOI 10.1161/CIRCULATIONAHA.117.028901
   van der Linden N, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000005703
   VanderWeele TJ, 2017, ANN INTERN MED, V167, P268, DOI 10.7326/M16-2607
   Zimmerman AM, 2016, J AM COLL SURGEONS, V223, P381, DOI 10.1016/j.jamcollsurg.2016.04.043
NR 28
TC 2
Z9 2
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD OCT
PY 2020
VL 50
IS 10
BP 925
EP 937
DI 10.4070/kcj.2020.0088
PG 13
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA NV8KA
UT WOS:000574562000008
PM 32812403
OA Green Published
DA 2021-04-22
ER

PT J
AU Lee, SH
   Lee, JY
   Kim, GH
   Jung, KJ
   Lee, S
   Kim, HC
   Jee, SH
AF Lee, Su Hyun
   Lee, Ji-Young
   Kim, Guen Hui
   Jung, Keum Ji
   Lee, Sunmi
   Kim, Hyeon Chang
   Jee, Sun Ha
TI Two-Sample Mendelian Randomization Study of Lipid levels and Ischemic
   Heart Disease
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Mendelian randomization analysis; Lipid; Ischemic heart disease
ID RISK; ATHEROSCLEROSIS; TRIGLYCERIDES
AB Background and Objectives: Associations between blood lipids and risk of ischemic heart disease (IHD) have been reported in observational studies. However, due to confounding and reverse causation, observational studies are influenced by bias, thus their results show inconsistency in the effects of lipid levels on IHD. In this study, we evaluate whether lipid levels have an effect on the risk of IHD in a Korean population.
   Methods: A 2-sample Mendelian randomization (MR) study, using the genetic variants associated with lipid levels as the instrumental variables was performed. Genetic variants significantly associated with lipid concentrations were obtained from the Korean Genome and Epidemiology Study (n=35,000), and the same variants on IHD were obtained from the Korean Cancer Prevention Study-II (n=13,855). Inverse variance weighting (IVW), weighted median, and MR-Egger approaches were used to assess the causal association between lipid levels and IHD. Radial MR methods were applied to remove outliers subject to pleiotropic bias.
   Results: Causal association between low-density lipoprotein-cholesterol (LDL-C) and IHD was observed in the IVW method (odds ratio, 1.013; 95% confidence interval, 1.007-1.109). However, high-density lipoprotein-cholesterol (HDL-C) and triglyceride (TG) did not show causal association with IHD. In the Radial MR analysis of the relationship between HDL-C, TG and IHD, outliers were detected. Interestingly, after removing the outliers, a causal association between TG and IHD was found.
   Conclusions: High levels LDL-C and TG were causally associated with increased IHD risk in a Korean population, these results are potentially useful as evidence of a significant causal relationship.
C1 [Lee, Su Hyun; Lee, Ji-Young; Kim, Guen Hui; Jung, Keum Ji; Jee, Sun Ha] Yonsei Univ, Grad Sch Publ Hlth, Inst Hlth Promot, Dept Epidemiol & Hlth Promot, 50-1 Yonsei Ro, Seoul 03722, South Korea.
   [Lee, Sunmi] Natl Hlth Insurance Serv, Hlth Insurance Policy Res Inst, Wonju, South Korea.
   [Kim, Hyeon Chang] Yonsei Univ, Dept Prevent Med, Coll Med, Seoul, South Korea.
RP Jee, SH (corresponding author), Yonsei Univ, Grad Sch Publ Hlth, Inst Hlth Promot, Dept Epidemiol & Hlth Promot, 50-1 Yonsei Ro, Seoul 03722, South Korea.
EM jsunha@yuhs.ac
RI ; Kim, Hyeon Chang/F-8796-2019
OI Jung, Keum Ji/0000-0003-4993-0666; Kim, Hyeon Chang/0000-0001-7867-1240;
   Lee, Su Hyun/0000-0002-4097-5158; , Guen hui/0000-0002-0485-720X
FU Korean Health Technology R&D Project, Ministry of Health & Welfare,
   Republic of Korea [HI13C0715, HI14C2686]; National Research Foundation
   of Korea (NRF) - Ministry of Education [NRF-2016R1A6A3A11933465,
   NRF-2017R1D1A1B03035170]; BBKO research fund
FX This study was funded by a grant of the Korean Health Technology R&D
   Project, Ministry of Health & Welfare, Republic of Korea (HI13C0715,
   HI14C2686) and a grant (NRF-2016R1A6A3A11933465,
   NRF-2017R1D1A1B03035170) from the National Research Foundation of Korea
   (NRF) funded by the Ministry of Education. This study was also made with
   the support of BBKO research fund.
CR Bennett DA, 2017, HEART, V103, P1400, DOI 10.1136/heartjnl-2016-310605
   Bowden J, 2018, INT J EPIDEMIOL, V47, P1264, DOI 10.1093/ije/dyy101
   Bowden J, 2016, GENET EPIDEMIOL, V40, P304, DOI 10.1002/gepi.21965
   Bowden J, 2015, INT J EPIDEMIOL, V44, P512, DOI 10.1093/ije/dyv080
   Burgess S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108891
   Di Angelantonio E, 2009, JAMA-J AM MED ASSOC, V302, P1993, DOI 10.1001/jama.2009.1619
   Didelez V, 2007, STAT METHODS MED RES, V16, P309, DOI 10.1177/0962280206077743
   Elosua R, 2017, REV ESP CARDIOL, V70, P754, DOI 10.1016/j.rec.2017.02.046
   Ference BA, 2017, EUR HEART J, V38, P2459, DOI 10.1093/eurheartj/ehx144
   Hemani G, 2018, ELIFE, V7, DOI 10.7554/eLife.34408
   Holmes MV, 2015, EUR HEART J, V36, P539, DOI 10.1093/eurheartj/eht571
   Jee YH, 2018, INT J EPIDEMIOL, V47, P385, DOI 10.1093/ije/dyx226
   Kim Y, 2017, INT J EPIDEMIOL, V46, P1350, DOI 10.1093/ije/dyx105
   Kimm H, 2012, KOREAN CIRC J, V42, P10, DOI 10.4070/kcj.2012.42.1.10
   Lawlor DA, 2016, INT J EPIDEMIOL, V45, P908, DOI 10.1093/ije/dyw127
   Linsel-Nitschke P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002986
   McBride P, 2008, CURR ATHEROSCLER REP, V10, P386, DOI 10.1007/s11883-008-0060-9
   Navar AM, 2019, JAMA-J AM MED ASSOC, V321, P347, DOI 10.1001/jama.2018.20044
   Reiner Z, 2017, NAT REV CARDIOL, V14, P401, DOI 10.1038/nrcardio.2017.31
   Shah S, 2013, CIRC-CARDIOVASC GENE, V6, P63, DOI 10.1161/CIRCGENETICS.112.963140
   Sheehan NA, 2008, PLOS MED, V5, P1205, DOI 10.1371/journal.pmed.0050177
   Tarchalski J, 2003, MOL CELL BIOCHEM, V246, P25, DOI 10.1023/A:1023443609730
   Varbo A, 2013, J AM COLL CARDIOL, V61, P427, DOI 10.1016/j.jacc.2012.08.1026
   Voight BF, 2012, LANCET, V380, P572, DOI 10.1016/S0140-6736(12)60312-2
NR 24
TC 1
Z9 1
U1 1
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD OCT
PY 2020
VL 50
IS 10
BP 940
EP 948
DI 10.4070/kcj.2020.0131
PG 9
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA NV8KA
UT WOS:000574562000010
PM 32812402
OA Green Published
DA 2021-04-22
ER

PT J
AU Kim, SJ
AF Kim, Soo-Joong
TI Ivabradine for the Therapy of Chronic Stable Angina Pectoris
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
ID CORONARY-ARTERY-DISEASE; I-F INHIBITOR; DOUBLE-BLIND; EFFICACY
C1 [Kim, Soo-Joong] Kyung Hee Univ, Kyung Hee Univ Hosp, Coll Med, Dept Internal Med,Div Cardiol, 23 Kyungheedae Ro, Seoul 02447, South Korea.
RP Kim, SJ (corresponding author), Kyung Hee Univ, Kyung Hee Univ Hosp, Coll Med, Dept Internal Med,Div Cardiol, 23 Kyungheedae Ro, Seoul 02447, South Korea.
EM soojoong27@daum.net
CR Baruscotti M, 2005, PHARMACOL THERAPEUT, V107, P59, DOI 10.1016/j.pharmthera.2005.01.005
   Borer JS, 2003, CIRCULATION, V107, P817, DOI 10.1161/01.CIR.0000048143.25023.87
   Fox K, 2008, LANCET, V372, P807, DOI 10.1016/S0140-6736(08)61170-8
   Fox K, 2014, NEW ENGL J MED, V371, P1091, DOI 10.1056/NEJMoa1406430
   Kalvelage C, 2020, KOREAN CIRC J, V50, P773, DOI 10.4070/kcj.2020.0031
   Knuuti J, 2020, EUR HEART J, V41, P407, DOI 10.1093/eurheartj/ehz425
   Ruzyllo W, 2007, DRUGS, V67, P393, DOI 10.2165/00003495-200767030-00005
   Tardif JC, 2005, EUR HEART J, V26, P2529, DOI 10.1093/eurheartj/ehi586
   Tardif JC, 2009, EUR HEART J, V30, P540, DOI 10.1093/eurheartj/ehn571
   Werdan K, 2012, CLIN RES CARDIOL, V101, P365, DOI 10.1007/s00392-011-0402-4
NR 10
TC 0
Z9 0
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD SEP
PY 2020
VL 50
IS 9
BP 787
EP 790
DI 10.4070/kcj.2020.0266
PG 4
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA NB8WH
UT WOS:000560795800004
PM 32812408
OA Green Published
DA 2021-04-22
ER

PT J
AU Lee, JH
AF Lee, Ju-Hee
TI Moderate Aortic Valve Stenosis with Left Ventricular Systolic
   Dysfunction: Potential Role of Early Aortic Valve Replacement
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
ID MANAGEMENT; SURGERY
C1 [Lee, Ju-Hee] Chungbuk Natl Univ, Chungbuk Natl Univ Hosp, Coll Med, Dept Internal Med,Div Cardiol, 776,1Sunhwan Ro, Cheongju 28644, South Korea.
RP Lee, JH (corresponding author), Chungbuk Natl Univ, Chungbuk Natl Univ Hosp, Coll Med, Dept Internal Med,Div Cardiol, 776,1Sunhwan Ro, Cheongju 28644, South Korea.
EM juheelee@chungbuk.ac.kr
CR Bastos MB, 2019, JACC-CARDIOVASC INTE, V12, P684, DOI 10.1016/j.jcin.2019.01.244
   Baumgartner H, 2017, EUR HEART J, V38, P2739, DOI 10.1093/eurheartj/ehx391
   Harold JG, 2014, J AM COLL CARDIOL, V63, pE57, DOI 10.1016/j.jacc.2014.02.536
   Ito S, 2020, JACC-CARDIOVASC IMAG, V13, P357, DOI 10.1016/j.jcmg.2019.01.009
   Kim C, 2019, KOREAN CIRC J, V49, P283, DOI 10.4070/kcj.2019.0044
   Moon I, 2020, KOREAN CIRC J, V50, P791, DOI 10.4070/kcj.2020.0037
   Samad Z, 2016, EUR HEART J, V37, P2276, DOI 10.1093/eurheartj/ehv701
   Spitzer E, 2016, AM HEART J, V182, P80, DOI 10.1016/j.ahj.2016.08.009
   van Gils L, 2017, J AM COLL CARDIOL, V69, P2383, DOI 10.1016/j.jacc.2017.03.023
   Yu CW, 2018, KOREAN CIRC J, V48, P382, DOI 10.4070/kcj.2018.0117
NR 10
TC 0
Z9 0
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD SEP
PY 2020
VL 50
IS 9
BP 801
EP 803
DI 10.4070/kcj.2020.0301
PG 3
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA NB8WH
UT WOS:000560795800006
PM 32812409
OA Green Published
DA 2021-04-22
ER

PT J
AU Kim, HK
   Tantry, US
   Gurbel, PA
   Jeong, YH
AF Kim, Hyun Kuk
   Tantry, Udaya S.
   Gurbel, Paul A.
   Jeong, Young-Hoon
TI Another Unmet Need against Residual Risk of Atherosclerotic
   Cardiovascular Disease: Can "Thrombin Pathway" Be a New Target for
   Therapy?
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
ID ARTERY-DISEASE; ANTIPLATELET; CORONARY
C1 [Kim, Hyun Kuk] Chosun Univ, Chosun Univ Hosp, Sch Med, Dept Internal Med, Gwangju, South Korea.
   [Tantry, Udaya S.; Gurbel, Paul A.] Sinai Hosp, Sinai Ctr Thrombosis Res & Drug Dev, 2401 W Belvedere Ave, Baltimore, MD 21215 USA.
   [Jeong, Young-Hoon] Gyeongsang Natl Univ, Sch Med, Dept Internal Med, 11 Samjeongja Ro, Chang Won 51472, South Korea.
   [Jeong, Young-Hoon] Gyeongsang Natl Univ, Changwon Hosp, Cardiovasc Ctr, 11 Samjeongja Ro, Chang Won 51472, South Korea.
RP Jeong, YH (corresponding author), Gyeongsang Natl Univ, Sch Med, Dept Internal Med, 11 Samjeongja Ro, Chang Won 51472, South Korea.; Jeong, YH (corresponding author), Gyeongsang Natl Univ, Changwon Hosp, Cardiovasc Ctr, 11 Samjeongja Ro, Chang Won 51472, South Korea.
EM goodoctor@naver.com
OI Tantry, Udaya/0000-0002-8542-8596; Jeong, Young-Hoon/0000-0003-0403-3726
FU Basic Science Research Program through the National Research Foundation
   (NRF) of Korea - Ministry of Science, ICT and Future Planning
   [NRF-2015R1A5A2008833]
FX This editorial is supported by the Basic Science Research Program
   through the National Research Foundation (NRF) of Korea funded by the
   Ministry of Science, ICT and Future Planning (NRF-2015R1A5A2008833).
CR Anand SS, 2018, LANCET, V391, P219, DOI 10.1016/S0140-6736(17)32409-1
   Bae JS, 2020, J THROMB THROMBOLYS, V50, P969, DOI 10.1007/s11239-020-02103-w
   Bhatt DL, 2010, JAMA-J AM MED ASSOC, V304, P1350, DOI 10.1001/jama.2010.1322
   Capodanno D, 2020, NAT REV CARDIOL, V17, P242, DOI 10.1038/s41569-019-0314-y
   Gurbel PA, 2019, CIRCULATION, V139, P2170, DOI 10.1161/CIRCULATIONAHA.118.033580
   Huo Y, 2019, SCI BULL, V64, P166, DOI 10.1016/j.scib.2018.12.020
   Jeong YH, 2020, J THROMB THROMBOLYSI
   Jeong YH, 2014, THROMB HAEMOSTASIS, V111, P713, DOI 10.1160/TH13-08-0643
   Knuuti J, 2020, EUR HEART J, V41, P407, DOI 10.1093/eurheartj/ehz425
   Sanda T, 2020, KOREAN CIRC J, V50, P804, DOI 10.4070/kcj.2020.0055
NR 10
TC 2
Z9 2
U1 1
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD SEP
PY 2020
VL 50
IS 9
BP 817
EP 821
DI 10.4070/kcj.2020.0287
PG 5
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA NB8WH
UT WOS:000560795800008
PM 32812410
OA Green Published
DA 2021-04-22
ER

PT J
AU Kim, DS
AF Kim, Dong-Soo
TI A Comprehensive Perspective of Clinical and Echocardiographic Features
   in the Differential Diagnosis of Cardiac Myxomas and Myxoma-Like Masses
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
ID TUMORS
C1 [Kim, Dong-Soo] Inje Univ, Busan Paik Hosp, Coll Med, Dept Internal Med,Div Cardiol, 75 Bokji Ro, Busan 47392, South Korea.
RP Kim, DS (corresponding author), Inje Univ, Busan Paik Hosp, Coll Med, Dept Internal Med,Div Cardiol, 75 Bokji Ro, Busan 47392, South Korea.
EM dongskim@inje.ac.kr
CR Bruce CJ, 2011, HEART, V97, P151, DOI 10.1136/hrt.2009.186320
   Cianciulli Tomas Francisco, 2019, J Cardiovasc Imaging, V27, P37, DOI 10.4250/jcvi.2019.27.e7
   Colin GC, 2018, INT J CARDIOVAS IMAG, V34, P1789, DOI 10.1007/s10554-018-1396-z
   Hur SH, 1995, J KOREAN SOC ECHOCAR, V3, P72
   Lee SH, 2020, KOREAN CIRC J, V50, P822, DOI 10.4070/kcj.2020.0024
   Lin YY, 2016, J CARDIOVASC MED, V17, P44, DOI 10.2459/JCM.0000000000000114
   Meng QY, 2002, INT J CARDIOL, V84, P69, DOI 10.1016/S0167-5273(02)00136-5
   Nomoto N, 2017, J CARDIOTHORAC SURG, V12, DOI 10.1186/s13019-017-0672-7
   Tyebally S, 2020, JACC-CARDIOONCOL, V2, P293, DOI 10.1016/j.jaccao.2020.05.009
NR 9
TC 0
Z9 0
U1 2
U2 2
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD SEP
PY 2020
VL 50
IS 9
BP 833
EP 835
DI 10.4070/kcj.2020.0309
PG 3
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA NB8WH
UT WOS:000560795800010
PM 32812411
OA Other Gold, Green Published
DA 2021-04-22
ER

PT J
AU Cha, JJ
   Hong, SJ
   Kim, JS
   Seo, J
   Lee, SH
   Lee, S
   Shim, CY
   Hong, GR
AF Cha, Jung-Joon
   Hong, Sung-Jin
   Kim, Jung-Sun
   Seo, Jiwon
   Lee, Seung Hyun
   Lee, Sak
   Shim, Chi Young
   Hong, Geu-Ru
TI A Case of Successful MitraClip for Severe Mitral Regurgitation with Left
   Ventricular Dysfunction in Korea
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
C1 [Cha, Jung-Joon; Hong, Sung-Jin; Kim, Jung-Sun; Seo, Jiwon; Shim, Chi Young; Hong, Geu-Ru] Yonsei Univ Hlth Syst, Yonsei Univ, Severance Cardiovasc Hosp, Coll Med,Div Cardiol, Seoul, South Korea.
   [Lee, Seung Hyun; Lee, Sak] Yonsei Univ Hlth Syst, Yonsei Univ, Severance Cardiovasc Hosp, Coll Med,Div Cardiovasc Surg, Seoul, South Korea.
RP Kim, JS (corresponding author), Yonsei Univ, Severance Cardiovasc Hosp, Coll Med, Div Cardiol, Yonsei Ro 50-1, Seoul 03722, South Korea.
EM kjs1218@yuhs.ac
RI Shim, Chi Young/AAK-1057-2021
OI Shim, Chi Young/0000-0002-6136-0136; Kim, Jung-Sun/0000-0003-2263-3274;
   Hong, Sung-Jin/0000-0003-4893-039X
CR Baumgartner H, 2017, EUR HEART J, V38, P2739, DOI 10.1093/eurheartj/ehx391
   Choi JY, 2019, KOREAN CIRC J, V49, P542, DOI 10.4070/kcj.2019.0154
   Stone GW, 2018, NEW ENGL J MED, V379, P2307, DOI 10.1056/NEJMoa1806640
NR 3
TC 0
Z9 0
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD SEP
PY 2020
VL 50
IS 9
BP 836
EP 838
DI 10.4070/kcj.2020.0062
PG 3
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA NB8WH
UT WOS:000560795800011
PM 32281326
OA Other Gold, Green Published
DA 2021-04-22
ER

PT J
AU Levesque, S
   Gaufroy, A
   Gamet, A
   Motreff, P
   Christiaens, LP
AF Levesque, Sebastien
   Gaufroy, Astrid
   Gamet, Alexandre
   Motreff, Pascal
   Christiaens, Luc-Philippe
TI Unpredictable Midterm Coronary Damage after Knuckle-reverse CART: Should
   We Be More Careful?
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
ID OCCLUSIONS
C1 [Levesque, Sebastien; Gaufroy, Astrid; Gamet, Alexandre; Christiaens, Luc-Philippe] CHU Poitiers, Ctr Cardiovasc, Dept Med, Cardiovasc Intervent Unit,Div Cardiol, F-86000 Poitiers, France.
   [Motreff, Pascal] CHU Clermont Ferrand, Cardiovasc Intervent Unit, Clermont Ferrand, France.
RP Levesque, S (corresponding author), CHU Poitiers, Ctr Cardiovasc, Dept Med, Cardiovasc Intervent Unit,Div Cardiol, F-86000 Poitiers, France.
EM selevesq@yahoo.fr
CR Galassi AR, 2016, JACC-CARDIOVASC INTE, V9, P1979, DOI 10.1016/j.jcin.2016.06.057
   Jia HB, 2017, CATHETER CARDIO INTE, V89, P582, DOI 10.1002/ccd.26969
   Srivatsa SS, 1997, J AM COLL CARDIOL, V29, P955, DOI 10.1016/S0735-1097(97)00035-1
NR 3
TC 0
Z9 0
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD SEP
PY 2020
VL 50
IS 9
BP 839
EP 842
DI 10.4070/kcj.2020.0058
PG 4
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA NB8WH
UT WOS:000560795800012
PM 32725986
OA Green Published, Other Gold
DA 2021-04-22
ER

PT J
AU Cicek, MB
   Karaduman, A
   Balaban, I
   Kilicgedik, A
   Kirma, C
AF Cicek, Mahmut Bugrahan
   Karaduman, Ahmet
   Balaban, Ismail
   Kilicgedik, Alev
   Kirma, Cevat
TI Multimodality Imaging of Large Left Ventricular Apical Pseudoaneurysm
   after Thoracic Surgery
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
C1 [Cicek, Mahmut Bugrahan; Karaduman, Ahmet; Balaban, Ismail; Kilicgedik, Alev; Kirma, Cevat] Kartal Kosuyolu Res & Educ Hosp, Dept Cardiol, Istanbul, Turkey.
RP Karaduman, A (corresponding author), Kartal Kosuyolu Yuksek Ihtisas Egitim & Arastirma, Kartal Kosuyolu Res & Educ Hosp, Dept Cardiol, Istanbul, Turkey.
EM ahmetkaraduman91@gmail.com
OI Balaban, Ismail/0000-0002-1866-349X
NR 0
TC 0
Z9 0
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD SEP
PY 2020
VL 50
IS 9
BP 843
EP 844
DI 10.4070/kcj.2020.0074
PG 2
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA NB8WH
UT WOS:000560795800013
PM 32725988
OA Green Published, Other Gold
DA 2021-04-22
ER

PT J
AU Chung, WB
   Youn, JC
   Youn, HJ
AF Chung, Woo-Baek
   Youn, Jong-Chan
   Youn, Ho-Joong
TI Cardiovascular Complications of Novel Anti-Cancer Immunotherapy: Old
   Problems from New Agents?
SO KOREAN CIRCULATION JOURNAL
LA English
DT Review
DE Anti-cancer therapy; Cardiovascular toxicity; Cancer immunotherapy;
   Immune checkpoint inhibitor; Chimeric antigen receptor T cell therapy
ID T-CELL THERAPY; MAGNETIC-RESONANCE; HEART-FAILURE; DILATED
   CARDIOMYOPATHY; AMERICAN SOCIETY; CANCER-PATIENTS; ADULT PATIENTS;
   MYOCARDITIS; MANAGEMENT; CARDIOTOXICITY
AB Many novel anti-cancer therapies have dramatically improved outcomes of various cancer patients. However, it also poses a risk for cardiovascular complications as well. For the novel anti-cancer agent with which physicians does not have enough clinical experiences to determine the characteristics of cardiovascular complications, it is important to assess risk factors for cardiotoxicity before starting anti-cancer therapy. High-risk patient should be consulted to cardiologist before initiating anti-cancer therapy and pre-emptive cardiac function monitoring plan might be prepared in advance. The biomarkers, electrocardiography and echocardiography are useful tools for the detection of subclinical cardiotoxicity during anti-cancer therapy. This review article tried to suggest the cardiac function monitoring strategies for newly encountered potential cardiotoxic anti-cancer agents and to summarize the cardiovascular complications of novel anti-cancer immunotherapies including immune checkpoint inhibitor (ICI) and chimeric antigen receptor (CAR) T-cell therapy. ICIs can cause fatal myocarditis, which usually occurs early after initiation, and prompt treatment with high-dose corticosteroid is necessary. CAR T-cell therapy can cause cytokine release syndrome, which may result in circulatory collapse. Supportive treatment as well as tocilizumab, an anti-interleukin-6 receptor antibody are cornerstones of treatment.
C1 [Chung, Woo-Baek; Youn, Jong-Chan; Youn, Ho-Joong] Catholic Univ Korea, Seoul St Marys Hosp, Coll Med, Dept Internal Med,Div Cardiol, 222 Banpo Daero, Seoul 06591, South Korea.
RP Youn, HJ (corresponding author), Catholic Univ Korea, Seoul St Marys Hosp, Coll Med, Dept Internal Med,Div Cardiol, 222 Banpo Daero, Seoul 06591, South Korea.
EM younhj@catholic.ac.kr
OI Youn, Jong-Chan/0000-0003-0998-503X
FU Korean Cardiac Research Foundation [20190302]; National Research
   Foundation of Korea (NRF) - Korean government (Ministry of Science and
   ICT) [NRF-2018R1C1B6005448]
FX This work was supported by the fund from the Korean Cardiac Research
   Foundation (20190302) and by the National Research Foundation of Korea
   (NRF) grant funded by the Korean government (Ministry of Science and
   ICT) (NRF-2018R1C1B6005448). The funders played no role in study design,
   data collection, data analysis, decision to publish, or preparation of
   the manuscript.
CR Abdel-Aty H, 2005, J AM COLL CARDIOL, V45, P1815, DOI 10.1016/j.jacc.2004.11.069
   Armenian SH, 2017, J CLIN ONCOL, V35, P893, DOI 10.1200/JCO.2016.70.5400
   Bonaca MP, 2019, CIRCULATION, V140, P80, DOI 10.1161/CIRCULATIONAHA.118.034497
   Brahmer JR, 2018, J CLIN ONCOL, V36, P1714, DOI 10.1200/JCO.2017.77.6385
   Cardinale D, 2020, FRONT CARDIOVASC MED, V7, DOI 10.3389/fcvm.2020.00026
   Choi HM, 2019, KOREAN J INTERN MED, V34, P11, DOI 10.3904/kjim.2018.428
   Chung WB, 2016, KOREAN J INTERN MED, V31, P625, DOI 10.3904/kjim.2016.017
   Chung WB, 2013, J BREAST CANCER, V16, P178, DOI 10.4048/jbc.2013.16.2.178
   Curigliano G, 2020, ANN ONCOL, V31, P171, DOI 10.1016/j.annonc.2019.10.023
   Davila ML, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008226
   Escudier M, 2017, CIRCULATION, V136, P2085, DOI 10.1161/CIRCULATIONAHA.117.030571
   Ferreira VM, 2018, J AM COLL CARDIOL, V72, P3158, DOI 10.1016/j.jacc.2018.09.072
   Friedrich MG, 2009, J AM COLL CARDIOL, V53, P1475, DOI 10.1016/j.jacc.2009.02.007
   Ganatra S, 2019, J AM COLL CARDIOL, V74, P3153, DOI 10.1016/j.jacc.2019.10.049
   Ganatra S, 2019, CARDIOL CLIN, V37, P385, DOI 10.1016/j.ccl.2019.07.008
   Gripp ED, 2018, ARQ BRAS CARDIOL, V110, P140, DOI 10.5935/abc.20180021
   Johnson DB, 2016, NEW ENGL J MED, V375, P1749, DOI 10.1056/NEJMoa1609214
   Kim D, 2019, J CARDIOL, V74, P175, DOI 10.1016/j.jjcc.2019.02.001
   Kim Hyungseop, 2018, J Cardiovasc Ultrasound, V26, P1, DOI 10.4250/jcu.2018.26.1.1
   Kim K-J., 2019, INT J HEART FAIL, V1, P4
   Kittiwarawut A, 2013, ASIA-PAC J CLIN ONCO, V9, P155, DOI 10.1111/j.1743-7563.2012.01588.x
   Le RQ, 2018, ONCOLOGIST, V23, P943, DOI 10.1634/theoncologist.2018-0028
   Lee DW, 2019, BIOL BLOOD MARROW TR, V25, P625, DOI 10.1016/j.bbmt.2018.12.758
   Lee HY, 2020, INT J HEART FAIL
   Lee JH, 2019, KOREAN CIRC J, V49, P22, DOI 10.4070/kcj.2018.0349
   Lichtman AH, 2013, J AUTOIMMUN, V45, P90, DOI 10.1016/j.jaut.2013.05.004
   Linette GP, 2013, BLOOD, V122, P863, DOI 10.1182/blood-2013-03-490565
   Love VA, 2007, CIRC RES, V101, P248, DOI 10.1161/CIRCRESAHA.106.147124
   Lyon AR, 2018, LANCET ONCOL, V19, pE447, DOI 10.1016/S1470-2045(18)30457-1
   Mahmood SS, 2018, J AM COLL CARDIOL, V71, P1755, DOI 10.1016/j.jacc.2018.02.037
   Mahrholdt H, 2004, CIRCULATION, V109, P1250, DOI 10.1161/01.CIR.0000118493.13323.81
   Masoudkabir F, 2017, ATHEROSCLEROSIS, V263, P343, DOI 10.1016/j.atherosclerosis.2017.06.001
   Maude SL, 2018, NEW ENGL J MED, V378, P439, DOI 10.1056/NEJMoa1709866
   Meijers WC, 2019, CARDIOVASC RES, V115, P844, DOI 10.1093/cvr/cvz035
   Michel L, 2020, EUR J HEART FAIL, V22, P350, DOI 10.1002/ejhf.1631
   Michel L, 2018, J THORAC DIS, V10, pS4282, DOI 10.21037/jtd.2018.08.15
   Moslehi JJ, 2018, LANCET, V391, P933, DOI 10.1016/S0140-6736(18)30533-6
   Neelapu SS, 2017, NEW ENGL J MED, V377, P2531, DOI 10.1056/NEJMoa1707447
   Negishi T, 2019, HEART LUNG CIRC, V28, P1331, DOI 10.1016/j.hlc.2019.04.023
   Nishimura H, 2001, SCIENCE, V291, P319, DOI 10.1126/science.291.5502.319
   Obstfeld AE, 2017, BLOOD, V130, P2569, DOI 10.1182/blood-2017-08-802413
   Okazaki T, 2003, NAT MED, V9, P1477, DOI 10.1038/nm955
   Palaskas N, 2020, J AM HEART ASSOC, V9, DOI 10.1161/JAHA.119.013757
   Pareek N, 2018, EUR J HEART FAIL, V20, P1721, DOI 10.1002/ejhf.1292
   Pathan N, 2004, LANCET, V363, P203, DOI 10.1016/S0140-6736(03)15326-3
   Plana JC, 2014, EUR HEART J-CARD IMG, V15, P1063, DOI 10.1093/ehjci/jeu192
   Postow MA, 2018, NEW ENGL J MED, V378, P158, DOI 10.1056/NEJMra1703481
   Salem JE, 2018, LANCET ONCOL, V19, P1579, DOI 10.1016/S1470-2045(18)30608-9
   Schuster SJ, 2019, NEW ENGL J MED, V380, P45, DOI 10.1056/NEJMoa1804980
   Stewart Coats AJ, 2019, INT J HEART FAIL, V1, P25, DOI DOI 10.36628/IJHF.2019.0004
   Tarrio ML, 2012, J IMMUNOL, V188, P4876, DOI 10.4049/jimmunol.1200389
   Uhm Jae-Sun, 2014, Clin Hypertens, V20, P8, DOI 10.1186/2056-5909-1-2
   Virizuela JA, 2019, CLIN TRANSL ONCOL, V21, P94, DOI 10.1007/s12094-018-02017-3
   Youn JC, 2017, KOREAN CIRC J, V47, P16, DOI 10.4070/kcj.2016.0429
   Zamorano JL, 2016, EUR HEART J, V37, P2768, DOI 10.1093/eurheartj/ehw211
   Zardavas D, 2017, J CLIN ONCOL, V35, P878, DOI 10.1200/JCO.2015.65.7916
NR 56
TC 0
Z9 0
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD SEP
PY 2020
VL 50
IS 9
BP 743
EP 753
DI 10.4070/kcj.2020.0158
PG 11
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA NB8WH
UT WOS:000560795800001
PM 32725983
OA Green Published, Other Gold
DA 2021-04-22
ER

PT J
AU Choi, EK
AF Choi, Eue-Keun
TI Cardiovascular Research Using the Korean National Health Information
   Database
SO KOREAN CIRCULATION JOURNAL
LA English
DT Review
DE National Health Insurance; National Health Insurance Service;
   Population-based data; Korea
ID ANTAGONIST ORAL ANTICOAGULANTS; NONVALVULAR ATRIAL-FIBRILLATION; ASIAN
   PATIENTS; STROKE PREVENTION; BLOOD-PRESSURE; CHA(2)DS(2)-VASC SCORE;
   RISK-FACTOR; MYOCARDIAL-INFARCTION; POPULATION; MORTALITY
AB The Korean National Health Information Database (NHID) contains nationwide claims data, including sociodemographic data, health care utilization, health screening data, and healthcare provider information. To compensate for the limitations of randomized clinical trials, real-world observational studies using claims data have emerged as a novel research tool. We summarized the structure of the Korean NHID and the recent researches conducted in the field of cardiovascular science. Epidemiological studies, prescription patterns, temporal trends, comparison of effectiveness and safety of treatments, variability index using laboratory data, and rare intractable disease constitute interesting topics of research in cardiovascular science using the NHID. The operational definition of covariates and clinical outcomes is important for researchers interested in using the NHID data as new tools to prove their hypothesis. A step-by-step approach adopted by a team of data scientists, epidemiologists, statisticians, and clinical researchers may be most effective while designing research studies. The ultimate direction of research using the NHID should aim to improve the welfare of the public by promoting public health, reducing medical costs, and guiding healthcare policies.
C1 [Choi, Eue-Keun] Seoul Natl Univ Hosp, Dept Internal Med, Div Cardiol, Seoul, South Korea.
RP Choi, EK (corresponding author), Seoul Natl Univ Hosp, Dept Internal Med, 101 Daehak Ro, Seoul 03080, South Korea.
EM choiek17@snu.ac.kr
RI Choi, Eue-Keun/J-5968-2014
OI Choi, Eue-Keun/0000-0002-0411-6372
FU BMS/PfizerPfizer; Biosense Webster; Chong Kun Dang;
   Daiichi-SankyoDaiichi Sankyo Company Limited;
   Sanofi-AventisSanofi-Aventis; Skylabs
FX Dr. Choi received research grants from BMS/Pfizer, Biosense Webster,
   Chong Kun Dang, Daiichi-Sankyo, Sanofi-Aventis, and Skylabs.
CR Benjamin EJ, 1998, CIRCULATION, V98, P946, DOI 10.1161/01.CIR.98.10.946
   Bottle A, 2018, HEART, V104, P600, DOI [10.1136/heartjnl-2017-312183, 10.1136/heartjnl-2017-312930]
   Cannon CP, 2017, NEW ENGL J MED, V377, P1513, DOI 10.1056/NEJMoa1708454
   Cha MJ, 2017, STROKE, V48, P3040, DOI 10.1161/STROKEAHA.117.018773
   Chan YH, 2016, J AM COLL CARDIOL, V68, P1389, DOI 10.1016/j.jacc.2016.06.062
   Chang CH, 2014, ATHEROSCLEROSIS, V232, P224, DOI 10.1016/j.atherosclerosis.2013.11.036
   Chao TF, 2019, EUR HEART J, V40, P1504, DOI 10.1093/eurheartj/ehy837
   Chao TF, 2018, CIRCULATION, V138, P37, DOI 10.1161/CIRCULATIONAHA.117.031658
   Chao TF, 2018, CHEST, V153, P453, DOI 10.1016/j.chest.2017.10.001
   Chao TF, 2018, J AM COLL CARDIOL, V71, P122, DOI 10.1016/j.jacc.2017.10.085
   Chao TF, 2015, CIRCULATION, V132, P1604, DOI 10.1161/CIRCULATIONAHA.114.013709
   Chao TF, 2015, J AM COLL CARDIOL, V66, P1339, DOI 10.1016/j.jacc.2015.07.026
   Chao TF, 2015, J AM COLL CARDIOL, V65, P635, DOI 10.1016/j.jacc.2014.11.046
   Cho MS., 2018, STROKE
   Choi YJ, 2019, WORLD J GASTROENTERO, V25, P2788, DOI 10.3748/wjg.v25.i22.2788
   Choi YJ, 2019, EUR HEART J, V40, P724, DOI 10.1093/eurheartj/ehy801
   Choi YJ, 2018, INT J CARDIOL, V273, P130, DOI 10.1016/j.ijcard.2018.08.038
   Connolly SJ, 2009, NEW ENGL J MED, V361, P1139, DOI 10.1056/NEJMoa0905561
   Gibson CM, 2016, NEW ENGL J MED, V375, P2423, DOI 10.1056/NEJMoa1611594
   Giugliano RP, 2013, NEW ENGL J MED, V369, P2093, DOI 10.1056/NEJMoa1310907
   Go AS, 2001, JAMA-J AM MED ASSOC, V285, P2370, DOI 10.1001/jama.285.18.2370
   Granger CB, 2011, NEW ENGL J MED, V365, P981, DOI 10.1056/NEJMoa1107039
   Ha KH, 2018, KOREAN CIRC J, V48, P395, DOI 10.4070/kcj.2017.0324
   Huisman MV, 2017, J AM COLL CARDIOL, V69, P777, DOI 10.1016/j.jacc.2016.11.061
   Joung B, 2018, KOREAN CIRC J, V48, P1033, DOI 10.4070/kcj.2018.0339
   Kang DH, 2018, J AM COLL CARDIOL, V71, P834, DOI 10.1016/S0735-1097(18)31375-5
   Kang SH, 2017, CIRC J, V81, P1158, DOI 10.1253/circj.CJ-16-1267
   Kang SH, 2016, INT J CARDIOL, V215, P449, DOI 10.1016/j.ijcard.2016.04.036
   Kim JA, 2017, J KOREAN MED SCI, V32, P718, DOI 10.3346/jkms.2017.32.5.718
   Kim MK, 2019, HYPERTENSION, V73, P319, DOI 10.1161/HYPERTENSIONAHA.118.12160
   Kim MK, 2018, CIRCULATION, V138, P2627, DOI [10.1161/CIRCULATIONAHA.118.034978, 10.1161/circulationaha.118.034978]
   Kim MK, 2017, EUR HEART J, V38, P3560, DOI 10.1093/eurheartj/ehx585
   Kim TH, 2017, STROKE, V48, P2984, DOI 10.1161/STROKEAHA.117.018551
   Kim TH, 2017, STROKE, V48, P1524, DOI 10.1161/STROKEAHA.117.016926
   Kim YG, 2020, EUROPACE, V22, P216, DOI 10.1093/europace/euz256
   Kwon S, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-54528-w
   Kwon S, 2019, INT J CARDIOL, V293, P153, DOI 10.1016/j.ijcard.2019.06.035
   Lee CJ, 2018, HYPERTENSION, V72, P1285, DOI 10.1161/HYPERTENSIONAHA.118.11787
   Lee E, 2019, INT J CARDIOL, V292, P106, DOI 10.1016/j.ijcard.2019.06.045
   Lee E, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0209687
   Lee H, 2020, EUR J PREV CARDIOL, V27, P870, DOI 10.1177/2047487319898571
   Lee HJ, 2019, J AM HEART ASSOC, V8, DOI 10.1161/JAHA.119.012771
   Lee J, 2017, INT J EPIDEMIOL, V46, DOI 10.1093/ije/dyv319
   Lee SS, 2017, EUR HEART J, V38, P2599, DOI 10.1093/eurheartj/ehx316
   Lee SR, 2020, CIRC-CARDIOVASC QUAL, V13, DOI 10.1161/CIRCOUTCOMES.119.005894
   Lee SR, 2020, STROKE, V51, P416, DOI 10.1161/STROKEAHA.119.028030
   Lee SR, 2020, HYPERTENSION, V75, P309, DOI 10.1161/HYPERTENSIONAHA.119.13708
   Lee SR, 2019, STROKE, V50, P1140, DOI 10.1161/STROKEAHA.118.024210
   Lee SR, 2019, STROKE, V50, P1480, DOI 10.1161/STROKEAHA.118.024264
   Lee SR, 2020, HEART RHYTHM, V17, P12, DOI 10.1016/j.hrthm.2019.07.006
   Lee SR, 2019, J AM COLL CARDIOL, V73, P3295, DOI 10.1016/j.jacc.2019.04.052
   Lee SR, 2019, STROKE, V50, P2245, DOI 10.1161/STROKEAHA.119.025536
   Lee SR, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-43224-4
   Lee SR, 2019, J AM COLL CARDIOL, V73, P919, DOI 10.1016/j.jacc.2018.11.051
   Lee SR, 2018, KOREAN CIRC J, V48, P622, DOI 10.4070/kcj.2017.0362
   Lee SR, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0189495
   Lee SR, 2017, INT J CARDIOL, V245, P149, DOI 10.1016/j.ijcard.2017.07.067
   Lee SR, 2017, INT J CARDIOL, V236, P226, DOI 10.1016/j.ijcard.2017.02.039
   Lee YH, 2016, DIABETES METAB J, V40, P79, DOI 10.4093/dmj.2016.40.1.79
   Li YG, 2018, KOREAN CIRC J, V48, P665, DOI 10.4070/kcj.2018.0190
   Lin YC, 2018, J AM COLL CARDIOL, V72, P477, DOI 10.1016/j.jacc.2018.04.084
   Lip GYH, 2015, INT J CARDIOL, V180, P246, DOI 10.1016/j.ijcard.2014.11.182
   Lip GYH, 2010, CHEST, V137, P263, DOI 10.1378/chest.09-1584
   Lopes RD, 2019, NEW ENGL J MED, V380, P1509, DOI 10.1056/NEJMoa1817083
   Moon I, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0227012
   Moon I, 2019, INT J CARDIOL, V275, P77, DOI 10.1016/j.ijcard.2018.10.024
   National Health Insurance Service, 2014, NAT HLTH SCREEN STAT
   Park J, 2019, INT J ARRHYTHMIA, V20, P5
   Park J, 2019, J CLIN MED, V8, P8
   Park J, 2019, AM J CARDIOL, V123, P1921, DOI 10.1016/j.amjcard.2019.03.024
   Park J, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0209593
   Park JB, 2020, CIRC RES, V126, P824, DOI 10.1161/CIRCRESAHA.119.315705
   Patel MR, 2011, NEW ENGL J MED, V365, P883, DOI 10.1056/NEJMoa1009638
   Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83
   Rhee TM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10556-y
   Schnabel RB, 2015, LANCET, V386, P154, DOI 10.1016/S0140-6736(14)61774-8
   Seong SC, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-016640
   Seong SC, 2017, INT J EPIDEMIOL, V46, P799, DOI 10.1093/ije/dyw253
   Shih CJ, 2016, CIRCULATION, V133, P265, DOI 10.1161/CIRCULATIONAHA.115.018294
   Song SO, 2014, DIABETES METAB J, V38, P395, DOI 10.4093/dmj.2014.38.5.395
   Torp-Pedersen C, 2020, EUROPACE, V22, P831, DOI 10.1093/europace/euz210
   U.S. Food and Drug Administration, 2015, PRESCR INF SAV ED
   Vranckx P, 2019, LANCET, V394, P1335, DOI 10.1016/S0140-6736(19)31872-0
   Yang PS, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25111-6
   Yu HT, 2020, KOREAN CIRC J, V50, P267, DOI 10.4070/kcj.2019.0207
   Yu HT, 2018, STROKE, V49, P2421, DOI 10.1161/STROKEAHA.118.021387
   원태영, 2007, [Journal of The Korean Society of Emergency Medicine, 대한응급의학회지], V18, P256
NR 87
TC 7
Z9 7
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD SEP
PY 2020
VL 50
IS 9
BP 754
EP 772
DI 10.4070/kcj.2020.0171
PG 19
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA NB8WH
UT WOS:000560795800002
PM 32725984
OA Green Published, Other Gold
DA 2021-04-22
ER

PT J
AU Kalvelage, C
   Stoppe, C
   Marx, N
   Marx, G
   Benstoem, C
AF Kalvelage, Christina
   Stoppe, Christian
   Marx, Nikolaus
   Marx, Gernot
   Benstoem, Carina
TI Ivabradine for the Therapy of Chronic Stable Angina Pectoris: a
   Systematic Review and Meta-Analysis
SO KOREAN CIRCULATION JOURNAL
LA English
DT Review
DE Ivabradine; Angina pectoris; Cardiovascular diseases; Systematic review;
   Meta-analysis
ID CORONARY-ARTERY-DISEASE; VENTRICULAR SYSTOLIC DYSFUNCTION; I-F
   INHIBITOR; DOUBLE-BLIND; EFFICACY; ATENOLOL; RANOLAZINE; GUIDELINES;
   MANAGEMENT; BEAUTIFUL
AB Background and Objectives: Coronary artery disease (CAD) is the number one cause of death worldwide. The I-f channel inhibitor ivabradine serves as second line medication for the CAD leading symptom angina pectoris. This systematic review and meta-analysis assess the existing evidence of ivabradine in angina pectoris.
   Methods: We systematically searched MEDLINE, Embase, CENTRAL, and Web of Science (September 2019) for randomized controlled trials (RCTs) that compared ivabradine versus placebo, standard therapy (ST) or other anti-anginal drugs. Two review authors independently assessed trials for inclusion and performed data extraction. We completed a 'risk of bias' assessment for all studies and assessed quality of the trial evidence using the Grading of Recommendations Assessment, Development and Evaluation methodology. We meta-analysed data were applicable and calculated mean differences (MDs) and risk ratios using a random-effects model.
   Results: A total of 11 RCTs (n=16,039) were included. Compared to placebo/ST, we found significant effects on the frequency of hospitalisation in a small cohort (n=90; hazard ratio [HR], 0.19; 95% confidence interval [CI], 0.04, -0.92; p=0.04), but no effects on cardiovascular mortality (n=19,102; HR, 1.10; 95% CI, 0.94, 1.28; p=0.25) or the frequency of angina pectoris episodes (n=167; weighted MD, -1.06; 95% CI, -2.74, -0.61; p=0.21).
   Conclusions: The present work makes an important contribution to optimal patient care in angina pectoris by complementing the current European Society of Cardiology guideline-recommending class Ila with evidence level B-decisively with 8 further studies.
C1 [Kalvelage, Christina; Stoppe, Christian; Marx, Gernot; Benstoem, Carina] Rhein Westfal TH Aachen, Med Fac, Dept Intens Care Med, Pauwelsstr 30, D-52074 Aachen, Germany.
   [Stoppe, Christian] Rhein Westfal TH Aachen, Med Fac, Cardiovasc Crit Care & Anesthesia Res & Evaluat 3, Aachen, Germany.
   [Marx, Nikolaus] Rhein Westfal TH Aachen, Med Fac, Dept Cardiol Pneumol Angiol & Intens Care, Aachen, Germany.
RP Benstoem, C (corresponding author), Rhein Westfal TH Aachen, Med Fac, Dept Intens Care Med, Pauwelsstr 30, D-52074 Aachen, Germany.
EM cbenstoem@ukaachen.de
OI Benstoem, Carina/0000-0002-4604-6771; Stoppe,
   Christian/0000-0002-2028-2039
CR Amosova E, 2011, CARDIOVASC DRUG THER, V25, P531, DOI 10.1007/s10557-011-6327-3
   Borer JS, 2017, CARDIOLOGY, V136, P138, DOI 10.1159/000449243
   Borer JS, 2003, CIRCULATION, V107, P817, DOI 10.1161/01.CIR.0000048143.25023.87
   Cochrane Collaboration, 2008, REV MAN REVMAN 5 0
   European Medicines Agency, 2014, PRAC REC MEAS RED RI
   European Medicines Agency (EMA), 2018, PROD INF IV
   Ferrari R, 2018, NAT REV CARDIOL, V15, P120, DOI 10.1038/nrcardio.2017.131
   Fox K, 2006, EUR HEART J, V27, P1341, DOI 10.1093/eurheartj/ehl001
   Fox K, 2008, LANCET, V372, P807, DOI 10.1016/S0140-6736(08)61170-8
   Fox K, 2014, NEW ENGL J MED, V371, P1091, DOI 10.1056/NEJMoa1406430
   Fox K, 2009, EUR HEART J, V30, P2337, DOI 10.1093/eurheartj/ehp358
   Glezer M, 2018, ADV THER, V35, P341, DOI 10.1007/s12325-018-0681-5
   Higgins JPT, 2020, COCHRANE HDB SYSTEMA
   Kaski JC, 2018, OPEN HEART, V5, DOI 10.1136/openhrt-2017-000725
   Li Y, 2014, PHARMACOEPIDEM DR S, V23, P1183, DOI 10.1002/pds.3628
   Mengesha HG, 2017, BMC CARDIOVASC DISOR, V17, DOI 10.1186/s12872-017-0540-3
   Montalescot G, 2013, EUR HEART J, V34, P2949, DOI 10.1093/eurheartj/eht296
   Naji F, 2014, EUR HEART J, V35, P127
   National Clinical Guidelines Centre, 2011, STABL ANG METH EV GU
   Picano E, 2002, J AM COLL CARDIOL, V40, P1305, DOI 10.1016/S0735-1097(02)02157-5
   Shavarov AA, 2013, TERAPEVT ARKH, V85, P77
   SPERTUS JA, 1995, J AM COLL CARDIOL, V25, P333, DOI 10.1016/0735-1097(94)00397-9
   Taccheri T, 2014, EUR HEART J, V35, P323
   Tardif JC, 2005, EUR HEART J, V26, P2529, DOI 10.1093/eurheartj/ehi586
   Tardif JC, 2009, EUR HEART J, V30, P540, DOI 10.1093/eurheartj/ehn571
   Tatarchenko IP, 2008, KARDIOLOGIYA, V48, P60
   Villano A, 2013, AM J CARDIOL, V112, P8, DOI 10.1016/j.amjcard.2013.02.045
   Werdan K, 2016, CARDIOLOGY, V135, P141, DOI 10.1159/000447443
   WILLIAMS A, 1990, HEALTH POLICY, V16, P199
   Ye LW, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003245
NR 30
TC 1
Z9 1
U1 0
U2 2
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD SEP
PY 2020
VL 50
IS 9
BP 773
EP 786
DI 10.4070/kcj.2020.0031
PG 14
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA NB8WH
UT WOS:000560795800003
PM 32725985
OA Other Gold, Green Published
DA 2021-04-22
ER

PT J
AU Moon, I
   Kim, M
   Choi, JW
   Park, JB
   Hwang, HY
   Kim, HK
   Kim, YJ
   Kim, KH
   Kim, KB
   Sohn, DW
   Lee, SP
AF Moon, Inki
   Kim, Minkwan
   Choi, Jae Woong
   Park, Jun Bean
   Hwang, Ho Young
   Kim, Hyung Kwan
   Kim, Yong Jin
   Kim, Kyung Hwan
   Kim, Ki Bong
   Sohn, Dae Won
   Lee, Seung Pyo
TI Early Surgery versus Watchful Waiting in Patients with Moderate Aortic
   Stenosis and Left Ventricular Systolic Dysfunction
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Aortic stenosis; Heart valve prosthesis implantation; Heart failure;
   Prognosis
ID VALVE-REPLACEMENT; EJECTION FRACTION; HEART-FAILURE; WALL STRESS;
   MANAGEMENT; DISEASE; MILD
AB Background and Objectives: Severe aortic stenosis (AS) with left ventricular systolic dysfunction (LVSD) is a class I indication for aortic valve replacement (AVR) but this recommendation is not well established in those at the stage of moderate AS. We investigate the clinical impact of AVR among patients with moderate AS and LVSD.
   Methods: From 2001 to 2017, we consecutively identified patients with moderate AS and LVSD, defined as aortic valve area 1.0-1.5 cm(2) and left ventricular ejection fraction <50%. The primary outcome was all-cause death. The outcomes were compared between those who underwent early surgical AVR (within 2 years of index echocardiography) at the stage of moderate AS versus those who were followed medically without AVR at the outpatient clinic.
   Results: Among 255 patients (70.1 +/- 11.3 years, male 62%), 37 patients received early AVR. The early AVR group was younger than the medical observation group (63.1 +/- 7.9 vs. 71.3 +/- 11.4) with a lower prevalence of hypertension and chronic kidney disease. During a median 1.8-year follow up, 121 patients (47.5%) died, and the early AVR group showed a significantly lower all-cause death rate than the medical observation group (5.03PY vs. 18.80PY, p<0.001). After multivariable Cox-proportional hazard regression adjusting forage, sex, comorbidities, and laboratory data, early AVR at the stage of moderate AS significantly reduced the risk of death (hazard ratio, 0.43; 95% confidence interval 0.20-0.91; p=0.028).
   Conclusions: In patients with moderate AS and LVSD, AVR reduces the risk of all-cause death. A prospective randomized trial is warranted to confirm our findings.
C1 [Moon, Inki] Soonchunhyang Univ, Dept Internal Med, Div Cardiol, Bucheon Hosp, Bucheon, South Korea.
   [Kim, Minkwan; Park, Jun Bean; Kim, Hyung Kwan; Kim, Yong Jin; Sohn, Dae Won; Lee, Seung Pyo] Seoul Natl Univ Hosp, Dept Internal Med, 101 Daehak Ro, Seoul 03080, South Korea.
   [Choi, Jae Woong; Hwang, Ho Young; Kim, Kyung Hwan; Kim, Ki Bong] Seoul Natl Univ Hosp, Dept Cardiovasc Thorac Surg, Seoul, South Korea.
RP Lee, SP (corresponding author), Seoul Natl Univ Hosp, Dept Internal Med, 101 Daehak Ro, Seoul 03080, South Korea.
EM sproll1@snu.ac.kr
OI Kim, Kyung-Hwan Kim/0000-0002-2718-8758; Park,
   Jun-Bean/0000-0003-4053-8713; Choi, Jae Woong/0000-0002-0921-756X; Sohn,
   Dae-Won/0000-0002-1092-3285; Kim, Hyung-Kwan/0000-0001-7950-2131; Moon,
   Inki/0000-0002-3404-3012; Kim, Minkwan/0000-0002-4079-8219
FU National Research Foundation of Korea (NRF) - Korea government (Ministry
   of Science and ICT) [2019R1A2C2084099]
FX This work was supported by the National Research Foundation of Korea
   (NRF) grant funded by the Korea government (Ministry of Science and ICT)
   (No. 2019R1A2C2084099).
CR Alter P, 2016, INT J CARDIOL, V202, P685, DOI 10.1016/j.ijcard.2015.09.032
   Bastos MB, 2019, JACC-CARDIOVASC INTE, V12, P684, DOI 10.1016/j.jcin.2019.01.244
   Baumgartner H, 2017, EUR HEART J, V38, P2739, DOI 10.1093/eurheartj/ehx391
   Feygin J, 2008, AM J PHYSIOL-HEART C, V294, pH2313, DOI 10.1152/ajpheart.01288.2007
   Gillinov A Marc, 2005, Curr Cardiol Rep, V7, P101, DOI 10.1007/s11886-005-0020-8
   Harold JG, 2014, J AM COLL CARDIOL, V63, pE57, DOI 10.1016/j.jacc.2014.02.536
   Ito S, 2020, JACC-CARDIOVASC IMAG, V13, P357, DOI 10.1016/j.jcmg.2019.01.009
   Mitchell C, 2019, J AM SOC ECHOCARDIOG, V32, P1, DOI 10.1016/j.echo.2018.06.004
   Mosterd A, 2007, HEART, V93, P1137, DOI 10.1136/hrt.2003.025270
   Narang N, 2017, FRONT CARDIOVASC MED, V4, DOI 10.3389/fcvm.2017.00014
   Ng ACT, 2011, EUR HEART J, V32, P1542, DOI 10.1093/eurheartj/ehr084
   Osnabrugge RLJ, 2013, J AM COLL CARDIOL, V62, P1002, DOI 10.1016/j.jacc.2013.05.015
   Pereira JJ, 2005, AM J MED, V118, P735, DOI 10.1016/j.amjmed.2005.01.072
   Pibarot P, 2019, JACC-CARDIOVASC IMAG, V12, P172, DOI 10.1016/j.jcmg.2018.10.021
   Samad Z, 2016, EUR HEART J, V37, P2276, DOI 10.1093/eurheartj/ehv701
   Smith WT, 2004, J AM COLL CARDIOL, V44, P1241, DOI 10.1016/j.jacc.2004.06.031
   Spitzer E, 2016, AM HEART J, V182, P80, DOI 10.1016/j.ahj.2016.08.009
   Strange G, 2019, J AM COLL CARDIOL, V74, P1851, DOI 10.1016/j.jacc.2019.08.004
   van Gils L, 2017, J AM COLL CARDIOL, V69, P2383, DOI 10.1016/j.jacc.2017.03.023
NR 19
TC 2
Z9 2
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD SEP
PY 2020
VL 50
IS 9
BP 791
EP 800
DI 10.4070/kcj.2020.0037
PG 10
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA NB8WH
UT WOS:000560795800005
PM 32725989
OA Green Published, Other Gold
DA 2021-04-22
ER

PT J
AU Sanda, T
   Yoshimura, M
   Hyodo, K
   Ishii, H
   Yamashita, T
AF Sanda, Tomohide
   Yoshimura, Manami
   Hyodo, Kanae
   Ishii, Hiromitu
   Yamashita, Tsutomu
TI Effects of Long-term Thrombin Inhibition (Dabigatran Etexilate) on
   Spontaneous Thrombolytic Activity during the Progression of
   Atherosclerosis in ApoE(-/-)-LDLR-/- Double-Knockout Mice
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Anticoagulants; Atherosclerosis; Fibrinolysis; PAI-1; TAFI; Dabigatran
   etexilate
ID PLASMINOGEN-ACTIVATOR INHIBITOR-1; ACUTE ISCHEMIC-STROKE; NITRIC-OXIDE;
   FIBRINOLYSIS; IMPACT; INJURY
AB Background and Objectives: Atherosclerosis is characterized by a hypercoagulable state, during which coagulation and fibrinolytic factors are activated simultaneously. However, details regarding the thrombolytic pathway in this context remain unknown. Here we investigated how direct long-term inhibition of thrombin influenced spontaneous thrombolytic activity during atherosclerotic progression in apolipoprotein E (ApoE)(-/-)-low density lipoprotein receptor (LDLR)(-/-) double-knockout mice.
   Methods: All mice received either standard chow (placebo group) or dabigatran-containing chow for 22 weeks, after which we evaluated them. The amount of atherosclerosis was estimated as the ratio of the atherosclerotic area to the total aortic intimal area. In addition, we used immunohistochemistry to analyze the expression of tissue plasminogen activator (t-PA), plasminogen activator inhibitor-1 (PAH), thrombin activatable fibrinolysis inhibitor (TAFI), and endothelial nitric oxide synthase (eNOS) in atherosclerotic regions. To evaluate thrombolysis, we used a He-Ne laser to induce thrombosis in vessels of the cremaster muscle and then measured the thrombus volume over time.
   Results: The atherosclerotic area was smaller and thrombolytic activity greater in the dabigatran-treated group than in the placebo group. Furthermore, according to the thrombolysis model, spontaneous thrombolytic activity was increased in the dabigatran-treated mice compared with the placebo mice. In support of these results, immunohistochemistry demonstrated decreased expression of PAI-1 and TAFI but increased expression of eNOS in the dabigatran group compared with the placebo group. However, t-PA expression did not differ between groups.
   Conclusions: Direct long-term inhibition by dabigatran etexilate of thrombin led to an increase in spontaneous thrombolytic activity decreasing the expression of PAH and TAFI.
C1 [Sanda, Tomohide; Yoshimura, Manami; Hyodo, Kanae; Ishii, Hiromitu; Yamashita, Tsutomu] Kobe Gakuin Univ, Fac Nutr, Lab Med Technol, Kobe, Hyogo, Japan.
   [Ishii, Hiromitu] Jinkeikai Ishii Hosp, Med Corp, Akashi, Hyogo, Japan.
RP Yamashita, T (corresponding author), Kobe Gakuin Univ, Fac Nutr, Lab Med Technol, Nishi Ku, 518 Arise Igawadani Cho, Kobe, Hyogo 6512180, Japan.
EM tsutomu@nutr.kobegakuin.ac.jp
OI ji cun, ai mei/0000-0002-1317-7222; Ishii,
   Hiromitsu/0000-0001-9885-8985; Hyodo, Kanae/0000-0001-7511-7797
CR Adams HP, 1996, STROKE, V27, P1711
   Bouchard L, 2010, OBES SURG, V20, P492, DOI 10.1007/s11695-010-0079-1
   Boulaftali Y, 2011, CIRCULATION, V123, P1326, DOI 10.1161/CIRCULATIONAHA.110.000885
   Connolly SJ, 2009, NEW ENGL J MED, V361, P1139, DOI 10.1056/NEJMoa0905561
   Danckwardt S, 2013, J MOL MED, V91, P1257, DOI 10.1007/s00109-013-1074-5
   Davies MJ, 1996, CIRCULATION, V94, P2013, DOI 10.1161/01.CIR.94.8.2013
   Esmon CT, 2014, THROMB HAEMOSTASIS, V111, P625, DOI 10.1160/TH13-09-0730
   Forood Afsaneh, 2014, Addict Health, V6, P119
   Fusaro M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133847
   Hankey GJ, 2011, CIRCULATION, V123, P1436, DOI 10.1161/CIRCULATIONAHA.110.004424
   Jennings LK, 2009, THROMB HAEMOSTASIS, V102, P248, DOI 10.1160/TH09-03-0192
   Kakar P, 2007, CURR OPIN INVEST DR, V8, P256
   Kang KW, 2003, J BIOL CHEM, V278, P17368, DOI 10.1074/jbc.M300471200
   Larsen TB, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i3189
   Lippi G, 2011, NAT REV CARDIOL, V8, P502, DOI 10.1038/nrcardio.2011.91
   Moncada S., 2006, V176, P213
   Ozmen S, 2008, J PLAST RECONSTR AES, V61, P939, DOI 10.1016/j.bjps.2007.05.017
   Ross JS, 2001, ANN NY ACAD SCI, V947, P271
   Sinkovic A, 2004, THROMB RES, V114, P251, DOI 10.1016/j.thromres.2004.06.040
   Stangier J, 2007, BRIT J CLIN PHARMACO, V64, P292, DOI 10.1111/j.1365-2125.2007.02899.x
   Stangier J, 2009, CLIN APPL THROMB-HEM, V15, p9S, DOI 10.1177/1076029609343004
   Tsantes AE, 2008, THROMB RES, V122, P736, DOI 10.1016/j.thromres.2007.09.005
   Vercauteren E, 2012, J THROMB HAEMOST, V10, P2555, DOI 10.1111/jth.12036
   Wang TJ, 2006, NEW ENGL J MED, V355, P2631, DOI 10.1056/NEJMoa055373
   Wienen W, 2007, THROMB HAEMOSTASIS, V98, P333, DOI 10.1160/TH07-02-0113
   Yamashita T, 2006, PLATELETS, V17, P201, DOI 10.1080/09537100500444063
   Yamashita T, 2005, THROMB RES, V116, P393, DOI 10.1016/j.thromres.2005.01.011
   YIN M, 2007, ZHONGHUA BING LI XUE, V36, P751
   Zhu YH, 1999, CIRCULATION, V99, P3050, DOI 10.1161/01.CIR.99.23.3050
   Zunker P, 1999, NEUROL RES, V21, P727, DOI 10.1080/01616412.1999.11741005
NR 30
TC 1
Z9 1
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD SEP
PY 2020
VL 50
IS 9
BP 804
EP 816
DI 10.4070/kcj.2020.0055
PG 13
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA NB8WH
UT WOS:000560795800007
PM 32725990
OA Green Published, Other Gold
DA 2021-04-22
ER

PT J
AU Lee, SH
   Park, JS
   Park, JH
   Chin, JY
   Yoon, WS
   Kim, HY
   Cho, JY
   Kim, KH
   Kim, WH
AF Lee, Sun Hwa
   Park, Joon Sung
   Park, Jae-Hyeong
   Chin, Jung Yeon
   Yoon, Won-Sik
   Kim, Hyung Yoon
   Cho, Jae Yeong
   Kim, Kye Hun
   Kim, Won-Ho
TI Comparison of Clinical and Echocardiographic Characteristics between
   Cardiac Myxomas and Masses Mimicking Myxoma
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Cardiac tumor; Echocardiography; Myxoma; Thrombus
ID MITRAL-VALVE; EXPERIENCE
AB Background and objectives: Cardiac myxoma is the most frequent benign cardiac tumor that can result in cardiac and systemic symptoms. We investigated clinical and echocardiographic characteristics of patients with cardiac masses suggesting myxoma.
   Methods: We investigated 265 consecutive patients with an echocardiographic diagnosis of cardiac myxomas in 4 teaching hospitals in Korea.
   Results: The mean age was 61 +/- 16 years and 169 patients (63.8%) were female. The most frequent referral reason for echocardiography was an evaluation of cardiac symptoms (43.4%). Tumors were incidentally detected in 82 patients (30.9%). Left atrium (LA) was the most frequently involved site (84.5%) and 19 patients (7.2%) had non-atrial tumors. The mean tumor size was 38.7x26.0 mm (range, 4-96 mm). Of 186 patients (70.2%) who had pathological diagnosis, 174 (93.5%) were confirmed with myxoma, 8 (4.3%) with other tumors and 4 (2.2%) with thrombi. Compared to myxoma, smaller size (20.4x12.6 mm vs. 41.4x27.6 mm, p <0.01) and non-LA location (87.5% vs. 10.5%, p<0.001) were associated with non-myxoma tumors, and more frequent atrial fibrillation (AF, 75.0% vs. 7.0%, p<0.001) and larger LA diameter (55.0 +/- 14.6 mm vs. 41.3 +/- 7.7 mm, p=0.001) were related to thrombi.
   Conclusions: Of 265 patients with an echocardiographic diagnosis with cardiac myxomas, 174 (65.7%) were surgically confirmed with myxomas. Compared with cardiac myxoma, other tumors were smaller and more frequently found in non-atrial sites. Thrombi were associated with AF and larger LA diameter.
C1 [Lee, Sun Hwa; Yoon, Won-Sik; Kim, Won-Ho] Jeonbuk Natl Univ, Med Sch, Dept Internal Med, Div Cardiol, Jeonju, South Korea.
   [Lee, Sun Hwa; Yoon, Won-Sik; Kim, Won-Ho] Jeonbuk Natl Univ, Jeonbuk Natl Univ Hosp, Biomed Res Inst, Res Inst Clin Med, Jeonju, South Korea.
   [Park, Joon Sung; Kim, Hyung Yoon; Cho, Jae Yeong; Kim, Kye Hun] Chonnam Natl Univ Hosp, Dept Cardiovasc Med, 42 Jebong Ro, Gwangju 61469, South Korea.
   [Park, Jae-Hyeong] Chungnam Natl Univ, Sch Med, Dept Cardiol Internal Med, Daejeon, South Korea.
   [Park, Jae-Hyeong] Chungnam Natl Univ Hosp, Reg Cardiocerebrovasc Ctr, Daejeon, South Korea.
   [Chin, Jung Yeon] Eulji Univ, Eulji Univ Hosp, Coll Med, Cardiovasc Ctr, Daejeon, South Korea.
   [Chin, Jung Yeon] Eulji Univ, Eulji Univ Hosp, Coll Med, Div Cardiol,Dept Internal Med, Daejeon, South Korea.
RP Kim, KH (corresponding author), Chonnam Natl Univ Hosp, Dept Cardiovasc Med, 42 Jebong Ro, Gwangju 61469, South Korea.; Park, JH (corresponding author), Chungnam Natl Univ, Chungnam Natl Univ Hosp, Reg Cardiocerebrovasc Ctr, Dept Cardiol Internal Med,Sch Med, 282 Munhwa Ro, Daejeon 35015, South Korea.
EM jaehpark@cnu.ac.kr; christiankyehun@hanmail.net
RI Park, Jae-Hyeong/AAD-9015-2021
OI Lee, Sun Hwa/0000-0001-9752-9717; Kim, Kye Hun/0000-0002-6885-1501; Kim,
   Hyung Yoon/0000-0002-0692-5640
FU Research Base Construction Fund Support Program - Jeonbuk National
   University; Fund of Biomedical Research Institute, Jeonbuk National
   University Hospital
FX This research was supported by Research Base Construction Fund Support
   Program funded by Jeonbuk National University in 2019. This paper was
   supported by Fund of Biomedical Research Institute, Jeonbuk National
   University Hospital.
CR Basso C, 1997, EUR J CARDIO-THORAC, V12, P730, DOI 10.1016/S1010-7940(97)00246-7
   Bullock-Palmer RP, 2010, ECHOCARDIOGR-J CARD, V27, pE62, DOI 10.1111/j.1540-8175.2010.01187.x
   BURKE AP, 1993, AM J CLIN PATHOL, V100, P671, DOI 10.1093/ajcp/100.6.671
   Cianciulli Tomas Francisco, 2019, J Cardiovasc Imaging, V27, P37, DOI 10.4250/jcvi.2019.27.e7
   Colin GC, 2018, INT J CARDIOVAS IMAG, V34, P1789, DOI 10.1007/s10554-018-1396-z
   Demirel M, 2017, KOREAN CIRC J, V47, P286, DOI 10.4070/kcj.2016.0223
   El Sabbagh A, 2017, JACC-CARDIOVASC IMAG, V10, P203, DOI 10.1016/j.jcmg.2016.06.018
   Erdoes G, 2010, EUR J ECHOCARDIOGR, V11, DOI 10.1093/ejechocard/jep192
   FANG BR, 1990, INT J CARDIOL, V29, P335, DOI 10.1016/0167-5273(90)90123-M
   Garatti A, 2012, ANN THORAC SURG, V93, P825, DOI 10.1016/j.athoracsur.2011.11.009
   GREENWOOD WF, 1968, AM J CARDIOL, V21, P367, DOI 10.1016/0002-9149(68)90141-0
   Karabinis A, 2018, MEDICINE, V97, DOI 10.1097/MD.0000000000012397
   Kodali S, 2010, ECHOCARDIOGR-J CARD, V27, P98
   Lee KS, 2017, J CARDIOTHORAC SURG, V12, DOI 10.1186/s13019-017-0583-7
   Pacini D, 2012, EUR J CARDIO-THORAC, V41, P812, DOI 10.1093/ejcts/ezr067
   Poterucha TJ, 2019, CURR TREAT OPTION ON, V20, DOI 10.1007/s11864-019-0662-1
   Singh Y, 2013, J THROMB THROMBOLYS, V36, P74, DOI 10.1007/s11239-013-0866-3
   Yu SH, 2006, YONSEI MED J, V47, P367, DOI 10.3349/ymj.2006.47.3.367
NR 18
TC 1
Z9 1
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD SEP
PY 2020
VL 50
IS 9
BP 822
EP 832
DI 10.4070/kcj.2020.0024
PG 11
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA NB8WH
UT WOS:000560795800009
PM 32725996
OA Green Published
DA 2021-04-22
ER

PT J
AU Lee, JY
AF Lee, Jae Young
TI Global Burden of Congenital Heart Disease: Experience in Korea as a
   Potential Solution to the Problem
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
C1 [Lee, Jae Young] Catholic Univ Korea, Seoul St Marys Hosp, Coll Med, Div Cardiol,Dept Pediat, 222 Banpo Daero, Seoul 06591, South Korea.
RP Lee, JY (corresponding author), Catholic Univ Korea, Seoul St Marys Hosp, Coll Med, Div Cardiol,Dept Pediat, 222 Banpo Daero, Seoul 06591, South Korea.
EM jaeyounglee@catholic.ac.kr
CR Bernier Pierre-Luc, 2010, Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu, V13, P26, DOI 10.1053/j.pcsu.2010.02.005
   Hoffman JIE, 2002, J AM COLL CARDIOL, V39, P1890, DOI 10.1016/S0735-1097(02)01886-7
   Hoffman JI, 2013, CARDIOVASC J AFR, V24, P141, DOI 10.5830/CVJA-2013-028
   Institute for Health Metrics and Evaluation, 2018, GLOB BURD DIS 2017
   Peyvandi S, 2020, J AM HEART ASSOC, V9, DOI 10.1161/JAHA.119.015255
   Shin HJ, 2020, KOREAN CIRC J, V50, P677, DOI 10.4070/kcj.2019.0364
   Tchervenkov CI, 2008, CARDIOL YOUNG, V18, P63, DOI 10.1017/S1047951108002801
   The Korean Heart Foundation, 2020, PRES STAT CARD SURG
   van der Linde D, 2011, J AM COLL CARDIOL, V58, P2241, DOI 10.1016/j.jacc.2011.08.025
   Zheleva B, 2017, LANCET, V389, P16, DOI 10.1016/S0140-6736(16)32185-7
NR 10
TC 1
Z9 1
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD AUG
PY 2020
VL 50
IS 8
BP 691
EP 694
DI 10.4070/kcj.2020.0216
PG 4
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA MU8ML
UT WOS:000555921500004
PM 32725976
OA Green Published, Other Gold
DA 2021-04-22
ER

PT J
AU Kim, MJ
AF Kim, Mi-Jeong
TI Non-alcoholic Fatty Liver Disease, Cardio-metabolic Syndrome and
   Hypertension: One Concept Fits Multi-systemic Presentations
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
ID ADIPOSITY
C1 [Kim, Mi-Jeong] Catholic Univ Korea, Incheon St Marys Hosp, Coll Med, Dept Cardiovasc Med, 56 Dongsu Ro, Incheon 21431, South Korea.
   [Kim, Mi-Jeong] Catholic Univ Korea, Coll Med, Dept Internal Med, Seoul, South Korea.
RP Kim, MJ (corresponding author), Catholic Univ Korea, Incheon St Marys Hosp, Coll Med, Dept Cardiovasc Med, 56 Dongsu Ro, Incheon 21431, South Korea.
EM mjkim@catholic.ac.kr
RI Kim, Mi-Jeong/AAK-3053-2021
OI Kim, Mi-Jeong/0000-0002-7887-3309
CR Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644
   Bedogni G, 2006, BMC GASTROENTEROL, V6, DOI 10.1186/1471-230X-6-33
   Bonnet F, 2017, J HYPERTENS, V35, P493, DOI 10.1097/HJH.0000000000001204
   Deng GJ, 2018, MEDICINE, V97, DOI 10.1097/MD.0000000000013262
   Lee JJ, 2018, AM J MED, V131, P684, DOI 10.1016/j.amjmed.2018.02.002
   Marchesini G, 2001, DIABETES, V50, P1844, DOI 10.2337/diabetes.50.8.1844
   Mechanick JI, 2020, J AM COLL CARDIOL, V75, P539, DOI 10.1016/j.jacc.2019.11.046
   Mechanick JI, 2020, J AM COLL CARDIOL, V75, P525, DOI 10.1016/j.jacc.2019.11.044
   Park J, 2014, INT J CARDIOL, V176, P951, DOI 10.1016/j.ijcard.2014.08.108
   Roh JH, 2020, KOREAN CIRC J, V50, P695, DOI 10.4070/kcj.2019.0379
   Wong RJ, 2015, GASTROENTEROLOGY, V148, P547, DOI 10.1053/j.gastro.2014.11.039
   Younossi ZM, 2016, HEPATOLOGY, V64, P73, DOI 10.1002/hep.28431
NR 12
TC 0
Z9 0
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD AUG
PY 2020
VL 50
IS 8
BP 706
EP 708
DI 10.4070/kcj.2020.0217
PG 3
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA MU8ML
UT WOS:000555921500006
PM 32725977
OA Green Published
DA 2021-04-22
ER

PT J
AU Cha, JJ
   Hong, SJ
AF Cha, Jung-Joon
   Hong, Soon Jun
TI A Simple Protocol to Save Time Delay for Patients with ST-Elevation
   Myocardial Infarction by Using Pre-hospital Electrocardiogram
   Transmission Program
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
ID SEGMENT ELEVATION; ANGIOPLASTY; MORTALITY
C1 [Cha, Jung-Joon; Hong, Soon Jun] Korea Univ, Anam Hosp, Coll Med, Dept Cardiol,Cardiovasc Ctr, 73 Goryeodae Ro, Seoul 02841, South Korea.
RP Hong, SJ (corresponding author), Korea Univ, Anam Hosp, Coll Med, Dept Cardiol,Cardiovasc Ctr, 73 Goryeodae Ro, Seoul 02841, South Korea.
EM psyche94@gmail.com
CR De Luca G, 2004, CIRCULATION, V109, P1223, DOI 10.1161/01.CIR.0000121424.76486.20
   Ibanez B, 2018, EUR HEART J, V39, P119, DOI 10.1093/eurheartj/ehx393
   Mahajan S, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2019.17885
   Menees DS, 2013, NEW ENGL J MED, V369, P901, DOI 10.1056/NEJMoa1208200
   Park K, 2020, KOREAN CIRC J, V50, P709, DOI 10.4070/kcj.2019.0337
   Park YH, 2012, J KOREAN MED SCI, V27, P864, DOI 10.3346/jkms.2012.27.8.864
   Patel A, 2018, J AM COLL CARDIOL, V71, P808, DOI 10.1016/j.jacc.2017.10.104
   Pedersen SH, 2009, J AM COLL CARDIOL, V54, P2296, DOI 10.1016/j.jacc.2009.06.056
   Shin DH, 2019, KOREAN CIRC J, V49, P1136, DOI 10.4070/kcj.2018.0413
   Zijistra F, 2002, EUR HEART J, V23, P550, DOI 10.1053/euhj.2001.2901
NR 10
TC 0
Z9 0
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD AUG
PY 2020
VL 50
IS 8
BP 720
EP 722
DI 10.4070/kcj.2020.0218
PG 3
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA MU8ML
UT WOS:000555921500008
PM 32725979
OA Green Published
DA 2021-04-22
ER

PT J
AU Kim, SH
AF Kim, Sung Hye
TI Cardiovascular Risk Factors and Obesity in Adolescents
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
ID BODY-MASS INDEX; TO-HEIGHT RATIO; WAIST CIRCUMFERENCE; CHILDREN;
   ADIPOSITY
C1 [Kim, Sung Hye] CHA Univ, CHA Bundang Med Ctr, Dept Pediat, 59 Yatap Ro, Seongnam 13496, South Korea.
RP Kim, SH (corresponding author), CHA Univ, CHA Bundang Med Ctr, Dept Pediat, 59 Yatap Ro, Seongnam 13496, South Korea.
EM rohetkim@yahoo.co.kr
CR Ashwell M, 2012, OBES REV, V13, P275, DOI 10.1111/j.1467-789X.2011.00952.x
   Berenson GS, 1998, NEW ENGL J MED, V338, P1650, DOI 10.1056/NEJM199806043382302
   Expert Panel on Integrated Guidelines for Cardiovascular Health and Risk Reduction in Children and Adolescents, 2011, Pediatrics, V128 Suppl 5, pS213, DOI 10.1542/peds.2009-2107C
   Freedman DS, 2007, J PEDIATR-US, V150, P12, DOI 10.1016/j.jpeds.2006.08.042
   Javed A, 2015, PEDIATR OBES, V10, P234, DOI 10.1111/ijpo.242
   Juonala M, 2010, CIRCULATION, V122, P2514, DOI 10.1161/CIRCULATIONAHA.110.966465
   Kim JH, 2020, J OBES METAB SYNDR, V29, P12, DOI 10.7570/jomes20002
   Lee JS, 2020, KOREAN CIRC J, V50, P723, DOI 10.4070/kcj.2019.0329
   Lo K, 2016, OBES REV, V17, P1258, DOI 10.1111/obr.12456
   Skinner AC, 2015, NEW ENGL J MED, V373, P1307, DOI 10.1056/NEJMoa1502821
NR 10
TC 0
Z9 0
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD AUG
PY 2020
VL 50
IS 8
BP 733
EP 735
DI 10.4070/kcj.2020.0247
PG 3
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA MU8ML
UT WOS:000555921500010
PM 32725981
OA Green Published
DA 2021-04-22
ER

PT J
AU Jung, SM
   Park, YH
   Lee, SH
   Lee, SY
   Park, KP
   Kim, JH
AF Jung, Soon Myung
   Park, Yong Hyun
   Lee, Sang Hyun
   Lee, Soo Yong
   Park, Kyung-Pil
   Kim, June Hong
TI Weeping Heart: Regrowing Thrombus at Basal Left Ventricle in Acute
   Stroke
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
C1 [Jung, Soon Myung; Park, Yong Hyun; Lee, Sang Hyun; Lee, Soo Yong; Kim, June Hong] Pusan Natl Univ, Yangsan Hosp, Dept Internal Med, Div Cardiol, 20 Geumo Ro, Yangsan 50612, South Korea.
   [Park, Kyung-Pil] Pusan Natl Univ, Yangsan Hosp, Dept Neurol, Yangsan, South Korea.
RP Park, YH (corresponding author), Pusan Natl Univ, Yangsan Hosp, Dept Internal Med, Div Cardiol, 20 Geumo Ro, Yangsan 50612, South Korea.
EM nadroj70@gmail.com
OI park, yong hyun/0000-0001-6122-214X; Park, Kyung-Pil/0000-0003-4952-3796
NR 0
TC 0
Z9 0
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD AUG
PY 2020
VL 50
IS 8
BP 736
EP 737
DI 10.4070/kcj.2020.0016
PG 2
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA MU8ML
UT WOS:000555921500011
PM 32096365
OA Other Gold, Green Published
DA 2021-04-22
ER

PT J
AU Kim, MC
   Ahn, Y
   Cho, KH
   Sim, DS
   Hong, YJ
   Kim, JH
   Jeong, MH
AF Kim, Min Chul
   Ahn, Youngkeun
   Cho, Kyung Hoon
   Sim, Doo Sun
   Hong, Young Joon
   Kim, Ju Han
   Jeong, Myung Ho
TI Image of Statin-Induced Rhabdomyolysis
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
C1 [Kim, Min Chul; Ahn, Youngkeun; Cho, Kyung Hoon; Sim, Doo Sun; Hong, Young Joon; Kim, Ju Han; Jeong, Myung Ho] Chonnam Natl Univ Hosp, Dept Internal Med, Div Cardiol, 42 Jebong Ro, Gwangju 61469, South Korea.
RP Ahn, Y (corresponding author), Chonnam Natl Univ Hosp, Dept Internal Med, Div Cardiol, 42 Jebong Ro, Gwangju 61469, South Korea.
EM cecilyk@hanmail.net
OI Kim, Min Chul/0000-0001-6026-1702; CHO, KYUNG HOON/0000-0002-0377-6352;
   Kim, Juhan/0000-0002-3186-0770
FU Bio & Medical Technology Development Program of the National Research
   Foundation of Korea - Korean government, MSIP [2017M3A9E8023020]
FX This study was supported by a grant of the Bio & Medical Technology
   Development Program of the National Research Foundation of Korea funded
   by the Korean government, MSIP (2017M3A9E8023020).
CR Esnault VLM, 2007, CLIN NUCL MED, V32, P519, DOI 10.1097/RLU.0b013e3180646a59
   Huerta-Alardin AL, 2005, CRIT CARE, V9, P158, DOI 10.1186/cc2978
   Pedersen TR, 1996, ARCH INTERN MED, V156, P2085, DOI 10.1001/archinte.156.18.2085
   Sinzinger H, 2016, NUCL MED COMMUN, V37, P1334, DOI 10.1097/MNM.0000000000000593
NR 4
TC 0
Z9 0
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD AUG
PY 2020
VL 50
IS 8
BP 738
EP 739
DI 10.4070/kcj.2019.0410
PG 2
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA MU8ML
UT WOS:000555921500012
PM 32153146
OA Green Published
DA 2021-04-22
ER

PT J
AU Kim, Y
   Kim, BK
   Hong, SJ
   Kim, JS
   Cho, DK
   Choi, D
   Hong, MK
   Jang, Y
AF Kim, Yongcheol
   Kim, Byeong-Keuk
   Hong, Sung-Jin
   Kim, Jung-Sun
   Cho, Deok-Kyu
   Choi, Donghoon
   Hong, Myeong-Ki
   Jang, Yangsoo
TI Successful Culotte Stenting for Unprotected Left Main Trifurcation
   Disease: Insights from Optical Coherence Tomography
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
C1 [Kim, Yongcheol; Cho, Deok-Kyu; Choi, Donghoon] Yonsei Univ, Coll Med, Dept Internal Med, Div Cardiol, Yongin, South Korea.
   [Kim, Yongcheol; Cho, Deok-Kyu; Choi, Donghoon] Yongin Severance Hosp, Cardiovasc Ctr, Yongin, South Korea.
   [Kim, Byeong-Keuk; Hong, Sung-Jin; Kim, Jung-Sun; Hong, Myeong-Ki; Jang, Yangsoo] Yonsei Univ, Severance Cardiovascular Hosp, Coll Med, Div Cardiol,Dept Internal Med, 250 Seongsan Ro, Seoul 03722, South Korea.
RP Kim, BK (corresponding author), Yonsei Univ, Severance Cardiovascular Hosp, Coll Med, Div Cardiol,Dept Internal Med, 250 Seongsan Ro, Seoul 03722, South Korea.
EM kimbk@yuhs.ac
OI Hong, Myeong-Ki/0000-0002-2090-2031; Kim, Yongcheol/0000-0001-5568-4161;
   Choi, Donghoon/0000-0002-2009-9760; Hong, Sung-Jin/0000-0003-4893-039X;
   Kim, Jung-Sun/0000-0003-2263-3274
CR Kim Y, 2020, KOREAN CIRC J, V50, P88, DOI 10.4070/kcj.2019.0222
   Lee CH, 2019, KOREAN CIRC J, V49, P771, DOI 10.4070/kcj.2019.0198
NR 2
TC 0
Z9 0
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD AUG
PY 2020
VL 50
IS 8
BP 740
EP 742
DI 10.4070/kcj.2020.0026
PG 3
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA MU8ML
UT WOS:000555921500013
PM 32725982
OA Green Published, Other Gold
DA 2021-04-22
ER

PT J
AU Cho, H
   Kang, J
   Kim, HS
   Park, KW
AF Cho, Haechan
   Kang, Jeehoon
   Kim, Hyo-Soo
   Park, Kyung Woo
TI Ethnic Differences in Oral Antithrombotic Therapy
SO KOREAN CIRCULATION JOURNAL
LA English
DT Review
DE Ethnic difference; Oral anthrombotic therapy; Antiplatelet therapy;
   Anticoagulation
ID NONVALVULAR ATRIAL-FIBRILLATION; EAST-ASIAN PATIENTS; PERCUTANEOUS
   CORONARY INTERVENTION; ACUTE MYOCARDIAL-INFARCTION; EXPERT CONSENSUS
   STATEMENT; HIGH-DOSE CLOPIDOGREL; ST-SEGMENT ELEVATION; ANTIPLATELET
   THERAPY; STENT THROMBOSIS; PLATELET REACTIVITY
AB Oral antithrombotic therapy (antiplatelet therapy and anticoagulation therapy) is a key element of pharmacotherapy in patients with cardiovascular (CV) disease. Several reports of ethnic differences have suggested that there may be difference therapeutic requirements and response to therapy for antithrombotic therapy. In particular for East Asians, there seems to be a lower incidence of ischemic outcomes and a higher incidence of bleeding outcomes compared to Westerners. The purpose of this review is to describe the ethnicity-related differences in antithrombotic therapy for CV disease and to discuss the need to establish a more effective and targeted antithrombotic treatment strategy in East Asians.
C1 [Cho, Haechan; Kang, Jeehoon; Kim, Hyo-Soo; Park, Kyung Woo] Seoul Natl Univ Hosp, Cardiovasc Ctr, Dept Internal Med, 101 Daehak Ro, Seoul 03080, South Korea.
RP Park, KW (corresponding author), Seoul Natl Univ Hosp, Cardiovasc Ctr, Dept Internal Med, 101 Daehak Ro, Seoul 03080, South Korea.
EM kwparkmd@snu.ac.kr
OI Kang, Jeehoon/0000-0002-9078-2231
CR Albert MA, 2007, NUTR REV, V65, pS234, DOI 10.1301/nr.2007.dec.S234-S238
   Anand SS, 2004, ARTERIOSCL THROM VAS, V24, P1509, DOI 10.1161/01.ATV.0000135845.95890.4e
   Aradi D, 2015, EUR HEART J, V36, P1762, DOI 10.1093/eurheartj/ehv104
   Aradi D, 2014, EUR HEART J, V35, P209, DOI 10.1093/eurheartj/eht375
   Bhatt DL, 2006, JAMA-J AM MED ASSOC, V295, P180, DOI 10.1001/jama.295.2.180
   Bray PF, 2007, J THROMB HAEMOST, V5, P1617, DOI 10.1111/j.1538-7836.2007.02618.x
   Chaturvedi N, 2003, HEART, V89, P681, DOI 10.1136/heart.89.6.681
   Chiang CE, 2017, J ARRYTHM, V33, P345, DOI 10.1016/j.joa.2017.05.004
   Chiang CE, 2014, THROMB HAEMOSTASIS, V111, P789, DOI 10.1160/TH13-11-0948
   Collins SD, 2010, CIRCULATION, V122, P1085, DOI 10.1161/CIRCULATIONAHA.109.907998
   Connolly SJ, 2008, CIRCULATION, V118, P2029, DOI 10.1161/CIRCULATIONAHA.107.750000
   Connolly SJ, 2009, NEW ENGL J MED, V361, P1139, DOI 10.1056/NEJMoa0905561
   Daemen J, 2007, LANCET, V369, P667, DOI 10.1016/S0140-6736(07)60314-6
   Dayoub EJ, 2018, JAMA INTERN MED, V178, P943, DOI 10.1001/jamainternmed.2018.0783
   Derry S, 2000, BMJ-BRIT MED J, V321, P1183, DOI 10.1136/bmj.321.7270.1183
   El Rouby S, 2004, J HEART VALVE DIS, V13, P15
   Folsom AR, 2009, ATHEROSCLEROSIS, V205, P272, DOI 10.1016/j.atherosclerosis.2008.11.005
   Gasevic D, 2015, CAN J CARDIOL, V31, P1169, DOI 10.1016/j.cjca.2015.06.017
   Giugliano RP, 2013, NEW ENGL J MED, V369, P2093, DOI 10.1056/NEJMoa1310907
   Goto S, 2011, HEART ASIA, V3, P93, DOI 10.1136/ha.2010.002691
   Granger CB, 2011, NEW ENGL J MED, V365, P981, DOI 10.1056/NEJMoa1107039
   Guirguis-Blake J. M., 2015, ASPIRIN PRIMARY PREV
   Gurbel PA, 2008, BLOOD COAGUL FIBRIN, V19, P268, DOI 10.1097/MBC.0b013e3282ff76ae
   Gurbel PA, 2016, CIRC RES, V118, P1380, DOI 10.1161/CIRCRESAHA.115.307016
   Hart RG, 2007, ANN INTERN MED, V146, P857, DOI 10.7326/0003-4819-146-12-200706190-00007
   Henderson SO, 2000, AM J MED SCI, V320, P18, DOI 10.1097/00000441-200007000-00004
   Huang WY, 2019, JAMA NEUROL, V76, P906, DOI 10.1001/jamaneurol.2019.1120
   Huo Y, 2019, SCI BULL, V64, P166, DOI 10.1016/j.scib.2018.12.020
   Iantorno M, 2019, AM J CARDIOL, V123, P1878, DOI 10.1016/j.amjcard.2019.02.047
   Ibanez B, 2018, EUR HEART J, V39, P119, DOI 10.1093/eurheartj/ehx393
   Inoue H, 2013, CIRC J, V77, P2264, DOI 10.1253/circj.CJ-13-0290
   January CT, 2019, CIRCULATION, V140, pE125, DOI 10.1161/CIR.0000000000000665
   Jeong YH, 2013, J THROMB HAEMOST, V11, P1194, DOI 10.1111/jth.12200
   Jeong YH, 2014, CURR CARDIOL REP, V16, DOI 10.1007/s11886-014-0485-4
   Kang HJ, 2015, AM HEART J, V169, P899, DOI 10.1016/j.ahj.2015.03.015
   Kang J, 2019, THROMB HAEMOSTASIS, V119, P1182, DOI 10.1055/s-0039-1688792
   Kang J, 2019, THROMB HAEMOSTASIS, V119, P149, DOI 10.1055/s-0038-1676545
   Kim C, 2017, KOREAN CIRC J, V47, P888, DOI 10.4070/kcj.2017.0072
   Kim IS, 2013, AM HEART J, V166, P95, DOI 10.1016/j.ahj.2013.03.030
   Kimura K, 2019, CIRC J, V83, P1085, DOI 10.1253/circj.CJ-19-0133
   Kimura T, 2009, CIRCULATION, V119, P987, DOI 10.1161/CIRCULATIONAHA.108.808311
   Kirchhof P, 2016, EUR HEART J, V37, P2893, DOI 10.1093/eurheartj/ehw210
   Kitamura A, 2006, STROKE, V37, P1374, DOI 10.1161/01.STR.0000221714.96986.5f
   Koskinas KC, 2015, CIRC-CARDIOVASC INTE, V8, DOI 10.1161/CIRCINTERVENTIONS.114.002053
   Kwon TJ, 2016, THROMB HAEMOSTASIS, V115, P979, DOI 10.1160/TH15-05-0366
   LAUPACIS A, 1994, ARCH INTERN MED, V154, P1449
   Lee SR, 2019, J AM COLL CARDIOL, V73, P919, DOI 10.1016/j.jacc.2018.11.051
   Lee YS, 2015, CIRC J, V79, P1248, DOI 10.1253/circj.CJ-15-0270
   Lei H, 2016, FRONT PHARMACOL, V7, DOI 10.3389/fphar.2016.00440
   Leong RW, 2009, GASTROENTEROL CLIN N, V38, P363, DOI 10.1016/j.gtc.2009.03.010
   Levine GN, 2016, J AM COLL CARDIOL, V68, P1082, DOI 10.1016/j.jacc.2016.03.513
   Levine GN, 2014, NAT REV CARDIOL, V11, P597, DOI 10.1038/nrcardio.2014.104
   Li JG, 2016, INT J CLIN PHARM TH, V54, P666, DOI 10.5414/CP202549
   Lutsey PL, 2006, J THROMB HAEMOST, V4, P2629, DOI 10.1111/j.1538-7836.2006.02237.x
   Ma CS, 2012, THROMB HAEMOSTASIS, V107, P1014, DOI 10.1160/TH11-04-0214
   Mak KH, 2009, AM HEART J, V157, P658, DOI 10.1016/j.ahj.2008.08.031
   Ogawa S, 2010, CIRC J, V74, P2479, DOI 10.1253/circj.CJ-88-0001
   Oh S, 2016, INT J CARDIOL, V223, P543, DOI 10.1016/j.ijcard.2016.08.236
   Ohman EM, 2017, LANCET, V389, P1799, DOI 10.1016/S0140-6736(17)30751-1
   Oldgren J, 2014, CIRCULATION, V129, P1568, DOI 10.1161/CIRCULATIONAHA.113.005451
   Park DW, 2019, CIRCULATION, V140, P1865, DOI 10.1161/CIRCULATIONAHA.119.041766
   Park DW, 2008, JACC-CARDIOVASC INTE, V1, P494, DOI 10.1016/j.jcin.2008.06.011
   Park KW, 2012, CARDIOVASC THER, V30, P5, DOI 10.1111/j.1755-5922.2010.00249.x
   Patel MR, 2011, NEW ENGL J MED, V365, P883, DOI 10.1056/NEJMoa1009638
   Patrono C, 2001, CHEST, V119, p39S, DOI 10.1378/chest.119.1_suppl.39S
   Price MJ, 2009, AM J CARDIOL, V103, P1339, DOI 10.1016/j.amjcard.2009.01.341
   Roe MT, 2012, NEW ENGL J MED, V367, P1297, DOI 10.1056/NEJMoa1205512
   Saito S, 2014, CIRC J, V78, P1684, DOI 10.1253/circj.CJ-13-1482
   Schick UM, 2016, AM J HUM GENET, V98, P229, DOI 10.1016/j.ajhg.2015.12.003
   Scott SA, 2013, CLIN PHARMACOL THER, V94, P317, DOI 10.1038/clpt.2013.105
   Shen AYJ, 2007, J AM COLL CARDIOL, V50, P309, DOI 10.1016/j.jacc.2007.01.098
   Steg PG, 2007, JAMA-J AM MED ASSOC, V297, P1197, DOI 10.1001/jama.297.11.1197
   Tantry US, 2013, J AM COLL CARDIOL, V62, P2261, DOI 10.1016/j.jacc.2013.07.101
   The Korean Society of Cardiology, 2012, GUID ANT THER PAT AC
   Wallentin L, 2009, NEW ENGL J MED, V361, P1045, DOI 10.1056/NEJMoa0904327
   Wang KL, 2015, STROKE, V46, P2555, DOI 10.1161/STROKEAHA.115.009947
   White RH, 2009, THROMB RES, V123, pS11, DOI 10.1016/S0049-3848(09)70136-7
   Yamaguchi T, 2000, STROKE, V31, P817, DOI 10.1161/01.STR.31.4.817
   Yokoi H, 2012, THROMB RES, V129, P623, DOI 10.1016/j.thromres.2011.11.023
   Zakai NA, 2011, J THROMB HAEMOST, V9, P1877, DOI 10.1111/j.1538-7836.2011.04443.x
NR 80
TC 1
Z9 1
U1 2
U2 2
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD AUG
PY 2020
VL 50
IS 8
BP 645
EP 657
DI 10.4070/kcj.2020.0098
PG 13
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA MU8ML
UT WOS:000555921500001
PM 32725974
OA Other Gold, Green Published
DA 2021-04-22
ER

PT J
AU Ferreira, VM
   Piechnik, SK
AF Ferreira, Vanessa M.
   Piechnik, Stefan K.
TI CMR Parametric Mapping as a Tool for Myocardial Tissue Characterization
SO KOREAN CIRCULATION JOURNAL
LA English
DT Review
DE Cardiovascular magnetic resonance; Parametric mapping; T1-mapping;
   T2-mapping; Myocardial tissue characterization
ID CARDIOVASCULAR MAGNETIC-RESONANCE; EXTRACELLULAR VOLUME QUANTIFICATION;
   INVERSION-RECOVERY; ADENOSINE STRESS; FABRY DISEASE; T1; DIAGNOSIS;
   MOLLI
AB Cardiovascular magnetic resonance (CMR) is the current gold standard for imaging cardiac anatomy, function, and advanced myocardial tissue characterization. After cine, late gadolinium enhancement (LGE), and perfusion imaging, parametric mapping is widely regarded as the 4th era of myocardial CMR development. In contrast to conventional CMR tissue characterization techniques, which rely on relative variations in image intensities to highlight abnormal tissues, parametric mapping provides direct visualization of tissue MR properties such as T1, T2 and T2* in absolute denominations (e.g. in milliseconds). Presentation as pixel-wise parametric maps adds spatial information for a more complete assessment of the myocardium. Advantages of parametric mapping include direct, quantitative comparisons inter- and within-individuals, as well as detection of diffuse disease not evident on conventional CMR imaging, without the need for contrast agents. CMR parametric mapping methods have matured over the past decade into clinical tools, demonstrating not only clinical utility but added value in a wide range of cardiac diseases. They are particularly useful for the evaluation of acute myocardial injury, suspected infiltration and heart failure of unclear etiology. This review discusses the background of parametric mapping, particularly T1-, T2- and ECV-mapping, general magnetic resonance physics principles, clinical applications (including imaging protocols, image analysis and reporting guidelines), current challenges and future directions. CMR parametric mapping is increasingly available on routine clinical scanners, and promises to deliver advanced myocardial tissue characterization beyond conventional CMR techniques, ultimately helping clinicians to benefit patients in their clinical management.
C1 [Ferreira, Vanessa M.; Piechnik, Stefan K.] Univ Oxford, Radcliffe Dept Med, Div Cardiovasc Med, Oxford Ctr Clin Magnet Resonance Res, Oxford, England.
RP Ferreira, VM (corresponding author), Univ Oxford, John Radcliffe Hosp, Oxford Ctr Clin Magnet Resonance Res, Div Cardiovasc Med,Radcliffe Dept Med, Level 0 OCMR,Headley Way, Oxford OX3 9DU, England.
EM vanessa.ferreira@cardiov.ox.ac.uk
FU National Institute of Health Research (NIHR) Biomedical Research Centre,
   OxfordNational Institute for Health Research (NIHR); British Heart
   Foundation Centre of Research Excellence, Oxford; British Heart
   FoundationBritish Heart Foundation
FX Drs. Ferreira and Piechnik acknowledge support from the National
   Institute of Health Research (NIHR) Biomedical Research Centre, Oxford,
   and the British Heart Foundation Centre of Research Excellence, Oxford.
   Dr. Ferreira is funded by the British Heart Foundation.
CR Abdel-Aty H, 2005, J AM COLL CARDIOL, V45, P1815, DOI 10.1016/j.jacc.2004.11.069
   Alkhalil M, 2020, J CARDIOVASC MAGN R, V22, DOI 10.1186/s12968-019-0593-9
   Baessler B, 2015, J CARDIOVASC MAGN R, V17, DOI 10.1186/s12968-015-0217-y
   Banypersad SM, 2015, EUR HEART J, V36, P244, DOI 10.1093/eurheartj/ehu444
   Carapella V, 2020, INT J CARDIOL, V298, P128, DOI 10.1016/j.ijcard.2019.08.058
   Celutkiene J, 2018, EUR J HEART FAIL, V20, P1615, DOI 10.1002/ejhf.1330
   Dabir D, 2014, J CARDIOVASC MAGN R, V16, DOI 10.1186/s12968-014-0069-x
   Dall'Armellina E, 2013, JACC-CARDIOVASC IMAG, V6, P739, DOI 10.1016/j.jcmg.2012.11.020
   Dall'Armellina E, 2012, J CARDIOVASC MAGN R, V14, DOI 10.1186/1532-429X-14-15
   Dass S, 2012, CIRC-CARDIOVASC IMAG, V5, P726, DOI 10.1161/CIRCIMAGING.112.976738
   Feng YQ, 2013, J MAGN RESON IMAGING, V38, P588, DOI 10.1002/jmri.24010
   Fernandez-Jimenez R, 2015, J CARDIOVASC MAGN R, V17, DOI 10.1186/s12968-015-0199-9
   Ferreira VM, 2018, J AM COLL CARDIOL, V72, P3158, DOI 10.1016/j.jacc.2018.09.072
   Ferreira VM, 2014, J CARDIOVASC MAGN R, V16, DOI 10.1186/1532-429X-16-36
   Ferreira VM, 2013, JACC-CARDIOVASC IMAG, V6, P1048, DOI 10.1016/j.jcmg.2013.03.008
   Ferreira VM, 2012, J CARDIOVASC MAGN R, V14, DOI 10.1186/1532-429X-14-42
   Ferreira VM, 2018, EACVI TXB CARDIOVASC, P133
   Flett AS, 2010, CIRCULATION, V122, P138, DOI 10.1161/CIRCULATIONAHA.109.930636
   Fontana M, 2014, JACC-CARDIOVASC IMAG, V7, P157, DOI 10.1016/j.jcmg.2013.10.008
   Fontana M, 2012, J CARDIOVASC MAGN R, V14, DOI 10.1186/1532-429X-14-88
   Formenti M., ARXIV201414094896
   Giri S, 2009, J CARDIOVASC MAGN R, V11, DOI 10.1186/1532-429X-11-56
   Karamitsos TD, 2013, JACC-CARDIOVASC IMAG, V6, P488, DOI 10.1016/j.jcmg.2012.11.013
   Kellman P, 2015, J CARDIOVASC MAGN R, V17, DOI 10.1186/s12968-015-0136-y
   Kellman P, 2012, J CARDIOVASC MAGN R, V14, DOI 10.1186/1532-429X-14-64
   Kramer CM, 2020, J CARDIOVASC MAGN R, V22, DOI 10.1186/s12968-020-00607-1
   Kramer CM, 2015, AM HEART J, V170, P223, DOI 10.1016/j.ahj.2015.05.013
   Liu A, 2016, JACC-CARDIOVASC IMAG, V9, P27, DOI 10.1016/j.jcmg.2015.08.018
   Liu D, 2017, DESTECH TRANS ENVIR, P10
   Liu JM, 2017, J CARDIOVASC MAGN R, V19, DOI 10.1186/s12968-017-0386-y
   Mahmod M, 2014, J CARDIOVASC MAGN R, V16, DOI 10.1186/s12968-014-0092-y
   Meduri A, 2017, EUR REV MED PHARMACO, V21, P4797
   Messroghli DR, 2017, J CARDIOVASC MAGN R, V19, DOI 10.1186/s12968-017-0389-8
   Messroghli DR, 2004, MAGN RESON MED, V52, P141, DOI 10.1002/mrm.20110
   Moon JC, 2013, J CARDIOVASC MAGN R, V15, DOI 10.1186/1532-429X-15-92
   Nakamori S, 2020, JACC-CARDIOVASC IMAG, V13, P667, DOI 10.1016/j.jcmg.2019.05.019
   Piechnik SK, 2018, MAGN RESON MATER PHY, V31, P131, DOI 10.1007/s10334-017-0649-5
   Piechnik SK, 2018, INT J CARDIOVAS IMAG, V34, P3, DOI 10.1007/s10554-017-1235-7
   Piechnik SK, 2013, J CARDIOVASC MAGN R, V15, DOI 10.1186/1532-429X-15-13
   Piechnik SK, 2010, J CARDIOVASC MAGN R, V12, DOI 10.1186/1532-429X-12-69
   Robson MD, 2013, MAGN RESON MED, V70, P664, DOI 10.1002/mrm.24867
   Sado DM, 2015, J MAGN RESON IMAGING, V41, P1505, DOI 10.1002/jmri.24727
   Sado DM, 2013, CIRC-CARDIOVASC IMAG, V6, P392, DOI 10.1161/CIRCIMAGING.112.000070
   Schulz-Menger J, 2020, J CARDIOVASC MAGN R, V22, DOI 10.1186/s12968-020-00610-6
   Schulz-Menger J, 2013, J CARDIOVASC MAGN R, V15, DOI 10.1186/1532-429X-15-35
   Sprinkart AM, 2015, J CARDIOVASC MAGN R, V17, DOI 10.1186/s12968-015-0127-z
   Thompson RB, 2013, CIRC-CARDIOVASC IMAG, V6, P637, DOI 10.1161/CIRCIMAGING.113.000482
   Treibel TA, 2016, JACC-CARDIOVASC IMAG, V9, P54, DOI 10.1016/j.jcmg.2015.11.008
   VONKNOBELSDORFFBRE, 2013, J CARDIOVASC MAGN R, V15, DOI DOI 10.1186/1532-429X-15-53
   Wamil M, 2019, INT J CARDIOVAS IMAG, V35, P1297, DOI 10.1007/s10554-019-01542-8
   White SK, 2013, JACC-CARDIOVASC IMAG, V6, P955, DOI 10.1016/j.jcmg.2013.01.011
   Wong TC, 2014, EUR HEART J, V35, P657, DOI 10.1093/eurheartj/eht193
   Wong TC, 2012, CIRCULATION, V126, P1206, DOI 10.1161/CIRCULATIONAHA.111.089409
NR 53
TC 0
Z9 0
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD AUG
PY 2020
VL 50
IS 8
BP 658
EP 676
DI 10.4070/kcj.2020.0157
PG 19
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA MU8ML
UT WOS:000555921500002
PM 32725975
OA Green Published, Other Gold
DA 2021-04-22
ER

PT J
AU Shin, HJ
   Park, YH
   Cho, BK
AF Shin, Hong Ju
   Park, Young Hwan
   Cho, Bum-Koo
TI Recent Surgical Outcomes of updates Congenital Heart Disease according
   to Korea Heart Foundation Data
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Heart defects; congenital; Treatment outcomes
ID MORTALITY-RATES; CASE VOLUMES; SURGERY
AB Background and objectives: This study presents an update of the surgical outcomes of congenital heart disease (CHD) according to Korea Heart Foundation (KHF) data.
   Methods: We investigated the data of the 7,305 patients who were economically supported by KHF in 2000-2014. Of them, we analyzed surgical outcomes of the 6,599 patients who underwent CHD surgery.
   Results: The median patient age was 1.9 years (range, 0-71.5 years). Of the 6,599 patients, 5,616 (85.1%) underwent biventricular repair and 983 (14.9%) underwent palliative procedures. The mean Basic Aristotle Score was 6.6 +/- 2.2. A complex procedure (defined as Basic Aristotle Score above 6) was performed in 3,368 patients (51.0%). The early mortality rate was 3.8%, while the late mortality rate was 1.8%. Previous reports of the KHF (1984-1999) showed that the early surgical and late mortality rates were 8.6%, and 5.3%, respectively. There were 491 neonates (7.4%); among them, the early mortality rate was 12.2% and late mortality rate was 3.7%. There were 2,617 infants (40.0%); among them, the early mortality rate was 6.0% and the late mortality rate was 2.3%. A total of 591 patients from 30 countries were helped by the KHF.
   Conclusions: More neonatal surgeries (491 vs. 74 patients) were performed than those in the past (1984-1999). The surgical outcomes were much better than before. Our surgical outcomes revealed that the Republic of Korea has been transformed from a country receiving help to a country that helps other low socioeconomic status countries.
C1 [Shin, Hong Ju] Korea Univ, Coll Med, Dept Thorac & Cardiovasc Surg, Ansan Hosp, Ansan, South Korea.
   [Park, Young Hwan] Yonsei Univ, Severance Cardiovasc Hosp, Congenital Heart Dis Ctr,Div Cardiovasc Surg, Dept Thorac & Cardiovasc Surg,Coll Med, 50-1 Yonsei Ro, Seoul 03722, South Korea.
   [Cho, Bum-Koo] Korea Heart Fdn, Seoul, South Korea.
RP Park, YH (corresponding author), Yonsei Univ, Severance Cardiovasc Hosp, Congenital Heart Dis Ctr,Div Cardiovasc Surg, Dept Thorac & Cardiovasc Surg,Coll Med, 50-1 Yonsei Ro, Seoul 03722, South Korea.
EM yhpark@yuhs.ac
OI Shin, Hong Ju/0000-0002-0731-3523; park, young hwan/0000-0001-9802-8017
CR [Anonymous], 1983, NY TIMES
   [Anonymous], 2019, GIFT LIFE KOREA
   Baptist Health, 2008, S KOR MAN RET JACKS
   Catholic Times, 1983, CATHOLIC TIMES
   Cavalcante CTDB, 2016, BRAZ J CARDIOVA SURG, V31, P219, DOI 10.5935/1678-9741.20160022
   Hoashi T, 2015, INTERACT CARDIOV TH, V21, P151, DOI 10.1093/icvts/ivv109
   Jacobs JP, 2009, PEDIATR CARDIOL, V30, P1117, DOI 10.1007/s00246-009-9496-0
   Jacobs JP, 2014, ANN THORAC SURG, V98, P1653, DOI 10.1016/j.athoracsur.2014.07.029
   Korean Heart Foundation, 2019, 2015 STAT CARD SURG
   Lacour-Gayet F, 2004, EUR J CARDIO-THORAC, V25, P911, DOI 10.1016/j.ejcts.2004.03.027
   McSharry B, 2019, J AM HEART ASSOC, V8, DOI 10.1161/JAHA.118.011390
   Welke KF, 2008, ANN THORAC SURG, V86, P889, DOI 10.1016/j.athoracsur.2008.04.077
   Welke KF, 2009, J THORAC CARDIOV SUR, V137, P1133, DOI 10.1016/j.jtcvs.2008.12.012
NR 13
TC 3
Z9 3
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD AUG
PY 2020
VL 50
IS 8
BP 677
EP 690
DI 10.4070/kcj.2019.0364
PG 14
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA MU8ML
UT WOS:000555921500003
PM 32212426
OA Other Gold, Green Published
DA 2021-04-22
ER

PT J
AU Roh, JH
   Park, JH
   Lee, H
   Yoon, YH
   Kim, M
   Kim, YG
   Park, GM
   Lee, JH
   Seong, IW
AF Roh, Jae-Hyung
   Park, Jae-Hyeong
   Lee, Hanbyul
   Yoon, Yong-Hoon
   Kim, Minsu
   Kim, Yong-Giun
   Park, Gyung-Min
   Lee, Jae-Hwan
   Seong, In-Whan
TI A Close Relationship between Non-Alcoholic Fatty Liver Disease Marker
   and New-Onset Hypertension in Healthy Korean Adults
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Fatty liver; nonalcoholic; Hypertension; Healthy people programs
ID CARDIOVASCULAR-DISEASE; METABOLIC SYNDROME; HEPATIC STEATOSIS; FIBROSIS;
   INSULIN; ASSOCIATION; DYSFUNCTION; OBESITY; RISK
AB Background and Objectives: Nonalcoholic fatty liver disease (NAFLD) is an excessive accumulation of fat into the liver as a result of increased inflammation and insulin resistance. Although there can be common pathogenic mechanisms for NAFLD and hypertension associated with the development of cardiovascular diseases, little data are showing the association between NAFLD and hypertension in a large-scale cohort study. Thus, we evaluated the ability of the fatty liver index (FLI), a surrogate marker of NAFLD, to predict the development of hypertension in healthy individuals.
   Methods: We included 334,280 healthy individuals without known comorbidities who underwent the National Health check-ups in South Korea from 2009 to 2014. The association between the FLI and hypertension was analyzed using multivariate Cox proportional-hazards models.
   Results: During a median of 5.2 years' follow-up, 24,678 subjects (7.4%) had new-onset hypertension. We categorized total subjects into quartile groups according to FLI (range: Q1, 0-4.9; Q2, 5.0-125; Q3, 12.6-31.0; and Q4, >31.0). The incidence of hypertension was higher in subjects with the highest FLI than in those with the lowest FLI (Q4, 9,968 [11.9%] vs. Q1, 2,277 [2.7%]; p<0.001). There was a significant correlation between the highest FLI and an increased risk of new-onset hypertension (adjusted hazard ratio between Q4 and Q1, 2.330; 95% confidence interval, 2.218-2.448; p<0.001). FLI was significantly associated with an increased risk of new-onset hypertension regardless of baseline characteristics.
   Conclusions: Higher FLI was independently associated with increased risk of hypertension in a healthy Korean population.
C1 [Roh, Jae-Hyung; Park, Jae-Hyeong; Yoon, Yong-Hoon; Kim, Minsu; Lee, Jae-Hwan; Seong, In-Whan] Chungnam Natl Univ, Chungnam Natl Univ Hosp, Dept Cardiol Internal Med, Sch Med, 282 Munhwa Ro, Daejeon 35015, South Korea.
   [Lee, Hanbyul] Kyungpook Natl Univ, Dept Stat, Daegu, South Korea.
   [Kim, Yong-Giun; Park, Gyung-Min] Univ Ulsan, Ulsan Univ Hosp, Dept Cardiol, Coll Med, Ulsan, South Korea.
RP Park, JH (corresponding author), Chungnam Natl Univ, Chungnam Natl Univ Hosp, Dept Cardiol Internal Med, Sch Med, 282 Munhwa Ro, Daejeon 35015, South Korea.
EM jaehpark@cnu.ac.kr
RI Park, Jae-Hyeong/AAD-9015-2021
OI Kim, Yong-Giun/0000-0002-0816-9025
FU Biomedical Research Institute grant, Kyungpook National University
   Hospital (2017)
FX This work was supported by Biomedical Research Institute grant,
   Kyungpook National University Hospital (2017).
CR Adams LA, 2017, GUT, V66, P1138, DOI 10.1136/gutjnl-2017-313884
   Aneni EC, 2015, J HYPERTENS, V33, P1207, DOI 10.1097/HJH.0000000000000532
   Angulo P, 2002, NEW ENGL J MED, V346, P1221, DOI 10.1056/NEJMra011775
   Angulo P, 2015, GASTROENTEROLOGY, V149, P389, DOI 10.1053/j.gastro.2015.04.043
   Bataller R, 2003, GASTROENTEROLOGY, V125, P117, DOI 10.1016/S0016-5085(03)00695-4
   Bedogni G, 2006, BMC GASTROENTEROL, V6, DOI 10.1186/1471-230X-6-33
   Benjamin EJ, 2019, CIRCULATION, V139, pE56, DOI 10.1161/CIR.0000000000000659
   Brandes RP, 2014, HYPERTENSION, V64, P924, DOI 10.1161/HYPERTENSIONAHA.114.03575
   Browning JD, 2004, J CLIN INVEST, V114, P147, DOI 10.1172/JCI200422422
   Donati G, 2004, GUT, V53, P1020, DOI 10.1136/gut.2003.027086
   Grundy SM, 2005, CIRCULATION, V112, P2735, DOI 10.1161/CIRCULATIONAHA.105.169404
   Hirose A, 2007, HEPATOLOGY, V45, P1375, DOI 10.1002/hep.21638
   Huh JH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143560
   Kim Hyeon Chang, 2019, Clin Hypertens, V25, P16, DOI 10.1186/s40885-019-0121-0
   Lee J, 2017, INT J EPIDEMIOL, V46, DOI 10.1093/ije/dyv319
   McPherson S, 2015, J HEPATOL, V62, P1148, DOI 10.1016/j.jhep.2014.11.034
   Ndumele CE, 2011, ARTERIOSCL THROM VAS, V31, P1927, DOI 10.1161/ATVBAHA.111.228262
   REAVEN GM, 1987, LANCET, V2, P435
   Ryoo JH, 2014, J GASTROEN HEPATOL, V29, P1926, DOI 10.1111/jgh.12643
   Saad MF, 2004, HYPERTENSION, V43, P1324, DOI 10.1161/01.HYP.0000128019.19363.f9
   Sigala B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072928
   Sung KC, 2014, J HEPATOL, V60, P1040, DOI 10.1016/j.jhep.2014.01.009
   Targher G, 2010, NEW ENGL J MED, V363, P1341, DOI 10.1056/NEJMra0912063
   VanWagner LB, 2015, HEPATOLOGY, V62, P773, DOI 10.1002/hep.27869
   Wang YH, 2016, HEPATOL RES, V46, P1304, DOI 10.1111/hepr.12688
   Warner FJ, 2007, CLIN SCI, V113, P109, DOI 10.1042/CS20070026
   Whelton PK, 2018, CIRCULATION, V138, pE484, DOI 10.1161/CIR.0000000000000596
   Yang BL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120443
   Yoo HJ, 2015, DIABETES METAB J, V39, P10, DOI 10.4093/dmj.2015.39.1.10
NR 29
TC 2
Z9 2
U1 2
U2 2
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD AUG
PY 2020
VL 50
IS 8
BP 695
EP 705
DI 10.4070/kcj.2019.0379
PG 11
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA MU8ML
UT WOS:000555921500005
PM 32281324
OA Other Gold, Green Published
DA 2021-04-22
ER

PT J
AU Park, K
   Park, JS
   Cho, YR
   Park, TH
   Kim, MH
   Yang, TH
   Kim, DI
   Kim, JH
   Lee, YH
   Lee, DW
   Seo, J
   Lee, GY
   Kim, YD
AF Park, Kyungil
   Park, Jong-Sung
   Cho, Young-Rak
   Park, Tae-Ho
   Kim, Moo-Hyun
   Yang, Tae-Hyun
   Kim, Doo-Il
   Kim, Jung-Hwan
   Lee, Yong-Hwan
   Lee, Dong-Won
   Seo, Jeongkee
   Lee, Geun-Young
   Kim, Young-Dae
TI Community-Based Pre-Hospital Electrocardiogram Transmission Program for
   Reducing Systemic Time Delay in Acute ST-Segment Elevation Myocardial
   Infarction
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE ST elevation myocardial infarction; Percutaneous coronary intervention;
   Triage
ID PRIMARY CORONARY ANGIOPLASTY; TO-BALLOON TIME; 12-LEAD
   ELECTROCARDIOGRAM; TASK-FORCE; MORTALITY; INTERVENTION; REPERFUSION;
   OUTCOMES; TRIAGE; IMPACT
AB Background and objectives: In acute ST-segment elevation myocardial infarction (STEMI), on-site transmission of electrocardiogram (ECG) has been shown to reduce systemic time delay to reperfusion and improve outcomes. However, it has not been adopted in community-based emergency transport system in Korea.
   Methods: Busan Regional Cardio-cerebrovascular Center and Busan Metropolitan City Fire and Safety Headquarters (BMFSH) jointly developed and conducted a pre-hospital ECG transmission program. Seven tertiary hospitals and 22 safety stations of BMFSH participated. Systemic time delay to reperfusion of STEMI patients in the program was compared with that of 95 patients transported by 119 emergency medical system (EMS) before the program was implemented.
   Results: During the study period, 289 ECG transmissions were made by 119 EMS personnel, executed within 5 minutes in 88.1% of cases. Of these, 42 ECGs were interpreted as ST-segment elevation. Final diagnosis of STEMI was made in 20 patients who underwent primary percutaneous coronary intervention. With the program, systemic time delay to reperfusion was significantly reduced (median [interquartile range; IQR], 76.0 [62.2-98.7] vs. 90.0 [75.0-112.0], p<0.01). Significant reduction of door-to-balloon time was also observed (median [IQR], 45.0 [34.0-69.5] vs. 58.0 [51.0-68.0], p=0.03). The proportion of patients with systemic time delay shorter than 90 minutes rose (51.6%vs. 75.0%, p=0.08) with pre-hospital ECG transmission.
   Conclusions: We developed and implemented a community-based pre-hospital ECG transmission program for expeditious triage of STEMI patients. Significant reductions of systemic time delay and door-to-balloon time were observed. The expanded use of prehospital ECG transmission should be encouraged to realize the full potential of this program.
C1 [Park, Kyungil; Park, Jong-Sung; Cho, Young-Rak; Park, Tae-Ho; Kim, Moo-Hyun; Kim, Young-Dae] Dong A Univ, Dong Univ Hosp A, Dept Cardiol, Coll Med, Busan, South Korea.
   [Park, Kyungil; Park, Jong-Sung; Cho, Young-Rak; Park, Tae-Ho; Kim, Moo-Hyun; Kim, Young-Dae] Dong A Univ Hosp, Busan Reg Cardio Cerebrovasc Ctr, Cardiovasc Ctr, 26 Daesingongwon Ro, Busan 49201, South Korea.
   [Yang, Tae-Hyun] Inje Univ, Univ Baek Hosp, Dept Inje, Coll Med, Busan, South Korea.
   [Kim, Doo-Il] Inje Univ, Coll Med, Dept Cardiol, Haeundae Baek Hosp, Busan, South Korea.
   [Kim, Jung-Hwan] Dong Eui Med Ctr, Dept Cardiol, Busan, South Korea.
   [Lee, Yong-Hwan] Dong Rae Bong Seng Hosp, Dept Cardiol, Busan, South Korea.
   [Lee, Dong-Won] Gupo Sungsh Hosp, Dept Cardiol, Busan, South Korea.
   [Seo, Jeongkee] BHS Hanseo Hosp, Dept Cardiol, Busan, South Korea.
   [Lee, Geun-Young] Metropolitan City Fire & Safety Headquarters, Busan, South Korea.
RP Kim, YD (corresponding author), Dong A Univ Hosp, Busan Reg Cardio Cerebrovasc Ctr, Cardiovasc Ctr, 26 Daesingongwon Ro, Busan 49201, South Korea.; Kim, YD (corresponding author), Dong A Univ, Coll Med, Dept Internal Med, Div Cardiol, 26 Daesingongwon Ro, Busan 49201, South Korea.
EM kimyd@mail.donga.ac.kr
OI Park, Kyungil/0000-0002-5212-2128
FU Busan Metropolitan City
FX We would like to deliver special thanks to Busan Metropolitan City for
   the generous funding for the program. Thanks to the fund, the personnel
   and ECG equipment could be secured, and pre-hospital ECG program could
   be launched in substance. We also feel much indebted to ex-chief of
   BMFSH, Mr. Haewoon Ryu, who made a great contribution to this program
   through his passion and leadership.
CR Berger PB, 1999, CIRCULATION, V100, P14, DOI 10.1161/01.CIR.100.1.14
   Bradley EH, 2009, JT COMM J QUAL PATIE, V35, P93, DOI 10.1016/S1553-7250(09)35012-6
   Brodie BR, 2001, AM J CARDIOL, V88, P1085, DOI 10.1016/S0002-9149(01)02039-2
   Brunetti ND, 2014, EUR HEART J-ACUTE CA, V3, P204, DOI 10.1177/2048872614527009
   De Luca G, 2004, CIRCULATION, V109, P1223, DOI 10.1161/01.CIR.0000121424.76486.20
   Denktas AE, 2011, JACC-CARDIOVASC INTE, V4, P599, DOI 10.1016/j.jcin.2011.02.012
   Diercks DB, 2009, J AM COLL CARDIOL, V53, P161, DOI 10.1016/j.jacc.2008.09.030
   Ducas RA, 2016, CAN J CARDIOL, V32, P1531, DOI 10.1016/j.cjca.2016.06.004
   Francone M, 2009, J AM COLL CARDIOL, V54, P2145, DOI 10.1016/j.jacc.2009.08.024
   Ibanez B, 2018, EUR HEART J, V39, P119, DOI 10.1093/eurheartj/ehx393
   Kahlon TS, 2017, CATHETER CARDIO INTE, V89, P245, DOI 10.1002/ccd.26567
   Kawakami S, 2016, CIRC J, V80, P1624, DOI 10.1253/circj.CJ-15-1322
   Kim HK, 2017, J CARDIOL, V69, P377, DOI 10.1016/j.jjcc.2016.09.002
   Le May MR, 2008, NEW ENGL J MED, V358, P231, DOI 10.1056/NEJMoa073102
   Le May MR, 2012, J AM COLL CARDIOL, V60, P1223, DOI 10.1016/j.jacc.2012.07.008
   Lee WC, 2017, INT J CARDIOL, V240, P66, DOI 10.1016/j.ijcard.2017.02.156
   McNamara RL, 2006, J AM COLL CARDIOL, V47, P2180, DOI 10.1016/j.jacc.2005.12.072
   Menees DS, 2013, NEW ENGL J MED, V369, P901, DOI 10.1056/NEJMoa1208200
   O'Gara PT, 2013, CIRCULATION, V127, pE362, DOI 10.1161/CIR.0b013e3182742cf6
   Ong MEH, 2013, ANN EMERG MED, V61, P339, DOI 10.1016/j.annemergmed.2012.08.020
   Park YH, 2012, J KOREAN MED SCI, V27, P864, DOI 10.3346/jkms.2012.27.8.864
   Pedersen SH, 2009, J AM COLL CARDIOL, V54, P2296, DOI 10.1016/j.jacc.2009.06.056
   Sejersten M, 2008, AM J CARDIOL, V101, P941, DOI 10.1016/j.amjcard.2007.11.038
   Terkelsen CJ, 2010, JAMA-J AM MED ASSOC, V304, P763, DOI 10.1001/jama.2010.1139
   Thygesen K, 2012, J AM COLL CARDIOL, V60, P1581, DOI 10.1016/j.jacc.2012.08.001
   Zijistra F, 2002, EUR HEART J, V23, P550, DOI 10.1053/euhj.2001.2901
NR 26
TC 1
Z9 1
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD AUG
PY 2020
VL 50
IS 8
BP 709
EP 719
DI 10.4070/kcj.2019.0337
PG 11
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA MU8ML
UT WOS:000555921500007
PM 32725978
OA Other Gold, Green Published
DA 2021-04-22
ER

PT J
AU Lee, JS
   Song, YH
AF Lee, Jue Seong
   Song, Young Hwan
TI Relationship between Waist Circumference and Cardiovascular Risk Factors
   in Adolescents: Analysis of the Korea National Health and Nutrition
   Examination Survey Data
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Waist circumference; Cardiovascular diseases; Adolescent; Obesity
ID BODY-MASS INDEX; TO-HEIGHT RATIO; DISEASE RISK; METABOLIC SYNDROME;
   GLOBAL BURDEN; CHILDREN; OBESITY; BMI; CHOLESTEROL; PREDICTORS
AB Background and Objectives: High waist circumference (WC) is associated with increased cardiovascular risk (CVR) in adulthood. We investigated this association in adolescents.
   Methods: We performed a cross-sectional analysis of data for 10-18-year-olds included in the Korea National Health and Nutrition Examination Survey (KNHANES) (2005-2014). The association between WC and CVR factors was evaluated. We analyzed this relationship according to age.
   Results: We analyzed 8,153 participants (4,319 boys and 3,834 girls) from the KNHANES. High WC was associated with increased incidence of CVR factors: hypertension (odds ratio (OR], 3.5 in boys, 1.9 in girls), high total cholesterol (OR, 3.9 in boys, 1.9 in girls), high triglycerides (OR, 4.9 in boys, 3.2 in girls), high low-density lipoprotein (LDL) cholesterol (OR, 5.0 in boys, 1.8 in girls), low high-density lipoprotein (HDL) cholesterol (OR, 2.6 in boys, 3.0 in girls), and hyperglycemia (OR, 2.8 in girls). In boys, the association between high WC and hypertension, high triglycerides, and low HDL cholesterol was noted in early adolescence. High WC was associated with high total cholesterol and high LDL cholesterol in middle adolescence. In girls, high WC was correlated with high total cholesterol, high triglycerides, and low HDL cholesterol in early adolescence. High WC was shown to be associated with hyperglycemia in middle adolescence, and with hypertension and high LDL cholesterol in late adolescence.
   Conclusions: High WC in adolescents is associated with increased CVR. The timing of this association differs according to sex and CVR factors.
C1 [Lee, Jue Seong] Korea Univ, Med Ctr, Dept Pediat, Coll Med, Seoul, South Korea.
   [Song, Young Hwan] Seoul Natl Univ, Dept Pediat, Div Pediat Cardiol, Bundang Hosp, 82 Gumi Ro 173 Beon Gil, Seongnam 13620, South Korea.
RP Song, YH (corresponding author), Seoul Natl Univ, Dept Pediat, Div Pediat Cardiol, Bundang Hosp, 82 Gumi Ro 173 Beon Gil, Seongnam 13620, South Korea.
EM yhsong@snubh.org
CR Ajala O, 2017, OBES REV, V18, P1061, DOI 10.1111/obr.12561
   Ashwell M, 2012, OBES REV, V13, P275, DOI 10.1111/j.1467-789X.2011.00952.x
   Bassali R, 2010, INT J PEDIATR OBES, V5, P97, DOI 10.3109/17477160903111722
   Bell L, 2013, J PAEDIATR CHILD H, V49, P955, DOI 10.1111/jpc.12298
   COOK S, 2009, J PEDIAT, V0155
   Expert Panel on Integrated Guidelines for Cardiovascular Health and Risk Reduction in Children and Adolescents, 2011, Pediatrics, V128 Suppl 5, pS213, DOI 10.1542/peds.2009-2107C
   FLODMARK CE, 1994, ACTA PAEDIATR, V83, P941, DOI 10.1111/j.1651-2227.1994.tb13177.x
   Flynn JT, 2018, PEDIATRICS, V142, DOI 10.1542/peds.2018-1739
   Freedman DS, 1999, AM J CLIN NUTR, V69, P308
   FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499
   Garnett SP, 2007, AM J CLIN NUTR, V86, P549
   Hirschler V, 2005, ARCH PEDIAT ADOL MED, V159, P740, DOI 10.1001/archpedi.159.8.740
   Janssen I, 2005, OBES RES, V13, P1106, DOI 10.1038/oby.2005.129
   Katzmarzyk PT, 2004, PEDIATRICS, V114, P198
   Kweon S, 2014, INT J EPIDEMIOL, V43, P69, DOI 10.1093/ije/dyt228
   LAUER RM, 1992, PEDIATRICS, V89, P495
   Lee CMY, 2008, J CLIN EPIDEMIOL, V61, P646, DOI 10.1016/j.jclinepi.2007.08.012
   Leibowitz KL, 2009, INT J PEDIATR OBES, V4, P150, DOI 10.1080/17477160802596130
   Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8
   Lloyd LJ, 2010, INT J OBESITY, V34, P18, DOI 10.1038/ijo.2009.61
   Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8
   Perichart-Perera O, 2007, J AM DIET ASSOC, V107, P81, DOI 10.1016/j.jada.2006.10.011
   Rodriguez-Rodriguez E, 2011, EUR J PEDIATR, V170, P35, DOI 10.1007/s00431-010-1260-1
   Savva SC, 2000, INT J OBESITY, V24, P1453, DOI 10.1038/sj.ijo.0801401
   Seidell JC, 2015, ANN NUTR METAB, V66, P7, DOI 10.1159/000375143
   Skinner AC, 2015, NEW ENGL J MED, V373, P1307, DOI 10.1056/NEJMoa1502821
   Van Gaal LF, 2006, NATURE, V444, P875, DOI 10.1038/nature05487
   WHO, 2000, WHO TECHN REP SER
   Zimmet P, 2007, PEDIATR DIABETES, V8, P299, DOI 10.1111/j.1399-5448.2007.00271.x
   문진수, 2008, Clinical and Experimental Pediatrics, V51, P1
NR 30
TC 1
Z9 1
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD AUG
PY 2020
VL 50
IS 8
BP 723
EP 732
DI 10.4070/kcj.2019.0329
PG 10
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA MU8ML
UT WOS:000555921500009
PM 32725980
OA Green Published, Other Gold
DA 2021-04-22
ER

PT J
AU Suh, YJ
AF Suh, Young Joo
TI Post-Procedural Computed Tomography after Transcatheter Aortic Valve
   Replacement: New Insights into Patient Management
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
ID SUBCLINICAL LEAFLET THROMBOSIS
C1 [Suh, Young Joo] Yonsei Univ, Coll Med, Dept Radiol, Severance Hosp, 50-1 Yonsei Ro, Seoul 03722, South Korea.
RP Suh, YJ (corresponding author), Yonsei Univ, Coll Med, Dept Radiol, Severance Hosp, 50-1 Yonsei Ro, Seoul 03722, South Korea.
EM rongzusuh@gmail.com
OI Suh, Young Joo/0000-0002-2078-5832
CR Chakravarty T, 2017, LANCET, V389, P2383, DOI 10.1016/S0140-6736(17)30757-2
   De Backer O, 2020, NEW ENGL J MED, V382, P130, DOI 10.1056/NEJMoa1911426
   Del Trigo M, 2016, J AM COLL CARDIOL, V67, P644, DOI 10.1016/j.jacc.2015.10.097
   Kapadia SR, 2015, LANCET, V385, P2485, DOI 10.1016/S0140-6736(15)60290-2
   Koo HJ, 2020, AM J CARDIOL, V125, P597, DOI 10.1016/j.amjcard.2019.11.015
   Lim SJ, 2020, KOREAN CIRC J, V50, P572, DOI 10.4070/kcj.2019.0385
   Mack MJ, 2015, LANCET, V385, P2477, DOI 10.1016/S0140-6736(15)60308-7
   Makkar RR, 2015, NEW ENGL J MED, V373, P2015, DOI 10.1056/NEJMoa1509233
   Sellers SL, 2019, JACC-CARDIOVASC IMAG, V12, P135, DOI 10.1016/j.jcmg.2018.06.028
   Woldendorp K, 2020, J THORAC CARDIOVASC
NR 10
TC 0
Z9 0
U1 0
U2 2
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JUL
PY 2020
VL 50
IS 7
BP 583
EP 585
DI 10.4070/kcj.2020.0186
PG 3
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA MD5ZJ
UT WOS:000544051000004
PM 32588566
OA Green Published, Other Gold
DA 2021-04-22
ER

PT J
AU Kim, MA
AF Kim, Myung-A
TI Heart Failure Awareness in the General Population: What Should We Do
   Next?
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
ID PUBLIC AWARENESS; KNOWLEDGE
C1 [Kim, Myung-A] Seoul Natl Univ, Boramae Med Ctr, Div Cardiol, Dept Internal Med,Coll Med,Seoul Metropolitan Gov, 20,Boramae Ro 5 Gil, Seoul 07061, South Korea.
RP Kim, MA (corresponding author), Seoul Natl Univ, Boramae Med Ctr, Div Cardiol, Dept Internal Med,Coll Med,Seoul Metropolitan Gov, 20,Boramae Ro 5 Gil, Seoul 07061, South Korea.
EM kma@snu.ac.kr
OI Kim, Myung-A/0000-0002-3064-7118
CR Dahrouge S, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0201802
   Jung MH, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0222264
   KACZOROWSKI J, 2011, BMJ-BRIT MED J, V342, DOI DOI 10.1136/BMJ.D442
   Kim HL, 2020, KOREAN CIRC J, V50, P586, DOI 10.4070/kcj.2019.0401
   Lainscak M, 2014, ARCH MED SCI, V10, P355, DOI 10.5114/aoms.2014.42589
   Nowak Karol, 2019, Folia Med Cracov, V59, P93
   Plotka A, 2017, PATIENT PREFER ADHER, V11, P1459, DOI 10.2147/PPA.S126133
   Remme WJ, 2005, EUR HEART J, V26, P2413, DOI 10.1093/eurheartj/ehi447
   Samsky MD, 2019, JAMA CARDIOL
   Stork S, 2016, EUR J HEART FAIL, V18, P66, DOI 10.1002/ejhf.425
   Zelenak C, 2017, ESC HEART FAIL, V4, P224, DOI 10.1002/ehf2.12144
NR 11
TC 0
Z9 0
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JUL
PY 2020
VL 50
IS 7
BP 596
EP 598
DI 10.4070/kcj.2020.0165
PG 3
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA MD5ZJ
UT WOS:000544051000006
PM 32588567
OA Green Published, Other Gold
DA 2021-04-22
ER

PT J
AU Cho, I
   Kim, WD
AF Cho, Iksung
   Kim, William Dowon
TI Early Testing and Prompt Initiation of Proper Treatment: a Clever
   Strategy to Fight with Tuberculosis Pericarditis
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
ID DIAGNOSIS
C1 [Cho, Iksung; Kim, William Dowon] Yonsei Univ Hlth Syst, Div Cardiol, Dept Internal Med, Yonsei Univ,Coll Med, 50-1 Yonsei Ro, Seoul 03722, South Korea.
RP Cho, I (corresponding author), Yonsei Univ Hlth Syst, Div Cardiol, Dept Internal Med, Yonsei Univ,Coll Med, 50-1 Yonsei Ro, Seoul 03722, South Korea.
EM iksungcho@yuhs.ac
CR Adler Y, 2015, EUR HEART J, V36, P2921, DOI 10.1093/eurheartj/ehv318
   Chang Sung A, 2019, J Cardiovasc Imaging, V27, P178, DOI 10.4250/jcvi.2019.27.e28
   Choi Hyung Oh, 2010, Korean Circ J, V40, P377, DOI 10.4070/kcj.2010.40.8.377
   Dunlap NE, 2000, AM J RESP CRIT CARE, V161, P1376, DOI 10.1164/ajrccm.161.4.16141
   FOWLER NO, 1995, CLIN CARDIOL, V18, P341, DOI 10.1002/clc.4960180610
   Howlett P, 2020, MICROBES INFECT
   Kim MS, 2020, KOREAN CIRC J, V50, P599, DOI 10.4070/kcj.2019.0317
   Mayosi BM, 2005, CIRCULATION, V112, P3608, DOI 10.1161/CIRCULATIONAHA.105.543066
   Ntsekhe M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077532
   SAGRISTASAULEDA J, 1988, J AM COLL CARDIOL, V11, P724, DOI 10.1016/0735-1097(88)90203-3
NR 10
TC 0
Z9 0
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JUL
PY 2020
VL 50
IS 7
BP 610
EP 612
DI 10.4070/kcj.2020.0179
PG 3
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA MD5ZJ
UT WOS:000544051000008
PM 32588568
OA Green Published, Other Gold
DA 2021-04-22
ER

PT J
AU Chae, CW
   Kwon, YW
AF Chae, Cheong-Whan
   Kwon, Yoo-Wook
TI The New Weapon to Inhibit Proliferation and Migration of Smooth Muscle
   Cell in Neointimal Formation
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
ID TALIN; BINDING
C1 [Chae, Cheong-Whan; Kwon, Yoo-Wook] Seoul Natl Univ Hosp, Strateg Ctr Cell & Bio Therapy Heart Diabet & Can, Biomed Res Inst, Seoul, South Korea.
   [Chae, Cheong-Whan; Kwon, Yoo-Wook] Seoul Natl Univ, Dept Med, Coll Med, Seoul, South Korea.
   [Kwon, Yoo-Wook] Seoul Natl Univ Hosp, Biomed Res Inst, 103 Daehak Ro, Seoul 03080, South Korea.
RP Kwon, YW (corresponding author), Seoul Natl Univ Hosp, Biomed Res Inst, 103 Daehak Ro, Seoul 03080, South Korea.
EM ywkwon@snu.ac.kr
CR Baumann Kim, 2012, Nat Rev Mol Cell Biol, V13, P138, DOI 10.1038/nrm3297
   Joo SJ, 2012, KOREAN CIRC J, V42, P295, DOI 10.4070/kcj.2012.42.5.295
   Klapholz B, 2017, J CELL SCI, V130, P2435, DOI 10.1242/jcs.190991
   Lawson C, 2012, J CELL BIOL, V196, P223, DOI 10.1083/jcb.201108078
   Lim IR, 2020, KOREAN CIRC J, V50, P613, DOI 10.4070/kcj.2019.0421
   Stefanini L, 2014, BLOOD, V123, P2722, DOI 10.1182/blood-2013-12-543363
   Tadokoro S, 2003, SCIENCE, V302, P103, DOI 10.1126/science.1086652
   Tang DD, 2017, RESP RES, V18, DOI 10.1186/s12931-017-0544-7
NR 8
TC 0
Z9 0
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JUL
PY 2020
VL 50
IS 7
BP 625
EP 627
DI 10.4070/kcj.2020.0197
PG 3
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA MD5ZJ
UT WOS:000544051000010
PM 32588570
OA Other Gold, Green Published
DA 2021-04-22
ER

PT J
AU Galeazzi, GL
   Loffi, M
   Di Tano, G
   Danzi, G
AF Galeazzi, Gian Luca
   Loffi, Marco
   Di Tano, Giuseppe
   Danzi, Gian Battista
TI Severe COVID-19 Pneumonia and Very Late Stent Thrombosis: a Trigger or
   Innocent Bystander?
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
C1 [Galeazzi, Gian Luca; Loffi, Marco; Di Tano, Giuseppe; Danzi, Gian Battista] Osped Cremona, Div Cardiol, Viale Concordia 1, I-26100 Cremona, Italy.
RP Danzi, G (corresponding author), Osped Cremona, Div Cardiol, Viale Concordia 1, I-26100 Cremona, Italy.
EM gbdanzi@tin.it
RI Danzi, Gian Battista/ABF-6413-2020; Danzi, Gian Battista/P-2244-2016
OI Danzi, Gian Battista/0000-0003-0897-8006; Danzi, Gian
   Battista/0000-0003-0897-8006; Galeazzi, Gian Luca/0000-0003-0262-7387
CR Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5
   Oudit GY, 2009, EUR J CLIN INVEST, V39, P618, DOI 10.1111/j.1365-2362.2009.02153.x
   Smeeth L, 2004, NEW ENGL J MED, V351, P2611, DOI 10.1056/NEJMoa041747
   Zheng YY, 2020, NAT REV CARDIOL, V17, P259, DOI 10.1038/s41569-020-0360-5
   Zvonarev V, 2019, CUREUS, V11, DOI 10.7759/cureus.5177
NR 5
TC 3
Z9 3
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JUL
PY 2020
VL 50
IS 7
BP 632
EP 633
DI 10.4070/kcj.2020.0166
PG 2
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA MD5ZJ
UT WOS:000544051000013
PM 32588573
OA Green Published
DA 2021-04-22
ER

PT J
AU Kim, IC
   Hwang, I
   Kim, YS
   Kim, JB
AF Kim, In-Cheol
   Hwang, Ilseon
   Kim, Yun Seok
   Kim, Jae-Bum
TI Successful Heart Transplantation to a Fulminant Myocarditis Patient
   during COVID-19 Outbreak - Lessons Learned
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
C1 [Kim, In-Cheol] Keimyung Univ, Sch Med, Dongsan Hosp, Div Cardiol,Dept Internal Med,Cardiovasc Ctr, 1035 Dalgubeol Daero, Daegu 42601, South Korea.
   [Hwang, Ilseon] Keimyung Univ, Sch Med, Dept Pathol, Dongsan Hosp, Daegu, South Korea.
   [Kim, Yun Seok; Kim, Jae-Bum] Keimyung Univ, Sch Med, Dept Cardiothorac Surg, Dongsan Hosp, Daegu, South Korea.
RP Kim, IC (corresponding author), Keimyung Univ, Sch Med, Dongsan Hosp, Div Cardiol,Dept Internal Med,Cardiovasc Ctr, 1035 Dalgubeol Daero, Daegu 42601, South Korea.
EM kimic@dsmc.or.kr
OI Kim, In-Cheol/0000-0002-5751-2328; Kim, Jae-Bum/0000-0002-8820-9866;
   Hwang, Ilseon/0000-0002-6122-4417
FU Bisa Research Grant of Keimyung University
FX This research was supported by the Bisa Research Grant of Keimyung
   University in 2017.
CR Choi HM, 2019, KOREAN J INTERN MED, V34, P11, DOI 10.3904/kjim.2018.428
   Kim IC, 2018, KOREAN CIRC J, V48, P565, DOI 10.4070/kcj.2018.0189
   Kim IC, 2017, KOREAN CIRC J, V47, P858, DOI 10.4070/kcj.2017.0330
   Kim K-J., 2019, INT J HEART FAIL, V1, P4
   Youn JC, 2019, KOREAN CIRC J, V49, P738, DOI 10.4070/kcj.2019.0117
NR 5
TC 2
Z9 2
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JUL
PY 2020
VL 50
IS 7
BP 634
EP 637
DI 10.4070/kcj.2020.0177
PG 4
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA MD5ZJ
UT WOS:000544051000014
PM 32588574
OA Green Published
DA 2021-04-22
ER

PT J
AU Kim, MJ
   Hong, GR
   Ha, JW
   Shim, CY
AF Kim, Min Ji
   Hong, Geu-Ru
   Ha, Jong-Won
   Shim, Chi Young
TI Acute Localized Myocarditis: Role of Speckle Tracking Echocardiography
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
C1 [Kim, Min Ji; Hong, Geu-Ru; Ha, Jong-Won; Shim, Chi Young] Yonsei Univ, Coll Med, Div Cardiol, Dept Internal Med,Severance Cardiovasc Hosp, 50-1 Yonsei Ro, Seoul 03722, South Korea.
RP Shim, CY (corresponding author), Yonsei Univ, Coll Med, Div Cardiol, Dept Internal Med,Severance Cardiovasc Hosp, 50-1 Yonsei Ro, Seoul 03722, South Korea.
EM cysprs@yuhs.ac
RI Shim, Chi Young/AAK-1057-2021
OI Shim, Chi Young/0000-0002-6136-0136; Hong, Geu-Ru/0000-0003-4981-3304;
   Ha, Jong-Won/0000-0002-8260-2958
NR 0
TC 0
Z9 0
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JUL
PY 2020
VL 50
IS 7
BP 638
EP 640
DI 10.4070/kcj.2019.0378
PG 3
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA MD5ZJ
UT WOS:000544051000015
PM 32212424
OA Other Gold, Green Published
DA 2021-04-22
ER

PT J
AU Kim, IC
   Kim, HA
   Park, JS
   Nam, CW
AF Kim, In-Cheol
   Kim, Hyun Ah
   Park, Jae Seok
   Nam, Chang-Wook
TI Updates of Cardiovascular Manifestations in COVID-19: Korean Experience
   to Broaden Worldwide Perspectives
SO KOREAN CIRCULATION JOURNAL
LA English
DT Review
DE Coronavirus; COVID-19; SARS-CoV-2; Heart; Cardiac manifestation; Cardiac
   injury
ID ACUTE HEART-FAILURE; CLINICAL CHARACTERISTICS; MYOCARDIAL-INFARCTION;
   BLOCKADE; OUTCOMES; SARS
AB The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has spread worldwide. Not just respiratory complications such as pneumonia and acute respiratory distress syndrome, cardiac manifestations have drawn attention due to the increased risk of mortality and morbidity related to SARS-CoV-2 infections. The mechanisms of the cardiac injury related to SARS-CoV-2 infections have been direct cardiac injury caused by angiotensin converting enzyme 2, hypoxemia, microvascular damage, and a systemic inflammatory response. Stress induced cardiomyopathy in a critically ill condition and acute coronary syndrome due to a vulnerable plaque rupture with coagulopathy can finally lead to acute heart failure with further cardiac manifestations. When dealing with the highly contagious viral disease-related cardiac manifestations, we should carefully apply the diagnostic and therapeutic methods to achieve the best therapeutic results without adding any risk of disease transmission.
C1 [Kim, In-Cheol; Nam, Chang-Wook] Keimyung Univ, Div Cardiol, Dept Internal Med, Cardiovasc Ctr,Dongsan Hosp,Coll Med, 1035 Dalgubeol Daero, Daegu 42601, South Korea.
   [Kim, Hyun Ah] Keimyung Univ, Div Infect Dis, Dept Internal Med, Dongsan Hosp,Coll Med, Daegu, South Korea.
   [Park, Jae Seok] Keimyung Univ, Div Pulmonol, Dept Internal Med, Dongsan Hosp,Coll Med, Daegu, South Korea.
RP Nam, CW (corresponding author), Keimyung Univ, Div Cardiol, Dept Internal Med, Cardiovasc Ctr,Dongsan Hosp,Coll Med, 1035 Dalgubeol Daero, Daegu 42601, South Korea.
EM ncwcv@dsmc.or.kr
OI Nam, Chang-Wook/0000-0002-3370-5774; Kim, In-Cheol/0000-0002-5751-2328
FU Keimyung University Dongsan Medical Center
FX This work was supported by the research promoting grant from the
   Keimyung University Dongsan Medical Center in 2018.
CR Akhmerov A, 2020, CIRC RES, V126, P1443, DOI 10.1161/CIRCRESAHA.120.317055
   Alhogbani T, 2016, ANN SAUDI MED, V36, P78, DOI 10.5144/0256-4947.2016.78
   Arentz M, 2020, JAMA-J AM MED ASSOC, V323, P1612, DOI 10.1001/jama.2020.4326
   Arrigo M, 2017, EUR J HEART FAIL, V19, P201, DOI 10.1002/ejhf.682
   Badawi A, 2016, INT J INFECT DIS, V49, P129, DOI 10.1016/j.ijid.2016.06.015
   Bangalore S, 2020, N ENGL J MED
   Beigel JH, 2020, NEW ENGL J MED, V383, P1813, DOI 10.1056/NEJMoa2007764
   Beristain-Covarrubias N, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.02569
   Bonow RO, 2020, JAMA CARDIOL
   Booth CM, 2003, JAMA-J AM MED ASSOC, V289, P2801, DOI 10.1001/jama.289.21.JOC30885
   Burchill LJ, 2012, CLIN SCI, V123, P649, DOI 10.1042/CS20120162
   Chan JWM, 2003, THORAX, V58, P686, DOI 10.1136/thorax.58.8.686
   Cho DH, 2020, INT J HEART FAIL, V2, P111
   Clerkin KJ, 2020, CIRCULATION, V141, P1648, DOI 10.1161/CIRCULATIONAHA.120.046941
   Cooper LT, 2009, NEW ENGL J MED, V360, P1526, DOI 10.1056/NEJMra0800028
   Daniels MJ, 2020, CIRCULATION
   DeFilippis EM, 2020, CIRCULATION
   Driggin E, 2020, J AM COLL CARDIOL, V75, P2352, DOI 10.1016/j.jacc.2020.03.031
   Ferrario CM, 2005, CIRCULATION, V111, P2605, DOI 10.1161/CIRCULATIONAHA.104.510461
   Fung G, 2016, CIRC RES, V118, P496, DOI 10.1161/CIRCRESAHA.115.306573
   Gao C, 2020, CRIT CARE MED, V48, P451, DOI 10.1097/CCM.0000000000004207
   Grein J, 2020, NEW ENGL J MED, V382, P2327, DOI 10.1056/NEJMoa2007016
   Guan W, 2020, NEW ENGL J MED, V382, P1708, DOI 10.1056/NEJMoa2002032
   Guo T, 2020, JAMA CARDIOL
   Hollander JE, 2020, NEW ENGL J MED, V382, P1679, DOI 10.1056/NEJMp2003539
   Holshue ML, 2020, NEW ENGL J MED, V382, P929, DOI 10.1056/NEJMoa2001191
   Hu H., 2020, EUR HEART J
   Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5
   Inciardi RM, 2020, JAMA CARDIOL, DOI 10.1001/jamacardio.2020.1096
   Ishiyama Y, 2004, HYPERTENSION, V43, P970, DOI 10.1161/01.HYP.0000124667.34652.1a
   Kim IC, 2020, KOREAN CIRC J, V50, pe103
   Kim IC, 2020, EUR HEART J
   Kim IC, 2020, EUR HEART J, V41, P1859, DOI 10.1093/eurheartj/ehaa288
   Kim JY, 2020, J KOREAN MED SCI, V35, DOI 10.3346/jkms.2020.35.e61
   Lazzerini PE, 2020, CIRCULATION
   Lee SE, 2017, KOREAN CIRC J, V47, P341, DOI 10.4070/kcj.2016.0419
   Li F, 2020, J HEART LUNG TRANSPL, V39, P496, DOI 10.1016/j.healun.2020.03.006
   Li H, 2020, LEUKEMIA, V34, P1503, DOI 10.1038/s41375-020-0848-3
   Libby P, 2001, CIRCULATION, V103, P1718, DOI 10.1161/01.CIR.103.13.1718
   Madjid M., 2020, JAMA CARDIOL
   Maisch B, 2000, HERZ, V25, P200, DOI 10.1007/s000590050007
   Morra ME, 2018, REV MED VIROL, V28, DOI 10.1002/rmv.1977
   Obi AT, 2019, J VASC SURG-VENOUS L, V7, P317, DOI 10.1016/j.jvsv.2018.08.010
   Pollack A, 2015, NAT REV CARDIOL, V12, P670, DOI 10.1038/nrcardio.2015.108
   Ren ZL, 2020, J HEART LUNG TRANSPL, V39, P412, DOI 10.1016/j.healun.2020.03.008
   Sagar S, 2012, LANCET, V379, P738, DOI 10.1016/S0140-6736(11)60648-X
   Sanders JM, 2020, JAMA-J AM MED ASSOC, V323, P1824, DOI 10.1001/jama.2020.6019
   Soler MJ, 2009, AM J PHYSIOL-RENAL, V296, pF398, DOI 10.1152/ajprenal.90488.2008
   Stefanini GG, 2020, CIRCULATION, V141, P1597, DOI 10.1161/CIRCULATIONAHA.120.047070
   Stockman LJ, 2006, PLOS MED, V3, P1525, DOI 10.1371/journal.pmed.0030343
   Sukumaran V, 2012, MOL CELL ENDOCRINOL, V351, P208, DOI 10.1016/j.mce.2011.12.010
   Tang N, 2020, J THROMB HAEMOST, V18, P844, DOI [10.1111/jth.14768, 10.1111/jth.14820]
   Tavazzi G, 2020, EUR J HEART FAIL, V22, P911, DOI 10.1002/ejhf.1828
   Thomson B., 2020, CIRCULATION
   Thygesen K, 2018, CIRCULATION, V138, pE618, DOI 10.1161/CIR.0000000000000617
   Vaduganathan M, 2020, NEW ENGL J MED, V382, P1653, DOI 10.1056/NEJMsr2005760
   van Doremalen N, 2013, EUROSURVEILLANCE, V18, P7, DOI 10.2807/1560-7917.ES2013.18.38.20590
   Wang DW, 2020, JAMA-J AM MED ASSOC, V323, P1061, DOI 10.1001/jama.2020.1585
   Wang T, 2020, LANCET HAEMATOL, V7, pE362, DOI 10.1016/S2352-3026(20)30109-5
   Welt FGP, 2020, J AM COLL CARDIOL, V75, P2372, DOI 10.1016/j.jacc.2020.03.021
   WHO, 2020, COR DIS COVID 19 OUT
   Wu ZY, 2020, JAMA-J AM MED ASSOC, V323, P1239, DOI 10.1001/jama.2020.2648
   Xiong TY, 2020, EUR HEART J, V41, P1798, DOI 10.1093/eurheartj/ehaa231
   Yang XB, 2020, LANCET RESP MED, V8, P475, DOI 10.1016/S2213-2600(20)30079-5
   Yang ZW, 2020, J INFECTION, V81, pE13, DOI 10.1016/j.jinf.2020.03.062
   Zeng J, 2020, INTENSIVE CARE MED
   Zha L, 2020, MED J AUSTRALIA, V212, P416, DOI 10.5694/mja2.50577
   Zheng YY, 2020, NAT REV CARDIOL, V17, P259, DOI 10.1038/s41569-020-0360-5
   Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3
   Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017
NR 70
TC 4
Z9 4
U1 2
U2 5
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JUL
PY 2020
VL 50
IS 7
BP 543
EP 554
DI 10.4070/kcj.2020.0205
PG 12
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA MD5ZJ
UT WOS:000544051000001
PM 32588565
OA Green Published
DA 2021-04-22
ER

PT J
AU Rhee, MY
   Jeong, YJ
AF Rhee, Moo-Yong
   Jeong, Yun-Jeong
TI Sodium Intake, Blood Pressure and Cardiovascular Disease
SO KOREAN CIRCULATION JOURNAL
LA English
DT Review
DE Sodium intake; Urine; Blood pressure; Cardiovascular
ID 24-HOUR URINARY SODIUM; SPOT URINE; POTASSIUM EXCRETION; SALT INTAKE;
   DIETARY-SODIUM; ADULT-POPULATION; NONPHARMACOLOGIC INTERVENTIONS;
   HYPERTENSION PREVENTION; JAPANESE MEN; 3 FORMULAS
AB Sodium intake reduction has been emphasized because sodium adversely impacts health, especially blood pressure (BP), and the cardiovascular (CV) disease risk. However, data obtained from several cohort studies have raised questions regarding the effects of high sodium intake on BP and the CV disease risk. In the present study, we systematically reviewed the literature to evaluate these associations. Studies showing negative associations between urine sodium and BP and CV outcomes relied on estimated 24-hour urine sodium from spot urine that is inappropriate for determining sodium intake at an individual level. Furthermore, controversy about the association between 24-hour urine sodium and BP may have been caused by different characteristics of study populations, such as age distribution, ethnicity, potassium intake and the inclusion of patients with hypertension, the different statistical methods and BP measurement methods. Regarding the association between sodium intake and the CV disease risk, studies showing negative or J- or U-shaped associations used a single baseline measurement of 24-hour urine sodium in their analyses. However, recent studies that employed average of subsequently measured 24-hour urine sodium showed positive, linear associations between sodium intake and CV outcomes, indicating that controversies are caused by the different sodium intake measurement methods and analytic designs. In conclusion, the study shows that positive associations exist between sodium intake and BP, CV outcomes, and mortality, and that the argument that reducing sodium intake is dangerous is invalid. Sodium intake reduction should be recommended to all, and not limited to patients with hypertension or CV disease.
C1 [Rhee, Moo-Yong] Dongguk Univ, Cardiovasc Ctr, Ilsan Hosp, 27 Dongguk Ro, Goyang 10326, South Korea.
   [Jeong, Yun-Jeong] Dongguk Univ, Dept Internal Med, Ilsan Hosp, Goyang, South Korea.
RP Rhee, MY (corresponding author), Dongguk Univ, Cardiovasc Ctr, Ilsan Hosp, 27 Dongguk Ro, Goyang 10326, South Korea.
EM mooyong_rhee@dumc.or.kr
FU Boryung Pharmaceutical Co. Ltd. Funding Source: Medline; Dong-A
   Pharmaceutical Co., Ltd. Funding Source: Medline
CR Adler AC, 2014, CULT CRIT, P1, DOI 10.1002/14651858.CD009217
   Adrogue HJ, 2007, NEW ENGL J MED, V356, P1966, DOI 10.1056/NEJMra064486
   Allen NB, 2017, AM J EPIDEMIOL, V186, P149, DOI 10.1093/aje/kwx056
   Angell SY, 2014, AM J PUBLIC HEALTH, V104, P2409, DOI 10.2105/AJPH.2013.301542
   [Anonymous], 2017, WHO STEPWISE APPROAC
   Appel LJ, 2001, ARCH INTERN MED, V161, P685, DOI 10.1001/archinte.161.5.685
   Brown IJ, 2009, INT J EPIDEMIOL, V38, P791, DOI 10.1093/ije/dyp139
   Cappuccio FP, 2000, J NEPHROL, V13, P169
   Chen SL, 2018, NUTRIENTS, V10, DOI 10.3390/nu10070900
   Cianciaruso B, 1998, MINER ELECTROL METAB, V24, P296, DOI 10.1159/000057385
   Cook NR, 2007, BMJ-BRIT MED J, V334, P885, DOI 10.1136/bmj.39147.604896.55
   Cook NR, 2016, J AM COLL CARDIOL, V68, P1609, DOI 10.1016/j.jacc.2016.07.745
   Cook NR, 2014, CIRCULATION, V129, P981, DOI 10.1161/CIRCULATIONAHA.113.006032
   Elijovich F, 2016, HYPERTENSION, V68, pE7, DOI 10.1161/HYP.0000000000000047
   ELLIOTT P, 1988, BRIT MED J, V297, P319
   Emeville E, 2019, BRIT J NUTR, V122, P186, DOI 10.1017/S0007114519000886
   Engberink RHGO, 2017, CIRCULATION, V136, P917, DOI 10.1161/CIRCULATIONAHA.117.029028
   Espeland MA, 2001, AM J EPIDEMIOL, V153, P996, DOI 10.1093/aje/153.10.996
   Glatz N, 2017, SWISS MED WKLY, V147, DOI 10.4414/smw.2017.14411
   Graudal NA, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004022.pub4
   Han WZ, 2015, AM J HYPERTENS, V28, P1368, DOI 10.1093/ajh/hpv037
   He FJ, 2009, J HUM HYPERTENS, V23, P363, DOI 10.1038/jhh.2008.144
   He FJ, 2019, HYPERTENSION, V74, P572, DOI 10.1161/HYPERTENSIONAHA.119.13117
   He FJ, 2018, INT J EPIDEMIOL, V47, P1784, DOI 10.1093/ije/dyy114
   He FJ, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1325
   He FJ, 2011, LANCET, V378, P380, DOI 10.1016/S0140-6736(11)61174-4
   Jackson SL, 2018, CIRCULATION, V137, P237, DOI 10.1161/CIRCULATIONAHA.117.029193
   Jedrusik P, 2018, J AM SOC HYPERTENS, V12, P457, DOI 10.1016/j.jash.2018.03.010
   Ji C, 2014, NUTR METAB CARDIOVAS, V24, P140, DOI 10.1016/j.numecd.2013.06.011
   Joosten MM, 2014, CIRCULATION, V129, P1121, DOI 10.1161/CIRCULATIONAHA.113.004290
   JULA AM, 1994, CIRCULATION, V89, P1023, DOI 10.1161/01.CIR.89.3.1023
   Kelly C, 2015, NUTR METAB CARDIOVAS, V25, P771, DOI 10.1016/j.numecd.2015.04.010
   Kim MK, 2019, EUR J PREV CARDIOL, V26, P952, DOI 10.1177/2047487318819528
   KUPARI M, 1994, CIRCULATION, V89, P1041, DOI 10.1161/01.CIR.89.3.1041
   Lelli D, 2018, J AM MED DIR ASSOC, V19, P229, DOI 10.1016/j.jamda.2017.09.004
   LUFT FC, 1982, HYPERTENSION, V4, P805, DOI 10.1161/01.HYP.4.6.805
   Ma WX, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14101211
   Maseko M, 2018, CARDIOVASC J AFR, V29, P172, DOI [10.5830/CVJA-2018-011, 10.5830/cvja-2018-011]
   McLean R, 2014, J HUM HYPERTENS, V28, P657, DOI 10.1038/jhh.2014.10
   McLean R, 2015, NUTRIENTS, V7, P8930, DOI 10.3390/nu7115439
   Mente A, 2018, LANCET, V392, P496, DOI [10.1016/S0140-6736(18)31376-X, 10.1016/s0140-6736(18)31376-x]
   Mente A, 2016, CAN J CARDIOL, V32, P319, DOI 10.1016/j.cjca.2015.06.020
   Mente A, 2014, J HYPERTENS, V32, P1005, DOI 10.1097/HJH.0000000000000122
   Mills KT, 2016, JAMA-J AM MED ASSOC, V315, P2200, DOI 10.1001/jama.2016.4447
   Mizehoun-Adissoda C, 2017, NUTRITION, V33, P35, DOI 10.1016/j.nut.2016.08.007
   Mohammadifard N, 2017, NUTR DIET, V74, P275, DOI 10.1111/1747-0080.12304
   Nagata C, 2004, STROKE, V35, P1543, DOI 10.1161/01.STR.0000130425.50441.b0
   Ndanuko RN, 2017, NUTRITION, V33, P285, DOI 10.1016/j.nut.2016.07.011
   O'Donnell M, 2014, NEW ENGL J MED, V371, P612, DOI 10.1056/NEJMoa1311889
   O'Donnell MJ, 2011, JAMA-J AM MED ASSOC, V306, P2229, DOI 10.1001/jama.2011.1729
   Peng YG, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149655
   Polonia J, 2017, J HYPERTENS, V35, P477, DOI 10.1097/HJH.0000000000001180
   Polonia J, 2016, BLOOD PRESS MONIT, V21, P301, DOI 10.1097/MBP.0000000000000205
   Rhee MY, 2017, J CLIN HYPERTENS, V19, P431, DOI 10.1111/jch.12922
   Rhee MY, 2015, KOREAN CIRC J, V45, P175, DOI 10.4070/kcj.2015.45.3.175
   Rhee MY, 2014, NUTRIENTS, V6, P2360, DOI 10.3390/nu6062360
   Rhee MY, 2014, STUDY EFFECT NATRIUM
   Rhee OJ, 2016, INT J CARDIOL, V215, P120, DOI 10.1016/j.ijcard.2016.04.109
   Rodrigues SL, 2015, BRAZ J MED BIOL RES, V48, P728, DOI 10.1590/1414-431X20154455
   Shin SJ, 2011, J KOREAN MED SCI, V26, P1061, DOI 10.3346/jkms.2011.26.8.1061
   Singer P, 2015, AM J HYPERTENS, V28, P335, DOI 10.1093/ajh/hpu141
   Stolarz-Skrzypek K, 2011, JAMA-J AM MED ASSOC, V305, P1777, DOI 10.1001/jama.2011.574
   Takahashi Y, 2006, J HYPERTENS, V24, P451, DOI 10.1097/01.hjh.0000209980.36359.16
   Thomas MC, 2011, DIABETES CARE, V34, P861, DOI 10.2337/dc10-1722
   Toft U, 2014, EUR J PREV CARDIOL, V21, P1300, DOI 10.1177/2047487313485517
   Tsugane S, 2004, BRIT J CANCER, V90, P128, DOI 10.1038/sj.bjc.6601511
   Vallejo M, 2017, ARCH MED RES, V48, P195, DOI 10.1016/j.arcmed.2017.03.012
   vanBuul BJA, 1997, HYPERTENS PREGNANCY, V16, P335, DOI 10.3109/10641959709031642
   Vidal-Petiot E, 2018, J HYPERTENS, V36, P785, DOI 10.1097/HJH.0000000000001609
   WHELTON PK, 1992, JAMA-J AM MED ASSOC, V267, P1213, DOI 10.1001/jama.1992.03480090061028
   Whelton PK, 1997, ARCH INTERN MED, V157, P657
   Whitton C, 2016, J NUTR, V146, P1609, DOI 10.3945/jn.116.232108
   Xu JW, 2017, KIDNEY BLOOD PRESS R, V42, P188, DOI 10.1159/000475486
   Xu JW, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-136
   Zhang Y, 2019, J HYPERTENS, V37, P99, DOI 10.1097/HJH.0000000000001879
   Zhou L, 2017, AM J CLIN NUTR, V105, P1291, DOI 10.3945/ajcn.116.147553
NR 76
TC 1
Z9 1
U1 0
U2 2
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JUL
PY 2020
VL 50
IS 7
BP 555
EP 571
DI 10.4070/kcj.2020.0042
PG 17
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA MD5ZJ
UT WOS:000544051000002
PM 32281323
OA Green Published, Other Gold
DA 2021-04-22
ER

PT J
AU Lim, SJ
   Koo, HJ
   Jung, SC
   Kang, DY
   Ahn, JM
   Park, DW
   Park, SJ
   Yang, DH
   Kang, JW
AF Lim, Su Jin
   Koo, Hyun Jung
   Jung, Seung Chai
   Kang, Do-Yoon
   Ahn, Jung-Min
   Park, Duk-Woo
   Park, Seung-Jung
   Yang, Dong Hyun
   Kang, Joon-Won
TI Sinus of Valsalva Thrombosis Detected on Computed Tomography after
   Transcatheter Aortic Valve Replacement
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Aortic valve stenosis; Multidetector computed tomography; Transcatheter
   aortic valve replacement; Thrombosis; Sinus of valsalva
ID RIGHT CORONARY-SINUS; IMPLANTATION; ASSOCIATION; GUIDELINES; ANEURYSM;
   STROKE; SILENT
AB Background and Objectives: Leaflet thrombosis after transcatheter aortic valve replacement (TAVR) has been reported recently, whereas thrombus formation in sinus of Valsalva has yet to be fully evaluated. This study describes clinical and cardiac computed tomography (CT) findings of patients with sinus of Valsalva thrombosis.
   Methods: Between March 2011 and Aug 2019, 192 patients underwent cardiac CT after TAVR. After a retrospective review of CT images, 9 patients (82 years, male:female=2:7) who had sinus of Valsalva thrombosis identified by cardiac CT were selected for this study. Patient demographics, interval between TAVR and cardiac CT scan, location and CT attenuation of sinus of Valsalva thrombosis, and presence of concurrent leaflet thrombosis were evaluated.
   Results: The median interval between TAVR and cardiac CT was 11 days. Sinus of Valsalva thrombosis was frequently detected in the non-coronary sinus (89%, 8/9), and predominantly located in the bottom of the sinus extending upward towards the sinotubular junction. Three patients had concomitant leaflet thrombosis, and 3 patients had subclinical embolic stroke noted on brain magnetic resonance imaging. All patients had been prescribed aspirin and clopidogrel after TAVR for at least 6 months without anticoagulants.
   Conclusions: Cardiac CT after TAVR can detect sinus of Valsalva thrombosis, and attention should be paid to this potential source of subsequent systemic embolization.
C1 [Lim, Su Jin; Koo, Hyun Jung; Jung, Seung Chai; Yang, Dong Hyun; Kang, Joon-Won] Univ Ulsan, Coll Med, Dept Radiol, Cardiac Imaging Ctr,Asan Med Ctr, 88,Olymp Ro 43 Gil, Seoul 05505, South Korea.
   [Lim, Su Jin; Koo, Hyun Jung; Jung, Seung Chai; Yang, Dong Hyun; Kang, Joon-Won] Univ Ulsan, Coll Med, Res Inst Radiol, Cardiac Imaging Ctr,Asan Med Ctr, 88,Olymp Ro 43 Gil, Seoul 05505, South Korea.
   [Kang, Do-Yoon; Ahn, Jung-Min; Park, Duk-Woo; Park, Seung-Jung] Univ Ulsan, Div Cardiol, Asan Med Ctr, Coll Med, Seoul, South Korea.
RP Kang, JW (corresponding author), Univ Ulsan, Coll Med, Dept Radiol, Cardiac Imaging Ctr,Asan Med Ctr, 88,Olymp Ro 43 Gil, Seoul 05505, South Korea.; Kang, JW (corresponding author), Univ Ulsan, Coll Med, Res Inst Radiol, Cardiac Imaging Ctr,Asan Med Ctr, 88,Olymp Ro 43 Gil, Seoul 05505, South Korea.
EM jwonkang@amc.seoul.kr
OI Park, Duk-Woo/0000-0001-6643-0239; Kang, Joon-Won/0000-0001-6478-0390;
   Koo, Hyun Jung/0000-0001-5640-3835
CR Arnold SV, 2014, CIRC-CARDIOVASC INTE, V7, P829, DOI 10.1161/CIRCINTERVENTIONS.114.001395
   Baumgartner H, 2017, EUR HEART J, V38, P2739, DOI 10.1093/eurheartj/ehx391
   Beck KS, 2017, CARDIOVASC IMAGING A, V1, P156
   Dasi LP, 2017, ANN BIOMED ENG, V45, P310, DOI 10.1007/s10439-016-1759-3
   Davlouros PA, 2018, J GERIATR CARDIOL, V15, P95, DOI 10.11909/j.issn.1671-5411.2018.01.008
   Ducci A, 2016, J BIOMECH, V49, P4080, DOI 10.1016/j.jbiomech.2016.10.050
   Ducci A, 2013, J HEART VALVE DIS, V22, P688
   Eguchi K, 2004, J AM SOC ECHOCARDIOG, V17, P173, DOI 10.1016/j.echo.2003.10.002
   Hisatomi K, 2011, ANN THORAC SURG, V92, P1508, DOI 10.1016/j.athoracsur.2011.04.037
   Huded CP, 2019, JAMA-J AM MED ASSOC, V321, P2306, DOI 10.1001/jama.2019.7525
   Kahlert P, 2010, CIRCULATION, V121, P870, DOI 10.1161/CIRCULATIONAHA.109.855866
   Kapadia S, 2016, CIRC-CARDIOVASC INTE, V9, DOI 10.1161/CIRCINTERVENTIONS.115.002981
   Kapadia SR, 2015, LANCET, V385, P2485, DOI 10.1016/S0140-6736(15)60290-2
   Kim YJ, 2015, KOREAN J RADIOL, V16, P251, DOI 10.3348/kjr.2015.16.2.251
   Mack MJ, 2015, LANCET, V385, P2477, DOI 10.1016/S0140-6736(15)60308-7
   Makkar RR, 2015, NEW ENGL J MED, V373, P2015, DOI 10.1056/NEJMoa1509233
   Mitchell C, 2019, J AM SOC ECHOCARDIOG, V32, P1, DOI 10.1016/j.echo.2018.06.004
   Mizuguchi Y, 2012, CIRC-CARDIOVASC IMAG, V5, P547, DOI 10.1161/CIRCIMAGING.112.975284
   Muralidharan A, 2016, AM J CARDIOL, V118, P1031, DOI 10.1016/j.amjcard.2016.07.011
   Nagata Y, 2004, CIRC J, V68, P795, DOI 10.1253/circj.68.795
   Nakata A, 2006, INTERNAL MED, V45, P909, DOI 10.2169/internalmedicine.45.1634
   Reardon MJ, 2017, NEW ENGL J MED, V376, P1321, DOI 10.1056/NEJMoa1700456
   SHAHRABANI RM, 1993, BRIT HEART J, V69, P266
   Smith CR, 2011, NEW ENGL J MED, V364, P2187, DOI 10.1056/NEJMoa1103510
   Stollberger C, 1996, STROKE, V27, P1424, DOI 10.1161/01.STR.27.8.1424
   Thyregod HGH, 2015, J AM COLL CARDIOL, V65, P2184, DOI 10.1016/j.jacc.2015.03.014
   Tsunaki T, 2016, JACC-CARDIOVASC INTE, V9, P2454, DOI 10.1016/j.jcin.2016.09.003
   Vahidkhah K, 2017, J BIOMECH, V58, P114, DOI 10.1016/j.jbiomech.2017.04.020
   Van Mieghem NM, 2015, JACC-CARDIOVASC INTE, V8, P718, DOI 10.1016/j.jcin.2015.01.020
   Willson AB, 2012, J AM COLL CARDIOL, V60, P581, DOI 10.1016/j.jacc.2012.02.045
NR 30
TC 2
Z9 2
U1 0
U2 3
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JUL
PY 2020
VL 50
IS 7
BP 572
EP 582
DI 10.4070/kcj.2019.0385
PG 11
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA MD5ZJ
UT WOS:000544051000003
PM 32281322
OA Green Published, Other Gold
DA 2021-04-22
ER

PT J
AU Kim, HL
   Jung, MH
   Choi, JH
   Lee, S
   Kong, MG
   Na, JO
   Cho, YH
   Cho, KI
   Choi, DJ
   Kim, EJ
AF Kim, Hack-Lyoung
   Jung, Mi-Hyang
   Choi, Jae Hyuk
   Lee, Sunki
   Kong, Min Gyu
   Na, Jin Oh
   Cho, Yang Hyun
   Cho, Kyoung-Im
   Choi, Dong-Ju
   Kim, Eung Ju
TI Factors Associated with Low Awareness of Heart Failure in the General
   Population of Korea
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Awareness; Health surveys; Heart failure; Telephone
ID PUBLIC AWARENESS; MORTALITY; EUROPE; TRENDS; CARE
AB Background and Objectives: Factors associated with low heart failure (HF) awareness have not been well-evaluated. This study was conducted to find out which demographic features would be associated with low HF awareness in the general population of Korea.
   Methods: A telephone interview was conducted with 1,032 adults (58 years and 50.6% were male) across the country. Based on answer to 15 questions about HF, we scored from 0 to 15 points (mean, 7.53 +/- 2.75; median, 8; interquartile range, 6-9). A score of <8 was defined as low HF awareness, and a score of IS was defined as high HF awareness.
   Results: A total of 478 subjects (46.3%) had low HF awareness. HF awareness scores were 5.18 +/- 1.85 and 9.55 +/- 1.50 in subjects of low and high HF awareness groups, respectively. Subjects with low HF awareness were older, more female-dominant, more diabetic, lower educational and house hold income levels, and more frequently living in rural areas, compared to those with high HF awareness (p<0.05 for each). In multivariable logistic regression analyses, older age (1.67 years: odds ratio [OR], 1.61; 95% confidence interval (CI), 1.16-2.19; p=0.004), female sex (OR, 1.33; 95% CI, 1.02-1.73; p=0.034) and low educational level (high school graduate or less vs. college graduate: OR, 2.38; 95% CI, 1.75-3.22; p<0.001) were significantly associated with low HF awareness even after controlling for potential confounders.
   Conclusions: Older age, female sex, and lower level of education were independently associated with low HF awareness in the general Korean population. More attention and education are needed for these vulnerable groups to improve HF awareness.
C1 [Kim, Hack-Lyoung] Seoul Natl Univ, Coll Med, Div Cardiol, Seoul Metropolitan Govt,Boramae Med Ctr, Seoul, South Korea.
   [Jung, Mi-Hyang; Choi, Jae Hyuk; Lee, Sunki] Hallym Univ, Coll Med, Div Cardiol, Dongtan Sacred Heart Hosp, Hwaseong, South Korea.
   [Kong, Min Gyu] Soonchunhyang Univ, Div Cardiol, Bucheon Hosp, Bucheon, South Korea.
   [Na, Jin Oh; Kim, Eung Ju] Korea Univ, Coll Med, Div Cardiol, Guro Hosp, 148 Gurodong Ro, Seoul 08308, South Korea.
   [Cho, Yang Hyun] Sungkyunkwan Univ, Sch Med, Dept Thorac & Cardiovasc Surg, Heart Vasc Stroke Inst,Samsung Med Ctr, Seoul, South Korea.
   [Cho, Kyoung-Im] Kosin Univ, Coll Med, Div Cardiol, Gospel Hosp, Busan, South Korea.
   [Choi, Dong-Ju] Seoul Natl Univ, Coll Med, Div Cardiol, Bundang Hosp, Seongnam, South Korea.
RP Kim, EJ (corresponding author), Korea Univ, Coll Med, Div Cardiol, Guro Hosp, 148 Gurodong Ro, Seoul 08308, South Korea.
EM withnoel@empal.com
RI Jung, Mi-Hyang/AAV-2013-2020
OI Jung, Mi-Hyang/0000-0003-0224-5178; Cho, Yang Hyun/0000-0003-1685-3641;
   KONG, MIN GYU/0000-0003-1336-5319; Choi, Jae Hyuk/0000-0002-9310-6503;
   Kim, Eung Ju/0000-0003-2322-6267
CR Azhar G, 2015, J RES DEV, V3, P128
   Braunwald E, 2013, JACC-HEART FAIL, V1, P1, DOI 10.1016/j.jchf.2012.10.002
   Chakraborty A, 2014, EUR J HEART FAIL, V16, P595, DOI 10.1002/ejhf.108
   Davis JD, 2017, AM J MED, V130, DOI 10.1016/j.amjmed.2016.07.030
   Edelberg HK, 1999, J AM GERIATR SOC, V47, P592, DOI 10.1111/j.1532-5415.1999.tb02574.x
   Evangelista LS, 2010, J CARD FAIL, V16, P9, DOI 10.1016/j.cardfail.2009.10.026
   Fabbri M, 2018, MAYO CLIN PROC, V93, P9, DOI 10.1016/j.mayocp.2017.09.018
   Jackson SL, 2018, CIRC-HEART FAIL, V11, DOI 10.1161/CIRCHEARTFAILURE.117.004873
   Jung MH, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0222264
   Jurgens CY, 2006, RES NURS HEALTH, V29, P74, DOI 10.1002/nur.20118
   Lainscak M, 2014, ARCH MED SCI, V10, P355, DOI 10.5114/aoms.2014.42589
   Laribi S, 2012, EUR J HEART FAIL, V14, P234, DOI 10.1093/eurjhf/hfr182
   Lee DS, 2011, CIRC-HEART FAIL, V4, P36, DOI 10.1161/CIRCHEARTFAILURE.110.957480
   Lee H, 2016, BMC CARDIOVASC DISOR, V16, DOI 10.1186/s12872-016-0404-2
   Murad K, 2015, JACC-HEART FAIL, V3, P542, DOI 10.1016/j.jchf.2015.03.004
   Nowak Karol, 2019, Folia Med Cracov, V59, P93
   Remme W, 2004, CARDIOVASC DRUG THER, V18, P153, DOI 10.1023/B:CARD.0000029033.83282.d0
   Remme WJ, 2005, EUR HEART J, V26, P2413, DOI 10.1093/eurheartj/ehi447
   Stork S, 2016, EUR J HEART FAIL, V18, P66, DOI 10.1002/ejhf.425
   Youn JC, 2017, KOREAN CIRC J, V47, P16, DOI 10.4070/kcj.2016.0429
   Zelenak C, 2017, ESC HEART FAIL, V4, P224, DOI 10.1002/ehf2.12144
NR 21
TC 1
Z9 1
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JUL
PY 2020
VL 50
IS 7
BP 586
EP 595
DI 10.4070/kcj.2019.0401
PG 10
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA MD5ZJ
UT WOS:000544051000005
PM 32212427
OA Green Published, Other Gold
DA 2021-04-22
ER

PT J
AU Kim, MS
   Chang, SA
   Kim, EK
   Choi, JO
   Park, SJ
   Lee, SC
   Park, SW
   Oh, JK
AF Kim, Min Sun
   Chang, Sung-A
   Kim, Eun Kyoung
   Choi, Jin-Oh
   Park, Sung-Ji
   Lee, Sang-Chol
   Park, Seung Woo
   Oh, Jae K.
TI The Clinical Course of Tuberculous Pericarditis in Immunocompetent Hosts
   Based on Serial Echocardiography
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Tuberculous pericarditis; Constrictive pericarditis; Echocardiography;
   Steroids
ID CONSTRICTIVE PERICARDITIS; GUIDELINES; MANAGEMENT; DIAGNOSIS; DISEASES;
   EFFUSION; SOCIETY
AB Background and Objectives: In East Asia, tuberculous pericarditis still occurs in immunocompetent patients. We aimed to investigate clinical course of tuberculous pericarditis and the trends of echocardiographic parameters for constrictive pericarditis.
   Methods: We retrospectively analyzed medical records of patients with tuberculous pericarditis between January 2010 and January 2017 in Samsung Medical Center. Treatment consists of the standard 4-drug anti-tuberculosis regimen for 6 months with or without corticosteroids. We performed echocardiography at initial diagnosis, 1, 3 and 6 months later.
   Results: Total 50 cases with tuberculous pericarditis in immunocompetent patients were enrolled. Echocardiographic finding at initial diagnosis divided into 3 groups: 1) pericardial effusion only (n=28, 56.0%), 2) effusive constrictive pericarditis (n=10, 20.0%) and 3) constrictive pericarditis (n=12, 24.0%). The proportion of patients with constrictive pericarditis decreased gradually over time. After 6 months, only 5 patients still had constrictive pericarditis. Out of the 28 patients who initially presented with effusion alone, only one patient developed constrictive pericarditis. Echocardiographic parameters representing constrictive pericarditis gradually disappeared over the follow up period. Ventricular interdependency improved significantly from 1 month follow-up, whereas septal bounce and pericardial thickening were still observed after 6 months without significant constrictive physiology.
   Conclusions: Tuberculous pericarditis with pericardial effusion without constrictive physiology is unlikely to develop into constrictive pericarditis in immunocompetent hosts, if treated with optimal anti-tuberculous medication and steroid therapy. Even though there were hemodynamic feature of constrictive pericarditis, more than 80% of the patients were improved from constrictive pericarditis.
C1 [Kim, Min Sun; Chang, Sung-A; Kim, Eun Kyoung; Choi, Jin-Oh; Park, Sung-Ji; Lee, Sang-Chol; Park, Seung Woo; Oh, Jae K.] Sungkyunkwan Univ, Sch Med, Div Cardiol, Dept Med,Heart Vasc Stroke Inst,Samsung Med Ctr, Seoul, South Korea.
   [Oh, Jae K.] Mayo Clin, Coll Med, Dept Cardiovasc Dis, Rochester, MN USA.
RP Chang, SA (corresponding author), Sungkyunkwan Univ, Sch Med, Div Cardiol, Dept Med, 81 Irwon Ro, Seoul 06351, South Korea.; Chang, SA (corresponding author), Sungkyunkwan Univ, Sch Med, Heart Vasc & Stroke Inst, Imaging Ctr,Samsung Med Ctr, 81 Irwon Ro, Seoul 06351, South Korea.
EM elisabet.chang@gmail.com
OI Lee, Sang-Chol/0000-0003-2176-0482; Park, Sung-Ji/0000-0002-7075-847X
CR Adler Y, 2015, G ITAL CARDIOL, V16, P702, DOI 10.1714/2088.22592
   Chang SA, 2017, CARDIOL CLIN, V35, P615, DOI 10.1016/j.ccl.2017.07.013
   Chang SA, 2017, J AM COLL CARDIOL, V69, P750, DOI 10.1016/j.jacc.2016.11.059
   Ha JW, 2001, CIRCULATION, V104, P976, DOI 10.1161/hc3401.095705
   Haley JH, 2004, J AM COLL CARDIOL, V43, P271, DOI 10.1016/j.jacc.2003.08.032
   Harvey AM, 1937, MEDICINE, V16, P45, DOI 10.1097/00005792-193702000-00002
   Kadhiravan Tamilarasu, 2010, Indian J Chest Dis Allied Sci, V52, P153
   Klein AL, 2013, J AM SOC ECHOCARDIOG, V26, P965, DOI 10.1016/j.echo.2013.06.023
   Maisch B, 2004, REV ESP CARDIOL, V57, P1090, DOI 10.1157/13068170
   Mayosi BM, 2005, CIRCULATION, V112, P3608, DOI 10.1161/CIRCULATIONAHA.105.543066
   Myers RBH, 1999, AM HEART J, V138, P219, DOI 10.1016/S0002-8703(99)70105-5
   Ntsekhe M, 2003, QJM-INT J MED, V96, P593, DOI 10.1093/qjmed/hcg100
   STRANG JIG, 1994, J INFECTION, V28, P251, DOI 10.1016/S0163-4453(94)91593-8
   Strang JIG, 2004, QJM-INT J MED, V97, P525, DOI 10.1093/qjmed/hch086
   STRANG JIG, 1988, LANCET, V2, P759
   Wiysonge C S, 2017, COCHRANE DB SYST REV, V9, pCD000526
NR 16
TC 3
Z9 3
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JUL
PY 2020
VL 50
IS 7
BP 599
EP 609
DI 10.4070/kcj.2019.0317
PG 11
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA MD5ZJ
UT WOS:000544051000007
PM 32096358
OA Other Gold, Green Published
DA 2021-04-22
ER

PT J
AU Lim, IR
   Kim, C
   Jung, JW
   Kim, JH
   Hong, SJ
AF Lim, I-Rang
   Kim, Chungho
   Jung, Jong-Wha
   Kim, Jong-Ho
   Hong, Soon Jun
TI Inhibition of Smooth Muscle Cell Proliferation and Migration by a Talin
   Modulator Attenuates Neointimal Formation after Femoral Arterial Injury
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Talin; Focal adhesion; Vascular smooth muscle cell; Vascular injury;
   Neointima formation
ID FOCAL ADHESION KINASE; ACTIVATION; SURVIVAL
AB Background and Objectives: Vascular smooth muscle cell (SMC) proliferation and migration play a critical role in neointimal formation. Focal adhesion is involved in cell proliferation and migration, and talin is known to be a key regulator of these processes. We synthesized a new talin modulator that binds to the talin protein, and investigated its effects on SMCs and neointimal formation after vascular injury.
   Methods: Human aortic SMCs (HAoSMCs) were treated with a newly synthesized talin modulator. Apolipoprotein E knockout (ApoE KO) mice were subjected to left femoral arterial injury and orally administered with the talin modulator daily. Laser Doppler imager was used to compare the blood flow, and injured femoral arteries and blood serum were analyzed after 28 days.
   Results: The talin modulator significantly inhibited cell proliferation in a concentration-dependent manner and suppressed the migration of HAoSMCs. Treatment with a talin modulator resulted in a significant reduction in the phosphorylation of focal adhesion molecules and downstream signaling molecules related to cell proliferation and migration. The effects of the talin modulator in HAoSMCs were found to be reversible, as evidenced by the reactivation of signaling pathways upon its removal. After 28 days of administration of the talin modulator, an improvement in the blood flow and reduction in neointimal formation in the injured femoral arteries were observed.
   Conclusions: We demonstrated the inhibitory effects of a talin modulator on SMC proliferation and migration, and that were associated with downregulation of signaling pathways, resulting in the attenuation of neointimal formation in ApoE KO mice.
C1 [Lim, I-Rang; Kim, Jong-Ho; Hong, Soon Jun] Korea Univ, Dept Cardiol, Cardiovasc Ctr, Coll Med, 73 Goryeodae Ro, Seoul 02841, South Korea.
   [Kim, Chungho] Korea Univ, Dept Life Sci, Coll Life Sci & Biotechnol, Seoul, South Korea.
   [Jung, Jong-Wha] Kyungpook Natl Univ, Pharmaceut Sci Res Inst, Coll Pharm, Daegu, South Korea.
RP Kim, JH; Hong, SJ (corresponding author), Korea Univ, Dept Cardiol, Cardiovasc Ctr, Coll Med, 73 Goryeodae Ro, Seoul 02841, South Korea.
EM mecey@naver.com; psyche94@hanmail.net
OI Lim, I-Rang/0000-0003-4906-9108; Jung, Jong-Wha/0000-0001-9885-3447
FU Korean Cardiac Research Foundation [201701-01]; Korea University
   [K1609881]; Bio & Medical Technology Development Program of the National
   Research Foundation (NRF) - Ministry of Science ICT
   [NRF-2018M3A9A8017949]
FX This research was supported by a research grant from the Korean Cardiac
   Research Foundation (201701-01), Korea University in 2016 (K1609881),
   and by the Bio & Medical Technology Development Program of the National
   Research Foundation (NRF) funded by the Ministry of Science & ICT
   (NRF-2018M3A9A8017949).
CR Bennett MR, 2016, CIRC RES, V118, P692, DOI 10.1161/CIRCRESAHA.115.306361
   Bouchard V, 2007, J CELL PHYSIOL, V212, P717, DOI 10.1002/jcp.21096
   CALALB MB, 1995, MOL CELL BIOL, V15, P954
   Camici GG, 2006, CIRCULATION, V114, P1512, DOI 10.1161/CIRCULATIONAHA.106.638460
   CHEN HC, 1995, J BIOL CHEM, V270, P16995, DOI 10.1074/jbc.270.28.16995
   Daniel JM, 2016, ARTERIOSCL THROM VAS, V36, P317, DOI 10.1161/ATVBAHA.115.305974
   Goult BT, 2018, J CELL BIOL, V217, P3776, DOI 10.1083/jcb.201808061
   Harburger DS, 2009, J CELL SCI, V122, P159, DOI 10.1242/jcs.018093
   Huttenlocher A, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005074
   Kaneda T, 2008, CANCER LETT, V270, P354, DOI 10.1016/j.canlet.2008.05.042
   KATSUDA S, 1988, EXP MOL PATHOL, V48, P48, DOI 10.1016/0014-4800(88)90045-7
   Kim J, 2014, J MOL CELL CARDIOL, V72, P157, DOI 10.1016/j.yjmcc.2014.03.008
   Kim JH, 2019, MOL MED, V25, DOI 10.1186/s10020-019-0095-0
   Kleinschmidt EG, 2017, CURR OPIN CELL BIOL, V45, P24, DOI 10.1016/j.ceb.2017.01.003
   Lim IR, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18010221
   Nagayama K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137960
   Son JE, 2014, CARDIOVASC RES, V101, P503, DOI 10.1093/cvr/cvt337
   Sun ZQ, 2019, NAT CELL BIOL, V21, P25, DOI 10.1038/s41556-018-0234-9
   Tomakidi P, 2014, CELL TISSUE RES, V357, P515, DOI 10.1007/s00441-014-1945-2
   Wang PB, 2011, J CELL BIOL, V195, P499, DOI 10.1083/jcb.201104128
   Wozniak MA, 2004, BBA-MOL CELL RES, V1692, P103, DOI 10.1016/j.bbamcr.2004.04.007
   Xia H, 2004, J BIOL CHEM, V279, P33024, DOI 10.1074/jbc.M313265200
   Ye F, 2012, BLOOD, V119, P26, DOI 10.1182/blood-2011-04-292128
NR 23
TC 1
Z9 1
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JUL
PY 2020
VL 50
IS 7
BP 613
EP 624
DI 10.4070/kcj.2019.0421
PG 12
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA MD5ZJ
UT WOS:000544051000009
PM 32588569
OA Other Gold, Green Published
DA 2021-04-22
ER

PT J
AU Agstam, S
AF Agstam, Sourabh
TI Septal Bounce or Ventricle Interdependence in Constrictive Pericarditis:
   Same or Different
SO KOREAN CIRCULATION JOURNAL
LA English
DT Letter
C1 [Agstam, Sourabh] Vardhman Mahavir Med Coll VMMC, Dept Cardiol, New Delhi 110023, India.
   [Agstam, Sourabh] Safdarjang Hosp, New Delhi 110023, India.
RP Agstam, S (corresponding author), Vardhman Mahavir Med Coll VMMC, Dept Cardiol, New Delhi 110023, India.; Agstam, S (corresponding author), Safdarjang Hosp, New Delhi 110023, India.
EM sourabhagstam@gmail.com
OI agstam, sourabh/0000-0002-3060-5794
CR Agstam S, 2019, INT J CLIN MED IMAGE, V6
   Chang Sung A, 2019, J Cardiovasc Imaging, V27, P178, DOI 10.4250/jcvi.2019.27.e28
   Coylewright M, 2013, HEART, V99, P1376, DOI 10.1136/heartjnl-2013-304070
   Kim MS, 2020, KOREAN CIRC J, V50, P599, DOI 10.4070/kcj.2019.0317
   Smith E., 1988, Research Report [Faculty of Agriculture, University College Dublin], P37
NR 5
TC 0
Z9 0
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JUL
PY 2020
VL 50
IS 7
BP 628
EP 629
DI 10.4070/kcj.2020.0178
PG 2
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA MD5ZJ
UT WOS:000544051000011
PM 32588571
OA Green Published, Other Gold
DA 2021-04-22
ER

PT J
AU Kim, MS
   Chang, SA
AF Kim, Min Sun
   Chang, Sung-A
TI Author's Reply to Septal Bounce or Ventricle Interdependence in
   Constrictive Pericarditis: Same or Different
SO KOREAN CIRCULATION JOURNAL
LA English
DT Letter
C1 [Kim, Min Sun] Sungkyunkwan Univ, Sch Med, Samsung Changwon Hosp, Div Cardiol,Dept Med, Seoul, South Korea.
   [Chang, Sung-A] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Cardiol,Dept Med,Heart Vasc Stroke Inst, Seoul, South Korea.
RP Chang, SA (corresponding author), Sungkyunkwan Univ, Sch Med, Div Cardiol, Dept Med,Samsung Med Ctr, 81 Irwon Ro, Seoul 06351, South Korea.; Chang, SA (corresponding author), Sungkyunkwan Univ, Sch Med, Heart Vasc & Stroke Inst Imaging Ctr, Samsung Med Ctr, 81 Irwon Ro, Seoul 06351, South Korea.
EM elisabet.chang@gmail.com
CR Chang SA, 2017, J AM COLL CARDIOL, V69, P750, DOI 10.1016/j.jacc.2016.11.059
   Ha JW, 2001, CIRCULATION, V104, P976, DOI 10.1161/hc3401.095705
   Himelman R B, 1988, J Am Soc Echocardiogr, V1, P333
   Kim MS, 2020, KOREAN CIRC J, V50, pe43
   Welch TD, 2014, CIRC-CARDIOVASC IMAG, V7, P526, DOI 10.1161/CIRCIMAGING.113.001613
NR 5
TC 0
Z9 0
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JUL
PY 2020
VL 50
IS 7
BP 630
EP 631
DI 10.4070/kcj.2020.1781
PG 2
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA MD5ZJ
UT WOS:000544051000012
PM 32588572
OA Green Published, Other Gold
DA 2021-04-22
ER

PT J
AU Kwak, JH
   Lee, J
   Ha, KS
AF Kwak, Ji Hee
   Lee, JungHwa
   Ha, Kee Soo
TI Significance of Differential Characteristics in Infantile Kawasaki
   Disease (vol 49, pg 755, 2020)
SO KOREAN CIRCULATION JOURNAL
LA English
DT Correction
C1 [Kwak, Ji Hee] Sungkyunkwan Univ, Sch Med, Kangbuk Samsung Hosp, Dept Pediat, Seoul, South Korea.
   [Lee, JungHwa; Ha, Kee Soo] Korea Univ, Coll Med, Guro Hosp, Dept Pediat, Seoul, South Korea.
RP Kwak, JH (corresponding author), Sungkyunkwan Univ, Sch Med, Kangbuk Samsung Hosp, Dept Pediat, Seoul, South Korea.
CR Kwak JH, 2019, KOREAN CIRC J, V49, P755, DOI 10.4070/kcj.2018.0434
NR 1
TC 1
Z9 1
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JUL
PY 2020
VL 50
IS 7
BP 641
EP 643
DI 10.4070/kcj.2020.0999
PG 3
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA MD5ZJ
UT WOS:000544051000016
PM 32588575
OA Green Published, Other Gold
DA 2021-04-22
ER

PT J
AU Kang, SJ
AF Kang, Soo-Jin
TI Clinical Impact of Beta-blockers in the Revascularization Era
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
ID ELEVATION MYOCARDIAL-INFARCTION; ST-SEGMENT ELEVATION; TASK-FORCE;
   ASSOCIATION; MANAGEMENT; OUTCOMES
C1 [Kang, Soo-Jin] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Cardiol, 88 Olymp Ro 43 Gil, Seoul 05505, South Korea.
RP Kang, SJ (corresponding author), Univ Ulsan, Coll Med, Asan Med Ctr, Dept Cardiol, 88 Olymp Ro 43 Gil, Seoul 05505, South Korea.
EM sjkang@amc.seoul.kr
CR Aarvik MD, 2019, EUR HEART J-CARD PHA, V5, P12, DOI 10.1093/ehjcvp/pvy034
   Bangalore S, 2014, AM J MED, V127, P939, DOI 10.1016/j.amjmed.2014.05.032
   Freemantle N, 1999, BMJ-BRIT MED J, V318, P1730, DOI 10.1136/bmj.318.7200.1730
   Ibanez B, 2018, EUR HEART J, V39, P119, DOI 10.1093/eurheartj/ehx393
   O'Gara PT, 2013, J AM COLL CARDIOL, V61, pE78, DOI 10.1016/j.jacc.2012.11.019
   Park J, 2018, J AM HEART ASSOC, V7, DOI 10.1161/JAHA.117.008055
   Puymirat E, 2016, BMJ-BRIT MED J, V354, pi4801
   Yang JH, 2014, JACC-CARDIOVASC INTE, V7, P592, DOI 10.1016/j.jcin.2013.12.206
NR 8
TC 0
Z9 0
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JUN
PY 2020
VL 50
IS 6
BP 509
EP 510
DI 10.4070/kcj.2020.0112
PG 2
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA LK9FY
UT WOS:000531164500005
PM 32419403
OA Green Published, Other Gold
DA 2021-04-22
ER

PT J
AU Kwon, CH
AF Kwon, Chang Hee
TI External Electrical Cardioversion is an Easy and Safe Intervention for
   Rhythm Control in Persistent Atrial Fibrillation
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
ID HEART-FAILURE; FOLLOW-UP; MANAGEMENT
C1 [Kwon, Chang Hee] Konkuk Univ, Sch Med, Med Ctr, Div Cardiol,Dept Internal Med, 120-1 Neungdong Ro, Seoul 05030, South Korea.
RP Kwon, CH (corresponding author), Konkuk Univ, Sch Med, Med Ctr, Div Cardiol,Dept Internal Med, 120-1 Neungdong Ro, Seoul 05030, South Korea.
EM vertex_77@naver.com
OI Kwon, Chang Hee/0000-0001-8716-1146
CR Benjamin EJ, 1998, CIRCULATION, V98, P946, DOI 10.1161/01.CIR.98.10.946
   Corley SD, 2004, CIRCULATION, V109, P1509, DOI 10.1161/01.CIR.0000121736.16643.11
   Hunter RJ, 2014, CIRC-ARRHYTHMIA ELEC, V7, P31, DOI 10.1161/CIRCEP.113.000806
   Hwang TH, 2020, KOREAN CIRC J, V50, P346, DOI 10.4070/kcj.2019.0268
   Kirchhof P, 2016, EUR HEART J, V37, P2893, DOI 10.1093/eurheartj/ehw210
   Kotecha D, 2014, LANCET, V384, P2235, DOI 10.1016/S0140-6736(14)61373-8
   Son NKL, 2020, KOREAN CIRC J, V50, P511, DOI 10.4070/kcj.2019.0310
   Park Miyoung, 2003, Korean Circulation Journal, V33, P918
   PAUL MH, 1962, CIRCULATION, V25, P604, DOI 10.1161/01.CIR.25.4.604
   Stewart S, 2002, AM J MED, V113, P359, DOI 10.1016/S0002-9343(02)01236-6
NR 10
TC 0
Z9 0
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JUN
PY 2020
VL 50
IS 6
BP 524
EP 526
DI 10.4070/kcj.2020.0122
PG 3
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA LK9FY
UT WOS:000531164500007
PM 32419404
OA Green Published, Other Gold
DA 2021-04-22
ER

PT J
AU Balaban, I
   Karaduman, A
   Keskin, B
   Kalkan, S
   Ceneli, D
   Kafkas, C
   Havan, N
   Kahveci, G
AF Balaban, Ismail
   Karaduman, Ahmet
   Keskin, Berhan
   Kalkan, Semih
   Ceneli, Dogancan
   Kafkas, Cagri
   Havan, Nuri
   Kahveci, Gokhan
TI Left Ventricular Systolic Dysfunction Caused by the Fistula from the
   Aortic Graft Pseudoaneurysm to the Left Ventricle
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
C1 [Balaban, Ismail; Karaduman, Ahmet; Keskin, Berhan; Kalkan, Semih; Ceneli, Dogancan; Kafkas, Cagri; Havan, Nuri; Kahveci, Gokhan] Kartal Kosuyolu Res & Educ Hosp, Istanbul, Turkey.
RP Balaban, I (corresponding author), Kartal Kosuyolu Yuksek Ihtisas Egitim & Arastirma, Cevizli Kavsagi 2, Istanbul 34840, Turkey.
EM ismailbalabanmd@gmail.com
OI Kalkan, Semih/0000-0002-1107-0296; keskin, berhan/0000-0002-5879-2245;
   Balaban, Ismail/0000-0002-1866-349X
NR 0
TC 0
Z9 0
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JUN
PY 2020
VL 50
IS 6
BP 536
EP 538
DI 10.4070/kcj.2019.0278
PG 3
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA LK9FY
UT WOS:000531164500011
PM 32096359
OA Green Published
DA 2021-04-22
ER

PT J
AU Kim, MC
   Kim, JH
   Cho, KH
   Sim, DS
   Hong, YJ
   Ahn, Y
   Jeong, MH
AF Kim, Min Chul
   Kim, Ju Han
   Cho, Kyung Hoon
   Sim, Doo Sun
   Hong, Young Joon
   Ahn, Youngkeun
   Jeong, Myung Ho
TI Infolding Distortion of Evolut R Valve after Transcatheter Aortic Valve
   Replacement
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
C1 [Kim, Min Chul; Kim, Ju Han; Cho, Kyung Hoon; Sim, Doo Sun; Hong, Young Joon; Ahn, Youngkeun; Jeong, Myung Ho] Chonnam Natl Univ Hosp, Dept Internal Med, Div Cardiol, 42 Jebong Ro, Gwangju 61469, South Korea.
RP Kim, JH (corresponding author), Chonnam Natl Univ Hosp, Dept Internal Med, Div Cardiol, 42 Jebong Ro, Gwangju 61469, South Korea.
EM kim@zuhan.com
OI CHO, KYUNG HOON/0000-0002-0377-6352; Kim, Juhan/0000-0002-3186-0770;
   Jeong, Myung Ho/0000-0003-2424-810X; Kim, Min Chul/0000-0001-6026-1702
FU Bio & Medical Technology Development Program of the NRF - Korean
   government, MSIP [2017M3A9E8023020]
FX This study was supported by a grant of the Bio & Medical Technology
   Development Program of the NRF funded by the Korean government, MSIP
   (2017M3A9E8023020).
CR Kamperidis V, 2014, EUR HEART J-CARD IMG, V15, P832, DOI 10.1093/ehjci/jeu005
   Kaple RK, 2017, CATHETER CARDIO INTE, V89, P499, DOI 10.1002/ccd.26265
   Kataoka A, 2018, JACC-CARDIOVASC INTE, V11, pE135, DOI 10.1016/j.jcin.2018.06.009
   Sinning JM, 2012, JACC-CARDIOVASC INTE, V5, P1288, DOI 10.1016/j.jcin.2012.07.014
   Wiper A, 2014, JACC-CARDIOVASC INTE, V7, P222, DOI 10.1016/j.jcin.2013.05.032
NR 5
TC 1
Z9 1
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JUN
PY 2020
VL 50
IS 6
BP 539
EP 541
DI 10.4070/kcj.2019.0406
PG 3
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA LK9FY
UT WOS:000531164500012
PM 32096360
OA Green Published
DA 2021-04-22
ER

PT J
AU Cheung, BMY
   Or, B
   Fei, Y
   Tsoi, MF
AF Cheung, Bernard M. Y.
   Or, Benjamin
   Fei, Yue
   Tsoi, Man-Fung
TI A 2020 Vision of Hypertension
SO KOREAN CIRCULATION JOURNAL
LA English
DT Review
DE Hypertension; Blood pressure; Guideline
ID BLOOD-PRESSURE CLASSIFICATION; CARDIOVASCULAR RISK-FACTORS; 2017
   AMERICAN-COLLEGE; METABOLIC SYNDROME; GLYCEMIC INDEX; YOUNG-ADULTS;
   ASSOCIATION; METAANALYSIS; PREVALENCE; TRIAL
AB Hypertension is a common chronic disease affecting a large section of the general population. Hypertension is highly prevalent in the elderly because blood pressure (BP) rises with age. The risk of developing hypertension increases with predisposing genes, intrauterine growth retardation, prematurity and childhood obesity. BP is easier to control in the young. Non-pharmacological treatment through lifestyle changes, such as weight control and leisure-time physical activity, is more likely to be successful in young people. Hypertension in older adults is more difficult to control, requiring the use of more than one antihypertensive drug. Adverse effects and compliance become problematic. Much research is now directed at novel ways of controlling BP such as denervation. The change in definition of hypertension in the American guideline highlights the need to identify and manage hypertension early, at a stage when it is potentially reversible.
C1 [Cheung, Bernard M. Y.; Or, Benjamin; Fei, Yue; Tsoi, Man-Fung] Univ Hong Kong, Dept Med, Div Clin Pharmacol & Therapeut, 102 Pok Fu Lam Rd, Hong Kong 999077, Peoples R China.
   [Cheung, Bernard M. Y.] Univ Hong Kong, State Key Lab Pharmaceut Biotechnol, Hong Kong, Peoples R China.
   [Cheung, Bernard M. Y.] Univ Hong Kong, Inst Cardiovasc Sci & Med, Hong Kong, Peoples R China.
RP Cheung, BMY (corresponding author), Univ Hong Kong, Dept Med, Div Clin Pharmacol & Therapeut, 102 Pok Fu Lam Rd, Hong Kong 999077, Peoples R China.
EM mycheung@hku.hk
RI FEI, YUE/AAN-6934-2020; TSOI, Man Fung/J-6964-2016; /E-9829-2010
OI FEI, YUE/0000-0002-4622-6377; TSOI, Man Fung/0000-0002-9892-0125;
   /0000-0001-9106-7363
CR Bhatt DL, 2014, NEW ENGL J MED, V370, P1393, DOI 10.1056/NEJMoa1402670
   Calkins K, 2011, CURR PROB PEDIATR AD, V41, P158, DOI 10.1016/j.cppeds.2011.01.001
   Centers for Disease Control and Prevention, 2018, HYPERTENSION
   Chan HMS, 2001, EUR J CLIN NUTR, V55, P1076, DOI 10.1038/sj.ejcn.1601265
   Cheung AJ, 2015, J HUM HYPERTENS S1, V29, pS15
   Cheung BMY, 2008, DIABETES CARE, V31, P1889, DOI 10.2337/dc08-0405
   Cheung BMY, 2008, CLIN ENDOCRINOL, V68, P730, DOI 10.1111/j.1365-2265.2007.03110.x
   Cheung BMY, 2008, AM J HYPERTENS, V21, P17, DOI 10.1038/ajh.2007.19
   Cheung BMY, 2017, POSTGRAD MED J, V93, P647, DOI 10.1136/postgradmedj-2016-134341
   Cheung BM, 2011, PUBLIC HLTH 21 CENTU, V1, P117
   Cheung BMY, 2005, J CARDIOVASC PHARM, V46, P125, DOI 10.1097/01.fjc.0000171752.43564.35
   Fei Y, 2019, CARDIOVASC DIABETOL, V18, DOI 10.1186/s12933-019-0916-z
   Fei Y, 2018, CAN J CARDIOL, V34, P1581, DOI 10.1016/j.cjca.2018.08.013
   Georgianos PI, 2019, DIABETES CARE, V42, P693, DOI 10.2337/dc18-2207
   Janus ED, 1997, CLIN EXP PHARMACOL P, V24, P987, DOI 10.1111/j.1440-1681.1997.tb02736.x
   Kim Hyeon Chang, 2019, Clin Hypertens, V25, P16, DOI 10.1186/s40885-019-0121-0
   Kotseva K, 2016, EUR J PREV CARDIOL, V23, P636, DOI 10.1177/2047487315569401
   Lobo MD, 2017, HYPERTENSION, V70, P1099, DOI 10.1161/HYPERTENSIONAHA.117.10142
   Ludwig DS, 2002, JAMA-J AM MED ASSOC, V287, P2414, DOI 10.1001/jama.287.18.2414
   Muntner P, 2018, J AM COLL CARDIOL, V71, P109, DOI 10.1016/j.jacc.2017.10.073
   Nakagami H, 2018, HYPERTENSION, V72, P1031, DOI 10.1161/HYPERTENSIONAHA.118.11084
   National Heart Lung and Blood Institute (US) National High Blood Pressure Education Program., 2004, 7 REP JOINT NAT COMM
   Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8
   Ong KL, 2008, HYPERTENSION, V51, P1142, DOI 10.1161/HYPERTENSIONAHA.107.105205
   Ong KL, 2007, HYPERTENSION, V49, P69, DOI 10.1161/01.HYP.0000252676.46043.18
   Or B, 2020, HONG KONG MED J S1, V26, P13
   Or B, 2020, HONG KONG MED J S1, V26, P14
   Parkinson JRC, 2013, PEDIATRICS, V131, pE1240, DOI 10.1542/peds.2012-2177
   Phillips MI, 2001, HYPERTENSION, V38, P543, DOI 10.1161/hy09t1.092927
   Sharma AM, 2002, J HYPERTENS, V20, P1873, DOI 10.1097/00004872-200209000-00034
   Son JS, 2018, JAMA-J AM MED ASSOC, V320, P1783, DOI 10.1001/jama.2018.16501
   Tsoi MF, 2018, HONG KONG MED J S1, V24, P54
   Vest AR, 2012, HEART, V98, P1763, DOI 10.1136/heartjnl-2012-301778
   Wang B, 2013, DIABETES OBES METAB, V15, P737, DOI 10.1111/dom.12085
   Wang ZW, 2018, CIRCULATION, V137, P2344, DOI 10.1161/CIRCULATIONAHA.117.032380
   Warren HR, 2017, NAT GENET, V49, P403, DOI 10.1038/ng.3768
   Whelton PK, 2018, HYPERTENSION, V71, P1269, DOI 10.1161/HYP.0000000000000066
   WILBER JA, 1972, AM J MED, V52, P653, DOI 10.1016/0002-9343(72)90055-1
   Williams B, 2018, EUR HEART J, V39, P3021, DOI 10.1093/eurheartj/ehy339
   Wright JT, 2015, NEW ENGL J MED, V373, P2103, DOI 10.1056/NEJMoa1511939
   Yano Y, 2018, JAMA-J AM MED ASSOC, V320, P1774, DOI 10.1001/jama.2018.13551
   Zhen Z, 2019, HYPERTENSION, V74, P47, DOI 10.1161/HYPERTENSIONAHA.118.12601
NR 42
TC 3
Z9 3
U1 0
U2 2
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JUN
PY 2020
VL 50
IS 6
BP 469
EP 475
DI 10.4070/kcj.2020.0067
PG 7
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA LK9FY
UT WOS:000531164500001
PM 32281321
OA Other Gold, Green Published
DA 2021-04-22
ER

PT J
AU Shin, J
   Cho, MC
AF Shin, Jinho
   Cho, Myeong-Chan
TI Updated Reasons and Clinical Implications of New Korean Hypertension
   Guidelines for Cardiologists
SO KOREAN CIRCULATION JOURNAL
LA English
DT Review
DE Hypertension; Practice guideline; Risk factors; Antihypertensive agents
ID BLOOD-PRESSURE; RISK; METAANALYSIS; ADULTS
AB Leaving behind substantial reflections or skepticisms on the shortage of evidences about blood pressure (BP) thresholds for antihypertensive drug therapy and target BPs, major hypertensive guidelines including Korean hypertension guidelines were recently updated for earlier and more intensive control of BP. Because hypertension is one of the major risk factors for death, stroke, cardiovascular (CV) disease, heart failure, and cognitive impairment, substantial improvement of hypertension management is necessary to reduce disease and socioeconomic burdens and to promote CV health. Theoretically, earlier intervention in terms of age and BP level and thorough control of BP into within normal range would prevent or delay major adverse CV events. Revised hypertension guidelines were developed by the American College of Cardiology/American Heart Association, Korean Society of Hypertension, European Society of Cardiology/European Society of Hypertension, and Japanese Society of Hypertension in order. In this article, recent updates and clinical significances of the Korean hypertension guidelines will be discussed with comparison of foreign hypertension guidelines and considerable changes in the management of hypertension will be introduced for cardiologists and general practitioners.
C1 [Shin, Jinho] Hanyang Univ Hosp, Dept Internal Med, Div Cardiol, Seoul, South Korea.
   [Cho, Myeong-Chan] Chungbuk Natl Univ, Coll Med, Dept Internal Med, Cheongju, South Korea.
RP Cho, MC (corresponding author), Chungbuk Natl Univ, Dept Cardiol, 776 Sunhwan 1 Ro, Cheongju 28644, South Korea.
EM mccho@cbnu.ac.kr
OI Cho, Myeong-Chan/0000-0002-0047-0227; Shin, Jinho/0000-0001-6706-6504
FU Research of Korea Centers for Disease Control and Prevention
   [2018-ER6303-00]
FX This research was supported by a fund (2018-ER6303-00) by Research of
   Korea Centers for Disease Control and Prevention.
CR Bangalore S, 2017, AM J MED, V130, P707, DOI 10.1016/j.amjmed.2017.01.004
   Black J, 2019, TEAM PERFORM MANAG, V25, P100, DOI 10.1108/TPM-01-2018-0005
   Ettehad D, 2016, LANCET, V387, P957, DOI 10.1016/S0140-6736(15)01225-8
   Huang YL, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-177
   Jung KJ, 2015, ATHEROSCLEROSIS, V242, P367, DOI 10.1016/j.atherosclerosis.2015.07.033
   Kim Hyeon Chang, 2019, Clin Hypertens, V25, P16, DOI 10.1186/s40885-019-0121-0
   Kimm H, 2018, KOREAN CIRC J, V48, P36, DOI 10.4070/kcj.2017.0036
   Kjeldsen SE, 2017, CURR HYPERTENS REP, V19, DOI 10.1007/s11906-017-0700-y
   Korean Society Hypertension (KSH), 2018, Clin Hypertens, V24, P13, DOI 10.1186/s40885-018-0098-0
   Lee Hae-Young, 2019, Clin Hypertens, V25, P20, DOI 10.1186/s40885-019-0124-x
   Lee JH, 2019, KOREAN J INTERN MED, V34, P687, DOI 10.3904/kjim.2019.196
   Lewington S, 2002, LANCET, V360, P1903
   Martin Jose F V, 2009, Recent Pat Cardiovasc Drug Discov, V4, P133
   Nerenberg KA, 2018, CAN J CARDIOL, V34, P506, DOI 10.1016/j.cjca.2018.02.022
   Pimenta E, 2010, NAT REV NEPHROL, V6, P21, DOI 10.1038/nrneph.2009.191
   Shin Jinho, 2015, Clin Hypertens, V21, P1, DOI 10.1186/s40885-014-0012-3
   Shin Jinho, 2015, Clin Hypertens, V21, P2, DOI 10.1186/s40885-014-0013-2
   Shin Jinho, 2015, Clin Hypertens, V21, P3, DOI 10.1186/s40885-014-0014-1
   Shin J, 2015, KOREAN J INTERN MED, V30, P610, DOI 10.3904/kjim.2015.30.5.610
   Thomopoulos C, 2016, J HYPERTENS, V34, P613, DOI 10.1097/HJH.0000000000000881
   Umemura S, 2019, HYPERTENS RES, V42, P1235, DOI 10.1038/s41440-019-0284-9
   Whelton PK, 2018, CIRCULATION, V138, pE484, DOI 10.1161/CIR.0000000000000596
   Williams B, 2018, EUR HEART J, V39, P3021, DOI 10.1093/eurheartj/ehy339
   Williams B, 2018, J HYPERTENS, V36, P1953, DOI [10.1097/HJH.0000000000001940, 10.1093/eurheartj/ehy339]
   Wright JT, 2015, NEW ENGL J MED, V373, P2103, DOI 10.1056/NEJMoa1511939
   Xie XF, 2016, LANCET, V387, P435, DOI 10.1016/S0140-6736(15)00805-3
NR 26
TC 2
Z9 2
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JUN
PY 2020
VL 50
IS 6
BP 476
EP 484
DI 10.4070/kcj.2019.0338
PG 9
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA LK9FY
UT WOS:000531164500002
PM 32281319
OA Green Published, Other Gold
DA 2021-04-22
ER

PT J
AU Cho, SMJ
   Lee, H
   Kim, HC
AF Cho, So Mi Jemma
   Lee, Hokyou
   Kim, Hyeon Chang
TI Comparison and Implication of the Contemporary Blood Pressure Guidelines
   on Korean Population
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Hypertension; Blood pressure; Prevalence; Guideline; Cardiovascular
   diseases
ID RISK; DISEASE; HEALTH
AB Background and Objectives: This study compared the potential impacts of the 2017 American College ofCardiology/American Heart Association (ACC/AHA) and the 2018 Korean Society of Hypertension (KSH) guidelines on prevalence of hypertension, recommended antihypertensive treatment, and achievement of target blood pressure (BP) in Korean population.
   Methods: We analyzed the 2007-2017 Korea National Health and Nutrition Examination Survey data to calculate guideline-specific hypertension prevalence and treatment implications on 59,767 adults aged 20 years or older by sex and age.
   Results: The prevalence of hypertension was markedly higher 46.3% by the ACC/AHA guideline due to the lowered BP cutoff than 25.9% by the KSH guideline; the increase was most pronounced in young adults. Yet, there was only a marginal 1.6% increase in the percentage of adults suggested pharmacological approach by the ACC/AHA guideline, but selectively in the older subgroups. Overall, 45.6% of Korean adults treated for hypertension failed to meet BP goal according to the KSH guideline; the underachievement extended to 61.7% of participants according to the ACC/AHA guideline.
   Conclusions: The lowered BP threshold, 130/80 mmHg, by the 2017 ACC/AHA guideline, in conjuncture with 10-year risk calculation largely driven by age, would increase pharmacological treatment preferentially in very old individuals, while increasing prevalence and uncontrolled rate mostly in younger subgroups. Adoption of lower BP cutoff to the KSH guideline would require validated cardiovascular disease risk assessment tools accounting for risk distributions specific to Korean population.
C1 [Cho, So Mi Jemma] Yonsei Univ, Dept Publ Hlth, Grad Sch, Seoul, South Korea.
   [Cho, So Mi Jemma; Lee, Hokyou; Kim, Hyeon Chang] Yonsei Univ, Dept Prevent Med, Coll Med, 50-1 Yonsei Ro, Seoul 03722, South Korea.
   [Lee, Hokyou] Yonsei Univ, Dept Internal Med, Coll Med, Seoul, South Korea.
RP Kim, HC (corresponding author), Yonsei Univ, Dept Prevent Med, Coll Med, 50-1 Yonsei Ro, Seoul 03722, South Korea.
EM hckim@yuhs.ac
RI ; Kim, Hyeon Chang/F-8796-2019
OI Cho, So Mi/0000-0003-2460-3335; Kim, Hyeon Chang/0000-0001-7867-1240;
   Lee, Hokyou/0000-0002-5034-8422
CR Benetos A, 2019, CIRC RES, V124, P1045, DOI 10.1161/CIRCRESAHA.118.313236
   Bohm M, 2017, LANCET, V389, P2226, DOI 10.1016/S0140-6736(17)30754-7
   Chadachan VM, 2018, INT J GEN MED, V11, P241, DOI 10.2147/IJGM.S164903
   Cho So Mi Jemma, 2019, Clin Hypertens, V25, P26, DOI 10.1186/s40885-019-0129-5
   Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2
   Chon D, 2018, J KOREAN MED SCI, V33, DOI 10.3346/jkms.2018.33.e332
   Dorresteijn JAN, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i1548
   Ettehad D, 2016, LANCET, V387, P957, DOI 10.1016/S0140-6736(15)01225-8
   Goff DC, 2014, J AM COLL CARDIOL, V63, P2935, DOI 10.1016/j.jacc.2013.11.005
   Jung KJ, 2015, ATHEROSCLEROSIS, V242, P367, DOI 10.1016/j.atherosclerosis.2015.07.033
   Kidney Disease: Improving Global Outcomes (KDIGO) Hepatitis C Work Group, 2018, KIDNEY INT S, V8, P91
   Kim MK, 2019, DIABETES METAB J, V43, P398, DOI 10.4093/dmj.2019.0137
   Kweon S, 2014, INT J EPIDEMIOL, V43, P69, DOI 10.1093/ije/dyt228
   Lee H, 2019, J CLIN MED, V8, DOI 10.3390/jcm8111832
   Lee H, 2019, J AM HEART ASSOC, V8, DOI 10.1161/JAHA.119.013148
   Lee JY, 2014, J KOREAN MED SCI, V29, P1590, DOI 10.3346/jkms.2014.29.12.1590
   Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006
   Lewington S, 2002, LANCET, V360, P1903
   Liu K, 2015, J AM HEART ASSOC, V4, DOI 10.1161/JAHA.115.002275
   Muntner P, 2018, CIRCULATION, V137, P109, DOI 10.1161/CIRCULATIONAHA.117.032582
   Panza GA, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0217623
   Peters SAE, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-019335
   Rapsomaniki E, 2014, LANCET, V383, P1899, DOI 10.1016/S0140-6736(14)60685-1
   Rhee FJ, 2019, KOREAN J INTERN MED, V34, P723, DOI 10.3904/kjim.2019.188
   Stanaway JD, 2018, LANCET, V392, P1923, DOI [10.1016/S0140-6736(18)32225-6, 10.1016/s0140-6736(18)32225-6]
   Whelton PK, 2018, HYPERTENSION, V71, pE13, DOI [10.1161/HYP.0000000000000065, 10.1161/HYP.0000000000000066]
   Williamson JD, 2016, JAMA-J AM MED ASSOC, V315, P2673, DOI 10.1001/jama.2016.7050
   Yang MH, 2017, KOREAN J FAM MED, V38, P173, DOI 10.4082/kjfm.2017.38.4.173
NR 28
TC 2
Z9 2
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JUN
PY 2020
VL 50
IS 6
BP 485
EP 498
DI 10.4070/kcj.2019.0347
PG 14
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA LK9FY
UT WOS:000531164500003
PM 32212423
OA Green Published
DA 2021-04-22
ER

PT J
AU Won, H
   Suh, Y
   Kim, GS
   Ko, YG
   Hong, MK
AF Won, Hoyoun
   Suh, Yongsung
   Kim, Gwang Sil
   Ko, Young-Guk
   Hong, Myeong-Ki
TI Clinical Impact of Beta Blockers in Patients with Myocardial Infarction
   from the Korean National Health Insurance Database
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Adrenergic beta-antagonists; Myocardial infarction; Secondary prevention
ID ASSOCIATION TASK-FORCE; ST-SEGMENT ELEVATION; HEART-ASSOCIATION;
   AMERICAN-COLLEGE; MANAGEMENT; GUIDELINE; CORONARY; DISCHARGE; THERAPY
AB Background and Objectives: Whether beta blockers favorably impact the clinical outcome in patients with acute myocardial infarction (AMI) remains in debate. We investigated the impact of beta blocker on major clinical outcomes during 2 years after percutaneous coronary intervention (PCI) in patients with AMI.
   Methods: All patients with the first AMI treated with PCI for the period of 2005 to 2014 from the Korean National Health Insurance Service claims database were enrolled. We defined the regular user as medication possession ratio (MPR) >= 80% and non-user as MPR=0%. We compared the occurrence of all cause death, myocardial infarction (MI) and stroke according to adherence of beta-blockers. A 1:1 propensity score-matching was conducted to adjust for between-group differences.
   Results: We identified a total 81,752 patients with met eligible criteria. At discharge, 63,885 (78%) patients were prescribed beta blockers. For 2 years follow tip period, regular users were 53,991 (66%) patients, non-users were 10,991 (13%). In the propensity score matched population, regular use of beta blocker was associated with a 36% reduced risk of composite adverse events (all death, MI or stroke) (hazard ratio [HR], 0.636; 95% confidence interval [CI], 0.555-0.728; p<0.001). Compared to no use of beta blocker, regular use significantly reduced all death (HR, 0.736; 95% CI, 0.668-0.812; p<0.001), MI (HR, 0.729; 95% CI, 0.611-0.803; p<0.001) and stroke (HR, 0.717; 95% CI, 0.650-0.791; p<0.001).
   Conclusions: Prescription of beta blocker in patients with AMI after PCI was sequentially increased. Continuous regular use of beta blocker for 2 years after AMI reduced major adverse events compared to no use of beta blocker.
C1 [Won, Hoyoun] Chung Ang Univ, Chung Ang Univ Hosp, Coll Med, Cardiovasc & Arrhythmia Ctr, Seoul, South Korea.
   [Suh, Yongsung] Myongji Hosp, Dept Cardiol, Goyang, South Korea.
   [Kim, Gwang Sil] Inje Univ, Sanggye Paik Hosp, Dept Cardiol, Coll Med, Seoul, South Korea.
   [Ko, Young-Guk; Hong, Myeong-Ki] Yonsei Univ Hlth Syst, Severance Cardiovasc Hosp, Div Cardiol, Seoul, South Korea.
   [Ko, Young-Guk; Hong, Myeong-Ki] Yonsei Univ, Cardiovasc Res Inst, Coll Med, Seoul, South Korea.
RP Hong, MK (corresponding author), Yonsei Univ, Severance Cardiovasc Hosp, Coll Med, Div Cardiol, 50-1 Yonsei Ro, Seoul 03722, South Korea.
EM mkhong61@yuhs.ac
OI Hong, Myeong-Ki/0000-0002-2090-2031; Ko, Young-Guk/0000-0001-7748-5788;
   Won, Hoyoun/0000-0001-7880-3477
FU Korean Society of Cardiology [201605-03]; Severance Hospital
   [4-2015-0700, 4-2018-0136]
FX This study was supported by a grant from the Korean Society of
   Cardiology (201605-03) and Severance Hospital (4-2015-0700,
   4-2018-0136). We thank you for J. Hwang, who is a professor of division
   of mathematics and big data science, Daegu University, Gyeongsan, Korea,
   to support statistical analysis.
CR Aarvik MD, 2019, EUR HEART J-CARD PHA, V5, P12, DOI 10.1093/ehjcvp/pvy034
   Amsterdam EA, 2014, CIRCULATION, V130, pE344, DOI 10.1161/CIR.0000000000000134
   Dargie HJ, 2001, LANCET, V357, P1385, DOI 10.1016/s0140-6736(00)04560-8
   Dondo TB, 2017, J AM COLL CARDIOL, V69, P2710, DOI 10.1016/j.jacc.2017.03.578
   FRIEDMAN LM, 1982, JAMA-J AM MED ASSOC, V247, P1707
   Hjalmarson A, 1997, AM J CARDIOL, V80, pJ35, DOI 10.1016/S0002-9149(97)00837-0
   Ibanez B, 2018, EUR HEART J, V39, P119, DOI 10.1093/eurheartj/ehx393
   Kimm H, 2012, KOREAN CIRC J, V42, P10, DOI 10.4070/kcj.2012.42.1.10
   Kozma CM, 2013, PATIENT PREFER ADHER, V7, P509, DOI 10.2147/PPA.S40736
   MAK IT, 1988, CIRC RES, V63, P262, DOI 10.1161/01.RES.63.1.262
   O'Gara PT, 2013, J AM COLL CARDIOL, V61, pE78, DOI 10.1016/j.jacc.2012.11.019
   Park J, 2018, J AM HEART ASSOC, V7, DOI 10.1161/JAHA.117.008055
   PEDERSEN TR, 1981, NEW ENGL J MED, V304, P801
   Poirier L, 2014, CAN J CARDIOL, V30, pS9, DOI 10.1016/j.cjca.2013.12.001
   Puymirat E, 2016, BMJ-BRIT MED J, V354, pi4801
   Quan HD, 2011, AM J EPIDEMIOL, V173, P676, DOI 10.1093/aje/kwq433
   ROBERTS R, 1984, NEW ENGL J MED, V311, P218, DOI 10.1056/NEJM198407263110403
   Smith SC, 2011, J AM COLL CARDIOL, V58, P2432, DOI 10.1016/j.jacc.2011.10.824
   Thomsen PEB, 2010, CIRCULATION, V122, P1258, DOI 10.1161/CIRCULATIONAHA.109.902148
   VONARNIM T, 1995, J AM COLL CARDIOL, V25, P231, DOI 10.1016/0735-1097(94)00345-Q
   Yang JH, 2014, JACC-CARDIOVASC INTE, V7, P592, DOI 10.1016/j.jcin.2013.12.206
NR 21
TC 3
Z9 3
U1 1
U2 5
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JUN
PY 2020
VL 50
IS 6
BP 499
EP 508
DI 10.4070/kcj.2019.0231
PG 10
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA LK9FY
UT WOS:000531164500004
PM 32096355
OA Green Published, Other Gold
DA 2021-04-22
ER

PT J
AU Son, NKL
   Park, JW
   Kim, M
   Yang, SY
   Yu, HT
   Kim, TH
   Uhm, JS
   Joung, B
   Lee, MH
   Pak, HN
AF Nguyen Khac Le Son
   Park, Je-Wook
   Kim, Min
   Yang, Song Yi
   Yu, Hee Tae
   Kim, Tae-Hoon
   Uhm, Jae-Sun
   Joung, Boyoung
   Lee, Moon-Hyoung
   Pak, Hui-Nam
TI Efficacy and Safety of Outpatient Clinic-based Elective External
   Electrical Cardioversion in Patients with Atrial Fibrillation
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Atrial fibrillation; Cardioversion; Recurrence
ID CATHETER ABLATION; HEART-FAILURE; SINUS RHYTHM; FOLLOW-UP; AMIODARONE;
   RECURRENCE; SUCCESS
AB Background and objectives: Little is known about the outcomes of outpatient clinic-based elective external cardioversion (OPC-ECV) for persistent atrial fibrillation (PeAF). We investigated the acute, short-term, and long-term elective external cardioversion (ECV) outcomes.
   Methods: We included 1,718 patients who underwent OPC-ECV (74% male, 61.1 +/- 11.0 years old, 90.9% long-standing PeAF, 9.1% after atrial fibrillation [AF] ablation) after excluding patients with atrial tachycardia or inappropriate antiarrhythmic drug medication, and in-patient ECV. Biphasic shocks were delivered sequentially until successful cardioversion was achieved (70-100-150-200-250 J). If ECV failed at 150 J, we administered intravenous amiodarone 150 mg and delivered 200 J.
   Results: ECV failed in 11.4%, and the complication rate was 0.47%. Within 3 months, AF recurred in 55.5% (44.7%as sustaining AF, 10.8%as paroxysmal AF), and the AF duration was independently associated (odds ratio [OR], 1.01 [1.00-1.02]; p=0.006), but amiodarone was independently protective (OR, 0.46 [0.27-0.76]; p=0.002, Log rank p<0.001) against an early recurrence. Regarding the long-term recurrence, pre-ECV heart failure was protective against an AF recurrence (hazard ratio, 0.63 [0.41-0.96], p=0.033) over 32 (9-66) months of follow-up. ECV energy (p<0.001) and early recurrence rate within 3 months (p=0.007, Log rank p=0.006) were significantly lower in post-ablation patients than in those with longstanding persistent AF.
   Conclusions: The success rate of OPC ECV was 88.6%, and the complication rate was low. However, AF recurred in 55.5% within 3 months. Amiodarone was protective against short-term AF recurrences, and long-term AF recurrences were less in patients with baseline heart failure.
C1 [Nguyen Khac Le Son; Park, Je-Wook; Kim, Min; Yang, Song Yi; Yu, Hee Tae; Kim, Tae-Hoon; Uhm, Jae-Sun; Joung, Boyoung; Lee, Moon-Hyoung; Pak, Hui-Nam] Yonsei Univ Hlth Syst, Dept Internal Med, Div Cardiol, 50 Yonsei Ro, Seoul 03722, South Korea.
RP Pak, HN (corresponding author), Yonsei Univ Hlth Syst, Dept Internal Med, Div Cardiol, 50 Yonsei Ro, Seoul 03722, South Korea.
EM hnpak@yuhs.ac
RI ; Pak, Hui-Nam/C-4266-2015
OI Kim, Min/0000-0002-8132-9873; Kim, Tae-Hoon/0000-0003-4200-3456; Lee,
   Moon-Hyoung/0000-0002-7268-0741; Uhm, Jae-Sun/0000-0002-1611-8172; Yang,
   Song Yi/0000-0002-0261-161X; Pak, Hui-Nam/0000-0002-3256-3620; Khac Le
   Son, Nguyen/0000-0002-6561-6813; Joung, Boyoung/0000-0001-9036-7225
FU Ministry of Health and WelfareMinistry of Health, Labour and Welfare,
   Japan [HI18C0070, HI19C0114]; Basic Science Research Program of the
   National Research Foundation of Korea (NRF) - Ministry of Science, ICT &
   Future Planning [NRF-2017R1A2B4003983]
FX This research was supported by grants (HI18C0070 and HI19C0114) from the
   Ministry of Health and Welfare and a grant (NRF-2017R1A2B4003983) from
   the Basic Science Research Program of the National Research Foundation
   of Korea (NRF), which is funded by the Ministry of Science, ICT & Future
   Planning.
CR Botkin SB, 2003, AM HEART J, V145, P233, DOI 10.1067/mhj.2003.112
   Chen PS, 2014, CIRC RES, V114, P1500, DOI 10.1161/CIRCRESAHA.114.303772
   Dries DL, 1998, J AM COLL CARDIOL, V32, P695, DOI 10.1016/S0735-1097(98)00297-6
   Ecker V, 2018, CLIN CARDIOL, V41, P862, DOI 10.1002/clc.22931
   Frick M, 2001, CLIN CARDIOL, V24, P238, DOI 10.1002/clc.4960240313
   Gronefeld G, 2003, EUR HEART J SUPPL, V5, pH19, DOI 10.1016/S1520-765X(03)90019-8
   Hellman T, 2018, CLIN CARDIOL, V41, P966, DOI 10.1002/clc.22986
   Hunter RJ, 2014, CIRC-ARRHYTHMIA ELEC, V7, P31, DOI 10.1161/CIRCEP.113.000806
   Hwang ES, 2012, PACE, V35, P1428, DOI 10.1111/j.1540-8159.2012.03517.x
   Inoue K, 2012, CIRC-ARRHYTHMIA ELEC, V5, P295, DOI 10.1161/CIRCEP.111.964080
   January CT, 2014, J AM COLL CARDIOL, V64, pE1, DOI 10.1016/j.jacc.2014.03.022
   Jin MN, 2019, CIRC-ARRHYTHMIA ELEC, V12, DOI 10.1161/CIRCEP.119.007197
   Joglar JA, 2004, CARDIOL CLIN, V22, P101, DOI 10.1016/S0733-8651(03)00119-X
   Kim D, 2018, AM HEART J, V202, P20, DOI 10.1016/j.ahj.2018.04.017
   Kim SS, 2009, CARDIOL CLIN, V27, P95, DOI 10.1016/j.ccl.2008.09.008
   Lang RM, 2015, EUR HEART J-CARD IMG, V16, P233, DOI 10.1093/ehjci/jev014
   Ling LH, 2016, NAT REV CARDIOL, V13, P131, DOI 10.1038/nrcardio.2015.191
   Ling LH, 2013, HEART RHYTHM, V10, P1334, DOI 10.1016/j.hrthm.2013.06.019
   Ling LH, 2012, CIRC-HEART FAIL, V5, P786, DOI 10.1161/CIRCHEARTFAILURE.112.968321
   Mansour M, 2018, AM J CARDIOL, V121, P1192, DOI 10.1016/j.amjcard.2018.01.043
   Marrouche NF, 2018, NEW ENGL J MED, V378, P417, DOI 10.1056/NEJMoa1707855
   Nakazawa H, 2000, EUR HEART J, V21, P327, DOI 10.1053/euhj.1999.1956
   Packer DL, 2019, JAMA-J AM MED ASSOC, V321, P1261, DOI 10.1001/jama.2019.0693
   Park JW, 2019, CIRC-ARRHYTHMIA ELEC, V12, DOI 10.1161/CIRCEP.118.007073
   Pisters R, 2012, EUROPACE, V14, P666, DOI 10.1093/europace/eur406
   Ponikowski P, 2016, EUR HEART J, V37, P2129, DOI 10.1093/eurheartj/ehw128
   Roy D, 2000, NEW ENGL J MED, V342, P913, DOI 10.1056/NEJM200003303421302
   Singh BN, 2005, NEW ENGL J MED, V352, P1861, DOI 10.1056/NEJMoa041705
   SPINALE FG, 1991, AM J PHYSIOL, V261, pH308
NR 29
TC 1
Z9 1
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JUN
PY 2020
VL 50
IS 6
BP 511
EP 523
DI 10.4070/kcj.2019.0310
PG 13
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA LK9FY
UT WOS:000531164500006
PM 32212425
OA Other Gold, Green Published
DA 2021-04-22
ER

PT J
AU Hu, WS
   Lin, CL
AF Hu, Wei-Syun
   Lin, Cheng-Li
TI Comparison of New-Onset Diabetes Mellitus among Patients with Atria
   Fibrillation or Atrial Flutter
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Atrial fibrillation; Atrial flutter; Diabetes mellitus
ID VASCULAR-DISEASE; CLINICAL CONSEQUENCES; MEDICAL THERAPY;
   PATHOPHYSIOLOGY; EPIDEMIOLOGY; MECHANISMS; RISK
AB Background and Objectives: The objective was to compare the rate of onset of diabetes mellitus (DM) in patients with atrial fibrillation (AF) as compared with atrial flutter (AFL).
   Methods: The incidence of DM through the national cohort registry in 14,014 newly diagnosed AF and 14,014 newly diagnosed AFL was investigated. Propensity score matching was used to optimize comparability between these 2 groups. Further analysis with Cox model, Kaplan-Meier methods and competing risk analysis were used to compare the incidence of DM in patients with AF and AFL.
   Results: The overall incidence of diabetes was higher among cases in AF cohort (1,653 diabetes cases, 11.7%) than in AFL cohort (1,448 diabetes cases, 10.3%). The risk of diabetes was 1.17-fold greater in the AF cohort compared with that in the AFL cohort (95% confidence interval [CI), 1.09-1.25; p<0.001). After adjustment for all relevant confounding factors in the competing risk regression model, the risk of diabetes remained significantly increased 1.16-fold in the AF cohort (95% CI, 1.09-1.25; p<0.001).
   Conclusions: The message of higher incidence rate of DM in patients with AF compared to those with AFL was delivered in this study.
C1 [Hu, Wei-Syun] China Med Univ, Coll Med, Sch Med, Taichung, Taiwan.
   [Hu, Wei-Syun] China Med Univ Hosp, Dept Med, Div Cardiovasc Med, 2 Yuh Der Rd, Taichung 40447, Taiwan.
   [Lin, Cheng-Li] China Med Univ Hosp, Management Off Hlth Data, Taichung, Taiwan.
RP Hu, WS (corresponding author), China Med Univ Hosp, Dept Med, Div Cardiovasc Med, 2 Yuh Der Rd, Taichung 40447, Taiwan.
EM weisyunhu@gmail.com
FU Taiwan Ministry of Health and Welfare Clinical Trial and Research Center
   of Excellence [MOHW107-TDU-B-212-123004]
FX This study was supported in part by Taiwan Ministry of Health and
   Welfare Clinical Trial and Research Center of Excellence
   (MOHW107-TDU-B-212-123004).
CR [Anonymous], 2014, 2014 US REN DAT SYST, P188
   Bohne LJ, 2019, FRONT PHYSIOL, V10, DOI 10.3389/fphys.2019.00135
   Chugh SS, 2014, CIRCULATION, V129, P837, DOI 10.1161/CIRCULATIONAHA.113.005119
   Conen D, 2011, JAMA-J AM MED ASSOC, V305, P2080, DOI 10.1001/jama.2011.659
   De Sensi F, 2015, CARDIOVASC DIAGN THE, V5, P364, DOI 10.3978/j.issn.2223-3652.2015.06.03
   Emdin CA, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.h7013
   Fuster V, 2006, CIRCULATION, V114, pE257, DOI 10.1161/CIRCULATIONAHA.106.177292
   Goudis CA, 2015, INT J CARDIOL, V184, P617, DOI 10.1016/j.ijcard.2015.03.052
   Hu WS, 2019, PROG NEURO-PSYCHOPH, V92, P470, DOI 10.1016/j.pnpbp.2019.01.013
   Hu WS, 2017, INT J CARDIOL, V235, P56, DOI 10.1016/j.ijcard.2017.02.097
   Luscher TF, 2003, CIRCULATION, V108, P1655, DOI 10.1161/01.CIR.0000089189.70578.E2
   Mareedu RK, 2010, CLIN MED RES, V8, P1, DOI 10.3121/cmr.2009.851
   *NAT HLTH RES I, 2020, NAT HLTH INS RES DAT
   Odutayo A, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i4482
   Paneni F, 2013, EUR HEART J, V34, P2436, DOI 10.1093/eurheartj/eht149
   Sarwar N, 2010, LANCET, V375, P2215, DOI 10.1016/S0140-6736(10)60484-9
   Serban RC, 2018, CAN J CARDIOL, V34, P1492, DOI 10.1016/j.cjca.2018.08.018
   Sowers JR, 2013, HYPERTENSION, V61, P943, DOI 10.1161/HYPERTENSIONAHA.111.00612
   Staerk L, 2017, CIRC RES, V120, P1501, DOI 10.1161/CIRCRESAHA.117.309732
NR 19
TC 0
Z9 0
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JUN
PY 2020
VL 50
IS 6
BP 527
EP 532
DI 10.4070/kcj.2019.0367
PG 6
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA LK9FY
UT WOS:000531164500008
PM 32281320
OA Other Gold, Green Published
DA 2021-04-22
ER

PT J
AU Lee, JC
   Huang, YTT
   Huang, YT
   Chong, JW
   Chik, WW
AF Lee, Joseph C.
   Huang, Yi-Tung Tom
   Huang, Yu-Ting
   Chong, Jia Wen
   Chik, William W.
TI The Long Journey of Cardiac Lymphoma Follow-up
SO KOREAN CIRCULATION JOURNAL
LA English
DT Letter
C1 [Lee, Joseph C.; Huang, Yu-Ting] Prince Charles Hosp, Dept Med Imaging, Rode Rd, Chermside, Qld 4032, Australia.
   [Lee, Joseph C.; Chong, Jia Wen] Univ Queensland, Fac Med, Herston, Qld, Australia.
   [Huang, Yi-Tung Tom] Gold Coast Univ Hosp, Dept Med Imaging, Southport, Qld, Australia.
   [Huang, Yi-Tung Tom] Griffith Univ, Sch Med, Southport, Qld, Australia.
   [Chik, William W.] Westmead Hosp, Dept Cardiol, Westmead, NSW, Australia.
   [Chik, William W.] Univ Notre Dame, Sch Med, Sydney, NSW, Australia.
RP Lee, JC (corresponding author), Prince Charles Hosp, Dept Med Imaging, Rode Rd, Chermside, Qld 4032, Australia.
EM Joseph.Lee@health.qld.gov.au
CR Cho SW, 2012, KOREAN CIRC J, V42, P776, DOI 10.4070/kcj.2012.42.11.776
   Cho Sung Woo, 2010, Korean Circ J, V40, P94, DOI 10.4070/kcj.2010.40.2.94
   Hwang HJ, 2010, CLIN CARDIOL, V33, pE69, DOI [10.1002/clc.20567, 10.1002/clc.20725]
   Kim S, 2020, KOREAN CIRC J, V50, P374, DOI 10.4070/kcj.2019.0298
   Mato AR, 2007, CANCER BIOL THER, V6, P1867, DOI 10.4161/cbt.6.12.5166
NR 5
TC 0
Z9 0
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JUN
PY 2020
VL 50
IS 6
BP 533
EP 534
DI 10.4070/kcj.2020.0101
PG 2
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA LK9FY
UT WOS:000531164500009
PM 32419405
OA Green Published, Other Gold
DA 2021-04-22
ER

PT J
AU Kim, S
   Kim, YR
   Choi, Y
   Kim, SH
   Oh, YS
AF Kim, Sunhwa
   Kim, Yoo Ri
   Choi, Young
   Kim, Sung-Hwan
   Oh, Yong-Seog
TI Author's reply to The Long Journey of Cardiac Lymphoma Follow-up
SO KOREAN CIRCULATION JOURNAL
LA English
DT Letter
C1 [Kim, Sunhwa; Choi, Young; Kim, Sung-Hwan; Oh, Yong-Seog] Catholic Univ Korea, Seoul St Marys Hosp, Coll Med, Div Cardiol,Dept Internal Med, 222 Banpo Daero, Seoul 06591, South Korea.
   [Kim, Yoo Ri] Dongguk Univ, Ilsan Hosp, Dept Internal Med, Div Cardiol, Goyang, South Korea.
RP Oh, YS (corresponding author), Catholic Univ Korea, Seoul St Marys Hosp, Coll Med, Div Cardiol,Dept Internal Med, 222 Banpo Daero, Seoul 06591, South Korea.
EM oys@catholic.ac.kr
OI Kim, Sunhwa/0000-0003-3109-9210; Choi, Young/0000-0003-3900-1943; Kim,
   Sung-Hwan/0000-0001-6805-0416
NR 0
TC 0
Z9 0
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JUN
PY 2020
VL 50
IS 6
BP 535
EP 535
DI 10.4070/kcj.2020.1011
PG 1
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA LK9FY
UT WOS:000531164500010
PM 32419406
OA Green Published, Other Gold
DA 2021-04-22
ER

PT J
AU Oh, JH
AF Oh, Jun-Hyok
TI Revisiting Application of Exercise Electrocardiography in Patients with
   Stable Ischemic Heart Disease
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
ID GUIDELINES; TESTS
C1 [Oh, Jun-Hyok] Pusan Natl Univ Hosp, Med Res Inst, Div Cardiol, Dept Internal Med, 179 Gudeok Ro, Busan 49241, South Korea.
RP Oh, JH (corresponding author), Pusan Natl Univ Hosp, Med Res Inst, Div Cardiol, Dept Internal Med, 179 Gudeok Ro, Busan 49241, South Korea.
EM jhoh724@hanmail.net
CR Christman MP, 2014, J AM COLL CARDIOL, V63, P1264, DOI 10.1016/j.jacc.2013.11.052
   Gibbons RJ, 2002, CIRCULATION, V106, P1883, DOI 10.1161/01.CIR.0000034670.06526.15
   Kim J, 2020, KOREAN CIRC J, V50, P406, DOI 10.4070/kcj.2019.0319
   Knuuti J, 2018, EUR HEART J, V39, P3322, DOI 10.1093/eurheartj/ehy267
   Knuuti J, 2020, EUR HEART J, V41, P407, DOI 10.1093/eurheartj/ehz425
   Montalescot G, 2013, EUR HEART J, V34, P2949, DOI 10.1093/eurheartj/eht296
   Renker M, 2015, RADIOL CLIN N AM, V53, P261, DOI 10.1016/j.rcl.2014.11.010
   Shaya GE, 2016, MAYO CLIN PROC, V91, P129, DOI 10.1016/j.mayocp.2015.11.012
NR 8
TC 0
Z9 0
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAY
PY 2020
VL 50
IS 5
BP 418
EP 419
DI 10.4070/kcj.2020.0052
PG 2
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA KX4DS
UT WOS:000521831400004
PM 32216175
OA Other Gold, Green Published
DA 2021-04-22
ER

PT J
AU Park, KM
AF Park, Kyoung-Min
TI Editorial: Simple Maneuver for Estimating the Depth of the Focal
   Activation Source in Myocardium
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
ID VENTRICULAR-TACHYCARDIA; SINUS RHYTHM
C1 [Park, Kyoung-Min] Sungkyunkwan Univ, Heart Vasc & Stroke Inst, Div Cardiol, Samsung Med Ctr,Sch Med, Seoul, South Korea.
RP Park, KM (corresponding author), Sungkyunkwan Univ, Heart Vasc Stroke Inst, Div Cardiol, Samsung Med Ctr,Sch Med, 81 Irwon Ro, Seoul 06351, South Korea.
EM kyoungmin.park@samsung.com
OI Park, Kyoung-Min/0000-0002-5416-9691
CR CASSIDY DM, 1984, CIRCULATION, V69, P1103, DOI 10.1161/01.CIR.69.6.1103
   CASSIDY DM, 1984, CIRCULATION, V70, P37, DOI 10.1161/01.CIR.70.1.37
   DEBAKKER JMT, 1990, J AM COLL CARDIOL, V15, P1594, DOI 10.1016/0735-1097(90)92832-M
   FENOGLIO JJ, 1983, CIRCULATION, V68, P518, DOI 10.1161/01.CIR.68.3.518
   Oh S, 2020, KOREAN CIRC J, V50, P420, DOI 10.4070/kcj.2019.0240
   Wetzel U, 2003, HERZ, V28, P583, DOI 10.1007/s00059-003-2492-x
NR 6
TC 0
Z9 0
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAY
PY 2020
VL 50
IS 5
BP 430
EP 431
DI 10.4070/kcj.2020.0039
PG 2
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA KX4DS
UT WOS:000521831400006
PM 32216176
OA Green Published, Other Gold
DA 2021-04-22
ER

PT J
AU Rhee, MY
AF Rhee, Moo-Yong
TI Sodium Intake Reduction in Real World
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
ID URINARY SODIUM; BLOOD-PRESSURE; MORTALITY; HYPERTENSION; EXCRETION
C1 [Rhee, Moo-Yong] Dongguk Univ, Cardiovasc Ctr, Ilsan Hosp, 27 Dongguk Ro, Goyang 10326, South Korea.
   [Rhee, Moo-Yong] Dongguk Univ, Div Cardiol, Dept Internal Med, Coll Med, Gyeongju, South Korea.
RP Rhee, MY (corresponding author), Dongguk Univ, Cardiovasc Ctr, Ilsan Hosp, 27 Dongguk Ro, Goyang 10326, South Korea.
EM mooyong_rhee@dumc.or.kr
CR Appel LJ, 2001, ARCH INTERN MED, V161, P685, DOI 10.1001/archinte.161.5.685
   Cook NR, 2016, J AM COLL CARDIOL, V68, P1609, DOI 10.1016/j.jacc.2016.07.745
   Engberink RHGO, 2017, CIRCULATION, V136, P917, DOI 10.1161/CIRCULATIONAHA.117.029028
   He FJ, 2019, HYPERTENSION, V74, P572, DOI 10.1161/HYPERTENSIONAHA.119.13117
   Kim S, 2016, HYPERTENSION, V67, P506, DOI 10.1161/HYPERTENSIONAHA.115.06731
   Mente A, 2018, LANCET, V392, P496, DOI [10.1016/S0140-6736(18)31376-X, 10.1016/s0140-6736(18)31376-x]
   O'Donnell M, 2014, NEW ENGL J MED, V371, P612, DOI 10.1056/NEJMoa1311889
   Rhee MY, 2019, J CLIN HYPERTENS, V21, P1057, DOI 10.1111/jch.13610
   Shim JS, 2020, KOREAN CIRC J, V50, P432, DOI 10.4070/kcj.2019.0230
   Stolarz-Skrzypek K, 2011, JAMA-J AM MED ASSOC, V305, P1777, DOI 10.1001/jama.2011.574
NR 10
TC 0
Z9 0
U1 0
U2 3
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAY
PY 2020
VL 50
IS 5
BP 441
EP 442
DI 10.4070/kcj.2020.0053
PG 2
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA KX4DS
UT WOS:000521831400008
PM 32153147
OA Other Gold, Green Published
DA 2021-04-22
ER

PT J
AU Hwang, J
   Kim, DB
   Park, HJ
AF Hwang, Jiwon
   Kim, Dong-Bin
   Park, Hun-Jun
TI Off-target Effects of Sodium-glucose Cotransporter 2 (SGLT-2) Inhibitor
   in Cardiovascular Disease
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
ID EMPAGLIFLOZIN; MICE
C1 [Hwang, Jiwon; Park, Hun-Jun] Catholic Univ Korea, Dept Med Life Sci, Coll Med, Seoul, South Korea.
   [Kim, Dong-Bin; Park, Hun-Jun] Catholic Univ Korea, Div Cardiol, Dept Internal Med, Coll Med, 222 Banpo Daero, Seoul 06591, South Korea.
RP Park, HJ (corresponding author), Catholic Univ Korea, Div Cardiol, Dept Internal Med, Coll Med, 222 Banpo Daero, Seoul 06591, South Korea.
EM cardioman@catholic.ac.kr
OI Hwang, Ji-Won/0000-0001-9922-364X; Kim, Dong-Bin/0000-0002-0219-190X
FU National Research Foundation of Korea grants, Bio & Medical Technology
   Development Program [NRF-2017M3A9B3061954]
FX This study was supported by National Research Foundation of Korea
   grants, Bio & Medical Technology Development Program
   (NRF-2017M3A9B3061954).
CR Baartscheer A, 2017, DIABETOLOGIA, V60, P568, DOI 10.1007/s00125-016-4134-x
   Han J, 2017, DIABETOLOGIA, V60, P364, DOI 10.1007/s00125-016-4158-2
   Juni RP, 2019, JACC-BASIC TRANSL SC, V4, P575, DOI 10.1016/j.jacbts.2019.04.003
   Lee SG, 2020, KOREAN CIRC J, V50, P443, DOI 10.4070/kcj.2019.0296
   Leng W, 2016, MEDIAT INFLAMM, V2016, DOI DOI 10.1155/2016/630573528104929
   Lim VG, 2019, JACC-BASIC TRANSL SC, V4, P15, DOI 10.1016/j.jacbts.2018.10.002
   McMurray JJV, 2019, NEW ENGL J MED, V381, P1995, DOI 10.1056/NEJMoa1911303
   Uthman L, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.01575
   Ye YM, 2017, CARDIOVASC DRUG THER, V31, P119, DOI 10.1007/s10557-017-6725-2
   Zelniker TA, 2019, LANCET, V393, P31, DOI 10.1016/S0140-6736(18)32590-X
NR 10
TC 1
Z9 1
U1 0
U2 2
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAY
PY 2020
VL 50
IS 5
BP 458
EP 460
DI 10.4070/kcj.2020.0066
PG 3
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA KX4DS
UT WOS:000521831400010
PM 32216177
OA Green Published, Other Gold
DA 2021-04-22
ER

PT J
AU Kim, D
   Shim, CY
   Hong, GR
   Chang, BC
AF Kim, Darae
   Shim, Chi Young
   Hong, Geu-Ru
   Chang, Byung-Chul
TI Unmasked Obstructive Hypertrophic Cardiomyopathy after Mitral Valve
   Repair for Severe Mitral Regurgitation
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
C1 [Kim, Darae] Sungkyunkwan Univ, Div Cardiol, Dept Med, Samsung Med Ctr,Sch Med, Seoul, South Korea.
   [Shim, Chi Young; Hong, Geu-Ru] Yonsei Univ, Severance Cardiovasc Hosp, Div Cardiol, Coll Med, 50 Yonsei Ro, Seoul 03722, South Korea.
   [Chang, Byung-Chul] Yonsei Univ, Dept Thorac & Cardiovasc Surg, Coll Med, Seoul, South Korea.
RP Shim, CY (corresponding author), Yonsei Univ, Severance Cardiovasc Hosp, Div Cardiol, Coll Med, 50 Yonsei Ro, Seoul 03722, South Korea.
EM cysprs@yuhs.ac
RI Chang, Byung/AAP-9674-2020; Shim, Chi Young/AAK-1057-2021
OI Shim, Chi Young/0000-0002-6136-0136; Hong, Geu-Ru/0000-0003-4981-3304
CR Maron MS, 2011, CIRCULATION, V124, P40, DOI 10.1161/CIRCULATIONAHA.110.985812
   PETRONE RK, 1992, J AM COLL CARDIOL, V20, P55, DOI 10.1016/0735-1097(92)90137-C
NR 2
TC 0
Z9 0
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAY
PY 2020
VL 50
IS 5
BP 461
EP 463
DI 10.4070/kcj.2019.0303
PG 3
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA KX4DS
UT WOS:000521831400011
PM 32096357
OA Other Gold, Green Published
DA 2021-04-22
ER

PT J
AU Kim, TO
   Koo, HJ
   Lee, CW
AF Kim, Tae Oh
   Koo, Hyun Jung
   Lee, Cheol Whan
TI Coronary Arteriovenous Fistulas Mimicking Coronary Perforation After
   Chronic Total Occlusion Recanalization
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
C1 [Kim, Tae Oh; Lee, Cheol Whan] Univ Ulsan, Heart Inst, Div Cardiol, Asan Med Ctr, 88 Olymp Ro,43 Gil, Seoul 05505, South Korea.
   [Koo, Hyun Jung] Univ Ulsan, Dept Radiol, Asan Med Ctr, Coll Med, Seoul, South Korea.
   [Koo, Hyun Jung] Univ Ulsan, Res Inst Radiol, Asan Med Ctr, Coll Med, Seoul, South Korea.
RP Lee, CW (corresponding author), Univ Ulsan, Heart Inst, Div Cardiol, Asan Med Ctr, 88 Olymp Ro,43 Gil, Seoul 05505, South Korea.
EM cheolwlee@amc.seoul.kr
OI Kim, Tae oh/0000-0002-7275-9302; Koo, Hyun Jung/0000-0001-5640-3835
CR Gowda RM, 2006, INT J CARDIOL, V107, P7, DOI 10.1016/j.ijcard.2005.01.067
NR 1
TC 0
Z9 0
U1 1
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAY
PY 2020
VL 50
IS 5
BP 464
EP 467
DI 10.4070/kcj.2019.0300
PG 4
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA KX4DS
UT WOS:000521831400012
PM 31960643
OA Other Gold, Green Published
DA 2021-04-22
ER

PT J
AU Ferrero, KM
   Koch, WJ
AF Ferrero, Kimberly M.
   Koch, Walter J.
TI Metabolic Crosstalk between the Heart and Feat
SO KOREAN CIRCULATION JOURNAL
LA English
DT Review
DE Cardiac myocytes; Adipocytes; Crosstalk; Adipokines; Cardiokines
ID EPICARDIAL ADIPOSE-TISSUE; BRAIN NATRIURETIC PEPTIDE; CHAIN AMINO-ACIDS;
   FETAL GENE PROGRAM; INSULIN-RESISTANCE; CARDIAC-HYPERTROPHY;
   DIABETES-MELLITUS; GLUCOSE-UPTAKE; FAT THICKNESS; EXPRESSION
AB It is now recognized that the heart can behave as a true endocrine organ, which can modulate the function of other tissues. Emerging evidence has shown that visceral fat is one such distant organ the heart communicates with. In fact, it appears that bi-directional crosstalk between adipose tissue and the myocardium is crucial to maintenance of normal function in both organs. In particular, factors secreted from the heart are now known to influence the metabolic activity of adipose tissue and other organs, as well as modulate the release of metabolic substrates and signaling molecules from the periphery. This review summarizes current knowledge regarding primary cardiokines and adipokines involved in heart-fat crosstalk, as well as implications of their dysregulation for cardiovascular health.
C1 [Ferrero, Kimberly M.; Koch, Walter J.] Temple Univ, Ctr Translat Med, Dept Pharmacol, Lewis Katz Sch Med, 3500 N Broad St, Philadelphia, PA 19140 USA.
RP Koch, WJ (corresponding author), Temple Univ, Ctr Translat Med, Dept Pharmacol, Lewis Katz Sch Med, 3500 N Broad St, Philadelphia, PA 19140 USA.
EM walter.koch@temple.edu
FU MERIT Award from the American Heart Association [AMERIT33900036]
FX Walter J. Koch is the W.W. Smith Endowed Chair of Cardiovascular
   Medicine. Funding for this research in part by MERIT Award
   (AMERIT33900036) from the American Heart Association.
CR Ahn J, 2013, EMBO MOL MED, V5, P1602, DOI 10.1002/emmm.201302647
   Antonopoulos AS, 2017, J PHYSIOL-LONDON, V595, P3907, DOI 10.1113/JP273049
   Antonopoulos AS, 2016, CIRC RES, V118, P842, DOI 10.1161/CIRCRESAHA.115.307856
   Arita Y, 1999, BIOCHEM BIOPH RES CO, V257, P79, DOI 10.1006/bbrc.1999.0255
   BAINES AD, 1983, CAN J PHYSIOL PHARM, V61, P1462, DOI 10.1139/y83-208
   Bamshad M, 1999, AM J PHYSIOL-REG I, V276, pR1569
   Baskin KK, 2014, EMBO MOL MED, V6, P1610, DOI 10.15252/emmm.201404218
   Batista CMDS, 2007, DIABETES, V56, P1655, DOI 10.2337/db06-1506
   Bauche IB, 2007, ENDOCRINOLOGY, V148, P1539, DOI 10.1210/en.2006-0838
   BEATTY CH, 1972, PEDIATR RES, V6, P813, DOI 10.1203/00006450-197211000-00002
   Bostjancic E, 2010, CARDIOLOGY, V115, P163, DOI 10.1159/000268088
   Bostrom P, 2012, NATURE, V481, P463, DOI 10.1038/nature10777
   Cabiati M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072959
   Callis TE, 2009, J CLIN INVEST, V119, P2772, DOI 10.1172/JCI36154
   Chen CH, 2009, HIGH ALT MED BIOL, V10, P83, DOI 10.1089/ham.2008.1064
   CHUA B, 1979, J BIOL CHEM, V254, P8358
   Ciccarelli M, 2011, CIRCULATION, V123, P1953, DOI 10.1161/CIRCULATIONAHA.110.988642
   Collins S, 2014, NAT REV ENDOCRINOL, V10, P157, DOI 10.1038/nrendo.2013.234
   de Bold AJ, 2001, CAN J PHYSIOL PHARM, V79, P705, DOI 10.1139/cjpp-79-8-705
   Dewey CM, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.115.003101
   Diez JJ, 2003, EUR J ENDOCRINOL, V148, P293, DOI 10.1530/eje.0.1480293
   Dirkx E, 2013, BBA-MOL BASIS DIS, V1832, P2414, DOI 10.1016/j.bbadis.2013.07.023
   Dong F, 2006, J ENDOCRINOL, V188, P25, DOI 10.1677/joe.1.06241
   Fain JN, 2008, INT J OBESITY, V32, P810, DOI 10.1038/sj.ijo.0803790
   Fernandez-Hernando C, 2011, CURR OPIN LIPIDOL, V22, P86, DOI 10.1097/MOL.0b013e3283428d9d
   Fewell JE, 2013, BIOL SYST, V2, P106
   Graeff DB, 2016, INT J CARDIOVAS IMAG, V32, P563, DOI 10.1007/s10554-015-0810-z
   Grajeda-Iglesias C, 2018, RAMBAM MAIMONIDES ME, V9, DOI 10.5041/RMMJ.10337
   Green CR, 2016, NAT CHEM BIOL, V12, P15, DOI [10.1038/NCHEMBIO.1961, 10.1038/nchembio.1961]
   Grueter CE, 2012, CELL, V149, P671, DOI 10.1016/j.cell.2012.03.029
   Grynberg A, 1996, J CARDIOVASC PHARM, V28, pS11
   Guo ZX, 2007, METABOLISM, V56, P1363, DOI 10.1016/j.metabol.2007.05.005
   Halama A, 2016, ARCH BIOCHEM BIOPHYS, V589, P93, DOI 10.1016/j.abb.2015.09.013
   Hall ME, 2015, WORLD J CARDIOL, V7, P511, DOI 10.4330/wjc.v7.i9.511
   Hammond SM, 2015, ADV DRUG DELIVER REV, V87, P3, DOI 10.1016/j.addr.2015.05.001
   Handzlik MK, 2018, J PHYSIOL-LONDON, V596, P3357, DOI 10.1113/JP275357
   HELLMER J, 1992, J CLIN ENDOCR METAB, V75, P15, DOI 10.1210/jc.75.1.15
   Herman MA, 2010, J BIOL CHEM, V285, P11348, DOI 10.1074/jbc.M109.075184
   Holland WL, 2011, NAT MED, V17, P55, DOI 10.1038/nm.2277
   HOSODA K, 1991, HYPERTENSION, V17, P1152, DOI 10.1161/01.HYP.17.6.1152
   Iacobellis G, 2005, NAT CLIN PRACT CARD, V2, P536, DOI 10.1038/ncpcardio0319
   Iacobellis G, 2013, BIOMARKERS CARDIOVAS, P1
   Iacobellis G, 2011, TRENDS ENDOCRIN MET, V22, P450, DOI 10.1016/j.tem.2011.07.003
   Iacomino G, 2016, GENES NUTR, V11, DOI 10.1186/s12263-016-0525-3
   Imbeault P, 2000, J LIPID RES, V41, P1367
   JAMIESON JD, 1964, J CELL BIOL, V23, P151, DOI 10.1083/jcb.23.1.151
   Jia GH, 2018, DIABETOLOGIA, V61, P21, DOI 10.1007/s00125-017-4390-4
   Joyner JM, 2000, J ENDOCRINOL, V166, P145, DOI 10.1677/joe.0.1660145
   Kadowaki T, 2005, ENDOCR REV, V26, P439, DOI 10.1210/er.2005-0005
   Kataoka Y, 2014, J AM COLL CARDIOL, V63, P2722, DOI 10.1016/j.jacc.2014.03.032
   Kazama K, 2013, J VET MED SCI, V75, P1029, DOI 10.1292/jvms.12-0537
   Kim SY, 2010, BIOCHEM BIOPH RES CO, V392, P323, DOI 10.1016/j.bbrc.2010.01.012
   Kong L, 2011, ACTA DIABETOL, V48, P61, DOI 10.1007/s00592-010-0226-0
   Kutlay O, 2019, ANATOL J CARDIOL, V21, P91, DOI 10.14744/AnatolJCardiol.2018.52333
   Lehman JJ, 2000, J CLIN INVEST, V106, P847, DOI 10.1172/JCI10268
   Li T, 2017, CELL METAB, V25, P374, DOI 10.1016/j.cmet.2016.11.005
   Liu DX, 2018, MOL METAB, V9, P192, DOI 10.1016/j.molmet.2017.12.017
   LOPASCHUK GD, 1992, CARDIOVASC RES, V26, P1172, DOI 10.1093/cvr/26.12.1172
   Maeda N, 2002, NAT MED, V8, P731, DOI 10.1038/nm724
   Matsuo K, 2015, J MOL CELL CARDIOL, V79, P195, DOI 10.1016/j.yjmcc.2014.11.019
   Munzberg H, 2015, METABOLISM, V64, P13, DOI 10.1016/j.metabol.2014.09.010
   Neinast MD, 2019, CELL METAB, V29, P417, DOI 10.1016/j.cmet.2018.10.013
   Ogawa T, 2014, ENDOCR CONNECT, V3, pR31, DOI 10.1530/EC-14-0012
   Ohashi K, 2010, J BIOL CHEM, V285, P6153, DOI 10.1074/jbc.M109.088708
   Opincariu D, 2016, J CARDIOVASC EMERG, V2, P11, DOI 10.1515/jce-2016-0003
   Paolisso G, 1999, HYPERTENSION, V34, P1047, DOI 10.1161/01.HYP.34.5.1047
   Pascual F, 2016, BBA-MOL CELL BIOL L, V1861, P1425, DOI 10.1016/j.bbalip.2016.03.014
   Plante E, 2014, DIABETOLOGIA, V57, P1257, DOI 10.1007/s00125-014-3201-4
   Pospisilik JA, 2010, CELL, V140, P148, DOI 10.1016/j.cell.2009.12.027
   Potter LR, 2006, ENDOCR REV, V27, P47, DOI 10.1210/er.2005-0014
   Purdham DM, 2004, AM J PHYSIOL-HEART C, V287, pH2877, DOI 10.1152/ajpheart.00499.2004
   Puurunen VP, 2017, ANN MED, V49, P448, DOI 10.1080/07853890.2017.1301678
   Rajabi M, 2007, HEART FAIL REV, V12, P331, DOI 10.1007/s10741-007-9034-1
   Razeghi P, 2001, CIRCULATION, V104, P2923, DOI 10.1161/hc4901.100526
   Rosenwald M, 2014, ADIPOCYTE, V3, P4, DOI 10.4161/adip.26232
   Ruiz-Canela M, 2016, CLIN CHEM, V62, P582, DOI 10.1373/clinchem.2015.251710
   Rutter MK, 2003, CIRCULATION, V107, P448, DOI 10.1161/01.CIR.0000045671.62860.98
   Sacks HS, 2007, AM HEART J, V153, P907, DOI 10.1016/j.ahj.2007.03.019
   Sainz N, 2015, METABOLISM, V64, P35, DOI 10.1016/j.metabol.2014.10.015
   SAITO Y, 1989, BIOCHEM BIOPH RES CO, V158, P360, DOI 10.1016/S0006-291X(89)80056-7
   Sarzani R, 1996, J ENDOCRINOL INVEST, V19, P581
   Sato P, 2017, J MOL CELL CARDIOL, V112, P152, DOI 10.1016/j.yjmcc.2017.07.067
   Schannwell CM, 2002, CARDIOLOGY, V98, P33, DOI 10.1159/000064682
   Schonke M, 2018, PROTEOMICS, V18, DOI 10.1002/pmic.201700375
   Seale P, 2008, NATURE, V454, P961, DOI 10.1038/nature07182
   Sengenes C, 2000, FASEB J, V14, P1345, DOI 10.1096/fj.14.10.1345
   Sethi JK, 2007, J LIPID RES, V48, P1253, DOI 10.1194/jlr.R700005-JLR200
   Shapiro L, 1998, CURR BIOL, V8, P335, DOI 10.1016/S0960-9822(98)70133-2
   Stanley WC, 2005, PHYSIOL REV, V85, P1093, DOI 10.1152/physrev.00006.2004
   Sun HP, 2016, CIRCULATION, V133, P2038, DOI 10.1161/CIRCULATIONAHA.115.020226
   Taegtmeyer H, 2004, J MOL CELL CARDIOL, V37, P7, DOI 10.1016/j.yjmcc.2004.05.001
   Taegtmeyer H, 2010, ANN NY ACAD SCI, V1188, P191, DOI 10.1111/j.1749-6632.2009.05100.x
   Thomou T, 2017, NATURE, V542, P450, DOI 10.1038/nature21365
   Van Rooij E, 2007, J CLIN INVEST, V117, P2369, DOI 10.1172/JCI33099
   van Rooij E, 2006, P NATL ACAD SCI USA, V103, P18255, DOI 10.1073/pnas.0608791103
   Wang TJ, 2004, CIRCULATION, V109, P594, DOI 10.1161/01.CIR.0000112582.16683.EA
   Wilson-Fritch L, 2003, MOL CELL BIOL, V23, P1085, DOI 10.1128/MCB.23.3.1085-1094.2003
   Woodall BP, 2019, JCI INSIGHT, V5
   Xie HM, 2009, DIABETES, V58, P1050, DOI 10.2337/db08-1299
   Yamawaki H, 2010, BIOCHEM BIOPH RES CO, V393, P668, DOI 10.1016/j.bbrc.2010.02.053
   YOUNG P, 1984, FEBS LETT, V167, P10, DOI 10.1016/0014-5793(84)80822-4
   Zhang LY, 2013, CIRC-HEART FAIL, V6, P1039, DOI 10.1161/CIRCHEARTFAILURE.112.000228
   Zhao Y, 2005, NATURE, V436, P214, DOI 10.1038/nature03817
NR 103
TC 1
Z9 1
U1 0
U2 2
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAY
PY 2020
VL 50
IS 5
BP 379
EP 394
DI 10.4070/kcj.2019.0400
PG 16
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA KX4DS
UT WOS:000521831400001
PM 32096362
OA Green Published
DA 2021-04-22
ER

PT J
AU Oh, CM
   Ryu, D
   Cho, S
   Jang, Y
AF Oh, Chang-Myung
   Ryu, Dongryeol
   Cho, Sungsoo
   Jang, Yangsoo
TI Mitochondrial Quality Control in the Heart: New Drug Targets for
   Cardiovascular Disease
SO KOREAN CIRCULATION JOURNAL
LA English
DT Review
DE Mitochondrial quality control; Heart; Urolithin A; Spermidine
ID UNFOLDED PROTEIN RESPONSE; STRESS-RESPONSE; THERAPEUTIC TARGET;
   LIFE-SPAN; MITOPHAGY; AUTOPHAGY; MECHANISMS; DYNAMICS; PARKIN;
   CARDIOPROTECTION
AB Despite considerable efforts to prevent and treat cardiovascular disease (CVD), it has become the leading cause of death worldwide. Cardiac mitochondria are crucial cell organelles responsible for creating energy-rich ATP and mitochondria! dysfunction is the root cause for developing heart failure. Therefore, maintenance of mitochondria! quality control (MQC) is an essential process for cardiovascular homeostasis and cardiac health. In this review, we describe the major mechanisms of MQC system, such as mitochondria! unfolded protein response and mitophagy. Moreover, we describe the results of MQC failure in cardiac mitochondria. Furthermore, we discuss the prospects of 2 drug candidates, urolithin A and spermidine, for restoring mitochondrial homeostasis to treat CVD.
C1 [Oh, Chang-Myung] Gwangju Inst Sci & Technol, Dept Biomed Sci & Engn, Gwangju, South Korea.
   [Ryu, Dongryeol] Sungkyunkwan Univ, Dept Mol Cell Biol, Sch Med, Suwon, South Korea.
   [Ryu, Dongryeol] Sungkyunkwan Univ SKKU, BICS, Suwon, South Korea.
   [Ryu, Dongryeol] Samsung Med Ctr, Samsung Biomed Res Inst, Seoul, South Korea.
   [Cho, Sungsoo] Dankook Univ, Dankook Univ Hosp, Dept Internal Med, Div Cardiovasc Med,Coll Med, Cheonan, South Korea.
   [Jang, Yangsoo] Yonsei Univ, Severance Hosp, Dept Internal Med, Div Cardiol,Coll Med, 50-1 Yonsei Ro, Seoul 03722, South Korea.
RP Jang, Y (corresponding author), Yonsei Univ, Severance Hosp, Dept Internal Med, Div Cardiol,Coll Med, 50-1 Yonsei Ro, Seoul 03722, South Korea.
EM JANGYS1212@yuhs.ac
RI Ryu, Dongryeol/AAQ-3642-2020
OI Ryu, Dongryeol/0000-0001-5905-6760; Oh, Chang-Myung/0000-0001-6681-4478
FU Basic Science Research Program through the National Research Foundation
   of Korea (NRF) - Ministry of Education [2016R1A6A3A04010466,
   2017R1D1A1B03032708]
FX This research was supported by the Basic Science Research Program
   through the National Research Foundation of Korea (NRF), which is funded
   by the Ministry of Education (2016R1A6A3A04010466 to C.M.O.) and
   (2017R1D1A1B03032708 to D.R.).
CR Andreux PA, 2019, NAT METAB, V1, P595, DOI 10.1038/s42255-019-0073-4
   Aviram M., 2012, EVID-BASED COMPL ALT, V2012
   Baker MJ, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a007559
   Bayeva M, 2013, J AM COLL CARDIOL, V61, P599, DOI 10.1016/j.jacc.2012.08.1021
   Billia F, 2011, P NATL ACAD SCI USA, V108, P9572, DOI 10.1073/pnas.1106291108
   Bravo-San Pedro JM, 2017, CIRC RES, V120, P1812, DOI 10.1161/CIRCRESAHA.117.311082
   Brown DA, 2017, NAT REV CARDIOL, V14, P238, DOI 10.1038/nrcardio.2016.203
   Campos JC, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00479
   Chan NC, 2011, HUM MOL GENET, V20, P1726, DOI 10.1093/hmg/ddr048
   Chinnery PF, 2013, BRIT MED BULL, V106, P135, DOI 10.1093/bmb/ldt017
   Cicero AFG, 2016, PHYTOMEDICINE, V23, P1134, DOI 10.1016/j.phymed.2015.11.009
   Diwan A, 2007, J CLIN INVEST, V117, P2825, DOI 10.1172/JCI32490
   Eisenberg T, 2016, NAT MED, V22, P1428, DOI 10.1038/nm.4222
   Elhassan YS, 2019, BIORXIV
   Fan JJ, 2017, ONCOTARGET, V8, P17475, DOI [10.18632/oncotarget.15420, 10.18632/oncotarget.15728]
   Felts SJ, 2000, J BIOL CHEM, V275, P3305, DOI 10.1074/jbc.275.5.3305
   Fiorese CJ, 2016, CURR BIOL, V26, P2037, DOI 10.1016/j.cub.2016.06.002
   Galloway CA, 2015, ANTIOXID REDOX SIGN, V22, P1545, DOI 10.1089/ars.2015.6293
   Goldman SJ, 2010, MITOCHONDRION, V10, P309, DOI 10.1016/j.mito.2010.01.005
   Guaragnella N, 2018, FEMS YEAST RES, V18, DOI 10.1093/femsyr/foy088
   HOHFELD J, 1994, J CELL BIOL, V126, P305, DOI 10.1083/jcb.126.2.305
   Hoshino A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3308
   Jang JY, 2018, J CLIN INVEST, V128, P3662, DOI 10.1172/JCI120842
   Jia GH, 2018, CIRC RES, V122, P624, DOI 10.1161/CIRCRESAHA.117.311586
   Jin SM, 2010, J CELL BIOL, V191, P933, DOI 10.1083/jcb.201008084
   Jing YH, 2018, EXP GERONTOL, V108, P77, DOI 10.1016/j.exger.2018.04.005
   Jovaisaite V, 2014, J EXP BIOL, V217, P137, DOI 10.1242/jeb.090738
   Kubli Dieter A, 2013, Commun Integr Biol, V6, pe24511, DOI 10.4161/cib.24511
   Kubli DA, 2013, J BIOL CHEM, V288, P915, DOI 10.1074/jbc.M112.411363
   Kuzmicic J, 2011, REV ESP CARDIOL, V64, P916, DOI 10.1016/j.recesp.2011.05.018
   Larque E, 2007, NUTRITION, V23, P87, DOI 10.1016/j.nut.2006.09.006
   LENZEN S, 1986, J BIOL CHEM, V261, P6478
   Liang QR, 2016, J MOL CELL CARDIOL, V95, P57, DOI 10.1016/j.yjmcc.2015.12.025
   Madeo F, 2019, AUTOPHAGY, V15, P165, DOI 10.1080/15548627.2018.1530929
   Madeo F, 2018, AGING-US, V10, P2209, DOI 10.18632/aging.101517
   McBride HM, 2006, CURR BIOL, V16, pR551, DOI 10.1016/j.cub.2006.06.054
   Melber A, 2018, CELL RES, V28, P281, DOI 10.1038/cr.2018.16
   Moehle EA, 2019, J BIOL CHEM, V294, P5396, DOI 10.1074/jbc.TM117.000893
   Murakawa T, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8527
   Nadtochiy SM, 2018, J MOL CELL CARDIOL, V121, P155, DOI 10.1016/j.yjmcc.2018.06.007
   Nah J, 2017, COMPR PHYSIOL, V7, P1407, DOI 10.1002/cphy.c170005
   Nargund AM, 2012, SCIENCE, V337, P587, DOI 10.1126/science.1223560
   OSTERMANN J, 1989, NATURE, V341, P125, DOI 10.1038/341125a0
   Pickles S, 2018, CURR BIOL, V28, pR170, DOI 10.1016/j.cub.2018.01.004
   Quiros PM, 2017, J CELL BIOL, V216, P2027, DOI 10.1083/jcb.201702058
   Rana A, 2013, P NATL ACAD SCI USA, V110, P8638, DOI 10.1073/pnas.1216197110
   Ren MD, 2014, PROG LIPID RES, V55, P1, DOI 10.1016/j.plipres.2014.04.001
   Ryu D, 2016, NAT MED, V22, P879, DOI 10.1038/nm.4132
   Savi M, 2017, CARDIOVASC DIABETOL, V16, DOI 10.1186/s12933-017-0561-3
   Seiferling D, 2016, EMBO REP, V17, P953, DOI 10.15252/embr.201642077
   Shirakabe A, 2016, CIRCULATION, V133, P1249, DOI 10.1161/CIRCULATIONAHA.115.020502
   Shires SE, 2015, J MOL MED, V93, P253, DOI 10.1007/s00109-015-1254-6
   Siddall HK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062400
   Smyrnias I, 2019, J AM COLL CARDIOL, V73, P1795, DOI 10.1016/j.jacc.2018.12.087
   Stegemann C, 2014, CIRCULATION, V129, P1821, DOI 10.1161/CIRCULATIONAHA.113.002500
   Sumner MD, 2005, AM J CARDIOL, V96, P810, DOI 10.1016/j.amjcard.2005.05.026
   Szklarczyk R, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0439
   Tondera D, 2009, EMBO J, V28, P1589, DOI 10.1038/emboj.2009.89
   Tong D, 2017, CIRC RES, V120, P1229, DOI 10.1161/CIRCRESAHA.117.310603
   Tong MM, 2019, CIRC RES, V124, P1360, DOI 10.1161/CIRCRESAHA.118.314607
   Vasanthi HR, 2012, CURR MED CHEM, V19, P2242
   Vicinanza R, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/247504
   Wang SJ, 2018, J CELL MOL MED, V22, P5132, DOI 10.1111/jcmm.13802
   Wang Y, 2018, J CELL BIOL, V217, P1915, DOI 10.1083/jcb.201708007
   Wang YT, 2018, BIORXIV
   Wang YT, 2019, AM J PHYSIOL-HEART C, V317, pH472, DOI 10.1152/ajpheart.00244.2019
   Wu XQ, 2019, CIRC RES, V125
   Xu M, 2019, CARDIOVASC RES, V115, P530, DOI 10.1093/cvr/cvy217
   Yarbrough WM, 2012, J THORAC CARDIOV SUR, V143, P656, DOI 10.1016/j.jtcvs.2011.04.044
   Yi HS, 2019, ENDOCRINOL METAB, V34, P39, DOI 10.3803/EnM.2019.34.1.39
   Youle RJ, 2012, SCIENCE, V337, P1062, DOI 10.1126/science.1219855
   Yussman MG, 2002, NAT MED, V8, P725, DOI 10.1038/nm719
   Zhang HF, 2008, J BIOL CHEM, V283, P10892, DOI 10.1074/jbc.M800102200
   Zhang JH, 2013, REDOX BIOL, V1, P19, DOI 10.1016/j.redox.2012.11.008
   Zhang W, 2016, ELIFE, V5, DOI 10.7554/eLife.11324
   Zhou B, 2018, J CLIN INVEST, V128, P3716, DOI 10.1172/JCI120849
NR 76
TC 5
Z9 5
U1 2
U2 14
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAY
PY 2020
VL 50
IS 5
BP 395
EP 405
DI 10.4070/kcj.2019.0416
PG 11
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA KX4DS
UT WOS:000521831400002
PM 32216174
OA Green Published, Other Gold
DA 2021-04-22
ER

PT J
AU Kim, J
   Lee, JM
   Choi, SH
   Choi, KH
   Park, TK
   Park, SJ
   Yang, JH
   Song, YB
   Hahn, JY
   Jang, MJ
   Koo, BK
   Gwon, HC
AF Kim, Jihoon
   Lee, Joo Myung
   Choi, Seung-Hyuk
   Choi, Ki Hong
   Park, Taek Kyu
   Park, Sung-Ji
   Yang, Jeong Hoon
   Song, Young Bin
   Hahn, Joo-Yong
   Jang, Mi Ja
   Koo, Bon-Kwon
   Gwon, Hyeon-Cheol
TI Comparison of Exercise Performance and Clinical Outcome Between
   Functional Complete and Incomplete Revascuarization
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Chronic stable angina; Percutaneous coronary intervention; Exercise;
   Prognosis
ID CORONARY-ARTERY-DISEASE; MEDICAL THERAPY; CARDIOVASCULAR EVENTS;
   PROGNOSTIC VALUE; HEART; REVASCULARIZATION; ISCHEMIA; CAPACITY;
   ANGIOPLASTY; OUTPATIENTS
AB Background and Objectives: Although percutaneous coronary intervention (PCI) is recommended to improve symptoms in patients with stable ischemic heart disease (SIHD), improvement of exercise performance is controversial. This study aimed to investigate changes in exercise duration after PCI according to functional completeness of revascularization by comparing pre- and post-PCI exercise stress test (EST).
   Methods: Patients with SIHD were enrolled from a prospective PCI registry, and divided into 2 groups: 1) functional complete revascularization (CR) group had a positive EST before PCI and negative EST after PCI, 2) functional incomplete revascularization (IR) group had positive EST before and after PCI. Primary outcome was change in exercise duration after PCI and secondary outcome was major adverse cardiac events (MACE, a composite of any death, any myocardial infarction, and any ischemia-driven revascularization) at 3 years after PCI.
   Results: A total of 256 patients (149 for CR group, and 107 for IR group) were eligible for analysis. Before PCI, exercise duration was not significantly different between the functional CR and IR groups (median 540 [interquartile range; IQR, 414, 602] vs. 480 [402, 589] seconds, p=0.091). After PCI, however, the CR group had a significantly higher increment of exercise duration than the IR group (median 62.0 [IQR, 12.0, 141.0] vs. 30.0 [-11.0, 103.5] seconds, p=0.011). The functional CR group also had a significantly lower risk of 3-year MACE (6.2% vs. 26.1%; adjusted hazard ratio, 0.19; 95% confidence interval, 0.09-0.41; p<0.001).
   Conclusions: Functional CR showed a higher increment of exercise duration than functional IR.
C1 [Kim, Jihoon; Lee, Joo Myung; Choi, Seung-Hyuk; Choi, Ki Hong; Park, Taek Kyu; Yang, Jeong Hoon; Song, Young Bin; Hahn, Joo-Yong; Gwon, Hyeon-Cheol] Sungkyunkwan Univ, Samsung Med Ctr, Heart Vasc Stroke Inst, Div Cardiol,Dept Internal Med,Sch Med, 81 Irwon Ro, Seoul 06351, South Korea.
   [Park, Sung-Ji] Sungkyunkwan Univ, Carcliovasc Imaging Ctr, Samsung Med Ctr, Heart Vasc Stroke Inst,Sch Med, Seoul, South Korea.
   [Jang, Mi Ja] Sungkyunkwan Univ, Cardiac Rehabil & Prevent Ctr, Samsung Med Ctr, Heart Vasc Stroke Inst,Sch Med, Seoul, South Korea.
   [Koo, Bon-Kwon] Seoul Natl Univ Hosp, Dept Internal Med, Seoul, South Korea.
   [Koo, Bon-Kwon] Seoul Natl Univ Hosp, Cardiovasc Ctr, Seoul, South Korea.
RP Lee, JM; Choi, SH (corresponding author), Sungkyunkwan Univ, Samsung Med Ctr, Heart Vasc Stroke Inst, Div Cardiol,Dept Internal Med,Sch Med, 81 Irwon Ro, Seoul 06351, South Korea.
EM drone80@hanmail.net; sh1214.choi@samsung.com
RI Hahn, Joo-Yong/AAU-7250-2020
OI Hahn, Joo-Yong/0000-0002-4412-377X; Park, Sung-Ji/0000-0002-7075-847X;
   Song, Young Bin/0000-0003-3986-9152; Kim, Jihoon/0000-0002-6919-446X;
   Lee, Joo Myung/0000-0002-2178-4014; JANG, MIJA/0000-0002-9145-4969;
   Yang, Jeong Hoon/0000-0001-8138-1367; Choi, Ki Hong/0000-0001-7511-9581
CR Al-Lamee R, 2018, CIRCULATION, V138, P1780, DOI 10.1161/CIRCULATIONAHA.118.033801
   Al-Lamee R, 2018, LANCET, V391, P31, DOI 10.1016/S0140-6736(17)32714-9
   Belardinelli R, 2003, EUR HEART J, V24, P1304, DOI 10.1016/S0195-668X(03)00210-0
   Choi Bernard C K, 2005, Prev Chronic Dis, V2, pA13
   Choi KH, 2018, JACC-CARDIOVASC INTE, V11, P237, DOI 10.1016/j.jcin.2017.09.009
   Fletcher GF, 2013, CIRCULATION, V128, P873, DOI 10.1161/CIR.0b013e31829b5b44
   Gehi AK, 2008, ARCH INTERN MED, V168, P1423, DOI 10.1001/archinte.168.13.1423
   Guazzi M, 2017, J AM COLL CARDIOL, V70, P1618, DOI 10.1016/j.jacc.2017.08.012
   Hachamovitch R, 2011, EUR HEART J, V32, P1012, DOI 10.1093/eurheartj/ehq500
   Hambrecht R, 2004, CIRCULATION, V109, P1371, DOI 10.1161/01.CIR.0000121360.31954.1F
   Hendel RC, 2009, CIRCULATION, V119, pE561, DOI 10.1161/CIRCULATIONAHA.109.192519
   Hung RK, 2014, MAYO CLIN PROC, V89, P1644, DOI 10.1016/j.mayocp.2014.07.011
   Lele SS, 1996, EUR HEART J, V17, P204
   MARK DB, 1991, NEW ENGL J MED, V325, P849, DOI 10.1056/NEJM199109193251204
   Myers J, 2002, NEW ENGL J MED, V346, P793, DOI 10.1056/NEJMoa011858
   Nissen SE, 2004, JAMA-J AM MED ASSOC, V292, P2217, DOI 10.1001/jama.292.18.2217
   Nissen SE, 2007, NEW ENGL J MED, V356, P1304, DOI 10.1056/NEJMoa070635
   PARISI AF, 1992, NEW ENGL J MED, V326, P10, DOI 10.1056/NEJM199201023260102
   Shaw LJ, 2008, CIRCULATION, V117, P1283, DOI 10.1161/CIRCULATIONAHA.107.743963
   Tajima A, 2009, CIRC J, V73, P1864, DOI 10.1253/circj.CJ-09-0222
   Thygesen K, 2012, J AM COLL CARDIOL, V60, P1581, DOI 10.1016/j.jacc.2012.08.001
   Tonino PAL, 2010, J AM COLL CARDIOL, V55, P2816, DOI 10.1016/j.jacc.2009.11.096
   Weintraub WS, 2008, NEW ENGL J MED, V359, P677, DOI 10.1056/NEJMoa072771
   Xaplanteris P, 2018, NEW ENGL J MED, V379, P250, DOI 10.1056/NEJMoa1803538
NR 24
TC 2
Z9 2
U1 0
U2 4
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAY
PY 2020
VL 50
IS 5
BP 406
EP 417
DI 10.4070/kcj.2019.0319
PG 12
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA KX4DS
UT WOS:000521831400003
PM 32096361
OA Other Gold, Green Published
DA 2021-04-22
ER

PT J
AU Oh, S
AF Oh, Seil
TI Simple Maneuver for Estimating the Depth of the Focal Activation Source
   in Myocardium
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Ventricular tachycardia; Left ventricle; Depth; Myocardium
ID ELECTRODE; ABLATION; MUSCLE
AB Background and Objectives: It is difficult to estimate the depth of the focal source by activation mapping. The present study was performed to demonstrate the usefulness of a simple maneuver in estimating the depth of the focal activation source (S).
   Methods: A total of 44 sites (15 shallow, depth<3.5 mm; 29 deep, depth>5.5 mm) were analyzed in 3 canine left ventricles tinder general anesthesia. A custom-made bipolar needle electrode was used to simulate a focal activation source. A mapping catheter with an electrode tip size of 2 mm, band electrode size of 1 mm, and inter-electrode spacing of 2-10-2 mm was placed at the mapping area. The position of the center of the distal 2 electrodes was kept at the insertion site of the needle electrode. The time interval between distal and proximal electrodes of the mapping catheter (T-tachy) was measured during needle electrode pacing. The time interval between distal and proximal electrodes (T-pace) was measured during pacing with distal electrodes of a mapping catheter. Depth index (delta) was defined as T-tachy/T-pace. Using in vivo data, simulation was performed to evaluate the depth and delta.
   Results: Ttachy was 24 +/- 7.7 ms and 15 +/- 5.6 ms for shallow source and deep source simulation, respectively (p<0.001). 6 values were 0.86 +/- 0.21 and 0.55 +/- 0.21 for shallow source and deep source simulation, respectively (p<0.001). According to simulation data, if 6<0.52, the depth of the focal source will be >5.5 mm.
   Conclusions: T-tachy was shorter and 8 was smaller fora deep S than fora shallow S.
   Conclusions: T-tachy was shorter and delta was smaller fora deep S than fora shallow S.
C1 [Oh, Seil] Seoul Natl Univ, Seoul Natl Univ Hosp, Dept Internal Med, Coll Med, 101 Daehak Ro, Seoul 03080, South Korea.
RP Oh, S (corresponding author), Seoul Natl Univ, Seoul Natl Univ Hosp, Dept Internal Med, Coll Med, 101 Daehak Ro, Seoul 03080, South Korea.
EM seil@snu.ac.kr
RI Oh, Seil/J-5539-2012
OI Oh, Seil/0000-0002-2504-9615
FU Bio & Medical Technology Development Program of the National Research
   Foundation - Ministry of Science & ICT, Republic of Korea
   [2015M3A9B6029139]
FX This research was supported by the Bio & Medical Technology Development
   Program of the National Research Foundation funded by the Ministry of
   Science & ICT, Republic of Korea (grant No. 2015M3A9B6029139).
CR CLERC L, 1976, J PHYSIOL-LONDON, V255, P335, DOI 10.1113/jphysiol.1976.sp011283
   Dorwarth U, 2003, PACE, V26, P1438, DOI 10.1046/j.1460-9592.2003.t01-1-00208.x
   NAKAGAWA H, 1995, CIRCULATION, V91, P2264, DOI 10.1161/01.CIR.91.8.2264
   Nakagawa Hiroshi, 2014, J Atr Fibrillation, V7, P1027, DOI 10.4022/jafib.1027
   NATH S, 1994, J CARDIOVASC ELECTR, V5, P863, DOI 10.1111/j.1540-8167.1994.tb01125.x
NR 5
TC 1
Z9 1
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAY
PY 2020
VL 50
IS 5
BP 420
EP 429
DI 10.4070/kcj.2019.0240
PG 10
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA KX4DS
UT WOS:000521831400005
PM 32096356
OA Other Gold, Green Published
DA 2021-04-22
ER

PT J
AU Shim, JS
   Oh, K
   Jung, SJ
   Kim, HC
AF Shim, Jee-Seon
   Oh, Kyungwon
   Jung, Sun Jae
   Kim, Hyeon Chang
TI Self-Reported Diet Management and Adherence to Dietary Guidelines in
   Korean Adults with Hypertension
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Hypertension; Dietary guideline; Diet therapy; Self-care
ID BLOOD-PRESSURE; PREVENT
AB Background and Objectives: Although dietary management is strongly recommended in patients with hypertension, little is known about how many manage their diet and follow the guidelines for hypertension. We investigated the prevalence of dietary management among adults with known hypertension and evaluated their compliance to the dietary guidelines.
   Methods: Data from the Korea National Health and Nutrition Examination Survey 2013-2016 were used. Among 15,870 adults aged 30-79 years, 4,162 reported a physician-diagnosed hypertension. Diet management behavior was defined by self-report response. Actual dietary intake was assessed by a 24-hour dietary recall. Dietary quality was evaluated using the Korean Healthy Eating Index (KHEI).
   Results: Among adults with hypertension, 28.O% reported that they were managing their diet. Those with hypertension consumed significantly less dietary sodium (p value<0.01), but also less potassium (p value<0.01), resulting in no difference of sodium-to-potassium ratio compared to those without hypertension (p value=0.66). Among those with hypertension, diet-managing adults had better KHEI score (66.9, p value<0.01) and consumed less sodium (3,354.3 mg, p value<0.01) than not-managing adults (63.6 score and 3,554.5 mg, respectively). However, total KHEI score was rather lower in those with hypertension (p value<0.01) than those without hypertension and their sodium intake was still over the recommended amount.
   Conclusions: More than two-thirds of Korean adults with hypertension did not manage their diet in daily life. More effective strategies are needed to increase the level of compliance with dietary recommendations for people with high blood pressure.
C1 [Shim, Jee-Seon; Jung, Sun Jae; Kim, Hyeon Chang] Yonsei Univ, Dept Prevent Med, Coll Med, 50-1 Yonsei Ro, Seoul 03722, South Korea.
   [Shim, Jee-Seon; Kim, Hyeon Chang] Yonsei Univ, Cardiovasc & Metab Dis Etiol Res Ctr, Coll Med, Seoul, South Korea.
   [Oh, Kyungwon] Ctr Dis Control & Prevent, Div Hlth & Nutr Survey, Cheongju, South Korea.
   [Jung, Sun Jae] Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA USA.
RP Kim, HC (corresponding author), Yonsei Univ, Dept Prevent Med, Coll Med, 50-1 Yonsei Ro, Seoul 03722, South Korea.
EM hckim@yuhs.ac
RI Jung, Sun Jae/ABC-7826-2020; Kim, Hyeon Chang/F-8796-2019; Jung, Sun
   Jae/D-5620-2011
OI Kim, Hyeon Chang/0000-0001-7867-1240; Shim,
   Jee-Seon/0000-0002-8671-3153; Jung, Sun Jae/0000-0002-5194-7339
FU Academic Research Fund of Korean Society of Hypertension [KSH-R-2018-06]
FX This study was supported by Academic Research Fund of Korean Society of
   Hypertension (KSH-R-2018-06).
CR Appel LJ, 2003, J AM SOC NEPHROL, V14, pS99, DOI 10.1097/01.ASN.0000070141.69483.5A
   Appel LJ, 2006, HYPERTENSION, V47, P296, DOI 10.1161/01.HYP.0000202568.01167.B6
   Ayala C, 2015, J CLIN HYPERTENS, V17, P172, DOI 10.1111/jch.12476
   Dauchet L, 2007, AM J CLIN NUTR, V85, P1650
   Davis CR, 2017, AM J CLIN NUTR, V105, P1305, DOI 10.3945/ajcn.116.146803
   Khan MS, 2014, J COMMUN HEALTH, V39, P732, DOI 10.1007/s10900-014-9819-9
   Korea Academy of Medical Sciences Korea Centers for Disease Control and Prevention, 2014, EV BAS GUID HYP PRIM
   Korea Centers for Disease Control and Prevention, 2019, ED MAT HYP DIAB COUN
   Kwan MWM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078412
   Kweon S, 2014, INT J EPIDEMIOL, V43, P69, DOI 10.1093/ije/dyt228
   Kyngas H, 1999, J ADV NURS, V29, P832, DOI 10.1046/j.1365-2648.1999.00962.x
   LAWSON M, 1991, J HYPERTENS, V9, pS50
   Lee ChulHee, 2012, Korean Journal of Community Nutrition, V17, P341
   Lee HY, 2015, PULSE, V3, P21, DOI 10.1159/000381994
   Lee H, 2019, KOREAN CIRC J, V49, P514, DOI 10.4070/kcj.2018.0358
   Lewington S, 2002, LANCET, V360, P1903
   da Silva TLN, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1999-4
   O'Brien E, 2017, J CLIN HYPERTENS, V19, P564, DOI 10.1111/jch.12998
   Puato M, 2017, BLOOD PRESSURE, V26, P48, DOI 10.1080/08037051.2016.1184964
   Rapsomaniki E, 2014, LANCET, V383, P1899, DOI 10.1016/S0140-6736(14)60685-1
   Salomaa V, 1994, SUOM LAAKARILEHTI, V49, P1926
   Shrivastava SR, 2013, J DIABETES METAB DIS, V12, DOI 10.1186/2251-6581-12-14
   The Korean Society of Hypertension, 2013, 2013 GUID TREATM HYP
   Whelton PK, 2018, HYPERTENSION, V71, pE13, DOI [10.1161/HYP.0000000000000065, 10.1161/HYP.0000000000000066]
   Willett W.C., 2012, NUTR EPIDEMIOLOGY, V3rd ed
   Yun S., 2018, PUBLIC HLTH WKLY REP, V11, P1764
NR 26
TC 2
Z9 2
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAY
PY 2020
VL 50
IS 5
BP 432
EP 440
DI 10.4070/kcj.2019.0230
PG 9
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA KX4DS
UT WOS:000521831400007
PM 32096363
OA Green Published, Other Gold
DA 2021-04-22
ER

PT J
AU Lee, SG
   Lee, SJ
   Lee, JJ
   Kim, JS
   Lee, OH
   Kim, CK
   Kim, D
   Lee, YH
   Oh, J
   Park, S
   Jeon, OH
   Hong, SJ
   Ahn, CM
   Kim, BK
   Ko, YG
   Choi, D
   Hong, MK
   Jang, Y
AF Lee, Seul-Gee
   Lee, Seung-Jun
   Lee, Jung-Jae
   Kim, Jung-Sun
   Lee, Oh-Hyun
   Kim, Choong-Ki
   Kim, Darae
   Lee, Yong-Ho
   Oh, Jaewon
   Park, Seit
   Jeon, Ok-Hee
   Hong, Sung-Jin
   Ahn, Chul-Min
   Kim, Byeong-Keuk
   Ko, Young-Guk
   Choi, Donghoon
   Hong, Myeong-Ki
   Jang, Yansoo
TI Anti-Inflammatory Effect for Atherosclerosis Progression by
   Sodium-Glucose Cotransporter 2 (SGLT-2) Inhibitor in a Normoglycemic
   Rabbit Model
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Atherosclerosis; Sodium-glucose transporter-2; Sodium-glucose
   transporter 2 inhibitors; Macrophages
ID DAPAGLIFLOZIN; EXPRESSION; LESSONS
AB Background and Objectives: We sought to investigate an anti-atherosclerotic and antiinflammatory effect of sodium-glucose cotransporter-2 (SGLT-2) inhibitors in normoglycemic atherosclerotic rabbit model.
   Methods: Male New Zealand white rabbits (n=26) were fed with a 1% high-cholesterol diet for 7 weeks followed by normal diet for 2 weeks. After balloon catheter injury, the rabbits were administered with the Dapagliflozin (1mg/kg/day) or control-medium for 8 weeks (n=13 for each group). All lesions were assessed with angiography, optical coherence tomography (OCT), and histological assessment.
   Results: Atheroma burden (38.51 +/- 3.16% vs. 21.91 +/- 1.22%, p<0.01) and lipid accumulation (18.90 +/- 3.63% vs. 10.20 +/- 2.03%, p=0.047) was significantly decreased by SGLT-2 inhibitor treatment. The SGLT-2 inhibitor group showed lower macrophage infiltration (20.23 +/- 1.89% vs. 12.72 +/- 1.95%, p=0.01) as well as tumor necrosis factor (TNF)-alpha expression (31.17 +/- 4.40% vs. 19.47 +/- 2.10%, p=0.025). Relative area of inducible nitric oxide synthase' macrophages was tended to be lower in the SGLT-2 inhibitor-treated group (1.00 +/- 0.16% vs. 0.71 +/- 0.10%, p=0.13), while relative proportion of Arg1(+) macrophage was markedly increased (1.00 +/- 0.27% vs. 2.43 +/- 0.64%, p=0.04). As a result, progression of atherosclerosis was markedly attenuated in SGLT-2 inhibitor treated group (OCT area stenosis, 32.13 +/- 1.20% vs. 22.77 +/- 0.88%, p<0.01). Mechanistically, SGLT-2 treatment mitigated the inflammatory responses in macrophage. Especially, Toll-like receptor 4/nuclear factor-kappa B signaling pathway, and their downstream effectors such as interleukin-6 and TNF-alpha were markedly suppressed by SGLT-2 inhibitor treatment.
   Conclusions: These results together suggest that SGLT-2 inhibitor exerts an antiatherosclerotic effect through favorable modulation of inflammatory response as well as macrophage characteristics in non-diabetic situation.
C1 [Lee, Seul-Gee; Kim, Jung-Sun; Hong, Sung-Jin; Ahn, Chul-Min; Kim, Byeong-Keuk; Ko, Young-Guk; Choi, Donghoon; Hong, Myeong-Ki; Jang, Yansoo] Yonsei Univ, Yonsei Cardiovasc Res Inst, Coll Med, Seoul, South Korea.
   [Lee, Seung-Jun; Kim, Jung-Sun; Oh, Jaewon; Hong, Sung-Jin; Ahn, Chul-Min; Kim, Byeong-Keuk; Ko, Young-Guk; Choi, Donghoon; Hong, Myeong-Ki; Jang, Yansoo] Yonsei Univ, Severance Cardiovasc Hosp, Cardiol Div, Coll Med, 50-1 Yonsei Ro, Seoul 03722, South Korea.
   [Lee, Jung-Jae] Yonsei Univ, Grad Program Sci Aging, Seoul, South Korea.
   [Kim, Jung-Sun; Park, Seit; Jeon, Ok-Hee; Hong, Myeong-Ki; Jang, Yansoo] Yonsei Univ, Cardiovasc Prod Evaluat Ctr, Coll Med, Seoul, South Korea.
   [Lee, Oh-Hyun] Yonsei Univ, Yongin Severance Hosp, Div Cardiol, Coll Med, Yongin, South Korea.
   [Kim, Choong-Ki] Ewha Womans Univ, Dept Cardiol, Seoul Hosp, Seoul, South Korea.
   [Kim, Darae] Sungkyunkwan Univ, Samsung Med Ctr, Dept Med, Div Cardiol,Sch Med, Seoul, South Korea.
   [Lee, Yong-Ho] Yonsei Univ, Severance Hosp, Dept Internal Med, Div Endocrinol & Metab,Coll Med, Seoul, South Korea.
RP Kim, JS (corresponding author), Yonsei Univ, Severance Cardiovasc Hosp, Cardiol Div, Coll Med, 50-1 Yonsei Ro, Seoul 03722, South Korea.
EM KJS1218@yuhs.ac
RI Lee, Yong-ho/AAT-4106-2020
OI Lee, Yong-ho/0000-0002-6219-4942; Kim, Jung-Sun/0000-0003-2263-3274;
   Choi, Donghoon/0000-0002-2009-9760; Hong, Sung-Jin/0000-0003-4893-039X;
   Ko, Young-Guk/0000-0001-7748-5788; Lee, Seul-Gee/0000-0002-9176-3075;
   Kim, Byeong-Keuk/0000-0003-2493-066X; Lee,
   Seung-Jun/0000-0002-9201-4818; Oh, Jaewon/0000-0002-4585-1488; Lee, Oh
   Hyun/0000-0001-7070-7720; Park, seil/0000-0002-4949-8976; Jang,
   Yangsoo/0000-0002-2169-3112; Hong, Myeong-Ki/0000-0002-2090-2031
FU Korean Society of Cardiology [201601-01]; Yonsei University College of
   Medicine [6-2016-0082]; Korea Health Industry Development Institute
   (KHIDI) - Ministry of Health & Welfare, Republic of Korea [HI15C1277];
   Cardiovascular Research Center (Seoul, Korea)
FX This study was supported by funding from the Korean Society of
   Cardiology (201601-01), and by a faculty research grant (6-2016-0082)
   from Yonsei University College of Medicine, and by a grant of the Korea
   Health Technology R&D Project through the Korea Health Industry
   Development Institute (KHIDI), funded by the Ministry of Health &
   Welfare, Republic of Korea (No. HI15C1277), and by the Cardiovascular
   Research Center (Seoul, Korea).
CR Abdul-Ghani M, 2016, DIABETES CARE, V39, P717, DOI 10.2337/dc16-0041
   Allahverdian S, 2012, CARDIOVASC RES, V95, P165, DOI 10.1093/cvr/cvs094
   Bhartia Mithun, 2011, Rev Diabet Stud, V8, P348, DOI 10.1900/RDS.2011.8.348
   Chinetti-Gbaguidi G, 2015, NAT REV CARDIOL, V12, P10, DOI 10.1038/nrcardio.2014.173
   Ferrannini E, 2012, NAT REV ENDOCRINOL, V8, P495, DOI 10.1038/nrendo.2011.243
   Glass CK, 2001, CELL, V104, P503, DOI 10.1016/S0092-8674(01)00238-0
   Han J, 2017, DIABETOLOGIA, V60, P364, DOI 10.1007/s00125-016-4158-2
   Heerspink HJL, 2016, CIRCULATION, V134, P752, DOI 10.1161/CIRCULATIONAHA.116.021887
   Henry RR, 2015, DIABETES CARE, V38, P412, DOI 10.2337/dc13-2955
   Kim JS, 2016, YONSEI MED J, V57, P1095, DOI 10.3349/ymj.2016.57.5.1095
   Kohan DE, 2014, KIDNEY INT, V85, P962, DOI 10.1038/ki.2013.356
   Lee SG, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0215604
   Leng W, 2016, MEDIAT INFLAMM, V2016, DOI DOI 10.1155/2016/630573528104929
   Libby P, 2002, NATURE, V420, P868, DOI 10.1038/nature01323
   Mancini SJ, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23420-4
   Marx N, 2016, EUR HEART J, V37, P3192, DOI 10.1093/eurheartj/ehw110
   McKellar GE, 2009, NAT REV CARDIOL, V6, P410, DOI 10.1038/nrcardio.2009.57
   Moriya J, 2019, J CARDIOL, V73, P22, DOI 10.1016/j.jjcc.2018.05.010
   Murray CJL, 2013, NEW ENGL J MED, V369, P448, DOI 10.1056/NEJMra1201534
   Peled M, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00579
   Pourcet B, 2013, TRENDS CARDIOVAS MED, V23, P143, DOI 10.1016/j.tcm.2012.10.003
   Rieg T, 2014, AM J PHYSIOL-RENAL, V306, pF188, DOI 10.1152/ajprenal.00518.2013
   Roszer T, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/816460
   Terasaki M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143396
   Tsunoda F, 2016, ATHEROSCLEROSIS, V247, P35, DOI 10.1016/j.atherosclerosis.2016.01.028
   Xu CK, 2018, BIOCHEM PHARMACOL, V152, P45, DOI 10.1016/j.bcp.2018.03.013
   Yan ZQ, 2006, ARTERIOSCL THROM VAS, V26, P2582, DOI 10.1161/01.ATV.0000250933.92917.dd
NR 27
TC 4
Z9 4
U1 0
U2 4
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAY
PY 2020
VL 50
IS 5
BP 443
EP 457
DI 10.4070/kcj.2019.0296
PG 15
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA KX4DS
UT WOS:000521831400009
PM 32153145
OA Other Gold, Green Published
DA 2021-04-22
ER

PT J
AU Lee, JH
   Park, JH
AF Lee, Jae-Hwan
   Park, Jae-Hyeong
TI Can Genoss DES (TM) Stand Out in the Crowd of Stents?
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
C1 [Lee, Jae-Hwan; Park, Jae-Hyeong] Chungnam Natl Univ, Chungnam Natl Univ Hosp, Dept Internal Med, Div Cardiol,Sch Med, 282 Munhwa Ro, Daejeon 35015, South Korea.
RP Park, JH (corresponding author), Chungnam Natl Univ, Chungnam Natl Univ Hosp, Dept Internal Med, Div Cardiol,Sch Med, 282 Munhwa Ro, Daejeon 35015, South Korea.
EM jaehpark@cnu.ac.kr
RI Park, Jae-Hyeong/AAD-9015-2021
CR El-Hayek G, 2017, JACC-CARDIOVASC INTE, V10, P462, DOI 10.1016/j.jcin.2016.12.002
   Holmes DR, 2007, J AM COLL CARDIOL, V50, P109, DOI 10.1016/j.jacc.2007.04.032
   Yang HM, 2017, KOREAN CIRC J, V47, P898, DOI 10.4070/kcj.2017.0094
   Youn YJ, 2020, KOREAN CIRC J, V50, P317, DOI 10.4070/kcj.2019.0258
NR 4
TC 0
Z9 0
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD APR
PY 2020
VL 50
IS 4
BP 328
EP 329
DI 10.4070/kcj.2020.0040
PG 2
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA KU7US
UT WOS:000519918700004
PM 32157832
OA Green Published
DA 2021-04-22
ER

PT J
AU Kim, HO
   Kim, W
AF Kim, Hyung Oh
   Kim, Weon
TI Reassembling Evidence for Treatment in Asymptomatic Carotid Artery
   Stenosis
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
ID RISK
C1 [Kim, Hyung Oh; Kim, Weon] Kyung Hee Univ, Kyung Hee Univ Hosp, Dept Internal Med, Div Cardiovasc, 23 Kyungheedae Ro, Seoul 02447, South Korea.
RP Kim, W (corresponding author), Kyung Hee Univ, Kyung Hee Univ Hosp, Dept Internal Med, Div Cardiovasc, 23 Kyungheedae Ro, Seoul 02447, South Korea.
EM mylovekw@hanmail.net
OI Kim, Hyung Oh/0000-0003-2157-441X
CR Chaturvedi S, 2015, J AM COLL CARDIOL, V65, P1134, DOI 10.1016/j.jacc.2014.12.045
   de Weerd M, 2010, STROKE, V41, P1294, DOI 10.1161/STROKEAHA.110.581058
   den Hartog AG, 2013, STROKE, V44, P1002, DOI 10.1161/STROKEAHA.111.669267
   Galyfos G, 2019, CARDIOVASC REVASCULA, V20, P413, DOI 10.1016/j.carrev.2018.07.003
   Hadar N, 2014, CEREBROVASC DIS, V38, P163, DOI 10.1159/000365206
   Halliday A, 2018, EUR J VASC ENDOVASC, V55, P301, DOI 10.1016/j.ejvs.2018.03.004
   Howard VJ, 2017, INT J STROKE, V12, P770, DOI 10.1177/1747493017706238
   Park S, 2019, KOREAN CIRC J, V49, P1002, DOI 10.4070/kcj.2019.0261
   Roh JH, 2020, KOREAN CIRC J, V50, P330, DOI 10.4070/kcj.2019.0125
   WALKER MD, 1995, JAMA-J AM MED ASSOC, V273, P1421, DOI 10.1001/jama.1995.03520420037035
NR 10
TC 0
Z9 0
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD APR
PY 2020
VL 50
IS 4
BP 343
EP 345
DI 10.4070/kcj.2020.0023
PG 3
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA KU7US
UT WOS:000519918700006
PM 32096364
OA Green Published, Other Gold
DA 2021-04-22
ER

PT J
AU Park, SJ
AF Park, Seung-Jung
TI Catheter Ablation is Effective for Recovery from Sinus Node Dysfunction
   in Patients with Atrial Fibrillation, But Close Monitoring is Still
   Needed
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
ID FIBROSIS
C1 [Park, Seung-Jung] Sungkyunkwan Univ, Heart Vasc Stroke Inst, Dept Internal Med, Div Cardiol,Samsung Med Ctr,Sch Med, Seoul, South Korea.
RP Park, SJ (corresponding author), Sungkyunkwan Univ, Heart Vasc Stroke Inst, Samsung Med Ctr, Div Cardiol,Dept Med,Sch Med, 81 Irwon Ro, Seoul 06351, South Korea.
EM orthovics@gmail.com
RI Park, Seung-Jung/AAT-8353-2020
OI Park, Seung-Jung/0000-0003-3288-0594
CR Akoum N, 2012, J CARDIOVASC ELECTR, V23, P44, DOI 10.1111/j.1540-8167.2011.02140.x
   Burstein B, 2008, J AM COLL CARDIOL, V51, P802, DOI 10.1016/j.jacc.2007.09.064
   Her AY, 2012, KOREAN CIRC J, V42, P311, DOI 10.4070/kcj.2012.42.5.311
   Hocini M, 2003, CIRCULATION, V108, P1172, DOI 10.1161/01.CIR.0000090685.13169.07
   Hwang TH, 2020, KOREAN CIRC J, V50, P346, DOI 10.4070/kcj.2019.0268
   Jeon Chang-Seok, 2017, Korean J Thorac Cardiovasc Surg, V50, P163, DOI 10.5090/kjtcs.2017.50.3.163
   Joung B, 2010, HEART RHYTHM, V7, P88, DOI 10.1016/j.hrthm.2009.09.018
   Kim DH, 2018, BMC CARDIOVASC DISOR, V18, DOI 10.1186/s12872-018-0834-0
   Kim JH, 2019, HEART RHYTHM, V16, P520, DOI 10.1016/j.hrthm.2018.11.030
   Yeh YH, 2009, CIRCULATION, V119, P1576, DOI 10.1161/CIRCULATIONAHA.108.789677
NR 10
TC 0
Z9 0
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD APR
PY 2020
VL 50
IS 4
BP 358
EP 360
DI 10.4070/kcj.2020.0033
PG 3
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA KU7US
UT WOS:000519918700008
PM 32157833
OA Other Gold, Green Published
DA 2021-04-22
ER

PT J
AU Park, JS
AF Park, Jin-Sun
TI Smoking Cessation as a Target of Arterial Destiffening
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
ID CIGARETTE-SMOKING
C1 [Park, Jin-Sun] Ajou Univ, Sch Med, Dept Cardiol, 164 World Cup Ro, Suwon 16499, South Korea.
RP Park, JS (corresponding author), Ajou Univ, Sch Med, Dept Cardiol, 164 World Cup Ro, Suwon 16499, South Korea.
EM lavioli@hanmail.net
OI Park, Jin-Sun/0000-0002-7775-4092
CR Doonan RJ, 2010, HYPERTENS RES, V33, P398, DOI 10.1038/hr.2010.25
   Dudenbostel T, 2012, CARDIOL REV, V20, P259, DOI 10.1097/CRD.0b013e31825d0a44
   Jha P, 2013, NEW ENGL J MED, V368, P341, DOI 10.1056/NEJMsa1211128
   Kim JW, 2005, BLOOD PRESSURE, V14, P80, DOI 10.1080/08037050510008896
   Lee GB, 2020, KOREAN CIRC J, V50, P361, DOI 10.4070/kcj.2019.0270
   Node K, 1997, AM J CARDIOL, V79, P1538, DOI 10.1016/S0002-9149(97)00189-6
   Rodilla E, 2017, AM J HYPERTENS, V30, P510, DOI 10.1093/ajh/hpw094
   Zhou JF, 2000, BIOMED ENVIRON SCI, V13, P44
NR 8
TC 0
Z9 0
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD APR
PY 2020
VL 50
IS 4
BP 370
EP 371
DI 10.4070/kcj.2020.0045
PG 2
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA KU7US
UT WOS:000519918700010
PM 32157834
OA Green Published
DA 2021-04-22
ER

PT J
AU Kaneko, U
   Kobayashi, K
   Hachinohe, D
   Mitsube, K
   Furugen, A
   Kawamura, T
   Koshima, R
   Fujita, T
AF Kaneko, Umihiko
   Kobayashi, Ken
   Hachinohe, Daisuke
   Mitsube, Keijiro
   Furugen, Azusa
   Kawamura, Takeshi
   Koshima, Ryuji
   Fujita, Tsutomu
TI Successful Use of an eSheath for Failed Introduction of the Evolut R
   Valve during Transfemoral Transcatheter Aortic Valve Implantation
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
C1 [Kaneko, Umihiko; Kobayashi, Ken; Hachinohe, Daisuke; Furugen, Azusa; Fujita, Tsutomu] Sapporo Heart Ctr, Dept Cardiovasc Med, Sapporo Cardio Vasc Clin, North 49,East 16,8-1 Higashi Ward, Sapporo, Hokkaido 0070849, Japan.
   [Mitsube, Keijiro; Koshima, Ryuji] Sapporo Heart Ctr, Sapporo Cardio Vasc Clin, Dept Cardiovasc Surg, Sapporo, Hokkaido, Japan.
   [Kawamura, Takeshi] Sapporo Heart Ctr, Sapporo Cardio Vasc Clin, Dept Anesthesiol, Sapporo, Hokkaido, Japan.
RP Kaneko, U (corresponding author), Sapporo Heart Ctr, Dept Cardiovasc Med, Sapporo Cardio Vasc Clin, North 49,East 16,8-1 Higashi Ward, Sapporo, Hokkaido 0070849, Japan.
EM uk434471@gmail.com
OI fujita, tsutomu/0000-0002-3651-6231
CR Buzzatti N, 2015, CIRC-CARDIOVASC INTE, V8, DOI 10.1161/CIRCINTERVENTIONS.114.002331
   Kaneko U, 2018, KOREAN CIRC J, V48, P949, DOI 10.4070/kcj.2018.0129
   Muller O, 2008, CIRCULATION, V118, pE677, DOI 10.1161/CIRCULATIONAHA.108.791210
   Naganuma T, 2017, ASIAINTERVENTION, V3, P90
NR 4
TC 1
Z9 1
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD APR
PY 2020
VL 50
IS 4
BP 372
EP 373
DI 10.4070/kcj.2019.0324
PG 2
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA KU7US
UT WOS:000519918700011
PM 31960639
OA Green Published, Other Gold
DA 2021-04-22
ER

PT J
AU Kim, S
   Kim, YR
   Choi, Y
   Kim, SH
   Oh, YS
AF Kim, Sunhwa
   Kim, Yoo Ri
   Choi, Young
   Kim, Sung-Hwan
   Oh, Yong-Seog
TI A Long Journey to the Truth: Primary Cardiac Lymphoma with Various
   Arrhythmias from Ventricular Tachycardia to Atrial Flutter
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
C1 [Kim, Sunhwa; Choi, Young; Kim, Sung-Hwan; Oh, Yong-Seog] Catholic Univ Korea, Seoul St Marys Hosp, Dept Internal Med, Div Cardiol,Coll Med, 222 Banpo Daero, Seoul 06591, South Korea.
   [Kim, Yoo Ri] Dongguk Univ, Ilsan Hosp, Dept Internal Med, Div Cardiol, Goyang, South Korea.
RP Oh, YS (corresponding author), Catholic Univ Korea, Seoul St Marys Hosp, Dept Internal Med, Div Cardiol,Coll Med, 222 Banpo Daero, Seoul 06591, South Korea.
EM oys@catholic.ac.kr
OI Choi, Young/0000-0003-3900-1943; Kim, Sung-Hwan/0000-0001-6805-0416;
   Kim, Sunhwa/0000-0003-3109-9210
CR Jeudy J, 2012, RADIOGRAPHICS, V32, P1369, DOI 10.1148/rg.325115126
   Mendelson L, 2018, CASE REP HEMATOL, V2018, DOI 10.1155/2018/6192452
   Petrich A, 2011, CANCER-AM CANCER SOC, V117, P581, DOI 10.1002/cncr.25444
   Tai CJ, 2001, JPN J CLIN ONCOL, V31, P217, DOI 10.1093/jjco/hye046
NR 4
TC 2
Z9 2
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD APR
PY 2020
VL 50
IS 4
BP 374
EP 378
DI 10.4070/kcj.2019.0298
PG 5
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA KU7US
UT WOS:000519918700012
PM 31960642
OA Green Published, Other Gold
DA 2021-04-22
ER

PT J
AU Talib, AK
   Nogami, A
AF Talib, Ahmed Karim
   Nogami, Akihiko
TI Catheter Ablation for Brugada Syndrome
SO KOREAN CIRCULATION JOURNAL
LA English
DT Review
DE Brugada syndrome; Ventricular fibrillation; Radiofrequency ablation;
   VF-trigger; Substrate
ID SUDDEN CARDIAC DEATH; ST SEGMENT ELEVATION; BUNDLE-BRANCH BLOCK;
   VENTRICULAR-FIBRILLATION; EPICARDIAL SUBSTRATE; PATIENT; ARRHYTHMIAS;
   PREVENTION; PREVALENCE; PHENOTYPE
AB Brugada syndrome (BrS) is an arrhythmogenic disease associated with an increased risk of ventricular fibrillation (VF) and sudden cardiac death (SCD). To date, the standard therapy for the prevention of SCD in BrS is the use ofan implantable cardioverter-defibrillator (ICU) especially in patients who have experienced a prior cardiac arrest or syncopal events secondary to VF. However, ICDs do not prevent the occurrence of VF but react to defibrillate the VF episode, thereby preventing SCD. Often patients with recurrent VF have to be maintained on antiarrhythmic drugs that are effective but have remarkable adverse effects. An alternative therapy for BrS with recurrent VF is catheter ablation which emerged as an effective therapy in eliminating VF-triggering premature ventricular complexes in limited case series; however, there has been a remarkable progress in effectiveness of catheter ablation since epicardial substrate ablation was first applied in 2011 and such approach is now widely applicable.
C1 [Talib, Ahmed Karim; Nogami, Akihiko] Univ Tsukuba, Fac Med, Dept Cardiol, 1-1-1 Tennodai, Tsukuba, Ibaraki 3058575, Japan.
   [Talib, Ahmed Karim] Al Najaf Ctr Cardiac Surg & Trans Catheter Therap, Div Cardiac Electrophysiol, Najaf, Iraq.
RP Nogami, A (corresponding author), Univ Tsukuba, Fac Med, Dept Cardiol, 1-1-1 Tennodai, Tsukuba, Ibaraki 3058575, Japan.
EM anogami@md.tsukuba.ac.jp
OI Nogami, Akihiko/0000-0003-0359-4601
CR Belhassen B, 2004, CIRCULATION, V110, P1731, DOI 10.1161/01.CIR.0000143159.30585.90
   Brugada J, 2015, CIRC-ARRHYTHMIA ELEC, V8, P1373, DOI 10.1161/CIRCEP.115.003220
   BRUGADA P, 1992, J AM COLL CARDIOL, V20, P1391, DOI 10.1016/0735-1097(92)90253-J
   Chung FP, 2017, HEART RHYTHM, V14, P508, DOI 10.1016/j.hrthm.2017.01.006
   Coronel R, 2005, CIRCULATION, V112, P2769, DOI 10.1161/CIRCULATIONAHA.105.532614
   Darmon JP, 2004, J INTERV CARD ELECTR, V11, P205, DOI 10.1023/B:JICE.0000048571.19462.54
   Furuhashi M, 2001, HEART, V86, P161, DOI 10.1136/heart.86.2.161
   Haissaguerre M, 2003, CIRCULATION, V108, P925, DOI 10.1161/01.CIR.0000088781.99943.95
   Hayashi Tatsuya, 2016, HeartRhythm Case Rep, V2, P428, DOI 10.1016/j.hrcr.2016.06.007
   Hermida JS, 2000, AM J CARDIOL, V86, P91, DOI 10.1016/S0002-9149(00)00835-3
   Kakishita M, 2000, J AM COLL CARDIOL, V36, P1646, DOI 10.1016/S0735-1097(00)00932-3
   Krittayaphong R, 2003, EUR HEART J, V24, P1771, DOI 10.1016/j.ehj.2003.06.005
   Morita H, 2003, J CARDIOVASC ELECTR, V14, P373, DOI 10.1046/j.1540-8167.2003.02365.x
   Morita H, 2009, HEART RHYTHM, V6, P665, DOI 10.1016/j.hrthm.2009.01.007
   Nademanee K, 2015, J AM COLL CARDIOL, V66, P1976, DOI 10.1016/j.jacc.2015.08.862
   Nademanee K, 2011, CIRCULATION, V123, P1270, DOI 10.1161/CIRCULATIONAHA.110.972612
   Nakagawa E, 2008, CIRC J, V72, P1025, DOI 10.1253/circj.72.1025
   Pappone C, 2017, CIRC-ARRHYTHMIA ELEC, V10, DOI 10.1161/CIRCEP.117.005053
   Priori SG, 2015, EUR HEART J, V36, P2793, DOI 10.1093/eurheartj/ehv316
   Sacher F, 2014, HEART RHYTHM, V11, P732, DOI 10.1016/j.hrthm.2013.05.023
   Shah AJ, 2011, J CARDIOVASC ELECTR, V22, P1290, DOI 10.1111/j.1540-8167.2011.02054.x
   Sunsaneewitayakul B, 2012, J CARDIOVASC ELECTR, V23, ps10, DOI 10.1111/j.1540-8167.2012.02433.x
   Talib AK, 2018, CIRC-ARRHYTHMIA ELEC, V11, DOI 10.1161/CIRCEP.117.005631
   Talib AK, 2016, J ARRYTHM, V32, P220, DOI 10.1016/j.joa.2015.12.008
   Viskin S, 2013, J AM COLL CARDIOL, V61, P2383, DOI 10.1016/j.jacc.2013.02.077
NR 25
TC 1
Z9 1
U1 0
U2 2
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD APR
PY 2020
VL 50
IS 4
BP 289
EP 301
DI 10.4070/kcj.2019.0344
PG 13
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA KU7US
UT WOS:000519918700001
PM 31960637
OA Green Published, Other Gold
DA 2021-04-22
ER

PT J
AU Giugno, L
   Faccini, A
   Carminati, M
AF Giugno, Luca
   Faccini, Alessia
   Carminati, Mario
TI Percutaneous Pulmonary Valve Implantation
SO KOREAN CIRCULATION JOURNAL
LA English
DT Review
DE Percutaneous pulmonary valve implantation; Transcatheter procedure;
   Congenital heart disease
ID 3-DIMENSIONAL ROTATIONAL ANGIOGRAPHY; VENTRICULAR OUTFLOW TRACT;
   CONGENITAL HEART-DISEASE; TRANSCATHETER AORTIC-VALVE; VENUS P-VALVE;
   SAPIEN 3; ECHOCARDIOGRAPHIC-ASSESSMENT; TRICUSPID REGURGITATION;
   EUROPEAN ASSOCIATION; RADIATION-EXPOSURE
AB Percutaneous pulmonary valve implantation (PPVI) is recognized as a feasible and low risk alternative to surgery to treat dysfunctional right ventricular outflow tract (RVOT) in usually pluri-operated patients. Evolving technology allowed to develop different kind of prosthesis and to go from an initial treatment exclusively of stenotic conduit to an actual approach extended also to wide native RVOT. The Melody transcatheter pulmonary valve (TPV) and the Edwards Sapien valve are nowadays the most commonly implanted prostheses. However, other devices have been developed to treat large RVOT (i.e., the Venus p-valve, the Medtronic Harmony TPV, the Alterra Adaptive Prestent, and the Pulsta valve). Indications for PPVI are the same as for surgical interventions on pulmonary valve, with limits related to the maximum diameter of the available percutaneous prosthesis. Therefore, an accurate preoperative evaluation is of paramount importance to select patients who could benefit from this procedure. The overall periprocedural mortality incidence is around 1.4%, while freedom from RVOT reintervention ranges from 100% at 4 months to 70% at 70 months, according to the different published studies.
C1 [Giugno, Luca; Faccini, Alessia; Carminati, Mario] IRCCS Policlin San Donato, Dept Pediat & Adult Congenital Cardiol & Cardiac, Piazza Edmondo Malan 1, I-20097 San Donato Milanese, Italy.
RP Carminati, M (corresponding author), IRCCS Policlin San Donato, Dept Pediat & Adult Congenital Cardiol & Cardiac, Piazza Edmondo Malan 1, I-20097 San Donato Milanese, Italy.
EM Mario.Carminati@grupposandonato.it
RI Lurz, Philipp C/B-6558-2009; Giugno, Luca/ABG-3238-2020; Carminati,
   Mario/ABG-3137-2020
OI Carminati, Mario/0000-0001-9734-3007
CR Aldoss O, 2016, PEDIATR CARDIOL, V37, P1211, DOI 10.1007/s00246-016-1418-3
   Ansari MM, 2015, J AM COLL CARDIOL, V66, P2246, DOI 10.1016/j.jacc.2015.09.055
   Baumgartner H, 2010, EUR HEART J, V31, P2915, DOI 10.1093/eurheartj/ehq249
   Baumgartner H, 2009, EUR J ECHOCARDIOGR, V10, P1, DOI 10.1093/ejechocard/jen303
   Biernacka EK, 2017, POSTEP KARDIOL INTER, V13, P3, DOI 10.5114/aic.2017.66180
   Binder RK, 2013, JACC-CARDIOVASC INTE, V6, P293, DOI 10.1016/j.jcin.2012.09.019
   Bonhoeffer P, 2000, LANCET, V356, P1403, DOI 10.1016/S0140-6736(00)02844-0
   Bonhoeffer P, 2000, CIRCULATION, V102, P813, DOI 10.1161/01.CIR.102.7.813
   Bonhoeffer P, 2002, J AM COLL CARDIOL, V39, P1664, DOI 10.1016/S0735-1097(02)01822-3
   Borik S, 2015, CIRC-CARDIOVASC INTE, V8, DOI 10.1161/CIRCINTERVENTIONS.114.001745
   Boshoff DE, 2013, CATHETER CARDIO INTE, V81, P987, DOI 10.1002/ccd.24594
   Chessa M, 2016, EUR HEART J, V37, P66, DOI 10.1093/eurheartj/ehv208
   Faccini A, 2018, CATHETER CARDIO INTE, V91, P927, DOI 10.1002/ccd.27527
   Garay F, 2017, NETH HEART J, V25, P76, DOI 10.1007/s12471-016-0932-5
   Goreczny S, 2017, NETH HEART J, V25, P91, DOI 10.1007/s12471-016-0941-4
   Hascoet S, 2019, EUROINTERVENTION, V14, P1386, DOI 10.4244/EIJ-D-18-00530
   Hascoet S, 2014, ARCH CARDIOVASC DIS, V107, P625, DOI 10.1016/j.acvd.2014.07.048
   Jones TK, 2016, J AM COLL CARDIOL, V68, P1525, DOI 10.1016/j.jacc.2016.07.734
   Kenny D, 2011, J AM COLL CARDIOL, V58, P2248, DOI 10.1016/j.jacc.2011.07.040
   Kim GB, 2018, CIRC-CARDIOVASC INTE, V11, DOI 10.1161/CIRCINTERVENTIONS.118.006494
   Lancellotti P, 2010, EUR J ECHOCARDIOGR, V11, P223, DOI 10.1093/ejechocard/jeq030
   Manica JLL, 2014, ARQ BRAS CARDIOL, V103, P131, DOI 10.5935/abc.20140118
   Lindsay I, 2016, CATHETER CARDIO INTE, V88, P814, DOI 10.1002/ccd.26547
   Lurz P, 2011, J AM COLL CARDIOL, V57, P724, DOI 10.1016/j.jacc.2010.07.056
   Lurz Philipp, 2009, Expert Rev Cardiovasc Ther, V7, P823, DOI 10.1586/erc.09.57
   Malekzadeh-Milani S, 2014, ARCH CARDIOVASC DIS, V107, P592, DOI 10.1016/j.acvd.2014.07.045
   McElhinney DB, 2013, ANN NY ACAD SCI, V1291, P77, DOI 10.1111/nyas.12194
   Meier LM, 2017, NETH HEART J, V25, P65, DOI 10.1007/s12471-016-0942-3
   Milani RV, 2006, MAYO CLIN PROC, V81, P1603, DOI 10.4065/81.12.1603
   Miliaresis C, 2014, CARDIOL REV, V22, P275, DOI 10.1097/CRD.0000000000000039
   Morray BH, 2013, CIRC-CARDIOVASC INTE, V6, P535, DOI 10.1161/CIRCINTERVENTIONS.113.000202
   Nguyen HH, 2016, PEDIATR CARDIOL, V37, P1429, DOI 10.1007/s00246-016-1453-0
   Pagourelias ED, 2017, CATHETER CARDIO INTE, V90, P407, DOI 10.1002/ccd.26966
   Promphan W, 2016, CARDIOL YOUNG, V26, P698, DOI 10.1017/S1047951115001067
   Qureshi AM, 2015, TEX HEART I J, V42, P195, DOI 10.14503/THIJ-14-4276
   Rudski LG, 2010, J AM SOC ECHOCARDIOG, V23, P685, DOI 10.1016/j.echo.2010.05.010
   Sanz J, 2012, CARDIOL CLIN, V30, P189, DOI 10.1016/j.ccl.2012.03.001
   Schoonbeek RC, 2016, CIRC-CARDIOVASC INTE, V9, DOI 10.1161/CIRCINTERVENTIONS.116.003920
   Shivaraju A, 2015, JACC-CARDIOVASC INTE, V8, P2041, DOI 10.1016/j.jcin.2015.10.006
   Silversides CK, 2010, CAN J CARDIOL, V26, P143, DOI 10.1016/S0828-282X(10)70352-4
   Stenger A, 2016, PEDIATR CARDIOL, V37, P528, DOI 10.1007/s00246-015-1310-6
   Stout KK, 2019, CIRCULATION, V139, pE637, DOI 10.1161/CIR.0000000000000602
   Suntharos P, 2017, WORLD J PEDIATR CONG, V8, P639, DOI 10.1177/2150135116655125
   Tezza M, 2019, EUR J RADIOL, V110, P88, DOI 10.1016/j.ejrad.2018.11.018
   Virk SA, 2015, INT J CARDIOL, V201, P487, DOI 10.1016/j.ijcard.2015.08.119
   Vricella LA, 2004, CARDIOL YOUNG, V14, P533, DOI 10.1017/S1047951104005116
   Vukicevic M, 2017, JACC-CARDIOVASC IMAG, V10, P171, DOI 10.1016/j.jcmg.2016.12.001
   Webb JG, 2009, J AM COLL CARDIOL, V53, P1855, DOI 10.1016/j.jacc.2008.07.075
   Wilson WM, 2015, JACC-CARDIOVASC INTE, V8, P1819, DOI 10.1016/j.jcin.2015.08.016
   Zahn EM, 2018, CATHETER CARDIO INTE, V91, P1125, DOI 10.1002/ccd.27581
NR 50
TC 0
Z9 0
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD APR
PY 2020
VL 50
IS 4
BP 302
EP 316
DI 10.4070/kcj.2019.0291
PG 15
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA KU7US
UT WOS:000519918700002
PM 32157831
OA Green Published, Other Gold
DA 2021-04-22
ER

PT J
AU Youn, YJ
   Yoo, SY
   Lee, JW
   Ahn, SG
   Lee, SH
   Yoon, J
   Park, JH
   Choi, WG
   Cho, S
   Lim, SW
   Jang, YS
   Kwon, KH
   Lee, NH
   Doh, JH
   Kang, WC
   Jeon, DW
   Lee, BK
   Heo, JH
   Hong, BK
   Choi, HH
AF Youn, Young Jin
   Yoo, Sang-Yong
   Lee, Jun-Won
   Ahn, Sung Gyun
   Lee, Seung-Hwan
   Yoon, Junghan
   Park, Jae Hyoung
   Choi, Woong Gil
   Cho, Sungsoo
   Lim, Sang-Wook
   Jang, Yang Soo
   Kwon, Ki Hwan
   Lee, Nam Ho
   Doh, Joon Hyung
   Kang, Woong Chol
   Jeon, Dong Woon
   Lee, Bong-Ki
   Heo, Jung Ho
   Hong, Bum-Kee
   Choi, Hyun-Hee
TI Safety and Efficacy of a New Ultrathin Sirolimus-Eluting Stent with
   Abluminal Biodegradable Polymer in Real-World Practice
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Drug-eluting stents; Percutaneous coronary intervention; Prospective
   studies; Registries
ID DUAL ANTIPLATELET THERAPY; CORONARY-ARTERY-DISEASE; FOCUSED UPDATE;
   INTERVENTION; CLOPIDOGREL; OUTCOMES; TRIALS
AB Background and Objectives: Recently, Genoss drug-eluting stent (DES)(TM) stent comprising cobalt-chromium platform with an ultrathin strut thickness, sirolimus, and an abluminal biodegradable polymer was developed. Owing to the lack of substantial evidence for the safety and efficacy of this stent, we report 12-month results of the Genoss DES (TM) stent.
   Methods: We analyzed subjects who were eligible for a 12-month follow-up from the ongoing Genoss DES (TM) registry, which is a prospective, single-arm, observational, multicenter trial to investigate the clinical outcomes after the successful Genoss DES (TM) stent implantation among all-comers. The primary endpoint was a device-oriented composite outcome, defined as cardiac death, target vessel-related myocardial infarction, and target lesion revascularization at 12-month follow-up.
   Results: Among 622 subjects, the mean age of subjects was 66.5 +/- 10.4 years, 70.6% were males, 67.5% had hypertension, and 38.3% had diabetes. The implanted stent number, diameter, and length per patient were 1.5 +/- 0.8, 3.1 +/- 0.4 mm, and 36.0 +/- 23.3 mm, respectively. At 12-month clinical follow-up, the primary endpoint occurred only in 4 (0.6%) subjects.
   Conclusions: The novel Genoss DES (TM) stent exhibited excellent safety and efficacy in real-world practice.
C1 [Youn, Young Jin; Lee, Jun-Won; Ahn, Sung Gyun; Lee, Seung-Hwan; Yoon, Junghan] Yonsei Univ, Wonju Severance Christian Hosp, Dept Internal Med, Div Cardiol,Wonju Coll Med, Wonju, South Korea.
   [Yoo, Sang-Yong] Univ Ulsan, Gangneung Asan Hosp, Dept Internal Med, Div Cardiol,Coll Med, Kangnung, South Korea.
   [Park, Jae Hyoung] Korea Univ, Anam Hosp, Cardiovasc Ctr, Dept Cardiol, Seoul, South Korea.
   [Choi, Woong Gil] Konkuk Univ, Coll Med, Dept Internal Med, Div Cardiol,Chungju Hosp, Chungju, South Korea.
   [Cho, Sungsoo] Dankook Univ, Coll Med, Dept Internal Med, Div Cardiovasc Med,Dankook Univ Hosp, Cheonan, South Korea.
   [Lim, Sang-Wook] CHA Univ, CHA Bundang Med Ctr, Dept Internal Med, Div Cardiol, Seongnam, South Korea.
   [Jang, Yang Soo] Ewha Womans Univ, Sch Med, Dept Internal Med, Div Cardiol,Mokdong Hosp, Seoul, South Korea.
   [Kwon, Ki Hwan] Hallym Univ, Kangnam Sacred Heart Hosp, Dept Internal Med, Div Cardiol, Seoul, South Korea.
   [Lee, Nam Ho] Inje Univ, Ilsan Paik Hosp, Dept Internal Med, Div Cardiol, Goyang, South Korea.
   [Doh, Joon Hyung] Gachon Univ, Gil Med Ctr, Dept Cardiol, Incheon, South Korea.
   [Kang, Woong Chol] Yonsei Univ, Severance Cardiovasc Hosp, Dept Internal Med, Div Cardiol,Coll Med, Seoul, South Korea.
   [Jeon, Dong Woon] Natl Hlth Insurance Serv Ilsan Hosp, Dept Internal Med, Div Cardiol, Goyang, South Korea.
   [Lee, Bong-Ki] Kangwon Natl Univ, Kangwon Natl Univ Hosp, Dept Internal Med, Chunchon, South Korea.
   [Heo, Jung Ho] Kosin Univ, Gospel Hosp, Dept Internal Med, Div Cardiol, Busan, South Korea.
   [Hong, Bum-Kee] Yonsei Univ, Gangnam Severance Hosp, Heart Ctr, Div Cardiol,Coll Med, Seoul, South Korea.
   [Choi, Hyun-Hee] Hallym Univ, Chuncheon Sacred Heart Hosp, Cardiovasc Ctr, Div Cardiol,Coll Med, Chunchon, South Korea.
RP Yoon, J (corresponding author), Yonsei Univ, Dept Internal Med, Div Cardiol, Wonju Coll Med, 20 Ilsan Ro, Wonju 26426, South Korea.
EM jyoon@yonsei.ac.kr
RI Ahn, Sung Gyun/AAG-5976-2020
OI Ahn, Sung Gyun/0000-0002-1528-2739; Yoon, Junghan/0000-0002-3363-2675;
   Choi, Woong Gil/0000-0002-2235-8041; Lee, Jun-Won/0000-0001-6206-1704;
   Lee, Seung-Hwan/0000-0002-1186-0917; Yoo, Sang-Yong/0000-0002-9054-4698;
   Youn, Young Jin/0000-0001-7066-7474
FU Genoss Company Limited, Suwon, South Korea
FX This study was funded by Genoss Company Limited, Suwon, South Korea.
CR Bangalore S, 2018, CIRCULATION, V138, P2216, DOI 10.1161/CIRCULATIONAHA.118.034456
   Bittl JA, 2016, J AM COLL CARDIOL, V68, P1116, DOI 10.1016/j.jacc.2016.03.512
   Cutlip DE, 2007, CIRCULATION, V115, P2344, DOI 10.1161/CIRCULATIONAHA.106.685313
   El-Hayek G, 2017, JACC-CARDIOVASC INTE, V10, P462, DOI 10.1016/j.jcin.2016.12.002
   Holmes DR, 2007, J AM COLL CARDIOL, V50, P109, DOI 10.1016/j.jacc.2007.04.032
   Jolly SS, 2011, LANCET, V377, P1409, DOI 10.1016/S0140-6736(11)60404-2
   Kang J, 2018, KOREAN CIRC J, V48, P537, DOI 10.4070/kcj.2018.0166
   Kang SH, 2014, EUR HEART J, V35, P1147, DOI 10.1093/eurheartj/eht570
   Kok MM, 2018, EUROINTERVENTION, V14, P915, DOI 10.4244/EIJ-D-18-00336
   Levine GN, 2014, NAT REV CARDIOL, V11, P597, DOI 10.1038/nrcardio.2014.104
   Moses JW, 2003, NEW ENGL J MED, V349, P1315, DOI 10.1056/NEJMoa035071
   Palmerini T, 2014, J AM COLL CARDIOL, V63, P299, DOI 10.1016/j.jacc.2013.09.061
   Stone GW, 2007, NEW ENGL J MED, V356, P998, DOI 10.1056/NEJMoa067193
   Stone GW, 2005, JAMA-J AM MED ASSOC, V294, P1215, DOI 10.1001/jama.294.10.1215
   Valgimigli M, 2018, EUR HEART J, V39, P213, DOI 10.1093/eurheartj/ehx419
   Wallentin L, 2009, NEW ENGL J MED, V361, P1045, DOI 10.1056/NEJMoa0904327
   Wiviott SD, 2007, NEW ENGL J MED, V357, P2001, DOI 10.1056/NEJMoa0706482
   Yang HM, 2017, KOREAN CIRC J, V47, P898, DOI 10.4070/kcj.2017.0094
   Zbinden R, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.116.003255
NR 19
TC 3
Z9 3
U1 1
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD APR
PY 2020
VL 50
IS 4
BP 317
EP 327
DI 10.4070/kcj.2019.0258
PG 11
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA KU7US
UT WOS:000519918700003
PM 31960640
OA Green Published, Other Gold
DA 2021-04-22
ER

PT J
AU Roh, JH
   Cho, HJ
   Lee, JH
   Kim, Y
   Park, Y
   Park, JH
   Park, HS
   Kim, M
   Jin, HG
   Cheon, Y
   Seong, IW
AF Roh, Jae Hyung
   Cho, Hyun Jun
   Lee, Jae Hwan
   Kim, Yongku
   Park, Yeongwoo
   Park, Jae Hyeong
   Park, Hee Soon
   Kim, Minsu
   Jin, Hyang Gon
   Cheon, Yeji
   Seong, In Whan
TI Role of Carotid Artery Stenting in Prevention of Stroke for Asymptomatic
   Carotid Stenosis: Bayesian Cross-Design and Network Meta-Analyses
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Carotid artery stenosis; Carotid endarterectomy
ID EARLY OUTCOMES; ENDARTERECTOMY; MANAGEMENT; DISEASE; IMPACT
AB Background and Objectives: There is insufficient evidence regarding the optimal treatment for asymptomatic carotid stenosis.
   Methods: Bayesian cross-design and network meta-analyses were performed to compare the safety and efficacy among carotid artery stenting (CAS), carotid endarterectomy (CEA), and medical treatment (MT). We identified 18 studies (4 randomized controlled trials (RCTs) and 14 nonrandomized, comparative studies (NRCSs)) comparing CAS with CEA, and 4 RCT5 comparing CEA with MT from MEDLINE, Cochrane Library, and Embase databases.
   Results: The risk for periprocedural stroke tended to increase in CAS, compared to CEA (odds ratio (OR), 1.86; 95% credible interval [CrI], 0.62-4.54). However, estimates for periprocedural myocardial infarction (MI) were quite heterogeneous in RCTs and NRCSs. Despite a trend of decreased risk with CAS in RCT5 (OR, 0.70; 95% CrI, 0.27-1.24), the risk was similar in NRCSs (OR, 1.02; 95% CrI, 0.87-1.18). In indirect comparisons of MT and CAS, MT showed a tendency to have a higher risk for the composite of periprocedural death, stroke, MI, or nonperiprocedural ipsilateral stroke (OR, 1.30; 95% CrI, 0.74-2.73). Analyses of study characteristics showed that CEA-versus-MT studies took place about 10-year earlier than CEA-versus-CAS studies.
   Conclusions: A similar risk for periprocedural MI between CEA and CAS in NRCSs suggested that concerns about periprocedural MI accompanied by CEA might not matter in real-world practice when preoperative evaluation and management are working. Maybe the benefits of CAS over MT have been overestimated considering advances in medical therapy within10-year gap between CEA-versus-MT and CEA-versus-CAS studies.
C1 [Park, Hee Soon] Korea Univ Med Ctr Anam Hosp, Dept Internal Med, Div Cardiol, Korea, Seoul, South Korea.
   [Roh, Jae Hyung; Lee, Jae Hwan; Park, Jae Hyeong; Kim, Minsu; Seong, In Whan] Chungnam Natl Univ, Chungnam Natl Univ Hosp, Sch Med, Dept Cardiol Internal Med, 282 Munhwa Ro, Daejeon 35015, South Korea.
   [Cho, Hyun Jun] Daegu Fatima Hosp, Dept Cardiol, Daegu, South Korea.
   [Kim, Yongku; Park, Yeongwoo; Jin, Hyang Gon; Cheon, Yeji] Kyungpook Natl Univ, Dept Stat, Daegu, South Korea.
   [Park, Hee Soon] Korea Univ, Dept Internal Med, Div Cardiol, Med Ctr,Anam Hosp, Seoul, South Korea.
RP Lee, JH (corresponding author), Chungnam Natl Univ, Chungnam Natl Univ Hosp, Sch Med, Dept Cardiol Internal Med, 282 Munhwa Ro, Daejeon 35015, South Korea.
EM myheart@cnu.ac.kr
RI Park, Jae-Hyeong/AAD-9015-2021
OI Cho, Hyun Jun/0000-0003-3006-0517; Kim, Yongku/0000-0002-3917-6279
FU Chungnam National University
FX This work was supported by research fund of Chungnam National
   University.
CR Aboyans V, 2018, EUR HEART J, V39, P763, DOI 10.1093/eurheartj/ehx095
   Bisdas T, 2012, EUR J VASC ENDOVASC, V44, P244, DOI 10.1016/j.ejvs.2012.06.009
   Bradac O, 2014, ACTA NEUROCHIR, V156, P1705, DOI 10.1007/s00701-014-2166-x
   Brewster LP, 2011, J VASC SURG, V54, P1000, DOI 10.1016/j.jvs.2011.03.279
   Brott TG, 2016, NEW ENGL J MED, V374, P1021, DOI 10.1056/NEJMoa1505215
   Choi JC, 2015, STROKE, V46, P120, DOI 10.1161/STROKEAHA.114.006209
   Gurm HS, 2008, NEW ENGL J MED, V358, P1572, DOI 10.1056/NEJMoa0708028
   Halliday A, 2010, LANCET, V376, P1074, DOI 10.1016/S0140-6736(10)61197-X
   HOBSON RW, 1993, NEW ENGL J MED, V328, P221, DOI 10.1056/NEJM199301283280401
   Jim J, 2012, J VASC SURG, V55, P1313, DOI 10.1016/j.jvs.2011.11.128
   KARTCHNER MM, 1977, SURGERY, V82, P840
   Kim LK, 2014, CIRC-CARDIOVASC INTE, V7, P692, DOI 10.1161/CIRCINTERVENTIONS.113.001338
   Kolos I, 2015, J VASC SURG, V62, P914, DOI 10.1016/j.jvs.2015.05.005
   Kougias P, 2015, J VASC SURG, V62, P355, DOI 10.1016/j.jvs.2015.02.057
   Lu G, 2004, STAT MED, V23, P3105, DOI 10.1002/sim.1875
   Marine LA, 2006, J VASC SURG, V43, P953, DOI 10.1016/j.jvs.2006.01.008
   McDonald RJ, 2014, STROKE, V45, P3311, DOI 10.1161/STROKEAHA.114.006323
   Nolan BW, 2012, J VASC SURG, V56, P990, DOI 10.1016/j.jvs.2012.03.009
   Prevost TC, 2000, STAT MED, V19, P3359, DOI 10.1002/1097-0258(20001230)19:24<3359::AID-SIM710>3.0.CO;2-N
   Raman G, 2013, ANN INTERN MED, V158, P676, DOI 10.7326/0003-4819-158-9-201305070-00007
   Rosenfield K, 2016, NEW ENGL J MED, V374, P1011, DOI [10.1056/NEJMoa1515706, 10.1016/j.jvs.2016.06.057]
   Sardar P, 2017, J AM COLL CARDIOL, V69, P2266, DOI 10.1016/j.jacc.2017.02.053
   Song FJ, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4909
   Tang GL, 2008, ARCH SURG-CHICAGO, V143, P653, DOI 10.1001/archsurg.143.7.653
   Vouyouka AG, 2012, J VASC SURG, V56, P334, DOI 10.1016/j.jvs.2012.01.066
   WALKER MD, 1995, JAMA-J AM MED ASSOC, V273, P1421, DOI 10.1001/jama.1995.03520420037035
   Yang SS, 2014, J VASC SURG, V59, P749, DOI 10.1016/j.jvs.2013.10.055
   Yuo TH, 2013, J VASC SURG, V57, P627, DOI 10.1016/j.jvs.2012.09.036
   Zarins CK, 2009, J ENDOVASC THER, V16, P397, DOI 10.1583/08-2685.1
NR 29
TC 1
Z9 1
U1 0
U2 2
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD APR
PY 2020
VL 50
IS 4
BP 330
EP 342
DI 10.4070/kcj.2019.0125
PG 13
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA KU7US
UT WOS:000519918700005
PM 32096354
OA Green Published, Other Gold
DA 2021-04-22
ER

PT J
AU Hwang, TH
   Yu, HT
   Kim, TH
   Uhm, JS
   Kim, JY
   Joung, B
   Lee, MH
   Pak, HN
AF Hwang, Tae Hyun
   Yu, Hee Tae
   Kim, Tae-Hoon
   Uhm, Jae-Sun
   Kim, Jong-Youn
   Joung, Boyoung
   Lee, Moon-Hyoung
   Pak, Hui-Nam
TI Permanent Pacemaker Implantations after Catheter Ablation in Patients
   with Atrial Fibrillation Associated with Underlying Sinus Node
   Dysfunction
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Sinus node dysfunction; Atrial fibrillation; Catheter ablation;
   Pacemaker; artificial
ID COLLABORATION; MANAGEMENT; SELECTION; DESIGN; TRIAL; ESC
AB Background and Objectives: The objective of this study was to evaluate the long-term clinical outcomes and the incidence of permanent pacemaker implantation after catheter ablation in patients with of atrial fibrillation (AF) and sinus node dysfunction (SND).
   Methods: Among 3,068 total consecutive patients who underwent AF catheter ablation (AFCA), this study included 222 (9.5%; men 53.2%, 63.7 +/- 9.2 years of age, 81.5% paroxysmal AF) with underlying SND and a regular rhythm follow-up. We analyzed the rhythm outcomes, changes in the mean heart rate or heart rate variability, and permanent pacemaker implantation rate.
   Results: During 47.5 +/- 28.8 months of follow-up, 25 (11.3%) patients received pacemaker implantations due to symptomatic SND. More than half (56.0%,14/25) underwent a pacemaker implantation within 3 months of the AFCA, and the annual pacemaker implantation rate was 2.0% afterwards. Both the early (68.0% vs. 31.0%, p<0.001) and clinical AF recurrence (68.0% vs. 32.S%, p=0.001) rates and continuous antiarrhythmic drug use after 3 months (44.0% vs. 24.4%, p=0.036) were significantly higher in patients requiring pacemaker implantations than those that did not. An anterior linear ablation (odds ratio [OR], 9.37 [3.03-28.9]; p<0.001) and the E/Em (OR, 1.15 [1.02-1.28]; p=0.018) were independently associated with permanent pacemaker implantations after AFCA in patients with AF and SND.
   Conclusions: After AFCA in patients with AF and SND, 1 of 9 patients needed a pacemaker implantation and half needed implantations within 3 months. The AF recurrence rate was significantly higher in those who required pacemaker implantations after the AFCA.
C1 [Hwang, Tae Hyun; Yu, Hee Tae; Kim, Tae-Hoon; Uhm, Jae-Sun; Kim, Jong-Youn; Joung, Boyoung; Lee, Moon-Hyoung; Pak, Hui-Nam] Yonsei Univ Hlth Syst, Dept Cardiol, 50-1 Yonsei Ro, Seoul 03722, South Korea.
RP Pak, HN (corresponding author), Yonsei Univ Hlth Syst, Dept Cardiol, 50-1 Yonsei Ro, Seoul 03722, South Korea.
EM hnpak@yuhs.ac
RI ; Pak, Hui-Nam/C-4266-2015
OI Uhm, Jae-Sun/0000-0002-1611-8172; Pak, Hui-Nam/0000-0002-3256-3620; Kim,
   Jong-Youn/0000-0001-7040-8771; Joung, Boyoung/0000-0001-9036-7225; Kim,
   Tae-Hoon/0000-0003-4200-3456; Lee, Moon-Hyoung/0000-0002-7268-0741;
   Hwang, Taehyun/0000-0001-6498-8992
FU Ministry of Health and WelfareMinistry of Health, Labour and Welfare,
   Japan [HI18C0070, HI19C0114]; National Research Foundation of Korea
   (NRF) - Ministry of Science, ICT & Future Planning (MSIP)
   [NRF-2017R1A2B4003983]
FX This work was supported by a grant (HI18C0070) and (HI19C0114) from the
   Ministry of Health and Welfare and a grant (NRF-2017R1A2B4003983) from
   the Basic Science Research Program run by the National Research
   Foundation of Korea (NRF), which is funded by the Ministry of Science,
   ICT & Future Planning (MSIP).
CR Calkins H, 2012, HEART RHYTHM, V9, P632, DOI 10.1016/j.hrthm.2011.12.016
   Cha TJ, 2004, CIRCULATION, V109, P412, DOI 10.1161/01.CIR.0000109501.47603.0C
   Chang HY, 2013, EUROPACE, V15, P205, DOI 10.1093/europace/eus219
   Chen YW, 2014, PACE, V37, P403, DOI 10.1111/pace.12340
   Cho MS, 2018, J AM HEART ASSOC, V7, DOI 10.1161/JAHA.118.009629
   Elvan A, 1996, CIRCULATION, V94, P2953, DOI 10.1161/01.CIR.94.11.2953
   Hayashi K, 2016, CIRC J, V80, P887, DOI 10.1253/circj.CJ-15-1384
   Hocini M, 2003, CIRCULATION, V108, P1172, DOI 10.1161/01.CIR.0000090685.13169.07
   Kirchhof P, 2016, EUR HEART J, V37, P2893, DOI 10.1093/eurheartj/ehw210
   Kusumoto FM, 2019, CIRCULATION, V140, pE382, DOI 10.1161/CIR.0000000000000628
   Lamas GA, 2000, AM HEART J, V140, P541, DOI 10.1067/mhj.2000.109652
   Lamas GA, 2002, NEW ENGL J MED, V346, P1854, DOI 10.1056/NEJMoa013040
   Lee JY, 2017, EUR HEART J, V38, P2586, DOI 10.1093/eurheartj/ehx213
   Morton JB, 2003, CIRCULATION, V107, P1775, DOI 10.1161/01.CIR.0000058164.68127.F2
   Nielsen JC, 2011, EUR HEART J, V32, P686, DOI 10.1093/eurheartj/ehr022
   Pak HN, 2011, HEART RHYTHM, V8, P199, DOI 10.1016/j.hrthm.2010.10.015
   Park J, 2014, HEART RHYTHM, V11, P953, DOI 10.1016/j.hrthm.2014.03.009
   Sparks PB, 2000, CIRCULATION, V102, P1807
   Wang J, 2010, P NATL ACAD SCI USA, V107, P9753, DOI 10.1073/pnas.0912585107
   Yeh YH, 2009, CIRCULATION, V119, P1576, DOI 10.1161/CIRCULATIONAHA.108.789677
   Yu HT, 2017, EUROPACE, V19, P1132, DOI 10.1093/europace/euw142
NR 21
TC 3
Z9 3
U1 1
U2 2
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD APR
PY 2020
VL 50
IS 4
BP 346
EP 357
DI 10.4070/kcj.2019.0268
PG 12
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA KU7US
UT WOS:000519918700007
PM 31960638
OA Green Published, Other Gold
DA 2021-04-22
ER

PT J
AU Lee, GB
   Shim, JS
   Kim, HC
AF Lee, Ga Bin
   Shim, Jee Seon
   Kim, Hyeon Chang
TI Dose-Response Association between Smoking Cessation and Arteria
   Stiffness: The Cardiovascular and Metabolic Diseases Etiology Research
   Center (CMERC) Cohort
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Smoking cessation; Tobacco smoking; Vascular stiffness; Radial artery;
   Health behavior
ID NITRIC-OXIDE SYNTHESIS; SYMPATHETIC-NERVE ACTIVITY;
   HEART-RATE-VARIABILITY; CIGARETTE-SMOKING; AUGMENTATION INDEX;
   BLOOD-PRESSURE; SYSTEM
AB Background and Objectives: Cigarette smoking has been reported to be associated with arterial stiffness. However, the clinical relevance of smoking cessation on arterial stiffness is debatable. Thus, we evaluated whether smoking cessation is associated with arterial stiffness.
   Methods: A total of1,169 male participants aged 30-64 years with absence of cardiovascular diseases in 2013-2017 were selected from the Cardiovascular and Metabolic Disease Etiology Research Center cohort study. The subjects were classified into the following 5 groups based on self-reporting: non-smokers, former smokers (<1,1 to <10, and >= 10, years after cessation) , and current smokers. Arterial stiffness was assessed using the augmentation index (Aix). The radial artery Aix was obtained from the peripheral artery waveform. The association was explored cross-sectionally.
   Results: The Aix of former smokers did not differ from that of non-smokers (p=0.089). However, after former smokers were stratified by duration of smoking cessation, we noted a linear trend according to the smoking status (p<0.001). Men who quit smoking <1 year ago showed an elevated Aix (beta=3.94, standard error=1.54, p=0.011) as much as ones of current smokers (beta=4.39, standard error=0.74, p<0.001), while those who quit more than a decade ago showed an Aix similar to that of non-smokers (beta=0.35, standard error=0.82, p=0.670) after controlling covariates.
   Conclusions: A dose-response association between smoking cessation and AIx was revealed, which implies the possibility of a reversible effect of smoking cessation on arterial stiffness. Therefore, our findings may motivate current smokers to modify their smoking habits to delay or reverse disease progression.
C1 [Lee, Ga Bin] Yonsei Univ, Dept Publ Hlth, Grad Sch, Seoul, South Korea.
   [Shim, Jee Seon; Kim, Hyeon Chang] Yonsei Univ, Cardiovasc & Metab Dis Etiol Res Ctr, Coll Med, Seoul, South Korea.
   [Kim, Hyeon Chang] Yonsei Univ, Dept Prevent Med, Coll Med, 50 Yonsei Ro, Seoul 03722, South Korea.
RP Kim, HC (corresponding author), Yonsei Univ, Dept Prevent Med, Coll Med, 50 Yonsei Ro, Seoul 03722, South Korea.
EM HCKIM@yuhs.ac
RI ; Kim, Hyeon Chang/F-8796-2019
OI Shim, Jee-Seon/0000-0002-8671-3153; Kim, Hyeon
   Chang/0000-0001-7867-1240; lee, gabin/0000-0001-6574-1414
FU Korea Health Technology R&D Project - Ministry of Health and Welfare,
   Republic of Korea [HI13C0715]
FX This work supported by a grant from the Korea Health Technology R&D
   Project funded by the Ministry of Health and Welfare, Republic of Korea
   (grant number HI13C0715).
CR Ambrose JA, 2004, J AM COLL CARDIOL, V43, P1731, DOI 10.1016/j.jacc.2003.12.047
   BALLIGAND JL, 1993, P NATL ACAD SCI USA, V90, P347, DOI 10.1073/pnas.90.1.347
   Chowdhary S, 2000, HYPERTENSION, V36, P264, DOI 10.1161/01.HYP.36.2.264
   Chun MY, 2012, KOREAN J FAM MED, V33, P144, DOI 10.4082/kjfm.2012.33.3.144
   HAYNES WG, 1993, J HYPERTENS, V11, P1375, DOI 10.1097/00004872-199312000-00009
   Howard G, 1998, JAMA-J AM MED ASSOC, V279, P119, DOI 10.1001/jama.279.2.119
   Jatoi NA, 2007, HYPERTENSION, V49, P981, DOI 10.1161/HYPERTENSIONAHA.107.087338
   Kohara K, 2005, AM J HYPERTENS, V18, p11S, DOI 10.1016/j.amjhyper.2004.10.010
   Ng M, 2014, JAMA-J AM MED ASSOC, V311, P183, DOI 10.1001/jama.2013.284692
   MCGILL HC, 1988, AM HEART J, V115, P250, DOI 10.1016/0002-8703(88)90645-X
   Meng LT, 2007, HYPERTENS RES, V30, P713
   Middlekauff HR, 2014, J AM COLL CARDIOL, V64, P1740, DOI 10.1016/j.jacc.2014.06.1201
   Middlekauff HR, 2013, AM J PHYSIOL-HEART C, V305, pH1560, DOI 10.1152/ajpheart.00502.2013
   Minami J, 1999, HYPERTENSION, V33, P586, DOI 10.1161/01.HYP.33.1.586
   Node K, 1997, AM J CARDIOL, V79, P1538, DOI 10.1016/S0002-9149(97)00189-6
   Oren S, 2006, ANGIOLOGY, V57, P564, DOI 10.1177/0003319706293119
   Rehill N, 2006, BRIT J CLIN PHARMACO, V61, P767, DOI 10.1111/j.1365-2125.2006.02630.x
   SAKUMA I, 1992, CIRC RES, V70, P607, DOI 10.1161/01.RES.70.3.607
   Sartori C, 2005, PHARMACOL THERAPEUT, V106, P209, DOI 10.1016/j.pharmthera.2004.11.009
   Scherrer U, 2000, EUR J ENDOCRINOL, V142, P315, DOI 10.1530/eje.0.1420315
   Shim JS, 2017, EPIDEMIOL HEALTH, V39, DOI 10.4178/epih.e2017016
   Sun ZJ, 2015, HYPERTENSION, V65, P252, DOI 10.1161/HYPERTENSIONAHA.114.03617
   Tanaka H, 2005, AM J HYPERTENS, V18, P137, DOI 10.1016/j.amjhyper.2004.07.008
   van den Berkmortel FWPJ, 2004, NETH J MED, V62, P235
   Vartiainen E, 2002, J EPIDEMIOL COMMUN H, V56, P167, DOI 10.1136/jech.56.3.167
   WAGENKNECHT LE, 1992, AM J PUBLIC HEALTH, V82, P33, DOI 10.2105/AJPH.82.1.33
   Yotsukura M, 1998, AM HEART J, V135, P1004, DOI 10.1016/S0002-8703(98)70065-1
   Yu-Jie W, 2013, ANGIOLOGY, V64, P273, DOI 10.1177/0003319712447888
   Zhou JF, 2000, BIOMED ENVIRON SCI, V13, P44
NR 29
TC 1
Z9 1
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD APR
PY 2020
VL 50
IS 4
BP 361
EP 369
DI 10.4070/kcj.2019.0270
PG 9
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA KU7US
UT WOS:000519918700009
PM 31960641
OA Other Gold, Green Published
DA 2021-04-22
ER

PT J
AU Seo, J
   Kim, JS
AF Seo, Jongkwon
   Kim, Jung-Sun
TI Optimal Timing of Coronary Intervention in Non-Culprit Lesion in ST
   Elevation Myocardial Infarction with Multi-Vessel Disease
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
ID SEGMENT ELEVATION
C1 [Seo, Jongkwon] Inje Univ, Coll Med, Sanggye Paik Hosp, Div Cardiol,Dept Internal Med, Seoul, South Korea.
   [Kim, Jung-Sun] Yonsei Univ, Coll Med, Severance Cardiovasc Hosp, Div Cardiol, 50-1 Yonsei Ro, Seoul 03722, South Korea.
RP Kim, JS (corresponding author), Yonsei Univ, Coll Med, Severance Cardiovasc Hosp, Div Cardiol, 50-1 Yonsei Ro, Seoul 03722, South Korea.
EM kjs1218@yuhs.ac
OI Kim, Jung-Sun/0000-0003-2263-3274
CR Ahn KT, 2020, KOREAN CIRC J, V50, P220, DOI 10.4070/kcj.2019.0176
   Ibanez B, 2018, EUR HEART J, V39, P119, DOI 10.1093/eurheartj/ehx393
   Kim I, 2017, KOREAN CIRC J, V47, P36, DOI 10.4070/kcj.2015.0358
   Kwon SW, 2018, KOREAN CIRC J, V48, P989, DOI 10.4070/kcj.2017.0387
   Wald DS, 2013, NEW ENGL J MED, V369, P1115, DOI 10.1056/NEJMoa1305520
NR 5
TC 0
Z9 0
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAR
PY 2020
VL 50
IS 3
BP 234
EP 235
DI 10.4070/kcj.2020.0041
PG 2
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA KR7XV
UT WOS:000517831100004
PM 32100480
OA Green Published, Other Gold
DA 2021-04-22
ER

PT J
AU Sung, J
AF Sung, Jidong
TI The Long and Winding Road: To the Proper Understanding of High-density
   Lipoprotein
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
ID SECONDARY PREVENTION; CHOLESTEROL
C1 [Sung, Jidong] Sungkyunkwan Univ, Prevent & Rehabil Ctr, Heart Vasc & Stroke Inst, Sch Med,Dept Med,Samsung Med Ctr,Div Cardiol, 81 Irwon Ro, Seoul 06351, South Korea.
RP Sung, J (corresponding author), Sungkyunkwan Univ, Prevent & Rehabil Ctr, Heart Vasc & Stroke Inst, Sch Med,Dept Med,Samsung Med Ctr,Div Cardiol, 81 Irwon Ro, Seoul 06351, South Korea.
EM jdsung@skku.edu
CR Briel M, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b92
   Cho Hongkeun, 2007, Korean Circulation Journal, V37, P187
   Choi S, 2020, KOREAN CIRC J, V50, P236, DOI 10.4070/kcj.2019.0195
   JIN KIM， BYUNG, 2018, [Journal of Lipid and Atherosclerosis, 지질Â·동맥경화학회지], V7, P12, DOI 10.12997/jla.2018.7.1.12
   Khera AV, 2011, NEW ENGL J MED, V364, P127, DOI 10.1056/NEJMoa1001689
   Kim KH, 2016, KOREAN CIRC J, V46, P324, DOI 10.4070/kcj.2016.46.3.324
   Marz W, 2017, CLIN RES CARDIOL, V106, P663, DOI 10.1007/s00392-017-1106-1
   Rubins HB, 1999, NEW ENGL J MED, V341, P410, DOI 10.1056/NEJM199908053410604
   WILSON PWF, 1988, ARTERIOSCLEROSIS, V8, P737, DOI 10.1161/01.ATV.8.6.737
NR 9
TC 1
Z9 1
U1 1
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAR
PY 2020
VL 50
IS 3
BP 248
EP 249
DI 10.4070/kcj.2020.0020
PG 2
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA KR7XV
UT WOS:000517831100006
PM 32100481
OA Green Published, Other Gold
DA 2021-04-22
ER

PT J
AU Seok, H
AF Seok, Heeyoung
TI A New Member of Myocardial Ischemia-Reperfusion (MI/R) Associated
   miRNAs, miR-484: Its Potential Cardiac Protection Role
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
ID MICRORNAS; HEART
C1 [Seok, Heeyoung] Korea Univ, Div Life Sci, Coll Life Sci & Biotechnol, 145 Anam Ro, Seoul 02841, South Korea.
RP Seok, H (corresponding author), Korea Univ, Div Life Sci, Coll Life Sci & Biotechnol, 145 Anam Ro, Seoul 02841, South Korea.
EM hyseok1@korea.ac.kr
RI seok, heeyoung/ABC-3957-2020
FU National Research Foundation of Korea - Ministry of Education
   [NRF-2017R1D1A1B03030852]
FX This work was supported by the grant from National Research Foundation
   of Korea funded by the Ministry of Education (NRF-2017R1D1A1B03030852)
   to H.S.
CR Boon RA, 2015, NAT REV CARDIOL, V12, P135, DOI 10.1038/nrcardio.2014.207
   Euler G, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00066
   Fiedler J, 2013, ARTERIOSCL THROM VAS, V33, P201, DOI 10.1161/ATVBAHA.112.300137
   Gabisonia K, 2019, NATURE, V569, P418, DOI 10.1038/s41586-019-1191-6
   Liu HZ, 2020, KOREAN CIRC J, V50, P250, DOI 10.4070/kcj.2019.0107
   Olson EN, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009008
   Sucharov C, 2008, J MOL CELL CARDIOL, V45, P185, DOI 10.1016/j.yjmcc.2008.04.014
   van Rooij E, 2006, P NATL ACAD SCI USA, V103, P18255, DOI 10.1073/pnas.0608791103
   Wang K, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1770
   Zhou SS, 2018, ACTA PHARMACOL SIN, V39, P1073, DOI 10.1038/aps.2018.30
   Zhu L, 2011, CELL BIOSCI, V1, DOI 10.1186/2045-3701-1-44
NR 11
TC 0
Z9 0
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAR
PY 2020
VL 50
IS 3
BP 264
EP 266
DI 10.4070/kcj.2019.0413
PG 3
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA KR7XV
UT WOS:000517831100008
PM 32100482
OA Other Gold, Green Published
DA 2021-04-22
ER

PT J
AU Lee, KH
AF Lee, Ki Hong
TI How to Overcome Social Inequalities of Oral Anticoagulation Usage in
   Korea?
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
ID ATRIAL-FIBRILLATION
C1 [Lee, Ki Hong] Chonnam Natl Univ Hosp, Dept Cardiovasc Med, 42 Jebong Ro, Gwangju 61469, South Korea.
RP Lee, KH (corresponding author), Chonnam Natl Univ Hosp, Dept Cardiovasc Med, 42 Jebong Ro, Gwangju 61469, South Korea.
EM drgood2@naver.com
OI Lee, Ki Hong/0000-0002-9938-3464
CR Fosbol EL, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000110
   Inoue H, 2014, CIRC J, V78, P1997, DOI 10.1253/circj.CJ-66-0092
   January CT, 2014, J AM COLL CARDIOL, V64, pE1, DOI 10.1016/j.jacc.2014.03.022
   Kirchhof P, 2016, EUROPACE, V18, DOI 10.1093/europace/euw295
   Lee EH, 2020, KOREAN J ORTHOD, V50, P3, DOI 10.4041/kjod.2020.50.1.3
   Lee KH, 2015, EUROPACE, V17, P69, DOI 10.1093/europace/euv198
   Lip GYH, 2015, INT J CARDIOL, V180, P246, DOI 10.1016/j.ijcard.2014.11.182
   Ruff CT, 2014, LANCET, V383, P955, DOI 10.1016/S0140-6736(13)62343-0
   Yu HT, 2020, KOREAN CIRC J, V50, P267, DOI 10.4070/kcj.2019.0207
NR 9
TC 0
Z9 0
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAR
PY 2020
VL 50
IS 3
BP 278
EP 280
DI 10.4070/kcj.2020.0007
PG 3
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA KR7XV
UT WOS:000517831100010
PM 32100484
OA Green Published
DA 2021-04-22
ER

PT J
AU Mohandes, M
   Pernigotti, A
   Morr, CI
   Bardaji, A
AF Mohandes, Mohsen
   Pernigotti, Alberto
   Morr, Carlos Igor
   Bardaji, Alfredo
TI Percutaneous Left Atrial Appendage Closure in the Presence of Thrombus
   Using LAmbre Device and Cerebral Protection System
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
C1 [Mohandes, Mohsen; Pernigotti, Alberto] Rovira & Virgili Univ, Joan XXIII Univ Hosp, Cardiol Div, IISPV,Intervent Cardiol Unit, Tarragona, Spain.
   [Morr, Carlos Igor] Rovira & Virgili Univ, Joan XXIII Univ Hosp, Cardiol Div, IISPV,Echocardiog & Image Dept, Tarragona, Spain.
   [Bardaji, Alfredo] Rovira & Virgili Univ, Joan XXIII Univ Hosp, IISPV, Cardiol Div, Tarragona, Spain.
RP Mohandes, M (corresponding author), Univ Rovira Virgili, Joan XXIII Univ Hosp, Cardiol Div, Intervent Cardiol Unit,IISPV, Calle Dr Mallafre Guasch 4, Tarragona 43007, Spain.
EM mohandesmohsen@hotmail.com
RI Bardaji, Alfredo/V-7985-2019
OI Bardaji, Alfredo/0000-0003-1900-6974
CR Bellmann B, 2017, INT J CARDIOL, V234, P146, DOI 10.1016/j.ijcard.2016.12.141
   Tarantini G, 2018, EUROINTERVENTION, V13, P1595, DOI 10.4244/EIJ-D-17-00777
NR 2
TC 1
Z9 1
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAR
PY 2020
VL 50
IS 3
BP 281
EP 283
DI 10.4070/kcj.2019.0305
PG 3
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA KR7XV
UT WOS:000517831100011
PM 31960636
OA Green Published, Other Gold
DA 2021-04-22
ER

PT J
AU Yang, HJ
   Shin, JA
   Kim, KM
   Yoon, JH
   Lee, JY
AF Yang, Hyo Ju
   Shin, Ju Ae
   Kim, Kyung Min
   Yoon, Ji Hong
   Lee, Jae Young
TI A Congenital Annular Pericardial Fibrous Band Diagnosed at Fetal Life
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
C1 [Yang, Hyo Ju; Shin, Ju Ae; Kim, Kyung Min; Yoon, Ji Hong; Lee, Jae Young] Catholic Univ Korea, Seoul St Marys Hosp, Coll Med, Dept Pediat, 222 Banpo Daero, Seoul 06591, South Korea.
RP Lee, JY (corresponding author), Catholic Univ Korea, Seoul St Marys Hosp, Coll Med, Dept Pediat, 222 Banpo Daero, Seoul 06591, South Korea.
EM jaeyounglee@catholic.ac.kr
OI Yoon, Ji Hong/0000-0001-8498-2352
CR Adler Y, 2015, EUR HEART J, V36, P2873, DOI 10.1093/eurheartj/ehv479
   Gautam MP, 2012, BMJ CASE REP, V2012
   Karakus A, 2017, ECHOCARDIOGR-J CARD, V34, P320, DOI 10.1111/echo.13424
   Parmar YJ, 2017, CARDIOL CLIN, V35, P601, DOI 10.1016/j.ccl.2017.07.012
NR 4
TC 1
Z9 1
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAR
PY 2020
VL 50
IS 3
BP 284
EP 287
DI 10.4070/kcj.2019.0274
PG 4
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA KR7XV
UT WOS:000517831100012
PM 31845560
OA Green Published, Other Gold
DA 2021-04-22
ER

PT J
AU Kay, FU
   Canan, A
   Abbara, S
AF Kay, Fernando Uliana
   Canan, Arzu
   Abbara, Suhny
TI Future Directions in Coronary CT Angiography: CT-Fractional Flow
   Reserve, Plaque Vulnerability, and Quantitative Plaque Assessment
SO KOREAN CIRCULATION JOURNAL
LA English
DT Review
DE Coronary computed tomography angiography; Coronary plaque; Fractional
   flow reserve; Plaque characterization; Plaque volume
ID COMPUTED-TOMOGRAPHY ANGIOGRAPHY; COMPUTATIONAL FLUID-DYNAMICS;
   NAPKIN-RING SIGN; DIAGNOSTIC PERFORMANCE; ARTERY-DISEASE; CHEST-PAIN;
   HIGH-RISK; NONINVASIVE ASSESSMENT; FUNCTIONAL SEVERITY; HEART-DISEASE
AB Coronary computed tomography angiography (CCTA) is a well-validated and noninvasive imaging modality for the assessment of coronary artery disease (CAD) in patients with stable ischemic heart disease and acute coronary syndromes (ACSs). CCTA not only delineates the anatomy of the heart and coronary arteries in detail, but also allows for intra- and extraluminal imaging of coronary arteries. Emerging technologies have promoted new CCTA applications, resulting in a comprehensive assessment of coronary plaques and their clinical significance. The application of computational fluid dynamics to CCTA resulted in a robust tool for noninvasive assessment of coronary blood flow hemodynamics and determination of hemodynamically significant stenosis. Detailed evaluation of plaque morphology and identification of high-risk plaque features by CCTA have been confirmed as predictors of future outcomes, identifying patients at risk for ACSs. With quantitative coronary plaque assessment, the progression of the CAD or the response to therapy could be monitored by CCTA. The aim of this article is to review the future directions of emerging applications in CCTA, such as computed tomography (CT)-fractional flow reserve, imaging of vulnerable plaque features, and quantitative plaque imaging. We will also briefly discuss novel methods appearing in the coronary imaging scenario, such as machine learning, radiomics, and spectral CT.
C1 [Kay, Fernando Uliana; Canan, Arzu; Abbara, Suhny] UT Southwestern Med Ctr, Dept Radiol, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.
RP Kay, FU (corresponding author), UT Southwestern Med Ctr, Dept Radiol, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.
EM fernando.kay@utsouthwestern.edu
OI Canan, Arzu/0000-0002-3303-8318; Kay, Fernando/0000-0002-9467-2013
CR AGATSTON AS, 1990, J AM COLL CARDIOL, V15, P827, DOI 10.1016/0735-1097(90)90282-T
   Alexanderson E, 2008, J NUCL CARDIOL, V15, P841, DOI 10.1007/BF03007367
   Bamberg F, 2011, EUR RADIOL, V21, P1424, DOI 10.1007/s00330-011-2062-1
   Barreto Mitya, 2008, J Cardiovasc Comput Tomogr, V2, P234, DOI 10.1016/j.jcct.2008.05.146
   Bittner DO, 2018, CIRC-CARDIOVASC IMAG, V11, DOI 10.1161/CIRCIMAGING.118.007657
   Boogers MJ, 2010, JACC-CARDIOVASC IMAG, V3, P699, DOI 10.1016/j.jcmg.2010.01.010
   Budoff MJ, 2008, J AM COLL CARDIOL, V52, P1724, DOI 10.1016/j.jacc.2008.07.031
   Cho IJ, 2018, J AM COLL CARDIOL, V71, P1998, DOI [10.1016/S0735-1097(18)32539-7, 10.1016/j.jacc.2018.02.079]
   Choi G, 2015, JACC-CARDIOVASC IMAG, V8, P1156, DOI 10.1016/j.jcmg.2015.04.024
   Chung JH, 2017, AM J CARDIOL, V120, P362, DOI 10.1016/j.amjcard.2017.04.057
   Coenen A, 2015, RADIOLOGY, V274, P674, DOI 10.1148/radiol.14140992
   Cury RC, 2016, JACC-CARDIOVASC IMAG, V9, P1099, DOI 10.1016/j.jcmg.2016.05.005
   de Vos BD, 2019, IEEE T MED IMAGING, V38, P2127, DOI 10.1109/TMI.2019.2899534
   Dey D, 2018, EUR RADIOL, V28, P2655, DOI 10.1007/s00330-017-5223-z
   Dey Damini, 2009, J Cardiovasc Comput Tomogr, V3, P372, DOI 10.1016/j.jcct.2009.09.004
   Douglas PS, 2015, EUR HEART J, V36, P3359, DOI 10.1093/eurheartj/ehv444
   Douglas PS, 2015, NEW ENGL J MED, V372, P1291, DOI 10.1056/NEJMoa1415516
   Dweck MR, 2012, J AM COLL CARDIOL, V59, P1539, DOI 10.1016/j.jacc.2011.12.037
   Fairbairn TA, 2018, EUR HEART J, V39, P3701, DOI 10.1093/eurheartj/ehy530
   Falk E, 2013, EUR HEART J, V34, P719, DOI 10.1093/eurheartj/ehs411
   Fearon WF, 2007, AM HEART J, V154, P632, DOI 10.1016/j.ahj.2007.06.012
   Fearon WF, 2010, CIRCULATION, V122, P2545, DOI 10.1161/CIRCULATIONAHA.109.925396
   Ferencik M, 2018, JAMA CARDIOL, V3, P144, DOI 10.1001/jamacardio.2017.4973
   Fordyce CB, 2016, J AM COLL CARDIOL, V67, P843, DOI 10.1016/j.jacc.2015.11.055
   GLAGOV S, 1987, NEW ENGL J MED, V316, P1371, DOI 10.1056/NEJM198705283162204
   Goeller M, 2018, J CARDIOVASC COMPUT, V12, P67, DOI 10.1016/j.jcct.2017.11.007
   Han D, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.116.004186
   Hedgire S, 2018, RADIOLOGY, V287, P808, DOI 10.1148/radiol.2017171568
   Hell MM, 2017, EUR HEART J-CARD IMG, V18, P1331, DOI 10.1093/ehjci/jex183
   Hlatky MA, 2015, J AM COLL CARDIOL, V66, P2315, DOI 10.1016/j.jacc.2015.09.051
   Hoffmann U, 2006, J AM COLL CARDIOL, V47, P1655, DOI 10.1016/j.jacc.2006.01.041
   Hoffmann U, 2012, NEW ENGL J MED, V367, P299, DOI 10.1056/NEJMoa1201161
   Itu L, 2016, J APPL PHYSIOL, V121, P42, DOI 10.1152/japplphysiol.00752.2015
   Kalisz K, 2017, RADIOGRAPHICS, V37, P1955, DOI 10.1148/rg.2017170100
   Kashiwagi M, 2009, JACC-CARDIOVASC IMAG, V2, P1412, DOI 10.1016/j.jcmg.2009.09.012
   Kelion AD, 2018, J CARDIOVASC COMPUT, V12, P516, DOI 10.1016/j.jcct.2018.09.001
   Kim HJ, 2010, ANN BIOMED ENG, V38, P3195, DOI 10.1007/s10439-010-0083-6
   Kim HJ, 2010, ANN BIOMED ENG, V38, P2314, DOI 10.1007/s10439-010-9992-7
   Kim HJ, 2009, ANN BIOMED ENG, V37, P2153, DOI 10.1007/s10439-009-9760-8
   Ko BS, 2017, JACC-CARDIOVASC IMAG, V10, P663, DOI 10.1016/j.jcmg.2016.07.005
   Kolossvary M, 2019, EUR HEART J-CARD IMG, V20, P1250, DOI 10.1093/ehjci/jez033
   Kolossvary M, 2017, CIRC-CARDIOVASC IMAG, V10, DOI 10.1161/CIRCIMAGING.117.006843
   Kolossvary M, 2018, J THORAC IMAG, V33, P26, DOI 10.1097/RTI.0000000000000268
   Koo BK, 2011, J AM COLL CARDIOL, V58, P1989, DOI 10.1016/j.jacc.2011.06.066
   Lee JM, 2019, JACC-CARDIOVASC IMAG, V12, P1032, DOI 10.1016/j.jcmg.2018.01.023
   Lee SE, 2016, AM HEART J, V182, P72, DOI 10.1016/j.ahj.2016.09.003
   Linde JJ, 2013, INT J CARDIOL, V168, P5257, DOI 10.1016/j.ijcard.2013.08.020
   Litt HI, 2012, NEW ENGL J MED, V366, P1393, DOI 10.1056/NEJMoa1201163
   Maroules CD, 2018, J CARDIOVASC COMPUT, V12, P125, DOI 10.1016/j.jcct.2017.11.014
   Maurovich-Horvat P, 2010, JACC-CARDIOVASC IMAG, V3, P440, DOI 10.1016/j.jcmg.2010.02.003
   Meijboom WB, 2008, J AM COLL CARDIOL, V52, P636, DOI 10.1016/j.jacc.2008.05.024
   Meijboom WB, 2008, J AM COLL CARDIOL, V52, P2135, DOI 10.1016/j.jacc.2008.08.058
   Miller JM, 2008, NEW ENGL J MED, V359, P2324, DOI 10.1056/NEJMoa0806576
   Min JK, 2012, JAMA-J AM MED ASSOC, V308, P1237, DOI 10.1001/2012.jama.11274
   Montalescot G, 2013, EUR HEART J, V34, P2949, DOI 10.1093/eurheartj/eht296
   Motoyama S, 2007, J AM COLL CARDIOL, V50, P319, DOI 10.1016/j.jacc.2007.03.044
   Motoyama S, 2007, CIRC J, V71, P363, DOI 10.1253/circj.71.363
   Motoyama S, 2015, J AM COLL CARDIOL, V66, P337, DOI 10.1016/j.jacc.2015.05.069
   Motoyama S, 2009, J AM COLL CARDIOL, V54, P49, DOI 10.1016/j.jacc.2009.02.068
   Nadjiri J, 2016, J CARDIOVASC COMPUT, V10, P97, DOI 10.1016/j.jcct.2016.01.007
   Narula J, 2013, J AM COLL CARDIOL, V61, P1041, DOI 10.1016/j.jacc.2012.10.054
   Newby D, 2015, LANCET, V385, P2383, DOI 10.1016/S0140-6736(15)60291-4
   Norgaard BL, 2014, J AM COLL CARDIOL, V63, P1145, DOI 10.1016/j.jacc.2013.11.043
   Oikonomou EK, 2018, LANCET, V392, P929, DOI 10.1016/S0140-6736(18)31114-0
   Otsuka K, 2013, JACC-CARDIOVASC IMAG, V6, P448, DOI 10.1016/j.jcmg.2012.09.016
   Ovrehus KA, 2018, J CARDIOVASC COMPUT, V12, P344, DOI 10.1016/j.jcct.2018.04.008
   Pijls NHJ, 1996, NEW ENGL J MED, V334, P1703, DOI 10.1056/NEJM199606273342604
   Pijls NHJ, 2010, J AM COLL CARDIOL, V56, P177, DOI 10.1016/j.jacc.2010.04.012
   Pontone G, 2019, JACC CARDIOVASC IMAG
   Puchner SB, 2014, J AM COLL CARDIOL, V64, P684, DOI 10.1016/j.jacc.2014.05.039
   Rogers IS, 2010, JACC-CARDIOVASC IMAG, V3, P388, DOI 10.1016/j.jcmg.2010.01.004
   Saremi F, 2015, AM J ROENTGENOL, V204, pW249, DOI 10.2214/AJR.14.13760
   Schaar JA, 2004, EUR HEART J, V25, P1077, DOI 10.1016/j.ehj.2004.01.002
   Scheske JA, 2013, RADIOLOGY, V268, P702, DOI 10.1148/radiol.13121901
   Shin S, 2017, JACC-CARDIOVASC IMAG, V10, P437, DOI 10.1016/j.jcmg.2016.04.013
   Singh G, 2018, J CARDIOVASC COMPUT, V12, P192, DOI 10.1016/j.jcct.2018.04.010
   Sullivan DC, 2015, RADIOLOGY, V277, P813, DOI 10.1148/radiol.2015142202
   Symons R, 2019, INT J CARDIOVAS IMAG, V35, P733, DOI 10.1007/s10554-018-1499-6
   Symons R, 2018, J CARDIOVASC COMPUT, V12, P509, DOI 10.1016/j.jcct.2018.10.008
   Taylor CA, 2013, J AM COLL CARDIOL, V61, P2233, DOI 10.1016/j.jacc.2012.11.083
   Thondapu V, 2017, EUR HEART J, V38, P81, DOI 10.1093/eurheartj/ehv689
   Tonino PAL, 2010, J AM COLL CARDIOL, V55, P2816, DOI 10.1016/j.jacc.2009.11.096
   Tonino PAL, 2009, NEW ENGL J MED, V360, P213, DOI 10.1056/NEJMoa0807611
   Tuncay V, 2018, J CARDIOVASC COMPUT, V12, P257, DOI 10.1016/j.jcct.2018.02.003
   Williams MC, 2019, J AM COLL CARDIOL, V73, P291, DOI 10.1016/j.jacc.2018.10.066
   Wolk MJ, 2014, J AM COLL CARDIOL, V63, P380, DOI 10.1016/j.jacc.2013.11.009
   Wykrzykowska J, 2009, J NUCL MED, V50, P563, DOI 10.2967/jnumed.108.055616
   Zhang JM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153070
   Zhou J, 2019, CIRC-CARDIOVASC IMAG, V12, DOI 10.1161/CIRCIMAGING.118.008002
NR 89
TC 1
Z9 1
U1 1
U2 9
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAR
PY 2020
VL 50
IS 3
BP 185
EP 202
DI 10.4070/kcj.2019.0315
PG 18
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA KR7XV
UT WOS:000517831100001
PM 31960635
OA Green Published, Other Gold
DA 2021-04-22
ER

PT J
AU Bhaskaran, A
   De Silva, K
   Rao, K
   Campbell, T
   Trivic, I
   Bennett, RG
   Kizana, E
   Kumar, S
AF Bhaskaran, Ashwin
   De Silva, Kasun
   Rao, Karan
   Campbell, Timothy
   Trivic, Ivana
   Bennett, Richard G.
   Kizana, Eddy
   Kumar, Saurabh
TI Ventricular Tachycardia Ablation in Non-ischemic Cardiomyopathy
SO KOREAN CIRCULATION JOURNAL
LA English
DT Review
DE Ventricular tachycardia; Catheter ablation; Cardiomyopathies
ID EPICARDIAL CATHETER ABLATION; CARDIAC SARCOIDOSIS; RADIOFREQUENCY
   ABLATION; INTRACARDIAC ECHOCARDIOGRAPHY; HYPERTROPHIC CARDIOMYOPATHY;
   SUBSTRATE ABLATION; POSITION STATEMENT; WORKING GROUP; SUDDEN-DEATH;
   SCAR
AB Non-ischemic cardiomyopathies are a heterogeneous group of diseases of the myocardium that have a distinct proclivity to ventricular arrhythmias. Of these, ventricular tachycardias pose significant management challenges with the risk of sudden cardiac death and morbidity from multiple causes. Catheter ablation of ventricular tachycardias is becoming an increasingly utilised intervention that has been found to have significant benefits with improving symptoms, reducing anti-arrhythmic drug burden and debilitating device therapies, thereby improving quality of life. Nonetheless, the approach to the ablation of ventricular tachycardias in non-ischemic cardiomyopathies is governed heavily by the disease process, with several distinct differences from ischemic cardiomyopathy including a preponderance to epicardial and deep intramural substrate. This contemporary review aims to present the various disease processes within non-ischemic cardiomyopathies, catheter ablation techniques which have been developed to target ventricular tachycardia and more novel adjunctive therapeutic measures.
C1 [Bhaskaran, Ashwin; De Silva, Kasun; Rao, Karan; Campbell, Timothy; Trivic, Ivana; Bennett, Richard G.; Kizana, Eddy; Kumar, Saurabh] Westmead Hosp, Dept Cardiol, Sydney, NSW, Australia.
   [Trivic, Ivana; Bennett, Richard G.; Kizana, Eddy; Kumar, Saurabh] Univ Sydney, Westmead Appl Res Ctr, Sydney, NSW, Australia.
   [Kizana, Eddy] Westmead Inst Med Res, Ctr Heart Res, Westmead, NSW, Australia.
RP Kumar, S (corresponding author), Univ Sydney, Cardiol Dept, Westmead Hosp, Westmead Appl Res Ctr, Corner Hawkesbury & Darcy Rd, Westmead, NSW 2145, Australia.
EM saurabh.kumar@health.nsw.gov.au
RI Hojsak, Iva/AAI-8937-2020
OI Hojsak, Iva/0000-0003-3262-5964; Bhaskaran, Ashwin/0000-0002-8049-5618;
   Campbell, Timothy/0000-0003-4793-7741; Rao, Karan/0000-0003-4689-9982;
   Kumar, Saurabh/0000-0002-5643-5076; Trivic, Ivana/0000-0003-3912-1486
CR AbdelWahab A, 2015, CIRC-ARRHYTHMIA ELEC, V8, P1181, DOI 10.1161/CIRCEP.115.002940
   Adabag AS, 2008, J AM COLL CARDIOL, V51, P1369, DOI 10.1016/j.jacc.2007.11.071
   Aliot EM, 2009, EUROPACE, V11, P771, DOI 10.1093/europace/eup098
   Arbustini E, 2014, J AM COLL CARDIOL, V64, P304, DOI 10.1016/j.jacc.2014.05.027
   Aryana Arash, 2017, Card Electrophysiol Clin, V9, P119, DOI 10.1016/j.ccep.2016.10.009
   Bai R, 2011, CIRC-ARRHYTHMIA ELEC, V4, P478, DOI 10.1161/CIRCEP.111.963066
   BAJAJ AK, 1988, AM HEART J, V116, P557, DOI 10.1016/0002-8703(88)90634-5
   Bala R, 2011, CIRC-ARRHYTHMIA ELEC, V4, P667, DOI 10.1161/CIRCEP.111.963553
   Berte B, 2015, J CARDIOVASC ELECTR, V26, P42, DOI 10.1111/jce.12555
   Betensky BP, 2012, HEART RHYTHM, V9, P884, DOI 10.1016/j.hrthm.2012.02.010
   Birnie DH, 2014, HEART RHYTHM, V11, P1304, DOI 10.1016/j.hrthm.2014.03.043
   BRIGDEN W, 1957, LANCET, V2, P1243
   Callans DJ, 1999, CIRCULATION, V100, P1744, DOI 10.1161/01.CIR.100.16.1744
   Cardoso R, 2019, J CARDIOVASC ELECTR, V30, P1537, DOI 10.1111/jce.14013
   Cuculich PS, 2017, NEW ENGL J MED, V377, P2325, DOI 10.1056/NEJMoa1613773
   D'Avila A, 2007, J CARDIOVASC ELECTR, V18, P1178, DOI 10.1111/j.1540-8167.2007.00945.x
   DEBAKKER JMT, 1993, CIRCULATION, V88, P915, DOI 10.1161/01.CIR.88.3.915
   Desjardins B, 2010, J AM COLL CARDIOL, V56, P1320, DOI 10.1016/j.jacc.2010.04.054
   Dickfeld T, 2011, CIRC-ARRHYTHMIA ELEC, V4, P172, DOI 10.1161/CIRCEP.110.958744
   Dukkipati SR, 2011, CIRC-ARRHYTHMIA ELEC, V4, P185, DOI 10.1161/CIRCEP.110.957290
   Elliott P, 2008, EUR HEART J, V29, P270, DOI 10.1093/eurheartj/ehm342
   Fiala M, 2010, J CARDIOVASC ELECTR, V21, P704, DOI 10.1111/j.1540-8167.2009.01674.x
   Garcia FC, 2009, CIRCULATION, V120, P366, DOI 10.1161/CIRCULATIONAHA.108.834903
   Geraghty L, 2019, HEART LUNG CIRC, V28, P123, DOI 10.1016/j.hlc.2018.10.005
   Glashan CA, 2018, EUR HEART J, V39, P2867, DOI 10.1093/eurheartj/ehy168
   Gokoglan Y, 2016, J AM COLL CARDIOL, V68, P1990, DOI 10.1016/j.jacc.2016.08.033
   Gonzalez Jaime E, 2016, Card Electrophysiol Clin, V8, P139, DOI 10.1016/j.ccep.2015.10.014
   GOODWIN JF, 1961, BRIT MED J, V1, P69, DOI 10.1136/bmj.1.5219.69
   Graham AJ, 2017, ARRHYTH ELECTROPHYSI, V6, P118, DOI 10.15420/aer.2017.20.1
   Gunda S, 2015, CIRC-ARRHYTHMIA ELEC, V8, P890, DOI 10.1161/CIRCEP.115.002921
   Haqqani HM, 2011, HEART RHYTHM, V8, P1169, DOI 10.1016/j.hrthm.2011.03.008
   Hsia HH, 2003, CIRCULATION, V108, P704, DOI 10.1161/01.CIR.0000083725.72693.EA
   Hutchinson MD, 2011, CIRC-ARRHYTHMIA ELEC, V4, P49, DOI 10.1161/CIRCEP.110.959957
   Ichinose A, 2008, AM J ROENTGENOL, V191, P862, DOI 10.2214/AJR.07.3089
   Igarashi M, 2018, JACC-CLIN ELECTROPHY, V4, P339, DOI 10.1016/j.jacep.2017.12.020
   Koplan BA, 2006, HEART RHYTHM, V3, P924, DOI 10.1016/j.hrthm.2006.03.031
   Koruth JS, 2012, HEART RHYTHM, V9, P1932, DOI 10.1016/j.hrthm.2012.08.001
   Kreidieh B, 2016, CIRC-ARRHYTHMIA ELEC, V9, DOI 10.1161/CIRCEP.116.004352
   Kumar S, 2017, CIRC-ARRHYTHMIA ELEC, V10, DOI 10.1161/CIRCEP.116.003676
   Kumar S, 2016, J AM COLL CARDIOL, V68, P2299, DOI 10.1016/j.jacc.2016.08.058
   Kumar S, 2016, CIRC-ARRHYTHMIA ELEC, V9, DOI 10.1161/CIRCEP.116.004357
   Kumar S, 2015, HEART RHYTHM, V12, P1691, DOI 10.1016/j.hrthm.2015.03.045
   Kumar S, 2015, CIRC-ARRHYTHMIA ELEC, V8, P606, DOI 10.1161/CIRCEP.114.002522
   Kumar S, 2015, CIRC-ARRHYTHMIA ELEC, V8, P87, DOI 10.1161/CIRCEP.114.002145
   Kumareswaran R, 2018, ARRHYTH ELECTROPHYSI, V7, P159, DOI 10.15420/aer.2018.10.2
   Lim HS, 2014, HEART RHYTHM, V11, P1658, DOI 10.1016/j.hrthm.2014.05.041
   Link MS, 2014, J AM COLL CARDIOL, V64, P119, DOI 10.1016/j.jacc.2014.04.035
   Liuba I, 2014, HEART RHYTHM, V11, P755, DOI 10.1016/j.hrthm.2014.02.012
   Maccabelli G, 2014, EUROPACE, V16, P1363, DOI 10.1093/europace/euu017
   Maron BJ, 2007, JAMA-J AM MED ASSOC, V298, P405, DOI 10.1001/jama.298.4.405
   Maron BJ, 2006, CIRCULATION, V113, P1807, DOI 10.1161/CIRCULATIONAHA.106.174287
   Maron MS, 2008, CIRCULATION, V118, P1541, DOI 10.1161/CIRCULATIONAHA.108.781401
   Meune C, 2006, NEW ENGL J MED, V354, P209, DOI 10.1056/NEJMc052632
   Michowitz Y, 2010, HEART RHYTHM, V7, P1635, DOI 10.1016/j.hrthm.2010.07.009
   Nagashima K, 2011, CIRC J, V75, P565, DOI 10.1253/circj.CJ-10-0870
   Nazarian S, 2017, NEW ENGL J MED, V377, P2555, DOI 10.1056/NEJMoa1604267
   Nguyen DT, 2018, JACC-CLIN ELECTROPHY, V4, P1176, DOI 10.1016/j.jacep.2018.06.021
   Nguyen Duy T, 2017, JACC Clin Electrophysiol, V3, P1103, DOI 10.1016/j.jacep.2017.03.006
   Nguyen DT, 2015, J CARDIOVASC ELECTR, V26, P792, DOI 10.1111/jce.12682
   Oloriz T, 2016, EUROPACE, V18, P1850, DOI 10.1093/europace/euv360
   Oloriz T, 2014, CIRC-ARRHYTHMIA ELEC, V7, P414, DOI 10.1161/CIRCEP.114.001568
   Pasotti M, 2008, J AM COLL CARDIOL, V52, P1250, DOI 10.1016/j.jacc.2008.06.044
   Piers SRD, 2013, CIRC-ARRHYTHMIA ELEC, V6, P875, DOI 10.1161/CIRCEP.113.000537
   Piers SRD, 2013, EUR HEART J, V34, P586, DOI 10.1093/eurheartj/ehs382
   Pinto YM, 2016, EUR HEART J, V37, P1850, DOI 10.1093/eurheartj/ehv727
   Ramana Ravi K, 2007, J Invasive Cardiol, V19, pE142
   Remo BF, 2014, HEART RHYTHM, V11, P541, DOI 10.1016/j.hrthm.2013.12.038
   Rigopoulos A, 2002, CARDIOLOGY, V98, P25, DOI 10.1159/000064677
   Robinson CG, 2019, CIRCULATION, V139, P313, DOI 10.1161/CIRCULATIONAHA.118.038261
   Romero J, 2019, HEART RHYTHM, pS1547
   Sacher F, 2013, CIRC-ARRHYTHMIA ELEC, V6, P144, DOI 10.1161/CIRCEP.111.974501
   Sacher F, 2010, J AM COLL CARDIOL, V55, P2366, DOI 10.1016/j.jacc.2009.10.084
   Santangeli P, 2015, CIRC-ARRHYTHMIA ELEC, V8, P1413, DOI 10.1161/CIRCEP.115.003562
   Sivagangabalan G, 2010, PACE, V33, P16, DOI 10.1111/j.1540-8159.2009.02602.x
   Soejima K, 2004, CIRCULATION, V110, P1197, DOI 10.1161/01.CIR.0000140725.42845.90
   Sohns C, 2019, EUROPACE, V21, P961, DOI 10.1093/europace/euz016
   Sosa E, 1996, J CARDIOVASC ELECTR, V7, P531, DOI 10.1111/j.1540-8167.1996.tb00559.x
   Stevenson WG, 2019, J AM COLL CARDIOL, V73, P1413, DOI 10.1016/j.jacc.2018.12.070
   Suk T, 2008, HEART LUNG CIRC, V17, P370, DOI 10.1016/j.hlc.2008.03.080
   Takahashi K, 2018, NICHIDAI IGAKU ZASSH, V77, P379
   Tung R, 2015, J BIOMED RES, V29, P56, DOI 10.7555/JBR.29.20140161
   Valles E, 2010, CIRC-ARRHYTHMIA ELEC, V3, P63, DOI 10.1161/CIRCEP.109.859942
   Weiford BC, 2004, CIRCULATION, V109, P2965, DOI 10.1161/01.CIR.0000132478.60674.D0
NR 83
TC 0
Z9 0
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAR
PY 2020
VL 50
IS 3
BP 203
EP 219
DI 10.4070/kcj.2019.0292
PG 17
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA KR7XV
UT WOS:000517831100002
PM 31845552
OA Other Gold, Green Published
DA 2021-04-22
ER

PT J
AU Ahn, KT
   Oh, JK
   Seong, SW
   Jin, SA
   Lee, JH
   Choi, SW
   Jeong, MH
   Chae, SC
   Kim, YJ
   Kim, CJ
   Kim, HS
   Cho, MC
   Gwon, HC
   Jeong, JO
   Seong, IW
AF Ahn, Kye Taek
   Oh, Jin Kyung
   Seong, Seok-Woo
   Jin, Seon-Ah
   Lee, Jae-Hwan
   Choi, Si Wan
   Jeong, Myung Ho
   Chae, Shung Chull
   Kim, Young Jo
   Kim, Chong Jin
   Kim, Hyo-Soo
   Cho, Myeong Chan
   Gwon, Hyeon Cheol
   Jeong, Jin-Ok
   Seong, In-Whan
CA Korea Acute Myocardial Infarction
TI One-Year Clinical Outcomes between Single- versus Multi-Staged PCI for
   ST Elevation Myocardial Infarction with Multi-Vessel Coronary Artery
   Disease: from Korea Acute Myocardial Infarction Registry-National
   Institute of Health (KAMIR-NIH)
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Myocardial infarction; Percutaneous coronary intervention; Myocardial
   revascularization; Coronary artery disease
ID SEGMENT ELEVATION; MULTIVESSEL DISEASE; RANDOMIZED-TRIAL; COMPLETE
   REVASCULARIZATION; STENT THROMBOSIS; CULPRIT LESION; INTERVENTION;
   ANGIOPLASTY; MANAGEMENT; IMPACT
AB Background and Objectives: Although complete revascularization is known superior to incomplete revascularization in ST elevation myocardial infarction (STEMI) patients with multi-vessel coronary artery disease (MVCD), there are no definite instructions on the optimal timing of non-culprit lesions percutaneous coronary intervention (PCI). We compared 1-year clinical outcomes between 2 different complete multi-vessel revascularization strategies.
   Methods: From the Korea Acute Myocardial Infarction Registry-National Institute of Health, 606 patients with STEMI and MVCD who underwent complete revascularization were enrolled from November 2011 to December 2015. The patients were assigned to multi-vessel single-staged PCI (SS PCI) group (n=254) or multi-vessel multi-staged PCI (MS PCI) group (n=352). Propensity score matched 1-year clinical outcomes were compared between the groups.
   Results: At one year, MS PCI showed a significantly lower rate of all-cause mortality (hazard ratio [HR], 0.42; 95% CI, 0.19-0.92; p=0.030) compared with SS PCI. In subgroup analysis, all-cause mortality increased in SS PCI with cardiogenic shock (HR, 4.60; 95% CI, 1.54-13.77; p=0.006), age >= 65 years (HR, 4.00; 95% CI, 1.67-9.58, p=0.002), Killip class III/IV (HR, 7.32; 95% CI, 1.68-31.87; p=0.008), and creatinine clearance <= 60 mL/min (HR, 2.81; 95% CI, 1.10-7.18; p=0.031). After propensity score-matching, MS PCI showed a significantly lower risk of major adverse cardiovascular event than SS PCI.
   Conclusions: SS PCI was associated with worse clinical outcomes compared with MS PCI. MS PCI for non-infarct-related artery could be a better option for patients with STEMI and MVCD, especially high-risk patients.
C1 [Ahn, Kye Taek; Oh, Jin Kyung; Seong, Seok-Woo; Jin, Seon-Ah; Lee, Jae-Hwan; Choi, Si Wan; Jeong, Jin-Ok; Seong, In-Whan] Chungnam Natl Univ, Chungnam Natl Univ Hosp, Dept Internal Med, Div Cardiol,Coll Med, 282 Munhwa Ro, Daejeon 35015, South Korea.
   [Jeong, Myung Ho] Chonnam Natl Univ Hosp, Dept Internal Med, Div Cardiol, Gwangju, South Korea.
   [Chae, Shung Chull] Kyungpook Natl Univ Hosp, Dept Internal Med, Div Cardiol, Daegu, South Korea.
   [Kim, Young Jo] Yeungnam Univ Hosp, Dept Internal Med, Div Cardiol, Daegu, South Korea.
   [Kim, Chong Jin] Kyung Hee Univ, Dept Internal Med, Div Cardiol, Coll Med, Seoul, South Korea.
   [Kim, Hyo-Soo] Seoul Natl Univ Hosp, Dept Internal Med, Div Cardiol, Seoul, South Korea.
   [Cho, Myeong Chan] Chungbuk Natl Univ Hosp, Dept Internal Med, Div Cardiol, Cheongju, South Korea.
   [Gwon, Hyeon Cheol] Sungkyunkwan Univ, Samsung Med Ctr, Sch Med, Div Cardiol,Dept Internal Med, Seoul, South Korea.
RP Jeong, JO (corresponding author), Chungnam Natl Univ, Chungnam Natl Univ Hosp, Dept Internal Med, Div Cardiol,Coll Med, 282 Munhwa Ro, Daejeon 35015, South Korea.
EM jojeong@cnu.ac.kr
OI Jeong, Myung Ho/0000-0003-2424-810X; /0000-0001-8371-9704; Seong,
   Seok-Woo/0000-0003-3267-4192; jin, seon-ah/0000-0001-6895-9101
FU Chungnam National University, a Basic Science Research Program through
   the National Research Foundation of Korea (NRF) - Ministry of Education
   [NRF-2014R1A6A1029617]; Research of Korea Centers for Disease Control
   and Prevention, Republic of Korea [2016ER6304-02]
FX This work was supported by a research fund of Chungnam National
   University (2017), a Basic Science Research Program through the National
   Research Foundation of Korea (NRF) funded by the Ministry of Education
   (NRF-2014R1A6A1029617), and a fund (2016ER6304-02) by Research of Korea
   Centers for Disease Control and Prevention, Republic of Korea.
CR Assaii AR, 2007, CATHETER CARDIO INTE, V69, P395, DOI 10.1002/ccd.20939
   Bangalore S, 2015, CIRC-CARDIOVASC INTE, V8, DOI 10.1161/CIRCINTERVENTIONS.114.002142
   Cavender MA, 2009, AM J CARDIOL, V104, P507, DOI 10.1016/j.amjcard.2009.04.016
   Claessen BE, 2014, JACC-CARDIOVASC INTE, V7, P1081, DOI 10.1016/j.jcin.2014.05.016
   Corpus RA, 2004, AM HEART J, V148, P493, DOI 10.1016/j.ahj.2004.03.051
   de Waha S, 2018, EUR HEART J-ACUTE CA, V7, P28, DOI 10.1177/2048872617719640
   Di Mario Carlo, 2004, Int J Cardiovasc Intervent, V6, P128
   Engstrom T, 2015, LANCET, V386, P665, DOI 10.1016/S0140-6736(15)60648-1
   Braga CG, 2017, REV ESP CARDIOL, V70, P425, DOI 10.1016/j.rec.2016.09.027
   Gershlick AH, 2015, J AM COLL CARDIOL, V65, P963, DOI 10.1016/j.jacc.2014.12.038
   Hanratty CG, 2002, J AM COLL CARDIOL, V40, P911, DOI 10.1016/S0735-1097(02)02049-1
   Heusch G, 2009, CIRCULATION, V120, P1822, DOI 10.1161/CIRCULATIONAHA.109.888784
   Ibanez B, 2018, EUR HEART J, V39, P119, DOI 10.1093/eurheartj/ehx393
   Kalarus Z, 2007, AM HEART J, V153, P304, DOI 10.1016/j.ahj.2006.10.033
   Kim JH, 2016, CIRC J, V80, P1427, DOI 10.1253/circj.CJ-16-0061
   Kolte D, 2017, CIRC-CARDIOVASC INTE, V10, DOI 10.1161/CIRCINTERVENTIONS.117.005582
   Kornowski R, 2011, J AM COLL CARDIOL, V58, P704, DOI 10.1016/j.jacc.2011.02.071
   Lee JM, 2018, J AM COLL CARDIOL, V71, P844, DOI 10.1016/j.jacc.2017.12.028
   Levine GN, 2016, J AM COLL CARDIOL, V67, P1235, DOI 10.1016/j.jacc.2015.10.005
   MULLER DWM, 1991, AM HEART J, V121, P1042, DOI 10.1016/0002-8703(91)90661-Z
   Peterson ED, 2010, J AM COLL CARDIOL, V55, P1923, DOI 10.1016/j.jacc.2010.02.005
   Politi L, 2010, HEART, V96, P662, DOI 10.1136/hrt.2009.177162
   Sianos G, 2007, J AM COLL CARDIOL, V50, P573, DOI 10.1016/j.jacc.2007.04.059
   Smits PC, 2017, NEW ENGL J MED, V376, P1234, DOI 10.1056/NEJMoa1701067
   Thiele H, 2018, NEW ENGL J MED, V379, P1699, DOI 10.1056/NEJMoa1808788
   Toma M, 2010, EUR HEART J, V31, P1701, DOI 10.1093/eurheartj/ehq129
   Varani E, 2008, CATHETER CARDIO INTE, V72, P927, DOI 10.1002/ccd.21722
   Vlaar PJ, 2011, J AM COLL CARDIOL, V58, P692, DOI 10.1016/j.jacc.2011.03.046
   Wald DS, 2013, NEW ENGL J MED, V369, P1115, DOI 10.1056/NEJMoa1305520
NR 29
TC 1
Z9 1
U1 1
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAR
PY 2020
VL 50
IS 3
BP 220
EP 233
DI 10.4070/kcj.2019.0176
PG 14
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA KR7XV
UT WOS:000517831100003
PM 32100479
OA Green Published, Other Gold
DA 2021-04-22
ER

PT J
AU Choi, S
   Park, YE
   Cheon, EJ
   Kim, KY
   Kim, M
   Ann, SJ
   Noh, HM
   Lee, J
   Lee, CJ
   Lee, ST
   Lee, C
   Lee, JE
   Lee, SH
AF Choi, Seungbum
   Park, Yae Eun
   Cheon, Eun Jeong
   Kim, Kyeong Yeon
   Kim, Miso
   Ann, Soo-jin
   Noh, Hye-Min
   Lee, Jaeho
   Lee, Chan Joo
   Lee, Seung-Taek
   Lee, Cheolju
   Lee, Ji Eun
   Lee, Sang-Hak
TI Novel Associations between Related Proteins and Cellular Effects of
   High-Density Lipoprotein
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Atherosclerosis; Cardiovascular diseases; Proteomics; Lipoproteins;
   Immunity
ID EPITHELIUM-DERIVED FACTOR; GROWTH-FACTOR-I; BINDING PROTEIN-3;
   ANTIINFLAMMATORY PROPERTIES; HDL; ATHEROSCLEROSIS; VITRONECTIN;
   SUPPRESSION; ACTIVATION; PATHWAYS
AB Background and Objectives: Recent studies have examined the structure-function relationship of high-density lipoprotein (HDL). This study aimed to identify and rank HDL-associated proteins involved in several biological function of HDL.
   Methods: HDLs isolated from 48 participants were analyzed. Cholesterol efflux capacity, effect of HDL on nitric oxide production, and vascular cell adhesion molecule-1 expression were assessed. The relative abundance of identified proteins in the highest vs. lowest quartile was expressed using the normalized spectral abundance factor ratio.
   Results: After adjustment by multiple testing, six proteins, thyroxine-binding globulin, alpha-1B-glycoprotein, plasma serine protease inhibitor, vitronectin, angiotensinogen, and serum amyloid A-4, were more abundant (relative abundance ratio >= 2) in HDLs with the highest cholesterol efflux capacity. In contrast, three proteins, complement C4-A, alpha-2-macroglobulin, and immunoglobulin mu chain C region, were less abundant (relative abundance ratio <0.5). In terms of nitric oxide production and vascular cell adhesion molecule-1 expression, no proteins showed abundance ratios >= 2 or <0.5 after adjustment. Proteins correlated with the functional parameters of HDL belonged to diverse biological categories.
   Conclusions: In summary, this study ranked proteins showing higher or lower abundance in HDLs with high functional capacities and newly identified multiple proteins linked to cholesterol efflux capacity.
C1 [Choi, Seungbum; Cheon, Eun Jeong; Kim, Miso; Ann, Soo-jin; Noh, Hye-Min; Lee, Jaeho; Lee, Chan Joo; Lee, Sang-Hak] Yonsei Univ, Cardiovasc Res Inst, Coll Med, Seoul, South Korea.
   [Park, Yae Eun; Kim, Kyeong Yeon; Lee, Cheolju; Lee, Ji Eun] Korean Inst Sci & Technol, Ctr Theragnosis, Biomed Res Inst, 5 Hwarang Ro 14 Gil, Seoul 02792, South Korea.
   [Park, Yae Eun; Lee, Seung-Taek] Yonsei Univ, Coll Life Sci & Biotechnol, Dept Biochem, Seoul, South Korea.
   [Kim, Kyeong Yeon] Sookmyung Womens Univ, Dept Chem, Seoul, South Korea.
   [Kim, Kyeong Yeon] Proteometech Inc, Seoul, South Korea.
   [Lee, Chan Joo; Lee, Sang-Hak] Yonsei Univ, Severance Hosp, Dept Internal Med, Div Cardiol,Coll Med, 50-1 Yonsei Ro, Seoul 03722, South Korea.
   [Lee, Cheolju] Kyung Hee Univ, KHU KIST Dept Converging Sci & Technol, Seoul, South Korea.
   [Lee, Cheolju] Korea Univ Sci & Technol, KIST Sch, Div Biomed Sci & Technol, Seoul, South Korea.
RP Lee, JE (corresponding author), Korean Inst Sci & Technol, Ctr Theragnosis, Biomed Res Inst, 5 Hwarang Ro 14 Gil, Seoul 02792, South Korea.; Lee, SH (corresponding author), Yonsei Univ, Severance Hosp, Dept Internal Med, Div Cardiol,Coll Med, 50-1 Yonsei Ro, Seoul 03722, South Korea.
EM jelee9137@kist.re.kr; shl1106@yuhs.ac
OI Lee, Seung-Taek/0000-0001-7300-9784; Lee, Jaeho/0000-0001-7946-0699;
   Lee, Chan Joo/0000-0002-8756-409X
FU Basic Science Research Program through the National Research Foundation
   of Korea (NRF) - Ministry of Education [2014R1A1A2056104]; Brain
   Research Program through the National Research Foundation of Korea (NRF)
   - Ministry of Science, ICT & Future Planning [2015M3C7A1064795]; KIST
   institutional programKorea Institute of Science & Technology (KIST)
FX This research was financially supported by the Basic Science Research
   Program through the National Research Foundation of Korea (NRF), funded
   by the Ministry of Education (2014R1A1A2056104) (SHL); the Brain
   Research Program through the National Research Foundation of Korea
   (NRF), funded by the Ministry of Science, ICT & Future Planning
   (2015M3C7A1064795) (JEL); and a KIST institutional program (JEL).
CR Abe-Dohmae S, 2006, J LIPID RES, V47, P1542, DOI 10.1194/jlr.M600145-JLR200
   Besler C, 2011, J CLIN INVEST, V121, P2693, DOI 10.1172/JCI42946
   Ceda GP, 1998, J CLIN ENDOCR METAB, V83, P499, DOI 10.1210/jc.83.2.499
   Craword SE, 2013, EXPERT OPIN DRUG DIS, V8, P769, DOI 10.1517/17460441.2013.794781
   Darabi M, 2016, PHARMACOL THERAPEUT, V157, P28, DOI 10.1016/j.pharmthera.2015.10.010
   Davidson WS, 2009, ARTERIOSCL THROM VAS, V29, P870, DOI 10.1161/ATVBAHA.109.186031
   Gordon SM, 2018, ATHEROSCLEROSIS, V278, P278, DOI 10.1016/j.atherosclerosis.2018.09.032
   Gordon SM, 2011, TRENDS ENDOCRIN MET, V22, P9, DOI 10.1016/j.tem.2010.10.001
   Han CY, 2016, J CLIN INVEST, V126, P266, DOI 10.1172/JCI83475
   Kawachi S, 2005, ARTERIOSCL THROM VAS, V25, P617, DOI 10.1161/01.ATV.0000154486.03017.35
   Khan AA, 2018, ARTERIOSCL THROM VAS, V38, P438, DOI 10.1161/ATVBAHA.117.310212
   Kopecky C, 2015, J AM SOC NEPHROL, V26, P565, DOI 10.1681/ASN.2013111219
   Lam CSP, 2010, ARTERIOSCL THROM VAS, V30, P1479, DOI 10.1161/ATVBAHA.110.203943
   Luo MD, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02601-7
   Min HK, 2016, FASEB J, V30, P4071, DOI 10.1096/fj.201600427R
   Pamir N, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.92176
   Rhainds D, 2019, CURR OPIN LIPIDOL, V30, P101, DOI 10.1097/MOL.0000000000000589
   Riwanto M, 2013, CIRCULATION, V127, P891, DOI 10.1161/CIRCULATIONAHA.112.108753
   Rosenson RS, 2013, CIRCULATION, V128, P1256, DOI 10.1161/CIRCULATIONAHA.113.000962
   Singh B, 2010, MOL MICROBIOL, V78, P545, DOI 10.1111/j.1365-2958.2010.07373.x
   Stonik JA, 2004, BIOCHEM BIOPH RES CO, V321, P936, DOI 10.1016/j.bbrc.2004.07.052
   Tahara N, 2011, ATHEROSCLEROSIS, V219, P311, DOI 10.1016/j.atherosclerosis.2011.06.022
   Vaisar T, 2007, J CLIN INVEST, V117, P746, DOI 10.1172/JCI26206
   Vaisar T, 2012, CURR VASC PHARMACOL, V10, P410, DOI 10.2174/157016112800812755
   van der Westhuyzen DR, 2005, J BIOL CHEM, V280, P35890, DOI 10.1074/jbc.M505685200
   Yamagishi S, 2005, CELL TISSUE RES, V320, P437, DOI 10.1007/s00441-005-1094-8
   Zhang QH, 2014, MICROVASC RES, V95, P76, DOI 10.1016/j.mvr.2014.07.009
   Zhou AW, 2003, NAT STRUCT BIOL, V10, P541, DOI 10.1038/nsb943
NR 28
TC 1
Z9 1
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAR
PY 2020
VL 50
IS 3
BP 236
EP 247
DI 10.4070/kcj.2019.0195
PG 12
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA KR7XV
UT WOS:000517831100005
PM 31845554
OA Other Gold, Green Published
DA 2021-04-22
ER

PT J
AU Liu, HZ
   Li, S
   Jiang, W
   Li, YJ
AF Liu, Huizi
   Li, Sai
   Jiang, Wei
   Li, Yinjun
TI MiR-484 Protects Rat Myocardial Cells from Ischemia-Reperfusion Injury
   by Inhibiting Caspase-3 and Caspase-9 during Apoptosis
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Apoptosis; Mitochondrial membrane potential; Caspase-3; Caspase-9
ID CANCER; ISCHEMIA/REPERFUSION; CARDIOMYOCYTES; IL-1-BETA
AB Background and Objectives: To reveal the detail mechanism of miR-484 on myocardial ischemia-reperfusion (MI/R) injury.
   Methods: Rats model of MI/R injury was established based on control (Con; sham operate) group, ischemia-reperfusion (I/R) group, miR-484 treatment (miR) group, and I/R-negative control (IR-C) group, followed by pathological and interleukin (IL)-6, tumor necrosis factor (TNF)-alpha, and IL-1 beta expression evaluation. Then the myocardial apoptosis, as well as the expression of miR-484, caspase-3, and caspase-9 in myocardium were examined. Finally, the regulatory relation between miR-484 and SMAD family member 7 (SMAD7) was predicated, followed by verification analysis.
   Results: Compared with Con group, the expression of miR-484 in I/R and IR-C group was decreased. Compared with I/R and IR-C group, the expression of miR-484 was increased in miR group. Compared with Con group, the expression levels of IL-6, TNF-alpha, and IL-1 beta in cardiac myocytes of I/R group and IR-C group were increased. Compared with Con group, the apoptotic index, membrane potential of I/R, and the expression of caspase-3/9 were increased in IR-C group. Compared with the I/R and IR-C groups, the apoptotic index of myocardial cells in the ischemic region was decreased, the membrane potential was increased, and the expression of caspase-3/9 was decreased significantly in the miR group. SMAD7 was the target gene of miR-484.
   Conclusions: MiR-484 protected myocardial cells from I/R injury by suppressing caspase-3 and caspase-9 expression during cardiomyocyte apoptosis. MiR-484 reduced the expression of IL-6, TNF-alpha, and IL-1 beta in MI/R. MiR-484 might alleviate the decreasing of mitochondrial membrane potential in MI/R cells.
C1 [Liu, Huizi] Jinzhou Med Univ, Dept Internal Med, Grad Sch, Jinzhou, Peoples R China.
   [Li, Sai; Jiang, Wei; Li, Yinjun] Fourth Peoples Hosp Shenyang, Dept Cardiol, 20 Huanghe South St, Shenyang 110031, Peoples R China.
RP Li, YJ (corresponding author), Fourth Peoples Hosp Shenyang, Dept Cardiol, 20 Huanghe South St, Shenyang 110031, Peoples R China.
EM yinjun2019@163.com
OI Li, Yinjun/0000-0002-3551-4314
CR Ahmed Farid E., 2009, Cancer Genomics & Proteomics, V6, P281
   Aurora AB, 2012, J CLIN INVEST, V122, P1222, DOI 10.1172/JCI59327
   Blanc C, 2000, CANCER RES, V60, P4386
   [陈颖伟 Chen Yingwei], 2005, [上海第二医科大学学报, Acta Universitatis Medicinalis Secondae Shanghai], V25, P131
   Hausenloy DJ, 2013, J CLIN INVEST, V123, P92, DOI 10.1172/JCI62874
   Hu X, 2013, 36 ANN CTRC AACR SAN
   Kimuta M, 1999, J CARD FAIL, V5, P48
   Kokkinopoulos I, 2013, NEUROBIOL AGING, V34, P602, DOI 10.1016/j.neurobiolaging.2012.04.014
   Li J, 2018, BIOCHEM BIOPH RES CO, V503, P3038, DOI 10.1016/j.bbrc.2018.08.090
   Li T, 2017, BIOMED PHARMACOTHER, V96, P153, DOI 10.1016/j.biopha.2017.09.102
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Loison F, 2014, J CLIN INVEST, V124, P4445, DOI 10.1172/JCI76246
   Lunsford KE, 2013, TRANSPLANTATION, V95, P1000, DOI 10.1097/TP.0b013e318286483a
   Marrone AK, 2015, EXPERT OPIN DRUG MET, V11, P601, DOI 10.1517/17425255.2015.1021687
   Mutharasan RK, 2011, AM J PHYSIOL-HEART C, V301, pH1519, DOI 10.1152/ajpheart.01080.2010
   Porter AG, 1999, CELL DEATH DIFFER, V6, P99, DOI 10.1038/sj.cdd.4400476
   Sodhi RK, 2009, ARCH PHARM RES, V32, P1037, DOI 10.1007/s12272-009-1709-9
   Solhjoo S, 2015, J MOL CELL CARDIOL, V78, P90, DOI 10.1016/j.yjmcc.2014.09.024
   Sun CK, 2005, MICROVASC RES, V70, P102, DOI 10.1016/j.mvr.2005.04.003
   Thukkani AK, 2016, AM J NUCL MED MOLEC, V6, P110
   Wang XH, 2010, CIRCULATION, V122, P1308, DOI 10.1161/CIRCULATIONAHA.110.964684
   Yamada T, 1998, TRANSPLANT P, V30, P2638, DOI 10.1016/S0041-1345(98)00760-X
   Yang Y, 2017, MOL MED REP, V15, P3699, DOI 10.3892/mmr.2017.6466
   Yao YL, 2018, BIOSCIENCE REP, V38, DOI 10.1042/BSR20171511
   Ylitalo KV, 2000, J MOL CELL CARDIOL, V32, P1223, DOI 10.1006/jmcc.2000.1157
   Yu XY, 2008, BIOCHEM BIOPH RES CO, V376, P548, DOI 10.1016/j.bbrc.2008.09.025
   Yuxian X, 2010, TRADIT CHIN MED ORTH, V25, P462
   Zhang BS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100298
   Zhou XA, 2010, ONCOL REP, V24, P195, DOI 10.3892/or_00000846
   Zhou Y, 2016, J CARDIOVASC PHARM T, V21, P296, DOI 10.1177/1074248415604463
NR 30
TC 7
Z9 9
U1 0
U2 5
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAR
PY 2020
VL 50
IS 3
BP 250
EP 263
DI 10.4070/kcj.2019.0107
PG 14
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA KR7XV
UT WOS:000517831100007
PM 31845557
OA Other Gold, Green Published
DA 2021-04-22
ER

PT J
AU Yu, HT
   Yang, PS
   Hwang, J
   Ryu, S
   Jang, E
   Kim, TH
   Uhm, JS
   Kim, JY
   Pak, HN
   Lee, MH
   Lip, GYH
   Joung, B
AF Yu, Hee Tae
   Yang, Pil-Sung
   Hwang, Jinseub
   Ryu, Soorack
   Jang, Eunsun
   Kim, Tae-Hoon
   Uhm, Jae-Sun
   Kim, Jong-Youn
   Pak, Hui-Nam
   Lee, Moon-Hyoung
   Lip, Gregory Y. H.
   Joung, Boyoung
TI Social Inequalities of Oral Anticoagulation after the Introduction of
   Non-Vitamin K Antagonists in Patients with Atrial Fibrillation
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Atrial fibrillation; Insurance; Anticoagulation; NOAC
ID STROKE PREVENTION; ADVERSE OUTCOMES; ASIAN PATIENTS; MANAGEMENT;
   GUIDELINE; THERAPY; TRENDS; SCORE
AB Background and Objectives: Nationwide social inequalities of oral anticoagulation (OAC) usage after the introduction of non-vitamin K antagonist oral anticoagulants (NOACs) have not been well identified in patients with atrial fibrillation (AF). This study assessed overall rate and social inequalities of OAC usage after the introduction of NOAC in Korea.
   Methods: Between January 2002 and December 2016, we identified 888,540 patients with AF in the Korea National Health Insurance system database. The change of OAC rate in different medical systems after the introduction of NOAC were evaluated.
   Results: In all population, overall OAC use increased from 13.2% to 23.4% (p for trend < 0.001), and NOAC use increased from 0% to 14.6% (p for trend < 0.001). Compared with pre-reimbursement (0.48%), the annual increase of OAC use was significantly higher after partial (1.16%, p<0.001), and full reimbursement of OAC (3.72%, p<0.001). Full reimbursement of NOAC (adjusted odds ratio, 2.10; 95% confidence interval, 2.04-2.15) was independently associated with higher OAC use. However, the difference of overall OAC usage between tertiary referral hospitals and nursing or public health centers increased from 17.9% in 2010 to 36.8% in 2016. Moreover, usage rate of NOAC was significantly different among different medical systems from 37.2% at the tertiary referral hospital and 5.5% at nursing or public health centers.
   Conclusions: Introduction of NOACs in routine practice for stroke prevention in AF was associated with improved rates of overall OAC use. However, significant practice-level variations in OAC and NOAC use remain producing social inequalities of OAC despite full reimbursement.
C1 [Yu, Hee Tae; Jang, Eunsun; Kim, Tae-Hoon; Uhm, Jae-Sun; Kim, Jong-Youn; Pak, Hui-Nam; Lee, Moon-Hyoung; Joung, Boyoung] Yonsei Univ, Dept Internal Med, Div Cardiol, Coll Med, Seoul, South Korea.
   [Yang, Pil-Sung] CHA Univ, CHA Bundang Med Ctr, Dept Cardiol, Seongnam, South Korea.
   [Hwang, Jinseub; Ryu, Soorack] Daegu Univ, Dept Comp Sci & Stat, Gyongsan, South Korea.
   [Lip, Gregory Y. H.] Univ Liverpool, Liverpool Ctr Cardiovasc Sci, Thomas Dr, Liverpool L14 3PE, Merseyside, England.
   [Lip, Gregory Y. H.] Liverpool Heart & Chest Hosp, Thomas Dr, Liverpool L14 3PE, Merseyside, England.
RP Joung, B (corresponding author), Yonsei Univ, Dept Internal Med, Div Cardiol, Coll Med, Seoul, South Korea.; Lip, GYH (corresponding author), Univ Liverpool, Liverpool Ctr Cardiovasc Sci, Thomas Dr, Liverpool L14 3PE, Merseyside, England.; Lip, GYH (corresponding author), Liverpool Heart & Chest Hosp, Thomas Dr, Liverpool L14 3PE, Merseyside, England.
EM g.y.h.lip@bham.ac.uk; cby6908@yuhs.ac
RI ; Pak, Hui-Nam/C-4266-2015
OI Joung, Boyoung/0000-0001-9036-7225; Kim, Jong-Youn/0000-0001-7040-8771;
   Kim, Tae-Hoon/0000-0003-4200-3456; Lee, Moon-Hyoung/0000-0002-7268-0741;
   Yang, Pil-sung/0000-0002-6552-1742; Pak, Hui-Nam/0000-0002-3256-3620;
   Uhm, Jae-Sun/0000-0002-1611-8172
FU Basic Science Research Program through the National Research Foundation
   of Korea - Ministry of Education, Science and Technology
   [NRF-2017R1A2B3003303, 2017R1C1B1008292]; Korean Healthcare technology
   R&D project - Ministry of Health Welfare [HI16C0058, HI15C1200]
FX This study was supported by a research grant from the Basic Science
   Research Program through the National Research Foundation of Korea
   funded by the Ministry of Education, Science and Technology
   (NRF-2017R1A2B3003303, 2017R1C1B1008292), and grants from the Korean
   Healthcare technology R&D project funded by the Ministry of Health &
   Welfare (HI16C0058, HI15C1200).
CR Bottle A, 2018, HEART, V104, P600, DOI [10.1136/heartjnl-2017-312183, 10.1136/heartjnl-2017-312930]
   Brown JD, 2016, DRUG AGING, V33, P427, DOI 10.1007/s40266-016-0369-y
   Decker C, 2012, J MULTIDISCIP HEALTH, V5, P129, DOI 10.2147/JMDH.S33045
   Fosbol EL, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000110
   Gage BF, 2000, STROKE, V31, P822, DOI 10.1161/01.STR.31.4.822
   Gorin L, 2011, CHEST, V140, P911, DOI 10.1378/chest.10-2436
   Hsu JC, 2016, JAMA CARDIOL, V1, P55, DOI 10.1001/jamacardio.2015.0374
   January CT, 2014, J AM COLL CARDIOL, V64, pE1, DOI 10.1016/j.jacc.2014.03.022
   Joung B, 2018, KOREAN CIRC J, V48, P1033, DOI 10.4070/kcj.2018.0339
   Kim D, 2018, J AM COLL CARDIOL, V72, P1233, DOI 10.1016/j.jacc.2018.05.076
   Kim D, 2018, AM HEART J, V202, P20, DOI 10.1016/j.ahj.2018.04.017
   Kim HK, 2019, KOREAN J INTERN MED
   Kim H, 2017, KOREAN CIRC J, V47, P877, DOI 10.4070/kcj.2017.0146
   Kim TH, 2019, EUR HEART J, V40, P809, DOI 10.1093/eurheartj/ehy877
   Kim TH, 2017, STROKE, V48, P2984, DOI 10.1161/STROKEAHA.117.018551
   Kim TH, 2017, STROKE, V48, P1524, DOI 10.1161/STROKEAHA.117.016926
   Kirchhof P, 2016, EUROPACE, V18, DOI 10.1093/europace/euw295
   Lee H, 2017, KOREAN CIRC J, V47, P56, DOI 10.4070/kcj.2016.0045
   Lee SR, 2018, KOREAN CIRC J, V48, P622, DOI 10.4070/kcj.2017.0362
   Lee YH, 2016, DIABETES METAB J, V40, P79, DOI 10.4093/dmj.2016.40.1.79
   Li CH, 2016, SCI REP-UK, V6, DOI 10.1038/srep30734
   Lip GYH, 2017, EUR HEART J, V38, P2980, DOI 10.1093/eurheartj/ehx554
   Marzec LN, 2017, J AM COLL CARDIOL, V69, P2475, DOI 10.1016/j.jacc.2017.03.540
   Proietti M, 2017, EUROPACE, V19, P722, DOI 10.1093/europace/euw112
   Ruff CT, 2014, LANCET, V383, P955, DOI 10.1016/S0140-6736(13)62343-0
   Wang KL, 2015, STROKE, V46, P2555, DOI 10.1161/STROKEAHA.115.009947
   Yang PS, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25111-6
NR 27
TC 2
Z9 2
U1 0
U2 2
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAR
PY 2020
VL 50
IS 3
BP 267
EP 277
DI 10.4070/kcj.2019.0207
PG 11
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA KR7XV
UT WOS:000517831100009
PM 32100483
OA Green Published, Other Gold
DA 2021-04-22
ER

PT J
AU Suh, JW
AF Suh, Jung-Won
TI Aspirin Monotherapy beyond 12 Months of Dual Antiplatelet Therapy in
   Patients with Acute Myocardial Infarction: Oldies But Goodies?
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
ID FOCUSED UPDATE; CLOPIDOGREL
C1 [Suh, Jung-Won] Seoul Natl Univ, Bundang Hosp, Cardiovasc Ctr, Dept Internal Med, 82,Gumi Ro 173Beon Gil, Seongnam 13620, South Korea.
   [Suh, Jung-Won] Seoul Natl Univ, Dept Internal Med, Coll Med, Seoul, South Korea.
RP Suh, JW (corresponding author), Seoul Natl Univ, Bundang Hosp, Cardiovasc Ctr, Dept Internal Med, 82,Gumi Ro 173Beon Gil, Seongnam 13620, South Korea.; Suh, JW (corresponding author), Seoul Natl Univ, Coll Med, Dept Internal Med, 82,Gumi Ro 173Beon Gil, Seongnam 13620, South Korea.
EM dasome2@snu.ac.kr
OI Suh, Jung-Won/0000-0002-0397-6071
CR Bhatt DL, 2006, NEW ENGL J MED, V354, P1706, DOI 10.1056/NEJMoa060989
   Bonaca MP, 2015, NEW ENGL J MED, V372, P1791, DOI 10.1056/NEJMoa1500857
   Choi SY, 2018, CIRC-CARDIOVASC INTE, V11, DOI 10.1161/CIRCINTERVENTIONS.118.006837
   Lee H, 2017, AM HEART J, V185, P17, DOI 10.1016/j.ahj.2016.12.001
   Levine GN, 2016, J AM COLL CARDIOL, V68, P1082, DOI 10.1016/j.jacc.2016.03.513
   Mauri L, 2014, NEW ENGL J MED, V371, P2155, DOI 10.1056/NEJMoa1409312
   Park TK, 2016, CIRC-CARDIOVASC INTE, V9, DOI 10.1161/CIRCINTERVENTIONS.115.002816
   Sim DS, 2020, KOREAN CIRC J, V50, P120, DOI 10.4070/kcj.2019.0166
   Valgimigli M, 2018, EUR J CARDIO-THORAC, V53, P34, DOI 10.1093/ejcts/ezx334
NR 9
TC 0
Z9 0
U1 0
U2 2
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD FEB
PY 2020
VL 50
IS 2
BP 130
EP 132
DI 10.4070/kcj.2019.0390
PG 3
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA KE0RE
UT WOS:000508267900004
PM 31960632
OA Green Published, Other Gold
DA 2021-04-22
ER

PT J
AU Yoon, CH
AF Yoon, Chang-Hwan
TI The Operator Volume of Primary Percutaneous Coronary Intervention for ST
   Segment Elevation Myocardial Infarction Does Not Guarantee Its Quality
   in Korea
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
ID OUTCOMES
C1 [Yoon, Chang-Hwan] Seoul Natl Univ, Div Cardiol, Dept Internal Med, Coll Med, Seoul, South Korea.
   [Yoon, Chang-Hwan] Seoul Natl Univ, Coll Med, Bundang Hosp, Cardiovasc Ctr, 82 Gumi Ro,173 Beon Gil, Seongnam 13620, South Korea.
RP Yoon, CH (corresponding author), Seoul Natl Univ, Coll Med, Bundang Hosp, Cardiovasc Ctr, 82 Gumi Ro,173 Beon Gil, Seongnam 13620, South Korea.
EM kunson2@snu.ac.kr
OI Yoon, Chang-Hwan/0000-0001-6305-4442
CR Armstrong Ehrin J, 2017, Interv Cardiol Clin, V6, pxi, DOI 10.1016/j.iccl.2017.01.001
   Fanaroff AC, 2017, J AM COLL CARDIOL, V69, P2913, DOI 10.1016/j.jacc.2017.04.032
   Lee JH, 2020, KOREAN CIRC J, V50, P133, DOI 10.4070/kcj.2019.0206
   Levine GN, 2011, J AM COLL CARDIOL, V58, pE44, DOI 10.1016/j.jacc.2011.08.007
   McGrath PD, 2000, JAMA-J AM MED ASSOC, V284, P3139, DOI 10.1001/jama.284.24.3139
   Sim DS, 2017, KOREAN CIRC J, V47, P811, DOI 10.4070/kcj.2017.0027
NR 6
TC 0
Z9 0
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD FEB
PY 2020
VL 50
IS 2
BP 145
EP 147
DI 10.4070/kcj.2019.0389
PG 3
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA KE0RE
UT WOS:000508267900006
PM 31960633
OA Other Gold, Green Published
DA 2021-04-22
ER

PT J
AU Shin, DG
   Lim, HE
AF Shin, Dong Geum
   Lim, Hong Euy
TI Atrial Fibrillation as a Risk Factor for Major Adverse Cardiac and
   Cerebrovascular Events after Non-cardiac Surgery
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
ID GLOBAL BURDEN; PREDICTION; DISEASE; STROKE; VALIDATION
C1 [Shin, Dong Geum] Hallym Univ, Kangnam Sacred Heart Hosp, Coll Med, Div Cardiol, Seoul, South Korea.
   [Lim, Hong Euy] Hallym Univ, Sacred Heart Hosp, Coll Med, Div Cardiol, 22 Gwanpyeong Ro 170Beon Gil, Anyang 14068, South Korea.
RP Lim, HE (corresponding author), Hallym Univ, Sacred Heart Hosp, Coll Med, Div Cardiol, 22 Gwanpyeong Ro 170Beon Gil, Anyang 14068, South Korea.
EM hongeuy1046@gmail.com
OI Lim, Hong Euy/0000-0001-8102-8352
CR Cho MS, 2020, KOREAN CIRC J, V50, P148, DOI 10.4070/kcj.2019.0219
   Chugh SS, 2014, CIRCULATION, V129, P837, DOI 10.1161/CIRCULATIONAHA.113.005119
   Delgado V, 2017, J AM COLL CARDIOL, V70, P3157, DOI 10.1016/j.jacc.2017.10.063
   Gupta PK, 2011, CIRCULATION, V124, P381, DOI 10.1161/CIRCULATIONAHA.110.015701
   Kamel H, 2016, STROKE, V47, P895, DOI 10.1161/STROKEAHA.115.012004
   Lee TH, 1999, CIRCULATION, V100, P1043, DOI 10.1161/01.CIR.100.10.1043
   McAlister FA, 2015, J THROMB HAEMOST, V13, P1768, DOI 10.1111/jth.13110
   Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4
   Raymond RJ, 1998, AM HEART J, V136, P435, DOI 10.1016/S0002-8703(98)70217-0
   van Diepen S, 2011, CIRCULATION, V124, P289, DOI 10.1161/CIRCULATIONAHA.110.011130
NR 10
TC 0
Z9 0
U1 1
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD FEB
PY 2020
VL 50
IS 2
BP 160
EP 162
DI 10.4070/kcj.2019.0386
PG 3
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA KE0RE
UT WOS:000508267900008
PM 31960634
OA Green Published, Other Gold
DA 2021-04-22
ER

PT J
AU Lee, SR
AF Lee, So-Ryoung
TI Is Lighter Intensity of Warfarin Therapy Enough for Korean Patients with
   Non-Valvular Atrial Fibrillation?
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
ID STROKE PREVENTION; SAFETY
C1 [Lee, So-Ryoung] Seoul Natl Univ Hosp, Div Cardiol, Dept Internal Med, Seoul, South Korea.
RP Lee, SR (corresponding author), Seoul Natl Univ Hosp, Dept Internal Med, 101 Daehak Ro, Seoul 03080, South Korea.
EM minerva1368@gmail.com
OI Lee, So-Ryoung/0000-0002-6351-5015
CR Chan YH, 2019, CHEST, V156, P529, DOI 10.1016/j.chest.2019.04.108
   Chiang CE, 2016, J FORMOS MED ASSOC, V115, P893, DOI 10.1016/j.jfma.2016.10.005
   Cho MS, 2019, STROKE, V50, P110, DOI 10.1161/STROKEAHA.118.023093
   Go AS, 2003, JAMA-J AM MED ASSOC, V290, P2685, DOI 10.1001/jama.290.20.2685
   Joung B, 2018, KOREAN CIRC J, V48, P1033, DOI 10.4070/kcj.2018.0339
   Lee KH, 2020, KOREAN CIRC J, V50, P163, DOI 10.4070/kcj.2019.0099
   Lin YC, 2018, J AM COLL CARDIOL, V72, P477, DOI 10.1016/j.jacc.2018.04.084
   Shen AYJ, 2007, J AM COLL CARDIOL, V50, P309, DOI 10.1016/j.jacc.2007.01.098
   Wallentin L, 2010, LANCET, V376, P975, DOI 10.1016/S0140-6736(10)61194-4
   Yao XX, 2017, J AM COLL CARDIOL, V69, P2779, DOI 10.1016/j.jacc.2017.03.600
NR 10
TC 0
Z9 0
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD FEB
PY 2020
VL 50
IS 2
BP 176
EP 178
DI 10.4070/kcj.2019.0350
PG 3
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA KE0RE
UT WOS:000508267900010
PM 31845561
OA Other Gold, Green Published
DA 2021-04-22
ER

PT J
AU Kim, AR
   Koo, HJ
   Lee, PH
AF Kim, Ah-Ram
   Koo, Hyun Jung
   Lee, Pil Hyung
TI A Characteristic Finding of Spontaneous Coronary Artery Dissection by
   Computed Tomographic Angiography
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
C1 [Kim, Ah-Ram; Lee, Pil Hyung] Univ Ulsan, Coll Med, Asan Med Ctr, Div Cardiol,Dept Internal Med, 88 Olymp Ro 43 Gil, Seoul 05505, South Korea.
   [Koo, Hyun Jung] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Radiol, Seoul, South Korea.
   [Koo, Hyun Jung] Univ Ulsan, Coll Med, Asan Med Ctr, Res Inst Radiol, Seoul, South Korea.
RP Lee, PH (corresponding author), Univ Ulsan, Coll Med, Asan Med Ctr, Div Cardiol,Dept Internal Med, 88 Olymp Ro 43 Gil, Seoul 05505, South Korea.
EM pilmo11@hanmail.net
OI Koo, Hyun Jung/0000-0001-5640-3835; Kim, Ah-Ram/0000-0003-2489-948X
CR Roura G, 2016, JACC-CARDIOVASC IMAG, V9, P896, DOI 10.1016/j.jcmg.2015.06.011
   Russo V, 2013, HEART, V99, P672, DOI 10.1136/heartjnl-2012-303215
   Saw J, 2016, J AM COLL CARDIOL, V68, P297, DOI 10.1016/j.jacc.2016.05.034
   Torres-Ayala SC, 2015, AM J CASE REP, V16, P130, DOI 10.12659/AJCR.892805
   Tweet MS, 2016, JACC-CARDIOVASC IMAG, V9, P436, DOI 10.1016/j.jcmg.2016.01.009
NR 5
TC 0
Z9 0
U1 0
U2 3
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD FEB
PY 2020
VL 50
IS 2
BP 179
EP 181
DI 10.4070/kcj.2019.0313
PG 3
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA KE0RE
UT WOS:000508267900011
PM 31845558
OA Other Gold, Green Published
DA 2021-04-22
ER

PT J
AU Lee, D
   Yoo, SM
   Lee, HY
   White, CS
AF Lee, Dongjun
   Yoo, Seung Min
   Lee, Hwa Yeon
   White, Charles S.
TI Computed Tomography Diagnosis of Patent Ductus Arteriosus Endarteritis
   and Septic Pulmonary Embolism
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
C1 [Lee, Dongjun] Mil Serv Korean Army, Seoul, South Korea.
   [Yoo, Seung Min] CHA Univ, Bundang Med Ctr, Dept Radiol, 59 Yatap Ro, Seongnam 13496, South Korea.
   [Lee, Hwa Yeon] Smile Radiol Clin, Seoul, South Korea.
   [White, Charles S.] Univ Maryland, Dept Radiol, Baltimore, MD 21201 USA.
RP Yoo, SM (corresponding author), CHA Univ, Bundang Med Ctr, Dept Radiol, 59 Yatap Ro, Seongnam 13496, South Korea.
EM smyoo@cha.ac.kr
OI Yoo, Seung Min/0000-0002-1990-8145
CR Parthenakis FI, 2000, HEART, V84, P619, DOI 10.1136/heart.84.6.619
NR 1
TC 1
Z9 1
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD FEB
PY 2020
VL 50
IS 2
BP 182
EP 183
DI 10.4070/kcj.2019.0289
PG 2
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA KE0RE
UT WOS:000508267900012
PM 31845559
OA Other Gold, Green Published
DA 2021-04-22
ER

PT J
AU Spiller, W
   Jung, KJ
   Lee, JY
   Ha Jee, S
AF Spiller, Wes
   Jung, Keum Ji
   Lee, Ji-Young
   Ha Jee, Sun
TI Precision Medicine and Cardiovascular Health: Insights from Mendelian
   Randomization Analyses
SO KOREAN CIRCULATION JOURNAL
LA English
DT Review
DE Mendelian randomization analysis; Precision medicine; Triangulation;
   Cardiovascular diseases
ID CORONARY-HEART-DISEASE; C-REACTIVE PROTEIN; BODY-MASS INDEX;
   MYOCARDIAL-INFARCTION; RISK-FACTORS; PHYSICAL-ACTIVITY; BLOOD-PRESSURE;
   CARDIOMETABOLIC TRAITS; HDL CHOLESTEROL; ARTERY-DISEASE
AB Cardiovascular disease (CVD) is considered a primary driver of global mortality and is estimated to be responsible for approximately 17.9 million deaths annually. Consequently, a substantial body of research related to CVD has developed, with an emphasis on identifying strategies for the prevention and effective treatment of CVD. In this review, we critically examine the existing CVD literature, and specifically highlight the contribution of Mendelian randomization analyses in CVD research. Throughout this review, we assess the extent to which research findings agree across a range of studies of differing design within a triangulation framework. If differing study designs are subject to non-overlapping sources of bias, consistent findings limit the extent to which results are merely an artefact of study design. Consequently, broad agreement across differing studies can be viewed as providing more robust causal evidence in contrast to limiting the scope of the review to a single specific study design. Utilising the triangulation approach, we highlight emerging patterns in research findings, and explore the potential of identified risk factors as targets for precision medicine and novel interventions.
C1 [Spiller, Wes] Univ Bristol, Dept Populat Hlth Sci, Bristol, Avon, England.
   [Jung, Keum Ji; Lee, Ji-Young; Ha Jee, Sun] Yonsei Univ, Grad Sch Publ Hlth, Inst Hlth Promot, Dept Epidemiol & Hlth Promot, 50-1 Yonsei Ro, Seoul 03722, South Korea.
RP Ha Jee, S (corresponding author), Yonsei Univ, Grad Sch Publ Hlth, Inst Hlth Promot, Dept Epidemiol & Hlth Promot, 50-1 Yonsei Ro, Seoul 03722, South Korea.
EM jsunha@yuhs.ac
OI Spiller, Wes/0000-0002-8169-5531; Jee, Sun Ha/0000-0001-9519-3068; Jung,
   Keum Ji/0000-0003-4993-0666
FU Wellcome TrustWellcome TrustEuropean Commission [108902/B/15/Z]; Korean
   Health Technology R&D Project, Ministry of Health & Welfare, Republic of
   Korea [HI14C2686]
FX Wes Spiller is supported by a Wellcome Trust studentship
   (108902/B/15/Z). Sun Ha Jee is funded by a grant of the Korean Health
   Technology R&D Project, Ministry of Health & Welfare, Republic of Korea
   (HI14C2686).
CR Ahmad OS, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8060
   ANDERSON TW, 1949, ANN MATH STAT, V20, P46, DOI 10.1214/aoms/1177730090
   [Anonymous], 1978, J Chronic Dis, V31, P201
   Asvold BO, 2014, INT J EPIDEMIOL, V43, P1458, DOI 10.1093/ije/dyu113
   Baker JL, 2007, NEW ENGL J MED, V357, P2329, DOI 10.1056/NEJMoa072515
   Bell S, 2017, BMJ-BRIT MED J, V356, DOI 10.1136/bmj.j909
   Benjamin EJ, 2019, CIRCULATION, V139, pE56, DOI 10.1161/CIR.0000000000000659
   BERLIN JA, 1990, AM J EPIDEMIOL, V132, P612, DOI 10.1093/oxfordjournals.aje.a115704
   Boden WE, 2011, NEW ENGL J MED, V365, P2255, DOI 10.1056/NEJMoa1107579
   Bowden J, 2018, INT J EPIDEMIOL, V47, P2100, DOI 10.1093/ije/dyy265
   Bowden J, 2016, INT J EPIDEMIOL, V45, P1961, DOI 10.1093/ije/dyw220
   Bowden J, 2016, GENET EPIDEMIOL, V40, P304, DOI 10.1002/gepi.21965
   Bowden J, 2015, INT J EPIDEMIOL, V44, P512, DOI 10.1093/ije/dyv080
   Burgess S, 2017, STAT METHODS MED RES, V26, P2333, DOI 10.1177/0962280215597579
   Burgess S, 2018, JAMA CARDIOL, V3, P619, DOI 10.1001/jamacardio.2018.1470
   Burgess S, 2016, CURR OPIN ENDOCRINOL, V23, P124, DOI 10.1097/MED.0000000000000230
   Burgess S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108891
   Burgess S, 2013, GENET EPIDEMIOL, V37, P658, DOI 10.1002/gepi.21758
   Buttar Harpal S, 2005, Exp Clin Cardiol, V10, P229
   Carnethon MR, 2009, AM J LIFESTYLE MED, V3, p44S, DOI 10.1177/1559827609332737
   Carter AR, 2019, BMJ-BRIT MED J, V365, DOI 10.1136/bmj.l1855
   Casas JP, 2006, INT J EPIDEMIOL, V35, P922, DOI 10.1093/ije/dyl041
   CASTELLI WP, 1977, CIRCULATION, V55, P767, DOI 10.1161/01.CIR.55.5.767
   Cha PC, 2010, HUM MOL GENET, V19, P4735, DOI 10.1093/hmg/ddq389
   Chen L, 2008, PLOS MED, V5, DOI 10.1371/journal.pmed.0050052
   Cho MH, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23729-0
   Cho Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep18422
   Choi S, 2018, JAMA INTERN MED, V178, P1060, DOI 10.1001/jamainternmed.2018.2310
   Christensen AL, 2018, J STROKE, V20, P218, DOI 10.5853/jos.2017.01466
   Cohen JC, 2006, NEW ENGL J MED, V354, P1264, DOI 10.1056/NEJMoa054013
   Cozlea D L, 2013, Curr Health Sci J, V39, P225
   Dale CE, 2017, CIRCULATION, V135, P2373, DOI 10.1161/CIRCULATIONAHA.116.026560
   Davey Smith G., 2019, DOES SCHIZOPHRENIA I
   Davies NM, 2015, STAT MED, V34, P454, DOI 10.1002/sim.6358
   de Ferranti S, 2002, CLIN CHIM ACTA, V317, P1, DOI 10.1016/S0009-8981(01)00797-5
   Denaxas SC, 2012, INT J EPIDEMIOL, V41, P1625, DOI 10.1093/ije/dys188
   DOYLE JT, 1962, NEW ENGL J MED, V266, P796, DOI 10.1056/NEJM196204192661602
   Emdin CA, 2017, JAMA-J AM MED ASSOC, V317, P626, DOI 10.1001/jama.2016.21042
   Engeland A, 2003, AM J EPIDEMIOL, V157, P517, DOI 10.1093/aje/kwf219
   Ference BA, 2018, J AM COLL CARDIOL, V72, P1141, DOI 10.1016/j.jacc.2018.06.046
   Ference BA, 2016, NEW ENGL J MED, V375, P2144, DOI 10.1056/NEJMoa1604304
   Ference BA, 2012, J AM COLL CARDIOL, V60, P2631, DOI 10.1016/j.jacc.2012.09.017
   Fernandez-Sola J, 2015, NAT REV CARDIOL, V12, P576, DOI 10.1038/nrcardio.2015.91
   Fox CS, 2004, JAMA-J AM MED ASSOC, V292, P2495, DOI 10.1001/jama.292.20.2495
   Frayling TM, 2018, CURR OPIN GENET DEV, V50, P111, DOI 10.1016/j.gde.2018.05.010
   Geng TT, 2018, DIABETES CARE, V41, P1089, DOI 10.2337/dc17-2141
   GOFMAN JW, 1966, CIRCULATION, V34, P679, DOI 10.1161/01.CIR.34.4.679
   GOLDSCHMID MG, 1994, CIRCULATION, V89, P991, DOI 10.1161/01.CIR.89.3.991
   Haase CL, 2012, J CLIN ENDOCR METAB, V97, pE248, DOI 10.1210/jc.2011-1846
   Hagg S, 2015, INT J EPIDEMIOL, V44, P578, DOI 10.1093/ije/dyv094
   Hartwig FP, 2017, INT J EPIDEMIOL, V46, P1985, DOI 10.1093/ije/dyx102
   Helgadottir A, 2007, SCIENCE, V316, P1491, DOI 10.1126/science.1142842
   Holmes MV, 2015, EUR HEART J, V36, P539, DOI 10.1093/eurheartj/eht571
   Holmes MV, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g4164
   Holmes MV, 2014, AM J HUM GENET, V94, P198, DOI 10.1016/j.ajhg.2013.12.014
   Hunter Wynn G, 2016, Curr Heart Fail Rep, V13, P119, DOI 10.1007/s11897-016-0289-5
   Jee SH, 1999, JAMA-J AM MED ASSOC, V282, P2149, DOI 10.1001/jama.282.22.2149
   Jee SH, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005025
   Jee SH, 2006, NEW ENGL J MED, V355, P779, DOI 10.1056/NEJMoa054017
   Jee YH, 2019, INT J RHEUM DIS, V22, P1912, DOI 10.1111/1756-185X.13668
   Jee YH, 2018, INT J EPIDEMIOL, V47, P385, DOI 10.1093/ije/dyx226
   Jee Y, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-024453
   Jeong SM, 2018, J AM HEART ASSOC, V7, DOI 10.1161/JAHA.118.008819
   Jiang MM, 2014, BMC COMPLEM ALTERN M, V14, DOI 10.1186/1472-6882-14-350
   Jung KJ, 2018, KOREAN CIRC J, V48, P731, DOI 10.4070/kcj.2018.0036
   Kachur S, 2017, MINERVA MED, V108, P212, DOI 10.23736/S0026-4806.17.05022-4
   Kahn R, 2005, DIABETES CARE, V28, P2289, DOI 10.2337/diacare.28.9.2289
   KANNEL WB, 1979, ANN INTERN MED, V90, P85, DOI 10.7326/0003-4819-90-1-85
   KANNEL WB, 1980, CIRCULATION, V61, P1183, DOI 10.1161/01.CIR.61.6.1183
   Kardys I, 2006, EUR HEART J, V27, P1331, DOI 10.1093/eurheartj/ehl018
   Kim SJ, 2010, EPIDEMIOL HEALTH, V32, DOI 10.4178/epih/e2010003
   Kim Y, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-025590
   Kjeldsen SE, 2018, PHARMACOL RES, V129, P95, DOI 10.1016/j.phrs.2017.11.003
   KLATSKY AL, 1974, ANN INTERN MED, V81, P294, DOI 10.7326/0003-4819-81-3-294
   KLATSKY AL, 1981, CIRCULATION, V64, P32
   Klatsky AL, 2001, AM J CARDIOL, V88, P703, DOI 10.1016/S0002-9149(01)01824-0
   Kosmas CE, 2018, DRUGS CONTEXT, V7, DOI [10.7573/dic.212525, DOI 10.7573/DIC.212525]
   Landray MJ, 2014, NEW ENGL J MED, V371, P203, DOI 10.1056/NEJMoa1300955
   Larsson SC, 2017, NEUROLOGY, V89, P454, DOI 10.1212/WNL.0000000000004173
   Lavie CJ, 2009, J AM COLL CARDIOL, V53, P1925, DOI 10.1016/j.jacc.2008.12.068
   Lawes CMM, 2003, HYPERTENSION, V42, P69, DOI 10.1161/01.HYP.0000075083.04415.4B
   Lawlor DA, 2016, INT J EPIDEMIOL, V45, P1866, DOI 10.1093/ije/dyw314
   Lewington S, 2002, LANCET, V360, P1903
   Lieb W, 2013, HYPERTENSION, V61, P995, DOI 10.1161/HYPERTENSIONAHA.111.00275
   Ligthart S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118859
   Liu YT, 2013, MOL BIOSYST, V9, P2823, DOI 10.1039/c3mb70222g
   Lyall DM, 2017, JAMA CARDIOL, V2, P882, DOI 10.1001/jamacardio.2016.5804
   McGarrah RW, 2018, CIRC RES, V122, P1238, DOI 10.1161/CIRCRESAHA.117.311002
   McPherson R, 2007, SCIENCE, V316, P1488, DOI 10.1126/science.1142447
   Mendall MA, 2000, EUR HEART J, V21, P1584, DOI 10.1053/euhj.1999.1982
   Miller M, 2011, CIRCULATION, V123, P2292, DOI 10.1161/CIR.0b013e3182160726
   Millwood IY, 2019, LANCET, V393, P1831, DOI 10.1016/S0140-6736(18)31772-0
   Mora S, 2007, CIRCULATION, V116, P2110, DOI 10.1161/CIRCULATIONAHA.107.729939
   Mukamal K, 2007, ANN EPIDEMIOL, V17, pS8, DOI 10.1016/j.annepidem.2007.01.003
   Mukamal K, 2017, BMJ-BRIT MED J, V356, DOI 10.1136/bmj.j1340
   National Center for Chronic Disease Prevention and Health Promotion (US), 2010, TOB SMOK CAUS DIS BI
   O'Donnel CJ, 2008, REV ESP CARDIOL, V61, P299, DOI 10.1016/S1885-5857(08)60118-8
   OECD, 2015, CARD DIS DIAB POL BE
   Park JE, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2263-7
   Park JY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135228
   Park Kwanjun, 2018, Osong Public Health Res Perspect, V9, P150, DOI 10.24171/j.phrp.2018.9.4.03
   Perera MA, 2013, LANCET, V382, P790, DOI 10.1016/S0140-6736(13)60681-9
   Pikula A, 2015, NEUROLOGY, V84, P472, DOI 10.1212/WNL.0000000000001202
   Poirier P, 2006, CIRCULATION, V113, P898, DOI 10.1161/CIRCULATIONAHA.106.171016
   Ridker PM, 2007, J AM COLL CARDIOL, V49, P2129, DOI 10.1016/j.jacc.2007.02.052
   RIFKIND BM, 1984, JAMA-J AM MED ASSOC, V251, P365
   ROBERTSON TL, 1977, AM J CARDIOL, V39, P239, DOI 10.1016/S0002-9149(77)80197-5
   Rocha VZ, 2009, NAT REV CARDIOL, V6, P399, DOI 10.1038/nrcardio.2009.55
   ROSENBERG L, 1990, NEW ENGL J MED, V322, P213, DOI 10.1056/NEJM199001253220401
   Rosenson RS, 2018, J AM COLL CARDIOL, V72, P314, DOI 10.1016/j.jacc.2018.04.054
   Rosenson RS, 2002, AM J CARDIOL, V90, P89, DOI 10.1016/S0002-9149(02)02427-X
   Ross S, 2015, CIRC-CARDIOVASC GENE, V8, P618, DOI 10.1161/CIRCGENETICS.114.000952
   Sabatine MS, 2017, NEW ENGL J MED, V376, P1713, DOI 10.1056/NEJMoa1615664
   SALONEN JT, 1991, CIRCULATION, V84, P129, DOI 10.1161/01.CIR.84.1.129
   Samani NJ, 2007, NEW ENGL J MED, V357, P443, DOI 10.1056/NEJMoa072366
   Sanderson E, 2019, INT J EPIDEMIOL, V48, P713, DOI 10.1093/ije/dyy262
   Shah SH, 2015, CIRC-CARDIOVASC GENE, V8, P410, DOI 10.1161/CIRCGENETICS.114.000223
   Smith GD, 2003, INT J EPIDEMIOL, V32, P1, DOI 10.1093/ije/dyg070
   Son JS, 2018, JAMA-J AM MED ASSOC, V320, P1783, DOI 10.1001/jama.2018.16501
   Spiller W, 2019, INT J EPIDEMIOL, V48, P702, DOI 10.1093/ije/dyy204
   Staley JR, 2017, GENET EPIDEMIOL, V41, P341, DOI 10.1002/gepi.22041
   Sun HP, 2016, CIRCULATION, V133, P2038, DOI 10.1161/CIRCULATIONAHA.115.020226
   Sun LL, 2019, NAT MED, V25, P569, DOI 10.1038/s41591-019-0366-x
   Takeuchi F, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000433
   Ueshima H, 2006, CIRC J, V70, P1249
   Ueshima H, 2007, J ATHEROSCLER THROMB, V14, P278, DOI 10.5551/jat.E529
   Ueshima H, 2008, CIRCULATION, V118, P2702, DOI 10.1161/CIRCULATIONAHA.108.790048
   Valdes-Marquez E, 2019, NEUROLOGY, V92, pE1176, DOI 10.1212/WNL.0000000000007091
   Voight BF, 2012, LANCET, V380, P572, DOI 10.1016/S0140-6736(12)60312-2
   von Hinke S, 2016, J HEALTH ECON, V45, P131, DOI 10.1016/j.jhealeco.2015.10.007
   Wade KH, 2018, BRIT J SPORT MED, V52, P890, DOI 10.1136/bjsports-2017-098995
   Wang XJ, 2012, ANAL CHEM, V84, P428, DOI 10.1021/ac202828r
   Wensley F, 2011, BRIT MED J, V342, DOI 10.1136/bmj.d548
   White J, 2016, JAMA CARDIOL, V1, P692, DOI 10.1001/jamacardio.2016.1884
   WILSON PW, 1981, AM J EPIDEMIOL, V114, P697, DOI 10.1093/oxfordjournals.aje.a113240
   Xu L, 2017, DIABETOLOGIA, V60, P2210, DOI 10.1007/s00125-017-4396-y
   Yoon YS, 2004, AM J CLIN NUTR, V80, P217
   Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9
   Zhang X, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25305-y
   Zhao QY, 2019, STAT SCI, V34, P317, DOI 10.1214/18-STS692
   Zhu MD, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.01017
   Zwaka TP, 2001, CIRCULATION, V103, P1194
NR 142
TC 1
Z9 1
U1 0
U2 2
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD FEB
PY 2020
VL 50
IS 2
BP 91
EP 111
DI 10.4070/kcj.2019.0293
PG 21
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA KE0RE
UT WOS:000508267900001
PM 31845553
OA Green Published, Other Gold
DA 2021-04-22
ER

PT J
AU Ishii, M
   Ebato, T
   Kato, H
AF Ishii, Masahiro
   Ebato, Takasuke
   Kato, Hirihisa
TI History and Future of Treatment for Acute Stage Kawasaki Disease
SO KOREAN CIRCULATION JOURNAL
LA English
DT Review
DE Kawasaki disease; Intravenous immunoglobulin; Infliximab; Intravenous
   methylprednisolone pulse; Prednisolone
ID TUMOR-NECROSIS-FACTOR; ADDITIONAL IMMUNE GLOBULIN; GAMMA-GLOBULIN;
   INITIAL TREATMENT; PLASMA-EXCHANGE; INFLIXIMAB; THERAPY; PREDICTION;
   EFFICACY; STRATEGY
AB Kawasaki disease is a form of vasculitis, mainly in small and medium arteries of unknown origin, occurring frequently in childhood. It is the leading form of childhood-onset acquired heart disease in developed countries and leads to complications of coronary artery aneurysms in approximately 25% of cases if left untreated. Although more than half a century has passed since Professor Tomisaku Kawasaki's first report in 1957, the cause is not yet clear. Currently, intravenous immunoglobulin therapy has been established as the standard treatment for Kawasaki disease. Various treatment strategies are still being studied under the slogan, "Ending powerful inflammation in the acute phase as early as possible and minimizing the incidence of coronary artery lesions," as the goal of acute phase treatments for Kawasaki disease. Currently, in addition to immunoglobulin therapy, steroid therapy, therapy using infliximab, biological products, suppression of elastase secretion inside and outside the neutrophils, inactivated ulinastatin therapy and cyclosporine therapy, plasma exchange, etc. are performed. This chapter outlines the history and transition of the acute phase treatment for Kawasaki disease.
C1 [Ishii, Masahiro] Ishii Pediat & Pediat Cardiol Off, Yokohama, Kanagawa, Japan.
   [Ebato, Takasuke] Kitasato Univ, Sch Med, Dept Pediat, Sagamihara, Kanagawa, Japan.
   [Kato, Hirihisa] Kurume Univ, Sch Med, Dept Pediat, Kurume, Fukuoka, Japan.
RP Ishii, M (corresponding author), Ishii Pediat & Pediat Cardiol Off, Tsurumi Ku, 1-19-4 Turumi Chuo, Yokohama, Kanagawa 2300051, Japan.
EM ishiim58@gmail.com
CR Burns JC, 2005, J PEDIATR-US, V146, P662, DOI 10.1016/j.jpeds.2004.12.022
   Ebato T, 2017, J PEDIATR-US, V191, P140, DOI 10.1016/j.jpeds.2017.08.076
   Egami K, 2006, J PEDIATR-US, V149, P237, DOI 10.1016/j.jpeds.2006.03.050
   FURUSHO K, 1983, LANCET, V2, P1359
   Hamada H, 2019, LANCET, V393, P1128, DOI 10.1016/S0140-6736(18)32003-8
   Hirono K, 2009, PEDIATR RES, V65, P696, DOI 10.1203/01.pdr.0000352115.41382.65
   Hokosaki T, 2012, PEDIATR INT, V54, P99, DOI 10.1111/j.1442-200X.2011.03487.x
   Imagawa T, 2004, EUR J PEDIATR, V163, P263, DOI 10.1007/s00431-003-1267-y
   Ishii M, 2001, PEDIATR INT, V43, P211, DOI 10.1046/j.1442-200x.2001.01373.x
   Kanai T, 2011, CIRCULATION, V124, P2822, DOI 10.1161/CIRCULATIONAHA.111.028423
   KATO H, 1979, PEDIATRICS, V63, P175
   Kawasaki T, 1967, JAP J ALLERG, V16, P178, DOI DOI 10.4070/KCJ.2018.0214
   Kobayashi T, 2006, CIRCULATION, V113, P2606, DOI 10.1161/CIRCULATIONAHA.105.592865
   Kobayashi T, 2012, LANCET, V379, P1613, DOI 10.1016/S0140-6736(11)61930-2
   LANG BA, 1989, J PEDIATR-US, V115, P939, DOI 10.1016/S0022-3476(89)80746-2
   MATSUBARA T, 1990, CLIN IMMUNOL IMMUNOP, V56, P29, DOI 10.1016/0090-1229(90)90166-N
   MAURY CPJ, 1989, J LAB CLIN MED, V113, P651
   Mori Masaaki, 2004, Mod Rheumatol, V14, P43, DOI 10.1007/s10165-003-0264-3
   NEWBURGER JW, 1991, NEW ENGL J MED, V324, P1633, DOI 10.1056/NEJM199106063242305
   Ogata S, 2012, PEDIATRICS, V129, pE17, DOI 10.1542/peds.2011-0148
   Ogata S, 2009, PEDIATR RES, V66, P577, DOI 10.1203/PDR.0b013e3181baa3c2
   Ogata S, 2009, J CARDIOL, V53, P15, DOI 10.1016/j.jjcc.2008.08.002
   Ogihara Y, 2014, PEDIATR RES, V76, P287, DOI 10.1038/pr.2014.92
   Okada K, 2009, EUR J PEDIATR, V168, P181, DOI 10.1007/s00431-008-0727-9
   Onouchi Y, 2013, PHARMACOGENOMICS J, V13, P52, DOI 10.1038/tpj.2011.45
   Raman V, 2001, PEDIATR INFECT DIS J, V20, P635, DOI 10.1097/00006454-200106000-00022
   Sano T, 2007, EUR J PEDIATR, V166, P131, DOI 10.1007/s00431-006-0223-z
   Suzuki H, 2011, PEDIATR INFECT DIS J, V30, P871, DOI 10.1097/INF.0b013e318220c3cf
   Tremoulet AH, 2014, LANCET, V383, P1731, DOI 10.1016/S0140-6736(13)62298-9
   Weiss JE, 2004, J RHEUMATOL, V31, P808
   Wright DA, 1996, J PEDIATR-US, V128, P146, DOI 10.1016/S0022-3476(96)70447-X
NR 31
TC 1
Z9 1
U1 2
U2 8
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD FEB
PY 2020
VL 50
IS 2
BP 112
EP 119
DI 10.4070/kcj.2019.0290
PG 8
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA KE0RE
UT WOS:000508267900002
PM 31845551
OA Other Gold, Green Published
DA 2021-04-22
ER

PT J
AU Sim, DS
   Jeong, MH
   Kim, HS
   Gwon, HC
   Seung, KB
   Rha, SW
   Chae, SC
   Kim, CJ
   Cha, KS
   Park, JS
   Yoon, JH
   Chae, JK
   Joo, SJ
   Choi, DJ
   Hur, SH
   Seong, IW
   Cho, MC
   Kim, DI
   Oh, SK
   Ahn, TH
   Hwang, JY
AF Sim, Doo Sun
   Jeong, Myung Ho
   Kim, Hyo Soo
   Gwon, Hyeon Cheol
   Seung, Ki Bae
   Rha, Seung Woon
   Chae, Shung Chull
   Kim, Chong Jin
   Cha, Kwang Soo
   Park, Jong Seon
   Yoon, Jung Han
   Chae, Jei Keon
   Joo, Seung Jae
   Choi, Dong Ju
   Hur, Seung Ho
   Seong, In Whan
   Cho, Myeong Chan
   Kim, Doo Il
   Oh, Seok Kyu
   Ahn, Tae Hoon
   Hwang, Jin Yong
CA KAMIR-NIH Registry Investigators
TI Clopidogrel versus Aspirin after Dual Antiplatelet Therapy in Acute
   Myocardial Infarction Patients Undergoing Drug-Eluting Stenting
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Antiplatelet agents; Drug-eluting stents; Myocardial infarction
ID PROPENSITY SCORE; FOCUSED UPDATE; VALIDATION; GUIDELINE; DISEASE;
   TRIALS; RISK
AB Background and Objectives: There is a paucity of data regarding the benefit of clopidogrel monotherapy after dual antiplatelet therapy (DAPT) in patients treated with drug-eluting stents (DES). This study compared outcome between clopidogrel versus aspirin as monotherapy after DES for acute myocardial infarction (MI).
   Methods: From Korea Acute Myocardial Infarction Registry-National Institute of Health database, 1,819 patients treated with DES who were switched to monotherapy with clopidogrel (n=534) or aspirin (n=1,285) after uneventful 12-month DAPT were analyzed. The primary endpoint was net adverse clinical events (NACE), defined as a composite of death from any cause, MI, repeat percutaneous coronary intervention (PCI), stent thrombosis, ischemic stroke, or major bleeding during the period from 12 to 24 months.
   Results: After adjustment using inverse probability of treatment weighting, patients who received clopidogrel, compared with those treated with aspirin, had a similar incidence of NACE (0.7% and 0.7%; hazard ratio, 1.06; 95% confidence interval, 0.31-3.60; p=0.923). The 2 groups had similar rates of death from any cause (0.1% in each group, p=0.789), MI (0.3% and 0.1%, respectively; p=0.226), repeat PCI (0.1% and 0.3%, respectively; p=0.548), stent thrombosis (0.1% and 0%, respectively; p=0.121), major bleeding (0.2% in each group, p=0.974), and major adverse cardiovascular and cerebrovascular events (0.5% in each group, p=0.924).
   Conclusions: Monotherapy with clopidogrel, compared to aspirin, after DAPT showed similar clinical outcomes in patients with acute MI treated with DES.
C1 [Sim, Doo Sun; Jeong, Myung Ho] Chonnam Natl Univ Hosp, Dept Cardiovasc Med, 42 Jebong Ro, Gwangju 61469, South Korea.
   [Kim, Hyo Soo] Seoul Natl Univ Hosp, Dept Cardiol, Seoul, South Korea.
   [Gwon, Hyeon Cheol] Sungkyunkwan Univ, Samsung Med Ctr, Dept Cardiol, Seoul, South Korea.
   [Seung, Ki Bae] Catholic Univ Korea, Seoul St Marys Hosp, Dept Cardiol, Seoul, South Korea.
   [Rha, Seung Woon] Korea Univ, Cardiovasc Ctr, Guro Hosp, Seoul, South Korea.
   [Chae, Shung Chull] Kyungpook Natl Univ Hosp, Dept Cardiol, Daegu, South Korea.
   [Kim, Chong Jin] Kyung Hee Univ Hosp Gangdong, Dept Cardiol, Seoul, South Korea.
   [Cha, Kwang Soo] Pusan Natl Univ Hosp, Dept Cardiol, Busan, South Korea.
   [Park, Jong Seon] Yeungnam Univ Hosp, Div Cardiol, Daegu, South Korea.
   [Yoon, Jung Han] Yonsei Univ, Wonju Severance Christian Hosp, Div Cardiol, Wonju Coll Med, Wonju, South Korea.
   [Chae, Jei Keon] Chunbuk Natl Univ Hosp, Dept Cardiol, Jeonju, South Korea.
   [Joo, Seung Jae] Jeju Natl Univ Hosp, Dept Cardiol, Jeju, South Korea.
   [Choi, Dong Ju] Seoul Natl Univ, Cardiovasc Ctr, Bundang Hosp, Seongnam, South Korea.
   [Hur, Seung Ho] Keimyung Univ, Dept Cardiol, Dongsan Med Ctr, Daegu, South Korea.
   [Seong, In Whan] Chungnam Natl Univ Hosp, Dept Cardiol, Daejeon, South Korea.
   [Cho, Myeong Chan] Chungbuk Natl Univ Hosp, Dept Cardiol, Cheongju, South Korea.
   [Kim, Doo Il] Inje Univ, Dept Cardiol, Haeundae Paik Hosp, Busan, South Korea.
   [Oh, Seok Kyu] Wonkwang Univ Hosp, Dept Cardiol, Iksan, South Korea.
   [Ahn, Tae Hoon] Gachon Univ, Dept Cardiol, Gil Med Ctr, Incheon, South Korea.
   [Hwang, Jin Yong] Kyungsang Natl Univ Hosp, Dept Cardiol, Jinju, South Korea.
RP Jeong, MH (corresponding author), Chonnam Natl Univ Hosp, Dept Cardiovasc Med, 42 Jebong Ro, Gwangju 61469, South Korea.
EM myungho@chollian.net
OI Jeong, Myung Ho/0000-0003-2424-810X
FU Research of Korea Centers for Disease Control and Prevention
   [2016-ER6304-01]
FX This research was supported by a fund (2016-ER6304-01) by Research of
   Korea Centers for Disease Control and Prevention.
CR Amsterdam EA, 2014, J AM COLL CARDIOL, V64, pE139, DOI 10.1016/j.jacc.2014.09.017
   Austin PC, 2015, STAT MED, V34, P3661, DOI 10.1002/sim.6607
   Austin PC, 2014, STAT MED, V33, P1242, DOI 10.1002/sim.5984
   Baigent C, 2002, BMJ-BRIT MED J, V324, P71, DOI 10.1136/bmj.324.7329.71
   Berger JS, 2008, AM J MED, V121, P43, DOI 10.1016/j.amjmed.2007.10.002
   Cole SR, 2008, AM J EPIDEMIOL, V168, P656, DOI 10.1093/aje/kwn164
   Costa F, 2017, LANCET, V389, P1025, DOI 10.1016/S0140-6736(17)30397-5
   Gent M, 1996, LANCET, V348, P1329, DOI 10.1016/s0140-6736(96)09457-3
   HANKEY GJ, 2000, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD001246
   Kim JH, 2016, CIRC J, V80, P1427, DOI 10.1253/circj.CJ-16-0061
   Levine GN, 2016, J AM COLL CARDIOL, V68, P1082, DOI 10.1016/j.jacc.2016.03.513
   Lunceford JK, 2004, STAT MED, V23, P2937, DOI 10.1002/SIM.1903
   Mauri L, 2007, NEW ENGL J MED, V356, P1020, DOI 10.1056/NEJMoa067731
   O'Gara PT, 2013, J AM COLL CARDIOL, V61, pE78, DOI 10.1016/j.jacc.2012.11.019
   Park TK, 2016, CIRC-CARDIOVASC INTE, V9, DOI 10.1161/CIRCINTERVENTIONS.115.002816
   RAO AK, 1988, J AM COLL CARDIOL, V11, P1
   Thygesen K, 2019, EUR HEART J, V40, P237, DOI [10.1016/j.jacc.2018.08.1038, 10.1093/eurheartj/ehy462]
   Valgimigli M, 2018, EUR HEART J, V39, P213, DOI 10.1093/eurheartj/ehx419
   Wallentin L, 2009, NEW ENGL J MED, V361, P1045, DOI 10.1056/NEJMoa0904327
   Yeh RW, 2016, JAMA-J AM MED ASSOC, V315, P1735, DOI 10.1001/jama.2016.3775
NR 20
TC 3
Z9 3
U1 0
U2 4
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD FEB
PY 2020
VL 50
IS 2
BP 120
EP 129
DI 10.4070/kcj.2019.0166
PG 10
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA KE0RE
UT WOS:000508267900003
PM 31845550
OA Other Gold, Green Published
DA 2021-04-22
ER

PT J
AU Lee, JH
   Eom, SY
   Kim, U
   Lee, CH
   Son, JW
   Jeon, DW
   Bae, JH
   Oh, SK
   Cha, KS
   Suh, Y
   Koh, YY
   Yang, TH
   Shim, DK
   Bae, JW
   Park, JS
AF Lee, Jung-Hee
   Eom, Sang-Yong
   Kim, Ung
   Lee, Chan-Hee
   Son, Jang-Won
   Jeon, Dong Woon
   Bae, Jang-Ho
   Oh, Seok Kyu
   Cha, Kwang Soo
   Suh, Yongsung
   Koh, Young Youp
   Yang, Tae-Hyun
   Shim, Dae Keun
   Bae, Jang-Whan
   Park, Jong-Seon
TI Effect of Operator Volume on In-Hospital Outcomes Following Primary
   Percutaneous Coronary Intervention for ST-Elevation Myocardial
   Infarction: Based on the 2014 Cohort of Korean Percutaneous Coronary
   Intervention (K-PCI) Registry
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE ST elevation myocardial infarction; Percutaneous coronary intervention;
   Operator volume; Treatment outcome
ID ANGIOGRAPHY; GUIDELINES; MANAGEMENT; IMPACT
AB Background and Objectives: The relationship between operator volume and outcomes of percutaneous coronary intervention (PCI) in patients with ST-elevation myocardial infarction (STEMI) has not been fully investigated. We aimed to investigate the relationship between operator PCI volume and in-hospital outcomes after primary PCI for STEMI.
   Methods: Among the total of 44,967 consecutive cases of PCI enrolled in the Korean nationwide, retrospective registry (K-PCI registry), 8,282 patients treated with PCI for STEMI by 373 operators were analyzed. PCI volumes above the 75th percentile (>30 cases/year), between the 75th and 25th percentile (10-30 cases/year), and below the 25th percentile (<10 cases/year) were defined as high, moderate, and low-volume operators, respectively. In-hospital outcomes including mortality, non-fatal myocardial infarction (MI), stent thrombosis, stroke, and urgent repeat PCI were analyzed.
   Results: The average number of primary PCI cases performed by 373 operators was 22.2 in a year. In-hospital mortality after PCI for STEMI was 571 cases (6.9%). In-hospital outcomes by operator volume showed no significant differences in the death rate, cardiac death, non-fatal MI, and stent thrombosis. However, the rate of urgent repeat PCI tended to be lower in the high-volume operator (0.6%) than in the moderate-(0.7%)/low-(1.5%) volume operator groups (p=0.095). The adjusted odds ratios for adverse in-hospital outcomes were similar in the 3 groups. Multivariate analysis also showed that operator volume was not a predictor for adverse in-hospital outcomes.
   Conclusions: In-hospital outcomes after primary PCI for STEMI were not associated with operator volume in the K-PCI registry.
C1 [Lee, Jung-Hee; Kim, Ung; Lee, Chan-Hee; Son, Jang-Won; Park, Jong-Seon] Yeungnam Univ, Med Ctr, Dept Internal Med, Div Cardiovasc,Coll Med, 170 Hyeonchung Ro, Daegu 42415, South Korea.
   [Eom, Sang-Yong] Chungbuk Natl Univ, Dept Prevent Med, Coll Med, Cheongju, South Korea.
   [Jeon, Dong Woon] Natl Hlth Insurance Serv NHIS Ilsan Hosp, Div Cardiol, Goyang, South Korea.
   [Bae, Jang-Ho] Konyang Univ Hosp, Heart Ctr, Daejeon, South Korea.
   [Oh, Seok Kyu] Wonkwang Univ Hosp, Reg Cardiocerebrovasc Ctr, Dept Cardiovasc Med, Iksan, South Korea.
   [Cha, Kwang Soo] Pusan Natl Univ Hosp, Dept Internal Med, Busan, South Korea.
   [Suh, Yongsung] Myongji Hosp, Dept Cardiol, Goyang, South Korea.
   [Koh, Young Youp] Chosun Univ, Dept Internal Med, Div Cardiol, Coll Med, Gwangju, South Korea.
   [Yang, Tae-Hyun] Inje Univ, Dept Cardiol, Busan Paik Hosp, Busan, South Korea.
   [Shim, Dae Keun] Good Morning Hosp, Dept Internal Med, Div Cardiovasc, Pyeongtaek, South Korea.
   [Bae, Jang-Whan] Chungbuk Natl Univ, Dept Internal Med, 1 Chungdae Ro, Cheongju 28644, South Korea.
RP Park, JS (corresponding author), Yeungnam Univ, Med Ctr, Dept Internal Med, Div Cardiovasc,Coll Med, 170 Hyeonchung Ro, Daegu 42415, South Korea.; Bae, JW (corresponding author), Chungbuk Natl Univ, Dept Internal Med, 1 Chungdae Ro, Cheongju 28644, South Korea.
EM drcorazon@hanmail.net; pjs@med.yu.ac.kr
RI ; Eom, Sang-Yong/B-5705-2016
OI Oh, Seok Kyu/0000-0001-7545-0143; Eom, Sang-Yong/0000-0002-4559-8152;
   Bae, Jang-Ho/0000-0001-9533-7527
FU Yeungnam University
FX This work was supported by the 2019 Yeungnam University research grant.
CR Badheka AO, 2014, CIRCULATION, V130, P1392, DOI 10.1161/CIRCULATIONAHA.114.009281
   Cutlip DE, 2007, CIRCULATION, V115, P2344, DOI 10.1161/CIRCULATIONAHA.106.685313
   Fanaroff AC, 2017, J AM COLL CARDIOL, V69, P2913, DOI 10.1016/j.jacc.2017.04.032
   Hannan EL, 2005, CIRCULATION, V112, P1171, DOI 10.1161/CIRCULATIONAHA.104.528455
   Harold JG, 2013, CATHETER CARDIO INTE, V82, pE69, DOI 10.1002/ccd.24985
   Hong SJ, 2015, JAMA-J AM MED ASSOC, V314, P2155, DOI 10.1001/jama.2015.15454
   Hulme W, 2018, EUR HEART J, V39, P1623, DOI 10.1093/eurheartj/ehy125
   Ibanez B, 2018, EUR HEART J, V39, P119, DOI 10.1093/eurheartj/ehx393
   Inohara T, 2017, JACC-CARDIOVASC INTE, V10, P918, DOI 10.1016/j.jcin.2017.02.015
   Jang JS, 2017, KOREAN CIRC J, V47, P328, DOI 10.4070/kcj.2017.0071
   Jolly SS, 2011, LANCET, V377, P1409, DOI 10.1016/S0140-6736(11)60404-2
   Levine GN, 2016, J AM COLL CARDIOL, V67, P1235, DOI 10.1016/j.jacc.2015.10.005
   Moscucci M, 2005, J AM COLL CARDIOL, V46, P625, DOI 10.1016/j.jacc.2005.05.048
   Srinivas VS, 2009, J AM COLL CARDIOL, V53, P574, DOI 10.1016/j.jacc.2008.09.056
   Thygesen K, 2019, EUR HEART J, V40, P237, DOI [10.1016/j.jacc.2018.08.1038, 10.1093/eurheartj/ehy462]
   Windecker S, 2015, EUROINTERVENTION, V10, P1024, DOI 10.4244/EIJY14M09_01
   Zhang JJ, 2018, J AM COLL CARDIOL, V72, P3126, DOI 10.1016/j.jacc.2018.09.013
NR 17
TC 2
Z9 2
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD FEB
PY 2020
VL 50
IS 2
BP 133
EP 144
DI 10.4070/kcj.2019.0206
PG 12
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA KE0RE
UT WOS:000508267900005
PM 31845555
OA Green Published, Other Gold
DA 2021-04-22
ER

PT J
AU Cho, MS
   Lee, CH
   Kim, J
   Ahn, JM
   Han, M
   Nam, GB
   Choi, KJ
   Kim, YH
AF Cho, Min Soo
   Lee, Cheol Hyun
   Kim, Jun
   Ahn, Jung-Min
   Han, Minkyu
   Nam, Gi-Byoung
   Choi, Kee-Joon
   Kim, You-Ho
TI Clinical Implications of Preoperative Nonvalvular Atrial Fibrillation
   with Respect to Postoperative Cardiovascular Outcomes in Patients
   Undergoing Non-Cardiac Surgery
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Atrial fibrillation; Stroke; Surgery; Risk assessment
ID CARDIAC RISK; MYOCARDIAL-ISCHEMIA; TASK-FORCE; STROKE; PREDICTORS;
   VALIDATION; MANAGEMENT; EVENTS; DEATH; INDEX
AB Background and Objectives: Atrial fibrillation (AF) is associated with a higher long-term risk of major cardiovascular events. However, its clinical implications with respect to peri-operative cardiovascular outcomes in patients undergoing non-cardiac surgery is unclear. We tried to examine the association between pre-operative AF and peri-operative cardiovascular outcomes.
   Methods: We retrospectively analyzed data from 26,501 consecutive patients who underwent comprehensive preoperative cardiac evaluations for risk stratification prior to receiving non-cardiac surgery at our center. Preoperative AF was diagnosed in 1,098 patients (4.1%), and their cardiovascular outcomes were compared with those of patients without AF. The primary outcome was the rate of major adverse cardiac and cerebrovascular events (MACCE) during immediate post-surgery period (<30 days).
   Results: Patients with AF were older and had higher proportion of male sex, higher rate of extra-cardiac comorbidities, higher CHA(2)DS(2)-VASc score, and higher revised cardiac risk index (RCRI) compared with those without AF. The rate of MACCE was significantly higher in AF patients compared to non-AF patients (4.6% vs. 1.2%, p<0.001). Preoperative AF was associated with higher risk of MACCE, even after multivariable adjustment (odds ratio, 2.97; 95% confidence interval, 2.13-4.07, p<0.001). The relative contribution of AF to MACCE was larger in patients with lower RCRI (p for interaction=0.010). The discriminating performance of RCRI was significantly enhanced by addition of AF.
   Conclusions: In patients undergoing non-cardiac surgery, preoperative AF was associated with a higher risk of peri-operative cardiovascular outcomes.
C1 [Cho, Min Soo; Kim, Jun; Ahn, Jung-Min; Nam, Gi-Byoung; Choi, Kee-Joon; Kim, You-Ho] Univ Ulsan, Asan Med Ctr, Dept Cardiol, Coll Med, 88 Olymp Ro 43 Gil, Seoul 05505, South Korea.
   [Lee, Cheol Hyun] Keimyung Univ, Dept Internal Med, Div Cardiol, Dongsan Hosp, Daegu, South Korea.
   [Han, Minkyu] Univ Ulsan, Asan Med Ctr, Dept Clin Epidemiol & Biostat, Coll Med, Seoul, South Korea.
RP Kim, J (corresponding author), Univ Ulsan, Asan Med Ctr, Dept Cardiol, Coll Med, 88 Olymp Ro 43 Gil, Seoul 05505, South Korea.
EM mdjunkim@gmail.com
OI Lee, Cheol Hyun/0000-0003-4203-1457; Cho, Min Soo/0000-0001-9867-4991
CR Baumgartner H, 2009, EUR J ECHOCARDIOGR, V10, P1, DOI 10.1093/ejechocard/jen303
   Botto F, 2014, ANESTHESIOLOGY, V120, P564, DOI 10.1097/ALN.0000000000000113
   Fihn SD, 2012, J AM COLL CARDIOL, V60, pE44, DOI 10.1016/j.jacc.2012.07.013
   GOLDMAN L, 1977, NEW ENGL J MED, V297, P845, DOI 10.1056/NEJM197710202971601
   Grau AJ, 2017, CEREBROVASC DIS, V43, P242, DOI 10.1159/000460827
   Gupta PK, 2011, CIRCULATION, V124, P381, DOI 10.1161/CIRCULATIONAHA.110.015701
   Hicks KA, 2015, J AM COLL CARDIOL, V66, P403, DOI 10.1016/j.jacc.2014.12.018
   HOLLENBERG M, 1992, JAMA-J AM MED ASSOC, V268, P205, DOI 10.1001/jama.268.2.205
   January CT, 2014, J AM COLL CARDIOL, V64, pE1, DOI 10.1016/j.jacc.2014.03.022
   Kaatz S, 2010, J THROMB HAEMOST, V8, P884, DOI 10.1111/j.1538-7836.2010.03781.x
   Kristensen SD, 2014, EUR HEART J, V35, P2383, DOI 10.1093/eurheartj/ehu282
   Lee TH, 1999, CIRCULATION, V100, P1043, DOI 10.1161/01.CIR.100.10.1043
   Lip GYH, 2010, CHEST, V137, P263, DOI 10.1378/chest.09-1584
   Longstreth WT, 2001, NEUROLOGY, V56, P368, DOI 10.1212/WNL.56.3.368
   McAlister FA, 2015, J THROMB HAEMOST, V13, P1768, DOI 10.1111/jth.13110
   Priebe HJ, 2004, BRIT J ANAESTH, V93, P9, DOI 10.1093/bja/aeh147
   Raymond RJ, 1998, AM HEART J, V136, P435, DOI 10.1016/S0002-8703(98)70217-0
   Smilowitz NR, 2017, JAMA CARDIOL, V2, P181, DOI 10.1001/jamacardio.2016.4792
   Stewart S, 2002, AM J MED, V113, P359, DOI 10.1016/S0002-9343(02)01236-6
   Thygesen K, 2012, J AM COLL CARDIOL, V60, P1581, DOI 10.1016/j.jacc.2012.08.001
   Urbanek C, 2014, CEREBROVASC DIS, V38, P370, DOI 10.1159/000368596
   van Diepen S, 2011, CIRCULATION, V124, P289, DOI 10.1161/CIRCULATIONAHA.110.011130
NR 22
TC 2
Z9 3
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD FEB
PY 2020
VL 50
IS 2
BP 148
EP 159
DI 10.4070/kcj.2019.0219
PG 12
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA KE0RE
UT WOS:000508267900007
PM 31845556
OA Other Gold, Green Published
DA 2021-04-22
ER

PT J
AU Lee, KH
   Cho, JG
   Lee, N
   Cho, KH
   Jeong, HK
   Park, H
   Kim, Y
   Cho, JY
   Kim, MC
   Sim, DS
   Yoon, HJ
   Yoon, N
   Kim, KH
   Hong, YJ
   Park, HW
   Ahn, Y
   Jeong, MH
   Park, JC
AF Lee, Ki Hong
   Cho, Jeong Gwan
   Lee, Nuri
   Cho, Kyung Hoon
   Jeong, Hyung Ki
   Park, Hyukjin
   Kim, Yongcheol
   Cho, Jae Yeong
   Kim, Min Chul
   Sim, Doo Sun
   Yoon, Hyun Ju
   Yoon, Namsik
   Kim, Kye Hun
   Hong, Young Joon
   Park, Hyung Wook
   Ahn, Youngkeun
   Jeong, Myung Ho
   Park, Jong Chun
TI Impact of Anticoagulation Intensity in Korean Patients with Atrial
   Fibrillation: Is It Different from Western Population?
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Warfarin; Prothrombin time; Atrial fibrillation; Thromboembolism; Safety
ID INTERNATIONAL NORMALIZED RATIO; J-RHYTHM REGISTRY; STROKE PREVENTION;
   JAPANESE PATIENTS; WARFARIN THERAPY; SECONDARY PREVENTION; ORAL
   ANTICOAGULANTS; DOSE WARFARIN; RISK; GUIDELINES
AB Background and Objectives: Although anticoagulation with warfarin is recommended as an international normalized ratio (INR) of prothrombin time between 2.0 and 3.0 and mean time in the therapeutic range (TTR) >= 70%, little has been proven that universal criteria might be suitable in Korean atrial fibrillation (AF) patients.
   Methods: We analyzed 710 patients with non-valvular AF who took warfarin. INR value and clinical outcomes were assessed during 2-year follow-up. Intensity of anticoagulation was assessed as mean INR value and TTR according to target INR range. Primary net-clinical outcome was defined as the composite of new-onset stroke and major bleeding. Secondary net-clinical outcome was defined as the composite of new-onset stroke, major bleeding and death.
   Results: Thromboembolism was significantly decreased when mean INR was over 1.6. Major bleeding was significantly decreased when TTR was over 70% and mean INR was less than 2.6. Mean INR 1.6-2.6 significantly reduced thromboembolism (adjusted hazard ratio [HR], 0.40; 95% confidence interval [CI], 0.19-0.85), major bleeding (HR, 0.43; 95% CI, 0.23-0.81), primary (HR, 0.50; 95% CI, 0.29-0.84) and secondary (HR, 0.45; 95% CI, 0.28-0.74) net-clinical outcomes, whereas mean INR 2.0-3.0 did not. Simultaneous satisfaction of mean INR 1.6-2.6 and TTR >= 70% was associated with significant risk reduction of major bleeding, primary and secondary net-clinical outcomes.
   Conclusions: Mean INR 1.6-2.6 was better than mean INR 2.0-3.0 for the prevention of thromboembolism and major bleeding. However, INR 1.6-2.6 and TTR >= 70% had similar clinical outcomes to INR 2.0-3.0 and TTR >= 70% in Korean patients with non-valvular AF.
C1 [Lee, Ki Hong; Cho, Jeong Gwan; Lee, Nuri; Cho, Kyung Hoon; Jeong, Hyung Ki; Park, Hyukjin; Kim, Yongcheol; Cho, Jae Yeong; Kim, Min Chul; Sim, Doo Sun; Yoon, Hyun Ju; Yoon, Namsik; Kim, Kye Hun; Hong, Young Joon; Park, Hyung Wook; Ahn, Youngkeun; Jeong, Myung Ho; Park, Jong Chun] Chonnam Natl Univ Hosp, Dept Cardiovasc Med, Heart Ctr, 42 Jebong Ro, Gwangju 61469, South Korea.
RP Cho, JG (corresponding author), Chonnam Natl Univ Hosp, Dept Cardiovasc Med, Heart Ctr, 42 Jebong Ro, Gwangju 61469, South Korea.
EM skawn77@gmail.com
OI LEE, NURI/0000-0003-4591-7157; Kim, Min Chul/0000-0001-6026-1702; Kim,
   Yongcheol/0000-0001-5568-4161; CHO, KYUNG HOON/0000-0002-0377-6352; Lee,
   Ki Hong/0000-0002-9938-3464; Park, Hyukjin/0000-0001-6832-9716; Jeong,
   Myung Ho/0000-0003-2424-810X; Jeong, Hyung Ki/0000-0001-5749-9525
FU Korean Society of Cardiology [201703-05]
FX This study was supported by a grant of the Korean Society of Cardiology
   (201703-05).
CR Atarashi H, 2011, J CARDIOL, V57, P95, DOI 10.1016/j.jjcc.2010.09.002
   Blackshear JL, 1996, LANCET, V348, P633
   Cabral KP, 2011, J THROMB HAEMOST, V9, P441, DOI 10.1111/j.1538-7836.2010.04179.x
   Capodanno D, 2010, THROMB HAEMOSTASIS, V104, P471, DOI 10.1160/TH10-04-0232
   Chenhsu RY, 2000, ANN PHARMACOTHER, V34, P1395
   CONNOLLY SJ, 1991, J AM COLL CARDIOL, V18, P349, DOI 10.1016/0735-1097(91)90585-W
   EZEKOWITZ MD, 1992, NEW ENGL J MED, V327, P1406, DOI 10.1056/NEJM199211123272002
   Gan GG, 2003, INT J HEMATOL, V78, P84, DOI 10.1007/BF02983247
   Inoue H, 2014, CIRC J, V78, P1997, DOI 10.1253/circj.CJ-66-0092
   Inoue H, 2013, CIRC J, V77, P2264, DOI 10.1253/circj.CJ-13-0290
   January CT, 2014, J AM COLL CARDIOL, V64, pE1, DOI 10.1016/j.jacc.2014.03.022
   Kirchhof P, 2016, EUR HEART J, V37, P2893, DOI 10.1093/eurheartj/ehw210
   KISTLER JP, 1990, NEW ENGL J MED, V323, P1505
   Kodani E, 2015, CIRC J, V79, P325, DOI 10.1253/circj.CJ-14-1057
   KOUDSTAAL PJ, 1995, NEW ENGL J MED, V333, P5
   Lee JY, 2017, EUR HEART J, V38, P2586, DOI 10.1093/eurheartj/ehx213
   Lip GYH, 2015, INT J CARDIOL, V180, P246, DOI 10.1016/j.ijcard.2014.11.182
   Marin F, 2009, J AM COLL CARDIOL, V54, P1041, DOI 10.1016/j.jacc.2009.04.084
   MCBRIDE R, 1991, CIRCULATION, V84, P527, DOI 10.1161/01.CIR.84.2.527
   PETERSEN P, 1989, LANCET, V1, P175
   POLLER L, 1982, BRIT J HAEMATOL, V51, P479, DOI 10.1111/j.1365-2141.1982.tb02805.x
   ROSENDAAL FR, 1993, THROMB HAEMOSTASIS, V69, P236
   Suzuki S, 2007, CIRC J, V71, P761, DOI 10.1253/circj.71.761
   Yamaguchi T, 2000, STROKE, V31, P817, DOI 10.1161/01.STR.31.4.817
   Yamashita T, 2015, J CARDIOL, V65, P175, DOI 10.1016/j.jjcc.2014.07.013
   Yasaka M, 2001, INTERNAL MED, V40, P1183, DOI 10.2169/internalmedicine.40.1183
   You JHS, 2005, BRIT J CLIN PHARMACO, V59, P582, DOI 10.1111/j.1365-2125.2005.02361.x
NR 27
TC 2
Z9 2
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD FEB
PY 2020
VL 50
IS 2
BP 163
EP 175
DI 10.4070/kcj.2019.0099
PG 13
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA KE0RE
UT WOS:000508267900009
PM 31642215
OA Other Gold, Green Published
DA 2021-04-22
ER

PT J
AU Kim, C
AF Kim, Choongki
TI Risk Stratification by SYNTAX Score Systems in Current Percutaneous
   Revascularization Era
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
ID EVEROLIMUS-ELUTING STENTS; CORONARY INTERVENTION; BYPASS-SURGERY
C1 [Kim, Choongki] Ewha Womans Univ, Seoul Hosp, Coll Med, Dept Cardiol, 25 Magokdong Ro 2 Gil, Seoul 07804, South Korea.
RP Kim, C (corresponding author), Ewha Womans Univ, Seoul Hosp, Coll Med, Dept Cardiol, 25 Magokdong Ro 2 Gil, Seoul 07804, South Korea.
EM splennov26@gmail.com
CR Capodanno D, 2009, CIRC-CARDIOVASC INTE, V2, P302, DOI 10.1161/CIRCINTERVENTIONS.108.847137
   Farooq V, 2013, LANCET, V381, P639, DOI 10.1016/S0140-6736(13)60108-7
   Garg S, 2011, JACC-CARDIOVASC INTE, V4, P432, DOI 10.1016/j.jcin.2011.01.008
   Kang J, KOREAN CIRC J, V50, P22
   Makikallio T, 2016, LANCET, V388, P2742
   Sianos Georgios, 2005, EuroIntervention, V1, P219
   Stone GW, 2016, NEW ENGL J MED, V375, P2223, DOI 10.1056/NEJMoa1610227
   Thuijs DJFM, 2019, LANCET, V394, P1325, DOI 10.1016/S0140-6736(19)31997-X
   Wykrzykowska JJ, 2010, J AM COLL CARDIOL, V56, P272, DOI 10.1016/j.jacc.2010.03.044
   Yadav M, 2013, J AM COLL CARDIOL, V62, P1219, DOI 10.1016/j.jacc.2013.06.047
NR 10
TC 0
Z9 0
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JAN
PY 2020
VL 50
IS 1
BP 35
EP 37
DI 10.4070/kcj.2019.0348
PG 3
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA JX0BP
UT WOS:000503409700004
PM 31854155
OA Green Published, Other Gold
DA 2021-04-22
ER

PT J
AU Lee, YS
AF Lee, Young Soo
TI Is Renal Denervation Using Radiofrequency a Treatment Option for the
   Ventricular Arrhythmia Following Acute Myocardial Infarction?
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
ID SYMPATHETIC DENERVATION; ABLATION
C1 [Lee, Young Soo] Catholic Univ Daegu, Coll Med, Dept Cardiol, 33 Duryugongwon Ro 17 Gil, Daegu 42472, South Korea.
RP Lee, YS (corresponding author), Catholic Univ Daegu, Coll Med, Dept Cardiol, 33 Duryugongwon Ro 17 Gil, Daegu 42472, South Korea.
EM mdleeys@cu.ac.kr
CR Azizi M, 2018, LANCET, V391, P2335, DOI 10.1016/S0140-6736(18)31082-1
   Cho Y, 2016, KOREAN CIRC J, V46, P747, DOI 10.4070/kcj.2016.46.6.747
   Hoffmann BA, 2013, J CARDIOVASC ELECTR, V24, P1175, DOI 10.1111/jce.12207
   Kim SS, 2020, KOREAN CIRC J, V50, P38, DOI 10.4070/kcj.2019.0106
   Schlaich MP, 2009, NEW ENGL J MED, V361, P932, DOI 10.1056/NEJMc0904179
   Steigerwald K, 2012, J HYPERTENS, V30, P2230, DOI 10.1097/HJH.0b013e32835821e5
   Tzafriri AR, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa3236
   Ukena C, 2016, CLIN RES CARDIOL, V105, P873, DOI 10.1007/s00392-016-1012-y
   Viskin S, 2017, KOREAN CIRC J, V47, P299, DOI 10.4070/kcj.2016.0303
NR 9
TC 1
Z9 1
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JAN
PY 2020
VL 50
IS 1
BP 50
EP 51
DI 10.4070/kcj.2019.0361
PG 2
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA JX0BP
UT WOS:000503409700006
PM 31854156
OA Green Published, Other Gold
DA 2021-04-22
ER

PT J
AU Lee, HY
AF Lee, Hae Young
TI Big Challenge in Big Data Research: Continual Dispute on Big Data
   Analysis
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
C1 [Lee, Hae Young] Seoul Natl Univ, Coll Med, Dept Internal Med, 101 Daehak Ro, Seoul 03080, South Korea.
RP Lee, HY (corresponding author), Seoul Natl Univ, Coll Med, Dept Internal Med, 101 Daehak Ro, Seoul 03080, South Korea.
EM hylee612@snu.ac.kr
OI Lee, Hae-Young/0000-0002-9521-4102
CR Cho SMJ, 2019, KOREAN CIRC J, V49, P1035, DOI 10.4070/kcj.2019.0049
   Cushman William C, 2002, J Clin Hypertens (Greenwich), V4, P393
   Hisamatsu T, 2019, KOREAN CIRC J, V49, P1049, DOI 10.4070/kcj.2019.0197
   Kim HS, 2019, J KOREAN MED SCI, V34, DOI 10.3346/jkms.2019.34.e28
   Kim HS, 2018, J KOREAN MED SCI, V33, DOI 10.3346/jkms.2018.33.e213
   Kim Hyeon Chang, 2019, Clin Hypertens, V25, P16, DOI 10.1186/s40885-019-0121-0
   Korean Society Hypertension (KSH), 2018, Clin Hypertens, V24, P13, DOI 10.1186/s40885-018-0098-0
   Lee CH, 2017, KIDNEY RES CLIN PRAC, V36, P3, DOI 10.23876/j.krcp.2017.36.1.3
   Lee Hae-Young, 2019, Clin Hypertens, V25, P20, DOI 10.1186/s40885-019-0124-x
   Lee H, 2019, KOREAN CIRC J, V49, P514, DOI 10.4070/kcj.2018.0358
   Lee SA, 2014, KOREAN J INTERN MED, V29, P315, DOI 10.3904/kjim.2014.29.3.315
   Park S, 2019, KOREAN CIRC J, V49, P1002, DOI 10.4070/kcj.2019.0261
   Williams B, 2018, EUR HEART J, V39, P3021, DOI 10.1093/eurheartj/ehy339
   You SC, 2020, KOREAN CIRC J, V50, P52, DOI 10.4070/kcj.2019.0173
NR 14
TC 0
Z9 0
U1 0
U2 6
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JAN
PY 2020
VL 50
IS 1
BP 69
EP 71
DI 10.4070/kcj.2019.0349
PG 3
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA JX0BP
UT WOS:000503409700008
PM 31854157
OA Green Published, Other Gold
DA 2021-04-22
ER

PT J
AU Kwon, O
   Na, W
   Kim, YH
AF Kwon, Osung
   Na, Wonjun
   Kim, Young-Hak
TI Machine Learning: a New Opportunity for Risk Prediction
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
ID TASK-FORCE; ASSOCIATION
C1 [Kwon, Osung] Catholic Univ Korea, Eunpyeong St Marys Hosp, Dept Internal Med, Div Cardiol, Seoul, South Korea.
   [Na, Wonjun; Kim, Young-Hak] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Internal Med,Div Cardiol, 88 Olymp Ro 43 Gil, Seoul 05505, South Korea.
RP Kim, YH (corresponding author), Univ Ulsan, Coll Med, Asan Med Ctr, Dept Internal Med,Div Cardiol, 88 Olymp Ro 43 Gil, Seoul 05505, South Korea.
EM mdyhkim@amc.seoul.kr
CR Alaa AM, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0213653
   Cho IJ, 2020, KOREAN CIRC J, V50, P72, DOI 10.4070/kcj.2019.0105
   Collins GS, 2015, ANN INTERN MED, V162, P55, DOI 10.7326/M14-0697
   Goff DC, 2014, J AM COLL CARDIOL, V63, P2935, DOI 10.1016/j.jacc.2013.11.005
   LeCun Y, 2015, NATURE, V521, P436, DOI 10.1038/nature14539
   Litjens G, 2019, JACC-CARDIOVASC IMAG, V12, P1549, DOI 10.1016/j.jcmg.2019.06.009
   Miotto R, 2018, BRIEF BIOINFORM, V19, P1236, DOI 10.1093/bib/bbx044
   Piepoli MF, 2016, ATHEROSCLEROSIS, V252, P207, DOI 10.1016/j.atherosclerosis.2016.05.037
   Roth GA, 2017, J AM COLL CARDIOL, V70, P1, DOI 10.1016/j.jacc.2017.04.052
   SIONTIS GCM, 2012, BMJ-BRIT MED J, V344, DOI DOI 10.1136/BMJ.E3318
NR 10
TC 1
Z9 1
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JAN
PY 2020
VL 50
IS 1
BP 85
EP 87
DI 10.4070/kcj.2019.0314
PG 3
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA JX0BP
UT WOS:000503409700010
PM 31854158
OA Green Published, Other Gold
DA 2021-04-22
ER

PT J
AU Kim, Y
   Johnson, TW
   Park, SH
   Kim, MC
   Kim, JH
   Hong, YJ
   Jeong, MH
   Ahn, Y
AF Kim, Yongcheol
   Johnson, Thomas W.
   Park, Soo Hwan
   Kim, Min Chul
   Kim, Ju Han
   Hong, Young Joon
   Jeong, Myung Ho
   Ahn, Youngkeun
TI Optical Coherence Tomography Findings of Non-ST Elevation Myocardial
   Infarction with Multivessel Disease
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
C1 [Kim, Yongcheol; Park, Soo Hwan; Kim, Min Chul; Kim, Ju Han; Hong, Young Joon; Jeong, Myung Ho; Ahn, Youngkeun] Chonnam Natl Univ Hosp, Dept Cardiol, 42 Jebong Ro, Gwangju 61469, South Korea.
   [Johnson, Thomas W.] Bristol Heart Inst, Dept Cardiol, Bristol, Avon, England.
RP Ahn, Y (corresponding author), Chonnam Natl Univ Hosp, Dept Cardiol, 42 Jebong Ro, Gwangju 61469, South Korea.
EM cecilyk@hanmail.net
OI Jeong, Myung Ho/0000-0003-2424-810X; Kim, Min Chul/0000-0001-6026-1702;
   Kim, Juhan/0000-0002-3186-0770; Kim, Yongcheol/0000-0001-5568-4161
FU Chonnam National University Hospital Biomedical Research Institute
   [BCRI18015]
FX This study was supported by a grant of Chonnam National University
   Hospital Biomedical Research Institute (BCRI18015).
CR Johnson TW, 2019, EUR HEART J, V40, P2566, DOI 10.1093/eurheartj/ehz332
   Kerensky RA, 2002, J AM COLL CARDIOL, V39, P1456, DOI 10.1016/S0735-1097(02)01770-9
NR 2
TC 1
Z9 1
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JAN
PY 2020
VL 50
IS 1
BP 88
EP 90
DI 10.4070/kcj.2019.0222
PG 3
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA JX0BP
UT WOS:000503409700011
PM 31854159
OA Other Gold, Green Published
DA 2021-04-22
ER

PT J
AU Song, JW
   Soh, S
   Shim, JK
AF Song, Jong Wook
   Soh, Sarah
   Shim, Jae-Kwang
TI Monitored Anesthesia Care for Cardiovascular Interventions
SO KOREAN CIRCULATION JOURNAL
LA English
DT Review
DE Sedation; Cardiovascular interventions; Monitored anesthesia care
ID INCREASING PLASMA-CONCENTRATIONS; ATRIAL-FIBRILLATION; PROPOFOL
   SEDATION; BISPECTRAL INDEX; PARADOXICAL REACTION; CATHETER ABLATION;
   RESPIRATORY DEPRESSION; CONSCIOUS SEDATION; DEEP SEDATION; MIDAZOLAM
AB The interventional cardiology is growing and evolving. Many complex procedures are now performed outside the operating room to manage cardiovascular pathologies which had been traditionally treated with cardiac surgery. Appropriate sedation strategy is crucial for improved patient comfort and successful procedure while ensuring safety. Sedation for cardiovascular intervention is frequently challenging, especially in critically-ill, high-risk patients. This review addresses pre-procedure evaluation and preparation of patients, proper monitoring, commonly used sedatives and analgesics, and considerations for specific procedures. Appropriate depth of sedation and analgesia should be balanced with patient, procedural and institutional factors. Understanding of the pharmacology of sedatives/analgesics, vigilant monitoring, ability and proper preparation for management of potential complications may improve outcomes in patients undergoing sedation for cardiovascular procedures.
C1 [Song, Jong Wook; Soh, Sarah; Shim, Jae-Kwang] Yonsei Univ, Coll Med, Yonsei Cardiovasc Hosp, Dept Anesthesiol & Pain Med,Anesthesia & Pain Res, 50 Yonsei Ro, Seoul 03722, South Korea.
RP Shim, JK (corresponding author), Yonsei Univ, Coll Med, Yonsei Cardiovasc Hosp, Dept Anesthesiol & Pain Med,Anesthesia & Pain Res, 50 Yonsei Ro, Seoul 03722, South Korea.
EM aneshim@yuhs.ac
RI Song, Jong Wook/AAF-7618-2021
OI Soh, Sarah/0000-0001-5022-4617; Shim, Jae-Kwang/0000-0001-9093-9692;
   Song, Jong Wook/0000-0001-7518-2070
CR AGARWAL A, 1989, ANAESTHESIA, V44, P632, DOI 10.1111/j.1365-2044.1989.tb13581.x
   Agrawal D, 2003, ANN EMERG MED, V42, P636, DOI 10.1016/S0196-0644(03)00516-X
   Amer Soc Anesthesiologists, 2017, ANESTHESIOLOGY, V126, P376, DOI 10.1097/ALN.0000000000001452
   Amer Soc Anesthesiologists Task F, 2018, ANESTHESIOLOGY, V128, P437, DOI 10.1097/ALN.0000000000002043
   Angst MS, 2004, ANESTHESIOLOGY, V101, P744, DOI 10.1097/00000542-200409000-00024
   BAUER TM, 1995, LANCET, V346, P145, DOI 10.1016/S0140-6736(95)91209-6
   Bell A, 2007, EMERG MED AUSTRALAS, V19, P405, DOI 10.1111/j.1742-6723.2007.00982.x
   BENNETT SN, 1995, NEW ENGL J MED, V333, P147, DOI 10.1056/NEJM199507203330303
   Bhana N, 2000, DRUGS, V59, P263, DOI 10.2165/00003495-200059020-00012
   Bhananker SM, 2006, ANESTHESIOLOGY, V104, P228, DOI 10.1097/00000542-200602000-00005
   Brechmann T, 2018, UNITED EUR GASTROENT, V6, P536, DOI 10.1177/2050640617736231
   BRYSON HM, 1995, DRUGS, V50, P513, DOI 10.2165/00003495-199550030-00008
   Cacho G, 2010, REV ESP ENFERM DIG, V102, P86, DOI 10.4321/s1130-01082010000200003
   Cho JS, 2014, EUROPACE, V16, P1000, DOI 10.1093/europace/eut365
   Choi JW, 2019, KOREAN J ANESTHESIOL, V72, P156, DOI 10.4097/kja.d.18.00198
   Criqui MH, 2015, CIRC RES, V116, P1509, DOI 10.1161/CIRCRESAHA.116.303849
   Dahan A, 2003, ADV EXP MED BIOL, V523, P81
   Di Biase L, 2011, HEART RHYTHM, V8, P368, DOI 10.1016/j.hrthm.2010.10.043
   Di Biase L, 2009, CIRC-ARRHYTHMIA ELEC, V2, P108, DOI 10.1161/CIRCEP.108.815266
   Ebert TJ, 2000, ANESTHESIOLOGY, V93, P382, DOI 10.1097/00000542-200008000-00016
   FORSTER A, 1980, ANESTHESIOLOGY, V53, P494, DOI 10.1097/00000542-198012000-00010
   Fruchter O, 2014, RESPIRATION, V87, P388, DOI 10.1159/000358440
   Giovannitti Joseph A Jr, 2015, Anesth Prog, V62, P31, DOI 10.2344/0003-3006-62.1.31
   Golparvar M, 2004, PEDIATR ANESTH, V14, P924, DOI 10.1111/j.1460-9592.2004.01349.x
   GOODMAN NW, 1987, BRIT J ANAESTH, V59, P1497, DOI 10.1093/bja/59.12.1497
   Guo TZ, 1996, ANESTHESIOLOGY, V84, P873, DOI 10.1097/00000542-199604000-00015
   Harrison SJ, 2002, HEART, V88, P117, DOI 10.1136/heart.88.2.117
   Hsu YW, 2004, ANESTHESIOLOGY, V101, P1066, DOI 10.1097/00000542-200411000-00005
   HUGHES MA, 1992, ANESTHESIOLOGY, V76, P334, DOI 10.1097/00000542-199203000-00003
   Jackson BF, 2015, J EMERG MED, V48, pE67, DOI 10.1016/j.jemermed.2014.09.062
   Jung SM, 2019, KOREAN J ANESTHESIOL
   Kalogridaki M, 2011, HELL J CARDIOL, V52, P483
   Kang D, 2019, KOREAN J ANESTHESIOL, V72, P164, DOI 10.4097/kja.d.18.00208
   Kang H, 2016, KOREAN J ANESTHESIOL, V69, P545, DOI 10.4097/kjae.2016.69.6.545
   Kazama T, 1999, ANESTHESIOLOGY, V90, P1517, DOI 10.1097/00000542-199906000-00004
   Khan LC, 1997, ANESTH ANALG, V85, P213, DOI 10.1097/00000539-199707000-00038
   Khan ZP, 1999, ANAESTHESIA, V54, P146, DOI 10.1046/j.1365-2044.1999.00659.x
   Kim SY, 2011, KOREAN J ANESTHESIOL, V61, P288, DOI 10.4097/kjae.2011.61.4.288
   Larsen R, 1988, Anaesthesia, V43 Suppl, P25, DOI 10.1111/j.1365-2044.1988.tb09064.x
   LAU W, 1993, AM J CARDIOL, V72, P177, DOI 10.1016/0002-9149(93)90156-7
   Lee S, 2019, KOREAN J ANESTHESIOL, V72, P323, DOI 10.4097/kja.19259
   Lewis SR, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010824.pub2
   Litman RS, 2000, J PAIN SYMPTOM MANAG, V19, P468, DOI 10.1016/S0885-3924(00)00141-X
   Mamiya H, 1998, Anesth Prog, V45, P18
   Mancuso CE, 2004, PHARMACOTHERAPY, V24, P1177, DOI 10.1592/phco.24.13.1177.38089
   Metzner J, 2010, CURR OPIN ANESTHESIO, V23, P523, DOI 10.1097/ACO.0b013e32833b7d7c
   Niksch A, 2010, PEDIATR CARDIOL, V31, P1079, DOI 10.1007/s00246-010-9768-8
   Park JH, 2019, J CLIN MED, V8, DOI 10.3390/jcm8040472
   Paspatis GA, 2009, ENDOSCOPY, V41, P1046, DOI 10.1055/s-0029-1215342
   PENTIKAINEN PJ, 1989, J CLIN PHARMACOL, V29, P272, DOI 10.1002/j.1552-4604.1989.tb03327.x
   Pires LA, 1996, CARDIOLOGY, V87, P319, DOI 10.1159/000177113
   Qadeer MA, 2009, GASTROENTEROLOGY, V136, P1568, DOI 10.1053/j.gastro.2009.02.004
   RAZA SMA, 1987, CLIN THER, V10, P40
   RIKER RR, 2005, PHARMACOTHERAPY S 2, V25, pS, DOI DOI 10.1592/PHCO.2005.25.5_PART_2.8S
   Robinson BJ, 1997, ANESTHESIOLOGY, V86, P64, DOI 10.1097/00000542-199701000-00010
   Sahinovic MM, 2018, CLIN PHARMACOKINET, V57, P1539, DOI 10.1007/s40262-018-0672-3
   Salukhe TV, 2012, EUROPACE, V14, P325, DOI 10.1093/europace/eur328
   Schuttler J, 2000, ANESTHESIOLOGY, V92, P727, DOI 10.1097/00000542-200003000-00017
   Servin F, 2003, ADV EXP MED BIOL, V523, P245
   Shabanie A, 2006, TECH VASC INTERV RAD, V9, P84, DOI 10.1053/j.tvir.2007.03.008
   SKARVAN K, 1986, ANAESTHESIST, V35, P17
   Sohn HM, 2016, KOREAN J ANESTHESIOL, V69, P319, DOI 10.4097/kjae.2016.69.4.319
   Trentman TL, 2009, J CARDIOTHOR VASC AN, V23, P841, DOI 10.1053/j.jvca.2009.01.027
   von Delius S, 2012, ENDOSCOPY, V44, P258, DOI 10.1055/s-0031-1291485
   Weaver CS, 2007, AM J EMERG MED, V25, P918, DOI 10.1016/j.ajem.2007.02.042
   Wutzler A, 2013, J INTERV CARD ELECTR, V38, P115, DOI 10.1007/s10840-013-9817-3
NR 66
TC 4
Z9 4
U1 0
U2 3
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JAN
PY 2020
VL 50
IS 1
BP 1
EP 11
DI 10.4070/kcj.2019.0269
PG 11
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA JX0BP
UT WOS:000503409700001
PM 31642214
OA Other Gold, Green Published
DA 2021-04-22
ER

PT J
AU Murohara, T
AF Murohara, Toyoaki
TI Therapeutic Angiogenesis with Somatic Stem Cell Transplantation
SO KOREAN CIRCULATION JOURNAL
LA English
DT Review
DE Angiogenesis; Adipose-derived regenerative cell; Therapeutic
   angiogenesis; Mesenchymal stem cell; Ischemia
ID ENDOTHELIAL PROGENITOR CELLS; HUMAN ADIPOSE-TISSUE; MARROW
   MONONUCLEAR-CELLS; HEPATOCYTE GROWTH-FACTOR; STROMAL CELLS; POSTNATAL
   NEOVASCULARIZATION; MYOCARDIAL-INFARCTION; INDUCE ANGIOGENESIS; ISCHEMIC
   DISEASE; IFATS COLLECTION
AB Therapeutic angiogenesis is an important strategy to rescue ischemic tissues in patients with critical limb ischemia having no other treatment option such as endovascular angioplasty or bypass surgery. Studies indicated so far possibilities of therapeutic angiogenesis using autologous bone marrow mononuclear cells, CD34(+) cells, peripheral blood mononuclear cells, adipose-derived stem/progenitor cells, and etc. Recent studies indicated that subcutaneous adipose tissue contains stem/progenitor cells that can give rise to several mesenchymal lineage cells. Moreover, these mesenchymal progenitor cells release a variety of angiogenic growth factors including vascular endothelial growth factor, fibroblast growth factor, hepatocyte growth factor and chemokine stromal cell-derived factor-1. Subcutaneous adipose tissues can be harvested by less invasive technique. These biological properties of adipose-derived regenerative cells (ADRCs) implicate that autologous subcutaneous adipose tissue would be a useful cell source for therapeutic angiogenesis in humans. In this review, I would like to discuss biological properties and future perspective of ADRCs-mediated therapeutic angiogenesis.
C1 [Murohara, Toyoaki] Nagoya Univ, Dept Cardiol, Grad Sch Med, Nagoya, Aichi, Japan.
RP Murohara, T (corresponding author), Nagoya Univ, Dept Cardiol, Grad Sch Med, Showa Ku, 65 Tsurumai Cho, Nagoya, Aichi 4668550, Japan.
EM murohara@med.nagoya-u.ac.jp
CR Amos PJ, 2008, STEM CELLS, V26, P2682, DOI 10.1634/stemcells.2008-0030
   Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964
   Asahara T, 1999, CIRC RES, V85, P221, DOI 10.1161/01.RES.85.3.221
   Asahara T, 1999, EMBO J, V18, P3964, DOI 10.1093/emboj/18.14.3964
   Bhang SH, 2009, STEM CELLS, V27, P1976, DOI 10.1002/stem.115
   Bleul CC, 1996, NATURE, V382, P829, DOI 10.1038/382829a0
   Cai LY, 2009, STEM CELLS, V27, P230, DOI 10.1634/stemcells.2008-0273
   Choi JH, 2004, ARTERIOSCL THROM VAS, V24, P1246, DOI 10.1161/01.ATV.0000133488.56221.4a
   Cianfarani F, 2013, WOUND REPAIR REGEN, V21, P545, DOI 10.1111/wrr.12051
   Delle Monache S, 2016, GROWTH FACTORS, V34, P87, DOI 10.1080/08977194.2016.1191481
   Eguchi S, 2019, J BIOL CHEM, V294, P11665, DOI 10.1074/jbc.RA119.007537
   FOLKMAN J, 1971, NEW ENGL J MED, V285, P1182
   FOLKMAN J, 1995, NAT MED, V1, P27, DOI 10.1038/nm0195-27
   Fraser JK, 2006, TRENDS BIOTECHNOL, V24, P150, DOI 10.1016/j.tibtech.2006.01.010
   Fujii T, 2008, ATHEROSCLEROSIS, V200, P51, DOI 10.1016/j.atherosclerosis.2007.12.012
   Gallagher KA, 2007, J CLIN INVEST, V117, P1249, DOI 10.1172/JCI29710
   Hao CN, 2014, AM J PHYSIOL-HEART C, V307, pH869, DOI 10.1152/ajpheart.00310.2014
   Heeschen C, 2004, CIRCULATION, V109, P1615, DOI 10.1161/01.CIR.0000124476.32871.E3
   Hiasa K, 2004, CIRCULATION, V109, P2454, DOI 10.1161/01.CIR.0000128213.96779.61
   Hill JM, 2003, NEW ENGL J MED, V348, P593, DOI 10.1056/NEJMoa022287
   Inoue O, 2019, BIOCHEM BIOPH RES CO, V517, P369, DOI 10.1016/j.bbrc.2019.07.081
   Ishii M, 2014, INT J CARDIOL, V175, P545, DOI 10.1016/j.ijcard.2014.06.034
   Isner JM, 2002, NATURE, V415, P234
   Isner JM, 1999, J CLIN INVEST, V103, P1231, DOI 10.1172/JCI6889
   Kajiguchi M, 2007, CIRC J, V71, P196, DOI 10.1253/circj.71.196
   Kalka C, 2000, ANN THORAC SURG, V70, P829, DOI 10.1016/S0003-4975(00)01633-7
   Kalka C, 2000, P NATL ACAD SCI USA, V97, P3422, DOI 10.1073/pnas.070046397
   Kamihata H, 2001, CIRCULATION, V104, P1046, DOI 10.1161/hc3501.093817
   Kang T, 2016, STEM CELL TRANSL MED, V5, P440, DOI 10.5966/sctm.2015-0177
   Kawamoto A, 2006, CIRCULATION, V114, P2163, DOI 10.1161/CIRCULATIONAHA.106.644518
   Kondo K, 2018, CIRC J, V82, P1168, DOI 10.1253/circj.CJ-17-0510
   Kondo K, 2009, ARTERIOSCL THROM VAS, V29, P61, DOI 10.1161/ATVBAHA.108.166496
   Kondo T, 2004, ARTERIOSCL THROM VAS, V24, P1442, DOI 10.1161/01.ATV.0000135655.52088.c5
   Lee CW, 2004, J AM COLL CARDIOL, V43, P474, DOI 10.1016/j.jacc.2003.09.033
   Lee HC, 2012, CIRC J, V76, P1750, DOI 10.1253/circj.CJ-11-1135
   Losordo DW, 2004, CIRCULATION, V109, P2692, DOI 10.1161/01.CIR.0000128596.49339.05
   Losordo DW, 2004, CIRCULATION, V109, P2487, DOI 10.1161/01.CIR.0000128595.79378.FA
   Matoba S, 2008, AM HEART J, V156, P1010, DOI 10.1016/j.ahj.2008.06.025
   Merino-Gonzalez C, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00024
   Miranville A, 2004, CIRCULATION, V110, P349, DOI 10.1161/01.CIR.0000135466.16823.D0
   Miyazaki T, 2005, DIFFERENTIATION, V73, P69, DOI 10.1111/j.1432-0436.2005.07302004.x
   Moon MH, 2006, CELL PHYSIOL BIOCHEM, V17, P279, DOI 10.1159/000094140
   Morishita R, 1999, HYPERTENSION, V33, P1379, DOI 10.1161/01.HYP.33.6.1379
   Moseley TA, 2006, PLAST RECONSTR SURG, V118, p121S, DOI 10.1097/01.prs.0000234609.74811.2e
   Murohara T, 2016, THERAPEUTIC ANGIOGEN, P67
   Murohara T, 2009, J CARDIOL, V53, P155, DOI 10.1016/j.jjcc.2009.01.003
   Nagasawa T, 1996, P NATL ACAD SCI USA, V93, P14726, DOI 10.1073/pnas.93.25.14726
   Nakagami H, 2005, ARTERIOSCL THROM VAS, V25, P2542, DOI 10.1161/01.ATV.0000190701.92007.6d
   Planat-Benard V, 2004, CIRCULATION, V109, P656, DOI 10.1161/01.CIR.0000114522.38265.61
   Powell RJ, 2008, CIRCULATION, V118, P58, DOI 10.1161/CIRCULATIONAHA.107.727347
   Rehman J, 2004, CIRCULATION, V109, P1292, DOI 10.1161/01.CIR.0000121425.42966.F1
   Saito Y, 2007, CIRC J, V71, P1187, DOI 10.1253/circj.71.1187
   Shintani S, 2001, CIRCULATION, V103, P897, DOI 10.1161/01.CIR.103.6.897
   Suga H, 2007, CYTOTHERAPY, V9, P738, DOI 10.1080/14653240701679873
   Sumi M, 2007, LIFE SCI, V80, P559, DOI 10.1016/j.lfs.2006.10.020
   Takahashi M, 2012, CIRC J, V76, P1597, DOI 10.1253/circj.CJ-12-0641
   Takahashi T, 1999, NAT MED, V5, P434
   TAKESHITA S, 1994, CIRCULATION, V90, P228
   TAKESHITA S, 1994, J CLIN INVEST, V93, P662, DOI 10.1172/JCI117018
   Tateishi-Yuyama E, 2002, LANCET, V360, P427, DOI 10.1016/S0140-6736(02)09670-8
   Traktuev DO, 2008, CIRC RES, V102, P77, DOI 10.1161/CIRCRESAHA.107.159475
   Van Belle E, 1998, CIRCULATION, V97, P381
   Yamaguchi J, 2003, CIRCULATION, V107, P1322, DOI 10.1161/01.CIR.0000055313.77510.22
   YANAGISAWAMIWA A, 1992, SCIENCE, V257, P1401, DOI 10.1126/science.1382313
   Zannettino ACW, 2008, J CELL PHYSIOL, V214, P413, DOI 10.1002/jcp.21210
   ZEIHER AM, 1993, J CLIN INVEST, V92, P652, DOI 10.1172/JCI116634
   Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859
NR 67
TC 4
Z9 4
U1 0
U2 3
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JAN
PY 2020
VL 50
IS 1
BP 12
EP 21
DI 10.4070/kcj.2019.0288
PG 10
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA JX0BP
UT WOS:000503409700002
PM 31854154
OA Green Published, Other Gold
DA 2021-04-22
ER

PT J
AU Kang, J
   Han, JK
   Kang, DY
   Zheng, C
   Yang, HM
   Park, KW
   Kang, HJ
   Koo, BK
   Kim, HS
AF Kang, Jeehoon
   Han, Jung-Kyu
   Kang, Do-Yoon
   Zheng, Chengbin
   Yang, Han-Mo
   Park, Kyung-Woo
   Kang, Hyun-Jae
   Koo, Bon-Kwon
   Kim, Hyo-Soo
TI SYNTAX Score and SYNTAX Score II Can Predict the Clinical Outcomes of
   Patients with Left Main and/or 3-Vessel Disease Undergoing Percutaneous
   Coronary Intervention in the Contemporary Cobalt-Chromium
   Everolimus-Eluting Stent Era
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Percutaneous coronary intervention; Drug-eluting stents
ID BYPASS GRAFT-SURGERY; ARTERY-DISEASE; REVASCULARIZATION; VALIDATION
AB Background and Objectives: The impact of SYNergy between percutaneous coronary intervention with TAXus and cardiac surgery score (SS) and SS II in patients who receive percutaneous coronary intervention with second-generation everolimus-eluting stents (EES) has not been fully validated.
   Methods: The SS, SS II were calculated in 1,248 patients with left main and/or 3-vessel disease treated with EES. Patient-oriented composite endpoint (POCE; all-cause death, any myocardial infarction (MI), any revascularization) and target lesion failure (TLF: cardiac death, target-vessel MI, target lesion revascularization) were analyzed.
   Results: The mean SS was 21.1 +/- 9.6. Three-year POCE increased according to the SS group (15.2% vs. 19.9% vs. 27.4% for low (<= 22), intermediate (>= 23, <= 32), high (>= 33) SS groups, p<0.001). By multivariate Cox proportional hazard analysis, SS group was an independent predictor of 3-year POCE (hazard ratio, 1.324; 95% confidence interval, 1.095-1.601; p=0.004). The receiver operating characteristic curves revealed that the SS II was superior to the SS for 3-year POCE prediction (area tinder the curve [AUC]: 0.611 vs. 0.669 for SS vs. SS II, p=0.019), but not for 3-year TLF (AUC: 0.631 vs. 0.660 for SS vs. SS II, p=0.996). In subgroup analysis, SS II was superior to SS in patients with cardiovascular clinical risk factors, and in those presenting as stable angina.
   Conclusions: The usefulness of SS and SS II was still valid in patients with left main and/or 3-vessel disease. SS II was superior to SS for the prediction of patient-oriented outcomes, but not for lesion-oriented outcomes.
C1 [Han, Jung-Kyu] Seoul Natl Univ Hosp, Dept Internal Med, Div Cardiol, 101 Daehak Ro, Seoul 03080, South Korea.
   [Han, Jung-Kyu] Seoul Natl Univ Hosp, Cardiovasc Ctr, 101 Daehak Ro, Seoul 03080, South Korea.
RP Han, JK (corresponding author), Seoul Natl Univ Hosp, Dept Internal Med, Div Cardiol, 101 Daehak Ro, Seoul 03080, South Korea.; Han, JK (corresponding author), Seoul Natl Univ Hosp, Cardiovasc Ctr, 101 Daehak Ro, Seoul 03080, South Korea.
EM hpcrates@gmail.com
RI Park, Kyung Woo/AAX-3046-2020
OI Kang, Jeehoon/0000-0002-9078-2231; Zheng, Chengbin/0000-0002-3793-2085
FU Korea Health Technology R&D Project "Korea Research-Driven Hospital"
   through the Korea Health Industry Development Institute (KHIDI) -
   Ministry of Health & Welfare, Republic of Korea [HI14C1277]
FX This work was supported by a grant of the Korea Health Technology R&D
   Project "Korea Research-Driven Hospital" through the Korea Health
   Industry Development Institute (KHIDI), funded by the Ministry of Health
   & Welfare, Republic of Korea (grant No. HI14C1277).
CR Amsterdam EA, 2014, J AM COLL CARDIOL, V64, pE139, DOI 10.1016/j.jacc.2014.09.017
   BANGALORE S, 2013, BMJ-BRIT MED J, V347, DOI DOI 10.1136/BMJ.F6625
   Cavalcante R, 2017, EUR HEART J, V38, P1969, DOI 10.1093/eurheartj/ehx138
   Chieffo A, 2012, JACC-CARDIOVASC INTE, V5, P718, DOI 10.1016/j.jcin.2012.03.022
   Farooq V, 2013, LANCET, V381, P639, DOI 10.1016/S0140-6736(13)60108-7
   Garg S, 2010, CIRC-CARDIOVASC INTE, V3, P317, DOI 10.1161/CIRCINTERVENTIONS.109.914051
   He JQ, 2017, INT HEART J, V58, P344, DOI 10.1536/ihj.16-292
   Head SJ, 2014, EUR HEART J, V35, P2821, DOI 10.1093/eurheartj/ehu213
   Hillis LD, 2011, J AM COLL CARDIOL, V58, pE123, DOI 10.1016/j.jacc.2011.08.009
   Kang J, 2016, AM J CARDIOL, V118, P641, DOI 10.1016/j.amjcard.2016.06.024
   Kang SH, 2014, EUR HEART J, V35, P1147, DOI 10.1093/eurheartj/eht570
   Kolh P, 2014, EUR HEART J, V35, P3235, DOI 10.1093/eurheartj/ehu422
   Mohr FW, 2013, LANCET, V381, P629, DOI 10.1016/S0140-6736(13)60141-5
   Morice MC, 2014, CIRCULATION, V129, P2388, DOI 10.1161/CIRCULATIONAHA.113.006689
   Nam CW, 2011, J AM COLL CARDIOL, V58, P1211, DOI 10.1016/j.jacc.2011.06.020
   Navarese EP, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6530
   Palmerini T, 2014, J AM COLL CARDIOL, V63, P299, DOI 10.1016/j.jacc.2013.09.061
   Park KW, 2014, AM HEART J, V167, P384, DOI 10.1016/j.ahj.2013.09.015
   Park KW, 2013, CIRC J, V77, P2912, DOI 10.1253/circj.CJ-13-0645
   Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929
   Serruys PW, 2009, NEW ENGL J MED, V360, P961, DOI 10.1056/NEJMoa0804626
   Song Y, 2018, CATHETER CARDIO INTE, V92, P40, DOI 10.1002/ccd.27321
   Xu B, 2014, JACC-CARDIOVASC INTE, V7, P1128, DOI 10.1016/j.jcin.2014.05.018
NR 23
TC 0
Z9 0
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JAN
PY 2020
VL 50
IS 1
BP 22
EP 34
DI 10.4070/kcj.2019.0097
PG 13
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA JX0BP
UT WOS:000503409700003
PM 31642213
OA Other Gold, Green Published
DA 2021-04-22
ER

PT J
AU Kim, SS
   Kim, HK
   Park, HW
   Jeong, MH
   Lim, KS
   Kee, HJ
   Ryu, YH
   Kim, HB
   Na, JY
   Ki, YJ
   Park, KH
   Choi, DH
   Lee, KH
   Yoon, NS
   Cho, JG
AF Kim, Sung Soo
   Kim, Hyun Kuk
   Park, Hyung Wook
   Jeong, Myung Ho
   Lim, Kyung Seob
   Kee, Hae Jin
   Ryu, Yu Hee
   Kim, Han Byul
   Na, Joo Young
   Ki, Young Jae
   Park, Keun Ho
   Choi, Dong Hyun
   Lee, Ki Hong
   Yoon, Nam Sik
   Cho, Jeong Gwan
TI Effect of Renal Denervation on Suppression of PVC and QT Prolongation in
   a Porcine Model of Acute Myocardial Infarction
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Myocardial infarction; Cardiac arrhythmia; Autonomic denervation
ID VENTRICULAR ELECTRICAL STORM; SYMPATHETIC DENERVATION; ACUTE-ISCHEMIA;
   ARRHYTHMIAS; TACHYCARDIA; INTERVAL
AB Background and Objectives: Antiarrhythmic effect of renal denervation (RDN) after acute myocardial infarction (AMI) remains unclear. The goal of this study was to evaluate the effect of RDN on ventricular arrhythmia (VA) after AMI in a porcine model.
   Methods: Twenty pigs were randomly divided into 2 groups based on RDN (RDN, n=10; Sham, n=10). After implanting a loop recorder, AMI was induced by occlusion of the middle left anterior descending coronary artery. Catheter-based RDN was performed for each renal artery immediately after creating AMI. Sham procedure used the same method, but a radiofrequency current was not delivered. Electrocardiography was monitored for 1 hour to observe VA. One week later, the animals were euthanized and the loop recorder data were analyzed.
   Results: Ventricular fibrillation event rate and the interval from AMI creation to first VA in acute phase were not different between the 2 groups. However, the incidence of premature ventricular complex (PVC) was lower in the RDN than in the Sham. Additionally, RDN inhibited prolongation of the corrected QT (QTc) interval after AMI. The frequency of non-sustained or sustained ventricular tachycardia, arrhythmic death was lower in the RDN group in the early period.
   Conclusions: RUN reduced the incidence of PVC, inhibited prolongation of the QTc interval, and reduced VA in the early period following an AMI. These results suggest that RDN might be a therapeutic option in patients with electrical instability after AMI.
C1 [Kim, Sung Soo; Kim, Hyun Kuk; Ki, Young Jae; Park, Keun Ho; Choi, Dong Hyun] Chosun Univ Hosp, Dept Cardiol, Gwangju, South Korea.
   [Park, Hyung Wook; Jeong, Myung Ho; Lee, Ki Hong; Yoon, Nam Sik; Cho, Jeong Gwan] Chonnam Natl Univ, Dept Cardiovasc Med, Med Sch, 42 Jebong Ro, Gwangju 61469, South Korea.
   [Lim, Kyung Seob] Korea Res Inst Biosci & Biotechnol, Futurist Anim Resource & Res Ctr, Ochang, South Korea.
   [Kee, Hae Jin; Ryu, Yu Hee; Kim, Han Byul; Na, Joo Young] Chonnam Natl Univ Hosp, Biomed Res Inst, Gwangju, South Korea.
RP Park, HW; Jeong, MH (corresponding author), Chonnam Natl Univ, Dept Cardiovasc Med, Med Sch, 42 Jebong Ro, Gwangju 61469, South Korea.
EM mdhwp@naver.com; myungho@chollian.net
OI Na, Joo-Young/0000-0003-1138-433X; Kim, Sung Soo/0000-0002-5190-227X;
   Jeong, Myung Ho/0000-0003-2424-810X; Kee, Hae Jin/0000-0002-9774-4828;
   Lim, Kyung Seob/0000-0002-9117-887X; kim, hanbyul/0000-0001-9935-6266
FU Korean Society of Cardiology [201202-1]; Chosun University
FX This study was supported by research funds from the Korean Society of
   Cardiology (201202-1) and Chosun University 2017.
CR Armaganijan LV, 2015, JACC-CARDIOVASC INTE, V8, P984, DOI 10.1016/j.jcin.2015.03.012
   Curran J, 2007, CIRC RES, V100, P391, DOI 10.1161/01.RES.0000258172.74570.e6
   Hoffmann BA, 2013, J CARDIOVASC ELECTR, V24, P1175, DOI 10.1111/jce.12207
   Jackson N, 2017, CIRC-CARDIOVASC INTE, V10, DOI 10.1161/CIRCINTERVENTIONS.116.004172
   JANSE MJ, 1986, J MOL CELL CARDIOL, V18, P339, DOI 10.1016/S0022-2828(86)80898-7
   KAPLINSKY E, 1979, CIRCULATION, V60, P397, DOI 10.1161/01.CIR.60.2.397
   Katra RP, 2005, CIRC RES, V96, P535, DOI 10.1161/01.RES.0000159387.00749.3c
   Kenigsberg DN, 2007, J AM COLL CARDIOL, V49, P1299, DOI 10.1016/j.jacc.2006.11.035
   Kiuchi MG, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000002287
   Linz D, 2013, HEART RHYTHM, V10, P1525, DOI 10.1016/j.hrthm.2013.07.015
   NAITO M, 1982, AM J CARDIOL, V49, P317, DOI 10.1016/0002-9149(82)90507-0
   O'Brien E, 2009, LANCET, V373, P2109, DOI 10.1016/S0140-6736(09)61146-6
   Remo BF, 2014, HEART RHYTHM, V11, P541, DOI 10.1016/j.hrthm.2013.12.038
   RUBERMAN W, 1977, NEW ENGL J MED, V297, P750, DOI 10.1056/NEJM197710062971404
   Sakakura K, 2014, JACC-CARDIOVASC INTE, V7, P1184, DOI 10.1016/j.jcin.2014.04.024
   Scholz EP, 2015, CLIN RES CARDIOL, V104, P79, DOI 10.1007/s00392-014-0749-4
   SCHOMIG A, 1990, CIRCULATION, V82, P13
   SCHWARTZ PJ, 1976, AM HEART J, V92, P589, DOI 10.1016/S0002-8703(76)80078-6
   Thomsen PEB, 2010, CIRCULATION, V122, P1258, DOI 10.1161/CIRCULATIONAHA.109.902148
   Ukena C, 2012, CLIN RES CARDIOL, V101, P63, DOI 10.1007/s00392-011-0365-5
   Zhou SM, 2001, J CARDIOVASC ELECTR, V12, P1068, DOI 10.1046/j.1540-8167.2001.01068.x
NR 21
TC 3
Z9 3
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JAN
PY 2020
VL 50
IS 1
BP 38
EP 49
DI 10.4070/kcj.2019.0106
PG 12
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA JX0BP
UT WOS:000503409700005
PM 31642212
OA Green Published, Other Gold
DA 2021-04-22
ER

PT J
AU You, SC
   Jung, S
   Swerdet, JN
   Ryan, PB
   Schuemie, MJ
   Suchard, MA
   Lee, S
   Cho, J
   Hripcsak, G
   Park, RW
   Park, S
AF You, Seng Chan
   Jung, Sungjae
   Swerdet, Joel N.
   Ryan, Patrick B.
   Schuemie, Martijn J.
   Suchard, Marc A.
   Lee, Seongwon
   Cho, Jaehyeong
   Hripcsak, George
   Park, Rae Woong
   Park, Sungha
TI Comparison of First-Line Dual Combination Treatments in Hypertension:
   Real-World Evidence from Multinational Heterogeneous Cohorts
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Hypertension; Antihypertensive agents; Angiotensin receptor antagonists;
   Calcium channel blockers; Diuretics
ID CALCIUM-CHANNEL BLOCKER; CARDIOVASCULAR EVENTS; THERAPY; RISK; DISEASE;
   AMLODIPINE; OUTCOMES; AGENTS; BIAS
AB Background and Objectives: 2018 ESC/ESH Hypertension guideline recommends 2-drug combination as initial anti-hypertensive therapy. However, real-world evidence for effectiveness of recommended regimens remains limited. We aimed to compare the effectiveness of first-line anti-hypertensive treatment combining 2 out of the following classes: angiotensin-converting enzyme (ACE) inhibitors/angiotensin-receptor blocker (A), calcium channel blocker (C), and thiazide-type diuretics (D).
   Methods: Treatment-naive hypertensive adults without cardiovascular disease (CVD) who initiated dual anti-hypertensive medications were identified in 5 databases from US and Korea. The patients were matched for each comparison set by large-scale propensity score matching. Primary endpoint was all-cause mortality. Myocardial infarction, heart failure, stroke, and major adverse cardiac and cerebrovascular events as a composite outcome comprised the secondary measure.
   Results: A total of 987,983 patients met the eligibility criteria. After matching, 222,686, 32,344, and 38,513 patients were allocated to A+C vs. A+D, C+D vs. A+C, and C+D vs. A+D comparison, respectively. There was no significant difference in the mortality during total of 1,806,077 person-years: A+C vs. A+D 1(hazard ratio [HR], 1.08; 95% confidence interval [CI], 0.97-1.20; p=0.127), C+D vs. A+C (HR, 0.93; 95% CI, 0.87-1.01; p=0.067), and C+D vs. A+D (HR, 1.18; 95% CI, 0.95-1.47; p=0.104). A+C was associated with a slightly higher risk of heart failure (HR, 1.09; 95% CI, 1.01-1.18; p=0.040) and stroke (HR, 1.08; 95% Cl, 1.01-1.17; p=0.040) than A+D.
   Conclusions: There was no significant difference in mortality among A+C, A+D, and C+D combination treatment in patients without previous CVD. This finding was consistent across multi-national heterogeneous cohorts in real-world practice.
C1 [You, Seng Chan; Jung, Sungjae; Lee, Seongwon; Cho, Jaehyeong; Park, Rae Woong] Ajou Univ, Sch Med, Dept Biomed Informat, 164 World Cup Ro, Suwon 16499, South Korea.
   [Jung, Sungjae] MediBloc Inc, Seoul, South Korea.
   [Swerdet, Joel N.; Ryan, Patrick B.; Schuemie, Martijn J.] Janssen Res & Dev, Titusville, NJ USA.
   [Suchard, Marc A.] Univ Calif Los Angeles, Dept Biomath, Los Angeles, CA USA.
   [Suchard, Marc A.] Univ Calif Los Angeles, Dept Biostat, Los Angeles, CA USA.
   [Suchard, Marc A.] Univ Calif Los Angeles, Dept Human Genet, Los Angeles, CA USA.
   [Hripcsak, George] Columbia Univ, Med Ctr, Dept Biomed Informat, New York, NY USA.
   [Hripcsak, George] NewYork Presbyterian Hosp, Med Informat Serv, New York, NY USA.
   [Park, Rae Woong] Ajou Univ, Grad Sch Med, Dept Biomed Sci, Suwon, South Korea.
   [Park, Sungha] Yonsei Univ, Coll Med, Severance Cardiovasc Hosp, Div Cardiol, 50-1 Yonsei Ro, Seoul 03722, South Korea.
   [Park, Sungha] Yonsei Univ, Coll Med, Cardiovasc Res Inst, 50-1 Yonsei Ro, Seoul 03722, South Korea.
RP Park, RW (corresponding author), Ajou Univ, Sch Med, Dept Biomed Informat, 164 World Cup Ro, Suwon 16499, South Korea.; Park, S (corresponding author), Yonsei Univ, Coll Med, Severance Cardiovasc Hosp, Div Cardiol, 50-1 Yonsei Ro, Seoul 03722, South Korea.; Park, S (corresponding author), Yonsei Univ, Coll Med, Cardiovasc Res Inst, 50-1 Yonsei Ro, Seoul 03722, South Korea.
EM veritas@ajou.ac.kr; shpark0530@yuhs.ac
RI ; Park, Rae Woong/K-8097-2013
OI Park, Sungha/0000-0001-5362-478X; Park, Rae Woong/0000-0003-4989-3287;
   You, Seng Chan/0000-0002-5052-6399; Schuemie,
   Martijn/0000-0002-0817-5361; JUNG, SUNGJAE/0000-0001-8266-0480
FU Korea Health Technology R&D Project through the Korea Health Industry
   Development Institute (KHIDI) - Ministry of Health & Welfare, Republic
   of Korea [HI16C0992]; Korean Centers for Disease Control and Prevention
   [2018ER630200]; Fire Fighting Safety & 119 Rescue Technology Research
   and Development Program - National Fire Agency
   [MPSS-FireSafety-2015-80]; US National Science FoundationNational
   Science Foundation (NSF) [IIS 1251151]
FX This work was supported by Korea Health Technology R&D Project through
   the Korea Health Industry Development Institute (KHIDI) funded by the
   Ministry of Health & Welfare, Republic of Korea (grant number:
   HI16C0992); supported by Korean Centers for Disease Control and
   Prevention (grant number: 2018ER630200, SHP); supported by the Fire
   Fighting Safety & 119 Rescue Technology Research and Development Program
   funded by National Fire Agency (grant number: MPSS-FireSafety-2015-80);
   and supported by the US National Science Foundation (grant number: IIS
   1251151).
CR Basile JN, 2013, J CLIN HYPERTENS, V15, P523, DOI 10.1111/jch.12124
   Chi C, 2016, J CLIN HYPERTENS, V18, P801, DOI 10.1111/jch.12771
   Corrao G, 2008, J HYPERTENS, V26, P819, DOI 10.1097/HJH.0b013e3282f4edd7
   Cushman William C, 2002, J Clin Hypertens (Greenwich), V4, P393
   Egan BM, 2012, HYPERTENSION, V59, P1124, DOI 10.1161/HYPERTENSIONAHA.112.194167
   Gradman AH, 2013, HYPERTENSION, V61, P309, DOI 10.1161/HYPERTENSIONAHA.112.201566
   Griswold MG, 2018, LANCET, V392, P1015, DOI [10.1016/S0140-6736(18)31310-2, 10.1016/S0140-6736(16)31679-8]
   Gupta AK, 2010, HYPERTENSION, V55, P399, DOI 10.1161/HYPERTENSIONAHA.109.139816
   Hripcsak G, 2015, STUD HEALTH TECHNOL, V216, P574, DOI 10.3233/978-1-61499-564-7-574
   Jamerson K, 2008, NEW ENGL J MED, V359, P2417, DOI 10.1056/NEJMoa0806182
   Julius S, 2004, LANCET, V363, P2022, DOI 10.1016/S0140-6736(04)16451-9
   Lee H, 2019, KOREAN CIRC J, V49, P514, DOI 10.4070/kcj.2018.0358
   Lee J, 2017, INT J EPIDEMIOL, V46, DOI 10.1093/ije/dyv319
   Lin DY, 2010, BIOMETRIKA, V97, P321, DOI 10.1093/biomet/asq006
   Lipsitch M, 2010, EPIDEMIOLOGY, V21, P383, DOI 10.1097/EDE.0b013e3181d61eeb
   Matsuzaki M, 2011, J HYPERTENS, V29, P1649, DOI 10.1097/HJH.0b013e328348345d
   Messerli FH, 2018, J AM COLL CARDIOL, V71, P1474, DOI 10.1016/j.jacc.2018.01.058
   Ogihara T, 2014, J HYPERTENS, V32, P2054, DOI 10.1097/HJH.0000000000000281
   Pepine CJ, 2003, JAMA-J AM MED ASSOC, V290, P2805, DOI 10.1001/jama.290.21.2805
   Psaty BN, 2003, JAMA-J AM MED ASSOC, V289, P2534, DOI 10.1001/jama.289.19.2534
   Schuemie MJ, 2018, P NATL ACAD SCI USA, V115, P2571, DOI 10.1073/pnas.1708282114
   Suchard MA, 2013, ACM T MODEL COMPUT S, V23, DOI 10.1145/2414416.2414791
   Suissa S, 2003, AM J RESP CRIT CARE, V168, P49, DOI 10.1164/rccm.200210-1231OC
   Thomopoulos C, 2015, J HYPERTENS, V33, P1321, DOI 10.1097/HJH.0000000000000614
   Tian YX, 2018, INT J EPIDEMIOL, V47, P2005, DOI 10.1093/ije/dyy120
   Turnbull F, 2008, EUR HEART J, V29, P2669, DOI 10.1093/eurheartj/ehn427
   Voss EA, 2017, J BIOMED INFORM, V66, P72, DOI 10.1016/j.jbi.2016.12.005
   Wassertheil-Smoller S, 2004, JAMA-J AM MED ASSOC, V292, P2849, DOI 10.1001/jama.292.23.2849
   Weber MA, 2013, LANCET, V381, P537, DOI 10.1016/S0140-6736(12)61343-9
   Williams B, 2018, EUR HEART J, V39, P3021, DOI 10.1093/eurheartj/ehy339
NR 30
TC 2
Z9 2
U1 0
U2 3
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JAN
PY 2020
VL 50
IS 1
BP 52
EP 68
DI 10.4070/kcj.2019.0173
PG 17
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA JX0BP
UT WOS:000503409700007
PM 31642211
OA Green Published, Other Gold
DA 2021-04-22
ER

PT J
AU Cho, IJ
   Sung, JM
   Kim, HC
   Lee, SE
   Chae, MH
   Kavousi, M
   Rueda-Ochoa, OL
   Ikram, MA
   Franco, OH
   Min, JK
   Chang, HJ
AF Cho, In-Jeong
   Sung, Ji Min
   Kim, Hyeon Chang
   Lee, Sang-Eun
   Chae, Myeong-Hun
   Kavousi, Maryam
   Rueda-Ochoa, Oscar L.
   Ikram, M. Arfan
   Franco, Oscar H.
   Min, James K.
   Chang, Hyuk-Jae
TI Development and External Validation of a Deep Learning Algorithm for
   Prognostication of Cardiovascular Outcomes
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Cardiovascular diseases; Artificial intelligence
ID HEART-DISEASE RISK; PREDICTION; FRAMINGHAM; SCORE; CLASSIFICATION;
   REGRESSION; MEDICINE
AB Background and Objectives: We aim to explore the additional discriminative accuracy of a deep learning (DL) algorithm using repeated-measures data for identifying people at high risk for cardiovascular disease (CVD), compared to Cox hazard regression.
   Methods: Two CVD prediction models were developed from National Health Insurance Service-Health Screening Cohort (NHIS-HEALS): a Cox regression model and a DL model. Performance of each model was assessed in the internal and 2 external validation cohorts in Koreans (National Health Insurance Service-National Sample Cohort; NHIS-NSC) and in Europeans (Rotterdam Study). A total of 412,030 adults in the NHIS-HEALS; 178,875 adults in the NHIS-NSC; and the 4,296 adults in Rotterdam Study were included.
   Results: Mean ages was 52 years (46% women) and there were 25,777 events (6.3%) in NHIS-HEALS during the follow-up. In internal validation, the DL approach demonstrated a C-statistic of 0.896 (95% confidence interval, 0.886-0.907) in men and 0.921 (0.908-0.934) in women and improved reclassification compared with Cox regression (net reclassification index [NM], 24.8% in men, 29.0% in women). In external validation with NHIS-NSC, DL demonstrated a C-statistic of 0.868 (0.860-0.876) in men and 0.889 (0.876-0.898) in women, and improved reclassification compared with Cox regression (NRI, 24.9% in men, 26.2% in women). In external validation applied to the Rotterdam Study, DL demonstrated a C-statistic of 0.860 (0.824-0.897) in men and 0.867 (0.830-0.903) in women, and improved reclassification compared with Cox regression (NRI, 36.9% in men, 31.8% in women).
   Conclusions: A DL algorithm exhibited greater discriminative accuracy than Cox model approaches.
C1 [Cho, In-Jeong] Ewha Womans Univ, Coll Med, Seoul Hosp, Div Cardiol,Dept Internal Med, Seoul, South Korea.
   [Cho, In-Jeong] Ewha Womans Univ, Grad Sch, Seoul, South Korea.
   [Cho, In-Jeong; Sung, Ji Min; Kim, Hyeon Chang; Lee, Sang-Eun; Chang, Hyuk-Jae] Yonsei Univ, Coll Med, Severance Cardiovasc Hosp, Div Cardiol, 50 Yonsei Ro, Seoul 03722, South Korea.
   [Kim, Hyeon Chang] Yonsei Univ, Coll Med, Dept Prevent Med, Seoul, South Korea.
   [Chae, Myeong-Hun] Selvas AI Inc, AI R&D Lab, Seoul, South Korea.
   [Kavousi, Maryam; Rueda-Ochoa, Oscar L.; Ikram, M. Arfan; Franco, Oscar H.] Erasmus MC, Dept Epidemiol, Rotterdam, Netherlands.
   [Rueda-Ochoa, Oscar L.] UIS, Fac Hlth, Sch Med, Bucaramanga, Colombia.
   [Ikram, M. Arfan] Erasmus MC, Dept Radiol, Rotterdam, Netherlands.
   [Min, James K.] New York Presbyterian Hosp, Dalio Inst Cardiovasc Imaging, Weill Cornell Med Coll, Dept Radiol & Med, New York, NY USA.
   [Chang, Hyuk-Jae] Yonsei Univ, Coll Med, Severance Biomed Sci Inst, Seoul, South Korea.
RP Chang, HJ (corresponding author), Yonsei Univ, Coll Med, Severance Cardiovasc Hosp, Div Cardiol, 50 Yonsei Ro, Seoul 03722, South Korea.
EM hjchang@yuhs.ac
RI Franco, Oscar H./ABE-2305-2020; Kim, Hyeon Chang/F-8796-2019
OI Franco, Oscar H./0000-0002-4606-4929; Chae,
   Myeonghun/0000-0001-6525-4827; Ikram, Mohammad
   Arfan/0000-0003-0372-8585; Kavousi, Maryam/0000-0001-5976-6519; Chang,
   Hyuk-Jae/0000-0002-6139-7545; Rueda-Ochoa, Oscar L./0000-0003-2684-9005;
   Lee, Sang-Eun/0000-0001-6645-4038; Kim, Hyeon Chang/0000-0001-7867-1240
FU Institute for Information & communications Technology Promotion (IITP) -
   Korean government (MSIT) [2017-0-00255, 2018-0-00861]; Erasmus MC,
   Rotterdam, The NetherlandsNetherlands Government; Erasmus University,
   Rotterdam, The NetherlandsNetherlands Government; Netherlands
   Organisation for Scientific Research (NWO)Netherlands Organization for
   Scientific Research (NWO); Netherlands Organisation for the Health
   Research and Development (ZonMw)Netherlands Organization for Health
   Research and Development; Research Institute for Diseases in the Elderly
   (RIDE); Ministry of Education, Culture and ScienceMinistry of Education,
   Culture, Sports, Science and Technology, Japan (MEXT); Ministry for
   Health, Welfare and Sports; European Commission (DG XII)European
   CommissionEuropean Commission Joint Research Centre; Municipality of
   Rotterdam; NWO VENI grant (VENI) [91616079]; COLCIENCIAS from Colombia;
   Universidad Industrial de Santander from Colombia; Nestle Nutrition
   (Nestec Ltd.); Metagenics Inc.; AXA
FX This research was supported by Institute for Information &
   communications Technology Promotion (IITP) grant funded by the Korean
   government (MSIT) (No. 2017-0-00255, Autonomous Digital Companion
   Development and No.2018-0-00861, Intelligent SW Technology Development
   for Medical Data Analysis).; The Rotterdam Study is funded by Erasmus MC
   and Erasmus University, Rotterdam, The Netherlands; The Netherlands
   Organisation for Scientific Research (NWO); The Netherlands Organisation
   for the Health Research and Development (ZonMw); The Research Institute
   for Diseases in the Elderly (RIDE); The Ministry of Education, Culture
   and Science; the Ministry for Health, Welfare and Sports; The European
   Commission (DG XII); and The Municipality of Rotterdam. M. Kavousi is
   supported by the NWO VENI grant (VENI, 91616079). Oscar L. Rueda is
   supported by a scholarship by COLCIENCIAS and Universidad Industrial de
   Santander from Colombia. O.H. Franco works in ErasmusAGE, a center for
   aging research across the life course funded by Nestle Nutrition (Nestec
   Ltd.); Metagenics Inc.; and AXA. The funding sources had no role in
   design and conduct of the study; collection, management, analysis, and
   interpretation of the data; preparation, review or approval of the
   manuscript; and decision to submit the manuscript for publication.
CR Antman EM, 2016, NAT REV CARDIOL, V13, P591, DOI 10.1038/nrcardio.2016.101
   Cho IJ, 2017, CIRC-CARDIOVASC QUAL, V10, DOI 10.1161/CIRCOUTCOMES.117.004197
   Conroy RM, 2003, EUR HEART J, V24, P987, DOI 10.1016/S0195-668X(03)00114-3
   D'Agostino RB, 2001, JAMA-J AM MED ASSOC, V286, P180, DOI 10.1001/jama.286.2.180
   Deo RC, 2015, CIRCULATION, V132, P1920, DOI 10.1161/CIRCULATIONAHA.115.001593
   Goldstein BA, 2017, EUR HEART J, V38, P1805, DOI 10.1093/eurheartj/ehw302
   Hinton G, 2012, IEEE SIGNAL PROC MAG, V29, P82, DOI 10.1109/MSP.2012.2205597
   Hippisley-Cox J, 2007, BMJ-BRIT MED J, V335, P136, DOI 10.1136/bmj.39261.471806.55
   Hochreiter S, 1997, NEURAL COMPUT, V9, P1735, DOI 10.1162/neco.1997.9.8.1735
   Hofman A, 2015, EUR J EPIDEMIOL, V30, P661, DOI 10.1007/s10654-015-0082-x
   Jung K, 2015, J BIOMED INFORM, V58, P168, DOI 10.1016/j.jbi.2015.10.006
   Kennedy EH, 2013, MED CARE, V51, P251, DOI 10.1097/MLR.0b013e31827da594
   Khatibi V, 2010, EXPERT SYST APPL, V37, P8536, DOI 10.1016/j.eswa.2010.05.022
   Kukar M, 1999, ARTIF INTELL MED, V16, P25, DOI 10.1016/S0933-3657(98)00063-3
   Liao L, 2016, INT J PROGN HEAL MAN, V7
   Lloyd-Jones DM, 2006, CIRCULATION, V113, P791, DOI 10.1161/CIRCULATIONAHA.105.548206
   Lopez V, 2013, INFORM SCIENCES, V250, P113, DOI 10.1016/j.ins.2013.07.007
   Murphy TP, 2012, ATHEROSCLEROSIS, V220, P160, DOI 10.1016/j.atherosclerosis.2011.10.037
   Narain R, 2016, PATIENT PREFER ADHER, V10, P1259, DOI 10.2147/PPA.S108203
   National Health Insurance Service, 2015, NAT HLTH SCREEN STAT
   Paynter NP, 2009, ANN INTERN MED, V150, P65, DOI 10.7326/0003-4819-150-2-200901200-00003
   Pencina MJ, 2009, CIRCULATION, V119, P3078, DOI 10.1161/CIRCULATIONAHA.108.816694
   Polonsky TS, 2010, JAMA-J AM MED ASSOC, V303, P1610, DOI 10.1001/jama.2010.461
   Ramsay SE, 2011, EUR J CARDIOV PREV R, V18, P186, DOI 10.1177/1741826710389394
   Ross EG, 2016, J VASC SURG, V64, P1515, DOI 10.1016/j.jvs.2016.04.026
   Seong SC, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-016640
   Seong SC, 2017, INT J EPIDEMIOL, V46, P799, DOI 10.1093/ije/dyw253
   Waljee AK, 2010, AM J GASTROENTEROL, V105, P1224, DOI 10.1038/ajg.2010.173
NR 28
TC 3
Z9 3
U1 0
U2 3
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JAN
PY 2020
VL 50
IS 1
BP 72
EP 84
DI 10.4070/kcj.2019.0105
PG 13
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA JX0BP
UT WOS:000503409700009
PM 31456363
OA Green Published, Other Gold
DA 2021-04-22
ER

PT J
AU Lee, KY
   Chang, K
AF Lee, Kwan Yong
   Chang, Kiyuk
TI Understanding Vulnerable Plaques: Current Status and Future Directions
SO KOREAN CIRCULATION JOURNAL
LA English
DT Review
DE Atherosclerotic plaque; Fibroatheroma; Coronary atherosclerosis;
   Microcalcification
ID ENDOTHELIAL SHEAR-STRESS; OPTICAL COHERENCE TOMOGRAPHY; THIN-CAP
   FIBROATHEROMA; INTRAVASCULAR ULTRASOUND; CORONARY ATHEROSCLEROSIS;
   MYOCARDIAL-INFARCTION; CULPRIT PLAQUE; HIGH-RISK; CALCIFICATION; RUPTURE
AB The main cause of acute myocardial infarction is plaque rupture accompanied by superimposed coronary thrombosis. Thin-cap fibroatheromas (TCFAs) have been suggested as a type of lesion with a vulnerability that can cause plaque rupture. However, not only the existence of a TCFA but also the fine and complex interactions of other anatomical and hemodynamic factors, such as microcalcification in the fibrous cap, cholesterol crystal-induced inflammasome activation, the apoptosis of intraplaque macrophages, and endothelial shear stress distribution should precede a clinical event caused by plaque rupture. Recent studies are being conducted to identify these mechanisms through molecular imaging and hemodynamic assessment using computational fluid dynamics, which will result in better clinical results through selective coronary interventions.
C1 [Lee, Kwan Yong] Catholic Univ Korea, Incheon St Marys Hosp, Coll Med, Cardiovasc Ctr, Seoul, South Korea.
   [Lee, Kwan Yong] Catholic Univ Korea, Incheon St Marys Hosp, Coll Med, Div Cardiol, Seoul, South Korea.
   [Chang, Kiyuk] Catholic Univ Korea, Seoul St Marys Hosp, Coll Med, Cardiovasc Ctr, 222 Banpo Daero, Seoul 06591, South Korea.
   [Chang, Kiyuk] Catholic Univ Korea, Seoul St Marys Hosp, Coll Med, Div Cardiol, 222 Banpo Daero, Seoul 06591, South Korea.
RP Chang, K (corresponding author), Catholic Univ Korea, Seoul St Marys Hosp, Coll Med, Cardiovasc Ctr, 222 Banpo Daero, Seoul 06591, South Korea.; Chang, K (corresponding author), Catholic Univ Korea, Seoul St Marys Hosp, Coll Med, Div Cardiol, 222 Banpo Daero, Seoul 06591, South Korea.
EM kiyuk@catholic.ac.kr
OI Lee, Kwan yong/0000-0002-0480-1046
FU National Research Foundation of KoreaNational Research Foundation of
   Korea [NRF-2017R1D1A1B03036436, NRF-2017M3A9D8061157] Funding Source:
   Medline
CR Arbab-Zadeh A, 2015, J AM COLL CARDIOL, V65, P846, DOI 10.1016/j.jacc.2014.11.041
   Beckman JA, 2001, ARTERIOSCL THROM VAS, V21, P1618, DOI 10.1161/hq0901.095554
   Chatzizisis YS, 2008, CIRCULATION, V117, P993, DOI 10.1161/CIRCULATIONAHA.107.695254
   Chatzizisis YS, 2011, CIRCULATION, V123, P621, DOI 10.1161/CIRCULATIONAHA.110.970038
   Clark E, 1936, ARCH PATHOL, V22, P183
   CONSTANTINIDES P, 1964, FED PROC, V23, P443
   Davies MJ, 1996, CIRCULATION, V94, P2013, DOI 10.1161/01.CIR.94.8.2013
   deFilippi CR, 2012, J AM COLL CARDIOL, V60, P2539, DOI 10.1016/j.jacc.2012.08.1006
   Ehara S, 2004, CIRCULATION, V110, P3424, DOI 10.1161/01.CIR.0000148131.41425.E9
   HERRICK JB, 1983, JAMA-J AM MED ASSOC, V250, P1757, DOI 10.1001/jama.250.13.1757
   Hlatky MA, 2012, J AM COLL CARDIOL, V60, P569, DOI 10.1016/j.jacc.2011.12.057
   Hwang BH, 2011, KOREAN CIRC J, V41, P497, DOI 10.4070/kcj.2011.41.9.497
   Jaffer FA, 2006, MOL IMAGING, V5, P85, DOI 10.2310/7290.2006.00009
   Jenniskens M, 2018, CHEST, V153, P733, DOI 10.1016/j.chest.2017.08.018
   Karanasos A, 2012, JACC-CARDIOVASC IMAG, V5, P1071, DOI 10.1016/j.jcmg.2012.04.010
   Kashiwagi M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102669
   Kietselaer BLJH, 2004, NEW ENGL J MED, V350, P1472, DOI 10.1056/NEJM200404013501425
   Kivimaki M, 2018, LANCET DIABETES ENDO, V6, P705, DOI 10.1016/S2213-8587(18)30140-2
   Kolodgie FD, 2004, HEART, V90, P1385, DOI 10.1136/hrt.2004.041798
   Kolodgie FD, 2001, CURR OPIN CARDIOL, V16, P285, DOI 10.1097/00001573-200109000-00006
   Koskinas KC, 2013, ARTERIOSCL THROM VAS, V33, P1494, DOI 10.1161/ATVBAHA.112.300827
   Koskinas KC, 2009, CURR OPIN CARDIOL, V24, P580, DOI 10.1097/HCO.0b013e328331630b
   Kubo T, 2010, J AM COLL CARDIOL, V55, P1590, DOI 10.1016/j.jacc.2009.07.078
   Kumar A, 2018, J AM COLL CARDIOL, V72, P1926, DOI 10.1016/j.jacc.2018.07.075
   Kwak BR, 2014, EUR HEART J, V35, P3013, DOI 10.1093/eurheartj/ehu353
   Moore KJ, 2011, CELL, V145, P341, DOI 10.1016/j.cell.2011.04.005
   Motoyama S, 2007, J AM COLL CARDIOL, V50, P319, DOI 10.1016/j.jacc.2007.03.044
   Nahrendorf M, 2009, CIRC-CARDIOVASC IMAG, V2, P56, DOI 10.1161/CIRCIMAGING.108.839092
   Nicholls SJ, 2018, J AM COLL CARDIOL, V72, P2012, DOI 10.1016/j.jacc.2018.06.078
   Otsuka F, 2014, ARTERIOSCL THROM VAS, V34, P724, DOI 10.1161/ATVBAHA.113.302642
   Pedrigi RM, 2014, ARTERIOSCL THROM VAS, V34, P2224, DOI 10.1161/ATVBAHA.114.303426
   Perlini S, 1997, J AM COLL CARDIOL, V29, P846, DOI 10.1016/S0735-1097(96)00569-4
   Phinikaridou A, 2013, CIRC-CARDIOVASC IMAG, V6, P302, DOI 10.1161/CIRCIMAGING.112.000176
   Ridker PM, 2017, NEW ENGL J MED, V377, P1119, DOI 10.1056/NEJMoa1707914
   Schaar JA, 2004, EUR HEART J, V25, P1077, DOI 10.1016/j.ehj.2004.01.002
   Schuurman AS, 2018, J AM COLL CARDIOL, V72, P2003, DOI 10.1016/j.jacc.2018.08.2140
   Sinusas AJ, 2008, CIRC-CARDIOVASC IMAG, V1, P244, DOI 10.1161/CIRCIMAGING.108.824359
   Stone PH, 2012, CIRCULATION, V126, P172, DOI 10.1161/CIRCULATIONAHA.112.096438
   Tabas I, 2010, CIRC RES, V107, P839, DOI 10.1161/CIRCRESAHA.110.224766
   Tabas I, 2010, NAT REV IMMUNOL, V10, P36, DOI 10.1038/nri2675
   Tian JW, 2014, J AM COLL CARDIOL, V63, P2209, DOI 10.1016/j.jacc.2014.01.061
   Toutouzas K, 2011, AM HEART J, V161, P1192, DOI 10.1016/j.ahj.2011.03.005
   Vedre A, 2009, ATHEROSCLEROSIS, V203, P89, DOI 10.1016/j.atherosclerosis.2008.06.027
   Vengrenyuk Y, 2006, P NATL ACAD SCI USA, V103, P14678, DOI 10.1073/pnas.0606310103
   Vergallo R, 2014, CIRC-CARDIOVASC IMAG, V7, P905, DOI 10.1161/CIRCIMAGING.114.001932
NR 45
TC 6
Z9 6
U1 0
U2 8
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD DEC
PY 2019
VL 49
IS 12
BP 1115
EP 1122
DI 10.4070/kcj.2019.0211
PG 8
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA JP1JY
UT WOS:000498029700001
PM 31760703
OA Green Published, Other Gold
DA 2021-04-22
ER

PT J
AU Kario, K
AF Kario, Kazuomi
TI Key Points of the 2019 Japanese Society of Hypertension Guidelines for
   the Management of Hypertension
SO KOREAN CIRCULATION JOURNAL
LA English
DT Review
DE Hypertension; Evidence-based practice; Antihypertensive agents; Japan
ID HOME BLOOD-PRESSURE; INITIATED ANTICIPATION MEDICINE;
   CORONARY-HEART-DISEASE; CARDIOVASCULAR-DISEASE; HOPE ASIA;
   MONITORING-SYSTEM; MORNING SURGE; WHITE-COAT; ELDERLY HYPERTENSIVES;
   GENERAL-POPULATION
AB The new 2019 Japanese Society of Hypertension (JSH) guidelines for the management of hypertension are now available; these update the previous guidelines published in 2014. The primary objective of the guideline is to provide all healthcare professionals with a standard management strategy and appropriate antihypertensive treatments to prevent hypertension-related target organ damage and cardiovascular events. The major changes in the new guideline relate to the definition of normal blood pressure (BP) and target BP. The terms 'normal BP' and 'high normal BP' used in the JSH 2014 guidelines are replaced with terms 'high normal BP' and 'elevated BP,' respectively. There was no change to the office BP diagnostic threshold for hypertension (140/90 mmHg). Recommended target office and home BP values for patients with hypertension aged <75 years and/or high-risk patients are <130/80 mmHg and <125/75 mmHg, respectively. Corresponding targets for elderly patients with hypertension (age >= 75 years) are 140/90 and 135/85 mmHg, respectively. The goal is that these changes will contribute to reducing cardiovascular events, especially stroke and heart failure, in Japan. The dissemination of the JSH 2019 guidelines and implementation of a home BP-based approach by all general practitioners in Japan might be facilitated by digital hypertension management using health information technology.
C1 [Kario, Kazuomi] Jichi Med Univ, Dept Med, Sch Med, Div Cardiovasc Med, 3311-1 Yakushiji, Shimotsuke, Tochigi 3290498, Japan.
RP Kario, K (corresponding author), Jichi Med Univ, Dept Med, Sch Med, Div Cardiovasc Med, 3311-1 Yakushiji, Shimotsuke, Tochigi 3290498, Japan.
EM kkario@jichi.ac.jp
CR Asayama K, 2019, HYPERTENS RES, V42, P1726, DOI 10.1038/s41440-019-0287-6
   Asayama K, 2016, HYPERTENS RES, V39, P179, DOI 10.1038/hr.2015.158
   Asayama K, 2009, J HYPERTENS, V27, P357, DOI 10.1097/HJH.0b013e32831967ca
   Banegas JR, 2018, NEW ENGL J MED, V378, P1509, DOI 10.1056/NEJMoa1712231
   Banegas JR, 2018, J HYPERTENS, V36, P446, DOI 10.1097/HJH.0000000000001615
   Boonyasai RT, 2019, CURR HYPERTENS REP, V21, DOI 10.1007/s11906-019-0936-9
   Brouwers MC, 2010, CAN MED ASSOC J, V182, pE839, DOI 10.1503/cmaj.090449
   Cheng HM, 2017, J AM HEART ASSOC, V6, DOI 10.1161/JAHA.117.007667
   Cheng HM, 2017, INT J CARDIOL, V230, P209, DOI 10.1016/j.ijcard.2016.12.170
   Chia YC, 2017, J CLIN HYPERTENS, V19, P1192, DOI 10.1111/jch.13058
   Conroy RM, 2003, EUR HEART J, V24, P987, DOI 10.1016/S0195-668X(03)00114-3
   Ettehad D, 2016, LANCET, V387, P957, DOI 10.1016/S0140-6736(15)01225-8
   Fujiwara T, 2018, JAMA CARDIOL, V3, P583, DOI 10.1001/jamacardio.2018.1233
   Hanazawa T, 2018, J AM HEART ASSOC, V7, DOI 10.1161/JAHA.117.008509
   Hoshide S, 2018, HYPERTENSION, V71, P177, DOI 10.1161/HYPERTENSIONAHA.117.10385
   Hoshide S, 2017, J CLIN HYPERTENS, V19, P1240, DOI 10.1111/jch.13086
   Hoshide S, 2015, HYPERTENSION, V66, P750, DOI 10.1161/HYPERTENSIONAHA.115.05958
   Hozawa A, 2000, ARCH INTERN MED, V160, P3301, DOI 10.1001/archinte.160.21.3301
   Imai Y, 2018, BLOOD PRESS MONIT, V23, P318, DOI 10.1097/MBP.0000000000000351
   Ishikawa Shizukiyo, 2007, J Clin Hypertens (Greenwich), V9, P677, DOI 10.1111/j.1524-6175.2007.07102.x
   Ito M, 2019, HYPERTENS RES, V42, P759, DOI 10.1038/s41440-018-0172-8
   Kario K, 2003, CIRCULATION, V107, P1401, DOI 10.1161/01.CIR.0000056521.67546.AA
   Kario K, 2001, HYPERTENSION, V38, P852, DOI 10.1161/hy1001.092640
   Kario K, 2019, HYPERTENSION
   Kario K, 2019, HYPERTENSION, V73, P1240, DOI 10.1161/HYPERTENSIONAHA.118.12740
   Kario K, 2019, CIRC RES, V124, P990, DOI 10.1161/CIRCRESAHA.118.313219
   Kario K, 2019, J CLIN HYPERTENS, V21, P896, DOI 10.1111/jch.13505
   Kario K, 2019, J CLIN HYPERTENS, V21, P344, DOI 10.1111/jch.13495
   Kario K, 2019, CIRCULATION, V139, P2089, DOI 10.1161/CIRCULATIONAHA.118.037076
   Kario K, 2019, BLOOD PRESS MONIT, V24, P38, DOI 10.1097/MBP.0000000000000357
   Kario K, 2018, J CLIN HYPERTENS, V20, P1686, DOI 10.1111/jch.13415
   Kario K, 2018, CIRCULATION, V138, P1602, DOI 10.1161/CIRCULATIONAHA.118.035588
   Kario K, 2018, J CLIN HYPERTENS, V20, P1527, DOI 10.1111/jch.13367
   Kario K, 2018, HYPERTENSION, V72, P854, DOI 10.1161/HYPERTENSIONAHA.118.11388
   Kario K, 2018, HYPERTENSION, V71, P997, DOI 10.1161/HYPERTENSIONAHA.118.10971
   Kario K, 2018, J CLIN HYPERTENS, V20, P456, DOI 10.1111/jch.13216
   Kario K, 2018, J CLIN HYPERTENS, V20, P212, DOI 10.1111/jch.13185
   Kario K, 2017, PROG CARDIOVASC DIS, V60, P435, DOI 10.1016/j.pcad.2017.10.002
   Kario K, 2018, HYPERTENSION, V71, P375, DOI 10.1161/HYPERTENSIONAHA.117.10238
   Kario K, 2018, CIRCULATION, V137, P543, DOI 10.1161/CIRCULATIONAHA.117.032851
   Kario K, 2018, J CLIN HYPERTENS, V20, P33, DOI 10.1111/jch.13145
   Kario K, 2016, PROG CARDIOVASC DIS, V59, P262, DOI 10.1016/j.pcad.2016.04.001
   Kario K, 2016, J AM COLL CARDIOL, V67, P1519, DOI 10.1016/j.jacc.2016.01.037
   Kario K, 2015, HYPERTENSION, V66, P1130, DOI 10.1161/HYPERTENSIONAHA.115.06260
   Kario K, 2014, HYPERTENSION, V64, P989, DOI 10.1161/HYPERTENSIONAHA.114.04262
   Kokubo Y, 2008, HYPERTENSION, V52, P652, DOI 10.1161/HYPERTENSIONAHA.108.118273
   Kokubo Y, 2010, HYPERTENS RES, V33, P1238, DOI 10.1038/hr.2010.174
   Kushiro T, 2017, HYPERTENS RES, V40, P87, DOI 10.1038/hr.2016.87
   Kuwabara M, 2019, J CLIN HYPERTENS, V21, P463, DOI 10.1111/jch.13464
   Kuwabara M, 2018, J CLIN HYPERTENS, V20, P1039, DOI 10.1111/jch.13308
   Law MR, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1665
   Li Y, 2013, HYPERTENSION, V61, P278, DOI 10.1161/HYPERTENSIONAHA.111.00217
   Lloyd-Jones DM, 2005, JAMA-J AM MED ASSOC, V294, P466, DOI 10.1001/jama.294.4.466
   Lonn EM, 2016, NEW ENGL J MED, V374, P2009, DOI 10.1056/NEJMoa1600175
   Ministry of Health Labour and Welfare (JP), 2017, VIT STAT JAP 2017
   Myers MG, 2017, AM J HYPERTENS, V30, P8, DOI 10.1093/ajh/hpw086
   Myers MG, 2016, J CLIN HYPERTENS, V18, P721, DOI 10.1111/jch.12820
   Myers MG, 2012, CAN J CARDIOL, V28, P341, DOI 10.1016/j.cjca.2011.09.004
   Nakamura K, 2012, CEREBROVASC DIS, V33, P480, DOI 10.1159/000336764
   Ninomiya T, 2007, STROKE, V38, P2063, DOI 10.1161/STROKEAHA.106.479642
   Nishizawa M, 2019, J CLIN HYPERTENS, V21, P208, DOI 10.1111/jch.13463
   Nishizawa M, 2017, J CLIN HYPERTENS, V19, P26, DOI 10.1111/jch.12864
   Noguchi Y, 2013, J HYPERTENS, V31, P1593, DOI 10.1097/HJH.0b013e328361732c
   Ohkubo T, 1998, J HYPERTENS, V16, P971, DOI 10.1097/00004872-199816070-00010
   Park JB, 2015, HYPERTENS RES, V38, P227, DOI 10.1038/hr.2014.169
   Park S, 2018, J HUM HYPERTENS, V32, P249, DOI 10.1038/s41371-017-0025-y
   Piepoli MF, 2016, ATHEROSCLEROSIS, V252, P207, DOI 10.1016/j.atherosclerosis.2016.05.037
   Sasaki N, 2018, HYPERTENSION, V72, P1133, DOI 10.1161/HYPERTENSIONAHA.118.11794
   Seo J, 2019, J HYPERTENS, V37, P42, DOI 10.1097/HJH.0000000000001868
   Shimamoto K, 2014, HYPERTENS RES, V37, P256, DOI [10.1038/hr.2014.20, 10.1038/hr.2014.18]
   Sogunuru GP, 2019, J CLIN HYPERTENS, V21, P324, DOI 10.1111/jch.13451
   Tanizaki Y, 2000, STROKE, V31, P2616, DOI 10.1161/01.STR.31.11.2616
   The Ministry of Health Labour and Welfare (JP), 2016, NAT HLTH NUTR SURV J
   Turana Y, 2019, J CLIN HYPERTENS, V21, P1091, DOI 10.1111/jch.13558
   UEDA K, 1988, J HYPERTENS, V6, P991, DOI 10.1097/00004872-198812000-00006
   Ueshima H, 2006, CIRC J, V70, P1249
   Ueshima H, 2007, J ATHEROSCLER THROMB, V14, P278, DOI 10.5551/jat.E529
   Umemura S, 2019, HYPERTENS RES, V42, P1235, DOI 10.1038/s41440-019-0284-9
   Verdecchia P, 2009, LANCET, V374, P525, DOI 10.1016/S0140-6736(09)61340-4
   Whelton PK, 2018, HYPERTENSION, V71, pE13, DOI [10.1161/HYP.0000000000000065, 10.1161/HYP.0000000000000066]
   Wright JT, 2015, NEW ENGL J MED, V373, P2103, DOI 10.1056/NEJMoa1511939
   Yasui D, 2010, AM J HYPERTENS, V23, P508, DOI 10.1038/ajh.2010.15
NR 82
TC 1
Z9 1
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD DEC
PY 2019
VL 49
IS 12
BP 1123
EP 1135
DI 10.4070/kcj.2019.0246
PG 13
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA JP1JY
UT WOS:000498029700002
PM 31760704
OA Green Published, Other Gold
DA 2021-04-22
ER

PT J
AU Shin, DH
   Kang, HJ
   Jang, JS
   Moon, KW
   Song, YB
   Park, DW
   Bae, JW
   Kim, J
   Hur, SH
   Kim, BO
   Jeon, DW
   Choi, D
   Han, KR
AF Shin, Dong-Ho
   Kang, Hyun-Jae
   Jang, Jae-Sik
   Moon, Keon-Woong
   Song, Young Bin
   Park, Duk-Woo
   Bae, Jang-Whan
   Kim, Juhan
   Hur, Seung-Ho
   Kim, Byung Ok
   Jeon, Dong Woon
   Choi, Donghoon
   Han, Kyoo-Rok
TI The Current Status of Percutaneous Coronary Intervention in Korea: Based
   on Year 2014 & 2016 Cohort of Korean Percutaneous Coronary Intervention
   (K-PCI) Registry
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Percutaneous coronary intervention; Coronary artery disease
ID ELEVATION MYOCARDIAL-INFARCTION; TIME; MORTALITY; OUTCOMES; ASSOCIATION;
   CLOPIDOGREL; TICAGRELOR; PRASUGREL; PATTERN; TRENDS
AB Background and objectives: In this second report from Korean percutaneous coronary intervention (K-PCI) registry, we sought to describe the updated information of PCI practices and Korean practice pattern of PCI (KP3).
   Methods: In addition to K-PCI registry of 2014, new cohort of 2016 from 92 participating centers was appended. Demographic and procedural information, as well as in-hospital outcomes, of PCI was collected using a web-based reporting system. KP3 class C was defined as any strategy with less evidence from randomized trials and more aggressive for PCI than medical therapy or bypass-surgery.
   Results: In 2016, total 48,823 PCI procedures were performed at 92 participating centers. Mean age of the patients was 65.7 +/- 11.6 years, and 71.7% were males. Overall patient characteristics and PCI practices in 2016 were similar to those in 2014. The biggest change was the decrease in the in-hospital occurrence of myocardial infarction (MI;1.6%-> 0.7%, p<0.001). Many associations between PCI volumes and demographic/procedural characteristics observed in 2014 have disappeared. The median of door-to-balloon time was 62 minutes, and 83.3% of ST-elevation MI patients received primary PCI within 90 minutes, while the median of total ischemic time was 168 minutes and patients who had total ischemic time within 120 and 180 minutes were 29.1% and 54.1%, respectively. The proportion of KP3 class C cases in non-acute coronary syndrome patients decreased from 13.5% in 2014 to 12.1% in 2016 (p<0.001).
   Conclusions: In this second report from K-PCI registry, we described the current practices of PCI and changes from 2014 to 2016 in Korea.
C1 [Shin, Dong-Ho] Yonsei Univ, Coll Med, Dept Internal Med, Severance Hosp, Seoul, South Korea.
   [Kang, Hyun-Jae] Seoul Natl Univ Hosp, Dept Internal Med, Seoul, South Korea.
   [Jang, Jae-Sik] Univ Inje, Busan Paik Hosp, Div Cardiol, Dept Internal Med,Coll Med, Busan, South Korea.
   [Moon, Keon-Woong] Catholic Univ Korea, Dept Internal Med, St Vincents Hosp, 93 Jungbu Daero, Suwon 16247, South Korea.
   [Song, Young Bin] Sungkyunkwan Univ, Div Cardiol, Dept Med, Samsung Med Ctr,Sch Med, Seoul, South Korea.
   [Park, Duk-Woo] Univ Ulsan, Dept Cardiol, Asan Med Ctr, Coll Med, Seoul, South Korea.
   [Bae, Jang-Whan] Chungbuk Natl Univ, Dept Internal Med, Coll Med, Cheongju, South Korea.
   [Kim, Juhan] Chonnam Natl Univ Hosp, Dept Cardiovasc Med, Ctr Heart, Gwangju, South Korea.
   [Hur, Seung-Ho] Keimyung Univ, Div Cardiol, Dept Internal Med, Dongsan Med Ctr, Daegu, South Korea.
   [Kim, Byung Ok] Univ Inje, Sanggye Paik Hosp, Div Cardiol, Dept Internal Med,Coll Med, Seoul, South Korea.
   [Jeon, Dong Woon] Ilsan Hosp, Dept Cardiol, NHIS, Goyang, South Korea.
   [Choi, Donghoon] Yonsei Univ, Dept Internal Med, Div Cardiol, Severance Cardiovasc Hosp,Coll Med, Seoul, South Korea.
   [Han, Kyoo-Rok] Hallym Univ, Gangdong Sacred Heart Hosp, Dept Internal Med, Med Ctr, Seoul, South Korea.
RP Moon, KW (corresponding author), Catholic Univ Korea, Dept Internal Med, St Vincents Hosp, 93 Jungbu Daero, Suwon 16247, South Korea.
EM cardiomoon@gmail.com
RI Jang, Jae-Sik/B-4379-2015
OI Jang, Jae-Sik/0000-0001-7865-124X; Shin, Dong-Ho/0000-0002-7874-5542;
   Kim, Byung Ok/0000-0002-7920-2750; Hur, Seung-Ho/0000-0002-3895-1915;
   Song, Young Bin/0000-0003-3986-9152; Moon,
   Keon-Woong/0000-0003-2726-3209; Park, Duk-Woo/0000-0001-6643-0239
FU Korean Society of Cardiology; Korean Society of Interventional
   Cardiology
FX This study was co-sponsored by the Korean Society of Cardiology and
   Korean Society of Interventional Cardiology.
CR Antman EM, 2008, J AM COLL CARDIOL, V52, P1216, DOI 10.1016/j.jacc.2008.07.011
   Borenstein M., 2009, INTRO META ANAL, P45
   Bradley SM, 2012, CIRC-CARDIOVASC QUAL, V5, P290, DOI 10.1161/CIRCOUTCOMES.112.966044
   COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155
   Denktas AE, 2011, JACC-CARDIOVASC INTE, V4, P599, DOI 10.1016/j.jcin.2011.02.012
   Durlak JA, 2009, J PEDIATR PSYCHOL, V34, P917, DOI 10.1093/jpepsy/jsp004
   Faxon DP, 2016, CIRCULATION, V133, P2697, DOI 10.1161/CIRCULATIONAHA.116.023551
   Gwon HC, 2017, KOREAN CIRC J, V47, P320, DOI 10.4070/kcj.2017.0070
   Han S, 2018, KOREAN CIRC J, V48, P310, DOI 10.4070/kcj.2017.0359
   Jang JS, 2017, KOREAN CIRC J, V47, P328, DOI 10.4070/kcj.2017.0071
   Jneid H, 2017, J AM COLL CARDIOL, V70, P2048, DOI 10.1016/j.jacc.2017.06.032
   Kim C, 2017, KOREAN CIRC J, V47, P888, DOI 10.4070/kcj.2017.0072
   Kim HK, 2017, J CARDIOL, V69, P377, DOI 10.1016/j.jjcc.2016.09.002
   Mamas MA, 2016, CIRCULATION, V133, P1655, DOI 10.1161/CIRCULATIONAHA.115.018083
   Mark DB, 2016, JAMA CARDIOL, V1, P1048, DOI 10.1001/jamacardio.2016.3312
   Masoudi FA, 2017, J AM COLL CARDIOL, V69, P1427, DOI 10.1016/j.jacc.2016.12.005
   Masoudi FA, 2013, J AM COLL CARDIOL, V62, P1931, DOI 10.1016/j.jacc.2013.05.099
   Rollando D, 2012, HEART, V98, P1738, DOI 10.1136/heartjnl-2012-302536
   Shiomi H, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e3257
   Sullivan Gail M, 2012, J Grad Med Educ, V4, P279, DOI 10.4300/JGME-D-12-00156.1
   Wallentin L, 2009, NEW ENGL J MED, V361, P1045, DOI 10.1056/NEJMoa0904327
   Wiviott SD, 2007, NEW ENGL J MED, V357, P2001, DOI 10.1056/NEJMoa0706482
NR 22
TC 6
Z9 6
U1 0
U2 2
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD DEC
PY 2019
VL 49
IS 12
BP 1136
EP 1151
DI 10.4070/kcj.2018.0413
PG 16
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA JP1JY
UT WOS:000498029700003
PM 31347316
OA Other Gold, Green Published
DA 2021-04-22
ER

PT J
AU Sung, J
   Hong, KP
AF Sung, Jidong
   Hong, Kyung Pyo
TI Descriptive Study on the Korean Status of Percutaneous Coronary
   Intervention Using National Health Insurance Service-National Sample
   Cohort (NHIS-NSC) Database: Focused on Temporal Trend
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Coronary artery disease; Percutaneous coronary intervention
ID UNITED-STATES; REVASCULARIZATION; PCI
AB Background and Objectives: Percutaneous coronary intervention (PCI) is an indispensable treatment modality in coronary artery disease. However, there is still inadequacy of comprehensive knowledge on the Korean status and trend of this important procedure using nation-wide and representative data.
   Methods: National Health Insurance Service-National Sample Cohort is a database containing demographic, health insurance reimbursement for patient management and health screening data of about one million Koreans for 12 years (2002-2013). Annual procedure rate for PCI was estimated by bootstrapping as per 100,000 person-years.
   Results: Among the whole cohort, total 12,186 PCI's were done during the study period. Mean age of subjects who underwent PCI was 57.6 +/- 11.2 years and male:female proportion was 68%:32%. Death from all cause occurred in 1,843 (15.1%), death from ischemic heart diseases in 662 (5.4%), death from all cardiovascular cause in 872 (7.2%) during the followup. The proportion of the primary PCI for acute myocardial infarction was estimated to be 24.0%. Estimated annual rate of PCI increased from median 29.1 (95% confidence interval [CI], 26.6-32.1) in 2002 to 107.7 (95% CI, 103.0-113.8) per 100,000 person-years in 2013. In this cohort, PCI was performed in total 180 hospitals, which annually increased from 59 in 2002 to 153 in 2013.
   Conclusions: PCI had increased in volume from 2002 to 2013. This descriptive data may be considered in policy making and planning further direction of management of coronary artery disease in Korea.
C1 [Sung, Jidong; Hong, Kyung Pyo] Sungkyunkwan Univ, Prevent & Rehabil Ctr, Heart Vasc & Stroke Inst, Div Cardiol,Dept Med,Samsung Med Ctr,Sch Med, 81 Irwon Ro, Seoul 06351, South Korea.
RP Sung, J (corresponding author), Sungkyunkwan Univ, Prevent & Rehabil Ctr, Heart Vasc & Stroke Inst, Div Cardiol,Dept Med,Samsung Med Ctr,Sch Med, 81 Irwon Ro, Seoul 06351, South Korea.
EM jdsung@skku.edu
FU Korean Society of Cardiology Policy Research
FX This study was funded by the Korean Society of Cardiology Policy
   Research 2015.
CR Al-Lamee RK, 2019, HEART, V105, P11, DOI 10.1136/heartjnl-2017-312755
   Choi YJ, 2015, YONSEI MED J, V56, P895, DOI 10.3349/ymj.2015.56.4.895
   Epstein AJ, 2011, JAMA-J AM MED ASSOC, V305, P1769, DOI 10.1001/jama.2011.551
   Gerber Y, 2007, J AM COLL CARDIOL, V50, P1223, DOI 10.1016/j.jacc.2007.06.022
   Goel K, 2017, JAMA CARDIOL, V2, P25, DOI 10.1001/jamacardio.2016.4188
   Huh C, 2009, TALE KOREAS 2 CRISES
   Jang JS, 2017, KOREAN CIRC J, V47, P328, DOI 10.4070/kcj.2017.0071
   Khang YH, 2016, INT J EQUITY HEALTH, V15, DOI 10.1186/s12939-016-0341-9
   Kim JA, 2017, J KOREAN MED SCI, V32, P718, DOI 10.3346/jkms.2017.32.5.718
   Kim LK, 2014, AM J CARDIOL, V114, P1003, DOI 10.1016/j.amjcard.2014.07.013
   Kimm H, 2012, KOREAN CIRC J, V42, P10, DOI 10.4070/kcj.2012.42.1.10
   Lee J, 2017, INT J EPIDEMIOL, V46, DOI 10.1093/ije/dyv319
   Mehta SR, 2005, JAMA-J AM MED ASSOC, V293, P2908, DOI 10.1001/jama.293.23.2908
   Movahed MR, 2009, EUROINTERVENTION, V5, P343, DOI 10.4244/V5I3A54
   Pilote L, 2003, AM HEART J, V146, P1030, DOI 10.1016/S0002-8703(03)00448-4
   Williams M., 2010, UNCONTROLLED RISK LE
   Yong CM, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.114.001029
NR 17
TC 2
Z9 2
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD DEC
PY 2019
VL 49
IS 12
BP 1155
EP 1163
DI 10.4070/kcj.2019.0080
PG 9
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA JP1JY
UT WOS:000498029700005
PM 31456371
OA Green Published, Other Gold
DA 2021-04-22
ER

PT J
AU Kim, SH
   Park, Y
   Song, YH
   An, HS
   Shin, JI
   Oh, JH
   Lee, JW
   Kim, SH
   Kim, HS
   Shin, HJ
   Lee, HK
   Park, YB
   Lee, HY
   Kim, NS
   Ha, IS
   Ahn, S
   Lee, W
   Hong, YM
AF Kim, Sung Hye
   Park, Youngmi
   Song, Young-Hwan
   An, Hyo Soon
   Shin, Jae Il
   Oh, Jin-Hee
   Lee, Jung Won
   Kim, Seong Heon
   Kim, Hae Soon
   Shin, Hye-Jung
   Lee, Hae Kyoung
   Park, Yeong Bong
   Lee, Hae Yong
   Kim, Nam Su
   Ha, Il-Soo
   Ahn, Soyeon
   Lee, Woojoo
   Hong, Young Mi
TI Blood Pressure Reference Values for Normal Weight Korean Children and
   Adolescents: Data from The Korea National Health and Nutrition
   Examination Survey 1998-2016: The Korean Working Group of Pediatric
   Hypertension
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Blood pressure; Hypertension; Adolescent; Auscultation
ID GUIDELINES; OVERWEIGHT
AB Background and Objectives: Hypertension is becoming one of the most common health conditions in children and adolescents due to increasing childhood obesity. We aimed to provide the auscultatory blood pressure (BP) normative reference values for Korean non-overweight children and adolescents.
   Methods: BP measurements in children and adolescents aged 10 to 18 years were performed in the Korean National Health and Nutrition Examination Survey (KNHANES) from 1998 to 2016. BP was measured using a mercury sphygmomanometer. Sex-, age- and height-specific systolic BP (SBP) and diastolic BP (DBP) percentiles were calculated in the non-overweight children (n=10,442). We used the General Additive Model for Location Scale and Shape method to calculate BP percentiles.
   Results: The 50th, 90th, 95th, and 99th percentiles of SBP and DBP tables and graphs of non-overweight children and adolescents aged 10 to 18 years were presented by age and height percentiles. We found that the SBP and DBP at the 95th percentile were well correlated with height. The BP tables presented by height contained BP values from 124 cm to 190 cm for boys and from 120 cm to 178 cm for girls. Boys had higher SBP and DBP.
   Conclusions: We provided the sex-, age- and height-specific auscultatory BP values using the KNHANES big data. These may be useful in diagnosis and treatment of hypertension in Korean children and adolescents.
C1 [Kim, Sung Hye] Hallym Univ, Sacred Heart Hosp, Dept Pediat, Anyang, South Korea.
   [Kim, Sung Hye; Song, Young-Hwan; An, Hyo Soon; Shin, Jae Il; Oh, Jin-Hee; Lee, Jung Won; Kim, Seong Heon; Kim, Hae Soon; Shin, Hye-Jung; Lee, Hae Kyoung; Park, Yeong Bong; Lee, Hae Yong; Kim, Nam Su; Ha, Il-Soo; Hong, Young Mi] Korean Working Grp Pediat Hypertens, Seoul, South Korea.
   [Park, Youngmi] Med Res Collaborating Ctr, Seongnam, South Korea.
   [Song, Young-Hwan] Seoul Natl Univ, Bundang Hosp, Dept Pediat, 82,Gumi Ro 173 Beon Gil, Seongnam 13620, South Korea.
   [An, Hyo Soon] Seoul Natl Univ, Dept Pediat, Seoul Metropolitan Govt, Boramae Med Ctr, Seoul, South Korea.
   [Shin, Jae Il] Yonsei Univ, Severance Childrens Hosp, Dept Pediat, Coll Med, Seoul, South Korea.
   [Oh, Jin-Hee] Catholic Univ Korea, St Vincents Hosp, Dept Pediat, Suwon, South Korea.
   [Lee, Jung Won; Kim, Hae Soon; Hong, Young Mi] Ewha Womans Univ, Dept Pediat, Coll Med, Suwon, South Korea.
   [Kim, Seong Heon] Pusan Natl Univ, Dept Pediat, Childrens Hosp, Pusan, South Korea.
   [Shin, Hye-Jung] Natl Med Ctr, Dept Pediat, Seoul, South Korea.
   [Lee, Hae Kyoung] VHS Med Ctr, Dept Pediat, Seoul, South Korea.
   [Park, Yeong Bong] Chosun Univ, Dept Pediat, Sch Med, Gwangju, South Korea.
   [Lee, Hae Yong] Yonsei Univ Wonju, Dept Pediat, Coll Med, Wonju, South Korea.
   [Kim, Nam Su] Hanyang Univ Hosp, Dept Pediat, Seoul, South Korea.
   [Ha, Il-Soo] Seoul Natl Univ, Dept Pediat, Coll Med, Seoul, South Korea.
   [Ahn, Soyeon] Seoul Natl Univ, Bundang Hosp, Med Res Collaborating Ctr, Div Stat, Seongnam, South Korea.
   [Lee, Woojoo] Inha Univ, Dept Stat, Incheon, South Korea.
RP Song, YH (corresponding author), Seoul Natl Univ, Bundang Hosp, Dept Pediat, 82,Gumi Ro 173 Beon Gil, Seongnam 13620, South Korea.
EM yhsong@snubh.org
RI Kim, Seong Heon/AAD-8853-2020; SHIN, JAE IL/J-6922-2017
OI An, Hyo Soon/0000-0001-6513-0592; SHIN, JAE IL/0000-0003-2326-1820
CR Barba G, 2014, INT J OBESITY, V38, pS48, DOI 10.1038/ijo.2014.135
   El-Shafie AM, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-020609
   Flynn J, 2013, PEDIATR NEPHROL, V28, P1059, DOI 10.1007/s00467-012-2344-0
   Flynn JT, 2017, PEDIATRICS, V140, DOI 10.1542/peds.2017-1904
   Harding S, 2006, J HYPERTENS, V24, P1507, DOI 10.1097/01.hjh.0000239285.20315.4d
   Harris KC, 2016, CAN J CARDIOL, V32, P589, DOI 10.1016/j.cjca.2016.02.075
   Jackson SL, 2018, MMWR-MORBID MORTAL W, V67, P758, DOI 10.15585/mmwr.mm6727a2
   Juhola J, 2013, CIRCULATION, V128, P217, DOI 10.1161/CIRCULATIONAHA.113.001614
   Kim HS, 2012, KOREAN CIRC J, V42, P809, DOI 10.4070/kcj.2012.42.12.809
   Koebnick C, 2013, J CLIN HYPERTENS, V15, P793, DOI 10.1111/jch.12199
   Korean Centers for Disease Control and Prevention, 2017, SOURC TITL
   Kweon S, 2014, INT J EPIDEMIOL, V43, P69, DOI 10.1093/ije/dyt228
   Lee Chong Guk, 2011, Korean J Pediatr, V54, P463, DOI 10.3345/kjp.2011.54.11.463
   Lurbe E, 2016, J HYPERTENS, V34, P1887, DOI 10.1097/HJH.0000000000001039
   Ministry of Health and Welfare (KR), 2018, KOR NAT HLTH NUTR EX
   Natl High Blood Pressure Educ Prog, 2004, PEDIATRICS, V114, P555
   Park MK, 2001, ARCH PEDIAT ADOL MED, V155, P50, DOI 10.1001/archpedi.155.1.50
   Raj Manu, 2012, Indian J Endocrinol Metab, V16, P13, DOI 10.4103/2230-8210.91176
   Yan WL, 2013, BMC PEDIATR, V13, DOI 10.1186/1471-2431-13-195
   이종국, 2008, Clinical and Experimental Pediatrics, V51, P33
NR 20
TC 3
Z9 3
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD DEC
PY 2019
VL 49
IS 12
BP 1167
EP 1180
DI 10.4070/kcj.2019.0075
PG 14
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA JP1JY
UT WOS:000498029700007
PM 31456368
OA Green Published, Other Gold
DA 2021-04-22
ER

PT J
AU Oh, CM
   Cho, S
   Jang, JY
   Kim, H
   Chun, S
   Choi, M
   Park, S
   Ko, YG
AF Oh, Chang-Myung
   Cho, Sungsoo
   Jang, Ji-Yong
   Kim, Hyeongseok
   Chun, Sukyung
   Choi, Minkyung
   Park, Sangkyu
   Ko, Young-Guk
TI Cardioprotective Potential of an SGLT2 Inhibitor Against
   Doxorubicin-Induced Heart Failure
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Heart failure; Doxycycline; Sodium-Glucose Transporter 2 Inhibitors
ID BETA-HYDROXYBUTYRATE; CARDIOMYOPATHY; EMPAGLIFLOZIN
AB Background and Objectives: Recent studies have shown that sodium-glucose co-transporter 2 (SGLT2) inhibitors reduce the risk of heart failure (HF)-associated hospitalization and mortality in patients with diabetes. However, it is not clear whether SGLT2 inhibitors have a cardiovascular benefit in patients without diabetes. We aimed to determine whether empagliflozin (EMPA), an SGLT2 inhibitor, has a protective role in HF without diabetes.
   Methods: Cardiomyopathy was induced in C57BL/6J mice using intraperitoneal injection of doxorubicin (Dox). Mice with HF were fed a normal chow diet (NCD) or an NCD containing 0.03% EMPA. Then we analyzed their phenotypes and performed in vitro experiments to reveal underlying mechanisms of the EMPA's effects.
   Results: Mice fed NCD with EMPA showed improved heart function and reduced fibrosis. In vitro studies showed similar results. Phloridzin, a non-specific SGLT inhibitor, did not show any protective effect against Dox toxicity in H9C2 cells. SGLT2 inhibitor can cause increase in blood ketone levels. Beta hydroxybutyrate (beta OHB), which is well known ketone body associated with SGLT2 inhibitor, showed a protective effect against Dox in H9C2 cells and in Dox-treated mice. These results suggest elevating beta OHB might be a convincing mechanism for the protective effects of SGLT2 inhibitor.
   Conclusions: SGLT2 inhibitors have a protective effect in Dox-induced HF in mice. This implied that SGLT2 inhibitor therapy could be a good treatment strategy even in HF patients without diabetes.
C1 [Oh, Chang-Myung; Chun, Sukyung; Choi, Minkyung] CHA Univ, Sch Med, CHA Bundang Med Ctr, Div Endocrinol & Metab, Seongnam, South Korea.
   [Cho, Sungsoo] Dankook Univ, Dankook Univ Hosp, Dept Internal Med, Div Cardiovasc Med,Sch Med, Cheonan, South Korea.
   [Jang, Ji-Yong] Natl Hlth Insurance Serv Ilsan Hosp, Div Cardiol, Goyang, South Korea.
   [Kim, Hyeongseok] Korea Adv Inst Sci & Technol, Grad Sch Med Sci & Engn, Daejeon, South Korea.
   [Park, Sangkyu] Catholic Kwandong Univ, Coll Med, Dept Biochem, 24,Beomil Ro 579beon Gil, Kangnung 25601, South Korea.
   [Ko, Young-Guk] Yonsei Univ, Coll Med, Severance Cardiovasc Hosp, Div Cardiol, 50 Yonsei Ro, Seoul 03722, South Korea.
RP Park, S (corresponding author), Catholic Kwandong Univ, Coll Med, Dept Biochem, 24,Beomil Ro 579beon Gil, Kangnung 25601, South Korea.; Ko, YG (corresponding author), Yonsei Univ, Coll Med, Severance Cardiovasc Hosp, Div Cardiol, 50 Yonsei Ro, Seoul 03722, South Korea.
EM 49park@cku.ac.kr; ygko@yuhs.ac
OI Oh, Chang-Myung/0000-0001-6681-4478; Kim,
   Hyeongsoek/0000-0002-7093-0399; Ko, Young-Guk/0000-0001-7748-5788; Jang,
   Ji-Yong/0000-0003-2842-7500; Park, Sangkyu/0000-0001-5525-2860
FU Basic Science Research Program through the National Research Foundation
   of Korea (NRF) - Ministry of Education [2016R1A6A3A04010466]; Korean
   Cardiac Research Foundation [201702-02]
FX This research was supported by the Basic Science Research Program
   through the National Research Foundation of Korea (NRF) funded by the
   Ministry of Education (2016R1A6A3A04010466 to Chang-Myung Oh) and by a
   research grant from the Korean Cardiac Research Foundation (201702-02 to
   Sungsoo Cho).
CR Abdul-Ghani M, 2016, DIABETES CARE, V39, P717, DOI 10.2337/dc16-0041
   Aubert G, 2016, CIRCULATION, V133, P698, DOI 10.1161/CIRCULATIONAHA.115.017355
   Berliner D, 2017, KOREAN CIRC J, V47, P543, DOI 10.4070/kcj.2017.0030
   Breckenridge R, 2010, DIS MODEL MECH, V3, P138, DOI 10.1242/dmm.005017
   Chen Jian, 2010, Diabetes Ther, V1, P57, DOI 10.1007/s13300-010-0006-4
   Ferrannini E, 2016, DIABETES, V65, P1190, DOI 10.2337/db15-1356
   Gao Shumin, 2011, Curr Protoc Mouse Biol, V1, P71
   Grabacka M, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17122093
   Guh JY, 2003, KIDNEY INT, V64, P2041, DOI 10.1046/j.1523-1755.2003.00330.x
   Jin Z, 2013, J CARDIOL, V62, P110, DOI 10.1016/j.jjcc.2013.03.018
   Joshi DC, 2011, JOVE-J VIS EXP, DOI 10.3791/2704
   Kong GG, 2017, J NEUROTRAUM, V34, P2645, DOI 10.1089/neu.2017.5192
   Lee BS, 2013, KOREAN CIRC J, V43, P400, DOI 10.4070/kcj.2013.43.6.400
   Lim S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024620
   Liu XJ, 2012, ACTA CARDIOL SIN, V28, P236
   Lopaschuk GD, 2016, CELL METAB, V24, P200, DOI 10.1016/j.cmet.2016.07.018
   Mitry MA, 2016, IJC HEART VASC, V10, P17, DOI 10.1016/j.ijcha.2015.11.004
   Mouli S, 2015, AM J PHYSIOL-HEART C, V309, pH844, DOI 10.1152/ajpheart.00182.2015
   Mudaliar S, 2015, DIABETES CARE, V38, P2344, DOI 10.2337/dc15-0642
   Napolitano A, 2014, J CLIN TRANSL ENDOCR, V1, pE3, DOI 10.1016/j.jcte.2013.12.001
   Octavia Y, 2012, J MOL CELL CARDIOL, V52, P1213, DOI 10.1016/j.yjmcc.2012.03.006
   Rosenstock J, 2015, DIABETES CARE, V38, P1638, DOI 10.2337/dc15-1380
   Sampson M, 2017, J INSUL RESIST, V2, P8
   Shimazu T, 2013, SCIENCE, V339, P211, DOI 10.1126/science.1227166
   Thapa S, 2016, 98 ANN M END SOC 201
   Vettor R, 2017, DIABETOLOGIA, V60, P395, DOI 10.1007/s00125-016-4194-y
   Youm YH, 2015, NAT MED, V21, P263, DOI 10.1038/nm.3804
   Yu YS, 2018, EUR J PHARMACOL, V829, P121, DOI 10.1016/j.ejphar.2018.04.019
   Zinman B, 2015, NEW ENGL J MED, V373, P2117, DOI 10.1056/NEJMoa1504720
NR 29
TC 17
Z9 17
U1 1
U2 3
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD DEC
PY 2019
VL 49
IS 12
BP 1183
EP 1195
DI 10.4070/kcj.2019.0180
PG 13
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA JP1JY
UT WOS:000498029700009
PM 31456369
OA Other Gold, Green Published
DA 2021-04-22
ER

PT J
AU Kim, Y
   Johnson, TW
   Jeong, MH
AF Kim, Yongcheol
   Johnson, Thomas W.
   Jeong, Myung Ho
TI Potent P2Y(12) Receptor Inhibition in Korean Patients with Acute
   Myocardial Infarction
SO KOREAN CIRCULATION JOURNAL
LA English
DT Letter
ID DUAL ANTIPLATELET THERAPY
C1 [Kim, Yongcheol; Jeong, Myung Ho] Chonnam Natl Univ, Chonnam Natl Univ Hosp, Div Cardiol, Dept Internal Med,Med Sch, 42 Jebong Ro, Gwangju 61469, South Korea.
   [Johnson, Thomas W.] Bristol Heart Inst, Dept Cardiol, Bristol, Avon, England.
RP Jeong, MH (corresponding author), Chonnam Natl Univ, Chonnam Natl Univ Hosp, Div Cardiol, Dept Internal Med,Med Sch, 42 Jebong Ro, Gwangju 61469, South Korea.
EM myungho@chollian.net
OI Jeong, Myung Ho/0000-0003-2424-810X; Kim, Yongcheol/0000-0001-5568-4161
FU Chonnam National University Hospital Biomedical Research Institute
   [BCRI18015]
FX This study was supported by a grant of Chonnam National University
   Hospital Biomedical Research Institute (BCRI18015).
CR Kang J, 2018, KOREAN CIRC J, V48, P537, DOI 10.4070/kcj.2018.0166
   Kim Y, 2019, KOREAN J INTERN MED, V34, P1, DOI 10.3904/kjim.2018.381
   Schupke S, 2019, NEW ENGL J MED, V381, P1524, DOI 10.1056/NEJMoa1908973
   Valgimigli M, 2018, EUR HEART J, V39, P213, DOI 10.1093/eurheartj/ehx419
   Yun KH, 2019, KOREAN CIRC J, V49, P1052, DOI 10.4070/kcj.2019.0098
NR 5
TC 1
Z9 1
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD DEC
PY 2019
VL 49
IS 12
BP 1199
EP 1200
DI 10.4070/kcj.2019.0301
PG 2
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA JP1JY
UT WOS:000498029700011
PM 31760706
OA Green Published, Other Gold
DA 2021-04-22
ER

PT J
AU Yun, KH
   Rhee, SJ
AF Yun, Kyeong Ho
   Rhee, Sang Jae
TI Author's Reply to Potent P2Y(12) Receptor Inhibition in Korean Patients
   with Acute Myocardial Infarction
SO KOREAN CIRCULATION JOURNAL
LA English
DT Letter
C1 [Yun, Kyeong Ho; Rhee, Sang Jae] Wonkwang Univ Hosp, Dept Cardiovasc Med, Reg Cardiocerebrovasc Ctr, 895 Muwang Ro, Iksan 54538, South Korea.
RP Yun, KH (corresponding author), Wonkwang Univ Hosp, Dept Cardiovasc Med, Reg Cardiocerebrovasc Ctr, 895 Muwang Ro, Iksan 54538, South Korea.
EM dryunkh@gmail.com
OI Yun, Kyeong Ho/0000-0003-4911-8854
CR Kim Y, 2019, KOREAN CIRC J, V49, P1199, DOI 10.4070/kcj.2019.0301
   Park DW, 2019, CIRCULATION
   Yun JE, 2019, J AM HEART ASSOC, V8, DOI 10.1161/JAHA.119.012078
   Yun KH, 2019, KOREAN CIRC J, V49, P1052, DOI 10.4070/kcj.2019.0098
NR 4
TC 0
Z9 0
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD DEC
PY 2019
VL 49
IS 12
BP 1201
EP 1202
DI 10.4070/kcj.2019.3011
PG 2
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA JP1JY
UT WOS:000498029700012
PM 31760707
OA Other Gold, Green Published
DA 2021-04-22
ER

PT J
AU Won, H
   Kim, SW
AF Won, Hoyoun
   Kim, Sang-Wook
TI The Second Report from K-PCI Registry: a Step toward Continuous Systemic
   Monitoring of Korean Percutaneous Coronary Intervention Practice
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
ID 2014 COHORT
C1 [Won, Hoyoun; Kim, Sang-Wook] Chung Ang Univ, Cardiovasc & Arrhythmia Ctr, Chung Ang Univ Hosp, Coll Med, 120 Heukseok Ro, Seoul 06973, South Korea.
RP Won, H (corresponding author), Chung Ang Univ, Cardiovasc & Arrhythmia Ctr, Chung Ang Univ Hosp, Coll Med, 120 Heukseok Ro, Seoul 06973, South Korea.
EM nowhy@cau.ac.kr
OI Won, Hoyoun/0000-0001-7880-3477; Kim, Sang-Wook/0000-0002-7208-8596
CR Barbato E, 2017, EUROINTERVENTION, V13, pZ6, DOI 10.4244/EIJV13IZA1
   Brindis R G, 2001, J Am Coll Cardiol, V37, P2240, DOI 10.1016/S0735-1097(01)01372-9
   Dehmer GJ, 2004, J AM COLL CARDIOL, V43, P893, DOI 10.1016/j.jacc.2004.01.014
   Gwon HC, 2017, KOREAN CIRC J, V47, P320, DOI 10.4070/kcj.2017.0070
   Jang JS, 2017, KOREAN CIRC J, V47, P328, DOI 10.4070/kcj.2017.0071
   Masoudi FA, 2017, J AM COLL CARDIOL, V69, P1427, DOI 10.1016/j.jacc.2016.12.005
   Shin DH, 2019, KOREAN CIRC J, V49, P1136, DOI 10.4070/kcj.2018.0413
NR 7
TC 0
Z9 0
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD DEC
PY 2019
VL 49
IS 12
BP 1152
EP 1154
DI 10.4070/kcj.2019.0247
PG 3
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA JP1JY
UT WOS:000498029700004
PM 31642216
OA Green Published, Other Gold
DA 2021-04-22
ER

PT J
AU Kim, MC
   Ahn, Y
AF Kim, Min Chul
   Ahn, Youngkeun
TI The Need for Re-evaluation of PCI Practice: from Proceduralists to
   Clinicians
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
ID PERCUTANEOUS CORONARY INTERVENTION; KOREA
C1 [Kim, Min Chul; Ahn, Youngkeun] Chonnam Natl Univ, Chonnam Natl Univ Hosp, Dept Internal Med, Div Cardiol,Med Sch, 42 Jebong Ro, Gwangju 61469, South Korea.
   [Ahn, Youngkeun] Chonnam Natl Univ Hosp, Cell Regenerat Res Ctr, Gwangju, South Korea.
   [Ahn, Youngkeun] Chonnam Natl Univ, Sch Med, BK21 PLUS Ctr Creat Biomed Scientists, Gwangju, South Korea.
RP Ahn, Y (corresponding author), Chonnam Natl Univ, Chonnam Natl Univ Hosp, Dept Internal Med, Div Cardiol,Med Sch, 42 Jebong Ro, Gwangju 61469, South Korea.
EM cecilyk@hanmail.net
OI Kim, Min Chul/0000-0001-6026-1702
CR Al-Lamee R, 2018, LANCET, V391, P31, DOI 10.1016/S0140-6736(17)32714-9
   Benjamin EJ, 2019, CIRCULATION, V139, pE56, DOI 10.1161/CIR.0000000000000659
   Han S, 2018, KOREAN CIRC J, V48, P310, DOI 10.4070/kcj.2017.0359
   Jang JS, 2017, KOREAN CIRC J, V47, P328, DOI 10.4070/kcj.2017.0071
   Kim Y, 2018, AM J CARDIOL, V122, P365, DOI 10.1016/j.amjcard.2018.04.026
   Maron DJ, 2018, AM HEART J, V201, P124, DOI 10.1016/j.ahj.2018.04.011
   Park SJ, 2003, NEW ENGL J MED, V348, P1537, DOI 10.1056/NEJMoa021007
   Sedlis SP, 2015, NEW ENGL J MED, V373, P1937, DOI 10.1056/NEJMoa1505532
   Shin DH, 2019, KOREAN CIRC J, V49, P1136, DOI 10.4070/kcj.2018.0413
   Sung J, 2019, KOREAN CIRC J, V49, P1155, DOI 10.4070/kcj.2019.0080
   Weintraub WS, 2008, NEW ENGL J MED, V359, P677, DOI 10.1056/NEJMoa072771
NR 11
TC 0
Z9 0
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD DEC
PY 2019
VL 49
IS 12
BP 1164
EP 1166
DI 10.4070/kcj.2019.0286
PG 3
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA JP1JY
UT WOS:000498029700006
PM 31642217
OA Green Published
DA 2021-04-22
ER

PT J
AU Eun, LY
AF Eun, Lucy Youngmin
TI Do We Know the Normal Blood Pressure Level in Korean Children and
   Adolescents?
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
C1 [Eun, Lucy Youngmin] Yonsei Univ, Coll Med, Dept Pediat, Div Pediat Cardiol, 50-1 Yonsei Ro, Seoul 03722, South Korea.
RP Eun, LY (corresponding author), Yonsei Univ, Coll Med, Dept Pediat, Div Pediat Cardiol, 50-1 Yonsei Ro, Seoul 03722, South Korea.
EM lucyeun@yuhs.ac
CR Cho SMJ, 2019, KOREAN CIRC J, V49, P1035, DOI 10.4070/kcj.2019.0049
   Flynn JT, 2017, PEDIATRICS, V140, DOI 10.1542/peds.2017-1904
   Harding S, 2006, J HYPERTENS, V24, P1507, DOI 10.1097/01.hjh.0000239285.20315.4d
   Hisamatsu T, 2019, KOREAN CIRC J, V49, P1049, DOI 10.4070/kcj.2019.0197
   Kim SH, 2019, KOREAN CIRC J, V49, P1167, DOI 10.4070/kcj.2019.0075
   Korean Society Hypertension (KSH), 2018, Clin Hypertens, V24, P13, DOI 10.1186/s40885-018-0098-0
   Lurbe E, 2016, J HYPERTENS, V34, P1887, DOI 10.1097/HJH.0000000000001039
   Natl High Blood Pressure Educ Prog, 2004, PEDIATRICS, V114, P555
   Yan WL, 2013, BMC PEDIATR, V13, DOI 10.1186/1471-2431-13-195
NR 9
TC 0
Z9 0
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD DEC
PY 2019
VL 49
IS 12
BP 1181
EP 1182
DI 10.4070/kcj.2019.0273
PG 2
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA JP1JY
UT WOS:000498029700008
PM 31760705
OA Green Published, Other Gold
DA 2021-04-22
ER

PT J
AU Kim, YS
   Ahn, Y
AF Kim, Yong Sook
   Ahn, Youngkeun
TI Benefits of SGLT2 Inhibitor: Preventing Heart Failure and Beyond
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
C1 [Kim, Yong Sook] Chonnam Natl Univ Hosp, Biomed Res Ctr, 42 Jebong Ro, Gwangju 61469, South Korea.
   [Kim, Yong Sook; Ahn, Youngkeun] Chonnam Natl Univ Hosp, Cell Regenerat Res Ctr, 42 Jebong Ro, Gwangju 61469, South Korea.
   [Ahn, Youngkeun] Chonnam Natl Univ, Dept Cardiol, Sch Med, Gwangju, South Korea.
   [Ahn, Youngkeun] Chonnam Natl Univ, BK21 PLUS Ctr Creat Biomed Scientists, Sch Med, Gwangju, South Korea.
RP Kim, YS (corresponding author), Chonnam Natl Univ Hosp, Biomed Res Ctr, 42 Jebong Ro, Gwangju 61469, South Korea.; Kim, YS (corresponding author), Chonnam Natl Univ Hosp, Cell Regenerat Res Ctr, 42 Jebong Ro, Gwangju 61469, South Korea.
EM reorgan@hanmail.net
CR Habibi J, 2017, CARDIOVASC DIABETOL, V16, DOI 10.1186/s12933-016-0489-z
   Kusaka H, 2016, CARDIOVASC DIABETOL, V15, DOI 10.1186/s12933-016-0473-7
   Lee TM, 2017, FREE RADICAL BIO MED, V104, P298, DOI 10.1016/j.freeradbiomed.2017.01.035
   Mahaffey KW, 2018, CIRCULATION, V137, P323, DOI 10.1161/CIRCULATIONAHA.117.032038
   Nagao M, 2016, BIOCHEM BIOPH RES CO, V475, P322, DOI 10.1016/j.bbrc.2016.05.097
   Nielsen R, 2019, CIRCULATION, V139, P2129, DOI 10.1161/CIRCULATIONAHA.118.036459
   Oh CM, 2019, KOREAN CIRC J, V49, P1183, DOI 10.4070/kcj.2019.0180
   Verma S, 2019, CIRCULATION, V140, P1693, DOI 10.1161/CIRCULATIONAHA.119.042375
   Voros G, 2018, CIRC-HEART FAIL, V11, DOI 10.1161/CIRCHEARTFAILURE.118.004953
   Yurista SR, 2019, EUR J HEART FAIL, V21, P862, DOI 10.1002/ejhf.1473
   Zinman B, 2015, NEW ENGL J MED, V373, P2117, DOI 10.1056/NEJMoa1504720
NR 11
TC 1
Z9 1
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD DEC
PY 2019
VL 49
IS 12
BP 1196
EP 1198
DI 10.4070/kcj.2019.0287
PG 3
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA JP1JY
UT WOS:000498029700010
PM 31642218
OA Green Published
DA 2021-04-22
ER

PT J
AU Park, JH
   Shin, JW
   Lee, JH
AF Park, Jae-Hyeong
   Shin, Jong Wook
   Lee, Jae-Hwan
TI Unilateral Pulsus Parvus et Tardus Waveform Discovered during Carotid
   Artery Doppler Examination: a Clue of Proximal Carotid Artery Occlusion
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
ID RADIATION
C1 [Park, Jae-Hyeong; Lee, Jae-Hwan] Chungnam Natl Univ, Sch Med, Chungnam Natl Univ Hosp, Div Cardiol,Dept Internal Med, 282 Munhwa Ro, Daejeon 35015, South Korea.
   [Shin, Jong Wook] Chungnam Natl Univ, Sch Med, Chungnam Natl Univ Hosp, Dept Neurol, Daejeon, South Korea.
RP Lee, JH (corresponding author), Chungnam Natl Univ, Sch Med, Chungnam Natl Univ Hosp, Div Cardiol,Dept Internal Med, 282 Munhwa Ro, Daejeon 35015, South Korea.
EM myheart@cnu.ac.kr
RI Park, Jae-Hyeong/AAD-9015-2021
CR Houdart E, 2001, STROKE, V32, P118, DOI 10.1161/01.STR.32.1.118
   MURROS KE, 1989, ARCH NEUROL-CHICAGO, V46, P449, DOI 10.1001/archneur.1989.00520400109029
   Park JH, 2018, KOREAN CIRC J, V48, P97, DOI 10.4070/kcj.2017.0208
   Venkatesulu BP, 2018, JACC-BASIC TRANSL SC, V3, P563, DOI 10.1016/j.jacbts.2018.01.014
NR 4
TC 0
Z9 0
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD DEC
PY 2019
VL 49
IS 12
BP 1203
EP 1205
DI 10.4070/kcj.2019.0178
PG 3
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA JP1JY
UT WOS:000498029700013
PM 31760708
OA Green Published, Other Gold
DA 2021-04-22
ER

PT J
AU Chun, JKR
   Bordignon, S
   Chen, SJ
   Tohoku, S
   Bologna, F
   Urbanek, L
   Schmidt, BH
AF Chun, Julian Kyoung-Ryul
   Bordignon, Stefano
   Chen, Shaojie
   Tohoku, Shota
   Bologna, Fabrizio
   Urbanek, Lukas
   Schmidt, Boris Heinrich
TI Current Status of Atrial Fibrillation Ablation with Balloon Strategy
SO KOREAN CIRCULATION JOURNAL
LA English
DT Review
DE Atrial fibrillation; Ablation balloon technology
ID PULMONARY VEIN ISOLATION; GUIDED LASER BALLOON; CRYOBALLOON-ABLATION;
   CATHETER ABLATION; 2ND-GENERATION CRYOBALLOON; RADIOFREQUENCY ABLATION;
   MULTICENTER; SAFETY; EFFICACY; AF
AB Catheter ablation of atrial fibrillation (AF) has been established worldwide and is recommended for symptomatic paroxysmal AF patients according to international guidelines. Importantly, the cornerstone of any AF ablation represents pulmonary vein isolation (PVI). Traditional radiofrequency (RF) point by point ablation within a 3D electroanatomic left atrial (LA) map requires profound understanding of LA anatomy and electrophysiology. This ablation strategy can be highly efficient and safe if performed in experienced hands and centers. However, procedural complexity causes a long learning curve and has limited its wide spread utilization. In contrast, balloon based PVI ablation strategies are based on an anatomic principle. Currently, two balloon types (cryoballoon and laserballoon) have been adopted to clinical routine. Both balloons are positioned at the target PV and circumferential energy ablation is enabled. This simplified anatomic approach facilitates reaching the procedural endpoint of PVI and demonstrated less operator dependency. Therefore, balloon PVI appears to be associated with improved procedural reproducibility and safety. Importantly, large scale randomized trials proved non-inferiority of balloon guided AF ablation (cryothermal and laser energy) vs. experienced operators using traditional "gold standard" RF ablation in paroxysmal and persistent AF. Ongoing technological refinements of both balloons as well as the introduction of novel energy dosing strategies and ablation targets may potentially impact the current way of ablating AF in future. This review will summarize current clinical experience of contemporary balloon devices and will look into future developments.
C1 [Chun, Julian Kyoung-Ryul; Bordignon, Stefano; Chen, Shaojie; Tohoku, Shota; Bologna, Fabrizio; Urbanek, Lukas; Schmidt, Boris Heinrich] Agaples Markus Krankenhaus, CCB Kardiol, Med Klin 3, D-60431 Frankfurt, Germany.
RP Chun, JKR (corresponding author), Agaples Markus Krankenhaus, CCB Kardiol, Med Klin 3, D-60431 Frankfurt, Germany.
EM j.chun@ccb.de
OI Tohoku, Shota/0000-0002-0299-362X; Schmidt, Boris/0000-0001-5347-9906;
   Bologna, Fabrizio/0000-0002-7922-3244; Bordignon,
   Stefano/0000-0002-0282-4658
CR Aryana A, 2018, HEART RHYTHM, V15, P1121, DOI 10.1016/j.hrthm.2018.05.014
   Aryana A, 2017, HEART RHYTHM, V14, P1319, DOI 10.1016/j.hrthm.2017.06.020
   Bordignon S, 2019, PACE, V42, P646, DOI 10.1111/pace.13690
   Bordignon S, 2016, EUROPACE, V18, P538, DOI 10.1093/europace/euv208
   Bordignon S, 2015, EUROPACE, V17, P725, DOI 10.1093/europace/euu331
   Bordignon S, 2013, J CARDIOVASC ELECTR, V24, P987, DOI 10.1111/jce.12192
   Boveda S, 2018, JACC-CLIN ELECTROPHY, V4, P1440, DOI 10.1016/j.jacep.2018.07.007
   Chen SJ, 2019, JACC-CLIN ELECTROPHY, V5, P551, DOI 10.1016/j.jacep.2019.03.012
   Chun K R Julian, 2017, JACC Clin Electrophysiol, V3, P154, DOI 10.1016/j.jacep.2016.07.002
   Chun KRJ, 2009, J CARDIOVASC ELECTR, V20, P1203, DOI 10.1111/j.1540-8167.2009.01549.x
   Chun KRJ, 2009, EUR HEART J, V30, P699, DOI 10.1093/eurheartj/ehn570
   De Regibus V, 2018, EUROPACE, V20, pF377, DOI 10.1093/europace/eux279
   Di Biase L, 2016, J AM COLL CARDIOL, V68, P1929, DOI 10.1016/j.jacc.2016.07.770
   Di Biase L, 2010, CIRCULATION, V122, P109, DOI 10.1161/CIRCULATIONAHA.109.928903
   Di Giovanni G, 2014, J CARDIOVASC ELECTR, V25, P834, DOI 10.1111/jce.12409
   Dorwarth U, 2011, J INTERV CARD ELECTR, V32, P205, DOI 10.1007/s10840-011-9585-x
   Dukkipati SR, 2015, J AM COLL CARDIOL, V66, P1350, DOI 10.1016/j.jacc.2015.07.036
   Dukkipati SR, 2012, HEART RHYTHM, V9, P919, DOI 10.1016/j.hrthm.2012.01.019
   Franceschi F, 2011, HEART RHYTHM, V8, P885, DOI 10.1016/j.hrthm.2011.01.031
   Furnkranz A, 2015, HEART RHYTHM, V12, P268, DOI 10.1016/j.hrthm.2014.10.033
   Furnkranz A, 2014, J CARDIOVASC ELECTR, V25, P840, DOI 10.1111/jce.12417
   Furnkranz A, 2013, J CARDIOVASC ELECTR, V24, P492, DOI 10.1111/jce.12082
   Gadiyaram VK, 2019, J CARDIOVASC ELECTR, V30, P511, DOI 10.1111/jce.13838
   Ghosh J, 2013, HEART RHYTHM, V10, P646, DOI 10.1016/j.hrthm.2013.01.011
   Haissaguerre M, 1998, NEW ENGL J MED, V339, P659, DOI 10.1056/NEJM199809033391003
   Hoffmann E, 2019, EUROPACE
   Kirchhof P, 2016, EUROPACE, V18, DOI 10.1093/europace/euw295
   Koektuerk B, 2015, CIRC-ARRHYTHMIA ELEC, V8, P1073, DOI 10.1161/CIRCEP.115.002776
   Krijthe BP, 2013, EUR HEART J, V34, P2746, DOI 10.1093/eurheartj/eht280
   Kuck KH, 2016, EUR HEART J, V37, P2858, DOI 10.1093/eurheartj/ehw285
   Kuck KH, 2016, NEW ENGL J MED, V374, P2235, DOI 10.1056/NEJMoa1602014
   Kuniss M, 2017, EUROPACE, V19, P1109, DOI 10.1093/europace/euw146
   Maltoni S, 2018, J CARDIOVASC MED, V19, P725, DOI 10.2459/JCM.0000000000000725
   Mark DB, 2019, JAMA-J AM MED ASSOC, V321, P1275, DOI 10.1001/jama.2019.0692
   Marrouche NF, 2018, NEW ENGL J MED, V378, P417, DOI 10.1056/NEJMoa1707855
   Martins RP, 2014, HEART RHYTHM, V11, P386, DOI 10.1016/j.hrthm.2014.01.002
   Metzner A, 2014, CIRC-ARRHYTHMIA ELEC, V7, P288, DOI 10.1161/CIRCEP.114.001473
   Metzner A, 2012, HEART RHYTHM, V9, P1380, DOI 10.1016/j.hrthm.2012.03.059
   Nagase T, 2019, PACE, V42, P837, DOI 10.1111/pace.13692
   Nagase T, 2018, CIRC J, V82, P1558, DOI 10.1253/circj.CJ-17-1324
   Natale A, 2014, J AM COLL CARDIOL, V64, P647, DOI 10.1016/j.jacc.2014.04.072
   Ouyang FF, 2004, CIRCULATION, V110, P2090, DOI 10.1161/01.CIR.0000144459.37455.EE
   Packer DL, 2019, JAMA-J AM MED ASSOC, V321, P1261, DOI 10.1001/jama.2019.0693
   Packer DL, 2013, J AM COLL CARDIOL, V61, P1713, DOI 10.1016/j.jacc.2012.11.064
   Perrotta L, 2014, J CARDIOVASC ELECTR, V25, P1293, DOI 10.1111/jce.12491
   Providencia R, 2017, EUROPACE, V19, P48, DOI 10.1093/europace/euw080
   Reddy VY, 2015, CIRCULATION, V132, P907, DOI 10.1161/CIRCULATIONAHA.114.014092
   Reddy VY, 2015, J CARDIOVASC ELECTR, V26, P493, DOI 10.1111/jce.12626
   Schmidt B, 2017, CIRC-ARRHYTHMIA ELEC, V10, DOI 10.1161/CIRCEP.117.005767
   Straube F, 2014, EUROPACE, V16, P1434, DOI 10.1093/europace/euu162
   Verma A, 2015, NEW ENGL J MED, V372, P1812, DOI 10.1056/NEJMoa1408288
   Wissner E, 2014, J CARDIOVASC ELECTR, V25, P253, DOI 10.1111/jce.12326
   Zender N, 2019, EUROPACE
NR 53
TC 2
Z9 2
U1 0
U2 4
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD NOV
PY 2019
VL 49
IS 11
BP 991
EP 1001
DI 10.4070/kcj.2019.0226
PG 11
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA JH3VF
UT WOS:000492695400001
PM 31646768
OA Green Published, Other Gold
DA 2021-04-22
ER

PT J
AU Park, S
AF Park, Sungha
TI Ideal Target Blood Pressure in Hypertension
SO KOREAN CIRCULATION JOURNAL
LA English
DT Review
DE Hypertension; Blood pressure; Cardiovascular diseases
ID ISOLATED SYSTOLIC HYPERTENSION; DISEASE; TRIAL; METAANALYSES;
   PROGRESSION; OUTCOMES; RISK
AB In the Systolic Blood Pressure Intervention Trial (SPRINT), intensive blood pressure (BP) lowering was associated with significant reduction in composite cardiovascular (CV) outcomes in hypertension. Subsequently, several meta-analyses have corroborated the findings from SPRINT and these benefits were more prominent in subjects with higher cardiovascular risk at baseline. As such, the recent American College of Cardiology (ACC)/American Heart Association (AHA) hypertension guideline and the European Society of Hypertension (ESH)/European Society of Cardiology (ESC) guideline recommended the lowering of target BP to less than 130/80 mmHg in most hypertensive subjects. However, one should keep in mind the potential harm of too much BP lowering. Post hoc analysis of clinical trials have demonstrated increased cardiovascular mortality and events with too much BP lowering. Therefore, although intensive BP lowering may be beneficial in further reducing CV outcomes, too much reduction below 120/70 mmHg may actually harmful. In conclusion, although intensive BP lowering to achieve target BP below 130/80 mmHg is beneficial in reducing CV outcomes, one should do so cautiously as to avoid adverse events. As such, the first target of anti-hypertensive treatment should be to achieve BP lowering below 140/90 mmHg. Once that target is achieved, one could target BP below 130/80 mmHg keeping in mind to avoid signs of organ hypoperfusion such as orthostatic hypotension, orthostatic dizziness, weakness and serum creatinine elevation.
C1 [Park, Sungha] Yonsei Univ, Severance Cardiovasc Hosp, Div Cardiol, Coll Med, 50-1 Yonsei Ro, Seoul 03722, South Korea.
RP Park, S (corresponding author), Yonsei Univ, Severance Cardiovasc Hosp, Div Cardiol, Coll Med, 50-1 Yonsei Ro, Seoul 03722, South Korea.
EM shpark0530@yuhs.ac
OI Park, Sungha/0000-0001-5362-478X
FU Fire Fighting Safety & 119 Rescue Technology Research and Development
   Program - National Fire Agency [MPSS-FireSafety-2015-80]; Korea Centers
   for Disease Control Prevention [2018ER630200]
FX This research was supported by a research grant from the Fire Fighting
   Safety & 119 Rescue Technology Research and Development Program funded
   by National Fire Agency (grant number: MPSS-FireSafety-2015-80), a
   research grant from the Korea Centers for Disease Control & Prevention
   (grant number: 2018ER630200).
CR [Anonymous], 1974, JAMA-J AM MED ASSOC, V229, P409
   [Anonymous], 1967, J AMER MED ASSOC, V202, P1028, DOI 10.1001/jama.1967.03130240070013
   [Anonymous], 1980, LANCET, V1, P1261
   [Anonymous], 1970, JAMA, V213, P1143
   Bansilal S, 2016, J AM COLL CARDIOL, V68, P789, DOI 10.1016/j.jacc.2016.06.005
   Beckett NS, 2008, NEW ENGL J MED, V358, P1887, DOI 10.1056/NEJMoa0801369
   Black J, 2019, TEAM PERFORM MANAG, V25, P100, DOI 10.1108/TPM-01-2018-0005
   Bohm M, 2017, LANCET, V389, P2226, DOI 10.1016/S0140-6736(17)30754-7
   Chobanian AV, 2003, JAMA-J AM MED ASSOC, V289, P2560, DOI 10.1001/jama.289.19.2560
   Cushman WC, 2010, NEW ENGL J MED, V362, P1575, DOI 10.1056/NEJMoa1001286
   Ettehad D, 2016, LANCET, V387, P957, DOI 10.1016/S0140-6736(15)01225-8
   GREENBERG G, 1985, BMJ-BRIT MED J, V291, P97
   Hansson L, 1998, LANCET, V351, P1755, DOI 10.1016/S0140-6736(98)04311-6
   Hypertension Detection and Follow-up Program Cooperative Group, 1979, JAMA-J AM MED ASSOC, V242, P2562, DOI DOI 10.1001/JAMA.1979.03300230018021
   James PA, 2014, JAMA-J AM MED ASSOC, V311, P1809, DOI 10.1001/jama.2013.284427
   Jatos Study Grp, 2008, HYPERTENS RES, V31, P2115, DOI 10.1291/hypres.31.2115
   Kimm H, 2018, KOREAN CIRC J, V48, P36, DOI 10.4070/kcj.2017.0036
   KLAHR S, 1994, NEW ENGL J MED, V330, P877, DOI 10.1056/NEJM199403313301301
   Lee CJ, 2018, HYPERTENSION, V72, P1285, DOI 10.1161/HYPERTENSIONAHA.118.11787
   Mancia G, 2013, J HYPERTENS, V31, P1281, DOI 10.1097/01.hjh.0000431740.32696.cc
   Messerli FH, 2006, ANN INTERN MED, V144, P884, DOI 10.7326/0003-4819-144-12-200606200-00005
   Ogihara T, 2010, HYPERTENSION, V56, P196, DOI 10.1161/HYPERTENSIONAHA.109.146035
   Pappaccogli M, 2019, HYPERTENSION, V73, P481, DOI 10.1161/HYPERTENSIONAHA.118.12079
   PROBSTFIELD JL, 1991, JAMA-J AM MED ASSOC, V265, P3255
   Roerecke M, 2019, JAMA INTERN MED, V179, P351, DOI 10.1001/jamainternmed.2018.6551
   Ruggenenti P, 2005, LANCET, V365, P939, DOI 10.1016/S0140-6736(05)71082-5
   Staessen JA, 1997, LANCET, V350, P757, DOI 10.1016/S0140-6736(97)05381-6
   Thomopoulos C, 2016, J HYPERTENS, V34, P1451, DOI 10.1097/HJH.0000000000000972
   Thomopoulos C, 2016, J HYPERTENS, V34, P613, DOI 10.1097/HJH.0000000000000881
   Wang JG, 2000, ARCH INTERN MED, V160, P211, DOI 10.1001/archinte.160.2.211
   Whelton PK, 2018, HYPERTENSION, V71, pE13, DOI [10.1161/HYP.0000000000000065, 10.1161/HYP.0000000000000066]
   Williams B, 2018, EUR HEART J, V39, P3021, DOI 10.1093/eurheartj/ehy339
   Williamson JD, 2016, JAMA-J AM MED ASSOC, V315, P2673, DOI 10.1001/jama.2016.7050
   Wright JT, 2015, NEW ENGL J MED, V373, P2103, DOI 10.1056/NEJMoa1511939
   Wright JT, 2002, JAMA-J AM MED ASSOC, V288, P2421, DOI 10.1001/jama.288.19.2421
   Xie XF, 2016, LANCET, V387, P435, DOI 10.1016/S0140-6736(15)00805-3
NR 36
TC 6
Z9 6
U1 0
U2 2
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD NOV
PY 2019
VL 49
IS 11
BP 1002
EP 1009
DI 10.4070/kcj.2019.0261
PG 8
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA JH3VF
UT WOS:000492695400002
PM 31646769
OA Green Published
DA 2021-04-22
ER

PT J
AU Yang, HM
   Yoon, MH
   Lim, HS
   Seo, KW
   Choi, BJ
   Choi, SY
   Hwang, GS
   Tahk, SJ
AF Yang, Hyoung-Mo
   Yoon, Myeong-Ho
   Lim, Hong-Seok
   Seo, Kyoung-Woo
   Choi, Byoung-Joo
   Choi, So-Yeon
   Hwang, Gyo-Seung
   Tahk, Seung-Jea
TI Lipid-Core Plaque Assessed by Near-Infrared Spectroscopy and Procedure
   Related Microvascular Injury
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Percutaneous coronary intervention; Coronary artery disease;
   Microvessel; Near-infrared spectroscopy
ID PERCUTANEOUS CORONARY INTERVENTION; EXPERT CONSENSUS DOCUMENT;
   INTRAVASCULAR ULTRASOUND; MYOCARDIAL-INFARCTION; DISTAL EMBOLIZATION;
   TROPONIN ELEVATION; INDEX; MICROCIRCULATION; CHOLESTEROL; ANGIOGRAPHY
AB Background and Objectives: Microvascular damage due to distal embolization during percutaneous coronary intervention (PCI) is an important cause of periprocedural myocardial infarction. We assessed the lipid-core plaque using near-infrared spectroscopy (NIRS) and microvascular dysfunction invasively with the index of microcirculatory resistance (IMR) and evaluated their relationship.
   Methods: This study is pilot retrospective observational study. We analyzed 39 patients who performed NIRS before and after PCI, while fractional flow reserve, thermo-dilution coronary flow reserve (CFR) and IMR were measured after PCI. The maximum value of lipid core burden index (LCBI) for any of the 4-mm segments at the culprit lesion (culprit LCBI4mm) was calculated at the culprit lesion. We divided the patients into 2 groups using a cutoff of culprit LCBI4mm >= 500.
   Results: Mean pre-PCI LCBI was 333 +/- 196 and mean post-PCI IMR was 20 +/- 14 U. Post-PCI IMR was higher (15.6 +/- 7.3 vs. 42.6 +/- 17.6 U, p<0.001) and post-PCI CFR was lower (3.7 +/- 2.2 vs. 2.1 +/- 1.0, p=0.029) in the high LCBI group. Pre-PCI LCBI was positively correlated with post-PCI IMR (rho=0.358, p=0.025) and negatively correlated with post-PCI CFR (rho=-0.494, p=0.001). The incidence of microvascular dysfunction (IMR >= 25 U) was higher in the high LCBI group (9.4% vs. 85.7%, p<0.001). However, there were no significant differences in the incidences of creatine Kinase-MB (9.4% vs. 14.3%, p=0.563) and troponin-I elevation (12.5% vs. 14.3%, p=1.000).
   Conclusions: A large lipid-core plaque at the 'culprit' lesion is observed higher incidence of post-PCI microvascular dysfunction after PCI. Prospective study with adequate subject numbers will be needed.
C1 [Yang, Hyoung-Mo; Yoon, Myeong-Ho; Lim, Hong-Seok; Seo, Kyoung-Woo; Choi, Byoung-Joo; Choi, So-Yeon; Hwang, Gyo-Seung; Tahk, Seung-Jea] Ajou Univ, Dept Cardiol, Sch Med, 164 World Cup Ro, Suwon 16499, South Korea.
RP Yoon, MH (corresponding author), Ajou Univ, Dept Cardiol, Sch Med, 164 World Cup Ro, Suwon 16499, South Korea.
EM yoonmh65@hanmail.net
OI Yang, Hyoung-Mo/0000-0003-3602-9772; Lim, Hong-Seok/0000-0002-3127-2071
CR Ahmed JM, 2000, CIRCULATION, V102, P7, DOI 10.1161/01.CIR.102.1.7
   Brilakis ES, 2012, CATHETER CARDIO INTE, V80, P1157, DOI 10.1002/ccd.23507
   Claessen BE, 2012, JACC-CARDIOVASC IMAG, V5, pS111, DOI 10.1016/j.jcmg.2011.11.018
   Cuisset T, 2008, J AM COLL CARDIOL, V51, P1060, DOI 10.1016/j.jacc.2007.11.059
   Fearon WF, 2003, CIRCULATION, V108, P2198, DOI 10.1161/01.CIR.0000099521.31396.9D
   Fearon WF, 2003, CIRCULATION, V107, P3129, DOI 10.1161/01.CIR.0000080700.98607.D1
   Goldstein JA, 2011, CIRC-CARDIOVASC INTE, V4, P429, DOI 10.1161/CIRCINTERVENTIONS.111.963264
   Henriques JPS, 2002, EUR HEART J, V23, P1112, DOI 10.1053/euhj.2001.3035
   Herrmann J, 2005, EUR HEART J, V26, P2493, DOI 10.1093/eurheartj/ehi455
   Hong YJ, 2011, EUR HEART J, V32, P2059, DOI 10.1093/eurheartj/ehp034
   Idris H, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.114.001086
   Jaross W, 1999, ATHEROSCLEROSIS, V147, P327, DOI 10.1016/S0021-9150(99)00203-8
   Kim MS, 2019, KOREAN CIRC J, V49, P46, DOI 10.4070/kcj.2018.0351
   Kobayashi Y, 2014, CIRC J, V78, P1021, DOI 10.1253/circj.CJ-14-0364
   Lee BK, 2016, KOREAN CIRC J, V46, P472, DOI 10.4070/kcj.2016.46.4.472
   Lee SY, 2009, JACC-CARDIOVASC INTE, V2, P65, DOI 10.1016/j.jcin.2008.08.022
   Lee T, 2011, CIRC-CARDIOVASC INTE, V4, P378, DOI 10.1161/CIRCINTERVENTIONS.111.962506
   Mintz GS, 2001, J AM COLL CARDIOL, V37, P1478, DOI 10.1016/S0735-1097(01)01175-5
   Moussa ID, 2013, J AM COLL CARDIOL, V62, P1563, DOI 10.1016/j.jacc.2013.08.720
   Neumeister V, 2002, ATHEROSCLEROSIS, V165, P251, DOI 10.1016/S0021-9150(02)00279-4
   Ng MKC, 2006, CIRCULATION, V113, P2054, DOI 10.1161/CIRCULATIONAHA.105.603522
   Prasad A, 2006, J AM COLL CARDIOL, V48, P1765, DOI 10.1016/j.jacc.2006.04.102
   Prati F, 2003, CIRCULATION, V107, P2320, DOI 10.1161/01.CIR.0000066695.24697.07
   Schuurman AS, 2018, EUR HEART J, V39, P295, DOI 10.1093/eurheartj/ehx247
   Selvanayagam JB, 2005, CIRCULATION, V111, P1027, DOI 10.1161/01.CIR.0000156328.28485.AD
   Stone GW, 2015, JACC-CARDIOVASC INTE, V8, P927, DOI 10.1016/j.jcin.2015.01.032
   Thygesen K, 2012, CIRCULATION, V126, P2020, DOI 10.1161/CIR.0b013e31826e1058
   Yamada R, 2010, CIRC J, V74, P1658, DOI 10.1253/circj.CJ-09-0992
NR 28
TC 3
Z9 3
U1 1
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD NOV
PY 2019
VL 49
IS 11
BP 1010
EP 1018
DI 10.4070/kcj.2019.0072
PG 9
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA JH3VF
UT WOS:000492695400003
PM 31456364
OA Green Published, Other Gold
DA 2021-04-22
ER

PT J
AU Kim, JH
   Choi, W
   Kim, KC
   Nam, CW
   Hong, BK
   Kim, JH
   Jeon, DS
   Bae, JW
   Kim, SH
   Moon, KW
   Cho, BR
   Kim, DI
   Jang, JS
AF Kim, Jin-Ho
   Choi, Woonggil
   Kim, Ki-Chang
   Nam, Chang-Wook
   Hong, Bum-Kee
   Kim, June-Hong
   Jeon, Doo Soo
   Bae, Jang-Whan
   Kim, Sang-Hyun
   Moon, Keon-Woong
   Cho, Byung-Ryul
   Kim, Doo Il
   Jang, Jae-Sik
TI The Current Status of Intervention for Intermediate Coronary Stenosis in
   the Korean Percutaneous Coronary Intervention (K-PCI) Registry
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Coronary artery disease; Percutaneous coronary intervention; Fractional
   flow reserve; myocardial
ID FRACTIONAL FLOW RESERVE; INTRAVASCULAR ULTRASOUND; ARTERY-DISEASE;
   FUNCTIONAL-SIGNIFICANCE; CLINICAL-OUTCOMES; 2014 COHORT; FOLLOW-UP;
   ANGIOGRAPHY; ASSOCIATION; GUIDELINES
AB Background and objectives: Intermediate coronary lesion that can be under- or overestimated by visual estimation frequently results in stenting of functionally nonsignificant lesions or deferral of percutaneous coronary intervention (PCI) of significant lesions inappropriately. We evaluated current status of PCI for intermediate lesions from a standardized database in Korea.
   Methods: We analyzed the Korean percutaneous coronary intervention (K-PCI) registry data which collected a standardized PCI database of the participating hospitals throughout the country from January 1, 2014, through December 31, 2014. Intermediate lesion was defined as a luminal narrowing between 50% and 70% by visual estimation and then compared whether the invasive physiologic or imaging study was performed or not.
   Results: Physiology-guided PCI for intermediate lesions was performed in 16.8% for left anterior descending artery (LAD), 9.8% for left circumflex artery (LCX), 13.2% for right coronary artery (RCA). PCI was more frequently performed using intravascular ultrasound (IVUS) than using fractional flow reserve (FFR) for coronary artery segments (27.7% vs. 13.9% for LAD, 32.9% vs. 8.1% for LCX, and 33.8% vs. 10.8% for RCA). In accordance with or without FFR, PCI for intermediate lesions was more frequently performed in the hospitals with available FFR device than without FFR, especially in left main artery (LM), proximal LAD lesion (40.9% vs. 5.9% for LM, 24.6% vs 7.6% for proximal LAD).
   Conclusions: These data provide the current PCI practice pattern with the use of FFR and IVUS in intermediate lesion. More common use of FFR for intermediate lesion should be encouraged.
C1 [Kim, Jin-Ho; Choi, Woonggil; Kim, Ki-Chang] Konkuk Univ, Dept Cardiol, Sch Med, Chungju, South Korea.
   [Nam, Chang-Wook] Keimyung Univ, Dept Internal Med, Div Cardiol, Dongsan Hosp, Daegu, South Korea.
   [Hong, Bum-Kee] Yonsei Univ, Div Cardiol, Coll Med, Gangnam Severance Hosp, Seoul, South Korea.
   [Kim, June-Hong] Pusan Natl Univ, Dept Cardiol, Yangsan Hosp, Busan, South Korea.
   [Jeon, Doo Soo] Catholic Univ Korea, Incheon St Marys Hosp, Dept Cardiol, Incheon, South Korea.
   [Bae, Jang-Whan] Chungbuk Natl Univ, Dept Internal Med, Coll Med, Cheongju, South Korea.
   [Kim, Sang-Hyun] Seoul Natl Univ, Seoul Metropolitan Govt, Boramae Med Ctr, Div Cardiol,Dept Internal Med,Coll Med, Seoul, South Korea.
   [Moon, Keon-Woong] Catholic Univ Korea, St Vincents Hosp, Div Cardiol, Suwon, South Korea.
   [Cho, Byung-Ryul] Kangwon Natl Univ, Dept Internal Med, Div Cardiol, Sch Med,Kangwon Natl Univ Hosp, Chunchon, South Korea.
   [Kim, Doo Il] Inje Univ, Coll Med, Div Cardiol, Heaundae Paik Hosp,Univ Inje, Busan, South Korea.
   [Jang, Jae-Sik] Univ Inje, Div Cardiol, Coll Med, Busan Paik Hosp, 75 Bokji Ro, Busan 47392, South Korea.
RP Jang, JS (corresponding author), Univ Inje, Div Cardiol, Coll Med, Busan Paik Hosp, 75 Bokji Ro, Busan 47392, South Korea.
EM jsjang71@gmail.com
OI Choi, Woong Gil/0000-0002-2235-8041; Moon,
   Keon-Woong/0000-0003-2726-3209; Nam, Chang-Wook/0000-0002-3370-5774
FU Korean Society of Cardiology; Korean Society of Interventional
   Cardiology
FX This study was co-sponsored by the Korean Society of Cardiology and the
   Korean Society of Interventional Cardiology.
CR Ahn JM, 2017, CIRCULATION, V135, P2241, DOI 10.1161/CIRCULATIONAHA.116.024433
   Chen ZW, 2016, BMC CARDIOVASC DISOR, V16, DOI 10.1186/s12872-015-0178-y
   Cho YK, 2015, EUROINTERVENTION, V11, P163, DOI 10.4244/EIJV11I2A30
   Dattilo PB, 2012, J AM COLL CARDIOL, V60, P2337, DOI 10.1016/j.jacc.2012.08.990
   De Bruyne B, 2014, NEW ENGL J MED, V371, P1208, DOI 10.1056/NEJMoa1408758
   Fearon WF, 2018, CIRCULATION, V137, P480, DOI 10.1161/CIRCULATIONAHA.117.031907
   Fearon WF, 2010, CIRCULATION, V122, P2545, DOI 10.1161/CIRCULATIONAHA.109.925396
   Gwon HC, 2017, KOREAN CIRC J, V47, P320, DOI 10.4070/kcj.2017.0070
   Han JK, 2014, CARDIOLOGY, V127, P256, DOI 10.1159/000356480
   Hong SJ, 2015, JAMA-J AM MED ASSOC, V314, P2155, DOI 10.1001/jama.2015.15454
   Inohara T, 2014, JACC-CARDIOVASC INTE, V7, P1000, DOI 10.1016/j.jcin.2014.06.006
   Jang JS, 2017, KOREAN CIRC J, V47, P328, DOI 10.4070/kcj.2017.0071
   Jang JS, 2016, KOREAN CIRC J, V46, P622, DOI 10.4070/kcj.2016.46.5.622
   Jang JS, 2014, JACC-CARDIOVASC INTE, V7, pE27, DOI 10.1016/j.jcin.2013.09.013
   KATRITSIS D, 1991, CLIN CARDIOL, V14, P20, DOI 10.1002/clc.4960140106
   Kolh P, 2014, EUR J CARDIO-THORAC, V46, P517, DOI [10.1093/eurheartj/ehu278, 10.1093/ejcts/ezu366]
   Levine GN, 2011, J AM COLL CARDIOL, V58, pE44, DOI 10.1016/j.jacc.2011.08.007
   Nam CW, 2010, JACC-CARDIOVASC INTE, V3, P812, DOI 10.1016/j.jcin.2010.04.016
   Parise H, 2011, AM J CARDIOL, V107, P374, DOI 10.1016/j.amjcard.2010.09.030
   Park SJ, 2012, JACC-CARDIOVASC INTE, V5, P1029, DOI 10.1016/j.jcin.2012.07.007
   Patel MR, 2017, J AM COLL CARDIOL, V69, P2212, DOI 10.1016/j.jacc.2017.02.001
   Pijls NHJ, 2007, J AM COLL CARDIOL, V49, P2105, DOI 10.1016/j.jacc.2007.01.087
   Pothineni NV, 2016, J AM COLL CARDIOL, V67, P732, DOI 10.1016/j.jacc.2015.11.042
   Safi Morteza, 2018, Acta Biomed, V89, P378, DOI 10.23750/abm.v89i3.5605
   Tanaka N, 2019, J CARDIOL, V73, P38, DOI 10.1016/j.jjcc.2018.05.018
   Tonino PAL, 2009, NEW ENGL J MED, V360, P213, DOI 10.1056/NEJMoa0807611
   TRASK N, 1984, J AM COLL CARDIOL, V3, P1145, DOI 10.1016/S0735-1097(84)80171-0
   Witzenbichler B, 2014, CIRCULATION, V129, P463, DOI 10.1161/CIRCULATIONAHA.113.003942
   Xaplanteris P, 2018, NEW ENGL J MED, V379, P250, DOI 10.1056/NEJMoa1803538
NR 29
TC 3
Z9 3
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD NOV
PY 2019
VL 49
IS 11
BP 1022
EP 1032
DI 10.4070/kcj.2019.0074
PG 11
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA JH3VF
UT WOS:000492695400005
PM 31190480
OA Green Published, Other Gold
DA 2021-04-22
ER

PT J
AU Cho, SMJ
   Lee, H
   Pyun, WB
   Kim, HC
AF Cho, So Mi Jemma
   Lee, Hokyou
   Pyun, Wook Bum
   Kim, Hyeon Chang
TI Differential Control Rate of Systolic and Diastolic Blood Pressure among
   Korean Adults with Hypertension: the Sixth Korean National Health and
   Nutrition Examination Survey, 2013-2015 (KNHANES VI)
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Hypertension; Blood pressure; Chronic disease
ID RISK; MIDDLE; PREVALENCE; MENOPAUSE; AWARENESS; DISEASE
AB Background and Objectives: Discrepancy in blood pressure (BP) control rate may be owed to different risk factors associated with elevated systolic and diastolic BP (SBP and DBP).
   Methods: In a nationally representative survey of Korean population with BP measurements, a total of 5,100 participants with hypertension was included in the analyses. Three separate types of control rates were calculated: SBP, DBP, and (combined) S&DBP among all participants with hypertension and participants with treated hypertension, separately. Control rates were compared across sex and age groups. Multivariable logistic regression was used to identify demographic factors associated with SBP, DBP, and S&DBP control rates, separately.
   Results: In total, SBP, DBP, and S&DBP control rates were 63.0%, 63.7%, and 42.5% among all hypertension patients, and 77.5%, 87.4%, and 71.6% among treated hypertension patients. Men aged 40-49 years with hypertension and 30-39 years treated for hypertension had the highest SBP control rate (74.6% and 96.2%), which decreased by older age. Inversely, DBP control rate progressively increased with older age. SBP control rate among women with hypertension was the highest in 40-49 years (67.0%) but without linear trend by age group. Interestingly, both combined and DBP control rates were noticeably low among women aged 50-59 years. Women with body mass index >= 25 were at higher odds of having controlled SBP. Lower DBP control rate was observed in men with lower education level, higher household income, and heavy drinkers.
   Conclusions: Separate examination of control rates demonstrated different sex- and age-differential trends, which would have been overlooked in combined control rates.
C1 [Cho, So Mi Jemma] Yonsei Univ, Dept Publ Hlth, Grad Sch, Seoul, South Korea.
   [Lee, Hokyou; Kim, Hyeon Chang] Yonsei Univ, Dept Prevent Med, Coll Med, 50-1 Yonsei Ro, Seoul 03722, South Korea.
   [Lee, Hokyou] Yonsei Univ, Dept Internal Med, Coll Med, Seoul, South Korea.
   [Pyun, Wook Bum] Ewha Womans Univ, Div Cardiol, Mokdong Hosp, Seoul, South Korea.
   [Kim, Hyeon Chang] Yonsei Univ, Cardiovasc & Metab Dis Etiol Res Ctr, Coll Med, Seoul, South Korea.
RP Kim, HC (corresponding author), Yonsei Univ, Dept Prevent Med, Coll Med, 50-1 Yonsei Ro, Seoul 03722, South Korea.
EM hckim@yuhs.ac
RI ; Kim, Hyeon Chang/F-8796-2019
OI Cho, So Mi/0000-0003-2460-3335; Kim, Hyeon Chang/0000-0001-7867-1240;
   Lee, Hokyou/0000-0002-5034-8422; Pyun, Wook Bum/0000-0002-6377-0411
CR Adab P, 2018, BMJ-BRIT MED J, V360, DOI 10.1136/bmj.k1274
   Bavishi C, 2016, AM J MED, V129, P1251, DOI 10.1016/j.amjmed.2016.08.032
   Bohm M, 2017, LANCET, V389, P2226, DOI 10.1016/S0140-6736(17)30754-7
   Chirinos JA, 2009, ARCH INTERN MED, V169, P580, DOI 10.1001/archinternmed.2008.611
   Chow CK, 2013, JAMA-J AM MED ASSOC, V310, P959, DOI 10.1001/jama.2013.184182
   Egan BM, 2010, JAMA-J AM MED ASSOC, V303, P2043, DOI 10.1001/jama.2010.650
   FANG J, 1995, HYPERTENSION, V26, P377, DOI 10.1161/01.HYP.26.3.377
   Grotto I, 2008, CURR OPIN CARDIOL, V23, P335, DOI 10.1097/HCO.0b013e3283021c70
   Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143
   Hamer M, 2012, J CLIN ENDOCR METAB, V97, P2482, DOI 10.1210/jc.2011-3475
   Hense HW, 2002, NEPHROL DIAL TRANSPL, V17, P1547, DOI 10.1093/ndt/17.9.1547
   Izumi Y, 2007, AM J HYPERTENS, V20, P1045, DOI 10.1016/j.amjhyper.2007.04.019
   James PA, 2014, JAMA-J AM MED ASSOC, V311, P1809, DOI 10.1001/jama.2013.284427
   Kim W, 2008, SUBST USE MISUSE, V43, P1078, DOI 10.1080/10826080801914212
   Kim Y, 2014, EPIDEMIOL HEALTH, V36, DOI 10.4178/epih/e2014002
   Korean Society Hypertension (KSH), 2018, Clin Hypertens, V24, P13, DOI 10.1186/s40885-018-0098-0
   Kweon S, 2014, INT J EPIDEMIOL, V43, P69, DOI 10.1093/ije/dyt228
   Lee CJ, 2018, HYPERTENSION, V72, P1285, DOI 10.1161/HYPERTENSIONAHA.118.11787
   Lee H, 2019, KOREAN CIRC J, V49, P514, DOI 10.4070/kcj.2018.0358
   Leonetti G, 2000, J HYPERTENS, V18, pS13
   Lloyd-Jones DM, 2000, HYPERTENSION, V36, P594, DOI 10.1161/01.HYP.36.4.594
   Maas AHEM, 2009, NETH HEART J, V17, P68, DOI 10.1007/BF03086220
   Nielsen WB, 1997, AM J HYPERTENS, V10, P634, DOI 10.1016/S0895-7061(96)00505-5
   Oh JY, 2007, KOREAN J FAM MED, V28, P532
   Shin Jinho, 2015, Clin Hypertens, V21, P1, DOI 10.1186/s40885-014-0012-3
   Shin Jinho, 2015, Clin Hypertens, V21, P2, DOI 10.1186/s40885-014-0013-2
   Stanaway JD, 2018, LANCET, V392, P1923, DOI [10.1016/S0140-6736(18)32225-6, 10.1016/s0140-6736(18)32225-6]
   Whelton PK, 2018, HYPERTENSION, V71, pE13, DOI [10.1161/HYP.0000000000000065, 10.1161/HYP.0000000000000066]
   World Health Organization, 2000, ASIA PACIFIC PERSPEC
NR 29
TC 5
Z9 5
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD NOV
PY 2019
VL 49
IS 11
BP 1035
EP 1048
DI 10.4070/kcj.2019.0049
PG 14
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA JH3VF
UT WOS:000492695400007
PM 31190479
OA Other Gold, Green Published
DA 2021-04-22
ER

PT J
AU Yun, KH
   Cho, JY
   Rhee, SJ
   Oh, SK
AF Yun, Kyeong Ho
   Cho, Jae Young
   Rhee, Sang Jae
   Oh, Seok Kyu
TI Temporal Variability of Platelet Reactivity in Patients Treated with
   Clopidogrel or Ticagrelor
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Platelet function tests; Clopidogrel; Ticagrelor
ID PERCUTANEOUS CORONARY INTERVENTION; ELUTING STENT IMPLANTATION;
   RANDOMIZED-TRIAL; ADAPT-DES; TIME; THERAPY
AB Background and Objectives: The degree of antiplatelet response to P2Y12 inhibitors has been associated with clinical outcomes. The aim of this study was to test the variability of platelet reactivity over time among patients treated with clopidogrel or ticagrelor.
   Methods: A single-center cohort of acute coronary syndrome patients that underwent percutaneous coronary intervention (PCI) was analyzed. Platelet reactivity was measured at baseline, 48 hours after PCI, 1 month, and 6 months after clopidogrel (n=79) or ticagrelor (n=93) treatment. High on-treatment platelet reactivity (HPR) was defined as >= 47 U, assessed by multiple electrode platelet aggregometry.
   Results: Platelet reactivity ill the clopidogrel group increased over time, 38.2 +/- 21.7 U at 48 hours, 41.4 +/- 22.3 U at 1 month, and 44.7 +/- 25.5 U at 6 months (p=0.018, 48 hours to 6 months). However, platelet reactivity in the ticagrelor group was not significantly changed, 21.4 +/- 12.6 U at 48 hours, 20.0 +/- 12.2 U at 1 month, and 22.8 +/- 13.8 U at 6 months (p=0.392). A platelet reactivity change over time of more than 20U was found in 67.1% of the patients with clopidogrel group and 34.4% of ticagrelor group (p<0.001). Between 48 hours and 6 months, 43% of patients changed their responder status in the clopidogrel group, and 13% in the ticagrelor group (p<0.001).
   Conclusions: Although ticagrelor treatment resulted in less temporal variability of platelet reactivity than clopidogrel treatment in terms of HPR, platelet reactivity varied over time in a significant proportion of patients.
C1 [Yun, Kyeong Ho; Cho, Jae Young; Rhee, Sang Jae; Oh, Seok Kyu] Wonkwang Univ Hosp, Reg Cardiocerebrovasc Ctr, Dept Cardiovasc Med, 895 Muwang Ro, Iksan 54538, South Korea.
RP Rhee, SJ (corresponding author), Wonkwang Univ Hosp, Reg Cardiocerebrovasc Ctr, Dept Cardiovasc Med, 895 Muwang Ro, Iksan 54538, South Korea.
EM shururuka73@gmail.com
RI Cho, Jae Young/AAW-7137-2020
OI Cho, Jae Young/0000-0001-7972-6223; Yun, Kyeong Ho/0000-0003-4911-8854;
   Oh, Seok Kyu/0000-0001-7545-0143
CR Breet NJ, 2010, JAMA-J AM MED ASSOC, V303, P754, DOI 10.1001/jama.2010.181
   Campo G, 2011, J AM COLL CARDIOL, V57, P2474, DOI 10.1016/j.jacc.2010.12.047
   Deharo P, 2016, PLATELETS, V27, P791, DOI 10.1080/09537104.2016.1190006
   Dorsam RT, 2004, J CLIN INVEST, V113, P340, DOI 10.1172/JCI200420986
   Gurbel PA, 2009, CIRCULATION, V120, P2577, DOI 10.1161/CIRCULATIONAHA.109.912550
   Hochholzer W, 2014, J AM COLL CARDIOL, V64, P361, DOI 10.1016/j.jacc.2014.03.051
   Nuhrenberg TG, 2015, THROMB HAEMOSTASIS, V114, P1020, DOI 10.1160/TH15-03-0257
   Park DW, 2011, J AM COLL CARDIOL, V58, P2630, DOI 10.1016/j.jacc.2011.08.057
   Patrono C, 2004, CHEST, V126, p234S, DOI 10.1378/chest.126.3_suppl.234S
   Price MJ, 2011, JAMA-J AM MED ASSOC, V305, P1097, DOI 10.1001/jama.2011.290
   Sibbing D, 2009, J AM COLL CARDIOL, V53, P849, DOI 10.1016/j.jacc.2008.11.030
   Stone GW, 2013, LANCET, V382, P614, DOI 10.1016/S0140-6736(13)61170-8
   Suh JW, 2011, J AM COLL CARDIOL, V57, P280, DOI 10.1016/j.jacc.2010.08.631
   Tantry US, 2013, J AM COLL CARDIOL, V62, P2261, DOI 10.1016/j.jacc.2013.07.101
   Trenk D, 2008, J AM COLL CARDIOL, V51, P1925, DOI 10.1016/j.jacc.2007.12.056
   Trenk D, 2012, J AM COLL CARDIOL, V59, P2159, DOI 10.1016/j.jacc.2012.02.026
   Yun KH, 2010, INT HEART J, V51, P13, DOI 10.1536/ihj.51.13
NR 17
TC 5
Z9 5
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD NOV
PY 2019
VL 49
IS 11
BP 1052
EP 1061
DI 10.4070/kcj.2019.0098
PG 10
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA JH3VF
UT WOS:000492695400009
PM 31347319
OA Green Published, Other Gold
DA 2021-04-22
ER

PT J
AU Kim, C
   Sung, J
   Lee, JH
   Kim, WS
   Lee, GJ
   Jee, S
   Jung, IY
   Rah, UW
   Kim, BO
   Choi, KH
   Kwon, BS
   Yoo, SD
   Bang, HJ
   Shin, HI
   Kim, YW
   Jung, H
   Kim, EJ
   Lee, JH
   Jung, IH
   Jung, JS
   Lee, JY
   Han, JY
   Han, EY
   Won, YH
   Han, W
   Baek, S
   Joa, KL
   Lee, SJ
   Kim, AR
   Lee, SY
   Kim, J
   Choi, HE
   Lee, BJ
   Kim, S
AF Kim, Chul
   Sung, Jidong
   Lee, Jong Hwa
   Kim, Won-Seok
   Lee, Goo Joo
   Jee, Sungju
   Jung, Il-Young
   Rah, Ueon Woo
   Kim, Byung Ok
   Choi, Kyoung Hyo
   Kwon, Bum Sun
   Yoo, Seung Don
   Bang, Heui Je
   Shin, Hyung-Ik
   Kim, Yong Wook
   Jung, Heeyoune
   Kim, Eung Ju
   Lee, Jung Hwan
   Jung, In Hyun
   Jung, Jae-Seung
   Lee, Jong-Young
   Han, Jae-Young
   Han, Eun Young
   Won, Yu Hui
   Han, Woosik
   Baek, Sora
   Joa, Kyung-Lim
   Lee, Sook Joung
   Kim, Ae Ryoung
   Lee, So Young
   Kim, Jihee
   Choi, Hee Eun
   Lee, Byeong-Ju
   Kim, Soon
TI Clinical Practice Guideline for Cardiac Rehabilitation in Korea:
   Recommendations for Cardiac Rehabilitation and Secondary Prevention
   after Acute Coronary Syndrome
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Acute coronary syndrome; Cardiac rehabilitation; Mortality; Clinical
   practice guideline; Secondary prevention
ID ACUTE MYOCARDIAL-INFARCTION; RANDOMIZED CONTROLLED-TRIAL;
   QUALITY-OF-LIFE; 2-YEAR FOLLOW-UP; ARTERY-DISEASE;
   CARDIOVASCULAR-DISEASE; PHYSICAL-ACTIVITY; HEART-DISEASE; MEDICATION
   ADHERENCE; EXERCISE CAPACITY
AB Though clinical practice guidelines (CPGs) for cardiac rehabilitation (CR) are an effective and widely used treatment method worldwide, they are as yet not widely accepted in Korea. Given that cardiovascular (CV) disease is the second leading cause of death in Korea, it is urgent that CR programs be developed. In 2008, the Government of Korea implemented CR programs at 11 university hospitals as part of its Regional Cardio-Cerebrovascular Center Project, and 3 additional medical facilities will be added in 2019. In addition, owing to the promotion of CR nationwide and the introduction of CR insurance benefits, 40 medical institutions nationwide have begun CR programs even as a growing number of medical institutions are preparing to offer CR. The purpose of this research was to develop evidence-based CPGs to support CR implementation in Korea. This study is based on an analysis of CPGs elsewhere in the world, an extensive literature search, a systematic analysis of multiple randomized control trials, and a CPG management, development, and assessment committee comprised of thirty-three authors-primarily rehabilitation specialists, cardiologists, and thoracic surgeons in 21 university hospitals and 2 general hospitals. Twelve consultants, primarily rehabilitation, sports medicine, and preventive medicine specialists, CPG experts, nurses, physical therapists, clinical nutritionists, and library and information experts participated in the research and development of these CPGs. After the draft guidelines were developed, 3 rounds of public hearings were held with staff members from relevant academic societies and stakeholders, after which the guidelines were further reviewed and modified. CR involves a more cost-effective use of healthcare resources relative to that of general treatments, and the exercise component of CR lowers CV mortality and readmission rates, regardless of the type of coronary heart disease and type and setting of CR. Individualized CR programs should be considered together with various factors, including differences in heart function and lifestyle, and doing so will boost participation and adherence with the CR program, ultimately meeting the final goals of the program, namely reducing the recurrence of myocardial infarction and mortality rates.
C1 [Kim, Chul] Inje Univ, Sanggye Paik Hosp, Dept Rehabil Med, Sch Med, Seoul, South Korea.
   [Sung, Jidong] Sungkyunkwan Univ, Dept Med, Div Cardiol, Sch Med,Heart Vasc Stroke Inst,Samsung Med Ctr, Seoul, South Korea.
   [Lee, Jong Hwa] Dong A Univ, Dept Phys Med & Rehabil, Coll Med, Reg Cardiocerebrovasc Ctr,Dong A Med Ctr, Busan, South Korea.
   [Kim, Won-Seok] Seoul Natl Univ, Dept Rehabil Med, Bundang Hosp, Coll Med, Seongnam, South Korea.
   [Kim, Won-Seok] Gyeonggi Reg Cardiocerebrovasc Ctr, Seongnam, South Korea.
   [Lee, Goo Joo; Bang, Heui Je] Chungbuk Natl Univ, Chungbuk Natl Univ Hosp, Chungbuk Reg Cardiocerebrovasc Ctr, Dept Rehabil Med,Coll Med, 776 1Shunhwan-Ro, Cheongju 28644, South Korea.
   [Jee, Sungju; Jung, Il-Young] Chungnam Natl Univ, Dept Rehabil Med, Daejeon Chungcheong Reg Cardiocerebrovasc Ctr, Chugnam Natl Univ Hosp,Coll Med, Daejeon, South Korea.
   [Rah, Ueon Woo] Ajou Univ, Dept Phys Med & Rehabil, Sch Med, Suwon, South Korea.
   [Kim, Byung Ok; Jung, In Hyun] Inje Univ, Sanggye Paik Hosp, Dept Internal Med, Sch Med, Seoul, South Korea.
   [Choi, Kyoung Hyo] Univ Ulsan, Asan Med Ctr, Dept Rehabil Med, Coll Med, Seoul, South Korea.
   [Kwon, Bum Sun] Dongguk Univ, Dept Rehabil Med, Sch Med, Goyang, South Korea.
   [Yoo, Seung Don] Kyung Hee Univ, Dept Rehabil Med, Coll Med, Seoul, South Korea.
   [Shin, Hyung-Ik] Seoul Natl Univ, Dept Rehabil Med, Childrens Hosp, Coll Med, Seoul, South Korea.
   [Kim, Yong Wook] Yonsei Univ, Dept & Inst Rehabil Med, Coll Med, Seoul, South Korea.
   [Jung, Heeyoune] Natl Traff Injury Rehabil Hosp, Yangpyeong, South Korea.
   [Kim, Eung Ju] Korea Univ, Dept Med, Div Cardiol, Guro Hosp,Coll Med, Seoul, South Korea.
   [Lee, Jung Hwan] Namdarun Rehabil Clin, Yongin, South Korea.
   [Jung, Jae-Seung] Korea Univ, Anam Hosp, Dept Thorac & Cardiovasc Surg, Med Ctr, Seoul, South Korea.
   [Lee, Jong-Young] Sungkyunkwan Univ, Kangbuk Samsung Hosp, Dept Internal Med, Div Cardiol,Sch Med, Seoul, South Korea.
   [Han, Jae-Young] Chonnam Natl Univ, Gwangju Jeonnam Reg Cardiocerebrovasc Ctr, Dept Rehabil Med, Med Sch & Hosp, Gwangju, South Korea.
   [Han, Eun Young; Lee, So Young] Jeju Natl Univ, Jeju Natl Univ Hosp, Dept Rehabil Med, Sch Med, Jeju, South Korea.
   [Won, Yu Hui] Chonbuk Natl Univ, Res Inst Clin Med, Dept Phys Med & Rehabil, Biomed Res Inst,Chonbuk Natl Univ Hosp, Jeonju, South Korea.
   [Han, Woosik] Chungnam Natl Univ Hosp, Dept Thorac Surg, Daejeon, South Korea.
   [Baek, Sora] Kangwon Natl Univ, Kangwon Reg Cardiocerebrovasc Ctr, Kangwon Natl Univ Hosp, Dept Rehabil Med,Sch Med, Chunchon, South Korea.
   [Joa, Kyung-Lim] Inha Univ Hosp, Dept Rehabil Med, Incheon, South Korea.
   [Lee, Sook Joung] Catholic Univ Korea, Daejeon St Marys Hosp, Coll Med, Daejeon, South Korea.
   [Kim, Ae Ryoung] Kyungpook Natl Univ, Dept Rehabil Med, Sch Med, Daegu, South Korea.
   [Kim, Jihee] Wonkwang Univ, Inst Wonkwang Med Sci, Dept Rehabil Med, Sch Med, Iksan, South Korea.
   [Choi, Hee Eun] Inje Univ, Dept Phys Med & Rehabil, Haeundae Paik Hosp, Coll Med, Busan, South Korea.
   [Lee, Byeong-Ju] Pusan Natl Univ Hosp, Dept Rehabil Med, Busan, South Korea.
   [Kim, Soon] Ewha Womans Univ, Res Inst Social Sci, Seoul, South Korea.
RP Lee, GJ (corresponding author), Chungbuk Natl Univ, Chungbuk Natl Univ Hosp, Chungbuk Reg Cardiocerebrovasc Ctr, Dept Rehabil Med,Coll Med, 776 1Shunhwan-Ro, Cheongju 28644, South Korea.
EM rmdr29@cbnuh.or.kr
RI Joa, Kyung-Lim/ABB-3860-2020; Yoo, Seung Don/AAI-8609-2020; ,
   김원석/AAJ-2334-2020; jee, sungju/E-8391-2016
OI Yoo, Seung Don/0000-0003-4513-2560; , 김원석/0000-0002-1199-5707; Choi,
   Kyoung Hyo/0000-0001-9137-3889; Kim, Byung Ok/0000-0002-7920-2750; Jung,
   Il Young/0000-0001-8204-8195; Jung, Jae Seung/0000-0002-8848-4112; KIM,
   YONGWOOK/0000-0002-5234-2454; jee, sungju/0000-0002-9400-9609; Shin,
   Hyungik/0000-0001-8805-3104
FU Ministry of Health and WelfareMinistry of Health, Labour and Welfare,
   Japan [HC17C0063] Funding Source: Medline
CR Abdelhamid R, 2018, CASE REP PERINAT MED, V7, DOI 10.1515/crpm-2018-0003
   Abell B, 2017, SPORTS MED-OPEN, V3, DOI 10.1186/s40798-017-0086-z
   ADES PA, 1992, ARCH INTERN MED, V152, P1033, DOI 10.1001/archinte.152.5.1033
   Ades PA, 2002, AM HEART J, V143, P151, DOI 10.1067/mhj.2002.119379
   Ades PA, 2017, MAYO CLIN PROC, V92, P234, DOI 10.1016/j.mayocp.2016.10.014
   Adler AJ, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD011851.pub2
   Aldahash R, 2016, ACTA MED INT, V3, P185
   Aldcroft SA, 2011, J CARDIOPULM REHABIL, V31, P273, DOI 10.1097/HCR.0b013e318220a7c9
   American Association of Cardiovascular & Pulmonary Rehabilitation, 2013, GUID CARDIA REH SEC
   American College of Sports Medicine, 2013, ACSMS GUIDELINES EXE, V9th
   Anderson L, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008895.pub3
   Anderson L, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007130.pub4
   Anderson L, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD011273.pub2
   Arrigo I, 2008, EUR J CARDIOV PREV R, V15, P306, DOI 10.1097/HJR.0b013e3282f40e01
   Audelin MC, 2008, J CARDIOPULM REHABIL, V28, P163, DOI 10.1097/01.HCR.0000320066.58599.e5
   Balady GJ, 2011, CIRCULATION, V124, P2951, DOI 10.1161/CIR.0b013e31823b21e2
   BALADY GJ, 1992, AM J CARDIOL, V69, P1259, DOI 10.1016/0002-9149(92)91217-R
   Barth J, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006886.pub2
   Bellet RN, 2012, PHYSIOTHERAPY, V98, P277, DOI 10.1016/j.physio.2011.11.003
   Berthold HK, 2006, JAMA-J AM MED ASSOC, V295, P2262, DOI 10.1001/jama.295.19.2262
   British Association for Cardiovascular Prevention and Rehabilitation, 2017, BACPR STANDARDS CORE
   Brown A, 2003, EXERCISE BASED CARDI
   Butler L, 2009, J CARDIOPULM REHABIL, V29, P105, DOI 10.1097/HCR.0b013e31819a01ff
   Canadian Association of Cardiac Rehabilitation, 2009, CAN GUID CARD REH CA
   Cardiac rehabilitation as secondary prevention, 1995, AM FAM PHYSICIAN, V52, P2257
   Carlson JJ, 2000, AM J CARDIOL, V86, P17, DOI 10.1016/S0002-9149(00)00822-5
   Carney RM, 2003, BIOL PSYCHIAT, V54, P241, DOI 10.1016/S0006-3223(03)00111-2
   Cha S, 2018, CIRC J, V82, P2523, DOI 10.1253/circj.CJ-17-1405
   Chan Erick, 2016, Monaldi Arch Chest Dis, V86, P759, DOI 10.4081/monaldi.2016.759
   Chase JAD, 2016, J CARDIOVASC NURS, V31, P357, DOI 10.1097/JCN.0000000000000259
   Chen YC, 2017, EUR J CARDIOVASC NUR, V16, P397, DOI 10.1177/1474515116684407
   Choi HY, 2018, ANN REHABIL MED-ARM, V42, P145, DOI 10.5535/arm.2018.42.1.145
   Chung H, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161268
   Claes J, 2017, EUR J PREV CARDIOL, V24, P244, DOI 10.1177/2047487316675823
   Clark AM, 2011, EUR J CARDIOV PREV R, V18, P761, DOI 10.1177/1741826710397107
   Clark RA, 2015, EUR J PREV CARDIOL, V22, P35, DOI 10.1177/2047487313501093
   Clement J, 2018, MOBILE INTERNET STAT
   Committee of Clinical Practice Guideline of the Korean Society of Lipid and Atherosclerosis, 2018, KOR GUID MAN DYSL
   Coorey GM, 2018, EUR J PREV CARDIOL, V25, P505, DOI 10.1177/2047487317750913
   Cossette S, 2012, NURS RES, V61, P119, DOI 10.1097/NNR.0b013e318240dc6b
   Coulter A, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010523.pub2
   de Lorgeril M, 1999, CIRCULATION, V99, P779, DOI 10.1161/01.CIR.99.6.779
   Nogueira PADS, 2006, INT HEART J, V47, P533, DOI 10.1536/ihj.47.533
   Devi R, 2014, J MED INTERNET RES, V16, DOI 10.2196/jmir.3340
   Dietary Reference Intakes for Koreans 2015, 2016, DIET REF INT KOR 201
   Duncan K, 2002, PROGR CARDIOVASCULAR, V17, P71
   Eckel R. H., 2014, Circulation, V129, pS76, DOI 10.1161/01.cir.0000437740.48606.d1
   Enns JE, 2014, BMC CARDIOVASC DISOR, V14, DOI 10.1186/1471-2261-14-70
   Estruch R, 2018, NEW ENGL J MED, V378, DOI [10.1056/NEJMoa1800389, 10.1056/nejmoa1800389]
   Ferrier S, 2011, EUR J CARDIOV PREV R, V18, P15, DOI 10.1097/HJR.0b013e32833ace0e
   Fletcher GF, 2001, CIRCULATION, V104, P1694, DOI 10.1161/hc3901.095960
   Fors A, 2017, INT J CARDIOL, V249, P42, DOI 10.1016/j.ijcard.2017.08.069
   Fournier M, 2018, BMC CARDIOVASC DISOR, V18, DOI 10.1186/s12872-018-0809-1
   Franck C, 2018, AM J CARDIOL, V121, P1105, DOI 10.1016/j.amjcard.2018.01.017
   Frasure-Smith N, 2000, J PSYCHOSOM RES, V48, P471, DOI 10.1016/S0022-3999(99)00088-4
   Frasure-Smith N, 2006, CAN J PSYCHIAT, V51, P730, DOI 10.1177/070674370605101202
   Gandapur Y, 2016, EUR HEART J-QUAL CAR, V2, P237, DOI 10.1093/ehjqcco/qcw018
   Gandhi S, 2017, CAN J CARDIOL, V33, P219, DOI 10.1016/j.cjca.2016.08.017
   Gehi A, 2005, ARCH INTERN MED, V165, P2508, DOI 10.1001/archinte.165.21.2508
   Germano G, 2012, EUR HEART J, V33, P137
   Glazer Kelly M, 2002, J Cardiopulm Rehabil, V22, P40, DOI 10.1097/00008483-200201000-00006
   Goble AJ, 1999, BEST PRACTICE GUIDEL
   Gong J, 2018, MOL NUTR FOOD RES, V62, DOI 10.1002/mnfr.201700280
   Goodwin L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153271
   Goto Y, 2014, PROG CARDIOVASC DIS, V56, P557, DOI 10.1016/j.pcad.2013.12.001
   Grace SL, 2016, MAYO CLIN PROC, V91, P140, DOI 10.1016/j.mayocp.2015.10.021
   Grace SL, 2011, CAN J CARDIOL, V27, P192, DOI 10.1016/j.cjca.2010.12.007
   Hamm LF, 2011, J CARDIOPULM REHABIL, V31, P2, DOI 10.1097/HCR.0b013e318203999d
   Hansen D, 2009, ACTA CARDIOL, V64, P639, DOI 10.2143/AC.64.5.2042694
   Hanson LC, 2012, PHYSIOTHER RES INT, V17, DOI 10.1002/pri.513
   Harris KM, 2017, J CARDIOPULM REHABIL, V37, P329, DOI 10.1097/HCR.0000000000000242
   Haykowsky M, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-92
   Haynes RB, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000011.pub3
   He F, 2002, J HUM HYPERTENS, V16, P761, DOI 10.1038/sj.jhh.1001459
   Hedback B, 2001, J CARDIOVASC RISK, V8, P153, DOI 10.1097/00043798-200106000-00006
   Heran BS, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001800.pub2
   Heron N, 2016, BRIT J GEN PRACT, V66, pE747, DOI 10.3399/bjgp16X686617
   Hill K, 2016, J CARDIOVASC NURS, V31, P507, DOI 10.1097/JCN.0000000000000294
   HILLEBRAND T, 1995, HERZ KREISLAUF, V27, P346
   Ho PM, 2009, CIRCULATION, V119, P3028, DOI 10.1161/CIRCULATIONAHA.108.768986
   Hollings M, 2017, EUR J PREV CARDIOL, V24, P1242, DOI 10.1177/2047487317713329
   HORGAN J, 1992, BRIT HEART J, V67, P412
   Huang KS, 2015, EUR J PREV CARDIOL, V22, P959, DOI 10.1177/2047487314561168
   Im HW, 2018, ANN REHABIL MED-ARM, V42, P154, DOI 10.5535/arm.2018.42.1.154
   Izawa KP, 2005, AM J PHYS MED REHAB, V84, P313, DOI 10.1097/01.PHM.0000156901.95289.09
   JIHEE KIM, 2016, [Journal of Korea Academia-Industrial cooperation Society, 한국산학기술학회논문지], V17, P464, DOI 10.5762/KAIS.2016.17.9.464
   Jolly K, 1999, BMJ-BRIT MED J, V318, P706
   Karagiannis C, 2017, ANN PHYS REHABIL MED, V60, P58, DOI 10.1016/j.rehab.2016.10.007
   Karmali KN, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007131.pub3
   Kavanagh T, 2003, J AM COLL CARDIOL, V42, P2139, DOI 10.1016/j.jacc.2003.07.028
   Kavanagh T, 2002, CIRCULATION, V106, P666, DOI 10.1161/01.CIR.0000024413.15949.ED
   Kim C, 2015, AM J PHYS MED REHAB, V94, P879, DOI 10.1097/PHM.0000000000000290
   Kim C, 2010, ANN REHABIL MED-ARM, V34, P491
   Kim C, 2012, ANN REHABIL MED-ARM, V36, P262, DOI 10.5535/arm.2012.36.2.262
   Kim C, 2011, ANN REHABIL MED-ARM, V35, P375, DOI 10.5535/arm.2011.35.3.375
   Klainin-Yobas P, 2016, PATIENT EDUC COUNS, V99, P512, DOI 10.1016/j.pec.2015.10.020
   Klompstra LV, 2014, EUR J CARDIOVASC NUR, V13, P388, DOI 10.1177/1474515113512203
   Kokkinos P, 2008, CIRCULATION, V117, P614, DOI 10.1161/CIRCULATIONAHA.107.734764
   Korean Statistical Information Service, 2016, CAUS DEATH STAT
   Kotb A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096581
   Kotwal S, 2012, CIRC-CARDIOVASC QUAL, V5, P808, DOI 10.1161/CIRCOUTCOMES.112.966168
   Kulik A, 2015, CIRCULATION, V131, P927, DOI 10.1161/CIR.0000000000000182
   Lear SA, 2014, CIRC-CARDIOVASC QUAL, V7, P952, DOI 10.1161/CIRCOUTCOMES.114.001230
   Lee H, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187108
   Lee IM, 1999, J NATL CANCER I, V91, P2102, DOI 10.1093/jnci/91.24.2102
   Lee IM, 2005, JAMA-J AM MED ASSOC, V294, P56, DOI 10.1001/jama.294.1.56
   Lee SW, 2015, KOREAN CIRC J, V45, P202, DOI 10.4070/kcj.2015.45.3.202
   Lee YH, 2013, J KOREAN MED SCI, V28, P564, DOI 10.3346/jkms.2013.28.4.564
   Lesperance F, 2000, J PSYCHOSOM RES, V48, P379, DOI 10.1016/S0022-3999(99)00102-6
   Liou K, 2016, HEART LUNG CIRC, V25, P166, DOI 10.1016/j.hlc.2015.06.828
   Loffredo L, 2015, NUTR METAB CARDIOVAS, V25, P354, DOI 10.1016/j.numecd.2015.01.008
   Lynggaard V, 2017, INT J CARDIOL, V236, P65, DOI 10.1016/j.ijcard.2017.02.051
   Maddison R, 2015, EUR J PREV CARDIOL, V22, P701, DOI 10.1177/2047487314535076
   Marazzi G, 2017, AM J CARDIOL, V120, P893, DOI 10.1016/j.amjcard.2017.06.015
   MARK DB, 1987, ANN INTERN MED, V106, P793, DOI 10.7326/0003-4819-106-6-793
   MARK DB, 1991, NEW ENGL J MED, V325, P849, DOI 10.1056/NEJM199109193251204
   McClure T, 2013, J CARDIOPULM REHABIL, V33, P59, DOI 10.1097/HCR.0b013e3182828f71
   McGowan MP, 2009, CURR ATHEROSCLER REP, V11, P470, DOI 10.1007/s11883-009-0070-2
   Mikulic M, 2017, NUMBER MHEALTH APP D
   Murphy BM, 2015, ANXIETY DEPRESSION P
   Myung SK, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f10
   National Heart Foundation of Australia and the Cardiac Society of Australia and New Zealand, 2012, RED RISK HEART DIS E
   National Institute for Health and Care Excellence, 2013, MYOC INF CARD REH PR
   Nohara R, 2014, CIRC J, V78, P2022, DOI 10.1253/circj.CJ-66-0094
   김세윤, 2012, [The Korea Journal of Sports Medicine, 대한스포츠의학회지], V30, P85, DOI 10.5763/kjsm.2012.30.2.85
   Oldridge N, 2012, FUTUR CARDIOL, V8, P729, DOI 10.2217/FCA.12.34
   Pack QR, 2013, CIRCULATION, V127, P349, DOI 10.1161/CIRCULATIONAHA.112.121996
   Pandey A, 2015, CIRC-HEART FAIL, V8, P33, DOI 10.1161/CIRCHEARTFAILURE.114.001615
   Pasquali SK, 2001, AM HEART J, V142, P748, DOI 10.1067/mhj.2001.119134
   Pew Research Center, 2016, SMARTPHONE OWNERSHIP
   Piepoli MF, 2016, EUR HEART J, V37, P2315, DOI 10.1093/eurheartj/ehw106
   Price J. A. D., 2012, THESIS
   Reid RD, 2012, EUR J PREV CARDIOL, V19, P1357, DOI 10.1177/1741826711422988
   Reid RD, 2012, EUR J PREV CARDIOL, V19, P161, DOI 10.1177/1741826711400519
   Rice VH, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001188.pub4
   RICH MW, 1992, AM J MED, V92, P7, DOI 10.1016/0002-9343(92)90008-Y
   Richards SL, 2017, ENVIRONMENTS, V4, DOI 10.3390/environments4020037
   Rigotti NA, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001837.pub2
   Rizos EC, 2017, CURR CARDIOL REP, V19, DOI 10.1007/s11886-017-0856-8
   Sacks FM, 2001, NEW ENGL J MED, V344, P3, DOI 10.1056/NEJM200101043440101
   Scottish Intercollegiate Guidelines Network (SIGN), 2017, CARD REH NAT CLIN GU
   Shepherd CW, 2012, INT J NURS STUD, V49, P755, DOI 10.1016/j.ijnurstu.2011.11.019
   Shibeshi WA, 2007, J AM COLL CARDIOL, V49, P2021, DOI 10.1016/j.jacc.2007.03.007
   Shin HY, 2016, J KOREAN MED ASSOC, V59, P221, DOI 10.5124/jkma.2016.59.3.221
   SINGH RB, 1992, BRIT MED J, V304, P1015, DOI 10.1136/bmj.304.6833.1015
   Singh RB, 2002, LANCET, V360, P1455, DOI 10.1016/S0140-6736(02)11472-3
   Smith SC, 2011, CIRCULATION, V124, P2458, DOI 10.1161/CIR.0b013e318235eb4d
   Sniehotta FF, 2006, BRIT J HEALTH PSYCH, V11, P23, DOI 10.1348/135910705X43804
   Sofi F, 2010, AM J CLIN NUTR, V92, P1189, DOI 10.3945/ajcn.2010.29673
   Stead LF, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009670.pub3
   Steering Committee for Clinical Practice Guideline, 2010, KOR APPR GUID RES EV
   Sumner J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177658
   Tallaj J A, 2001, J Cardiopulm Rehabil, V21, P221, DOI 10.1097/00008483-200107000-00005
   Taylor RS, 2004, AM J MED, V116, P682, DOI 10.1016/j.amjmed.2004.01.009
   ter Hoeve N, 2018, INT J CARDIOL, V255, P221, DOI 10.1016/j.ijcard.2017.12.015
   ter Hoeve N, 2015, PHYS THER, V95, P167, DOI 10.2522/ptj.20130509
   The British Association for Cardiovascular Prevention and Rehabilitation, 2012, BACPR STAND COR COMP
   The Committee of Hypertension Clinical Guideline of Korean Academy of Medical Sciences, 2018, EV BAS REC HYP PRIM
   Threapleton DE, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6879
   Tierney S, 2011, HEALTH PSYCHOL, V30, P401, DOI 10.1037/a0022848
   Tingstrom Pia R, 2005, Eur J Cardiovasc Nurs, V4, P324, DOI 10.1016/j.ejcnurse.2005.04.008
   van den Berg-Emons RJ, 2005, PHYS THER, V85, P1340, DOI 10.1093/ptj/85.12.1340
   van Halewijn G, 2017, INT J CARDIOL, V232, P294, DOI 10.1016/j.ijcard.2016.12.125
   VANHEES L, 1994, J AM COLL CARDIOL, V23, P358, DOI 10.1016/0735-1097(94)90420-0
   Verrill DE, 2003, HEART LUNG, V32, P41, DOI 10.1067/mhl.2003.7
   von Kanel R, 2018, PSYCHOTHER PSYCHOSOM, V87, P75, DOI 10.1159/000486099
   Weibel L, 2016, EUR J CARDIOVASC NUR, V15, P213, DOI 10.1177/1474515114556713
   Williams MA, 2007, CIRCULATION, V116, P572, DOI 10.1161/CIRCULATIONAHA.107.185214
   World Health Organization, 2011, GLOBAL OBSERVATORY E, V3
   Wright DJ, 2001, CLIN REHABIL, V15, P119, DOI 10.1191/026921501671364449
   Wyer SJ, 2001, CORONATY HLTH CARE, V5, P154, DOI [10.1054/chec.2001.0131, DOI 10.1054/CHEC.2001.0131]
   Xanthos PD, 2017, INT J CARDIOL, V230, P493, DOI 10.1016/j.ijcard.2016.12.076
   Xu K, 2016, CARDIOVASC THER, V34, P337, DOI 10.1111/1755-5922.12204
   Yamamoto S, 2016, J CARDIOL, V68, P125, DOI 10.1016/j.jjcc.2015.09.005
   Ye YZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056803
   Zhang YM, 2016, DISABIL REHABIL, V38, P268, DOI 10.3109/09638288.2015.1036174
   Zhang ZZ, 2013, EUR J EPIDEMIOL, V28, P119, DOI 10.1007/s10654-013-9783-1
   Zullig LL, 2017, CURR CARDIOL REP, V19, DOI 10.1007/s11886-017-0918-y
NR 178
TC 2
Z9 6
U1 4
U2 16
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD NOV
PY 2019
VL 49
IS 11
BP 1066
EP 1111
DI 10.4070/kcj.2019.0194
PG 46
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA JH3VF
UT WOS:000492695400011
PM 31646772
OA Green Published
DA 2021-04-22
ER

PT J
AU Heo, JH
AF Heo, Jung Ho
TI Glimpse of Relation between Imaging and Physiology
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
ID CORONARY MICROVASCULAR DYSFUNCTION; INTRAVASCULAR ULTRASOUND;
   TOMOGRAPHY; STENOSIS
C1 [Heo, Jung Ho] Kosin Univ, Gospel Hosp, Div Cardiol, 262 Gamcheon Ro, Busan 49267, South Korea.
RP Heo, JH (corresponding author), Kosin Univ, Gospel Hosp, Div Cardiol, 262 Gamcheon Ro, Busan 49267, South Korea.
EM duggymdc@gmail.com
OI Heo, Jung Ho/0000-0002-6491-2426
CR Corban MT, 2018, JACC-CARDIOVASC INTE, V11, P2069, DOI 10.1016/j.jcin.2018.07.059
   De Bruyne B, 2001, CIRCULATION, V104, P2003, DOI 10.1161/hc4201.099223
   Fearon WF, 2003, CIRCULATION, V107, P3129, DOI 10.1161/01.CIR.0000080700.98607.D1
   Herrmann J, 2012, EUR HEART J, V33, P2771, DOI 10.1093/eurheartj/ehs246
   Jang IK, 2012, CIRC-CARDIOVASC INTE, V5, P10, DOI 10.1161/CIRCINTERVENTIONS.111.967935
   Kang SJ, 2015, JACC-CARDIOVASC IMAG, V8, P184, DOI 10.1016/j.jcmg.2014.09.021
   Marinescu MA, 2015, JACC-CARDIOVASC IMAG, V8, P210, DOI 10.1016/j.jcmg.2014.12.008
   Pu J, 2012, EUR HEART J, V33, P372, DOI 10.1093/eurheartj/ehr387
   Takagi A, 1999, CIRCULATION, V100, P250, DOI 10.1161/01.CIR.100.3.250
   Usui E, 2018, JACC-CARDIOVASC INTE, V11, P2058, DOI 10.1016/j.jcin.2018.07.012
   Yang HM, 2019, KOREAN CIRC J, V49, P1010, DOI 10.4070/kcj.2019.0072
   Yang HM, 2016, CIRCULATION, V133, P1945, DOI 10.1161/CIRCULATIONAHA.115.018741
NR 12
TC 0
Z9 0
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD NOV
PY 2019
VL 49
IS 11
BP 1019
EP 1021
DI 10.4070/kcj.2019.0295
PG 3
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA JH3VF
UT WOS:000492695400004
PM 31646770
OA Green Published, Other Gold
DA 2021-04-22
ER

PT J
AU Ahn, SG
   Lee, SJ
AF Ahn, Sung Gyun
   Lee, Sang Jun
TI Dose Coronary Angiography Suffice for Assessment of Intermediate
   Coronary Stenosis?
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
ID 2014 COHORT; INTERVENTION; SEVERITY
C1 [Ahn, Sung Gyun; Lee, Sang Jun] Yonsei Univ, Dept Internal Med, Wonju Severance Christian Hosp, Wonju Coll Med, Wonju, South Korea.
RP Ahn, SG (corresponding author), Yonsei Univ, Dept Internal Med, Wonju Severance Christian Hosp, Div Cardiol,Wonju Coll Med, 20 Ilsan Ro, Wonju 26426, South Korea.
EM sgahn@yonsei.ac.kr
OI Ahn, Sung Gyun/0000-0002-1528-2739
CR Ahn SG, 2019, CATHETER CARDIOVASC
   Ahn SG, 2017, JACC-CARDIOVASC INTE, V10, P999, DOI 10.1016/j.jcin.2017.03.006
   Gwon HC, 2017, KOREAN CIRC J, V47, P320, DOI 10.4070/kcj.2017.0070
   Jang JS, 2017, KOREAN CIRC J, V47, P328, DOI 10.4070/kcj.2017.0071
   Kim JH, 2019, KOREAN CIRC J, V49, P1022, DOI 10.4070/kcj.2019.0074
   Lee JM, 2019, J AM COLL CARDIOL, V73, P2413, DOI 10.1016/j.jacc.2019.02.060
   Park SJ, 2012, JACC-CARDIOVASC INTE, V5, P1029, DOI 10.1016/j.jcin.2012.07.007
   Tobis J, 2007, J AM COLL CARDIOL, V49, P839, DOI 10.1016/j.jacc.2006.10.055
   Xaplanteris P, 2018, NEW ENGL J MED, V379, P250, DOI 10.1056/NEJMoa1803538
   Zimmermann FM, 2015, EUR HEART J, V36, P3182, DOI 10.1093/eurheartj/ehv452
NR 10
TC 0
Z9 0
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD NOV
PY 2019
VL 49
IS 11
BP 1033
EP 1034
DI 10.4070/kcj.2019.0227
PG 2
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA JH3VF
UT WOS:000492695400006
PM 31456370
OA Other Gold, Green Published
DA 2021-04-22
ER

PT J
AU Hisamatsu, T
AF Hisamatsu, Takashi
TI Control Rates of Systolic and Diastolic Blood Pressure among
   Hypertensive Adults in Korea
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
C1 [Hisamatsu, Takashi] Shimane Univ, Fac Med, Dept Environm Med & Publ Hlth, 89-1 Enya Cho, Izumo, Shimane 6938501, Japan.
   [Hisamatsu, Takashi] Shiga Univ Med Sci, Dept Publ Hlth, Otsu, Shiga, Japan.
RP Hisamatsu, T (corresponding author), Shimane Univ, Fac Med, Dept Environm Med & Publ Hlth, 89-1 Enya Cho, Izumo, Shimane 6938501, Japan.
EM hisataka@med.shimane-u.ac.jp
RI Hisamatsu, Takashi/AAH-8576-2019
OI Hisamatsu, Takashi/0000-0002-6244-1763
CR Adab P, 2018, BMJ-BRIT MED J, V360, DOI 10.1136/bmj.k1274
   Cho SMJ, 2019, KOREAN CIRC J, V49, P1035, DOI 10.4070/kcj.2019.0049
   Franklin SS, 2001, CIRCULATION, V103, P1245
   Ihm SH, 2019, CIRC J, V83, P504, DOI 10.1253/circj.CJ-18-1293
   Japanese Society of Hypertension Committee for Guidelines for the Management of Hypertension, 2019, HYPERTENS RES
   Jo I, 2001, J HYPERTENS, V19, P1523, DOI 10.1097/00004872-200109000-00002
   Korean Society Hypertension (KSH), 2018, Clin Hypertens, V24, P13, DOI 10.1186/s40885-018-0098-0
   Lloyd-Jones DM, 2000, HYPERTENSION, V36, P594, DOI 10.1161/01.HYP.36.4.594
   Whelton PK, 2018, HYPERTENSION, V71, pE13, DOI [10.1161/HYP.0000000000000065, 10.1161/HYP.0000000000000066]
   Williams B, 2018, EUR HEART J, V39, P3021, DOI 10.1093/eurheartj/ehy339
NR 10
TC 3
Z9 3
U1 1
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD NOV
PY 2019
VL 49
IS 11
BP 1049
EP 1051
DI 10.4070/kcj.2019.0197
PG 3
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA JH3VF
UT WOS:000492695400008
PM 31456366
OA Green Published
DA 2021-04-22
ER

PT J
AU Jeong, YH
   Tantry, US
   Gurbel, PA
AF Jeong, Young-Hoon
   Tantry, Udaya S.
   Gurbel, Paul A.
TI Temporal Variability of Platelet Reactivity Phenotype: Another Barrier
   to Personalized Antiplatelet Strategy Guided by Platelet Function
   Testing
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
ID CLOPIDOGREL; TIME; TICAGRELOR; PRASUGREL
C1 [Jeong, Young-Hoon] Gyeongsang Natl Univ, Sch Med, Dept Internal Med, 11 Samjeongja Ro, Chang Won 51472, South Korea.
   [Jeong, Young-Hoon] Gyeongsang Natl Univ, Changwon Hosp, Cardiovasc Ctr, 11 Samjeongja Ro, Chang Won 51472, South Korea.
   [Tantry, Udaya S.] Sinai Hosp, Sinai Ctr Trombosis Res, 2401 W Belvedere Ave, Baltimore, MD 21215 USA.
   [Gurbel, Paul A.] Inova Heart & Vasc Inst, Inova Ctr Thrombosis Res & Drug Dev, Fairfax, VA USA.
RP Jeong, YH (corresponding author), Gyeongsang Natl Univ, Sch Med, Dept Internal Med, 11 Samjeongja Ro, Chang Won 51472, South Korea.; Jeong, YH (corresponding author), Gyeongsang Natl Univ, Changwon Hosp, Cardiovasc Ctr, 11 Samjeongja Ro, Chang Won 51472, South Korea.
EM goodoctor@naver.com
RI Jeong, Young-Hoon/AAO-4401-2020; Jeong, Young-Hoon/F-3476-2015
OI Jeong, Young-Hoon/0000-0003-0403-3726
CR Alexopoulos D, 2013, DIABETES CARE, V36, P2211, DOI 10.2337/dc12-2510
   Campo G, 2011, J AM COLL CARDIOL, V57, P2474, DOI 10.1016/j.jacc.2010.12.047
   Gurbel PA, 2009, CIRCULATION, V120, P2577, DOI 10.1161/CIRCULATIONAHA.109.912550
   Hochholzer W, 2014, J AM COLL CARDIOL, V64, P361, DOI 10.1016/j.jacc.2014.03.051
   Huo Y, 2019, SCI BULL, V64, P166, DOI 10.1016/j.scib.2018.12.020
   Jaitner J, 2011, THROMB HAEMOSTASIS, V105, P107, DOI 10.1160/TH10-07-0440
   Sibbing D, 2019, JACC-CARDIOVASC INTE, V12, P1521, DOI 10.1016/j.jcin.2019.03.034
   Wallentin L, 2009, NEW ENGL J MED, V361, P1045, DOI 10.1056/NEJMoa0904327
   Wiviott SD, 2007, NEW ENGL J MED, V357, P2001, DOI 10.1056/NEJMoa0706482
   Yun KH, 2019, KOREAN CIRC J, V49, P1052, DOI 10.4070/kcj.2019.0098
NR 10
TC 0
Z9 0
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD NOV
PY 2019
VL 49
IS 11
BP 1062
EP 1065
DI 10.4070/kcj.2019.0260
PG 4
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA JH3VF
UT WOS:000492695400010
PM 31646771
OA Green Published
DA 2021-04-22
ER

PT J
AU Yoo, JS
   Kim, KH
AF Yoo, Jae Suk
   Kim, Kyung-Hee
TI Images of Mitral Valve Perforation due to Atrial Septal Occluder Device
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
ID CLOSURE
C1 [Yoo, Jae Suk] Sejong Gen Hosp, Dept Thorac & Cardiovasc Surg, Bucheon, South Korea.
   [Kim, Kyung-Hee] Sejong Gen Hosp, Div Cardiovasc Dis, 28,Hohyeon Ro 489beon Gil, Bucheon 14754, South Korea.
RP Kim, KH (corresponding author), Sejong Gen Hosp, Div Cardiovasc Dis, 28,Hohyeon Ro 489beon Gil, Bucheon 14754, South Korea.
EM learnbyliving9@gmail.com
OI Yoo, Jae Suk/0000-0002-7008-054X; Kim, Kyung-Hee/0000-0003-0708-8685
CR Masura J, 2005, J AM COLL CARDIOL, V45, P505, DOI 10.1016/j.jacc.2004.10.066
   Mishaly D, 2008, ANN THORAC SURG, V85, P831, DOI 10.1016/j.athoracsur.2007.11.068
   Moore J, 2013, JACC-CARDIOVASC INTE, V6, P433, DOI 10.1016/j.jcin.2013.02.005
NR 3
TC 0
Z9 0
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD NOV
PY 2019
VL 49
IS 11
BP 1112
EP 1113
DI 10.4070/kcj.2019.0244
PG 2
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA JH3VF
UT WOS:000492695400012
PM 31646773
OA Green Published
DA 2021-04-22
ER

PT J
AU Lowres, N
   Giskes, K
   Hespe, C
   Freedman, B
AF Lowres, Nicole
   Giskes, Katrina
   Hespe, Charlotte
   Freedman, Ben
TI Reducing Stroke Risk in Atrial Fibrillation: Adherence to Guidelines Has
   Improved, but Patient Persistence with Anticoagulant Therapy Remains
   Suboptimal
SO KOREAN CIRCULATION JOURNAL
LA English
DT Review
DE Atrial fibrillation; Oral anticoagulant; Prescription; Persistence (or
   adherence); Temporal trends
ID ANTAGONIST ORAL ANTICOAGULANTS; LONG-TERM PERSISTENCE; NEWLY-INITIATED
   WARFARIN; VITAMIN-K ANTAGONISTS; MEDICATION ADHERENCE; ANTITHROMBOTIC
   THERAPY; CHINESE PATIENTS; TEMPORAL TRENDS; INSIGHTS; OUTCOMES
AB Atrial fibrillation (AF) is a significant risk factor for avoidable stroke. Among high-risk patients with AF, stroke risk can be mitigated using oral anticoagulants (OACs), however reduction is largely contingent on physician prescription and patient persistence with OAC therapy. Over the past decade significant advances have occurred, with revisions to clinical practice guidelines relating to management of stroke risk in AF in several countries, and the introduction of non-vitamin K antagonist OACs (NOACs). This paper summarises the evolving body of research examining guideline-based clinician prescription over the past decade, and patient-level factors associated with OAC persistence. The review shows clinicians' management over the past decade has increasingly reflected guideline recommendations, with an increasing proportion of high-risk patients receiving OACs, driven by an upswing in NOACs. However, a treatment gap remains, as 25-35% of high-risk patients still do not receive OAC treatment, with great variation between countries. Reduction in stroke risk directly relates to level of OAC prescription and therapy persistence. Persistence and adherence to OAC thromboprophylaxis remains an ongoing issue, with 2-year persistence as low as 50%, again with wide variation between countries and practice settings. Multiple patient-level factors contribute to poor persistence, in addition to concerns about bleeding. Considered review of individual patient's factors and circumstances will assist clinicians to implement appropriate strategies to address poor persistence. This review highlights the interplay of both clinician's awareness of guideline recommendations and understanding of individual patient-level factors which impact adherence and persistence, which are required to reduce the incidence of preventable stroke attributable to AF.
C1 [Lowres, Nicole; Giskes, Katrina; Freedman, Ben] Charles Perkins Ctr, Heart Res Inst, Camperdown, NSW, Australia.
   [Lowres, Nicole; Freedman, Ben] Univ Sydney, Fac Med & Hlth, Sydney, NSW, Australia.
   [Giskes, Katrina; Hespe, Charlotte] Univ Notre Dame, Sch Med, Sydney, NSW, Australia.
   [Freedman, Ben] Univ Sydney, Concord Hosp, Dept Cardiol, Concord Clin Sch, Concord, Australia.
RP Lowres, N (corresponding author), Charles Perkins Ctr, Heart Res Inst, John Hopkins Dr, Sydney, NSW 2006, Australia.
EM nicole.lowres@sydney.edu.au
RI Freedman, Saul B/C-1625-2013; Hespe, Charlotte/P-5240-2015
OI Freedman, Saul B/0000-0002-3809-2911; Hespe,
   Charlotte/0000-0002-4582-7728; Lowres, Nicole/0000-0001-9061-3406
FU NSW Health Early Career Fellowship [H16/52168]; Royal Australian College
   of General Practitioners; Australian GovernmentAustralian
   GovernmentCGIAR
FX Nicole Lowres is funded by a NSW Health Early Career Fellowship
   (H16/52168). Katrina Giskes is supported by the Royal Australian College
   of General Practitioners with funding from the Australian Government
   under the Australian General Practice Training program.
CR Abdou JK, 2016, BRIT J HAEMATOL, V174, P30, DOI 10.1111/bjh.14134
   Aggarwal B, 2013, ANN BEHAV MED, V46, P237, DOI 10.1007/s12160-013-9492-8
   Ahmed I, 2018, JMIR MHEALTH UHEALTH, V6, DOI 10.2196/mhealth.6432
   Alberts MJ, 2016, INT J CARDIOL, V215, P11, DOI 10.1016/j.ijcard.2016.03.212
   Aldeer M., 2018, APPL SYSTEM INNOVATI, V1, P14, DOI [10.3390/asi1020014, DOI 10.3390/ASI1020014]
   Andersson T, 2013, EUR HEART J, V34, P1061, DOI 10.1093/eurheartj/ehs469
   Apenteng PN, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-018905
   Bastida C, 2017, INT J CLIN PHARM-NET, V39, P478, DOI 10.1007/s11096-017-0431-9
   Ben Freedman S, 2015, EUR HEART J, V36, P653, DOI 10.1093/eurheartj/ehu494
   Beyer-Westendorf J, 2016, EUROPACE, V18, P1150, DOI 10.1093/europace/euv421
   Bjorck F, 2016, CARDIOVASC THER, V34, P468, DOI 10.1111/1755-5922.12224
   Blaschke TF, 2012, ANNU REV PHARMACOL, V52, P275, DOI 10.1146/annurev-pharmtox-011711-113247
   Borne RT, 2017, BMC CARDIOVASC DISOR, V17, DOI 10.1186/s12872-017-0671-6
   Brieger D, 2018, HEART LUNG CIRC, V27, P1209, DOI 10.1016/j.hlc.2018.06.1043
   Brown JD, 2017, J MANAG CARE SPEC PH, V23, P958, DOI 10.18553/jmcp.2017.23.9.958
   Camm AJ, 2015, EUROPACE, V17, P1007, DOI 10.1093/europace/euv068
   Chao TF, 2018, CIRCULATION, V138, P1485, DOI 10.1161/CIRCULATIONAHA.118.036046
   Chatterjee S, 2014, MAYO CLIN PROC, V89, P896, DOI 10.1016/j.mayocp.2014.01.030
   Clarkesmith DE, 2017, THROMB RES, V153, P19, DOI 10.1016/j.thromres.2017.03.002
   Collings SL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185642
   Connolly SJ, 2019, NEW ENGL J MED, V380, P1326, DOI 10.1056/NEJMoa1814051
   Cowan JC, 2018, EUR HEART J, V39, P2975, DOI 10.1093/eurheartj/ehy411
   Cramer JA, 2008, VALUE HEALTH, V11, P44, DOI 10.1111/j.1524-4733.2007.00213.x
   Crowley MJ, 2015, J GEN INTERN MED, V30, P83, DOI 10.1007/s11606-014-3072-x
   Dalgaard F, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195175
   Deitelzweig SB, 2013, CLIN THER, V35, P1201, DOI 10.1016/j.clinthera.2013.06.005
   Deshpande CG, 2018, CURR MED RES OPIN, V34, P1285, DOI 10.1080/03007995.2018.1428543
   Desteghe L, 2018, EUR HEART J, V39, P1394, DOI 10.1093/eurheartj/ehx762
   Di Minno A, 2014, THROMB RES, V133, P699, DOI 10.1016/j.thromres.2014.01.016
   Dupclay L, 2012, PATIENT PREFER ADHER, V6, P677, DOI 10.2147/PPA.S37120
   Engdahl J, 2018, EUROPACE, V20, pF306, DOI 10.1093/europace/euy045
   Fan JH, 2016, DIABETES EDUCATOR, V42, P199, DOI 10.1177/0145721715624969
   Fang MC, 2010, CIRC-CARDIOVASC QUAL, V3, P624, DOI 10.1161/CIRCOUTCOMES.110.937680
   Fischer MA, 2010, J GEN INTERN MED, V25, P284, DOI 10.1007/s11606-010-1253-9
   Forslund T, 2016, EUR J CLIN PHARMACOL, V72, P329, DOI 10.1007/s00228-015-1983-z
   Freedman B, 2018, EUR HEART J, V39, P2984, DOI 10.1093/eurheartj/ehy487
   Freedman SB, 2015, EUR HEART J, V36, P862
   Gadsboll K, 2017, EUR HEART J, V38, P899, DOI 10.1093/eurheartj/ehw658
   Gallagher AM, 2008, J THROMB HAEMOST, V6, P1500, DOI 10.1111/j.1538-7836.2008.03059.x
   Gerber BS, 2010, AM J GERIATR PHARMAC, V8, P136, DOI 10.1016/j.amjopharm.2010.03.002
   Gieling EM, 2017, BRIT J CLIN PHARMACO, V83, P1844, DOI 10.1111/bcp.13265
   Gomes T, 2012, ARCH INTERN MED, V172, P1687, DOI 10.1001/archinternmed.2012.4485
   Gulker JE, 2018, CIRC-CARDIOVASC QUAL, V11, DOI 10.1161/CIRCOUTCOMES.117.004470
   Guo YT, 2015, CHEST, V148, P62, DOI 10.1378/chest.14-2018
   Ha JT, 2019, ANN INTERN MED
   Haas S, 2019, AM HEART J, V213, P35, DOI 10.1016/j.ahj.2019.03.013
   Haastrup SB, 2018, BASIC CLIN PHARMACOL, V123, P452, DOI 10.1111/bcpt.13024
   Han S, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0214666
   Hart RG, 2007, ANN INTERN MED, V146, P857, DOI 10.7326/0003-4819-146-12-200706190-00007
   Healey JS, 2016, LANCET, V388, P1161, DOI 10.1016/S0140-6736(16)30968-0
   Healey JS, 2012, NEW ENGL J MED, V366, P120, DOI 10.1056/NEJMoa1105575
   Hohnloser SH, 2019, THROMB HAEMOSTASIS, V119, P882, DOI 10.1055/s-0039-1683428
   Hui DS, 2015, AM HEART J, V169, P448, DOI 10.1016/j.ahj.2014.12.015
   Hurtado-Navarro I, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.01353
   January CT, 2014, J AM COLL CARDIOL, V64, pE1, DOI 10.1016/j.jacc.2014.03.022
   Jin Jing, 2008, Ther Clin Risk Manag, V4, P269
   Johnson ME, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-011471
   Joung B, 2018, KOREAN CIRC J, V48, P1033, DOI 10.4070/kcj.2018.0339
   Kjerpeseth LJ, 2018, EUR J CLIN PHARMACOL, V74, P1653, DOI 10.1007/s00228-018-2540-3
   Lee SR, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0189495
   Leung LY, 2017, J STROKE, V19, P232, DOI 10.5853/jos.2016.01102
   Lip GYH, 2018, CHEST, V154, P1121, DOI 10.1016/j.chest.2018.07.040
   Liu C, 2019, MED SCI MONITOR, V25, P2649, DOI 10.12659/MSM.915875
   Lubitz SA, 2018, AM HEART J, V200, P24, DOI 10.1016/j.ahj.2018.03.003
   Madhavan M, 2018, MAYO CLIN PROC, V93, P145, DOI 10.1016/j.mayocp.2017.09.021
   Martinez C, 2016, THROMB HAEMOSTASIS, V115, P31, DOI 10.1160/TH15-04-0350
   Marzec LN, 2017, J AM COLL CARDIOL, V69, P2475, DOI 10.1016/j.jacc.2017.03.540
   Maura G, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-026645
   McKenzie SJ, 2015, DRUG AGING, V32, P217, DOI 10.1007/s40266-015-0245-1
   Miyasaka Y, 2006, CIRCULATION, V114, P119, DOI 10.1161/CIRCULATIONAHA.105.595140
   Miyazaki M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0204814
   Montalescot G, 2019, AM J CARDIOVASC DRUG, DOI 10.1007/s40256-019-00356-2.
   Mueller T, 2017, PHARMACOEPIDEM DR S, V26, P1378, DOI 10.1002/pds.4272
   Obamiro KO, 2018, J CARDIOVASC PHARM T, V23, P337, DOI 10.1177/1074248418770201
   Pandya EY, 2017, PATIENT, V10, P163, DOI 10.1007/s40271-016-0180-1
   Pilote L, 2013, CAN J CARDIOL, V29, P1241, DOI 10.1016/j.cjca.2012.09.021
   Pollack CV, 2017, NEW ENGL J MED, V377, P431, DOI 10.1056/NEJMoa1707278
   Protty MB, 2017, J CLIN PHARM THER, V42, P132, DOI 10.1111/jcpt.12481
   Robson J, 2014, BRIT J GEN PRACT, V64, pE275, DOI 10.3399/bjgp14X679705
   Rohan JM, 2015, J PEDIATR PSYCHOL, V40, P75, DOI 10.1093/jpepsy/jst093
   Rolls CA, 2017, CARDIOVASC THER, V35, DOI 10.1111/1755-5922.12304
   Santo K, 2019, HEART, V105, P323, DOI 10.1136/heartjnl-2018-313479
   Schnabel RB, 2015, LANCET, V386, P154, DOI 10.1016/S0140-6736(14)61774-8
   Shiga T, 2015, J ARRYTHM, V31, P339, DOI 10.1016/j.joa.2015.04.004
   Shore S, 2014, AM HEART J, V167, P810, DOI 10.1016/j.ahj.2014.03.023
   Simons LA, 2017, CURR MED RES OPIN, V33, P1337, DOI 10.1080/03007995.2017.1321535
   Simons LA, 2016, CURR MED RES OPIN, V32, P1857, DOI 10.1080/03007995.2016.1218325
   Sindet-Pedersen C, 2018, HEART, V104, P912, DOI 10.1136/heartjnl-2017-311976
   Smet L, 2018, J ADV NURS, V74, P2577, DOI 10.1111/jan.13780
   Sohal M, 2017, EUR CARDIOL REV, V12, P38, DOI 10.15420/ecr.2017:10:2
   Soo Y, 2017, J NEUROL NEUROSUR PS, V88, P744, DOI 10.1136/jnnp-2017-315735
   Stacey D, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001431.pub5
   Steinberg BA, 2017, AM HEART J, V189, P40, DOI 10.1016/j.ahj.2017.03.024
   Stephenson JJ, 2018, PATIENT PREFER ADHER, V12, P105, DOI 10.2147/PPA.S148697
   Suzuki T, 2018, AM J CARDIOVASC DRUG, V18, P311, DOI 10.1007/s40256-018-0278-z
   Thakkar J, 2016, JAMA INTERN MED, V176, P340, DOI 10.1001/jamainternmed.2015.7667
   Thompson LE, 2017, J AM HEART ASSOC, V6, DOI 10.1161/JAHA.117.005801
   Urbaniak AM, 2017, DRUG AGING, V34, P635, DOI 10.1007/s40266-017-0476-4
   van Heuckelum M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185453
   Verheugt FWA, 2018, EUR HEART J, V39, P464, DOI 10.1093/eurheartj/ehx730
   Vinereanu D, 2017, LANCET, V390, P1737, DOI 10.1016/S0140-6736(17)32165-7
   von Scheele B, 2013, ANN PHARMACOTHER, V47, P671, DOI 10.1345/aph.1R411
   Wang ZZ, 2016, CIRC-CARDIOVASC QUAL, V9, P380, DOI 10.1161/CIRCOUTCOMES.115.002337
   Weeda ER, 2016, INT J CARDIOL, V216, P104, DOI 10.1016/j.ijcard.2016.04.082
   Wei Y, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-24878-y
   Weitz JI, 2015, CLIN THER, V37, P2506, DOI 10.1016/j.clinthera.2015.09.008
   Wilke T, 2017, PATIENT, V10, P17, DOI 10.1007/s40271-016-0185-9
   Willey V, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-020676
   Zalesak M, 2013, CIRC-CARDIOVASC QUAL, V6, P567, DOI 10.1161/CIRCOUTCOMES.113.000192
   Zhao SJ, 2017, PATIENT PREFER ADHER, V11, P213, DOI 10.2147/PPA.S120962
   Zhu JY, 2018, PHARMACOTHERAPY, V38, P907, DOI 10.1002/phar.2158
NR 111
TC 9
Z9 9
U1 0
U2 3
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD OCT
PY 2019
VL 49
IS 10
BP 883
EP 907
DI 10.4070/kcj.2019.0234
PG 25
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA IY5LE
UT WOS:000486432700001
PM 31535493
OA Green Published, Other Gold
DA 2021-04-22
ER

PT J
AU Park, JH
AF Park, Jae-Hyeong
TI Two-dimensional Echocardiographic Assessment of Myocardial Strain:
   Important Echocardiographic Parameter Readily Useful in Clinical Field
SO KOREAN CIRCULATION JOURNAL
LA English
DT Review
DE Echocardiography; Strain; Prognosis; Diagnosis; Left ventricle; Right
   ventricle
ID GLOBAL LONGITUDINAL STRAIN; SPECKLE-TRACKING ECHOCARDIOGRAPHY;
   RIGHT-VENTRICULAR FUNCTION; SEVERE AORTIC-STENOSIS; PAROXYSMAL
   ATRIAL-FIBRILLATION; HEART-FAILURE; PROGNOSTIC VALUE; EJECTION FRACTION;
   FREE-WALL; INDEPENDENT PREDICTOR
AB Echocardiography is the first and is the most-available imaging modality for many cardiovascular diseases, and echocardiographic parameters can give much important information for diagnosis, treatment, and prognostic evaluations. Left ventricular ejection fraction (LVEF) is the most commonly used echocardiographic parameter for left ventricular (LV) systolic function. Although LVEF is used routinely in daily practice, it is calculated from volumetric change without representing true myocardial properties. Recently, strain echocardiography has been used to objectively measure myocardial deformation. Myocardial strain can give accurate information about intrinsic myocardial function, and it can be used to detect early-stage cardiovascular diseases, monitor myocardial changes with specific therapies, differentiate cardiomyopathies, and predict the prognosis of several cardiovascular diseases. Although strain echocardiography has been applied to measure the right ventricle and left atrium, in addition to analyzing the LV, many cardiologists who are not imaging specialists are unaware of its clinical use and importance. Therefore, this review describes the measurement and clinical utility of 2-dimensional strain analysis in various cardiovascular diseases.
C1 [Park, Jae-Hyeong] Chungnam Natl Univ, Coll Med, Chungnam Natl Univ Hosp, Dept Cardiol Internal Med, 282 Munhwa Ro, Daejeon 35015, South Korea.
RP Park, JH (corresponding author), Chungnam Natl Univ, Coll Med, Chungnam Natl Univ Hosp, Dept Cardiol Internal Med, 282 Munhwa Ro, Daejeon 35015, South Korea.
EM jaehpark@cnu.ac.kr
RI Park, Jae-Hyeong/AAD-9015-2021
CR Ali MT, 2016, J AM SOC ECHOCARDIOG, V29, P522, DOI 10.1016/j.echo.2016.02.018
   Aneq MA, 2012, CARDIOVASC ULTRASOUN, V10, DOI 10.1186/1476-7120-10-37
   Argiriou M, 2014, J THORAC DIS, V6, pS52, DOI 10.3978/j.issn.2072-1439.2013.10.26
   Aung SM, 2017, HERZ, V42, P194, DOI 10.1007/s00059-016-4456-y
   Baumgartner H, 2017, EUR HEART J, V38, P2739, DOI 10.1093/eurheartj/ehx391
   Bertini M, 2009, AM J CARDIOL, V104, P480, DOI 10.1016/j.amjcard.2009.04.010
   Biering-Sorensen T, 2014, CIRC-CARDIOVASC IMAG, V7, P58, DOI 10.1161/CIRCIMAGING.113.000989
   Buss SJ, 2012, J AM COLL CARDIOL, V60, P1067, DOI 10.1016/j.jacc.2012.04.043
   Butz T, 2011, INT J CARDIOVAS IMAG, V27, P91, DOI 10.1007/s10554-010-9665-5
   Cameli M, 2012, J CARD FAIL, V18, P208, DOI 10.1016/j.cardfail.2011.12.002
   Caselli S, 2015, J AM SOC ECHOCARDIOG, V28, P245, DOI 10.1016/j.echo.2014.10.010
   Charbonnel C, 2017, EUR HEART J-CARD IMG, V18, P392, DOI 10.1093/ehjci/jew223
   Cho GY, 2006, AM J CARDIOL, V97, P1661, DOI 10.1016/j.amjcard.2005.12.063
   Cho GY, 2009, J AM COLL CARDIOL, V54, P618, DOI 10.1016/j.jacc.2009.04.061
   Choi SW, 2015, INT J CARDIOL, V196, P165, DOI 10.1016/j.ijcard.2015.05.186
   Collier P, 2017, J AM COLL CARDIOL, V69, P1043, DOI 10.1016/j.jacc.2016.12.012
   Cramariuc D, 2010, HEART, V96, P106, DOI 10.1136/hrt.2009.172569
   D'Andrea A, 2017, INT J CARDIOL, V227, P209, DOI 10.1016/j.ijcard.2016.11.150
   D'Andrea A, 2016, INT J CARDIOL, V222, P908, DOI 10.1016/j.ijcard.2016.07.288
   D'Andrea A, 2010, EUR J ECHOCARDIOGR, V11, P492, DOI 10.1093/ejechocard/jeq007
   Debonnaire P, 2013, J AM SOC ECHOCARDIOG, V26, P1053, DOI 10.1016/j.echo.2013.05.019
   Donal E, 2016, EUR HEART J-CARD IMG, V17, P355, DOI 10.1093/ehjci/jev354
   Enomoto M, 2015, CIRC J, V79, P1749, DOI 10.1253/circj.CJ-15-0012
   Ersboll M, 2013, CIRC-CARDIOVASC IMAG, V6, P26, DOI 10.1161/CIRCIMAGING.112.978296
   Ewer MS, 2015, NAT REV CARDIOL, V12, P620, DOI 10.1038/nrcardio.2015.133
   Farsalinos KE, 2015, J AM SOC ECHOCARDIOG, V28, P1171, DOI 10.1016/j.echo.2015.06.011
   Fine NM, 2015, ECHOCARDIOGR-J CARD, V32, P787, DOI 10.1111/echo.12806
   Fine NM, 2013, CIRC-CARDIOVASC IMAG, V6, P711, DOI 10.1161/CIRCIMAGING.113.000640
   Fine NM, 2013, INT J CARDIOVAS IMAG, V29, P571, DOI 10.1007/s10554-012-0120-7
   Focardi M, 2015, EUR HEART J-CARD IMG, V16, P47, DOI 10.1093/ehjci/jeu156
   Freed BH, 2015, ECHOCARDIOGR-J CARD, V32, P257, DOI 10.1111/echo.12662
   Fukuda Y, 2011, J AM SOC ECHOCARDIOG, V24, P1101, DOI 10.1016/j.echo.2011.06.005
   Galli E, 2016, EUR HEART J-CARD IMG, V17, P533, DOI 10.1093/ehjci/jev230
   Gorcsan J, 2011, J AM COLL CARDIOL, V58, P1401, DOI 10.1016/j.jacc.2011.06.038
   Grant ADM, 2012, J AM COLL CARDIOL, V60, P521, DOI 10.1016/j.jacc.2012.02.073
   Haddad F, 2008, CIRCULATION, V117, P1436, DOI 10.1161/CIRCULATIONAHA.107.653576
   Haland TF, 2016, EUR HEART J-CARD IMG, V17, P613, DOI 10.1093/ehjci/jew005
   Haugaa KH, 2013, JACC-CARDIOVASC IMAG, V6, P841, DOI 10.1016/j.jcmg.2013.03.005
   Holman WL, 2009, J HEART LUNG TRANSPL, V28, P44, DOI 10.1016/j.healun.2008.10.011
   Ikeda S, 2014, LIFE SCI, V111, P12, DOI 10.1016/j.lfs.2014.06.024
   Ishizu T, 2014, HYPERTENSION, V63, P500, DOI 10.1161/HYPERTENSIONAHA.113.02149
   Jamal F, 2003, AM J PHYSIOL-HEART C, V285, pH2842, DOI 10.1152/ajpheart.00218.2003
   Joyce E, 2014, CIRC-CARDIOVASC IMAG, V7, P74, DOI 10.1161/CIRCIMAGING.113.000982
   Jung Mi Hyang, 2019, J Cardiovasc Imaging, V27, P156, DOI 10.4250/jcvi.2019.27.e15
   Keramida K, 2019, EUR J HEART FAIL, V21, P529, DOI 10.1002/ejhf.1385
   Kim Hyungseop, 2018, J Cardiovasc Ultrasound, V26, P1, DOI 10.4250/jcu.2018.26.1.1
   Kim Kyung-Hee, 2017, J Cardiovasc Ultrasound, V25, P20, DOI 10.4250/jcu.2017.25.1.20
   Kim M, 2018, J AM COLL CARDIOL, V71, P1399, DOI 10.1016/S0735-1097(18)31940-5
   Kobayashi T, 2013, AM HEART J, V166, P503, DOI 10.1016/j.ahj.2013.06.011
   Kojima T, 2012, EUR HEART J-CARD IMG, V13, P227, DOI 10.1093/ejechocard/jer281
   Kumler T, 2010, EUR J HEART FAIL, V12, P805, DOI 10.1093/eurjhf/hfq071
   Lancellotti P, 2010, HEART, V96, P1364, DOI 10.1136/hrt.2009.190942
   Lang RM, 2015, EUR HEART J-CARD IMG, V16, P233, DOI 10.1093/ehjci/jev014
   Lee Jae-Hwan, 2014, J Cardiovasc Ultrasound, V22, P65, DOI 10.4250/jcu.2014.22.2.65
   Lee JY, 2018, KOREAN CIRC J, V48, P1148, DOI 10.4070/kcj.2018.0115
   Lee JH, 2019, KOREAN CIRC J, V49, P1, DOI 10.4070/kcj.2018.0373
   Lee Ju-Hee, 2018, J Cardiovasc Imaging, V26, P111, DOI 10.4250/jcvi.2018.26.e11
   Lee Ju-Hee, 2017, J Cardiovasc Ultrasound, V25, P91, DOI 10.4250/jcu.2017.25.3.91
   Lee K, 2019, HEART VESSELS, V34, P1187, DOI 10.1007/s00380-019-01340-1
   Lee SH, 2019, KOREAN CIRC J, V49, pe69
   Lemarie J, 2015, J AM SOC ECHOCARDIOG, V28, P818, DOI 10.1016/j.echo.2015.02.019
   Lisi M, 2015, JACC-CARDIOVASC IMAG, V8, P514, DOI 10.1016/j.jcmg.2014.12.026
   Liu D, 2013, CIRC-CARDIOVASC IMAG, V6, P1066, DOI 10.1161/CIRCIMAGING.113.000683
   Lu KJ, 2015, ECHOCARDIOGR-J CARD, V32, P966, DOI 10.1111/echo.12783
   Zamorano JL, 2017, EUR J HEART FAIL, V19, P9, DOI 10.1002/ejhf.654
   Marwick TH, 2006, J AM COLL CARDIOL, V47, P1313, DOI 10.1016/j.jacc.2005.11.063
   Marwick TH, 2009, JACC-CARDIOVASC IMAG, V2, P80, DOI 10.1016/j.jcmg.2007.12.007
   Mascle S, 2012, J AM SOC ECHOCARDIOG, V25, P766, DOI 10.1016/j.echo.2012.04.009
   Mentias A, 2016, J AM COLL CARDIOL, V68, P1974, DOI 10.1016/j.jacc.2016.08.030
   Meris A, 2010, J AM SOC ECHOCARDIOG, V23, P823, DOI 10.1016/j.echo.2010.05.009
   Mora V, 2018, CARDIOVASC ULTRASOUN, V16, DOI 10.1186/s12947-018-0135-x
   Morris DA, 2017, EUR HEART J-CARD IMG, V18, P212, DOI 10.1093/ehjci/jew011
   Morris DA, 2015, INT J CARDIOVAS IMAG, V31, P301, DOI 10.1007/s10554-014-0551-4
   Motoji Y, 2013, CIRC J, V77, P756, DOI 10.1253/circj.CJ-12-1083
   Mukherjee M, 2016, CIRC-CARDIOVASC IMAG, V9, DOI 10.1161/CIRCIMAGING.115.003792
   Muraru D, 2016, CIRC-CARDIOVASC IMAG, V9, DOI 10.1161/CIRCIMAGING.115.003866
   Nakai H, 2009, EUR J ECHOCARDIOGR, V10, P926, DOI 10.1093/ejechocard/jep097
   Negishi K, 2014, EUR HEART J-CARD IMG, V15, P324, DOI 10.1093/ehjci/jet159
   Negishi K, 2013, J AM SOC ECHOCARDIOG, V26, P493, DOI 10.1016/j.echo.2013.02.008
   Nishimura RA, 2017, CIRCULATION, V135, pE1159, DOI 10.1161/CIR.0000000000000503
   Noh H, 2019, ASIAN J TECHNOL INNO, V27, P1, DOI 10.1080/19761597.2019.1594320
   Obokata M, 2014, J AM SOC ECHOCARDIOG, V27, P709, DOI 10.1016/j.echo.2014.03.010
   Okamatsu K, 2009, J AM SOC ECHOCARDIOG, V22, P70, DOI 10.1016/j.echo.2008.11.006
   Otterstad JE, 1997, EUR HEART J, V18, P507
   Park JH, 2018, J AM HEART ASSOC, V7, DOI 10.1161/JAHA.118.009331
   Park JH, 2018, JACC-CARDIOVASC IMAG, V11, P1719, DOI 10.1016/j.jcmg.2018.02.012
   Park JH, 2018, INT J CARDIOVAS IMAG, V34, P177, DOI 10.1007/s10554-017-1217-9
   Park Jae-Hyeong, 2016, J Cardiovasc Ultrasound, V24, P285, DOI 10.4250/jcu.2016.24.4.285
   Park JH, 2015, KOREAN CIRC J, V45, P398, DOI 10.4070/kcj.2015.45.5.398
   Park Jae-Hyeong, 2014, J Cardiovasc Ultrasound, V22, P113, DOI 10.4250/jcu.2014.22.3.113
   Park SJ, 2015, JACC-CARDIOVASC IMAG, V8, P161, DOI 10.1016/j.jcmg.2014.10.011
   Park YH, 2008, J AM SOC ECHOCARDIOG, V21, P262, DOI 10.1016/j.echo.2007.08.026
   Pathan F, 2017, J AM SOC ECHOCARDIOG, V30, P59, DOI 10.1016/j.echo.2016.09.007
   Pelliccia A, 2002, CIRCULATION, V105, P944, DOI 10.1161/hc0802.104534
   Phelan D, 2014, J AM SOC ECHOCARDIOG, V27, P888, DOI 10.1016/j.echo.2014.04.015
   Ponikowski P, 2016, EUR HEART J, V37, P2129, DOI 10.1093/eurheartj/ehw128
   Providencia R, 2013, J AM SOC ECHOCARDIOG, V26, P801, DOI 10.1016/j.echo.2013.05.010
   Rimbas RC, 2016, ECHOCARDIOGR-J CARD, V33, P1866, DOI 10.1111/echo.13362
   Santos ABS, 2016, CIRC-HEART FAIL, V9, DOI 10.1161/CIRCHEARTFAILURE.115.002763
   Sarvari SI, 2011, EUR HEART J, V32, P1089, DOI 10.1093/eurheartj/ehr069
   Sato K, 2014, CIRC J, V78, P2750, DOI 10.1253/circj.CJ-14-0726
   Schneider C, 2008, EUR HEART J, V29, P1397, DOI 10.1093/eurheartj/ehn168
   Senapati A, 2016, HEART, V102, P748, DOI 10.1136/heartjnl-2015-308657
   Seo Hye Sun, 2018, J Cardiovasc Imaging, V26, P189, DOI 10.4250/jcvi.2018.26.e28
   Shah AM, 2015, CIRCULATION, V132, P402, DOI 10.1161/CIRCULATIONAHA.115.015884
   Sjoli B, 2009, JACC-CARDIOVASC IMAG, V2, P24, DOI 10.1016/j.jcmg.2008.10.007
   Smiseth OA, 2016, EUR HEART J, V37, P1196, DOI 10.1093/eurheartj/ehv529
   Sugimoto T, 2017, EUR HEART J-CARD IMG, V18, P833, DOI 10.1093/ehjci/jex140
   Sugiura E, 2009, J AM SOC ECHOCARDIOG, V22, P1353, DOI 10.1016/j.echo.2009.09.005
   Takigiku K, 2012, CIRC J, V76, P2623, DOI 10.1253/circj.CJ-12-0264
   Teske AJ, 2012, J AM SOC ECHOCARDIOG, V25, P997, DOI 10.1016/j.echo.2012.05.008
   Thavendiranathan P, 2014, J AM COLL CARDIOL, V63, P2751, DOI 10.1016/j.jacc.2014.01.073
   Vitarelli A, 2014, J AM SOC ECHOCARDIOG, V27, P329, DOI 10.1016/j.echo.2013.11.013
   Vitarelli A, 2013, AM J CARDIOL, V111, P1344, DOI 10.1016/j.amjcard.2013.01.279
   Vizzardi E, 2015, J ULTRAS MED, V34, P247, DOI 10.7863/ultra.34.2.247
   Wang J, 2007, J AM SOC ECHOCARDIOG, V20, P1058, DOI 10.1016/j.echo.2007.01.038
   Witkowski TG, 2013, EUR HEART J-CARD IMG, V14, P69, DOI 10.1093/ehjci/jes155
   Yancy CW, 2016, J AM COLL CARDIOL, V68, P1476, DOI 10.1016/j.jacc.2016.05.011
   Yang LT, 2015, J AM SOC ECHOCARDIOG, V28, P1309, DOI 10.1016/j.echo.2015.07.004
   Yingchoncharoen T, 2013, J AM SOC ECHOCARDIOG, V26, P185, DOI 10.1016/j.echo.2012.10.008
   Yingchoncharoen T, 2012, CIRC-CARDIOVASC IMAG, V5, P719, DOI 10.1161/CIRCIMAGING.112.977348
   Yiu KH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036115
   Yoon YE, 2015, J AM SOC ECHOCARDIOG, V28, P709, DOI 10.1016/j.echo.2015.01.017
   Zornoff LAM, 2002, J AM COLL CARDIOL, V39, P1450, DOI 10.1016/S0735-1097(02)01804-1
NR 124
TC 0
Z9 0
U1 0
U2 4
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD OCT
PY 2019
VL 49
IS 10
BP 908
EP 931
DI 10.4070/kcj.2019.0200
PG 24
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA IY5LE
UT WOS:000486432700002
PM 31456367
OA Green Published
DA 2021-04-22
ER

PT J
AU Jang, GY
   Ha, KS
AF Jang, Gi Young
   Ha, Kee Soo
TI Self-Expandable Stents in Vascular Stenosis of Moderate to Large-Sized
   Vessels in Congenital Heart Disease: Early and Intermediate-Term Results
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Congenital; Heart; Stents; Catheterization
ID NATIVE COARCTATION; EXPANDING STENTS; LONG-TERM; RECURRENT COARCTATION;
   BALLOON ANGIOPLASTY; PULMONARY-ARTERIES; AORTA; IMPLANTATION;
   COMPLICATIONS
AB Background and Objectives: Vascular stenosis after surgical repair frequently occurs in congenital heart disease. Although conventional balloon dilation is a useful option for stenotic lesions, restenosis may occur. Consequently, balloon expandable stents have been used; however, there are a limited number of balloon expandable stents in our country. Here, we report the early and intermediate-term outcomes of self-expandable stents in vascular stenosis of moderate to large-sized vessels in congenital heart disease.
   Methods: Twelve self-expandable stents were implanted in 9 patients between February 2012 and January 2019. The median age and weight were 12 years (range, 4-39 years) and 38 kg (range, 19-69 kg), respectively. The patients were followed-up for a median duration of 43 months (range, 1-83 months) after stent implantation.
   Results: Nine self-expandable stents were implanted in the pulmonary artery, 2 stents in the right ventricle to the pulmonary artery conduit, and 1 stent in the coarctation. The narrowest diameter of the stented vessel increased from 5.7 +/- 3.2 mm to 12.6 +/- 3.4 mm (p<0.05). The mean pressure gradient across the stenotic lesion decreased from 23.0 +/- 28.2 mmHg to 3.2 +/- 3.6 mmHg (p<0.05). Distal migration of the stent occurred in 1 patient, and significant neointimal ingrowth was noted in 1 patient.
   Conclusions: The self-expandable stent may be a useful option to relieve vascular stenosis in moderate to large-sized vessels with acceptable intermediate-term outcomes.
C1 [Jang, Gi Young; Ha, Kee Soo] Korea Univ Hosp, Dept Pediat, 123 Jeokgeum Ro, Ansan 15355, South Korea.
RP Jang, GY (corresponding author), Korea Univ Hosp, Dept Pediat, 123 Jeokgeum Ro, Ansan 15355, South Korea.
EM jgynhg@naver.com
OI JANG, GI YOUNG/0000-0002-4831-1188
CR Adjagba PM, 2014, PEDIATR CARDIOL, V35, P1155, DOI 10.1007/s00246-014-0909-3
   Chakrabarti S, 2010, HEART, V96, P1212, DOI 10.1136/hrt.2009.170928
   Cheung YF, 2000, J AM COLL CARDIOL, V35, P1007, DOI 10.1016/S0735-1097(99)00644-0
   Cowley CG, 2005, CIRCULATION, V111, P3453, DOI 10.1161/CIRCULATIONAHA.104.510198
   Fawzy ME, 2004, J AM COLL CARDIOL, V43, P1062, DOI 10.1016/j.jacc.2003.10.040
   Forbes TJ, 2007, CATHETER CARDIO INTE, V70, P276, DOI 10.1002/ccd.21164
   Frias PA, 1999, CATHETER CARDIO INTE, V47, P52, DOI 10.1002/(SICI)1522-726X(199905)47:1<52::AID-CCD11>3.0.CO;2-N
   Gendera K, 2018, INT J CARDIOL, V263, P34, DOI 10.1016/j.ijcard.2018.02.054
   Gonzalez I, 2013, PEDIATR CARDIOL, V34, P179, DOI 10.1007/s00246-012-0439-9
   Goreczny S, 2017, CARDIOL YOUNG, V27, P837, DOI 10.1017/S1047951116001347
   Krisnanda C, 2013, HEART LUNG CIRC, V22, P56, DOI 10.1016/j.hlc.2012.08.008
   Lastovickova J, 2008, CARDIOVASC INTER RAD, V31, P43, DOI 10.1007/s00270-007-9222-3
   Lou WS, 2009, KOREAN J RADIOL, V10, P135, DOI 10.3348/kjr.2009.10.2.135
   MULLINS CE, 1988, CIRCULATION, V77, P188, DOI 10.1161/01.CIR.77.1.188
   Okubo M, 2001, CURR OPIN CARDIOL, V16, P84, DOI 10.1097/00001573-200103000-00002
   OLAUGHLIN MP, 1993, CIRCULATION, V88, P605, DOI 10.1161/01.CIR.88.2.605
   OLAUGHLIN MP, 1991, CIRCULATION, V83, P1923, DOI 10.1161/01.CIR.83.6.1923
   Pavithran S, 2018, INDIAN HEART J, V70, P879, DOI 10.1016/j.ihj.2018.04.010
   Peters B, 2009, ANN PEDIAT CARDIOL, V2, P3, DOI 10.4103/0974-2069.52802
   POWELL AJ, 1995, CIRCULATION, V92, P3282, DOI 10.1161/01.CIR.92.11.3282
   Quandt D, 2015, CATHETER CARDIO INTE, V85, P259, DOI 10.1002/ccd.25543
   REDINGTON AN, 1994, BRIT HEART J, V72, P378
   Rodes-Cabau J, 2007, AM HEART J, V154, P186, DOI 10.1016/j.ahj.2007.03.046
   van Gameren M, 2006, EUR HEART J, V27, P2709, DOI 10.1093/eurheartj/ehl328
   Zeinali AMH, 2017, CATHETER CARDIO INTE, V90, P425, DOI 10.1002/ccd.27178
NR 25
TC 1
Z9 1
U1 0
U2 2
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD OCT
PY 2019
VL 49
IS 10
BP 932
EP 942
DI 10.4070/kcj.2019.0067
PG 11
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA IY5LE
UT WOS:000486432700003
PM 31190478
OA Green Published, Other Gold
DA 2021-04-22
ER

PT J
AU Kwon, JM
   Jeon, KH
   Kim, HM
   Kim, MJ
   Lim, S
   Kim, KH
   Song, PS
   Park, J
   Choi, RK
   Oh, BH
AF Kwon, Joon-myoung
   Jeon, Ki-Hyun
   Kim, Hyue Mee
   Kim, Min Jeong
   Lim, Sungmin
   Kim, Kyung-Hee
   Song, Pil Sang
   Park, Jinsik
   Choi, Rak Kyeong
   Oh, Byung-Hee
TI High Incidence and Mortality of Out-of-Hospital Cardiac Arrest on
   Traditional Holiday in South Korea
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Epidemiology; Out-of-hospital cardiac arrest; Mortality; Heart arrest
ID INCREASES; SURVIVAL; CALENDAR; VISITS; DEATH
AB Background and Objectives: This study aimed to confirm the effects of traditional holidays on the incidence and outcomes of out-of-hospital cardiac arrest (OHCA) in South Korea.
   Methods: We studied 95,066 OHCAs of cardiac cause from a nationwide, prospective study from the Korea OHCA Registry from January 2012 to December 2016. We compared the incidence of OHCA, in-hospital mortality, and neurologic outcomes between traditional holidays, Seollal (Lunar New Year's Day) and Chuseok (Korean Thanksgiving Day), and other day types (weekday, weekend, and public holiday).
   Results: OHCA occurred more frequently on traditional holidays than on the other days. The median OHCA incidence were 51.0 (interquartile range [IQR], 44.0-58.0), 53.0 (IQR, 46.0-60.5), 52.5 (IQR, 45.3-59.8), and 60.0 (IQR, 52.0-69.0) cases/day on weekday, weekend, public holiday, and traditional holiday, respectively (p<0.001). The OHCA occurred more often at home rather than in public place, lesser bystander cardiopulmonary resuscitation (CPR) was performed, and the rate of cessation of CPR within 20 minutes without recovery of spontaneous circulation was higher on traditional holiday. After multivariable adjustment, traditional holiday was associated with higher in-hospital mortality (adjusted hazard ratio [HR], 1.339; 95% confidence interval [CI], 1.058-1.704; p=0.016) but better neurologic outcomes (adjusted HR, 0.503; 95% CI, 0.281-0.894; p=0.020) than weekdays.
   Conclusions: The incidence of OHCAs was associated with day types in a year. It occurred more frequently on traditional holidays than on other day types. It was associated with higher in-hospital mortality and favorable neurologic outcomes than weekday.
C1 [Kwon, Joon-myoung] Mediplex Sejong Hosp, Dept Emergency Med, Incheon, South Korea.
   [Jeon, Ki-Hyun; Kim, Hyue Mee; Kim, Min Jeong; Lim, Sungmin; Kim, Kyung-Hee; Song, Pil Sang; Park, Jinsik; Choi, Rak Kyeong; Oh, Byung-Hee] Mediplex Sejong Hosp, Cardiovasc Ctr, Dept Internal Med, Div Cardiol, 20 Gyeyangmunhwa Ro, Incheon 21080, South Korea.
RP Jeon, KH (corresponding author), Mediplex Sejong Hosp, Cardiovasc Ctr, Dept Internal Med, Div Cardiol, 20 Gyeyangmunhwa Ro, Incheon 21080, South Korea.
EM imcardio@gmail.com
RI ; Oh, Byung-Hee/G-9875-2011
OI JEON, KI HYUN/0000-0002-6277-7697; Kwon,
   Joon-myoung/0000-0001-6754-1010; Kim, Min Jeong/0000-0001-8398-7020;
   Kim, Kyung-Hee/0000-0003-0708-8685; Lim, Sungmin/0000-0003-4833-4440;
   Oh, Byung-Hee/0000-0002-9945-4306
CR Adrie C, 2006, EUR HEART J, V27, P2840, DOI 10.1093/eurheartj/ehl335
   Arntz HR, 2000, EUR HEART J, V21, P315, DOI 10.1053/euhj.1999.1739
   Bagai A, 2013, CIRCULATION, V128, P2595, DOI 10.1161/CIRCULATIONAHA.113.004164
   Batal H, 2001, ACAD EMERG MED, V8, P48, DOI 10.1111/j.1553-2712.2001.tb00550.x
   Benjamin EJ, 2018, CIRCULATION, V137, pE67, DOI 10.1161/CIR.0000000000000558
   Brooks SC, 2010, RESUSCITATION, V81, P175, DOI 10.1016/j.resuscitation.2009.10.021
   Grasner JT, 2016, RESUSCITATION, V105, P188, DOI 10.1016/j.resuscitation.2016.06.004
   Holleman DR, 1996, J GEN INTERN MED, V11, P237, DOI 10.1007/BF02642481
   Kim JY, 2018, CLIN EXP EMERG MED, V5, P165, DOI 10.15441/ceem.17.259
   Kim YT, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-016925
   Mauri R, 2016, EUROPACE, V18, P398, DOI 10.1093/europace/euv218
   Nishiyama C, 2011, RESUSCITATION, V82, P1008, DOI 10.1016/j.resuscitation.2011.03.035
   Phillips DP, 2004, CIRCULATION, V110, P3781, DOI 10.1161/01.CIR.0000151424.02045.F7
   Savopoulos C, 2006, ANGIOLOGY, V57, P197, DOI 10.1177/000331970605700210
   Sohn K, 2017, SUICIDE LIFE-THREAT, V47, P217, DOI 10.1111/sltb.12281
   Takahashi K, 2015, RESUSCITATION, V96, P156, DOI 10.1016/j.resuscitation.2015.08.003
   WILLICH SN, 1990, AM J CARDIOL, V66, pG15, DOI 10.1016/0002-9149(90)90387-G
NR 17
TC 1
Z9 1
U1 1
U2 2
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD OCT
PY 2019
VL 49
IS 10
BP 945
EP 956
DI 10.4070/kcj.2019.0040
PG 12
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA IY5LE
UT WOS:000486432700005
PM 31165598
OA Other Gold, Green Published
DA 2021-04-22
ER

PT J
AU Lee, SH
   Lee, SR
   Rhee, KS
   Chae, JK
   Kim, WH
AF Lee, Sun Hwa
   Lee, Sang-Rok
   Rhee, Kyoung-Suk
   Chae, Jei-Keon
   Kim, Won-Ho
TI Usefulness of Myocardial Longitudinal Strain in Prediction of Heart
   Failure in Patients with Successfully Reperfused Anterior Wall
   ST-segment Elevation Myocardial Infarction
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Anterior wall myocardial infarction; Echocardiography; Heart failure;
   Strain
ID PERCUTANEOUS CORONARY INTERVENTION; SPECKLE-TRACKING ECHOCARDIOGRAPHY;
   STABLE SURVIVORS; DYSFUNCTION; MORTALITY; RECOVERY
AB Background and Objectives: Acute myocardial infarction-related heart failure (HF) is associated with poor outcome. This study was designed to investigate the usefulness of global longitudinal strain (GLS), global circumferential strain (GCS) and mean longitudinal strain of left anterior descending artery territory (LSant) measured by 2-dimensional speckle tracking echocardiography (2D STE) in prediction of acute anterior wall ST-segment elevation myocardial infarction (ant-STEMI)-related HF.
   Methods: A total of 171 patients with ant-STEMI who underwent successful primary coronary intervention and had available 2D STE data were enrolled. Patients were divided into 3 groups: in-hospital HF, post-discharge HF, and no-HF groups.
   Results: In-hospital and post-discharge HF developed in 39 (22.8%) and 13 (7.6%) of patients, respectively and 113 patients (69.6%) remained without HF. Multivariate analysis showed that GLS was the only factor significantly associated with the development of in-hospital HF. For post-discharge HF, LSant was the only independent predictor. Other echocardiographic or laboratory parameters did not show independent association with the development of ant-STEMI-related HF.
   Conclusions: GLS is a powerful echocardiographic parameter related to development of in-hospital HF and LSant was significantly associated with post-discharge HF in patients with successfully reperfused ant-STEMI.
C1 [Lee, Sun Hwa; Lee, Sang-Rok; Rhee, Kyoung-Suk; Chae, Jei-Keon; Kim, Won-Ho] Chonbuk Natl Univ, Dept Internal Med, Div Cardiol, Med Sch, 20 Geonji Ro, Jeonju 54907, South Korea.
   [Lee, Sun Hwa; Lee, Sang-Rok; Rhee, Kyoung-Suk; Chae, Jei-Keon; Kim, Won-Ho] Chonbuk Natl Univ, Res Inst Clin Med, Jeonju, South Korea.
   [Lee, Sun Hwa; Lee, Sang-Rok; Rhee, Kyoung-Suk; Chae, Jei-Keon; Kim, Won-Ho] Chonbuk Natl Univ Hosp, Biomed Res Inst, Jeonju, South Korea.
RP Lee, SH (corresponding author), Chonbuk Natl Univ, Dept Internal Med, Div Cardiol, Med Sch, 20 Geonji Ro, Jeonju 54907, South Korea.
EM shleemd@jbnu.ac.kr
OI Lee, Sun Hwa/0000-0001-9752-9717
CR Antoni ML, 2012, AM J CARDIOL, V109, P187, DOI 10.1016/j.amjcard.2011.08.029
   Antoni ML, 2010, EUR HEART J, V31, P2006, DOI 10.1093/eurheartj/ehq198
   Antoni ML, 2010, EUR HEART J, V31, P1640, DOI 10.1093/eurheartj/ehq105
   Biere L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086959
   Bochenek T, 2011, J AM SOC ECHOCARDIOG, V24, P1342, DOI 10.1016/j.echo.2011.09.003
   Bonios MJ, 2014, HELL J CARDIOL, V55, P305
   Choi SW, 2015, INT J CARDIOL, V196, P165, DOI 10.1016/j.ijcard.2015.05.186
   Ersboll M, 2013, J AM COLL CARDIOL, V61, P2365, DOI 10.1016/j.jacc.2013.02.061
   Ersboll M, 2012, J AM SOC ECHOCARDIOG, V25, P1280, DOI 10.1016/j.echo.2012.09.006
   Ersboll M, 2012, EUR J HEART FAIL, V14, P1121, DOI 10.1093/eurjhf/hfs107
   Farsalinos KE, 2015, J AM SOC ECHOCARDIOG, V28, P1171, DOI 10.1016/j.echo.2015.06.011
   Grabka M, 2013, CORONARY ARTERY DIS, V24, P127, DOI 10.1097/MCA.0b013e32835b6798
   Hellermann JP, 2003, AM J EPIDEMIOL, V157, P1101, DOI 10.1093/aje/kwg078
   Jang SY, 2016, ECHOCARDIOGR-J CARD, V33, P984, DOI 10.1111/echo.13208
   Kalam K, 2014, HEART, V100, P1673, DOI 10.1136/heartjnl-2014-305538
   Kelly DJ, 2011, AM HEART J, V162, P663, DOI 10.1016/j.ahj.2011.08.002
   Lang RM, 2015, EUR HEART J-CARD IMG, V16, P233, DOI 10.1093/ehjci/jev014
   Lewis EF, 2003, J AM COLL CARDIOL, V42, P1446, DOI 10.1016/S0735-1097(03)01057-X
   Lewis EF, 2008, EUR HEART J, V29, P748, DOI 10.1093/eurheartj/ehn062
   Mega JL, 2004, J AM COLL CARDIOL, V44, P335, DOI 10.1016/j.jacc.2004.04.033
   Meimoun P, 2015, J AM SOC ECHOCARDIOG, V28, P1366, DOI 10.1016/j.echo.2015.07.022
   Mignot A, 2010, J AM SOC ECHOCARDIOG, V23, P1019, DOI 10.1016/j.echo.2010.07.019
   Munk K, 2011, EUR J ECHOCARDIOGR, V12, DOI 10.1093/ejechocard/jeq168
   Park Seong-Mi, 2010, Korean Circ J, V40, P639, DOI 10.4070/kcj.2010.40.12.639
   Park YH, 2008, J AM SOC ECHOCARDIOG, V21, P262, DOI 10.1016/j.echo.2007.08.026
   Santoro GM, 2008, EUR J HEART FAIL, V10, P780, DOI 10.1016/j.ejheart.2008.06.004
   Shehata M, 2015, ECHOCARDIOGR-J CARD, V32, P630, DOI 10.1111/echo.12704
   Stanton T, 2009, CIRC-CARDIOVASC IMAG, V2, P356, DOI 10.1161/CIRCIMAGING.109.862334
   Velazquez EJ, 2004, EUR HEART J, V25, P1911, DOI 10.1016/j.ehj.2004.08.006
   Zaliaduonyte-Peksiene D, 2012, ECHOCARDIOGR-J CARD, V29, P419, DOI 10.1111/j.1540-8175.2011.01597.x
NR 30
TC 2
Z9 2
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD OCT
PY 2019
VL 49
IS 10
BP 960
EP 972
DI 10.4070/kcj.2018.0421
PG 13
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA IY5LE
UT WOS:000486432700007
PM 31074229
OA Green Published, Other Gold
DA 2021-04-22
ER

PT J
AU Jung, SY
   Kim, AY
   Jung, JW
   Choi, JY
AF Jung, Se Yong
   Kim, Ah Young
   Jung, Jo Won
   Choi, Jae Young
TI Procedural, Early and Long-term Outcomes after Percutaneous Closure of
   Atrial Septal Defect: Comparison between Large and Very Large Atrial
   Septal Defect Groups
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Atrial septal defect; Septal occluder; Cardiac catheterization; Clinical
   outcomes
ID BALLOON-ASSISTED TECHNIQUE; TRANSCATHETER CLOSURE; DEVICE CLOSURE;
   PULMONARY-HYPERTENSION; OCCLUDER; MIGRAINE; CHILDREN; GUIDANCE; DISEASE;
   SAFETY
AB Background: This study aimed to compare procedural, early and long-term outcome of device closure of atrial septal defect (ASD) between large ASD patients and very large ASD patients.
   Methods: We carried a retrospective study of adult large ASD (defined as >= 25 mm) treated by percutaneous closure using Amplatzer septal occluder during 12-year period (May 2003-February 2015) at a single tertiary center. A total of 269 patients were divided into 2 groups, according to the pre-procedural maximal ASD diameter; 25 mm <= ASD<35mm, group 1 (n=216) and 35 mm=ASD, group 2 (n=53). We compared procedural parameters, early complications and long-term follow-up results between 2 groups.
   Results: The need of modified implantation techniques (MITs) was higher group 2 (23.6% vs. 37.7%, p=0.034). Procedural success rate was considerably high in both groups (99.1% in group 1 vs. 100% in group 2, p=0.620). Major complications were occurred in 4 (1.5%) patients (1.4% vs. 1.9%, p=0.804). Minor complication rate was not different between 2 groups. During long-term follow-up (47.2 +/- 32.0 months, range, 6.0-135.5), there was one major complication (0.4%) of stroke. Most common long-term minor event was migraine headache (3.9%) followed by arrhythmias (1.9%) without statistical difference between 2 groups.
   Conclusions: Although MIT was more frequently required in very large ASD groups, the procedural, early and long-term outcomes after percutaneous ASD closure were similar in both groups. This suggested that percutaneous ASD closure for very large ASD could be considered a good treatment option.
C1 [Jung, Se Yong; Kim, Ah Young; Jung, Jo Won; Choi, Jae Young] Yonsei Univ, Dept Pediat, Div Pediat Cardiol, Coll Med, 50-1 Yonsei Ro, Seoul 03722, South Korea.
RP Choi, JY (corresponding author), Yonsei Univ, Dept Pediat, Div Pediat Cardiol, Coll Med, 50-1 Yonsei Ro, Seoul 03722, South Korea.
EM cjy0122@yuhs.ac
RI Jung, Yong/AAR-3286-2020
OI Jung, Yong/0000-0003-1337-563X; Kim, Ah Young/0000-0002-0713-4461; Choi,
   Jae Young/0000-0002-1247-6669; Jung, Jo Won/0000-0001-5384-9161
CR Abaci A, 2013, CATHETER CARDIO INTE, V82, P1123, DOI 10.1002/ccd.24875
   Amin Z, 2006, CATHETER CARDIO INTE, V68, P778, DOI 10.1002/ccd.20872
   Amoozgar H, 2014, PEDIATR CARDIOL, V35, P1301, DOI 10.1007/s00246-014-0986-3
   Anonymous, 2007, Zhonghua Xinxueguanbing Zazhi, V35, P797
   Asrress KN, 2009, HEART, V95, P327, DOI 10.1136/hrt.2007.135137
   Balint OH, 2008, HEART, V94, P1189, DOI 10.1136/hrt.2006.114660
   Baruteau AE, 2014, CIRC-CARDIOVASC INTE, V7, P837, DOI 10.1161/CIRCINTERVENTIONS.113.001254
   CHERIAN G, 1983, AM HEART J, V105, P952, DOI 10.1016/0002-8703(83)90396-4
   Dalvi BV, 2005, CATHETER CARDIO INTE, V64, P102, DOI 10.1002/ccd.20248
   Du ZD, 2002, J AM COLL CARDIOL, V39, P1836, DOI 10.1016/S0735-1097(02)01862-4
   Du ZD, 2001, AM J CARDIOL, V88, P1450, DOI 10.1016/S0002-9149(01)02135-X
   Du ZD, 2001, AM J CARDIOL, V88, pA9
   El-Said H, 2015, CATHETER CARDIO INTE, V85, P227, DOI 10.1002/ccd.25684
   Everett AD, 2009, PEDIATR CARDIOL, V30, P240, DOI 10.1007/s00246-008-9325-x
   Feltes TF, 2011, CIRCULATION, V123, P2607, DOI 10.1161/CIR.0b013e31821b1f10
   Geva T, 2014, LANCET, V383, P1921, DOI 10.1016/S0140-6736(13)62145-5
   HELLENBRAND WE, 1990, AM J CARDIOL, V66, P207, DOI 10.1016/0002-9149(90)90590-W
   Kazmouz S, 2013, J INVASIVE CARDIOL, V25, P257
   Kim NK, 2012, CIRC J, V76, P2119, DOI 10.1253/circj.CJ-11-1286
   KING TD, 1976, JAMA-J AM MED ASSOC, V235, P2506, DOI 10.1001/jama.235.23.2506
   Lopez K, 2005, CATHETER CARDIO INTE, V66, P580, DOI 10.1002/ccd.20468
   Masura J, 1997, CATHETER CARDIO DIAG, V42, P388, DOI 10.1002/(SICI)1097-0304(199712)42:4<388::AID-CCD7>3.0.CO;2-7
   Masura J, 2005, J AM COLL CARDIOL, V45, P505, DOI 10.1016/j.jacc.2004.10.066
   Moore J, 2013, JACC-CARDIOVASC INTE, V6, P433, DOI 10.1016/j.jcin.2013.02.005
   Mortelmans K, 2005, EUR HEART J, V26, P1533, DOI 10.1093/eurheartj/ehi170
   Narin N, 2014, J INVASIVE CARDIOL, V26, P597
   Nyboe C, 2015, HEART, V101, P706, DOI 10.1136/heartjnl-2014-306552
   Pillai AA, 2014, CARDIOVASC DIAGN THE, V4, P21, DOI 10.3978/j.issn.2223-3652.2014.02.05
   Rodes-Cabau J, 2003, CATHETER CARDIO INTE, V60, P540, DOI 10.1002/ccd.10713
   Rodes-Cabau J, 2008, AM J CARDIOL, V101, P688, DOI 10.1016/j.amjcard.2007.10.034
   Rodriguez M, 2003, REV ESP CARDIOL, V56, P888, DOI 10.1157/13051616
   Rohit Manoj Kumar, 2014, Indian Heart J, V66, P366, DOI 10.1016/j.ihj.2014.03.013
   Romanelli G, 2014, HEART LUNG CIRC, V23, P127, DOI 10.1016/j.hlc.2013.07.020
   STEELE PM, 1987, CIRCULATION, V76, P1037, DOI 10.1161/01.CIR.76.5.1037
   Thomson JDR, 2002, HEART, V87, P466, DOI 10.1136/heart.87.5.466
   Varma C, 2004, CATHETER CARDIO INTE, V61, P131, DOI 10.1002/ccd.10700
   Veldtman GR, 2001, J AM COLL CARDIOL, V37, P2108, DOI 10.1016/S0735-1097(01)01305-5
   Wahab HA, 2011, CATHETER CARDIO INTE, V78, P1041, DOI 10.1002/ccd.23182
NR 38
TC 4
Z9 5
U1 0
U2 7
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD OCT
PY 2019
VL 49
IS 10
BP 975
EP 986
DI 10.4070/kcj.2018.0391
PG 12
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA IY5LE
UT WOS:000486432700009
PM 31165594
OA Green Published, Other Gold
DA 2021-04-22
ER

PT J
AU Lee, SY
AF Lee, Sang-Yun
TI The Significance of Self-Expandable Stents in Patients with Congenital
   Heart Disease in Current Era
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
ID IMPLANTATION
C1 [Lee, Sang-Yun] Seoul Natl Univ Hosp, Dept Pediat, 101 Daehak Ro, Seoul 03080, South Korea.
RP Lee, SY (corresponding author), Seoul Natl Univ Hosp, Dept Pediat, 101 Daehak Ro, Seoul 03080, South Korea.
EM saeng123@hanmail.net
CR Bergersen L, 2017, JACC-CARDIOVASC INTE, V10, P1763, DOI 10.1016/j.jcin.2017.05.034
   Cheung YF, 2000, J AM COLL CARDIOL, V35, P1007, DOI 10.1016/S0735-1097(99)00644-0
   Hijazi ZM, 1996, CATHETER CARDIO DIAG, V38, P16
   Jang GY, 2019, KOREAN CIRC J, V49, P932, DOI 10.4070/kcj.2019.0067
   Kenny D, 2018, KOREAN CIRC J, V48, P350, DOI 10.4070/kcj.2018.0064
   Kim GB, 2018, CIRC-CARDIOVASC INTE, V11, DOI 10.1161/CIRCINTERVENTIONS.118.006494
   Lee SY, 2012, PEDIATR CARDIOL, V33, P1446, DOI 10.1007/s00246-012-0268-x
   Morgan G, 2019, EUROINTERVENTION, V14, P1363, DOI 10.4244/EIJ-D-18-00299
   MULLINS CE, 1988, CIRCULATION, V77, P188, DOI 10.1161/01.CIR.77.1.188
   Vollenbroich R, 2019, INT J CARDIOL, V290, P45, DOI 10.1016/j.ijcard.2019.03.050
NR 10
TC 0
Z9 0
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD OCT
PY 2019
VL 49
IS 10
BP 943
EP 944
DI 10.4070/kcj.2019.0201
PG 2
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA IY5LE
UT WOS:000486432700004
PM 31456365
OA Other Gold, Green Published
DA 2021-04-22
ER

PT J
AU Lee, JM
AF Lee, Ju-Mi
TI Are Traditional Holidays (Seollal and Chuseok) Harmful for Cardiac
   Arrest?
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
C1 [Lee, Ju-Mi] Eulji Coll Med, Dept Prevent Med, 77,Gyeryong Ro 771Beon Gil, Daejeon 34824, South Korea.
RP Lee, JM (corresponding author), Eulji Coll Med, Dept Prevent Med, 77,Gyeryong Ro 771Beon Gil, Daejeon 34824, South Korea.
EM JMLee01@eulji.ac.kr
CR Eagle K, 2012, J APPL TOXICOL, V32, P751, DOI 10.1002/jat.2764
   Esler M, 2017, NEUROSCI BIOBEHAV R, V74, P269, DOI 10.1016/j.neubiorev.2016.10.011
   Kwon JM, 2019, KOREAN CIRC J, V49, P945, DOI 10.4070/kcj.2019.0040
   Mohammad MA, 2018, BMJ-BRIT MED J, V363, DOI 10.1136/bmj.k4811
   Phillips DP, 2004, CIRCULATION, V110, P3781, DOI 10.1161/01.CIR.0000151424.02045.F7
   Pyun WB, 2018, KOREAN CIRC J, V48, P652, DOI 10.4070/kcj.2018.0194
   Reedman Lisa Armstrong, 2008, Congest Heart Fail, V14, P307, DOI 10.1111/j.1751-7133.2008.00021.x
   Shah M, 2016, CLIN RES CARDIOL, V105, P865, DOI 10.1007/s00392-016-0995-8
   Wirtz PH, 2017, CURR CARDIOL REP, V19, DOI 10.1007/s11886-017-0919-x
NR 9
TC 0
Z9 0
U1 1
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD OCT
PY 2019
VL 49
IS 10
BP 957
EP 959
DI 10.4070/kcj.2019.0159
PG 3
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA IY5LE
UT WOS:000486432700006
PM 31347315
OA Green Published, Other Gold
DA 2021-04-22
ER

PT J
AU Chung, H
AF Chung, Hyemoon
TI Myocardial Longitudinal Strain in Prediction of Heart Failure after
   Acute Myocardial Infarction
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
ID TASK-FORCE; MANAGEMENT; ELEVATION
C1 [Chung, Hyemoon] Kyung Hee Univ, Med Ctr, Div Cardiol, Dept Internal Med, 23 Kyungheedae Ro, Seoul 02447, South Korea.
RP Chung, H (corresponding author), Kyung Hee Univ, Med Ctr, Div Cardiol, Dept Internal Med, 23 Kyungheedae Ro, Seoul 02447, South Korea.
EM bluesunny52@gmail.com
CR Biere L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086959
   Carluccio E, 2000, AM J CARDIOL, V85, P411, DOI 10.1016/S0002-9149(99)00764-X
   Ersboll M, 2013, J AM COLL CARDIOL, V61, P2365, DOI 10.1016/j.jacc.2013.02.061
   Ersboll M, 2012, J AM SOC ECHOCARDIOG, V25, P1280, DOI 10.1016/j.echo.2012.09.006
   Ibanez B, 2018, EUR HEART J, V39, P119, DOI 10.1093/eurheartj/ehx393
   Lee SH, 2019, KOREAN CIRC J, V49, P960, DOI 10.4070/kcj.2018.0421
   Moller JE, 2006, AM HEART J, V151, P419, DOI 10.1016/j.ahj.2005.03.042
   O'Gara PT, 2013, J AM COLL CARDIOL, V61, pE78, DOI 10.1016/j.jacc.2012.11.019
   Park YH, 2008, J AM SOC ECHOCARDIOG, V21, P262, DOI 10.1016/j.echo.2007.08.026
   Wang N, 2016, EUR HEART J, V37, P466, DOI 10.1093/eurheartj/ehv558
NR 10
TC 1
Z9 1
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD OCT
PY 2019
VL 49
IS 10
BP 973
EP 974
DI 10.4070/kcj.2019.0132
PG 2
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA IY5LE
UT WOS:000486432700008
PM 31165601
OA Green Published, Other Gold
DA 2021-04-22
ER

PT J
AU Jang, SI
AF Jang, So-Ick
TI Procedural, Early and Long-Term Outcomes after Transcatheter Atrial
   Septal Defects Closure: Comparison between Large and Very Large Atrial
   Septal Defect Groups
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
ID DEVICE CLOSURE; ECHOCARDIOGRAPHY
C1 [Jang, So-Ick] Sejong Gen Hosp, Dept Pediat, 28,Hohyeon Ro 489Beon Gil, Bucheon 14754, South Korea.
RP Jang, SI (corresponding author), Sejong Gen Hosp, Dept Pediat, 28,Hohyeon Ro 489Beon Gil, Bucheon 14754, South Korea.
EM prelud15@korea.com
CR Alqahtani F, 2017, J INTERV CARDIOL, V30, P234, DOI 10.1111/joic.12382
   Amedro P, 2019, J THORAC DIS, V11, P708, DOI 10.21037/jtd.2019.02.89
   Berger F, 2001, J Interv Cardiol, V14, P63, DOI 10.1111/j.1540-8183.2001.tb00714.x
   Chen Q, 2017, J CARDIOTHORAC SURG, V12, DOI 10.1186/s13019-017-0639-8
   Jung SY, 2019, KOREAN CIRC J, V49, P975, DOI 10.4070/kcj.2018.0391
   Kazmouz S, 2013, J INVASIVE CARDIOL, V25, P257
   Kim JY, 2017, KOREAN CIRC J, V47, P245, DOI 10.4070/kcj.2016.0205
   Medford BA, 2014, J AM SOC ECHOCARDIOG, V27, P984, DOI 10.1016/j.echo.2014.05.017
   Narin N, 2014, J INVASIVE CARDIOL, V26, P597
   Pillai AA, 2018, CARDIOL YOUNG, V28, P1122, DOI 10.1017/S1047951118001099
   Varma C, 2004, CATHETER CARDIO INTE, V61, P131, DOI 10.1002/ccd.10700
NR 11
TC 1
Z9 1
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD OCT
PY 2019
VL 49
IS 10
BP 987
EP 989
DI 10.4070/kcj.2019.0165
PG 3
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA IY5LE
UT WOS:000486432700010
PM 31347317
OA Other Gold, Green Published
DA 2021-04-22
ER

PT J
AU Lee, CH
   Hur, SH
AF Lee, Cheol Hyun
   Hur, Seung-Ho
TI Optimization of Percutaneous Coronary Intervention Using Optical
   Coherence Tomography
SO KOREAN CIRCULATION JOURNAL
LA English
DT Review
DE Coronary artery disease; Percutaneous coronary intervention; Optical
   coherence tomography
ID ELUTING STENT IMPLANTATION; INTRAVASCULAR ULTRASOUND ANALYSIS; ACUTE
   MYOCARDIAL-INFARCTION; FRACTIONAL FLOW RESERVE; TAXUS ATLAS WORKHORSE;
   GUIDE DECISION-MAKING; TISSUE PROLAPSE; CLINICAL IMPACT; HARMONIZING
   OUTCOMES; PLAQUE MORPHOLOGY
AB Compared to the luminogram obtained by angiography, intravascular modalities produce cross-sectional images of coronary arteries with a far greater spatial resolution. It is capable of accurately determining the vessel size and plaque morphology. It also eliminates some disadvantages such as contrast streaming, foreshortening, vessel overlap, and angle dependency inherent to angiography. Currently, the development of its system and the visualization of coronary arteries has shown significant advancement. Of those, optical coherence tomography (OCT) makes it possible to obtain high-resolution images of intraluminal and transmural coronary structures leading to navigation of the treatment strategy before and after stent implantations. The aim of this review is to summarize the published data on the clinical utility of OCT, focusing on the use of OCT in interventional cardiology practice to optimize percutaneous coronary intervention.
C1 [Lee, Cheol Hyun; Hur, Seung-Ho] Keimyung Univ, Dept Internal Med, Div Cardiol, Dongsan Hosp, 1035 Dalgubeol Daero, Daegu 42601, South Korea.
RP Hur, SH (corresponding author), Keimyung Univ, Dept Internal Med, Div Cardiol, Dongsan Hosp, 1035 Dalgubeol Daero, Daegu 42601, South Korea.
EM shur@dsmc.or.kr
OI Hur, Seung-Ho/0000-0002-3895-1915; Lee, Cheol Hyun/0000-0003-4203-1457
CR Adriaenssens T, 2017, CIRCULATION, V136, P1007, DOI 10.1161/CIRCULATIONAHA.117.026788
   Ali ZA, 2016, LANCET, V388, P2618, DOI 10.1016/S0140-6736(16)31922-5
   Antonsen L, 2015, CIRC-CARDIOVASC INTE, V8, DOI 10.1161/CIRCINTERVENTIONS.114.002446
   Bavishi C, 2017, AM HEART J, V185, P26, DOI 10.1016/j.ahj.2016.10.008
   Calvert PA, 2016, CATHETER CARDIO INTE, V88, P340, DOI 10.1002/ccd.26275
   Cheneau E, 2003, CIRCULATION, V108, P43, DOI 10.1161/01.CIR.0000078636.71728.40
   Choi SY, 2011, CIRC-CARDIOVASC INTE, V4, P239, DOI 10.1161/CIRCINTERVENTIONS.110.959791
   Christou MAC, 2007, AM J CARDIOL, V99, P450, DOI 10.1016/j.amjcard.2006.09.092
   Costa MA, 2008, AM J CARDIOL, V101, P1704, DOI 10.1016/j.amjcard.2008.02.053
   de Jaegere P, 1998, EUR HEART J, V19, P1214, DOI 10.1053/euhj.1998.1012
   Doi H, 2009, JACC-CARDIOVASC INTE, V2, P1269, DOI 10.1016/j.jcin.2009.10.005
   Fischer JJ, 2002, AM J CARDIOL, V90, P210, DOI 10.1016/S0002-9149(02)02456-6
   Francaviglia B, 2016, JACC-CARDIOVASC IMAG, V9, P210, DOI 10.1016/j.jcmg.2015.01.011
   Fujii K, 2005, J AM COLL CARDIOL, V45, P995, DOI 10.1016/j.jacc.2004.12.066
   Fujino A, 2018, EUROINTERVENTION, V13, pE2182, DOI 10.4244/EIJ-D-17-00962
   Futamatsu H, 2006, J AM COLL CARDIOL, V48, P1139, DOI 10.1016/j.jacc.2006.05.050
   Galougahi KK, 2016, JACC-CARDIOVASC INTE, V9, P2362, DOI 10.1016/j.jcin.2016.09.028
   Gonzalo N, 2009, HEART, V95, P1913, DOI 10.1136/hrt.2009.172072
   Guo N, 2010, CIRCULATION, V122, P1077, DOI 10.1161/CIRCULATIONAHA.109.906040
   Habara M, 2012, CIRC-CARDIOVASC INTE, V5, P193, DOI 10.1161/CIRCINTERVENTIONS.111.965111
   Hodgson J M, 1989, Int J Card Imaging, V4, P187, DOI 10.1007/BF01745149
   Hong MK, 2006, EUR HEART J, V27, P1305, DOI 10.1093/eurheartj/ehi882
   Hong SJ, 2015, JAMA-J AM MED ASSOC, V314, P2155, DOI 10.1001/jama.2015.15454
   Hong YJ, 2013, INT J CARDIOL, V166, P646, DOI 10.1016/j.ijcard.2011.11.092
   Hong YJ, 2008, JACC-CARDIOVASC IMAG, V1, P489, DOI 10.1016/j.jcmg.2008.04.004
   Iannaccone M, 2017, CATHETER CARDIO INTE, V90, pE46, DOI 10.1002/ccd.26880
   Ikenaga H, 2013, J CARDIOL, V62, P71, DOI 10.1016/j.jjcc.2013.03.005
   Imola F, 2013, AM J CARDIOL, V111, P526, DOI 10.1016/j.amjcard.2012.10.033
   Imola F, 2010, EUROINTERVENTION, V6, P575, DOI 10.4244/EIJV6I5A97
   Jakabcin J, 2010, CATHETER CARDIO INTE, V75, P578, DOI 10.1002/ccd.22244
   Jang IK, 2001, CIRCULATION, V104, P2754, DOI 10.1161/hc4701.098069
   Jang JS, 2014, JACC-CARDIOVASC INTE, V7, pE27, DOI 10.1016/j.jcin.2013.09.013
   Jin QH, 2011, CARDIOLOGY, V119, P197, DOI 10.1159/000331442
   Jones DA, 2018, JACC-CARDIOVASC INTE, V11, P1313, DOI 10.1016/j.jcin.2018.01.274
   Kang SJ, 2013, AM J CARDIOL, V111, P1408, DOI 10.1016/j.amjcard.2013.01.288
   Katagiri Y, 2019, CATHETER CARDIO INTE, V93, pE225, DOI 10.1002/ccd.28105
   Kim IC, 2016, INT J CARDIOL, V221, P860, DOI 10.1016/j.ijcard.2016.07.080
   Kim IC, 2016, J INTERV CARDIOL, V29, P216, DOI 10.1111/joic.12276
   Kini AS, 2015, JACC-CARDIOVASC INTE, V8, P937, DOI 10.1016/j.jcin.2015.03.016
   Kobayashi N, 2016, CIRC-CARDIOVASC INTE, V9, DOI 10.1161/CIRCINTERVENTIONS.115.003553
   Kobayashi Y, 2014, CIRC J, V78, P2209, DOI 10.1253/circj.CJ-14-0108
   Kolh P, 2014, EUR J CARDIO-THORAC, V46, P517, DOI [10.1093/eurheartj/ehu278, 10.1093/ejcts/ezu366]
   Kubo T, 2017, EUR HEART J, V38, P3139, DOI 10.1093/eurheartj/ehx351
   Kubo T, 2013, JACC-CARDIOVASC IMAG, V6, P1095, DOI 10.1016/j.jcmg.2013.04.014
   Kubo T, 2008, JACC-CARDIOVASC IMAG, V1, P475, DOI 10.1016/j.jcmg.2008.03.012
   Lee SY, 2018, JACC-CARDIOVASC IMAG, V11, P1810, DOI 10.1016/j.jcmg.2017.12.014
   Lee T, 2011, CIRC-CARDIOVASC INTE, V4, P378, DOI 10.1161/CIRCINTERVENTIONS.111.962506
   Levine GN, 2011, J AM COLL CARDIOL, V58, pE44, DOI 10.1016/j.jacc.2011.08.007
   Liu J, 2009, AM J CARDIOL, V103, P501, DOI 10.1016/j.amjcard.2008.10.010
   Liu XB, 2009, JACC-CARDIOVASC INTE, V2, P428, DOI 10.1016/j.jcin.2009.01.011
   Maehara Akiko, 2015, Interv Cardiol Clin, V4, P285, DOI 10.1016/j.iccl.2015.02.003
   Maehara A, 2015, JACC-CARDIOVASC INTE, V8, P1704, DOI 10.1016/j.jcin.2015.07.024
   Maejima N, 2016, CIRC J, V80, P1413, DOI 10.1253/circj.CJ-15-1059
   MAILLOUX L, 1967, NEW ENGL J MED, V277, P1113, DOI 10.1056/NEJM196711232772103
   Meneveau N, 2016, CIRCULATION, V134, P906, DOI 10.1161/CIRCULATIONAHA.116.024393
   MINTZ GS, 1995, J AM COLL CARDIOL, V25, P1479, DOI 10.1016/0735-1097(95)00088-L
   Morino Y, 2001, AM J CARDIOL, V88, P301, DOI 10.1016/S0002-9149(01)01646-0
   Neumann FJ, 2019, EUR HEART J, V40, P87, DOI 10.1093/eurheartj/ehy394
   Nijjer SS, 2015, CARDIOVASC REVASCULA, V16, P167, DOI 10.1016/j.carrev.2015.01.006
   Okabe T, 2007, AM J CARDIOL, V100, P615, DOI 10.1016/j.amjcard.2007.03.072
   Okamura T, 2014, EUROINTERVENTION, V10, P907, DOI 10.4244/EIJV10I8A157
   Otake H, 2018, JACC-CARDIOVASC IMAG, V11, P111, DOI 10.1016/j.jcmg.2017.06.021
   Park SJ, 2012, JACC-CARDIOVASC INTE, V5, P1029, DOI 10.1016/j.jcin.2012.07.007
   Patel MR, 2010, NEW ENGL J MED, V362, P886, DOI 10.1056/NEJMoa0907272
   Porto I, 2012, CIRC-CARDIOVASC INTE, V5, P89, DOI 10.1161/CIRCINTERVENTIONS.111.965624
   Prail F, 2015, JACC-CARDIOVASC IMAG, V8, P1297, DOI 10.1016/j.jcmg.2015.08.013
   Prati F, 2012, EUROINTERVENTION, V8, P823, DOI 10.4244/EIJV8I7A125
   Qiu FY, 2016, JACC-CARDIOVASC INTE, V9, P1499, DOI 10.1016/j.jcin.2016.05.043
   Romagnoli E, 2008, JACC-CARDIOVASC INTE, V1, P22, DOI 10.1016/j.jcin.2007.10.005
   Sakurai R, 2005, AM J CARDIOL, V96, P1251, DOI 10.1016/j.amjcard.2005.06.066
   Shlofmitz Evan, 2018, Interv Cardiol Clin, V7, P329, DOI 10.1016/j.iccl.2018.03.001
   Soeda T, 2015, CIRCULATION, V132, P1020, DOI 10.1161/CIRCULATIONAHA.114.014704
   Sohn J, 2015, INT J CARDIOVAS IMAG, V31, P21, DOI 10.1007/s10554-014-0540-7
   Song HG, 2014, CATHETER CARDIO INTE, V83, P873, DOI 10.1002/ccd.24560
   Sonoda S, 2004, J AM COLL CARDIOL, V43, P1959, DOI 10.1016/j.jacc.2004.01.044
   Souteyrand G, 2016, EUR HEART J, V37, P1208, DOI 10.1093/eurheartj/ehv711
   Steinberg DH, 2010, JACC-CARDIOVASC INTE, V3, P486, DOI 10.1016/j.jcin.2010.03.007
   Sugiyama T, 2014, INT J CARDIOL, V176, P182, DOI 10.1016/j.ijcard.2014.07.005
   Tanaka A, 2009, EUR HEART J, V30, P1348, DOI 10.1093/eurheartj/ehp122
   Tearney GJ, 2012, J AM COLL CARDIOL, V59, P1058, DOI 10.1016/j.jacc.2011.09.079
   van der Sijde JN, 2016, EUROINTERVENTION, V12, P855, DOI 10.4244/EIJV12I7A140
   Wijns W, 2015, EUR HEART J, V36, P3346, DOI 10.1093/eurheartj/ehv367
   Yabushita H, 2002, CIRCULATION, V106, P1640, DOI 10.1161/01.CIR.0000029927.92825.F6
   Yonetsu T, 2011, INT J CARDIOL, V146, P80, DOI 10.1016/j.ijcard.2010.06.010
NR 84
TC 7
Z9 7
U1 0
U2 3
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD SEP
PY 2019
VL 49
IS 9
BP 771
EP 793
DI 10.4070/kcj.2019.0198
PG 23
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA IU4YT
UT WOS:000483593700001
PM 31456372
OA Other Gold, Green Published
DA 2021-04-22
ER

PT J
AU Joung, B
AF Joung, Boyoung
TI Risk Factor Management for Atrial Fibrillation
SO KOREAN CIRCULATION JOURNAL
LA English
DT Review
DE Atrial fibrillation; Risk factors; Hypertension; Obesity
ID BODY-FAT DISTRIBUTION; C-REACTIVE PROTEIN; AIR-POLLUTION;
   CHA(2)DS(2)-VASC SCORE; ASIAN PATIENTS; CARDIOVASCULAR-DISEASE; ORAL
   ANTICOAGULANTS; PARTICULATE MATTER; STROKE PREVENTION; FEMALE SEX
AB Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia in the general population. Many cardiovascular diseases and concomitant conditions increase the risk of the development of AF, recurrent AF, and AF-associated complications. Knowledge of these factors and their management is hence important for the optimal management of patients with AF. Recent studies have suggested that lowering the blood pressure threshold can improve the patients' outcome. Moreover, adverse events associated with a longer duration of hypertension can be prevented through strict blood pressure control. Pre-hypertension, impaired fasting glucose, abdominal obesity, weight fluctuation, and exposure to air pollution are related to the development of AF. Finally, female sex is not a risk factor of stroke, and the age threshold for stroke prevention should be lowered in Asian populations. The management of diseases related to AF should be provided continuously, whereas lifestyle factors should be monitored in an integrated manner.
C1 [Joung, Boyoung] Yonsei Univ, Yonsei Cardiovasc Hosp, Dept Internal Med, Div Cardiol,Coll Med, 50 Yonsei Ro, Seoul 03722, South Korea.
RP Joung, B (corresponding author), Yonsei Univ, Yonsei Cardiovasc Hosp, Dept Internal Med, Div Cardiol,Coll Med, 50 Yonsei Ro, Seoul 03722, South Korea.
EM cby6908@yuhs.ac
OI Joung, Boyoung/0000-0001-9036-7225
FU Korean Healthcare Technology R&D project - Ministry of Health Welfare
   [HI15C1200]
FX This study was supported by a research grant from the Korean Healthcare
   Technology R&D project funded by the Ministry of Health & Welfare
   (HI15C1200).
CR Abed HS, 2013, HEART RHYTHM, V10, P90, DOI 10.1016/j.hrthm.2012.08.043
   Baek YS, 2017, J AM HEART ASSOC, V6, DOI 10.1161/JAHA.116.004705
   Britton KA, 2013, J AM COLL CARDIOL, V62, P921, DOI 10.1016/j.jacc.2013.06.027
   Brook RD, 2010, CIRCULATION, V121, P2331, DOI 10.1161/CIR.0b013e3181dbece1
   Chao TF, 2016, STROKE, V47, P2462, DOI 10.1161/STROKEAHA.116.013880
   Chao TF, 2015, J AM COLL CARDIOL, V66, P1339, DOI 10.1016/j.jacc.2015.07.026
   Chao TF, 2015, J AM COLL CARDIOL, V65, P635, DOI 10.1016/j.jacc.2014.11.046
   Chung MK, 2001, CIRCULATION, V104, P2886, DOI 10.1161/hc4901.101760
   Friberg L, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e3522
   Frost L, 2014, OBESITY, V22, P1546, DOI 10.1002/oby.20706
   Guo YT, 2013, INT J CARDIOL, V168, P904, DOI 10.1016/j.ijcard.2012.10.052
   Huxley RR, 2014, CIRC-ARRHYTHMIA ELEC, V7, P620, DOI 10.1161/CIRCEP.113.001244
   Hwang HJ, 2011, INT J CARDIOL, V146, P28, DOI 10.1016/j.ijcard.2009.05.065
   Joung B, 2018, KOREAN CIRC J, V48, P1033, DOI 10.4070/kcj.2018.0339
   Kang SH, 2017, CIRC J, V81, P1158, DOI 10.1253/circj.CJ-16-1267
   Kim D, 2018, J AM COLL CARDIOL, V72, P1233, DOI 10.1016/j.jacc.2018.05.076
   Kim D, 2019, EUR HEART J, V40, P2313, DOI 10.1093/eurheartj/ehz386
   Kim IS, 2019, INT J CARDIOL, V283, P178, DOI 10.1016/j.ijcard.2018.12.048
   Kim IS, 2017, INT J CARDIOL, V240, P214, DOI 10.1016/j.ijcard.2017.03.122
   Kim TH, 2019, EUR HEART J, V40, P809, DOI 10.1093/eurheartj/ehy877
   Kim TH, 2018, STROKE, V49, P1872, DOI 10.1161/STROKEAHA.118.021047
   Kim TH, 2017, STROKE, V48, P2984, DOI 10.1161/STROKEAHA.117.018551
   Kim TH, 2017, STROKE, V48, P1524, DOI 10.1161/STROKEAHA.117.016926
   Kirchhof P, 2016, EUR J CARDIO-THORAC, V50, pE1, DOI 10.1093/ejcts/ezw313
   Lee H, 2017, KOREAN CIRC J, V47, P56, DOI 10.4070/kcj.2016.0045
   Lee HY, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13061-4
   Lee SS, 2017, EUR HEART J, V38, P2599, DOI 10.1093/eurheartj/ehx316
   Lim YM, 2019, MAYO CLIN PROC, V94, P225, DOI 10.1016/j.mayocp.2018.10.019
   Link MS, 2013, J AM COLL CARDIOL, V62, P816, DOI 10.1016/j.jacc.2013.05.043
   Lip GYH, 2017, NAT REV CARDIOL, V14, P627, DOI 10.1038/nrcardio.2017.153
   Lip GYH, 2017, THROMB HAEMOSTASIS, V117, P1230, DOI 10.1160/TH16-11-0876
   Lip GYH, 2015, INT J CARDIOL, V180, P246, DOI 10.1016/j.ijcard.2014.11.182
   Malouf JF, 2005, J AM COLL CARDIOL, V46, P1284, DOI 10.1016/j.jacc.2005.06.053
   Manolis AJ, 2012, J HYPERTENS, V30, P239, DOI 10.1097/HJH.0b013e32834f03bf
   Mazurek M, 2017, MAYO CLIN PROC, V92, P1203, DOI 10.1016/j.mayocp.2017.05.023
   Mikkelsen AP, 2012, J THROMB HAEMOST, V10, P1745, DOI 10.1111/j.1538-7836.2012.04853.x
   Nielsen PB, 2018, CIRCULATION, V137, P832, DOI 10.1161/CIRCULATIONAHA.117.029081
   Olesen JB, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d124
   Pathak RK, 2015, J AM COLL CARDIOL, V65, P2159, DOI 10.1016/j.jacc.2015.03.002
   Pedersen OD, 2006, EUR HEART J, V27, P290, DOI 10.1093/eurheartj/ehi629
   Peters A, 2001, CIRCULATION, V103, P2810
   Schnabel RB, 2015, LANCET, V386, P154, DOI 10.1016/S0140-6736(14)61774-8
   Siu CW, 2014, HEART RHYTHM, V11, P1401, DOI 10.1016/j.hrthm.2014.04.021
   Sohn J, 2016, ENVIRON SCI POLLUT R, V23, P19432, DOI 10.1007/s11356-016-7144-9
   Soliman EZ, 2014, JAMA INTERN MED, V174, pE107, DOI 10.1001/jamainternmed.2013.11912
   Tedrow UB, 2010, J AM COLL CARDIOL, V55, P2319, DOI 10.1016/j.jacc.2010.02.029
   Wang TJ, 2004, JAMA-J AM MED ASSOC, V292, P2471, DOI 10.1001/jama.292.20.2471
   Yoon M, 2018, THROMB HAEMOSTASIS, V118, P1296, DOI 10.1055/s-0038-1651482
NR 48
TC 12
Z9 12
U1 0
U2 6
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD SEP
PY 2019
VL 49
IS 9
BP 794
EP 807
DI 10.4070/kcj.2019.0212
PG 14
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA IU4YT
UT WOS:000483593700002
PM 31456373
OA Green Published, Other Gold
DA 2021-04-22
ER

PT J
AU Kim, DY
   Kim, SH
   Ryu, KH
AF Kim, Do Young
   Kim, Sung Hea
   Ryu, Kyu-Hyung
TI Tachycardia induced Cardiomyopathy
SO KOREAN CIRCULATION JOURNAL
LA English
DT Review
DE Heart failure; Tachycardia; Cardiomyopathies
ID CONGESTIVE-HEART-FAILURE; ATRIAL-FIBRILLATION; MEDIATED CARDIOMYOPATHY;
   CARDIOVERSION; ASSOCIATION; DIAGNOSIS; RECOVERY; PATHOPHYSIOLOGY;
   REVERSIBILITY; IMPROVEMENT
AB Recent studies on radiofrequency catheter ablation (RFCA) in atrial fibrillation show its effectiveness in heart failure (HF) patients; hence, tachycardia-induced cardiomyopathy (T-CMP) is gaining attention. Tachycardia-mediated cardiomyopathy is a reversible left ventricular (LV) dysfunction, which can be induced by any tachyarrhythmia. Early recognition ofT-CMP with appropriate treatment of the arrhythmia culprit will lead to the recovery of LV function. Patients with tachycardia and LV dysfunction should be suspected of having T-CMP, with or without established etiology of HF, because T-CMP may present by itself or contribute as a co-existent component. Therapeutic options include rate control, anti-arrhythmic drugs, or catheter ablation. Unlike in animal models, clinical data on human T-CMP is limited. Hence, future research should be more focused on tachyarrhythmia-induced cardiomyopathy as its burden is increasing.
C1 [Kim, Do Young] Korea Univ, Cardiovasc Ctr, Anam Hosp, Seoul, South Korea.
   [Kim, Sung Hea] Konkuk Univ, Dept Med, Div Cardiol, Med Ctr, Seoul, South Korea.
   [Ryu, Kyu-Hyung] Hallym Univ, Dongtan Sacred Heart Hosp, Dept Cardiol, Coll Med, 7 Keunjaebong Gil, Hwaseong 18450, South Korea.
RP Ryu, KH (corresponding author), Hallym Univ, Dongtan Sacred Heart Hosp, Dept Cardiol, Coll Med, 7 Keunjaebong Gil, Hwaseong 18450, South Korea.
EM khryumd@hanmail.net
OI Kim, Do Young/0000-0002-5601-9427
CR Aguinaga L, 1998, PACE, V21, P2073, DOI 10.1111/j.1540-8159.1998.tb01126.x
   Anter E, 2009, CIRCULATION, V119, P2516, DOI 10.1161/CIRCULATIONAHA.108.821306
   Balijepalli RC, 2003, CARDIOVASC RES, V59, P67, DOI 10.1016/S0008-6363(03)00325-0
   Batul SA, 2017, KOREAN CIRC J, V47, P644, DOI 10.4070/kcj.2017.0040
   Boldt LH, 2008, AM HEART J, V155, P890, DOI 10.1016/j.ahj.2007.12.015
   Bozkurt B, 2016, CIRCULATION, V134, pE579, DOI 10.1161/CIR.0000000000000455
   CRUZ FES, 1990, J AM COLL CARDIOL, V16, P739, DOI 10.1016/0735-1097(90)90368-Y
   Dandamudi G, 2008, HEART RHYTHM, V5, P1111, DOI 10.1016/j.hrthm.2008.04.023
   Deshmukh PM, 2004, INT J MOL MED, V13, P455
   EDNER M, 1995, BRIT HEART J, V74, P261
   Ellis ER, 2013, ARRHYTH ELECTROPHYSI, V2, P82, DOI 10.15420/aer.2013.2.2.82
   Gopinathannair R, 2015, J AM COLL CARDIOL, V66, P1714, DOI 10.1016/j.jacc.2015.08.038
   Gupta S, 2014, INT J CARDIOL, V172, P40, DOI 10.1016/j.ijcard.2013.12.180
   Hasdemir C, 2012, PACE, V35, P465, DOI 10.1111/j.1540-8159.2011.03324.x
   HOWARD RJ, 1988, CAN J PHYSIOL PHARM, V66, P1505, DOI 10.1139/y88-246
   Huizar JF, 2019, J AM COLL CARDIOL, V73, P2328, DOI 10.1016/j.jacc.2019.02.045
   Jeong YH, 2008, CLIN CARDIOL, V31, P172, DOI 10.1002/clc.20161
   KAJSTURA J, 1995, CIRCULATION, V92, P2306, DOI 10.1161/01.CIR.92.8.2306
   Khasnis A, 2005, PACE, V28, P710, DOI 10.1111/j.1540-8159.2005.00143.x
   Kim HS, 2001, KOREAN CIRC J, V31, P949
   Ling LH, 2013, CIRC-ARRHYTHMIA ELEC, V6, P697, DOI 10.1161/CIRCEP.113.000681
   Lip GYH, 2016, EUROPACE, V18, P12, DOI 10.1093/europace/euv191
   LIPKIN DP, 1988, BRIT HEART J, V59, P572
   Marrouche NF, 2018, NEW ENGL J MED, V378, P417, DOI 10.1056/NEJMoa1707855
   Martin CA, 2017, HEART, V103, P1543, DOI 10.1136/heartjnl-2016-310391
   Medi C, 2009, J AM COLL CARDIOL, V53, P1791, DOI 10.1016/j.jacc.2009.02.014
   Meti Nicholas, 2016, HeartRhythm Case Rep, V2, P142, DOI 10.1016/j.hrcr.2015.11.012
   Mueller KAL, 2017, J AM COLL CARDIOL, V69, P2160, DOI 10.1016/j.jacc.2017.02.049
   MUKHERJEE R, 1995, J MOL CELL CARDIOL, V27, P1333, DOI 10.1016/S0022-2828(05)82396-X
   Nerheim P, 2004, CIRCULATION, V110, P247, DOI 10.1161/01.CIR.0000135472.28234.CC
   Nia AM, 2011, CLIN RES CARDIOL, V100, P887, DOI 10.1007/s00392-011-0319-y
   OBRIEN PJ, 1990, CAN J PHYSIOL PHARM, V68, P34, DOI 10.1139/y90-004
   Ponikowski P, 2016, EUR HEART J, V37, P2129, DOI 10.1093/eurheartj/ehw128
   Poutiainen AM, 1999, EUR HEART J, V20, P694, DOI 10.1053/euhj.1998.1313
   Redfield MM, 2000, MAYO CLIN PROC, V75, P790, DOI 10.4065/75.8.790
   ROSS J, 1995, CIRCULATION, V92, P2327, DOI 10.1161/01.CIR.92.8.2327
   Ryu K, 2006, EUR J HEART FAIL S, V5, P146
   Ryu K H, 1997, J Card Fail, V3, P27, DOI 10.1016/S1071-9164(97)90006-3
   SCHOCKEN DD, 1992, J AM COLL CARDIOL, V20, P301, DOI 10.1016/0735-1097(92)90094-4
   Selvaraj R, 2013, PACE, V36, pE4, DOI 10.1111/j.1540-8159.2011.03210.x
   Shinbane JS, 1997, J AM COLL CARDIOL, V29, P709, DOI 10.1016/S0735-1097(96)00592-X
   Singh B, 1996, PACE, V19, P1391, DOI 10.1111/j.1540-8159.1996.tb04222.x
   SPINALE FG, 1991, AM J PHYSIOL, V261, pH308
   SPINALE FG, 1992, BASIC RES CARDIOL, V87, P65, DOI 10.1007/BF00795391
   TOMITA M, 1991, CIRCULATION, V83, P635, DOI 10.1161/01.CIR.83.2.635
   Van Gelder IC, 2010, NEW ENGL J MED, V362, P1363, DOI 10.1056/NEJMoa1001337
   VANGELDER IC, 1993, AM J CARDIOL, V72, P560, DOI 10.1016/0002-9149(93)90352-D
   Wang NC, 2011, PACE, V34, P1671, DOI 10.1111/j.1540-8159.2011.03218.x
   Watanabe H, 2008, INT HEART J, V49, P39, DOI 10.1536/ihj.49.39
   WEBER KT, 1990, CIRCULATION, V82, P1387, DOI 10.1161/01.CIR.82.4.1387
   Yancy CW, 2013, CIRCULATION, V128, P1810, DOI 10.1161/CIR.0b013e31829e8807
   Yom HJ, 2001, KOREAN CIRC J, V31, P1305
   Youn JC, 2017, KOREAN CIRC J, V47, P16, DOI 10.4070/kcj.2016.0429
   ZELLNER JL, 1991, CIRC RES, V69, P590, DOI 10.1161/01.RES.69.3.590
   Zhao DH, 2013, J INTERV CARD ELECTR, V36, P27, DOI 10.1007/s10840-012-9727-9
NR 55
TC 3
Z9 3
U1 1
U2 2
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD SEP
PY 2019
VL 49
IS 9
BP 808
EP 817
DI 10.4070/kcj.2019.0199
PG 10
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA IU4YT
UT WOS:000483593700003
PM 31456374
OA Green Published
DA 2021-04-22
ER

PT J
AU Cho, MC
AF Cho, Myeong-Chan
TI Clinical Significance and Therapeutic Implication of Nocturnal
   Hypertension: Relationship between Nighttime Blood Pressure and Quality
   of Sleep
SO KOREAN CIRCULATION JOURNAL
LA English
DT Review
DE Nocturnal hypertension; Circadian BP rhythm; Chronotherapy
ID CONVERTING-ENZYME-INHIBITOR; TARGET-ORGAN DAMAGE; CARDIOVASCULAR EVENTS;
   RESISTANT HYPERTENSION; PROGNOSTIC VALUE; SYSTEMATIC ANALYSIS;
   GENERAL-POPULATION; HOME; RISK; CHRONOTHERAPY
AB Recent global hypertension guidelines recommend an early, strict and 24-hour blood pressure (BP) control for the prevention of target organ damage and cardiovascular events. Out-of-office BP measurement such as ambulatory BP monitoring and home BP monitoring is now widely utilized to rule out white-coat hypertension, to detect masked hypertension, to evaluate the effects of antihypertensive medication, to analyze diurnal BP variation, and to increase drug adherence. Nocturnal hypertension has been neglected in the management of hypertension despite of its clinical significance. Nighttime BP and non-dipping patterns of BP are stronger risk predictors for the future cardiovascular mortality and morbidity than clinic or daytime BP. In addition to ambulatory or home daytime BP and 24-hour mean BP, nocturnal BP should be a new therapeutic target for the optimal treatment of hypertension to improve prognosis in hypertensive patients. This review will provide an overview of epidemiology, characteristics, and pathophysiology of nocturnal hypertension and clinical significance, therapeutic implication and future perspectives of nocturnal hypertension will be discussed.
C1 [Cho, Myeong-Chan] Chungbuk Natl Univ, Coll Med, Dept Internal Med, 1 Chungdae Ro, Cheongju 28644, South Korea.
RP Cho, MC (corresponding author), Chungbuk Natl Univ, Coll Med, Dept Internal Med, 1 Chungdae Ro, Cheongju 28644, South Korea.
EM mccho@cbnu.ac.kr
OI Cho, Myeong-Chan/0000-0002-0047-0227
FU Chungbuk National University; Research of Korea Centers for Disease
   Control and Prevention [2018-ER630300]
FX This work was supported by the intramural research grant of Chungbuk
   National University in 2015 and a fund (2018-ER630300) by Research of
   Korea Centers for Disease Control and Prevention.
CR Amer Diabet Assoc, 2016, DIABETES CARE, V39, pS60, DOI 10.2337/dc16-S011
   American Diabetes Association, 2019, Diabetes Care, V42, pS103, DOI 10.2337/dc19-S010
   Andreadis EA, 2016, J HYPERTENS, V34, P438, DOI 10.1097/HJH.0000000000000815
   Asayama K, 2019, J HYPERTENS, V37, P905, DOI 10.1097/HJH.0000000000001987
   Baguet JP, 2005, J HYPERTENS, V23, P521, DOI 10.1097/01.hjh.0000160207.58781.4e
   Bavishi C, 2015, EUR HEART J, V36, P1967, DOI 10.1093/eurheartj/ehv142
   Ben-Dov IZ, 2007, HYPERTENSION, V49, P1235, DOI 10.1161/HYPERTENSIONAHA.107.087262
   Bisognano JD, 2011, J AM COLL CARDIOL, V58, P765, DOI 10.1016/j.jacc.2011.06.008
   Boggia J, 2007, LANCET, V370, P1219, DOI 10.1016/S0140-6736(07)61538-4
   Boggia J, 2011, HYPERTENSION, V57, P397, DOI 10.1161/HYPERTENSIONAHA.110.156828
   Carek Andrew M, 2017, Proc ACM Interact Mob Wearable Ubiquitous Technol, V1, DOI 10.1145/3130905
   Chen A, 2019, SAMSUNGS GALAXY WATC
   de la Sierra A, 2014, AM J HYPERTENS, V27, P680, DOI 10.1093/ajh/hpt175
   Fagard RH, 2008, HYPERTENSION, V51, P55, DOI 10.1161/HYPERTENSIONAHA.107.100727
   Fan HQ, 2010, J HYPERTENS, V28, P2036, DOI 10.1097/HJH.0b013e32833b49fe
   Gorostidi M, 2015, CARDIOL THER, V4, pS19, DOI 10.1007/s40119-015-0042-2
   Haentjens P, 2007, ARCH INTERN MED, V167, P757, DOI 10.1001/archinte.167.8.757
   Hansen TW, 2011, HYPERTENSION, V57, P3, DOI 10.1161/HYPERTENSIONAHA.109.133900
   Head GA, 2017, J HYPERTENS, V35, P463, DOI 10.1097/HJH.0000000000001244
   Hermida RC, 2008, HYPERTENSION, V51, P69, DOI 10.1161/HYPERTENSIONAHA.107.096933
   Hermida RC, 2007, HYPERTENSION, V50, P715, DOI 10.1161/HYPERTENSIONAHA.107.094235
   Hermida RC, 2007, CHRONOBIOL INT, V24, P749, DOI 10.1080/07420520701535837
   Hermida RC, 2010, CHRONOBIOL INT, V27, P1629, DOI 10.3109/07420528.2010.510230
   Hermida RC, 2009, HYPERTENSION, V54, P40, DOI 10.1161/HYPERTENSIONAHA.109.130203
   Hoshide S, 2007, HYPERTENS RES, V30, P143, DOI 10.1291/hypres.30.143
   Hoshide S, 2015, HYPERTENSION, V66, P750, DOI 10.1161/HYPERTENSIONAHA.115.05958
   Hosohata K, 2007, HYPERTENS RES, V30, P707, DOI 10.1291/hypres.30.707
   Imaizumi Y, 2016, J CLIN HYPERTENS, V18, P315, DOI 10.1111/jch.12668
   Ishikawa J, 2012, HYPERTENSION, V60, P921, DOI 10.1161/HYPERTENSIONAHA.112.198101
   Kario K, 2001, HYPERTENSION, V38, P852, DOI 10.1161/hy1001.092640
   Kario K., 2015, ESSENTIAL MANUAL 24
   Kario K, 2019, CIRCULATION, V139, P2089, DOI 10.1161/CIRCULATIONAHA.118.037076
   Kario K, 2018, HYPERTENSION, V71, P997, DOI 10.1161/HYPERTENSIONAHA.118.10971
   Kario K, 2017, CIRC J, V81, P948, DOI 10.1253/circj.CJ-17-0109
   Kario K, 2016, KOREAN CIRC J, V46, P456, DOI 10.4070/kcj.2016.46.4.456
   Kario K, 2016, CIRC J, V80, P1404, DOI 10.1253/circj.CJ-16-0035
   Kario K, 2013, HYPERTENS RES, V36, P478, DOI 10.1038/hr.2013.19
   Kimura G, 2008, HYPERTENSION, V51, P827, DOI 10.1161/HYPERTENSIONAHA.108.110213
   Kollias A, 2017, J HYPERTENS, V35, P442, DOI 10.1097/HJH.0000000000001189
   Komori T, 2008, HYPERTENS RES, V31, P289, DOI 10.1291/hypres.31.289
   Korean Society Hypertension (KSH), 2018, Clin Hypertens, V24, P13, DOI 10.1186/s40885-018-0098-0
   Krum H, 2009, LANCET, V373, P1275, DOI 10.1016/S0140-6736(09)60566-3
   Kuwabara M, 2019, J CLIN HYPERTENS, V21, P463, DOI 10.1111/jch.13464
   Lee Hae-Young, 2019, Clin Hypertens, V25, P20, DOI 10.1186/s40885-019-0124-x
   Legramante JM, 2005, CIRCULATION, V112, P786, DOI 10.1161/CIRCULATIONAHA.105.555714
   Li Y, 2007, HYPERTENSION, V50, P333, DOI 10.1161/HYPERTENSIONAHA.107.087767
   Li Y, 2013, HYPERTENSION, V61, P278, DOI 10.1161/HYPERTENSIONAHA.111.00217
   Lim YH, 2013, KOREAN CIRC J, V43, P391, DOI 10.4070/kcj.2013.43.6.391
   Lindroos AS, 2016, J HYPERTENS, V34, P1730, DOI 10.1097/HJH.0000000000000995
   Liu MC, 2003, NEPHROL DIAL TRANSPL, V18, P563, DOI 10.1093/ndt/18.3.563
   Lombardi F, 2000, CARDIOVASC RES, V45, P200, DOI 10.1016/S0008-6363(99)00329-6
   Lopez AD, 2006, LANCET, V367, P1747, DOI 10.1016/S0140-6736(06)68770-9
   Mahabala C, 2013, VASC HEALTH RISK MAN, V9, P125, DOI 10.2147/VHRM.S33515
   Marin JM, 2012, JAMA-J AM MED ASSOC, V307, P2169, DOI 10.1001/jama.2012.3418
   Matsui Y, 2009, HYPERTENSION, V54, P716, DOI 10.1161/HYPERTENSIONAHA.109.131466
   McMurray JJV, 2014, NEW ENGL J MED, V371, P993, DOI 10.1056/NEJMoa1409077
   Melgarejo JD, 2017, HYPERTENSION, V70, P50, DOI 10.1161/HYPERTENSIONAHA.117.09188
   Mills KT, 2016, CIRCULATION, V134, P441, DOI 10.1161/CIRCULATIONAHA.115.018912
   OBRIEN E, 1988, LANCET, V2, P397
   Ohkubo T, 2002, J HYPERTENS, V20, P2183, DOI 10.1097/00004872-200211000-00017
   Pareek AK, 2016, J AM COLL CARDIOL, V67, P379, DOI 10.1016/j.jacc.2015.10.083
   Pepin JL, 2014, SLEEP MED REV, V18, P509, DOI 10.1016/j.smrv.2014.03.003
   Roush GC, 2014, J HYPERTENS, V32, P2332, DOI 10.1097/HJH.0000000000000355
   Sakhuja S, 2019, AM J HYPERTENS, V32, P759, DOI 10.1093/ajh/hpz017
   Salvetti M, 2001, J HUM HYPERTENS, V15, P879, DOI 10.1038/sj.jhh.1001286
   Sega R, 2005, CIRCULATION, V111, P1777, DOI 10.1161/01.CIR.0000160923.04524.5B
   Shin Jinho, 2014, Clin Hypertens, V20, P9, DOI 10.1186/2056-5909-1-3
   Svensson P, 2001, HYPERTENSION, V38, pE28, DOI 10.1161/hy1101.099502
   Thomas SJ, 2017, J AM SOC HYPERTENS, V11, P204, DOI 10.1016/j.jash.2017.02.001
   Povedano ST, 2009, J CLIN HYPERTENS, V11, P426, DOI 10.1111/j.1751-7176.2009.00152.x
   Turnbull F, 2003, LANCET, V362, P1527
   Ushio H, 2009, CLIN EXP NEPHROL, V13, P480, DOI 10.1007/s10157-009-0192-4
   Uzu T, 1997, CIRCULATION, V96, P1859, DOI 10.1161/01.CIR.96.6.1859
   Wang GH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053841
   Whelton PK, 2017, CIRCULATION, V138, P484
   Williams B, 2018, EUR HEART J, V39, P3021, DOI 10.1093/eurheartj/ehy339
   Yano Y, 2012, HYPERTENS RES, V35, P695, DOI 10.1038/hr.2012.26
   Yasuda G, 2005, DIABETIC MED, V22, P1394, DOI 10.1111/j.1464-5491.2005.01636.x
   Yusuf S, 2000, NEW ENGL J MED, V342, P145
   Zinman B, 2015, NEW ENGL J MED, V373, P2117, DOI 10.1056/NEJMoa1504720
NR 80
TC 3
Z9 4
U1 1
U2 4
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD SEP
PY 2019
VL 49
IS 9
BP 818
EP 828
DI 10.4070/kcj.2019.0245
PG 11
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA IU4YT
UT WOS:000483593700004
PM 31456375
OA Green Published, Other Gold
DA 2021-04-22
ER

PT J
AU Oh, JK
   Park, JH
   Lee, JH
   Kim, J
   Seong, IW
AF Oh, Jin Kyung
   Park, Jae-Hyeong
   Lee, Jae-Horan
   Kim, Jeongai
   Seong, In-Whan
TI Shape and Mobility of a Left Ventricular Thrombus Are Predictors of
   Thrombus Resolution
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Thrombus; Left ventricle; Anticoagulants; Embolism
ID ACUTE MYOCARDIAL-INFARCTION; 2-DIMENSIONAL ECHOCARDIOGRAPHY; EMBOLISM
AB Background and Objectives: Left ventricular (LV) apical thrombi are usually present with LV dilatation, and oral anticoagulants reduce embolic risk in these patients. However, echocardiographic data regarding thrombus resolution remain limited. We studied its echocardiographic features that were associated with early resolution (within 1 month).
   Methods: We performed a retrospective observational study by reviewing baseline and follow-up echocardiographic images and medical records in patients with LV apical thrombi.
   Results: Between January 2005 and December 2017, 77 patients (59 males, mean 61 +/- 12 years old) were enrolled. Patients were classified into 2 groups based on duration of thrombus resolution: group 1 showing resolution within 1 month (n=23) and group 2 with persistence after 1 month (n=54). Thrombus size was significantly smaller in group 1(10.7 +/- 4.2 vs. 12.1 +/- 5.5 mm, p=0.046). Grade 1 mobility (partially mobile; odds ratio [OR], 7.800; p=0.012) and grade 2 mobility (highly mobile; OR, 14.625; p=0.002) were significantly associated with the early resolution. Round thrombi were associated with early resolution than mural form (OR, 3.187; p=0.026). Multivariate analysis showed that the mobility was the most important parameter, and a highly mobile (grade 2 mobility) LV apical thrombi showed earlier resolution (OR, 12.525; p=0.013). During the follow-up over 62 +/- 44 months, 25 patients (32.5%) had >= 1 adverse clinical events. The late resolution of thrombi was associated with poor long-term clinical outcomes (hazard ratio, 5.727; p=0.020).
   Conclusions: Mobility of LV apical thrombi was the most important parameter associated with early thrombus resolution. Late resolution of LV apical thrombi was associated with poor long-term clinical outcomes.
C1 [Oh, Jin Kyung; Park, Jae-Hyeong; Lee, Jae-Horan; Kim, Jeongai; Seong, In-Whan] Chungnam Natl Univ, Chungnam Natl Univ Hosp, Sch Med, Dept Cardiol Internal Med, 282 Munhwa Ro, Daejeon 35015, South Korea.
RP Park, JH (corresponding author), Chungnam Natl Univ, Chungnam Natl Univ Hosp, Sch Med, Dept Cardiol Internal Med, 282 Munhwa Ro, Daejeon 35015, South Korea.
EM jaehpark@cnu.ac.kr
RI Park, Jae-Hyeong/AAD-9015-2021
OI /0000-0001-8371-9704
CR Choi UL, 2018, HEART VESSELS, V33, P447, DOI 10.1007/s00380-017-1079-z
   Delewi R, 2012, HEART, V98, P1743, DOI 10.1136/heartjnl-2012-301962
   FRIEDMAN MJ, 1982, AM J MED, V72, P894, DOI 10.1016/0002-9343(82)90848-8
   HAUGLAND JM, 1984, CIRCULATION, V70, P588, DOI 10.1161/01.CIR.70.4.588
   Ibanez B, 2018, EUR HEART J, V39, P119, DOI 10.1093/eurheartj/ehx393
   JUGDUTT BI, 1989, J AM COLL CARDIOL, V13, P554, DOI 10.1016/0735-1097(89)90592-5
   KEREN A, 1990, J AM COLL CARDIOL, V15, P790, DOI 10.1016/0735-1097(90)90275-T
   KUPPER AJF, 1989, J AM COLL CARDIOL, V13, P1514
   LAMAS GA, 1988, AM J CARDIOL, V62, P31, DOI 10.1016/0002-9149(88)91360-4
   Maniwa N, 2018, EUR HEART J, V39, P201, DOI 10.1093/eurheartj/ehx551
   Meurin P, 2015, AM HEART J, V170, P256, DOI 10.1016/j.ahj.2015.04.029
   Sharma ND, 2000, CHEST, V117, P314, DOI 10.1378/chest.117.2.314
   STRATTON JR, 1988, CIRCULATION, V78, P1388, DOI 10.1161/01.CIR.78.6.1388
   STRATTON JR, 1982, CIRCULATION, V66, P156, DOI 10.1161/01.CIR.66.1.156
   WEINREICH DJ, 1984, ANN INTERN MED, V100, P789, DOI 10.7326/0003-4819-100-6-789
   WEYMAN AE, 1976, CIRCULATION, V54, P936, DOI 10.1161/01.CIR.54.6.936
NR 16
TC 2
Z9 2
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD SEP
PY 2019
VL 49
IS 9
BP 829
EP 837
DI 10.4070/kcj.2018.0346
PG 9
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA IU4YT
UT WOS:000483593700005
PM 31074225
OA Green Published
DA 2021-04-22
ER

PT J
AU Lee, JH
   Lee, SR
   Choi, EK
   Jeong, J
   Park, HD
   You, SJ
   Lee, SS
   Oh, S
AF Lee, Ji Hyun
   Lee, So-Ryoung
   Choi, Eue-Keun
   Jeong, Jaehan
   Park, Hyung-Deuk
   You, So-Jeong
   Lee, Sang-Soo
   Oh, Seil
TI Temporal Trends of Cardiac Implantable Electronic Device Implantations:
   a Nationwide Population-based Study
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Artificial pacemaker; Implantable defibrillators; Epidemiology
ID PERMANENT PACEMAKER IMPLANTATION; HEART-FAILURE;
   CARDIOVERTER-DEFIBRILLATORS; RESYNCHRONIZATION THERAPY; PRIMARY
   PREVENTION; EUROPEAN-SOCIETY; ESC GUIDELINES; UNITED-STATES; WORLD
   SURVEY; ARRHYTHMIAS
AB Background and Objectives: Implantation of cardiac implantable electronic devices (CIED), including permanent pacemakers (PM), implantable cardioverter-defibrillators (LCD), and cardiac resynchronization therapy (CRT) devices, has increased significantly over the past several years. However, limited data exists regarding temporal trends of CIED implantations in Asian population. This study aimed to investigate temporal trends of CIED treatment in Korea.
   Methods: Using the National Health Insurance Service database of the entire Korean adult population, temporal trends of CIED procedures between 2009 and 2016 were evaluated. Additionally, temporal changes in the prevalence of patients' comorbidities were evaluated.
   Results: A total of 35,421 CIED procedures (new implantations: 27,771, replacements: 7,650) were performed during the study period. The mean age of new CIED recipients and the prevalence of comorbidities, including hypertension, diabetes mellitus, heart failure, stroke, and atrial fibrillation, increased substantially with time. Compared to 2009, the number of new implantations of PM, ICD, and CRT devices increased by 2.0 (1,977 to 3,910), 3.6 (230 to 822), and 4.9 (44 to 217) times in 2016, respectively. The annual new implantation rate of CIED also increased accordingly (5.1 to 9.3 for PM, 0.6 to 1.9 for ICD, and 0.1 to 0.5 for CRT devices, per 100,000 persons).
   Conclusions: The number of CIED implantation increased substantially from 2009 to 2016 in Korea. Also, the patients with CIED have been changed to be older and have more comorbidities. Therefore, the burden of health care cost in patients with CIED would be expected to increase in the future.
C1 [Lee, Ji Hyun] Seoul Natl Univ, Bundang Hosp, Cardiovasc Ctr, Dept Cardiol, Seongnam, South Korea.
   [Lee, So-Ryoung; Choi, Eue-Keun; Oh, Seil] Seoul Natl Univ Hosp, Dept Internal Med, 101 Daehak Ro, Seoul 03080, South Korea.
   [Jeong, Jaehan; Park, Hyung-Deuk; You, So-Jeong; Lee, Sang-Soo] Medtron Korea Ltd, Seoul, South Korea.
   [Lee, Sang-Soo] Sungkyunkwan Univ, Samsung Adv Inst Hlth Sci & Technol, Grad Sch Med Device Management & Res, Seoul, South Korea.
RP Choi, EK (corresponding author), Seoul Natl Univ Hosp, Dept Internal Med, 101 Daehak Ro, Seoul 03080, South Korea.
EM choiek17@snu.ac.kr
RI Oh, Seil/J-5539-2012; Choi, Eue-Keun/J-5968-2014
OI Oh, Seil/0000-0002-2504-9615; Choi, Eue-Keun/0000-0002-0411-6372; Lee,
   Sang-Soo/0000-0002-3619-6303; Lee, Ji Hyun/0000-0002-7162-1248; Lee,
   So-Ryoung/0000-0002-6351-5015
FU Technology Innovation Program - Ministry of Trade, Industry and Energy
   (MOTIE, Sejong, Republic of Korea) [10052668]
FX This study was supported by the Technology Innovation Program (or
   Industrial Strategic Technology Development Program, Project No.
   10052668, Development of wearable self-powered energy source and
   low-power wireless communication system for a pacemaker) funded by the
   Ministry of Trade, Industry and Energy (MOTIE, Sejong, Republic of
   Korea).
CR Al-Khatib Sana M, 2018, J Am Coll Cardiol, V72, pe91, DOI 10.1016/j.jacc.2017.10.054
   Brignole M, 2013, EUR HEART J, V34, P2281, DOI 10.1093/eurheartj/eht150
   Bristow MR, 2004, NEW ENGL J MED, V350, P2140, DOI 10.1056/NEJMoa032423
   Brunner M, 2004, EUR HEART J, V25, P88, DOI 10.1016/j.ehj.2003.10.022
   Castellanos JM, 2012, HEART RHYTHM, V9, P874, DOI 10.1016/j.hrthm.2012.01.029
   Curtis AB, 2009, AM HEART J, V158, P956, DOI 10.1016/j.ahj.2009.10.011
   Defaye P, 2017, EUROPACE, V19, P1478, DOI 10.1093/europace/euw230
   Epstein AE, 2013, J AM COLL CARDIOL, V61, pE6, DOI 10.1016/j.jacc.2012.11.007
   Greenspon AJ, 2012, J AM COLL CARDIOL, V60, P1540, DOI 10.1016/j.jacc.2012.07.017
   Greenspon AJ, 2011, J AM COLL CARDIOL, V58, P1001, DOI 10.1016/j.jacc.2011.04.033
   Hatfield LA, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.116.003532
   Hu ZY, 2016, HEART LUNG CIRC, V25, P148, DOI 10.1016/j.hlc.2015.07.008
   Hubinette C, 2014, EUROPACE, V16, P1580, DOI 10.1093/europace/eut416
   Hyun KR, 2016, HEALTH ECON, V25, P1239, DOI 10.1002/hec.3209
   Kim J, 2012, KOREAN CIRC J, V42, P173, DOI 10.4070/kcj.2012.42.3.173
   Konishi M, 2016, ESC HEART FAIL, V3, P145, DOI 10.1002/ehf2.12103
   Kurtz SM, 2010, PACE, V33, P705, DOI 10.1111/j.1540-8159.2009.02670.x
   Lee H, 2016, BMC CARDIOVASC DISOR, V16, DOI 10.1186/s12872-016-0404-2
   Lee SH, 2014, J KOREAN MED SCI, V29, P1651, DOI 10.3346/jkms.2014.29.12.1651
   Levine PA, 2002, PACE, V25, P1667, DOI 10.1046/j.1460-9592.2002.01667.x
   Lubinski A, 2011, EUROPACE, V13, P654, DOI 10.1093/europace/eur066
   Mehra MR, 2009, HEART RHYTHM, V6, P1727, DOI 10.1016/j.hrthm.2009.08.022
   Mond HG, 2008, PACE, V31, P1202, DOI 10.1111/j.1540-8159.2008.01164.x
   Mond HG, 2011, PACE, V34, P1013, DOI 10.1111/j.1540-8159.2011.03150.x
   Moss AJ, 2002, NEW ENGL J MED, V346, P877, DOI 10.1056/NEJMoa013474
   Moss AJ, 2009, NEW ENGL J MED, V361, P1329, DOI 10.1056/NEJMoa0906431
   Peterson PN, 2017, J AM HEART ASSOC, V6, DOI 10.1161/JAHA.117.006937
   Ponikowski P, 2016, EUR HEART J, V37, P2129, DOI 10.1093/eurheartj/ehw128
   Priori SG, 2015, EUROPACE, V17, P1601, DOI 10.1093/europace/euv319
   Raatikainen MJP, 2015, EUROPACE, V17, pI1, DOI 10.1093/europace/euu300
   Satake H, 2015, CIRC J, V79, P381, DOI 10.1253/circj.CJ-14-0925
   Udo EO, 2013, HEART, V99, P1573, DOI 10.1136/heartjnl-2013-304445
   Uhm JS, 2019, YONSEI MED J, V60, P48, DOI 10.3349/ymj.2019.60.1.48
   Uslan DZ, 2008, AM HEART J, V155, P896, DOI 10.1016/j.ahj.2007.12.022
   Yancy CW, 2017, J AM COLL CARDIOL, V70, P776, DOI 10.1016/j.jacc.2017.04.025
   Zeitler EP, 2018, EUROPACE, V20, P1621, DOI 10.1093/europace/euy183
NR 36
TC 9
Z9 9
U1 1
U2 4
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD SEP
PY 2019
VL 49
IS 9
BP 841
EP 852
DI 10.4070/kcj.2018.0444
PG 12
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA IU4YT
UT WOS:000483593700007
PM 31074230
OA Green Published
DA 2021-04-22
ER

PT J
AU Ramchandani, BK
   Polo, L
   Sanchez, R
   Rey, J
   Gonzalez, A
   Diez, J
   Aroca, A
AF Ramchandani, Bunty K.
   Polo, Luz
   Sanchez, Raul
   Rey, Juvenal
   Gonzalez, Alvaro
   Diez, Jesus
   Aroca, Angel
TI External Validation of 3 Risk Scores in Adults with Congenital Heart
   Disease
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Congenital heart defect; Validation studies
ID PREDICTION MODELS; SURGERY; ADJUSTMENT; COMPLEXITY; EUROSCORE; MORTALITY
AB Background and objectives: Adults with congenital heart disease (CHD) are an increasing group of patients thanks to the survival of over 85% of children with CHD. 20% of these patients shall warrant a surgical procedure during their life span. However, currently there is no one risk score that assess correctly the mortality of these procedures. Thus, we analyse the risk scores used at our institution.
   Methods: From May 1991 till June 2017, 608 procedures in adults with CHD were performed. The 3 risk scores (risk adjustment for congenital heart surgery [RACHS-1], Aristotle, and Euroscore I) of each procedure were analysed. We used area under the receiver operating characteristic curve (c-index) to measure model discrimination, and Hosmer-Lemeshow (H-L) statistic along with calibration plots to measure calibration.
   Results: There was no statistical difference between the area under the curve for the 3 scores (chi(2)=0.58 with 2 df, p=0.750). There was no evidence of lack of fit for RACHS-1 (H-L, 1=2.61; p=0.271) and Aristotle score (H-L, chi(2)=5.69; p=0.459). However, there was evidence in lack of calibration in the Euroscore I scoring system (H-L, chi(2)=33.69; p<0.001). The calibration slope for RACHS-1 was 0.912, for Aristotle (stratified in risk groups) was -0.14 and for Euroscore 1 (stratified in risk groups) was 0.46.
   Conclusions: RACHS-1 seems to be best risk scoring system for calculating mortality applied to surgery in adults with CHD.
C1 [Ramchandani, Bunty K.] Hosp Univ Clin San Carlos, Sect Cardiac Surg, Calle Prof Martin Lagos S-N, Madrid 28040, Spain.
   [Polo, Luz; Sanchez, Raul; Rey, Juvenal; Gonzalez, Alvaro; Aroca, Angel] Hosp Univ La Paz, Madrid, Spain.
   [Diez, Jesus] Hosp Univ La Paz, Inst Invest, Madrid, Spain.
RP Ramchandani, BK (corresponding author), Hosp Univ Clin San Carlos, Sect Cardiac Surg, Calle Prof Martin Lagos S-N, Madrid 28040, Spain.
EM bunty.r@gmail.com
OI Polo, Luz/0000-0002-2615-5858; Ramchandani, Bunty/0000-0002-3304-2317;
   Gonzalez Rocafort, Alvaro/0000-0001-9257-1174; SANCHEZ PEREZ,
   RAUL/0000-0002-0145-9097
CR Altman DG, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b605
   Aroca A, 2009, REV ESP CARDIOL S, V09, P98
   Aroca Ángel, 2014, Arch. Cardiol. Méx., V84, P262, DOI 10.1016/j.acmx.2014.02.003
   Fuller S, 2016, WORLD J PEDIATR CONG, V7, P436, DOI 10.1177/2150135116656122
   Fuller SM, 2015, ANN THORAC SURG, V100, P1728, DOI 10.1016/j.athoracsur.2015.07.002
   Hickey GL, 2016, J THORAC CARDIOV SUR, V152, P351, DOI 10.1016/j.jtcvs.2016.04.023
   Horer J, 2016, WORLD J PEDIATR CONG, V7, P425, DOI 10.1177/2150135116656001
   Jacobs JP, 2012, EUR J CARDIO-THORAC, V42, P775, DOI 10.1093/ejcts/ezs026
   Jacobs ML, 2008, CARDIOL YOUNG, V18, P163, DOI 10.1017/S1047951108002904
   Jenkins KJ, 2002, J THORAC CARDIOV SUR, V123, P110, DOI 10.1067/mtc.2002.119064
   Kieser TM, 2016, EUR J CARDIO-THORAC, V50, P509, DOI 10.1093/ejcts/ezw072
   Kogon B, 2014, J THORAC CARDIOV SUR, V147, P666, DOI 10.1016/j.jtcvs.2013.09.053
   Lacour-Gayet F, 2004, EUR J CARDIO-THORAC, V25, P911, DOI 10.1016/j.ejcts.2004.03.027
   Lafuente S, 2008, REV ESP CARDIOL, V61, P589
   Nashef SAM, 2016, EUR J CARDIO-THORAC, V50, P519, DOI 10.1093/ejcts/ezw143
   Roques F, 1999, EUR J CARDIO-THORAC, V15, P816, DOI 10.1016/S1010-7940(99)00106-2
   Schafer JL, 1999, STAT METHODS MED RES, V8, P3, DOI 10.1191/096228099671525676
   Steyerberg EW, 2014, EUR HEART J, V35, P1925, DOI 10.1093/eurheartj/ehu207
   Verheugt CL, 2017, EUR J PREV CARDIOL, V24, P1319, DOI 10.1177/2047487317710355
   Zomer AC, 2011, CIRCULATION, V124, P2195, DOI 10.1161/CIRCULATIONAHA.111.027763
NR 20
TC 2
Z9 2
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD SEP
PY 2019
VL 49
IS 9
BP 856
EP 863
DI 10.4070/kcj.2019.0015
PG 8
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA IU4YT
UT WOS:000483593700009
PM 31165593
OA Other Gold, Green Published
DA 2021-04-22
ER

PT J
AU Lee, H
   Yeom, A
   Kim, KC
   Hong, YM
AF Lee, Hyeryon
   Yeom, Arim
   Kim, Kwan Chang
   Hong, Young Mi
TI Effect of Ambrisentan Therapy on the Expression of Endothelin Receptor,
   Endothelial Nitric Oxide Synthase and NADPH Oxidase 4 in
   Monocrotaline-induced Pulmonary Arterial Hypertension Rat Model
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Hypertension; pulmonary; Endothelin receptor antagonists; Monocrotaline;
   Gene expression
ID OXIDATIVE STRESS; PROLIFERATION; CELLS; GENE; LUNGS; ETA
AB Background and Objectives: Elevated endothelin (ET)-1 level is strongly correlated with the pathogenesis of pulmonary arterial hypertension (PAH). Expression level of nicotinamide adenine dinucleotide phosphate oxidase (NOX) 4 is increased in the PAH patients. Ambrisentan, a selective endothelin receptor A (ERA) antagonist, is widely used in PAH therapy. The current study was undertaken to evaluate the effects of ambrisentan treatment in the monocrotaline (MCT)-induced PAH rat model.
   Methods: Rats were categorized into control group (C), monocrotaline group (M) and ambrisentan group (Am). The M and Am were subcutaneously injected 60 mg/kg MCT at day 0, and in Am, ambrisentan was orally administered the day after MCI injection for 4 weeks. The right ventricle (RV) pressure was measured and pathological changes of the lung tissues were observed by Victoria blue staining. Protein expressions of ET-1, ERA, endothelial nitric oxide synthase (eNOS) and NOX4 were confirmed by western blot analysis.
   Results: Ambrisentan treatment resulted in a recovery of the body weight and RV/left ventricle+septum at week 4. The RV pressure was lowered at weeks 2 and 4 after ambrisentan administration. Medial wall thickening of pulmonary arterioles and the number of intra-acinar arteries were also attenuated by ambrisentan at week 4. Protein expression levels of ET-1 and eNOS were recovered at weeks 2 and 4, and ERA levels recovered at week 4.
   Conclusions: Ambrisentan administration resulted in the recovery of ET-1, ERA and eNOS protein expression levels in the PAH model. However, the expression level of NOX4 remained unaffected after ambrisentan treatment.
C1 [Lee, Hyeryon; Yeom, Arim; Hong, Young Mi] Ewha Womans Univ, Dept Pediat, Coll Med, 1071 Anyangcheon Ro, Seoul 07985, South Korea.
   [Kim, Kwan Chang] Ewha Womans Univ, Coll Med, Dept Thorac & Cardiovasc Surg, Seoul, South Korea.
RP Hong, YM (corresponding author), Ewha Womans Univ, Dept Pediat, Coll Med, 1071 Anyangcheon Ro, Seoul 07985, South Korea.
EM ymhong@ewha.ac.kr
RI kim, kwan chang/V-9944-2018
OI Lee, Hyeryon/0000-0002-8566-7503
CR Barman Scott A, 2017, Adv Exp Med Biol, V967, P1, DOI 10.1007/978-3-319-63245-2_1
   Barst RJ, 2007, VASC HEALTH RISK MAN, V3, P11
   Bowers R, 2004, AM J RESP CRIT CARE, V169, P764, DOI 10.1164/rccm.200301-147OC
   Casserly B, 2009, DRUG DES DEV THER, V3, P269
   Chester Adrian H, 2014, Glob Cardiol Sci Pract, V2014, P62, DOI 10.5339/gcsp.2014.29
   Cooke JP, 2003, CIRCULATION, V108, P1420, DOI 10.1161/01.CIR.0000087153.11050.AB
   Craige SM, 2011, CIRCULATION, V124, P731, DOI 10.1161/CIRCULATIONAHA.111.030775
   Dong F, 2005, BRIT J PHARMACOL, V145, P323, DOI 10.1038/sj.bjp.0706193
   Dubois M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082594
   GIAID A, 1993, NEW ENGL J MED, V328, P1732, DOI 10.1056/NEJM199306173282402
   GIAID A, 1995, NEW ENGL J MED, V333, P214, DOI 10.1056/NEJM199507273330403
   HUANG PL, 1995, NATURE, V377, P239, DOI 10.1038/377239a0
   Iglarz M, 2015, J CARDIOVASC PHARM, V66, P332, DOI 10.1097/FJC.0000000000000283
   Ismail S, 2009, AM J PHYSIOL-LUNG C, V296, pL489, DOI 10.1152/ajplung.90488.2008
   Jasmin JF, 2003, CLIN SCI, V105, P647, DOI 10.1042/CS20030139
   Jernigan NL, 2004, AM J PHYSIOL-LUNG C, V287, pL801, DOI 10.1152/ajplung.00443.2003
   Kim KC, 2016, KOREAN CIRC J, V46, P79, DOI 10.4070/kcj.2016.46.1.79
   Kingman M, 2009, EXPERT OPIN PHARMACO, V10, P1847, DOI 10.1517/14656560903061275
   Koo HS, 2011, KOREAN CIRC J, V41, P83, DOI 10.4070/kcj.2011.41.2.83
   Kosanovic D, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-87
   Lee Hyeryon, 2018, Korean J Pediatr, V61, P271, DOI 10.3345/kjp.2018.06457
   Lee H, 2016, PEDIATR RES, V80, P119, DOI 10.1038/pr.2016.38
   Li LX, 2003, CIRCULATION, V107, P1053, DOI 10.1161/01.CIR.0000051459.74466.46
   Lim Kyoung Ah, 2010, Korean Circ J, V40, P459, DOI 10.4070/kcj.2010.40.9.459
   Patel BB, 2015, CARDIOL REV, V23, P33, DOI 10.1097/CRD.0000000000000042
   Peng JJ, 2017, N-S ARCH PHARMACOL, V390, P331, DOI 10.1007/s00210-017-1359-2
   Sturrock A, 2006, AM J PHYSIOL-LUNG C, V290, pL661, DOI 10.1152/ajplung.00269.2005
   Sun Li-rong, 2008, Zhonghua Jiehe He Huxi Zazhi, V31, P335
   Tuder RM, 2009, J AM COLL CARDIOL, V54, pS3, DOI 10.1016/j.jacc.2009.04.009
   Wu F, 2017, BIOMED PHARMACOTHER, V89, P632, DOI 10.1016/j.biopha.2017.02.033
NR 30
TC 2
Z9 2
U1 0
U2 2
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD SEP
PY 2019
VL 49
IS 9
BP 866
EP 876
DI 10.4070/kcj.2019.0006
PG 11
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA IU4YT
UT WOS:000483593700011
PM 31165592
OA Other Gold, Green Published
DA 2021-04-22
ER

PT J
AU Choi, JO
AF Choi, Jin-Oh
TI Thrombus in Left Ventricle, Is This a Game Changer or a Marker of
   Disease?
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
ID MYOCARDIAL-INFARCTION; ISCHEMIC-STROKE; RISK
C1 [Choi, Jin-Oh] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Heart Vasc Stroke Inst,Dept Med,Div Cardiol, 81 Irwon Ro, Seoul 06351, South Korea.
RP Choi, JO (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Heart Vasc Stroke Inst,Dept Med,Div Cardiol, 81 Irwon Ro, Seoul 06351, South Korea.
EM choijean5@gmail.com
CR Chiarella F, 1998, AM J CARDIOL, V81, P822, DOI 10.1016/S0002-9149(98)00003-4
   Friberg L, 2012, EUR HEART J, V33, P1500, DOI 10.1093/eurheartj/ehr488
   Greenberg B, 2019, JAMA CARDIOL, V4, P515, DOI 10.1001/jamacardio.2019.1049
   Habash F, 2017, THER ADV CARDIO DIS, V11, P203, DOI 10.1177/1753944717711139
   Kim MS, 2017, KOREAN CIRC J, V47, P555, DOI 10.4070/kcj.2017.0009
   Lee GY, 2015, MAYO CLIN PROC, V90, P441, DOI 10.1016/j.mayocp.2014.12.025
   Melgaard L, 2015, JAMA-J AM MED ASSOC, V314, P1030, DOI 10.1001/jama.2015.10725
   Oh JK, 2019, KOREAN CIRC J, V49, P829, DOI 10.4070/kcj.2018.0346
   Son JW, 2012, CIRC J, V76, P2640, DOI 10.1253/circj.CJ-12-0360
   STRATTON JR, 1987, CIRCULATION, V75, P1004, DOI 10.1161/01.CIR.75.5.1004
NR 10
TC 0
Z9 0
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD SEP
PY 2019
VL 49
IS 9
BP 838
EP 840
DI 10.4070/kcj.2019.0236
PG 3
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA IU4YT
UT WOS:000483593700006
PM 31456376
OA Green Published, Other Gold
DA 2021-04-22
ER

PT J
AU Bae, MH
AF Bae, Myung Hwan
TI Cardiac Implantable Electronic Device Therapy in Korea: Increasing but
   Still Quite Low
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
ID CARDIOVERTER-DEFIBRILLATORS; WORLD SURVEY; SOCIETY
C1 [Bae, Myung Hwan] Kyungpook Natl Univ, Sch Med, Dept Internal Med, Div Cardiol, 130 Dongdeok Ro, Daegu 41944, South Korea.
RP Bae, MH (corresponding author), Kyungpook Natl Univ, Sch Med, Dept Internal Med, Div Cardiol, 130 Dongdeok Ro, Daegu 41944, South Korea.
EM bmh0325@knu.ac.kr
CR Greenspon AJ, 2012, J AM COLL CARDIOL, V60, P1540, DOI 10.1016/j.jacc.2012.07.017
   Kim J, 2012, KOREAN CIRC J, V42, P173, DOI 10.4070/kcj.2012.42.3.173
   Lee JH, 2019, KOREAN CIRC J, V49, P841, DOI 10.4070/kcj.2018.0444
   Mond HG, 2008, PACE, V31, P1202, DOI 10.1111/j.1540-8159.2008.01164.x
   Mond HG, 2011, PACE, V34, P1013, DOI 10.1111/j.1540-8159.2011.03150.x
   Park KH, 2017, KOREAN CIRC J, V47, P72, DOI 10.4070/kcj.2016.0242
   Raatikainen MJP, 2015, EUROPACE, V17, pI1, DOI 10.1093/europace/euu300
   Uhm JS, 2017, YONSEI MED J, V58, P514, DOI 10.3349/ymj.2017.58.3.514
NR 8
TC 0
Z9 0
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD SEP
PY 2019
VL 49
IS 9
BP 853
EP 855
DI 10.4070/kcj.2019.0131
PG 3
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA IU4YT
UT WOS:000483593700008
PM 31165602
OA Green Published, Other Gold
DA 2021-04-22
ER

PT J
AU Park, HK
AF Park, Han Ki
TI Risk Stratification Models for Adults with Congenital Heart Disease
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
ID SURGERY
C1 [Park, Han Ki] Severance Cardiovasc Hosp, Div Cardiovasc Surg, 50-1 Yonsei Ro, Seoul 03722, South Korea.
   [Park, Han Ki] Yonsei Univ, Coll Med, Dept Thorac & Cardiovasc Surg, Seoul, South Korea.
RP Park, HK (corresponding author), Severance Cardiovasc Hosp, Div Cardiovasc Surg, 50-1 Yonsei Ro, Seoul 03722, South Korea.
EM hank@yuhs.ac
OI Park, Han Ki/0000-0002-7472-7822
CR Fuller SM, 2015, ANN THORAC SURG, V100, P1728, DOI 10.1016/j.athoracsur.2015.07.002
   Horer J, 2016, WORLD J PEDIATR CONG, V7, P425, DOI 10.1177/2150135116656001
   Kogon B, 2014, J THORAC CARDIOV SUR, V147, P666, DOI 10.1016/j.jtcvs.2013.09.053
   Niwa K, 2019, KOREAN CIRC J, V49, P691, DOI 10.4070/kcj.2019.0187
   Ramchandani BK, 2019, KOREAN CIRC J, V49, P856, DOI 10.4070/kcj.2019.0015
   van Gameren M, 2011, EUR J CARDIO-THORAC, V39, P490, DOI 10.1016/j.ejcts.2010.07.032
NR 6
TC 0
Z9 0
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD SEP
PY 2019
VL 49
IS 9
BP 864
EP 865
DI 10.4070/kcj.2019.0259
PG 2
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA IU4YT
UT WOS:000483593700010
PM 31456377
OA Green Published, Other Gold
DA 2021-04-22
ER

PT J
AU Chung, H
   Sohn, IS
AF Chung, Hyemoon
   Sohn, Il Suk
TI Moving Beyond the Endothelium is Still Challenging-Complex Interplay
   between Endothelin and Reactive Oxygen Species in Pulmonary Arterial
   Hypertension
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
ID NADPH OXIDASE 4
C1 [Chung, Hyemoon] Kyung Hee Univ, Med Ctr, Dept Cardiol, Seoul, South Korea.
   [Sohn, Il Suk] Kyung Hee Univ Hosp Gangdong, Dept Cardiol, Seoul, South Korea.
RP Sohn, IS (corresponding author), Kyung Hee Univ, Kyung Hee Univ Hosp Gangdong, Coll Med, Dept Cardiol, 892 Dongnam Ro, Seoul 05278, South Korea.
EM issohn@khu.ac.kr
RI SOHN, ILSUK/AAI-1097-2020
OI SOHN, ILSUK/0000-0001-8004-5185
CR Barman Scott A, 2017, Adv Exp Med Biol, V967, P1, DOI 10.1007/978-3-319-63245-2_1
   Barman SA, 2014, ARTERIOSCL THROM VAS, V34, P1704, DOI 10.1161/ATVBAHA.114.303848
   Chen F, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00412
   Chester Adrian H, 2014, Glob Cardiol Sci Pract, V2014, P62, DOI 10.5339/gcsp.2014.29
   Galie N, 2016, EUR HEART J, V37, P67, DOI 10.1093/eurheartj/ehv317
   Kim KH, 2018, KOREAN CIRC J, V48, P839, DOI 10.4070/kcj.2017.0394
   Lee H, 2019, KOREAN CIRC J, V49, P866, DOI 10.4070/kcj.2019.0006
   Lee Hyeryon, 2018, Korean J Pediatr, V61, P271, DOI 10.3345/kjp.2018.06457
   Nogueira-Ferreira R, 2014, BBA-MOL CELL RES, V1843, P885, DOI 10.1016/j.bbamcr.2014.01.030
   Simonneau G, 2013, J AM COLL CARDIOL, V62, pD34, DOI [10.1016/j.jacc.2013.10.029, 10.1016/j.jacc.2009.04.012]
NR 10
TC 0
Z9 0
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD SEP
PY 2019
VL 49
IS 9
BP 877
EP 878
DI 10.4070/kcj.2019.0167
PG 2
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA IU4YT
UT WOS:000483593700012
PM 31347318
OA Green Published, Other Gold
DA 2021-04-22
ER

PT J
AU Choi, SW
   Hur, SH
   Lee, CH
   Cho, YK
   Yoon, HJ
   Nam, CW
   Kim, KB
AF Choi, Sang-Woong
   Hur, Seung-Ho
   Lee, Cheol Hyun
   Cho, Yun-Kyeong
   Yoon, Hyuck-Jun
   Nam, Chang-Wook
   Kim, Kwon-Bae
TI Optical Coherence Tomography: Defined Plaque Erosion after Removal of a
   Coronary Guidewire
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
C1 [Choi, Sang-Woong; Hur, Seung-Ho; Lee, Cheol Hyun; Cho, Yun-Kyeong; Yoon, Hyuck-Jun; Nam, Chang-Wook; Kim, Kwon-Bae] Keimyung Univ, Dongsan Med Ctr, Div Cardiol, Daegu, South Korea.
RP Choi, SW (corresponding author), Keimyung Univ, Dongsan Med Ctr, Dept Internal Med, Div Cardiol, 56 Dalseong Ro, Daegu 42601, South Korea.
EM shur@dsmc.or.kr
OI Nam, Chang-Wook/0000-0002-3370-5774; Sang-Woong,
   Choi/0000-0002-7811-4812; Hur, Seung-Ho/0000-0002-3895-1915; Lee, Cheol
   Hyun/0000-0003-4203-1457
CR Kubo T, 2007, J AM COLL CARDIOL, V50, P933, DOI 10.1016/j.jacc.2007.04.082
NR 1
TC 0
Z9 0
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD SEP
PY 2019
VL 49
IS 9
BP 879
EP 881
DI 10.4070/kcj.2019.0088
PG 3
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA IU4YT
UT WOS:000483593700013
PM 31456378
OA Green Published
DA 2021-04-22
ER

PT J
AU Shlofmitz, E
   Shlofmitz, R
   Lee, MS
AF Shlofmitz, Evan
   Shlofmitz, Richard
   Lee, Michael S.
TI The Role of Novel Oral Anticoagulants and Antiplatelet Therapy after
   Percutaneous Coronary Intervention: Individualizing Therapy to Optimize
   Outcomes
SO KOREAN CIRCULATION JOURNAL
LA English
DT Review
DE Antiplatelet therapy; Oral anticoagulant; Non-vitamin K antagonist oral
   anticoagulants; Percutaneous coronary intervention
ID DRUG-ELUTING STENTS; RESIDUAL PLATELET REACTIVITY; ACUTE
   MYOCARDIAL-INFARCTION; ATRIAL-FIBRILLATION; ANTITHROMBOTIC THERAPY;
   FOCUSED UPDATE; CLOPIDOGREL; IMPLANTATION; THROMBOSIS; WARFARIN
AB The number of patients undergoing percutaneous coronary intervention (PCI) who mandate additional oral anticoagulant therapy has been increasing. Dual antiplatelet therapy (DAPT) is associated with reduced ischemic events including stent thrombosis, myocardial infarction and stroke following PCI. However, the tradeoff is an increased risk for bleeding while on DAPT. The addition of a novel oral anticoagulant (NOAC) further increases the likelihood of bleeding while on antiplatelet therapy. Thus, the overall risks and benefits for each patient undergoing PCI on NOAC must be assessed and therapy individualized to ensure optimal therapy for each unique situation. Patients on NOAC undergoing PCI should undergo routine assessment with intravascular imaging as the role of high-risk lesion-related features have increased importance prior to determining optimal duration of treatment with DAPT. We review the best practices for the pharmacologic management of patients requiring anticoagulation with NOAC who are treated with PCI and require antiplatelet therapy.
C1 [Shlofmitz, Evan] MedStar Washington Hosp Ctr, Washington, DC USA.
   [Shlofmitz, Richard] St Francis Hosp, Heart Ctr, Roslyn, NY USA.
   [Lee, Michael S.] Ronald Reagan UCLA Med Ctr, 757 Westwood Plaza, Los Angeles, CA 90095 USA.
RP Lee, MS (corresponding author), Ronald Reagan UCLA Med Ctr, 757 Westwood Plaza, Los Angeles, CA 90095 USA.
EM MSLee@mednet.ucla.edu
RI Shlofmitz, Evan/H-9979-2019
OI Shlofmitz, Evan/0000-0002-0907-5258
CR [Anonymous], 2019, Rev Esp Cardiol (Engl Ed), V72, P73, DOI 10.1016/j.rec.2018.11.012
   Brener SJ, 2016, JACC-CARDIOVASC INTE, V9, P1450, DOI 10.1016/j.jcin.2016.04.037
   Cannon CP, 2017, NEW ENGL J MED, V377, P1513, DOI 10.1056/NEJMoa1708454
   Choi KH, 2019, JACC-CARDIOVASC INTE, V12, P607, DOI 10.1016/j.jcin.2019.01.227
   Choi SY, 2011, CIRC-CARDIOVASC INTE, V4, P239, DOI 10.1161/CIRCINTERVENTIONS.110.959791
   Connolly SJ, 2009, NEW ENGL J MED, V361, P1139, DOI 10.1056/NEJMoa0905561
   Costa F, 2017, LANCET, V389, P1025, DOI 10.1016/S0140-6736(17)30397-5
   Cutlip DE, 2017, JACC-CARDIOVASC INTE, V10, P160, DOI 10.1016/j.jcin.2016.10.037
   Degheim G, 2017, AM J CARDIOVASC DIS, V7, P98
   Fujii K, 2005, J AM COLL CARDIOL, V45, P995, DOI 10.1016/j.jacc.2004.12.066
   Genereux P, 2015, J AM COLL CARDIOL, V66, P1036, DOI 10.1016/j.jacc.2015.06.1323
   Gibson CM, 2016, NEW ENGL J MED, V375, P2423, DOI 10.1056/NEJMoa1611594
   Giugliano RP, 2013, NEW ENGL J MED, V369, P2093, DOI 10.1056/NEJMoa1310907
   Granger CB, 2011, NEW ENGL J MED, V365, P981, DOI 10.1056/NEJMoa1107039
   Hahn JY, 2018, LANCET, V391, P1274, DOI 10.1016/S0140-6736(18)30493-8
   Hong SJ, 2015, JAMA-J AM MED ASSOC, V314, P2155, DOI 10.1001/jama.2015.15454
   Jang JY, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0207386
   Joung B, 2017, KOREAN CIRC J, V47, P833, DOI 10.4070/kcj.2017.0158
   Kang J, 2019, THROMB HAEMOSTASIS, V119, P149, DOI 10.1055/s-0038-1676545
   Kazi DS, 2015, J AM COLL CARDIOL, V65, P1411, DOI 10.1016/j.jacc.2015.01.047
   Kearon C, 2016, CHEST, V149, P315, DOI 10.1016/j.chest.2015.11.026
   Konigstein M, 2019, AM HEART J, V213, P105, DOI 10.1016/j.ahj.2019.03.011
   Larsen TB, 2015, EUROPACE, V17, P819, DOI 10.1093/europace/euv116
   Lee JM, 2018, KOREAN CIRC J, V48, P519, DOI 10.4070/kcj.2017.0389
   Lee MS, 2017, AM J CARDIOL, V119, P991, DOI 10.1016/j.amjcard.2016.11.057
   Lee SH, 2013, KOREAN CIRC J, V43, P343, DOI 10.4070/kcj.2013.43.5.343
   Levine GN, 2016, J AM COLL CARDIOL, V68, P1082, DOI 10.1016/j.jacc.2016.03.513
   Lip GYH, 2011, J AM COLL CARDIOL, V57, P173, DOI 10.1016/j.jacc.2010.09.024
   Liu XB, 2009, JACC-CARDIOVASC INTE, V2, P997, DOI 10.1016/j.jcin.2009.07.012
   Liu XB, 2009, JACC-CARDIOVASC INTE, V2, P428, DOI 10.1016/j.jcin.2009.01.011
   Lopes RD, 2019, NEW ENGL J MED, V380, P1509, DOI 10.1056/NEJMoa1817083
   Maehara A, 2018, CIRC-CARDIOVASC INTE, V11, DOI 10.1161/CIRCINTERVENTIONS.117.006243
   Miyasaka Y, 2006, CIRCULATION, V114, P119, DOI 10.1161/CIRCULATIONAHA.105.595140
   Mozaffarian D, 2015, CIRCULATION, V131, pE29, DOI [10.1161/CIR.0000000000000152, 10.1161/01.cir.0000441139.02102.80, 10.1161/CIR.0b013e31828124ad]
   Neumann FJ, 2019, EUR HEART J, V40, P79, DOI 10.1093/eurheartj/ehy855
   Okabe T, 2007, AM J CARDIOL, V100, P615, DOI 10.1016/j.amjcard.2007.03.072
   Oldgren J, 2019, EUR HEART J, V40, P1553, DOI 10.1093/eurheartj/ehz059
   Park KH, 2018, J CARDIOL, V71, P36, DOI 10.1016/j.jjcc.2017.05.003
   Parodi G, 2011, JAMA-J AM MED ASSOC, V306, P1215, DOI 10.1001/jama.2011.1332
   Patel MR, 2011, NEW ENGL J MED, V365, P883, DOI 10.1056/NEJMoa1009638
   Price MJ, 2008, EUR HEART J, V29, P992, DOI 10.1093/eurheartj/ehn046
   Price MJ, 2011, JAMA-J AM MED ASSOC, V305, P1097, DOI 10.1001/jama.2011.290
   Price MJ, 2009, AM HEART J, V157, P818, DOI 10.1016/j.ahj.2009.02.012
   Rozemeijer R, 2019, NETH HEART J, V27, P321, DOI 10.1007/s12471-019-1253-2
   Saito S, 2014, CIRC J, V78, P1684, DOI 10.1253/circj.CJ-13-1482
   Shlofmitz E, 2019, MINERVA CARDIOANGIOL
   Shlofmitz E, 2019, CARDIOVASC REVASCULA, V20, P273, DOI 10.1016/j.carrev.2019.02.008
   Shlofmitz Evan, 2018, Interv Cardiol Clin, V7, P329, DOI 10.1016/j.iccl.2018.03.001
   Skelley JW, 2017, J THROMB THROMBOLYS, V43, P24, DOI 10.1007/s11239-016-1428-2
   Steffel J, 2018, EUR HEART J, V39, P1330, DOI 10.1093/eurheartj/ehy136
   Trenk D, 2012, J AM COLL CARDIOL, V59, P2159, DOI 10.1016/j.jacc.2012.02.026
   Valgimigli M, 2018, EUR HEART J, V39, P213, DOI 10.1093/eurheartj/ehx419
   Valle JA, 2016, CIRC-CARDIOVASC INTE, V9, DOI 10.1161/CIRCINTERVENTIONS.115.003519
   Varenne O, 2018, LANCET, V391, P41, DOI 10.1016/S0140-6736(17)32713-7
   Vranckx P, 2018, LANCET, V392, P940, DOI 10.1016/S0140-6736(18)31858-0
   Watanabe H, 2019, AM COLL CARD ANN SCI
   Yoshida R, 2019, J CARDIOL, V73, P479, DOI 10.1016/j.jjcc.2018.10.013
   Zhang JJ, 2018, J AM COLL CARDIOL, V72, P3126, DOI 10.1016/j.jacc.2018.09.013
NR 58
TC 1
Z9 1
U1 0
U2 5
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD AUG
PY 2019
VL 49
IS 8
BP 645
EP 656
DI 10.4070/kcj.2019.0185
PG 12
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA IM3DQ
UT WOS:000477872700001
PM 31347321
OA Other Gold, Green Published
DA 2021-04-22
ER

PT J
AU Choi, MS
   Sung, K
   Cho, YH
AF Choi, Min Suk
   Sung, Kiick
   Cho, Yang Hyun
TI Clinical Pearls of Venoarterial Extracorporeal Membrane Oxygenation for
   Cardiogenic Shock
SO KOREAN CIRCULATION JOURNAL
LA English
DT Review
DE Extracorporeal membrane oxygenation; Physiology; Shock; Postoperative
   complications
ID LEFT ATRIAL DECOMPRESSION; LEFT-HEART DECOMPRESSION; LIFE-SUPPORT;
   CARDIOPULMONARY-RESUSCITATION; PERCUTANEOUS CANNULATION; LEFT-VENTRICLE;
   ARTERIAL COMPLICATIONS; AORTIC DISSECTION; CARDIAC-ARREST; ECMO
AB Extracorporeal membrane oxygenation (ECMO) is a technique that uses a pump to drain blood from a body, circulate blood through a membrane lung, and return the oxygenated blood back into the body. Venoarterial (VA) ECMO is a simplified version of the heart-lung machine that assists native pulmonary and/or cardiac function. VA ECMO is composed of a drainage cannula in the venous system and a return cannula in the arterial system. Because VA ECMO can increase tissue perfusion by increasing the arterial blood flow, it is used to treat medically refractory cardiogenic shock or cardiac arrest. VA ECMO has a distinct physiology that is referred to as differential flows. It can cause several complications such as left ventricular distension with pulmonary edema, distal limb ischemia, bleeding, and thromboembolism. Physicians who are using this technology should be knowledgeable on the prevention and management of these complications. We review the basic physiology of VA ECMO, the mechanism of complications, and the simple management of VA ECMO.
C1 [Choi, Min Suk] Dongguk Univ, Sch Med, Ilsan Hosp, Dept Thorac & Cardiovasc Surg, Goyang, South Korea.
   [Sung, Kiick; Cho, Yang Hyun] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Thorac & Cardiovasc Surg, 81 Irwon Ro, Seoul 06351, South Korea.
RP Cho, YH (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Thorac & Cardiovasc Surg, 81 Irwon Ro, Seoul 06351, South Korea.
EM yanghyun.cho@samsung.com
OI Cho, Yang Hyun/0000-0003-1685-3641
CR Alhussein M, 2017, J CARDIAC SURG, V32, P396, DOI 10.1111/jocs.13146
   Alkhouli M, 2016, J CARDIAC SURG, V31, P177, DOI 10.1111/jocs.12696
   Asaki M, 2018, CASE REP CRIT CARE, V2018
   Aso S, 2016, CRIT CARE MED, V44, P1974, DOI 10.1097/CCM.0000000000001828
   Auzinger G, 2014, J CARDIOTHOR VASC AN, V28, P1307, DOI 10.1053/j.jvca.2013.06.027
   Avalli L, 2016, MINERVA ANESTESIOL, V82, P36
   Avalli L, 2011, ASAIO J, V57, P38, DOI 10.1097/MAT.0b013e3181fe5d0b
   Aziz F, 2014, ANN VASC SURG, V28, P178, DOI 10.1016/j.avsg.2013.03.011
   Barbone A, 2011, INTERACT CARDIOV TH, V13, P293, DOI 10.1510/icvts.2011.269795
   BARTLETT RH, 2017, EXTRACORPOREAL LIFE, P31
   Baruteau AE, 2018, EUR HEART J-ACUTE CA, V7, P70, DOI 10.1177/2048872616675485
   Batista PM, 2013, ANN THORAC SURG, V95, P357, DOI 10.1016/j.athoracsur.2012.05.125
   Beiderlinden M, 2007, ARTIF ORGANS, V31, P461, DOI 10.1111/j.1525-1594.2007.00388.x
   Ben Sivarajan V, 2011, INTENS CARE MED, V37, P853, DOI 10.1007/s00134-011-2168-6
   Burkhoff D, 2015, J AM COLL CARDIOL, V66, P2664, DOI 10.1016/j.jacc.2015.10.017
   Centofanti Paolo, 2017, J Extra Corpor Technol, V49, P201
   Chen YS, 2008, LANCET, V372, P554, DOI 10.1016/S0140-6736(08)60958-7
   Cheng A, 2013, ASAIO J, V59, P533, DOI 10.1097/MAT.0b013e31829f0e52
   Cheung Michael M H, 2003, Pediatr Crit Care Med, V4, P447, DOI 10.1097/01.PCC.0000075325.53339.CA
   Cho YH, 2014, ASAIO J, V60, P280, DOI 10.1097/MAT.0000000000000063
   Chvojka J, 2019, SHOCK
   Coughlin MA, 2015, ASAIO J, V61, P652, DOI 10.1097/MAT.0000000000000273
   Donker DW, 2018, PERFUSION-UK, V33, P31, DOI 10.1177/0267659118766438
   Dulnuan K, 2018, J AM COLL CARDIOL, V71, P1358, DOI 10.1016/S0735-1097(18)31899-0
   Eastaugh LJ, 2015, PEDIATR CRIT CARE ME, V16, P59, DOI 10.1097/PCC.0000000000000276
   Fortenberry JD, 2017, EXTRACORPOREAL LIFE, P1
   Fumagalli R, 2004, INT J ARTIF ORGANS, V27, P410
   Goslar T, 2016, INTERACT CARDIOV TH, V22, P507, DOI 10.1093/icvts/ivv366
   Guglin M, 2019, J AM COLL CARDIOL, V73, P698, DOI 10.1016/j.jacc.2018.11.038
   Guirgis M, 2010, INTERACT CARDIOV TH, V10, P672, DOI 10.1510/icvts.2009.228346
   Haft JW, 2012, ECMO EXTRACORPOREAL, P323
   Huang SC, 2008, CRIT CARE MED, V36, P1607, DOI 10.1097/CCM.0b013e318170b82b
   Hwang JW, 2016, J VASC SURG, V63, P998, DOI 10.1016/j.jvs.2015.10.067
   Hysi I, 2014, J CARDIAC SURG, V29, P268, DOI 10.1111/jocs.12229
   Jang WJ, 2018, ANN INTENSIVE CARE, V8, DOI 10.1186/s13613-018-0445-z
   Jaski BE, 2010, J THORAC CARDIOV SUR, V139, P753, DOI 10.1016/j.jtcvs.2009.11.018
   Javidfar J, 2012, ASAIO J, V58, P494, DOI 10.1097/MAT.0b013e318268ea15
   Jayaraman AL, 2017, ANN CARD ANAESTH, V20, pS11, DOI 10.4103/0971-9784.197791
   Johnston TA, 1999, CATHETER CARDIO INTE, V46, P197, DOI 10.1002/(SICI)1522-726X(199902)46:2<197::AID-CCD17>3.0.CO;2-G
   Kafi A, 2017, BMJ CASE REP, V2017
   Kapur NK, 2015, HEART FAIL CLIN, V11, P215, DOI 10.1016/j.hfc.2014.12.012
   Karatolios K, 2016, INT J CARDIOL, V222, P247, DOI 10.1016/j.ijcard.2016.07.227
   Keenan JE, 2016, ASAIO J, V62, pE30, DOI 10.1097/MAT.0000000000000333
   Keshavamurthy Suresh, 2015, Asian Cardiovasc Thorac Ann, V23, P347, DOI 10.1177/0218492314539523
   Kim Chilsung, 2014, Korean J Thorac Cardiovasc Surg, V47, P409, DOI 10.5090/kjtcs.2014.47.4.409
   Kim WH, 2017, ASAIO J, V63, P346, DOI 10.1097/MAT.0000000000000472
   Kim YS, 2018, MEDICINE, V97, DOI 10.1097/MD.0000000000013235
   Konstantinides SV, 2014, EUR HEART J, V35, P3145, DOI 10.1093/eurheartj/ehu393
   Kredel M, 2017, AM J CASE REP, V18, P723, DOI 10.12659/AJCR.902485
   Lamb KM, 2013, J CARDIAC SURG, V28, P190, DOI 10.1111/jocs.12058
   Lee SI, 2017, J INTENSIVE CARE MED, V32, P405, DOI 10.1177/0885066617696851
   Lees NJ, 2016, J ARTIF ORGANS, V19, P399, DOI 10.1007/s10047-016-0915-8
   Lin YN, 2017, CIRC J, V81, P1419, DOI 10.1253/circj.CJ-16-1308
   Lindsey JL, 2018, RESPIR MED CASE REP, V25, P6, DOI 10.1016/j.rmcr.2018.05.029
   Link MS, 2015, CIRCULATION, V132, pS444, DOI 10.1161/CIR.0000000000000261
   Liu Changzhi, 2017, Zhonghua Wei Zhong Bing Ji Jiu Yi Xue, V29, P1140, DOI 10.3760/cma.j.issn.2095-4352.2017.12.018
   Loforte A, 2019, ANN CARDIOTHORAC SUR, V8, P163, DOI 10.21037/acs.2018.08.06
   Lorusso R, 2017, ANN THORAC SURG, V104, P62, DOI 10.1016/j.athoracsur.2016.10.023
   MacLaren G, 2017, EXTRACORPOREAL LIFE, P613
   MacLaren G, 2011, PEDIATR CRIT CARE ME, V12, P133, DOI 10.1097/PCC.0b013e3181e2a4a1
   Madershahian N, 2006, J CARDIAC SURG, V21, P168, DOI 10.1111/j.1540-8191.2006.00201.x
   Montoya J P, 1992, ASAIO J, V38, pM399, DOI 10.1097/00002480-199207000-00064
   Moon D, 2018, ANN SAUDI MED, V38, P174, DOI 10.5144/0256-4947.2018.174
   Na SJ, 2019, REV ESP CARDIOL, V72, P40, DOI [10.1016/j.recesp.2017.12.020, 10.1016/j.rec.2018.01.003]
   Napp LC, 2016, CLIN RES CARDIOL, V105, P283, DOI 10.1007/s00392-015-0941-1
   Narain S, 2012, CASE REP CRIT CARE, V2012, P459296
   Park TK, 2014, BMC ANESTHESIOL, V14, DOI 10.1186/1471-2253-14-27
   Perdue SM, 2018, J CARDIAC SURG, V33, P50, DOI 10.1111/jocs.13508
   Pozzi M, 2017, J THORAC DIS, V9, P1988, DOI 10.21037/jtd.2017.06.81
   Pranikoff TH., 2012, ECMO EXTRACORPOREAL, P133
   Prasad A, 2018, ARTIF ORGANS, V42, P664, DOI 10.1111/aor.13082
   Prodhan P, 2009, RESUSCITATION, V80, P1124, DOI 10.1016/j.resuscitation.2009.07.004
   Rao AS, 2010, J ENDOVASC THER, V17, P51, DOI 10.1583/09-2845.1
   Riera J, 2018, ASAIO J
   Rihal CS, 2015, J AM COLL CARDIOL, V65, pE7, DOI 10.1016/j.jacc.2015.03.036
   Rother RP, 2005, JAMA-J AM MED ASSOC, V293, P1653, DOI 10.1001/jama.293.13.1653
   Schmack B, 2017, PEERJ, V5, DOI 10.7717/peerj.3813
   Shin TG, 2011, CRIT CARE MED, V39, P1, DOI 10.1097/CCM.0b013e3181feb339
   Simek M, 2015, Rozhl Chir, V94, P103
   Sirol M, 2012, ANN THORAC SURG, V93, P2070, DOI 10.1016/j.athoracsur.2011.11.016
   Swol J, 2013, MED KLIN-INTENSIVMED, V108, P63, DOI 10.1007/s00063-012-0164-4
   Tay CK, 2018, ASAIO J, V64, P1, DOI 10.1097/MAT.0000000000000657
   Tay Chee Kiang, 2016, Crit Care Med, V44, pe1251
   Thiara APS, 2007, PERFUSION-UK, V22, P323, DOI 10.1177/0267659107086270
   TOOMASIAN JM, 2017, EXTRACORPOREAL LIFE, P49
   Watanabe Y, 2017, INT HEART J, V58, P831, DOI 10.1536/ihj.16-483
   Weymann A, 2014, J CARDIOTHORAC SURG, V9, DOI 10.1186/1749-8090-9-60
   Yang F, 2018, ANN INTENSIVE CARE, V8, DOI 10.1186/s13613-018-0417-3
   Yeo HJ, 2016, J INTERV CARDIOL, V29, P431, DOI 10.1111/joic.12309
   Yusuff HO, 2015, PERFUSION-UK, V30, P611, DOI 10.1177/0267659115583377
NR 90
TC 7
Z9 7
U1 0
U2 4
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD AUG
PY 2019
VL 49
IS 8
BP 657
EP 677
DI 10.4070/kcj.2019.0188
PG 21
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA IM3DQ
UT WOS:000477872700002
PM 31364329
OA Green Published
DA 2021-04-22
ER

PT J
AU Shin, YR
   Park, YH
   Park, HK
AF Shin, Yu Rim
   Park, Young-Hwan
   Park, Han Ki
TI Pediatric Ventricular Assist Device
SO KOREAN CIRCULATION JOURNAL
LA English
DT Review
DE Heart failure; Pediatric; Ventricular assist device; Extracorporeal
   membranous oxygenation; Cardiac transplantation
ID MECHANICAL CIRCULATORY SUPPORT; TOTAL ARTIFICIAL-HEART; INHALED
   NITRIC-OXIDE; PULMONARY VASCULAR-RESISTANCE; INTERAGENCY REGISTRY;
   DILATED CARDIOMYOPATHY; UNITED-STATES; CHILDREN; BRIDGE; FAILURE
AB There have been great advances in ventricular assist device (VAD) treatment for pediatric patients with advanced heart failure. VAD support provides more time for the patient in the heart transplant waiting list. Augmented cardiac output improves heart failure symptoms, end-organ function, and general condition, and consequently provides beneficial effects on post-transplant outcomes. Miniaturized continuous flow devices are more widely adopted for pediatric patient with promising results. For infants and small children, still paracorporeal pulsatile device is the only option for long-term support. Younger age, congenital heart disease, biventricular support, patient's status and end-organ dysfunction at the time of implantation are risks for poor outcomes. Patient selection, timing of implantation, and selection of device for each patient are critical for optimal clinical outcomes.
C1 [Shin, Yu Rim; Park, Young-Hwan; Park, Han Ki] Yonsei Univ, Coll Med, Severance Cardiovasc Hosp, Div Cardiovasc Surg,Dept Thorac & Cardiovasc Surg, 50-1 Yonsei Ro, Seoul 03722, South Korea.
RP Park, HK (corresponding author), Yonsei Univ, Coll Med, Severance Cardiovasc Hosp, Div Cardiovasc Surg,Dept Thorac & Cardiovasc Surg, 50-1 Yonsei Ro, Seoul 03722, South Korea.
EM hank@yuhs.ac
OI Park, Han Ki/0000-0002-7472-7822; park, young hwan/0000-0001-9802-8017
CR Adachi I, 2017, ISHLT MONOGRAPH SERI, P46
   Adachi I, 2016, J HEART LUNG TRANSPL, V35, P688, DOI 10.1016/j.healun.2016.01.1218
   Adachi I, 2015, J THORAC DIS, V7, P2194, DOI 10.3978/j.issn.2072-1439.2015.12.61
   Almond CS, 2013, CIRCULATION, V127, P1702, DOI 10.1161/CIRCULATIONAHA.112.000685
   Argenziano M, 1998, ANN THORAC SURG, V65, P340, DOI 10.1016/S0003-4975(97)01307-6
   Birks EJ, 2013, CIRC RES, V113, P777, DOI 10.1161/CIRCRESAHA.113.301413
   Blume ED, 2006, CIRCULATION, V113, P2313, DOI 10.1161/CIRCULATIONAHA.105.577601
   Blume ED, 2016, J HEART LUNG TRANSPL, V35, P578, DOI 10.1016/j.healun.2016.01.1227
   Burkhoff D, 2015, J AM COLL CARDIOL, V66, P2664, DOI 10.1016/j.jacc.2015.10.017
   Cedars A, 2018, J HEART LUNG TRANSPL, V37, P619, DOI 10.1016/j.healun.2017.11.010
   Chang JC, 1997, ASAIO J, V43, pM418
   Conway J, 2018, SEMIN THORAC CARDIOV, V30, P327, DOI 10.1053/j.semtcvs.2018.03.003
   Copeland JG, 2004, NEW ENGL J MED, V351, P859, DOI 10.1056/NEJMoa040186
   Cruz DN, 2013, CONTRIB NEPHROL, V182, P117, DOI 10.1159/000349968
   Fraser CD, 2012, NEW ENGL J MED, V367, P532, DOI 10.1056/NEJMoa1014164
   Hetzer R, 2006, ANN THORAC SURG, V82, P917, DOI 10.1016/j.athoracsur.2006.03.065
   Hetzer R, 2016, EUR J CARDIO-THORAC, V50, P203, DOI 10.1093/ejcts/ezw011
   Horne David, 2015, Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu, V18, P17, DOI 10.1053/j.pcsu.2015.02.002
   Imielski BR, 2017, ARTIF ORGANS, V41, P40, DOI 10.1111/aor.12852
   Iodice F, 2015, NEUROMUSCULAR DISORD, V25, P19, DOI 10.1016/j.nmd.2014.08.008
   Karimova A, 2014, J THORAC CARDIOV SUR, V147, P1691, DOI 10.1016/j.jtcvs.2013.11.012
   Klodell CT, 2007, ANN THORAC SURG, V83, P68, DOI 10.1016/j.athoracsur.2006.08.051
   Kormos RL, 2010, J THORAC CARDIOV SUR, V139, P1316, DOI 10.1016/j.jtcvs.2009.11.020
   Kumarasinghe G, 2018, ESC HEART FAIL, V5, P695, DOI 10.1002/ehf2.12284
   Lal AK, 2014, ASAIO J, V60, P119, DOI 10.1097/MAT.0000000000000007
   Lovich MA, 2015, ASAIO J, V61, P379, DOI 10.1097/MAT.0000000000000211
   Miera O, 2011, ANN THORAC SURG, V91, P1256, DOI 10.1016/j.athoracsur.2010.12.013
   Morales DLS, 2019, ANN THORAC SURG, V107, P993, DOI 10.1016/j.athoracsur.2019.01.038
   Morales DLS, 2012, SEMIN THORAC CARDIOV, V24, P142, DOI 10.1053/j.semtcvs.2012.04.006
   Morales DLS, 2011, J THORAC CARDIOV SUR, V142, pE138, DOI 10.1016/j.jtcvs.2011.05.018
   Nishi H, 2013, J ARTIF ORGANS, V16, P404, DOI 10.1007/s10047-013-0724-2
   Padalino MA, 2014, ARTIF ORGANS, V38, P418, DOI 10.1111/aor.12185
   Park SJ, 2004, J THORAC CARDIOV SUR, V127, P264, DOI 10.1016/S0022-5223(03)01301-1
   Patel AM, 2013, CLIN J AM SOC NEPHRO, V8, P484, DOI 10.2215/CJN.06210612
   Pearce FB, 2009, J THORAC CARDIOV SUR, V137, pE40, DOI 10.1016/j.jtcvs.2008.02.044
   Peng DM, 2017, ISHLT MONOGRAPH SERI, P76
   Peura JL, 2012, CIRCULATION, V126, P2648, DOI 10.1161/CIR.0b013e3182769a54
   Pretre R, 2008, ANN THORAC SURG, V86, P1018, DOI 10.1016/j.athoracsur.2008.03.003
   Reddy SLC, 2004, EUR J CARDIO-THORAC, V25, P605, DOI 10.1016/j.ejcts.2004.01.030
   Rose EA, 2001, NEW ENGL J MED, V345, P1435, DOI 10.1056/NEJMoa012175
   Rossano JW, 2015, KOREAN CIRC J, V45, P1, DOI 10.4070/kcj.2015.45.1.1
   Rossano JW, 2014, ANN THORAC SURG, V97, P1438, DOI 10.1016/j.athoracsur.2013.06.120
   Rossano JW, 2012, J CARD FAIL, V18, P459, DOI 10.1016/j.cardfail.2012.03.001
   Ryan TD, 2014, ASAIO J, V60, P246, DOI 10.1097/MAT.0000000000000050
   Salzberg SP, 2005, EUR J CARDIO-THORAC, V27, P222, DOI 10.1016/j.ejcts.2004.11.001
   Schmitt B, 2010, CIRC-CARDIOVASC IMAG, V3, P623, DOI 10.1161/CIRCIMAGING.109.931592
   Sharma MS, 2006, ANN THORAC SURG, V82, P926, DOI 10.1016/j.athoracsur.2006.02.087
   Slaughter MS, 2009, NEW ENGL J MED, V361, P2241, DOI 10.1056/NEJMoa0909938
   Stein ML, 2016, J HEART LUNG TRANSPL, V35, P92, DOI 10.1016/j.healun.2015.06.006
   Stein ML, 2010, CIRC-HEART FAIL, V3, P682, DOI 10.1161/CIRCHEARTFAILURE.109.918672
   Stiller B, 2003, J HEART LUNG TRANSPL, V22, P1201, DOI 10.1016/S1053-2498(02)01233-0
   Topilsky Y, 2011, CIRC-HEART FAIL, V4, P266, DOI 10.1161/CIRCHEARTFAILURE.110.959288
   Tromp TR, 2015, HEART FAIL REV, V20, P519, DOI 10.1007/s10741-015-9481-z
   Tunuguntla H, 2016, J THORAC CARDIOV SUR, V151, pE11, DOI 10.1016/j.jtcvs.2015.08.031
   Valeske K, 2014, J THORAC CARDIOV SUR, V147, P1712, DOI 10.1016/j.jtcvs.2014.01.012
   Weinstein S, 2014, J THORAC CARDIOV SUR, V147, P697, DOI 10.1016/j.jtcvs.2013.10.030
   Wilmot Ivan, 2013, Korean J Thorac Cardiovasc Surg, V46, P391, DOI 10.5090/kjtcs.2013.46.6.391
   Yilmaz B, 2013, PEDIATR TRANSPLANT, V17, pE113, DOI 10.1111/petr.12096
   박영환, 2009, Korean Circulation Journal, V39, P1
NR 59
TC 2
Z9 2
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD AUG
PY 2019
VL 49
IS 8
BP 678
EP 690
DI 10.4070/kcj.2019.0163
PG 13
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA IM3DQ
UT WOS:000477872700003
PM 31347320
OA Green Published, Other Gold
DA 2021-04-22
ER

PT J
AU Niwa, K
AF Niwa, Koichiro
TI Metabolic Syndrome in Adult Congenital Heart Disease
SO KOREAN CIRCULATION JOURNAL
LA English
DT Review
DE Adult congenital heart disease; Metabolic syndrome; Cardiovascular
   diseases; Coronary artery disease; Cyanotic congenital heart disease
ID ARTERIAL SWITCH OPERATION; EXERCISE-INDUCED HYPERTENSION; CARDIOVASCULAR
   RISK-FACTORS; LEFT-VENTRICULAR MASS; CORONARY-ARTERIES;
   PHYSICAL-ACTIVITY; SCIENTIFIC STATEMENT; BLOOD-PRESSURE; WORKING GROUP;
   EXPERT PANEL
AB In adult congenital heart disease (ACHD), residua and sequellae after initial repair develop late complications such as cardiac failure, arrhythmias, thrombosis, aortopathy, pulmonary hypertension and others. Acquired lesions with aging such as hypertension, diabetes mellitus, obesity can be negative influence on original cardiovascular disease (CVD). Also, atherosclerosis may pose an additional health problem to ACHD when they grow older and reach the age at which atherosclerosis becomes clinically relevant. In spite of the theoretical risk of atherosclerosis in ACHD due to above mentioned factors, cyanotic ACHDs even after repair are noted to have minimal incidence of coronary artery disease (CAD). Acyanotic ACHD has similar prevalence of CAD as the general population. However, even in cyanotic ACHD, CAD can develop when they have several risk factors for CAD. The prevalence of risk factor is similar between ACHD and the general population. Risk of premature atherosclerotic CVD in ACHD is based, 3 principal mechanisms: lesions with coronary artery abnormalities, obstructive lesions of left ventricle and aorta such as coarctation of the aorta and aortopathy. Coronary artery abnormalities are directly affected or altered surgically, such as arterial switch in transposition patients, may confer greater risk for premature atherosclerotic CAD. Metabolic syndrome is more common among ACHD than in the general population, and possibly increases the incidence of atherosclerotic CAD even in ACHD in future. Thus, ACHD should be screened for metabolic syndrome and eliminating risk factors for atherosclerotic CAD.
C1 [Niwa, Koichiro] St Lukes Int Hosp, Cardiovasc Ctr, Dept Cardiol, Tokyo, Japan.
   [Niwa, Koichiro] St Lukes Int Hosp, Cardiovasc Ctr, Dept Cardiol, Chuo Ku, 9-1 Akashi Cho, Tokyo 1048560, Japan.
RP Niwa, K (corresponding author), St Lukes Int Hosp, Cardiovasc Ctr, Dept Cardiol, Chuo Ku, 9-1 Akashi Cho, Tokyo 1048560, Japan.
EM koniwa@luke.or.jp
CR Afilalo J, 2011, J AM COLL CARDIOL, V58, P1509, DOI 10.1016/j.jacc.2011.06.041
   Arias-Stella J, 1971, ANATOMY CORONARY ART, P149
   Barker DJP, 2005, NEW ENGL J MED, V353, P1802, DOI 10.1056/NEJMoa044160
   Basso C, 2000, J AM COLL CARDIOL, V35, P1493, DOI 10.1016/S0735-1097(00)00566-0
   BEEKMAN RH, 1983, AM J CARDIOL, V52, P112, DOI 10.1016/0002-9149(83)90080-2
   BROUWER RMHJ, 1994, J THORAC CARDIOV SUR, V108, P525, DOI 10.1016/S0022-5223(94)70264-0
   Chugh R, 2004, AM J CARDIOL, V94, P1355, DOI 10.1016/j.amjcard.2004.07.135
   Chung ST, 2016, PEDIATR CARDIOL, V37, P192, DOI 10.1007/s00246-015-1265-7
   Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486
   CLICK RL, 1989, J AM COLL CARDIOL, V13, P531, DOI 10.1016/0735-1097(89)90588-3
   Cohen MS, 2012, EUR J PEDIATR, V171, P1145, DOI 10.1007/s00431-012-1736-2
   Connolly HM, 2003, MAYO CLIN PROC, V78, P1491, DOI 10.4065/78.12.1491
   DANIELS SR, 1985, J PEDIATR-US, V106, P249, DOI 10.1016/S0022-3476(85)80297-3
   DANIELS SR, 1995, CIRCULATION, V92, P3249, DOI 10.1161/01.CIR.92.11.3249
   Deen JF, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.114.001132
   Dellborg M, 2015, SCAND CARDIOVASC J, V49, P344, DOI 10.3109/14017431.2015.1085595
   Diller GP, 2005, CIRCULATION, V112, P828, DOI 10.1161/CIRCULATIONAHA.104.529800
   Duffels MGJ, 2010, CIRC J, V74, P1436, DOI 10.1253/circj.CJ-09-0858
   Engelfriet P, 2005, EUR HEART J, V26, P2325, DOI 10.1093/eurheartj/ehi396
   FREED MD, 1979, AM J CARDIOL, V43, P253, DOI 10.1016/S0002-9149(79)80012-0
   Freud LR, 2015, WORLD J PEDIATR CONG, V6, P514, DOI 10.1177/2150135115598212
   Fyfe A, 2005, AM J CARDIOL, V96, P283, DOI 10.1016/j.amjcard.2005.03.060
   Gagliardi MG, 2005, J AM COLL CARDIOL, V46, P1565, DOI 10.1016/j.jacc.2005.06.065
   Giannakoulas G, 2009, AM J CARDIOL, V103, P1445, DOI 10.1016/j.amjcard.2009.01.353
   GIDDING SS, 1985, CIRCULATION, V71, P495, DOI 10.1161/01.CIR.71.3.495
   Gross SS, 1999, P NATL ACAD SCI USA, V96, P9967, DOI 10.1073/pnas.96.18.9967
   Hamada H, 2007, INT J CARDIOL, V120, P66, DOI 10.1016/j.ijcard.2006.08.106
   Higashi K, 2006, NIHON SHONI JUNKANKI, V22, P432
   Javier AD, 2013, NIHON SHONI JUNKANKI, V29, pS137
   Joffres M, 2013, CAN J PUBLIC HEALTH, V104, pE252, DOI 10.17269/cjph.104.3783
   Kavey REW, 2006, CIRCULATION, V114, P2710, DOI 10.1161/CIRCULATIONAHA.106.179568
   KOLLER A, 1993, CIRC RES, V72, P1276, DOI 10.1161/01.RES.72.6.1276
   Lerman JB, 2017, AM J CARDIOL, V119, P638, DOI 10.1016/j.amjcard.2016.10.050
   LEVY D, 1990, NEW ENGL J MED, V322, P1561, DOI 10.1056/NEJM199005313222203
   Lill MC, 2006, AM J CARDIOL, V98, P254, DOI 10.1016/j.amjcard.2006.01.083
   Longmuir PE, 2013, CIRCULATION, V127, P2147, DOI 10.1161/CIR.0b013e318293688f
   Vieira TCL, 2007, ARQ BRAS CARDIOL, V89, P219, DOI 10.1590/S0066-782X2007001600002
   Lui GK, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.114.001076
   Madhavan M, 1997, ATHEROSCLEROSIS, V131, P107, DOI 10.1016/S0021-9150(97)06088-7
   Malinski T, 1998, POL J PHARMACOL, V50, P387
   Martinez SC, 2016, CONGENIT HEART DIS, V11, P71, DOI 10.1111/chd.12296
   Martinez-Quintana E, 2014, CONGENIT HEART DIS, V9, P63, DOI 10.1111/chd.12093
   Martinez-Quintana E, 2010, METABOLISM, V59, P1642, DOI 10.1016/j.metabol.2010.03.014
   Maser RE, 2007, CURR DIABETES REV, V3, P204, DOI 10.2174/157339907781368931
   Moons P, 2006, EUR J CARDIOV PREV R, V13, P612, DOI 10.1097/01.hjr.0000197472.81694.2b
   Mottillo S, 2010, J AM COLL CARDIOL, V56, P1113, DOI 10.1016/j.jacc.2010.05.034
   Murakami T, 2013, J ADULT CONGENIT HEA, V5, P99
   Niwa K, 1999, J AM COLL CARDIOL, V34, P223, DOI 10.1016/S0735-1097(99)00153-9
   Niwa K, 2001, CIRCULATION, V103, P393
   Niwa K., 2017, AORTOPATHY, P15
   Niwa K, 2007, ASIA PACIFIC CARDIOL, V1, P70
   Niwa K, 2006, INTERNAL MED, V45, P1199, DOI 10.2169/internalmedicine.45.0169
   Niwa Koichiro, 2017, Cardiol Young, V27, P1959, DOI 10.1017/S1047951117002116
   Niwa K, 2015, CURR OPIN PEDIATR, V27, P576, DOI 10.1097/MOP.0000000000000270
   Niwa K, 2013, KOREAN CIRC J, V43, P215, DOI 10.4070/kcj.2013.43.4.215
   Ohuchi H, 2014, INT J CARDIOL, V174, P306, DOI 10.1016/j.ijcard.2014.04.070
   Ohuchi H, 2009, AM HEART J, V158, P30, DOI 10.1016/j.ahj.2009.04.021
   Owens JL, 2009, NUTR CLIN PRACT, V24, P242, DOI 10.1177/0884533609332086
   Pasquali SK, 2010, CONGENIT HEART DIS, V5, P16, DOI 10.1111/j.1747-0803.2009.00359.x
   Pasquali SK, 2009, AM HEART J, V158, P473, DOI 10.1016/j.ahj.2009.06.019
   Pedra SRFF, 2005, J AM COLL CARDIOL, V45, P2061, DOI 10.1016/j.jacc.2005.02.076
   Pemberton VL, 2010, CIRCULATION, V121, P1153, DOI 10.1161/CIRCULATIONAHA.109.921544
   Perloff JK, 2004, INT J CARDIOL, V97, P79, DOI 10.1016/j.ijcard.2004.08.018
   Perloff JK, 2012, CURR CARDIOL REV, V8, P1, DOI 10.2174/157340312801215836
   Pillutla P, 2009, AM HEART J, V158, P874, DOI 10.1016/j.ahj.2009.08.014
   Reiner Z, 2011, EUR HEART J, V32, P1769, DOI [10.1093/eurheartj/ehr158, 10.1016/j.atherosclerosis.2011.06.012]
   Reybrouck T, 2005, EUR J CARDIOV PREV R, V12, P498, DOI 10.1097/01.hjr.0000176510.84165.eb
   Rhodes J, 2005, PEDIATRICS, V116, P1339, DOI 10.1542/peds.2004-2697
   ROBERTS WC, 1986, AM HEART J, V111, P941, DOI 10.1016/0002-8703(86)90646-0
   ROBERTS WC, 1970, AM J MED, V49, P151, DOI 10.1016/S0002-9343(70)80070-5
   Senzaki H, 2008, HEART, V94, P70, DOI 10.1136/hrt.2006.114306
   Shiina Y, 2019, J CARDIOL, V74, P84, DOI 10.1016/j.jjcc.2019.01.003
   Shustak RJ, 2012, PEDIATR CARDIOL, V33, P8, DOI 10.1007/s00246-011-0049-y
   Stefan MA, 2005, ARCH PEDIAT ADOL MED, V159, P477, DOI 10.1001/archpedi.159.5.477
   STRAFFORD MA, 1982, PEDIATRICS, V69, P159
   Tarp JB, 2019, INT J CARDIOL, V277, P97, DOI 10.1016/j.ijcard.2018.08.104
   The Ministry of Health Labour and Welfare, RES NAT HLTH NUTR SU
   Vogt KN, 2007, J AM COLL CARDIOL, V50, P1876, DOI 10.1016/j.jacc.2007.07.050
   Vriend JWJ, 2004, J HYPERTENS, V22, P501, DOI 10.1097/00004872-200403000-00012
   Wellnitz K, 2015, EUR J CLIN NUTR, V69, P1105, DOI 10.1038/ejcn.2015.68
   WILLIAMS JC, 1961, CIRCULATION, V24, P1311, DOI 10.1161/01.CIR.24.6.1311
   Yalonetsky S, 2013, INT J CARDIOL, V164, P217, DOI 10.1016/j.ijcard.2011.07.021
   Zaidi AN, 2011, CONGENIT HEART DIS, V6, P241, DOI 10.1111/j.1747-0803.2011.00522.x
NR 83
TC 7
Z9 7
U1 0
U2 2
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD AUG
PY 2019
VL 49
IS 8
BP 691
EP 708
DI 10.4070/kcj.2019.0187
PG 18
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA IM3DQ
UT WOS:000477872700004
PM 31347322
OA Other Gold, Green Published
DA 2021-04-22
ER

PT J
AU Park, KH
   Ahn, Y
   Koh, YY
   Ki, YJ
   Kim, SS
   Kim, HK
   Choi, DH
   Hong, YJ
   Hwang, JY
   Kim, DH
   Rhew, JY
   Ryu, JK
   Park, JS
   Park, TH
   Yang, TH
   Oh, SK
   Lee, BR
   Lee, SU
   Lee, SG
   Chun, KJ
   Cho, JH
   Cha, KS
   Chae, JK
   Hur, SH
   Hwang, SH
   Park, HS
   Kim, DI
AF Park, Keun-Ho
   Ahn, Youngkeun
   Koh, Young-Youp
   Ki, Young-Jae
   Kim, Sung Soo
   Kim, Hyun Kuk
   Choi, Dong-Hyun
   Hong, Young Joon
   Hwang, Jin-Yong
   Kim, Do Hoi
   Rhew, Jay Young
   Ryu, Jae Kean
   Park, Jong-Seon
   Park, Tae Ho
   Yang, Tae Hyun
   Oh, Seok Kyu
   Lee, Bong Ryeot
   Lee, Seung-Uk
   Lee, Sang Gon
   Chun, Kook Jin
   Cho, Jang-Hyun
   Cha, Kwang Soo
   Chae, Jei Keon
   Hur, Seung-Ho
   Hwang, Sun Ho
   Park, Hun-Sik
   Kim, Doo-Il
TI Effectiveness and Safety of Zotarolimus-Eluting Stent (Resolute (TM)
   Integrity) in Patients with Diffuse Long Coronary Artery Disease
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Drug-eluting stents; Coronary artery disease; Treatment outcome
ID 3-YEAR CLINICAL-OUTCOMES; POOLED ANALYSIS; LESION LENGTH; EVEROLIMUS;
   IMPACT; EFFICACY; INTERVENTION; RESTENOSIS; SYSTEM
AB Background and Objectives: Diffuse long coronary artery disease (DLCAD) still has unfavorable clinical outcomes after successful percutaneous coronary intervention (PCI). Therefore, we aimed to evaluate the effectiveness and safety of Resolute (TM) zotarolimus-eluting stent (R-ZES; Resolute (TM) Integrity) for patients with DLCAD.
   Methods: From December 2011 to December 2014, 1,011 patients who underwent PCI using R-ZES for CAD with longer than 25 mm lesion were prospectively enrolled from 21 hospitals in Korea. We assessed the clinical outcome of major adverse cardiac events (MACE) defined as the composite of cardiac death, non-fatal myocardial infarction (MI), and clinically-driven target vessel revascularization at 12 months.
   Results: Mean age was 63.8 +/- 10.8 years, 701 (69.3%) patients were male, 572 (87.0%) patients had hypertension, 339 (33.8%) patients had diabetes, 549 (54.3%) patients diagnosed with acute MI and 545 (53.9%) patients had multi-vessel disease (MVD). A total of 1,697 stents were implanted into a total of 1,472 lesions. The mean diameter was 3.07 +/- 0.38 mm and the length was 28.27 +/- 6.97 mm. Multiple overlapping stents were performed in 205 (13.8%) lesions. A 12-month clinical follow-up was available in 1,004 patients (99.3%). The incidences of MACE and definite stent thrombosis at 12-month were 3.0% and 0.3% respectively. On multivariate Cox-regression analysis, multiple overlapping stents implantation, previous congestive heart failure, MVD, and age >= 75 years were independent predictors of one-year MACE.
   Conclusions: Our study shows that R-ZES has an excellent 1-year clinical outcome in Korean patients with DLCAD.
C1 [Park, Keun-Ho; Koh, Young-Youp; Ki, Young-Jae; Kim, Sung Soo; Kim, Hyun Kuk; Choi, Dong-Hyun] Chosun Univ Hosp, Dept Internal Med, Div Cardiol, Gwangju, South Korea.
   [Ahn, Youngkeun; Hong, Young Joon] Chonnam Natl Univ, Med Sch, Chonnam Natl Univ Hosp, Div Cardiol,Dept Internal Med, Gwangju, South Korea.
   [Hwang, Jin-Yong] Gyeongsang Natl Univ Hosp, Dept Internal Med, Div Cardiol, Jinju, South Korea.
   [Kim, Do Hoi] Soonchunhyang Univ Hosp Gumi, Dept Internal Med, Div Cardiol, Gumi, South Korea.
   [Rhew, Jay Young] Presbyterian Med Ctr, Div Cardiol, Jeonju, South Korea.
   [Ryu, Jae Kean] Daegu Catholic Univ, Dept Internal Med, Div Cardiol, Med Ctr, Daegu, South Korea.
   [Park, Jong-Seon] Yeungnam Univ, Dept Internal Med, Div Cardiol, Med Ctr, Daegu, South Korea.
   [Park, Tae Ho] Dong A Univ Hosp, Dept Internal Med, Div Cardiol, Busan, South Korea.
   [Yang, Tae Hyun] Inje Univ, Dept Internal Med, Div Cardiol, Busan Paik Hosp, Busan, South Korea.
   [Oh, Seok Kyu] Wonkwang Univ Hosp, Dept Internal Med, Div Cardiol, Iksan, South Korea.
   [Lee, Bong Ryeot] Daegu Fatima Hosp, Div Cardiol, Daegu, South Korea.
   [Lee, Seung-Uk] Kwangju Christian Hosp, Div Cardiol, Gwangju, South Korea.
   [Lee, Sang Gon] Ulsan Univ Hosp, Dept Internal Med, Div Cardiol, Ulsan, South Korea.
   [Chun, Kook Jin] Pusan Natl Univ, Dept Internal Med, Div Cardiol, Yangsan Hosp, Yangsan, South Korea.
   [Cho, Jang-Hyun] St Carollo Hosp, Div Cardiol, Sunchon, South Korea.
   [Cha, Kwang Soo] Pusan Natl Univ Hosp, Dept Internal Med, Div Cardiol, Busan, South Korea.
   [Chae, Jei Keon] Chonbuk Natl Univ Hosp, Dept Internal Med, Div Cardiol, Jeonju, South Korea.
   [Hur, Seung-Ho] Keimyung Univ, Dept Internal Med, Div Cardiol, Dongsan Hosp, Daegu, South Korea.
   [Hwang, Sun Ho] Gwangju Vet Hosp, Div Cardiol, Gwangju, South Korea.
   [Park, Hun-Sik] Kyungpook Natl Univ Hosp, Dept Internal Med, Div Cardiol, Daegu, South Korea.
   [Kim, Doo-Il] Inje Univ, Dept Internal Med, Div Cardiol, Haeundae Paik Hosp, Busan, South Korea.
RP Ahn, Y (corresponding author), Chonnam Natl Univ, Med Sch, Chonnam Natl Univ Hosp, Div Cardiol,Dept Internal Med,Cardiovasc Ctr, 42 Jebong Ro, Gwangju 61469, South Korea.
EM cecilyk@hanmail.net
OI Kim, Sung Soo/0000-0002-5190-227X
FU MedtronicMedtronic
FX This study was supported by Medtronic.
CR Ahn JM, 2012, CIRC-CARDIOVASC INTE, V5, P633, DOI 10.1161/CIRCINTERVENTIONS.111.965673
   Bahuleyan C G, 2015, Indian Heart J, V67, P233, DOI 10.1016/j.ihj.2015.03.014
   Banerjee S, 2013, CARDIOL THER, V2, P17, DOI 10.1007/s40119-012-0010-z
   Choi IJ, 2014, AM J CARDIOL, V113, P457, DOI 10.1016/j.amjcard.2013.10.029
   Claessen BE, 2011, JACC-CARDIOVASC INTE, V4, P1209, DOI 10.1016/j.jcin.2011.07.016
   Dawkins Keith D, 2007, EuroIntervention, V3, P213, DOI 10.4244/EIJV3I2A37
   Durante A, 2016, INT J CARDIOL, V221, P1008, DOI 10.1016/j.ijcard.2016.07.050
   Im E, 2013, J INTERV CARDIOL, V26, P378, DOI 10.1111/joic.12047
   Kastrati A, 1999, AM J CARDIOL, V83, P1617, DOI 10.1016/S0002-9149(99)00165-4
   Kastrati A, 1997, J AM COLL CARDIOL, V30, P1428, DOI 10.1016/S0735-1097(97)00334-3
   Kereiakes DJ, 2006, J AM COLL CARDIOL, V48, P21, DOI 10.1016/j.jacc.2006.02.058
   Kitabata H, 2013, AM J CARDIOL, V112, P1093, DOI 10.1016/j.amjcard.2013.05.054
   Kobayashi Y, 1999, J AM COLL CARDIOL, V34, P651, DOI 10.1016/S0735-1097(99)00303-4
   Lee M, 2013, AM J CARDIOL, V112, P1335, DOI 10.1016/j.amjcard.2013.06.012
   Park KH, 2013, INT J CARDIOL, V168, P1853, DOI 10.1016/j.ijcard.2012.12.070
   Park KW, 2013, J AM COLL CARDIOL, V61, P536, DOI 10.1016/j.jacc.2012.11.015
   Patra S, 2017, CARDIOVASC REVASCULA, V18, P160, DOI 10.1016/j.carrev.2016.12.007
   Qiao SB, 2014, AM J CARDIOL, V113, P613, DOI 10.1016/j.amjcard.2013.10.042
   Raber L, 2010, J AM COLL CARDIOL, V55, P1178, DOI 10.1016/j.jacc.2009.11.052
   Raungaard B, 2017, JACC-CARDIOVASC INTE, V10, P255, DOI 10.1016/j.jcin.2016.11.007
   Richardt G, 2013, JACC-CARDIOVASC INTE, V6, P905, DOI 10.1016/j.jcin.2013.04.017
   Taniwaki M, 2014, J AM COLL CARDIOL, V63, P1617, DOI 10.1016/j.jacc.2013.12.036
   von Birgelen C, 2016, LANCET, V388, P2607, DOI 10.1016/S0140-6736(16)31920-1
   Yeh RW, 2017, JACC-CARDIOVASC INTE, V10, P247, DOI 10.1016/j.jcin.2016.11.004
   Yeung AC, 2011, J AM COLL CARDIOL, V57, P1778, DOI 10.1016/j.jacc.2011.03.005
NR 25
TC 4
Z9 4
U1 0
U2 2
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD AUG
PY 2019
VL 49
IS 8
BP 709
EP 720
DI 10.4070/kcj.2019.0018
PG 12
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA IM3DQ
UT WOS:000477872700005
PM 31165595
OA Green Published
DA 2021-04-22
ER

PT J
AU Kim, D
   Choi, JO
   Oh, J
   Cho, HJ
   Jung, SH
   Lee, HY
   Kang, SM
   Kim, JJ
   Jeon, ES
AF Kim, Darae
   Choi, Jin-Oh
   Oh, Jaewon
   Cho, Hyun Jai
   Jung, Sung-Ho
   Lee, Hae-Young
   Kang, Seok-Min
   Kim, Jae-Joong
   Jeon, Eun-Seok
TI The Korean Organ Transplant Registry (KOTRY): Second Official Adult
   Heart Transplant Report
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Heart transplantation; Heart failure; Registries
ID INTERNATIONAL SOCIETY; PATIENTS OLDER; AGE
AB Background and Objectives: This second adult heart transplantation (HTx) report is based on Korean Organ Transplant Registry data submitted on 400 HTxs in recipients of all ages.
   Methods: From March 2014 to December 2017, a total of 400 HTxs were performed at 4 major centers in Korea. We analyzed demographics and characteristics according to transplant years. Patterns of immunosuppression, allograft rejection, and survival after HTx were analyzed. Donor and recipient age were highlighted.
   Results: Some distinct differences in HTx statistics were noted. Mean donor age increased significantly in the most recent years compared to 2014-2015, while mean recipient age did not change. The proportion of patients on pre-transplant extracorporeal membrane oxygenation (ECMO) increased over time. One-year and intermediate-term survival was significantly worse in patients on pre-transplant ECMO compared to those without mechanical support. Over the years, tacrolimus has increased to become the most frequently used calcineurin inhibitor over cyclosporine, while the number of patients using steroids both at discharge and 1-year follow-up has declined. Age did not affect 1-year survival, but significantly affected intermediate-term survival.
   Conclusions: From 2014 to 2017, centers were willing to accept older donors to address increasing organ shortages and more patients received transplant under ECMO care. Increasing age was a strong independent factor for intermediate-term survival, however, post-transplant comorbidities did not differ among age groups. Further studies with longer follow-up duration are needed to better understand age-related post-transplant prognosis.
C1 [Kim, Darae; Choi, Jin-Oh; Jeon, Eun-Seok] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Cardiol,Dept Med,Heart Vasc Stroke Inst, 81 Irwon Ro, Seoul 06351, South Korea.
   [Oh, Jaewon; Kang, Seok-Min] Yonsei Univ, Dept Internal Med, Coll Med, Seoul, South Korea.
   [Cho, Hyun Jai; Lee, Hae-Young] Seoul Natl Univ, Dept Internal Med, Coll Med, Seoul, South Korea.
   [Jung, Sung-Ho] Univ Ulsan, Asan Med Ctr, Dept Thorac Surg, Coll Med, Seoul, South Korea.
   [Kim, Jae-Joong] Univ Ulsan, Asan Med Ctr, Dept Internal Med, Coll Med, Seoul, South Korea.
RP Choi, JO (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Cardiol,Dept Med,Heart Vasc Stroke Inst, 81 Irwon Ro, Seoul 06351, South Korea.
EM choijean5@gmail.com
OI Lee, Hae-Young/0000-0002-9521-4102; Kang, Seok-Min/0000-0001-9856-9227
FU Research of Korea Centers for Disease Control and Prevention
   [2014-ER6301-00, 2014-ER6301-01, 2014-ER6301-02, 2017-ER6301-00]
FX This research was supported by a grant from the Research of Korea
   Centers for Disease Control and Prevention (code 2014-ER6301-00,
   2014-ER6301-01, 2014-ER6301-02, and 2017-ER6301-00).
CR Blanche C, 2001, J THORAC CARDIOV SUR, V121, P532, DOI 10.1067/mtc.2001.112831
   Daneshvar D, 2011, TRANSPL P, V43, P3851, DOI 10.1016/j.transproceed.2011.08.086
   Demers P, 2003, J THORAC CARDIOV SUR, V126, P224, DOI 10.1016/S0022-5223(03)00055-2
   Fukuhara S, 2018, J THORAC CARDIOV SUR, V155, P1607, DOI 10.1016/j.jtcvs.2017.10.152
   Fulop T, 2010, ANN NY ACAD SCI, V1197, P158, DOI 10.1111/j.1749-6632.2009.05370.x
   Gao SZ, 1997, J AM COLL CARDIOL, V29, P623, DOI 10.1016/S0735-1097(96)00521-9
   Khush K, 2018, J HEART LUNG TRANSPL, V37, pS341
   Kim IC, 2018, KOREAN CIRC J, V48, P565, DOI 10.4070/kcj.2018.0189
   Kim IC, 2017, KOREAN CIRC J, V47, P858, DOI 10.4070/kcj.2017.0330
   Laks H, 2003, J THORAC CARDIOV SUR, V125, P49, DOI 10.1067/mtc.2003.62
   Lee HY, 2017, KOREAN CIRC J, V47, P868, DOI 10.4070/kcj.2016.0403
   Lund LH, 2013, J HEART LUNG TRANSPL, V32, P951, DOI 10.1016/j.healun.2013.08.006
   Mehra MR, 2016, J HEART LUNG TRANSPL, V35, P1, DOI 10.1016/j.healun.2015.10.023
   Prieto D, 2015, THORAC CARDIOV SURG, V63, P684, DOI 10.1055/s-0034-1393959
   Prieto D, 2015, EUR J CARDIO-THORAC, V47, P672, DOI 10.1093/ejcts/ezu257
   Tse T, 2017, J HEART LUNG TRANSPL, V36, pS411
   Viana LA, 2018, AM J TRANSPLANT
NR 17
TC 2
Z9 2
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD AUG
PY 2019
VL 49
IS 8
BP 724
EP 737
DI 10.4070/kcj.2018.0392
PG 14
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA IM3DQ
UT WOS:000477872700007
PM 31074219
OA Green Published, Other Gold
DA 2021-04-22
ER

PT J
AU Yang, PS
   Jeong, J
   You, SJ
   Yu, HT
   Kim, TH
   Sung, JH
   Lee, SS
   Park, HD
   Joung, B
AF Yang, Pil-Sung
   Jeong, Jaehan
   You, So-Jeong
   Yu, Hee Tae
   Kim, Tae-Hoon
   Sung, Jung-Hoon
   Lee, Sang-Soo
   Park, Hyung-Deuk
   Joung, Boyoung
TI The Burden and Risk Factors for Infection of Transvenous Cardiovascular
   Implantable Electronic Device: a Nationwide Cohort Study
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Pacemaker; Implantable cardioverter-defibrillator; Infection; Cost; Risk
   factors
ID ASSOCIATION TASK-FORCE; CARDIOVERTER-DEFIBRILLATORS; PERMANENT
   PACEMAKER; PRACTICE GUIDELINES; HIGH PREVALENCE; HEART-FAILURE;
   UNITED-STATES; MANAGEMENT; RATES; UPDATE
AB Background and Objectives: There are limited published data on the incidence and cost associated with cardiac implantable electrical device (CIED) infection for Asian patients. We analyzed the infection burden associated with the implantation of CIEDs in Korea.
   Methods: In the Health Insurance Review & Assessment Service (HIRA) database during the period from January 1, 2014 to December 31, 2016, we identified 16,908 patients with CIED implantation. CIED infection was defined as either: 1) Infection-related diagnosis code by the Korean Standard Classification of Diseases after any CIED procedure; or 2) CIED removal along with systemic infection.
   Results: The proportions of first implantation and replacement were 77.6% and 22.4%, respectively. During the follow-up period of 17.1 +/- 10.6 months, a total of 462 patients had CIED infection with incidence of 1.95 per 100 person-years with higher infection rate in replacement than first implantation (3.97 vs. 1.4 per 100 person-years, p<0.001). The average cost per person was US$ 16,584 (pacemaker, $13,736; implantable cardioverter defibrillator, $28,402; cardiac resynchronization therapy, $29,674). The risk factors of CIED infection were generator replacement (adjusted hazard ratio [aHR], 3.14; 95% confidence interval [CI], 2.60-3.78), diabetes mellitus (aHR, 1.94; 95% CI, 1.58-2.38), and congestive heart failure (aHR, 1.86; 95% CI, 1.51-2.28).
   Conclusions: The rate of CIED infection in Korea was 1.95 per 100 person-years with average cost of US$ 16,584. The most important risk factor was generator replacement. This result suggests that generator replacement should be performed cautiously to avoid CIED infection.
C1 [Yang, Pil-Sung; Sung, Jung-Hoon] CHA Univ, CHA Bundang Med Ctr, Dept Cardiol, Seongnam, South Korea.
   [Jeong, Jaehan; You, So-Jeong; Lee, Sang-Soo; Park, Hyung-Deuk] Medtron Korea Ltd, 17F Glass Tower,534 Teheran Ro, Seoul 06181, South Korea.
   [Yu, Hee Tae; Kim, Tae-Hoon; Joung, Boyoung] Yonsei Univ, Coll Med, Severance Cardiovasc Hosp, Div Cardiol,Dept Internal Med, 50-1 Yonsei Ro, Seoul 03722, South Korea.
   [Lee, Sang-Soo] Sungkyunkwan Univ, SAIHST, Grad Sch Med Device Management & Res, Seoul, South Korea.
RP Park, HD (corresponding author), Medtron Korea Ltd, 17F Glass Tower,534 Teheran Ro, Seoul 06181, South Korea.; Joung, B (corresponding author), Yonsei Univ, Coll Med, Severance Cardiovasc Hosp, Div Cardiol,Dept Internal Med, 50-1 Yonsei Ro, Seoul 03722, South Korea.
EM hyung.deuk.park@medtronic.com; cby6908@yuhs.ac
OI Kim, Tae-Hoon/0000-0003-4200-3456; Yang, Pil-sung/0000-0002-6552-1742;
   Sung, Jung -Hoon/0000-0003-3515-5283; Joung,
   Boyoung/0000-0001-9036-7225; Lee, Sang-Soo/0000-0002-3619-6303
FU Basic Science Research Program through the National Research Foundation
   of Korea - Ministry of Education, Science and Technology
   [NRF-2017R1A2B3003303]; Korean Healthcare Technology R&D project -
   Ministry of Health Welfare [HI16C0058, HIC5C1200]
FX This work was supported by a research grant from the Basic Science
   Research Program through the National Research Foundation of Korea
   funded by the Ministry of Education, Science and Technology
   (NRF-2017R1A2B3003303), and grants from the Korean Healthcare Technology
   R&D project funded by the Ministry of Health & Welfare (HI16C0058,
   HIC5C1200).
CR Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   Baddour LM, 2010, CIRCULATION, V121, P458, DOI 10.1161/CIRCULATIONAHA.109.192665
   Cabell CH, 2004, AM HEART J, V147, P582, DOI 10.1016/j.ahj.2003.06.005
   Catanchin Andrei, 2007, Heart Lung Circ, V16, P434, DOI 10.1016/j.hlc.2007.02.097
   Costea A, 2008, J CARDIOVASC ELECTR, V19, P266, DOI 10.1111/j.1540-8167.2007.01047.x
   Eberhardt F, 2005, HEART, V91, P500, DOI 10.1136/hrt.2003.025411
   Epstein AE, 2013, CIRCULATION, V127, pE283, DOI 10.1161/CIR.0b013e318276ce9b
   Esposito S, 2008, INT J ANTIMICROB AG, V32, P287, DOI 10.1016/j.ijantimicag.2008.03.010
   Herce B, 2013, EUROPACE, V15, P66, DOI 10.1093/europace/eus284
   Hunt SA, 2009, J AM COLL CARDIOL, V53, pE1, DOI 10.1016/j.jacc.2008.11.013
   Johansen JB, 2011, EUR HEART J, V32, P991, DOI 10.1093/eurheartj/ehq497
   Kim TH, 2017, STROKE, V48, P1524, DOI 10.1161/STROKEAHA.117.016926
   Klug D, 2005, AM HEART J, V149, P322, DOI 10.1016/j.ahj.2004.07.032
   Klug D, 2004, HEART, V90, P882, DOI 10.1136/hrt.2003.010595
   Klug D, 2007, CIRCULATION, V116, P1349, DOI 10.1161/CIRCULATIONAHA.106.678664
   Lekkerkerker JC, 2009, HEART, V95, P715, DOI 10.1136/hrt.2008.151985
   Mangram AJ, 1999, INFECT CONT HOSP EP, V20, P250, DOI 10.1086/501620
   Marschall J, 2007, INFECT CONT HOSP EP, V28, P1299, DOI 10.1086/520744
   McKibben L, 2005, AM J INFECT CONTROL, V33, P217, DOI 10.1016/j.ajic.2005.04.001
   Mond HG, 2008, PACE, V31, P1202, DOI 10.1111/j.1540-8159.2008.01164.x
   Pichlmaier M, 2008, EUROPACE, V10, P1067, DOI 10.1093/europace/eun191
   Sohail MR, 2007, CLIN INFECT DIS, V45, P166, DOI 10.1086/518889
   Sohail MR, 2011, ARCH INTERN MED, V171, P1821, DOI 10.1001/archinternmed.2011.441
   Subbiahdoss G, 2009, ACTA BIOMATER, V5, P1399, DOI 10.1016/j.actbio.2008.12.011
   Uslan DZ, 2008, EXPERT REV MED DEVIC, V5, P183, DOI 10.1586/17434440.5.2.183
   Uslan DZ, 2007, ARCH INTERN MED, V167, P669, DOI 10.1001/archinte.167.7.669
   Voigt A, 2006, J AM COLL CARDIOL, V48, P590, DOI 10.1016/j.jacc.2006.05.016
   Voigt A, 2010, PACE, V33, P414, DOI 10.1111/j.1540-8159.2009.02569.x
NR 28
TC 2
Z9 2
U1 1
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD AUG
PY 2019
VL 49
IS 8
BP 742
EP 752
DI 10.4070/kcj.2018.0361
PG 11
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA IM3DQ
UT WOS:000477872700009
PM 31074228
OA Green Published
DA 2021-04-22
ER

PT J
AU Kwak, JH
   Lee, J
   Ha, KS
AF Kwak, Ji Hee
   Lee, JungHwa
   Ha, Kee Soo
TI Significance of Differential Characteristics in Infantile Kawasaki
   Disease
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Kawasaki disease; Infant; Differential leukocyte count; Hemoglobin
ID PERIPHERAL-BLOOD EOSINOPHILIA; LYMPH-NODE SYNDROME; INTRAVENOUS
   IMMUNOGLOBULIN; DIAGNOSIS; MANAGEMENT; CHILDREN
AB Background and Objectives: Immunological variability in Kawasaki disease (KD) shows age-specific differences; however, specific differences in laboratory values have not been compared between infants and non-infants with KD. We compared age-adjusted Z-values (Z) of white and red blood cells in infants with KD with those in non-infants with KD.
   Methods: This study retrospectively investigated 192 infants and 667 non-infants recruited between 2003 and 2015 at the Korea University Hospital. Laboratory values for infants with KD and non-infants with KD were analyzed and age-unadjusted raw values (R) and age-adjusted Z for blood cells counts were determined.
   Results: Z in infants with KD during pre-intravenous immunoglobulin (IVIG), post-IVIG, and chronic phases showed increased lymphopenia and eosinophilia, low neutrophil: lymphocyte and neutrophil: eosinophil ratios, worse anemia, increased thrombocytosis, and reduced erythrocyte sedimentation rates compared with those in non-infants with KD. The optimal cut-off value for pre-IVIG Z-hemoglobin for prediction of KD in all patients was <-0.01 (area under the curve [AUC], 0.914; sensitivity/specificity, 0.999/0.886; p=0.04). The optimal cutoff value for pre-IVIG C-reactive protein (CRP) for prediction of KD in infants compared to that in febrile control infants was >40 mg/L (AUC, 0.811; sensitivity/specificity, 0.712/0.700; p=0.04).
   Conclusions: Laboratory characteristics enable differentiation between infants and non-infants with KD and contribute to a better understanding of changes in blood cell counts. Infants with incomplete KD can be more easily differentiated from infants with simple febrile illness using pre-IVIG Z-hemoglobin and pre-IVIG CRP values.
C1 [Kwak, Ji Hee] Sungkyunkwan Univ, Kangbuk Samsung Hosp, Dept Pediat, Sch Med, Seoul, South Korea.
   [Lee, JungHwa; Ha, Kee Soo] Korea Univ, Coll Med, Dept Pediat, Guro Hosp, 148 Gurodong Ro, Seoul 08308, South Korea.
RP Ha, KS (corresponding author), Korea Univ, Coll Med, Dept Pediat, Guro Hosp, 148 Gurodong Ro, Seoul 08308, South Korea.
EM kissuha@naver.com
CR Ahn HS, 2012, HONG CES TXB PEDIAT
   Alves NRD, 2011, REV ASSOC MED BRAS, V57, P295
   Bal AK, 2014, PEDIATR NEONATOL, V55, P387, DOI 10.1016/j.pedneo.2013.11.007
   Bellamy GJ, 2000, CLIN LAB HAEMATOL, V22, P81, DOI 10.1046/j.1365-2257.2000.00288.x
   Dallaire F, 2011, J AM SOC ECHOCARDIOG, V24, P60, DOI 10.1016/j.echo.2010.10.004
   Huang YH, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18040820
   Kawasaki T, 1967, Arerugi, V16, P178
   KAWASAKI T, 1974, PEDIATRICS, V54, P271
   Kitano N, 2018, NEW ENGL J MED, V378, P2048, DOI 10.1056/NEJMc1804312
   Kliegman R., 2016, NELSON TXB PEDIAT
   Lanzkowsky P., 2016, LANZKOWSKYS MANUAL P, V6th ed.
   Matsubara T, 2005, CLIN EXP IMMUNOL, V141, P381, DOI 10.1111/j.1365-2249.2005.02821.x
   Newburger JW, 2004, CIRCULATION, V110, P2747, DOI 10.1161/01.CIR.0000145143.19711.78
   NIWA Y, 1984, J PEDIATR-US, V104, P56, DOI 10.1016/S0022-3476(84)80589-2
   Ogawa S, 2014, CIRC J, V78, P2521, DOI 10.1253/circj.CJ-66-0096
   Oner T, 2012, ANATOL J CARDIOL, V12, P160, DOI 10.5152/akd.2012.042
   ROSENFELD EA, 1995, J PEDIATR-US, V126, P524, DOI 10.1016/S0022-3476(95)70344-6
   Rothenberg ME, 1998, NEW ENGL J MED, V338, P1592, DOI 10.1056/NEJM199805283382206
   Singh S, 2018, INT J RHEUM DIS, V21, P36, DOI 10.1111/1756-185X.13224
   Tacke CE, 2014, PEDIATR INFECT DIS J, V33, P793, DOI 10.1097/INF.0000000000000271
   Taylor MRH, 1997, CLIN LAB HAEMATOL, V19, P1, DOI 10.1046/j.1365-2257.1997.00204.x
   Terai M, 2002, PEDIATR INFECT DIS J, V21, P777, DOI 10.1097/00006454-200208000-00015
   Tremoulet AH, 2008, J PEDIATR-US, V153, P117, DOI 10.1016/j.jpeds.2007.12.021
   Tremoulet AH, 2014, LANCET, V383, P1731, DOI 10.1016/S0140-6736(13)62298-9
   Tremoulet AH, 2011, PEDIATR INFECT DIS J, V30, P1022, DOI 10.1097/INF.0b013e31822d4f56
   Yoshimura K, 2009, EUR J PEDIATR, V168, P1037, DOI 10.1007/s00431-008-0872-1
NR 26
TC 6
Z9 6
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD AUG
PY 2019
VL 49
IS 8
BP 755
EP 765
DI 10.4070/kcj.2018.0434
PG 11
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA IM3DQ
UT WOS:000477872700011
PM 31074226
OA Other Gold, Green Published
DA 2021-04-22
ER

PT J
AU Oh, PC
   Han, SH
AF Oh, Pyung Chun
   Han, Seung Hwan
TI Diffuse Long Coronary Artery Disease is Still an Obstacle for
   Percutaneous Coronary Intervention in the Second-Generation Drug-Eluting
   Stent Era?
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
ID OUTCOMES
C1 [Oh, Pyung Chun; Han, Seung Hwan] Gachon Univ, Gil Med Ctr, Coll Med, Div Cardiol,Dept Internal Med, 21 Namdong Daero 774beon Gil, Incheon 21565, South Korea.
RP Han, SH (corresponding author), Gachon Univ, Gil Med Ctr, Coll Med, Div Cardiol,Dept Internal Med, 21 Namdong Daero 774beon Gil, Incheon 21565, South Korea.
EM shhan@gilhospital.com
OI Oh, Pyung Chun/0000-0002-9955-223X
CR Ahn JM, 2012, CIRC-CARDIOVASC INTE, V5, P633, DOI 10.1161/CIRCINTERVENTIONS.111.965673
   Bahuleyan C G, 2015, Indian Heart J, V67, P233, DOI 10.1016/j.ihj.2015.03.014
   BOURASSA MG, 1991, J AM COLL CARDIOL, V18, P368, DOI 10.1016/0735-1097(91)90588-Z
   Chang SW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054564
   Gwon HC, 2017, KOREAN CIRC J, V47, P320, DOI 10.4070/kcj.2017.0070
   Hong SJ, 2015, JAMA-J AM MED ASSOC, V314, P2155, DOI 10.1001/jama.2015.15454
   Lee M, 2013, AM J CARDIOL, V112, P1335, DOI 10.1016/j.amjcard.2013.06.012
   Park KH, 2019, KOREAN CIRC J, V49, P709, DOI 10.4070/kcj.2019.0018
   Patra S, 2017, CARDIOVASC REVASCULA, V18, P160, DOI 10.1016/j.carrev.2016.12.007
   Taniwaki M, 2014, J AM COLL CARDIOL, V63, P1617, DOI 10.1016/j.jacc.2013.12.036
NR 10
TC 0
Z9 1
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD AUG
PY 2019
VL 49
IS 8
BP 721
EP 723
DI 10.4070/kcj.2019.0150
PG 3
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA IM3DQ
UT WOS:000477872700006
PM 31347314
OA Other Gold, Green Published
DA 2021-04-22
ER

PT J
AU Youn, JC
   Kim, IC
   Park, NH
   Kim, H
AF Youn, Jong-Chan
   Kim, In-Cheol
   Park, Nam-Hee
   Kim, Hyungseop
TI Increased Risk with Older Donor Age and More Frequent Pre-transplant
   ECMO: the Second Official KOTRY Report
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
ID HEART-FAILURE
C1 [Youn, Jong-Chan] Catholic Univ Korea, Seoul St Marys Hosp, Dept Internal Med, Div Cardiol,Coll Med, Seoul, South Korea.
   [Kim, In-Cheol; Kim, Hyungseop] Keimyung Univ, Dongsan Hosp, Cardiovasc Ctr, Div Cardiol, 1035 Dalgubeol Daero, Daegu 42601, South Korea.
   [Park, Nam-Hee] Keimyung Univ, Dongsan Hosp, Cardiovasc Ctr, Div Cardiothorac Surg, Daegu, South Korea.
RP Kim, IC (corresponding author), Keimyung Univ, Dongsan Hosp, Cardiovasc Ctr, Div Cardiol, 1035 Dalgubeol Daero, Daegu 42601, South Korea.
EM kimic@dsmc.or.kr
RI Youn, Jong-Chan/AAS-1405-2020
OI Kim, Hyungseop/0000-0001-7056-4221; Youn, Jong-Chan/0000-0003-0998-503X;
   Kim, In-Cheol/0000-0002-5751-2328
FU Korea Health Technology R&D Project through the Korea Health Industry
   Development Institute (KHIDI) - ministry of Health & Welfare, Republic
   of Korea [HI18C0575]; Basic Science Research Program through the
   National Research Foundation of Korea (NRF) - Ministry of Science, ICT &
   Future Planning [NRF-2018R1C1B6005448]
FX This study was supported by the Korea Health Technology R&D Project
   through the Korea Health Industry Development Institute (KHIDI) funded
   by the ministry of Health & Welfare, Republic of Korea (HI18C0575). This
   study was supported by Basic Science Research Program through the
   National Research Foundation of Korea (NRF) funded by the Ministry of
   Science, ICT & Future Planning (NRF-2018R1C1B6005448).
CR Choi HM, 2019, KOREAN J INTERN MED, V34, P11, DOI 10.3904/kjim.2018.428
   Fukushima Norihide, 2016, Kyobu Geka, V69, P65
   Khush K, 2018, J HEART LUNG TRANSPL, V37, pS341
   Kim D, 2019, KOREAN CIRC J, V49, P724, DOI 10.4070/kcj.2018.0392
   Kim IC, 2018, KOREAN CIRC J, V48, P565, DOI 10.4070/kcj.2018.0189
   Kim IC, 2017, KOREAN CIRC J, V47, P858, DOI 10.4070/kcj.2017.0330
   Lee HY, 2017, KOREAN CIRC J, V47, P868, DOI 10.4070/kcj.2016.0403
   Youn JC, 2017, KOREAN CIRC J, V47, P16, DOI 10.4070/kcj.2016.0429
NR 8
TC 1
Z9 1
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD AUG
PY 2019
VL 49
IS 8
BP 738
EP 741
DI 10.4070/kcj.2019.0117
PG 4
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA IM3DQ
UT WOS:000477872700008
PM 31165597
OA Green Published, Other Gold
DA 2021-04-22
ER

PT J
AU Oh, IY
AF Oh, Il-Young
TI Small but Persistent Infection of Cardiac Implantable Electronic Devices
   (CIED)
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
ID GENERATOR REPLACEMENT; PACEMAKER
C1 [Oh, Il-Young] Seoul Natl Univ, Bundang Hosp, Dept Internal Med, Div Cardiol, 82 Gumi Ro 173beon Gil, Seongnam 13620, South Korea.
RP Oh, IY (corresponding author), Seoul Natl Univ, Bundang Hosp, Dept Internal Med, Div Cardiol, 82 Gumi Ro 173beon Gil, Seongnam 13620, South Korea.
EM ilyoung.oh@snubh.org
CR Baddour LM, 2010, CIRCULATION, V121, P458, DOI 10.1161/CIRCULATIONAHA.109.192665
   Deering TF, 2017, PACE, V40, P615, DOI 10.1111/pace.13061
   Greenspon AJ, 2011, J AM COLL CARDIOL, V58, P1001, DOI 10.1016/j.jacc.2011.04.033
   Kleemann T, 2010, EUROPACE, V12, P58, DOI 10.1093/europace/eup334
   Krahn AD, 2018, J AM COLL CARDIOL, V72, P3098, DOI 10.1016/j.jacc.2018.09.068
   Lakkireddy D, 2015, HEART RHYTHM, V12, P950, DOI [10.1016/j.hrthm.2015.01.035, 10.1016/jhrthm.2015.01.035]
   Mela T, 2001, AM J CARDIOL, V88, P750, DOI 10.1016/S0002-9149(01)01845-8
   Poole JE, 2010, CIRCULATION, V122, P1553, DOI 10.1161/CIRCULATIONAHA.110.976076
   Tarakji MG, 2019, N ENGL J MED
   Uslan DZ, 2007, ARCH INTERN MED, V167, P669, DOI 10.1001/archinte.167.7.669
   Yang PS, 2019, KOREAN CIRC J, V49, P742, DOI 10.4070/kcj.2018.0361
NR 11
TC 0
Z9 0
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD AUG
PY 2019
VL 49
IS 8
BP 753
EP 754
DI 10.4070/kcj.2019.0134
PG 2
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA IM3DQ
UT WOS:000477872700010
PM 31165600
OA Other Gold, Green Published
DA 2021-04-22
ER

PT J
AU Yoo, G
AF Yoo, Gyeonghee
TI Laboratory Markers Helpful in Diagnosing Kawasaki Disease in Febrile
   Infant: Role of Age-adjusted Z-values of Blood Cells
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
C1 [Yoo, Gyeonghee] Soonchunhyang Univ, Cheonan Hosp, Coll Med, Dept Pediat, 31 Suncheonhyang 6 Gil, Cheonan 31151, South Korea.
RP Yoo, G (corresponding author), Soonchunhyang Univ, Cheonan Hosp, Coll Med, Dept Pediat, 31 Suncheonhyang 6 Gil, Cheonan 31151, South Korea.
EM yoogh@schmc.ac.kr
OI Yoo, Gyeonghee/0000-0002-6290-8861
CR Chen YB, 2019, FRONT PEDIATR, V7, DOI 10.3389/fped.2019.00081
   Ha KS, 2018, KOREAN CIRC J, V48, P287, DOI 10.4070/kcj.2017.0342
   Ha KS, 2013, EUR J PEDIATR, V172, P343, DOI 10.1007/s00431-012-1891-5
   Kang JH, 2015, KOREAN CIRC J, V45, P510, DOI 10.4070/kcj.2015.45.6.510
   Kwak JH, 2019, KOREAN CIRC J, V49, P755, DOI 10.4070/kcj.2018.0434
   McCrindle BW, 2017, CIRCULATION, V135, pE927, DOI 10.1161/CIR.0000000000000484
   Tremoulet AH, 2011, PEDIATR INFECT DIS J, V30, P1022, DOI 10.1097/INF.0b013e31822d4f56
   Yamashita M, 2017, PEDIATR CARDIOL, V38, P375, DOI 10.1007/s00246-016-1525-1
NR 8
TC 0
Z9 0
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD AUG
PY 2019
VL 49
IS 8
BP 766
EP 768
DI 10.4070/kcj.2019.0133
PG 3
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA IM3DQ
UT WOS:000477872700012
PM 31165599
OA Green Published, Other Gold
DA 2021-04-22
ER

PT J
AU Kim, CS
   Kim, HY
   Lee, KS
   Bae, EH
   Ma, SK
   Kim, SW
AF Kim, Chang Seong
   Kim, Hyung Yoon
   Lee, Kyo Seon
   Bae, Eun Hui
   Ma, Seong Kwon
   Kim, Soo Wan
TI Vascular Stent Migration to Right Ventricle
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
C1 [Kim, Chang Seong; Bae, Eun Hui; Ma, Seong Kwon; Kim, Soo Wan] Chonnam Natl Univ, Med Sch, Dept Internal Med, 42 Jebong Ro, Gwangju 61469, South Korea.
   [Kim, Hyung Yoon] Chonnam Natl Univ Hosp, Dept Cardiovasc Med, Gwangju, South Korea.
   [Lee, Kyo Seon] Chonnam Natl Univ, Med Sch, Dept Thorac & Cardiovasc Surg, Gwangju, South Korea.
RP Kim, SW (corresponding author), Chonnam Natl Univ, Med Sch, Dept Internal Med, 42 Jebong Ro, Gwangju 61469, South Korea.
EM skimw@chonnam.ac.kr
OI Kim, Hyung Yoon/0000-0002-0692-5640; Kim, Chang
   Seong/0000-0001-8753-7641; Kim, Soo Wan/0000-0002-3540-9004
FU National Research Foundation of Korea (NRF) - Korea government (Ministry
   of Science and ICT) [NRF-2017M3A9E8023018]; NRF - Ministry of Education
   [NRF-2018R1D1A1B07042999]
FX This work was supported by the National Research Foundation of Korea
   (NRF) grant funded by the Korea government (Ministry of Science and ICT)
   (NRF-2017M3A9E8023018) and by the Basic Science Research Program through
   the NRF funded by the Ministry of Education (NRF-2018R1D1A1B07042999).
CR Ho JM, 2013, J VASC ACCESS, V14, P175, DOI 10.5301/jva.5000105
   Sequeira A, 2016, J VASC ACCESS, V17, P380, DOI 10.5301/jva.5000585
NR 2
TC 0
Z9 0
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD AUG
PY 2019
VL 49
IS 8
BP 769
EP 770
DI 10.4070/kcj.2019.0120
PG 2
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA IM3DQ
UT WOS:000477872700013
PM 31347323
OA Green Published, Other Gold
DA 2021-04-22
ER

PT J
AU Walsh, SJ
   Cosgrove, C
   Spratt, JC
   Hanratty, CG
AF Walsh, Simon J.
   Cosgrove, Claudia
   Spratt, James C.
   Hanratty, Colm G.
TI A Technical Focus on Antegrade Dissection and Re-entry for Coronary
   Chronic Total Occlusions a Practice Update for 2019
SO KOREAN CIRCULATION JOURNAL
LA English
DT Review
DE Percutaneous coronary intervention; Chronic total occlusion; Antegrade
   dissection and re-entry
ID PERCUTANEOUS INTERVENTION; SUBINTIMAL TRACKING; OUTCOMES; STRATEGY;
   REVASCULARIZATION; ALGORITHM; IMPACT; CTO
AB Coronary chronic total occlusions (CTOs) are a commonly encountered lesion. These present in a diverse patient population with variable anatomy. Technical success rates of similar to 90% are achievable for CTO lesions in centers with appropriate expertise. Many lesions can be crossed with wire-based techniques. However, the most anatomically complex and technically challenging lesions will often require more advanced approaches such as retrograde access and/or the application of blunt dissection techniques in the vessel to safely navigate long and/or ambiguous CTO segments. Retrograde dissection and re-entry (RDR) and antegrade dissection and re-entry (ADR) strategies are often needed to treat such lesions. In many circumstances, ADR offers a safe and efficient means to successfully cross a CTO lesion. Therefore, operators must remain cognizant of the risks and benefits of differing technical approaches during CTO percutaneous coronary intervention, particularly when both ADR and RDR are feasible. This article provides an overview of the ADR technique in addition to updated approaches in contemporary clinical practice.
C1 [Walsh, Simon J.; Hanratty, Colm G.] Royal Victoria Hosp, Belfast Hlth & Social Care Trust, 274 Grosvenor Rd, Belfast BT12 6BA, Antrim, North Ireland.
   [Cosgrove, Claudia; Spratt, James C.] St Georges Univ Hosp, London, England.
RP Walsh, SJ (corresponding author), Royal Victoria Hosp, Belfast Hlth & Social Care Trust, 274 Grosvenor Rd, Belfast BT12 6BA, Antrim, North Ireland.
EM simon.j.walsh@btinternet.com
RI Spratt, James/AAH-3589-2020
OI Spratt, James/0000-0001-8719-4538; Walsh, Simon/0000-0001-9787-6524
FU Boston ScientificBoston Scientific
FX Simon J. Walsh, James C. Spratt, and Colm G. Hanratty are a consultant
   to Boston Scientific. And Simon J. Walsh was supported research funding
   from Boston Scientific. Another author has no financial conflicts of
   interest.
CR Azzalini L, 2017, EUROINTERVENTION, V13, P978, DOI 10.4244/EIJ-D-16-01010
   Azzalini L, 2017, INT J CARDIOL, V231, P78, DOI 10.1016/j.ijcard.2016.11.273
   Brilakis ES, 2012, JACC-CARDIOVASC INTE, V5, P367, DOI 10.1016/j.jcin.2012.02.006
   Carlino M, 2008, CATHETER CARDIO INTE, V72, P790, DOI 10.1002/ccd.21699
   Colombo A, 2005, CATHETER CARDIO INTE, V64, P407, DOI 10.1002/ccd.20307
   Galassi AR, 2014, CAN J CARDIOL, V30, P1400, DOI 10.1016/j.cjca.2014.07.016
   Galassi AR, 2012, CATHETER CARDIO INTE, V79, P30, DOI 10.1002/ccd.22998
   Godino C, 2012, CATHETER CARDIO INTE, V79, P20, DOI 10.1002/ccd.23058
   Harding SA, 2017, JACC-CARDIOVASC INTE, V10, P2135, DOI 10.1016/j.jcin.2017.06.071
   Maeremans J, 2018, J INVASIVE CARDIOL, V30, P62
   Maeremans J, 2017, CIRC-CARDIOVASC INTE, V10, DOI 10.1161/CIRCINTERVENTIONS.116.004791
   Maeremans J, 2016, J AM COLL CARDIOL, V68, P1958, DOI 10.1016/j.jacc.2016.08.034
   Muhammad KI, 2012, CATHETER CARDIO INTE, V79, P43, DOI 10.1002/ccd.23139
   Song L, 2017, JACC-CARDIOVASC INTE, V10, P1011, DOI 10.1016/j.jcin.2017.02.043
   Tajti P, 2018, JACC-CARDIOVASC INTE, V11, P1325, DOI 10.1016/j.jcin.2018.02.036
   Tsujita K, 2009, JACC-CARDIOVASC INTE, V2, P846, DOI 10.1016/j.jcin.2009.06.012
   Valenti R, 2013, J AM COLL CARDIOL, V61, P545, DOI 10.1016/j.jacc.2012.10.036
   Walsh SJ, 2017, EUROINTERVENTION, V12, P1805
   Whitlow PL, 2012, JACC-CARDIOVASC INTE, V5, P393, DOI 10.1016/j.jcin.2012.01.014
   Wilson WM, 2017, CATHETER CARDIO INTE, V90, P703, DOI 10.1002/ccd.26980
   Wilson WM, 2016, HEART, V102, P1486, DOI 10.1136/heartjnl-2015-308891
NR 21
TC 0
Z9 0
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JUL
PY 2019
VL 49
IS 7
BP 559
EP 567
DI 10.4070/kcj.2019.0160
PG 9
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA IF5RS
UT WOS:000473140500001
PM 31243929
OA Green Published, Other Gold, Green Accepted
DA 2021-04-22
ER

PT J
AU Eisen, HJ
AF Eisen, Howard J.
TI Left Ventricular Assist Devices (LVADS): History, Clinical Application
   and Complications
SO KOREAN CIRCULATION JOURNAL
LA English
DT Review
DE Congestive heart failure; Circulatory shock; Ventricular assist device;
   Pumps, heartassist; Cardiac transplantation
ID MECHANICAL CIRCULATORY SUPPORT; HEART-FAILURE PATIENTS; INTERNATIONAL
   SOCIETY; MANAGEMENT; EXPERIENCE; OUTCOMES; REGISTRY; PUMP; IMPLANTATION;
   INHIBITORS
AB Congestive heart failure is a major cause of morbidity and mortality as well as a major health care cost in the developed world. Despite the introduction of highly effective heart failure medical therapies and simple devices such as cardiac resynchronization therapy that reduce mortality, improve cardiac function and quality of life, there remains a large number of patients who do not respond to these therapies or whose heart failure progresses despite optimal therapy. For these patients, cardiac transplantation is an option but is limited by donor availability as well as co-morbidities which may limit survival post-transplant. For these patients, left ventricular assist devices (LVADs) offer an alternative that can improve survival as well as exercise tolerance and quality of life. These devices have continued to improve as technology has improved with substantially improved durability of the devices and fewer post-implant complications. Pump thrombosis, stroke, gastrointestinal bleeding and arrhythmias post-implant have become less common with the newest devices, making destination therapy where ventricular assist device are implanted permanently in patients with advanced heart failure, a reality and an appropriate option for many patients. This may offer an opportunity for long term survival in many patients. As the first of the totally implantable devices are introduced and go to clinical trials, LVADs may be introduced that may truly be alternatives to cardiac transplantation in selected patients. Post-implant right ventricular failure remains a significant complication and better ways to identify patients at risk as well as to manage this complication must be developed.
C1 [Eisen, Howard J.] Penn State Univ, Milton S Hershey Med Ctr, Heart & Vasc Inst, 500 Univ Dr, Hershey, PA 17033 USA.
RP Eisen, HJ (corresponding author), Penn State Univ, Milton S Hershey Med Ctr, Heart & Vasc Inst, 500 Univ Dr, Hershey, PA 17033 USA.
EM heisen@pennstatehealth.psu.edu
CR Aggarwal A, 2012, ANN THORAC SURG, V93, P1534, DOI 10.1016/j.athoracsur.2012.02.035
   Aissaoui N, 2015, ARCH CARDIOVASC DIS, V108, P300, DOI 10.1016/j.acvd.2015.01.011
   Ambardekar AV, 2016, J HEART LUNG TRANSPL, V35, P722, DOI 10.1016/j.healun.2016.01.014
   Balcioglu O, 2013, TRANSPL P, V45, P1020, DOI 10.1016/j.transproceed.2013.02.072
   Bellavia D, 2017, EUR J HEART FAIL, V19, P926, DOI 10.1002/ejhf.733
   Bennett MK, 2015, J THORAC DIS, V7, P2125, DOI 10.3978/j.issn.2072-1439.2015.11.05
   Birks EJ, 2006, NEW ENGL J MED, V355, P1873, DOI 10.1056/NEJMoa053063
   Cai AW, 2017, AM J TRANSPLANT, V17, P3020, DOI 10.1111/ajt.14403
   Centers for Disease Control and Prevention, 2019, HEART FAIL FACT SHEE
   Cooper David K C, 2018, Glob Cardiol Sci Pract, V2018, P11, DOI 10.21542/gcsp.2018.11
   Dowling RD, 2000, ASAIO J, V46, P579, DOI 10.1097/00002480-200009000-00014
   Drakos SG, 2016, J HEART LUNG TRANSPL, V35, P413, DOI 10.1016/j.healun.2016.01.001
   Drakos SG, 2012, CIRCULATION, V126, P230, DOI 10.1161/CIRCULATIONAHA.111.040261
   Draper K, 2014, GASTROENTEROLOGY, V146, pS558
   Eisen HJ, 2003, NEW ENGL J MED, V349, P847, DOI 10.1056/NEJMoa022171
   Eisen HJ, 2018, J AM COLL CARDIOL, V71, P651, DOI 10.1016/j.jacc.2017.12.033
   Estep JD, 2015, J AM COLL CARDIOL, V66, P1747, DOI 10.1016/j.jacc.2015.07.075
   Frazier O H, 2000, Semin Thorac Cardiovasc Surg, V12, P207
   GIBBON J H Jr, 1954, Minn Med, V37, P171
   Harvey L, 2015, ANN THORAC SURG, V100, P535, DOI 10.1016/j.athoracsur.2015.02.094
   Hayek S, 2014, CIRC-CARDIOVASC IMAG, V7, P379, DOI 10.1161/CIRCIMAGING.113.001127
   Hayes HM, 2010, ARTIF ORGANS, V34, P703, DOI 10.1111/j.1525-1594.2010.01084.x
   Hogness J.R., 1991, ARTIFICIAL HEART PRO
   Holman WL, 2015, CIRC J, V79, P478, DOI 10.1253/circj.CJ-15-0093
   Houston BA, 2017, J HEART LUNG TRANSPL, V36, P701, DOI 10.1016/j.healun.2017.03.014
   INTERMACS, 2013, IN AN SUSP PUMP THRO
   Kauffman HM, 2005, TRANSPLANTATION, V80, P883, DOI 10.1097/01.TP.0000184006.43152.8D
   Khazanie Prateeti, 2011, Congest Heart Fail, V17, P227, DOI 10.1111/j.1751-7133.2011.00236.x
   Kim JH, 2018, CARDIOL CLIN, V36, P519, DOI 10.1016/j.ccl.2018.06.006
   Kimura M, 2015, J CARDIOL, V65, P383, DOI 10.1016/j.jjcc.2014.06.007
   Kirklin JK, 2008, J HEART LUNG TRANSPL, V27, P1065, DOI 10.1016/j.healun.2008.07.021
   Kirklin JK, 2015, J HEART LUNG TRANSPL, V34, P1495, DOI 10.1016/j.healun.2015.10.003
   Klodell CT, 2015, J CARDIAC SURG, V30, P775, DOI 10.1111/jocs.12607
   Kransdorf EP, 2017, J HEART LUNG TRANSPL, V36, P1027, DOI 10.1016/j.healun.2017.07.024
   Lok SI, 2014, EUR J CARDIO-THORAC, V45, P400, DOI 10.1093/ejcts/ezt589
   Maltais S, 2017, J HEART LUNG TRANSPL, V36, P1, DOI 10.1016/j.healun.2016.10.001
   Marsano J, 2015, DIGEST DIS SCI, V60, P1859, DOI 10.1007/s10620-015-3538-7
   Martin SI, 2013, CURR INFECT DIS REP, V15, P472, DOI 10.1007/s11908-013-0366-9
   McIlvennan CK, 2014, CIRC-HEART FAIL, V7, P1003, DOI 10.1161/CIRCHEARTFAILURE.114.001391
   Mehra MR, 2019, NEW ENGL J MED, V380, P1618, DOI 10.1056/NEJMoa1900486
   Mehra MR, 2018, NEW ENGL J MED, V378, P1386, DOI 10.1056/NEJMoa1800866
   Mehra MR, 2017, NEW ENGL J MED, V376, P440, DOI 10.1056/NEJMoa1610426
   Mehta Sanjay M, 2006, ASAIO J, V52, pe31, DOI 10.1097/01.mat.0000249019.38139.4b
   Miller LW, 2007, NEW ENGL J MED, V357, P885, DOI 10.1056/NEJMoa067758
   Miller LW, 2013, J AM COLL CARDIOL, V61, P1209, DOI 10.1016/j.jacc.2012.08.1029
   Narang N, 2018, CARDIOL CLIN, V36, P561, DOI 10.1016/j.ccl.2018.06.013
   Pae WE, 2007, J HEART LUNG TRANSPL, V26, P219, DOI 10.1016/j.healun.2006.12.007
   Pagani FD, 2015, J HEART LUNG TRANSPL, V34, pS9, DOI 10.1016/j.healun.2015.01.012
   Patel CB, 2011, PROG CARDIOVASC DIS, V54, P132, DOI 10.1016/j.pcad.2011.06.002
   Pedrotty DM, 2013, CURR OPIN CARDIOL, V28, P360, DOI 10.1097/HCO.0b013e32835fb7dc
   Pichiule P, 2004, J BIOL CHEM, V279, P12171, DOI 10.1074/jbc.M305146200
   Rose EA, 2001, NEW ENGL J MED, V345, P1435, DOI 10.1056/NEJMoa012175
   Rosenbaum AN, 2019, J AM HEART ASSOC, V8, DOI 10.1161/JAHA.118.010232
   Schmitto JD, 2014, NEW ENGL J MED, V370, P1463, DOI 10.1056/NEJMc1401768
   Seng BJJ, 2017, INT J ARTIF ORGANS, V40, P636, DOI 10.5301/ijao.5000620
   Slaughter MS, 2009, NEW ENGL J MED, V361, P2241, DOI 10.1056/NEJMoa0909938
   Starling RC, 2017, JACC-HEART FAIL, V5, P518, DOI 10.1016/j.jchf.2017.02.016
   Stehlik J, 2012, J HEART LUNG TRANSPL, V31, P1052, DOI 10.1016/j.healun.2012.08.002
   Stewart GC, 2014, HEART FAIL CLIN, V10, pS1, DOI 10.1016/j.hfc.2013.08.003
   Stewart GC, 2012, CIRCULATION, V125, P1304, DOI 10.1161/CIRCULATIONAHA.111.060830
   Tsiouris A, 2015, WORLD J CARDIOL, V7, P792, DOI 10.4330/wjc.v7.i11.792
   Uriel N, 2016, JACC-HEART FAIL, V4, P208, DOI 10.1016/j.jchf.2015.10.001
   Uriel N, 2012, J AM COLL CARDIOL, V60, P1764, DOI 10.1016/j.jacc.2012.07.052
   Uriel N, 2010, J AM COLL CARDIOL, V56, P1207, DOI 10.1016/j.jacc.2010.05.016
   Vukelic S, 2018, CIRC-HEART FAIL, V11, DOI 10.1161/CIRCHEARTFAILURE.118.004899
   WRITING COMMITTEE MEMBERS, 2013, Circulation, V128, pe240, DOI 10.1161/CIR.0b013e31829e8776
   Yamakawa M, 2003, CIRC RES, V93, P664, DOI 10.1161/01.RES.0000093984.48643.D7
   Yusen RD, 2014, J HEART LUNG TRANSPL, V33, P1009, DOI 10.1016/j.healun.2014.08.004
   Zilbershlag Michael, COMMUNICATION
NR 69
TC 4
Z9 4
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JUL
PY 2019
VL 49
IS 7
BP 568
EP 585
DI 10.4070/kcj.2019.0161
PG 18
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA IF5RS
UT WOS:000473140500002
PM 31243930
OA Green Published, Other Gold
DA 2021-04-22
ER

PT J
AU Park, Y
   Choi, SW
   Oh, JH
   Shin, ES
   Lee, SY
   Kim, J
   Kim, W
   Suh, JW
   Yang, DH
   Hong, YJ
   Chan, MY
   Koh, JS
   Hwang, JY
   Park, JH
   Jeong, YH
AF Park, Yongwhi
   Choi, Si Wan
   Oh, Ju Hyeon
   Shin, Eun-Seok
   Lee, Sang Yeub
   Kim, Jeongsu
   Kim, Weon
   Suh, Jeong-Won
   Yang, Dong Heon
   Hong, Young-Joon
   Chan, Mark Y.
   Koh, Jin Sin
   Hwang, Jin-Yong
   Park, Jae-Hyeong
   Jeong, Young-Hoon
CA HEALING-AMI Trial Investigators
TI Rationale and Design of the High Platelet Inhibition with Ticagrelor to
   Improve Left Ventricular Remodeling in Patients with ST-Segment
   Elevation Myocardial Infarction (HEALING-AMI) Trial
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Myocardial infarction; Ventricular Remodeling; Platelet; Ticagrelor;
   Clopidogrel
ID HEART-FAILURE; TASK-FORCE; INFLAMMATION; GUIDELINES; CARDIOLOGY; UPDATE;
   ESC; MANAGEMENT; SOCIETY; INJURY
AB Background and Objectives: Impaired recovery from left ventricular (LV) dysfunction is a major prognostic factor after myocardial infarction (MI). Because P2Y(12) receptor blockade inhibits myocardial injury, ticagrelor with off-target properties may have myocardial protection over clopidogrel. In animal models, ticagrelor vs. clopidogrel protects myocardium against reperfusion injury and improves remodeling after MI. We aimed to investigate the effect of ticagrelor on sequential myocardial remodeling process after MI. Methods: High platelet inhibition with ticagrelor to improve LV remodeling in patients with ST-segment elevation MI (HEALING-AMI) is an investigator-initiated, randomized, open-label, assessor-blinded, multi-center trial done at 10 sites in Korea. Patients will be enrolled if they have ST-segment elevation MI (STEMI) treated with primary percutaneous coronary intervention and a planned duration of dual antiplatelet treatment of at least 6 months. Screened patients will be randomly assigned (1:1) using an internet-based randomization with a computer-generated blocking with stratification across study sites to either ticagrelor or clopidogrel treatment. The co-primary primary endpoints are LV remodeling index with three-dimensional echocardiography and the level of N-terminal prohormone B-type natriuretic peptide (NT-proBNP) at 6 months representing post-MI remodeling processes. Changes of LV end-systolic/diastolic volume indices and LV ejection fraction between baseline and 6-month follow-up will be also evaluated. Analysis is per protocol. Conclusions: HEALING-AMI is testing the effect of ticagrelor in reducing adverse LV remodeling following STEMI. Our trial would show the benefit of ticagrelor vs. clopidogrel related to the recovery of post-MI LV dysfunction beyond potent platelet inhibition.
C1 [Park, Yongwhi; Jeong, Young-Hoon] Gyeongsang Natl Univ, Changwon Hosp, Dept Internal Med, 11 Samjeortgja Ro, Chang Won 51472, South Korea.
   [Choi, Si Wan; Park, Jae-Hyeong] Chungnam Natl Univ Hosp, Dept Internal Med, Div Cardiol, Daejeon, South Korea.
   [Oh, Ju Hyeon] Changwon Samsung Med Ctr, Dept Internal Med, Chang Won, South Korea.
   [Shin, Eun-Seok] Ulsan Univ Hosp, Dept Internal Med, Div Cardiol, Ulsan, South Korea.
   [Lee, Sang Yeub] Chungbuk Natl Univ Hosp, Dept Internal Med, Div Cardiol, Cheongju, South Korea.
   [Kim, Jeongsu] Pusan Natl Univ, Yangsan Hosp, Dept Internal Med, Div Cardiol, Yangsan, South Korea.
   [Kim, Weon] Kyung Hee Univ Hosp, Dept Internal Med, Div Cardiol, Seoul, South Korea.
   [Suh, Jeong-Won] Seoul Natl Univ, Bundang Hosp, Dept Internal Med, Div Cardiol, Seongnam, South Korea.
   [Yang, Dong Heon] Kyungpook Natl Univ Hosp, Dept Internal Med, Div Cardiol, Daegu, South Korea.
   [Hong, Young-Joon] Chonnam Natl Univ Hosp, Dept Internal Med, Div Cardiol, Gwangju, South Korea.
   [Chan, Mark Y.] Singapore Natl Univ, Dept Cardiol, Heart Ctr, Singapore, Singapore.
   [Koh, Jin Sin; Hwang, Jin-Yong] Gyeongsang Natl Univ Hosp, Dept Internal Med, Jinju, Singapore.
RP Jeong, YH (corresponding author), Gyeongsang Natl Univ, Changwon Hosp, Dept Internal Med, 11 Samjeortgja Ro, Chang Won 51472, South Korea.
EM goodoctor@naver.com
RI Jeong, Young-Hoon/F-3476-2015; Jeong, Young-Hoon/AAO-4401-2020; Park,
   Jae-Hyeong/AAD-9015-2021
OI Jeong, Young-Hoon/0000-0003-0403-3726; Park,
   Yongwhi/0000-0003-3626-9717; Kim, Jeongsu/0000-0001-6877-4289; Chan, Yan
   Yee Mark/0000-0003-0389-7450
FU AstraZeneca KoreaAstraZeneca; Basic Science Research Program through the
   National Research Foundation (NRF) of Korea - Ministry of Science, ICT
   and Future Planning [NRF-2015R1A5A2008833]
FX This study is supported by research grants from AstraZeneca Korea and
   the Basic Science Research Program through the National Research
   Foundation (NRF) of Korea funded by the Ministry of Science, ICT and
   Future Planning (NRF-2015R1A5A2008833).
CR Anzai T, 2013, CIRC J, V77, P580, DOI 10.1253/circj.CJ-13-0013
   Bae JS, 2018, CURR VASC PHARMACOL, V16, P459, DOI 10.2174/1570161116666180117103238
   Benjamin EJ, 2018, CIRCULATION, V137, pE67, DOI 10.1161/CIR.0000000000000558
   Burchfield JS, 2013, CIRCULATION, V128, P388, DOI 10.1161/CIRCULATIONAHA.113.001878
   Du XJ, 2011, THROMB HAEMOSTASIS, V105, P356, DOI 10.1160/TH10-07-0449
   Gerber Y, 2016, CIRC-HEART FAIL, V9, DOI 10.1161/CIRCHEARTFAILURE.115.002460
   Gerber Y, 2015, JAMA INTERN MED, V175, P996, DOI 10.1001/jamainternmed.2015.0924
   Gerczuk PZ, 2012, J AM COLL CARDIOL, V59, P969, DOI 10.1016/j.jacc.2011.07.054
   Ibanez B, 2018, EUR HEART J, V39, P119, DOI 10.1093/eurheartj/ehx393
   Italiano JE, 2008, BLOOD, V111, P1227, DOI 10.1182/blood-2007-09-113837
   Jenkins C, 2009, EUR HEART J, V30, P98, DOI 10.1093/eurheartj/ehn484
   Kang J, 2018, KOREAN CIRC J, V48, P537, DOI 10.4070/kcj.2018.0166
   Kang MG, 2017, J AM COLL CARDIOL, V69, P125
   Levine GN, 2016, CIRCULATION, V134, pE123, DOI 10.1161/CIR.0000000000000404
   Liehn EA, 2011, J AM COLL CARDIOL, V58, P2357, DOI 10.1016/j.jacc.2011.08.034
   Liu Y, 2011, ARTERIOSCL THROM VAS, V31, P834, DOI 10.1161/ATVBAHA.110.220467
   Nanhwan MK, 2014, ARTERIOSCL THROM VAS, V34, P2078, DOI 10.1161/ATVBAHA.114.304002
   Nurden AT, 2011, THROMB HAEMOSTASIS, V105, pS13, DOI 10.1160/THS10-11-0720
   Opie LH, 2006, LANCET, V367, P356, DOI 10.1016/S0140-6736(06)68074-4
   Park Y, 2017, THROMB HAEMOSTASIS, V117, P911, DOI 10.1160/TH16-10-0744
   Ponikowski P, 2016, EUR HEART J, V37, P2129, DOI 10.1093/eurheartj/ehw128
   Rondina MT, 2013, CIRC RES, V112, P1506, DOI 10.1161/CIRCRESAHA.113.300512
   Semple JW, 2011, NAT REV IMMUNOL, V11, P264, DOI 10.1038/nri2956
   Sjoblom J, 2014, CIRCULATION, V130, P743, DOI 10.1161/CIRCULATIONAHA.114.009924
   Storey RF, 2010, J AM COLL CARDIOL, V56, P1456, DOI 10.1016/j.jacc.2010.03.100
   Swiatkiewicz I, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/250867
   Tapp LD, 2012, J THROMB HAEMOST, V10, P1231, DOI 10.1111/j.1538-7836.2011.04603.x
   Thygesen K, 2012, EUR HEART J, V33, P2001, DOI 10.1093/eurheartj/ehq509
   Vilahur G, 2016, CIRCULATION, V134, P1708, DOI 10.1161/CIRCULATIONAHA.116.024014
   Yancy CW, 2017, CIRCULATION, V136, pE137, DOI 10.1161/CIR.0000000000000509
   Ye YM, 2015, ARTERIOSCL THROM VAS, V35, P1805, DOI 10.1161/ATVBAHA.115.305655
   Ziegler-Heitbrock L, 2007, J LEUKOCYTE BIOL, V81, P584, DOI 10.1189/jlb.0806510
NR 32
TC 4
Z9 4
U1 0
U2 2
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JUL
PY 2019
VL 49
IS 7
BP 586
EP 599
DI 10.4070/kcj.2018.0415
PG 14
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA IF5RS
UT WOS:000473140500003
PM 31074220
OA Other Gold, Green Published
DA 2021-04-22
ER

PT J
AU Lee, JH
   Park, JJ
   Cho, Y
   Oh, IY
   Yoo, BS
   Kim, JJ
   Kim, KH
   Kang, SM
   Baek, SH
   Jeon, ES
   Cho, MC
   Chae, SC
   Oh, BH
   Choi, DJ
AF Lee, Ji Hyun
   Park, Jin Joo
   Cho, Youngjin
   Oh, Il-Young
   Yoo, Byung-Su
   Kim, Jae-Joong
   Kim, Kye Hun
   Kang, Seok-Min
   Baek, Sang Hong
   Jeon, Eun-Seok
   Cho, Myeong-Chan
   Chae, Shung Chull
   Oh, Byung-Hee
   Choi, Dong-Ju
TI Prognostic Implication of Ventricular Conduction Disturbance Pattern in
   Hospitalized Patients with Acute Heart Failure Syndrome
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Cardiac conduction system disease; Bundle branch block; Prognosis; Heart
   failure
ID BUNDLE-BRANCH BLOCK; LONG-TERM MORTALITY; CLINICAL CHARACTERISTICS; QRS
   PROLONGATION; PREDICTORS; DURATION; OUTCOMES; DELAY
AB Background and Objectives: Conflicting data exist regarding the prognostic implication of ventricular conduction disturbance pattern in patients with heart failure (HF). This study investigated the prognostic impact of ventricular conduction pattern in hospitalized patients with acute HF.
   Methods: Data from the Korean Acute Heart Failure registry were used. Patients were categorized into four groups: narrow QRS (<120 ms), right bundle branch block (RBBB), left bundle branch block (LBBB), and nonspecific intraventricular conduction delay (NICD). The NICD was defined as prolonged QRS (>= 120 ms) without typical features of LBBB or RBBB. The primary endpoint was the composite of all-cause mortality or rehospitalization for HF aggravation within 1 year after discharge.
   Results: This study included 5,157 patients. The primary endpoint occurred in 39.7% of study population. The LBBB group showed the highest incidence of primary endpoint followed by NICD, RBBB, and narrow QRS groups (52.5% vs. 49.7% vs. 44.4% vs. 37.5%, p<0.001). In a multivariable Cox-proportional hazards regression analysis, LBBB and NICD were associated with 39% and 28% increased risk for primary endpoint (LBBB hazard ratio [HR], 1.392; 95% confidence interval [CI], 1.152-1.681; NICD HR, 1.278; 95% CI, 1.074-1.520) compared with narrow QRS group. The HR of RBBB for the primary endpoint was 1.103 (95% CI, 0.915-1.329).
   Conclusions: MB and NICD were independently associated with an increased risk of 1-year adverse event in hospitalized patients with HF, whereas the prognostic impacts of RBBB were limited.
C1 [Lee, Ji Hyun; Yoo, Byung-Su] Yonsei Univ, Wonju Coll Med, Dept Internal Med, Wonju, South Korea.
   [Park, Jin Joo; Cho, Youngjin; Oh, Il-Young; Choi, Dong-Ju] Seoul Natl Univ, Bundang Hosp, Dept Cardiol, Cardiovasc Ctr, 82 Gumi Ro 173 Beon-gil, Seongnam 13620, South Korea.
   [Kim, Jae-Joong] Univ Ulsan, Asan Med Ctr, Div Cardiol, Heart Inst, Seoul, South Korea.
   [Kim, Kye Hun] Chonnam Natl Univ, Heart Res Ctr, Dept Internal Med, Gwangju, South Korea.
   [Kang, Seok-Min] Yonsei Univ, Coll Med, Dept Internal Med, Seoul, South Korea.
   [Baek, Sang Hong] Catholic Univ Korea, Coll Med, Dept Internal Med, Seoul, South Korea.
   [Jeon, Eun-Seok] Sungkyunkwan Univ, Coll Med, Dept Internal Med, Seoul, South Korea.
   [Cho, Myeong-Chan] Chungbuk Natl Univ, Coll Med, Dept Internal Med, Cheongju, South Korea.
   [Chae, Shung Chull] Kyungpook Natl Univ, Coll Med, Dept Internal Med, Daegu, South Korea.
   [Oh, Byung-Hee] Seoul Natl Univ Hosp, Dept Internal Med, Seoul, South Korea.
RP Choi, DJ (corresponding author), Seoul Natl Univ, Bundang Hosp, Dept Cardiol, Cardiovasc Ctr, 82 Gumi Ro 173 Beon-gil, Seongnam 13620, South Korea.
EM djchoi@snubh.org
OI Lee, Ji Hyun/0000-0002-7162-1248; Kim, Kye Hun/0000-0002-6885-1501;
   Baek, Sang Hong/0000-0002-7065-3432; Kang, Seok-Min/0000-0001-9856-9227
FU Research of Korea Centers for Disease Control and Prevention
   [2010-E63003-00, 2011-E63002-00, 2012-E63005-00, 2013-E63003-00,
   2013-E63003-01, 2013-E63003-02, 2016-ER6303-00]
FX This work was supported by the Research of Korea Centers for Disease
   Control and Prevention (2010-E63003-00, 2011-E63002-00, 2012-E63005-00,
   2013-E63003-00, 2013-E63003-01, 2013-E63003-02, and 2016-ER6303-00).
CR Abdel-Qadir HM, 2011, INT J CARDIOL, V146, P213, DOI 10.1016/j.ijcard.2010.01.012
   Aro AL, 2011, CIRC-ARRHYTHMIA ELEC, V4, P704, DOI 10.1161/CIRCEP.111.963561
   Barsheshet A, 2011, AM J CARDIOL, V107, P540, DOI 10.1016/j.amjcard.2010.10.007
   Cinca J, 2013, EUR J HEART FAIL, V15, P877, DOI 10.1093/eurjhf/hft042
   Derval N, 2017, CIRC-ARRHYTHMIA ELEC, V10, DOI 10.1161/CIRCEP.117.005073
   Eschalier R, 2015, HEART RHYTHM, V12, P1071, DOI 10.1016/j.hrthm.2015.01.023
   Farwell D, 2000, EUR HEART J, V21, P1246, DOI 10.1053/euhj.1999.1985
   Gijsberts CM, 2016, HEART, V102, P1464, DOI 10.1136/heartjnl-2015-309212
   Hong SJ, 2012, INT J CARDIOL, V157, P416, DOI 10.1016/j.ijcard.2012.03.155
   Lee SE, 2017, KOREAN CIRC J, V47, P341, DOI 10.4070/kcj.2016.0419
   Lee SE, 2014, EUR J HEART FAIL, V16, P700, DOI 10.1002/ejhf.91
   McCullough PA, 2005, INT J CARDIOL, V102, P303, DOI 10.1016/j.ijcard.2004.10.008
   Mueller C, 2006, J INTERN MED, V260, P421, DOI 10.1111/j.1365-2796.2006.01703.x
   Park HS, 2013, CARDIOLOGY, V125, P96, DOI 10.1159/000348334
   Park SJ, 2013, AM HEART J, V165, P57, DOI 10.1016/j.ahj.2012.10.009
   Tabrizi F, 2007, EUR HEART J, V28, P2449, DOI 10.1093/eurheartj/ehm262
   Tolppanen H, 2016, ESC HEART FAIL, V3, P35, DOI 10.1002/ehf2.12068
   Wang NC, 2008, JAMA-J AM MED ASSOC, V299, P2656, DOI 10.1001/jama.299.22.2656
   WILLEMS JL, 1985, J AM COLL CARDIOL, V5, P1261, DOI 10.1016/S0735-1097(85)80335-1
   Zimetbaum PJ, 2004, CIRCULATION, V110, P766, DOI 10.1161/01.CIR.0000139311.32278.32
NR 20
TC 0
Z9 0
U1 1
U2 2
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JUL
PY 2019
VL 49
IS 7
BP 602
EP 611
DI 10.4070/kcj.2018.0290
PG 10
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA IF5RS
UT WOS:000473140500005
PM 30891964
OA Green Published, Other Gold
DA 2021-04-22
ER

PT J
AU Kim, I
   Park, CS
   Lee, HY
AF Kim, Inho
   Park, Chan Soon
   Lee, Hae-Young
TI Angiotensin II Type 1 Receptor Blocker, Fimasartan, Reduces Vascular
   Smooth Muscle Cell Senescence by Inhibiting the CYR61 Signaling Pathway
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Coronary
   vessels; Cellular Senescence
ID IMMEDIATE-EARLY GENE; FIBROSIS; EXPRESSION; OXIDASE; SYSTEM
AB Background and Objectives: Angiotensin II (Ang II) has been suggested to accelerate vascular senescence, however the molecular mechanism(s) remain unknown.
   Methods: We cultured human coronary artery smooth muscle cells (hCSMCs) and treated Ang II and/or fimasartan. Or we transfected adenoviral vectors expressing CYR61 (Ad-CYR61) or antisense CYR61 (Ad-As-CYR61). Cellular senescence was evaluated senescence-associated beta-galactosidase (SA-beta-gal) assay. The molecular mechanisms were investigated real-time PCR and western blots.
   Results: SA-beta-gal-positive cells significantly increased in Ang II-treated hCSMCs (5.77 +/- 1.43-fold compared with the control). The effect of Ang II was significantly attenuated by pretreatment with the Ang II type 1 receptor blocker, fimasartan (2.00 +/- 0.92-fold). The expression of both p53 and p16 senescence regulators was significantly increased by Ang II (p53: 1.39 +/- 0.17, p16: 1.19 +/- 0.10-fold vs. the control), and inhibited by fimasartan. Cysteine-rich angiogenic protein 61 (CYR61) was rapidly induced by Ang II. Compared with the control, Ad-CYR61-transfected hCSMCs showed significantly increased SA-beta-gal-positive cells (3.47 +/- 0.65-fold). Upon transfecting Ad-AS-CYR61, Ang H-induced senescence (3.74 +/- 0.23-fold) was significantly decreased (1.77 +/- 0.60-fold). p53 expression by Ang II was significantly attenuated by Ad-AS-CYR61, whereas p16 expression was not regulated. Ang II activated ERK1/2 and p38 MAPK, which was significantly blocked by fimasartan. ERK and p38 inhibition both regulated Ang II-induced CYR61 expression. However, p53 expression was only regulated by ERK1/2, whereas p16 expression was only attenuated by p38 MAPK.
   Conclusions: Ang II induced vascular senescence by the ERK/p38 MAPK-CYR61 pathway and ARB, fimasartan, protected against Ang II-induced vascular senescence.
C1 [Kim, Inho; Park, Chan Soon; Lee, Hae-Young] Seoul Natl Univ Hosp, Dept Internal Med, 101 Daehak Ro, Seoul 03080, South Korea.
   [Kim, Inho] Seoul Natl Univ, Coll Med, Dept Microbiol & Immunol, Seoul, South Korea.
RP Lee, HY (corresponding author), Seoul Natl Univ Hosp, Dept Internal Med, 101 Daehak Ro, Seoul 03080, South Korea.
EM hylee612@snu.ac.kr
OI Lee, Hae-Young/0000-0002-9521-4102
FU Bio & Medical Technology Development Program of the National Research
   Foundation (NRF) by the Korean government (MSIP MOHW) [2015M3A9B6029139]
FX This research was supported by the Bio & Medical Technology Development
   Program of the National Research Foundation (NRF) by the Korean
   government (MSIP & MOHW) (No. 2015M3A9B6029139).
CR ANDERSON S, 1993, AM J PHYSIOL, V265, pF477
   Babic AM, 1998, P NATL ACAD SCI USA, V95, P6355, DOI 10.1073/pnas.95.11.6355
   Basso N, 2007, AM J PHYSIOL-HEART C, V293, pH1351, DOI 10.1152/ajpheart.00393.2007
   Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233
   de Cavanagh EMV, 2011, CARDIOVASC RES, V89, P31, DOI 10.1093/cvr/cvq285
   DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363
   HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0
   Hilfiker A, 2002, CIRCULATION, V106, P254, DOI 10.1161/01.CIR.0000021426.87274.62
   Jo YI, 2016, KOREAN J INTERN MED, V31, P335, DOI 10.3904/kjim.2014.266
   Jun JI, 2010, NAT CELL BIOL, V12, P676, DOI 10.1038/ncb2070
   Kim TW, 2012, BIOORG MED CHEM LETT, V22, P1649, DOI 10.1016/j.bmcl.2011.12.116
   Kranzhofer R, 1999, ARTERIOSCL THROM VAS, V19, P1623, DOI 10.1161/01.ATV.19.7.1623
   Kunieda T, 2006, CIRCULATION, V114, P953, DOI 10.1161/CIRCULATIONAHA.106.626606
   Lau LF, 1999, EXP CELL RES, V248, P44, DOI 10.1006/excr.1999.4456
   Lee HY, 2007, CIRC RES, V100, P372, DOI 10.1161/01.RES.0000257945.97958.77
   Lee JH, 2016, KOREAN J INTERN MED, V31, P267, DOI 10.3904/kjim.2014.268
   Lee SE, 2017, KOREAN CIRC J, V47, P341, DOI 10.4070/kcj.2016.0419
   Lee SJ, 2013, KOREAN CIRC J, V43, P73, DOI 10.4070/kcj.2013.43.2.73
   Li YW, 2017, KOREAN CIRC J, V47, P182, DOI 10.4070/kcj.2015.0295
   Min LJ, 2009, AGEING RES REV, V8, P113, DOI 10.1016/j.arr.2008.12.002
   Nilsson PM, 2013, J HYPERTENS, V31, P1517, DOI 10.1097/HJH.0b013e328361e4bd
   Norheim OF, 2015, LANCET, V385, P239, DOI 10.1016/S0140-6736(14)61591-9
   OBRIEN TP, 1990, MOL CELL BIOL, V10, P3569, DOI 10.1128/MCB.10.7.3569
   Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9
   Shim KY, 2018, KOREAN J INTERN MED, V33, P453, DOI 10.3904/kjim.2017.317
   Sim DS, 2015, J KOREAN MED SCI, V30, P34, DOI 10.3346/jkms.2015.30.1.34
   Tsai IC, 2016, J MOL CELL CARDIOL, V98, P18, DOI 10.1016/j.yjmcc.2016.07.001
   WEBER KT, 1991, CIRCULATION, V83, P1849, DOI 10.1161/01.CIR.83.6.1849
   Yang XL, 2016, INFLAMM RES, V65, P115, DOI 10.1007/s00011-015-0895-9
   Zhou MS, 2006, HYPERTENSION, V47, P81, DOI 10.1161/01.HYP.0000197182.65554.c7
NR 30
TC 8
Z9 9
U1 2
U2 4
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JUL
PY 2019
VL 49
IS 7
BP 615
EP 626
DI 10.4070/kcj.2018.0379
PG 12
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA IF5RS
UT WOS:000473140500007
PM 31074217
OA Green Published, Other Gold
DA 2021-04-22
ER

PT J
AU Kwon, JM
   Kim, KH
   Jeon, KH
   Kim, HM
   Kim, MJ
   Lim, SM
   Song, PS
   Park, J
   Choi, RK
   Oh, BH
AF Kwon, Joon-myoung
   Kim, Kyung-Hee
   Jeon, Ki-Hyun
   Kim, Hyue Mee
   Kim, Min Jeong
   Lim, Sung-Min
   Song, Pil Sang
   Park, Jinsik
   Choi, Rak Kyeong
   Oh, Byung-Hee
TI Development and Validation of Deep-Learning Algorithm for
   Electrocardiography-Based Heart Failure Identification
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Deep learning; Heart failure; Electrocardiography; Machine learning;
   Artificial intelligence
ID ARTIFICIAL-INTELLIGENCE; MULTILAYER PERCEPTRON; SYSTEM; CLASSIFICATION;
   PREDICTION; MODEL; TREE
AB Background and Objectives: Screening and early diagnosis for heart failure (HF) are critical. However, conventional screening diagnostic methods have limitations, and electrocardiography (ECG)-based HF identification may be helpful. This study aimed to develop and validate a deep-learning algorithm for ECG-based HF identification (DEHF).
   Methods: The study involved 2 hospitals and 55,163 ECGs of 22,765 patients who performed echocardiography within 4 weeks were study subjects. ECGs were divided into derivation and validation data. Demographic and ECG features were used as predictive variables. The primary endpoint was detection of HF with reduced ejection fraction (HFrEF; ejection fraction [EF]<= 40%), and the secondary endpoint was HF with mid-range to reduced EF (<= 50%). We developed the DEHF using derivation data and the algorithm representing the risk of HF between 0 and 1. We confirmed accuracy and compared logistic regression (LR) and random forest (RF) analyses using validation data.
   Results: The area under the receiver operating characteristic curves (AUROCs) of DEHF for identification of HFrEF were 0.843 (95% confidence interval, 0.840-0.845) and 0.889 (0.887-0.891) for internal and external validation, respectively, and these results significantly outperformed those of LR (0.800 [0.797-0.803], 0.847 [0.844-0.850]) and RF (0.807 [0.804-0.810], 0.853 [0.850-0.855]) analyses. The AUROCs of deep learning for identification of the secondary endpoint was 0.821 (0.819-0.823) and 0.850 (0.848-0.852) for internal and external validation, respectively, and these results significantly outperformed those of LR and RF.
   Conclusions: The deep-learning algorithm accurately identified HF using ECG features and outperformed other machine-learning methods.
C1 [Kwon, Joon-myoung] Mediplex Sejong Hosp, Dept Emergency Med, Incheon, South Korea.
   [Kim, Kyung-Hee; Jeon, Ki-Hyun; Kim, Hyue Mee; Kim, Min Jeong; Lim, Sung-Min; Song, Pil Sang; Park, Jinsik; Choi, Rak Kyeong; Oh, Byung-Hee] Mediplex Sejong Hosp, Cardiovasc Ctr, Dept Internal Med, Div Cardiol, 20 Gyeyangrnunhwa Ro, Incheon 21080, South Korea.
RP Kim, KH (corresponding author), Mediplex Sejong Hosp, Cardiovasc Ctr, Dept Internal Med, Div Cardiol, 20 Gyeyangrnunhwa Ro, Incheon 21080, South Korea.
EM learnbyliving9@gmail.com
RI ; Oh, Byung-Hee/G-9875-2011
OI JEON, KI HYUN/0000-0002-6277-7697; Kim, Min Jeong/0000-0001-8398-7020;
   Kwon, Joon-myoung/0000-0001-6754-1010; Oh,
   Byung-Hee/0000-0002-9945-4306; Kim, Kyung-Hee/0000-0003-0708-8685; Lim,
   Sungmin/0000-0003-4833-4440
CR Abadi M., 2016, P 12 USENIX S OP SYS
   Alonso-Betanzos A, 2015, CLIN MED INSIGHTS-CA, V9, P57, DOI 10.4137/CMC.S18746
   Ambrosy AP, 2014, J AM COLL CARDIOL, V63, P1123, DOI 10.1016/j.jacc.2013.11.053
   Attia ZI, 2019, NAT MED, V25, P70, DOI 10.1038/s41591-018-0240-2
   Bagley SC, 2001, J CLIN EPIDEMIOL, V54, P979, DOI 10.1016/S0895-4356(01)00372-9
   Breiman L, 2001, STAT SCI, V16, P199, DOI 10.1214/ss/1009213726
   Calcagno V, 2010, J STAT SOFTW, V34, P1
   Carpenter J, 2000, STAT MED, V19, P1141, DOI 10.1002/(SICI)1097-0258(20000515)19:9<1141::AID-SIM479>3.0.CO;2-F
   Fong RC, 2017, IEEE I CONF COMP VIS, P3449, DOI 10.1109/ICCV.2017.371
   Guidi G, 2014, IEEE J BIOMED HEALTH, V18, P1750, DOI 10.1109/JBHI.2014.2337752
   Hendry PB, 2016, CARDIOL RES, V7, P110, DOI 10.14740/cr473w
   Isler Y, 2016, COMPUT BIOL MED, V76, P113, DOI 10.1016/j.compbiomed.2016.06.029
   Jayalakshmi T, 2011, IJCTE, V3, P1793, DOI DOI 10.7763/IJCTE.2011.V3.288
   Johnson KW, 2018, J AM COLL CARDIOL, V71, P2668, DOI 10.1016/j.jacc.2018.03.521
   Khalilia M, 2011, BMC MED INFORM DECIS, V11, DOI 10.1186/1472-6947-11-51
   Kwon JM, 2018, J AM HEART ASSOC, V7, DOI 10.1161/JAHA.118.008678
   LeCun Y, 2015, NATURE, V521, P436, DOI 10.1038/nature14539
   Masetic Z, 2016, COMPUT METH PROG BIO, V130, P54, DOI 10.1016/j.cmpb.2016.03.020
   Melillo P, 2013, IEEE J BIOMED HEALTH, V17, P727, DOI 10.1109/JBHI.2013.2244902
   Nainwal A, 2016, 2 INT C ADV COMP COM
   Nair V., 2010, RECTIFIED LINEAR UNI
   PAL SK, 1992, IEEE T NEURAL NETWOR, V3, P683, DOI 10.1109/72.159058
   Ponikowski P, 2014, ESC HEART FAIL, V1, P4, DOI 10.1002/ehf2.12005
   Sengupta PP, 2018, J AM COLL CARDIOL, V71, P1650, DOI 10.1016/j.jacc.2018.02.024
   Shouval R, 2017, INT J CARDIOL, V246, P7, DOI 10.1016/j.ijcard.2017.05.067
   Son CS, 2012, J BIOMED INFORM, V45, P999, DOI 10.1016/j.jbi.2012.04.013
   Ting DSW, 2017, JAMA-J AM MED ASSOC, V318, P2211, DOI 10.1001/jama.2017.18152
   Wolpert DH, 2002, SOFT COMPUTING AND INDUSTRY, P25
   Yancy CW, 2017, J AM COLL CARDIOL, V70, P776, DOI 10.1016/j.jacc.2017.04.025
   Ziaeian B, 2016, NAT REV CARDIOL, V13, P368, DOI 10.1038/nrcardio.2016.25
NR 30
TC 11
Z9 11
U1 1
U2 18
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JUL
PY 2019
VL 49
IS 7
BP 629
EP 639
DI 10.4070/kcj.2018.0446
PG 11
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA IF5RS
UT WOS:000473140500009
PM 31074221
OA Green Published, Other Gold
DA 2021-04-22
ER

PT J
AU Park, KW
AF Park, Kyung Woo
TI Will Ticagrelor Help Post-Myocardial Infarction 'Healing'?
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
ID MYOCARDIAL-INFARCTION; CLOPIDOGREL; SIZE
C1 [Park, Kyung Woo] Seoul Natl Univ Hosp, Dept Internal Med, Cardiovasc Ctr, 101 Daehak Ro, Seoul 03080, South Korea.
RP Park, KW (corresponding author), Seoul Natl Univ Hosp, Dept Internal Med, Cardiovasc Ctr, 101 Daehak Ro, Seoul 03080, South Korea.
EM kwparkmd@snu.ac.kr
RI Park, Kyung Woo/AAX-3046-2020
CR Burchfield JS, 2013, CIRCULATION, V128, P388, DOI 10.1161/CIRCULATIONAHA.113.001878
   Du XJ, 2011, THROMB HAEMOSTASIS, V105, P356, DOI 10.1160/TH10-07-0449
   Kim EK, 2017, J AM COLL CARDIOL, V69, P2098, DOI 10.1016/j.jacc.2017.02.034
   Liehn EA, 2011, J AM COLL CARDIOL, V58, P2357, DOI 10.1016/j.jacc.2011.08.034
   Park Y, 2019, KOREAN CIRC J, V49, P586, DOI 10.4070/kcj.2018.0415
   Storey RF, 2010, J AM COLL CARDIOL, V56, P1456, DOI 10.1016/j.jacc.2010.03.100
   Tapp LD, 2012, J THROMB HAEMOST, V10, P1231, DOI 10.1111/j.1538-7836.2011.04603.x
   Wallentin L, 2009, NEW ENGL J MED, V361, P1045, DOI 10.1056/NEJMoa0904327
   Ye YM, 2015, ARTERIOSCL THROM VAS, V35, P1805, DOI 10.1161/ATVBAHA.115.305655
   Yun KH, 2017, KOREAN CIRC J, V47, P705, DOI 10.4070/kcj.2017.0044
NR 10
TC 0
Z9 0
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JUL
PY 2019
VL 49
IS 7
BP 600
EP 601
DI 10.4070/kcj.2019.0179
PG 2
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA IF5RS
UT WOS:000473140500004
PM 31243931
OA Other Gold, Green Published
DA 2021-04-22
ER

PT J
AU Kim, KH
AF Kim, Kyung-Hee
TI Ventricular Conduction Disturbance in Acute Heart Failure Syndrome: Does
   It Matter for Prognosis?
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
ID QRS DURATION; MORTALITY; PREDICTORS; DELAY
C1 [Kim, Kyung-Hee] Sejong Gen Hosp, Div Cardiol, Cardiovasc Ctr, 28 Hohyeon Ro,489beon Gil, Bucheon 14754, South Korea.
RP Kim, KH (corresponding author), Sejong Gen Hosp, Div Cardiol, Cardiovasc Ctr, 28 Hohyeon Ro,489beon Gil, Bucheon 14754, South Korea.
EM learnbyliving9@gmail.com
OI Kim, Kyung-Hee/0000-0003-0708-8685
CR Aro AL, 2011, CIRC-ARRHYTHMIA ELEC, V4, P704, DOI 10.1161/CIRCEP.111.963561
   Derval N, 2017, CIRC-ARRHYTHMIA ELEC, V10, DOI 10.1161/CIRCEP.117.005073
   Eschalier R, 2015, HEART RHYTHM, V12, P1071, DOI 10.1016/j.hrthm.2015.01.023
   Lee JH, 2019, KOREAN CIRC J, V49, P22, DOI 10.4070/kcj.2018.0349
   Lee SE, 2017, KOREAN CIRC J, V47, P341, DOI 10.4070/kcj.2016.0419
   Oikarinen L, 2004, HYPERTENSION, V43, P1029, DOI 10.1161/01.HYP.0000125230.46080.c6
   Tolppanen H, 2016, ESC HEART FAIL, V3, P35, DOI 10.1002/ehf2.12068
   Wang NC, 2008, JAMA-J AM MED ASSOC, V299, P2656, DOI 10.1001/jama.299.22.2656
   Zimetbaum PJ, 2004, CIRCULATION, V110, P766, DOI 10.1161/01.CIR.0000139311.32278.32
NR 9
TC 0
Z9 0
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JUL
PY 2019
VL 49
IS 7
BP 612
EP 614
DI 10.4070/kcj.2019.0116
PG 3
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA IF5RS
UT WOS:000473140500006
PM 31165596
OA Green Published, Other Gold
DA 2021-04-22
ER

PT J
AU Song, P
   Kim, JH
AF Song, Parkyong
   Kim, Jae Ho
TI Benefits of Angiotensin Receptor Blockade: Preventing Smooth Muscle Cell
   Senescence and Beyond
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
C1 [Song, Parkyong] Pusan Natl Univ, Sch Med, Dept Convergence Med, Yangsan, South Korea.
   [Kim, Jae Ho] Pusan Natl Univ, Sch Med, Dept Physiol, Yangsan, South Korea.
   [Kim, Jae Ho] Pusan Natl Univ, Yangsan Hosp, Res Inst Convergence Biomed Sci & Technol, 20 Geumo Ro, Yangsan 50612, South Korea.
RP Kim, JH (corresponding author), Pusan Natl Univ, Yangsan Hosp, Res Inst Convergence Biomed Sci & Technol, 20 Geumo Ro, Yangsan 50612, South Korea.; Kim, JH (corresponding author), Pusan Natl Univ, Sch Med, Dept Physiol, 20 Geumo Ro, Yangsan 50612, South Korea.
EM jhkimst@pusan.ac.kr
OI Song, Parkyong/0000-0002-5004-3389
CR Baker DJ, 2008, NAT CELL BIOL, V10, P825, DOI 10.1038/ncb1744
   Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233
   Campisi J, 2013, ANNU REV PHYSIOL, V75, P685, DOI 10.1146/annurev-physiol-030212-183653
   Coppe JP, 2010, ANNU REV PATHOL-MECH, V5, P99, DOI 10.1146/annurev-pathol-121808-102144
   Kim I, 2019, KOREAN CIRC J, V49, P615, DOI 10.4070/kcj.2018.0379
   Kunieda T, 2006, CIRCULATION, V114, P953, DOI 10.1161/CIRCULATIONAHA.106.626606
   Min LJ, 2009, AGEING RES REV, V8, P113, DOI 10.1016/j.arr.2008.12.002
   Min SH, 2018, KOREAN CIRC J, V48, P198, DOI 10.4070/kcj.2017.0200
   SHAY JW, 1991, EXP CELL RES, V196, P33, DOI 10.1016/0014-4827(91)90453-2
   Welch WJ, 2008, HYPERTENSION, V52, P51, DOI 10.1161/HYPERTENSIONAHA.107.090472
NR 10
TC 0
Z9 0
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JUL
PY 2019
VL 49
IS 7
BP 627
EP 628
DI 10.4070/kcj.2019.0164
PG 2
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA IF5RS
UT WOS:000473140500008
PM 31243932
OA Other Gold, Green Published
DA 2021-04-22
ER

PT J
AU Park, J
AF Park, Junbeom
TI Can artificial Intelligence Prediction Algorithms Exceed Statistical
   Predictions?
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
C1 [Park, Junbeom] Ewha Womans Univ, Dept Cardiol, Coll Med, 1071 Annyangcheon Ro, Seoul, South Korea.
RP Park, J (corresponding author), Ewha Womans Univ, Dept Cardiol, Coll Med, 1071 Annyangcheon Ro, Seoul, South Korea.
EM newriser@naver.com
RI Park, Junbeom/AAH-6065-2021
FU Basic Science Research Program through the National Research Foundation
   of Korea (NRF) - Ministry of Science, ICT & Future Planning
   [NRF-2017R1E1A1A01078382]
FX Basic Science Research Program through the National Research Foundation
   of Korea (NRF) funded by the Ministry of Science, ICT & Future Planning
   (NRF-2017R1E1A1A01078382).
CR Attia ZI, 2019, NAT MED, V25, P70, DOI 10.1038/s41591-018-0240-2
   Chilamkurthy S, 2018, LANCET, V392, P2388, DOI 10.1016/S0140-6736(18)31645-3
   Gulshan V, 2016, JAMA-J AM MED ASSOC, V316, P2402, DOI 10.1001/jama.2016.17216
   Hendry PB, 2016, CARDIOL RES, V7, P110, DOI 10.14740/cr473w
   Kwon JM, 2019, KOREAN CIRC J, V49, P629, DOI 10.4070/kcj.2018.0446
   Park J, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-38928-6
   Sengupta PP, 2018, J AM COLL CARDIOL, V71, P1650, DOI 10.1016/j.jacc.2018.02.024
   Ziaeian B, 2016, NAT REV CARDIOL, V13, P368, DOI 10.1038/nrcardio.2016.25
NR 8
TC 1
Z9 1
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JUL
PY 2019
VL 49
IS 7
BP 640
EP 641
DI 10.4070/kcj.2019.0110
PG 2
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA IF5RS
UT WOS:000473140500010
PM 31074231
OA Green Published, Other Gold
DA 2021-04-22
ER

PT J
AU Lee, JH
   Nam, JH
   Park, JS
   Lee, DH
AF Lee, Jung-Hee
   Nam, Jong-Ho
   Park, Jong-Seon
   Lee, Dong-Hyup
TI Early Transcatheter Aortic Valve Failure Accompanied with Leaflet
   Perforation
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
C1 [Lee, Jung-Hee; Nam, Jong-Ho; Park, Jong-Seon] Yeungnam Univ, Coll Med, Med Ctr, Div Cardiol,Dept Internal Med, 170 Hyeonchung Ro, Daegu 42415, South Korea.
   [Lee, Dong-Hyup] Yeungnam Univ, Coll Med, Med Ctr, Dept Thorac & Cardiovasc Surg, Daegu, South Korea.
RP Lee, JH (corresponding author), Yeungnam Univ, Coll Med, Med Ctr, Div Cardiol,Dept Internal Med, 170 Hyeonchung Ro, Daegu 42415, South Korea.
EM seranflute@gmail.com
OI Nam, Jong-Ho/0000-0001-5106-8361
CR Mylotte D, 2015, EUR HEART J, V36, P1306, DOI 10.1093/eurheartj/ehu388
   Salaun E, 2018, JACC-CARDIOVASC IMAG, V11, P143, DOI 10.1016/j.jcmg.2017.05.016
NR 2
TC 1
Z9 1
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JUL
PY 2019
VL 49
IS 7
BP 642
EP 643
DI 10.4070/kcj.2018.0457
PG 2
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA IF5RS
UT WOS:000473140500011
PM 31190481
OA Green Published, Other Gold
DA 2021-04-22
ER

PT J
AU Hwang, D
   Lee, JM
   Rhee, TM
   Kim, YC
   Park, J
   Park, J
   Ahn, C
   Song, YB
   Hahn, JY
   Kim, KB
   Lee, YT
   Koo, BK
AF Hwang, Doyeon
   Lee, Joo Myung
   Rhee, Tae-Min
   Kim, Young-Chan
   Park, Jiesuck
   Park, Jonghanne
   Ahn, Chul
   Song, Young Bin
   Hahn, Joo-Yong
   Kim, Ki-Bong
   Lee, Young-Tak
   Koo, Bon-Kwon
TI The Effects of Preoperative Aspirin on Coronary Artery Bypass Surgery: a
   Systematic Meta-Analysis
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Coronary artery bypass surgery; Aspirin
ID THORACIC SURGEONS; THERAPY; TRIAL; MORTALITY; DIPYRIDAMOLE; RESTENOSIS;
   GUIDELINE; SOCIETY; UPDATE
AB Background and Objectives: Aspirin plays an important role in the maintenance of graft patency and the prevention of thrombotic event after coronary artery bypass graft surgery (CABG). However, the use of preoperative aspirin is still under debate due to the risk of bleeding.
   Methods: From PubMed, EMBASE, and Cochrane Central Register of Controlled Trials, data were extracted by 2 independent reviewers. Meta-analysis using random effect model was performed.
   Results: We performed a systemic meta-analysis of 17 studies (12 randomized controlled studies and 5 non-randomized registries) which compared clinical outcomes of 9,101 patients who underwent CABG with or without preoperative aspirin administration. Preoperative aspirin increased chest tube drainage (weighted mean difference 177.4 mL, 95% confidence interval [CI], 41.3-313.4; p=0.011). However, the risk of re-operation for bleeding was not different between the preoperative aspirin group and the control group (3.2% vs. 2.4%; odds ratio [OR], 1.23; 95% CI, 0.94-1.60; p=0.102). There was no difference in the rates of all-cause mortality (1.6% vs. 1.5%; OR, 0.98; 95%CI, 0.64-1.49; p=0.920) and myocardial infarction (MI) (8.7% vs. 10.4%; OR, 0.83; 95% CI, 0.66-1.04; p=0.102) between patients with and without preoperative aspirin administration.
   Conclusions: Although aspirin increased the amount of chest tube drainage, it was not associated with increased risk of re-operation for bleeding. In addition, the risks of early postoperative all-cause mortality and MI were not reduced by using preoperative aspirin.
C1 [Hwang, Doyeon; Rhee, Tae-Min; Kim, Young-Chan; Park, Jiesuck; Park, Jonghanne; Koo, Bon-Kwon] Seoul Natl Univ Hosp, Dept Internal Med, 101 Daehak Ro, Seoul 03080, South Korea.
   [Hwang, Doyeon; Rhee, Tae-Min; Kim, Young-Chan; Park, Jiesuck; Park, Jonghanne; Koo, Bon-Kwon] Seoul Natl Univ Hosp, Cardiovasc Ctr, 101 Daehak Ro, Seoul 03080, South Korea.
   [Lee, Joo Myung; Song, Young Bin; Hahn, Joo-Yong] Sungkyunkwan Univ, Samsung Med Ctr, Dept Internal Med, Sch Med, Seoul, South Korea.
   [Lee, Joo Myung; Song, Young Bin; Hahn, Joo-Yong] Sungkyunkwan Univ, Samsung Med Ctr, Cardiovasc Ctr, Sch Med, Seoul, South Korea.
   [Ahn, Chul] US FDA, Div Biostat, Ctr Devices & Radiol Hlth, Silver Spring, MD USA.
   [Kim, Ki-Bong] Seoul Natl Univ Hosp, Dept Thorac & Cardiovasc Surg, Seoul, South Korea.
   [Lee, Young-Tak] Sungkyunkwan Univ, Samsung Med Ctr, Dept Thorac & Cardiovasc Surg, Sch Med, Seoul, South Korea.
   [Koo, Bon-Kwon] Seoul Natl Univ, Inst Aging, Seoul, South Korea.
RP Koo, BK (corresponding author), Seoul Natl Univ Hosp, Dept Internal Med, 101 Daehak Ro, Seoul 03080, South Korea.; Koo, BK (corresponding author), Seoul Natl Univ Hosp, Cardiovasc Ctr, 101 Daehak Ro, Seoul 03080, South Korea.
EM bkkoo@snu.ac.kr
RI Hahn, Joo-Yong/AAU-7250-2020
OI Hahn, Joo-Yong/0000-0002-4412-377X; Song, Young Bin/0000-0003-3986-9152;
   Lee, Joo Myung/0000-0002-2178-4014; Park, Jonghanne/0000-0002-8860-8445;
   Park, Jiesuck/0000-0001-6924-7106
CR Ahmed I, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.d7762
   ALTMAN R, 1994, BMJ-BRIT MED J, V308, P81, DOI 10.1136/bmj.308.6921.81
   Awtry EH, 2000, CIRCULATION, V101, P1206, DOI 10.1161/01.CIR.101.10.1206
   Bybee KA, 2005, CIRCULATION, V112, pI286, DOI 10.1161/CIRCULATIONAHA.104.522805
   Cahill RA, 2005, J AM COLL SURGEONS, V200, P564, DOI 10.1016/j.jamcollsurg.2004.11.002
   CHESEBRO JH, 1982, NEW ENGL J MED, V307, P73, DOI 10.1056/NEJM198207083070201
   Dacey LJ, 2000, ANN THORAC SURG, V70, P1986, DOI 10.1016/S0003-4975(00)02133-0
   FERRARIS VA, 1988, ANN THORAC SURG, V45, P71, DOI 10.1016/S0003-4975(10)62401-0
   Ferraris VA, 2012, ANN THORAC SURG, V94, P1761, DOI 10.1016/j.athoracsur.2012.07.086
   Ferraris VA, 2011, ANN THORAC SURG, V91, P944, DOI 10.1016/j.athoracsur.2010.11.078
   FULLER JK, 1985, VASCULAR SURG, V19, P174, DOI 10.1177/153857448501900305
   Ghaffarinejad Mohammad Hassan, 2007, Cardiol J, V14, P453
   GOLDMAN S, 1991, CIRCULATION, V84, P520, DOI 10.1161/01.CIR.84.2.520
   GOLDMAN S, 1988, CIRCULATION, V77, P1324, DOI 10.1161/01.CIR.77.6.1324
   Hastings S, 2015, BRIT J ANAESTH, V115, P376, DOI 10.1093/bja/aev164
   Head SJ, 2013, EUR HEART J, V34, P2862, DOI 10.1093/eurheartj/eht330
   Hillis LD, 2012, J THORAC CARDIOV SUR, V143, P4, DOI 10.1016/j.jtcvs.2011.10.015
   Hillis LD, 2011, CIRCULATION, V124, pE652, DOI 10.1161/CIR.0b013e31823c074e
   HOCKINGS BEF, 1993, MED J AUSTRALIA, V159, P376, DOI 10.5694/j.1326-5377.1993.tb137909.x
   Klein M, 1998, EUR J CARDIO-THORAC, V14, P360, DOI 10.1016/S1010-7940(98)00192-4
   Leon MB, 1998, NEW ENGL J MED, V339, P1665, DOI 10.1056/NEJM199812033392303
   Mangano DT, 2002, NEW ENGL J MED, V347, P1309, DOI 10.1056/NEJMoa020798
   Myles PS, 2016, NEW ENGL J MED, V374, P728, DOI 10.1056/NEJMoa1507688
   Myles PS, 2011, CIRCULATION, V123, P571, DOI 10.1161/CIRCULATIONAHA.110.010470
   SAVAGE MP, 1995, CIRCULATION, V92, P3194, DOI 10.1161/01.CIR.92.11.3194
   SCHWARTZ L, 1988, NEW ENGL J MED, V318, P1714, DOI 10.1056/NEJM198806303182603
   Sun JCJ, 2008, EUR HEART J, V29, P1057, DOI 10.1093/eurheartj/ehn104
NR 27
TC 2
Z9 3
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JUN
PY 2019
VL 49
IS 6
BP 498
EP 510
DI 10.4070/kcj.2018.0296
PG 13
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA IB2TA
UT WOS:000470120400004
PM 30891961
OA Other Gold, Green Published
DA 2021-04-22
ER

PT J
AU Dewan, P
   Docherty, KF
   McMurray, JJV
AF Dewan, Pooja
   Docherty, Kieran F.
   McMurray, John J., V
TI Sacubitril/Valsartan in Asian Patients with Heart Failure with Reduced
   Ejection Fraction
SO KOREAN CIRCULATION JOURNAL
LA English
DT Review
DE Asians; Sacubitril/valsartan; Heart failure
ID ATRIAL-NATRIURETIC-FACTOR; GUIDELINE PHARMACOLOGICAL-TREATMENT; NEUTRAL
   ENDOPEPTIDASE INHIBITOR; ANGIOTENSIN-CONVERTING ENZYME; NEPRILYSIN
   INHIBITION; RANDOMIZED TRIAL; EC 3.4.24.11; DOUBLE-BLIND; ENALAPRIL;
   LCZ696
AB The Prospective comparison of Angiotensin Receptor-neprilysin inhibitor (ARNI) with Angiotensin converting enzyme inhibitor (ACEI) to Determine Impact on Global Mortality and morbidity in Heart Failure (HF) trial (PARADIGM-HF) showed that adding a neprilysin inhibitor (sacubitril) to a renin-angiotensin system blocker (and other standard therapy) reduced morbidity and mortality in ambulatory patients with chronic HF with reduced ejection fraction (HFrEF). In PARADIGM-HF, valsartan combined with sacubitril (a socalled ARNI) was superior to the current gold standard of an ACEI, specifically enalapril, reducing the risk of the primary composite outcome of cardiovascular (CV) death or first HF hospitalization by 20% and all-cause death by 16%. Following the results of PARADIGM-HF, sacubitril/valsartan was approved by American and European regulatory authorities for the treatment of HFrEF. The burden of HF in Asia is substantial, both due to the huge population of the region and as a result of increasing CV risk factors and disease. Both the prevalence and mortality associated with HF are high in Asia. In the following review, we discuss the development of sacubitril/valsartan, the prototype ARNI, and the available evidence for its efficacy and safety in Asian patients with HFrEF.
C1 [Dewan, Pooja; Docherty, Kieran F.; McMurray, John J., V] Univ Glasgow, British Heart Fdn, Inst Cardiovasc & Med Sci, Cardiovasc Res Ctr, 126 Univ Pl, Glasgow G12 8TA, Lanark, Scotland.
RP McMurray, JJV (corresponding author), Univ Glasgow, British Heart Fdn, Inst Cardiovasc & Med Sci, Cardiovasc Res Ctr, 126 Univ Pl, Glasgow G12 8TA, Lanark, Scotland.
EM john.mcmurray@glasgow.ac.uk
RI Dewan, Pooja/AAC-7130-2021; mcmurray, John/B-2467-2013
OI mcmurray, John/0000-0002-6317-3975; Docherty, Kieran/0000-0002-5446-9969
FU British Heart FoundationBritish Heart Foundation [PG/17/23/32850]
   Funding Source: Medline
CR Ayalasomayajula S, 2017, CLIN PHARMACOKINET, V56, P1461, DOI 10.1007/s40262-017-0543-3
   Bayes-Genis A, 2016, J AM COLL CARDIOL, V68, P639, DOI 10.1016/j.jacc.2016.04.060
   BEVAN EG, 1992, J HYPERTENS, V10, P607
   Buakhamsri A., 2019, Journal of the Medical Association of Thailand, V102, P240
   Cada Dennis J, 2015, Hosp Pharm, V50, P1025, DOI 10.1310/hpj5011-1025
   Cannon JA, 2017, EUR J HEART FAIL, V19, P129, DOI 10.1002/ejhf.687
   Cohn JN, 2001, NEW ENGL J MED, V345, P1667, DOI 10.1056/NEJMoa010713
   COHN JN, 1991, NEW ENGL J MED, V325, P303, DOI 10.1056/NEJM199108013250502
   Dalzell JR, 2014, CARDIOVASC THER, V32, P13, DOI 10.1111/1755-5922.12053
   Daniels LB, 2007, J AM COLL CARDIOL, V50, P2357, DOI 10.1016/j.jacc.2007.09.021
   DEBOLD AJ, 1981, LIFE SCI, V28, P89, DOI 10.1016/0024-3205(81)90370-2
   Desai AS, 2015, EUR HEART J, V36, P1990, DOI 10.1093/eurheartj/ehv186
   Dewan P, 2019, EUR J HEART FAIL, V21, P577, DOI 10.1002/ejhf.1347
   Dokainish H, 2017, LANCET GLOB HEALTH, V5, pE665, DOI [10.1016/S2214-109X(17)30196-1, 10.1016/s2214-109x(17)30196-1]
   Feng LL, 2012, TETRAHEDRON LETT, V53, P275, DOI 10.1016/j.tetlet.2011.11.029
   Ferro CJ, 1998, CIRCULATION, V97, P2323, DOI 10.1161/01.CIR.97.23.2323
   Fryer RM, 2008, BRIT J PHARMACOL, V153, P947, DOI 10.1038/sj.bjp.0707641
   GROS C, 1989, P NATL ACAD SCI USA, V86, P7580, DOI 10.1073/pnas.86.19.7580
   Gu J, 2010, J CLIN PHARMACOL, V50, P401, DOI 10.1177/0091270009343932
   Guha S, 2018, INDIAN HEART J, V70, pS1, DOI 10.1016/j.ihj.2018.05.003
   Hasan MS, 2013, INT J NEUROSCI, V123, P143, DOI 10.3109/00207454.2012.744308
   Heart Online Technology (CN), 2018, GUID CHRON HFREF DRU
   Jhund PS, 2015, EUR HEART J, V36, P2576, DOI 10.1093/eurheartj/ehv330
   KAHN JC, 1990, LANCET, V335, P118, DOI 10.1016/0140-6736(90)90595-V
   KERR MA, 1974, BIOCHEM J, V137, P477, DOI 10.1042/bj1370477
   Kim MS, 2017, KOREAN CIRC J, V47, P555, DOI 10.4070/kcj.2017.0009
   Komajda M, 2004, EUR J HEART FAIL, V6, P467, DOI 10.1016/j.ejheart.2003.12.019
   Kostis OB, 2004, AM J HYPERTENS, V17, P103, DOI 10.1016/j.amjhyper.2003.09.014
   Kristensen SL, 2016, EUR HEART J, V37, P3167, DOI 10.1093/eurheartj/ehw226
   Lam CSP, 2016, EUR HEART J, V37, P3141, DOI 10.1093/eurheartj/ehw331
   McKinnie SMK, 2016, CHEMBIOCHEM, V17, P1495, DOI 10.1002/cbic.201600244
   McMurray JJV, 2016, NEW ENGL J MED, V374, P1521, DOI 10.1056/NEJMoa1514859
   McMurray JJV, 2014, NEW ENGL J MED, V371, P993, DOI 10.1056/NEJMoa1409077
   Mentz RJ, 2016, JACC-HEART FAIL, V4, P419, DOI 10.1016/j.jchf.2016.01.013
   Ministry of Health Malaysia, 2014, MAN HEART FAIL
   Ministry of Health Singapore, 2004, CLIN PRACT GUID HEAR
   NICKLAS JM, 1992, NEW ENGL J MED, V327, P685
   Northridge DB, 1999, AM HEART J, V138, P1149, DOI 10.1016/S0002-8703(99)70082-7
   NORTHRIDGE DB, 1989, LANCET, V2, P591
   O'Connor CM, 2011, NEW ENGL J MED, V365, P32, DOI 10.1056/NEJMoa1100171
   Okumura N, 2016, CIRC-HEART FAIL, V9, DOI 10.1161/CIRCHEARTFAILURE.116.003212
   Packer M, 2002, CIRCULATION, V106, P920, DOI 10.1161/01.CIR.0000029801.86489.50
   Packer M, 2017, NEW ENGL J MED, V376, P1956, DOI 10.1056/NEJMoa1601895
   Pocock SJ, 2015, J AM COLL CARDIOL, V66, P2536, DOI 10.1016/j.jacc.2015.10.014
   Ponikowski P, 2016, EUR HEART J, V37, P2129, DOI 10.1093/eurheartj/ehw128
   Potter LR, 2011, FEBS J, V278, P1808, DOI 10.1111/j.1742-4658.2011.08082.x
   Reyes EB, 2016, INT J CARDIOL, V223, P163, DOI 10.1016/j.ijcard.2016.07.256
   Robl JA, 1997, J MED CHEM, V40, P1570, DOI 10.1021/jm970041e
   ROQUES BP, 1980, NATURE, V288, P286, DOI 10.1038/288286a0
   Rouleau JL, 2000, LANCET, V356, P615, DOI 10.1016/S0140-6736(00)02602-7
   Savarese Gianluigi, 2017, Card Fail Rev, V3, P7, DOI 10.15420/cfr.2016:25:2
   Senni M, 2016, EUR J HEART FAIL, V18, P1193, DOI 10.1002/ejhf.548
   SHEPPERSON NB, 1991, CLIN SCI, V80, P265, DOI 10.1042/cs0800265
   Solomon SD, 2018, CIRC-HEART FAIL, V11, DOI 10.1161/CIRCHEARTFAILURE.118.004962
   Solomon SD, 2017, JACC-HEART FAIL, V5, P471, DOI 10.1016/j.jchf.2017.04.013
   Solomon SD, 2016, EUR J HEART FAIL, V18, P1238, DOI 10.1002/ejhf.603
   SWEDBERG K, 1987, NEW ENGL J MED, V316, P1429
   Teng THK, 2018, LANCET GLOB HEALTH, V6, pE1008, DOI 10.1016/S2214-109X(18)30306-1
   Tsutsui H, 2017, J CARDIOL, V70, P225, DOI 10.1016/j.jjcc.2016.11.011
   Velazquez EJ, 2019, NEW ENGL J MED, V380, P539, DOI 10.1056/NEJMoa1812851
   Wachter R, 2018, J CARD FAIL, V24, pS15, DOI 10.1016/j.cardfail.2018.07.045
   Wang CC, 2012, ACTA CARDIOL SIN, V28, P161
   Willenheimer R, 2005, CIRCULATION, V112, P2426, DOI 10.1161/CIRCULATIONAHA.105.582320
   WOO KS, 1995, BRIT J CLIN PHARMACO, V40, P141
   Yancy CW, 2017, CIRCULATION, V136, pE137, DOI 10.1161/CIR.0000000000000509
   Yingchoncharoen T., 2019, Journal of the Medical Association of Thailand, V102, P368
   YUSUF S, 1991, NEW ENGL J MED, V325, P293, DOI 10.1056/NEJM199108013250501
NR 67
TC 4
Z9 5
U1 0
U2 3
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JUN
PY 2019
VL 49
IS 6
BP 469
EP 484
DI 10.4070/kcj.2019.0136
PG 16
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA IB2TA
UT WOS:000470120400001
PM 31172710
OA Green Published, Other Gold, Green Accepted
DA 2021-04-22
ER

PT J
AU Yang, JH
   Lee, JM
   Park, TK
   Song, YB
   Hahn, JY
   Choi, JH
   Choi, SH
   Yu, CW
   Chun, WJ
   Oh, JH
   Koo, BK
   Jeong, JO
   Kim, HS
   Gwon, HC
AF Yang, Jeong Hoon
   Lee, Joo Myung
   Park, Taek Kyu
   Song, Young Bin
   Hahn, Joo-Yong
   Choi, Jin-Ho
   Choi, Seung-Hyuk
   Yu, Cheol Woong
   Chun, Woo Jung
   Oh, Ju Hyeon
   Koo, Bon-Kwon
   Jeong, Jin-Ok
   Kim, Hyo-Soo
   Gwon, Hyeon-Cheol
TI The Proximal Optimization Technique Improves Clinical Outcomes When
   Treated without Kissing Ballooning in Patients with a Bifurcation Lesion
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Percutaneous coronary intervention; Coronary artery disease; Drug
   eluting stents
ID INTRAVASCULAR ULTRASOUND; CONSENSUS DOCUMENT; CORONARY; ANGIOGRAPHY
AB Background and Objectives: There are limited data regarding the clinical efficacy of the proximal optimization technique (POT) in the treatment of coronary bifurcation lesions. We investigated the influence of POT on the clinical outcomes of patients with coronary bifurcation lesions.
   Methods: We enrolled a total of 1,191 patients with a bifurcation lesion with a side branch (SB) diameter >= 2.5 mm treated with a drug-eluting stent from 18 centers between January 2003 and December 2009. The primary outcome was major adverse cardiac events (MACEs: cardiac death, myocardial infarction or target lesion revascularization [TLR]). We performed one-to-many (1:N) propensity score matching with non-fixed matching ratio.
   Results: POT was performed in 252 patients. During follow-up (median 37 months), the incidence of MACE was lower in the POT group than it was in the non-POT group (adjusted hazard ratio, 0.43; 95% confidence interval [CI], 0.24-0.79; p=0.006). After propensity score matching, these were 0.34; 95% CI, 0.17-0.69; p=0.003 for MACE and 0.37; 95% CI, 0.17-0.78; p=0.01 for TLR. The use of POT was associated with significantly lower TLR in patients treated without kissing ballooning, but was not in those who underwent kissing ballooning (p for interaction=0.03).
   Conclusions: In coronary bifurcation lesions with a large SB, POT may be beneficial to improve long-term clinical outcome, particularly in patients treated without kissing ballooning during the procedure.
C1 [Yang, Jeong Hoon; Lee, Joo Myung; Park, Taek Kyu; Song, Young Bin; Hahn, Joo-Yong; Choi, Jin-Ho; Choi, Seung-Hyuk; Gwon, Hyeon-Cheol] Sungkyunkwan Univ, Samsung Med Ctr, Heart Vasc Stroke Inst, Dept Med,Sch Med,Div Cardiol, 81 Irwon Ro, Seoul 06351, South Korea.
   [Yu, Cheol Woong] Korea Univ, Cardiovasc Ctr, Div Cardiol, Anam Hosp, Seoul, South Korea.
   [Chun, Woo Jung; Oh, Ju Hyeon] Sungkyunkwan Univ, Samsung Changwon Hosp, Dept Med, Div Cardiol,Sch Med, Chang Won, South Korea.
   [Koo, Bon-Kwon; Kim, Hyo-Soo] Seoul Natl Univ Hosp, Dept Med, Div Cardiol, Seoul, South Korea.
   [Jeong, Jin-Ok] Chungnam Natl Univ Hosp, Dept Med, Div Cardiol, Daejeon, South Korea.
RP Gwon, HC (corresponding author), Sungkyunkwan Univ, Samsung Med Ctr, Heart Vasc Stroke Inst, Dept Med,Sch Med,Div Cardiol, 81 Irwon Ro, Seoul 06351, South Korea.
EM hcgwon@naver.com
RI Hahn, Joo-Yong/AAU-7250-2020
OI Hahn, Joo-Yong/0000-0002-4412-377X; Yu, Cheol Woong/0000-0002-5871-4562;
   Yang, Jeong Hoon/0000-0001-8138-1367; Lee, Joo Myung/0000-0002-2178-4014
FU Korean Society of Interventional Cardiology, Seoul, and Republic of
   Korea
FX This work was supported by the Korean Society of Interventional
   Cardiology, Seoul, and Republic of Korea.
CR Blasini R, 1997, CATHETER CARDIO DIAG, V42, P113, DOI 10.1002/(SICI)1097-0304(199710)42:2<113::AID-CCD2>3.0.CO;2-G
   Darremont O, 2015, EUROINTERVENTION S5, V11, pV86
   Derimay F, 2019, INT J CARDIOL, V274, P71, DOI 10.1016/j.ijcard.2018.09.041
   Hahn JY, 2008, ATHEROSCLEROSIS, V201, P326, DOI 10.1016/j.atherosclerosis.2008.02.021
   Hakim D, 2017, CIRC-CARDIOVASC INTE, V10, DOI 10.1161/CIRCINTERVENTIONS.117.005535
   Lansky AJ, 2002, J AM COLL CARDIOL, V39, P274, DOI 10.1016/S0735-1097(01)01745-4
   Lassen JF, 2016, EUROINTERVENTION, V12, P38, DOI 10.4244/EIJV12I1A7
   Lefevre T, 2018, REV ESP CARDIOL, V71, P418, DOI [10.1016/j.recesp.2017.10.053, 10.1016/j.rec.2017.11.005]
   Matsuda Y, 2018, J INTERV CARDIOL, V31, P624, DOI 10.1111/joic.12543
   Medina A, 2006, REV ESP CARDIOL, V59, P183, DOI 10.1016/S1885-5857(06)60130-8
   Mintz GS, 2001, J AM COLL CARDIOL, V37, P1478, DOI 10.1016/S0735-1097(01)01175-5
   Mylotte D, 2013, CATHETER CARDIO INTE, V82, pE437, DOI 10.1002/ccd.24901
   Yu CW, 2015, JACC-CARDIOVASC INTE, V8, P1297, DOI 10.1016/j.jcin.2015.04.015
NR 13
TC 2
Z9 2
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JUN
PY 2019
VL 49
IS 6
BP 485
EP 494
DI 10.4070/kcj.2018.0352
PG 10
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA IB2TA
UT WOS:000470120400002
PM 30891962
OA Green Published, Other Gold
DA 2021-04-22
ER

PT J
AU Lee, H
   Park, S
   Kim, HC
AF Lee, Hokyou
   Park, Sungha
   Kim, Hyeon Chang
TI Temporal and Geospatial Trends of Hypertension Management in Korea: a
   Nationwide Study 2002-2016
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Hypertension; Medication adherence; Spatio-temporal analysis
ID PREVALENCE; AWARENESS; MIDDLE
AB Background and Objectives: Geographic distribution of hypertension management in Korea has never been reported. We investigated temporal and regional trends of hypertension management in Korea.
   Methods: For each calendar year from 2002 to 2016, we identified 2,423,245 to 7,549,989 persons aged >= 30 years treated for hypertension (total 80,564,109 cases). We calculated yearly age-sex standardized rates for medication adherence, combination therapy, blood test, and urine test according to geographic regions. We then used multivariate logistic regression to calculate odds ratios for hypertension management adjusted for individual-level sociodemographic factors.
   Results: Adherence rates have markedly increased from 24.4% (2002) to 71.6% (2016) nationwide. Regional difference was prominent in 2002 (highest, 31.7% in Seoul; lowest, 14.4% in Jeonbuk), but has become less noticeable over 15 years (highest, 73.1% in Daejeon; lowest, 69.0% in Jeonnam, 2016). Combination therapy rates increased from 42.8% (2002) to 61.0% (2011), but are in decreasing trend after 2011. Blood test rates were 58.8% in 2016, whereas urine test rates have been stagnant below 50% across all regions. Geographic variations of combination therapy and complication screening rates were not profound. Results from multivariable logistic regression, adjusted for age and sex, were in agreement with trends observed by standardized rates. The odds ratios remained unchanged when the models were further adjusted for employment status and household income.
   Conclusions: Regional difference in hypertension management was evident in the past, but has become less apparent over the last 15 years in Korea.
C1 [Lee, Hokyou; Kim, Hyeon Chang] Yonsei Univ, Dept Prevent Med, Coll Med, 50-1 Yonsei Ro, Seoul 03722, South Korea.
   [Lee, Hokyou; Park, Sungha; Kim, Hyeon Chang] Yonsei Univ, Dept Internal Med, Coll Med, Seoul, South Korea.
   [Lee, Hokyou] Yonsei Univ, Grad Sch, Coll Med, Seoul, South Korea.
   [Park, Sungha] Yonsei Univ, Severance Cardiovasc Hosp, Div Cardiol, Coll Med, Seoul, South Korea.
   [Park, Sungha] Yonsei Univ, Cardiovasc Res Inst, Coll Med, Seoul, South Korea.
   [Kim, Hyeon Chang] Natl Hlth Insurance Serv, Big Data Steering Dept, Wonju, South Korea.
RP Kim, HC (corresponding author), Yonsei Univ, Dept Prevent Med, Coll Med, 50-1 Yonsei Ro, Seoul 03722, South Korea.
EM hckim@yuhs.ac
RI Kim, Hyeon Chang/F-8796-2019
OI Kim, Hyeon Chang/0000-0001-7867-1240; Lee, Hokyou/0000-0002-5034-8422;
   Park, Sungha/0000-0001-5362-478X
FU Korea Health Technology R&D Project through the Korea Health Industry
   Development Institute - Ministry of Health and Welfare, Republic of
   Korea [HI13C0715]; Physician-Scientist Fellowship Program, Yonsei
   University College of Medicine, Seoul, Korea
FX This work was partially supported by a grant of the Korea Health
   Technology R&D Project through the Korea Health Industry Development
   Institute, funded by the Ministry of Health and Welfare, Republic of
   Korea (grant No. HI13C0715). HL was supported by the Physician-Scientist
   Fellowship Program, Yonsei University College of Medicine, Seoul, Korea.
CR Chow CK, 2013, JAMA-J AM MED ASSOC, V310, P959, DOI 10.1001/jama.2013.184182
   Cushman WC, 2010, NEW ENGL J MED, V362, P1575, DOI 10.1056/NEJMoa1001286
   Gakidou E, 2017, LANCET, V390, P1345, DOI 10.1016/S0140-6736(17)32366-8
   Grotto I, 2008, CURR OPIN CARDIOL, V23, P335, DOI 10.1097/HCO.0b013e3283021c70
   Halpern MT, 2006, HYPERTENSION, V47, P1039, DOI 10.1161/01.HYP.0000222373.59104.3d
   James PA, 2014, JAMA-J AM MED ASSOC, V311, P1809, DOI 10.1001/jama.2013.284427
   Kauhl B, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-017-5017-x
   Lloyd-Sherlock P, 2014, INT J EPIDEMIOL, V43, P116, DOI 10.1093/ije/dyt215
   Mancia G, 2013, J HYPERTENS, V31, P1281, DOI 10.1097/01.hjh.0000431740.32696.cc
   Marques-Vidal P, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-246
   Mindell JS, 2012, PUBLIC HEALTH, V126, P317, DOI 10.1016/j.puhe.2012.01.008
   National Health Insurance Service, 2017, 2016 NAT HLTH SCREEN
   Pedigo A, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-644
   Reynolds K, 2003, J HYPERTENS, V21, P1273, DOI 10.1097/00004872-200307000-00014
   Seong SC, 2017, INT J EPIDEMIOL, V46, P799, DOI 10.1093/ije/dyw253
   Shin Jinho, 2015, Clin Hypertens, V21, P1, DOI 10.1186/s40885-014-0012-3
   Shin Jinho, 2015, Clin Hypertens, V21, P2, DOI 10.1186/s40885-014-0013-2
   Stockl D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156736
   Whelton PK, 2018, HYPERTENSION, V71, pE13, DOI [10.1161/HYP.0000000000000065, 10.1161/HYP.0000000000000066]
   Williams B, 2018, EUR HEART J, V39, P3021, DOI 10.1093/eurheartj/ehy339
   Wright JT, 2015, NEW ENGL J MED, V373, P2103, DOI 10.1056/NEJMoa1511939
   Yin MH, 2016, SCI REP-UK, V6, DOI 10.1038/srep37020
NR 22
TC 9
Z9 9
U1 0
U2 2
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JUN
PY 2019
VL 49
IS 6
BP 514
EP 527
DI 10.4070/kcj.2018.0358
PG 14
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA IB2TA
UT WOS:000470120400006
PM 30808085
OA Green Published, Other Gold
DA 2021-04-22
ER

PT J
AU Lee, CW
   Sung, SH
   Huang, WM
   Tsai, YL
   Chen, HY
   Hsu, CP
   Shih, CC
   Chung, KP
AF Lee, Ching-Wei
   Sung, Shih-Hsien
   Huang, Wei-Ming
   Tsai, Yi-Lin
   Chen, Hsiang-Yao
   Hsu, Chiao-Po
   Shih, Chun-Che
   Chung, Kuo-Piao
TI Can Elderly Patients with Severe Mitral Regurgitation Benefit from
   Trans-catheter Mitral Valve Repair?
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Elderly; Mitral regurgitation
ID NATIVE VALVULAR REGURGITATION; ONE-YEAR OUTCOMES; AMERICAN-SOCIETY;
   EUROPEAN-ASSOCIATION; PERCUTANEOUS REPAIR; EUROSCORE II; HEART;
   MORTALITY; SURGERY; ECHOCARDIOGRAPHY
AB Background and Objectives: Age is a traditional risk factor for open-heart surgery. The efficacy and safety of transcatheter edge-to-edge mitral valve repair, using MitraClip (Abbott Vascular), has been demonstrated in patients with severe mitral regurgitation (MR). Since octogenarians or older patients are usually deferred to receive open-heart surgery, the main interest of this study is to elucidate the procedural safety and long-term clinical impact of MitraClip in elderly patients.
   Methods: Patients with symptomatic severe MR were evaluated by the heart team. For those with high or prohibitive surgical risks, transcatheter mitral valve repair was performed in hybrid operation room. Transthoracic echocardiography (TTE), blood tests, and six-minute walk test (6MWT) were performed before, 1-month, 6-months, and 1 year after index procedure.
   Results: A total of 46 consecutive patients receiving MitraClip procedure were enrolled. Nineteen patients (84.2 +/- 4.0 years) were over 80-year-old and 27 (73.4 +/- 11.1 years) were younger than 80. Compare to baseline, the significant reduction in MR severity was achieved after the procedure and sustained. All the patients benefited from significant improvement in New York Heart Association functional class. The 6-minute walk test (6MWT) increased from 259 +/- 114 to 319 +/- 92 meters (p=0.03) at 1 year. The overall 1-year survival rate was 80% in the elderly and 88% in those <80 years, p=0.590. Baseline 6MWT was a predictor for all-cause mortality (odds ratio, 0.99; 95% confidence interval, 0.982-0.999; p=0.026) after the MitraClip procedure.
   Conclusions: Trans-catheter edge-to-edge mitral valve repairs are safe and have positive clinical impact in subjects with severe MR, even in advanced age.
C1 [Lee, Ching-Wei; Sung, Shih-Hsien; Huang, Wei-Ming; Tsai, Yi-Lin; Chen, Hsiang-Yao] Natl Yang Ming Univ, Dept Med, Div Cardiol, Taipei, Taiwan.
   [Lee, Ching-Wei] Natl Yang Ming Univ, Dept Med Affairs & Planning, Taipei, Taiwan.
   [Lee, Ching-Wei; Sung, Shih-Hsien; Huang, Wei-Ming; Tsai, Yi-Lin; Chen, Hsiang-Yao; Hsu, Chiao-Po; Shih, Chun-Che] Natl Yang Ming Univ, Cardiovasc Res Ctr, Taipei, Taiwan.
   [Lee, Ching-Wei; Chung, Kuo-Piao] Natl Taiwan Univ, Coll Publ Hlth, Inst Hlth Policy & Management, 17 Xu Zhou Rd, Taipei 100, Taiwan.
   [Hsu, Chiao-Po; Shih, Chun-Che] Natl Yang Ming Univ, Dept Surg, Div Cardiovasc Surg, Taipei, Taiwan.
RP Chung, KP (corresponding author), Natl Taiwan Univ, Coll Publ Hlth, Inst Hlth Policy & Management, 17 Xu Zhou Rd, Taipei 100, Taiwan.
EM kpchung@ntu.edu.tw
OI Sung, Shih-Hsien/0000-0001-9441-1836; Huang, Wei
   Ming/0000-0002-9253-8240; Lee, Ching-Wei/0000-0001-9871-6514
FU Taipei Veterans General Hospital, Taiwan, R.O.C.Taipei Veterans General
   Hospital [V106B-019]
FX This work was supported by a grant from the Taipei Veterans General
   Hospital, Taiwan, R.O.C. (V106B-019).
CR Andalib A, 2014, EUROINTERVENTION, V9, P1225, DOI 10.4244/EIJV9I10A205
   Buccheri S, 2017, AM J CARDIOL, V119, P1443, DOI 10.1016/j.amjcard.2017.01.024
   Buzzatti N, 2015, AM J CARDIOL, V115, P487, DOI 10.1016/j.amjcard.2014.11.031
   Coffey S, 2014, AM HEART J, V167, P562, DOI 10.1016/j.ahj.2013.12.030
   Enriquez-Sarano M, 2009, LANCET, V373, P1382, DOI 10.1016/S0140-6736(09)60692-9
   Feldman T, 2015, J AM COLL CARDIOL, V66, P2844, DOI 10.1016/j.jacc.2015.10.018
   Feldman T, 2011, NEW ENGL J MED, V364, P1395, DOI 10.1056/NEJMoa1009355
   Goel SS, 2014, J AM COLL CARDIOL, V63, P185, DOI 10.1016/j.jacc.2013.08.723
   Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005
   Ledwoch J, 2018, CLIN RES CARDIOL, V107, P241, DOI 10.1007/s00392-017-1177-z
   Lee CW, 2018, J CHIN MED ASSOC, V81, P305, DOI 10.1016/j.jcma.2017.11.006
   Maisano F, 2013, J AM COLL CARDIOL, V62, P1052, DOI 10.1016/j.jacc.2013.02.094
   Metze C, 2017, JACC-CARDIOVASC INTE, V10, P1920, DOI 10.1016/j.jcin.2017.07.042
   Mirabel M, 2007, EUR HEART J, V28, P1358, DOI 10.1093/eurheartj/ehm001
   Nashef SAM, 2012, EUR J CARDIO-THORAC, V41, P734, DOI 10.1093/ejcts/ezs043
   Nickenig G, 2014, J AM COLL CARDIOL, V64, P875, DOI 10.1016/j.jacc.2014.06.1166
   Nishimura RA, 2017, J AM COLL CARDIOL, V70, P252, DOI 10.1016/j.jacc.2017.03.011
   Nkomo Vuyisile T, 2006, Lancet, V368, P1005, DOI 10.1016/S0140-6736(06)69208-8
   Puls M, 2016, EUR HEART J, V37, P703, DOI 10.1093/eurheartj/ehv627
   Roques F, 2003, EUR HEART J, V24, P881, DOI 10.1016/S0195-668X(02)00799-6
   Rudski LG, 2010, J AM SOC ECHOCARDIOG, V23, P685, DOI 10.1016/j.echo.2010.05.010
   Scandura S, 2016, INT J CARDIOL, V224, P440, DOI 10.1016/j.ijcard.2016.09.076
   Scholtz S, 2018, HEART LUNG CIRC, V27, P725, DOI 10.1016/j.hlc.2017.05.137
   Stone GW, 2015, J AM COLL CARDIOL, V66, P308, DOI 10.1016/j.jacc.2015.05.049
   UCHMANOWICZ I, 2015, CLIN INTERV AGING, V10, DOI DOI 10.2147/CIA.S90077
   Wang C, 2016, HEART LUNG, V45, P423, DOI 10.1016/j.hrtlng.2016.06.002
   Zhang GX, 2013, HEART LUNG CIRC, V22, P606, DOI 10.1016/j.hlc.2012.12.012
   Zoghbi WA, 2003, J AM SOC ECHOCARDIOG, V16, P777, DOI 10.1016/S0894-7317(03)00335-3
   Zoghbi WA, 2017, J AM SOC ECHOCARDIOG, V30, P303, DOI 10.1016/j.echo.2017.01.007
NR 29
TC 2
Z9 2
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JUN
PY 2019
VL 49
IS 6
BP 532
EP 541
DI 10.4070/kcj.2018.0417
PG 10
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA IB2TA
UT WOS:000470120400008
PM 30891963
OA Green Published, Other Gold
DA 2021-04-22
ER

PT J
AU Lim, K
   Chang, SA
   Oh, SY
   Lee, JH
   Song, J
   Kang, IS
   Huh, J
   Park, SJ
   Park, SW
   Kim, DK
AF Lim, Kyunghee
   Chang, Sung-A
   Oh, Soo-young
   Lee, Jong-Hwan
   Song, Jinyoung
   Kang, I-Seok
   Huh, June
   Park, Sung-Ji
   Park, Seung Woo
   Kim, Duk-Kyung
TI Pulmonary Arterial Hypertension and Pregnancy: Single Center Experience
   in Current Era of Targeted Therapy
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Hypertension, pulmonary; Pregnancy
ID BLOOD-VOLUME; OUTCOMES; DISEASE; PLASMA
AB Objectives: To report our experiences in pregnant patients with pulmonary arterial hypertension (PAH) who were treated with targeted therapy.
   Methods: From 2011 to 2017, women who decided to maintain pregnancies in our PAH clinic were included. Clinical data, management, and outcomes of the mothers and fetuses were reviewed.
   Results: Nine women with PAH and 10 deliveries were reviewed. The median maternal age was 28 (26-32) years old. The functional status of each patient was New York Heart Association functional class II or III at first visit. Sildenafil was prescribed in advance in 9 cases of delivery. Multidiscipline team approach management and intensive care were performed during the peripartum period. There was no maternal or fetal mortality. Severe cardiac events occurred in 2 patients with Eisenmenger syndrome: cardiac arrest and uncontrolled arrhythmia. Non-cardiac events occurred in 3 cases: postpartum bleeding, urinary tract infection, and pneumonia. The median gestational period at delivery was about 34 (32-38) weeks. Three cases were emergent delivery because of unexpected preterm labor. Intrauterine growth restriction developed in 4 fetuses.
   Conclusions: Pregnancy could be maintained by the introduction of targeted therapy rather more safely than the previous era in the case of maintenance of pregnancy. Intensive care and a multidisciplinary team approach can possibly improve the outcomes of the pregnant women with PAH and their babies. However, pregnancy in patients with PAH is still strongly prohibited and it can be tried in expert center where there has sufficient multidisciplinary team approach in case of inevitability.
C1 [Lim, Kyunghee; Chang, Sung-A; Park, Sung-Ji; Park, Seung Woo; Kim, Duk-Kyung] Sungkyunkwan Univ, Samsung Med Ctr, Heart Vasc Stroke Inst, Div Cardiol,Dept Internal Med,Sch Med, 81 Irwon Ro, Seoul 06351, South Korea.
   [Oh, Soo-young] Sungkyunkwan Univ, Samsung Med Ctr, Dept Obstet & Gynecol, Sch Med, Seoul, South Korea.
   [Lee, Jong-Hwan] Sungkyunkwan Univ, Samsung Med Ctr, Dept Anesthesiol & Pain Med, Sch Med, Seoul, South Korea.
   [Song, Jinyoung; Kang, I-Seok; Huh, June] Sungkyunkwan Univ, Samsung Med Ctr, Dept Pediat, Sch Med, Seoul, South Korea.
RP Chang, SA (corresponding author), Sungkyunkwan Univ, Samsung Med Ctr, Heart Vasc Stroke Inst, Div Cardiol,Dept Internal Med,Sch Med, 81 Irwon Ro, Seoul 06351, South Korea.
EM elisabet.chang@gmail.com
OI Park, Sung-Ji/0000-0002-7075-847X; Kim, Duk-Kyung/0000-0002-2348-8948;
   Kang, I-Seok/0000-0003-4264-0826; Lim, Kyunghee/0000-0002-7262-1848; Oh,
   Soo-young/0000-0003-3002-0048; Huh, June/0000-0003-4523-9632
CR Bedard E, 2009, EUR HEART J, V30, P256, DOI 10.1093/eurheartj/ehn597
   Bernstein IM, 2001, OBSTET GYNECOL, V97, P669, DOI 10.1016/S0029-7844(00)01222-9
   Galie N, 2016, EUR HEART J, V37, P67, DOI 10.1093/eurheartj/ehv317
   Hemnes AR, 2015, PULM CIRC, V5, P435, DOI 10.1086/682230
   Hsu CH, 2011, INT J CLIN PRACT, V65, P6, DOI 10.1111/j.1742-1241.2011.02711.x
   Ladouceur M, 2017, HEART, V103, P287, DOI 10.1136/heartjnl-2016-310003
   LUND CJ, 1967, AM J OBSTET GYNECOL, V98, P393, DOI 10.1016/0002-9378(67)90160-3
   Moran AM, 2002, CLIN CARDIOL, V25, P124, DOI 10.1002/clc.4960250308
   Obican SG, 2014, SEMIN PERINATOL, V38, P289, DOI 10.1053/j.semperi.2014.04.018
   Olsson KM, 2016, EUR RESPIR REV, V25, P431, DOI 10.1183/16000617.0079-2016
   PRITCHAR.JA, 1965, ANESTHESIOLOGY, V26, P393, DOI 10.1097/00000542-196507000-00004
   Regitz-Zagrosek V, 2011, EUR HEART J, V32, P3147, DOI 10.1093/eurheartj/ehr218
   Sanghavi M, 2014, CIRCULATION, V130, P1003, DOI 10.1161/CIRCULATIONAHA.114.009029
   Simmons LA, 2002, AM J PHYSIOL-HEART C, V283, pH1627, DOI 10.1152/ajpheart.00966.2001
   Sliwa K, 2016, EUR J HEART FAIL, V18, P1119, DOI 10.1002/ejhf.594
   SMEDSTAD KG, 1994, CAN J ANAESTH, V41, P502, DOI 10.1007/BF03011545
   vanOppen ACC, 1996, OBSTET GYNECOL, V87, P310, DOI 10.1016/0029-7844(95)00348-7
   Weiss BM, 1998, J AM COLL CARDIOL, V31, P1650, DOI 10.1016/S0735-1097(98)00162-4
NR 18
TC 2
Z9 2
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JUN
PY 2019
VL 49
IS 6
BP 545
EP 554
DI 10.4070/kcj.2018.0350
PG 10
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA IB2TA
UT WOS:000470120400010
PM 31074218
OA Green Published, Other Gold
DA 2021-04-22
ER

PT J
AU Daggubati, R
   Brahmbhatt, K
   Rigatelli, G
AF Daggubati, Ramesh
   Brahmbhatt, Kunal
   Rigatelli, Gianluca
TI Don't Touch My POT!
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
ID LEFT MAIN; FLOW; IMPACT
C1 [Daggubati, Ramesh; Brahmbhatt, Kunal] NYU, Winthrop Hosp, Dept Cardiol, 259 1st St, Mineola, NY 11501 USA.
   [Rigatelli, Gianluca] Rovigo Gen Hosp, Cardiovasc Diag & Endoluminal Intervent, Rovigo, Italy.
RP Daggubati, R (corresponding author), NYU, Winthrop Hosp, Dept Cardiol, 259 1st St, Mineola, NY 11501 USA.
EM daggur@yahoo.com
OI Rigatelli, Gianluca/0000-0002-7318-3640; Brahmbhatt,
   Kunal/0000-0003-1374-3869
CR Beier S, 2016, J BIOMECH, V49, P1570, DOI 10.1016/j.jbiomech.2016.03.038
   Darremont O, 2015, EUROINTERVENTION S5, V11, pV86
   Derimay F, 2019, INT J CARDIOL, V274, P71, DOI 10.1016/j.ijcard.2018.09.041
   Katritsis DG, 2012, CIRC-CARDIOVASC INTE, V5, P530, DOI 10.1161/CIRCINTERVENTIONS.112.968347
   Lassen JF, 2016, EUROINTERVENTION, V12, P38, DOI 10.4244/EIJV12I1A7
   Matsuda Y, 2018, J INTERV CARDIOL, V31, P624, DOI 10.1111/joic.12543
   Rigatelli G, 2019, CARDIOVASC REVASCULA, V20, P108, DOI 10.1016/j.carrev.2018.05.014
   Rigatelli G, 2017, J TRANSL INTERN MED, V5, P205, DOI 10.1515/jtim-2017-0035
   Takagi K, 2016, CARDIOVASC REVASCULA, V17, P515, DOI 10.1016/j.carrev.2016.08.012
   Yang JH, 2019, KOREAN CIRC J, V49, P485, DOI 10.4070/kcj.2018.0352
NR 10
TC 0
Z9 0
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JUN
PY 2019
VL 49
IS 6
BP 495
EP 497
DI 10.4070/kcj.2019.0065
PG 3
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA IB2TA
UT WOS:000470120400003
PM 31074222
OA Other Gold, Green Published
DA 2021-04-22
ER

PT J
AU Ahn, JM
AF Ahn, Jung-Min
TI Feel Free to Use Aspirin before Coronary Artery Bypass Surgery
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
ID INTERVENTION
C1 [Ahn, Jung-Min] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Cardiol, Seoul, South Korea.
RP Ahn, JM (corresponding author), Univ Ulsan, Coll Med, Asan Med Ctr, Dept Cardiol,Cardiac Ctr, 88 Olymp Ro 43 Gil, Seoul 05505, South Korea.
EM drjmahn@gmail.com
FU Ministry of Trade, Industry & Energy (MOTIE), Korea Institute for
   Advancement of Technology (KIAT) through the Encouragement Program for
   The Industries of Economic Cooperation Region
FX This research was supported by the Ministry of Trade, Industry & Energy
   (MOTIE), Korea Institute for Advancement of Technology (KIAT) through
   the Encouragement Program for The Industries of Economic Cooperation
   Region.
CR ALTMAN R, 1994, BMJ-BRIT MED J, V308, P81, DOI 10.1136/bmj.308.6921.81
   Cho SC, 2019, KOREAN CIRC J, V49, P369, DOI 10.4070/kcj.2019.0112
   Ferraris VA, 2012, ANN THORAC SURG, V94, P1761, DOI 10.1016/j.athoracsur.2012.07.086
   Fleisher LA, 2014, J AM COLL CARDIOL, V64, pE77, DOI 10.1016/j.jacc.2014.07.944
   Hwang D, 2019, KOREAN CIRC J, V49, P498, DOI 10.4070/kcj.2018.0296
   Myles PS, 2016, NEW ENGL J MED, V374, P728, DOI 10.1056/NEJMoa1507688
   Serruys PW, 2009, NEW ENGL J MED, V360, P961, DOI 10.1056/NEJMoa0804626
   Solo K, 2018, J THORAC DIS, V10, P3444, DOI 10.21037/jtd.2018.05.187
NR 8
TC 0
Z9 0
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JUN
PY 2019
VL 49
IS 6
BP 511
EP 513
DI 10.4070/kcj.2019.0155
PG 3
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA IB2TA
UT WOS:000470120400005
PM 31172711
OA Other Gold, Green Published
DA 2021-04-22
ER

PT J
AU Jung, MH
   Ihm, SH
AF Jung, Mi-Hyang
   Ihm, Sang-Hyun
TI Improving the Quality of Hypertension Management: Multifaceted Approach
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
ID MEDICATION ADHERENCE; COMPLICATIONS
C1 [Jung, Mi-Hyang] Hallym Univ, Coll Med, Chuncheon Sacred Heart Hosp, Cardiovasc Ctr, Chunchon, South Korea.
   [Ihm, Sang-Hyun] Catholic Univ Korea, Coll Med, Bucheon St Marys Hosp, Div Cardiol,Dept Internal Med, 327 Sosa Ro, Seoul 14647, South Korea.
RP Ihm, SH (corresponding author), Catholic Univ Korea, Coll Med, Bucheon St Marys Hosp, Div Cardiol,Dept Internal Med, 327 Sosa Ro, Seoul 14647, South Korea.
EM limsh@catholic.ac.kr
RI Jung, Mi-Hyang/AAV-2013-2020
OI Jung, Mi-Hyang/0000-0003-0224-5178; Ihm, Sang Hyun/0000-0001-5017-5421
CR Banegas JR, 2018, J HYPERTENS, V36, P446, DOI 10.1097/HJH.0000000000001615
   Carey RM, 2018, J AM COLL CARDIOL, V72, P1278, DOI 10.1016/j.jacc.2018.07.008
   Cramer JA, 2008, VALUE HEALTH, V11, P44, DOI 10.1111/j.1524-4733.2007.00213.x
   Halladay JR, 2017, PATIENT EDUC COUNS, V100, P542, DOI 10.1016/j.pec.2016.10.015
   Ho PM, 2009, CIRCULATION, V119, P3028, DOI 10.1161/CIRCULATIONAHA.108.768986
   Jung MH, 2017, INT J CARDIOL, V227, P387, DOI 10.1016/j.ijcard.2016.11.044
   Kim HJ, 2016, KOREAN CIRC J, V46, P384, DOI 10.4070/kcj.2016.46.3.384
   Lee CJ, 2018, KOREAN CIRC J, V48, P637, DOI 10.4070/kcj.2017.0349
   LEE H, 2019, KOREAN CIRC J, V49, P51, DOI DOI 10.1007/S11165-017-9614-6
   Verma AA, 2018, PLOS MED, V15, DOI 10.1371/journal.pmed.1002584
NR 10
TC 0
Z9 0
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JUN
PY 2019
VL 49
IS 6
BP 528
EP 531
DI 10.4070/kcj.2019.0055
PG 4
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA IB2TA
UT WOS:000470120400007
PM 31074223
OA Other Gold, Green Published
DA 2021-04-22
ER

PT J
AU Choi, JY
   Hong, GR
AF Choi, Jah Yeon
   Hong, Geu-Ru
TI Transcatheter Mitral Valve Repair: Growing Evidence Regarding It's
   Efficacy and Optimal Indication
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
ID GUIDELINES; MANAGEMENT; OUTCOMES; SURGERY
C1 [Choi, Jah Yeon] Korea Univ, Guro Hosp, Cardiovasc Ctr, Seoul, South Korea.
   [Hong, Geu-Ru] Yonsei Univ, Coll Med, Yonsei Univ Hlth Syst, Div Cardiol,Severance Cardiovasc Hosp, Seoul, South Korea.
RP Hong, GR (corresponding author), Yonsei Univ, Coll Med, Severance Cardiovasc Hosp, Div Cardiol, 50-1 Yonsei Ro, Seoul 03722, South Korea.
EM grhong@yuhs.ac
OI Choi, Jah Yeon/0000-0002-6793-4137; Hong, Geu-Ru/0000-0003-4981-3304
CR Ailawadi G, 2019, CIRCULATION, V139, P37, DOI 10.1161/CIRCULATIONAHA.117.031733
   Baumgartner H, 2017, EUR HEART J, V38, P2739, DOI 10.1093/eurheartj/ehx391
   Feldman T, 2011, NEW ENGL J MED, V364, P1395, DOI 10.1056/NEJMoa1009355
   Goldstein D, 2016, NEW ENGL J MED, V374, P344, DOI 10.1056/NEJMoa1512913
   Hayashida K, 2017, CIRC J, V81, P1116, DOI 10.1253/circj.CJ-17-0115
   Kar S, 2018, HEART
   Kim MS, 2017, KOREAN CIRC J, V47, P555, DOI 10.4070/kcj.2017.0009
   Lee CW, 2019, KOREAN CIRC J, V49, P532, DOI 10.4070/kcj.2018.0417
   Michler RE, 2016, NEW ENGL J MED, V374, P1932, DOI 10.1056/NEJMoa1602003
   Nasser R, 2017, JACC-HEART FAIL, V5, P652, DOI 10.1016/j.jchf.2017.06.015
   Nishimura RA, 2017, CIRCULATION, V135, pE1159, DOI 10.1161/CIR.0000000000000503
NR 11
TC 2
Z9 2
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JUN
PY 2019
VL 49
IS 6
BP 542
EP 544
DI 10.4070/kcj.2019.0154
PG 3
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA IB2TA
UT WOS:000470120400009
PM 31172712
OA Other Gold, Green Published
DA 2021-04-22
ER

PT J
AU Park, JH
AF Park, Jae-Hyeong
TI Pregnancy in Patients with Pulmonary Arterial Hypertension "To Deliver,
   or Not to Deliver: That Is the Question"
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
ID MANAGEMENT
C1 [Park, Jae-Hyeong] Chungnam Natl Univ, Sch Med, Chungnam Natl Univ Hosp, Dept Cardiol Internal Med, Daejeon, South Korea.
RP Park, JH (corresponding author), Chungnam Natl Univ, Dept Cardiol, Sch Med, Chungnam Natl Univ Hosp,Internal Med, 282 Munhwa Ro, Daejeon 35015, South Korea.
EM jaehpark@cnu.ac.kr
RI Park, Jae-Hyeong/AAD-9015-2021
CR Bildirici I, 2004, OBSTET GYNECOL, V103, P1102, DOI 10.1097/01.AOG.0000121826.75294.39
   Bonnin M, 2005, ANESTHESIOLOGY, V102, P1133, DOI 10.1097/00000542-200506000-00012
   Galie N, 2016, EUR HEART J, V37, P67, DOI 10.1093/eurheartj/ehv317
   Gleicher N, 1979, Obstet Gynecol Surv, V34, P721, DOI 10.1097/00006254-197910000-00001
   Hemnes AR, 2015, PULM CIRC, V5, P435, DOI 10.1086/682230
   Jais X, 2012, EUR RESPIR J, V40, P881, DOI 10.1183/09031936.00141211
   Kiely DG, 2010, BJOG-INT J OBSTET GY, V117, P565, DOI 10.1111/j.1471-0528.2009.02492.x
   Lim K, 2019, KOREAN CIRC J, V49, P545, DOI 10.4070/kcj.2018.0350
   Regitz-Zagrosek V, 2011, EUR HEART J, V32, P3147, DOI 10.1093/eurheartj/ehr218
   Weiss BM, 1998, J AM COLL CARDIOL, V31, P1650, DOI 10.1016/S0735-1097(98)00162-4
NR 10
TC 0
Z9 0
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JUN
PY 2019
VL 49
IS 6
BP 555
EP 556
DI 10.4070/kcj.2019.0061
PG 2
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA IB2TA
UT WOS:000470120400011
PM 31074224
OA Other Gold, Green Published
DA 2021-04-22
ER

PT J
AU Arsanjani, R
   Agasthi, P
   Ahn, DH
   Mookadam, F
   Yang, M
AF Arsanjani, Reza
   Agasthi, Pradyumna
   Ahn, Daniel H.
   Mookadam, Farouk
   Yang, Ming
TI Metastatic Neuroendocrine Tumor with Cardiac Involvement Utilizing
   Multi-Modality Imaging
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
ID CARCINOID HEART-DISEASE
C1 [Arsanjani, Reza; Agasthi, Pradyumna; Mookadam, Farouk] Mayo Clin, Div Cardiovasc Med, 13400 East Shea Blvd, Scottsdale, AZ 85259 USA.
   [Ahn, Daniel H.] Mayo Clin, Div Hematol Med Oncol, Phoenix, AZ USA.
   [Yang, Ming] Mayo Clin, Dept Radiol, Scottsdale, AZ USA.
RP Arsanjani, R (corresponding author), Mayo Clin, Div Cardiovasc Med, 13400 East Shea Blvd, Scottsdale, AZ 85259 USA.
EM Arsanjani.Reza@mayo.edu
RI Agasthi, Pradyumna/Y-6598-2019
OI Agasthi, Pradyumna/0000-0003-3067-6979; Yang, Ming/0000-0003-3001-7105;
   Arsanjani, Reza/0000-0001-7081-4286
CR Bhattacharyya S, 2010, CIRC-CARDIOVASC IMAG, V3, P103, DOI 10.1161/CIRCIMAGING.109.886846
   Davar J, 2017, J AM COLL CARDIOL, V69, P1288, DOI 10.1016/j.jacc.2016.12.030
NR 2
TC 0
Z9 0
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JUN
PY 2019
VL 49
IS 6
BP 557
EP 558
DI 10.4070/kcj.2018.0367
PG 2
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA IB2TA
UT WOS:000470120400012
PM 31074227
OA Green Published, Other Gold
DA 2021-04-22
ER

PT J
AU Kim, MC
   Ahn, Y
   Cho, JY
   Lee, KH
   Sim, DS
   Yoon, NS
   Yoon, HJ
   Kim, KH
   Hong, YJ
   Park, HW
   Kim, JH
   Jeong, MH
   Cho, JG
   Park, JC
   Chang, K
   Seung, KB
AF Kim, Min Chul
   Ahn, Youngkeun
   Cho, Jae Yeong
   Lee, Ki Hong
   Sim, Doo Sun
   Yoon, Nam Sik
   Yoon, Hyun Ju
   Kim, Kye Hun
   Hong, Young Joon
   Park, Hyung Wook
   Kim, Ju Han
   Jeong, Myung Ho
   Cho, Jeong Gwan
   Park, Jong Chun
   Chang, Kiyuk
   Seung, Ki-Bae
TI Benefit of Early Statin Initiation within 48 Hours after Admission in
   Statin-Naive Patients with Acute Myocardial Infarction Undergoing
   Percutaneous Coronary Intervention
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Myocardial infarction; Hydroxymethylglutaryl-CoA reductase inhibitors;
   Percutaneous coronary intervention
ID IN-HOSPITAL INITIATION; ST-SEGMENT ELEVATION; CLINICAL-OUTCOMES;
   ARTERY-DISEASE; TASK-FORCE; THERAPY; ATORVASTATIN; INTENSITY;
   MANAGEMENT; EFFICACY
AB Background and Objectives: Although current guidelines recommend early initiation of statin in patients with acute myocardial infarction (AMI), there is no consensus for optimal timing of statin initiation.
   Methods: A total of 3,921 statin-naive patients undergoing percutaneous coronary intervention were analyzed, and divided into 3 groups according to statin initiation time: group I (statin initiation <24 hours after admission), group 2 (24-48 hours) and group 3 (2:48 hours). We also made 3 stratified models to reduce bias: model 1 (<24 hours vs. >= 24 hours), model 2 (<48 hours vs. >= 48 hours) and model 3 (<24 hours vs. 24-48 hours). The endpoint was major adverse cardiac events (MACE; composite of cardiac death, myocardial infarction and target-vessel revascularization) during median 3.8 years.
   Results: During follow-up, incidence of MACE was lower in early statin group in both model 1 (14.3% vs. 18.4%, hazard ratio [HR], 0.77; 95% confidence interval [CI], 0.66-0.91; p=0.002) and model 2 (14.6% vs. 19.7%, HR, 0.81; 95% CI, 0.67-0.97; p=0.022). After propensity-score matching, results remained unaltered. Statin initiation <24 hours reduced MACE compared to statin initiation >= 24 hours in model 1. Statin initiation <48 hours also reduced MACE compared to statin initiation later in model 2. However, there was no difference in incidence of MACE between statin initiation <24 hours and 24-48 hours) in model 3.
   Conclusions: Early statin therapy within 48 hours after admission in statin-naive patients with AMI reduced long-term clinical outcomes compared with statin initiation later.
C1 [Kim, Min Chul; Ahn, Youngkeun; Cho, Jae Yeong; Lee, Ki Hong; Sim, Doo Sun; Yoon, Nam Sik; Yoon, Hyun Ju; Kim, Kye Hun; Hong, Young Joon; Park, Hyung Wook; Kim, Ju Han; Jeong, Myung Ho; Cho, Jeong Gwan; Park, Jong Chun] Chonnam Natl Univ, Sch Med, Chonnam Natl Univ Hosp, Div Cardiol,Dept Internal Med, 42 Jebong Ro, Gwangju 61469, South Korea.
   [Chang, Kiyuk; Seung, Ki-Bae] Catholic Univ Korea, Seoul St Marys Hosp, Coll Med, Div Cardiol,Dept Internal Med, Seoul, South Korea.
RP Ahn, Y (corresponding author), Chonnam Natl Univ, Sch Med, Chonnam Natl Univ Hosp, Div Cardiol,Dept Internal Med, 42 Jebong Ro, Gwangju 61469, South Korea.
EM cecilyk@hanmail.net
OI Jeong, Myung Ho/0000-0003-2424-810X; Kim, Kye Hun/0000-0002-6885-1501;
   Lee, Ki Hong/0000-0002-9938-3464; Kim, Min Chul/0000-0001-6026-1702;
   Yoon, Namsik/0000-0001-9112-150X
FU Bio & Medical Technology Development Program of the National Research
   Foundation of Korea (NRF) - Korean government, MSIP [2017M3A9E8023001]
FX This study was supported by a grant of the Bio & Medical Technology
   Development Program of the National Research Foundation of Korea (NRF)
   funded by the Korean government, MSIP (2017M3A9E8023001).
CR Amsterdam EA, 2014, J AM COLL CARDIOL, V64, pE139, DOI 10.1016/j.jacc.2014.09.017
   Aronow HD, 2003, ARCH INTERN MED, V163, P2576, DOI 10.1001/archinte.163.21.2576
   Briel M, 2006, JAMA-J AM MED ASSOC, V295, P2046, DOI 10.1001/jama.295.17.2046
   Cannon CP, 2015, NEW ENGL J MED, V372, P2387, DOI 10.1056/NEJMoa1410489
   Choo EH, 2014, HEART, V100, P492, DOI 10.1136/heartjnl-2013-305137
   Cutlip DE, 2007, CIRCULATION, V115, P2344, DOI 10.1161/CIRCULATIONAHA.106.685313
   Fonarow GC, 2005, AM J CARDIOL, V96, P611, DOI 10.1016/j.amjcard.2005.04.029
   Greque GV, 2016, CATHETER CARDIO INTE, V87, P222, DOI 10.1002/ccd.24937
   Grundy SM, 2004, CIRCULATION, V110, P227, DOI 10.1161/01.CIR.0000133317.49796.0E
   Hwang D, 2018, CIRC J, V82, P1112, DOI 10.1253/circj.CJ-17-1221
   Ibanez B, 2018, EUR HEART J, V39, P119, DOI 10.1093/eurheartj/ehx393
   Kenaan M, 2014, AM HEART J, V168, P110, DOI 10.1016/j.ahj.2014.03.016
   Kim JS, 2010, JACC-CARDIOVASC INTE, V3, P332, DOI 10.1016/j.jcin.2009.11.021
   Kim MC, 2011, INT HEART J, V52, P1, DOI 10.1536/ihj.52.1
   Kim MC, 2015, AM J CARDIOL, V115, P1, DOI 10.1016/j.amjcard.2014.09.039
   Ko DT, 2011, CIRC-CARDIOVASC QUAL, V4, P459, DOI 10.1161/CIRCOUTCOMES.111.960740
   Kurth T, 2006, AM J EPIDEMIOL, V163, P262, DOI 10.1093/aje/kwj047
   Lee CH, 2014, J GERIATR CARDIOL, V11, P93, DOI 10.3969/j.issn.1671-5411.2014.02.010
   Lee KH, 2011, J AM COLL CARDIOL, V58, P1664, DOI 10.1016/j.jacc.2011.05.057
   Lenderink T, 2006, EUR HEART J, V27, P1799, DOI 10.1093/eurheartj/ehl125
   Li YH, 2007, INT HEART J, V48, P677, DOI 10.1536/ihj.48.677
   Liu Z, 2016, INT J CARDIOL, V222, P22, DOI 10.1016/j.ijcard.2016.07.140
   Newby LK, 2002, JAMA-J AM MED ASSOC, V287, P3087, DOI 10.1001/jama.287.23.3087
   O'Gara PT, 2013, J AM COLL CARDIOL, V61, pE78, DOI 10.1016/j.jacc.2012.11.019
   Patti G, 2007, J AM COLL CARDIOL, V49, P1272, DOI 10.1016/j.jacc.2007.02.025
   Roffi M, 2016, EUR HEART J, V37, P267, DOI 10.1093/eurheartj/ehv320
   Rosenson RS, 2017, J AM COLL CARDIOL, V69, P2696, DOI 10.1016/j.jacc.2017.03.585
   Sposito AC, 2011, ARTERIOSCL THROM VAS, V31, P1240, DOI 10.1161/ATVBAHA.110.218685
   Yun KH, 2009, INT J CARDIOL, V137, P246, DOI 10.1016/j.ijcard.2008.06.055
NR 29
TC 3
Z9 3
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAY
PY 2019
VL 49
IS 5
BP 419
EP 433
DI 10.4070/kcj.2018.0341
PG 15
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA HX7TC
UT WOS:000467607800004
PM 30808084
OA Other Gold, Green Published
DA 2021-04-22
ER

PT J
AU Hwang, J
   Kim, J
   Choi, KJ
   Cho, MS
   Nam, GB
   Kim, YH
AF Hwang, Jongmin
   Kim, Jun
   Choi, Kee-Joon
   Cho, Min Soo
   Nam, Gi-Byoung
   Kim, You-Ho
TI Assessing Accuracy of Wrist-Worn Wearable Devices in Measurement of
   Paroxysmal Supraventricular Tachycardia Heart Rate
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Heart rate; Photoplethysmography; Tachyarrhythmia
ID SMARTPHONE APPLICATIONS; PHOTOPLETHYSMOGRAPHY
AB Background and Objectives: Wrist-worn wearable devices provide heart rate (HR) monitoring function via photoplethysmography technology. Recently, these devices have been used by patients to measure the HR when palpitation occurs, but few validation studies of these instruments have been conducted. We assessed the accuracy of these devices for measuring a HR.
   Methods: This study enrolled 51 consecutive patients with a history of paroxysmal supraventricular tachyarrhythmia (SVT) or paroxysmal palpitations who were scheduled to undergo an electrophysiological study (EPS). Three devices were assessed: Apple Watch Series 2 (Apple), Samsung Galaxy Gear S3 (Galaxy), and Fitbit Charge 2 (Fitbit). Patients were randomly assigned to wear 2 different devices. The HR at baseline and induced SVT were measured during the EPS. After successful ablation of SVT, HR measurements was also done during atrial and ventricular pacing study.
   Results: The mean patient age was 44.4 +/- 16.6 years and 27 patients were male (53%). The accuracy (within +/- 5 beats per minute [bpm] of an electrocardiogram [ECG] measurement) of the baseline HR measurements was 100%, 100%, and 94%, for Apple, Galaxy, and Fitbit, respectively. The HR during induced SVT ranged from 108 bpm to 228 bpm and the accuracy (within +/- 10 bpm of an ECG) was 100%, 90%, and 87% for the Apple, Galaxy, and Fitbit, respectively. During pacing study, accuracy of these devices was also acceptable but tended to decrease as the HR increased, and showed differences between the devices.
   Conclusions: Wrist-worn wearable devices accurately measure baseline and induced SVT HR.
C1 [Hwang, Jongmin; Kim, Jun; Choi, Kee-Joon; Cho, Min Soo; Nam, Gi-Byoung; Kim, You-Ho] Univ Ulsan, Coll Med, Asan Med Ctr, Div Cardiol,Dept Internal Med, 88,Olymp Ro 43 Gil, Seoul 05505, South Korea.
   [Hwang, Jongmin] Keimyung Univ, Dongsan Med Ctr, Dept Internal Med, Div Cardiol, Daegu, South Korea.
RP Kim, J (corresponding author), Univ Ulsan, Coll Med, Asan Med Ctr, Div Cardiol,Dept Internal Med, 88,Olymp Ro 43 Gil, Seoul 05505, South Korea.
EM mdjunkim@gmail.com
OI Hwang, Jongmin/0000-0001-9710-0945; Cho, Min Soo/0000-0001-9867-4991
CR Allen J, 2007, PHYSIOL MEAS, V28, pR1, DOI 10.1088/0967-3334/28/3/R01
   Carpenter A, 2016, EUROPACE, V18, P791, DOI 10.1093/europace/euv427
   Case MA, 2015, JAMA-J AM MED ASSOC, V313, P625, DOI 10.1001/jama.2014.17841
   Chan PH, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.116.003428
   Halcox JPJ, 2017, CIRCULATION, V136, P1784, DOI 10.1161/CIRCULATIONAHA.117.030583
   McManus DD, 2016, J CARDIOVASC ELECTR, V27, P51, DOI 10.1111/jce.12842
   McManus DD, 2013, HEART RHYTHM, V10, P315, DOI 10.1016/j.hrthm.2012.12.001
   Scully CG, 2012, IEEE T BIO-MED ENG, V59, P303, DOI 10.1109/TBME.2011.2163157
   Spierer David K., 2015, Journal of Medical Engineering & Technology, V39, P264, DOI 10.3109/03091902.2015.1047536
   Wackel P, 2014, J PEDIATR-US, V164, P1133, DOI 10.1016/j.jpeds.2014.01.047
   Wang R, 2017, JAMA CARDIOL, V2, P104, DOI 10.1001/jamacardio.2016.3340
NR 11
TC 11
Z9 12
U1 1
U2 5
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAY
PY 2019
VL 49
IS 5
BP 437
EP 445
DI 10.4070/kcj.2018.0323
PG 9
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA HX7TC
UT WOS:000467607800006
PM 30808083
OA Green Published, Other Gold
DA 2021-04-22
ER

PT J
AU Cho, SC
   Park, DW
   Park, SJ
AF Cho, Sang-Cheol
   Park, Duk-Woo
   Park, Seung-Jung
TI Percutaneous Coronary Intervention and Coronary Artery Bypass Grafting
   for the Treatment of Left Main Coronary Artery Disease
SO KOREAN CIRCULATION JOURNAL
LA English
DT Review
DE Coronary artery disease; Percutaneous coronary intervention; Coronary
   artery bypass; Angioplasty; balloon; coronary; Drug-eluting stents;
   Treatment outcome
ID ELUTING STENT IMPLANTATION; FRACTIONAL FLOW RESERVE; ASSOCIATION
   TASK-FORCE; DOUBLE KISSING CRUSH; LONG-TERM OUTCOMES; WAVE-FREE RATIO;
   INTRAVASCULAR ULTRASOUND; BIFURCATION LESIONS; RANDOMIZED-TRIAL;
   FOLLOW-UP
AB Severe stenosis of the left main coronary artery (LMCA) generally occurs as a result of atherosclerosis and compromises the blood supply to a wide area of myocardium, thereby increasing the risk of serious adverse cardiac events. Current revascularization strategies for patients with significant LMCA disease include coronary artery bypass grafting (CABG) and percutaneous coronary intervention (PCI), both of which have a range of advantages and disadvantages. In general, PCI is associated with a lower rate of periprocedural adverse events and provides more rapid recovery, while CABG provides more durable revascularization. Most clinical trials comparing PCI and CABG for the treatment of LMCA disease have shown PCI to be non-inferior to CABG with respect to mortality and the serious composite outcome of death, myocardial infarction, or stroke in patients with low-to-intermediate anatomical complexities. Remarkable advancements in PCI standards, including safer and more effective stents, adjunctive intravascular imaging or physiologic evaluation, and antithrombotic treatment, may have contributed to these favorable results. This review provides an update on the current management of LMCA disease with an emphasis on clinical data and academic and clinical knowledge that supports the use of PCI in an increasing proportion of patients with LMCA disease.
C1 [Cho, Sang-Cheol; Park, Duk-Woo; Park, Seung-Jung] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Cardiol, 88,Olymph Ro 43 Gil, Seoul 05505, South Korea.
RP Park, SJ (corresponding author), Univ Ulsan, Coll Med, Asan Med Ctr, Dept Cardiol, 88,Olymph Ro 43 Gil, Seoul 05505, South Korea.
EM sjpark@amc.seoul.kr
OI Park, Duk-Woo/0000-0001-6643-0239; Cho, Sang-Cheol/0000-0001-7587-5037
CR Ahn JM, 2015, J AM COLL CARDIOL, V65, P2198, DOI 10.1016/j.jacc.2015.03.033
   Bangalore S, 2012, CIRCULATION, V125, P2873, DOI 10.1161/CIRCULATIONAHA.112.097014
   Baron SJ, 2017, J AM COLL CARDIOL, V70, P3113, DOI 10.1016/j.jacc.2017.10.036
   Boden WE, 2007, NEW ENGL J MED, V356, P1503, DOI 10.1056/NEJMoa070829
   Boudriot E, 2011, J AM COLL CARDIOL, V57, P538, DOI 10.1016/j.jacc.2010.09.038
   Buszman PE, 2016, JACC-CARDIOVASC INTE, V9, P318, DOI 10.1016/j.jcin.2015.10.044
   Buszman PE, 2009, J AM COLL CARDIOL, V54, P1500, DOI 10.1016/j.jacc.2009.07.007
   Chen SL, 2017, J AM COLL CARDIOL, V70, P2605, DOI 10.1016/j.jacc.2017.09.1066
   Chen SL, 2015, JACC-CARDIOVASC INTE, V8, P1335, DOI 10.1016/j.jcin.2015.05.017
   Chen SL, 2013, J AM COLL CARDIOL, V61, P1482, DOI 10.1016/j.jacc.2013.01.023
   Chieffo A, 2005, CIRCULATION, V111, P791, DOI 10.1161/01.CIR.0000155256.88940.F8
   Chieffo A, 2007, CIRCULATION, V116, P158, DOI 10.1161/CIRCULATIONAHA.107.692178
   Chieffo A, 2017, JACC-CARDIOVASC INTE, V10, P2401, DOI 10.1016/j.jcin.2017.08.050
   Colombo A, 2009, CIRCULATION, V119, P71, DOI 10.1161/CIRCULATIONAHA.108.808402
   CONLEY MJ, 1978, CIRCULATION, V57, P947, DOI 10.1161/01.CIR.57.5.947
   Davies JE, 2017, NEW ENGL J MED, V376, P1824, DOI 10.1056/NEJMoa1700445
   Hernandez JMD, 2011, J AM COLL CARDIOL, V58, P351, DOI 10.1016/j.jacc.2011.02.064
   DETRE KM, 1984, NEW ENGL J MED, V311, P1333
   Farooq V, 2013, J AM COLL CARDIOL, V61, P282, DOI 10.1016/j.jacc.2012.10.017
   Fihn SD, 2014, CIRCULATION, V130, P1749, DOI 10.1161/CIR.0000000000000095
   Giacoppo D, 2017, JAMA CARDIOL, V2, P1079, DOI 10.1001/jamacardio.2017.2895
   Gotberg M, 2017, NEW ENGL J MED, V376, P1813, DOI 10.1056/NEJMoa1616540
   Hamilos M, 2009, CIRCULATION, V120, P1505, DOI 10.1161/CIRCULATIONAHA.109.850073
   Head SJ, 2018, LANCET, V391, P939, DOI 10.1016/S0140-6736(18)30423-9
   Hildick-Smith D, 2010, CIRCULATION, V121, P1235, DOI 10.1161/CIRCULATIONAHA.109.888297
   HWANG MH, 1990, J AM COLL CARDIOL, V16, P1066, DOI 10.1016/0735-1097(90)90533-U
   Kang SJ, 2011, CIRC-CARDIOVASC INTE, V4, P562, DOI 10.1161/CIRCINTERVENTIONS.111.964643
   Kang SJ, 2011, CIRC-CARDIOVASC INTE, V4, P355, DOI 10.1161/CIRCINTERVENTIONS.110.961045
   Kim WJ, 2011, CATHETER CARDIO INTE, V77, P775, DOI 10.1002/ccd.22915
   Kim YH, 2012, JACC-CARDIOVASC INTE, V5, P708, DOI 10.1016/j.jcin.2012.05.002
   Kolh P, 2014, EUR J CARDIO-THORAC, V46, P517, DOI [10.1093/eurheartj/ehu278, 10.1093/ejcts/ezu366]
   Kushner FG, 2009, J AM COLL CARDIOL, V54, P2205, DOI 10.1016/j.jacc.2009.10.015
   Lee PH, 2018, J AM COLL CARDIOL, V71, P832, DOI 10.1016/j.jacc.2017.12.032
   Lee PH, 2016, J AM COLL CARDIOL, V68, P1233, DOI 10.1016/j.jacc.2016.05.089
   Levine GN, 2011, CIRCULATION, V124, P2574, DOI 10.1161/CIR.0b013e31823a5596
   Mack M, 2016, LANCET, V388, P2715, DOI 10.1016/S0140-6736(16)32067-0
   Maeng M, 2013, J AM COLL CARDIOL, V62, P30, DOI 10.1016/j.jacc.2013.04.015
   Makikallio T, 2016, LANCET, V388, P2742
   Modi BN, 2017, EUROINTERVENTION, V13, P820, DOI 10.4244/EIJ-D-17-00135
   Morice MC, 2014, CIRCULATION, V129, P2388, DOI 10.1161/CIRCULATIONAHA.113.006689
   Morice MC, 2010, CIRCULATION, V121, P2645, DOI 10.1161/CIRCULATIONAHA.109.899211
   Moussa ID, 2013, J AM COLL CARDIOL, V62, P1563, DOI 10.1016/j.jacc.2013.08.720
   Naganuma T, 2013, JACC-CARDIOVASC INTE, V6, P1242, DOI 10.1016/j.jcin.2013.08.005
   Neumann FJ, 2019, EUR HEART J, V40, P87, DOI 10.1093/eurheartj/ehy394
   Palmerini T, 2017, AM HEART J, V190, P54, DOI 10.1016/j.ahj.2017.05.005
   Palmerini T, 2015, J AM COLL CARDIOL, V65, P2496, DOI 10.1016/j.jacc.2015.04.017
   Palmerini T, 2012, LANCET, V379, P1393, DOI 10.1016/S0140-6736(12)60324-9
   Park DW, 2018, J AM COLL CARDIOL, V72, P2813, DOI 10.1016/j.jacc.2018.09.012
   Park DW, 2017, CIRC-CARDIOVASC INTE, V10, DOI 10.1161/CIRCINTERVENTIONS.117.004792
   Park DW, 2011, J AM COLL CARDIOL, V57, P2152, DOI 10.1016/j.jacc.2011.01.033
   Park DW, 2010, J AM COLL CARDIOL, V56, P117, DOI 10.1016/j.jacc.2010.04.004
   Park SJ, 2014, JACC-CARDIOVASC INTE, V7, P868, DOI 10.1016/j.jcin.2014.02.015
   Park SJ, 2012, JACC-CARDIOVASC INTE, V5, P1029, DOI 10.1016/j.jcin.2012.07.007
   Park SJ, 2010, EUROINTERVENTION, V6, pJ112, DOI 10.4244/EIJV6SUPJA18
   Park SJ, 2011, NEW ENGL J MED, V364, P1718, DOI 10.1056/NEJMoa1100452
   Park SJ, 2009, CIRC-CARDIOVASC INTE, V2, P59, DOI 10.1161/CIRCINTERVENTIONS.108.831701
   Park SJ, 2001, J AM COLL CARDIOL, V38, P1054, DOI 10.1016/S0735-1097(01)01491-7
   Park SJ, 1998, J AM COLL CARDIOL, V31, P37, DOI 10.1016/S0735-1097(97)00425-7
   Park SJ, 2005, J AM COLL CARDIOL, V45, P351, DOI 10.1016/j.jacc.2004.10.039
   Puri R, 2012, JACC-CARDIOVASC INTE, V5, P697, DOI 10.1016/j.jcin.2012.02.018
   Serruys PW, 2009, NEW ENGL J MED, V360, P961, DOI 10.1056/NEJMoa0804626
   Seung KB, 2008, NEW ENGL J MED, V358, P1781, DOI 10.1056/NEJMoa0801441
   Silber S, 2005, EUR HEART J, V26, P804, DOI 10.1093/eurheartj/ehi138
   Smith Jr SC, 2006, J AM COLL CARDIOL, V47, P1, DOI DOI 10.1016/J.JACC.2005.12.001
   Stefanini GG, 2013, NEW ENGL J MED, V368, P254, DOI 10.1056/NEJMra1210816
   Stone GW, 2016, NEW ENGL J MED, V375, P2223, DOI 10.1056/NEJMoa1610227
   Takagi T, 2002, CIRCULATION, V106, P698, DOI 10.1161/01.CIR.0000024983.34728.5D
   TAKARO T, 1982, CIRCULATION, V66, P14, DOI 10.1161/01.CIR.66.1.14
   VARNAUSKAS E, 1988, NEW ENGL J MED, V319, P332, DOI 10.1056/NEJM198808113190603
   Wijns W, 2010, EUR HEART J, V31, P2501, DOI 10.1093/eurheartj/ehq277
   Xu B, 2016, JACC-CARDIOVASC INTE, V9, P2086, DOI 10.1016/j.jcin.2016.08.011
NR 71
TC 5
Z9 5
U1 2
U2 4
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAY
PY 2019
VL 49
IS 5
BP 369
EP 383
DI 10.4070/kcj.2019.0112
PG 15
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA HX7TC
UT WOS:000467607800001
PM 31074210
OA Other Gold, Green Published
DA 2021-04-22
ER

PT J
AU O'Brien, T
   Park, MS
   Youn, JC
   Chung, ES
AF O'Brien, Thomas
   Park, Myung-Soo
   Youn, Jong-Chan
   Chung, Eugene S.
TI The Past, Present and Future of Cardiac Resynchronization Therapy
SO KOREAN CIRCULATION JOURNAL
LA English
DT Review
DE Heart failure; Cardiac resynchronization therapy; Current status; Future
   innovations
ID CONGESTIVE-HEART-FAILURE; LEFT-VENTRICULAR DYSFUNCTION; BUNDLE-BRANCH
   BLOCK; DUAL-CHAMBER; ATRIAL-FIBRILLATION; QRS DURATION; IMPLANTABLE
   DEFIBRILLATOR; SYSTOLIC ASYNCHRONY; DISEASE PROGRESSION; AMBULATORY
   PATIENTS
AB Cardiac resynchronization therapy (CRT) has revolutionized the care of the patients with heart failure with reduced ejection fraction and electrical dyssynchrony. The current guidelines for patient selection include measurement of left ventricular systolic function, QRS duration and morphology, and functional classification. Despite consistent and increasing evidence supporting CRT use in appropriate patients, CRT has been underutilized. Notwithstanding the heterogeneous definitions of non-response, more than one-third of patients demonstrate a lack of echocardiographic reverse remodeling or poor clinical outcome following CRT. Since the causes of this non-response are multifactorial, it will require multidisciplinary efforts to overcome including optimal patient selection, procedural strategies, as well as optimizing post-implant care in patients undergoing CRT. The innovations of novel pacing approaches combined with advanced imaging technologies may eventually offer a personalized CRT system uniquely tailored to each patient's dyssynchrony signature.
C1 [O'Brien, Thomas; Chung, Eugene S.] Christ Hosp, Heart & Vasc Ctr, 2123 Auburn Ave,Ste 424, Cincinnati, OH 45219 USA.
   [O'Brien, Thomas; Chung, Eugene S.] Lindner Ctr Res & Educ, Cincinnati, OH USA.
   [Park, Myung-Soo; Youn, Jong-Chan] Hallym Univ, Coll Med, Dongtan Sacred Heart Hosp, Div Cardiol, 7 Keunjaebong Gil, Hwaseong 18450, South Korea.
RP Chung, ES (corresponding author), Christ Hosp, Heart & Vasc Ctr, 2123 Auburn Ave,Ste 424, Cincinnati, OH 45219 USA.; Youn, JC (corresponding author), Hallym Univ, Coll Med, Dongtan Sacred Heart Hosp, Div Cardiol, 7 Keunjaebong Gil, Hwaseong 18450, South Korea.
EM jong.chan.youn@gmail.com; eugene.chung@thechristhospital.com
RI Youn, Jong-Chan/AAS-1405-2020
OI Youn, Jong-Chan/0000-0003-0998-503X
FU Basic Science Research Program through the National Research Foundation
   of Korea (NRF) - Ministry of Science, ICT & Future Planning
   [NRF-2018R1C1B6005448]; Hallym University Research Fund [HURF-2017-73,
   HURF-2018-31]
FX This study was supported by Basic Science Research Program through the
   National Research Foundation of Korea (NRF) funded by the Ministry of
   Science, ICT & Future Planning (NRF-2018R1C1B6005448) and by Hallym
   University Research Fund (HURF-2017-73, HURF-2018-31).
CR Aaronaes M, 2010, SCAND CARDIOVASC J, V44, P337, DOI 10.3109/14017431.2010.508537
   Aaronson KD, 1997, CIRCULATION, V95, P2660, DOI 10.1161/01.CIR.95.12.2660
   Abraham WT, 2004, CIRCULATION, V110, P2864, DOI 10.1161/01.CIR.0000146336.92331.D1
   Abraham WT, 2002, NEW ENGL J MED, V346, P1845, DOI 10.1056/NEJMoa013168
   Achilli A, 2006, PACE, V29, pS11, DOI 10.1111/j.1540-8159.2006.00486.x
   Ajijola OA, 2017, HEART RHYTHM, V14, P1353, DOI 10.1016/j.hrthm.2017.04.003
   Aksoy H, 2010, EUROPACE, V12, P1256, DOI 10.1093/europace/euq150
   Allen LA, 2012, CIRCULATION, V125, P1928, DOI 10.1161/CIR.0b013e31824f2173
   Altman RK, 2012, EUR HEART J, V33, P2181, DOI 10.1093/eurheartj/ehs107
   Anand IS, 2009, CIRCULATION, V119, P969, DOI 10.1161/CIRCULATIONAHA.108.793273
   AURICCHIO A, 1993, PACE, V16, P2034, DOI 10.1111/j.1540-8159.1993.tb00997.x
   Auricchio A, 2014, EUROPACE, V16, P681, DOI 10.1093/europace/eut435
   Baldasseroni S, 2002, AM HEART J, V143, P398, DOI 10.1067/mhj.2002.121264
   Bank AJ, 2014, J CARD FAIL, V20, P696, DOI 10.1016/j.cardfail.2014.06.005
   Bank AJ, 2009, J CARD FAIL, V15, P401, DOI 10.1016/j.cardfail.2008.12.009
   Bax JJ, 2004, J AM COLL CARDIOL, V44, P1834, DOI 10.1016/j.jacc.2004.08.016
   Bordachar P, 2010, J CARD FAIL, V16, P709, DOI 10.1016/j.cardfail.2010.04.010
   Boriani G, 2017, HEART FAIL CLIN, V13, P117, DOI 10.1016/j.hfc.2016.07.010
   Boriani G, 2010, AM HEART J, V159, P1052, DOI 10.1016/j.ahj.2010.03.008
   Brignole M, 2013, EUR HEART J, V34, P2281, DOI 10.1093/eurheartj/eht150
   Bristow MR, 2004, NEW ENGL J MED, V350, P2140, DOI 10.1056/NEJMoa032423
   Cazeau S, 2001, NEW ENGL J MED, V344, P873, DOI 10.1056/NEJM200103223441202
   Cazeau S, 1996, PACE, V19, P1748, DOI 10.1111/j.1540-8159.1996.tb03218.x
   Chatterjee Neal A, 2018, Curr Treat Options Cardiovasc Med, V20, P20, DOI 10.1007/s11936-018-0614-2
   Chatterjee NA, 2015, HEART FAIL CLIN, V11, P287, DOI 10.1016/j.hfc.2014.12.007
   Choi HM, 2019, KOREAN J INTERN MED, V34, P11, DOI 10.3904/kjim.2018.428
   Chung ES, 2008, CIRCULATION, V117, P2608, DOI 10.1161/CIRCULATIONAHA.107.743120
   Cleland JGF, 2005, NEW ENGL J MED, V352, P1539, DOI 10.1056/NEJMoa050496
   Curtis AB, 2013, NEW ENGL J MED, V368, P1585, DOI 10.1056/NEJMoa1210356
   Daubert C, 2017, EUR HEART J, V38, P1463, DOI 10.1093/eurheartj/ehw270
   Daubert JC, 2012, HEART RHYTHM, V9, P1524, DOI 10.1016/j.hrthm.2012.07.025
   Davis DR, 2005, CAN J CARDIOL, V21, P413
   Derval N, 2010, J AM COLL CARDIOL, V55, P566, DOI 10.1016/j.jacc.2009.08.045
   Di Biase L, 2016, CIRCULATION, V133, P1637, DOI 10.1161/CIRCULATIONAHA.115.019406
   Diaz-Infante E, 2005, AM J CARDIOL, V95, P1436, DOI 10.1016/j.amjcard.2005.02.009
   Ellenbogen KA, 2010, CIRCULATION, V122, P2660, DOI 10.1161/CIRCULATIONAHA.110.992552
   Epstein AE, 2013, J AM COLL CARDIOL, V61, pE6, DOI 10.1016/j.jacc.2012.11.007
   FOSTER AH, 1995, ANN THORAC SURG, V59, P294, DOI 10.1016/0003-4975(94)00878-B
   GOLD MR, 1995, J AM COLL CARDIOL, V26, P967, DOI 10.1016/0735-1097(95)00292-0
   Gorcsan J, 2007, J AM COLL CARDIOL, V50, P1476, DOI 10.1016/j.jacc.2007.06.043
   Higgins SL, 2003, J AM COLL CARDIOL, V42, P1454, DOI 10.1016/S0735-1097(03)01042-8
   HOCHLEITNER M, 1990, AM J CARDIOL, V66, P198, DOI 10.1016/0002-9149(90)90588-R
   HOCHLEITNER M, 1992, AM J CARDIOL, V70, P1320, DOI 10.1016/0002-9149(92)90769-U
   Hsu LF, 2004, NEW ENGL J MED, V351, P2373, DOI 10.1056/NEJMoa041018
   Kang SH, 2015, J KOREAN MED SCI, V30, P24, DOI 10.3346/jkms.2015.30.1.24
   Kaufman Christopher L, 2010, Clin Cardiol, V33, pE31, DOI 10.1002/clc.20529
   Khan FZ, 2012, J AM COLL CARDIOL, V59, P1509, DOI 10.1016/j.jacc.2011.12.030
   Khan MN, 2008, NEW ENGL J MED, V359, P1778, DOI 10.1056/NEJMoa0708234
   Kim MS, 2017, KOREAN CIRC J, V47, P555, DOI 10.4070/kcj.2017.0009
   Leclercq C, 1998, J AM COLL CARDIOL, V32, P1825, DOI 10.1016/S0735-1097(98)00492-6
   Leclercq C, 2019, EUR HEART J
   Leclercq C, 2019, AM HEART J, V209, P1, DOI 10.1016/j.ahj.2018.12.004
   Lecoq G, 2005, EUR HEART J, V26, P1094, DOI 10.1093/eurheartj/ehi146
   Lee JH, 2019, KOREAN CIRC J, V49, P1, DOI 10.4070/kcj.2018.0373
   Lee SH, 2014, J KOREAN MED SCI, V29, P1651, DOI 10.3346/jkms.2014.29.12.1651
   Leyva F, 2014, J AM COLL CARDIOL, V64, P1047, DOI 10.1016/j.jacc.2014.06.1178
   Leyva F, 2011, J CARDIOVASC MAGN R, V13, DOI 10.1186/1532-429X-13-29
   Linde C, 2002, J AM COLL CARDIOL, V40, P111, DOI 10.1016/S0735-1097(02)01932-0
   Linde C, 2009, J AM COLL CARDIOL, V53, pA183, DOI 10.1016/j.jacc.2009.08.011
   Linde C, 2008, J AM COLL CARDIOL, V52, P1834, DOI 10.1016/j.jacc.2008.08.027
   Linde CM, 2018, EUR J HEART FAIL, V20, P1457, DOI 10.1002/ejhf.1235
   Lund LH, 2014, EUR J HEART FAIL, V16, P1073, DOI 10.1002/ejhf.162
   Lustgarten Daniel L, 2018, Card Electrophysiol Clin, V10, P491, DOI 10.1016/j.ccep.2018.05.012
   Lustgarten DL, 2010, HEART RHYTHM, V7, P15, DOI 10.1016/j.hrthm.2009.09.066
   Maggioni AP, 2013, EUR J HEART FAIL, V15, P1173, DOI 10.1093/eurjhf/hft134
   Mar Philip L, 2019, Curr Heart Fail Rep, V16, P47, DOI 10.1007/s11897-019-0423-2
   Marrouche NF, 2018, NEW ENGL J MED, V378, P417, DOI 10.1056/NEJMoa1707855
   Molhoek SG, 2004, AM J CARDIOL, V94, P1506, DOI 10.1016/j.amjcard.2004.08.028
   Molhoek SG, 2004, PACE, V27, P308, DOI 10.1111/j.1540-8159.2004.00433.x
   Molhoek SG, 2004, AM J CARDIOL, V93, P860, DOI 10.1016/j.amjcard.2003.12.024
   Morgan JM, 2016, EUR HEART J, V37, P2118, DOI 10.1093/eurheartj/ehv723
   Moss AJ, 2009, NEW ENGL J MED, V361, P1329, DOI 10.1056/NEJMoa0906431
   Muto C, 2010, HEART RHYTHM, V7, P1600, DOI 10.1016/j.hrthm.2010.07.036
   Normand C, 2018, JACC-HEART FAIL, V6, P309, DOI 10.1016/j.jchf.2018.01.022
   Obeng-Gyimah Edmond, 2019, Card Electrophysiol Clin, V11, P49, DOI 10.1016/j.ccep.2018.11.007
   Pappone C, 2015, HEART RHYTHM, V12, P1250, DOI 10.1016/j.hrthm.2015.02.008
   Pitzalis MV, 2005, J AM COLL CARDIOL, V45, P65, DOI 10.1016/j.jacc.2004.09.058
   Ponikowski P, 2016, EUR HEART J, V37, P2129, DOI 10.1093/eurheartj/ehw128
   Randolph TC, 2017, AM HEART J, V189, P48, DOI 10.1016/j.ahj.2017.04.001
   Reddy VY, 2017, J AM COLL CARDIOL, V69, P2119, DOI 10.1016/j.jacc.2017.02.059
   Reuter S, 2002, AM J CARDIOL, V89, P346, DOI 10.1016/S0002-9149(01)02240-8
   Rocchi G, 2009, EUR HEART J, V30, P89, DOI 10.1093/eurheartj/ehn483
   Ruschitzka F, 2013, NEW ENGL J MED, V369, P1395, DOI 10.1056/NEJMoa1306687
   Seo Y, 2011, CIRC J, V75, P1156, DOI 10.1253/circj.CJ-10-0861
   Shetty AK, 2014, EUROPACE, V16, P873, DOI 10.1093/europace/eut420
   Singh JP, 2018, ESC HEART FAIL, V5, P1184, DOI 10.1002/ehf2.12340
   Sommer A, 2016, EUR J HEART FAIL, V18, P1365, DOI 10.1002/ejhf.530
   Stavrakis S, 2012, J CARDIOVASC ELECTR, V23, P163, DOI 10.1111/j.1540-8167.2011.02144.x
   Stellbrink C, 2001, J AM COLL CARDIOL, V38, P1957, DOI 10.1016/S0735-1097(01)01637-0
   Stellbrink C, 2002, J AM COLL CARDIOL, V40, P2031, DOI 10.1016/S0735-1097(02)02568-8
   Suffoletto MS, 2006, CIRCULATION, V113, P960, DOI 10.1161/CIRCULATIONAHA.105.571455
   Tanaka H, 2010, EUR HEART J, V31, P1690, DOI 10.1093/eurheartj/ehq213
   Tang ASL, 2010, NEW ENGL J MED, V363, P2385, DOI 10.1056/NEJMoa1009540
   Tolosana Jose Maria, 2019, Card Electrophysiol Clin, V11, P89, DOI 10.1016/j.ccep.2018.11.010
   Uhm JS, 2019, YONSEI MED J, V60, P48, DOI 10.3349/ymj.2019.60.1.48
   Vidal B, 2010, EUR J HEART FAIL, V12, P283, DOI 10.1093/eurjhf/hfq003
   Vijayaraman P, 2017, J AM COLL CARDIOL, V69, P3099, DOI 10.1016/j.jacc.2017.05.005
   Wilkoff BL, 2002, JAMA-J AM MED ASSOC, V288, P3115
   Yancy CW, 2013, J AM COLL CARDIOL, V62, pE147, DOI 10.1016/j.jacc.2013.05.019
   Youn JC, 2017, KOREAN CIRC J, V47, P16, DOI 10.4070/kcj.2016.0429
   Ypenburg C, 2007, EUR HEART J, V28, P33, DOI 10.1093/eurheartj/ehl379
   Yu CM, 2006, HEART, V92, P1452, DOI 10.1136/hrt.2005.083592
   Yu CM, 2006, J AM COLL CARDIOL, V48, P2251, DOI 10.1016/j.jacc.2006.07.054
   Yu CM, 2005, J AM COLL CARDIOL, V45, P677, DOI 10.1016/j.jacc.2004.12.003
   Yu CM, 2004, J CARDIOVASC ELECTR, V15, P1058, DOI 10.1046/j.1540-8167.2004.03648.x
   Yu CM, 2004, CIRCULATION, V110, P66, DOI 10.1161/01.CIR.0000133276.45198.A5
   Zanon F, 2015, HEART RHYTHM, V12, P975, DOI 10.1016/j.hrthm.2015.01.034
   2008, J AM COLL CARDIOL, V52, P438, DOI DOI 10.1016/J.JACC.2008.04.036
   1999, CIRCULATION, V99, P2993
NR 109
TC 3
Z9 3
U1 0
U2 2
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAY
PY 2019
VL 49
IS 5
BP 384
EP 399
DI 10.4070/kcj.2019.0114
PG 16
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA HX7TC
UT WOS:000467607800002
PM 31074211
OA Green Published, Other Gold
DA 2021-04-22
ER

PT J
AU Ullah, W
   Mukhtar, M
   Abdullah, HM
   Rashid, MU
   Ahmad, A
   Hurairah, A
   Sarwar, U
   Figueredo, VM
AF Ullah, Waqas
   Mukhtar, Maryam
   Abdullah, Hafez Mohammad
   Rashid, Mamoon Ur
   Ahmad, Asrar
   Hurairah, Abu
   Sarwar, Usman
   Figueredo, Vincent M.
TI Diagnosis and Management of Isolated Superior Mesenteric Artery
   Dissection: A Systematic Review and Meta-Analysis
SO KOREAN CIRCULATION JOURNAL
LA English
DT Review
DE Arterial dissection; Spontaneous dissection; CT angiography;
   Arteriography Endovascular repair
ID PERCUTANEOUS STENT PLACEMENT; ENDOVASCULAR TREATMENT; MAIN TRUNK; RARE
   CAUSE; NONOPERATIVE MANAGEMENT; ANEURYSM; PSEUDOANEURYSM; ANGIOGRAPHY;
   HEMORRHAGE; RUPTURE
AB The objective of this study was to analyze the three different management modalities for isolated superior mesenteric artery (SMA) dissection. We did a comprehensive literature search and found 703 articles on the initial search, out of which 111 articles consisting of 145 patients were selected for analysis. The mean age was 55.7 years (standard deviation, 9.7; 33-85) and 80.6% were male. These patients were managed conservatively (41.3%), endovascularly (28.1%) or surgically (30%). The median follow-up was 10 months (interquartile range [IQR], 4-18 months), 12 months (IQR, 6-19 months) and 14 months (IQR, 6-20 months) respectively. Contrast-enhanced computed tomography (CT) was the most commonly used diagnostic tool in the conservative group (43.8%), while conventional CT scan was the most widely used in endovascular (58.1%) and surgical group (50%). 17% percent of the conservative group had SMA angiography for diagnosis, while this was less than 3% in the other groups. Of these patients, 96.7%, 97.4%, and 100.0% recovered successfully in the conservative, endovascular, and surgical groups respectively. There was no significant difference in the mortality between the three groups (Pearson chi(2)=0.482). This suggests a conservative and endovascular approach could be used in most patients, which can reduce costs and surgery-related morbidity and mortality. Surgical management should be reserved for cases having infarction or widespread bowel ischemia and in cases where other treatment modalities fail.
C1 [Ullah, Waqas; Ahmad, Asrar; Sarwar, Usman] Abington Hosp Jefferson Hlth, Dept Internal Med, 1200 Old York Rd, Abington, PA 19001 USA.
   [Mukhtar, Maryam] Fauji Fdn Hosp, Dept Internal Med, Rawalpindi, Pakistan.
   [Abdullah, Hafez Mohammad] Univ South Dakota, Dept Internal Med, Sanford Sch Med, Vermillion, SD USA.
   [Rashid, Mamoon Ur] Florida Hosp Orlando, Dept Internal Med, Orlando, FL USA.
   [Hurairah, Abu] Advent Hlth Orlando, Dept Gastroenterol, Orlando, FL USA.
   [Figueredo, Vincent M.] St Mary Hosp, Div Cardiol, Langhorne, PA USA.
RP Ullah, W (corresponding author), Abington Hosp Jefferson Hlth, Dept Internal Med, 1200 Old York Rd, Abington, PA 19001 USA.
EM waqasullah.dr@gmail.com
RI Rashid, Mamoon Ur/AAD-4059-2019; Ullah, Waqas/AAQ-5927-2020
OI Ullah, Waqas/0000-0002-4850-0309; Ahmad, Asrar/0000-0002-6727-2591;
   Rashid, Mamoon Ur/0000-0002-3843-4352; Mukhtar,
   Maryam/0000-0003-4870-3269
CR Akpinar S, 2016, SAUDI MED J, V37, P1033, DOI 10.15537/smj.2016.9.15050
   Akuzawa N, 2015, J EMERG MED, V48, pE111, DOI 10.1016/j.jemermed.2014.12.017
   Allen RC, 1996, J VASC SURG, V24, P415, DOI 10.1016/S0741-5214(96)70197-0
   AMBO T, 1994, SURG TODAY, V24, P933, DOI 10.1007/BF01651014
   ANDO M, 1995, SURG TODAY, V25, P468, DOI 10.1007/BF00311831
   Armstrong PJ, 2006, VASCULAR, V14, P109, DOI 10.2310/6670.2006.00015
   Bair MJ, 2010, INTERNAL MED, V49, P195, DOI 10.2169/internalmedicine.49.2790
   Baldi S, 2009, ANN VASC SURG, V23, DOI 10.1016/j.avsg.2008.12.004
   Barmeir E, 1998, AM J ROENTGENOL, V171, P1429, DOI 10.2214/ajr.171.5.9798897
   BASHOUR TT, 1985, J CLIN ULTRASOUND, V13, P210, DOI 10.1002/jcu.1870130313
   BAUERSFELD SR, 1947, ANN INTERN MED, V26, P873, DOI 10.7326/0003-4819-26-6-873
   Brandt LJ, 2000, GASTROENTEROLOGY, V118, P954, DOI 10.1016/S0016-5085(00)70183-1
   Bruns F, 2009, DEUT MED WOCHENSCHR, V134, P1808, DOI 10.1055/s-0029-1237515
   Carter R, 2011, VASC ENDOVASC SURG, V45, P295, DOI 10.1177/1538574410389341
   Casella IB, 2008, J VASC SURG, V47, P197, DOI 10.1016/j.jvs.2007.07.051
   Chaillou P, 1997, ANN VASC SURG, V11, P413, DOI 10.1007/s100169900070
   Chang CF, 2014, VASC ENDOVASC SURG, V48, P83, DOI 10.1177/1538574413510617
   Chang SH, 2006, AM J EMERG MED, V24, P385, DOI 10.1016/j.ajem.2005.11.003
   Common AA, 1999, CAN ASSOC RADIOL J, V50, P23
   CORBETTI F, 1989, J COMPUT ASSIST TOMO, V13, P965, DOI 10.1097/00004728-198911000-00006
   CORMIER F, 1992, J VASC SURG, V15, P424, DOI 10.1016/0741-5214(92)90265-A
   Corral MA, 2014, RADIOLOGIA-MADRID, V56, P175, DOI 10.1016/j.rx.2010.12.017
   Daghfous A, 2015, REV MED INTERNE, V36, P131, DOI 10.1016/j.revmed.2013.11.015
   Davis CB, 2013, J EMERG MED, V45, P894, DOI 10.1016/j.jemermed.2013.04.025
   de l'Escalopier N, 2015, J EMERG MED, V49, pE155, DOI 10.1016/j.jemermed.2015.05.010
   Desgranges P, 2000, J ENDOVASC THER, V7, P501, DOI 10.1583/1545-1550(2000)007<0501:PSOAIS>2.0.CO;2
   Dushnitsky T, 1998, J ULTRAS MED, V17, P781
   Dzieciuchowicz L, 2015, INTERACT CARDIOV TH, V21, P539, DOI 10.1093/icvts/ivv157
   FOORD AG, 1959, ARCH PATHOL, V68, P553
   Froment P, 2004, CARDIOVASC INTER RAD, V27, P529, DOI 10.1007/s00270-003-0158-y
   Funahashi H, 2016, INT J SURG CASE REP, V26, P17, DOI 10.1016/j.ijscr.2016.07.003
   Furukawa H, 2002, J COMPUT ASSIST TOMO, V26, P143, DOI 10.1097/00004728-200201000-00025
   Gao DN, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000008598
   Ghuysen A., 2008, Annales de Cardiologie et d'Angeiologie, V57, P238, DOI 10.1016/j.ancard.2008.01.002
   Gobble RM, 2009, J VASC SURG, V50, P1326, DOI 10.1016/j.jvs.2009.07.019
   Goueffic Y, 2002, J VASC SURG, V35, P1003, DOI 10.1067/mva.2002.122152
   GRAINGER K, 1961, BRIT J RADIOL, V34, P265, DOI 10.1259/0007-1285-34-400-265
   Ham EM, 2014, VASC ENDOVASC SURG, V48, P352, DOI 10.1177/1538574413518615
   Hirai Shinji, 2002, Ann Thorac Cardiovasc Surg, V8, P236
   Hoek J, 2016, NED TIJDSCHR GENEES, V160, pA9767
   Hwang CK, 2010, ANN VASC SURG, V24, DOI 10.1016/j.avsg.2009.09.013
   Iha K, 2000, Ann Thorac Cardiovasc Surg, V6, P65
   Iwase K, 2007, HEPATO-GASTROENTEROL, V54, P1161
   Jang ES, 2009, CARDIOVASC INTER RAD, V32, P367, DOI 10.1007/s00270-008-9442-1
   Javerliat I, 2003, EUR J VASC ENDOVASC, V25, P180, DOI 10.1053/ejvs.2002.1785
   Jia ZZ, 2015, ANN VASC SURG, V29, P160, DOI 10.1016/j.avsg.2014.09.007
   Kang Tarina Lee, 2011, J Emerg Med, V40, pe21, DOI 10.1016/j.jemermed.2007.12.038
   Kim JH, 2004, KOREAN J RADIOL, V5, P134, DOI 10.3348/kjr.2004.5.2.134
   Kochi K, 2005, ANN VASC SURG, V19, P418, DOI 10.1007/s10016-005-0018-0
   Kokai H, 2012, TRANSPL P, V44, P588, DOI 10.1016/j.transproceed.2012.01.020
   Koto K, 1989, JPN J CARDIOVASC SUR, V19, P25
   Kugai T, 2002, JPN J VASC SURG, V11, P495
   Kutlu R, 2007, CARDIOVASC INTER RAD, V30, P121, DOI 10.1007/s00270-005-0392-6
   Kwak Jae Wuk, 2010, Korean J Gastroenterol, V55, P58
   Lee B M, 1971, IMJ Ill Med J, V139, P589
   Lee TC, 2006, RHEUMATOL INT, V26, P1061, DOI 10.1007/s00296-006-0137-0
   Lee Wook Hyun, 2013, Korean J Gastroenterol, V62, P310
   Leonard M, 2017, Rev Med Liege, V72, P175
   Leung DA, 2000, EUR RADIOL, V10, P1916, DOI 10.1007/s003300000520
   Lim EH, 2011, J VASC INTERV RADIOL, V22, P1206, DOI 10.1016/j.jvir.2011.01.446
   Matsuo R, 2000, ANGIOLOGY, V51, P603, DOI 10.1177/000331970005100710
   Matsushima K, 2006, J AM COLL SURGEONS, V203, P970, DOI 10.1016/j.jamcollsurg.2006.03.018
   Mei ZJ, 2011, ABDOM IMAGING, V36, P578, DOI 10.1007/s00261-010-9659-8
   Mitsuoka H, 2016, ANN VASC SURG, V35, DOI 10.1016/j.avsg.2016.01.029
   Miyamoto Noriyuki, 2005, Radiat Med, V23, P520
   Moreno-Machuca Francisco Javier, 2014, Rev. esp. enferm. dig., V106, P151
   Morris JT, 2008, J VASC SURG, V47, P649, DOI 10.1016/j.jvs.2007.08.052
   Mousa AY, 2009, VASCULAR, V17, P359, DOI 10.2310/6670.2009.00053
   Nagai T, 2004, INTERNAL MED, V43, P473, DOI 10.2169/internalmedicine.43.473
   Nakai M, 2012, J VASC INTERV RADIOL, V23, P1381, DOI 10.1016/j.jvir.2012.06.034
   Nakamura K, 1997, SURG TODAY, V27, P272, DOI 10.1007/BF00941661
   Namikawa T, 2011, J GASTROEN HEPATOL, V26, P1811, DOI 10.1111/j.1440-1746.2011.06936.x
   Nath Anand, 2016, Case Rep Gastroenterol, V10, P775, DOI 10.1159/000448879
   Nishi M, 2017, INTERNAL MED, V56, P1363, DOI 10.2169/internalmedicine.56.8043
   Nomura Y, 2011, J VASC SURG, V54, P1808, DOI 10.1016/j.jvs.2011.05.006
   Nozu Tsukasa, 2004, Gastroenterology, V127, P1282, DOI 10.1053/j.gastro.2004.01.069
   Ogul H, 2014, JOINT BONE SPINE, V81, P450, DOI 10.1016/j.jbspin.2013.12.012
   Patel Tejas, 2010, J Invasive Cardiol, V22, pE61
   Picquet J, 2005, J VASC SURG, V42, P788, DOI 10.1016/j.jvs.2005.05.048
   RALSTON LS, 1960, ARCH INTERN MED, V105, P935, DOI 10.1001/archinte.1960.00270180113015
   RAMCHAND S, 1969, CAN MED ASSOC J, V101, P356
   Rignault D, 1976, ANGIEIOLOGIE, V28, P29
   Saba L, 2010, EUR REV MED PHARMACO, V14, P235
   Saguchi T, 2013, VASC ENDOVASC SURG, V47, P314, DOI 10.1177/1538574413485647
   Sakamoto I, 2007, EUR J RADIOL, V64, P103, DOI 10.1016/j.ejrad.2007.05.027
   Sartelet H, 2003, INTENS CARE MED, V29, P505, DOI 10.1007/s00134-003-1634-1
   Sheldon PJ, 2001, CARDIOVASC INTER RAD, V24, P329, DOI 10.1007/s00270-001-2565-0
   Shimizu T, 2012, BMJ CASE REP, V2012
   Sirignano P, 2015, ACTA CHIR BELG, V115, P319
   SISTERON A, 1975, CHIRURG ARTERIOPATHI, P197
   Solis M M, 1993, Ann Vasc Surg, V7, P457, DOI 10.1007/BF02002130
   Sparks SR, 2000, ANN VASC SURG, V14, P105, DOI 10.1007/s100169910019
   Spence Sean, 2016, J Med Case Rep, V10, P153, DOI 10.1186/s13256-016-0937-0
   STANLEY JC, 1986, J VASC SURG, V3, P836, DOI 10.1067/mva.1986.avs0030836
   Subhas G, 2009, ANN VASC SURG, V23, P788, DOI 10.1016/j.avsg.2008.12.006
   Suzuki S, 2004, ABDOM IMAGING, V29, P153, DOI 10.1007/s00261-003-0110-2
   Takayama H, 2002, INTERNAL MED, V41, P713, DOI 10.2169/internalmedicine.41.713
   Takayama T, 2008, J VASC SURG, V48, P329, DOI 10.1016/j.jvs.2008.03.002
   TAKEHARA Y, 1988, J COMPUT ASSIST TOMO, V12, P678, DOI 10.1097/00004728-198807000-00036
   Tameo MN, 2011, J VASC SURG, V53, P1107, DOI 10.1016/j.jvs.2010.11.034
   Totsugawa T, 2009, ACTA MED OKAYAMA, V63, P157
   Tsai JL, 2008, J EMERG MED, V35, P81, DOI 10.1016/j.jemermed.2007.07.073
   Tsuji Yoshihiko, 2004, Vasc Endovascular Surg, V38, P469, DOI 10.1177/153857440403800513
   van Uden DJP, 2011, VASC MED, V16, P79, DOI 10.1177/1358863X10392475
   VIGNATI PV, 1992, J VASC SURG, V16, P109, DOI 10.1016/0741-5214(92)90426-9
   Wadhwani R, 2001, J CLIN ULTRASOUND, V29, P247, DOI 10.1002/jcu.1028
   Wall ML, 2014, ANN VASC SURG, V28
   Watring NJ, 2010, J EMERG MED, V39, P576, DOI 10.1016/j.jemermed.2007.05.054
   WATSON AJ, 1956, J PATHOL BACTERIOL, V72, P439, DOI 10.1002/path.1700720209
   Wu XM, 2009, CATHETER CARDIO INTE, V73, P145, DOI 10.1002/ccd.21806
   Yamashiro Satoshi, 2002, Ann Thorac Cardiovasc Surg, V8, P231
   Yang HJ, 2011, YONSEI MED J, V52, P859, DOI 10.3349/ymj.2011.52.5.859
   Yasuhara H, 1998, J VASC SURG, V27, P776, DOI 10.1016/S0741-5214(98)70250-2
   Yoo BR, 2012, J CLIN ULTRASOUND, V40, P255, DOI 10.1002/jcu.21906
   Yoon YW, 2003, CARDIOVASC INTER RAD, V26, P475
   Zimmermam-Lima PM, 2000, ANN VASC SURG, V14, P410, DOI 10.1007/s100169910074
   Zink JN, 2015, J VASC SURG, V61, P1605, DOI 10.1016/j.jvs.2014.04.009
   Zinsser D, 2014, ROFO-FORTSCHR RONTG, V186, P1035, DOI 10.1055/s-0034-1366225
   1985, J VASC SURG, V2, P731
NR 119
TC 6
Z9 7
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAY
PY 2019
VL 49
IS 5
BP 400
EP 418
DI 10.4070/kcj.2018.0429
PG 19
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA HX7TC
UT WOS:000467607800003
PM 31074212
OA Other Gold, Green Published
DA 2021-04-22
ER

PT J
AU Lee, W
   Yoon, YE
   Kwon, O
   Lee, H
   Park, HE
   Chun, EJ
   Choi, SY
   Cho, GY
   Chang, HJ
AF Lee, Wonjae
   Yoon, Yeonyee E.
   Kwon, Ohkyung
   Lee, Heesun
   Park, Hyo Eun
   Chun, Eun Ju
   Choi, Su-Yeon
   Cho, Goo-Yeong
   Chang, Hyuk-Jae
TI Evaluation of Coronary Artery Calcium Progression in Asymptomatic
   Individuals with an Initial Score of Zero
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Coronary arteries; Calcium; Risk assessment
ID HEINZ NIXDORF RECALL; WARRANTY PERIOD; HEART-DISEASE; RISK-FACTORS;
   CALCIFICATION; OUTCOMES; EVENTS; MESA
AB Background and Objectives: Coronary artery calcium (CAC) scoring in the asymptomatic population can improve cardiovascular risk prediction. We aimed to assess CAC progression and the impact of coronary risk factors on the CAC progression rate in asymptomatic Korean individuals with a baseline CAC score of zero.
   Methods: The study population was derived from the Korea Initiatives on Coronary Artery Calcification (KOICA) registry: a retrospective, single ethnicity, multicenter registry of asymptomatic individuals who underwent CAC scoring as a part of a health checkup. Individuals with at least two CAC scores and an initial score of zero were included. CAC progression was defined as [root CAC score (follow-up) - root CAC score (baseline)] >= 2.5. The 10-year atherosclerotic cardiovascular disease (ASCVD) risk was calculated.
   Results: Among 6,268 participants (mean age, 48.0 +/- 7.1 years; male, 80.5%), 719 (11.5%) experienced CAC progression during follow-up (median, 109 months; interquartile range, 78-208 months). The CAC progression rate was 0.3%, 1.9%, 4.3%, 8.6%, and 16.7% in years 1-5, respectively. The chance of CAC progression at 5 years was 13.1%, 22.0%, and 27.9% for individuals with a 10-year ASCVD risk of <5%, >= 5% but <7.5%, and >= 7.5%, respectively. A multivariable analysis revealed age, male sex, waist circumference, diabetes, and low-density lipoprotein cholesterol level as independently associated with annualized CAC progression (p<0.001, p=0.017, p=0.025, p=0.032, and p=0.003, respectively).
   Conclusions: The probability of CAC progression is very low in Korean individuals with a CAC score of zero. However, the risk of CAC progression increases nonlinearly over time, and increases as the 10-year ASCVD risk increases.
C1 [Lee, Wonjae; Yoon, Yeonyee E.; Kwon, Ohkyung; Lee, Heesun; Park, Hyo Eun; Chun, Eun Ju; Choi, Su-Yeon; Cho, Goo-Yeong] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul, South Korea.
   [Lee, Wonjae; Yoon, Yeonyee E.; Kwon, Ohkyung; Cho, Goo-Yeong] Seoul Natl Univ, Bundang Hosp, Dept Cardiol, Ctr Cardiovasc, Seongnam, South Korea.
   [Lee, Heesun; Park, Hyo Eun; Choi, Su-Yeon] Seoul Natl Univ Hosp, Healthcare Syst Gangnam Ctr, Seoul, South Korea.
   [Chun, Eun Ju] Seoul Natl Univ, Bundang Hosp, Div Radiol, Seongnam, South Korea.
   [Chang, Hyuk-Jae] Yonsei Univ Hlth Syst, Div Cardiol, Yonsei Cardiovasc Ctr, Seoul, South Korea.
   [Chang, Hyuk-Jae] Yonsei Univ, Div Cardiol, Yonsei Univ Hlth Syst, Severance Cardiovasc Hosp,Coll Med, Seoul, South Korea.
RP Yoon, YE (corresponding author), Seoul Natl Univ, Coll Med, Dept Internal Med, Div Cardiol, 82,Gumi Ro 173 Beon Gil, Seongnam 13620, South Korea.; Yoon, YE (corresponding author), Seoul Natl Univ, Bundang Hosp, Ctr Cardiovasc, 82,Gumi Ro 173 Beon Gil, Seongnam 13620, South Korea.
EM yeonyeeyoon@gmail.com
RI Choi, Su-Yeon/C-4312-2013
OI Choi, Su-Yeon/0000-0001-9977-4740; Kwon, Ohkyung/0000-0002-6749-5963;
   Cho, Goo-Yeong/0000-0002-7067-5535; Yoon, Yeonyee/0000-0002-8479-9889;
   Chang, Hyuk-Jae/0000-0002-6139-7545; Park, Hyo Eun/0000-0001-7233-1771
FU CardioVascular Research Foundation (CVRF) in the Republic of Korea
FX This study was performed with the support of the CardioVascular Research
   Foundation (CVRF) in the Republic of Korea.
CR AGATSTON AS, 1990, J AM COLL CARDIOL, V15, P827, DOI 10.1016/0735-1097(90)90282-T
   Blaha M, 2009, JACC-CARDIOVASC IMAG, V2, P692, DOI 10.1016/j.jcmg.2009.03.009
   Brook RD, 2018, J AM SOC HYPERTENS, V12, P238, DOI 10.1016/j.jash.2018.01.004
   Budoff MJ, 2013, J CARDIOVASC COMPUT, V7, P182, DOI 10.1016/j.jcct.2013.05.009
   Budoff MJ, 2013, J AM COLL CARDIOL, V61, P1231, DOI 10.1016/j.jacc.2012.12.035
   Budoff MJ, 2010, JACC-CARDIOVASC IMAG, V3, P1229, DOI 10.1016/j.jcmg.2010.08.018
   Cho I, 2013, KOREAN CIRC J, V43, P154, DOI 10.4070/kcj.2013.43.3.154
   Detrano R, 2008, NEW ENGL J MED, V358, P1336, DOI 10.1056/NEJMoa072100
   Dwivedi A, 2018, KOREAN CIRC J, V48, P124, DOI 10.4070/kcj.2017.0392
   Erbel R, 2014, EUR HEART J, V35, P2960, DOI 10.1093/eurheartj/ehu288
   Goff DC, 2014, CIRCULATION, V129, pS49, DOI 10.1161/01.cir.0000437741.48606.98
   Gopal A, 2007, INT J CARDIOL, V117, P227, DOI 10.1016/j.ijcard.2006.04.081
   Hokanson JE, 2004, AM J ROENTGENOL, V182, P1327, DOI 10.2214/ajr.182.5.1821327
   Kronmal RA, 2007, CIRCULATION, V115, P2722, DOI 10.1161/CIRCULATIONAHA.106.674143
   Lee JH, 2016, CIRC J, V80, P2356, DOI 10.1253/circj.CJ-16-0731
   Lee Ji Hyun, 2015, J Cardiovasc Ultrasound, V23, P195, DOI 10.4250/jcu.2015.23.4.195
   McEvoy JW, 2010, J AM COLL CARDIOL, V56, P1613, DOI 10.1016/j.jacc.2010.06.038
   Min JK, 2010, J AM COLL CARDIOL, V55, P1110, DOI 10.1016/j.jacc.2009.08.088
   Polonsky TS, 2010, JAMA-J AM MED ASSOC, V303, P1610, DOI 10.1001/jama.2010.461
   Radford NB, 2016, JACC-CARDIOVASC IMAG, V9, P1420, DOI 10.1016/j.jcmg.2016.03.010
   Shaw LJ, 2003, RADIOLOGY, V228, P826, DOI 10.1148/radiol.2283021006
   Stone NJ, 2014, CIRCULATION, V129, pS1, DOI 10.1161/01.cir.0000437738.63853.7a
   Taylor AJ, 2005, J AM COLL CARDIOL, V46, P807, DOI 10.1016/j.jacc.2005.05.049
   Valenti V, 2015, JACC-CARDIOVASC IMAG, V8, P900, DOI 10.1016/j.jcmg.2015.01.025
   Yeboah J, 2012, JAMA-J AM MED ASSOC, V308, P788, DOI 10.1001/jama.2012.9624
NR 25
TC 3
Z9 3
U1 0
U2 2
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAY
PY 2019
VL 49
IS 5
BP 448
EP 457
DI 10.4070/kcj.2018.0318
PG 10
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA HX7TC
UT WOS:000467607800008
PM 30808082
OA Green Published, Other Gold
DA 2021-04-22
ER

PT J
AU Jeong, HS
   Hong, SJ
AF Jeong, Han Saem
   Hong, Soon Jun
TI Benefit of Early Statin Therapy in Acute Myocardial Infarction in Korea
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
ID MANAGEMENT
C1 [Jeong, Han Saem; Hong, Soon Jun] Korea Univ, Anam Hosp, Dept Cardiol, Ctr Cardiovasc, 73 Inchon Ro,Anam Dong, Seoul 02841, South Korea.
RP Hong, SJ (corresponding author), Korea Univ, Anam Hosp, Dept Cardiol, Ctr Cardiovasc, 73 Inchon Ro,Anam Dong, Seoul 02841, South Korea.
EM psyche94@gmail.com
OI Jeong, Han Saem/0000-0002-6035-4332
CR Cannon CP, 2004, NEW ENGL J MED, V350, P1495, DOI 10.1056/NEJMoa040583
   Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486
   Fonarow GC, 2005, AM J CARDIOL, V96, P611, DOI 10.1016/j.amjcard.2005.04.029
   Fonarow GC, 2001, AM J CARDIOL, V87, P819, DOI 10.1016/S0002-9149(00)01519-8
   Ibanez B, 2018, EUR HEART J, V39, P119, DOI 10.1093/eurheartj/ehx393
   Kim MC, 2019, KOREAN CIRC J, V49, P419, DOI 10.4070/kcj.2018.0341
   Liao JK, 2005, ANNU REV PHARMACOL, V45, P89, DOI 10.1146/annurev.pharmtox.45.120403.095748
   Schwartz GG, 2001, JAMA-J AM MED ASSOC, V285, P1711, DOI 10.1001/jama.285.13.1711
   Sim DS, 2017, KOREAN CIRC J, V47, P811, DOI 10.4070/kcj.2017.0027
   Winchester DE, 2010, J AM COLL CARDIOL, V56, P1099, DOI 10.1016/j.jacc.2010.04.023
NR 10
TC 2
Z9 2
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAY
PY 2019
VL 49
IS 5
BP 434
EP 436
DI 10.4070/kcj.2019.0045
PG 3
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA HX7TC
UT WOS:000467607800005
PM 30891965
OA Green Published, Other Gold
DA 2021-04-22
ER

PT J
AU Ko, J
   Kim, NH
AF Ko, Jumsuk
   Kim, Nam-Ho
TI Evolution of Smart Health Wearables: Novel Application for Detection of
   Arrhythmia
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
C1 [Ko, Jumsuk; Kim, Nam-Ho] Wonkwang Univ, Sch Med, Dept Internal Med, Div Cardiol, 460 Iksan Daero, Iksan 54538, South Korea.
RP Ko, J (corresponding author), Wonkwang Univ, Sch Med, Dept Internal Med, Div Cardiol, 460 Iksan Daero, Iksan 54538, South Korea.
EM nermor@daum.net
OI ko, jumsuk/0000-0002-8573-0066
CR Bonomi AG, 2018, J AM HEART ASSOC, V7, DOI 10.1161/JAHA.118.009351
   Bumgarner JM, 2018, J AM COLL CARDIOL, V71, P2381, DOI 10.1016/j.jacc.2018.03.003
   Hwang J, 2019, KOREAN CIRC J, V49, P437, DOI 10.4070/kcj.2018.0323
   Lee H, 2017, KOREAN CIRC J, V47, P56, DOI 10.4070/kcj.2016.0045
   McManus DD, 2013, HEART RHYTHM, V10, P315, DOI 10.1016/j.hrthm.2012.12.001
NR 5
TC 0
Z9 0
U1 2
U2 5
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAY
PY 2019
VL 49
IS 5
BP 446
EP 447
DI 10.4070/kcj.2019.0078
PG 2
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA HX7TC
UT WOS:000467607800007
PM 31074213
OA Green Published, Other Gold
DA 2021-04-22
ER

PT J
AU Ko, SM
AF Ko, Sung Min
TI Which Individuals Could Benefit from Repeat Coronary Calcium Scans among
   Asymptomatic Korean Adults with a Baseline Coronary Artery Calcium Score
   of Zero?
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
ID WARRANTY PERIOD; CALCIFICATION
C1 [Ko, Sung Min] Konkuk Univ, Sch Med, Med Ctr, Dept Radiol, 120-1 Neungdong Ro, Seoul 05030, South Korea.
RP Ko, SM (corresponding author), Konkuk Univ, Sch Med, Med Ctr, Dept Radiol, 120-1 Neungdong Ro, Seoul 05030, South Korea.
EM 20070437@kuh.ac.kr
CR Bild DE, 2005, CIRCULATION, V111, P1313, DOI 10.1161/01.CIR.0000157730.94423.4B
   Cho I, 2018, EUR HEART J, V39, P934, DOI 10.1093/eurheartj/ehx774
   Dwivedi A, 2018, KOREAN CIRC J, V48, P124, DOI 10.4070/kcj.2017.0392
   Erbel R, 2014, EUR HEART J, V35, P2960, DOI 10.1093/eurheartj/ehu288
   Greenland P, 2018, J AM COLL CARDIOL, V72, P434, DOI 10.1016/j.jacc.2018.05.027
   Hecht HS, 2015, JACC-CARDIOVASC IMAG, V8, P580, DOI 10.1016/j.jcmg.2015.02.006
   Lee JH, 2016, CIRC J, V80, P2356, DOI 10.1253/circj.CJ-16-0731
   Lee W, 2019, KOREAN CIRC J, V49, P448, DOI 10.4070/kcj.2018.0318
   Valenti V, 2015, JACC-CARDIOVASC IMAG, V8, P900, DOI 10.1016/j.jcmg.2015.01.025
   Vliegenthart R, 2005, CIRCULATION, V112, P572, DOI 10.1161/CIRCULATIONAHA.104.488916
NR 10
TC 0
Z9 0
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAY
PY 2019
VL 49
IS 5
BP 458
EP 460
DI 10.4070/kcj.2019.0076
PG 3
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA HX7TC
UT WOS:000467607800009
PM 31074214
OA Green Published, Other Gold
DA 2021-04-22
ER

PT J
AU Masuda, S
   Shibui, T
   Nagamine, S
   Tsuchiyama, T
   Ashikaga, T
AF Masuda, Shinichiro
   Shibui, Takashi
   Nagamine, Sho
   Tsuchiyama, Takaaki
   Ashikaga, Takashi
TI Coronary Angioscopy Findings before and after Excimer Laser Coronary
   Angioplasty for Bare-Metal Stent In-Stent Restenosis
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
ID BALLOON
C1 [Masuda, Shinichiro; Shibui, Takashi; Nagamine, Sho; Tsuchiyama, Takaaki] Tokyo Metropolitan Hiroo Gen Hosp, Dept Cardiol, Tokyo, Japan.
   [Ashikaga, Takashi] Japanese Red Cross Musashino Hosp, Dept Cardiol, Tokyo, Japan.
RP Masuda, S (corresponding author), Tokyo Metropolitan Hiroo Gen Hosp, Dept Cardiol, Shibuya Ku, 2-34-10 Ebisu, Tokyo 1500013, Japan.
EM giga627@yahoo.co.jp
OI Shibui, Takashi/0000-0002-0676-5595; Tsuchiyama,
   Takaaki/0000-0002-6923-9832
CR Ambrosini V, 2017, CARDIOVASC REVASCULA, V18, P165, DOI 10.1016/j.carrev.2016.12.012
   Hirose S, 2016, LASER MED SCI, V31, P1691, DOI 10.1007/s10103-016-2039-z
NR 2
TC 0
Z9 0
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAY
PY 2019
VL 49
IS 5
BP 461
EP 463
DI 10.4070/kcj.2019.0010
PG 3
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA HX7TC
UT WOS:000467607800010
PM 31074216
OA Other Gold, Green Published
DA 2021-04-22
ER

PT J
AU Kwon, S
   Lee, SP
   Park, SS
   Kim, BJ
   Kim, HK
   Cho, HJ
   Seong, MW
   Sohn, DW
AF Kwon, Soonil
   Lee, Seung-Pyo
   Park, Seung Shin
   Kim, Beom Joon
   Kim, Hyung-Kwan
   Cho, Hyun-Jai
   Seong, Moon-Woo
   Sohn, Dae-Won
TI Fabry Disease that Phenocopies Hypertrophic Cardiomyopathy: a thorough
   Genetic 'Detective' Identifies the 'Rogue' Hidden in the GLA Gene
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
C1 [Kwon, Soonil; Lee, Seung-Pyo; Kim, Hyung-Kwan; Cho, Hyun-Jai; Sohn, Dae-Won] Seoul Natl Univ Hosp, Div Cardiol, Dept Internal Med, 101 Daehak Ro, Seoul 03080, South Korea.
   [Park, Seung Shin] Seoul Natl Univ Hosp, Div Endocrinol, Dept Internal Med, Seoul, South Korea.
   [Kim, Beom Joon] Seoul Natl Univ, Bundang Hosp, Dept Neurol, Seongnam, South Korea.
   [Kim, Beom Joon] Seoul Natl Univ, Bundang Hosp, Cerebrovasc Ctr, Seongnam, South Korea.
   [Seong, Moon-Woo] Seoul Natl Univ Hosp, Dept Lab Med, Seoul, South Korea.
RP Lee, SP (corresponding author), Seoul Natl Univ Hosp, Div Cardiol, Dept Internal Med, 101 Daehak Ro, Seoul 03080, South Korea.
EM splee0624@gmail.com
RI Kim, Beom Joon/C-2904-2011; Kwon, Soonil/ABG-1649-2020
OI Kim, Beom Joon/0000-0002-2719-3012; Kwon, Soonil/0000-0002-4791-6855;
   Kim, Hyung-Kwan/0000-0001-7950-2131; Seong, Moon-Woo/0000-0003-2954-3677
CR Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057
   Lukas J, 2016, HUM MUTAT, V37, P43, DOI 10.1002/humu.22910
   Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30
   Thurberg BL, 2009, CIRCULATION, V119, P2561, DOI 10.1161/CIRCULATIONAHA.108.841494
NR 4
TC 1
Z9 1
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAY
PY 2019
VL 49
IS 5
BP 464
EP 467
DI 10.4070/kcj.2018.0404
PG 4
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA HX7TC
UT WOS:000467607800011
PM 31074215
OA Green Published, Other Gold
DA 2021-04-22
ER

PT J
AU Kim, JY
AF Kim, Jang Young
TI Closure of Atrial Septal Defects with the Recent Generation Devices
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
ID TRANSCATHETER CLOSURE
C1 [Kim, Jang Young] Yonsei Univ, Wonju Coll Med, Div Cardiol, Dept Internal Med, 20 Ilsan Ro, Wonju 26426, South Korea.
RP Kim, JY (corresponding author), Yonsei Univ, Wonju Coll Med, Div Cardiol, Dept Internal Med, 20 Ilsan Ro, Wonju 26426, South Korea.
EM kimjy@yonsei.ac.kr
OI Kim, Jang Young/0000-0002-0813-7082
CR Jung SY, 2018, J THORAC DIS, V10, pS2909, DOI 10.21037/jtd.2018.02.19
   Kim AY, 2019, KOREAN CIRC J, V49, P326, DOI 10.4070/kcj.2018.0278
   Masura J, 1997, CATHETER CARDIO DIAG, V42, P388, DOI 10.1002/(SICI)1097-0304(199712)42:4<388::AID-CCD7>3.0.CO;2-7
NR 3
TC 0
Z9 0
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD APR
PY 2019
VL 49
IS 4
BP 336
EP 337
DI 10.4070/kcj.2019.0077
PG 2
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA HP6BU
UT WOS:000461768300005
PM 30895758
OA Green Published, Other Gold
DA 2021-04-22
ER

PT J
AU Lin, CY
   Hu, YF
   Lin, YJ
   Chen, SA
AF Lin, Chin-Yu
   Hu, Yu-Feng
   Lin, Yenn-Jiang
   Chen, Shih-Ann
TI Can Genetic Risk Scoring Predict Atrial Fibrillation Ablation Outcomes?
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
C1 [Lin, Chin-Yu; Hu, Yu-Feng; Lin, Yenn-Jiang; Chen, Shih-Ann] Taipei Vet Gen Hosp, Dept Med, Div Cardiol, Heart Rhythm Ctr, 201,Sect 2,Shipai Rd, Taipei, Taiwan.
   [Lin, Chin-Yu; Hu, Yu-Feng; Lin, Yenn-Jiang; Chen, Shih-Ann] Natl Yang Ming Univ, Inst Clin Med, Taipei, Taiwan.
   [Lin, Chin-Yu; Hu, Yu-Feng; Lin, Yenn-Jiang; Chen, Shih-Ann] Natl Yang Ming Univ, Cardiovasc Res Inst, Taipei, Taiwan.
   [Lin, Chin-Yu] Taipei Vet Gen Hosp, Dept Med, YuanShan Branch, Yilan, Taiwan.
RP Lin, CY (corresponding author), Taipei Vet Gen Hosp, Dept Med, Div Cardiol, Heart Rhythm Ctr, 201,Sect 2,Shipai Rd, Taipei, Taiwan.
EM clouaa@gmail.com
OI Lin, Chin-Yu/0000-0003-3282-7523
FU Center for Dynamical Biomarkers and Translational Medicine, Ministry of
   Science and Technology [MOST106-2314-B-075-073-MY3]
FX This work was supported by the Center for Dynamical Biomarkers and
   Translational Medicine, Ministry of Science and Technology
   (MOST106-2314-B-075-073-MY3).
CR Calkins H, 2017, HEART RHYTHM, V14, pE275, DOI 10.1016/j.hrthm.2017.05.012
   Chen YH, 2003, SCIENCE, V299, P251, DOI 10.1126/science.1077771
   Choe WS, 2019, KOREAN CIRC J, V49, P338, DOI 10.4070/kcj.2018.0161
   Choi EK, 2015, J AM HEART ASSOC, V4, DOI 10.1161/JAHA.115.002046
   Hu YF, 2016, ACTA CARDIOL SIN, V32, P523, DOI 10.6515/ACS20150827A
   Huang HD, 2017, CAN J CARDIOL, V33, P422, DOI 10.1016/j.cjca.2016.12.006
   Husser D, 2010, J AM COLL CARDIOL, V55, P747, DOI 10.1016/j.jacc.2009.11.041
   Rattanawong Pattara, 2018, J Atr Fibrillation, V10, P1666, DOI 10.4022/jafib.1666
   Weng LC, 2018, CIRCULATION, V137, P1027, DOI 10.1161/CIRCULATIONAHA.117.031431
NR 9
TC 0
Z9 0
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD APR
PY 2019
VL 49
IS 4
BP 350
EP 352
DI 10.4070/kcj.2019.0004
PG 3
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA HP6BU
UT WOS:000461768300007
PM 30808086
OA Green Published, Other Gold
DA 2021-04-22
ER

PT J
AU Kim, HY
   Kim, KH
AF Kim, Hyung Yoon
   Kim, Kye Hun
TI Udenafil as a Therapeutic Option for Pulmonary Arterial Hypertension
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
ID PRESSURE
C1 [Kim, Hyung Yoon; Kim, Kye Hun] Chonnam Natl Univ Hosp, Dept Cardiovasc Med, 42 Jebong Ro, Gwangju 61469, South Korea.
RP Kim, KH (corresponding author), Chonnam Natl Univ Hosp, Dept Cardiovasc Med, 42 Jebong Ro, Gwangju 61469, South Korea.
EM christiankyehun@hanmail.net
OI Kim, Hyung Yoon/0000-0002-0692-5640; Kim, Kye Hun/0000-0002-6885-1501
CR Benza RL, 2012, CHEST, V142, P448, DOI 10.1378/chest.11-1460
   Chang SA, 2019, KOREAN CIRC J, V49, P353, DOI 10.4070/kcj.2018.0281
   Galie N, 2005, NEW ENGL J MED, V353, P2148, DOI 10.1056/NEJMoa050010
   Galie N, 2016, EUR HEART J, V37, P67, DOI 10.1093/eurheartj/ehv317
   Galie N, 2009, CIRCULATION, V119, P2894, DOI 10.1161/CIRCULATIONAHA.108.839274
   Kang SG, 2013, THER ADV UROL, V5, P101, DOI 10.1177/1756287212470019
   Kim HL, 2015, HYPERTENS RES, V38, P597, DOI 10.1038/hr.2015.46
   Kim KH, 2013, TRIALS, V14, DOI 10.1186/1745-6215-14-188
   Kreisel W, 2015, DIGEST LIVER DIS, V47, P144, DOI 10.1016/j.dld.2014.10.018
   Yoon KL, 2018, KOREAN CIRC J, V48, P1145, DOI 10.4070/kcj.2018.0250
NR 10
TC 2
Z9 2
U1 0
U2 3
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD APR
PY 2019
VL 49
IS 4
BP 361
EP 362
DI 10.4070/kcj.2019.0023
PG 2
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA HP6BU
UT WOS:000461768300009
PM 30808087
OA Other Gold, Green Published
DA 2021-04-22
ER

PT J
AU Lee, SI
   Park, CH
   Kang, WC
   Oh, PC
AF Lee, Seok In
   Park, Chul-Hyun
   Kang, Woong Chol
   Oh, Pyung Chun
TI Computerized Tomography is an Effective Modality to Evaluate Iatrogenic
   Aortocoronary Dissection with Acute Myocardial Infarction
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
ID RIGHT CORONARY-ARTERY; INTERVENTION
C1 [Lee, Seok In; Park, Chul-Hyun] Gachon Univ, Gachon Cardiovasc Res Inst, Coll Med, Dept Thorac & Cardiovasc Surg,Gil Med Ctr, Incheon, South Korea.
   [Kang, Woong Chol; Oh, Pyung Chun] Gachon Univ, Gachon Cardivasc Res Inst, Coll Med, Cardiol Div,Dept Internal Med,Gil Med Ctr, 21,Namdong Daero 774 Beon Gil, Incheon 21565, South Korea.
RP Oh, PC (corresponding author), Gachon Univ, Gachon Cardivasc Res Inst, Coll Med, Cardiol Div,Dept Internal Med,Gil Med Ctr, 21,Namdong Daero 774 Beon Gil, Incheon 21565, South Korea.
EM likemed@gilhospital.com
OI Oh, Pyung Chun/0000-0002-9955-223X; lee, seokin/0000-0002-8538-4511
CR Celik M, 2013, CARDIOVASC DIAGN THE, V3, P244, DOI 10.3978/j.issn.2223-3652.2013.10.04
   Dahdouh Z, 2012, KOREAN CIRC J, V42, P504, DOI 10.4070/kcj.2012.42.7.504
   Dunning DW, 2000, CATHETER CARDIO INTE, V51, P387, DOI 10.1002/1522-726X(200012)51:4<387::AID-CCD3>3.3.CO;2-2
   Li L, 2011, CLIN MED INSIGHTS-CA, V5, P41, DOI 10.4137/CMC.S6447
   Shorrock D, 2014, CATHETER CARDIO INTE, V84, P670, DOI 10.1002/ccd.25338
NR 5
TC 0
Z9 0
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD APR
PY 2019
VL 49
IS 4
BP 363
EP 365
DI 10.4070/kcj.2018.0284
PG 3
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA HP6BU
UT WOS:000461768300010
PM 30895759
OA Other Gold, Green Published
DA 2021-04-22
ER

PT J
AU Lee, PH
   Lee, SW
   Habara, M
   Nasu, K
AF Lee, Pil Hyung
   Lee, Seung-Whan
   Habara, Maoto
   Nasu, Kenya
TI Unexpected Stenosis within Significantly Enlarged Distal Vessel after
   Successful Coronary Chronic Total Occlusion Recanalization
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
C1 [Lee, Pil Hyung; Lee, Seung-Whan] Univ Ulsan, Asan Med Ctr, Coll Med, Div Cardiol,Dept Internal Med, 88,Olymp Ro 43 Gil, Seoul, South Korea.
   [Habara, Maoto; Nasu, Kenya] Toyohashi Heart Ctr, Dept Cardiovasc Med, Toyohashi, Aichi, Japan.
RP Lee, SW (corresponding author), Univ Ulsan, Asan Med Ctr, Coll Med, Div Cardiol,Dept Internal Med, 88,Olymp Ro 43 Gil, Seoul, South Korea.
EM seungwlee@amc.seoul.kr
OI Lee, Seung-Whan/0000-0002-2662-5952
CR Galassi AR, 2012, J AM COLL CARDIOL, V59, P711, DOI 10.1016/j.jacc.2011.10.894
   Neishi Y, 2015, CIRC J, V79, P607, DOI 10.1253/circj.CJ-14-0917
   Zivelonghi C, 2018, JACC-CARDIOVASC INTE, V11, P2343, DOI 10.1016/j.jcin.2018.07.038
NR 3
TC 0
Z9 0
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD APR
PY 2019
VL 49
IS 4
BP 366
EP 368
DI 10.4070/kcj.2018.0435
PG 3
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA HP6BU
UT WOS:000461768300011
PM 30895760
OA Other Gold, Green Published
DA 2021-04-22
ER

PT J
AU Kim, C
   Hong, MK
AF Kim, Choongki
   Hong, Myeong-Ki
TI Aortic Stenosis and Transcatheter Aortic Valve Implantation: Current
   Status and Future Directions in Korea
SO KOREAN CIRCULATION JOURNAL
LA English
DT Review
DE Aortic valve stenosis; Transcatheter aortic valve replacement
ID HIGH-RISK PATIENTS; VALVULAR HEART-DISEASE; LONG-TERM OUTCOMES;
   CLINICAL-OUTCOMES; LIFE EXPECTANCY; TASK-FORCE; REPLACEMENT; MORTALITY;
   INTERMEDIATE; COMPLICATIONS
AB Transcatheter aortic valve implantation (TAVI) has been accepted as one of primary options for treatment of symptomatic severe aortic stenosis. Although TAVI has been predominantly used for patients at high risk or with old age who were not considered optimal candidates for surgical aortic valve replacement (SAVR), its indication is now expanding toward low risk profile and younger age. Many clinical trials are now ongoing to test the possibility of TAVI for use in patients even with uncharted indications who are not eligible for SAVR in current guidelines but may benefit from valve replacement. Current issues including periprocedural safety, long-term adverse events, hemodynamics and durability associated with TAVI should be also solved for expanding use of TAVI. The review presents current status and future directions of TAVI and discusses perspectives in Korea.
C1 [Kim, Choongki; Hong, Myeong-Ki] Yonsei Univ, Coll Med, Dept Internal Med, 50-1 Yonsei Ro, Seoul 03722, South Korea.
   [Kim, Choongki] Ewha Womans Univ, Seoul Hosp, Dept Cardiol, Seoul, South Korea.
   [Hong, Myeong-Ki] Yonsei Univ, Coll Med, Cardiovasc Res Inst, Seoul, South Korea.
RP Hong, MK (corresponding author), Yonsei Univ, Coll Med, Dept Internal Med, 50-1 Yonsei Ro, Seoul 03722, South Korea.
EM mkhong61@yuhs.ac
OI Hong, Myeong-Ki/0000-0002-2090-2031
CR Adams DH, 2014, NEW ENGL J MED, V370, P1790, DOI 10.1056/NEJMoa1400590
   Arsalan M, 2018, EUROINTERVENTION, V13, P1520, DOI 10.4244/EIJ-D-17-00421
   Auffret V, 2017, J AM COLL CARDIOL, V70, P42, DOI 10.1016/j.jacc.2017.04.053
   Badenco N, 2017, INT J CARDIOL, V236, P216, DOI 10.1016/j.ijcard.2017.02.029
   Barbanti M, 2015, JACC-CARDIOVASC INTE, V8, P1084, DOI 10.1016/j.jcin.2015.03.024
   Barbash IM, 2015, AM J CARDIOL, V116, P1916, DOI 10.1016/j.amjcard.2015.09.030
   Baumgartner H, 2017, EUR HEART J, V38, P2739, DOI 10.1093/eurheartj/ehx391
   Bekeredjian R, 2018, EUR HEART J
   Brennan JM, 2014, ANN THORAC SURG, V98, P2016, DOI 10.1016/j.athoracsur.2014.07.051
   Brown JM, 2009, J THORAC CARDIOV SUR, V137, P82, DOI 10.1016/j.jtcvs.2008.08.015
   Cahill TJ, 2018, EUR HEART J, V39, P2625, DOI 10.1093/eurheartj/ehy244
   Guimaraes LDC, 2018, CIRC-CARDIOVASC INTE, V11, DOI 10.1161/CIRCINTERVENTIONS.118.007038
   Capodanno D, 2014, AM J CARDIOL, V113, P1851, DOI 10.1016/j.amjcard.2014.03.014
   Chen ZF, 2018, EUR HEART J, V39, P1208, DOI [10.1093/eurheartj/ehx562, 10.1093/eurheartj/ehx671]
   Coffey S, 2014, J AM COLL CARDIOL, V63, P2852, DOI 10.1016/j.jacc.2014.04.018
   Collas VM, 2015, INT J CARDIOL, V194, P13, DOI 10.1016/j.ijcard.2015.05.015
   Cribier A, 2002, CIRCULATION, V106, P3006, DOI 10.1161/01.CIR.0000047200.36165.B8
   Culler SD, 2018, ANN THORAC SURG, V105, P1137, DOI 10.1016/j.athoracsur.2017.10.057
   Debonnaire P, 2015, AM J CARDIOL, V115, P234, DOI 10.1016/j.amjcard.2014.10.029
   Duncan A, 2015, JACC-CARDIOVASC INTE, V8, P645, DOI 10.1016/j.jcin.2015.01.009
   Durko AP, 2018, J AM COLL CARDIOL, V72, P2109, DOI 10.1016/j.jacc.2018.07.093
   Edwards FH, 2016, JAMA CARDIOL, V1, P46, DOI 10.1001/jamacardio.2015.0326
   Englum BR, 2016, ANN THORAC SURG, V101, P110, DOI 10.1016/j.athoracsur.2015.06.083
   Fassa AA, 2013, NAT REV CARDIOL, V10, P685, DOI 10.1038/nrcardio.2013.156
   Genereux P, 2012, J AM COLL CARDIOL, V59, P2317, DOI 10.1016/j.jacc.2012.02.022
   Gilard M, 2016, J AM COLL CARDIOL, V68, P1637, DOI 10.1016/j.jacc.2016.07.747
   Gilard M, 2012, NEW ENGL J MED, V366, P1705, DOI 10.1056/NEJMoa1114705
   Gleason TG, 2018, J AM COLL CARDIOL, V72, P2687, DOI 10.1016/j.jacc.2018.08.2146
   Gozdek M, 2018, EUR J CARDIO-THORAC, V53, P495, DOI 10.1093/ejcts/ezx347
   Hamm CW, 2014, EUR HEART J, V35, P1588, DOI 10.1093/eurheartj/eht381
   Harrison JK, 2017, JACC-CARDIOVASC INTE, V10, P168, DOI 10.1016/j.jcin.2016.11.002
   Hayashida K, 2013, CIRC-CARDIOVASC INTE, V6, P284, DOI 10.1161/CIRCINTERVENTIONS.112.000084
   Iung B, 2003, EUR HEART J, V24, P1231, DOI 10.1016/S0195-668X(03)00201-X
   Kahlert P, 2010, CIRCULATION, V121, P870, DOI 10.1161/CIRCULATIONAHA.109.855866
   Kapadia SR, 2015, LANCET, V385, P2485, DOI 10.1016/S0140-6736(15)60290-2
   Khatri PJ, 2013, ANN INTERN MED, V158, P35, DOI 10.7326/0003-4819-158-1-201301010-00007
   Kim BG, 2018, INT J CARDIOL, V255, P206, DOI 10.1016/j.ijcard.2017.11.065
   Kodali SK, 2012, NEW ENGL J MED, V366, P1686, DOI 10.1056/NEJMoa1200384
   Kontis V, 2017, LANCET, V389, P1323, DOI 10.1016/S0140-6736(16)32381-9
   Kvidal P, 2000, J AM COLL CARDIOL, V35, P747, DOI 10.1016/S0735-1097(99)00584-7
   Lansky AJ, 2016, AM J CARDIOL, V118, P1519, DOI 10.1016/j.amjcard.2016.08.013
   Leon MB, 2016, NEW ENGL J MED, V374, P1609, DOI 10.1056/NEJMoa1514616
   Leon MB, 2010, NEW ENGL J MED, V363, P1597, DOI 10.1056/NEJMoa1008232
   Mack MJ, 2015, LANCET, V385, P2477, DOI 10.1016/S0140-6736(15)60308-7
   Malaisrie SC, 2014, ANN THORAC SURG, V98, P1564, DOI 10.1016/j.athoracsur.2014.06.040
   Michelena HI, 2011, JAMA-J AM MED ASSOC, V306, P1104, DOI 10.1001/jama.2011.1286
   Moat NE, 2011, J AM COLL CARDIOL, V58, P2130, DOI 10.1016/j.jacc.2011.08.050
   Mohananey D, 2017, CIRC-CARDIOVASC INTE, V10, DOI 10.1161/CIRCINTERVENTIONS.117.005046
   Muralidharan A, 2016, AM J CARDIOL, V118, P1031, DOI 10.1016/j.amjcard.2016.07.011
   Nishimura RA, 2017, CIRCULATION, V135, pE1159, DOI 10.1161/CIR.0000000000000503
   Nombela-Franco L, 2012, CIRCULATION, V126, P3041, DOI 10.1161/CIRCULATIONAHA.112.110981
   Otto CM, 2017, J AM COLL CARDIOL, V69, P1313, DOI 10.1016/j.jacc.2016.12.006
   Reardon MJ, 2017, NEW ENGL J MED, V376, P1321, DOI 10.1056/NEJMoa1700456
   Rosenhek R, 2000, NEW ENGL J MED, V343, P611, DOI 10.1056/NEJM200008313430903
   Rubin JM, 2011, CIRC-CARDIOVASC INTE, V4, P280, DOI 10.1161/CIRCINTERVENTIONS.111.961649
   Schoenenberger AW, 2018, JACC-CARDIOVASC INTE, V11, P395, DOI 10.1016/j.jcin.2017.11.012
   Seeger J, 2018, EUR HEART J
   Seiffert M, 2014, CLIN RES CARDIOL, V103, P631, DOI 10.1007/s00392-014-0692-4
   Siemieniuk RA, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i5130
   Siontis GCM, 2016, EUR HEART J, V37, P3503, DOI 10.1093/eurheartj/ehw225
   Smith CR, 2011, NEW ENGL J MED, V364, P2187, DOI 10.1056/NEJMoa1103510
   Statistics Korea, 2018, LIF TABL KOR 2017
   Taniguchi T, 2015, J AM COLL CARDIOL, V66, P2827, DOI 10.1016/j.jacc.2015.10.001
   Thourani VH, 2016, LANCET, V387, P2218, DOI 10.1016/S0140-6736(16)30073-3
   Thyregod HGH, 2015, J AM COLL CARDIOL, V65, P2184, DOI 10.1016/j.jacc.2015.03.014
   Thyregod HG, 2018, AM COLL CARD 2018 AN
   Urena M, 2014, CIRCULATION, V129, P1233, DOI 10.1161/CIRCULATIONAHA.113.005479
   Van Mieghem NM, 2015, JACC-CARDIOVASC INTE, V8, P718, DOI 10.1016/j.jcin.2015.01.020
   van Rosendael PJ, 2018, EUR HEART J, V39, P2003, DOI 10.1093/eurheartj/ehx785
   Waksman R, 2018, J AM COLL CARDIOL, V72, P2095, DOI 10.1016/j.jacc.2018.08.1033
   Walther T, 2015, J AM COLL CARDIOL, V65, P2173, DOI 10.1016/j.jacc.2015.03.034
   Wassef AWA, 2018, JACC-CARDIOVASC INTE, V11, P1669, DOI 10.1016/j.jcin.2018.06.044
   Wells JA, 2017, JACC-CARDIOVASC INTE, V10, P500, DOI 10.1016/j.jcin.2016.11.043
   Yang S, 2010, AM J PUBLIC HEALTH, V100, P896, DOI 10.2105/AJPH.2009.160341
   Yoon SH, 2017, J AM COLL CARDIOL, V69, P2579, DOI 10.1016/j.jacc.2017.03.017
   Young Michael N, 2018, Curr Treat Options Cardiovasc Med, V20, P62, DOI 10.1007/s11936-018-0648-5
   Yu CW, 2018, KOREAN CIRC J, V48, P382, DOI 10.4070/kcj.2018.0117
NR 77
TC 5
Z9 5
U1 0
U2 4
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD APR
PY 2019
VL 49
IS 4
BP 283
EP 297
DI 10.4070/kcj.2019.0044
PG 15
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA HP6BU
UT WOS:000461768300001
PM 30895756
OA Other Gold, Green Published
DA 2021-04-22
ER

PT J
AU Alkashkari, W
   Albugami, S
   Hijazi, ZM
AF Alkashkari, Wail
   Albugami, Saad
   Hijazi, Ziyad M.
TI Management of Coarctation of The Aorta in Adult Patients: State of The
   Art
SO KOREAN CIRCULATION JOURNAL
LA English
DT Review
DE Stents; Aortic Coarctation; Balloon angioplasty; Cardiac Catheterization
ID CONGENITAL HEART-DISEASE; FOLLOW-UP; INTRACRANIAL ANEURYSMS;
   ENDOVASCULAR TREATMENT; BALLOON ANGIOPLASTY; STENT IMPLANTATION; NATIVE
   COARCTATION; LATE HYPERTENSION; REPAIR; OUTCOMES
AB Coarctation of the aorta (CoA) is a common form of congenital heart disease. Adult patients with CoA may be asymptomatic or may present with hypertension. Over the last few years, endovascular management of adult patients with CoA emerged as the preferred strategy. Stent implantation, though technically challenging, offers the best and most lasting therapy. In this paper, we will review technical considerations and outcome of patients undergoing stent implantation for CoA.
C1 [Alkashkari, Wail; Albugami, Saad] King Saud Bin Abdulaziz Univ Hlth Sci, Jeddah 22384, Saudi Arabia.
   [Alkashkari, Wail; Albugami, Saad] Minist Natl Guard Hlth Affairs, King Faisal Cardiac Ctr, Dept Cardiol, Jeddah, Saudi Arabia.
   [Alkashkari, Wail; Albugami, Saad] King Abdullah Int Med Res Ctr Jeddah, Jeddah, Saudi Arabia.
   [Hijazi, Ziyad M.] Sidra Med, Sidra Heart Ctr, Dept Pediat, Doha, Qatar.
   [Hijazi, Ziyad M.] Weill Cornell Med, New York, NY USA.
RP Alkashkari, W (corresponding author), King Saud Bin Abdulaziz Univ Hlth Sci, Jeddah 22384, Saudi Arabia.; Alkashkari, W (corresponding author), King Faisal Cardiac Ctr, Jeddah 22384, Saudi Arabia.
EM wakash73@hotmail.com
OI King Saud Bin Abdulaziz University for Health Sciences, Jeddah, College
   of Medicine,/0000-0001-9073-534X; Alkashkari, Wail/0000-0003-0234-1899;
   Hijazi, Ziyad M./0000-0002-0072-6034
CR ANDERSON KR, 1979, BRIT HEART J, V41, P28
   Baumgartner H, 2010, EUR HEART J, V31, P2915, DOI 10.1093/eurheartj/ehq249
   BEEKMAN RH, 1986, J AM COLL CARDIOL, V8, P1406, DOI 10.1016/S0735-1097(86)80314-X
   Bocelli A, 2013, PEDIATR CARDIOL, V34, P620, DOI 10.1007/s00246-012-0508-0
   Bulbul ZR, 1996, CATHETER CARDIO DIAG, V39, P36, DOI 10.1002/(SICI)1097-0304(199609)39:1<36::AID-CCD7>3.3.CO;2-Z
   Burch PT, 2009, J THORAC CARDIOV SUR, V138, P547, DOI 10.1016/j.jtcvs.2009.04.046
   CAMPBELL M, 1970, BRIT HEART J, V32, P633
   Canniffe C, 2013, INT J CARDIOL, V167, P2456, DOI 10.1016/j.ijcard.2012.09.084
   Carr JA, 2006, J AM COLL CARDIOL, V47, P1101, DOI 10.1016/j.jacc.2005.10.063
   Cheatham JP, 2001, CATHETER CARDIO INTE, V54, P112, DOI 10.1002/ccd.1249
   Choudhary P, 2015, HEART, V101, P1190, DOI 10.1136/heartjnl-2014-307035
   Connolly HM, 2003, MAYO CLIN PROC, V78, P1491, DOI 10.4065/78.12.1491
   Donti A, 2015, AM J CARDIOL, V116, P630, DOI 10.1016/j.amjcard.2015.05.030
   Forbes TJ, 2007, CATHETER CARDIO INTE, V70, P569, DOI 10.1002/ccd.21191
   Forbes TJ, 2007, CATHETER CARDIO INTE, V70, P276, DOI 10.1002/ccd.21164
   Forbes TJ, 2011, J AM COLL CARDIOL, V58, P2664, DOI 10.1016/j.jacc.2011.08.053
   Golden AB, 2007, CATHETER CARDIO INTE, V69, P289, DOI 10.1002/ccd.21009
   Hartman EMJ, 2015, EUROINTERVENTION, V11, P660, DOI 10.4244/EIJV11I6A133
   Hoffman JIE, 2002, J AM COLL CARDIOL, V39, P1890, DOI 10.1016/S0735-1097(02)01886-7
   Kaemmerer H., 2011, DIAGNOSIS MANAGEMENT, P261
   Karamlou T, 2009, J THORAC CARDIOV SUR, V137, P1163, DOI 10.1016/j.jtcvs.2008.07.065
   Kenny D, 2011, CARDIOL J, V18, P487, DOI 10.5603/CJ.2011.0003
   Kenny D, 2011, HYPERTENS RES, V34, P543, DOI 10.1038/hr.2011.22
   LIBERTHSON RR, 1979, AM J CARDIOL, V43, P835, DOI 10.1016/0002-9149(79)90086-9
   Lin AE, 2008, GENET MED, V10, P469, DOI [10.1097/GIM.0b013e3181772111, 10.1097GIM.0b013e3181772111]
   LOCK JE, 1983, CIRCULATION, V68, P109, DOI 10.1161/01.CIR.68.1.109
   Marshall AC, 2000, AM HEART J, V139, P1054, DOI 10.1067/mhj.2000.106616
   Meadows J, 2015, CIRCULATION, V131, P1656, DOI 10.1161/CIRCULATIONAHA.114.013937
   MENDELSOHN AM, 1994, AM J CARDIOL, V74, P696, DOI 10.1016/0002-9149(94)90312-3
   O'Sullivan J, 2014, CURR HYPERTENS REP, V16, DOI 10.1007/s11906-014-0421-4
   OLAUGHLIN MP, 1991, CIRCULATION, V83, P1923, DOI 10.1161/01.CIR.83.6.1923
   Pilla Carlo B, 2005, Expert Rev Cardiovasc Ther, V3, P879, DOI 10.1586/14779072.3.5.879
   Preventza O, 2013, ANN THORAC SURG, V95, P1961, DOI 10.1016/j.athoracsur.2013.03.062
   Reller MD, 2008, J PEDIATR-US, V153, P807, DOI 10.1016/j.jpeds.2008.05.059
   Rhodes JF, 2008, CIRCULATION, V117, P1228, DOI 10.1161/CIRCULATIONAHA.107.742072
   RUDOLPH AM, 1972, AM J CARDIOL, V30, P514, DOI 10.1016/0002-9149(72)90042-2
   Sohrabi B, 2014, JACC-CARDIOVASC INTE, V7, P416, DOI 10.1016/j.jcin.2013.11.018
   Stout KK, 2018, J AM COLL CARDIOL, pS0735
   Taggart NW, 2016, JACC-CARDIOVASC INTE, V9, P484, DOI 10.1016/j.jcin.2015.11.038
   Thomson JDR, 2006, HEART, V92, P90, DOI 10.1136/hrt.2004.058685
   TRENT MS, 1990, J VASC SURG, V11, P707, DOI 10.1067/mva.1990.18435
   Wada T, 2001, ANN THORAC SURG, V72, P80, DOI 10.1016/S0003-4975(01)02639-X
   Walhout RJ, 2003, J THORAC CARDIOV SUR, V126, P521, DOI 10.1016/S0022-5223(03)00030-8
   Wilson PD, 1998, AM J EPIDEMIOL, V148, P414
   Yang LQ, 2016, INT J CARDIOL, V223, P1025, DOI 10.1016/j.ijcard.2016.08.295
NR 45
TC 11
Z9 11
U1 0
U2 4
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD APR
PY 2019
VL 49
IS 4
BP 298
EP 313
DI 10.4070/kcj.2018.0433
PG 16
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA HP6BU
UT WOS:000461768300002
PM 30895757
OA Other Gold, Green Published
DA 2021-04-22
ER

PT J
AU Mohsin, S
   Houser, SR
AF Mohsin, Sadia
   Houser, Steven R.
TI Cortical Bone Derived Stem Cells for Cardiac Wound Healing
SO KOREAN CIRCULATION JOURNAL
LA English
DT Review
DE Cell therapy; Myocardial infarction; Wound healing; Immunomodulation;
   Fibrosis
ID MYOCARDIAL-INFARCTION; PROGENITOR CELLS; ISCHEMIC CARDIOMYOPATHY;
   PARACRINE MECHANISMS; VENTRICULAR-FUNCTION; MARROW; HEART; REPAIR;
   MOUSE; TRANSPLANTATION
AB Ischemic heart disease can lead to myocardial infarction (MI), a major cause of morbidity and mortality worldwide. Adoptive transfer of multiple stem cell types into failing human hearts has demonstrated safety however the beneficial effects in patients with cardiovascular disorders have been modest. Modest improvement in patients with cardiac complications warrants identification of a novel stem cell population that possesses effective reparative properties and improves cardiac function after injury. Recently we have shown in a mouse model and a porcine pre-clinical animal model, that cortical bone derived stem cells (CBSCs) enhance cardiac function after MI and/or ischemia-reperfusion injury. These beneficial effects of allogeneic cell delivery appear to be mediated by paracrine mechanisms rather than by transdifferentiation of injected cells into vessels and/or immature myocytes. This review will discuss role of CBSCs in cardiac wound healing. After having modest beneficial improvement in most of the clinical trials, a critical need is to understand the interaction of the transplanted stem cells with the ischemic cardiac environment. Transplanted stem cells are exposed to pro-inflammatory factors and activated immune cells and fibroblasts, but their interactions remain unknown. We have shown that CBSCs modulate different processes including modulation of the immune response, angiogenesis, and restriction of infarct sizes after cardiac injury. This review will provide information on unique protective signature of CBSCs in rodent/swine animal models for heart repair that should provide basis for developing novel therapies for treating heart failure patients.
C1 [Mohsin, Sadia] Temple Univ, Lewis Katz Sch Med, Dept Pharmacol, Cardiovasc Res Ctr, 3500 N Broad St, Philadelphia, PA 19140 USA.
   [Houser, Steven R.] Temple Univ, Lewis Katz Sch Med, Dept Physiol, Cardiovasc Res Ctr, 3500 N Broad St, Philadelphia, PA 19140 USA.
RP Mohsin, S (corresponding author), Temple Univ, Lewis Katz Sch Med, Dept Pharmacol, Cardiovasc Res Ctr, 3500 N Broad St, Philadelphia, PA 19140 USA.; Houser, SR (corresponding author), Temple Univ, Lewis Katz Sch Med, Dept Physiol, Cardiovasc Res Ctr, 3500 N Broad St, Philadelphia, PA 19140 USA.
EM sadia.mohsin@temple.edu; srhouser@temple.edu
OI Houser, Steven/0000-0001-6359-5425; Mohsin, Sadia/0000-0002-2106-1094
FU NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [R01HL139960, R56-HL137850,
   RO1-HL137850]; American Heart AssociationAmerican Heart Association
   [SDG-15SDG25550038]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)
   [R01HL137850, R01HL137850, R01HL137850] Funding Source: NIH RePORTER
FX Houser SR received funding from NIH (R01HL139960) and Mohsin S received
   funding from NIH (R56-HL137850, RO1-HL137850) and (SDG-15SDG25550038)
   from American Heart Association.
CR Anversa P, 2006, CIRCULATION, V113, P1451, DOI 10.1161/CIRCULATIONAHA.105.595181
   Aurora AB, 2014, J CLIN INVEST, V124, P1382, DOI 10.1172/JCI72181
   Beltrami AP, 2003, CELL, V114, P763, DOI 10.1016/S0092-8674(03)00687-1
   Ben Nasr M, 2015, ACTA DIABETOL, V52, P917, DOI 10.1007/s00592-015-0735-y
   Bolli R, 2011, LANCET, V378, P1847, DOI 10.1016/S0140-6736(11)61590-0
   Caplan AI, 2006, J CELL BIOCHEM, V98, P1076, DOI 10.1002/jcb.20886
   Chen SL, 2004, AM J CARDIOL, V94, P92, DOI 10.1016/j.amjcard.2004.03.034
   Christia P, 2013, J HISTOCHEM CYTOCHEM, V61, P555, DOI 10.1369/0022155413493912
   Chugh AR, 2012, CIRCULATION, V126, pS54, DOI 10.1161/CIRCULATIONAHA.112.092627
   Czubryt MP, 2012, FIBROGENESIS TISSUE, V5, DOI 10.1186/1755-1536-5-19
   Duran JM, 2013, CIRC RES, V113, P539, DOI 10.1161/CIRCRESAHA.113.301202
   Epelman S, 2015, NAT REV IMMUNOL, V15, P117, DOI 10.1038/nri3800
   Epelman S, 2014, IMMUNITY, V40, P91, DOI 10.1016/j.immuni.2013.11.019
   Gerdes AM, 2002, J CARD FAIL, V8, pS264, DOI 10.1054/jcaf.2002.129280
   Gnecchi M, 2005, NAT MED, V11, P367, DOI 10.1038/nm0405-367
   Gnecchi M, 2008, CIRC RES, V103, P1204, DOI 10.1161/CIRCRESAHA.108.176826
   Gnecchi M, 2006, FASEB J, V20, P661, DOI 10.1096/fj.05-5211com
   Golpanian S, 2016, STEM CELL TRANSL MED, V5, P186, DOI 10.5966/sctm.2015-0101
   Hodgkinson CP, 2016, CIRC RES, V118, P95, DOI 10.1161/CIRCRESAHA.115.305373
   Holmes JW, 2005, ANNU REV BIOMED ENG, V7, P223, DOI 10.1146/annurev.bioeng.7.060804.100453
   Karantalis V, 2015, CIRC RES, V116, P1413, DOI 10.1161/CIRCRESAHA.116.303614
   Karantalis V, 2014, CIRC RES, V114, P1302, DOI 10.1161/CIRCRESAHA.114.303180
   Kinnaird T, 2004, CIRCULATION, V109, P1543, DOI 10.1161/01.CIR.0000124062.31102.57
   Kishore R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060161
   Kucia M, 2004, CIRC RES, V95, P1191, DOI 10.1161/01.RES.0000150856.47324.5b
   Lavine KJ, 2014, P NATL ACAD SCI USA, V111, P16029, DOI 10.1073/pnas.1406508111
   Li L, 1998, AM J PHYSIOL-HEART C, V274, pH1335
   Li TS, 2012, J AM COLL CARDIOL, V59, P942, DOI 10.1016/j.jacc.2011.11.029
   Lorell BH, 2000, CIRCULATION, V102, P470
   Loughran John H, 2013, Curr Heart Fail Rep, V10, P73, DOI 10.1007/s11897-012-0128-2
   Makkar RR, 2012, LANCET, V379, P895, DOI 10.1016/S0140-6736(12)60195-0
   Mazhari Ramesh, 2007, Nat Clin Pract Cardiovasc Med, V4 Suppl 1, pS21, DOI 10.1038/ncpcardio0770
   Murry CE, 2004, NATURE, V428, P664, DOI 10.1038/nature02446
   Orlic D, 2001, NATURE, V410, P701, DOI 10.1038/35070587
   Piacentino V, 2003, CIRC RES, V92, P651, DOI 10.1161/01.RES.0000062469.83985.9B
   Prabhu SD, 2016, CIRC RES, V119, P91, DOI 10.1161/CIRCRESAHA.116.303577
   Qian L, 2012, NATURE, V485, P593, DOI 10.1038/nature11044
   Rota M, 2008, CIRC RES, V103, P107, DOI 10.1161/CIRCRESAHA.108.178525
   Rota M, 2007, P NATL ACAD SCI USA, V104, P17783, DOI 10.1073/pnas.0706406104
   Schachinger V, 2006, NEW ENGL J MED, V355, P1210, DOI 10.1056/NEJMoa060186
   Sharp TE, 2017, CIRC RES, V121, P1263, DOI 10.1161/CIRCRESAHA.117.311174
   Smith RR, 2007, CIRCULATION, V115, P896, DOI 10.1161/CIRCULATIONAHA.106.655209
   Smith SC, 2015, CIRC RES, V117, P926, DOI 10.1161/CIRCRESAHA.115.307527
   Song KH, 2012, NATURE, V485, P599, DOI 10.1038/nature11139
   Tang XL, 2015, CIRC-HEART FAIL, V8, P757, DOI 10.1161/CIRCHEARTFAILURE.115.002210
   Tang XL, 2010, CIRCULATION, V121, P293, DOI 10.1161/CIRCULATIONAHA.109.871905
   Urbanek K, 2005, CIRC RES, V97, P663, DOI 10.1161/01.RES.0000183733.53101.11
   Urbanek K, 2006, P NATL ACAD SCI USA, V103, P9226, DOI 10.1073/pnas.0600635103
   van Berlo JH, 2014, NATURE, V509, P337, DOI 10.1038/nature13309
   Wallner M, 2016, CIRC RES, V119, P865, DOI 10.1161/CIRCRESAHA.116.308687
   Weirather J, 2014, CIRC RES, V115, P55, DOI 10.1161/CIRCRESAHA.115.303895
   Wessels A, 2003, PHYSIOL GENOMICS, V15, P165, DOI 10.1152/physiolgenomics.00033.2003
   Williams AR, 2011, CIRC RES, V109, P923, DOI 10.1161/CIRCRESAHA.111.243147
   Xu D, 2016, ANNU REV PHARMACOL, V56, P323, DOI 10.1146/annurev-pharmtox-010715-103644
   Yousef M, 2009, J AM COLL CARDIOL, V53, P2262, DOI 10.1016/j.jacc.2009.02.051
   Zeng LP, 2007, CIRCULATION, V115, P1866, DOI 10.1161/CIRCULATIONAHA.106.659730
   Zhu H, 2010, NAT PROTOC, V5, P550, DOI 10.1038/nprot.2009.238
   ZSEBO KM, 1990, CELL, V63, P213, DOI 10.1016/0092-8674(90)90302-U
NR 58
TC 4
Z9 4
U1 0
U2 5
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD APR
PY 2019
VL 49
IS 4
BP 314
EP 325
DI 10.4070/kcj.2018.0437
PG 12
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA HP6BU
UT WOS:000461768300003
PM 30808081
OA Green Published, Other Gold
DA 2021-04-22
ER

PT J
AU Kim, AY
   Jung, SY
   Chang, JY
   Jung, JW
   Choi, JY
AF Kim, Ah Young
   Jung, Se Yong
   Chang, Jenny Yeonsoo
   Jung, Jo Won
   Choi, Jae Young
TI Early to Mid-Term Follow-Up Outcomes of Percutaneous Closure of Atrial
   Septal Defects Using Recent Generation Devices: a Single-Center
   Experience
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Congenital heart defects; Atrial septal defects; Septa] occluder device;
   Cardiac catheterization
ID CONGENITAL HEART-DISEASE; FIGULLA ASD OCCLUDER; TRANSCATHETER CLOSURE;
   CLINICAL-EXPERIENCE; CARDIAC EROSION; COMPLICATIONS; CHILDREN; IMPACT
AB Background and Objectives: This study aimed to describe our early to mid-term experience with transcatheter atrial septal defect (ASD) closure using the Occlutech Figulle (R) Flex II device (FSO), Gore (R) Cardioform septal occluder (GSO), and Amplatzer (R) septal occluder (ASO) after they were first approved in Korea in 2014, and to compare the three aforementioned kinds of ASD closure devices.
   Methods: Between September 2014 and August 2016, 267 patients underwent transcatheter ASD closure in our institution. Baseline characteristics, hemodynamic features, comorbidities, and procedural success and complication rates were analyzed retrospectively. The unpaired Student t-test or variance analysis was used in the statistical analysis.
   Results: The FSO was most commonly used (n=152, 56.9%), followed by the ASO (n=98, 36.7%) and GSO (n=17, 6.4%). Baseline characteristics and hemodynamic features were similar between the devices, except that the defect size and pulmonary flow-to-systemic flow ratio were lower in the GSO group than in the other groups. Overall, the procedural success rate remained at 100%, and major complication rate was <1%. No late complication occurred during the follow-up.
   Conclusions: The FSO and GSO are feasible, safe options for use in transcatheter ASD closure, and they are comparable to the ASO.
C1 [Kim, Ah Young; Jung, Se Yong; Jung, Jo Won; Choi, Jae Young] Yonsei Univ, Severance Cardiovasc Hosp, Ctr Congenital Heart Dis, Div Pediat Cardiol,Coll Med, Seoul, South Korea.
   [Chang, Jenny Yeonsoo] Univ Penn, Coll Arts & Sci, Dept Biol Basis Behav, Philadelphia, PA 19104 USA.
RP Choi, JY (corresponding author), Yonsei Univ, Severance Cardiovasc Hosp, Div Pediat Cardiol, Coll Med, 50-1 Yonsei Ro, Seoul 03722, South Korea.
EM cjy0122@yuhs.ac
RI Jung, Yong/AAR-3286-2020
OI Jung, Yong/0000-0003-1337-563X; Choi, Jae Young/0000-0002-1247-6669;
   Kim, Ah Young/0000-0002-0713-4461
CR Amin Z, 2004, CATHETER CARDIO INTE, V63, P496, DOI 10.1002/ccd.20211
   Aytemir K, 2012, J INTERV CARDIOL, V25, P375, DOI 10.1111/j.1540-8183.2012.00734.x
   Baumgartner H, 2010, EUR HEART J, V31, P2915, DOI 10.1093/eurheartj/ehq249
   Berger F, 1999, J THORAC CARDIOV SUR, V118, P674, DOI 10.1016/S0022-5223(99)70013-9
   Butera G, 2008, AM HEART J, V156, P706, DOI 10.1016/j.ahj.2008.06.008
   Cansel M, 2011, ARCH CARDIOVASC DIS, V104, P155, DOI 10.1016/j.acvd.2010.12.006
   Crawford GB, 2012, CATHETER CARDIO INTE, V80, P157, DOI 10.1002/ccd.24347
   Godart F, 2015, ARCH CARDIOVASC DIS, V108, P57, DOI 10.1016/j.acvd.2014.09.005
   Grohmann J, 2014, CATHETER CARDIO INTE, V84, pE51, DOI 10.1002/ccd.25494
   Grohmann J, 2017, CATHETER CARDIO INTE, V89, pE226, DOI 10.1002/ccd.26881
   Haas NA, 2016, CATHETER CARDIO INTE, V88, P571, DOI 10.1002/ccd.26497
   Haas NA, 2016, EUROINTERVENTION, V11, P1153, DOI 10.4244/EIJY14M12_09
   Halabi A, 2008, CATHETER CARDIO INTE, V71, P853, DOI 10.1002/ccd.21451
   Ilkay E, 2010, TURK KARDIYOL DERN A, V38, P189
   Jung SY, 2018, J THORAC DIS, V10, pS2909, DOI 10.21037/jtd.2018.02.19
   Mathewson JW, 2004, J AM SOC ECHOCARDIOG, V17, P62, DOI 10.1016/j.echo.2003.09.018
   McElhinney DB, 2016, CIRCULATION, V133, P1738, DOI 10.1161/CIRCULATIONAHA.115.019987
   Medford BA, 2014, J AM SOC ECHOCARDIOG, V27, P984, DOI 10.1016/j.echo.2014.05.017
   Mitchelson B, 2017, CARDIOL YOUNG, V27, P1153, DOI 10.1017/S1047951116002663
   Nassif M, 2016, EXPERT REV MED DEVIC, V13, P555, DOI 10.1080/17434440.2016.1182860
   O'Byrne ML, 2017, CATHETER CARDIO INTE, V89, P102, DOI 10.1002/ccd.26585
   Pac A, 2009, J INTERV CARDIOL, V22, P489, DOI 10.1111/j.1540-8183.2009.00497.x
   Roymanee S, 2015, PEDIATR CARDIOL, V36, P935, DOI 10.1007/s00246-015-1103-y
   Smith B, 2014, CATHETER CARDIO INTE, V83, P581, DOI 10.1002/ccd.25216
   Sondergaard L, 2013, EUROINTERVENTION, V9, P959, DOI 10.4244/EIJV9I8A160
NR 25
TC 2
Z9 2
U1 0
U2 2
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD APR
PY 2019
VL 49
IS 4
BP 326
EP 335
DI 10.4070/kcj.2018.0278
PG 10
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA HP6BU
UT WOS:000461768300004
PM 30808079
OA Green Published, Other Gold
DA 2021-04-22
ER

PT J
AU Choe, WS
   Kang, JH
   Choi, EK
   Shin, SY
   Lubitz, SA
   Ellinor, PT
   Oh, S
   Lim, HE
AF Choe, Won-Seok
   Kang, Jun Hyuk
   Choi, Eue-Keun
   Shin, Seung Yong
   Lubitz, Steven A.
   Ellinor, Patrick T.
   Oh, Seit
   Lim, Hong Euy
TI A Genetic Risk Score for Atrial Fibrillation Predicts the Response to
   Catheter Ablation
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Atrial fibrillation; Genetics; Catheter ablation; Recurrence
ID NUCLEOTIDE POLYMORPHISM; VARIANTS; RECURRENCE; INDIVIDUALS
AB Background and Objectives: The association of susceptibility loci for atrial fibrillation (AF) with AF recurrence after ablation has been reported, although with controversial results. In this prospective cohort analysis, we aimed to investigate whether a genetic risk score (GRS) can predict the rhythm outcomes after catheter ablation of AF.
   Methods: We determined the association between 20 AF-susceptible single nucleotide polymorphisms (SNPs) and AF recurrence after catheter ablation in 746 patients (74% males; age, 59 +/- 11 years; 56% paroxysmal AF). A GRS was calculated by summing the unweighted numbers of risk alleles of selected SNPs. A Cox proportional hazard model was used to identify the association between the GRS and risk of AF recurrence after catheter ablation.
   Results: AF recurrences after catheter ablation occurred in 168 (22.5%) subjects with a median follow-up of 23 months. The GRS was calculated using 5 SNPs (rs1448818, rs2200733, rs6843082, rs6838973 at chromosome 4q25 [PITX2] and rs2106261 at chromosome 16q22 [ZFHX3]), which showed modest associations with AF recurrence. The GRS was significantly associated with AF recurrence (hazard ratio [HR] per each score, 1.13; 95% confidence interval [CI], 1.03-1.24). Patients with intermediate (GRS 4-6) and high risks (GRS 7-10) showed HRs of 2.00 (95% CI, 0.99-4.04) and 2.66 (95% CI, 1.32-5.37), respectively, compared to patients with low risk (GRS 0-3).
   Conclusions: Our novel GRS using 5 AF-susceptible SNPs was strongly associated with AF recurrence after catheter ablation in Korean population, beyond clinical risk factors. Further efforts are warranted to construct a generalizable, robust genetic prediction model which can guide the optimal treatment strategies.
C1 [Choe, Won-Seok] Sejong Hosp, Dept Internal Med, Div Cardiol, Bucheon, South Korea.
   [Kang, Jun Hyuk] Korea Univ, Dept Internal Med, Div Cardiol, Guro Hosp, Seoul, South Korea.
   [Choi, Eue-Keun; Oh, Seit] Seoul Natl Univ Hosp, Dept Internal Med, Div Cardiol, Seoul, South Korea.
   [Shin, Seung Yong] Chung Ang Univ, Coll Med, Heart Res Inst, Div Cardiol, Seoul, South Korea.
   [Lubitz, Steven A.; Ellinor, Patrick T.] Massachusetts Gen Hosp, Cardiac Arrhythmia Serv, Boston, MA 02114 USA.
   [Lubitz, Steven A.; Ellinor, Patrick T.] Massachusetts Gen Hosp, Cardiovasc Res Ctr, Boston, MA 02114 USA.
   [Lubitz, Steven A.; Ellinor, Patrick T.] Brd Inst Harvard & MIT, Program Med & Populat Genet, Cambridge, MA USA.
   [Lim, Hong Euy] Hallym Univ, Coll Med, Div Cardiol, Sacred Heart Hosp, 22 Gwanpyeong Ro 170beon Gil, Anyang 14068, South Korea.
RP Lim, HE (corresponding author), Hallym Univ, Coll Med, Div Cardiol, Sacred Heart Hosp, 22 Gwanpyeong Ro 170beon Gil, Anyang 14068, South Korea.; Choi, EK (corresponding author), Seoul Natl Univ Hosp, Dept Internal Med, 101 Daehak Ro, Seoul 03080, South Korea.
EM choiek17@snu.ac.kr; hongeuy1046@gmail.com
RI Choi, Eue-Keun/J-5968-2014; Shin, Seung Yong/AAF-7226-2019; Oh,
   Seil/J-5539-2012
OI Choi, Eue-Keun/0000-0002-0411-6372; Shin, Seung
   Yong/0000-0002-3408-6899; Oh, Seil/0000-0002-2504-9615; Ellinor,
   Patrick/0000-0002-2067-0533; Lim, Hong Euy/0000-0001-8102-8352
FU Seoul National University Hospital Research Fund, a Korea National
   Research Foundation of Korea - Ministry of Education, Science and
   Technology [2520140060, 2014R1A1A2A16055218]
FX This study was supported by grant No. 2520140060 from the Seoul National
   University Hospital Research Fund, a Korea National Research Foundation
   of Korea funded by the Ministry of Education, Science and Technology
   (2014R1A1A2A16055218). The funding source has no involvement in the
   current study.
CR Benjamin EJ, 2009, NAT GENET, V41, P879, DOI 10.1038/ng.416
   Berruezo A, 2007, EUR HEART J, V28, P836, DOI 10.1093/eurheartj/ehm027
   Burgess S, 2013, INT J EPIDEMIOL, V42, P1134, DOI 10.1093/ije/dyt093
   Calkins H, 2018, EUROPACE, V20, pE1, DOI 10.1093/europace/eux274
   Choi EK, 2015, J AM HEART ASSOC, V4, DOI 10.1161/JAHA.115.002046
   Ellinor PT, 2012, NAT GENET, V44, P670, DOI 10.1038/ng.2261
   Ellinor PT, 2010, NAT GENET, V42, P240, DOI 10.1038/ng.537
   Everett BM, 2013, EUR HEART J, V34, P2243, DOI 10.1093/eurheartj/eht033
   Go AS, 2001, JAMA-J AM MED ASSOC, V285, P2370, DOI 10.1001/jama.285.18.2370
   Gudbjartsson DF, 2007, NATURE, V448, P353, DOI 10.1038/nature06007
   Haissaguerre M, 1998, NEW ENGL J MED, V339, P659, DOI 10.1056/NEJM199809033391003
   Hussein AA, 2011, CIRCULATION, V123, P2077, DOI 10.1161/CIRCULATIONAHA.110.007252
   Husser D, 2010, J AM COLL CARDIOL, V55, P747, DOI 10.1016/j.jacc.2009.11.041
   January CT, 2014, J AM COLL CARDIOL, V64, pE1, DOI 10.1016/j.jacc.2014.03.022
   Kim MH, 2011, CIRC-CARDIOVASC QUAL, V4, P313, DOI 10.1161/CIRCOUTCOMES.110.958165
   Lubitz SA, 2014, J AM COLL CARDIOL, V63, P1200, DOI 10.1016/j.jacc.2013.12.015
   Mohanty S, 2016, J INTERV CARD ELECTR, V45, P7, DOI 10.1007/s10840-015-0069-2
   Mommersteeg MTM, 2007, CIRC RES, V101, P902, DOI 10.1161/CIRCRESAHA.107.161182
   Muse ED, 2018, PLOS MED, V15, DOI 10.1371/journal.pmed.1002525
   Nojiri S, 2004, BIOCHEM BIOPH RES CO, V314, P97, DOI 10.1016/j.bbrc.2003.12.054
   Ouyang F, 2010, CIRCULATION, V122, P2368, DOI 10.1161/CIRCULATIONAHA.110.946806
   Park Jeong-Hwan, 2009, Korean Circ J, V39, P185, DOI 10.4070/kcj.2009.39.5.185
   Park JK, 2017, J CARDIOL, V69, P584, DOI 10.1016/j.jjcc.2016.04.017
   Parvez B, 2013, HEART RHYTHM, V10, P849, DOI 10.1016/j.hrthm.2013.02.018
   Parvez B, 2012, J AM COLL CARDIOL, V60, P539, DOI 10.1016/j.jacc.2012.01.070
   Sawhney N, 2009, AM J CARDIOL, V104, P366, DOI 10.1016/j.amjcard.2009.03.044
   Shoemaker MB, 2015, CIRC-ARRHYTHMIA ELEC, V8, P296, DOI 10.1161/CIRCEP.114.001909
   Shoemaker MB, 2013, HEART RHYTHM, V10, P394, DOI 10.1016/j.hrthm.2012.11.012
   Sinner MF, 2014, CIRCULATION, V130, P1225, DOI 10.1161/CIRCULATIONAHA.114.009892
   Tada H, 2014, STROKE, V45, P2856, DOI 10.1161/STROKEAHA.114.006072
NR 30
TC 8
Z9 8
U1 1
U2 2
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD APR
PY 2019
VL 49
IS 4
BP 338
EP 349
DI 10.4070/kcj.2018.0161
PG 12
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA HP6BU
UT WOS:000461768300006
PM 30808078
OA Green Published, Other Gold
DA 2021-04-22
ER

PT J
AU Chang, SA
   Kim, HK
   Chang, HJ
   Kim, DK
AF Chang, Sung-A
   Kim, Hyung-Kwan
   Chang, Hyuk Jae
   Kim, Duk-Kyung
TI Acute Hemodynamic Changes after Single Administration of Udenafil in
   Pulmonary Arterial Hypertension: a Phase IIa Study
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Hypertension; Pulmonary; Phosphodiesterase 5 inhibitors; Hemodynamic
   monitoring
ID ERECTILE DYSFUNCTION; DOUBLE-BLIND; INHIBITOR; EFFICACY; SAFETY;
   PHARMACOKINETICS; PRESSURE; THERAPY
AB Background and Objectives: Udenafil, a new phosphodiesterase-5 inhibitor (PDE5i), has been used to treat erectile dysfunction. Given the proven benefit of PDE5i in pulmonary arterial hypertension (PAH), we evaluated serial hemodynamic changes after single udenafil administration to determine the appropriate therapeutic dose.
   Methods: Eighteen patients were randomly allocated into one of 3 groups: placebo, udenafil 50 mg (U50), and udenafil 100 mg (U100). Diagnosis for inclusion was idiopathic PAH or PAH associated with connective tissue disease. Patients with any contraindication to PDE5i, and/or PDE5i treatment in the past 1 month were excluded. Continuous hemodynamic monitoring was performed by placing a Swan-Ganz catheter. Information on cardiac index (CI), mean pulmonary arterial pressure (mPAP), mean systemic arterial pressure (mSAP), pulmonary arterial wedge pressure (PAWP), and pulmonary vascular resistance index (PVRI) was obtained for 4 hours after drug administration.
   Results: The mPAP significantly decreased in both the USO and U100 (-11 mmHg and -8 mmHg from baseline, respectively, p<0.1). The mSAP also decreased in both U50 and U100; however, the decrease was greater in the U100 (Delta =-8.5 mmHg and Delta=-14.0 mmHg). CI increased in the U50, but decreased in the U100. Although PVRI decreased in both, statistical significance was only achieved in the USO compared to placebo. PAWP was stable during monitoring. U50 had at least 4 hour-effect after administration. Only 2 patients with U100 experienced mild adverse events.
   Conclusions: This is the first demonstration of the acute hemodynamic changes induced by udenafil. U50 is considered an optimal dose for treating PAH with more than 4-hour treatment effect.
C1 [Chang, Sung-A; Kim, Duk-Kyung] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Cardiol,Dept Med,Heart Vasc Stroke Inst, 81 Irwon Ro, Seoul 06351, South Korea.
   [Kim, Hyung-Kwan] Seoul Natl Univ Hosp, Dept Internal Med, Div Cardiol, Seoul, South Korea.
   [Chang, Hyuk Jae] Yonsei Severance Hosp, Dept Cardiol, Seoul, South Korea.
RP Kim, DK (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Cardiol,Dept Med,Heart Vasc Stroke Inst, 81 Irwon Ro, Seoul 06351, South Korea.
EM dukkyung.kim@gmail.com
RI Kim, Hyung-Kwan/R-8375-2019
OI Kim, Hyung-Kwan/0000-0001-7950-2131; Chang, Hyuk-Jae/0000-0002-6139-7545
FU Dong-A ST, Seoul, Korea
FX This study was supported by Dong-A ST, Seoul, Korea.
CR Fitzgerald AA, 2011, J CARD FAIL, V17, P664, DOI 10.1016/j.cardfail.2011.04.011
   Frishman William H, 2007, Cardiol Rev, V15, P257, DOI 10.1097/CRD.0b013e3180cabbe7
   Galie N, 2005, NEW ENGL J MED, V353, P2148, DOI 10.1056/NEJMoa050010
   Galie N, 2009, CIRCULATION, V119, P2894, DOI 10.1161/CIRCULATIONAHA.108.839274
   Ghofrani HA, 2004, J AM COLL CARDIOL, V44, P1488, DOI 10.1016/j.jacc.2004.06.060
   Kim BH, 2008, BRIT J CLIN PHARMACO, V65, P848, DOI 10.1111/j.1365-2125.2008.03107.x
   Kim HL, 2015, HYPERTENS RES, V38, P597, DOI 10.1038/hr.2015.46
   Kim KH, 2015, AM HEART J, V169, P813, DOI 10.1016/j.ahj.2015.03.018
   Kim TE, 2009, BRIT J CLIN PHARMACO, V68, P43, DOI 10.1111/j.1365-2125.2009.03404.x
   Kreisel W, 2015, DIGEST LIVER DIS, V47, P144, DOI 10.1016/j.dld.2014.10.018
   Paick JS, 2008, J SEX MED, V5, P946, DOI 10.1111/j.1743-6109.2007.00723.x
   Park HJ, 2010, J SEX MED, V7, P2209, DOI 10.1111/j.1743-6109.2010.01817.x
   Salem EA, 2006, CURR OPIN INVEST DR, V7, P661
   Zhao C, 2011, EUR UROL, V60, P380, DOI 10.1016/j.eururo.2011.03.025
NR 14
TC 3
Z9 3
U1 0
U2 2
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD APR
PY 2019
VL 49
IS 4
BP 353
EP 360
DI 10.4070/kcj.2018.0281
PG 8
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA HP6BU
UT WOS:000461768300008
PM 30808080
OA Green Published, Other Gold
DA 2021-04-22
ER

PT J
AU Ryan, M
   Briceno, N
   Perera, D
AF Ryan, Matt
   Briceno, Natalia
   Perera, Divaka
TI Mechanical Circulatory Support in the Cardiac Catheterization Laboratory
   for Cardiogenic Shock
SO KOREAN CIRCULATION JOURNAL
LA English
DT Review
DE Shock, cardiogenic; Myocardial infarction; Extracorporeal membrane
   oxygenation
ID ACUTE MYOCARDIAL-INFARCTION; INTRAAORTIC BALLOON PUMP; EXTRACORPOREAL
   MEMBRANE-OXYGENATION; PERCUTANEOUS CORONARY INTERVENTION; RANDOMIZED
   CLINICAL-TRIAL; VENTRICULAR ASSIST DEVICE; HEMODYNAMIC SUPPORT;
   HEART-FAILURE; RECOVER RIGHT; IMPELLA 2.5
AB Despite the development of acute revascularisation, the mortality rate for cardiogenic shock remains around 50%. Mechanical circulatory support devices have long held promise in improving outcomes in shock, but high-quality evidence of benefit has not been forthcoming. In this article we review the currently available devices for treating shock, their physiological effects and the evidence base for their use in practice. We subsequently look ahead within this developing field, including new devices and novel indications for established technology.
C1 [Ryan, Matt; Briceno, Natalia; Perera, Divaka] Kings Coll London, Sch Cardiovasc Med & Sci, London, England.
RP Perera, D (corresponding author), Kings Coll London, St Thomas Hosp, Rayne Inst, Cardiovasc Div, 4th Floor Lambeth Wing,Westminster Bridge Rd, London SE1 7EH, England.
EM divaka.perera@kcl.ac.uk
OI Perera, Divaka/0000-0001-6362-1291
FU British Heart FoundationBritish Heart Foundation [FS/18/16/33396,
   FS/15/78/31678, FS/13/15/30026, FS/16/49/32320] Funding Source: Medline;
   Department of HealthEuropean Commission [10/57/67] Funding Source:
   Medline
CR Anderson M, 2018, J HEART LUNG TRANSPL, V37, P1448, DOI 10.1016/j.healun.2018.08.001
   Anderson MB, 2015, J HEART LUNG TRANSPL, V34, P1549, DOI 10.1016/j.healun.2015.08.018
   [Anonymous], 2018, DAN CARD SHOCK TRIAL
   Aso S, 2016, CRIT CARE MED, V44, P1974, DOI 10.1097/CCM.0000000000001828
   Baruteau AE, 2018, EUR HEART J-ACUTE CA, V7, P70, DOI 10.1177/2048872616675485
   Basir MB, 2018, CATHETER CARDIO INTE, V91, P454, DOI 10.1002/ccd.27427
   Briceno N, 2018, J AM COLL CARDIOL, V72, pB181, DOI 10.1016/j.jacc.2018.08.1618
   De Silva K, 2014, JACC-CARDIOVASC INTE, V7, P631, DOI 10.1016/j.jcin.2013.11.023
   Hall SA, 2016, J HEART LUNG TRANSPL, V35, pS54, DOI 10.1016/j.healun.2016.01.150
   Hawranek M, 2018, JACC-CARDIOVASC INTE, V11, P1885, DOI 10.1016/j.jcin.2018.07.030
   Henriques JPS, 2014, AM HEART J, V167, P472, DOI 10.1016/j.ahj.2013.12.018
   Hochman JS, 1999, NEW ENGL J MED, V341, P625, DOI 10.1056/NEJM199908263410901
   Ibanez B, 2018, EUR HEART J, V39, P119, DOI 10.1093/eurheartj/ehx393
   Kamioka N, 2017, CATHETER CARDIOVASC
   KANTROWITZ A, 1968, J AMER MED ASSOC, V203, P113, DOI 10.1001/jama.203.2.113
   Kapur NK, 2015, J AM COLL CARDIOL, V66, pB74, DOI 10.1016/j.jacc.2015.08.210
   Kuchibhotla S, 2017, J AM HEART ASSOC, V6, DOI 10.1161/JAHA.117.006670
   Lima B, 2016, AM J CARDIOL, V117, P1622, DOI 10.1016/j.amjcard.2016.02.038
   Marasco SF, 2008, HEART LUNG CIRC, V17, pS41, DOI 10.1016/j.hlc.2008.08.009
   Mathur M, 2016, JACC-CARDIOVASC INTE, V9, P1196, DOI 10.1016/j.jcin.2016.03.028
   Moriyama N, 2018, EUROINTERVENTION
   O'Neill WW, 2018, AM HEART J, V202, P33, DOI 10.1016/j.ahj.2018.03.024
   O'Neill WW, 2012, CIRCULATION, V126, P1717, DOI 10.1161/CIRCULATIONAHA.112.098194
   Ouweneel DM, 2017, J AM COLL CARDIOL, V69, P278, DOI 10.1016/j.jacc.2016.10.022
   Ouweneel M, 2016, J AM COLL CARDIOL
   Perera D, 2013, CIRCULATION, V127, P207, DOI 10.1161/CIRCULATIONAHA.112.132209
   Perera D, 2010, JAMA-J AM MED ASSOC, V304, P867, DOI 10.1001/jama.2010.1190
   Remmelink M, 2007, CATHETER CARDIO INTE, V70, P532, DOI 10.1002/ccd.21160
   Schmidt M, 2015, EUR HEART J, V36, P2246, DOI 10.1093/eurheartj/ehv194
   Schrage B, 2018, JACC-HEART FAIL, V6, P1035, DOI 10.1016/j.jchf.2018.09.009
   Seyfarth M, 2008, J AM COLL CARDIOL, V52, P1584, DOI 10.1016/j.jacc.2008.05.065
   Sjauw KD, 2009, EUR HEART J, V30, P459, DOI 10.1093/eurheartj/ehn602
   Sorajja P, 2017, CATHETER CARDIO INTE, V89, pE233, DOI 10.1002/ccd.26888
   Thiele H, 2017, NEW ENGL J MED, V377, P2419, DOI 10.1056/NEJMoa1710261
   Thiele H, 2018, CIRCULATION
   Thiele H, 2013, LANCET, V382, P1638, DOI 10.1016/S0140-6736(13)61783-3
   Thiele H, 2012, NEW ENGL J MED, V367, P1287, DOI 10.1056/NEJMoa1208410
   Truong HTD, 2018, CARDIOVASC REVASCULA, V19, P540, DOI 10.1016/j.carrev.2017.12.016
   Valgimigli M, 2005, CATHETER CARDIO INTE, V65, P263, DOI 10.1002/ccd.20380
   van Diepen S, 2017, CIRCULATION, V136, pE232, DOI 10.1161/CIR.0000000000000525
   van Nunen LX, 2013, NETH HEART J, V21, P554, DOI 10.1007/s12471-013-0485-9
   Yancy CW, 2013, J AM COLL CARDIOL, V62, pE147, DOI 10.1016/j.jacc.2013.05.019
NR 42
TC 1
Z9 1
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAR
PY 2019
VL 49
IS 3
BP 197
EP 213
DI 10.4070/kcj.2018.0443
PG 17
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA HM8EJ
UT WOS:000459710900001
PM 30808071
OA Other Gold, Green Published
DA 2021-04-22
ER

PT J
AU Ahn, CM
   Hiromi, M
AF Ahn, Chul-Min
   Hiromi, Matsubara
TI Chronic Thromboembolic Pulmonary Hypertension: Endovascular Treatment
SO KOREAN CIRCULATION JOURNAL
LA English
DT Review
DE Hypertension, pulmonary; Pulmonary embolism; Thromboembolism;
   Angioplasty
ID ANGIOPLASTY; HEMODYNAMICS
AB Chronic thromboembolic pulmonary hypertension (CTEPH) is a rare cause of pulmonary hypertension; less than 5% of pulmonary hypertension is caused by recurrent pulmonary thromboembolism (PTE). By definition, CTEPH happens within the first two years after symptomatic PTE; however, cases are often diagnosed without a history of acute PTE. Because of the poor functional status and chronicity of this disease, the classic and curative strategy of open pulmonary endarterectomy cannot be applied in some patients with lesions that involve the distal subsegmental pulmonary artery. Bridging therapy is needed for cases that are technically operable but have an unacceptable risk-benefit assessment or residual symptomatic pulmonary hypertension following surgical removal. Groups in Europe and Japan recently introduced balloon pulmonary angioplasty or percutaneous transluminal pulmonary angioplasty, which has led to significant improvement in functional and hemodynamic parameters in patients with CTEPH. This article introduces recent updates in patient selection and interventional procedures for this chronic and devastating disease.
C1 [Ahn, Chul-Min] Yonsei Univ, Severance Cardiovasc Hosp, Div Cardiol, Dept Internal Med,Coll Med, 50 Yonsei Ro, Seoul 03722, South Korea.
   [Hiromi, Matsubara] Natl Hosp Org, Okayama Med Ctr, Dept Cardiol, Okayama, Japan.
   [Hiromi, Matsubara] Natl Hosp Org, Okayama Med Ctr, Dept Clin Sci, Okayama, Japan.
RP Ahn, CM (corresponding author), Yonsei Univ, Severance Cardiovasc Hosp, Div Cardiol, Dept Internal Med,Coll Med, 50 Yonsei Ro, Seoul 03722, South Korea.
EM drcello@yuhs.ac
OI Ahn, Chul-Min/0000-0002-7071-4370
CR Ende-Verhaar YM, 2017, EUR RESPIR J, V49, DOI 10.1183/13993003.01792-2016
   Fedullo PF, 2001, NEW ENGL J MED, V345, P1465, DOI 10.1056/NEJMra010902
   Fedullo PF, 2001, CLIN CHEST MED, V22, P561, DOI 10.1016/S0272-5231(05)70292-6
   Feinstein JA, 2001, CIRCULATION, V103, P10
   Galie N, 2016, EUR HEART J, V37, P67, DOI 10.1093/eurheartj/ehv317
   Galie N, 2009, EUR HEART J, V30, P2493, DOI 10.1093/eurheartj/ehp297
   Ghofrani HA, 2013, NEW ENGL J MED, V369, P319, DOI 10.1056/NEJMoa1209657
   Kataoka M, 2012, CIRC-CARDIOVASC INTE, V5, P756, DOI 10.1161/CIRCINTERVENTIONS.112.971390
   Kawakami T, 2016, CIRC-CARDIOVASC INTE, V9, DOI 10.1161/CIRCINTERVENTIONS.115.003318
   Kim NH, 2018, EUR RESPIR J, V52, DOI 10.1183/13993003.01581-2018
   Kwon W, 2018, J KOREAN MED SCI, V33, DOI 10.3346/jkms.2018.33.e24
   Lang IM, 2013, EUR RESPIR J, V41, P462, DOI 10.1183/09031936.00049312
   Mahmud E, 2018, J AM COLL CARDIOL, V71, P2468, DOI 10.1016/j.jacc.2018.04.009
   Mizoguchi H, 2012, CIRC-CARDIOVASC INTE, V5, P748, DOI 10.1161/CIRCINTERVENTIONS.112.971077
   Ogawa A, 2018, CIRC J, V82, P1222, DOI 10.1253/circj.CJ-18-0258
   Ogawa A, 2017, CIRC-CARDIOVASC QUAL, V10, DOI 10.1161/CIRCOUTCOMES.117.004029
   Ogawa A, 2014, INTERNAL MED, V53, P729, DOI 10.2169/internalmedicine.53.1343
   Oh DK, 2019, HEART LUNG, V48, P28, DOI 10.1016/j.hrtlng.2018.07.008
   Park JS, 2017, KOREAN J INTERN MED, V32, P85, DOI 10.3904/kjim.2014.175
   Pepke-Zaba J, 2017, EUR RESPIR REV, V26, DOI 10.1183/16000617.0107-2016
   Sugimura K, 2012, CIRC J, V76, P485, DOI 10.1253/circj.CJ-11-1217
NR 21
TC 0
Z9 1
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAR
PY 2019
VL 49
IS 3
BP 214
EP 222
DI 10.4070/kcj.2018.0380
PG 9
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA HM8EJ
UT WOS:000459710900002
PM 30808072
OA Green Published, Other Gold
DA 2021-04-22
ER

PT J
AU Oh, JH
   Hong, YM
AF Oh, Jin-Hee
   Hong, Young Mi
TI Blood Pressure Trajectories from Childhood to Adolescence in Pediatric
   Hypertension
SO KOREAN CIRCULATION JOURNAL
LA English
DT Review
DE Blood pressure; Hypertension; Children; Low birth weight; Infant,
   premature
ID CARDIOVASCULAR-DISEASE RISK; LOW-BIRTH-WEIGHT; PRETERM BIRTH;
   POSTNATAL-GROWTH; SUBCLINICAL ATHEROSCLEROSIS; ARTERIAL STIFFNESS; YOUNG
   ADULTHOOD; GEORGIA STRESS; RENAL-FUNCTION; AGE
AB It has been known for a long time that elevated blood pressure (BP) in the young may persist and progress into adult hypertension (HTN). Multiple studies have revealed the predicted BP trajectory lines starting from childhood and related them to later cardiovascular (CV) risks in adulthood. As a small baby grows into a tall adult, BP will also naturally increase. Among early-life predictors of adult HTN, birth history, such as prematurity, and low birth weight have been popular subjects in research on pediatric HTN, because body size at birth has been reported to be inversely related to the risk of adulthood HTN. The hypothesis of HTN in prematurely born adolescents has been postulated as a physiological predisposition to postnatal excessive weight gain. Current body weight is a well-known independent predictor of HTN in children, and some studies showed that children demonstrating upward crossing of their weight percentiles while growing into adolescents have significantly increased risk for elevated BP later in life. Recently, reports focused on the adverse effect of excessive catch-up growth in this population are gradually drawing attention. Accordingly, children born prematurely or with intrauterine growth restriction who show rapid changes in their weight percentile should be under surveillance with BP monitoring. Prevention of childhood obesity, along with special care for premature infants or infants small for their gestational age, by providing healthy nutritional guidelines should be cardinal strategies for the prevention of adult HTN and CV risks later in life.
C1 [Oh, Jin-Hee] Catholic Univ Korea, St Vincents Hosp, Dept Pediat, Seoul, South Korea.
   [Hong, Young Mi] Ewha Womans Univ Hosp, Coll Med, Dept Pediat, Seoul, South Korea.
RP Hong, YM (corresponding author), Ewha Womans Univ, Coll Med, Dept Pediat, 1071 Anyangcheon Ro, Seoul 07985, South Korea.
EM ymhong@ewha.ac.kr
CR Agarwal R, 2016, NAT REV NEPHROL, V12, P127, DOI 10.1038/nrneph.2016.2
   AlGhatrif M, 2013, HYPERTENSION, V62, P934, DOI 10.1161/HYPERTENSIONAHA.113.01445
   Allen NB, 2014, JAMA-J AM MED ASSOC, V311, P490, DOI 10.1001/jama.2013.285122
   Aris IM, 2017, INT J OBESITY, V41, P1011, DOI 10.1038/ijo.2017.40
   BAO WH, 1995, AM J HYPERTENS, V8, P657, DOI 10.1016/0895-7061(95)00116-7
   BARKER DJP, 1989, BRIT MED J, V298, P564, DOI 10.1136/bmj.298.6673.564
   Bonamy AKE, 2005, PEDIATR RES, V58, P845, DOI 10.1203/01.PDR.0000181373.29290.80
   Bowers K, 2011, PEDIATRICS, V127, pE1272, DOI 10.1542/peds.2010-2213
   Brenner BM, 1996, KIDNEY INT, V49, P1774, DOI 10.1038/ki.1996.265
   Buscot MJ, 2018, EUR HEART J, V39, P2263, DOI 10.1093/eurheartj/ehy161
   Carmody JB, 2013, PEDIATRICS, V131, P1168, DOI 10.1542/peds.2013-0009
   Cho WK, 2014, PEDIATR INT, V56, P344, DOI 10.1111/ped.12278
   Dotsch J, 2009, HYPERTENS RES, V32, P238, DOI 10.1038/hr.2009.4
   Falkner B, 2004, HYPERTENSION, V43, P203, DOI 10.1161/01.HYP.0000109322.72948.24
   Ferreira VR, 2018, J PEDIAT-BRAZIL, V94, P184, DOI 10.1016/j.jped.2017.04.007
   Flynn JT, 2017, PEDIATRICS, V140, DOI 10.1542/peds.2017-1904
   Frankfurt JA, 2012, PEDIATR NEPHROL, V27, P2285, DOI 10.1007/s00467-012-2265-y
   Fuller-Rowell TE, 2017, AM J EPIDEMIOL, V185, P888, DOI 10.1093/aje/kww198
   Furer A, 2018, CARDIOVASC DIABETOL, V17, DOI 10.1186/s12933-018-0727-7
   Gubhaju L, 2011, REPROD SCI, V18, P322, DOI 10.1177/1933719111401659
   Hao G, 2017, HYPERTENSION, V69, P435, DOI 10.1161/HYPERTENSIONAHA.116.08312
   Hemachandra AH, 2007, PEDIATRICS, V119, pE1264, DOI 10.1542/peds.2005-2486
   Hibino S, 2015, PEDIATR NEPHROL, V30, P1889, DOI 10.1007/s00467-015-3149-8
   Hindmarsh PC, 2010, PEDIATRICS, V126, pE1507, DOI 10.1542/peds.2010-0358
   Howe LD, 2013, CIRC-CARDIOVASC GENE, V6, P608, DOI 10.1161/CIRCGENETICS.113.000197
   Ingelfinger JR, 2008, ADV CHRONIC KIDNEY D, V15, P107, DOI 10.1053/j.ackd.2008.01.003
   Inomata S, 2015, PEDIATR INT, V57, P1126, DOI 10.1111/ped.12732
   Jackson SL, 2018, AM J TRANSPLANT, V18, P2356, DOI 10.1111/ajt.15050
   Juhola J, 2013, CIRCULATION, V128, P217, DOI 10.1161/CIRCULATIONAHA.113.001614
   Juonala M, 2015, J HYPERTENS, V33, P1542, DOI 10.1097/HJH.0000000000000612
   Kwok MK, 2013, J HYPERTENS, V31, P1785, DOI 10.1097/HJH.0b013e3283622ea0
   Leeson CPM, 2001, CIRCULATION, V103, P1264
   Lei XP, 2015, J PEDIATR-US, V166, P54, DOI 10.1016/j.jpeds.2014.09.025
   Natl High Blood Pressure Educ Prog, 2004, PEDIATRICS, V114, P555
   Niiranen TJ, 2018, JAMA CARDIOL, V3, P427, DOI 10.1001/jamacardio.2018.0250
   Nuyt AM, 2017, CLIN PERINATOL, V44, P315, DOI 10.1016/j.clp.2017.01.010
   Ohmi Hiroki, 2013, J Rural Med, V8, P176, DOI 10.2185/jrm.8.176
   Paquette K, 2018, HYPERTENSION, V72, P918, DOI 10.1161/HYPERTENSIONAHA.118.11397
   Parker ED, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2015-1662
   Perng W, 2016, HYPERTENSION, V67, P301, DOI 10.1161/HYPERTENSIONAHA.115.06635
   Podoll A, 2007, PEDIATRICS, V119, pE538, DOI 10.1542/peds.2006-1686
   Primatesta P, 2005, HYPERTENSION, V45, P75, DOI 10.1161/01.HYP.0000150037.98835.10
   Rosner B, 2013, HYPERTENSION, V62, P247, DOI 10.1161/HYPERTENSIONAHA.111.00831
   Rossi P, 2011, J ADOLESCENT HEALTH, V48, P520, DOI 10.1016/j.jadohealth.2010.08.004
   SHEAR CL, 1986, PEDIATRICS, V77, P862
   Simonetti GD, 2008, HYPERTENSION, V52, P625, DOI 10.1161/HYPERTENSIONAHA.108.114983
   Singhal A, 2004, CIRCULATION, V109, P1108, DOI 10.1161/01.CIR.0000118500.23649.DF
   Staley JR, 2015, J AM HEART ASSOC, V4, DOI 10.1161/JAHA.114.001422
   Steen E, 2015, ACTA PAEDIATR, V104, P1098, DOI 10.1111/apa.13095
   Stock K, 2018, J PEDIATR-US, V201, P49, DOI 10.1016/j.jpeds.2018.05.056
   Su SY, 2015, CIRCULATION, V131, P1674, DOI 10.1161/CIRCULATIONAHA.114.013104
   Sutherland M, 2014, CLIN PERINATOL, V41, P561, DOI 10.1016/j.clp.2014.05.006
   Sylvestre MP, 2017, J HYPERTENS, V35, P1416, DOI 10.1097/HJH.0000000000001322
   Theodore RF, 2015, HYPERTENSION, V66, P1108, DOI 10.1161/HYPERTENSIONAHA.115.05831
   Thomas R, 2009, KIDNEY INT, V76, P361, DOI 10.1038/ki.2009.181
   Wang XL, 2006, CIRCULATION, V114, P2780, DOI 10.1161/CIRCULATIONAHA.106.643940
   Washburn LK, 2015, J RENIN-ANGIO-ALDO S, V16, P529, DOI 10.1177/1470320314526940
   WEBBER LS, 1983, J CHRON DIS, V36, P647, DOI 10.1016/0021-9681(83)90081-4
   WHINCUP P, 1995, BRIT MED J, V311, P773, DOI 10.1136/bmj.311.7008.773
   Whincup PH, 1999, AM J EPIDEMIOL, V149, P730
   Wills AK, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000440
   Wright JT, 2015, NEW ENGL J MED, V373, P2103, DOI 10.1056/NEJMoa1511939
   Zachariah JP, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.113.000725
   Zhang T, 2018, HYPERTENSION, V72, P93, DOI 10.1161/HYPERTENSIONAHA.118.10975
NR 64
TC 2
Z9 3
U1 0
U2 3
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAR
PY 2019
VL 49
IS 3
BP 223
EP 237
DI 10.4070/kcj.2018.0448
PG 15
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA HM8EJ
UT WOS:000459710900003
PM 30808073
OA Other Gold, Green Published
DA 2021-04-22
ER

PT J
AU Kim, SH
   Yun, SC
   Park, JJ
   Lee, SE
   Jeon, ES
   Kim, JJ
   Cho, MC
   Chae, SC
   Kang, SM
   Choi, DJ
   Yoo, BS
   Kim, KH
   Oh, BH
   Baek, SH
AF Kim, Sung-Hwan
   Yun, Sung-Cheol
   Park, Jin Joo
   Lee, Sang Eun
   Jeon, Eun-Seok
   Kim, Jae-Joong
   Cho, Myeong-Chan
   Chae, Shung Chult
   Kang, Seok-Min
   Choi, Dong-Ju
   Yoo, Byung-Su
   Kim, Kye Hun
   Oh, Byung-Hee
   Baek, Sang Hong
CA KorAHF Investigator
TI Beta-Blockers in Patients with Heart Failure with Preserved Ejection
   Fraction: Results from The Korea Acute Heart Failure (KorAHF) Registry
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Adrenergic beta-antagonist; Heart failure; Diastole
ID THERAPIES; ASSOCIATION; PREVALENCE; OUTCOMES
AB Background and Objectives: Beta-blockers are indicated in patients with heart failure (HF) with reduced ejection fraction. However, their efficacy in patients with HF with preserved ejection fraction (HFpEF) is uncertain. We investigated the hypothesis that beta-blockers are associated with reduced adverse events in patients with HFpEF.
   Methods: The Korea Acute Heart Failure (KorAHF) is a prospective observational multicentre cohort study. The 5,625 patients hospitalized for acute HF syndrome in 10 tertiary university hospitals across the country have been consecutively enrolled between March 2011 and February 2014. Of these patients, 2,152 patients with HFpEF (ejection fraction >= 40%) were investigated. The primary outcome was all-cause mortality according to beta-blocker use.
   Results: During a median follow-up duration of 807 days, 702 patients died. In Cox proportional hazards model beta-blocker use was associated with a 14% reduced all-cause death (hazard ratio [HR), 0.86; 95% confidence interval [CI], 0.75-0.98), but not with reduce rehospitalization (HR, 1.03; 95% CI, 0.85-1.27). In the propensity-score matched population, beta-blockers were also associated with reduced all-cause death (HR, 0.80; 95% CI, 0.69-0.94) but not with reduced rehospitalization (HR, 1.08; 95% CI, 0.87-1.33).
   Conclusions: In Korean patients with HFpEF, use of beta-blockers is associated with reduced all-cause death but not with reduced rehospitalization.
C1 [Kim, Sung-Hwan; Baek, Sang Hong] Catholic Univ Korea, Div Cardiol, Dept Internal Med, Seoul St Marys Hosp,Coll Med, 222 Banpo Daero, Seoul 06591, South Korea.
   [Yun, Sung-Cheol] Univ Ulsan, Coll Med, Dept Biostat, Asan Med Ctr, Seoul, South Korea.
   [Park, Jin Joo; Choi, Dong-Ju] Seoul Natl Univ, Bundang Hosp, Dept Cardiol, Cardiovasc Ctr, Seongnam, South Korea.
   [Lee, Sang Eun; Kim, Jae-Joong] Univ Ulsan, Div Cardiol, Heart Inst, Asan Med Ctr, Seoul, South Korea.
   [Jeon, Eun-Seok] Sungkyunkwan Univ, Coll Med, Dept Internal Med, Seoul, South Korea.
   [Cho, Myeong-Chan] Chungbuk Natl Univ, Dept Internal Med, Coll Med, Cheongju, South Korea.
   [Chae, Shung Chult] Kyungpook Natl Univ, Dept Internal Med, Coll Med, Daegu, South Korea.
   [Kang, Seok-Min] Yonsei Univ, Coll Med, Dept Internal Med, Seoul, South Korea.
   [Yoo, Byung-Su] Yonsei Univ, Wonju Coll Med, Dept Internal Med, Wonju, South Korea.
   [Kim, Kye Hun] Chonnam Natl Univ, Dept Internal Med, Heart Res Ctr, Gwangju, South Korea.
   [Oh, Byung-Hee] Seoul Natl Univ Hosp, Dept Internal Med, Seoul, South Korea.
RP Baek, SH (corresponding author), Catholic Univ Korea, Div Cardiol, Dept Internal Med, Seoul St Marys Hosp,Coll Med, 222 Banpo Daero, Seoul 06591, South Korea.
EM whitesh@catholic.ac.kr
OI Kim, Sung-Hwan/0000-0001-6805-0416; Cho,
   Myeong-Chan/0000-0002-0047-0227; Lee, Sang Eun/0000-0002-7290-2463;
   Kang, Seok-Min/0000-0001-9856-9227
FU Research of Korea Centers for Disease Control and Prevention
   [2010-E63003-00, 2011-E63002-00, 2012-E63005-00, 2013-E63003-00,
   2013-E63003-01, 2013-E63003-02, 2016-ER6303-00]
FX This work was supported by the Research of Korea Centers for Disease
   Control and Prevention (2010-E63003-00, 2011-E63002-00, 2012-E63005-00,
   2013-E63003-00, 2013-E63003-01, 2013-E63003-02, and 2016-ER6303-00).
CR Bavishi C, 2015, HEART FAIL REV, V20, P193, DOI 10.1007/s10741-014-9453-8
   Borlaug BA, 2014, NAT REV CARDIOL, V11, P507, DOI 10.1038/nrcardio.2014.83
   Butler J, 2014, JACC-HEART FAIL, V2, P97, DOI 10.1016/j.jchf.2013.10.006
   Cleland JGF, 2006, EUR HEART J, V27, P2338, DOI 10.1093/eurheartj/ehl250
   Cleland JGF, 2018, EUR HEART J, V39, P26, DOI 10.1093/eurheartj/ehx564
   Gupta AK, 2010, INT J PREVENTIVE MED, V1, P217
   Kelly JP, 2015, J AM COLL CARDIOL, V65, P1668, DOI 10.1016/j.jacc.2015.03.043
   Komajda M, 2017, EUR J HEART FAIL, V19, P1495, DOI 10.1002/ejhf.876
   Kotecha D, 2014, LANCET, V384, P2235, DOI 10.1016/S0140-6736(14)61373-8
   Lee SE, 2017, KOREAN CIRC J, V47, P341, DOI 10.4070/kcj.2016.0419
   Lee SE, 2014, EUR J HEART FAIL, V16, P700, DOI 10.1002/ejhf.91
   Lim S, 2011, DIABETES CARE, V34, P1323, DOI 10.2337/dc10-2109
   Liu F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090555
   Lund LH, 2014, JAMA-J AM MED ASSOC, V312, P2008, DOI 10.1001/jama.2014.15241
   Moon KW., 2015, R STAT GRAPHS MED PA
   O'Connor CM, 2011, J AM COLL CARDIOL, V58, P915, DOI 10.1016/j.jacc.2011.03.057
   Ogawa R, 2014, CLIN PHARMACOKINET, V53, P1083, DOI 10.1007/s40262-014-0189-3
   Pitt B, 2014, NEW ENGL J MED, V370, P1383, DOI 10.1056/NEJMoa1313731
   Ponikowski P, 2016, EUR HEART J, V37, P2129, DOI 10.1093/eurheartj/ehw128
   R Development Core Team, 2016, R LANG ENV STAT COMP
   Senni M, 2014, EUR HEART J, V35, P2797, DOI 10.1093/eurheartj/ehu204
   Steinberg BA, 2012, CIRCULATION, V126, P65, DOI 10.1161/CIRCULATIONAHA.111.080770
   Yamamoto K, 2013, EUR J HEART FAIL, V15, P110, DOI 10.1093/eurjhf/hfs141
   Yusuf S, 2003, LANCET, V362, P777, DOI 10.1016/S0140-6736(03)14285-7
NR 24
TC 4
Z9 4
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAR
PY 2019
VL 49
IS 3
BP 238
EP 248
DI 10.4070/kcj.2018.0259
PG 11
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA HM8EJ
UT WOS:000459710900004
PM 30468042
OA Green Published, Other Gold
DA 2021-04-22
ER

PT J
AU Kim, H
   Kim, H
   Cho, SK
   Kim, JB
   Joung, B
   Kim, C
AF Kim, Hyunmee
   Kim, Hyeongsoo
   Cho, Seong-Kyung
   Kim, Jin-Bae
   Joung, Boyoung
   Kim, Changsoo
TI Cos Effectiveness of Rivaroxaban Compared to Warfarin for Stroke
   Prevention in Atrial Fibrillation
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Atrial fibrillation; Rivaroxaban; Warfarin; Cost effectiveness
ID DABIGATRAN; APIXABAN; EDOXABAN; TRENDS
AB Background and Objectives: Rivaroxaban is noninferior to warfarin for preventing stroke or systemic embolism in patients with high-risk atrial fibrillation (AF) and is associated with a lower rate of intracranial hemorrhage (ICH). We assessed the cost-effectiveness of rivaroxaban compared to adjusted-dose warfarin for the prevention of stroke in patients with nonvalvular AF.
   Methods: We built a Markov model using the Korean Health Insurance Review & Assessment Service database. The base-case analysis assumed a cohort of patients with prevalent AF who were aged 18 years or older without contraindications to anticoagulation.
   Results: Number of patients with CHA(2)DS(2)-VASc scores 0, 1 and >= 2 were 56 (0.2%), 1,944 (6.3%) and 28,650 (93.5%), respectively. In patients with CHA(2)DS(2)-VASc scores >= 2, the incidence rate of ischemic stroke was 3.11% and 3.76% in warfarin and rivaroxaban groups, respectively. The incidence rates of ICH were 0.42% and 0.15%, and those of gastrointestinal bleeding were 0.32% and 0.15% in warfarin and rivaroxaban, respectively. Patients with AF treated with rivaroxaban lived an average of 11.8 quality-adjusted life years (QALYs) at a lifetime treatment cost of $20,886. Those receiving warfarin lived an average of 11.4 QALYs and incurred costs of $17,151. Patients with rivaroxaban gained an additional 0.4 QALYs over a lifetime with an additional cost of $3,735, resulting in an incremental cost-effectiveness ratio of $9,707 per QALY.
   Conclusions: Patients who had been treated with rivaroxaban may be a cost-effective alternative to warfarin for stroke prevention in Korean patients with AF.
C1 [Kim, Hyunmee; Cho, Seong-Kyung; Kim, Changsoo] Yonsei Univ, Dept Prevent Med, Inst Human Complex & Syst Sci, Coll Med, 50 Yonsei Ro, Seoul 03722, South Korea.
   [Kim, Hyeongsoo; Joung, Boyoung] Yonsei Univ, Coll Med, Div Cardiol, Severance Cardiovasc Hosp,Dept Internal Med, 50 Yonsei Ro, Seoul 03722, South Korea.
   [Kim, Jin-Bae] Kyung Hee Univ, Div Cardiol, Dept Internal Med, Kyung Hee Univ Hosp, Seoul, South Korea.
RP Kim, C (corresponding author), Yonsei Univ, Dept Prevent Med, Inst Human Complex & Syst Sci, Coll Med, 50 Yonsei Ro, Seoul 03722, South Korea.; Joung, B (corresponding author), Yonsei Univ, Coll Med, Div Cardiol, Severance Cardiovasc Hosp,Dept Internal Med, 50 Yonsei Ro, Seoul 03722, South Korea.
EM cby6908@yuhs.ac; preman@yuhs.ac
OI Joung, Boyoung/0000-0001-9036-7225; kim, hyeongsoo/0000-0002-5030-952X;
   Kim, Changsoo/0000-0002-5940-5649; a, gokul/0000-0003-2226-4691
FU Basic Science Research Program through the National Research Foundation
   of Korea - Ministry of Education, Science and Technology; Korean
   Healthcare Technology R&D project - Ministry of Health Welfare
   [HC15C1200]
FX This study was supported by a research grant from the Basic Science
   Research Program through the National Research Foundation of Korea
   funded by the Ministry of Education, Science and Technology, and grants
   from the Korean Healthcare Technology R&D project funded by the Ministry
   of Health & Welfare (HC15C1200).
CR Ades AE, 2002, MED DECIS MAKING, V22, P359, DOI 10.1177/027298902400448920
   Baek YS, 2017, J AM HEART ASSOC, V6, DOI 10.1161/JAHA.116.004705
   Camm AJ, 2012, EUR HEART J, V33
   Connolly SJ, 2009, NEW ENGL J MED, V361, P1139, DOI 10.1056/NEJMoa0905561
   Decker C, 2012, J MULTIDISCIP HEALTH, V5, P129, DOI 10.2147/JMDH.S33045
   Freeman JV, 2011, ANN INTERN MED, V154, P1, DOI 10.7326/0003-4819-154-1-201101040-00289
   Giugliano RP, 2013, NEW ENGL J MED, V369, P2093, DOI 10.1056/NEJMoa1310907
   Granger CB, 2011, NEW ENGL J MED, V365, P981, DOI 10.1056/NEJMoa1107039
   Hart RG, 2007, ANN INTERN MED, V146, P857, DOI 10.7326/0003-4819-146-12-200706190-00007
   HYLEK EM, 1994, ANN INTERN MED, V120, P897, DOI 10.7326/0003-4819-120-11-199406010-00001
   January CT, 2014, J AM COLL CARDIOL, V64, pE1, DOI 10.1016/j.jacc.2014.03.022
   Kim D, 2018, HEART
   Kim D, 2018, AM HEART J, V202, P20, DOI 10.1016/j.ahj.2018.04.017
   Kim TH, 2017, STROKE, V48, P1524, DOI 10.1161/STROKEAHA.117.016926
   Kim TH, 2018, STROKE, V39
   Kirchhof P, 2016, EUR HEART J, V37, P2893, DOI 10.1093/eurheartj/ehw210
   Korean Statistical Information Service (KOSIS), 2016, KOR LIF EXP
   Lanitis T, 2014, THROMB RES, V134, P278, DOI 10.1016/j.thromres.2014.05.027
   Lee H, 2017, KOREAN CIRC J, V47, P56, DOI 10.4070/kcj.2016.0045
   Lee HY, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13061-4
   Lee S, 2012, AM J CARDIOL, V110, P845, DOI 10.1016/j.amjcard.2012.05.011
   Lopez-Lopez JA, 2017, BMJ-BRIT MED J, V359, DOI 10.1136/bmj.j5058
   Magnuson EA, 2015, AM HEART J, V170, P1140, DOI 10.1016/j.ahj.2015.09.011
   Nelson WW, 2014, CURR MED RES OPIN, V30, P2461, DOI 10.1185/03007995.2014.933577
   Neumann PJ, 2000, HEALTH AFFAIR, V19, P92, DOI 10.1377/hlthaff.19.2.92
   O'Brien CL, 2005, JAMA-J AM MED ASSOC, V293, P699, DOI 10.1001/jama.293.6.699
   Patel MR, 2010, NEW ENGL J MED, V362, P886, DOI 10.1056/NEJMoa0907272
   Pink J, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d6333
   Sorensen SV, 2011, THROMB HAEMOSTASIS, V105, P908, DOI 10.1160/TH11-02-0089
   Sullivan PW, 2006, MED DECIS MAKING, V26, P401, DOI 10.1177/0272989X06290496
NR 30
TC 5
Z9 5
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAR
PY 2019
VL 49
IS 3
BP 252
EP 263
DI 10.4070/kcj.2018.0220
PG 12
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA HM8EJ
UT WOS:000459710900006
PM 30468041
OA Green Published, Other Gold
DA 2021-04-22
ER

PT J
AU Song, BM
   Kim, HC
   Shim, JS
   Kang, DR
AF Song, Bo Mi
   Kim, Hyeon Chang
   Shim, Jee-Seon
   Kang, Dae Ryong
TI Comparison between Right and Left Upper Arms in Detection of
   Hypertension
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Blood pressure; Koreans; Population
ID BLOOD-PRESSURE DIFFERENCE; ASSOCIATION; POPULATION; PREVENTION
AB Background and Objectives: This study aimed to investigate the right-left arm difference in detection of hypertension in the general Korean population.
   Methods: This study analyzed data from the Cardiovascular and Metabolic Disease Etiology Research Center cohort. Study population was 2,103 people who were aged 30 to 64 years old, without history of major cardiovascular diseases, and did not use antihypertensive medication. Brachial blood pressures (BPs) were measured for both arms using an automated oscillometric device equipped with 2 cuffs for simultaneous double-arm measurements. Systolic and diastolic blood pressures (SBP and DBP) were measured 3 times, and the average value was used in the analysis. Overall hypertension was defined as elevated blood pressure (SBP/DBP >= 140/90 mmHg) at the arm with higher value, while right-arm or left-arm hypertension was defined as elevated BP at each arm. Sensitivity was calculated as the number of each-arm hypertension divided by the number of overall hypertension.
   Results: Overall 8.6% of the population had hypertension at either arm, while 7.8% had rightarm hypertension, 7.2% had left-arm hypertension, and 6.4% had both arms hypertension. The sensitivity for the detection of hypertension was 90.6% when BP was measured only at right arm, and 83.4% when measured only at left arm. Corresponding sensitivity were 87.9% and 87.1% in men, and 95.4% and 76.9% in women.
   Conclusions: Single-arm measurements, compared to double-arm measurements, may underestimate the prevalence of hypertension. However, if double-arm measurements are unavailable, right arm is preferred for measurement of BP, especially in women.
C1 [Song, Bo Mi; Kim, Hyeon Chang; Shim, Jee-Seon] Yonsei Univ, Coll Med, Cardiovasc & Metab Dis Etiol Res Ctr, Seoul, South Korea.
   [Kim, Hyeon Chang] Yonsei Univ, Dept Prevent Med, Coll Med, Seoul, South Korea.
   [Kang, Dae Ryong] Yonsei Univ, Ctr Biomed Data Sci, Coll Med, 20 Ilsan Ro, Wonju 26426, South Korea.
RP Kang, DR (corresponding author), Yonsei Univ, Ctr Biomed Data Sci, Coll Med, 20 Ilsan Ro, Wonju 26426, South Korea.
EM dr.kang@yonsei.ac.kr
RI Kim, Hyeon Chang/F-8796-2019
OI Kim, Hyeon Chang/0000-0001-7867-1240; Song, Bo Mi/0000-0003-3181-5803;
   Shim, Jee-Seon/0000-0002-8671-3153; Kang, Dae Ryong/0000-0002-8792-9730
FU Korean Health Technology R&D Project, Ministry of Health Welfare
   [HI13C0715]
FX The work was supported by grants from the Korean Health Technology R&D
   Project, Ministry of Health & Welfare (HI13C0715).
CR AGARWAL NK, 2013, DRUG DISCOV, V7, P9
   AMSTERDAM B, 1943, NY STATE J MED, V43, P2294
   [Anonymous], 1978, J Chronic Dis, V31, P651
   Cassidy P, 2001, J HUM HYPERTENS, V15, P519, DOI 10.1038/sj.jhh.1001224
   Chang Y, 2018, AM J HYPERTENS, V31, P35, DOI 10.1093/ajh/hpx126
   Chobanian AV, 2003, JAMA-J AM MED ASSOC, V289, P2560, DOI 10.1001/jama.289.19.2560
   Jin Tak Young, 2013, Clinical Hypertension, V19, P71
   Johansson JK, 2014, J HYPERTENS, V32, P260, DOI 10.1097/HJH.0000000000000040
   Kim J, 2013, NEUROLOGY, V80, P1457, DOI 10.1212/WNL.0b013e31828cf87c
   Kimura A, 2004, J HYPERTENS, V22, P2277, DOI 10.1097/00004872-200412000-00009
   Lane D, 2002, J HYPERTENS, V20, P1089, DOI 10.1097/00004872-200206000-00019
   Maeda S, 2013, BLOOD PRESS MONIT, V18, P133, DOI 10.1097/MBP.0b013e32836175e3
   Park SJ, 2017, ATHEROSCLEROSIS, V263, P171, DOI 10.1016/j.atherosclerosis.2017.06.023
   Perry IJ, 1991, HDB HYPERTENSION, V14, P175
   PETRIE JC, 1986, BRIT MED J, V293, P611, DOI 10.1136/bmj.293.6547.611
   Song BM, 2016, KOREAN CIRC J, V46, P374, DOI 10.4070/kcj.2016.46.3.374
   Southby R, 1935, MED J AUSTRALIA, V2, P569
   STAMLER J, 1993, ARCH INTERN MED, V153, P598, DOI 10.1001/archinte.153.5.598
   Su HM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041173
   Verberk WJ, 2011, AM J HYPERTENS, V24, P1201, DOI 10.1038/ajh.2011.125
   Weinberg I, 2014, AM J MED, V127, P209, DOI 10.1016/j.amjmed.2013.10.027
   Whelton PK, 2018, J AM COLL CARDIOL, V71, P2275, DOI 10.1016/j.jacc.2018.03.016
NR 22
TC 2
Z9 2
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAR
PY 2019
VL 49
IS 3
BP 267
EP 277
DI 10.4070/kcj.2018.0147
PG 11
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA HM8EJ
UT WOS:000459710900008
PM 30468034
OA Other Gold, Green Published
DA 2021-04-22
ER

PT J
AU Cho, JY
AF Cho, Jae Yeong
TI Beta-Blockers in Heart Failure with Preserved Ejection Fraction: Could
   Their Use Be Vindicated as an Acceptable Option in the Future Treatment
   Guideline?
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
ID INTERVENTION; CARVEDILOL; SURVIVAL
C1 [Cho, Jae Yeong] Chonnam Natl Univ Hosp, Dept Cardiovasc Med, 42 Jebong Ro, Gwangju 61469, South Korea.
RP Cho, JY (corresponding author), Chonnam Natl Univ Hosp, Dept Cardiovasc Med, 42 Jebong Ro, Gwangju 61469, South Korea.
EM jaeycho@chonnam.ac.kr
CR Cleland JGF, 2018, EUR HEART J, V39, P26, DOI 10.1093/eurheartj/ehx564
   Hjalmarson A, 1999, LANCET, V353, P2001
   Kim MS, 2017, KOREAN CIRC J, V47, P555, DOI 10.4070/kcj.2017.0009
   Kim SH, 2019, KOREAN CIRC J, V49, P238, DOI 10.4070/kcj.2018.0259
   Lechat P, 1999, LANCET, V353, P9
   Packer M, 2002, CIRCULATION, V106, P2194, DOI 10.1161/01.CIR.0000035653.72855.BF
   Packer M, 2001, NEW ENGL J MED, V344, P1651, DOI 10.1056/NEJM200105313442201
   Pitt B, 2014, NEW ENGL J MED, V370, P1383, DOI 10.1056/NEJMoa1313731
   Tsujimoto T, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-27799-y
   van Veldhuisen DJ, 2009, J AM COLL CARDIOL, V53, P2150, DOI 10.1016/j.jacc.2009.02.046
NR 10
TC 1
Z9 1
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAR
PY 2019
VL 49
IS 3
BP 249
EP 251
DI 10.4070/kcj.2018.0431
PG 3
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA HM8EJ
UT WOS:000459710900005
PM 30808074
OA Other Gold, Green Published
DA 2021-04-22
ER

PT J
AU Choi, JI
AF Choi, Jong-Il
TI Benefit, Risk and Cost in Oral Anticoagulation for Stroke Prevention: Is
   It the Third Factor?
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
ID ATRIAL-FIBRILLATION; WARFARIN; RIVAROXABAN
C1 [Choi, Jong-Il] Korea Univ, Coll Med, Dept Internal Med, Div Cardiol, 73 Inchon Ro, Seoul 02841, South Korea.
   [Choi, Jong-Il] Korea Univ, Med Ctr, 73 Inchon Ro, Seoul 02841, South Korea.
RP Choi, JI (corresponding author), Korea Univ, Coll Med, Dept Internal Med, Div Cardiol, 73 Inchon Ro, Seoul 02841, South Korea.; Choi, JI (corresponding author), Korea Univ, Med Ctr, 73 Inchon Ro, Seoul 02841, South Korea.
EM jongilchoi@korea.ac.kr
OI Choi, Jong-Il/0000-0001-6617-508X
CR Desteghe L, 2018, EUR HEART J, V39, P1394, DOI 10.1093/eurheartj/ehx762
   Harrington AR, 2013, STROKE, V44, P1676, DOI 10.1161/STROKEAHA.111.000402
   Kim H, 2019, KOREAN CIRC J, V49, P252, DOI 10.4070/kcj.2018.0220
   Lee S, 2012, AM J CARDIOL, V110, P845, DOI 10.1016/j.amjcard.2012.05.011
   Neumann PJ, 2017, NEW ENGL J MED, V376, P203, DOI 10.1056/NEJMp1612619
   Ruff CT, 2014, LANCET, V383, P955, DOI 10.1016/S0140-6736(13)62343-0
   Sabbag A, 2018, KOREAN CIRC J, V48, P873, DOI 10.4070/kcj.2018.0261
   Shah A, 2016, STROKE, V47, P1555, DOI 10.1161/STROKEAHA.115.012325
   Shankar PR, 2014, J PHARMACOL PHARMACO, V5, P74, DOI 10.4103/0976-500X.124434
   Steffel J, 2018, EUR HEART J, V39, P1330, DOI 10.1093/eurheartj/ehy136
NR 10
TC 0
Z9 0
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAR
PY 2019
VL 49
IS 3
BP 264
EP 266
DI 10.4070/kcj.2019.0007
PG 3
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA HM8EJ
UT WOS:000459710900007
PM 30808075
OA Other Gold, Green Published
DA 2021-04-22
ER

PT J
AU Shin, J
AF Shin, Jinho
TI Implications of Simultaneously Measured Inter-Arm Difference
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
ID SYSTOLIC BLOOD-PRESSURE
C1 [Shin, Jinho] Hanyang Univ, Coll Med, Dept Internal Med, Div Cardiol, 222 Wangsimni Ro, Seoul 04763, South Korea.
RP Shin, J (corresponding author), Hanyang Univ, Coll Med, Dept Internal Med, Div Cardiol, 222 Wangsimni Ro, Seoul 04763, South Korea.
EM jhs2003@hanyang.ac.kr
OI Shin, Jinho/0000-0001-6706-6504
CR Canepa M, 2013, J CLIN HYPERTENS, V15, P880, DOI 10.1111/jch.12178
   Clark CE, 2016, BRIT J GEN PRACT, V66, pE838, DOI 10.3399/bjgp16X687553
   Fonseca-Reyes S, 2012, BLOOD PRESS MONIT, V17, P149, DOI 10.1097/MBP.0b013e32835681e2
   Mehlsen J, 2014, INT J VASC MED, V2014, DOI 10.1155/2014/841542
   Shin Jinho, 2015, Clin Hypertens, V21, P1, DOI 10.1186/s40885-014-0012-3
   Song BM, 2019, KOREAN CIRC J, V49, P267, DOI 10.4070/kcj.2018.0147
   Song BM, 2016, KOREAN CIRC J, V46, P374, DOI 10.4070/kcj.2016.46.3.374
   Weinberg I, 2014, AM J MED, V127, P209, DOI 10.1016/j.amjmed.2013.10.027
NR 8
TC 0
Z9 0
U1 0
U2 2
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAR
PY 2019
VL 49
IS 3
BP 278
EP 279
DI 10.4070/kcj.2018.0416
PG 2
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA HM8EJ
UT WOS:000459710900009
PM 30808076
OA Other Gold, Green Published
DA 2021-04-22
ER

PT J
AU Choi, JY
   Shim, CY
   Hong, GR
   Ahn, CM
   Ko, YG
   Hong, MK
AF Choi, Jah Yeon
   Shim, Chi Young
   Hong, Geu-Ru
   Ahn, Chul-Min
   Ko, Young-Guk
   Hong, Myeong-Ki
TI Iliac Artery Rupture and Retroperitoneal Migration of a Stent Graft
   during Transcatheter Aortic Valve Replacement
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
C1 [Choi, Jah Yeon; Shim, Chi Young; Hong, Geu-Ru; Ahn, Chul-Min; Ko, Young-Guk; Hong, Myeong-Ki] Yonsei Univ, Coll Med, Severance Cardiovasc Hosp, Div Cardiol, 50 Yonsei Ro, Seoul 03722, South Korea.
RP Shim, CY (corresponding author), Yonsei Univ, Coll Med, Severance Cardiovasc Hosp, Div Cardiol, 50 Yonsei Ro, Seoul 03722, South Korea.
EM cysprs@yuhs.ac
RI Shim, Chi Young/AAK-1057-2021
OI Shim, Chi Young/0000-0002-6136-0136; Ko, Young-Guk/0000-0001-7748-5788;
   Ahn, Chul-Min/0000-0002-7071-4370; Hong, Geu-Ru/0000-0003-4981-3304;
   Hong, Myeong-Ki/0000-0002-2090-2031; Choi, Jah Yeon/0000-0002-6793-4137
NR 0
TC 0
Z9 0
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAR
PY 2019
VL 49
IS 3
BP 280
EP 281
DI 10.4070/kcj.2018.0266
PG 2
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA HM8EJ
UT WOS:000459710900010
PM 30808077
OA Green Published, Other Gold
DA 2021-04-22
ER

PT J
AU Yada, H
   Soejima, K
AF Yada, Hirotaka
   Soejima, Kyoko
TI Management of Arrhythmias Associated with Cardiac Sarcoidosis
SO KOREAN CIRCULATION JOURNAL
LA English
DT Review
DE Arrhythmias, cardiac; Sarcoidosis; Catheter ablation; Immunosuppression;
   Defibrillators, implantable
ID VENTRICULAR-TACHYCARDIA; CATHETER ABLATION; ELECTROPHYSIOLOGICAL
   CHARACTERISTICS; NONISCHEMIC CARDIOMYOPATHY; CORTICOSTEROID-THERAPY;
   PULMONARY-EMBOLISM; F-18-FDG PET; INVOLVEMENT; ENHANCEMENT; EVENTS
AB Sarcoidosis is a multisystem granulomatous disorder of unknown etiology. The annual incidence of systemic sarcoidosis is estimated at 10-20 per 100,000 individuals. Owing to the recent advances in imaging modalities, cardiac sarcoidosis (CS) is diagnosed more frequently. The triad of CS includes conduction abnormality, ventricular tachycardia, and heart failure. Atrial and ventricular arrhythmias are caused by either inflammation or scar formation. Inflammation should be treated with immunosuppression and antiarrhythmic agents and scar formation should be treated with antiarrhythmics and/or ablation, in addition to implantable cardioverter defibrillator (ICD) implantation, if necessary. Ablation can provide a good outcome, but it might require bipolar ablation if the critical portion is located mid-myocardium. Late recurrence might be caused by reactivation of sarcoidosis, which would need to be evaluated by positron emission tomography-computed tomography imaging. Risk of sudden cardiac death (SCD) in patients with advanced atrioventricular block is not low, and ICD implantation could be considered instead of a pacemaker. For risk stratification for SCD, late gadolinium enhancement by cardiac magnetic resonance imaging or program stimulation is often used.
C1 [Yada, Hirotaka] Natl Def Med Coll, Dept Cardiol, Tokorozawa, Saitama, Japan.
   [Soejima, Kyoko] Kyorin Univ, Dept Cardiol, Sch Med, 6-20-2 Shinkawa, Mitaka, Tokyo 1818611, Japan.
RP Soejima, K (corresponding author), Kyorin Univ, Dept Cardiol, Sch Med, 6-20-2 Shinkawa, Mitaka, Tokyo 1818611, Japan.
EM skyoko@ks.kyorin-u.ac.jp
CR Ahmadian A, 2014, J NUCL CARDIOL, V21, P925, DOI 10.1007/s12350-014-9901-9
   Aizer A, 2005, AM J CARDIOL, V96, P276, DOI 10.1016/j.amjcard.2005.03.059
   Betensky BP, 2012, HEART RHYTHM, V9, P884, DOI 10.1016/j.hrthm.2012.02.010
   Birnie DH, 2014, HEART RHYTHM, V11, P1304, DOI 10.1016/j.hrthm.2014.03.043
   Blankstein R, 2014, J AM COLL CARDIOL, V63, P329, DOI 10.1016/j.jacc.2013.09.022
   Cain MA, 2014, AM J CARDIOL, V113, P1556, DOI 10.1016/j.amjcard.2014.01.434
   Coleman GC, 2017, JACC-CARDIOVASC IMAG, V10, P411, DOI 10.1016/j.jcmg.2016.05.009
   Crawford T, 2014, CIRC-ARRHYTHMIA ELEC, V7, P1109, DOI 10.1161/CIRCEP.113.000156
   Crawshaw AP, 2011, THORAX, V66, P447, DOI 10.1136/thx.2010.134429
   Cummings KW, 2009, RADIOGRAPHICS, V29, P89, DOI 10.1148/rg.291085052
   Dechering DG, 2013, HEART RHYTHM, V10, P158, DOI 10.1016/j.hrthm.2012.10.019
   ECHT DS, 1991, NEW ENGL J MED, V324, P781, DOI 10.1056/NEJM199103213241201
   Futamatsu H, 2006, INT J CARDIOVAS IMAG, V22, P443, DOI 10.1007/s10554-005-9043-x
   Greulich S, 2013, JACC-CARDIOVASC IMAG, V6, P501, DOI 10.1016/j.jcmg.2012.10.021
   Hulten E, 2016, CIRC-CARDIOVASC IMAG, V9, DOI 10.1161/CIRCIMAGING.116.005001
   Ichinose A, 2008, AM J ROENTGENOL, V191, P862, DOI 10.2214/AJR.07.3089
   Ishimaru S, 2005, EUR HEART J, V26, P1538, DOI 10.1093/eurheartj/ehi180
   Jefic D, 2009, HEART RHYTHM, V6, P189, DOI 10.1016/j.hrthm.2008.10.039
   Kandolin R, 2015, CIRCULATION, V131, P624, DOI 10.1161/CIRCULATIONAHA.114.011522
   Koplan BA, 2006, HEART RHYTHM, V3, P924, DOI 10.1016/j.hrthm.2006.03.031
   Kron J, 2013, EUROPACE, V15, P347, DOI 10.1093/europace/eus316
   Kumar S, 2018, J CARDIOVASC ELECTR, V29, P79, DOI 10.1111/jce.13346
   Kumar S, 2015, J CARDIOVASC ELECTR, V26, P119, DOI 10.1111/jce.12575
   Ladyjanskaia GA, 2010, J CARDIOVASC ELECTR, V21, P94, DOI 10.1111/j.1540-8167.2009.01479.x
   Mehta D, 2011, CIRC-ARRHYTHMIA ELEC, V4, P43, DOI 10.1161/CIRCEP.110.958322
   Murtagh G, 2016, CIRC-CARDIOVASC IMAG, V9, DOI 10.1161/CIRCIMAGING.115.003738
   Muser D, 2018, JACC-CLIN ELECTROPHY, V4, P291, DOI 10.1016/j.jacep.2017.09.175
   Muser D, 2016, CIRC-ARRHYTHMIA ELEC, V9, DOI 10.1161/CIRCEP.116.004328
   Nagai S, 2014, INTERNAL MED, V53, P427, DOI 10.2169/internalmedicine.53.0794
   Namboodiri Narayanan, 2012, Indian Pacing Electrophysiol J, V12, P284
   Naruse Y, 2014, CIRC-ARRHYTHMIA ELEC, V7, P407, DOI 10.1161/CIRCEP.113.000734
   Nordenswan HK, 2018, CIRC-ARRHYTHMIA ELEC, V11, DOI 10.1161/CIRCEP.117.006145
   Okumura W, 2004, J NUCL MED, V45, P1989
   Papageorgiou N, 2018, EUROPACE, V20, P682, DOI 10.1093/europace/eux077
   Patel MR, 2009, CIRCULATION, V120, P1969, DOI 10.1161/CIRCULATIONAHA.109.851352
   Philips B, 2014, CIRC-ARRHYTHMIA ELEC, V7, P230, DOI 10.1161/CIRCEP.113.000932
   Reek S, 2017, EUROPACE, V19, P335, DOI 10.1093/europace/euw180
   Sadek MM, 2013, CAN J CARDIOL, V29, P1034, DOI 10.1016/j.cjca.2013.02.004
   Schuller JL, 2012, J CARDIOVASC ELECTR, V23, P925, DOI 10.1111/j.1540-8167.2012.02350.x
   Segawa M, 2016, CIRC-ARRHYTHMIA ELEC, V9, DOI 10.1161/CIRCEP.115.003353
   Sekhri V, 2011, ARCH MED SCI, V7, P546, DOI 10.5114/aoms.2011.24118
   Shiraishi J, 2003, CIRC J, V67, P169, DOI 10.1253/circj.67.169
   Smedema JP, 2005, CHEST, V128, P1629, DOI 10.1378/chest.128.3.1629
   Smedema JP, 2005, CHEST, V128, P30, DOI 10.1378/chest.128.1.30
   Soejima K, 2009, J CARDIOVASC ELECTR, V20, P578, DOI 10.1111/j.1540-8167.2008.01417.x
   Sperry BW, 2018, JACC-CARDIOVASC IMAG, V11, P336, DOI 10.1016/j.jcmg.2017.04.020
   Srivatsa Uma N, 2012, Indian Pacing Electrophysiol J, V12, P290
   Swigris JJ, 2011, CHEST, V140, P1261, DOI 10.1378/chest.11-0324
   Theodore J, 2018, HEARTRHYTHM CASE REP
   Tracy CM, 2012, J THORAC CARDIOV SUR, V144, pE127, DOI 10.1016/j.jtcvs.2012.08.032
   Viles-Gonzalez JF, 2011, CIRC-ARRHYTHMIA ELEC, V4, P526, DOI 10.1161/CIRCEP.110.961508
   Vita T, 2018, CIRC-CARDIOVASC IMAG, V11, DOI 10.1161/CIRCIMAGING.117.007030
   Wicks EC, 2018, EUR HEART J-CARD IMG, V19, P757, DOI 10.1093/ehjci/jex340
   Willner JM, 2014, J CARDIOVASC ELECTR, V25, P958, DOI 10.1111/jce.12424
   Yazaki Y, 2001, AM J CARDIOL, V88, P1006, DOI 10.1016/S0002-9149(01)01978-6
   Yodogawa K, 2011, ANN NONINVAS ELECTRO, V16, P140, DOI 10.1111/j.1542-474X.2011.00418.x
NR 56
TC 2
Z9 2
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD FEB
PY 2019
VL 49
IS 2
BP 119
EP 133
DI 10.4070/kcj.2018.0432
PG 15
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA HJ4BU
UT WOS:000457119700001
PM 30693680
OA Green Published, Other Gold
DA 2021-04-22
ER

PT J
AU Pak, HN
AF Pak, Hui-Nam
TI Catheter Ablation of Long-standing Persistent Atrial Fibrillation: a
   Reckless Challenge or a Way to Real Cure?
SO KOREAN CIRCULATION JOURNAL
LA English
DT Review
DE Persistent atrial fibrillation; Catheter ablation; Pulmonary veins
ID EXPERT CONSENSUS STATEMENT; PULMONARY VEIN ISOLATION; OPEN-CHEST DOGS;
   FOLLOW-UP; RADIOFREQUENCY ABLATION; CLINICAL RECURRENCE; SURGICAL
   ABLATION; VENTRICULAR-FIBRILLATION; CONVENTIONAL ABLATION; PROCEDURAL
   TECHNIQUES
AB Long-standing persistent atrial fibrillation (L-PeAF) is a category in which rhythm control is attempted while atrial fibrillation (AF) is maintained for more than 1 year. Because AF is a progressive disease and L-PeAF accompanies significant electrical and structural remodeling of atria, it is difficult to restore and maintain sinus rhythm in patients with L-PeAF. Nonetheless, the rhythm outcome is being increasingly improved by the development of sophisticated mapping devices, highly efficient catheters, and evidence-based ablation strategies, and the rational choice of patient selection criteria. This review discusses the evolution of the rhythm control outcome of L-PeAF and its future direction of development.
C1 [Pak, Hui-Nam] Yonsei Univ Hlth Syst, Div Cardiol, Dept Internal Med, 50-1,Yonsei Ro, Seoul 03722, South Korea.
RP Pak, HN (corresponding author), Yonsei Univ Hlth Syst, Div Cardiol, Dept Internal Med, 50-1,Yonsei Ro, Seoul 03722, South Korea.
EM hnpak@yuhs.ac
RI Pak, Hui-Nam/C-4266-2015
OI Pak, Hui-Nam/0000-0002-3256-3620
FU Korea Health 21 RAMP;D Project, Ministry of Health and Welfare
   [HI18C0070]; Basic Science Research Program run by the National Research
   Foundation of Korea (NRF) - Ministry of Science, ICT AMP; Future
   Planning (MSIP) [NRF-2017R1A2B4003983]
FX This work was supported by a grant (HI18C0070) from the Korea Health 21
   R&D Project, Ministry of Health and Welfare and a grant
   (NRF-2017R1A2B4003983) from the Basic Science Research Program run by
   the National Research Foundation of Korea (NRF), which is funded by the
   Ministry of Science, ICT & Future Planning (MSIP).
CR Adiyaman A, 2018, CIRC-ARRHYTHMIA ELEC, V11, DOI 10.1161/CIRCEP.118.006182
   Baek YS, 2016, INT J CARDIOL, V223, P276, DOI 10.1016/j.ijcard.2016.08.222
   Berruezo A, 2007, EUR HEART J, V28, P836, DOI 10.1093/eurheartj/ehm027
   Beyer E, 2009, J THORAC CARDIOV SUR, V137, P521, DOI 10.1016/j.jtcvs.2008.11.031
   Boersma LVA, 2012, CIRCULATION, V125, P23, DOI 10.1161/CIRCULATIONAHA.111.074047
   Brooks AG, 2010, HEART RHYTHM, V7, P835, DOI 10.1016/j.hrthm.2010.01.017
   BRUGADA J, 1991, CIRCULATION, V84, P1307, DOI 10.1161/01.CIR.84.3.1307
   Buch E, 2016, HEART RHYTHM, V13, P636, DOI 10.1016/j.hrthm.2015.10.031
   Bunch TJ, 2011, J CARDIOVASC ELECTR, V22, P839, DOI 10.1111/j.1540-8167.2011.02035.x
   Calkins H, 2012, HEART RHYTHM, V9, P632, DOI 10.1016/j.hrthm.2011.12.016
   Calkins H, 2012, EUROPACE, V14, P528, DOI 10.1093/europace/eus027
   Calo L, 2006, J AM COLL CARDIOL, V47, P2504, DOI 10.1016/j.jacc.2006.02.047
   Camm AJ, 2010, EUROPACE, V12, P1360, DOI [10.1093/eurheartj/ehq278, 10.1093/europace/euq350]
   Canpolat U, 2013, INT J CARDIOL, V168, P4801, DOI 10.1016/j.ijcard.2013.07.039
   Chen SA, 1999, CIRCULATION, V100, P1879, DOI 10.1161/01.CIR.100.18.1879
   Cho SW, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.113.000693
   Choi JI, 2010, EUROPACE, V12, P508, DOI 10.1093/europace/eup407
   COUMEL P, 1994, EUR HEART J, V15, P9, DOI 10.1093/eurheartj/15.suppl_A.9
   Coumel P, 1996, J CARDIOVASC ELECTR, V7, P999, DOI 10.1111/j.1540-8167.1996.tb00474.x
   De Vos CB, 2012, AM HEART J, V163, P887, DOI 10.1016/j.ahj.2012.02.015
   de Vos CB, 2010, J AM COLL CARDIOL, V55, P725, DOI 10.1016/j.jacc.2009.11.040
   Di Biase L, 2013, CURR OPIN CARDIOL, V28, P26, DOI 10.1097/HCO.0b013e32835b59bb
   Edgerton JR, 2010, J THORAC CARDIOV SUR, V140, P823, DOI 10.1016/j.jtcvs.2009.11.065
   Elayi CS, 2010, HEART RHYTHM, V7, P1216, DOI 10.1016/j.hrthm.2010.01.038
   Gibson DN, 2011, HEART RHYTHM, V8, P1364, DOI 10.1016/j.hrthm.2011.02.026
   GRAY RA, 1995, SCIENCE, V270, P1222, DOI 10.1126/science.270.5239.1222
   Gudbjartsson DF, 2007, NATURE, V448, P353, DOI 10.1038/nature06007
   Haissaguerre M, 2005, J CARDIOVASC ELECTR, V16, P1125, DOI 10.1111/j.1540-8167.2005.00307.x
   Haissaguerre M, 1998, NEW ENGL J MED, V339, P659, DOI 10.1056/NEJM199809033391003
   Haissaguerre MHR, 2005, J CARDIOVASC ELECTR, V16, P1138, DOI 10.1111/j.1540-8167.2005.00308.x
   Ho SY, 1999, J CARDIOVASC ELECTR, V10, P1525
   Hocini M, 2005, CIRCULATION, V112, P3688, DOI 10.1161/CIRCULATIONAHA.105.541052
   Husser D, 2010, J AM COLL CARDIOL, V55, P747, DOI 10.1016/j.jacc.2009.11.041
   Hwang M, 2014, PROG BIOPHYS MOL BIO, V116, P40, DOI 10.1016/j.pbiomolbio.2014.09.006
   Inoue K, 2012, CIRC-ARRHYTHMIA ELEC, V5, P295, DOI 10.1161/CIRCEP.111.964080
   Jacquemet V, 2009, HEART RHYTHM, V6, P803, DOI 10.1016/j.hrthm.2009.02.026
   Jadidi AS, 2012, CIRC-ARRHYTHMIA ELEC, V5, P32, DOI 10.1161/CIRCEP.111.964197
   Jais P, 2004, CIRCULATION, V110, P2996, DOI 10.1161/01.CIR.0000146917.75041.58
   Jais P, 2007, HEART RHYTHM, V4, P803, DOI 10.1016/j.hrthm.2007.01.021
   January CT, 2014, J AM COLL CARDIOL, V64, pE1, DOI 10.1016/j.jacc.2014.03.022
   Kang KW, 2014, EUROPACE, V16, P1738, DOI 10.1093/europace/euu226
   Kim IS, 2017, J CARDIOL, V69, P162, DOI 10.1016/j.jjcc.2016.02.014
   Kim TH, 2017, J AM HEART ASSOC, V6, DOI 10.1161/JAHA.116.004811
   Kim TH, 2014, INT J CARDIOL, V176, P841, DOI 10.1016/j.ijcard.2014.08.008
   Kim YH, 2012, CIRC J, V76, P1299, DOI 10.1253/circj.CJ-12-0432
   Knecht S, 2008, EUR HEART J, V29, P2359, DOI 10.1093/eurheartj/ehn302
   Konings KTS, 1997, CIRCULATION, V95, P1231
   KONINGS KTS, 1994, CIRCULATION, V89, P1665, DOI 10.1161/01.CIR.89.4.1665
   Krul SPJ, 2011, CIRC-ARRHYTHMIA ELEC, V4, P262, DOI 10.1161/CIRCEP.111.961862
   Kumar S, 2012, CIRC-ARRHYTHMIA ELEC, V5, P531, DOI 10.1161/CIRCEP.111.968859
   Lee KN, 2018, CIRC-ARRHYTHMIA ELEC, V11, DOI 10.1161/CIRCEP.117.005019
   Lee SH, 2005, J AM COLL CARDIOL, V46, P1054, DOI 10.1016/j.jacc.2005.06.016
   Lemery R, 2006, HEART RHYTHM, V3, P387, DOI 10.1016/j.hrthm.2006.01.009
   Lo LW, 2009, J CARDIOVASC ELECTR, V20, P1305, DOI 10.1111/j.1540-8167.2009.01617.x
   Lo LW, 2009, J CARDIOVASC ELECTR, V20, P1211, DOI 10.1111/j.1540-8167.2009.01546.x
   Mansour M, 2018, AM J CARDIOL, V121, P1192, DOI 10.1016/j.amjcard.2018.01.043
   Marrouche NF, 2018, NEW ENGL J MED, V378, P417, DOI 10.1056/NEJMoa1707855
   Marrouche NF, 2014, JAMA-J AM MED ASSOC, V311, P498, DOI 10.1001/jama.2014.3
   McClelland JH, 2007, J CARDIOVASC ELECTR, V18, P1289, DOI 10.1111/j.1540-8167.2007.00977.x
   Nademanee K, 2004, J AM COLL CARDIOL, V43, P2044, DOI 10.1016/j.jacc.2003.12.054
   Narayan SM, 2014, J AM COLL CARDIOL, V63, P1761, DOI 10.1016/j.jacc.2014.02.543
   Narayan SM, 2012, J AM COLL CARDIOL, V60, P628, DOI 10.1016/j.jacc.2012.05.022
   Nitta T, 2004, J THORAC CARDIOV SUR, V127, P770, DOI 10.1016/j.jtcvs.2003.05.001
   O'Brien EC, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.115.002721
   O'Neill MD, 2009, EUR HEART J, V30, P1105, DOI 10.1093/eurheartj/ehp063
   Oh S, 2006, HEART RHYTHM, V3, P701, DOI 10.1016/j.hrthm.2006.02.020
   Oral H, 2006, NEW ENGL J MED, V354, P934, DOI 10.1056/NEJMoa050955
   Oral H, 2008, J CARDIOVASC ELECTR, V19, P466, DOI 10.1111/j.1540-8167.2007.01089.x
   Oral H, 2008, CIRC-ARRHYTHMIA ELEC, V1, P6, DOI 10.1161/CIRCEP.107.748780
   Oral H, 2009, J AM COLL CARDIOL, V53, P782, DOI 10.1016/j.jacc.2008.10.054
   ORTIZ J, 1994, CIRC RES, V74, P882, DOI 10.1161/01.RES.74.5.882
   Pak HN, 2004, J CARDIOVASC ELECTR, V15, P581, DOI 10.1046/j.1540-8167.2004.03573.x
   Pak HN, 2008, CIRC J, V72, P1185, DOI 10.1253/circj.72.1185
   Pak HN, 2006, J CARDIOVASC ELECTR, V17, P818, DOI 10.1111/j.1540-8167.2006.00503.x
   Pak HN, 2006, J CARDIOVASC ELECTR, V17, P777, DOI 10.1111/j.1540-8167.2006.00511.x
   Pandit SV, 2013, CIRC RES, V112, P849, DOI 10.1161/CIRCRESAHA.111.300158
   Pappone C, 2004, CIRCULATION, V109, P327, DOI 10.1161/01.CIR.0000112641.16340.C7
   Pappone C, 2000, CIRCULATION, V102, P2619
   Park JH, 2009, J CARDIOVASC ELECTR, V20, P266, DOI 10.1111/j.1540-8167.2008.01321.x
   Park JH, 2013, CARDIOVASC PATHOL, V22, P58, DOI 10.1016/j.carpath.2012.05.001
   Park JH, 2011, EUROPACE, V13, P1541, DOI 10.1093/europace/eur135
   Park JH, 2010, CIRC J, V74, P1557, DOI 10.1253/circj.CJ-10-0048
   Park JK, 2017, J CARDIOL, V69, P584, DOI 10.1016/j.jjcc.2016.04.017
   Park J, 2014, HEART RHYTHM, V11, P953, DOI 10.1016/j.hrthm.2014.03.009
   Rostock T, 2011, HEART RHYTHM, V8, P1391, DOI 10.1016/j.hrthm.2011.04.012
   Ruchat P, 2007, EUROPACE S6, V9
   Saksena S, 2005, J CARDIOVASC ELECTR, V16, P494, DOI 10.1111/j.1540-8167.2005.40531.x
   Schauerte P, 2000, CIRCULATION, V102, P2774, DOI 10.1161/01.CIR.102.22.2774
   Shim J, 2013, INT J CARDIOL, V167, P2667, DOI 10.1016/j.ijcard.2012.06.120
   Song JS, 2018, CIRC J
   SPACH MS, 1986, CIRC RES, V58, P356, DOI 10.1161/01.RES.58.3.356
   Teh AW, 2010, HEART RHYTHM, V7, P1200, DOI 10.1016/j.hrthm.2010.05.011
   Tilz RR, 2012, J AM COLL CARDIOL, V60, P1921, DOI 10.1016/j.jacc.2012.04.060
   Verma A, 2015, NEW ENGL J MED, V372, P1812, DOI 10.1056/NEJMoa1408288
   Verma A, 2010, EUR HEART J, V31, P1344, DOI 10.1093/eurheartj/ehq041
   Wazni O, 2011, NEW ENGL J MED, V365, P2296, DOI 10.1056/NEJMct1109977
   WEST TC, 1962, AM J PHYSIOL, V202, P232
   Wu TJ, 1999, J CARDIOVASC ELECTR, V10, P1077, DOI 10.1111/j.1540-8167.1999.tb00280.x
   Wynn GJ, 2014, CIRC-ARRHYTHMIA ELEC, V7, P841, DOI 10.1161/CIRCEP.114.001759
   Yilmaz A, 2010, EUR J CARDIO-THORAC, V38, P356, DOI 10.1016/j.ejcts.2010.01.058
   Yu HT, 2018, CIRC J, V82, P2259, DOI 10.1253/circj.CJ-17-1358
   Yu HT, 2017, CIRC-ARRHYTHMIA ELEC, V10, DOI 10.1161/CIRCEP.116.004915
NR 102
TC 1
Z9 1
U1 0
U2 6
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD FEB
PY 2019
VL 49
IS 2
BP 134
EP 145
DI 10.4070/kcj.2018.0418
PG 12
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA HJ4BU
UT WOS:000457119700002
PM 30693681
OA Green Published, Other Gold
DA 2021-04-22
ER

PT J
AU Lee, SE
   Nguyen, C
   Xie, YB
   Deng, ZX
   Zhou, ZW
   Li, DB
   Chang, HJ
AF Lee, Sang-Eun
   Nguyen, Christopher
   Xie, Yibin
   Deng, Zixin
   Zhou, Zhengwei
   Li, Debiao
   Chang, Hyuk-Jae
TI Recent Advances in Cardiac Magnetic Resonance Imaging
SO KOREAN CIRCULATION JOURNAL
LA English
DT Review
DE Cardiology; Magnetic resonance imaging; Cardiac magnetic resonance
ID CORONARY-ARTERY-DISEASE; FRACTIONAL FLOW RESERVE; DIFFUSION-TENSOR MRI;
   MYOCARDIAL-INFARCTION; HISTOLOGICAL VALIDATION; DILATED CARDIOMYOPATHY;
   EXTRACELLULAR VOLUME; DIAGNOSTIC-ACCURACY; COMPUTED-TOMOGRAPHY;
   BREATH-HOLD
AB Cardiac magnetic resonance (CMR) imaging provides accurate anatomic information and advanced soft contrast, making it the reference standard for assessing cardiac volumes and systolic function. In this review, we summarize the recent advances in CMR sequences. New technical development has widened the use of CMR imaging beyond the simple characterization of myocardial scars and assessment of contractility. These novel CMR sequences offer comprehensive assessments of coronary plaque characterization, myocardial fiber orientation, and even metabolic activity, and they can be readily applied in clinical settings. CMR imaging is able to provide new insights into understanding the pathophysiologic process of underlying cardiac disease, and it can help physicians choose the best treatment strategies. Although several limitations, including the high cost and time-consuming process, have limited the widespread clinical use of CMR imaging so far, recent advances in software and hardware technologies have made the future more promising.
C1 [Lee, Sang-Eun; Chang, Hyuk-Jae] Yonsei Univ, Yonsei Univ Hlth Syst, Coll Med, Div Cardiol,Severance Cardiovasc Hosp, Seoul, South Korea.
   [Lee, Sang-Eun; Chang, Hyuk-Jae] Yonsei Univ Hlth Syst, Integrat Cardiovasc Imaging Ctr, Seoul, South Korea.
   [Lee, Sang-Eun; Nguyen, Christopher; Xie, Yibin; Deng, Zixin; Zhou, Zhengwei; Li, Debiao] Cedars Sinai Med Ctr, Biomed Imaging Res Inst, Los Angeles, CA 90048 USA.
   [Nguyen, Christopher] Massachusetts Gen Hosp, Cardiovasc Res Ctr, Charlestown, MA USA.
   [Nguyen, Christopher] Harvard Med Sch, Boston, MA USA.
RP Chang, HJ (corresponding author), Yonsei Univ, Yonsei Univ Hlth Syst, Yonsei Cedars Sinai Integrat Cardiovasc Imaging R, Div Cardiol,Severance Cardiovasc Hosp,Coll Med, 50-1 Yonsei Ro, Seoul 03722, South Korea.
EM hjchang@yuhs.ac
OI Chang, Hyuk-Jae/0000-0002-6139-7545; Lee, Sang-Eun/0000-0001-6645-4038
FU Leading Foreign Research Institute Recruitment Program through the
   National Research Foundation of Korea - Ministry of Science, ICT &
   Future Planning [2012027176]
FX This study was supported by Leading Foreign Research Institute
   Recruitment Program through the National Research Foundation of Korea
   funded by the Ministry of Science, ICT & Future Planning (grant No.
   2012027176).
CR Aliotta E, 2017, MAGN RESON MED, V77, P717, DOI 10.1002/mrm.26166
   Andia ME, 2013, MAGN RESON MED, V69, P150, DOI 10.1002/mrm.24231
   Bodi V, 2005, J AM COLL CARDIOL, V46, P1747, DOI 10.1016/j.jacc.2005.07.039
   Bohnen S, 2015, CIRC-CARDIOVASC IMAG, V8, DOI 10.1161/CIRCIMAGING.114.003073
   Cai KJ, 2012, NAT MED, V18, P302, DOI 10.1038/nm.2615
   Chen Y, 2015, CELL TRANSPLANT, V24, P971, DOI 10.3727/096368913X675746
   Cheng ASH, 2007, J AM COLL CARDIOL, V49, P2440, DOI 10.1016/j.jacc.2007.03.028
   Christodoulou AG, 2018, NAT BIOMED ENG, V2, P215, DOI 10.1038/s41551-018-0217-y
   Chung K, 2013, NATURE, V497, P332, DOI 10.1038/nature12107
   Dass S, 2012, CIRC-CARDIOVASC IMAG, V5, P726, DOI 10.1161/CIRCIMAGING.112.976738
   Deng ZX, 2017, MAGN RESON MED, V77, P529, DOI 10.1002/mrm.26579
   Desai MY, 2005, EUR HEART J, V26, P2320, DOI 10.1093/eurheartj/ehi357
   Di Leo G, 2016, EUR RADIOL, V26, P3706, DOI 10.1007/s00330-015-4134-0
   Doenst T, 2013, CIRC RES, V113, P709, DOI 10.1161/CIRCRESAHA.113.300376
   Dweck MR, 2016, J AM COLL CARDIOL, V68, P2201, DOI 10.1016/j.jacc.2016.08.047
   Dweck MR, 2016, JACC-CARDIOVASC IMAG, V9, P306, DOI 10.1016/j.jcmg.2015.12.003
   Dzeja P P, 2000, Curr Cardiol Rep, V2, P212, DOI 10.1007/s11886-000-0071-9
   Escaned J, 2015, JACC-CARDIOVASC INTE, V8, P824, DOI 10.1016/j.jcin.2015.01.029
   Fayad ZA, 2000, CIRCULATION, V102, P506
   Friedrich MG, 2008, J AM COLL CARDIOL, V51, P1581, DOI 10.1016/j.jacc.2008.01.019
   Friedrich MG, 2010, NAT REV CARDIOL, V7, P292, DOI 10.1038/nrcardio.2010.28
   Garlid KD, 2003, BBA-BIOENERGETICS, V1606, P1, DOI 10.1016/S0005-2728(03)00109-9
   GARRIDO L, 1994, CIRC RES, V74, P789, DOI 10.1161/01.RES.74.5.789
   Gerretsen S, 2013, EUR RADIOL, V23, P115, DOI 10.1007/s00330-012-2576-1
   Gilad AA, 2007, NAT BIOTECHNOL, V25, P217, DOI 10.1038/nbt1277
   Gilbert SH, 2012, AM J PHYSIOL-HEART C, V302, pH287, DOI 10.1152/ajpheart.00824.2011
   Giri S, 2012, MAGN RESON MED, V68, P1570, DOI 10.1002/mrm.24139
   Grobner T, 2007, KIDNEY INT, V72, P260, DOI 10.1038/sj.ki.5002338
   Gutberlet M, 2005, EUR RADIOL, V15, P872, DOI 10.1007/s00330-005-2653-9
   Haaf P, 2016, J CARDIOVASC MAGN R, V18, DOI 10.1186/s12968-016-0308-4
   Hales PW, 2012, PROG BIOPHYS MOL BIO, V110, P319, DOI 10.1016/j.pbiomolbio.2012.07.014
   Haris M, 2014, NAT MED, V20, P209, DOI 10.1038/nm.3436
   He Y, 2012, J MAGN RESON IMAGING, V35, P72, DOI 10.1002/jmri.22652
   Hinojar R, 2015, CIRC-CARDIOVASC IMAG, V8, DOI 10.1161/CIRCIMAGING.115.003285
   Iles LM, 2015, EUR HEART J-CARD IMG, V16, P14, DOI 10.1093/ehjci/jeu182
   Jahnke C, 2005, EUR HEART J, V26, P2313, DOI 10.1093/eurheartj/ehi391
   Jeserich M, 2012, CLIN CARDIOL, V35, P371, DOI 10.1002/clc.21979
   Kammerlander AA, 2016, JACC-CARDIOVASC IMAG, V9, P14, DOI 10.1016/j.jcmg.2015.11.002
   Kawel N, 2012, J CARDIOVASC MAGN R, V14, DOI 10.1186/1532-429X-14-27
   Kim RJ, 1999, CIRCULATION, V100, P1992, DOI 10.1161/01.CIR.100.19.1992
   Kim RJ, 2000, NEW ENGL J MED, V343, P1445, DOI 10.1056/NEJM200011163432003
   Kim WY, 2001, NEW ENGL J MED, V345, P1863, DOI 10.1056/NEJMoa010866
   Kolodgie FD, 2003, NEW ENGL J MED, V349, P2316, DOI 10.1056/NEJMoa035655
   Kramer CM, 2013, J CARDIOVASC MAGN R, V15, DOI 10.1186/1532-429X-15-91
   Kwong RY, 2006, CIRCULATION, V113, P2733, DOI 10.1161/CIRCULATIONAHA.105.570648
   Lee SE, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-24622-6
   Leong DP, 2012, EUR HEART J, V33, P640, DOI 10.1093/eurheartj/ehr391
   Lombardi R, 2009, CIRCULATION, V119, P1398, DOI 10.1161/CIRCULATIONAHA.108.790501
   Mavrogeni S, 2017, CARDIOLOGY, V138, P207, DOI 10.1159/000478901
   McAlindon E, 2015, EUR HEART J-CARD IMG, V16, P738, DOI 10.1093/ehjci/jev001
   McAlindon EJ, 2015, RADIOLOGY, V275, P61, DOI 10.1148/radiol.14131980
   McCrohon A, 2003, CIRCULATION, V108, P54, DOI 10.1161/01.CIR.0000078641.19365.4C
   Mekkaoui C, 2017, NMR BIOMED, V30, DOI 10.1002/nbm.3426
   Messroghli DR, 2017, J CARDIOVASC MAGN R, V19, DOI 10.1186/s12968-017-0389-8
   Miao CL, 2009, J AM COLL CARDIOL, V53, P1708, DOI 10.1016/j.jacc.2008.12.063
   Naghavi M, 2003, CIRCULATION, V108, P1664, DOI 10.1161/01.CIR.0000087480.94275.97
   Nguyen C, 2016, MAGN RESON MED, V76, P1354, DOI 10.1002/mrm.26380
   Nguyen C, 2015, J CARDIOVASC MAGN R, V17, DOI 10.1186/s12968-015-0214-1
   Nguyen C, 2014, MAGN RESON MED, V72, P1257, DOI 10.1002/mrm.25038
   Nguyen CT, 2018, JACC-BASIC TRANSL SC, V3, P97, DOI 10.1016/j.jacbts.2017.09.005
   Nielles-Vallespin S, 2013, MAGN RESON MED, V70, P454, DOI 10.1002/mrm.24488
   Noguchi T, 2015, J AM COLL CARDIOL, V66, P245, DOI 10.1016/j.jacc.2015.05.056
   Noguchi T, 2014, J AM COLL CARDIOL, V63, P989, DOI 10.1016/j.jacc.2013.11.034
   Ntim WO, 2010, J AM COLL CARDIOL, V55, P171, DOI 10.1016/j.jacc.2009.08.043
   Ogawa R, 2017, CLIN RADIOL, V72, P828, DOI 10.1016/j.crad.2017.05.010
   Patel AR, 2017, JACC-CARDIOVASC IMAG, V10, P1180, DOI 10.1016/j.jcmg.2017.08.005
   PIJLS NHJ, 1995, CIRCULATION, V92, P3183, DOI 10.1161/01.CIR.92.11.3183
   Plein S, 2007, MAGN RESON MED, V58, P777, DOI 10.1002/mrm.21381
   Puchner SB, 2014, J AM COLL CARDIOL, V64, P684, DOI 10.1016/j.jacc.2014.05.039
   Puntmann VG, 2018, J AM COLL CARDIOL, V71, P766, DOI 10.1016/j.jacc.2017.12.020
   Puntmann VO, 2013, JACC-CARDIOVASC IMAG, V6, P475, DOI 10.1016/j.jcmg.2012.08.019
   Regenfus M, 2000, J AM COLL CARDIOL, V36, P44, DOI 10.1016/S0735-1097(00)00672-0
   REIBEL DK, 1978, AM J PHYSIOL, V234, pH620
   Sado DM, 2012, HEART, V98, P1436, DOI 10.1136/heartjnl-2012-302346
   Salerno M, 2018, JACC-CARDIOVASC IMAG, V11, P206, DOI 10.1016/j.jcmg.2017.01.024
   Saloner D, 2015, MAGN RESON IMAGING C, V23, P1, DOI 10.1016/j.mric.2014.08.004
   Schelbert EB, 2012, JAMA-J AM MED ASSOC, V308, P890, DOI 10.1001/2012.jama.11089
   Schuetz GM, 2010, ANN INTERN MED, V152, P167, DOI 10.7326/0003-4819-152-3-201002020-00008
   Schulz-Menger J, 2013, J CARDIOVASC MAGN R, V15, DOI 10.1186/1532-429X-15-35
   Sen S, 2012, J AM COLL CARDIOL, V59, P1392, DOI 10.1016/j.jacc.2011.11.003
   Sosnovik DE, 2014, CIRCULATION, V129, P1731, DOI 10.1161/CIRCULATIONAHA.113.005841
   Stuber M, 2002, MAGNET RESON MED, V48, P425, DOI 10.1002/mrm.10240
   Thavendiranathan P, 2012, CIRC-CARDIOVASC IMAG, V5, P102, DOI 10.1161/CIRCIMAGING.111.967836
   Tonino PAL, 2009, NEW ENGL J MED, V360, P213, DOI 10.1056/NEJMoa0807611
   Ugander M, 2012, EUR HEART J, V33, P1268, DOI 10.1093/eurheartj/ehr481
   Usman AA, 2012, CIRC-CARDIOVASC IMAG, V5, P782, DOI 10.1161/CIRCIMAGING.111.971101
   Verbrugge FH, 2017, EUR HEART J-CARD IMG, V18, P787, DOI 10.1093/ehjci/jew131
   Verhaert D, 2011, JACC-CARDIOVASC IMAG, V4, P269, DOI 10.1016/j.jcmg.2010.09.023
   Vo HQ, 2018, JACC-CARDIOVASC IMAG, V11, P196, DOI 10.1016/j.jcmg.2016.12.025
   VONKNOBELSDORFFBRE, 2013, J CARDIOVASC MAGN R, V15, DOI DOI 10.1186/1532-429X-15-53
   Walker JC, 2005, J THORAC CARDIOV SUR, V129, P382, DOI 10.1016/j.jtcvs.2004.06.006
   Xie GX, 2016, MAGN RESON MED, V75, P997, DOI 10.1002/mrm.25585
   Xie YB, 2017, JACC-CARDIOVASC IMAG, V10, P637, DOI 10.1016/j.jcmg.2016.06.014
   Yonezawa M, 2014, RADIOLOGY, V271, P356, DOI 10.1148/radiol.13122491
   Zhou JY, 2003, NAT MED, V9, P1085, DOI 10.1038/nm907
   Zhou ZW, 2017, J CARDIOVASC MAGN R, V19, DOI 10.1186/s12968-017-0411-1
NR 96
TC 0
Z9 0
U1 1
U2 15
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD FEB
PY 2019
VL 49
IS 2
BP 146
EP 159
DI 10.4070/kcj.2018.0246
PG 14
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA HJ4BU
UT WOS:000457119700003
PM 30468040
OA Other Gold, Green Published
DA 2021-04-22
ER

PT J
AU Oh, JK
   Park, JH
   Hwang, JK
   Lee, CH
   Park, JS
   Park, JI
   Park, HK
   Cho, JS
   Seo, BS
   Seong, SW
   Sun, BJ
   Lee, JH
   Seong, IW
AF Oh, Jin Kyung
   Park, Jae-Hyeong
   Hwang, Jin Kyung
   Lee, Chang Hoon
   Park, Jong Seon
   Park, Joong-Il
   Park, Hoon-Ki
   Cho, Jung Sun
   Seo, Bong-suk
   Seong, Seok-Woo
   Sun, Byung Joo
   Lee, Jae-Hwan
   Seong, In-Whan
TI Long-term Survival in Korean Elderly Patients with Symptomatic Severe
   Aortic Stenosis Who Refused Aortic Valve Replacement
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Aortic valve stenosis; Survival; Prognosis; Drug therapy
ID DISEASE
AB Background and objectives: Aortic valve replacement (AVR) is the treatment of choice in severe symptomatic aortic stenosis (AS) patients. However, a substantial number of elderly patients refuse AVR and treated medically. We investigated their long-term prognosis.
   Methods: From January 2005 to December 2016, we analyzed elderly patients with severe symptomatic AS who refused to have AVR.
   Results: After screening of total 534 patients, we analyzed total 180 severe symptomatic AS patients (78 +/- 7 years old, 96 males). Hypertension was the most common cardiovascular risk factor (72%) and the most common symptom was dyspnea (66%). Calculated aortic stenosis area was 0.73 +/- 0.20 cm(2) and mean left ventricular ejection fraction (LVEF) was 57.8 +/- 12.2%. Total 102 patients died during follow-tip period (39.1 +/- 31.0 months). One-, 3-, and 5-year all-cause mortality rate was 21.1 +/- 3.0%, 43.1 +/- 3.8%, and 56.5 +/- 4.2%, respectively. Of them, 87 died from cardiac causes, and 1-, 3-, and 5-year cardiac mortality rate was 18.0 +/- 2.9%, 38.2 +/- 3.8%, and 50.7 +/- 4.3%, respectively. Their all-cause mortality and cardiac mortality were significantly higher than those of controls. Univariate analysis showed that age, anemia, LVEF, and Log N-terminal pro B-type natriuretic peptide (NT-proBNP) were significant parameters in all-cause mortality (p<0.001, p=0.001, p=0.039, and p=0.047, respectively) and in cardiac mortality (p<0.001, p<0.001, p=0.046, and p=0.026, respectively). Multivariate analysis showed that age and anemia were significant prognostic factors for cardiac and all-cause mortality.
   Conclusions: In elderly severe symptomatic AS patients who treated medically, their 1-, 3- and 5-year all-cause mortality rate was 21.1 +/- 3.0%, 43.1 +/- 3.8%, and 56.5 +/- 4.2%, respectively. Age and anemia were significant prognostic factors for cardiac and all-cause mortality.
C1 [Oh, Jin Kyung; Park, Jae-Hyeong; Seo, Bong-suk; Seong, Seok-Woo; Sun, Byung Joo; Lee, Jae-Hwan; Seong, In-Whan] Chungnam Natl Univ, Chungnam Natl Univ Hosp, Dept Cardiol Internal Med, Sch Med, 282 Munhwa Ro, Daejeon 35015, South Korea.
   [Hwang, Jin Kyung; Lee, Chang Hoon; Park, Jong Seon; Park, Joong-Il; Park, Hoon-Ki] Vet Hlth Serv Med Ctr, Dept Internal Med, Div Cardiol, Seoul, South Korea.
   [Cho, Jung Sun] Catholic Univ Korea, Daejeon St Marys Hosp, Dept Internal Med, Div Cardiol,Coll Med, Daejeon, South Korea.
RP Park, JH (corresponding author), Chungnam Natl Univ, Chungnam Natl Univ Hosp, Dept Cardiol Internal Med, Sch Med, 282 Munhwa Ro, Daejeon 35015, South Korea.
EM jaehpark@cnu.ac.kr
RI Park, Jae-Hyeong/AAD-9015-2021
OI Hwang, Jin Kyung/0000-0002-9378-0311; Seong,
   In-Whan/0000-0003-4628-0258; Park, Jae-Hyeong/0000-0001-7035-286X; i,
   changhun/0000-0002-1622-272X; /0000-0001-8371-9704; Seong,
   Seok-Woo/0000-0003-3267-4192; Cho, Jung Sun/0000-0002-0308-0021; Lee,
   Jae-Hwan/0000-0002-6561-7760
CR Avila-Vanzzini Nydia, 2016, J Cardiovasc Ultrasound, V24, P303, DOI 10.4250/jcu.2016.24.4.303
   Bach DS, 2007, J HEART VALVE DIS, V16, P362
   Bach DS, 2009, CIRC-CARDIOVASC QUAL, V2, P533, DOI 10.1161/CIRCOUTCOMES.109.848259
   Clark MA, 2012, CIRC-CARDIOVASC QUAL, V5, P697, DOI 10.1161/CIRCOUTCOMES.112.966002
   FRANK S, 1973, BRIT HEART J, V35, P41
   Jang SY, 2014, INT J CARDIOL, V174, P355, DOI 10.1016/j.ijcard.2014.04.112
   Lang RM, 2015, EUR HEART J-CARD IMG, V16, P233, DOI 10.1093/ehjci/jev014
   Leon MB, 2010, NEW ENGL J MED, V363, P1597, DOI 10.1056/NEJMoa1008232
   Makkar RR, 2012, NEW ENGL J MED, V366, P1696, DOI 10.1056/NEJMoa1202277
   Ng ACT, 2015, EUR J HEART FAIL, V17, P1042, DOI 10.1002/ejhf.297
   Nkomo Vuyisile T, 2006, Lancet, V368, P1005, DOI 10.1016/S0140-6736(06)69208-8
   ROSS J, 1968, CIRCULATION, V38, pV61, DOI 10.1161/01.CIR.38.1S5.V-61
   Shinn SH, 2018, ANN THORAC SURG, V106, P924, DOI 10.1016/j.athoracsur.2018.03.059
   Yoon SH, 2016, J AM COLL CARDIOL, V68, P1195, DOI 10.1016/j.jacc.2016.06.041
   Yu CW, 2018, KOREAN CIRC J, V48, P382, DOI 10.4070/kcj.2018.0117
NR 15
TC 3
Z9 3
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD FEB
PY 2019
VL 49
IS 2
BP 160
EP 169
DI 10.4070/kcj.2018.0208
PG 10
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA HJ4BU
UT WOS:000457119700004
PM 30468030
OA Green Published, Other Gold
DA 2021-04-22
ER

PT J
AU Kim, IC
   Chang, HJ
   Cho, IJ
   Shim, CY
   Hong, GR
   Heo, JH
   Nam, HS
   Kim, YJ
   Choi, BW
   Chung, N
AF Kim, In-Cheol
   Chang, Hyuk-Jae
   Cho, In-Jeong
   Shim, Chi Young
   Hong, Geu-Ru
   Heo, Ji Hoe
   Nam, Hyo Suk
   Kim, Young-Jin
   Choi, Byoung-Wook
   Chung, Namsik
TI Benefit of Four-Dimensional Computed Tomography Derived Ejection
   Fraction of the Left Atrial Appendage to Predict Thromboembolic Risk in
   the Patients with Valvular Heart Disease
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Computed tomography; Atrial appendage; Thrombus
ID SPONTANEOUS ECHOCARDIOGRAPHIC CONTRAST; SPONTANEOUS ECHO CONTRAST;
   AORTIC-VALVE-REPLACEMENT; FLOW VELOCITY; STROKE; THROMBUS; FIBRILLATION
AB Background and Objectives: Decreased left atrial appendage (LAA) emptying velocity in transesophageal echocardiography (TEE) is related with higher incidence of thrombus and increased risk of stroke. Patients with valve disease are at higher risk of thrombus formation before and after surgery. The aim of this study was to investigate the role of 4-dimensional cardiac computed tomography (4DCT) to predict the risk of thrombus formation.
   Methods: Between March 2010 to March 2015, total of 62 patients (mean 60 +/- 15 years old, male: 53.2%) who underwent 4DCT and TEE for cardiac valve evaluation before surgery were retrospectively included in the current study. Fractional area change in TEE view and emptying velocity at left atrial appendage in TEE view (Ve(TEE) ) were measured. Ejection fraction (EF) of left atrial appendage in computed tomography (EFCT ) was calculated by 4DCT with full volume analysis. The best cut-off value of EFCT predicting presence of spontaneous echo contrast (SEC) or thrombus was evaluated, and correlation between the parameters were also estimated.
   Results: SEC or thrombus was observed in 45.2%. EFCT and Ve(TEE )were significantly correlated (r=0.452, p<0.001). However, fractional area change measured by TEE showed no correlation with VeTEE (r=0.085, p=0.512). EF cT <37.5% best predicted SEC or thrombus in the patients with valve disease who underwent 4DCT and TEE (area under the curve, 0.654; p=0.038).
   Conclusions: In the patients who underwent 4DCT for cardiac valve evaluation before surgery, EF(CT )by volume analysis might have additional role to evaluate LAA function and estimate the risk of thrombus.
C1 [Kim, In-Cheol; Chang, Hyuk-Jae; Cho, In-Jeong; Shim, Chi Young; Hong, Geu-Ru; Chung, Namsik] Yonsei Univ, Severance Cardiovasc Hosp, Div Cardiol, Coll Med, Seoul, South Korea.
   [Kim, In-Cheol] Keimyung Univ, Dongsan Med Ctr, Dept Internal Med, Div Cardiol,Coll Med, Daegu, South Korea.
   [Heo, Ji Hoe; Nam, Hyo Suk] Yonsei Univ, Dept Neurol, Coll Med, Seoul, South Korea.
   [Kim, Young-Jin; Choi, Byoung-Wook] Yonsei Univ, Severance Hosp, Dept Radiol, Coll Med, Seoul, South Korea.
RP Chang, HJ (corresponding author), Yonsei Univ, Coll Med, Yonsei Univ Hlth Syst, Div Cardiol,Severance Cardiovasc Hosp, 50-1 Yonsei Ro, Seoul 03722, South Korea.
EM HJCHANG@yuhs.ac
RI Shim, Chi Young/AAK-1057-2021
OI Shim, Chi Young/0000-0002-6136-0136; Kim, In-Cheol/0000-0002-5751-2328;
   Kim, Young Jin/0000-0002-6235-6550; Heo, Ji Hoe/0000-0001-9898-3321;
   Choi, Byoung Wook/0000-0002-8873-5444; Hong, Geu-Ru/0000-0003-4981-3304;
   Chang, Hyuk-Jae/0000-0002-6139-7545; NAM, HYO SUK/0000-0002-4415-3995
CR DANIEL WG, 1988, J AM COLL CARDIOL, V11, P1204, DOI 10.1016/0735-1097(88)90283-5
   Delgado V, 2009, JACC-CARDIOVASC IMAG, V2, P556, DOI 10.1016/j.jcmg.2008.12.025
   FATKIN D, 1994, J AM COLL CARDIOL, V23, P961, DOI 10.1016/0735-1097(94)90644-0
   Hahn RT, 2013, J AM SOC ECHOCARDIOG, V26, P921, DOI 10.1016/j.echo.2013.07.009
   Handke M, 2005, J AM SOC ECHOCARDIOG, V18, P1366, DOI 10.1016/j.echo.2005.05.006
   Hur J, 2009, STROKE, V40, P2073, DOI 10.1161/STROKEAHA.108.537928
   Iwasaki K, 2016, CARDIOLOGY, V133, P205, DOI 10.1159/000441277
   Jilaihawi H, 2012, J AM COLL CARDIOL, V59, P1275, DOI 10.1016/j.jacc.2011.11.045
   Kim IC, 2018, CIRC-CARDIOVASC IMAG, V11, DOI 10.1161/CIRCIMAGING.117.006986
   Ko SB, 2010, CEREBROVASC DIS, V29, P313, DOI 10.1159/000278926
   Kupczynska K, 2013, ARCH MED SCI, V9, P808, DOI 10.5114/aoms.2013.38674
   Messe SR, 2014, CIRCULATION, V129, P2253, DOI 10.1161/CIRCULATIONAHA.113.005084
   Palmer S, 2017, JACC-CARDIOVASC INTE, V10, P176, DOI 10.1016/j.jcin.2016.10.043
   Romero J, 2013, CIRC-CARDIOVASC IMAG, V6, P185, DOI 10.1161/CIRCIMAGING.112.000153
   Russo A, 2008, J AM COLL CARDIOL, V51, P1203, DOI 10.1016/j.jacc.2007.10.058
   Takahashi K, 2005, INT J CARDIOVAS IMAG, V21, P141, DOI 10.1007/s10554-004-5344-8
   Yoo J, 2016, STROKE, V47, P1920, DOI 10.1161/STROKEAHA.116.013351
   Zhao YP, 2016, SCI REP-UK, V6, DOI 10.1038/srep27650
NR 18
TC 2
Z9 2
U1 0
U2 3
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD FEB
PY 2019
VL 49
IS 2
BP 173
EP 180
DI 10.4070/kcj.2018.0152
PG 8
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA HJ4BU
UT WOS:000457119700006
PM 30468031
OA Green Published, Other Gold
DA 2021-04-22
ER

PT J
AU Hur, G
   Song, MS
   Sohn, S
   Lee, HD
   Kim, GB
   Cho, HJ
   Yoon, KL
   Uhngjoo, C
   Hyun, MC
   Kim, CH
AF Hur, Gyu
   Song, Min Seob
   Sohn, Sejung
   Lee, Hyoung Doo
   Kim, Gi Beom
   Cho, Hwa Jin
   Yoon, Kyung Lim
   Uhngjoo, Chan
   Hyun, Myung Chut
   Kim, Chut Ho
TI Infliximab Treatment for Intravenous Immunoglobulin-resistant Kawasaki
   Disease: a Multicenter Study in Korea
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Kawasaki disease; Coronary artery; Infliximab; Intravenous
   immunoglobulins
ID GAMMA-GLOBULIN TREATMENT; CORONARY ANEURYSMS; PULSE THERAPY;
   RETREATMENT; RISK
AB Background and Objectives: We investigated the status of infliximab use in intravenous immunoglobulin (IVIG)-resistant Kawasaki disease (KD) patients and the incidence of coronary artery aneurysms (CAAs) according to treatment regimens.
   Methods: Between March 2010 and February 2017, 16 hospitals participated in this study. A total of 102 (32.3 +/- 19.9 months, 72 males) who received infliximab at any time after first WIG treatment failure were enrolled. Data were retrospectively collected using a questionnaire.
   Results: Subjects were divided into two groups according to the timing of infliximab administration. Early treatment (group 1) had shorter fever duration (10.5 +/- 4.4 days) until infliximab infusion than that in late treatment (group 2) (16.4 +/- 4.5 days; p<0.001). We investigated the response rate to infliximab and the incidence of significant CAA (z-score >5 ) Overall response rate to infliximab was 89/102 (87.3%) and the incidence of significant CAA was lower in group 1 than in group 2 (1/42 [2.4%] vs. 17/60 [28.3%], p<0.001).
   Conclusions: This study suggests that the early administration of infliximab may reduce the incidence of significant CAA in patients with IVIG-resistant KD. However, further prospective randomized studies with larger sample sizes are required.
C1 [Hur, Gyu; Song, Min Seob] Inje Univ, Haeundae Paik Hosp, Dept Pediat, 875 Haeun Daero, Busan 48108, South Korea.
   [Sohn, Sejung] Ewha Womans Univ, Mokdong Hosp, Dept Pediat, Seoul, South Korea.
   [Lee, Hyoung Doo] Busan Natl Univ, Childrens Hosp, Dept Pediat, Busan, South Korea.
   [Kim, Gi Beom] Seoul Natl Univ, Childrens Hosp, Dept Pediat, Seoul, South Korea.
   [Cho, Hwa Jin] Chonnam Natl Univ, Childrens Hosp, Dept Pediat, Gwangju, South Korea.
   [Yoon, Kyung Lim] Kyung Hee Univ Hosp Gangdong, Dept Pediat, Seoul, South Korea.
   [Uhngjoo, Chan] Chonbuk Natl Univ, Childrens Hosp, Dept Pediat, Med Sch, Cheonju, South Korea.
   [Hyun, Myung Chut] Kyungpook Natl Univ, Sch Med, Dept Pediat, Daegu, South Korea.
   [Kim, Chut Ho] Inje Univ, Busan Paik Hosp, Dept Pediat, Busan, South Korea.
RP Song, MS (corresponding author), Inje Univ, Haeundae Paik Hosp, Dept Pediat, 875 Haeun Daero, Busan 48108, South Korea.
EM msped@hanmail.net
RI Kim, Gi Beom/AAK-3377-2021; Song, Min Seob/R-3075-2019
OI Kim, Gi Beom/0000-0002-7880-280X; cho, hwa jin/0000-0002-2458-8529
CR Azmoon S, 2010, CONGENIT HEART DIS, V5, P321, DOI 10.1111/j.1747-0803.2009.00361.x
   Burns JC, 2005, J PEDIATR-US, V146, P662, DOI 10.1016/j.jpeds.2004.12.022
   Burns JC, 1998, PEDIATR INFECT DIS J, V17, P1144, DOI 10.1097/00006454-199812000-00009
   Crandall WV, 2003, ALIMENT PHARM THER, V17, P75, DOI 10.1046/j.1365-2036.2003.01411.x
   Friedman KG, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.116.003289
   Furukawa T, 2008, ARCH DIS CHILD, V93, P142, DOI 10.1136/adc.2007.126144
   Hyams JS, 2017, GASTROENTEROLOGY, V152, P1901, DOI 10.1053/j.gastro.2017.02.004
   Jang H, 2018, YONSEI MED J, V59, P113, DOI 10.3349/ymj.2018.59.1.113
   KATO H, 1979, PEDIATRICS, V63, P175
   Keane J, 2001, NEW ENGL J MED, V345, P1098, DOI 10.1056/NEJMoa011110
   Kibata T, 2016, INT J CARDIOL, V214, P209, DOI 10.1016/j.ijcard.2016.03.017
   Lee J, 2014, KOREAN CIRC J, V44, P54, DOI 10.4070/kcj.2014.44.1.54
   McCrindle BW, 2017, CIRCULATION, V135, pE927, DOI 10.1161/CIR.0000000000000484
   Micallef Eynaud S, 2016, Images Paediatr Cardiol, V18, P9
   Minozzi S, 2016, EXPERT OPIN DRUG SAF, V15, P11, DOI 10.1080/14740338.2016.1240783
   Miura M, 2005, ARCH DIS CHILD, V90, P1096, DOI 10.1136/adc.2004.062299
   Mori M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-18387-7
   Olivieri L, 2009, J AM SOC ECHOCARDIOG, V22, P159, DOI 10.1016/j.echo.2008.11.003
   Sivakumar K, 2013, PEDIATR CARDIOL, V34, P444, DOI 10.1007/s00246-012-0285-9
   Son MB, 2011, J PEDIATR-US, V158, P644, DOI 10.1016/j.jpeds.2010.10.012
   Song Min Seob, 2010, Korean Circ J, V40, P334, DOI 10.4070/kcj.2010.40.7.334
   Tremoulet AH, 2014, LANCET, V383, P1731, DOI 10.1016/S0140-6736(13)62298-9
   Wallace CA, 2000, PEDIATRICS, V105, part. no., DOI 10.1542/peds.105.6.e78
   Wardle AJ, 2017, COCHRANE DB SYST REV, V1
   Wright DA, 1996, J PEDIATR-US, V128, P146, DOI 10.1016/S0022-3476(96)70447-X
   Youn Y, 2016, PEDIATR INFECT DIS J, V35, P457, DOI 10.1097/INF.0000000000001039
NR 26
TC 5
Z9 6
U1 1
U2 3
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD FEB
PY 2019
VL 49
IS 2
BP 183
EP 191
DI 10.4070/kcj.2018.0214
PG 9
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA HJ4BU
UT WOS:000457119700008
PM 30468032
OA Green Published, Other Gold
DA 2021-04-22
ER

PT J
AU Lee, HJ
   Kim, HK
AF Lee, Hyun-Jung
   Kim, Hyung-Kwan
TI Natural History Data in Symptomatic Severe Aortic Stenosis Alerts
   Cardiologists to the Dangers of No Action
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
ID VALVE-REPLACEMENT; LOW-GRADIENT; LOW-FLOW
C1 [Kim, Hyung-Kwan] Seoul Natl Univ Hosp, Sect Cardiovasc Imaging, Dept Internal Med, Div Cardiol, 101 Daehak Ro, Seoul 03080, South Korea.
   [Kim, Hyung-Kwan] Seoul Natl Univ Hosp, Cardiovasc Ctr, 101 Daehak Ro, Seoul 03080, South Korea.
RP Kim, HK (corresponding author), Seoul Natl Univ Hosp, Sect Cardiovasc Imaging, Dept Internal Med, Div Cardiol, 101 Daehak Ro, Seoul 03080, South Korea.; Kim, HK (corresponding author), Seoul Natl Univ Hosp, Cardiovasc Ctr, 101 Daehak Ro, Seoul 03080, South Korea.
EM cardiman73@gmail.com
RI Kim, Hyung-Kwan/R-8375-2019
OI Lee, Hyun-Jung/0000-0002-7498-0705; Kim, Hyung-Kwan/0000-0001-7950-2131
CR Abudiab MM, 2017, KOREAN CIRC J, V47, P82, DOI 10.4070/kcj.2016.0126
   Bach DS, 2009, CIRC-CARDIOVASC QUAL, V2, P533, DOI 10.1161/CIRCOUTCOMES.109.848259
   Leon MB, 2010, NEW ENGL J MED, V363, P1597, DOI 10.1056/NEJMoa1008232
   Nishimura RA, 2014, CIRCULATION, V129, P2440, DOI 10.1161/CIR.0000000000000029
   Oh JK, 2019, KOREAN CIRC J, V49, P160, DOI 10.4070/kcj.2018.0208
   Osnabrugge RLJ, 2013, J AM COLL CARDIOL, V62, P1002, DOI 10.1016/j.jacc.2013.05.015
   Tribouilloy C, 2015, J AM COLL CARDIOL, V65, P55, DOI 10.1016/j.jacc.2014.09.080
   Varadarajan P, 2006, ANN THORAC SURG, V82, P2111, DOI 10.1016/j.athoracsur.2006.07.048
   World Bank, 2017, LIF EXP BIRTH TOT YE
NR 9
TC 0
Z9 0
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD FEB
PY 2019
VL 49
IS 2
BP 170
EP 172
DI 10.4070/kcj.2018.0344
PG 3
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA HJ4BU
UT WOS:000457119700005
PM 30468037
OA Green Published, Other Gold
DA 2021-04-22
ER

PT J
AU Park, JJ
AF Park, Jin Joo
TI Computed Tomography for Assessment of Left Atrial Appendage Function
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
C1 [Park, Jin Joo] Seoul Natl Univ, Cardiovasc Ctr, Bundang Hosp, Div Cardiol,Dept Internal Med, 82 Gumi Ro 173 Beon Gil, Seongnam 13620, South Korea.
RP Park, JJ (corresponding author), Seoul Natl Univ, Cardiovasc Ctr, Bundang Hosp, Div Cardiol,Dept Internal Med, 82 Gumi Ro 173 Beon Gil, Seongnam 13620, South Korea.
EM jinjooparkmd@gmail.com
CR Beigel R, 2014, JACC-CARDIOVASC IMAG, V7, P1251, DOI 10.1016/j.jcmg.2014.08.009
   Blackshear JL, 1996, ANN THORAC SURG, V61, P755, DOI 10.1016/0003-4975(95)00887-X
   Chan Kwan-Leung, 1998, Annals of Internal Medicine, V128, P639
   Joung B, 2017, KOREAN CIRC J, V47, P833, DOI 10.4070/kcj.2017.0158
   Kim IC, 2019, KOREAN CIRC J, V49, P173, DOI 10.4070/kcj.2018.0152
   MANNING WJ, 1995, ANN INTERN MED, V123, P817, DOI 10.7326/0003-4819-123-11-199512010-00001
NR 6
TC 0
Z9 0
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD FEB
PY 2019
VL 49
IS 2
BP 181
EP 182
DI 10.4070/kcj.2018.0355
PG 2
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA HJ4BU
UT WOS:000457119700007
PM 30468038
OA Other Gold, Green Published
DA 2021-04-22
ER

PT J
AU Eun, LY
AF Eun, Lucy Youngmin
TI Infliximab, Is It Really a New Horizon for the Treatment of Kawasaki
   Disease?
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
ID INTRAVENOUS IMMUNOGLOBULIN THERAPY; RISK
C1 [Eun, Lucy Youngmin] Yonsei Univ, Div Pediat Cardiol, Dept Pediat, Coll Med, 50-1 Yonsei Ro, Seoul 03722, South Korea.
RP Eun, LY (corresponding author), Yonsei Univ, Div Pediat Cardiol, Dept Pediat, Coll Med, 50-1 Yonsei Ro, Seoul 03722, South Korea.
EM lucyeun@yuhs.ac
OI Eun, Lucy/0000-0002-4577-3168
CR Bayry J, 2011, NAT REV RHEUMATOL, V7, P349, DOI 10.1038/nrrheum.2011.61
   Burns JC, 2015, EXPERT REV CLIN IMMU, V11, P819, DOI 10.1586/1744666X.2015.1044980
   Burns JC, 2005, J PEDIATR-US, V146, P662, DOI 10.1016/j.jpeds.2004.12.022
   Burns JC, 1998, PEDIATR INFECT DIS J, V17, P1144, DOI 10.1097/00006454-199812000-00009
   Han JW, 2017, KOREAN CIRC J, V47, P179, DOI 10.4070/kcj.2017.0011
   Hur G, 2018, KOREAN CIRC J, V49, P183
   Hyams JS, 2017, GASTROENTEROLOGY, V152, P1901, DOI 10.1053/j.gastro.2017.02.004
   Kim SJ, 2018, KOREAN CIRC J, V48, P329, DOI 10.4070/kcj.2018.0077
   Negi VS, 2007, J CLIN IMMUNOL, V27, P233, DOI 10.1007/s10875-007-9088-9
   Tremoulet AH, 2014, LANCET, V383, P1731, DOI 10.1016/S0140-6736(13)62298-9
NR 10
TC 0
Z9 0
U1 0
U2 2
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD FEB
PY 2019
VL 49
IS 2
BP 192
EP 193
DI 10.4070/kcj.2018.0460
PG 2
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA HJ4BU
UT WOS:000457119700009
PM 30693682
OA Green Published, Other Gold
DA 2021-04-22
ER

PT J
AU Seo, KW
   Park, JS
AF Seo, Kyoung-Woo
   Park, Jin-Sun
TI Sinus of Valsalva Aneurysm and Multiple Aortic Aneurysms Provoked by
   Viral Myocarditis
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
C1 [Seo, Kyoung-Woo; Park, Jin-Sun] Ajou Univ, Dept Cardiol, Sch Med, 164 World Cup Ro, Suwon 16499, South Korea.
RP Park, JS (corresponding author), Ajou Univ, Dept Cardiol, Sch Med, 164 World Cup Ro, Suwon 16499, South Korea.
EM lavioli@hanmail.net
OI Park, Jin-Sun/0000-0002-7775-4092
CR Batiste C, 2004, J AM SOC ECHOCARDIOG, V17, P474, DOI 10.1016/j.echo.2004.01.002
   Medeiros Sobrinho J H, 1989, Arq Bras Cardiol, V52, P341
NR 2
TC 2
Z9 2
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD FEB
PY 2019
VL 49
IS 2
BP 194
EP 196
DI 10.4070/kcj.2018.0309
PG 3
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA HJ4BU
UT WOS:000457119700010
PM 30693683
OA Green Published, Other Gold
DA 2021-04-22
ER

PT J
AU Lee, PH
   Lee, SW
AF Lee, Pil Hyung
   Lee, Seung-Whan
TI Stent Selection in Complex Coronary Interventions: Thinking Complex?
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
ID DUAL ANTIPLATELET THERAPY; BIODEGRADABLE POLYMER; DURABLE POLYMER;
   ELUTING STENT; REVASCULARIZATION; LEADERS; SAFETY
C1 [Lee, Pil Hyung; Lee, Seung-Whan] Univ Ulsan, Coll Med, Dept Cardiol, Asan Med Ctr, 88,Olymp Ro 43 Gil, Seoul 05505, South Korea.
RP Lee, PH (corresponding author), Univ Ulsan, Coll Med, Dept Cardiol, Asan Med Ctr, 88,Olymp Ro 43 Gil, Seoul 05505, South Korea.
EM pilmo11@hanmail.net
CR Byrne RA, 2017, LANCET, V390, P781, DOI 10.1016/S0140-6736(17)31927-X
   Giustino G, 2016, J AM COLL CARDIOL, V68, P1851, DOI 10.1016/j.jacc.2016.07.760
   Lee SY, 2017, KOREAN CIRC J, V47, P823, DOI 10.4070/kcj.2017.0157
   Piccolo R, 2015, LANCET, V386, P702, DOI 10.1016/S0140-6736(15)61220-X
   Serruys PW, 2013, JACC-CARDIOVASC INTE, V6, P777, DOI 10.1016/j.jcin.2013.04.011
   Song PS, 2018, KOREAN CIRC J, V49, P69
   Stefanini GG, 2014, HEART, V100, P1051, DOI 10.1136/heartjnl-2012-303522
   Werner N, 2018, CLIN RES CARDIOL, V107, pS64, DOI 10.1007/s00392-018-1316-1
   Windecker S, 2008, LANCET, V372, P1163, DOI 10.1016/S0140-6736(08)61244-1
   Yeh RW, 2017, J AM COLL CARDIOL, V70, P2213, DOI 10.1016/j.jacc.2017.09.011
NR 10
TC 0
Z9 0
U1 0
U2 2
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JAN
PY 2019
VL 49
IS 1
BP 81
EP 83
DI 10.4070/kcj.2018.0285
PG 3
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA HJ4BY
UT WOS:000457120200005
PM 30468036
OA Other Gold, Green Published
DA 2021-04-22
ER

PT J
AU Kim, J
AF Kim, Jun
TI Non-fluoroscopic Catheter Tracking System for Atrial Fibrillation
   Ablation
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
ID INITIAL-EXPERIENCE
C1 [Kim, Jun] Univ Ulsan, Coll Med, Dept Cardiol, Asan Med Ctr, 88,Olymp Ro 43 Gil, Seoul 05505, South Korea.
RP Kim, J (corresponding author), Univ Ulsan, Coll Med, Dept Cardiol, Asan Med Ctr, 88,Olymp Ro 43 Gil, Seoul 05505, South Korea.
EM junkim@amc.seoul.kr
CR Calkins H, 2017, HEART RHYTHM, V14, pE275, DOI 10.1016/j.hrthm.2017.05.012
   Cha MJ, 2016, KOREAN CIRC J, V46, P646, DOI 10.4070/kcj.2016.46.5.646
   Gaspar T, 2012, EUROPACE, V14, pII24, DOI 10.1093/europace/eus215
   Kistler PM, 2006, J CARDIOVASC ELECTR, V17, P341, DOI 10.1111/j.1540-8167.2006.00371.x
   Sommer P, 2014, CIRC-ARRHYTHMIA ELEC, V7, P869, DOI 10.1161/CIRCEP.114.001542
   Sommer P, 2013, EUROPACE, V15, P1292, DOI 10.1093/europace/eut090
   Sommer P, 2013, EUROPACE, V15, P578, DOI 10.1093/europace/eus226
   Yamada S, 2019, KOREAN CIRC J, V49, P84, DOI 10.4070/kcj.2018.0195
NR 8
TC 0
Z9 0
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JAN
PY 2019
VL 49
IS 1
BP 97
EP 98
DI 10.4070/kcj.2018.0319
PG 2
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA HJ4BY
UT WOS:000457120200007
PM 30468033
OA Green Published, Other Gold
DA 2021-04-22
ER

PT J
AU Yoo, BW
AF Yoo, Byung Won
TI New Insight to the Pathogenetic Mechanism of Kawasaki Disease (KD): the
   Relationship between Clinical Diversity and Genetic Heterogeneity
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
ID GENOME-WIDE ASSOCIATION; SUSCEPTIBILITY LOCUS; SNP RS28493229; ITPKC
   GENE; FCGR2A; POLYMORPHISM; RISK
C1 [Yoo, Byung Won] Yonsei Univ, Coll Med, Severance Hosp, Dept Clin Pharmacol,Clin Trial Ctr, 50-1 Yonsei Ro, Seoul 03722, South Korea.
   [Yoo, Byung Won] Yonsei Univ, Coll Med, Dept Pediat, Div Pediat Cardiol, Seoul, South Korea.
RP Yoo, BW (corresponding author), Yonsei Univ, Coll Med, Severance Hosp, Dept Clin Pharmacol,Clin Trial Ctr, 50-1 Yonsei Ro, Seoul 03722, South Korea.
EM bwyoo@yuhs.ac
OI Yoo, Byung Won/0000-0001-6895-1484
CR Burgner D, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000319
   Chang RKR, 2002, PEDIATR INFECT DIS J, V21, P1150, DOI 10.1097/00006454-200212000-00013
   Chatzikyriakidou A, 2015, CARDIOL YOUNG, V25, P681, DOI 10.1017/S1047951114000626
   Chi H, 2010, HUM MOL GENET, V19, P1147, DOI 10.1093/hmg/ddp586
   FUJITA Y, 1989, PEDIATRICS, V84, P666
   Holman Robert C, 2010, Hawaii Med J, V69, P194
   JOFFE A, 1995, WESTERN J MED, V162, P322
   Khor CC, 2011, NAT GENET, V43, P1241, DOI 10.1038/ng.981
   Kim JJ, 2013, J HUM GENET, V58, P521, DOI 10.1038/jhg.2013.43
   Kim JJ, 2011, HUM GENET, V129, P487, DOI 10.1007/s00439-010-0937-x
   Kuo HC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154943
   Kwon YC, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184248
   Lee YC, 2012, NAT GENET, V44, P522, DOI 10.1038/ng.2227
   Lin L, 2015, GENET MOL RES, V14, P6256, DOI 10.4238/2015.June.9.12
   Newburger JW, 2004, CIRCULATION, V110, P2747, DOI 10.1161/01.CIR.0000145143.19711.78
   No SJ, 2013, PEDIATR CARDIOL, V34, P286, DOI 10.1007/s00246-012-0440-3
   Onouchi Y, 2012, NAT GENET, V44, P517, DOI 10.1038/ng.2220
   Peng Qian, 2011, Zhonghua Yixue Yichuanxue Zazhi, V28, P644, DOI 10.3760/cma.j.issn.1003-9406.2011.06.010
   Sim BK, 2019, KOREAN CIRC J, V49, P99, DOI 10.4070/kcj.2018.0224
   Tsai FJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016853
NR 20
TC 0
Z9 0
U1 0
U2 3
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JAN
PY 2019
VL 49
IS 1
BP 109
EP 112
DI 10.4070/kcj.2018.0365
PG 4
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA HJ4BY
UT WOS:000457120200009
PM 30468043
OA Green Published, Other Gold
DA 2021-04-22
ER

PT J
AU Chung, Y
   Roh, SY
AF Chung, Yuna
   Roh, Seung-Young
TI Ovoid-shaped Left Main Coronary Calcified Aneurysm Leading to Unstable
   Angina Requiring Surgical Intervention
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
ID DISEASE
C1 [Roh, Seung-Young] Dongguk Univ, Coll Med, Div Cardiol, Dept Internal Med, 27 Dongguk Ro, Goyang 10326, South Korea.
   [Roh, Seung-Young] Dongguk Univ, Med Ctr, 27 Dongguk Ro, Goyang 10326, South Korea.
RP Roh, SY (corresponding author), Dongguk Univ, Coll Med, Div Cardiol, Dept Internal Med, 27 Dongguk Ro, Goyang 10326, South Korea.; Roh, SY (corresponding author), Dongguk Univ, Med Ctr, 27 Dongguk Ro, Goyang 10326, South Korea.
EM rsy008@gmail.com
CR Aggarwal A, 2016, WORLD J CARDIOL, V8, P728, DOI 10.4330/wjc.v8.i12.728
   Bang JS, 2017, KOREAN CIRC J, V47, P516, DOI 10.4070/kcj.2016.0163
   Beiser AS, 1998, AM J CARDIOL, V81, P1116, DOI 10.1016/S0002-9149(98)00116-7
NR 3
TC 0
Z9 0
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JAN
PY 2019
VL 49
IS 1
BP 113
EP 114
DI 10.4070/kcj.2018.0243
PG 2
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA HJ4BY
UT WOS:000457120200010
PM 30468039
OA Other Gold, Green Published
DA 2021-04-22
ER

PT J
AU Choi, YJ
   Cho, HJ
AF Choi, You-Jung
   Cho, Hyun-Jai
TI Clinical and Histological Response to Immunosuppressive Therapy in Giant
   Cell Myocarditis
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
C1 [Choi, You-Jung; Cho, Hyun-Jai] Seoul Natl Univ Hosp, Dept Internal Med, Div Cardiol, 101 Daehak Ro, Seoul 03080, South Korea.
RP Cho, HJ (corresponding author), Seoul Natl Univ Hosp, Dept Internal Med, Div Cardiol, 101 Daehak Ro, Seoul 03080, South Korea.
EM hyunjaicho@snu.ac.kr
CR Fluschnik N, 2014, BMJ CASE REP, V2014
   KODAMA M, 1990, CLIN IMMUNOL IMMUNOP, V57, P250, DOI 10.1016/0090-1229(90)90039-S
   Vaideeswar P, 2013, CARDIOVASC PATHOL, V22, P70, DOI 10.1016/j.carpath.2012.06.003
   Weimer R, 2005, TRANSPL INT, V18, P226, DOI 10.1111/j.1432-2277.2004.00047.x
NR 4
TC 0
Z9 0
U1 0
U2 2
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JAN
PY 2019
VL 49
IS 1
BP 115
EP 117
DI 10.4070/kcj.2018.0305
PG 3
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA HJ4BY
UT WOS:000457120200011
PM 30637996
OA Green Published, Other Gold
DA 2021-04-22
ER

PT J
AU Lee, JH
   Kim, MS
   Kim, EJ
   Park, DG
   Cho, HJ
   Yoo, BS
   Kang, SM
   Choi, DJ
AF Lee, Ju-Hee
   Kim, Min-Seok
   Kim, Eung Ju
   Park, Dae-Gyun
   Cho, Hyun-Jai
   Yoo, Byung-Su
   Kang, Seok-Min
   Choi, Dong-Ju
TI KSHF Guidelines for the Management of Acute Heart Failure: Part I.
   Definition, Epidemiology and Diagnosis of Acute Heart Failure
SO KOREAN CIRCULATION JOURNAL
LA English
DT Review
DE Heart failure; Guideline; Epidemiology; Diagnosis
ID BRAIN NATRIURETIC PEPTIDE; ELEVATION MYOCARDIAL-INFARCTION; 2013
   ACCF/AHA GUIDELINE; ASSOCIATION TASK-FORCE; FAMILY-MEMBER ST2;
   EUROPEAN-SOCIETY; EMERGENCY-DEPARTMENT; PULMONARY-EMBOLISM; CARDIAC
   TROPONIN; PROGNOSTIC VALUE
AB The prevalence of heart failure (HF) is on the rise due to the aging of society. Furthermore, the continuous progress and widespread adoption of screening and diagnostic strategies have led to an increase in the detection rate of HF, effectively increasing the number of patients requiring monitoring and treatment. Because HF is associated with substantial rates of mortality and morbidity, as well as high socioeconomic burden, there is an increasing need for developing specific guidelines for HF management. The Korean guidelines for the diagnosis and management of chronic HF were introduced in March 2016. However, chronic and acute heart failure (AHF) represent distinct disease entities. Here, we introduce the Korean guidelines for the management of AHF with reduced or preserved ejection fraction. Part I of this guideline covers the definition, epidemiology, and diagnosis of AHF.
C1 [Lee, Ju-Hee] Chungbuk Natl Univ, Chungbuk Natl Univ Hosp, Dept Internal Med, Div Cardiol,Coll Med, Cheongju, South Korea.
   [Kim, Min-Seok] Univ Ulsan, Coll Med, Dept Internal Med, Asan Med Ctr, Seoul, South Korea.
   [Kim, Eung Ju] Korea Univ, Guro Hosp, Dept Cardiol, Cardiovasc Ctr, Seoul, South Korea.
   [Park, Dae-Gyun] Hallym Univ, Coll Med, Dept Cardiol, Kangdong Sacred Heart Hosp, Seoul, South Korea.
   [Cho, Hyun-Jai] Seoul Natl Univ Hosp, Dept Internal Med, Seoul, South Korea.
   [Yoo, Byung-Su] Yonsei Univ, Wonju Coll Med, Dept Med, Div Cardiol, Wonju, South Korea.
   [Kang, Seok-Min] Yonsei Univ, Coll Med, Dept Med, Div Cardiol, Seoul, South Korea.
   [Choi, Dong-Ju] Seoul Natl Univ, Bundang Hosp, Cardiovasc Ctr, Dept Internal Med, Seongnam, South Korea.
RP Choi, DJ (corresponding author), Seoul Natl Univ, Bundang Hosp, Dept Internal Med, Coll Med, 82,Gumi Ro 173 Beon Gil, Seongnam 13620, South Korea.
EM djchoi@snubh.org
OI PARK, DAE-GYUN/0000-0001-5150-9729; Kim, Eung Ju/0000-0003-2322-6267;
   Kang, Seok-Min/0000-0001-9856-9227
CR Adams KF, 2005, AM HEART J, V149, P209, DOI 10.1016/j.ahj.2004.08.005
   Amsterdam EA, 2014, J AM COLL CARDIOL, V64, pE139, DOI 10.1016/j.jacc.2014.09.017
   Arcand J, 2011, AM J CLIN NUTR, V93, P332, DOI 10.3945/ajcn.110.000174
   Bettencourt P, 2004, CIRCULATION, V110, P2168, DOI 10.1161/01.CIR.0000144310.04433.BE
   Chakeabarti S, 2010, J CARD FAIL, V16, pS53, DOI 10.1016/j.cardfail.2010.04.004
   CHAKKO S, 1991, AM J MED, V90, P353, DOI 10.1016/0002-9343(91)90576-J
   Cheng V, 2001, J AM COLL CARDIOL, V37, P386, DOI 10.1016/S0735-1097(00)01157-8
   Choi DJ, 2011, KOREAN CIRC J, V41, P363, DOI 10.4070/kcj.2011.41.7.363
   Dao Q, 2001, J AM COLL CARDIOL, V37, P379, DOI 10.1016/S0735-1097(00)01156-6
   DAVIS M, 1994, LANCET, V343, P440, DOI 10.1016/S0140-6736(94)92690-5
   De Luca G, 2004, CIRCULATION, V109, P1223, DOI 10.1161/01.CIR.0000121424.76486.20
   Dhaliwal AS, 2009, J CARD FAIL, V15, P293, DOI 10.1016/j.cardfail.2008.11.007
   Drazner MH, 2001, NEW ENGL J MED, V345, P574, DOI 10.1056/NEJMoa010641
   Elliott WJ, 2006, PROG CARDIOVASC DIS, V48, P316, DOI 10.1016/j.pcad.2006.02.004
   Flaherty JD, 2009, J AM COLL CARDIOL, V53, P254, DOI 10.1016/j.jacc.2008.08.072
   Fonarow GC, 2008, ARCH INTERN MED, V168, P847, DOI 10.1001/archinte.168.8.847
   Fonarow GC, 2008, AM J CARDIOL, V101, P231, DOI 10.1016/j.amjcard.2007.07.066
   Gheorghiade M, 2006, JAMA-J AM MED ASSOC, V296, P2217, DOI 10.1001/jama.296.18.2217
   Gheorghiade M, 2009, J AM COLL CARDIOL, V53, P557, DOI 10.1016/j.jacc.2008.10.041
   Gloth FM, 2007, J AM GERIATR SOC, V55, P305, DOI 10.1111/j.1532-5415.2007.01051.x
   Granger BB, 2005, LANCET, V366, P2005, DOI 10.1016/S0140-6736(05)67760-4
   Hugli O, 2005, AM J CARDIOL, V96, P1537, DOI 10.1016/j.amjcard.2005.07.064
   Ilva T, 2008, EUR J HEART FAIL, V10, P772, DOI 10.1016/j.ejheart.2008.06.009
   Jaff MR, 2011, CIRCULATION, V123, P1788, DOI 10.1161/CIR.0b013e318214914f
   Januzzi JL, 2007, J AM COLL CARDIOL, V50, P607, DOI 10.1016/j.jacc.2007.05.014
   Januzzi JL, 2006, ARCH INTERN MED, V166, P315, DOI 10.1001/archinte.166.3.315
   Joffe SW, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000053
   Kazanegra R, 2001, J CARD FAIL, V7, P21, DOI 10.1054/jcaf.2001.23355
   Kim MS, 2017, KOREAN CIRC J, V47, P555, DOI 10.4070/kcj.2017.0009
   Konstantinides SV, 2014, EUR HEART J, V35, P3033, DOI 10.1093/eurheartj/ehu283
   Lee DS, 2012, ANN INTERN MED, V156, P767, DOI 10.7326/0003-4819-156-11-201206050-00003
   Lee SE, 2014, EUR J HEART FAIL, V16, P700, DOI 10.1002/ejhf.91
   LEMERY R, 1992, AM J CARDIOL, V70, P147, DOI 10.1016/0002-9149(92)91266-7
   Levy P, 2007, ANN EMERG MED, V50, P144, DOI 10.1016/j.annemergmed.2007.02.022
   Logeart D, 2004, J AM COLL CARDIOL, V43, P635, DOI 10.1016/j.jacc.2003.09.044
   Maisel A, 2004, J AM COLL CARDIOL, V44, P1328, DOI 10.1016/j.jacc.2004.06.015
   Maisel AS, 2008, J AM COLL CARDIOL, V52, P534, DOI 10.1016/j.jacc.2008.05.010
   Maisel AS, 2002, NEW ENGL J MED, V347, P161, DOI 10.1056/NEJMoa020233
   Manzano-Fernandez S, 2011, AM J CARDIOL, V107, P259, DOI 10.1016/j.amjcard.2010.09.011
   McMullan MH, 2001, ANN THORAC SURG, V71, P1894, DOI 10.1016/S0003-4975(01)02625-X
   McMurray JJV, 2012, EUR J HEART FAIL, V14, P803, DOI 10.1093/eurjhf/hfs105
   Mebazaa A, 2015, EUR HEART J, V36, P1958, DOI 10.1093/eurheartj/ehv066
   Moe GW, 2007, CIRCULATION, V115, P3103, DOI 10.1161/CIRCULATIONAHA.106.666255
   Mueller C, 2004, NEW ENGL J MED, V350, P647, DOI 10.1056/NEJMoa031681
   Nohria A, 2002, JAMA-J AM MED ASSOC, V287, P628, DOI 10.1001/jama.287.5.628
   O'Gara PT, 2013, CIRCULATION, V127, P529, DOI 10.1161/CIR.0b013e3182742c84
   Park JJ, 2014, AM J CARDIOL, V113, P511, DOI 10.1016/j.amjcard.2013.10.022
   Paterna S, 2009, AM J CARDIOL, V103, P93, DOI 10.1016/j.amjcard.2008.08.043
   Peacock WF, 2008, NEW ENGL J MED, V358, P2117, DOI 10.1056/NEJMoa0706824
   Peacock William Frank, 2009, Congest Heart Fail, V15, P256, DOI 10.1111/j.1751-7133.2009.00112.x
   Pinto DS, 2006, CIRCULATION, V114, P2019, DOI 10.1161/CIRCULATIONAHA.106.638353
   Priori SG, 2015, EUR HEART J, V36, P2793, DOI 10.1093/eurheartj/ehv316
   Rathore SS, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1807
   Roffi M, 2016, EUR HEART J, V37, P267, DOI 10.1093/eurheartj/ehv320
   Rogers RK, 2009, AM HEART J, V158, P777, DOI 10.1016/j.ahj.2009.09.002
   Slater J, 2000, J AM COLL CARDIOL, V36, P1117, DOI 10.1016/S0735-1097(00)00845-7
   Steg PG, 2012, EUR HEART J, V33, P2569, DOI 10.1093/eurheartj/ehs215
   Stevenson LW, 2005, EUR J HEART FAIL, V7, P323, DOI 10.1016/j.ejheart.2005.01.004
   STEVENSON LW, 1989, JAMA-J AM MED ASSOC, V261, P884, DOI 10.1001/jama.261.6.884
   Tang WHW, 2011, AM J CARDIOL, V108, P385, DOI 10.1016/j.amjcard.2011.03.056
   TEPE NA, 1985, J THORAC CARDIOV SUR, V89, P525
   Terkelsen CJ, 2011, ANN INTERN MED, V155, P361, DOI 10.7326/0003-4819-155-6-201109200-00004
   Terkelsen CJ, 2010, JAMA-J AM MED ASSOC, V304, P763, DOI 10.1001/jama.2010.1139
   van Kimmenade RRJ, 2006, AM J CARDIOL, V98, P386, DOI 10.1016/j.amjcard.2006.02.043
   Wang CS, 2005, JAMA-J AM MED ASSOC, V294, P1944, DOI 10.1001/jama.294.15.1944
   Yancy CW, 2013, J AM COLL CARDIOL, V62, pE147, DOI 10.1016/j.jacc.2013.05.019
   Zairis MN, 2010, INT J CARDIOL, V141, P284, DOI 10.1016/j.ijcard.2008.12.017
   Zanotti-Cavazzoni SL, 2009, CURR OPIN CRIT CARE, V15, P392, DOI 10.1097/MCC.0b013e3283307a4e
NR 68
TC 11
Z9 11
U1 0
U2 5
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JAN
PY 2019
VL 49
IS 1
BP 1
EP 21
DI 10.4070/kcj.2018.0373
PG 21
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA HJ4BY
UT WOS:000457120200001
PM 30637993
OA Green Published, Other Gold
DA 2021-04-22
ER

PT J
AU Lee, JH
   Kim, MS
   Yoo, BS
   Park, SJ
   Park, JJ
   Shin, MS
   Youn, JC
   Lee, SE
   Jang, SY
   Choi, S
   Cho, HJ
   Kang, SM
   Choi, DJ
AF Lee, Ju-Hee
   Kim, Min-Seok
   Yoo, Byung Su
   Park, Sung-Ji
   Park, Jin Joo
   Shin, Mi-Seung
   Youn, Jong-Chan
   Lee, Sang Eun
   Jang, Se Yong
   Choi, Seonghoon
   Cho, Hyun-Jai
   Kang, Seok-Min
   Choi, Dong-Ju
TI KSHF Guidelines for the Management of Acute Heart Failure: Part II.
   Treatment of Acute Heart Failure
SO KOREAN CIRCULATION JOURNAL
LA English
DT Review
DE Heart failure; Guideline; Treatment
ID ACUTE MYOCARDIAL-INFARCTION; INTRAAORTIC BALLOON PUMP; ASSOCIATION
   TASK-FORCE; LEFT-VENTRICULAR DYSFUNCTION; HIGH-DOSE FUROSEMIDE;
   CARDIOGENIC-SHOCK; PERFORMANCE-MEASURES; CLINICAL-OUTCOMES; TRANSITIONAL
   CARE; AMERICAN-COLLEGE
AB The prevalence of heart failure (HF) is on the rise due to the aging of society. Furthermore, the continuous progress and widespread adoption of screening and diagnostic strategies have led to an increase in the detection rate of HF, effectively increasing the number of patients requiring monitoring and treatment. Because HF is associated with substantial rates of mortality and morbidity, as well as high socioeconomic burden, there is an increasing need for developing specific guidelines for HF management. The Korean guidelines for the diagnosis and management of chronic HF were introduced in March 2016. However, chronic and acute HF represent distinct disease entities. Here, we introduce the Korean guidelines for the management of acute HF with reduced or preserved ejection fraction. Part II of this guideline covers the treatment of acute HF.
C1 [Lee, Ju-Hee] Chungbuk Natl Univ, Chungbuk Natl Univ Hosp, Dept Internal Med, Div Cardiol,Coll Med, Cheongju, South Korea.
   [Kim, Min-Seok; Lee, Sang Eun] Univ Ulsan, Coll Med, Dept Internal Med, Asan Med Ctr, Seoul, South Korea.
   [Yoo, Byung Su] Yonsei Univ, Wonju Coll Med, Dept Med, Div Cardiol, 20 Ilsan Ro, Wonju 26426, South Korea.
   [Park, Sung-Ji] Sungkyunkwan Univ, Samsung Med Ctr, Sch Med, Div Cardiol,Dept Med, Seoul, South Korea.
   [Park, Jin Joo; Choi, Dong-Ju] Seoul Natl Univ, Bundang Hosp, Cardiovasc Ctr, Dept Internal Med, Seongnam, South Korea.
   [Shin, Mi-Seung] Gachon Univ, Gil Med Ctr, Dept Internal Med, Div Cardiol, Incheon, South Korea.
   [Youn, Jong-Chan] Hallym Univ, Coll Med, Dongtan Sacred Heart Hosp, Div Cardiol, Hwaseong, South Korea.
   [Jang, Se Yong] Kyungpook Natl Univ Hosp, Dept Internal Med, Div Cardiol, Daegu, South Korea.
   [Choi, Seonghoon] Hallym Univ, Coll Med, Kangnam Sacred Heart Hosp, Div Cardiol, Seoul, South Korea.
   [Cho, Hyun-Jai] Seoul Natl Univ Hosp, Dept Internal Med, Seoul, South Korea.
   [Kang, Seok-Min] Yonsei Univ, Coll Med, Dept Med, Div Cardiol, Seoul, South Korea.
RP Yoo, BS (corresponding author), Yonsei Univ, Wonju Coll Med, Dept Med, Div Cardiol, 20 Ilsan Ro, Wonju 26426, South Korea.
EM yubs@yonsei.ac.kr
RI Youn, Jong-Chan/AAS-1405-2020
OI Park, Sung-Ji/0000-0002-7075-847X; Shin, Mi-Seung/0000-0002-0273-0109;
   Choi, Seonghoon/0000-0001-9247-2002; Kang, Seok-Min/0000-0001-9856-9227;
   Lee, Sang Eun/0000-0002-7290-2463; Youn, Jong-Chan/0000-0003-0998-503X
CR [Anonymous], 1989, NEW ENGL J MED, V321, P406
   Bagchi AD, 2007, CLIN THER, V29, P1771, DOI 10.1016/j.clinthera.2007.08.015
   Bahekar A, 2012, J CARDIOVASC PHARM T, V17, P44, DOI 10.1177/1074248410395019
   Barkoudah E, 2015, ARQ BRAS CARDIOL, V104, P417, DOI 10.5935/abc.20140212
   Bart BA, 2005, J AM COLL CARDIOL, V46, P2043, DOI 10.1016/j.jacc.2005.05.098
   Bart BA, 2012, NEW ENGL J MED, V367, P2296, DOI 10.1056/NEJMoa1210357
   Bart BA, 2012, J CARD FAIL, V18, P176, DOI 10.1016/j.cardfail.2011.12.009
   Bartlett RH, 2000, JAMA-J AM MED ASSOC, V283, P904, DOI 10.1001/jama.283.7.904
   Basra SS, 2011, CURR OPIN CARDIOL, V26, P548, DOI 10.1097/HCO.0b013e32834b803c
   Bernheim SM, 2007, AM HEART J, V153, P313, DOI 10.1016/j.ahj.2006.10.037
   Bonow RO, 2012, CIRCULATION, V125, P2382, DOI 10.1161/CIR.0b013e3182507bec
   Bonow RO, 2008, CIRCULATION, V118, P2662, DOI 10.1161/CIRCULATIONAHA.108.191107
   Boren SA, 2009, INT J EVID-BASED HEA, V7, P159, DOI 10.1111/j.1744-1609.2009.00134.x
   Braunstein JB, 2003, J AM COLL CARDIOL, V42, P1226, DOI 10.1016/S0735-1097(03)00947-1
   Burkhoff D, 2006, AM HEART J, V152, DOI 10.1016/j.ahj.2006.05.031
   Butler J, 2006, J AM COLL CARDIOL, V47, P2462, DOI 10.1016/j.jacc.2006.03.030
   Castrini AI, 2015, EXPERT REV CLIN PHAR, V8, P549, DOI 10.1586/17512433.2015.1073587
   CHAKKO S, 1991, AM J MED, V90, P353, DOI 10.1016/0002-9343(91)90576-J
   CHANNER KS, 1994, BRIT HEART J, V71, P146
   Chen YS, 2003, J AM COLL CARDIOL, V41, P197, DOI 10.1016/S0735-1097(02)02716-X
   Clemo HF, 1998, AM J CARDIOL, V81, P594, DOI 10.1016/S0002-9149(97)00962-4
   Coleman EA, 2003, J AM GERIATR SOC, V51, P556, DOI 10.1046/j.1532-5415.2003.51186.x
   Coleman EA, 2003, J AM GERIATR SOC, V51, P549, DOI 10.1046/j.1532-5415.2003.51185.x
   Coleman EA, 2005, MED CARE, V43, P246, DOI 10.1097/00005650-200503000-00007
   Colucci WS, 2000, NEW ENGL J MED, V343, P246, DOI 10.1056/NEJM200007273430403
   COLUCCI WS, 1986, CIRCULATION, V73, P175
   Cooper LT, 2009, NEW ENGL J MED, V360, P1526, DOI 10.1056/NEJMra0800028
   Costanzo MR, 2007, J AM COLL CARDIOL, V49, P675, DOI 10.1016/j.jacc.2006.07.073
   Costanzo MR, 2010, J CARD FAIL, V16, P277, DOI 10.1016/j.cardfail.2009.12.009
   Cotter G, 1998, LANCET, V351, P389, DOI 10.1016/S0140-6736(97)08417-1
   Crenshaw BS, 2000, CIRCULATION, V101, P27, DOI 10.1161/01.CIR.101.1.27
   Cuffe MS, 2002, JAMA-J AM MED ASSOC, V287, P1541, DOI 10.1001/jama.287.12.1541
   Dalrymple-Hay M J, 1998, Semin Thorac Cardiovasc Surg, V10, P111
   Deja MA, 2000, EUR J CARDIO-THORAC, V18, P194, DOI 10.1016/S1010-7940(00)00482-6
   Delle Karth G, 2001, CRIT CARE MED, V29, P1149, DOI 10.1097/00003246-200106000-00011
   Dentali F, 2007, ANN INTERN MED, V146, P278, DOI 10.7326/0003-4819-146-4-200702200-00007
   Dormans TPJ, 1996, J AM COLL CARDIOL, V28, P376, DOI 10.1016/0735-1097(96)00161-1
   Drazner MH, 2001, NEW ENGL J MED, V345, P574, DOI 10.1056/NEJMoa010641
   DUPUIS J, 1990, J AM COLL CARDIOL, V16, P923, DOI 10.1016/S0735-1097(10)80342-0
   Elkayam U, 2004, AM J CARDIOL, V93, P237, DOI 10.1016/j.amjcard.2003.09.051
   ELKAYAM U, 1987, CIRCULATION, V76, P577, DOI 10.1161/01.CIR.76.3.577
   Felker GM, 2014, J AM COLL CARDIOL, V64, P1591, DOI 10.1016/j.jacc.2014.05.071
   Felker GM, 2011, NEW ENGL J MED, V364, P797, DOI 10.1056/NEJMoa1005419
   Follath F, 2002, LANCET, V360, P196, DOI 10.1016/S0140-6736(02)09455-2
   Fonarow GC, 2008, J AM COLL CARDIOL, V52, P190, DOI 10.1016/j.jacc.2008.03.048
   Fonarow GC, 2011, CIRCULATION, V123, P1601, DOI 10.1161/CIRCULATIONAHA.110.989632
   Foraker RE, 2011, CIRC-HEART FAIL, V4, P308, DOI 10.1161/CIRCHEARTFAILURE.110.959031
   FUNG HL, 1994, CARDIOVASC DRUG THER, V8, P489, DOI 10.1007/BF00877927
   Giamouzis G, 2010, J CARD FAIL, V16, P922, DOI 10.1016/j.cardfail.2010.07.246
   Gislason GH, 2007, CIRCULATION, V116, P737, DOI 10.1161/CIRCULATIONAHA.106.669101
   Givertz MM, 1996, J AM COLL CARDIOL, V28, P1775, DOI 10.1016/S0735-1097(96)00399-3
   Greenberg B, 2008, CIRCULATION, V118, P1241, DOI 10.1161/CIRCULATIONAHA.108.773275
   Gwadry-Sridhar FH, 2005, AM HEART J, V150, DOI 10.1016/j.ahj.2005.08.016
   Hernandez AF, 2010, JAMA-J AM MED ASSOC, V303, P1716, DOI 10.1001/jama.2010.533
   HOU ZY, 1995, EUR HEART J, V16, P521, DOI 10.1093/oxfordjournals.eurheartj.a060945
   Ihdayhid AR, 2014, CURR OPIN CARDIOL, V29, P285, DOI 10.1097/HCO.0000000000000075
   Izumi T, 2011, CIRC J, V75, DOI 10.1253/circj.CJ-88-0008
   Jaski BE, 2003, J CARD FAIL, V9, P227, DOI 10.1054/jcaf.2003.28
   Kapur NK, 2015, HEART FAIL CLIN, V11, P215, DOI 10.1016/j.hfc.2014.12.012
   Kettner J, 2013, AM J CARDIOL, V112, P1709, DOI 10.1016/j.amjcard.2013.07.035
   Kim MS, 2017, KOREAN CIRC J, V47, P555, DOI 10.4070/kcj.2017.0009
   Kober L, 2008, NEW ENGL J MED, V358, P2678, DOI 10.1056/NEJMoa0800456
   Koelling TM, 2005, CIRCULATION, V111, P179, DOI 10.1161/01.CIR.0000151811.53450.B8
   Krumholz HM, 2000, CIRCULATION, V101, pE122, DOI 10.1161/01.CIR.101.12.e122
   Lambrinou E, 2012, INT J NURS STUD, V49, P610, DOI 10.1016/j.ijnurstu.2011.11.002
   Lappe JM, 2004, ANN INTERN MED, V141, P446, DOI 10.7326/0003-4819-141-6-200409210-00010
   LONDON RE, 1962, CIRCULATION, V25, P780, DOI 10.1161/01.CIR.25.5.780
   LOPEZSENDON J, 1992, J AM COLL CARDIOL, V19, P1145, DOI 10.1016/0735-1097(92)90315-E
   Maeda JLK, 2010, J CARD FAIL, V16, P411, DOI 10.1016/j.cardfail.2010.01.005
   Maisel AS, 2008, J AM COLL CARDIOL, V52, P534, DOI 10.1016/j.jacc.2008.05.010
   McAlister FA, 2004, J AM COLL CARDIOL, V44, P810, DOI 10.1016/j.jacc.2004.05.055
   McDonagh TA, 2011, EUR J HEART FAIL, V13, P235, DOI 10.1093/eurjhf/hfq221
   Mebazaa A, 2009, EUR J HEART FAIL, V11, P304, DOI 10.1093/eurjhf/hfn045
   Metra M, 2007, EUR J HEART FAIL, V9, P901, DOI 10.1016/j.ejheart.2007.05.011
   Metra M, 2013, EUR HEART J, V34, P3128, DOI 10.1093/eurheartj/eht371
   Metra M, 2013, J AM COLL CARDIOL, V61, P196, DOI 10.1016/j.jacc.2012.11.005
   MONRAD ES, 1986, CIRCULATION, V73, P168
   Mullens W, 2008, J AM COLL CARDIOL, V52, P200, DOI 10.1016/j.jacc.2008.02.083
   NAYLOR M, 1994, ANN INTERN MED, V120, P999, DOI 10.7326/0003-4819-120-12-199406150-00005
   Naylor MD, 2004, J AM GERIATR SOC, V52, P675, DOI 10.1111/j.1532-5415.2004.52202.x
   Nichol G, 2006, RESUSCITATION, V70, P381, DOI 10.1016/j.resuscitation.2006.01.018
   Nieminen MS, 2005, EUR HEART J, V26, P384
   Nohria A, 2003, J AM COLL CARDIOL, V41, P1797, DOI 10.1016/S0735-1097(03)00309-7
   Norkiene Ieva, 2007, Interact Cardiovasc Thorac Surg, V6, P66
   O'Connor CM, 2011, NEW ENGL J MED, V365, P32, DOI 10.1056/NEJMoa1100171
   O'Connor CM, 2008, AM HEART J, V156, P662, DOI 10.1016/j.ahj.2008.04.030
   O'Connor CM, 1999, AM HEART J, V138, P78, DOI 10.1016/S0002-8703(99)70250-4
   Peacock WF, 2007, CARDIOLOGY, V107, P44, DOI 10.1159/000093612
   Phillips CO, 2004, JAMA-J AM MED ASSOC, V291, P1358, DOI 10.1001/jama.291.11.1358
   POHJOLASINTONEN S, 1989, AM HEART J, V117, P809, DOI 10.1016/0002-8703(89)90617-0
   Ponikowski P, 2016, EUR HEART J, V37, P2129, DOI 10.1093/eurheartj/ehw128
   Prins KW, 2015, JACC-HEART FAIL, V3, P647, DOI 10.1016/j.jchf.2015.03.008
   Rahimi AR, 2007, JAMA-J AM MED ASSOC, V297, P1063, DOI 10.1001/jama.297.10.1063
   Rihal CS, 2015, J CARD FAIL, V21, P499, DOI 10.1016/j.cardfail.2015.03.002
   Romeo F, 2013, AM HEART J, V165, P679, DOI 10.1016/j.ahj.2013.02.020
   Rosenberg J, 2005, CARDIOVASC DRUG THER, V19, P301, DOI 10.1007/s10557-005-3350-2
   Samama MM, 1999, NEW ENGL J MED, V341, P793, DOI 10.1056/NEJM199909093411103
   Schrier RW, 2006, NEW ENGL J MED, V355, P2099, DOI 10.1056/NEJMoa065181
   Seyfarth M, 2008, J AM COLL CARDIOL, V52, P1584, DOI 10.1016/j.jacc.2008.05.065
   Shepperd S, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000313.pub4
   SIGURD B, 1975, AM HEART J, V89, P163, DOI 10.1016/0002-8703(75)90041-1
   Sjauw KD, 2009, EUR HEART J, V30, P459, DOI 10.1093/eurheartj/ehn602
   Smolderen KG, 2009, CIRC-CARDIOVASC QUAL, V2, P328, DOI 10.1161/CIRCOUTCOMES.109.868588
   Spertus JA, 2010, J AM COLL CARDIOL, V56, P1767, DOI 10.1016/j.jacc.2010.09.009
   STEVENSON LW, 1989, JAMA-J AM MED ASSOC, V261, P884, DOI 10.1001/jama.261.6.884
   Subramanian D, 2011, CIRC-HEART FAIL, V4, P456, DOI 10.1161/CIRCHEARTFAILURE.110.958496
   Tavakoli R, 2002, EUR J CARDIO-THORAC, V21, P818, DOI 10.1016/S1010-7940(02)00065-9
   Teerlink JR, 2013, LANCET, V381, P29, DOI 10.1016/S0140-6736(12)61855-8
   Thiele H, 2013, LANCET, V382, P1638, DOI 10.1016/S0140-6736(13)61783-3
   Thiele H, 2012, NEW ENGL J MED, V367, P1287, DOI 10.1056/NEJMoa1208410
   Thompson CR, 2000, J AM COLL CARDIOL, V36, P1104, DOI 10.1016/S0735-1097(00)00846-9
   Turpie AGG, 2000, AM J CARDIOL, V86, p48M
   van de Borne P, 1998, CIRCULATION, V98, P126, DOI 10.1161/01.CIR.98.2.126
   VARGO DL, 1995, CLIN PHARMACOL THER, V57, P601, DOI 10.1016/0009-9236(95)90222-8
   Waldo AL, 1996, LANCET, V348, P7, DOI 10.1016/S0140-6736(96)02149-6
   Windham BG, 2003, AM J MANAG CARE, V9, P447
   Yancy CW, 2013, J AM COLL CARDIOL, V62, pE147, DOI 10.1016/j.jacc.2013.05.019
   Yoo BS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086596
   Youn YJ, 2012, CIRC J, V76, P1151, DOI 10.1253/circj.CJ-11-1093
NR 119
TC 5
Z9 5
U1 1
U2 5
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JAN
PY 2019
VL 49
IS 1
BP 22
EP 45
DI 10.4070/kcj.2018.0349
PG 24
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA HJ4BY
UT WOS:000457120200002
PM 30637994
OA Green Published, Other Gold
DA 2021-04-22
ER

PT J
AU Kim, MS
   Lee, JH
   Cho, HJ
   Cho, JY
   Choi, JO
   Hwang, KK
   Yoo, BS
   Kang, SM
   Choi, DJ
AF Kim, Min-Seok
   Lee, Ju-Hee
   Cho, Hyun-Jai
   Cho, Jae Yeong
   Choi, Jin-Oh
   Hwang, Kyung Kuk
   Yoo, Byung Su
   Kang, Seok-Min
   Choi, Dong-Ju
TI KSHF Guidelines for the Management of Acute Heart Failure: Part III.
   Specific Management of Acute Heart Failure According to the Etiology and
   Co-morbidity
SO KOREAN CIRCULATION JOURNAL
LA English
DT Review
DE Heart failure; Guideline; Comorbidity
ID AORTIC-VALVE-REPLACEMENT; APICAL BALLOONING SYNDROME; ACUTE
   MYOCARDIAL-INFARCTION; WORSENING RENAL-FUNCTION; PREMATURE VENTRICULAR
   COMPLEXES; EXTRACORPOREAL MEMBRANE-OXYGENATION; TACHYCARDIA-INDUCED
   CARDIOMYOPATHY; CORONARY-ARTERY-DISEASE; CARDIOVASCULAR
   MAGNETIC-RESONANCE; ACUTE PULMONARY-EMBOLISM
AB The prevalence of heart failure (HF) is on the rise due to the aging of society. Furthermore, the continuous progress and widespread adoption of screening and diagnostic strategies have led to an increase in the detection rate of HF, effectively increasing the number of patients requiring monitoring and treatment. Because HF is associated with substantial rates of mortality and morbidity, as well as high socioeconomic burden, there is an increasing need for developing specific guidelines for HF management. The Korean guidelines for the diagnosis and management of chronic heart failure (CHF) were introduced in March 2016. However, CHF and acute heart failure (AHF) represent distinct disease entities. Here, we introduce the Korean guidelines for the management of AHF with reduced or preserved ejection fraction. Part III of this guideline covers management strategies optimized according to the etiology of AHF and the presence of co-morbidities.
C1 [Kim, Min-Seok] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Internal Med, Seoul, South Korea.
   [Lee, Ju-Hee; Hwang, Kyung Kuk] Chungbuk Natl Univ, Chungbuk Natl Univ Hosp, Dept Internal Med, Div Cardiol,Coll Med, Cheongju, South Korea.
   [Cho, Hyun-Jai] Seoul Natl Univ Hosp, Dept Internal Med, Div Cardiol, 101 Daehak Ro, Seoul 03080, South Korea.
   [Cho, Jae Yeong] Chonnam Natl Univ Hosp, Dept Cardiovasc Med, Gwangju, South Korea.
   [Choi, Jin-Oh] Sungkyunkwan Univ, Samsung Med Ctr, Sch Med, Div Cardiol,Dept Med, Seoul, South Korea.
   [Yoo, Byung Su] Yonsei Univ, Wonju Coll Med, Dept Med, Div Cardiol, Wonju, South Korea.
   [Kang, Seok-Min] Yonsei Univ, Coll Med, Dept Med, Div Cardiol, Seoul, South Korea.
   [Choi, Dong-Ju] Seoul Natl Univ, Bundang Hosp, Cardiovasc Ctr, Dept Internal Med, Seongnam, South Korea.
RP Cho, HJ (corresponding author), Seoul Natl Univ Hosp, Dept Internal Med, Div Cardiol, 101 Daehak Ro, Seoul 03080, South Korea.
EM hyunjaicho@snu.ac.kr
OI Kang, Seok-Min/0000-0001-9856-9227; Hwang, Kyung-Kuk/0000-0003-3464-3023
CR Adelstein EC, 2010, PACE, V33, P850, DOI 10.1111/j.1540-8159.2010.02705.x
   Akashi YJ, 2008, CIRCULATION, V118, P2754, DOI 10.1161/CIRCULATIONAHA.108.767012
   ALDERMAN EL, 1983, CIRCULATION, V68, P785, DOI 10.1161/01.CIR.68.4.785
   Anand IS, 2009, CIRCULATION, V120, P1577, DOI 10.1161/CIRCULATIONAHA.109.853648
   ANDERSEN HR, 1987, J AM COLL CARDIOL, V10, P1223, DOI 10.1016/S0735-1097(87)80122-5
   APPLEBY P, 1994, LANCET, V343, P311, DOI 10.1016/S0140-6736(94)91161-4
   ARETZ HT, 1987, HUM PATHOL, V18, P619
   Arlt M, 2011, EUR J CARDIO-THORAC, V40, P689, DOI 10.1016/j.ejcts.2010.12.055
   Atluri P, 2013, EUR J CARDIO-THORAC, V43, P379, DOI 10.1093/ejcts/ezs242
   Aurigemma GP, 2006, AM J MED, V119, P18, DOI 10.1016/j.amjmed.2005.10.031
   Aversano T, 2002, JAMA-J AM MED ASSOC, V287, P1943, DOI 10.1001/jama.287.15.1943
   BAKER DW, 1994, JAMA-J AM MED ASSOC, V272, P1528, DOI 10.1001/jama.272.19.1528
   Baman TS, 2010, HEART RHYTHM, V7, P865, DOI 10.1016/j.hrthm.2010.03.036
   Ban JE, 2013, EUROPACE, V15, P735, DOI 10.1093/europace/eus371
   Bart BA, 2005, J AM COLL CARDIOL, V46, P2043, DOI 10.1016/j.jacc.2005.05.098
   Bart BA, 2012, NEW ENGL J MED, V367, P2296, DOI 10.1056/NEJMoa1210357
   BENOTTI JR, 1984, CLIN CHEST MED, V5, P403
   BLOOMFIELD P, 1988, LANCET, V2, P329
   Bogun F, 2007, HEART RHYTHM, V4, P863, DOI 10.1016/j.hrthm.2007.03.003
   Bonow RO, 2011, NEW ENGL J MED, V364, P1617, DOI 10.1056/NEJMoa1100358
   BOUNOUS EP, 1988, CIRCULATION, V78, P151
   Bowers TR, 1998, NEW ENGL J MED, V338, P933, DOI 10.1056/NEJM199804023381401
   Brembilla-Perrot B, 2015, INT J CARDIOL, V199, P84, DOI 10.1016/j.ijcard.2015.07.048
   Bybee KA, 2004, ANN INTERN MED, V141, P858, DOI 10.7326/0003-4819-141-11-200412070-00010
   Bybee KA, 2008, CIRCULATION, V118, P397, DOI 10.1161/CIRCULATIONAHA.106.677625
   Chen HH, 2013, JAMA-J AM MED ASSOC, V310, P2533, DOI 10.1001/jama.2013.282190
   Choi DJ, 2011, KOREAN CIRC J, V41, P363, DOI 10.4070/kcj.2011.41.7.363
   Cleveland JC, 2011, J HEART LUNG TRANSPL, V30, P862, DOI 10.1016/j.healun.2011.04.004
   Cooper WO, 2006, NEW ENGL J MED, V354, P2443, DOI 10.1056/NEJMoa055202
   Costanzo MR, 2007, AM HEART J, V154, P267, DOI 10.1016/j.ahj.2007.04.033
   Costanzo MR, 2007, J AM COLL CARDIOL, V49, P675, DOI 10.1016/j.jacc.2006.07.073
   Cotter G, 1998, LANCET, V351, P389, DOI 10.1016/S0140-6736(97)08417-1
   CRUZ FES, 1990, J AM COLL CARDIOL, V16, P739, DOI 10.1016/0735-1097(90)90368-Y
   Dec GW, 2005, CIRCULATION, V111, P388, DOI 10.1161/01.CIR.0000155234.69439.E4
   Dib C, 2009, AM HEART J, V157, P933, DOI 10.1016/j.ahj.2008.12.023
   Dote K, 1991, J Cardiol, V21, P203
   Eitel I, 2011, JAMA-J AM MED ASSOC, V306, P277, DOI 10.1001/jama.2011.992
   ELEFTERIADES JA, 1993, J AM COLL CARDIOL, V22, P1411, DOI 10.1016/0735-1097(93)90551-B
   Elkayam U, 2005, CIRCULATION, V111, P2050, DOI 10.1161/01.CIR.0000162478.36652.7E
   Elkayam U, 2001, NEW ENGL J MED, V344, P1567, DOI 10.1056/NEJM200105243442101
   Elliott WJ, 2001, CRIT CARE CLIN, V17, P435, DOI 10.1016/S0749-0704(05)70176-7
   Ellis Ethan R, 2013, Curr Heart Fail Rep, V10, P296, DOI 10.1007/s11897-013-0150-z
   Eschalier R, 2013, J AM COLL CARDIOL, V62, P1585, DOI 10.1016/j.jacc.2013.04.086
   Feldman T, 2015, J AM COLL CARDIOL, V66, P2844, DOI 10.1016/j.jacc.2015.10.018
   Feldman T, 2011, NEW ENGL J MED, V364, P1395, DOI 10.1056/NEJMoa1009355
   Forman DE, 2004, J AM COLL CARDIOL, V43, P61, DOI 10.1016/j.jacc.2003.07.031
   Friedrich MG, 2009, J AM COLL CARDIOL, V53, P1475, DOI 10.1016/j.jacc.2009.02.007
   Ganesan AN, 2015, HEART LUNG CIRC, V24, P270, DOI 10.1016/j.hlc.2014.09.012
   Gariboldi V, 2010, ANN THORAC SURG, V90, P1548, DOI 10.1016/j.athoracsur.2010.06.091
   Gentlesk PJ, 2007, J CARDIOVASC ELECTR, V18, P9, DOI 10.1111/j.1540-8167.2006.00653.x
   Giamouzis G, 2010, J CARD FAIL, V16, P922, DOI 10.1016/j.cardfail.2010.07.246
   Gianni M, 2006, EUR HEART J, V27, P1523, DOI 10.1093/eurheartj/ehl032
   Gierlotka M, 2011, AM J CARDIOL, V107, P501, DOI 10.1016/j.amjcard.2010.10.008
   Goldhaber SZ, 2003, CIRCULATION, V108, P2726, DOI 10.1161/01.CIR.0000097829.89204.0C
   Gopinathannair R, 2015, J AM COLL CARDIOL, V66, P1714, DOI 10.1016/j.jacc.2015.08.038
   Greene SJ, 2013, EUR J HEART FAIL, V15, P1401, DOI 10.1093/eurjhf/hft110
   Gupta S, 2014, INT J CARDIOL, V172, P40, DOI 10.1016/j.ijcard.2013.12.180
   HAUPT HM, 1983, CIRCULATION, V67, P1268, DOI 10.1161/01.CIR.67.6.1268
   Heywood JT, 2007, J CARD FAIL, V13, P422, DOI 10.1016/j.cardfail.2007.03.011
   Hilfiker-Kleiner D, 2014, NAT REV CARDIOL, V11, P364, DOI 10.1038/nrcardio.2014.37
   Hochman JS, 1999, NEW ENGL J MED, V341, P625, DOI 10.1056/NEJM199908263410901
   Iakobishvili Zaza, 2011, Acute Card Care, V13, P76, DOI 10.3109/17482941.2011.575165
   Ito K, 2003, ANN NUCL MED, V17, P115, DOI 10.1007/BF02988449
   JARDIN F, 1987, J AM COLL CARDIOL, V10, P1201, DOI 10.1016/S0735-1097(87)80119-5
   Jones DG, 2013, J AM COLL CARDIOL, V61, P1894, DOI 10.1016/j.jacc.2013.01.069
   Keeley EC, 2003, LANCET, V361, P13, DOI 10.1016/S0140-6736(03)12113-7
   Keeley EC, 2004, JAMA-J AM MED ASSOC, V291, P736, DOI 10.1001/jama.291.6.736
   Keeley EC, 2007, NEW ENGL J MED, V356, P47, DOI 10.1056/NEJMct063503
   Khasnis A, 2005, PACE, V28, P710, DOI 10.1111/j.1540-8159.2005.00143.x
   Kiernan MS, 2015, JACC-HEART FAIL, V3, P214, DOI 10.1016/j.jchf.2014.11.004
   Kim MS, 2017, KOREAN CIRC J, V47, P555, DOI 10.4070/kcj.2017.0009
   KINCH JW, 1994, NEW ENGL J MED, V330, P1211, DOI 10.1056/NEJM199404283301707
   Kindermann I, 2008, CIRCULATION, V118, P639, DOI 10.1161/CIRCULATIONAHA.108.769489
   Kindermann I, 2012, J AM COLL CARDIOL, V59, P779, DOI 10.1016/j.jacc.2011.09.074
   Kirklin JK, 2013, J HEART LUNG TRANSPL, V32, P1205, DOI 10.1016/j.healun.2013.09.001
   Kober L, 2008, NEW ENGL J MED, V358, P2678, DOI 10.1056/NEJMoa0800456
   Kociol RD, 2010, AM J CARDIOL, V105, P1786, DOI 10.1016/j.amjcard.2010.01.361
   Kodali SK, 2012, NEW ENGL J MED, V366, P1686, DOI 10.1056/NEJMoa1200384
   Konstantinides SV, 2014, EUR HEART J, V35, P3033, DOI 10.1093/eurheartj/ehu283
   Krumholz HM, 2000, AM J CARDIOL, V85, P1110, DOI 10.1016/S0002-9149(00)00705-0
   Kucher N, 2005, CIRCULATION, V112, pE28, DOI 10.1161/CIRCULATIONAHA.105.551374
   Kurowski V, 2007, CHEST, V132, P809, DOI 10.1378/chest.07-0608
   KUSACHI S, 1982, AM J PHYSIOL, V243, pH761
   LAMPERT MB, 1993, AM J OBSTET GYNECOL, V168, P493, DOI 10.1016/0002-9378(93)90479-3
   LEE F A, 1992, Cardiology Clinics, V10, P59
   Lee Jun-Won, 2010, Korean Circ J, V40, P277, DOI 10.4070/kcj.2010.40.6.277
   Lee PH, 2010, J AM SOC ECHOCARDIOG, V23, P766, DOI 10.1016/j.echo.2010.05.002
   Lee SE, 2014, EUR J HEART FAIL, V16, P700, DOI 10.1002/ejhf.91
   Leon MB, 2016, NEW ENGL J MED, V374, P1609, DOI 10.1056/NEJMoa1514616
   Leon MB, 2010, NEW ENGL J MED, V363, P1597, DOI 10.1056/NEJMoa1008232
   Lesogor A, 2013, EUR J HEART FAIL, V15, P1236, DOI 10.1093/eurjhf/hft089
   Levy P, 2007, ANN EMERG MED, V50, P144, DOI 10.1016/j.annemergmed.2007.02.022
   Lim ST, 2003, AM J CARDIOL, V92, P1203, DOI 10.1016/j.amjcard.2003.07.032
   Lyon AR, 2008, NAT CLIN PRACT CARD, V5, P22, DOI 10.1038/ncpcardio1066
   Madhavan M, 2011, J AM COLL CARDIOL, V57, P1400, DOI 10.1016/j.jacc.2010.10.038
   Maejima Y, 2004, CIRC J, V68, P829, DOI 10.1253/circj.68.829
   Makkar RR, 2012, NEW ENGL J MED, V366, P1696, DOI 10.1056/NEJMoa1202277
   Mancia G, 2013, J HYPERTENS, V31, P1281, DOI 10.1097/01.hjh.0000431740.32696.cc
   Mauri L, 2013, J AM COLL CARDIOL, V62, P317, DOI 10.1016/j.jacc.2013.04.030
   McCarthy RE, 2000, NEW ENGL J MED, V342, P690, DOI 10.1056/NEJM200003093421003
   Mebazaa A, 2011, INTENS CARE MED, V37, P290, DOI 10.1007/s00134-010-2073-4
   Medi C, 2009, J AM COLL CARDIOL, V53, P1791, DOI 10.1016/j.jacc.2009.02.014
   Mehta SR, 2005, JAMA-J AM MED ASSOC, V293, P2908, DOI 10.1001/jama.293.23.2908
   Meyer G, 2014, NEW ENGL J MED, V370, P1402, DOI 10.1056/NEJMoa1302097
   Miller DC, 2012, J THORAC CARDIOV SUR, V143, P832, DOI 10.1016/j.jtcvs.2012.01.055
   Moioli M, 2010, ARCH GYNECOL OBSTET, V281, P183, DOI 10.1007/s00404-009-1170-5
   Moloney ED, 2005, J HEART LUNG TRANSPL, V24, P1103, DOI 10.1016/j.healun.2004.06.015
   MUHLBAIER LH, 1992, CIRCULATION, V86, P198
   Mullens W, 2008, J AM COLL CARDIOL, V51, P300, DOI 10.1016/j.jacc.2007.09.043
   Mullens W, 2009, J AM COLL CARDIOL, V53, P589, DOI 10.1016/j.jacc.2008.05.068
   Nef HM, 2007, EUR HEART J, V28, P2456, DOI 10.1093/eurheartj/ehl570
   Nielsen HHM, 2012, EUROINTERVENTION, V8, P383, DOI 10.4244/EIJV8I3A58
   O'Connor CM, 2011, NEW ENGL J MED, V365, P32, DOI 10.1056/NEJMoa1100171
   O'Connor CM, 2002, AM J CARDIOL, V90, P101, DOI 10.1016/S0002-9149(02)02429-3
   Packer M, 1996, NEW ENGL J MED, V334, P1349, DOI 10.1056/NEJM199605233342101
   Park JH, 2005, CHEST, V128, P296, DOI 10.1378/chest.128.1.296
   Park SM, 2009, MAYO CLIN PROC, V84, P514, DOI 10.1016/S0025-6196(11)60583-1
   Peacock WF, 2008, EMERG MED J, V25, P205, DOI 10.1136/emj.2007.050419
   Pearson GD, 2000, JAMA-J AM MED ASSOC, V283, P1183, DOI 10.1001/jama.283.9.1183
   PEREZAYUSO RM, 1983, GASTROENTEROLOGY, V84, P961
   Pfisterer M, 2003, LANCET, V362, P392, DOI 10.1016/S0140-6736(03)14028-7
   Piazza G, 2005, CHEST, V128, P1836, DOI 10.1378/chest.128.3.1836
   PIGOTT JD, 1985, J AM COLL CARDIOL, V5, P1036, DOI 10.1016/S0735-1097(85)80003-6
   Pizzale S, 2009, CAN J CARDIOL, V25, P469, DOI 10.1016/S0828-282X(09)70119-9
   Ponikowski P, 2016, EUR HEART J, V37, P2129, DOI 10.1093/eurheartj/ehw128
   Prasad A, 2008, AM HEART J, V155, P408, DOI 10.1016/j.ahj.2007.11.008
   Rajagopal SK, 2010, CRIT CARE MED, V38, P382, DOI 10.1097/CCM.0b013e3181bc8293
   Reynolds MR, 2012, J AM COLL CARDIOL, V60, P548, DOI 10.1016/j.jacc.2012.03.075
   Reynolds MR, 2012, CIRCULATION, V125, P1102, DOI 10.1161/CIRCULATIONAHA.111.054072
   Reynolds MR, 2011, CIRCULATION, V124, P1964, DOI 10.1161/CIRCULATIONAHA.111.040022
   Ro Angela, 2006, Cardiol Rev, V14, P35, DOI 10.1097/01.crd.0000174805.68081.f7
   Ronco C, 2008, J AM COLL CARDIOL, V52, P1527, DOI 10.1016/j.jacc.2008.07.051
   Rossi JS, 2008, EUR J HEART FAIL, V10, P1215, DOI 10.1016/j.ejheart.2008.09.009
   Roy D, 2008, NEW ENGL J MED, V358, P2667, DOI 10.1056/NEJMoa0708789
   Saurav A, 2015, CLIN CARDIOL, V38, P251, DOI 10.1002/clc.22371
   Schaefer C, 2003, BIRTH DEFECTS RES A, V67, P591, DOI 10.1002/bdra.10081
   Schomig A, 2005, JAMA-J AM MED ASSOC, V293, P2865, DOI 10.1001/jama.293.23.2865
   Sharkey SW, 2010, J AM COLL CARDIOL, V55, P333, DOI 10.1016/j.jacc.2009.08.057
   Sharon A, 2000, J AM COLL CARDIOL, V36, P832, DOI 10.1016/S0735-1097(00)00785-3
   Shelton RJ, 2009, HEART, V95, P924, DOI 10.1136/hrt.2008.158931
   Singh K, 2014, AM J CARDIOL, V113, P1420, DOI 10.1016/j.amjcard.2014.01.419
   Sliwa K, 2010, EUR J HEART FAIL, V12, P767, DOI 10.1093/eurjhf/hfq120
   Sliwa K, 2010, CIRCULATION, V121, P1465, DOI 10.1161/CIRCULATIONAHA.109.901496
   Smith CR, 2011, NEW ENGL J MED, V364, P2187, DOI 10.1056/NEJMoa1103510
   Smith GL, 2003, J CARD FAIL, V9, P13, DOI 10.1054/jcaf.2003.3
   Smith GL, 2006, J AM COLL CARDIOL, V47, P1987, DOI 10.1016/j.jacc.2005.11.084
   STAMPFER M, 1968, CIRCULATION, V37, P900, DOI 10.1161/01.CIR.37.6.900
   Sutton MGS, 2000, CIRCULATION, V101, P2981, DOI 10.1161/01.CIR.101.25.2981
   SWEDBERG K, 1987, NEW ENGL J MED, V316, P1429
   Tarakji KG, 2006, CIRCULATION, V113, P230, DOI 10.1161/CIRCULATIONAHA.105.541664
   Testani JM, 2010, CIRCULATION, V122, P265, DOI 10.1161/CIRCULATIONAHA.109.933275
   Tokmakova MP, 2004, CIRCULATION, V110, P3667, DOI 10.1161/01.CIR.0000149806.01354.BF
   Tsuyuki RT, 2006, CAN MED ASSOC J, V175, P361, DOI 10.1503/cmaj.060108
   Van Gelder IC, 2002, NEW ENGL J MED, V347, P1834, DOI 10.1056/NEJMoa021375
   Velazquez EJ, 2011, NEW ENGL J MED, V364, P1607, DOI 10.1056/NEJMoa1100356
   Vidt D G, 2001, J Clin Hypertens (Greenwich), V3, P158, DOI 10.1111/j.1524-6175.2001.00449.x
   Wakai A, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005151.pub2
   Weinfeld MS, 1999, AM HEART J, V138, P285, DOI 10.1016/S0002-8703(99)70113-4
   Wu AH, 2002, J AM COLL CARDIOL, V40, P1389, DOI 10.1016/S0735-1097(02)02173-3
   Wyse DG, 2002, NEW ENGL J MED, V347, P1825, DOI 10.1056/nejmoa021328
   Yancy CW, 2013, J AM COLL CARDIOL, V62, pE147, DOI 10.1016/j.jacc.2013.05.019
   Yoshizawa S, 2013, AM J CARDIOL, V112, P405, DOI 10.1016/j.amjcard.2013.03.042
   Young JB, 2002, JAMA-J AM MED ASSOC, V287, P1531
   YUSUF S, 1994, LANCET, V344, P563, DOI 10.1016/S0140-6736(94)91963-1
   YUSUF S, 1991, NEW ENGL J MED, V325, P293, DOI 10.1056/NEJM199108013250501
   Zang MH, 2014, HEART, V100, P787, DOI 10.1136/heartjnl-2013-305175
   ZIJLSTRA F, 1993, NEW ENGL J MED, V328, P680, DOI 10.1056/NEJM199303113281002
NR 167
TC 4
Z9 4
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JAN
PY 2019
VL 49
IS 1
BP 46
EP 68
DI 10.4070/kcj.2018.0351
PG 23
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA HJ4BY
UT WOS:000457120200003
PM 30637995
OA Green Published, Other Gold
DA 2021-04-22
ER

PT J
AU Song, PS
   Park, KT
   Kim, MJ
   Jeon, KH
   Park, JS
   Choi, RK
   Song, YB
   Choi, SH
   Choi, JH
   Lee, SH
   Gwon, HC
   Jeong, JO
   Im, ES
   Kim, SW
   Chun, WJ
   Oh, JH
   Hahn, JY
AF Song, Pil Sang
   Park, Kyu Tae
   Kim, Min Jeong
   Jeon, Ki-Hyun
   Park, Jin-Sik
   Choi, Rak Kyeong
   Song, Young Bin
   Choi, Seung-Hyuk
   Choi, Jin-Ho
   Lee, Sang Hoon
   Gwon, Hyeon-Cheol
   Jeong, Jin-Ok
   Im, Eul Soon
   Kim, Sang Wook
   Chun, Woo Jung
   Oh, Ju Hyeon
   Hahn, Joo-Yong
TI Safety and Efficacy of Biodegradable Polymer-biolimus-eluting Stents
   (BP-BES) Compared with Durable Polymer-everolimus-eluting Stents
   (DP-EES) in Patients Undergoing Complex Percutaneous Coronary
   Intervention
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Coronary artery disease; Percutaneous coronary intervention;
   Drug-eluting stents
ID CLINICAL-OUTCOMES; GENERATION; DISEASE; TRIAL; IMPLANTATION
AB Background and Objectives: There are no data comparing clinical outcomes of complex percutaneous coronary intervention (PCI) between biodegradable polymer-biolimus-eluting stents (BP-BES) and durable polymer-everolimus-eluting stents (DP-EES). We sought to evaluate the safety and efficacy of BP-BES compared with DP-EES in patients undergoing complex PCI.
   Methods: Patients enrolled in the SMART-DESK registry were stratified into 2 categories based on the complexity of PCI. Complex PCI was defined as having at least one of the following features: unprotected left main lesion, >= 2 lesions treated, total stent length >40 mm, minimal stent diameter <= 2.5 mm, or bifurcation as target lesion. The primary outcome was target lesion failure (TLF), defined as a composite of cardiac death, target vessel-related myocardial infarction (TV-MI), or target lesion revascularization (TLR) at 2 years of follow-up.
   Results: Of1,999 patients, 1,145 (57.3%) underwent complex PCI: 521 patients were treated with BP-BES and 624 with DP-EES. In propensity-score matching analysis (481 pairs), the risks of TLF (3.8% vs. 5.2%, adjusted hazard ratio [HR], 0.578; 95% confidence interval [CI], 0.246-1.359; p=0.209), cardiac death (2.5% vs. 2.5%, adjusted HR, 0.787; 95% CI, 0.244-2.539; p=0.689), TV-MI (0.5% vs. 0.4%, adjusted HR, 1.128; 95% CI, 0.157-8.093; p=0.905), and TLR (1.1% vs. 2.9%, adjusted HR, 0.390; 95% CI, 0.139-1.095; p=0.074) did not differ between 2 stent groups after complex PCI.
   Conclusions: Clinical outcomes of BP-BES were comparable to those of DP-EES at 2 years after complex PCI. Our data suggest that use of BP-BES is acceptable, even for complex PCI.
C1 [Song, Pil Sang; Kim, Min Jeong; Jeon, Ki-Hyun; Park, Jin-Sik; Choi, Rak Kyeong] Mediplex Sejong Gen Hosp, Cardiovasc Ctr, Div Cardiol, Incheon, South Korea.
   [Park, Kyu Tae; Song, Young Bin; Choi, Seung-Hyuk; Choi, Jin-Ho; Lee, Sang Hoon; Gwon, Hyeon-Cheol; Hahn, Joo-Yong] Sungkyunkwan Univ, Samsung Med Ctr, Heart Vasc Stroke Inst, Div Cardiol,Dept Med,Sch Med, 81 Irwon Ro, Seoul 06351, South Korea.
   [Jeong, Jin-Ok] Chungnam Natl Univ, Chungnam Natl Univ Hosp, Dept Internal Med, Sch Med, Daejeon, South Korea.
   [Im, Eul Soon] Dongsuwon Gen Hosp, Div Cardiol, Suwon, South Korea.
   [Kim, Sang Wook] Chung Ang Univ Hosp, Dept Internal Med, Div Cardiol, Seoul, South Korea.
   [Chun, Woo Jung; Oh, Ju Hyeon] Sungkyunkwan Univ, Samsung Changwon Hosp, Dept Internal Med, Div Cardiol,Sch Med, 158 Palyoung Ro, Chang Won 51353, South Korea.
RP Hahn, JY (corresponding author), Sungkyunkwan Univ, Samsung Med Ctr, Heart Vasc Stroke Inst, Div Cardiol,Dept Med,Sch Med, 81 Irwon Ro, Seoul 06351, South Korea.; Oh, JH (corresponding author), Sungkyunkwan Univ, Samsung Changwon Hosp, Dept Internal Med, Div Cardiol,Sch Med, 158 Palyoung Ro, Chang Won 51353, South Korea.
EM mccoyojh@gmail.com; jyhahn@skku.edu
RI Hahn, Joo-Yong/AAU-7250-2020
OI Hahn, Joo-Yong/0000-0002-4412-377X; Jeong, Jin-Ok/0000-0003-0763-4754;
   Song, Young Bin/0000-0003-3986-9152; Kim, Min Jeong/0000-0001-8398-7020;
   JEON, KI HYUN/0000-0002-6277-7697
FU Korea Health Technology R&D Project through the Korea Health Industry
   Development Institute (KHIDI) - Ministry of Health & Welfare, Republic
   of Korea [HI10C2020]; Biosensors Inc.
FX This research was supported by a grant of the Korea Health Technology
   R&D Project through the Korea Health Industry Development Institute
   (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea
   (Grant number: HI10C2020) and Biosensors Inc.
CR Austin PC, 2014, STAT MED, V33, P1242, DOI 10.1002/sim.5984
   BANGALORE S, 2013, BMJ-BRIT MED J, V347, DOI DOI 10.1136/BMJ.F6625
   Cavalcante R, 2017, EUR HEART J, V38, P1969, DOI 10.1093/eurheartj/ehx138
   Cutlip DE, 2007, CIRCULATION, V115, P2344, DOI 10.1161/CIRCULATIONAHA.106.685313
   Giustino G, 2016, JACC-CARDIOVASC INTE, V9, P674, DOI 10.1016/j.jcin.2015.12.013
   Grube E, 2006, EXPERT REV MED DEVIC, V3, P731, DOI 10.1586/17434440.3.6.731
   Grundeken MJ, 2016, CATHETER CARDIO INTE, V87, pE248, DOI 10.1002/ccd.26344
   Gwon HC, 2012, CIRCULATION, V125, P505, DOI 10.1161/CIRCULATIONAHA.111.059022
   Hausleiter J, 2003, AM HEART J, V146, P882, DOI 10.1016/S0002-8703(03)00435-6
   Ho Daniel E., 2011, J STAT SOFTW, V42, P1, DOI DOI 10.18637/JSS.V042.I08
   Im E, 2016, J INTERV CARDIOL, V29, P162, DOI 10.1111/joic.12283
   Kaiser C, 2015, CIRCULATION, V131, P74, DOI 10.1161/CIRCULATIONAHA.114.013520
   Kang SH, 2014, EUR HEART J, V35, P1147, DOI 10.1093/eurheartj/eht570
   Kolandaivelu K, 2011, CIRCULATION, V123, P1400, DOI 10.1161/CIRCULATIONAHA.110.003210
   Lee DH, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183079
   Migliorini A, 2016, JACC-CARDIOVASC INTE, V9, P1001, DOI 10.1016/j.jcin.2016.02.016
   Minha S, 2013, J INTERV CARDIOL, V26, P561, DOI 10.1111/joic.12063
   Navarese EP, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6530
   Pache J, 2003, J AM COLL CARDIOL, V41, P1283, DOI 10.1016/S0735-1097(03)00119-0
   Sakurai R, 2016, INT J CARDIOL, V223, P1066, DOI 10.1016/j.ijcard.2016.07.078
   Sim DS, 2015, KOREAN CIRC J, V45, P110, DOI 10.4070/kcj.2015.45.2.110
   Smits PC, 2013, LANCET, V381, P651, DOI 10.1016/S0140-6736(12)61852-2
   Vlachojannis GJ, 2017, JACC-CARDIOVASC INTE, V10, P1215, DOI 10.1016/j.jcin.2017.02.029
   박덕우, 2005, Korean Circulation Journal, V35, P791
NR 24
TC 2
Z9 2
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JAN
PY 2019
VL 49
IS 1
BP 69
EP 80
DI 10.4070/kcj.2018.0097
PG 12
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA HJ4BY
UT WOS:000457120200004
PM 30468035
OA Green Published, Other Gold
DA 2021-04-22
ER

PT J
AU Yamada, S
   Lo, LW
   Lin, YJ
   Chang, SL
   Chung, FP
   Hu, YF
   Tuan, TC
   Chao, TF
   Liao, JN
   Lin, CY
   Chen, SA
AF Yamada, Shinya
   Lo, Li-Wei
   Lin, Yenn-Jiang
   Chang, Shih-Lin
   Chung, Fa-Po
   Hu, Yu-Feng
   Tuan, Ta-Chuan
   Chao, Tze-Fan
   Liao, Jo-Nan
   Lin, Chin-Yu
   Chen, Shih-Ann
TI The Accuracy and Clinical Applicability of a Sensor Based
   Electromagnetic Non-fluoroscopic Catheter Tracking System
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Atrial fibrillation; Atrial flutter; Anatomy; Cardiovascular imaging;
   Fluoroscopy
ID ATRIAL-FIBRILLATION; ABLATION TECHNIQUES; INITIAL-EXPERIENCE; IMAGE
   INTEGRATION; NAVIGATION SYSTEM; MEDIGUIDE; EFFICACY; IMPACT
AB Background and Objectives: The differences between electromagnetic-based mapping (EM) and impedance-based mapping (IM) in 3D anatomical reconstruction have not been fully clarified. We aimed to investigate the anatomical accuracy between EM (MediGuide (TM)) and IM (EnSite Velocity (TM)) systems.
   Methods: We investigated 15 consecutive patients (10 males, mean age 58 +/- 9 years) who underwent pulmonary veins (PVs) isolation for paroxysmal atrial fibrillation (PAF). Contrast-enhanced computed tomography (CT) image of the left atrium (LA) was acquired before ablation and the 3D geometry of the LA was constructed using EM during ablation procedure. We measured the 4 PV angles between the main trunk of each PV and the posterior LA after field scaling. Additionally, the posterior LA surface area was measured. The variables were compared to those of CT-based geometry. A control group of 40 patients who underwent conventional PVs isolation using IM were also evaluated.
   Results: The actual and relative changes of EM and CT-based geometry in all PV angles and posterior LA were significantly smaller compared to those of IM and CT-based geometry. Intraclass correlation coefficient (ICC) between EM and CT-based geometry were 0.871 (right superior pulmonary vein [RSINJ), 0.887 (right inferior pulmonary vein [RIM), 0.853 (left superior pulmonary vein [LSPVI), 0.911 (left inferior pulmonary vein [LIPV)), and 0.833 (posterior LA). On the other hand, ICC between IM and CT-based geometry were 0.548 (UP!), 0.639 (RIPV), 0.691 (LSPV), 0.706 (LIPV), and 0.568 (posterior LA).
   Conclusions: Image integration with EM enables high accurate visualization of cardiac anatomy compared to IM in PAF ablation.
C1 [Yamada, Shinya; Lo, Li-Wei; Lin, Yenn-Jiang; Chang, Shih-Lin; Chung, Fa-Po; Hu, Yu-Feng; Tuan, Ta-Chuan; Chao, Tze-Fan; Liao, Jo-Nan; Lin, Chin-Yu; Chen, Shih-Ann] Taipei Vet Gen Hosp, Dept Med, Div Cardiol, 201,Sec 2,Shih Pai Rd, Taipei 112, Taiwan.
   [Yamada, Shinya] Fukushima Med Univ, Dept Cardiovasc Med, Fukushima, Japan.
   [Lo, Li-Wei; Lin, Yenn-Jiang; Chang, Shih-Lin; Chung, Fa-Po; Hu, Yu-Feng; Tuan, Ta-Chuan; Chao, Tze-Fan; Liao, Jo-Nan; Chen, Shih-Ann] Natl Yang Ming Univ, Dept Med, Sch Med, Taipei, Taiwan.
RP Chen, SA (corresponding author), Taipei Vet Gen Hosp, Dept Med, Div Cardiol, 201,Sec 2,Shih Pai Rd, Taipei 112, Taiwan.
EM epsachen@ms41.hinet.net
FU Taipei Veterans General HospitalTaipei Veterans General Hospital
   [V102B-002, V102E7-003, V103C-042, V103C-126, V103E7-002,
   VGHUST103-G1-3-1, V104C-131, V104E7-003, VA105C-60]; Ministry of Science
   and Technology [NSC 101-2911-I-008-001, NSC 102-2325-B-010-005, MOST
   103-2314-B-075-062-MY3, MOST 104-2314-B-075-065-MY2]; Research
   Foundation of Cardiovascular Medicine [RFCM 100-02-011, 101-01-001,
   104-01-009-01]
FX The present work was supported by the Taipei Veterans General Hospital
   (V102B-002, V102E7-003, V103C-042, V103C-126, V103E7-002,
   VGHUST103-G1-3-1, V104C-131, V104E7-003, and VA105C-60), Ministry of
   Science and Technology (NSC 101-2911-I-008-001, NSC 102-2325-B-010-005,
   MOST 103-2314-B-075-062-MY3, and MOST 104-2314-B-075-065-MY2), and
   Research Foundation of Cardiovascular Medicine (RFCM 100-02-011,
   101-01-001, and 104-01-009-01).
CR Bourier F, 2015, J CARDIOVASC ELECTR, V26, P1140, DOI 10.1111/jce.12741
   Bourier F, 2014, J CARDIOVASC ELECTR, V25, P74, DOI 10.1111/jce.12264
   Brooks AG, 2008, HEART RHYTHM, V5, P526, DOI 10.1016/j.hrthm.2008.01.008
   Calkins H, 2012, EUROPACE, V14, P528, DOI 10.1093/europace/eus027
   Cappato R, 2010, CIRC-ARRHYTHMIA ELEC, V3, P32, DOI 10.1161/CIRCEP.109.859116
   Chang SL, 2007, J CARDIOVASC ELECTR, V18, P1134, DOI 10.1111/j.1540-8167.2007.00941.x
   Chang SL, 2009, J CARDIOVASC ELECTR, V20, P1113, DOI 10.1111/j.1540-8167.2009.01517.x
   Chida K, 2006, AM J ROENTGENOL, V186, P774, DOI 10.2214/AJR.04.1653
   Estner HL, 2006, EUROPACE, V8, P583, DOI 10.1093/europace/eul079
   Fahmy TS, 2007, J CARDIOVASC ELECTR, V18, P276, DOI 10.1111/j.1540-8167.2007.00727.x
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Mansour M, 2004, J CARDIOVASC ELECTR, V15, P387, DOI 10.1046/j.1540-8167.2004.03515.x
   Pillarisetti J, 2014, J INTERV CARD ELECTR, V40, P221, DOI 10.1007/s10840-014-9909-8
   Roguin A, 2013, AM J CARDIOL, V111, P1368, DOI 10.1016/j.amjcard.2012.12.060
   Rolf S, 2012, CIRC-ARRHYTHMIA ELEC, V5, P684, DOI 10.1161/CIRCEP.112.971705
   Sommer P, 2014, CIRC-ARRHYTHMIA ELEC, V7, P869, DOI 10.1161/CIRCEP.114.001542
   Sommer P, 2013, EUROPACE, V15, P1292, DOI 10.1093/europace/eut090
   Tsao HM, 2010, J CARDIOVASC ELECTR, V21, P270, DOI 10.1111/j.1540-8167.2009.01618.x
NR 18
TC 1
Z9 1
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JAN
PY 2019
VL 49
IS 1
BP 84
EP 96
DI 10.4070/kcj.2018.0195
PG 13
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA HJ4BY
UT WOS:000457120200006
PM 30468028
OA Green Published, Other Gold
DA 2021-04-22
ER

PT J
AU Sim, BK
   Park, H
   Kim, JJ
   Yun, SW
   Yu, JJ
   Yoon, KL
   Lee, KY
   Kil, HR
   Kim, GB
   Han, MK
   Song, MS
   Lee, HD
   Ha, KS
   Sohn, S
   Hong, YM
   Jang, GY
   Lee, JK
AF Sim, Bo Kyung
   Park, Hyein
   Kim, Jae-Jung
   Yun, Sin Weon
   Yu, Jeong Jin
   Yoon, Kyung Lim
   Lee, Kyung-Yil
   Kil, Hong-Ryang
   Kim, Gi Beom
   Han, Myung-Ki
   Song, Min Seob
   Lee, Hyoung Doo
   Ha, Kee Soo
   Sohn, Sejung
   Hong, Young Mi
   Jang, Gi Young
   Lee, Jong-Keuk
CA Korean Kawasaki Dis Genetics
TI Assessment of the Clinical Heterogeneity of Kawasaki Disease Using
   Genetic Variants of BLK and FCGR2A
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Mucocutaneous lymph node syndrome; Genome-wide association study;
   Polymorphism; single nucleotide
ID GENOME-WIDE ASSOCIATION; LONG-TERM MANAGEMENT; FC-GAMMA-RIIA;
   EPIDEMIOLOGIC FEATURES; SUSCEPTIBILITY LOCI
AB Background and objectives: Patients with Kawasaki disease (KU) are clinically heterogeneous because its diagnosis is based solely on clinical observation and there are no definitive biomarkers. We dissected the clinical heterogeneity of KD patients using the KD-associated genetic variants.
   Methods: We performed a genetic association analysis in several KD subgroups categorized by clinical characteristics using the KD-associated variants of the B lymphoid tyrosine kinase (BLK; rs6993775) and Fc gamma receptor II a (FCGR2A; rs1801274) in a large number of case (n=1,011) and control (n=4,533) samples.
   Results: BLKand FCGR2A were very significantly associated with KD in Korean KD patients (odds ratio [OR),1.48; p=4.63x10(-11) for BLK, and OR, 1.26; p=1.42x10(-4) for FCGR2A). However, in KD subgroup analysis, we found that neither BLK nor FCGR2A were associated with either incomplete Kawasaki disease (iKD) type patients or those older than 5 years of age (p>0.2), suggesting that patients with iKD or those older than 5 years of age are a unique subgroup of Ka In genetic association analysis after excluding iKD patients and those older than 5 years old, we found that BLKwas associated with all KD subgroups, whereas FCGR2A was specifically associated with male KD patients younger than 1 year of age (OR, 2.22; p=2.35x10(-5)).
   Conclusions: KD is a clinically and genetically heterogeneous disease. These findings will provide new insights into the clinical and genetic heterogeneity of KD.
C1 [Sim, Bo Kyung; Park, Hyein; Kim, Jae-Jung; Lee, Jong-Keuk] Univ Ulsan, Asan Inst Life Sci, Coll Med, 88 Olymp Ro 43 Gil, Seoul 05505, South Korea.
   [Yun, Sin Weon] Chung Ang Univ Hosp, Dept Pediat, Seoul, South Korea.
   [Yu, Jeong Jin] Univ Ulsan, Asan Med Ctr, Dept Pediat, Coll Med, Seoul, South Korea.
   [Yoon, Kyung Lim] Kyung Hee Univ Hosp Gangdong, Dept Pediat, Seoul, South Korea.
   [Lee, Kyung-Yil] Catholic Univ Korea, Daejeon St Marys Hosp, Dept Pediat, Daejeon, South Korea.
   [Kil, Hong-Ryang] Chungnam Natl Univ Hosp, Dept Pediat, Daejeon, South Korea.
   [Kim, Gi Beom] Seoul Natl Univ Childrens Hosp, Dept Pediat, Seoul, South Korea.
   [Han, Myung-Ki] Univ Ulsan, Gangneung Asan Hosp, Dept Pediat, Coll Med, Kangnung, South Korea.
   [Song, Min Seob] Inje Univ, Dept Pediat, Paik Hosp, Busan, South Korea.
   [Lee, Hyoung Doo] Pusan Natl Univ Hosp, Dept Pediat, Busan, South Korea.
   [Ha, Kee Soo; Jang, Gi Young] Univ Korea Hosp, Dept Pediat, Seoul, South Korea.
   [Sohn, Sejung; Hong, Young Mi] Ewha Womans Univ, Dept Pediat, Med Ctr, Seoul, South Korea.
RP Lee, JK (corresponding author), Univ Ulsan, Asan Inst Life Sci, Coll Med, 88 Olymp Ro 43 Gil, Seoul 05505, South Korea.
EM cookiejklee@hotmail.com
RI Song, Min Seob/R-3075-2019; Kim, Gi Beom/AAK-3377-2021
OI Kim, Gi Beom/0000-0002-7880-280X; Yun, Sin Weon/0000-0001-8947-703X;
   Sim, Bo Kyung/0000-0001-5928-4923; Kil, Hong Ryang/0000-0003-4925-8240
FU Ministry of Health & Welfare of the Republic of KoreaMinistry of Health
   & Welfare, Republic of Korea [HI15C1575]; Korea Center for Disease
   Control and Prevention [2014-ER7402-00]
FX This work was supported by a grant from the Ministry of Health & Welfare
   of the Republic of Korea (HI15C1575) and a grant from the Korea Center
   for Disease Control and Prevention (2014-ER7402-00).
CR Burns JC, 2004, LANCET, V364, P533, DOI 10.1016/S0140-6736(04)16814-1
   Burns JC, 1998, PEDIATR INFECT DIS J, V17, P1144, DOI 10.1097/00006454-199812000-00009
   Burns JC, 2000, PEDIATRICS, V106, DOI 10.1542/peds.106.2.e27
   Chang CN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061196
   Vigato-Ferreira ICC, 2014, AUTOIMMUNITY, V47, P451, DOI 10.3109/08916934.2014.921809
   DAJANI AS, 1994, CIRCULATION, V89, P916, DOI 10.1161/01.CIR.89.2.916
   DURONGPISITKUL K, 1995, PEDIATRICS, V96, P1057
   FUJITA Y, 1989, PEDIATRICS, V84, P666
   Huang WC, 2009, PEDIATRICS, V123, pe401, DOI 10.1542/peds.2008-2187
   Kato H, 1996, CIRCULATION, V94, P1379, DOI 10.1161/01.CIR.94.6.1379
   KAWASAKI T, 1974, PEDIATRICS, V54, P271
   Khor CC, 2011, NAT GENET, V43, P1241, DOI 10.1038/ng.981
   Kim Gi Beom, 2017, Pediatr Infect Dis J, V36, P482, DOI [10.1097/inf.0000000000001474, 10.1097/INF.0000000000001474]
   Kim GB, 2014, PEDIATR INFECT DIS J, V33, P24, DOI 10.1097/INF.0000000000000010
   Kim JJ, 2017, J HUM GENET, V62, P1023, DOI 10.1038/jhg.2017.87
   Kwon Ki-Sung, 2016, Genomics & Informatics, V14, P85, DOI 10.5808/GI.2016.14.3.85
   Lee YC, 2012, NAT GENET, V44, P522, DOI 10.1038/ng.2227
   Makino N, 2015, J EPIDEMIOL, V25, P239, DOI 10.2188/jea.JE20140089
   McCrindle BW, 2017, CIRCULATION, V135, pE927, DOI 10.1161/CIR.0000000000000484
   NEWBURGER JW, 1986, NEW ENGL J MED, V315, P341, DOI 10.1056/NEJM198608073150601
   Onouchi Y, 2012, NAT GENET, V44, P517, DOI 10.1038/ng.2220
   PARREN PWHI, 1992, J CLIN INVEST, V90, P1537, DOI 10.1172/JCI116022
   Purcell S, 2003, BIOINFORMATICS, V19, P149, DOI 10.1093/bioinformatics/19.1.149
   Sonobe T, 2007, PEDIATR INT, V49, P421, DOI 10.1111/j.1442-200X.2007.02396.x
   Tsai FJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016853
   Uehara R, 2004, ARCH PEDIAT ADOL MED, V158, P1166, DOI 10.1001/archpedi.158.12.1166
   WARMERDAM PAM, 1991, J IMMUNOL, V147, P1338
   YANAGAWA H, 1988, J INFECT DIS, V158, P1296, DOI 10.1093/infdis/158.6.1296
   Yellen ES, 2010, PEDIATRICS, V125, pE234, DOI 10.1542/peds.2009-0606
NR 29
TC 4
Z9 5
U1 0
U2 2
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JAN
PY 2019
VL 49
IS 1
BP 99
EP 108
DI 10.4070/kcj.2018.0224
PG 10
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA HJ4BY
UT WOS:000457120200008
PM 30468029
OA Other Gold, Green Published
DA 2021-04-22
ER

PT J
AU Joung, B
   Lee, JM
   Lee, KH
   Kim, TH
   Choi, EK
   Lim, WH
   Kang, KW
   Shim, J
   Lim, HE
   Park, J
   Lee, SR
   Lee, YS
   Kim, JB
AF Joung, Boyoung
   Lee, Jung Myung
   Lee, Ki Hong
   Kim, Tae-Hoon
   Choi, Eue-Keun
   Lim, Woo-Hyun
   Kang, Ki-Woon
   Shim, Jaemin
   Lim, Hong Euy
   Park, Junbeom
   Lee, So-Ryoung
   Lee, Young Soo
   Kim, Jin-Bae
CA KHRS Atrial Fibrillation Guideline
TI 2018 Korean Guideline of Atrial Fibrillation Management
SO KOREAN CIRCULATION JOURNAL
LA English
DT Review
DE Atrial fibrillation; Guideline; Anticoagulants; Therapy
ID ADHERENT ANTITHROMBOTIC TREATMENT; VITAMIN-K ANTAGONIST; PERCUTANEOUS
   CORONARY INTERVENTION; CONGESTIVE-HEART-FAILURE; RENIN-ANGIOTENSIN
   SYSTEM; PLACEBO-CONTROLLED TRIAL; RADIOFREQUENCY CATHETER ABLATION;
   STROKE RISK STRATIFICATION; TRANSIENT ISCHEMIC ATTACK; TYPE-2
   DIABETES-MELLITUS
AB Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia in the general population. The Korean Heart Rhythm Society organized a Korean AF Management Guideline Committee and analyzed all available studies regarding the management of AF, including studies on Korean patients. This guideline is based on recent data of the Korean population and the recent guidelines of the European Society of Cardiology, European Association for Cardio-Thoracic Surgery, American Heart Association, and Asia Pacific Heart Rhythm Society. Expert consensus or guidelines for the optimal management of Korean patients with AF were achieved after a systematic review with intensive discussion. This article provides general principles for appropriate risk stratification and selection of anticoagulation therapy in Korean patients with AF. This guideline deals with optimal stroke prevention, screening, rate and rhythm control, risk factor management, and integrated management of AF.
C1 [Joung, Boyoung] Yonsei Univ, Coll Med, Dept Internal Med, Div Cardiol, Seoul, South Korea.
   [Lee, Jung Myung; Kim, Tae-Hoon; Kim, Jin-Bae] Kyung Hee Univ, Med Coll, Dept Internal Med, Div Cardiol, Seoul, South Korea.
   [Lee, Ki Hong] Chonnam Natl Univ Hosp, Dept Cardiol, Gwangju, South Korea.
   [Choi, Eue-Keun; Lim, Woo-Hyun] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul, South Korea.
   [Kang, Ki-Woon] Eulji Univ, Coll Med, Div Cardiol, Daejeon, South Korea.
   [Shim, Jaemin; Lim, Hong Euy] Korea Univ, Coll Med, Dept Internal Med, Div Cardiol, Seoul, South Korea.
   [Park, Junbeom] Ewha Woman Univ, Dept Cardiol, Seoul, South Korea.
   [Lee, So-Ryoung] Soon Chun Hyang Univ Hosp, Dept Internal Med, Div Cardiol, Seoul, South Korea.
   [Lee, Young Soo] Daegu Catholic Univ, Dept Internal Med, Div Cardiol, Daegu, South Korea.
RP Joung, B (corresponding author), Yonsei Univ, Yonsei Cardiovasc Hosp, Med Coll, Dept Internal Med,Div Cardiol, 50 Yonsei Ro, Seoul 03722, South Korea.
EM cby6908@yuhs.ac
RI Park, Junbeom/AAH-6065-2021; Choi, Eue-Keun/J-5968-2014; Lee, Jung
   Myung/S-6184-2019
OI Choi, Eue-Keun/0000-0002-0411-6372; Lee, Jung Myung/0000-0002-1904-5335;
   Lim, Woo-Hyun/0000-0001-9298-8500; Shim, Jaemin/0000-0001-8251-1522;
   Joung, Boyoung/0000-0001-9036-7225; Lim, Hong Euy/0000-0001-8102-8352;
   Kang, Ki-Woon/0000-0002-1361-0022; Kim, Tae-Hoon/0000-0003-4200-3456
FU Korean Healthcare Technology RAMP;D project - Ministry of Health Welfare
   [HI15C1200]
FX This study was supported by a research grant from the Korean Healthcare
   Technology R&D project funded by the Ministry of Health & Welfare
   (HI15C1200).
CR ADAMS HP, 1993, STROKE, V24, P35, DOI 10.1161/01.STR.24.1.35
   Al-Khatib SM, 2014, ANN INTERN MED, V160, P760, DOI 10.7326/M13-1467
   Alboni P, 2004, NEW ENGL J MED, V351, P2384, DOI 10.1056/NEJMoa041233
   Aliot E, 2011, EUROPACE, V13, P161, DOI 10.1093/europace/euq382
   Allan V, 2017, THROMB HAEMOSTASIS, V117, P837, DOI 10.1160/TH16-11-0825
   Alonso-Coello P, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-221
   Anand K, 2006, AM HEART J, V152, P217, DOI 10.1016/j.ahj.2006.01.007
   Ancedy Y, 2016, INT J CARDIOL, V203, P987, DOI 10.1016/j.ijcard.2015.11.090
   Anselmino M, 2014, CIRC-ARRHYTHMIA ELEC, V7, P1011, DOI 10.1161/CIRCEP.114.001938
   Arbelo E, 2014, EUR HEART J, V35, P1466, DOI 10.1093/eurheartj/ehu001
   Aronsson M, 2015, EUROPACE, V17, P1023, DOI 10.1093/europace/euv083
   Arya A, 2007, PACE, V30, P458, DOI 10.1111/j.1540-8159.2007.00693.x
   Esteve-Pastor MA, 2017, THROMB HAEMOSTASIS, V117, P2261, DOI 10.1160/TH17-10-0710
   Atarashi H, 2002, CIRC J, V66, P553, DOI 10.1253/circj.66.553
   Badheka AO, 2015, CIRC-ARRHYTHMIA ELEC, V8, P42, DOI 10.1161/CIRCEP.114.001413
   Baek YS, 2017, J AM HEART ASSOC, V6, P6
   Bash LD, 2012, CARDIOVASC DRUG THER, V26, P167, DOI 10.1007/s10557-012-6374-4
   Benjamin EJ, 1998, CIRCULATION, V98, P946, DOI 10.1161/01.CIR.98.10.946
   BENJAMIN EJ, 1994, JAMA-J AM MED ASSOC, V271, P840, DOI 10.1001/jama.1994.03510350050036
   Bianconi L, 1996, J AM COLL CARDIOL, V28, P700, DOI 10.1016/0735-1097(96)00230-6
   Bin Gwag H, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197352
   Bodenheimer T, 2002, JAMA-J AM MED ASSOC, V288, P1775, DOI 10.1001/jama.288.14.1775
   Boersma LVA, 2016, EUR HEART J, V37, P2465, DOI 10.1093/eurheartj/ehv730
   Boriani G, 2015, AM J MED, V128, P509, DOI 10.1016/j.amjmed.2014.11.026
   Boriani G, 2014, EUR HEART J, V35, P508, DOI 10.1093/eurheartj/eht491
   Brambatti M, 2014, CIRCULATION, V129, P2094, DOI 10.1161/CIRCULATIONAHA.113.007825
   Calkins H, 2017, HEART RHYTHM, V14, pE275, DOI 10.1016/j.hrthm.2017.05.012
   Calkins H, 2017, NEW ENGL J MED, V376, P1627, DOI 10.1056/NEJMoa1701005
   Camm AJ, 2011, J AM COLL CARDIOL, V57, P313, DOI 10.1016/j.jacc.2010.07.046
   Cannon CP, 2017, NEW ENGL J MED, V377, P1513, DOI 10.1056/NEJMoa1708454
   Cappato R, 2015, EUR HEART J, V36, P1805, DOI 10.1093/eurheartj/ehv177
   Cappato R, 2014, EUR HEART J, V35, P3346, DOI 10.1093/eurheartj/ehu367
   Casu G, 2017, EUR HEART J SUPPL, V19, pD333, DOI 10.1093/eurheartj/sux008
   Cha MJ, 2017, STROKE, V48, P3040, DOI 10.1161/STROKEAHA.117.018773
   Chan KE, 2009, J AM SOC NEPHROL, V20, P2223, DOI 10.1681/ASN.2009030319
   Chan NC, 2015, J THROMB HAEMOST, V13, P353, DOI 10.1111/jth.12823
   Chan NY, 2018, HEART RHYTHM, V15, P1306, DOI 10.1016/j.hrthm.2018.06.006
   Channer KS, 2004, EUR HEART J, V25, P144, DOI 10.1016/j.ehj.2003.10.020
   Chao TF, 2018, CIRCULATION, V138, P37, DOI 10.1161/CIRCULATIONAHA.117.031658
   Chao TF, 2018, THROMB HAEMOSTASIS, V118, P768, DOI 10.1055/s-0038-1636534
   Chao TF, 2018, INT J CARDIOL, V254, P157, DOI 10.1016/j.ijcard.2017.11.025
   Chao TF, 2018, CHEST, V153, P453, DOI 10.1016/j.chest.2017.10.001
   Chao TF, 2018, J AM COLL CARDIOL, V71, P122, DOI 10.1016/j.jacc.2017.10.085
   Chao TF, 2015, J AM COLL CARDIOL, V66, P1339, DOI 10.1016/j.jacc.2015.07.026
   Chao TF, 2014, J AM COLL CARDIOL, V64, P1658, DOI 10.1016/j.jacc.2014.06.1203
   Chatterjee S, 2013, PACE, V36, P122, DOI 10.1111/j.1540-8159.2012.03513.x
   Chevalier P, 2003, J AM COLL CARDIOL, V41, P255, DOI 10.1016/S0735-1097(02)02705-5
   Chiang CE, 2017, J ARRYTHM, V33, P345, DOI 10.1016/j.joa.2017.05.004
   Chiang CE, 2010, J FORMOS MED ASSOC, V109, P740, DOI 10.1016/S0929-6646(10)60120-9
   Chimienti M, 1995, EUR HEART J, V16, P1943, DOI 10.1093/oxfordjournals.eurheartj.a060852
   Cho MY, 2017, HEART RHYTHM
   Choi HI, 2017, JACC-CARDIOVASC INTE, V10, pE107, DOI 10.1016/j.jcin.2017.02.028
   Choi YJ, 2018, YONSEI MED J, V59, P258, DOI 10.3349/ymj.2018.59.2.258
   Chugh SS, 2004, J AM COLL CARDIOL, V44, P1268, DOI 10.1016/j.jacc.2004.06.029
   Chun KJ, 2014, CLIN THER, V36, P1169, DOI 10.1016/j.clinthera.2014.07.013
   Clemo HF, 1998, AM J CARDIOL, V81, P594, DOI 10.1016/S0002-9149(97)00962-4
   Conen D, 2008, JAMA-J AM MED ASSOC, V300, P2489, DOI 10.1001/jama.2008.755
   Connolly S, 2006, LANCET, V367, P1903, DOI 10.1016/s0140-6736(06)68845-4
   Connolly SJ, 2011, NEW ENGL J MED, V365, P2268, DOI 10.1056/NEJMoa1109867
   Connolly SJ, 2009, NEW ENGL J MED, V361, P1139, DOI 10.1056/NEJMoa0905561
   Coppens M, 2013, EUR HEART J, V34, P170, DOI 10.1093/eurheartj/ehs314
   Coyne KS, 2006, VALUE HEALTH, V9, P348, DOI 10.1111/j.1524-4733.2006.00124.x
   Darby AE, 2012, CIRCULATION, V125, P945, DOI 10.1161/CIRCULATIONAHA.111.019935
   Davis RC, 2012, EUROPACE, V14, P1553, DOI 10.1093/europace/eus087
   de Denus S, 2005, ARCH INTERN MED, V165, P258, DOI 10.1001/archinte.165.3.258
   De Simone A, 1999, J AM COLL CARDIOL, V34, P810, DOI 10.1016/S0735-1097(99)00256-9
   Delle Karth G, 2001, CRIT CARE MED, V29, P1149, DOI 10.1097/00003246-200106000-00011
   Dewilde WJM, 2013, LANCET, V381, P1107, DOI 10.1016/S0140-6736(12)62177-1
   Di Biase L, 2015, HEART RHYTHM, V12, P1162, DOI 10.1016/j.hrthm.2015.02.028
   Douketis JD, 2016, NEW ENGL J MED, V374, P93, DOI 10.1056/NEJMc1513255
   Douketis JD, 2015, NEW ENGL J MED, V373, P823, DOI 10.1056/NEJMoa1501035
   Du X, 2009, EUR HEART J, V30, P1128, DOI 10.1093/eurheartj/ehp055
   ECHT DS, 1991, NEW ENGL J MED, V324, P781, DOI 10.1056/NEJM199103213241201
   Eckman MH, 2011, CIRC-CARDIOVASC QUAL, V4, P14, DOI 10.1161/CIRCOUTCOMES.110.958108
   Eikelboom JW, 2012, J STROKE CEREBROVASC, V21, P429, DOI 10.1016/j.jstrokecerebrovasdis.2012.05.007
   ELLENBOGEN KA, 1991, J AM COLL CARDIOL, V18, P891, DOI 10.1016/0735-1097(91)90743-S
   Engdahl J, 2013, CIRCULATION, V127, P930, DOI 10.1161/CIRCULATIONAHA.112.126656
   Ezekowitz MD, 2018, EUR HEART J, V39, P2959, DOI 10.1093/eurheartj/ehy148
   Fang MC, 2005, CIRCULATION, V112, P1687, DOI 10.1161/CIRCULATIONAHA.105.553438
   Fangel MV, 2018, INT J CARDIOL, V268, P137, DOI 10.1016/j.ijcard.2018.05.037
   Fatemi O, 2014, AM J CARDIOL, V114, P1217, DOI 10.1016/j.amjcard.2014.07.045
   Flaker G, 2014, J AM COLL CARDIOL, V63, P1082, DOI 10.1016/j.jacc.2013.09.062
   Fox KAA, 2011, EUR HEART J, V32, P2387, DOI 10.1093/eurheartj/ehr342
   Freedman B, 2017, CIRCULATION, V135, P1851, DOI 10.1161/CIRCULATIONAHA.116.026693
   Freedman B, 2016, LANCET, V388, P806, DOI 10.1016/S0140-6736(16)31257-0
   Freemantle N, 2011, EUROPACE, V13, P329, DOI 10.1093/europace/euq450
   Friberg L, 2014, STROKE, V45, P2599, DOI 10.1161/STROKEAHA.114.006070
   Friberg L, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e3522
   Furniss SS, 2015, HEART, V101, P1526, DOI 10.1136/heartjnl-2015-307656
   Gage BF, 2005, AM J MED, V118, P612, DOI 10.1016/j.amjmed.2005.02.022
   Gami AS, 2007, J AM COLL CARDIOL, V49, P565, DOI 10.1016/j.jacc.2006.08.060
   Gibson CM, 2016, NEW ENGL J MED, V375, P2423, DOI 10.1056/NEJMoa1611594
   Giugliano RP, 2013, NEW ENGL J MED, V369, P2093, DOI 10.1056/NEJMoa1310907
   Gladstone DJ, 2014, NEW ENGL J MED, V370, P2467, DOI 10.1056/NEJMoa1311376
   Glotzer TV, 2009, CIRC-ARRHYTHMIA ELEC, V2, P474, DOI 10.1161/CIRCEP.109.849638
   Glotzer TV, 2003, CIRCULATION, V107, P1614, DOI 10.1161/01.CIR.0000057981.70380.45
   Go AS, 2001, JAMA-J AM MED ASSOC, V285, P2370, DOI 10.1001/jama.285.18.2370
   Goette A, 2016, LANCET, V388, P1995, DOI 10.1016/S0140-6736(16)31474-X
   Goldschlager N, 2007, HEART RHYTHM, V4, P1250, DOI 10.1016/j.hrthm.2007.07.020
   GOLDSTEIN RE, 1991, CIRCULATION, V83, P52, DOI 10.1161/01.CIR.83.1.52
   Golwala HB, 2018, EUR HEART J, V39, P1726, DOI 10.1093/eurheartj/ehy162
   Gorin L, 2011, CHEST, V140, P911, DOI 10.1378/chest.10-2436
   Granger CB, 2011, NEW ENGL J MED, V365, P981, DOI 10.1056/NEJMoa1107039
   Guha K, 2013, CURR CARDIOL REV, V9, P123, DOI 10.2174/1573403X11309020005
   Guo YT, 2018, AM J MED, V131, P185, DOI 10.1016/j.amjmed.2017.09.009
   Guo YT, 2017, AM J MED, V130, P1388, DOI 10.1016/j.amjmed.2017.07.003
   Guo YT, 2013, INT J CARDIOL, V168, P904, DOI 10.1016/j.ijcard.2012.10.052
   Halcox JPJ, 2017, CIRCULATION, V136, P1784, DOI 10.1161/CIRCULATIONAHA.117.030583
   Halvorsen S, 2014, EUR HEART J, V35, P1864, DOI 10.1093/eurheartj/ehu046
   Hansen ML, 2015, EUROPACE, V17, P18, DOI 10.1093/europace/euu189
   Hart RG, 2007, ANN INTERN MED, V146, P857, DOI 10.7326/0003-4819-146-12-200706190-00007
   Hart RG, 2011, CLIN J AM SOC NEPHRO, V6, P2599, DOI 10.2215/CJN.02400311
   Healey JS, 2017, CIRCULATION, V136, P1276, DOI 10.1161/CIRCULATIONAHA.117.028845
   Healey JS, 2012, NEW ENGL J MED, V366, P120, DOI 10.1056/NEJMoa1105575
   Healey JS, 2005, J AM COLL CARDIOL, V45, P1832, DOI 10.1016/j.jacc.2004.11.070
   Heeringa J, 2008, AM HEART J, V156, P1163, DOI 10.1016/j.ahj.2008.08.003
   Heidbuchel H, 2015, EUROPACE, V17, P1467, DOI 10.1093/europace/euv309
   Hemels MEW, 2006, J AM COLL CARDIOL, V48, P1001, DOI 10.1016/j.jacc.2006.05.043
   Hendriks JML, 2010, INT J NURS STUD, V47, P1310, DOI 10.1016/j.ijnurstu.2009.12.017
   Hijazi Z, 2014, CIRCULATION, V129, P961, DOI 10.1161/CIRCULATIONAHA.113.003628
   Hindricks G, 2010, CIRC-ARRHYTHMIA ELEC, V3, P141, DOI 10.1161/CIRCEP.109.877852
   Hobbs F D R, 2005, Health Technol Assess, V9, piii
   Hohnloser SH, 2013, EUROPACE, V15, P1407, DOI 10.1093/europace/eut241
   Hohnloser SH, 2012, EUR HEART J, V33, P2821, DOI 10.1093/eurheartj/ehs274
   Hohnloser SH, 2009, NEW ENGL J MED, V360, P668, DOI 10.1056/NEJMoa0803778
   Holmes DR, 2009, LANCET, V374, P534, DOI 10.1016/S0140-6736(09)61343-X
   Holmes DR, 2015, J AM COLL CARDIOL, V65, P2614, DOI 10.1016/j.jacc.2015.04.025
   Holmes DR, 2014, J AM COLL CARDIOL, V64, P1, DOI 10.1016/j.jacc.2014.04.029
   Hori M, 2014, CIRC J, V78, P1349, DOI 10.1253/circj.CJ-13-1324
   HWANG JJ, 1993, AM J CARDIOL, V72, P677
   Hylek EM, 2006, STROKE, V37, P1075, DOI 10.1161/01.STR.0000209239.71702.ce
   Iguchi Y, 2008, CIRC J, V72, P909, DOI 10.1253/circj.72.909
   January CT, 2014, J AM COLL CARDIOL, V64, pE1, DOI 10.1016/j.jacc.2014.03.022
   Jibrini MB, 2008, AM J THER, V15, P36, DOI 10.1097/MJT.0b013e31804beb59
   Jones C, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g3655
   Joung B, 2017, KOREAN CIRC J, V47, P833, DOI 10.4070/kcj.2017.0158
   Kang DH, 2018, J AM COLL CARDIOL, V71, P834, DOI 10.1016/S0735-1097(18)31375-5
   Kang SH, 2017, CIRC J, V81, P1158, DOI 10.1253/circj.CJ-16-1267
   KANNEL WB, 1998, AM J CARDIOL, V82
   Karki K, 1997, EUR HEART J, V18, P649
   Khan IA, 2003, INT J CARDIOL, V89, P239, DOI 10.1016/S0167-5273(02)00477-1
   Khan IA, 2003, INT J CARDIOL, V87, P121, DOI 10.1016/S0167-5273(02)00467-9
   Kim D, 2018, HEART
   Kim D, 2018, J AM COLL CARDIOL, V72, P1233, DOI 10.1016/j.jacc.2018.05.076
   Kim D, 2018, AM HEART J, V202, P20, DOI 10.1016/j.ahj.2018.04.017
   Kim DS, 1997, KOREAN CIRC J, V27, P860
   Kim H, 2017, KOREAN CIRC J, V47, P877, DOI 10.4070/kcj.2017.0146
   Kim MH, 2011, CIRC-CARDIOVASC QUAL, V4, P313, DOI 10.1161/CIRCOUTCOMES.110.958165
   Kim TH, 2018, STROKE, V49, P1872, DOI 10.1161/STROKEAHA.118.021047
   Kim TH, 2017, STROKE, V48, P2984, DOI 10.1161/STROKEAHA.117.018551
   Kim TH, 2017, STROKE, V48, P1524, DOI 10.1161/STROKEAHA.117.016926
   Kim TH, 2016, J CARDIOL, V68, P104, DOI 10.1016/j.jjcc.2015.10.008
   Kirchhof P, 2002, LANCET, V360, P1275, DOI 10.1016/S0140-6736(02)11315-8
   Kirchhof P, 2005, EUR HEART J, V26, P1292, DOI 10.1093/eurheartj/ehi160
   Kirchhof P, 2016, EUROPACE, V18, DOI 10.1093/europace/euw295
   Kirchhof P, 2018, EUR HEART J, V39, P2942, DOI 10.1093/eurheartj/ehy176
   Kirchhof P, 2013, AM HEART J, V166, P442, DOI 10.1016/j.ahj.2013.05.015
   Kirchhof P, 2012, LANCET, V380, P238, DOI 10.1016/S0140-6736(12)60570-4
   Kirchhof P, 2009, J AM COLL CARDIOL, V54, P143, DOI 10.1016/j.jacc.2009.03.043
   Klein AL, 2001, NEW ENGL J MED, V344, P1411, DOI 10.1056/NEJM200105103441901
   Kober L, 2008, NEW ENGL J MED, V358, P2678, DOI 10.1056/NEJMoa0800456
   Kong KA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185024
   Kotecha D, 2014, LANCET, V384, P2235, DOI 10.1016/S0140-6736(14)61373-8
   Kotecha Dipak, 2014, Evid Based Med, V19, P222, DOI 10.1136/ebmed-2014-110062
   Kottmaier M, 2018, AM J CARDIOL, V121, P445, DOI 10.1016/j.amjcard.2017.11.015
   Kowey PR, 2009, CIRC-ARRHYTHMIA ELEC, V2, P652, DOI 10.1161/CIRCEP.109.870204
   Krijthe BP, 2013, EUR HEART J, V34, P2746, DOI 10.1093/eurheartj/eht280
   Lafuente-Lafuente C, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005049.pub4
   Lakkireddy D, 2014, J AM COLL CARDIOL, V63, P982, DOI 10.1016/j.jacc.2013.11.039
   Lamberts M, 2014, CIRCULATION, V129, P1577, DOI 10.1161/CIRCULATIONAHA.113.004834
   Lau DH, 2017, CIRCULATION, V136, P583, DOI 10.1161/CIRCULATIONAHA.116.023163
   Lee H, 2017, KOREAN CIRC J, V47, P56, DOI 10.4070/kcj.2016.0045
   Lee SS, 2017, EUR HEART J, V38, P2599, DOI 10.1093/eurheartj/ehx316
   Lee SR, 2018, KOREAN CIRC J, V48, P622, DOI 10.4070/kcj.2017.0362
   Lee SR, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0189495
   Lee SR, 2017, INT J CARDIOL, V236, P226, DOI 10.1016/j.ijcard.2017.02.039
   Lee SR, 2016, INT J CARDIOL, V223, P953, DOI 10.1016/j.ijcard.2016.08.296
   Lee Won Chan, 2008, J Med Econ, V11, P281, DOI 10.3111/13696990802063425
   Leon MB, 1998, NEW ENGL J MED, V339, P1665, DOI 10.1056/NEJM199812033392303
   Letelier LM, 2003, ARCH INTERN MED, V163, P777, DOI 10.1001/archinte.163.7.777
   Levin LA, 2015, EUROPACE, V17, P207, DOI 10.1093/europace/euu213
   Li CH, 2016, SCI REP-UK, V6, DOI 10.1038/srep30734
   Li YG, 2018, INT J CARDIOL, V261, P92, DOI 10.1016/j.ijcard.2018.02.051
   Li YG, 2018, CHEST
   Lin LY, 2011, ATHEROSCLEROSIS, V217, P292, DOI 10.1016/j.atherosclerosis.2011.03.033
   Lin YC, 2018, J AM COLL CARDIOL, V72, P477, DOI 10.1016/j.jacc.2018.04.084
   Lip GYH, 2016, J THROMB HAEMOST, V14, P1711, DOI 10.1111/jth.13386
   Lip GYH, 2017, NAT REV CARDIOL, V14, P627, DOI 10.1038/nrcardio.2017.153
   Lip GYH, 2017, THROMB HAEMOSTASIS, V117, P1230, DOI 10.1160/TH16-11-0876
   Lip GYH, 2016, EUROPACE, V18, P12, DOI 10.1093/europace/euv191
   Lip GYH, 2015, INT J CARDIOL, V180, P246, DOI 10.1016/j.ijcard.2014.11.182
   Lip GYH, 2014, THROMB HAEMOSTASIS, V111, P933, DOI 10.1160/TH13-09-0734
   Lip Gregory Y. H., 2018, EUROPACE, V2018
   Lip GYH, 2018, CHEST
   Lopes RD, 2018, AM HEART J, V200, P17, DOI 10.1016/j.ahj.2018.03.001
   Lorig KR, 2003, ANN BEHAV MED, V26, P1, DOI 10.1207/S15324796ABM2601_01
   Lowres N, 2013, THROMB HAEMOSTASIS, V110, P213, DOI 10.1160/TH13-02-0165
   Madrid AH, 2002, CIRCULATION, V106, P331, DOI 10.1161/01.CIR.0000022665.18619.83
   Mairesse GH, 2017, EUROPACE, V19, P1589, DOI 10.1093/europace/eux177
   Man-Son-Hing M, 1999, ARCH INTERN MED, V159, P677, DOI 10.1001/archinte.159.7.677
   MANNING WJ, 1995, ANN INTERN MED, V123, P817, DOI 10.7326/0003-4819-123-11-199512010-00001
   Manolis AJ, 2012, J HYPERTENS, V30, P239, DOI 10.1097/HJH.0b013e32834f03bf
   Mant J, 2007, LANCET, V370, P493, DOI 10.1016/S0140-6736(07)61233-1
   Marott SCW, 2014, EUR HEART J, V35, P1205, DOI 10.1093/eurheartj/eht507
   Marrouche NF, 2018, NEW ENGL J MED, V378, P417, DOI 10.1056/NEJMoa1707855
   Mazurek M, 2017, MAYO CLIN PROC, V92, P1203, DOI 10.1016/j.mayocp.2017.05.023
   Mikkelsen AP, 2012, J THROMB HAEMOST, V10, P1745, DOI 10.1111/j.1538-7836.2012.04853.x
   Mittal S, 2000, CIRCULATION, V101, P1282, DOI 10.1161/01.CIR.101.11.1282
   Miyasaka Y, 2006, CIRCULATION, V114, P119, DOI 10.1161/CIRCULATIONAHA.105.595140
   Mun HS, 2013, CIRC J, V77, P2255, DOI 10.1253/circj.CJ-12-1615
   Munoz FD, 2016, AM J CARDIOL, V117, P69, DOI 10.1016/j.amjcard.2015.09.046
   Nagarakanti R, 2011, CIRCULATION, V123, P131, DOI 10.1161/CIRCULATIONAHA.110.977546
   Nielsen PB, 2018, CIRCULATION, V137, P832, DOI 10.1161/CIRCULATIONAHA.117.029081
   Nieuwlaat R, 2007, AM HEART J, V153, P1006, DOI 10.1016/j.ahj.2007.03.008
   Nuno R, 2012, HEALTH POLICY, V105, P55, DOI 10.1016/j.healthpol.2011.10.006
   Olesen JB, 2012, THROMB HAEMOSTASIS, V107, P1172, DOI 10.1160/TH12-03-0175
   Opolski G, 2004, CHEST, V126, P476, DOI 10.1378/chest.126.2.476
   Patel MR, 2010, NEW ENGL J MED, V362, P886, DOI 10.1056/NEJMoa0907272
   Perera KS, 2016, STROKE, V47, P2197, DOI 10.1161/STROKEAHA.116.013378
   Piccini JP, 2013, J AM COLL CARDIOL, V61, P1998, DOI 10.1016/j.jacc.2013.02.025
   PLATIA EV, 1989, AM J CARDIOL, V63, P925, DOI 10.1016/0002-9149(89)90141-0
   Potpara TS, 2018, NAT REV NEPHROL, V14, P337, DOI 10.1038/nrneph.2018.19
   Potpara TS, 2013, INT J CARDIOL, V168, P4744, DOI 10.1016/j.ijcard.2013.07.234
   Proietti M, 2018, AM J MED
   Proietti M, 2016, CLIN RES CARDIOL, V105, P912, DOI 10.1007/s00392-016-0999-4
   Reddy VY, 2014, JAMA-J AM MED ASSOC, V312, P1988, DOI 10.1001/jama.2014.15192
   Reddy VY, 2013, CIRCULATION, V127, P720, DOI 10.1161/CIRCULATIONAHA.112.114389
   Reisinger J, 1998, AM J CARDIOL, V81, P1450, DOI 10.1016/S0002-9149(98)00223-9
   Reisinger J, 2004, EUR HEART J, V25, P1318, DOI 10.1016/j.ehj.2004.04.030
   Rizzo MR, 2015, J DIABETES COMPLICAT, V29, P88, DOI 10.1016/j.jdiacomp.2014.09.002
   Roh SY, 2011, CIRC-ARRHYTHMIA ELEC, V4, P815, DOI 10.1161/CIRCEP.110.960435
   Roy D, 2000, NEW ENGL J MED, V342, P913, DOI 10.1056/NEJM200003303421302
   Roy D, 2008, NEW ENGL J MED, V358, P2667, DOI 10.1056/NEJMoa0708789
   Roy D, 2008, CIRCULATION, V117, P1518, DOI 10.1161/CIRCULATIONAHA.107.723866
   Rubboli A, 2014, THROMB HAEMOSTASIS, V112, P1080, DOI 10.1160/TH14-08-0681
   Ruff CT, 2014, LANCET, V383, P955, DOI 10.1016/S0140-6736(13)62343-0
   Saborido CM, 2010, HEALTH TECHNOL ASSES, V14, P1
   Santini M, 2011, J AM COLL CARDIOL, V57, P167, DOI 10.1016/j.jacc.2010.08.624
   Schadlich PK, 2007, AM J CARDIOVASC DRUG, V7, P199
   Scheuermeyer FX, 2013, ACAD EMERG MED, V20, P222, DOI 10.1111/acem.12091
   Schmidt M, 2016, INT J CARDIOL, V225, P30, DOI 10.1016/j.ijcard.2016.09.071
   Schmidt M, 2014, NEUROLOGY, V82, P340, DOI 10.1212/WNL.0000000000000062
   Schmidt-Lucke C, 2007, THROMB RES, V119, P27, DOI 10.1016/j.thromres.2005.11.016
   Schnabel RB, 2015, LANCET, V386, P154, DOI 10.1016/S0140-6736(14)61774-8
   Schneider MP, 2010, J AM COLL CARDIOL, V55, P2299, DOI 10.1016/j.jacc.2010.01.043
   Schoen T, 2012, J AM COLL CARDIOL, V60, P1421, DOI 10.1016/j.jacc.2012.06.030
   Schreck DM, 1997, ANN EMERG MED, V29, P135, DOI 10.1016/S0196-0644(97)70319-6
   Schwartzenberg S, 2016, AM J CARDIOL, V117, P477, DOI 10.1016/j.amjcard.2015.10.065
   Seaburg L, 2014, CIRCULATION, V129, P704, DOI 10.1161/CIRCULATIONAHA.113.004498
   Sharma M, 2015, CIRCULATION, V132, P194, DOI 10.1161/CIRCULATIONAHA.114.013267
   Shi LZ, 2015, EXP THER MED, V10, P816, DOI 10.3892/etm.2015.2545
   Shin DG, 2015, YONSEI MED J, V56, P1552, DOI 10.3349/ymj.2015.56.6.1552
   Singh BN, 2005, NEW ENGL J MED, V352, P1861, DOI 10.1056/NEJMoa041705
   Singh BN, 2007, NEW ENGL J MED, V357, P987, DOI 10.1056/NEJMoa054686
   SINGH SN, 1995, NEW ENGL J MED, V333, P77, DOI 10.1056/NEJM199507133330201
   Singh SN, 2009, HEART RHYTHM, V6, P152, DOI 10.1016/j.hrthm.2008.10.036
   Siontis KC, 2018, CIRCULATION, V138, P1519, DOI 10.1161/CIRCULATIONAHA.118.035418
   Siontis KC, 2016, HEART RHYTHM, V13, P1418, DOI 10.1016/j.hrthm.2016.03.003
   Siu CW, 2014, HEART RHYTHM, V11, P1401, DOI 10.1016/j.hrthm.2014.04.021
   Siu CW, 2009, CRIT CARE MED, V37, P2174, DOI 10.1097/CCM.0b013e3181a02f56
   Son MK, 2018, J EPIDEMIOL, V28, P81, DOI [10.2188/jea.JE20160149, 10.2188/jea.je20160149]
   Sposato LA, 2015, LANCET NEUROL, V14, P377, DOI 10.1016/S1474-4422(15)70027-X
   Stambler BS, 1996, CIRCULATION, V94, P1613, DOI 10.1161/01.CIR.94.7.1613
   Steensig K, 2018, J AM COLL CARDIOL
   Steffel J, 2018, EUR HEART J, V39, P1330, DOI 10.1093/eurheartj/ehy136
   STEINBERG JS, 1987, J AM COLL CARDIOL, V9, P405, DOI 10.1016/S0735-1097(87)80396-0
   Stellbrink C, 2004, CIRCULATION, V109, P997, DOI 10.1161/01.CIR.0000120509.64740.DC
   Stewart S, 2004, HEART, V90, P286, DOI 10.1136/hrt.2002.008748
   Stewart S, 2002, AM J MED, V113, P359, DOI 10.1016/S0002-9343(02)01236-6
   Stiggelbout AM, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e256
   Stock S, 2014, HEALTH AFFAIR, V33, P1540, DOI 10.1377/hlthaff.2014.0428
   Swedberg K, 2012, J AM COLL CARDIOL, V59, P1598, DOI 10.1016/j.jacc.2011.11.063
   Thijs VN, 2016, NEUROLOGY, V86, P261, DOI 10.1212/WNL.0000000000002282
   Thomas SP, 2004, AM HEART J, V147, DOI 10.1016/S0002-8703(03)00526-X
   Tisdale JE, 1998, AM HEART J, V135, P739, DOI 10.1016/S0002-8703(98)70031-6
   Tomita H, 2015, CIRC J, V79, P1719, DOI 10.1253/circj.CJ-15-0095
   Tsadok MA, 2012, JAMA-J AM MED ASSOC, V307, P1952, DOI 10.1001/jama.2012.3490
   Ueng KC, 2003, EUR HEART J, V24, P2090, DOI 10.1016/j.ehj.2003.08.014
   Valgimigli M, 2018, EUR HEART J, V39, P213, DOI 10.1093/eurheartj/ehx419
   Van Gelder IC, 2002, NEW ENGL J MED, V347, P1834, DOI 10.1056/NEJMoa021375
   Van Gelder IC, 2017, EUR HEART J, V38, P1339, DOI 10.1093/eurheartj/ehx042
   Van Gelder IC, 2016, LANCET, V388, P818, DOI 10.1016/S0140-6736(16)31258-2
   Van Gelder IC, 2010, NEW ENGL J MED, V362, P1363, DOI 10.1056/NEJMoa1001337
   VANGELDER IC, 1989, AM J CARDIOL, V64, P1317, DOI 10.1016/0002-9149(89)90574-2
   Vijayalakshmi K, 2006, AM HEART J, V151, DOI 10.1016/j.ahj.2005.09.009
   Villani G Q, 2000, Am Heart J, V140, pe12
   Vranckx P, 2018, AM HEART J, V196, P105, DOI 10.1016/j.ahj.2017.10.009
   Wachtell K, 2005, J AM COLL CARDIOL, V45, P712, DOI 10.1016/j.jacc.2004.10.068
   Wang TJ, 2004, JAMA-J AM MED ASSOC, V292, P2471, DOI 10.1001/jama.292.20.2471
   Wang TJ, 2003, JAMA-J AM MED ASSOC, V290, P1049, DOI 10.1001/jama.290.8.1049
   Whitlock R, 2014, ANN CARDIOTHORAC SUR, V3, P45, DOI 10.3978/j.issn.2225-319X.2013.12.06
   Wilber DJ, 2010, JAMA-J AM MED ASSOC, V303, P333, DOI 10.1001/jama.2009.2029
   Winkelmayer WC, 2011, CLIN J AM SOC NEPHRO, V6, P2662, DOI 10.2215/CJN.04550511
   Wizemann V, 2010, KIDNEY INT, V77, P1098, DOI 10.1038/ki.2009.477
   Wyse DG, 2002, NEW ENGL J MED, V347, P1825, DOI 10.1056/nejmoa021328
   Yamashita Y, 2016, CHEST, V149, P401, DOI 10.1378/chest.15-1095
   Yang PS, 2018, KOREAN CIRC J, V48, P635, DOI [10.4070/kcj.2018.0116, 10.4070/kcj.2018.0094]
   Yang PS, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25111-6
   Yap KB, 2008, J ELECTROCARDIOL, V41, P94, DOI 10.1016/j.jelectrocard.2007.03.012
   Yoon M, 2018, THROMB HAEMOSTASIS, V118, P1296, DOI 10.1055/s-0038-1651482
   Yu HT, 2018, STROKE, V49, P2421, DOI 10.1161/STROKEAHA.118.021387
   Yu HT, 2018, CIRC J, V82, P652, DOI 10.1253/circj.CJ-17-0669
   Ziolo MT, 2015, J CARDIOVASC ELECTR, V26, P223, DOI 10.1111/jce.12560
   Zulkifly H, 2018, HEART RHYTHM, V15, P615, DOI 10.1016/j.hrthm.2017.11.026
   Zulkifly H, 2017, AM J CARDIOL, V120, P1139, DOI 10.1016/j.amjcard.2017.06.058
NR 305
TC 40
Z9 40
U1 3
U2 16
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD DEC
PY 2018
VL 48
IS 12
BP 1033
EP 1080
DI 10.4070/kcj.2018.0339
PG 48
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA HB0WL
UT WOS:000450739200001
PM 30403013
OA Green Published
DA 2021-04-22
ER

PT J
AU Oh, IY
   Cha, MJ
   Lee, TH
   Seo, JW
   Oh, S
AF Oh, Il-Young
   Cha, Myung-Jin
   Lee, Tae-Hui
   Seo, Jeong-Wook
   Oh, Seil
TI Unsolved Questions on the Anatomy of the Ventricular Conduction System
SO KOREAN CIRCULATION JOURNAL
LA English
DT Review
DE Heart conduction system; Purkinje fibers; Tachycardia, ventricular;
   Myocardial infarction
ID STRUCTURAL HEART-DISEASE; CATHETER ABLATION; PURKINJE NETWORK;
   DISCOVERY; TACHYCARDIA; TOMOGRAPHY
AB We reviewed the anatomical characteristics of the conduction system in the ventricles of human and ungulate hearts and then raised some questions to be answered by clinical and anatomical studies in the future. The ventricular conduction system is a 3-dimensional structure as compared to the 2-dimensional character of the atrial conduction system. The proximal part consisting of the atrioventricular node, the bundle of His and fascicles are groups of conducting cells surrounded by fibrous connective tissue so as to insulate from the underlying myocardium. Their location and morphological characters are well established. The bundle of His is a cord like structure but the left and right fascicles are broad at the proximal and branching at the distal part. The more distal part of fascicles and Purkinje system are linear networks of conducting cells at the immediate subendocardium but the intra-mural network is detected at the inner half of the ventricular wall. The papillary muscle also harbors Purkinje system not in the deeper part. It is hard to recognize histologically in human hearts but conducting cells as well as Purkinje cells are easily recognized in ungulate hearts. Further observation on human and ungulate hearts with myocardial infarct, we could find preserved Purkinje system at the subendocardium in contrast to the damaged system at the deeper myocardium. Further studies are necessary on the anatomical characteristics of this peripheral conduction system so as to correlate the clinical data on hearts with ventricular arrhythmias.
C1 [Oh, Il-Young] Seoul Natl Univ, Bundang Hosp, Coll Med, Dept Internal Med, Seongnam, South Korea.
   [Cha, Myung-Jin; Oh, Seil] Seoul Natl Univ Hosp, Dept Internal Med, Div Cardiol, Seoul, South Korea.
   [Lee, Tae-Hui] Mediplex Sejong Hosp, Dept Pathol, Incheon, South Korea.
   [Seo, Jeong-Wook] Seoul Natl Univ, Coll Med, Dept Pathol, 103 Daehak Ro, Seoul 03080, South Korea.
RP Seo, JW (corresponding author), Seoul Natl Univ, Coll Med, Dept Pathol, 103 Daehak Ro, Seoul 03080, South Korea.
EM jwseo@snu.ac.kr
RI Oh, Seil/J-5539-2012
OI Oh, Seil/0000-0002-2504-9615; Cha, Myung-Jin/0000-0001-6180-0157; Lee,
   Tae Hui/0000-0002-7630-5455; Seo, Jeong-Wook/0000-0003-0242-1805
FU Woochon Cardio-Neuro Vascular Research Foundation
FX This work was supported by a grant (2018) from the Woochon Cardio-Neuro
   Vascular Research Foundation.
CR Ansari A, 1999, ANAT REC, V254, P92, DOI 10.1002/(SICI)1097-0185(19990101)254:1<92::AID-AR12>3.0.CO;2-3
   Assomull RG, 2006, J AM COLL CARDIOL, V48, P1977, DOI 10.1016/j.jacc.2006.07.049
   BHARATI S, 1992, PACE, V15, P1291, DOI 10.1111/j.1540-8159.1992.tb03140.x
   Cho Y, 2012, EUROPACE, V14, P1104, DOI 10.1093/europace/eus051
   DAVIES MJ, 1971, PATHOLOGY CONDUCTING
   De Almeida MC, 2015, ANAT SCI INT, V90, P240, DOI 10.1007/s12565-014-0255-9
   Deo M, 2010, AM J PHYSIOL-HEART C, V299, pH1002, DOI 10.1152/ajpheart.01237.2009
   Dong J, 2007, Herzschrittmacherther Elektrophysiol, V18, P122, DOI 10.1007/s00399-007-0571-z
   Dukkipati SR, 2017, J AM COLL CARDIOL, V70, P2924, DOI 10.1016/j.jacc.2017.10.030
   Garcia-Bustos V, 2017, J ANAT, V230, P664, DOI 10.1111/joa.12594
   나찬영, 2002, The Korean Journal of Thoracic and Cardiovascular Surgery, V35, P1
   JACKMAN WM, 1991, NEW ENGL J MED, V324, P1605, DOI 10.1056/NEJM199106063242301
   MASSING GK, 1976, CIRCULATION, V53, P609, DOI 10.1161/01.CIR.53.4.609
   Moorman AFM, 2005, HEART RHYTHM, V2, P875, DOI 10.1016/j.hrthm.2005.04.025
   Muser D, 2017, WORLD J CARDIOL, V9, P521, DOI 10.4330/wjc.v9.i6.521
   Saffitz JE, 2016, CARDIOVASC PATHOL, V25, P149, DOI 10.1016/j.carpath.2015.11.005
   Seo JW, 2010, INT J ARRHYTHM, V11, P6
   Seo JW, 1983, KOREAN J PATHOL, V17, P127
   Silverman ME, 2007, HEART, V93, P1184, DOI 10.1136/hrt.2006.105049
   Silverman ME, 2006, CIRCULATION, V113, P2775, DOI 10.1161/CIRCULATIONAHA.106.616771
   Tawara S., 2000, CONDUCTION SYSTEM MA
NR 21
TC 5
Z9 5
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD DEC
PY 2018
VL 48
IS 12
BP 1081
EP 1096
DI 10.4070/kcj.2018.0335
PG 16
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA HB0WL
UT WOS:000450739200002
PM 30403014
OA Green Published
DA 2021-04-22
ER

PT J
AU Reiner, Z
AF Reiner, Zeljko
TI Triglyceride-Rich Lipoproteins and Novel Targets for
   Anti-atherosclerotic Therapy
SO KOREAN CIRCULATION JOURNAL
LA English
DT Review
DE Triglycerides; Cardiovascular diseases; Fibrates; Omega-3 fatty acids;
   Volanesorsen
ID CORONARY-HEART-DISEASE; TYPE-2 DIABETES-MELLITUS; APOLIPOPROTEIN C-III;
   ATHEROSCLEROTIC CARDIOVASCULAR-DISEASE; BEZAFIBRATE INFARCTION
   PREVENTION; GENOME-WIDE ASSOCIATION; STATIN-TREATED PATIENTS; RESIDUAL
   VASCULAR RISK; MODULATOR SPPARM-ALPHA; ALL-CAUSE MORTALITY
AB Although elevated serum low-density lipoprotein-cholesterol (LDL-C) is without any doubts accepted as an important risk factor for cardiovascular disease (CVD), the role of elevated triglycerides (TGs)-rich lipoproteins as an independent risk factor has until recently been quite controversial. Recent data strongly suggest that elevated TG-rich lipoproteins are an independent risk factor for CVD and that therapeutic targeting of them could possibly provide further benefit in reducing CVD morbidity, events and mortality, apart from LDL-C lowering. Today elevated TGs are treated with lifestyle interventions, and with fibrates which could be combined with omega-3 fatty acids. There are also some new drugs. Volanesorsen, is an antisense oligonucleotid that inhibits the production of the Apo C-III which is crucial in regulating TGs metabolism because it inhibits lipoprotein lipase (LPL) and hepatic lipase activity but also hepatic uptake of TGs-rich particles. Evinacumab is a monoclonal antibody against angiopoietin-like protein 3 (ANGPTL3) and it seems that it can substantially lower elevated TGs levels because ANGPTL3 also regulates TGs metabolism. Pemafibrate is a selective peroxisome proliferator-activated receptor alpha modulator which also decreases TGs, and improves other lipid parameters. It seems that it also has some other possible antiatherogenic effects. Alipogene tiparvovec is a nonreplicating adeno-associated viral vector that delivers copies of the LPL gene to muscle tissue which accelerates the clearance of TG-rich lipoproteins thus decreasing extremely high TGs levels. Pradigastat is a novel diacylglycerol acyltransferase 1 inhibitor which substantially reduces extremely high TGs levels and appears to be promising in treatment of the rare familial chylomicronemia syndrome.
C1 [Reiner, Zeljko] Univ Zagreb, Univ Hosp, Ctr Zagreb, Sch Med,Dept Internal Med, Kispaticeva 12, Zagreb 10000, Croatia.
RP Reiner, Z (corresponding author), Univ Zagreb, Univ Hosp, Ctr Zagreb, Sch Med,Dept Internal Med, Kispaticeva 12, Zagreb 10000, Croatia.
EM zreiner@kbc-zagreb.hr
CR Abdelhamid AS, 2018, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003177.pub3
   Aguiar C, 2015, ATHEROSCLEROSIS SUPP, V19, DOI 10.1016/S1567-5688(15)30001-5
   Alaupovic P, 1997, ARTERIOSCL THROM VAS, V17, P715, DOI 10.1161/01.ATV.17.4.715
   American City Business Journals, 2016, LANDM TRIAL ENT PROM
   Arai H, 2018, J ATHEROSCLER THROMB, V25, P521, DOI 10.5551/jat.44412
   Arca M, 2018, EXPERT REV CARDIOVAS, V16, P537, DOI 10.1080/14779072.2018.1487290
   Ariza MJ, 2018, J CLIN LIPIDOL
   ASCEND Study Collaborative Group, 2018, N ENGL J MED
   Austin MA, 2003, J LIPID RES, V44, P2161, DOI 10.1194/jlr.M300272-JLR200
   Bajaj M, 2007, DIABETOLOGIA, V50, P1723, DOI 10.1007/s00125-007-0698-9
   Baldi S, 2013, DIABETES CARE, V36, P4125, DOI 10.2337/dc13-0682
   Beigneux AP, 2007, CELL METAB, V5, P279, DOI 10.1016/j.cmet.2007.02.002
   Bhatt DL, 2017, CLIN CARDIOL, V40, P138, DOI 10.1002/clc.22692
   Black RNA, 2014, J DIABETES COMPLICAT, V28, P323, DOI 10.1016/j.jdiacomp.2014.01.001
   Carbajo MA, 2017, SURG ENDOSC, V31, P416, DOI 10.1007/s00464-016-4990-y
   Carey VJ, 2010, AM J CARDIOL, V106, P757, DOI 10.1016/j.amjcard.2010.05.002
   Catapano AL, 2016, EUR HEART J, V37, P2999, DOI 10.1093/eurheartj/ehw272
   Caussy C, 2016, ATHEROSCLEROSIS, V246, P280, DOI 10.1016/j.atherosclerosis.2016.01.010
   Chadwick AC, 2018, CIRCULATION, V137, P975, DOI 10.1161/CIRCULATIONAHA.117.031335
   Chapman MJ, 2011, EUR HEART J, V32, P1345, DOI 10.1093/eurheartj/ehr112
   Chun S, 2016, AM HEART J, V177, P17, DOI 10.1016/j.ahj.2016.03.018
   Climie RE, 1985, J APPL PHYSL
   Cohen DE, 2013, SEMIN LIVER DIS, V33, P380, DOI 10.1055/s-0033-1358519
   Crosby J, 2014, NEW ENGL J MED, V371, P22, DOI 10.1056/NEJMoa1307095
   Dallinga-Thie GM, 2016, CURR CARDIOL REP, V18, DOI 10.1007/s11886-016-0745-6
   DATTILO AM, 1992, AM J CLIN NUTR, V56, P320
   Davidson M, 2018, J CLIN LIPIDOL, V12, P898, DOI 10.1016/j.jacl.2018.04.009
   De Backer G, 2015, ATHEROSCLEROSIS, V241, P169, DOI 10.1016/j.atherosclerosis.2015.04.809
   de Koning L, 2012, CIRCULATION, V125, P1735, DOI 10.1161/CIRCULATIONAHA.111.067017
   Dewey FE, 2017, NEW ENGL J MED, V377, P211, DOI 10.1056/NEJMoa1612790
   Dewey FF, 2016, NEW ENGL J MED, V374, P1123, DOI 10.1056/NEJMoa1510926
   Di Angelantonio E, 2009, JAMA-J AM MED ASSOC, V302, P1993, DOI 10.1001/jama.2009.1619
   Do R, 2013, NAT GENET, V45, P1345, DOI 10.1038/ng.2795
   Egeland GM, 2015, EUR J PREV CARDIOL, V22, P872, DOI 10.1177/2047487314535681
   Faergeman O, 2009, AM J CARDIOL, V104, P459, DOI 10.1016/j.amjcard.2009.04.008
   Fayyad R, 2018, CIRCULATION
   Ferrari R, 2016, EUR HEART J SUPPL, V18, pC2, DOI 10.1093/eurheartj/suw009
   FRICK MH, 1987, NEW ENGL J MED, V317, P1237, DOI 10.1056/NEJM198711123172001
   Fruchart JC, 2001, PHARMACOL RES, V44, P345, DOI 10.1006/phrs.2001.0871
   Fruchart JC, 2013, CARDIOVASC DIABETOL, V12, DOI 10.1186/1475-2840-12-82
   Fruchart JC, 2008, DIABETES VASC DIS RE, V5, P319, DOI 10.3132/dvdr.2008.046
   Fruchart JC, 2008, AM J CARDIOL, V102, p1K, DOI [10.1016/j.amjcard.2008.10.002, 10.1016/S0002-9149(08)01833-X]
   Gaudet D, 2017, NEW ENGL J MED, V377, P296, DOI 10.1056/NEJMc1705994
   Gaudet D, 2016, HUM GENE THER, V27, P916, DOI 10.1089/hum.2015.158
   Gaudet D, 2015, NEW ENGL J MED, V373, P438, DOI 10.1056/NEJMoa1400283
   Germano G, 2012, EUR HEART J, V33, P137
   Ginsberg HN, 2011, DIABETES CARE, V34, pS107, DOI 10.2337/dc11-s203
   Ginsberg HN, 2010, NEW ENGL J MED, V362, P1563, DOI 10.1056/NEJMoa1001282
   Ginsberg HN, 2002, CIRCULATION, V106, P2137, DOI 10.1161/01.CIR.0000035280.64322.31
   Goff DC, 2014, CIRCULATION, V129, pS49, DOI 10.1161/01.cir.0000437741.48606.98
   GOLDBERG IJ, 1990, J BIOL CHEM, V265, P4266
   GOLDSTEIN JL, 1973, J CLIN INVEST, V52, P1544, DOI 10.1172/JCI107332
   Goulbourne CN, 2014, CELL METAB, V19, P849, DOI 10.1016/j.cmet.2014.01.017
   Graham I, 2012, CURR CARDIOL REP, V14, P709, DOI 10.1007/s11886-012-0313-7
   Graham MJ, 2017, NEW ENGL J MED, V377, P222, DOI 10.1056/NEJMoa1701329
   Graham MJ, 2013, CIRC RES, V112, P1479, DOI 10.1161/CIRCRESAHA.111.300367
   Gronholdt MLM, 1996, STROKE, V27, P2166, DOI 10.1161/01.STR.27.12.2166
   Hansen D, 2018, SPORTS MED, V48, P1781, DOI 10.1007/s40279-018-0930-4
   Harmer JA, 2018, DIABETES RES CLIN PR, V141, P156, DOI 10.1016/j.diabres.2018.05.006
   Hegele RA, 2014, LANCET DIABETES ENDO, V2, P655, DOI 10.1016/S2213-8587(13)70191-8
   Hennuyer N, 2016, ATHEROSCLEROSIS, V249, P200, DOI 10.1016/j.atherosclerosis.2016.03.003
   Hokanson J E, 1996, J Cardiovasc Risk, V3, P213, DOI 10.1097/00043798-199604000-00014
   Holmes MV, 2015, EUR HEART J, V36, P539, DOI 10.1093/eurheartj/eht571
   Huff MW, 2013, CIRC RES, V112, P1405, DOI 10.1161/CIRCRESAHA.113.301464
   HULLEY SB, 1980, NEW ENGL J MED, V302, P1383, DOI 10.1056/NEJM198006193022503
   Hussain MM, 2014, CURR OPIN LIPIDOL, V25, P200, DOI 10.1097/MOL.0000000000000084
   Ishibashi S, 2016, ATHEROSCLEROSIS, V249, P36, DOI 10.1016/j.atherosclerosis.2016.02.029
   Iso H, 2014, ATHEROSCLEROSIS, V237, P361, DOI 10.1016/j.atherosclerosis.2014.08.028
   Jacobson TA, 2014, J CLIN LIPIDOL, V8, P473, DOI 10.1016/j.jacl.2014.07.007
   Johansen CT, 2011, ARTERIOSCL THROM VAS, V31, P1916, DOI 10.1161/ATVBAHA.111.226365
   Johansen CT, 2010, NAT GENET, V42, P684, DOI 10.1038/ng.628
   Jorgensen AB, 2013, EUR HEART J, V34, P1826, DOI 10.1093/eurheartj/ehs431
   Joshi PH, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.115.002765
   Jun M, 2010, LANCET, V375, P1875, DOI 10.1016/S0140-6736(10)60656-3
   Karlson BW, 2016, AM J CARDIOL, V117, P1444, DOI 10.1016/j.amjcard.2016.02.011
   Kastelein JJP, 2016, CARDIOLOGY, V135, P3, DOI 10.1159/000445047
   Keech A, 2005, LANCET, V366, P1849, DOI 10.1016/S0140-6736(05)67667-2
   Kersten S, 2014, BBA-MOL CELL BIOL L, V1841, P919, DOI 10.1016/j.bbalip.2014.03.013
   Kieffer SK, 2018, MAYO CLIN PROC, V93, P1191, DOI 10.1016/j.mayocp.2018.03.029
   Kim EH, 2015, CARDIOLOGY, V131, P228, DOI 10.1159/000380941
   Klempfner R, 2016, CIRC-CARDIOVASC QUAL, V9, P100, DOI 10.1161/CIRCOUTCOMES.115.002104
   Kodama S, 2018, CLIN NUTR ESPEN, V27, P53, DOI 10.1016/j.clnesp.2018.07.001
   Kotwal S, 2012, CIRC-CARDIOVASC QUAL, V5, P808, DOI 10.1161/CIRCOUTCOMES.112.966168
   Kurano M, 2016, J HUM GENET, V61, P427, DOI 10.1038/jhg.2015.170
   Li Y, 2016, META GENE, V9, P104, DOI 10.1016/j.mgene.2016.04.004
   Lind L, 2018, METAB SYNDR RELAT D, V16, P433, DOI 10.1089/met.2018.0058
   Liu J, 2012, DIABETES RES CLIN PR, V96, P217, DOI 10.1016/j.diabres.2011.12.018
   Liu ZM, 2015, EXPERT OPIN INV DRUG, V24, P611, DOI 10.1517/13543784.2015.1006359
   Makoveichuk E, 2012, BIOCHEM BIOPH RES CO, V425, P138, DOI 10.1016/j.bbrc.2012.07.048
   Matsuba I, 2018, J DIABETES INVESTIG
   MDText. com Inc, 2000, ENDOTEXT
   Mehta N, 2014, ARTERIOSCL THROM VAS, V34, P1057, DOI 10.1161/ATVBAHA.113.302802
   Meyers CD, 2015, LIPIDS HEALTH DIS, V14, DOI 10.1186/s12944-015-0006-5
   Millan J, 2018, CLIN INVEST ARTERIOS, V30, P30, DOI 10.1016/j.arteri.2017.11.001
   Miller M, 2008, J AM COLL CARDIOL, V51, P724, DOI 10.1016/j.jacc.2007.10.038
   Miller M, 2011, CIRCULATION, V123, P2292, DOI 10.1161/CIR.0b013e3182160726
   Mosca L, 2017, AM J CARDIOL, V119, P397, DOI 10.1016/j.amjcard.2016.10.027
   Moulin P, 2018, ATHEROSCLEROSIS, V275, P265, DOI 10.1016/j.atherosclerosis.2018.06.814
   Nelson SD, 2013, ANN PHARMACOTHER, V47, P1517, DOI 10.1177/1060028013504079
   Nicholls SJ, 2018, CLIN CARDIOL
   Nichols GA, 2018, DIABETES OBES METAB
   Norata GD, 2015, TRENDS PHARMACOL SCI, V36, P675, DOI 10.1016/j.tips.2015.07.001
   Nordestgaard BG, 2007, JAMA-J AM MED ASSOC, V298, P299, DOI 10.1001/jama.298.3.299
   Nordestgaard BG, 2016, CIRC RES, V118, P547, DOI 10.1161/CIRCRESAHA.115.306249
   Nordestgaard BG, 2014, LANCET, V384, P626, DOI 10.1016/S0140-6736(14)61177-6
   Nordmann AJ, 2006, ARCH INTERN MED, V166, P285, DOI 10.1001/archinte.166.3.285
   Patel L, 2018, NUTRIENTS, V10, DOI 10.3390/nu10091261
   Pecin I, 2016, DRUG FUTURE, V41, P417, DOI 10.1358/dof.2016.041.07.2485368
   Puri R, 2016, ARTERIOSCL THROM VAS, V36, P2220, DOI 10.1161/ATVBAHA.116.307601
   Ray KK, 2014, EUR HEART J, V35, P960, DOI 10.1093/eurheartj/ehu107
   Reiner Z, 2013, NUTR METAB CARDIOVAS, V23, P799, DOI 10.1016/j.numecd.2013.05.002
   Reiner Z, 2018, EUR J PREV CARDIOL, V25, P1095, DOI 10.1177/2047487318781360
   Reiner Z, 2015, NAT REV CARDIOL, V12, P565, DOI 10.1038/nrcardio.2015.92
   Reiner Z, 2014, CIRC RES, V114, P233, DOI 10.1161/CIRCRESAHA.113.302952
   Reiner Z, 2013, ATHEROSCLEROSIS, V231, P300, DOI 10.1016/j.atherosclerosis.2013.09.020
   Reiner Z, 2013, NAT REV CARDIOL, V10, P453, DOI 10.1038/nrcardio.2013.80
   Reiner Z, 2011, EUR HEART J, V32, P1769, DOI [10.1093/eurheartj/ehr158, 10.1016/j.atherosclerosis.2011.06.012]
   Reiner Z, 2010, FUND CLIN PHARMACOL, V24, P19, DOI 10.1111/j.1472-8206.2009.00764.x
   Robins SJ, 2001, JAMA-J AM MED ASSOC, V285, P1585, DOI 10.1001/jama.285.12.1585
   Romeo S, 2007, NAT GENET, V39, P513, DOI 10.1038/ng1984
   Sacks FM, 2014, CIRCULATION, V129, P999, DOI 10.1161/CIRCULATIONAHA.113.002529
   Saeed A, 2018, J AM COLL CARDIOL, V72, P156, DOI 10.1016/j.jacc.2018.04.050
   Sahebkar A, 2018, ANN MED, V1-22
   Sahebkar A, 2018, J CLIN LIPIDOL, V12, P801, DOI 10.1016/j.jacl.2018.01.008
   Sahebkar A, 2016, CURR MED CHEM, V23, P4490, DOI 10.2174/0929867323666161007155310
   Sarwar N, 2007, CIRCULATION, V115, P450, DOI 10.1161/CIRCULATIONAHA.106.637793
   Sarwar N, 2010, LANCET, V375, P1634, DOI 10.1016/S0140-6736(10)60545-4
   Schlein C, 2016, CELL METAB, V23, P441, DOI 10.1016/j.cmet.2016.01.006
   Schlesinger Z, 2000, CIRCULATION, V102, P21, DOI 10.1161/01.CIR.102.1.21
   Schoonjans K, 1996, EMBO J, V15, P5336, DOI 10.1002/j.1460-2075.1996.tb00918.x
   Schwartz GG, 2015, J AM COLL CARDIOL, V65, P2267, DOI 10.1016/j.jacc.2015.03.544
   Shiochi H, 2014, DIABETOL METAB SYNDR, V6, DOI 10.1186/1758-5996-6-113
   Simic I, 2015, CURR PHARM DESIGN, V21, P1220, DOI 10.2174/1381612820666141013134447
   Stanhope KL, 2009, J CLIN INVEST, V119, P1322, DOI 10.1172/JCI37385
   Stanhope KL, 2008, AM J CLIN NUTR, V88, p1733S, DOI 10.3945/ajcn.2008.25825D
   Stitziel NO, 2016, NEW ENGL J MED, V374, P1134, DOI 10.1056/NEJMoa1507652
   Surendran RP, 2012, J INTERN MED, V272, P185, DOI 10.1111/j.1365-2796.2012.02516.x
   Thomsen M, 2014, CLIN CHEM, V60, P737, DOI 10.1373/clinchem.2013.219881
   TVERDAL A, 1989, AM J EPIDEMIOL, V129, P458, DOI 10.1093/oxfordjournals.aje.a115157
   Vanhees L, 2012, EUR J PREV CARDIOL, V19, P670, DOI 10.1177/2047487312437059
   Varbo A, 2013, J AM COLL CARDIOL, V61, P427, DOI 10.1016/j.jacc.2012.08.1026
   Vatner DF, 2018, DIABETOLOGIA, V61, P1435, DOI 10.1007/s00125-018-4579-1
   Veerkamp MJ, 2002, ARTERIOSCL THROM VAS, V22, P274, DOI 10.1161/hq0202.104059
   Wang H, 2009, AM J PHYSIOL-ENDOC M, V297, pE271, DOI 10.1152/ajpendo.90920.2008
   Yamashita S, 2018, J CLIN LIPIDOL, V12, P1267, DOI 10.1016/j.jacl.2018.06.010
   Yang XH, 2016, J LIPID RES, V57, P706, DOI 10.1194/jlr.M066399
NR 146
TC 4
Z9 5
U1 0
U2 5
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD DEC
PY 2018
VL 48
IS 12
BP 1097
EP 1119
DI 10.4070/kcj.2018.0343
PG 23
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA HB0WL
UT WOS:000450739200003
PM 30403015
OA Green Published
DA 2021-04-22
ER

PT J
AU Lee, DS
   Jung, YW
AF Lee, Dong Seok
   Jung, Yong Wook
TI Protective Effect of Right Ventricular Mitochondrial Damage by
   Cyclosporine A in Monocrotaline-induced Pulmonary Hypertension
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Pulmonary circulation; Pulmonary hypertension; Heart ventricles;
   Mitochondria
ID PERMEABILITY TRANSITION PORE; ARTERIAL-HYPERTENSION;
   MYOCARDIAL-INFARCTION; CELL-DEATH; APOPTOSIS; INJURY; HEART;
   REPERFUSION; DYSFUNCTION; FAILURE
AB Background and Objectives: Mitochondria play a key role in the pathophysiology of heart failure and mitochondria! permeability transition pore (MPTP) play a critical role in cell death and a critical target for cardioprotection. The aim of this study was to evaluate the protective effects of cyclosporine A (CsA), one of MPTP blockers, and morphological changes of mitochondria and MPTP related proteins in monocrotaline (MCT) induced pulmonary arterial hypertension (PAH).
   Methods: Eight weeks old Sprague-Dawley rats were randomized to control, MCT (60 mg/ kg) and MCT plus CsA (10 mg/kg/day) treatment groups. Four weeks later, right ventricular hypertrophy (RVH) and morphological changes of right ventricle (RV) were done. Western blot and reverse transcription polymerase chain reaction (RT-PCR) for MPTP related protein were performed.
   Results: In electron microscopy, CsA treatment prevented MCT-induced mitochondrial disruption of RV. RVH was significantly increased in MCT group compared to that of the controls but RVH was more increased with CsA treatment. Thickened medial wall thickness of pulmonary arteriole in PAH was not changed after CsA treatment. In western blot, caspase-3 was significantly increased in MCT group, and was attenuated in CsA treatment. There were no significant differences in voltage-dependent anion channel, adenine nucleotide translocator 1 and cyclophilin D expression in western blot and RT-PCR between the 3 groups.
   Conclusions: CsA reduces MCT induced RV mitochondrial damage. Although, MPTP blocking does not reverse pulmonary pathology, it may reduce RV dysfunction in PAH. The results suggest that it could serve as an adjunctive therapy to PAH treatment.
C1 [Lee, Dong Seok] Dongguk Univ, Dept Pediat, Sch Med, 87 Dongdae Ro, Gyeongju 38067, South Korea.
   [Jung, Yong Wook] Dongguk Univ, Dept Anat, Sch Med, Gyeongju, South Korea.
RP Lee, DS (corresponding author), Dongguk Univ, Dept Pediat, Sch Med, 87 Dongdae Ro, Gyeongju 38067, South Korea.
EM lds117@dongguk.ac.kr
FU Korean Society of Circulation; Dongguk University
FX This work was financially supported by the grant of The Korean Society
   of Circulation in 2011 and the research fund from Dongguk University.
CR Bach PH, 2013, NEPHROTOXICITY IN VI, P707
   Baines CP, 2005, NATURE, V434, P658, DOI 10.1038/nature03434
   Campian ME, 2009, J NUCL MED, V50, P1371, DOI 10.2967/jnumed.108.061366
   Cregan SP, 2004, ONCOGENE, V23, P2785, DOI 10.1038/sj.onc.1207517
   CROMPTON M, 1988, EUR J BIOCHEM, V178, P489, DOI 10.1111/j.1432-1033.1988.tb14475.x
   Daicho T, 2009, J PHARMACOL SCI, V111, P33, DOI 10.1254/jphs.08322FP
   Ghaffari S, 2013, CARDIOVASC THER, V31, pE34, DOI 10.1111/1755-5922.12010
   Gomez L, 2009, CARDIOVASC RES, V83, P226, DOI 10.1093/cvr/cvp063
   GRIFFITHS EJ, 1995, BIOCHEM J, V307, P93, DOI 10.1042/bj3070093
   Halestrap AP, 2015, J MOL CELL CARDIOL, V78, P129, DOI 10.1016/j.yjmcc.2014.08.018
   Halestrap AP, 2009, J MOL CELL CARDIOL, V46, P821, DOI 10.1016/j.yjmcc.2009.02.021
   Hausenloy DJ, 2012, BRIT J PHARMACOL, V165, P1235, DOI 10.1111/j.1476-5381.2011.01700.x
   HAWORTH RA, 1979, ARCH BIOCHEM BIOPHYS, V195, P460, DOI 10.1016/0003-9861(79)90372-2
   Hong YM, 2014, KOREAN CIRC J, V44, P97, DOI 10.4070/kcj.2014.44.2.97
   Humbert M, 2004, J AM COLL CARDIOL, V43, p13S, DOI 10.1016/j.jacc.2004.02.029
   Kinnally KW, 2011, BBA-MOL CELL RES, V1813, P616, DOI 10.1016/j.bbamcr.2010.09.013
   Kwong JQ, 2015, CELL METAB, V21, P206, DOI 10.1016/j.cmet.2014.12.001
   Lee SH, 2005, J INTERN MED, V258, P199, DOI 10.1111/j.1365-2796.2005.01542.x
   Lim SY, 2011, J CELL MOL MED, V15, P2443, DOI 10.1111/j.1582-4934.2010.01235.x
   Lim WY, 2012, BRIT J PHARMACOL, V165, P2034, DOI 10.1111/j.1476-5381.2011.01691.x
   Martin KB, 2006, RESPIROLOGY, V11, P6, DOI 10.1111/j.1440-1843.2006.00778.x
   Piot C, 2008, NEW ENGL J MED, V359, P473, DOI 10.1056/NEJMoa071142
   Ramachandran A, 2011, FREE RADICAL RES, V45, P156, DOI 10.3109/10715762.2010.520319
   Rosca MG, 2013, HEART FAIL REV, V18, P607, DOI 10.1007/s10741-012-9340-0
   Sheu JJ, 2011, INT J CARDIOL, V147, P79, DOI 10.1016/j.ijcard.2009.08.008
   Voelkel NF, 2011, COMPR PHYSIOL, V1, P525, DOI 10.1002/cphy.c090008
   Zungu-Edmondson M, 2016, CARDIOVASC RES, V110, P30, DOI 10.1093/cvr/cvw014
   Zuo XR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044485
NR 28
TC 6
Z9 6
U1 0
U2 3
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD DEC
PY 2018
VL 48
IS 12
BP 1135
EP 1144
DI 10.4070/kcj.2018.0061
PG 10
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA HB0WL
UT WOS:000450739200006
PM 30403017
OA Green Published
DA 2021-04-22
ER

PT J
AU Lee, JY
   Sunwoo, JS
   Kwon, KY
   Roh, H
   Ahn, MY
   Lee, MH
   Park, BW
   Hyon, MS
   Lee, KB
AF Lee, Jeong-Yoon
   Sunwoo, Jun-Sang
   Kwon, Kyum-Yil
   Roh, Hakjae
   Ahn, Moo-Young
   Lee, Min-Ho
   Park, Byoung-Won
   Hyon, Min Su
   Lee, Kyung Bok
TI Left Ventricular Ejection Fraction Predicts Poststroke Cardiovascular
   Events and Mortality in Patients without Atrial Fibrillation and
   Coronary Heart Disease
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Echocardiography; Stroke; Left ventricular function; Mortality
ID ACUTE ISCHEMIC-STROKE; SYSTOLIC DYSFUNCTION; CEREBRAL INFARCTION;
   FAILURE; RISK; REGISTRY; ASSOCIATION; CARDIOLOGY; STATEMENT; COMMUNITY
AB Background and Objectives: It is controversial that decreased left ventricular function could predict poststroke outcomes. The purpose of this study is to elucidate whether left ventricular ejection fraction (LVEF) can predict cardiovascular events and mortality in acute ischemic stroke (AIS) without atrial fibrillation (AF) and coronary heart disease (CHD).
   Methods: Transthoracic echocardiography was conducted consecutively in patients with AIS or transient ischemic attack at Soonchunhyang University Hospital between January 2008 and July 2016. The clinical data and echocardiographic LVEF of 1,465 patients were reviewed after excluding AF and CHD. Poststroke disability, major adverse cardiac events (MACE; nonfatal stroke, nonfatal myocardial infarction, and cardiovascular death) and all-cause mortality during 1 year after index stroke were prospectively captured. Cox proportional hazards regressions analysis were applied adjusting traditional risk factors and potential determinants.
   Results: The mean follow-up time was 259.9 +/- 148.8 days with a total of 29 non-fatal strokes, 3 myocardial infarctions, 33 cardiovascular deaths, and 53 all-cause mortality. The cumulative incidence of MACE and all-cause mortality were significantly higher in the lowest LVEF (<55) group compared with the others (p=0.022 and 0.009). In prediction models, LVEF (per 10%) had hazards ratios of 0.54 (95% confidence interval [CI], 0.36-0.80, p=0.002) for MACE and 0.61 (95% CI, 0.39-0.97, p=0.037) for all-cause mortality.
   Conclusions: LVEF could be an independent predictor of cardiovascular events and mortality after AIS ill the absence of AF and CHD.
C1 [Lee, Jeong-Yoon; Sunwoo, Jun-Sang; Kwon, Kyum-Yil; Roh, Hakjae; Ahn, Moo-Young; Lee, Kyung Bok] Soonchunhyang Univ, Dept Neurol, Sch Med, Seoul, South Korea.
   [Lee, Min-Ho; Park, Byoung-Won; Hyon, Min Su] Soonchunhyang Univ, Dept Cardiol, Sch Med, Seoul, South Korea.
RP Lee, KB (corresponding author), Soonchunhyang Univ, Sch Med, Seoul Hosp, Dept Neurol, 59 Daesagwan Ro, Seoul 04401, South Korea.
EM kblee@schmc.ac.kr
RI Lee, Minho/AAJ-6477-2020
OI Lee, Minho/0000-0003-0748-7766; Lee, Jeong-Yoon/0000-0002-4297-1791;
   Kwon, Kyum-Yil/0000-0001-5443-0952; Sunwoo, Jun-Sang/0000-0001-8834-0568
FU CJ Healthcare Corp.; Soonchunhyang University Research Fund
FX This study was supported by 1) CJ Healthcare Corp. and 2) Soonchunhyang
   University Research Fund.
CR Adams RJ, 2003, CIRCULATION, V108, P1278, DOI 10.1161/01.CIR.0000090444.87006.CF
   Altman DG, 2006, BRIT MED J, V332, P1080, DOI 10.1136/bmj.332.7549.1080
   Appelros P, 2002, STROKE, V33, P2357, DOI 10.1161/01.STR.0000030318.99727.FA
   BAMFORD J, 1990, J NEUROL NEUROSUR PS, V53, P16, DOI 10.1136/jnnp.53.1.16
   Brockel U, 1996, J AM COLL CARDIOL  S, V27, P25
   Cherian TS, 2017, AM J CARDIOL, V119, P1763, DOI 10.1016/j.amjcard.2017.02.050
   Colivicchi F, 2004, STROKE, V35, P2094, DOI 10.1161/01.STR.0000138452.81003.4c
   Cuadrado-Godia E, 2010, CURR CARDIOL REV, V6, P202, DOI 10.2174/157340310791658776
   Di Tullio MR, 2016, STROKE, V47, P2031, DOI 10.1161/STROKEAHA.116.013679
   Elliott P, 2008, EUR HEART J, V29, P270, DOI 10.1093/eurheartj/ehm342
   Furie KL, 2018, STROKE, V49, P509, DOI 10.1161/STROKEAHA.118.020176
   Grau AJ, 2001, STROKE, V32, P2559, DOI 10.1161/hs1101.098524
   Hays AG, 2006, STROKE, V37, P1715, DOI 10.1161/01.STR.0000227121.34717.40
   Hicks KA, 2015, CIRCULATION, V132, P302, DOI 10.1161/CIR.0000000000000156
   Holmstrom A, 2013, BMC NEUROL, V13, DOI 10.1186/1471-2377-13-122
   Holmstrom A, 2013, INT J CARDIOL, V167, P2747, DOI 10.1016/j.ijcard.2012.06.095
   Kelly R, 1999, QJM-INT J MED, V92, P295, DOI 10.1093/qjmed/92.6.295
   Kim BJ, 2015, J STROKE, V17, P38, DOI 10.5853/jos.2015.17.1.38
   Lin HJ, 1996, STROKE, V27, P1760, DOI 10.1161/01.STR.27.10.1760
   Lip GYH, 1999, J AM COLL CARDIOL, V33, P1424
   Milionis H, 2013, INT J CARDIOL, V168, P1082, DOI 10.1016/j.ijcard.2012.11.036
   Ois A, 2008, J NEUROL, V255, P385, DOI 10.1007/s00415-008-0677-1
   PFEFFER MA, 1992, NEW ENGL J MED, V327, P669, DOI 10.1056/NEJM199209033271001
   Pullicino PM, 2000, NEUROLOGY, V54, P288, DOI 10.1212/WNL.54.2.288
   Putaala J, 2009, STROKE, V40, P2698, DOI 10.1161/STROKEAHA.109.554998
   SACCO RL, 1994, NEUROLOGY, V44, P626, DOI 10.1212/WNL.44.4.626
   Seo JY, 2014, STROKE, V45, P2757, DOI 10.1161/STROKEAHA.114.006108
   Sulter G, 1999, STROKE, V30, P1538, DOI 10.1161/01.STR.30.8.1538
   Zuccala G, 1997, J NEUROL NEUROSUR PS, V63, P509, DOI 10.1136/jnnp.63.4.509
NR 29
TC 6
Z9 7
U1 0
U2 3
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD DEC
PY 2018
VL 48
IS 12
BP 1148
EP 1156
DI 10.4070/kcj.2018.0115
PG 9
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA HB0WL
UT WOS:000450739200008
PM 30403019
OA Green Published
DA 2021-04-22
ER

PT J
AU Roh, JH
   Lee, JH
AF Roh, Jae-Hyung
   Lee, Jae-Hwan
TI Distal Radial Approach through the Anatomical Snuff Box for Coronary
   Angiography and Percutaneous Coronary Intervention
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
ID CANNULATION; ACCESS; ARTERY
C1 [Roh, Jae-Hyung; Lee, Jae-Hwan] Chungnam Natl Univ, Chungnam Natl Univ Hosp, Sch Med, Dept Internal Med,Div Cardiol, 282 Munhwa Ro, Daejeon 35015, South Korea.
RP Lee, JH (corresponding author), Chungnam Natl Univ, Chungnam Natl Univ Hosp, Sch Med, Dept Internal Med,Div Cardiol, 282 Munhwa Ro, Daejeon 35015, South Korea.
EM myheart@cnu.ac.kr
OI Lee, Jae-Hwan/0000-0002-6561-7760; Roh, Jae-Hyung/0000-0003-3675-3541
CR Deepika K, 2010, ANESTH ANALG, V111, P1078, DOI 10.1213/ANE.0b013e3181ef343a
   Jang HJ, 2016, KOREAN CIRC J, V46, P161, DOI 10.4070/kcj.2016.46.2.161
   Kiemeneij F, 2017, EUROINTERVENTION, V13, P851, DOI 10.4244/EIJ-D-17-00079
   Kim Y, 2018, KOREAN CIRC J, V48, P532, DOI [10.4070/kcj.2018.0016, 10.4070/kcj.2018.0181]
   Pua U, 2018, J VASC INTERV RADIOL, V29, P44, DOI 10.1016/j.jvir.2017.07.011
   PYLES ST, 1983, SURG GYNECOL OBSTET, V156, P227
NR 6
TC 12
Z9 12
U1 0
U2 3
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD DEC
PY 2018
VL 48
IS 12
BP 1131
EP 1134
DI 10.4070/kcj.2018.0293
PG 4
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA HB0WL
UT WOS:000450739200005
PM 30403016
OA Green Published
DA 2021-04-22
ER

PT J
AU Yoon, KL
AF Yoon, Kyung Lim
TI New Therapeutic Target for Pulmonary Arterial Hypertension
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
C1 [Yoon, Kyung Lim] Kyung Hee Univ Hosp Gangdong, Dept Pediat, 892 Dongnam Ro, Seoul 05278, South Korea.
RP Yoon, KL (corresponding author), Kyung Hee Univ Hosp Gangdong, Dept Pediat, 892 Dongnam Ro, Seoul 05278, South Korea.
EM ykr3215@hanmail.net
CR Broughton KM, 2018, CIRC RES, V122, P1151, DOI 10.1161/CIRCRESAHA.117.312586
   Burks M, 2018, AM J CARDIOVASC DRUG, V18, P249, DOI 10.1007/s40256-018-0272-5
   Kim KC, 2016, KOREAN CIRC J, V46, P79, DOI 10.4070/kcj.2016.46.1.79
   Lee DS, 2018, KOREAN CIRC J, V48, P1135, DOI 10.4070/kcj.2018.0061
   Li ZL, 2018, LIFE SCI, V205, P26, DOI 10.1016/j.lfs.2018.05.014
   Marcu R, 2015, CIRC RES, V116, P1336, DOI 10.1161/CIRCRESAHA.116.304881
   McGee M, 2018, CLIN TOXICOL, V56, P1
   Stenmark KR, 2010, PEDIATR CRIT CARE ME, V11, pS85, DOI 10.1097/PCC.0b013e3181c76db3
   Yu L, 2017, CELL PHYSIOL BIOCHEM, V42, P55, DOI 10.1159/000477115
NR 9
TC 5
Z9 5
U1 0
U2 2
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD DEC
PY 2018
VL 48
IS 12
BP 1145
EP 1147
DI 10.4070/kcj.2018.0250
PG 3
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA HB0WL
UT WOS:000450739200007
PM 30403018
OA Green Published
DA 2021-04-22
ER

PT J
AU Kim, HL
AF Kim, Hack-Lyoung
TI The Role of Transthoracic Echocardiography in Patients with Acute
   Ischemic Stroke: We Should Pay More Attention to Left Ventricular
   Ejection Fraction
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
ID HEART-FAILURE; ASSOCIATION; GUIDELINES; DISEASE
C1 [Kim, Hack-Lyoung] Seoul Natl Univ, Coll Med, Boramae Med Ctr, Dept Internal Med,Div Cardiol, 20 Boramae Ro 5 Gil, Seoul 07061, South Korea.
RP Kim, HL (corresponding author), Seoul Natl Univ, Coll Med, Boramae Med Ctr, Dept Internal Med,Div Cardiol, 20 Boramae Ro 5 Gil, Seoul 07061, South Korea.
EM khl2876@gmail.com
RI Kim, Hack-Lyoung/AAL-5038-2020
OI Kim, Hack-Lyoung/0000-0002-6703-1472
CR Batul SA, 2017, KOREAN CIRC J, V47, P644, DOI 10.4070/kcj.2017.0040
   Benjamin EJ, 2017, CIRCULATION, V135, pE146, DOI 10.1161/CIR.0000000000000485
   Lee JY, 2018, KOREAN CIRC J, V48, P1148, DOI 10.4070/kcj.2018.0115
   Matsumoto N, 1973, STROKE, V4, P20, DOI 10.1161/01.STR.4.1.20
   Milionis H, 2013, INT J CARDIOL, V168, P1082, DOI 10.1016/j.ijcard.2012.11.036
   Ois A, 2008, J NEUROL, V255, P385, DOI 10.1007/s00415-008-0677-1
   Powers WJ, 2018, STROKE, V49, pE46, DOI 10.1161/STR.0000000000000158
   ROTH EJ, 1994, ARCH PHYS MED REHAB, V75, P94
   Saric M, 2016, J AM SOC ECHOCARDIOG, V29, P1, DOI 10.1016/j.echo.2015.09.011
   Vemmos K, 2012, EUR J HEART FAIL, V14, P211, DOI 10.1093/eurjhf/hfr172
NR 10
TC 0
Z9 0
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD DEC
PY 2018
VL 48
IS 12
BP 1157
EP 1159
DI 10.4070/kcj.2018.0269
PG 3
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA HB0WL
UT WOS:000450739200009
PM 30403020
OA Green Published
DA 2021-04-22
ER

PT J
AU Kolla, KR
   Larsen, CM
   Click, RL
   Chaliki, HP
   Maltais, S
AF Kolla, Kantha R.
   Larsen, Carolyn M.
   Click, Roger L.
   Chaliki, Hari P.
   Maltais, Simon
TI Pivotal Role of Intraoperative Transesophageal Echocardiography for
   Detecting Iatrogenic Aortic Regurgitation due to Cardiac Catheterization
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
C1 [Kolla, Kantha R.; Larsen, Carolyn M.; Chaliki, Hari P.] Mayo Clin, Dept Cardiovasc Dis, 13400 E Shea Blvd, Scottsdale, AZ 85259 USA.
   [Click, Roger L.] Mayo Clin, Dept Cardiovasc Med, Rochester, MN USA.
   [Maltais, Simon] Mayo Clin, Dept Cardiovasc Surg, Rochester, MN USA.
RP Chaliki, HP (corresponding author), Mayo Clin, Dept Cardiovasc Dis, 13400 E Shea Blvd, Scottsdale, AZ 85259 USA.
EM chaliki.hari@mayo.edu
OI Larsen, Carolyn/0000-0001-6530-3545
CR Denyer M H, 1988, J Card Surg, V3, P155, DOI 10.1111/j.1540-8191.1988.tb00233.x
   Fundaro P, 1996, J HEART VALVE DIS, V5, P281
   Rolf T, 2011, INTERACT CARDIOV TH, V12, P205, DOI 10.1510/icvts.2010.252155
   Wyss CA, 2008, J INVASIVE CARDIOL, V20, P380
NR 4
TC 1
Z9 1
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD DEC
PY 2018
VL 48
IS 12
BP 1160
EP 1162
DI 10.4070/kcj.2018.0136
PG 3
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA HB0WL
UT WOS:000450739200010
PM 30403021
OA Green Published
DA 2021-04-22
ER

PT J
AU Kang, TS
   Choi, HY
   Park, SH
AF Kang, Tae Soo
   Choi, Ha-Young
   Park, Sang-Ho
TI Adrenal Insufficiency in a Patient with Acute Myocardial Infarction Plus
   Shock
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
C1 [Kang, Tae Soo] Dankook Univ Hosp, Dept Internal Med, Div Cardiol, Cheonan, South Korea.
   [Choi, Ha-Young; Park, Sang-Ho] Soonchunhyang Univ, Cheonan Hosp, Dept Internal Med, Div Cardiol, 31 Suncheonhyang 6 Gil, Cheonan 31151, South Korea.
RP Park, SH (corresponding author), Soonchunhyang Univ, Cheonan Hosp, Dept Internal Med, Div Cardiol, 31 Suncheonhyang 6 Gil, Cheonan 31151, South Korea.
EM matsalong@schmc.ac.kr
OI Kang, Tae Soo/0000-0002-4298-6272; Park, Sang-Ho/0000-0001-7912-0336
FU Soonchunhyang research fund
FX This study was supported by Soonchunhyang research fund.
CR Reynolds HR, 2008, CIRCULATION, V117, P686, DOI 10.1161/CIRCULATIONAHA.106.613596
   Vincent JL, 2013, NEW ENGL J MED, V369, P1726, DOI 10.1056/NEJMra1208943
NR 2
TC 0
Z9 0
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD DEC
PY 2018
VL 48
IS 12
BP 1163
EP 1164
DI 10.4070/kcj.2018.0145
PG 2
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA HB0WL
UT WOS:000450739200011
PM 30403022
OA Green Published
DA 2021-04-22
ER

PT J
AU Kim, Y
   Ahn, Y
   Kim, I
   Lee, DH
   Kim, MC
   Sim, DS
   Hong, YJ
   Kim, JH
   Jeong, MH
AF Kim, Yongcheol
   Ahn, Youngkeun
   Kim, Inna
   Lee, Doo Hwan
   Kim, Min Chul
   Sim, Doo Sun
   Hong, Young Joon
   Kim, Ju Han
   Jeong, Myung Ho
TI Feasibility of Coronary Angiography and Percutaneous Coronary
   Intervention via Left Snuffbox Approach
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Radial artery; Corollary angiography; Percutaneous coronary intervention
ID LEFT RADIAL APPROACH; DISTAL TRANSRADIAL ACCESS; ANATOMICAL SNUFFBOX;
   ARTERY ACCESS; CATHETERIZATION; DISEASE
AB Background and Objectives: Feasibility of coronary angiography (CAG) and percutaneous coronary intervention (PCI) via left snuffbox approach is still concerned. We aimed to investigate efficacy and safety of the left snuffbox approach for CAG and PCI.
   Methods: Left snuffbox approach was tried in 150 patients who planned to perform CAG or PCI for suspected myocardial ischemia between 1 November 2017 and 31 March 2018.
   Results: Success rate of radial artery (RA) cannulation via snuffbox approach was 88.0% (n=132). Among 132 individuals, 58 (43.9%) acute coronary syndrome (ACS) patients were included. The diameter of snuffbox RA was significantly smaller than conventional RA (2.57 mm vs. 2.72 mm, p<0.001) from quantitative computed angiography of 101 patients. However, CAG via snuffbox approach by 6 French sheath was successfully performed in all 132 patients. In addition, there was significant correlation between the snuffbox and conventional RA diameter (r=0.856, p<0.001). In 42 PCI cases, including 25 patients with acute myocardial infarction (AMI), the success rate of PCI via snuffbox approach was 97.6% (n=41). Intravascular imaging-guided PCI was performed in 8 (19.5%) patients and multi-vessel PCI in 4 (9.8%) cases. Regarding vascular complication, forearm swelling with bruising, not requiring surgery or transfusion, occurred in 2 (4.9%) PCI cases.
   Conclusions: Left snuffbox approach is suitable for CAG and PCI compared with the conventional radial approach.
C1 [Kim, Yongcheol; Ahn, Youngkeun; Kim, Inna; Lee, Doo Hwan; Kim, Min Chul; Sim, Doo Sun; Hong, Young Joon; Kim, Ju Han; Jeong, Myung Ho] Chonnam Natl Univ Hosp, Cardiovasc Ctr, Dept Cardiol, 42 Jebong Ro, Gwangju 61469, South Korea.
RP Ahn, Y (corresponding author), Chonnam Natl Univ Hosp, Cardiovasc Ctr, Dept Cardiol, 42 Jebong Ro, Gwangju 61469, South Korea.
EM cecilyk@hanmail.net
CR Archbold RA, 2004, BRIT MED J, V329, P443, DOI 10.1136/bmj.329.7463.443
   Bertrand OF, 2010, JACC-CARDIOVASC INTE, V3, P1022, DOI 10.1016/j.jcin.2010.07.013
   Biondi-Zoccai G, 2013, INT J CARDIOL, V166, P621, DOI 10.1016/j.ijcard.2011.11.100
   Doyle BJ, 2009, J AM COLL CARDIOL, V53, P2019, DOI 10.1016/j.jacc.2008.12.073
   Freixa X, 2012, CATHETER CARDIO INTE, V80, P267, DOI 10.1002/ccd.23474
   Ibanez B, 2018, EUR HEART J, V39, P119, DOI 10.1093/eurheartj/ehx393
   Jang HJ, 2016, KOREAN CIRC J, V46, P161, DOI 10.4070/kcj.2016.46.2.161
   Jurga J, 2011, STROKE, V42, P1475, DOI 10.1161/STROKEAHA.110.608638
   Kado H, 2014, JACC-CARDIOVASC INTE, V7, P810, DOI 10.1016/j.jcin.2013.11.026
   Kiemeneij F, 2017, EUROINTERVENTION, V13, P851, DOI 10.4244/EIJ-D-17-00079
   Kim SM, 2017, KOREAN CIRC J, V47, P222, DOI 10.4070/kcj.2016.0312
   Kim Y, 2018, KOREAN CIRC J, V48, P532, DOI [10.4070/kcj.2018.0016, 10.4070/kcj.2018.0181]
   Norgaz T, 2012, CATHETER CARDIO INTE, V80, P260, DOI 10.1002/ccd.23463
   Ovalsecchi O, 2018, J INVASIVE CARDIOL, V30, P218
   Park JY, 2017, YONSEI MED J, V58, P521, DOI 10.3349/ymj.2017.58.3.521
   Roffi M, 2016, EUR HEART J, V37, P267, DOI 10.1093/eurheartj/ehv320
   Santas E, 2009, REV ESP CARDIOL, V62, P482, DOI 10.1016/S0300-8932(09)71028-0
   Sciahbasi A, 2011, AM J CARDIOL, V108, P185, DOI 10.1016/j.amjcard.2011.03.022
   Sciahbasi A, 2011, AM HEART J, V161, DOI 10.1016/j.ahj.2010.10.003
   Soydan E, 2018, ANATOL J CARDIOL
NR 20
TC 2
Z9 2
U1 1
U2 3
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD DEC
PY 2018
VL 48
IS 12
BP 1120
EP 1130
DI 10.4070/kcj.2018.0181
PG 11
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA HB0WL
UT WOS:000450739200004
OA Green Published
DA 2021-04-22
ER

PT J
AU Han, KH
AF Han, Ki Hoon
TI Functional Implications of HMG-CoA Reductase Inhibition on Glucose
   Metabolism
SO KOREAN CIRCULATION JOURNAL
LA English
DT Review
DE HMG-CoA reductase; Statins; Diabetes; Insulin sensitivity; Glucogenesis
ID PANCREATIC BETA-CELLS; ELEMENT-BINDING PROTEIN-1C; CONTROLLED
   CLINICAL-TRIALS; FREE FATTY-ACIDS; NLRP3 INFLAMMASOME;
   INSULIN-RESISTANCE; DIABETES-MELLITUS; STATIN THERAPY; GLUCOKINASE GENE;
   SKELETAL-MUSCLE
AB HMG-CoA reductase inhibitors, i.e. statins, are effective in reducing cardiovascular disease events but also in cardiac-related and overall mortality. Statins are in general well-tolerated, but currently the concerns are raised if statins may increase the risk of new-onset diabetes mellitus (NOD). In this review, the possible effects of statins on organs/tissues being involved in glucose metabolism, i.e. liver, pancreas, adipose tissue, and muscles, had been discussed. The net outcome seems to be inconsistent and often contradictory, which may be largely affected by in vitro experimental settings or/and in vivo animal conditions. The majority of studies point out statin-induced changes of regulations of isoprenoid metabolites and cell-associated cholesterol contents as predisposing factors related to the statin-induced NOD. On the other hand, it should be considered that dysfunctions of isoprenoid pathway and mitochondrial ATP production and the cholesterol homeostasis are already developed under (pre)diabetic and hypercholesterolemic conditions. In order to connect the basic findings with the clinical manifestation more clearly, further research efforts are needed.
C1 [Han, Ki Hoon] Ulsan Univ, Coll Med, Asan Med Ctr, Dept Internal Med, 88 Olymp Ro 43 Gil, Seoul 05505, South Korea.
RP Han, KH (corresponding author), Ulsan Univ, Coll Med, Asan Med Ctr, Dept Internal Med, 88 Olymp Ro 43 Gil, Seoul 05505, South Korea.
EM steadyhan@amc.seoul.kr
FU National Research Foundation of KoreaNational Research Foundation of
   Korea [2014R1A2A1A11053353]; Asan Institute for Life Sciences, Asan
   Medical Center, Seoul, Korea [2014-288, 2015-288]
FX This study is in part supported by a grant 2014R1A2A1A11053353 from
   National Research Foundation of Korea. This study was supported by a
   grant 2014-288 and 2015-288 from the Asan Institute for Life Sciences,
   Asan Medical Center, Seoul, Korea.
CR Abe M, 2008, ARTERIOSCL THROM VAS, V28, P871, DOI 10.1161/ATVBAHA.107.160663
   Altaf A, 2015, CORONARY ARTERY DIS, V26, P409, DOI 10.1097/MCA.0000000000000255
   Anello M, 2005, DIABETOLOGIA, V48, P282, DOI 10.1007/s00125-004-1627-9
   Augustin R, 2010, IUBMB LIFE, V62, P315, DOI 10.1002/iub.315
   Berk-Planken IIL, 2003, DIABETES CARE, V26, P427, DOI 10.2337/diacare.26.2.427
   Bey L, 2002, PHARMACOLOGY, V66, P51, DOI 10.1159/000063256
   Black RNA, 2014, J DIABETES COMPLICAT, V28, P323, DOI 10.1016/j.jdiacomp.2014.01.001
   Brand MD, 2010, DIABETES OBES METAB, V12, P134, DOI 10.1111/j.1463-1326.2010.01264.x
   Chakera AJ, 2015, DIABETES CARE, V38, P1383, DOI 10.2337/dc14-2769
   Chamberlain LH, 2001, FEBS LETT, V507, P357, DOI 10.1016/S0014-5793(01)03007-1
   Chen ZY, 2014, LIPIDS HEALTH DIS, V13, DOI 10.1186/1476-511X-13-98
   Chew GT, 2004, QJM-INT J MED, V97, P537, DOI 10.1093/qjmed/hch089
   Chrusciel P, 2016, ATHEROSCLEROSIS, V253, P194, DOI 10.1016/j.atherosclerosis.2016.07.897
   Contreras JL, 2002, TRANSPLANTATION, V74, P1063, DOI 10.1097/00007890-200210270-00001
   Coppieters KT, 2011, DIABETES-METAB RES, V27, P746, DOI 10.1002/dmrr.1246
   De Meyts P., 2000, ENDOTEXT
   ELLIOTT KRF, 1984, INT J BIOCHEM, V16, P1251, DOI 10.1016/0020-711X(84)90224-6
   ENDO A, 1989, ADV ENZYME REGUL, V28, P53, DOI 10.1016/0065-2571(89)90063-0
   Favaro E, 2008, AM J PATHOL, V173, P442, DOI 10.2353/ajpath.2008.080238
   Fex M, 2018, J ENDOCRINOL, V236, pR145, DOI 10.1530/JOE-17-0367
   Fraulob JC, 2012, CLIN SCI, V123, P259, DOI 10.1042/CS20110373
   Gazzerro P, 2012, PHARMACOL REV, V64, P102, DOI 10.1124/pr.111.004994
   Gotoh S, 2015, SCI REP-UK, V5, DOI 10.1038/srep14076
   Hao M, 2007, DIABETES, V56, P2328, DOI 10.2337/db07-0056
   Hegarty BD, 2005, P NATL ACAD SCI USA, V102, P791, DOI 10.1073/pnas.0405067102
   Henquin JC, 2000, DIABETES, V49, P1751, DOI 10.2337/diabetes.49.11.1751
   Henriksbo BD, 2015, ADIPOCYTE, V4, P232, DOI 10.1080/21623945.2015.1024394
   Henriksbo BD, 2014, DIABETES, V63, P3742, DOI 10.2337/db13-1398
   Ivarsson R, 2005, DIABETES, V54, P2132, DOI 10.2337/diabetes.54.7.2132
   IYNEDJIAN PB, 1989, P NATL ACAD SCI USA, V86, P7838, DOI 10.1073/pnas.86.20.7838
   Jiang ZH, 2016, MED SCI MONITOR, V22, P2825, DOI 10.12659/MSM.897047
   Keembiyehetty C, 2006, MOL ENDOCRINOL, V20, P686, DOI 10.1210/me.2005-0010
   Khan T, 2009, ENDOCRINOLOGY, V150, P5262, DOI 10.1210/en.2009-0603
   Kim TH, 2009, J BIOL CHEM, V284, P15071, DOI 10.1074/jbc.M109.006742
   Kong FQ, 2016, BIOMED PHARMACOTHER, V82, P167, DOI 10.1016/j.biopha.2016.04.043
   Lalli CA, 2008, METABOLISM, V57, P57, DOI 10.1016/j.metabol.2007.07.021
   Lesna IK, 2018, EUR J PREV CARDIOL, V25, P328, DOI 10.1177/2047487317743355
   Leturque A, 2009, AM J PHYSIOL-ENDOC M, V296, pE985, DOI 10.1152/ajpendo.00004.2009
   Li WH, 2016, BIOMED PHARMACOTHER, V83, P194, DOI 10.1016/j.biopha.2016.06.029
   Liang Y, 1997, HORM METAB RES, V29, P255, DOI 10.1055/s-2007-979032
   Lorza-Gil E, 2016, TOXICOLOGY, V344, P42, DOI 10.1016/j.tox.2015.12.007
   Luo BB, 2014, CARDIOVASC DRUG THER, V28, P33, DOI 10.1007/s10557-013-6498-1
   Lupi R, 2004, DIABETES-METAB RES, V20, P246, DOI 10.1002/dmrr.460
   MacDonald MJ, 2009, DIABETOLOGIA, V52, P1087, DOI 10.1007/s00125-009-1319-6
   McVie-Wylie AJ, 2001, GENOMICS, V72, P113, DOI 10.1006/geno.2000.6457
   Miao J, 2014, J LIPID RES, V55, P659, DOI 10.1194/jlr.M043711
   Mohammed A, 2012, INT J CANCER, V131, P1951, DOI 10.1002/ijc.27456
   Murthy S, 2005, J BIOL CHEM, V280, P41793, DOI 10.1074/jbc.M504101200
   Naples M, 2008, ATHEROSCLEROSIS, V198, P94, DOI 10.1016/j.atherosclerosis.2007.11.003
   Nordlie RC, 1999, ANNU REV NUTR, V19, P379, DOI 10.1146/annurev.nutr.19.1.379
   O'Doherty RM, 1999, DIABETES, V48, P2022, DOI 10.2337/diabetes.48.10.2022
   Ohira M, 2012, METABOLISM, V61, P1452, DOI 10.1016/j.metabol.2012.03.010
   Otani M, 2010, BRIT J PHARMACOL, V159, P462, DOI 10.1111/j.1476-5381.2009.00548.x
   Pramfalk C, 2011, J INTERN MED, V269, P333, DOI 10.1111/j.1365-2796.2010.02305.x
   Roden M, 2004, NEWS PHYSIOL SCI, V19, P92, DOI 10.1152/nips.01459.2003
   Sadighara M, 2017, BASIC CLIN PHARMACOL, V120, P131, DOI 10.1111/bcpt.12656
   Sahebkar A, 2016, BRIT J CLIN PHARMACO, V82, P1674, DOI 10.1111/bcp.13086
   Sahebkar A, 2016, PHARMACOL RES, V111, P827, DOI 10.1016/j.phrs.2016.07.031
   Sahebkar A, 2016, BRIT J CLIN PHARMACO, V81, P807, DOI 10.1111/bcp.12854
   Salunkhe VA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151592
   Schonewille M, 2016, J LIPID RES, V57, P1455, DOI 10.1194/jlr.M067488
   Singh LP, 2014, CARDIOVASC DRUG THER, V28, P5, DOI 10.1007/s10557-013-6501-x
   Singh P, 2018, PHYSIOL REP, V6, DOI 10.14814/phy2.13566
   Steele AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065326
   Stone NJ, 2014, J AM COLL CARDIOL, V63, P2889, DOI 10.1016/j.jacc.2013.11.002
   Szendroedi J, 2009, DIABETES CARE, V32, P209, DOI 10.2337/dc08-1123
   Takaguri A, 2008, J PHARMACOL SCI, V107, P80, DOI 10.1254/jphs.FP0072403
   Tappy L, 1997, DIABETES, V46, P204, DOI 10.2337/diabetes.46.2.204
   The Human Protein Atlas, GEN INF LDLR
   Tomita T, 2016, BOSNIAN J BASIC MED, V16, P162, DOI 10.17305/bjbms.2016.919
   TSAI AC, 1973, J NUTR, V103, P93
   Urbano F, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11070-x
   Wang L, 2018, MOL MED REP, V18, P789, DOI 10.3892/mmr.2018.9062
   Wang SL, 2017, MOL PHARMACOL, V92, P256, DOI 10.1124/mol.116.108100
   WILLIAMS ML, 1992, J LIPID RES, V33, P193
   Yaluri N, 2016, BIOCHEM BIOPH RES CO, V480, P194, DOI 10.1016/j.bbrc.2016.10.026
   Yaluri N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142902
   Yang CY, 2018, INT J MED SCI, V15, P517, DOI 10.7150/ijms.22454
   Yu SY, 2017, INT J CARDIOL, V229, P23, DOI 10.1016/j.ijcard.2016.11.219
   Zaki NM, 2016, DRUG DELIV, V23, P1868, DOI 10.3109/10717544.2014.993747
   Zhang YY, 2016, J ETHNOPHARMACOL, V192, P256, DOI 10.1016/j.jep.2016.07.002
   Zhao W, 2015, DRUG DES DEV THER, V9, P6211, DOI 10.2147/DDDT.S87979
NR 82
TC 5
Z9 5
U1 0
U2 4
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD NOV
PY 2018
VL 48
IS 11
BP 951
EP 963
DI 10.4070/kcj.2018.0307
PG 13
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA HB0VT
UT WOS:000450737300001
PM 30334382
OA Green Published
DA 2021-04-22
ER

PT J
AU Kim, DH
   Kang, DH
AF Kim, Dae-Hee
   Kang, Duk-Hyun
TI Early Surgery in Valvular Heart Disease
SO KOREAN CIRCULATION JOURNAL
LA English
DT Review
DE Mitral valve insufficiency; Aortic valve stenosis; Aortic valve
   insufficiency; Endocarditis; Cardiac surgical procedures
ID SEVERE AORTIC-STENOSIS; SEVERE MITRAL REGURGITATION; EARLY SURGICAL
   INTERVENTION; INFECTIVE ENDOCARDITIS; CONVENTIONAL TREATMENT;
   VALVE-REPLACEMENT; NATURAL-HISTORY; RISK-FACTORS; ASSOCIATION;
   MANAGEMENT
AB The burden of valvular heart disease (VHD) is increasing with age, and the elderly patients with moderate or severe VHD are notably common. When to operate in asymptomatic patients with VHD remains controversial. The controversy is whether early surgical intervention should be preferred, or a watchful waiting approach should be followed. The beneficial effects of early surgery should be balanced against operative mortality and long-term results. Indications of early surgery in each of the VHD will be discussed in this review on the basis of the latest American and European guidelines.
C1 [Kim, Dae-Hee; Kang, Duk-Hyun] Univ Ulsan, Coll Med, Asan Med Ctr, Div Cardiol, 88,Olymp Ro 43 Gil, Seoul 05505, South Korea.
RP Kang, DH (corresponding author), Univ Ulsan, Coll Med, Asan Med Ctr, Div Cardiol, 88,Olymp Ro 43 Gil, Seoul 05505, South Korea.
EM dhkang@amc.seoul.kr
OI Kang, Duk-Hyun/0000-0003-4031-8649; Kim, Dae-Hee/0000-0002-8275-4871
CR Anguera I, 2005, EUR HEART J, V26, P288, DOI 10.1093/eurheartj/ehi034
   Banovic M, 2016, AM HEART J, V174, P147, DOI 10.1016/j.ahj.2016.02.001
   Baumgartner H, 2017, EUR HEART J, V38, P2739, DOI 10.1093/eurheartj/ehx391
   Benjamin EJ, 2018, CIRCULATION, V137, pE67, DOI 10.1161/CIR.0000000000000558
   BONOW RO, 1991, CIRCULATION, V84, P1625, DOI 10.1161/01.CIR.84.4.1625
   D'Agostino RB, 1998, STAT MED, V17, P2265, DOI 10.1002/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO;2-B
   de Meester C, 2015, J THORAC CARDIOV SUR, V150, P1100, DOI 10.1016/j.jtcvs.2015.07.053
   Delahaye F, 2011, ARCH CARDIOVASC DIS, V104, P35, DOI 10.1016/j.acvd.2010.11.003
   Dickerman SA, 2007, AM HEART J, V154, P1086, DOI 10.1016/j.ahj.2007.07.023
   Edwards FH, 2001, J AM COLL CARDIOL, V37, P885, DOI 10.1016/S0735-1097(00)01202-X
   Enriquez-Sarano M, 2005, NEW ENGL J MED, V352, P875, DOI 10.1056/NEJMoa041451
   Garcia-Cabrera E, 2013, CIRCULATION, V127, P2272, DOI 10.1161/CIRCULATIONAHA.112.000813
   Genereux P, 2016, J AM COLL CARDIOL, V67, P2263, DOI 10.1016/j.jacc.2016.02.057
   Habib G, 2015, EUR HEART J, V36, P3075, DOI [10.1093/eurheartj/ehv319, 10.1093/eurheartj/ehv488]
   Iung B, 2011, NAT REV CARDIOL, V8, P162, DOI 10.1038/nrcardio.2010.202
   Kang DH, 2016, KOREAN CIRC J, V46, P846, DOI 10.4070/kcj.2016.46.6.846
   Kang DH, 2015, HEART, V101, P1786, DOI 10.1136/heartjnl-2015-307878
   Kang DH, 2014, J AM COLL CARDIOL, V63, P2398, DOI 10.1016/j.jacc.2014.02.577
   Kang DH, 2012, NEW ENGL J MED, V366, P2466, DOI 10.1056/NEJMoa1112843
   Kang DH, 2010, CIRCULATION, V121, P1502, DOI 10.1161/CIRCULATIONAHA.109.909903
   Kang DH, 2009, CIRCULATION, V119, P797, DOI 10.1161/CIRCULATIONAHA.108.802314
   Kiefer T, 2011, JAMA-J AM MED ASSOC, V306, P2239, DOI 10.1001/jama.2011.1701
   Kim DH, 2010, CIRCULATION, V122, pS17, DOI 10.1161/CIRCULATIONAHA.109.927665
   KING RM, 1984, CIRCULATION, V70, P193
   La Canna G, 2011, AM J CARDIOL, V107, P1365, DOI 10.1016/j.amjcard.2010.12.048
   Le Tourneau T, 2010, HEART, V96, P1311, DOI 10.1136/hrt.2009.186486
   LEUNG DYC, 1994, BRIT HEART J, V72, P175
   Lim WY, 2017, HEART, V103, P268, DOI 10.1136/heartjnl-2016-309830
   Lopez J, 2013, EUR HEART J, V34, P1749, DOI 10.1093/eurheartj/ehs379
   Murdoch DR, 2009, ARCH INTERN MED, V169, P463, DOI 10.1001/archinternmed.2008.603
   Mylonakis E, 2001, NEW ENGL J MED, V345, P1318, DOI 10.1056/NEJMra010082
   Nishimura RA, 2017, J AM COLL CARDIOL, V70, P252, DOI 10.1016/j.jacc.2017.03.011
   Nishimura RA, 2014, J THORAC CARDIOV SUR, V148, pE1, DOI 10.1016/j.jtcvs.2014.05.014
   Nkomo Vuyisile T, 2006, Lancet, V368, P1005, DOI 10.1016/S0140-6736(06)69208-8
   Pai RG, 2006, ANN THORAC SURG, V82, P2116, DOI 10.1016/j.athoracsur.2006.07.043
   Pellikka PA, 2005, CIRCULATION, V111, P3290, DOI 10.1161/CIRCULATIONAHA.104.495903
   PELLIKKA PA, 1990, J AM COLL CARDIOL, V15, P1012, DOI 10.1016/0735-1097(90)90234-G
   Prendergast BD, 2010, CIRCULATION, V121, P1141, DOI 10.1161/CIRCULATIONAHA.108.773598
   Rosenhek R, 2000, NEW ENGL J MED, V343, P611, DOI 10.1056/NEJM200008313430903
   ROSS J, 1968, CIRCULATION, V38, pV61, DOI 10.1161/01.CIR.38.1S5.V-61
   Staab ME, 1999, J HEART VALVE DIS, V8, P567
   Suri RM, 2013, JAMA-J AM MED ASSOC, V310, P609, DOI 10.1001/jama.2013.8643
   Taniguchi T, 2015, J AM COLL CARDIOL, V66, P2827, DOI 10.1016/j.jacc.2015.10.001
   The United States National Library of Medicine, 2018, EARL SURG VERS CONV
   Tornos P, 2005, HEART, V91, P571, DOI 10.1136/hrt.2003.032128
   Vikram HR, 2003, JAMA-J AM MED ASSOC, V290, P3207, DOI 10.1001/jama.290.24.3207
NR 46
TC 1
Z9 1
U1 0
U2 3
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD NOV
PY 2018
VL 48
IS 11
BP 964
EP 973
DI 10.4070/kcj.2018.0308
PG 10
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA HB0VT
UT WOS:000450737300002
PM 30334383
OA Green Published
DA 2021-04-22
ER

PT J
AU Park, M
   Yoon, YS
AF Park, Misun
   Yoon, Young-sup
TI Cardiac Regeneration with Human Pluripotent Stem Cell-Derived
   Cardiomyocytes
SO KOREAN CIRCULATION JOURNAL
LA English
DT Review
DE Pluripotent stem cells; Cardiomyocytes; Cell- and tissue-based therapy;
   Regeneration; Biomaterials
ID ACUTE MYOCARDIAL-INFARCTION; CARDIOVASCULAR PROGENITOR CELLS;
   WNT/BETA-CATENIN; HEART-FAILURE; DOUBLE-BLIND; LONG-TERM; FUNCTIONAL
   CARDIOMYOCYTES; DIRECTED DIFFERENTIATION; INTRACORONARY INJECTION;
   ELECTRICAL INTEGRATION
AB Embryonic stem cells (ESCs) and induced pluripotent stem cells (iPSCs), which are collectively called pluripotent stem cells (PSCs), have emerged as a promising source for regenerative medicine. Particularly, human pluripotent stem cell-derived cardiomyocytes (hPSC-CMs) have shown robust potential for regenerating injured heart. Over the past two decades, protocols to differentiate hPSCs into CMs at high efficiency have been developed, opening the door for clinical application. Studies further demonstrated therapeutic effects of hPSC-CMs in small and large animal models and the underlying mechanisms of cardiac repair. However, gaps remain in explanations of the therapeutic effects of engrafted hPSC-CMs. In addition, bioengineering technologies improved survival and therapeutic effects of hPSC-CMs in vivo. While most of the original concerns associated with the use of hPSCs have been addressed, several issues remain to be resolved such as immaturity of transplanted cells, lack of electrical integration leading to arrhythmogenic risk, and tumorigenicity. Cell therapy with hPSC-CMs has shown great potential for biological therapy of injured heart; however, more studies are needed to ensure the therapeutic effects, underlying mechanisms, and safety, before this technology can be applied clinically.
C1 [Park, Misun; Yoon, Young-sup] Yonsei Univ, Coll Med, Biomed Sci Inst, Seoul, South Korea.
   [Yoon, Young-sup] Emory Univ, Sch Med, Div Cardiol, Dept Med, 101 Woodruff Circle,WMB 3309, Atlanta, GA 30322 USA.
RP Yoon, YS (corresponding author), Emory Univ, Sch Med, Div Cardiol, Dept Med, 101 Woodruff Circle,WMB 3309, Atlanta, GA 30322 USA.
EM yyoon5@emory.edu
OI Park, Misun/0000-0002-9858-4408
FU Bio & Medical Technology Development Program of the Korea National
   Research Foundation (NRF) - Korean government [2015M3A9C6031514,
   2018R1D1A1B07046955]; Korea Health Technology R&D Project through the
   Korea Health Industry Development Institute (KHIDI); Ministry of Health
   & Welfare, Republic of KoreaMinistry of Health & Welfare, Republic of
   Korea [HI15C2782, HI16C2211]; NHLBIUnited States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USANIH National
   Heart Lung & Blood Institute (NHLBI) [R01HL127759, R01HL129511];
   NIDDKUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Diabetes &
   Digestive & Kidney Diseases (NIDDK) [DP3-DK108245]; NIHUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USA [1R01HL125391-01, P30CA013148]; NATIONAL CANCER INSTITUTEUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USANIH National Cancer Institute (NCI) [P30CA013148,
   P30CA013148, P30CA013148, P30CA013148, P30CA013148, P30CA013148,
   P30CA013148, P30CA013148, P30CA013148, P30CA013148, P30CA013148,
   P30CA013148, P30CA013148, P30CA013148, P30CA013148, P30CA013148,
   P30CA013148, P30CA013148, P30CA013148, P30CA013148, P30CA013148,
   P30CA013148, P30CA013148, P30CA013148, P30CA013148, P30CA013148,
   P30CA013148, P30CA013148, P30CA013148, P30CA013148, P30CA013148,
   P30CA013148, P30CA013148, P30CA013148, P30CA013148, P30CA013148,
   P30CA013148, P30CA013148, P30CA013148, P30CA013148, P30CA013148,
   P30CA013148, P30CA013148, P30CA013148, P30CA013148, P30CA013148,
   P30CA013148, P30CA013148, P30CA013148, P30CA013148, P30CA013148,
   P30CA013148, P30CA013148, P30CA013148, P30CA013148, P30CA013148,
   P30CA013148, P30CA013148, P30CA013148, P30CA013148, P30CA013148,
   P30CA013148, P30CA013148, P30CA013148, P30CA013148, P30CA013148,
   P30CA013148, P30CA013148, P30CA013148, P30CA013148, P30CA013148,
   P30CA013148, P30CA013148, P30CA013148, P30CA013148, P30CA013148,
   P30CA013148, P30CA013148, P30CA013148, P30CA013148, P30CA013148,
   P30CA013148, P30CA013148, P30CA013148, P30CA013148, P30CA013148,
   P30CA013148, P30CA013148, P30CA013148, P30CA013148, P30CA013148,
   P30CA013148, P30CA013148, P30CA013148, P30CA013148, P30CA013148,
   P30CA013148, P30CA013148, P30CA013148, P30CA013148, P30CA013148,
   P30CA013148, P30CA013148, P30CA013148, P30CA013148, P30CA013148,
   P30CA013148, P30CA013148, P30CA013148, P30CA013148, P30CA013148,
   P30CA013148, P30CA013148, P30CA013148, P30CA013148, P30CA013148,
   P30CA013148, P30CA013148, P30CA013148, P30CA013148, P30CA013148,
   P30CA013148, P30CA013148, P30CA013148, P30CA013148, P30CA013148,
   P30CA013148, P30CA013148, P30CA013148, P30CA013148, P30CA013148,
   P30CA013148, P30CA013148, P30CA013148, P30CA013148, P30CA013148,
   P30CA013148, P30CA013148, P30CA013148, P30CA013148, P30CA013148,
   P30CA013148, P30CA013148, P30CA013148, P30CA013148, P30CA013148,
   P30CA013148, P30CA013148, P30CA013148, P30CA013148, P30CA013148,
   P30CA013148, P30CA013148, P30CA013148, P30CA013148, P30CA013148,
   P30CA013148, P30CA013148, P30CA013148, P30CA013148, P30CA013148,
   P30CA013148, P30CA013148, P30CA013148, P30CA013148, P30CA013148,
   P30CA013148, P30CA013148, P30CA013148, P30CA013148, P30CA013148,
   P30CA013148, P30CA013148, P30CA013148, P30CA013148, P30CA013148,
   P30CA013148, P30CA013148, P30CA013148, P30CA013148, P30CA013148,
   P30CA013148, P30CA013148, P30CA013148, P30CA013148, P30CA013148,
   P30CA013148, P30CA013148, P30CA013148, P30CA013148, P30CA013148,
   P30CA013148, P30CA013148, P30CA013148, P30CA013148, P30CA013148,
   P30CA013148, P30CA013148, P30CA013148, P30CA013148, P30CA013148,
   P30CA013148, P30CA013148, P30CA013148, P30CA013148, P30CA013148,
   P30CA013148, P30CA013148, P30CA013148, P30CA013148, P30CA013148,
   P30CA013148, P30CA013148, P30CA013148, P30CA013148, P30CA013148,
   P30CA013148, P30CA013148, P30CA013148, P30CA013148, P30CA013148,
   P30CA013148, P30CA013148, P30CA013148, P30CA013148, P30CA013148,
   P30CA013148, P30CA013148, P30CA013148, P30CA013148, P30CA013148,
   P30CA013148, P30CA013148, P30CA013148, P30CA013148, P30CA013148,
   P30CA013148, P30CA013148, P30CA013148, P30CA013148, P30CA013148,
   P30CA013148, P30CA013148, P30CA013148, P30CA013148, P30CA013148,
   P30CA013148, P30CA013148, P30CA013148, P30CA013148, P30CA013148,
   P30CA013148, P30CA013148, P30CA013148, P30CA013148, P30CA013148,
   P30CA013148, P30CA013148, P30CA013148, P30CA013148, P30CA013148,
   P30CA013148, P30CA013148, P30CA013148, P30CA013148, P30CA013148,
   P30CA013148, P30CA013148, P30CA013148, P30CA013148, P30CA013148,
   P30CA013148, P30CA013148, P30CA013148, P30CA013148, P30CA013148,
   P30CA013148, P30CA013148, P30CA013148, P30CA013148, P30CA013148,
   P30CA013148, P30CA013148, P30CA013148, P30CA013148, P30CA013148,
   P30CA013148, P30CA013148, P30CA013148, P30CA013148, P30CA013148,
   P30CA013148, P30CA013148, P30CA013148, P30CA013148, P30CA013148,
   P30CA013148, P30CA013148, P30CA013148, P30CA013148, P30CA013148,
   P30CA013148, P30CA013148, P30CA013148, P30CA013148, P30CA013148,
   P30CA013148, P30CA013148, P30CA013148, P30CA013148, P30CA013148,
   P30CA013148, P30CA013148, P30CA013148, P30CA013148, P30CA013148,
   P30CA013148, P30CA013148, P30CA013148, P30CA013148, P30CA013148,
   P30CA013148, P30CA013148, P30CA013148, P30CA013148, P30CA013148,
   P30CA013148, P30CA013148, P30CA013148, P30CA013148, P30CA013148,
   P30CA013148, P30CA013148, P30CA013148, P30CA013148, P30CA013148,
   P30CA013148, P30CA013148, P30CA013148, P30CA013148, P30CA013148,
   P30CA013148, P30CA013148, P30CA013148, P30CA013148, P30CA013148,
   P30CA013148, P30CA013148, P30CA013148, P30CA013148, P30CA013148,
   P30CA013148, P30CA013148, P30CA013148, P30CA013148, P30CA013148,
   P30CA013148, P30CA013148, P30CA013148, P30CA013148, P30CA013148,
   P30CA013148, P30CA013148, P30CA013148, P30CA013148, P30CA013148,
   P30CA013148, P30CA013148, P30CA013148, P30CA013148, P30CA013148,
   P30CA013148, P30CA013148, P30CA013148, P30CA013148, P30CA013148,
   P30CA013148, P30CA013148, P30CA013148, P30CA013148, P30CA013148,
   P30CA013148, P30CA013148, P30CA013148, P30CA013148, P30CA013148,
   P30CA013148, P30CA013148, P30CA013148, P30CA013148, P30CA013148,
   P30CA013148, P30CA013148, P30CA013148, P30CA013148, P30CA013148,
   P30CA013148, P30CA013148, P30CA013148, P30CA013148, P30CA013148,
   P30CA013148, P30CA013148, P30CA013148, P30CA013148, P30CA013148,
   P30CA013148, P30CA013148, P30CA013148, P30CA013148, P30CA013148,
   P30CA013148, P30CA013148, P30CA013148, P30CA013148, P30CA013148,
   P30CA013148, P30CA013148, P30CA013148, P30CA013148, P30CA013148,
   P30CA013148, P30CA013148, P30CA013148, P30CA013148, P30CA013148,
   P30CA013148, P30CA013148, P30CA013148, P30CA013148, P30CA013148,
   P30CA013148, P30CA013148, P30CA013148, P30CA013148, P30CA013148,
   P30CA013148, P30CA013148, P30CA013148, P30CA013148, P30CA013148,
   P30CA013148, P30CA013148, P30CA013148, P30CA013148, P30CA013148,
   P30CA013148, P30CA013148, P30CA013148, P30CA013148, P30CA013148,
   P30CA013148, P30CA013148, P30CA013148, P30CA013148, P30CA013148,
   P30CA013148, P30CA013148, P30CA013148, P30CA013148, P30CA013148,
   P30CA013148, P30CA013148, P30CA013148, P30CA013148, P30CA013148,
   P30CA013148, P30CA013148, P30CA013148, P30CA013148, P30CA013148,
   P30CA013148, P30CA013148, P30CA013148, P30CA013148, P30CA013148,
   P30CA013148, P30CA013148, P30CA013148, P30CA013148, P30CA013148,
   P30CA013148, P30CA013148, P30CA013148, P30CA013148, P30CA013148,
   P30CA013148, P30CA013148, P30CA013148, P30CA013148, P30CA013148,
   P30CA013148, P30CA013148, P30CA013148, P30CA013148, P30CA013148,
   P30CA013148, P30CA013148, P30CA013148, P30CA013148, P30CA013148,
   P30CA013148, P30CA013148, P30CA013148, P30CA013148, P30CA013148,
   P30CA013148, P30CA013148, P30CA013148, P30CA013148, P30CA013148,
   P30CA013148, P30CA013148, P30CA013148, P30CA013148, P30CA013148,
   P30CA013148, P30CA013148, P30CA013148, P30CA013148, P30CA013148,
   P30CA013148, P30CA013148, P30CA013148, P30CA013148, P30CA013148,
   P30CA013148, P30CA013148, P30CA013148, P30CA013148, P30CA013148,
   P30CA013148, P30CA013148, P30CA013148, P30CA013148, P30CA013148,
   P30CA013148, P30CA013148, P30CA013148, P30CA013148, P30CA013148,
   P30CA013148, P30CA013148, P30CA013148, P30CA013148, P30CA013148,
   P30CA013148, P30CA013148, P30CA013148, P30CA013148, P30CA013148,
   P30CA013148, P30CA013148, P30CA013148, P30CA013148, P30CA013148,
   P30CA013148, P30CA013148, P30CA013148, P30CA013148, P30CA013148,
   P30CA013148, P30CA013148, P30CA013148, P30CA013148, P30CA013148,
   P30CA013148, P30CA013148, P30CA013148, P30CA013148, P30CA013148,
   P30CA013148, P30CA013148, P30CA013148, P30CA013148, P30CA013148,
   P30CA013148, P30CA013148, P30CA013148, P30CA013148, P30CA013148,
   P30CA013148, P30CA013148, P30CA013148, P30CA013148, P30CA013148,
   P30CA013148, P30CA013148, P30CA013148, P30CA013148, P30CA013148,
   P30CA013148, P30CA013148, P30CA013148, P30CA013148, P30CA013148,
   P30CA013148, P30CA013148, P30CA013148, P30CA013148, P30CA013148,
   P30CA013148, P30CA013148, P30CA013148, P30CA013148, P30CA013148,
   P30CA013148, P30CA013148, P30CA013148, P30CA013148, P30CA013148,
   P30CA013148, P30CA013148, P30CA013148, P30CA013148, P30CA013148,
   P30CA013148, P30CA013148, P30CA013148, P30CA013148, P30CA013148,
   P30CA013148, P30CA013148, P30CA013148, P30CA013148, P30CA013148,
   P30CA013148, P30CA013148, P30CA013148, P30CA013148, P30CA013148,
   P30CA013148, P30CA013148, P30CA013148, P30CA013148, P30CA013148,
   P30CA013148, P30CA013148, P30CA013148, P30CA013148, P30CA013148,
   P30CA013148, P30CA013148, P30CA013148, P30CA013148, P30CA013148,
   P30CA013148, P30CA013148, P30CA013148, P30CA013148, P30CA013148,
   P30CA013148, P30CA013148, P30CA013148, P30CA013148, P30CA013148,
   P30CA013148, P30CA013148, P30CA013148, P30CA013148, P30CA013148,
   P30CA013148, P30CA013148, P30CA013148, P30CA013148, P30CA013148,
   P30CA013148, P30CA013148, P30CA013148, P30CA013148, P30CA013148,
   P30CA013148, P30CA013148, P30CA013148, P30CA013148, P30CA013148,
   P30CA013148, P30CA013148, P30CA013148, P30CA013148, P30CA013148,
   P30CA013148, P30CA013148, P30CA013148, P30CA013148, P30CA013148,
   P30CA013148, P30CA013148, P30CA013148, P30CA013148, P30CA013148,
   P30CA013148, P30CA013148, P30CA013148, P30CA013148, P30CA013148,
   P30CA013148, P30CA013148, P30CA013148, P30CA013148, P30CA013148,
   P30CA013148, P30CA013148, P30CA013148, P30CA013148, P30CA013148,
   P30CA013148, P30CA013148, P30CA013148, P30CA013148, P30CA013148] Funding
   Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)
   [R01HL127759, R01HL127759, R01HL125391, R01HL129511, R01HL129511,
   R01HL125391, R01HL129511, R01HL127759, R01HL125391, R01HL125391,
   R01HL129511, R01HL125391, R01HL127759] Funding Source: NIH RePORTER;
   NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASESUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USANIH National Institute of Diabetes & Digestive &
   Kidney Diseases (NIDDK) [DP3DK108245, DP3DK108245] Funding Source: NIH
   RePORTER
FX This work was supported by the Bio & Medical Technology Development
   Program of the Korea National Research Foundation (NRF) funded by the
   Korean government (No. 2015M3A9C6031514 and 2018R1D1A1B07046955), and
   the Korea Health Technology R&D Project through the Korea Health
   Industry Development Institute (KHIDI), funded by the Ministry of Health
   & Welfare, Republic of Korea (HI15C2782, HI16C2211) and grants from
   NHLBI (R01HL127759, R01HL129511), NIDDK (DP3-DK108245), NIH
   (1R01HL125391-01), NIH (P30CA013148).
CR Amado LC, 2005, P NATL ACAD SCI USA, V102, P11474, DOI 10.1073/pnas.0504388102
   Anderson ME, 2014, CIRC RES, V115, P335, DOI 10.1161/CIRCRESAHA.114.304616
   Ban K, 2017, THERANOSTICS, V7, P2067, DOI 10.7150/thno.19427
   Ban K, 2014, ACS NANO, V8, P10815, DOI 10.1021/nn504617g
   Ban KW, 2013, CIRCULATION, V128, P1897, DOI 10.1161/CIRCULATIONAHA.113.004228
   Benjamin EJ, 2018, CIRCULATION, V137, pE67, DOI 10.1161/CIR.0000000000000558
   Bergmann O, 2015, CELL, V161, P1566, DOI 10.1016/j.cell.2015.05.026
   Burridge PW, 2014, NAT METHODS, V11, P855, DOI [10.1038/NMETH.2999, 10.1038/nmeth.2999]
   Cahill TJ, 2017, NAT REV DRUG DISCOV, V16, P699, DOI 10.1038/nrd.2017.106
   Caspi O, 2007, J AM COLL CARDIOL, V50, P1884, DOI 10.1016/j.jacc.2007.07.054
   Cho HJ, 2007, J EXP MED, V204, P3257, DOI 10.1084/jem.20070166
   Chong JJH, 2014, NATURE, V510, P273, DOI 10.1038/nature13233
   Choudry F, 2016, EUR HEART J, V37, P256, DOI 10.1093/eurheartj/ehv493
   Chow A, 2017, STEM CELL REP, V9, P1415, DOI 10.1016/j.stemcr.2017.09.003
   Christman KL, 2004, J AM COLL CARDIOL, V44, P654, DOI 10.1016/j.jacc.2004.04.040
   Cunningham JJ, 2012, NAT BIOTECHNOL, V30, P849, DOI 10.1038/nbt.2329
   Dow J, 2005, CARDIOVASC RES, V67, P301, DOI 10.1016/j.cardiores.2005.04.011
   Eschenhagen T, 2017, CIRCULATION, V136, P680, DOI 10.1161/CIRCULATIONAHA.117.029343
   EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0
   Feaster TK, 2015, CIRC RES, V117, P995, DOI 10.1161/CIRCRESAHA.115.307580
   Fernandes S, 2010, J MOL CELL CARDIOL, V49, P941, DOI 10.1016/j.yjmcc.2010.09.008
   Fong AH, 2016, TISSUE ENG PT A, V22, P1016, DOI [10.1089/ten.tea.2016.0027, 10.1089/ten.TEA.2016.0027]
   Freytes Donald O, 2014, Methods Mol Biol, V1181, P69, DOI 10.1007/978-1-4939-1047-2_7
   Fu JD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027417
   Fusaki N, 2009, P JPN ACAD B-PHYS, V85, P348, DOI 10.2183/pjab.85.348
   Gadue P, 2006, P NATL ACAD SCI USA, V103, P16806, DOI 10.1073/pnas.0603916103
   Gao L, 2018, CIRCULATION, V137, P1712, DOI 10.1161/CIRCULATIONAHA.117.030785
   Gao L, 2017, CIRC RES, V120, P1318, DOI 10.1161/CIRCRESAHA.116.310277
   Geckil H, 2010, NANOMEDICINE-UK, V5, P469, DOI [10.2217/nnm.10.12, 10.2217/NNM.10.12]
   Gerbin KA, 2015, CARDIOVASC PATHOL, V24, P133, DOI 10.1016/j.carpath.2015.02.004
   Gnecchi M, 2005, NAT MED, V11, P367, DOI 10.1038/nm0405-367
   Graichen R, 2008, DIFFERENTIATION, V76, P357, DOI 10.1111/j.1432-0436.2007.00236.x
   Gutierrez-Aranda I, 2010, STEM CELLS, V28, P1568, DOI 10.1002/stem.471
   Guyette JP, 2016, CIRC RES, V118, P56, DOI 10.1161/CIRCRESAHA.115.306874
   Hare JM, 2009, J AM COLL CARDIOL, V54, P2277, DOI 10.1016/j.jacc.2009.06.055
   Hattori F, 2010, NAT METHODS, V7, P61, DOI [10.1038/nmeth.1403, 10.1038/NMETH.1403]
   He JQ, 2003, CIRC RES, V93, P32, DOI 10.1161/01.RES.0000080317.92718.99
   Hernandez Melissa J, 2017, JACC Basic Transl Sci, V2, P212, DOI 10.1016/j.jacbts.2016.11.008
   Higuchi T, 2015, CELL TRANSPLANT, V24, P2479, DOI 10.3727/096368914X685799
   Hong SG, 2016, MOL THER, V24, P1165, DOI 10.1038/mt.2016.131
   Hong SG, 2014, CELL REP, V7, P1298, DOI 10.1016/j.celrep.2014.04.019
   Ivashchenko CY, 2013, AM J PHYSIOL-HEART C, V305, pH913, DOI 10.1152/ajpheart.00819.2012
   Janssens S, 2006, LANCET, V367, P113, DOI 10.1016/S0140-6736(05)67861-0
   Kadota S, 2017, STEM CELL REP, V8, P278, DOI 10.1016/j.stemcr.2016.10.009
   Kamakura T, 2013, CIRC J, V77, P1307, DOI 10.1253/circj.CJ-12-0987
   Karantalis V, 2014, CIRC RES, V114, P1302, DOI 10.1161/CIRCRESAHA.114.303180
   Kawamura M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08869-z
   Kawamura M, 2012, CIRCULATION, V126, pS29, DOI 10.1161/CIRCULATIONAHA.111.084343
   Kehat I, 2001, J CLIN INVEST, V108, P407, DOI 10.1172/JCI200112131
   Kuppusamy KT, 2015, P NATL ACAD SCI USA, V112, pE2785, DOI 10.1073/pnas.1424042112
   Laflamme MA, 2007, NAT BIOTECHNOL, V25, P1015, DOI 10.1038/nbt1327
   Landa N, 2008, CIRCULATION, V117, P1388, DOI 10.1161/CIRCULATIONAHA.107.727420
   Lee JH, 2017, CELL STEM CELL, V21, P179, DOI 10.1016/j.stem.2017.07.003
   Lee SJ, 2017, CIRCULATION, V136, P1939, DOI 10.1161/CIRCULATIONAHA.116.026329
   Li X, 2016, BIOFABRICATION, V8, DOI 10.1088/1758-5090/8/3/035017
   Lian XJ, 2012, P NATL ACAD SCI USA, V109, pE1848, DOI 10.1073/pnas.1200250109
   Lieu DK, 2009, STEM CELLS DEV, V18, P1493, DOI 10.1089/scd.2009.0052
   Lindsley RC, 2006, DEVELOPMENT, V133, P3787, DOI 10.1242/dev.02551
   Liu YW, 2018, NAT BIOTECHNOL, V36, P597, DOI 10.1038/nbt.4162
   Lu WN, 2009, TISSUE ENG PT A, V15, P1437, DOI 10.1089/ten.tea.2008.0143
   Lunde K, 2006, NEW ENGL J MED, V355, P1199, DOI 10.1056/NEJMoa055706
   Lundy SD, 2013, STEM CELLS DEV, V22, P1991, DOI 10.1089/scd.2012.0490
   Maherali N, 2007, CELL STEM CELL, V1, P55, DOI 10.1016/j.stem.2007.05.014
   Makikallio T, 2016, LANCET, V388, P2743, DOI 10.1016/S0140-6736(16)32052-9
   Marquardt LM, 2016, CURR STEM CELL REP, V2, P207, DOI 10.1007/s40778-016-0058-0
   Masumoto H, 2014, SCI REP-UK, V4, DOI 10.1038/srep06716
   McGarvey JR, 2014, J PHARMACOL EXP THER, V350, P701, DOI 10.1124/jpet.114.215798
   Menasche P, 2015, EUR HEART J, V36, P2011, DOI 10.1093/eurheartj/ehv189
   Miki K, 2015, CELL STEM CELL, V16, P699, DOI 10.1016/j.stem.2015.04.005
   Moon SH, 2013, INT J CARDIOL, V168, P41, DOI 10.1016/j.ijcard.2012.09.077
   Mummery C, 2003, CIRCULATION, V107, P2733, DOI 10.1161/01.CIR.0000068356.38592.68
   Naito AT, 2006, P NATL ACAD SCI USA, V103, P19812, DOI 10.1073/pnas.0605768103
   Nguyen PK, 2016, JAMA CARDIOL, V1, P831, DOI 10.1001/jamacardio.2016.2225
   Nguyen PK, 2016, JAMA CARDIOL, V1, P953, DOI 10.1001/jamacardio.2016.2750
   Nunes SS, 2013, NAT METHODS, V10, P781, DOI [10.1038/nmeth.2524, 10.1038/NMETH.2524]
   Nussbaum J, 2007, FASEB J, V21, P1345, DOI 10.1096/fj.06-6769com
   Ogasawara T, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09217-x
   Okita K, 2011, NAT METHODS, V8, P409, DOI [10.1038/nmeth.1591, 10.1038/NMETH.1591]
   Ong SG, 2015, CIRCULATION, V132, P762, DOI 10.1161/CIRCULATIONAHA.114.015231
   Paige SL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011134
   Perin EC, 2003, CIRCULATION, V107, P2294, DOI 10.1161/01.CIR.0000070596.30552.8B
   Perin EC, 2012, JAMA-J AM MED ASSOC, V307, P1717, DOI 10.1001/jama.2012.418
   Pesl M, 2014, HEART VESSELS, V29, P834, DOI 10.1007/s00380-013-0436-9
   Protze SI, 2017, NAT BIOTECHNOL, V35, P56, DOI 10.1038/nbt.3745
   Rane AA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021571
   Reinecke H, 1999, CIRCULATION, V100, P193, DOI 10.1161/01.CIR.100.2.193
   Reis LA, 2012, ACTA BIOMATER, V8, P1022, DOI 10.1016/j.actbio.2011.11.030
   Ribeiro AJS, 2015, P NATL ACAD SCI USA, V112, P12705, DOI 10.1073/pnas.1508073112
   Riegler J, 2015, CIRC RES, V117, P720, DOI 10.1161/CIRCRESAHA.115.306985
   Ritner C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016004
   Schachinger V, 2006, NEW ENGL J MED, V355, P1210, DOI 10.1056/NEJMoa060186
   Seif-Naraghi SB, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005503
   Shadrin IY, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01946-x
   Shiba Y, 2016, NATURE, V538, P388, DOI 10.1038/nature19815
   Shiba Y, 2014, J CARDIOVASC PHARM T, V19, P368, DOI 10.1177/1074248413520344
   Shiba Y, 2012, NATURE, V489, P322, DOI 10.1038/nature11317
   Stadtfeld M, 2008, SCIENCE, V322, P945, DOI 10.1126/science.1162494
   Stone GW, 2016, NEW ENGL J MED, V375, P2223, DOI 10.1056/NEJMoa1610227
   Strauer BE, 2002, CIRCULATION, V106, P1913, DOI 10.1161/01.CIR.0000034046.87607.1C
   Surder D, 2013, CIRCULATION, V127, P1968, DOI 10.1161/CIRCULATIONAHA.112.001035
   Sumi T, 2008, DEVELOPMENT, V135, P2969, DOI 10.1242/dev.021121
   Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019
   Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024
   Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145
   Tohyama S, 2016, CELL METAB, V23, P663, DOI 10.1016/j.cmet.2016.03.001
   Tohyama S, 2013, CELL STEM CELL, V12, P127, DOI 10.1016/j.stem.2012.09.013
   Tonsho M, 2014, CSH PERSPECT MED, V4, DOI 10.1101/cshperspect.a015636
   Tzatzalos E, 2016, ADV DRUG DELIVER REV, V96, P234, DOI 10.1016/j.addr.2015.09.010
   Ueno S, 2007, P NATL ACAD SCI USA, V104, P9685, DOI 10.1073/pnas.0702859104
   Uosaki H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023657
   van Laake LW, 2008, CIRC RES, V102, P1008, DOI 10.1161/CIRCRESAHA.108.175505
   van Laake LW, 2007, STEM CELL RES, V1, P9, DOI 10.1016/j.scr.2007.06.001
   Veerman CC, 2015, STEM CELLS DEV, V24, P1035, DOI 10.1089/scd.2014.0533
   Warren L, 2010, CELL STEM CELL, V7, P618, DOI 10.1016/j.stem.2010.08.012
   Weinberger F, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf8781
   Weis S, 2004, J CLIN INVEST, V113, P885, DOI 10.1172/JCI200420702
   Wollert KC, 2004, LANCET, V364, P141, DOI 10.1016/S0140-6736(04)16626-9
   World Health Organization, 2014, GLOB HLTH EST DEATHS
   Xu CH, 2002, CIRC RES, V91, P501, DOI 10.1161/01.RES.0000035254.80718.91
   Yang L, 2008, NATURE, V453, P524, DOI 10.1038/nature06894
   Yang XL, 2014, CIRC RES, V114, P511, DOI 10.1161/CIRCRESAHA.114.300558
   Ye L, 2014, CELL STEM CELL, V15, P750, DOI 10.1016/j.stem.2014.11.009
   Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526
   Yu JY, 2009, SCIENCE, V324, P797, DOI 10.1126/science.1172482
   Zhang JH, 2012, CIRC RES, V111, P1125, DOI 10.1161/CIRCRESAHA.112.273144
   Zhang JH, 2009, CIRC RES, V104, pE30, DOI 10.1161/CIRCRESAHA.108.192237
   Zhang M, 2001, J MOL CELL CARDIOL, V33, P907, DOI 10.1006/jmcc.2001.1367
   Zhang YM, 2002, CIRCULATION, V106, P1294, DOI 10.1161/01.CIR.0000027585.05868.67
   Zhu KY, 2018, CIRC RES, V122, P958, DOI 10.1161/CIRCRESAHA.117.311578
   Zhu WZ, 2010, CIRC RES, V107, P776, DOI 10.1161/CIRCRESAHA.110.223917
   Ziegelhoeffer T, 2004, CIRC RES, V94, P230, DOI 10.1161/01.RES.0000110419.50982.1C
   Ziman AP, 2010, J MOL CELL CARDIOL, V48, P379, DOI 10.1016/j.yjmcc.2009.09.016
   Zwi L, 2009, CIRCULATION, V120, P1513, DOI 10.1161/CIRCULATIONAHA.109.868885
NR 133
TC 10
Z9 10
U1 2
U2 13
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD NOV
PY 2018
VL 48
IS 11
BP 974
EP 988
DI 10.4070/kcj.2018.0312
PG 15
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA HB0VT
UT WOS:000450737300003
PM 30334384
OA Green Published
DA 2021-04-22
ER

PT J
AU Kwon, SW
   Park, SD
   Moon, J
   Oh, PC
   Jang, HJ
   Park, HW
   Kim, TN
   Lee, K
   Suh, J
   Kang, W
AF Kwon, Sung Woo
   Park, Sang-Don
   Moon, Jeonggeun
   Oh, Pyung Chun
   Jang, Ho-Jun
   Park, Hyun Woo
   Kim, Tae-Noon
   Lee, Kyounghoon
   Suh, Jon
   Kang, WoongChol
TI Complete Versus Culprit-Only Revascularization for ST-Segment Elevation
   Myocardial Infarction and Multivessel Disease in the 2nd Generation
   Drug-Eluting Stent Era: Data from the INTERSTELLAR Regisry
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE ST elevation myocardial infarction; Percutaneous coronary intervention
ID PERCUTANEOUS CORONARY INTERVENTION; BARE-METAL STENTS; RANDOMIZED-TRIAL;
   MULTI-VESSEL; METAANALYSIS; THROMBOSIS; LESION; STEMI; MANAGEMENT;
   THERAPY
AB Background and Objectives: We aimed to compare outcomes of complete revascularization (CR) versus culprit-only revascularization for ST-segment elevation myocardial infarction (STEMI) and multivessel disease (MVD) in the 2nd generation drug-eluting stent (DES) era.
   Methods: From 2009 to 2014, patients with STEMI and MVD, who underwent primary percutaneous coronary intervention (PCI) using a 2nd generation DES for culprit lesions were enrolled. CR was defined as PCI for a non-infarct-related artery during the index admission. Major adverse cardiovascular event (MACE) was defined as cardiovascular (CV) death, non-fatal myocardial infarction, target lesion revascularization, or heart failure during the follow-up year.
   Results: In total, 705 MVD patients were suitable for the analysis, of whom 286 (41%) underwent culprit-only PCI and 419 (59%) underwent CR during the index admission. The incidence of MACE was 11.5% in the CR group versus 18.5% in the culprit-only group (hazard ratio [HR], 0.56; 95% confidence interval [CI], 0.37-0.86; p<0.01; adjusted HR, 0.64; 95% CI, 0.40-0.99; p=0.04). The CR group revealed a significantly lower incidence of CV death (7.2% vs. 12.9%; HR, 0.51; 95% CI, 0.31-0.86; p=0.01 and adjusted HR, 0.57; 95% CI; 0.32-0.97; p=0.03, respectively).
   Conclusions: CR was associated with better outcomes including reductions in MACE and CV death at 1 year of follow-up compared with culprit-only PCI in the 2nd generation DES era.
C1 [Kwon, Sung Woo; Park, Sang-Don] Inha Univ Hosp, Dept Cardiol, 27 Inhang Ro, Incheon 22332, South Korea.
   [Moon, Jeonggeun; Oh, Pyung Chun; Lee, Kyounghoon; Kang, WoongChol] Gachon Univ, Dept Cardiol, Gil Med Ctr, Incheon, South Korea.
   [Jang, Ho-Jun; Kim, Tae-Noon] Sejong Gen Hosp, Dept Cardiol, Bucheon, South Korea.
   [Park, Hyun Woo; Suh, Jon] Soonchunhyang Univ, Dept Cardiol, Bucheon Hosp, Bucheon, South Korea.
RP Park, SD (corresponding author), Inha Univ Hosp, Dept Cardiol, 27 Inhang Ro, Incheon 22332, South Korea.
EM denki1@inha.ac.kr
RI Kim, Tae-Hoon/AAG-3292-2021
OI Kim, Tae-Hoon/0000-0002-4032-1285; Jang, Ho-Jun/0000-0001-9891-2603;
   Kwon, Sung Woo/0000-0002-0679-1523; Suh, Jon/0000-0001-9593-8453; Oh,
   Pyung Chun/0000-0002-9955-223X
FU foundation of Inha University
FX This work was supported by the foundation of Inha University.
CR Baber U, 2011, J AM COLL CARDIOL, V58, P1569, DOI 10.1016/j.jacc.2011.06.049
   Cutlip DE, 2007, CIRCULATION, V115, P2344, DOI 10.1161/CIRCULATIONAHA.106.685313
   Dahal K, 2014, CARDIOVASC REVASCULA, V15, P408, DOI 10.1016/j.carrev.2014.10.007
   Di Lorenzo E, 2016, INT J CARDIOL, V202, P177, DOI 10.1016/j.ijcard.2015.08.123
   Di Lorenzo E, 2014, JACC-CARDIOVASC INTE, V7, P849, DOI 10.1016/j.jcin.2014.02.016
   Di Mario Carlo, 2004, Int J Cardiovasc Intervent, V6, P128
   El-Hayek GE, 2015, AM J CARDIOL, V115, P1481, DOI 10.1016/j.amjcard.2015.02.046
   Engstrom T, 2015, LANCET, V386, P665, DOI 10.1016/S0140-6736(15)60648-1
   Gershlick AH, 2015, J AM COLL CARDIOL, V65, P963, DOI 10.1016/j.jacc.2014.12.038
   Giustino G, 2015, AM J CARDIOL, V116, P845, DOI 10.1016/j.amjcard.2015.06.010
   Levine GN, 2016, J AM COLL CARDIOL, V67, P1235, DOI 10.1016/j.jacc.2015.10.005
   Mauri L, 2014, NEW ENGL J MED, V371, P2155, DOI 10.1056/NEJMoa1409312
   Narayanan MA, 2016, INT J CARDIOL, V216, P18, DOI 10.1016/j.ijcard.2016.04.054
   Navarese EP, 2011, EUROINTERVENTION, V7, P985, DOI 10.4244/EIJV7I8A155
   Nordmann AJ, 2006, EUR HEART J, V27, P2784, DOI 10.1093/eurheartj/ehl282
   Ong ATL, 2005, J AM COLL CARDIOL, V45, P2088, DOI 10.1016/j.jacc.2005.02.086
   Palmerini T, 2012, LANCET, V379, P1393, DOI 10.1016/S0140-6736(12)60324-9
   Politi L, 2010, HEART, V96, P662, DOI 10.1136/hrt.2009.177162
   Raber L, 2012, CIRCULATION, V125, P1110, DOI 10.1161/CIRCULATIONAHA.111.058560
   Sarno G, 2014, J AM COLL CARDIOL, V64, P16, DOI 10.1016/j.jacc.2014.04.022
   Steg PG, 2012, EUR HEART J, V33, P2569, DOI 10.1093/eurheartj/ehs215
   Thiele H, 2017, NEW ENGL J MED, V377, P2419, DOI 10.1056/NEJMoa1710261
   Villablanca PA, 2016, INT J CARDIOL, V220, P251, DOI 10.1016/j.ijcard.2016.06.098
   Wald DS, 2013, NEW ENGL J MED, V369, P1115, DOI 10.1056/NEJMoa1305520
   Yu XF, 2016, KOREAN CIRC J, V46, P774, DOI 10.4070/kcj.2016.46.6.774
NR 25
TC 3
Z9 3
U1 0
U2 3
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD NOV
PY 2018
VL 48
IS 11
BP 989
EP 999
DI 10.4070/kcj.2017.0387
PG 11
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA HB0VT
UT WOS:000450737300004
PM 30334385
OA Green Published
DA 2021-04-22
ER

PT J
AU Choi, KH
   Han, S
   Lee, GY
   Choi, JO
   Jeon, ES
   Lee, HY
   Lee, SE
   Kim, JJ
   Chae, SC
   Baek, SH
   Kang, SM
   Choi, DJ
   Yoo, BS
   Kim, KH
   Cho, MC
   Park, HY
   Oh, BH
AF Choi, Ki Hong
   Han, Seongwook
   Lee, Ga Yeon
   Choi, Jin-Oh
   Jeon, Eun-Seok
   Lee, Hae-Young
   Lee, Sang Eun
   Kim, Jae-Joong
   Chae, Shung Chull
   Baek, Sang Hong
   Kang, Seok-Min
   Choi, Dong-Ju
   Yoo, Byung-Su
   Kim, Kye Hun
   Cho, Myeong-Chan
   Park, Hyun-Young
   Oh, Byung-Hee
TI Prognostic Significance of Left Axis Deviation in Acute Heart Failure
   Patients with Left Bundle branch block: an Analysis from the Korean
   Acute Heart Failure (KorAHF) Registry
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Bundle-branch block; Heart failure; Electrocardiography
ID CARDIAC-RESYNCHRONIZATION THERAPY; RIGHT-VENTRICULAR FUNCTION; QRS AXIS;
   ASSOCIATION; ELECTROCARDIOGRAM; METAANALYSIS; CARDIOLOGY; MORTALITY;
   SOCIETY
AB Background and Objectives: The prognostic impact of left axis deviation (LAD) on clinical outcomes in acute heart failure syndrome (AHFS) with left bundle branch block (LBBB) is unknown. The aim of this study was to determine the prognostic significance of axis deviation in acute heart failure patients with LBBB.
   Methods: Between March 2011 and February 2014, 292 consecutive AHFS patients with LBBB were recruited from 10 tertiary university hospitals. They were divided into groups with no LAD (n=189) or with LAD (n=103) groups according to QRS axis <-30 degree. The primary outcome was all-cause mortality.
   Results: The median follow-up duration was 24 months. On multivariate analysis, the rate of all-cause death did not significantly differ between the normal axis and LAD groups (39.7% vs. 46.6%, adjusted hazard ratio, 1.01; 95% confidence interval, 0.66, 1.53; p=0.97). However, on the multiple linear regression analysis to evaluate the predictors of the left ventricular ejection fraction (LVEF), presence of LAD significantly predicted a worse LVEF (adjusted beta, -3.25; 95% confidence interval, -5.82, -0.67; p=0.01). Right ventricle (RV) dilatation was defined as at least 2 of 3 electrocardiographic criteria (late R. in lead aVR, low voltages in limb leads, and R/S ratio <1 in lead V-5 ) and was more frequent in the LAD group than in the normal axis group (p<0.001).
   Conclusions: Among the AHFS with LBBB patients, LAD did not predict mortality, but it could be used as a significant predictor of worse LVEF and RV dilatation
C1 [Choi, Ki Hong; Lee, Ga Yeon; Choi, Jin-Oh; Jeon, Eun-Seok] Sungkyunkwan Univ, Dept Med, Div Cardiol, Sch Med, Seoul, South Korea.
   [Han, Seongwook; Oh, Byung-Hee] Keimyung Univ, Dept Med, Div Cardiol, Dongsan Med Ctr, Daegu, South Korea.
   [Lee, Hae-Young; Lee, Sang Eun] Seoul Natl Univ Hosp, Dept Internal Med, Div Cardiol, Seoul, South Korea.
   [Kim, Jae-Joong] Univ Ulsan, Dept Med, Div Cardiol, Coll Med, Seoul, South Korea.
   [Chae, Shung Chull] Kyungpook Natl Univ, Dept Med, Div Cardiol, Coll Med, Daegu, South Korea.
   [Baek, Sang Hong] Catholic Univ Korea, Dept Med, Div Cardiol, Seoul, South Korea.
   [Kang, Seok-Min] Yonsei Univ, Dept Med, Div Cardiol, Coll Med, Seoul, South Korea.
   [Choi, Dong-Ju] Seoul Natl Univ, Dept Med, Div Cardiol, Bundang Hosp, Seongnam, South Korea.
   [Yoo, Byung-Su] Yonsei Univ, Dept Med, Div Cardiol, Wonju Coll Med, Wonju, South Korea.
   [Kim, Kye Hun] Chonnam Natl Univ, Heart Res Ctr, Dept Med, Div Cardiol, Gwangju, South Korea.
   [Cho, Myeong-Chan] Chungbuk Natl Univ, Dept Med, Div Cardiol, Coll Med, Cheongju, South Korea.
   [Park, Hyun-Young] NIH, Dept Biomed Sci, Div Cardiovasc & Rare Dis, Osong, South Korea.
RP Jeon, ES (corresponding author), Sungkyunkwan Univ, Samsung Med Ctr, Sch Med, Div Cardiol,Dept Med,Cardiac & Vasc Ctr, 81 Irwon Ro, Seoul 06351, South Korea.
EM esjeon1107@gmail.com
RI choi, jo/O-5940-2014
OI Lee, Hae-Young/0000-0002-9521-4102; Choi, Ki Hong/0000-0001-7511-9581;
   Han, Seongwook/0000-0002-0496-7249; Kang, Seok-Min/0000-0001-9856-9227
FU Korea Centers for Disease Control and Prevention [2010-E63003-00,
   2011-E63002-00, 2012-E63005-00, 2013-E63003-00, 2013-18 E63003-01,
   2013-E63003-02, 2016-ER6303-00]
FX This work was supported by the Research of Korea Centers for Disease
   Control and Prevention (2010-E63003-00, 2011-E63002-00, 2012-E63005-00,
   2013-E63003-00, 2013-18 E63003-01, 2013-E63003-02, and 2016-ER6303-00).
CR Baldasseroni S, 2002, AM HEART J, V143, P398, DOI 10.1067/mhj.2002.121264
   Brenyo A, 2013, J CARDIOVASC ELECTR, V24, P442, DOI 10.1111/jce.12057
   Bristow MR, 2004, NEW ENGL J MED, V350, P2140, DOI 10.1056/NEJMoa032423
   Damy T, 2013, J AM COLL CARDIOL, V61, P2153, DOI 10.1016/j.jacc.2013.02.049
   Das MK, 2001, AM HEART J, V142, P756, DOI 10.1067/mhj.2001.118735
   de Groote P, 1998, J AM COLL CARDIOL, V32, P948, DOI 10.1016/S0735-1097(98)00337-4
   DHINGRA RC, 1978, AM J CARDIOL, V42, P551, DOI 10.1016/0002-9149(78)90622-7
   FLOWERS NC, 1987, J AM COLL CARDIOL, V9, P684, DOI 10.1016/S0735-1097(87)80065-7
   Ghio S, 2001, J AM COLL CARDIOL, V37, P183, DOI 10.1016/S0735-1097(00)01102-5
   HAFT JI, 1971, CIRCULATION, V43, P279, DOI 10.1161/01.CIR.43.2.279
   HAVELDA CJ, 1982, CIRCULATION, V65, P445, DOI 10.1161/01.CIR.65.3.445
   Lee SE, 2017, KOREAN CIRC J, V47, P341, DOI 10.4070/kcj.2016.0419
   Lee SE, 2014, EUR J HEART FAIL, V16, P700, DOI 10.1002/ejhf.91
   LICHSTEIN E, 1979, AM J CARDIOL, V44, P239, DOI 10.1016/0002-9149(79)90311-4
   Park CS, 2017, KOREAN CIRC J, V47, P263, DOI 10.4070/kcj.2016.0359
   Patel PJ, 2013, AM J CARDIOL, V112, P390, DOI 10.1016/j.amjcard.2013.03.045
   Perrotta L, 2016, J CARDIOVASC ELECTR, V27, P315, DOI 10.1111/jce.12887
   Ponikowski P, 2016, EUR HEART J, V37, P2129, DOI 10.1093/eurheartj/ehw128
   RABKIN SW, 1979, AM J CARDIOL, V43, P605, DOI 10.1016/0002-9149(79)90020-1
   Rapacciuolo A, 2016, CLIN CARDIOL, V39, P640, DOI 10.1002/clc.22574
   Schiller N B, 1989, J Am Soc Echocardiogr, V2, P358
   Sharma A, 2016, AM J CARDIOL, V117, P1315, DOI 10.1016/j.amjcard.2016.01.029
   Surawicz B, 2009, J AM COLL CARDIOL, V53, P976, DOI 10.1016/j.jacc.2008.12.013
   SWIRYN S, 1980, AM J CARDIOL, V46, P53, DOI 10.1016/0002-9149(80)90605-0
   Van Bommel RJ, 2011, AM J CARDIOL, V107, P736, DOI 10.1016/j.amjcard.2010.10.051
   YANO K, 1975, AM J CARDIOL, V35, P809, DOI 10.1016/0002-9149(75)90116-2
   Zareba W, 2011, CIRCULATION, V123, P1061, DOI 10.1161/CIRCULATIONAHA.110.960898
   Zusterzeel R, 2014, JAMA INTERN MED, V174, P1340, DOI 10.1001/jamainternmed.2014.2717
NR 28
TC 2
Z9 2
U1 0
U2 2
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD NOV
PY 2018
VL 48
IS 11
BP 1002
EP 1011
DI 10.4070/kcj.2018.0048
PG 10
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA HB0VT
UT WOS:000450737300006
PM 30334387
OA Green Published
DA 2021-04-22
ER

PT J
AU Rao, ZJ
   Wang, SQ
   Bunner, WP
   Chang, Y
   Shi, RF
AF Rao, Zhijian
   Wang, Shiqiang
   Bunner, Wyatt Paul
   Chang, Yun
   Shi, Rengfei
TI Exercise induced Right Ventricular Fibrosis is Associated with
   Myocardial Damage and Inflammation
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Exercise; Fibrosis; Heart Ventricles; Heart injuries; Inflammation
ID INTENSE ENDURANCE EXERCISE; EXHAUSTIVE EXERCISE; RAT MODEL; HEART;
   IMPACT; HARM
AB Background and Objectives: Intense exercise (IE) induced myocardial fibrosis (MF) showed contradictory findings in human studies, making the relationship between IE and the development of MF unclear. This study aims to demonstrate exercise induced MF is associated with cardiac damage, and inflammation is essential to the development of exercise induced MF.
   Methods: Sprague-Dawley rats were submitted to daily 60-minutes treadmill exercise sessions at vigorous or moderate intensity, with 8-, 12-, and 16-week durations; time-matched sedentary rats served as controls. Enzyme-linked immunosorbent assay (ELISA) was used to measure serum cardiac troponin I (cTnI) concentration. After completion of the exercise protocol rats were euthanized. Biventricular morphology, ultrastructure, and collagen deposition were then examined. Protein expression of interleukin (IL)-1 beta and monocyte chemotactic protein (MCP)-1 was evaluated in both ventricles.
   Results: After IE, right but not left ventricle (LV) MF occurred. Serum cTnI levels increased and right ventricular damage was observed at the ultrastructure level in rats that were subjected to long-term IE. Leukocyte infiltration into the right ventricle (RV) rather than LV was observed after long-term IE. Long-term IE also increased protein expression of pro-inflammation factors including IL-1 beta and MCP-1 in the RV.
   Conclusions: Right ventricular damage induced by long-term IE is pathological and the following inflammatory response is essential to the development of exercise induced MF.
C1 [Rao, Zhijian; Shi, Rengfei] Shanghai Univ Sport, Sch Kinesiol, 399 Changhai Rd, Shanghai 200438, Peoples R China.
   [Rao, Zhijian; Chang, Yun] China Inst Sport Sci, Sport Hlth & Rehabil Ctr, Beijing, Peoples R China.
   [Rao, Zhijian; Bunner, Wyatt Paul] East Carolina Univ, Dept Kinesiol, Greenville, NC 27858 USA.
   [Wang, Shiqiang] Hunan Univ Technol, Zhuzhou, Peoples R China.
RP Shi, RF (corresponding author), Shanghai Univ Sport, Sch Kinesiol, 399 Changhai Rd, Shanghai 200438, Peoples R China.
EM raoz17@ecu.edu
OI Shi, Rengfei/0000-0002-8310-6526; Bunner, Wyatt/0000-0001-7590-5312
FU Key Laboratory of Exercise and Health Sciences (Shanghai University of
   Sport), Ministry of Education; National Nature Science Foundation of
   ChinaNational Natural Science Foundation of China (NSFC) [31371197,
   30800542]; Ministry of Science and Technology of ChinaMinistry of
   Science and Technology, China [CISS-BSF16-21]
FX This study was supported by Research Grants from the Key Laboratory of
   Exercise and Health Sciences (Shanghai University of Sport), Ministry of
   Education; the National Nature Science Foundation of China (31371197,
   30800542); and the fund of CISS-BSF16-21 from Ministry of Science and
   Technology of China.
CR Arbab-Zadeh A, 2014, CIRCULATION, V130, P2152, DOI 10.1161/CIRCULATIONAHA.114.010775
   Aschar-Sobbi R, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7018
   BEDFORD TG, 1979, J APPL PHYSIOL, V47, P1278
   Benito B, 2011, CIRCULATION, V123, P13, DOI 10.1161/CIRCULATIONAHA.110.938282
   Chang Y, 2015, INT J SPORTS MED, V36, P1, DOI 10.1055/s-0034-1384545
   Eijsvogels TMH, 2016, PHYSIOL REV, V96, P99, DOI 10.1152/physrev.00029.2014
   Eijsvogels TMH, 2014, AM J CARDIOL, V114, P624, DOI 10.1016/j.amjcard.2014.05.047
   Eijsvogels TMH, 2014, INT J CARDIOL, V171, pE3, DOI 10.1016/j.ijcard.2013.11.050
   Gay-Jordi G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055427
   Heidbuchel H, 2012, BRIT J SPORT MED, V46, P44, DOI 10.1136/bjsports-2012-091162
   Knackstedt C, 2015, HEART VESSELS, V30, P369, DOI 10.1007/s00380-014-0481-z
   La Gerche A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130031
   La Gerche A, 2015, CAN J CARDIOL, V31, P502, DOI 10.1016/j.cjca.2015.01.022
   La Gerche A, 2014, CIRCULATION, V130, P992, DOI 10.1161/CIRCULATIONAHA.114.008141
   La Gerche A, 2013, CURR SPORT MED REP, V12, P63, DOI 10.1249/JSR.0b013e318287488a
   La Gerche A, 2012, EUR HEART J, V33, P998, DOI 10.1093/eurheartj/ehr397
   La Gerche A, 2011, MED SCI SPORT EXER, V43, P974, DOI 10.1249/MSS.0b013e31820607a3
   Levine BD, 2014, CIRCULATION, V130, P987, DOI 10.1161/CIRCULATIONAHA.114.008142
   McDiarmid AK, 2016, CIRC-CARDIOVASC IMAG, V9, DOI 10.1161/CIRCIMAGING.115.003579
   Olah A, 2015, INT J CARDIOL, V182, P258, DOI 10.1016/j.ijcard.2014.12.045
   Pedersen BK, 2006, ESSAYS BIOCHEM, V42, P105, DOI 10.1042/bse0420105
   Prabhu SD, 2016, CIRC RES, V119, P91, DOI 10.1161/CIRCRESAHA.116.303577
   Sanchis-Gomar F, 2016, INT J CARDIOL, V222, P171, DOI 10.1016/j.ijcard.2016.07.197
   Sanchis-Gomar F, 2016, TRENDS CARDIOVAS MED, V26, P241, DOI 10.1016/j.tcm.2015.07.008
   Sato T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066724
   Schnell F, 2016, BRIT J SPORT MED, V50, P111, DOI 10.1136/bjsports-2014-094546
   Utomi V, 2014, HEART, V100, P1264, DOI 10.1136/heartjnl-2014-305904
   van de Schoor FR, 2016, MAYO CLIN PROC, V91, P1617, DOI 10.1016/j.mayocp.2016.07.012
   Wilhelm M, 2014, SCAND J MED SCI SPOR, V24, P519, DOI 10.1111/sms.12030
   Wilson M, 2011, J APPL PHYSIOL, V110, P1622, DOI 10.1152/japplphysiol.01280.2010
NR 30
TC 6
Z9 9
U1 2
U2 7
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD NOV
PY 2018
VL 48
IS 11
BP 1014
EP 1024
DI 10.4070/kcj.2018.0084
PG 11
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA HB0VT
UT WOS:000450737300008
PM 30334389
OA Green Published
DA 2021-04-22
ER

PT J
AU Lee, SJ
   Kim, JS
AF Lee, Seung-Jun
   Kim, Jung-Sun
TI Treat or Not to Treat Non-culprit Coronary Artery with Significant
   Stenosis during Primary Percutaneous Coronary Intervention
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
ID ELEVATION MYOCARDIAL-INFARCTION; ST-SEGMENT ELEVATION; MULTIVESSEL
   DISEASE; RANDOMIZED-TRIAL; REVASCULARIZATION; MANAGEMENT; VESSEL; LESION
C1 [Lee, Seung-Jun; Kim, Jung-Sun] Yonsei Univ, Coll Med, Div Cardiol, Severance Cardiovasc Hosp, 50-1 Yonsei Ro, Seoul 03722, South Korea.
RP Kim, JS (corresponding author), Yonsei Univ, Coll Med, Div Cardiol, Severance Cardiovasc Hosp, 50-1 Yonsei Ro, Seoul 03722, South Korea.
EM kjs1218@yuhs.ac
OI Kim, Jung-Sun/0000-0003-2263-3274
CR Engstrom T, 2015, LANCET, V386, P665, DOI 10.1016/S0140-6736(15)60648-1
   Gershlick AH, 2015, J AM COLL CARDIOL, V65, P963, DOI 10.1016/j.jacc.2014.12.038
   Hannan EL, 2010, JACC-CARDIOVASC INTE, V3, P22, DOI 10.1016/j.jcin.2009.10.017
   Kim I, 2017, KOREAN CIRC J, V47, P36, DOI 10.4070/kcj.2015.0358
   Kwon SW, 2018, KOREAN CIRC J, V48, P989, DOI 10.4070/kcj.2017.0387
   Levine GN, 2016, J AM COLL CARDIOL, V67, P1235, DOI 10.1016/j.jacc.2015.10.005
   Steg PG, 2012, EUR HEART J, V33, P2569, DOI 10.1093/eurheartj/ehs215
   Wald DS, 2013, NEW ENGL J MED, V369, P1115, DOI 10.1056/NEJMoa1305520
NR 8
TC 0
Z9 0
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD NOV
PY 2018
VL 48
IS 11
BP 1000
EP 1001
DI 10.4070/kcj.2018.0193
PG 2
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA HB0VT
UT WOS:000450737300005
PM 30334386
OA Green Published
DA 2021-04-22
ER

PT J
AU Choi, EK
AF Choi, Eue-Keun
TI Left Axis Deviation in Patients with Acute Heart Failure with Left
   Bundle Branch Block: Does It Really Matter?
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
ID CARDIAC RESYNCHRONIZATION THERAPY; QRS AXIS; ASSOCIATION
C1 [Choi, Eue-Keun] Seoul Natl Univ Hosp, Dept Internal Med, Div Cardiol, 101 Daehak Ro, Seoul 03080, South Korea.
RP Choi, EK (corresponding author), Seoul Natl Univ Hosp, Dept Internal Med, Div Cardiol, 101 Daehak Ro, Seoul 03080, South Korea.
EM choiek17@snu.ac.kr
RI Choi, Eue-Keun/J-5968-2014
OI Choi, Eue-Keun/0000-0002-0411-6372
CR Brenyo A, 2013, J CARDIOVASC ELECTR, V24, P442, DOI 10.1111/jce.12057
   Brignole M, 2013, EUR HEART J, V34, P2281, DOI 10.1093/eurheartj/eht150
   Choi KH, 2018, KOREAN CIRC J, V48, P1002, DOI 10.4070/kcj.2018.0048
   DHINGRA RC, 1978, AM J CARDIOL, V42, P551, DOI 10.1016/0002-9149(78)90622-7
   Park CS, 2017, KOREAN CIRC J, V47, P263, DOI 10.4070/kcj.2016.0359
   Patel PJ, 2013, AM J CARDIOL, V112, P390, DOI 10.1016/j.amjcard.2013.03.045
   Perrotta L, 2016, J CARDIOVASC ELECTR, V27, P315, DOI 10.1111/jce.12887
   Reynolds MR, 2004, PACE, V27, P1513, DOI 10.1111/j.1540-8159.2004.00669.x
NR 8
TC 0
Z9 0
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD NOV
PY 2018
VL 48
IS 11
BP 1012
EP 1013
DI 10.4070/kcj.2018.0222
PG 2
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA HB0VT
UT WOS:000450737300007
PM 30334388
OA Green Published
DA 2021-04-22
ER

PT J
AU Park, Y
   Kim, EJ
AF Park, Yoonjee
   Kim, Eung Ju
TI Prolonged Intensive Exercise: When the Right Ventricle Goes Wrong
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
C1 [Park, Yoonjee; Kim, Eung Ju] Korea Univ, Guro Hosp, Dept Internal Med, Div Cardiol, 148 Gurodong Ro, Seoul 08308, South Korea.
RP Kim, EJ (corresponding author), Korea Univ, Guro Hosp, Dept Internal Med, Div Cardiol, 148 Gurodong Ro, Seoul 08308, South Korea.
EM withnoel@empal.com
OI Kim, Eung Ju/0000-0003-2322-6267
CR Arbab-Zadeh A, 2014, CIRCULATION, V130, P2152, DOI 10.1161/CIRCULATIONAHA.114.010775
   Fukui H, 2017, KOREAN CIRC J, V47, P160, DOI 10.4070/kcj.2016.0280
   Jacques D, 2005, PEPTIDES, V26, P1427, DOI 10.1016/j.peptides.2005.03.048
   La Gerche A, 2012, EUR HEART J, V33, P998, DOI 10.1093/eurheartj/ehr397
   La Gerche A, 2011, MED SCI SPORT EXER, V43, P974, DOI 10.1249/MSS.0b013e31820607a3
   Molina CE, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.114.000858
   Rao ZJ, 2018, KOREAN CIRC J, V48, P1014, DOI 10.4070/kcj.2018.0084
   THIENE G, 1988, NEW ENGL J MED, V318, P129, DOI 10.1056/NEJM198801213180301
   van de Schoor FR, 2016, MAYO CLIN PROC, V91, P1617, DOI 10.1016/j.mayocp.2016.07.012
   Waskova-Arnostova P, 2013, CELL PHYSIOL BIOCHEM, V31, P66, DOI 10.1159/000343350
NR 10
TC 0
Z9 0
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD NOV
PY 2018
VL 48
IS 11
BP 1025
EP 1027
DI 10.4070/kcj.2018.0218
PG 3
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA HB0VT
UT WOS:000450737300009
PM 30334390
OA Green Published
DA 2021-04-22
ER

PT J
AU Youn, YJ
   Khalid, S
   Azrin, M
   Lee, J
AF Youn, Young Jin
   Khalid, Salman
   Azrin, Michael
   Lee, Juyong
TI Defining Coronary Artery Perforation with Ultrasound Contrast Agent
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
C1 [Youn, Young Jin] Yonsei Univ, Wonju Coll Med, Dept Internal Med, Div Cardiol, Wonju, South Korea.
   [Khalid, Salman; Azrin, Michael; Lee, Juyong] Univ Connecticut, Sch Med, Calhoun Cardiovasc Ctr, Div Cardiovasc Med, 263 Farmington Ave, Farmington, CT 06030 USA.
RP Azrin, M (corresponding author), Univ Connecticut, Sch Med, Calhoun Cardiovasc Ctr, Div Cardiovasc Med, 263 Farmington Ave, Farmington, CT 06030 USA.
EM azrin@uchc.edu
OI Lee, Juyong/0000-0001-5412-5472; Youn, Young Jin/0000-0001-7066-7474;
   Azrin, Michael/0000-0002-2669-0703
CR ELLIS SG, 1994, CIRCULATION, V90, P2725, DOI 10.1161/01.CIR.90.6.2725
   Main ML, 2014, JACC-CARDIOVASC IMAG, V7, P40, DOI 10.1016/j.jcmg.2013.08.012
   Muskula PR, 2017, CIRC-CARDIOVASC IMAG, V10, DOI 10.1161/CIRCIMAGING.116.005459
   Oreglia JA, 2010, CATHETER CARDIO INTE, V76, P975, DOI 10.1002/ccd.22551
NR 4
TC 0
Z9 0
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD NOV
PY 2018
VL 48
IS 11
BP 1028
EP 1029
DI 10.4070/kcj.2018.0179
PG 2
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA HB0VT
UT WOS:000450737300010
PM 30334391
OA Green Published
DA 2021-04-22
ER

PT J
AU Lee, JH
   Kim, U
AF Lee, Jung-Hee
   Kim, Ung
TI Optical Coherence Tomography-guided Treatment of Multiple Stent Fracture
   in Patients with Overlapping Drug-eluting Stents
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
ID OUTCOMES
C1 [Lee, Jung-Hee; Kim, Ung] Yeungnam Univ, Coll Med, Med Ctr, Div Cardiol, 170 Hyeonchung Ro, Daegu 42415, South Korea.
RP Lee, JH (corresponding author), Yeungnam Univ, Coll Med, Med Ctr, Div Cardiol, 170 Hyeonchung Ro, Daegu 42415, South Korea.
EM seranflute@gmail.com
FU Yeungnam University, Korea
FX This work was supported by a grant from the Yeungnam University, Korea.
CR Doi H, 2009, AM J CARDIOL, V103, P818, DOI 10.1016/j.amjcard.2008.11.051
   Kan J, 2016, JACC-CARDIOVASC INTE, V9, P1115, DOI 10.1016/j.jcin.2016.02.025
   Kim U, 2012, INT J CARDIOL, V158, P83, DOI 10.1016/j.ijcard.2011.01.013
NR 3
TC 0
Z9 0
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD NOV
PY 2018
VL 48
IS 11
BP 1030
EP 1031
DI 10.4070/kcj.2018.0138
PG 2
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA HB0VT
UT WOS:000450737300011
PM 30334392
OA Green Published
DA 2021-04-22
ER

PT J
AU Kupka, D
   Sibbing, D
AF Kupka, Danny
   Sibbing, Dirk
TI De-Escalation of P2Y(12) Receptor Inhibitor Therapy after Acute Coronary
   Syndromes in Patients Undergoing Percutaneous Coronary Intervention
SO KOREAN CIRCULATION JOURNAL
LA English
DT Review
DE Acute coronary syndrome; P2Y(12) Inhibitors; DAPT de-escalation
ID TREATMENT PLATELET REACTIVITY; DUAL ANTIPLATELET THERAPY; ANTITHROMBOTIC
   THERAPY; PRIMARY ANGIOPLASTY; CLINICAL-OUTCOMES; EXPERT CONSENSUS; STENT
   THROMBOSIS; OPEN-LABEL; CLOPIDOGREL; PRASUGREL
AB Dual antiplatelet therapy (DAPT) - a combination of a P2Y(12) receptor inhibitor and aspirin - has revolutionized antithrombotic treatment. Potent P2Y(12) inhibitors such as prasugrel and ticagrelor exhibit a strong and more consistent platelet inhibition when compared to clopidogrel. Therefore, ticagrelor and prasugrel significantly reduce ischemic events, but at an expense of an increased bleeding risk in acute coronary syndrome (ACS) patients undergoing percutaneous coronary intervention (PCI). These observations have engaged intensive clinical research in alternative DAPT regimens to achieve sufficient platelet inhibition with an acceptable bleeding risk. Our review focusses on P2Y(12) receptor therapy de-escalation defined as a switch from a potent antiplatelet agent (ticagrelor or prasugrel) to clopidogrel. Recently, both unguided (platelet function testing independent) and guided (platelet function testing dependent) DAPT de-escalation strategies have been investigated in different clinical studies and both switching strategies could be possible options to prevent bleeding complications without increasing ischemic risk. In light of the still limited data currently available, future large-scale trials should accumulate more data on various DAPT de-escalation regimens with both ticagrelor and prasugrel in unguided and guided de-escalation approaches. In the current review we aim at summarizing and discussing the current evidence on this still emerging topic in the field of antiplatelet treatment.
C1 [Kupka, Danny; Sibbing, Dirk] Ludwig Maximilians Univ Munchen, Dept Cardiol, Marchioninistr 15, D-81377 Munich, Germany.
   [Kupka, Danny; Sibbing, Dirk] DZHK German Ctr Cardiovasc Res, Munich Heart Alliance, Munich, Germany.
RP Kupka, D; Sibbing, D (corresponding author), Ludwig Maximilians Univ Munchen, Dept Cardiol, Marchioninistr 15, D-81377 Munich, Germany.
EM danny.kupka@med.uni-muenchen.de; dirk.sibbing@med.uni-muenchen.de
OI kupka, danny/0000-0002-6125-4114
CR Alexopoulos D, 2017, PLATELETS, V28, P691, DOI 10.1080/09537104.2016.1265919
   Alexopoulos D, 2014, AM HEART J, V167, P68, DOI 10.1016/j.ahj.2013.10.010
   Amsterdam EA, 2014, J AM COLL CARDIOL, V64, pE139, DOI 10.1016/j.jacc.2014.09.017
   Angiolillo DJ, 2017, CIRCULATION, V136, P1955, DOI 10.1161/CIRCULATIONAHA.117.031164
   Antman EM, 2008, J AM COLL CARDIOL, V51, P2028, DOI [10.1016/j.jacc.2008.04.002, 10.1016/j.jacc.2007.10.001]
   Aradi D, 2015, EUR HEART J, V36, P1762, DOI 10.1093/eurheartj/ehv104
   Bagai A, 2015, EUR HEART J-ACUTE CA, V4, P499, DOI 10.1177/2048872614564082
   Becker RC, 2011, EUR HEART J, V32, P2933, DOI 10.1093/eurheartj/ehr422
   Bonaca MP, 2016, JAMA CARDIOL, V1, P425, DOI 10.1001/jamacardio.2016.1017
   Bonaca MP, 2015, NEW ENGL J MED, V372, P1791, DOI 10.1056/NEJMoa1500857
   Cannon CP, 2017, NEW ENGL J MED, V377, P1513, DOI 10.1056/NEJMoa1708454
   Cayla G, 2016, LANCET, V388, P2015, DOI 10.1016/S0140-6736(16)31323-X
   Clemmensen P, 2015, EUR HEART J-ACUTE CA, V4, P220, DOI 10.1177/2048872614547449
   Cuisset T, 2017, EUR HEART J, V38, P3070, DOI 10.1093/eurheartj/ehx175
   De Luca L, 2017, EUROINTERVENTION, V13, P459, DOI 10.4244/EIJ-D-17-00092
   De Luca L, 2015, EUR HEART J-ACUTE CA, V4, P441, DOI 10.1177/2048872614560505
   Deharo P, 2017, JACC-CARDIOVASC INTE, V10, P2560, DOI 10.1016/j.jcin.2017.08.044
   Franchi F, 2015, NAT REV CARDIOL, V12, P30, DOI 10.1038/nrcardio.2014.156
   Gurbel PA, 2003, CIRCULATION, V107, P2908, DOI 10.1161/01.CIR.0000072771.11429.83
   Gurbel PA, 2005, J AM COLL CARDIOL, V46, P1827, DOI 10.1016/j.jacc.2005.07.056
   Ibanez B, 2018, EUR HEART J, V39, P119, DOI 10.1093/eurheartj/ehx393
   Levine GN, 2014, NAT REV CARDIOL, V11, P597, DOI 10.1038/nrcardio.2014.104
   Mega JL, 2010, LANCET, V376, P1312, DOI 10.1016/S0140-6736(10)61273-1
   Mega JL, 2010, JAMA-J AM MED ASSOC, V304, P1821, DOI 10.1001/jama.2010.1543
   Mega JL, 2009, NEW ENGL J MED, V360, P354, DOI 10.1056/NEJMoa0809171
   Montalescot G, 2009, LANCET, V373, P723, DOI 10.1016/S0140-6736(09)60441-4
   Motovska Z, 2018, J AM COLL CARDIOL, V71, P371, DOI 10.1016/j.jacc.2017.11.008
   Motovska Z, 2016, CIRCULATION, V134, P1603, DOI 10.1161/CIRCULATIONAHA.116.024823
   Roffi M, 2016, EUR HEART J, V37, P267, DOI 10.1093/eurheartj/ehv320
   Rollini F, 2016, NAT REV CARDIOL, V13, P11, DOI 10.1038/nrcardio.2015.113
   Saito S, 2014, CIRC J, V78, P1684, DOI 10.1253/circj.CJ-13-1482
   Schomig A, 1996, NEW ENGL J MED, V334, P1084, DOI 10.1056/NEJM199604253341702
   Sibbing D, 2018, EUR HEART J, V39, P2749, DOI 10.1093/eurheartj/ehy332
   Sibbing D, 2017, LANCET, V390, P1747, DOI 10.1016/S0140-6736(17)32155-4
   Sibbing D, 2017, THROMB HAEMOSTASIS, V117, P1240, DOI 10.1160/TH16-12-0963
   Sibbing D, 2017, THROMB HAEMOSTASIS, V117, P188, DOI 10.1160/TH16-07-0557
   Sibbing D, 2016, LANCET, V388, P1962, DOI 10.1016/S0140-6736(16)31387-3
   Sibbing D, 2009, J AM COLL CARDIOL, V53, P849, DOI 10.1016/j.jacc.2008.11.030
   Stone GW, 2013, LANCET, V382, P614, DOI 10.1016/S0140-6736(13)61170-8
   Tantry US, 2013, J AM COLL CARDIOL, V62, P2261, DOI 10.1016/j.jacc.2013.07.101
   Valgimigli M, 2018, EUR HEART J, V39, P213, DOI 10.1093/eurheartj/ehx419
   Velders MA, 2016, HEART, V102, P617, DOI 10.1136/heartjnl-2015-308963
   Wallentin L, 2010, LANCET, V376, P1320, DOI 10.1016/S0140-6736(10)61274-3
   Wallentin L, 2009, NEW ENGL J MED, V361, P1045, DOI 10.1056/NEJMoa0904327
   Wiviott SD, 2008, CIRCULATION, V118, P1626, DOI 10.1161/CIRCULATIONAHA.108.791061
   Wiviott SD, 2007, NEW ENGL J MED, V357, P2001, DOI 10.1056/NEJMoa0706482
   Zettler ME, 2017, AM HEART J, V183, P62, DOI 10.1016/j.ahj.2016.10.006
NR 47
TC 6
Z9 7
U1 0
U2 5
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD OCT
PY 2018
VL 48
IS 10
BP 863
EP 872
DI 10.4070/kcj.2018.0255
PG 10
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA HB0VB
UT WOS:000450735300001
PM 30238704
OA Green Published
DA 2021-04-22
ER

PT J
AU Sabbag, A
   Yao, XX
   Siontis, KC
   Noseworthy, PA
AF Sabbag, Avi
   Yao, Xiaoxi
   Siontis, Konstantinos C.
   Noseworthy, Peter A.
TI Anticoagulation for Stroke Prevention in Older Adults with Atrial
   Fibrillation and Comorbidity: Current Evidence and Treatment Challenges
SO KOREAN CIRCULATION JOURNAL
LA English
DT Review
DE Frailty; Warfarin; NOAC; Stroke; Bleeding
ID CHRONIC KIDNEY-DISEASE; VITAMIN-K ANTAGONISM; STAGE RENAL-DISEASE;
   ANTITHROMBOTIC THERAPY; ELDERLY-PATIENTS; ORAL ANTICOAGULATION;
   CLINICAL-PRACTICE; INTRACRANIAL HEMORRHAGE; RISK STRATIFICATION;
   SYSTEMIC EMBOLISM
AB The burden of atrial fibrillation (AF) is projected to increase substantially over the next decade in parallel with the aging of the population. The increasing age, level of comorbidity, and polypharmacy will complicate the treatment of older adults with AF. For instance, advanced age and chronic kidney disease have been shown to increase the risk of both thromboembolism and bleeding in patients with AF. Frailty, recurrent falls and polypharmacy, while very common among elderly patients with AF, are often overlooked in the clinical decision making despite their significant interaction with oral anticoagulant (OAC) and profound impact on the patient's clinical outcomes. Such factors should be recognized, evaluated and considered in a comprehensive decision-making process. The introduction of non-vitamin K oral anticoagulants has radically changed the management of AF allowing for a more individualized selection of OAC. An understanding of the available data regarding the performance of each of the available OAC in a variety of at risk patient populations is paramount for the safe and effective management of this patient population. The aim of this review is to appraise the current evidence, point out the gaps in knowledge, and provide recommendations regarding stroke prevention in older adults with AF and comorbid conditions.
C1 [Sabbag, Avi; Siontis, Konstantinos C.; Noseworthy, Peter A.] Mayo Clin, Dept Cardiovasc Dis, Rochester, MN USA.
   [Yao, Xiaoxi; Noseworthy, Peter A.] Mayo Clin, Robert D & Patricia E Kern Ctr Sci Hlth Care Deli, Rochester, MN USA.
RP Noseworthy, PA (corresponding author), Mayo Clin, Div Cardiovasc Dis, Coll Med, 200 First St SW, Rochester, MN 55905 USA.
EM noseworthy.peter@mayo.edu
RI Sabbag, Avi/AAA-1532-2021
OI sabbag, avi/0000-0003-4295-6679
CR Bandeen-Roche K, 2015, J GERONTOL A-BIOL, V70, P1427, DOI 10.1093/gerona/glv133
   Banerjee A, 2014, AM J MED, V127, P972, DOI 10.1016/j.amjmed.2014.05.035
   Bansal N, 2013, CIRCULATION, V127, P569, DOI 10.1161/CIRCULATIONAHA.112.123992
   Battistella M, 2005, ARCH INTERN MED, V165, P189, DOI 10.1001/archinte.165.2.189
   BENIGNI A, 1993, AM J KIDNEY DIS, V22, P668, DOI 10.1016/S0272-6386(12)80429-X
   Bohm M, 2015, J AM COLL CARDIOL, V65, P2481, DOI 10.1016/j.jacc.2015.03.577
   Bohula EA, 2016, CIRCULATION, V134, P24, DOI 10.1161/CIRCULATIONAHA.116.022361
   Bonde AN, 2014, J AM COLL CARDIOL, V64, P2471, DOI 10.1016/j.jacc.2014.09.051
   Brodsky SV, 2011, KIDNEY INT, V80, P182, DOI 10.1038/ki.2011.44
   Brodsky SV, 2010, NEPHRON CLIN PRACT, V115, pC142, DOI 10.1159/000312877
   Brodsky SV, 2009, AM J KIDNEY DIS, V54, P1121, DOI 10.1053/j.ajkd.2009.04.024
   Bushardt RL, 2008, CLIN INTERV AGING, V3, P383, DOI 10.2147/CIA.S2468
   Chan KE, 2015, CIRCULATION, V131, P972, DOI 10.1161/CIRCULATIONAHA.114.014113
   Chan YH, 2018, INT J CARDIOL, V265, P83, DOI 10.1016/j.ijcard.2018.02.075
   Chang SH, 2017, JAMA-J AM MED ASSOC, V318, P1250, DOI 10.1001/jama.2017.13883
   Chao TF, 2018, CIRCULATION, V138, P37, DOI 10.1161/CIRCULATIONAHA.117.031658
   Chokesuwattanaskul R, 2018, PACE, V41, P627, DOI 10.1111/pace.13331
   Chugh SS, 2014, CIRCULATION, V129, P837, DOI 10.1161/CIRCULATIONAHA.113.005119
   De Vriese AS, 2015, AM J KIDNEY DIS, V66, P91, DOI 10.1053/j.ajkd.2015.01.022
   Donze J, 2012, AM J MED, V125, P773, DOI 10.1016/j.amjmed.2012.01.033
   Fox KAA, 2011, EUR HEART J, V32, P2387, DOI 10.1093/eurheartj/ehr342
   Friberg L, 2012, EUR HEART J, V33, P1500, DOI 10.1093/eurheartj/ehr488
   Fried LP, 2001, J GERONTOL A-BIOL, V56, pM146, DOI 10.1093/gerona/56.3.M146
   Gage BF, 2005, AM J MED, V118, P612, DOI 10.1016/j.amjmed.2005.02.022
   Gale CR, 2015, AGE AGEING, V44, P162, DOI [10.1093/ageing/afv154, 10.1093/ageing/afu148]
   Galloway PAG, 2015, NEPHRON, V129, P197, DOI 10.1159/000371449
   Garwood CL, 2008, ANN PHARMACOTHER, V42, P523, DOI 10.1345/aph.1K498
   Giugliano RP, 2013, NEW ENGL J MED, V369, P2093, DOI 10.1056/NEJMoa1310907
   Gomez C, 2015, GERONTOLOGY, V61, P301, DOI 10.1159/000365328
   Granger CB, 2011, NEW ENGL J MED, V365, P981, DOI 10.1056/NEJMoa1107039
   Halperin JL, 2014, CIRCULATION, V130, P138, DOI 10.1161/CIRCULATIONAHA.113.005008
   Halvorsen S, 2014, EUR HEART J, V35, P1864, DOI 10.1093/eurheartj/ehu046
   Hart RG, 1999, ANN INTERN MED, V131, P492, DOI 10.7326/0003-4819-131-7-199910050-00003
   Hart RG, 2007, NEUROLOGY, V69, P546
   Hart RG, 2013, CAN J CARDIOL, V29, pS71, DOI 10.1016/j.cjca.2013.04.005
   Harttgen K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075847
   Hijazi Z, 2016, JAMA CARDIOL, V1, P451, DOI 10.1001/jamacardio.2016.1170
   Hijazi Z, 2014, CIRCULATION, V129, P961, DOI 10.1161/CIRCULATIONAHA.113.003628
   Hohnloser SH, 2012, EUR HEART J, V33, P2821, DOI 10.1093/eurheartj/ehs274
   Holbrook A, 2012, CHEST, V141, pE152S, DOI 10.1378/chest.11-2295
   Hwang HS, 2014, AM J NEPHROL, V40, P345, DOI 10.1159/000368422
   January CT, 2014, J AM COLL CARDIOL, V64, pE1, DOI 10.1016/j.jacc.2014.03.022
   Jaspers Focks Jeroen, 2016, BMJ, V353, pi2868, DOI 10.1136/bmj.i2868
   Jha V, 2013, LANCET, V382, P260, DOI 10.1016/S0140-6736(13)60687-X
   Kanapuru B, 2009, AM J MED, V122, P605, DOI 10.1016/j.amjmed.2009.01.030
   Kato ET, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.116.003432
   Kaufman DW, 2002, JAMA-J AM MED ASSOC, V287, P337, DOI 10.1001/jama.287.3.337
   Kim SW, 2017, ARCH GERONTOL GERIAT, V70, P1, DOI 10.1016/j.archger.2016.12.001
   Kimachi M, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD011373.pub2
   Kirchhof P, 2016, EUROPACE, V18, DOI 10.1093/europace/euw295
   Kooiman J, 2011, J THROMB HAEMOST, V9, P1652, DOI 10.1111/j.1538-7836.2011.04347.x
   Koretsune Y, 2015, CIRC J, V79, P1486, DOI 10.1253/circj.CJ-14-0942
   Kubitza D, 2010, BRIT J CLIN PHARMACO, V70, P703, DOI 10.1111/j.1365-2125.2010.03753.x
   Lau YC, 2016, J AM COLL CARDIOL, V68, P1452, DOI 10.1016/j.jacc.2016.06.057
   Lauw MN, 2017, HEART, V103, P1015, DOI 10.1136/heartjnl-2016-310358
   Lee JG, 2013, CEREBROVASC DIS, V35, P53, DOI 10.1159/000345087
   Lefebvre MCD, 2016, CAN J CARDIOL, V32, P169, DOI 10.1016/j.cjca.2015.05.012
   Levin A, 2013, KIDNEY INT SUPPL, V3, P5, DOI 10.1038/kisup.2012.77
   Lim LM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173466
   Lip GYH, 2018, AM J MED, V131, DOI 10.1016/j.amjmed.2017.11.046
   Lip GYH, 2010, CHEST, V137, P263, DOI 10.1378/chest.09-1584
   Lomashvili KA, 2011, J BIOL CHEM, V286, P28715, DOI 10.1074/jbc.M111.251462
   Lopes RD, 2017, BLOOD, V129, P2980, DOI 10.1182/blood-2016-08-731638
   Maher RL, 2014, EXPERT OPIN DRUG SAF, V13, P57, DOI 10.1517/14740338.2013.827660
   Man-Son-Hing M, 1999, ARCH INTERN MED, V159, P677, DOI 10.1001/archinte.159.7.677
   Mant J, 2007, LANCET, V370, P493, DOI 10.1016/S0140-6736(07)61233-1
   Martinez BK, 2018, J AM HEART ASSOC, V7, DOI 10.1161/JAHA.118.008643
   Mavrakanas TA, 2017, J AM SOC NEPHROL, V28, P2241, DOI 10.1681/ASN.2016090980
   Miyasaka Y, 2006, CIRCULATION, V114, P119, DOI 10.1161/CIRCULATIONAHA.105.595140
   Molshatzki N, 2011, CEREBROVASC DIS, V31, P271, DOI 10.1159/000322155
   Nelson SE, 2012, J AM HEART ASSOC, V1, DOI 10.1161/JAHA.112.002097
   Ng KP, 2013, AM J KIDNEY DIS, V62, P615, DOI 10.1053/j.ajkd.2013.02.381
   Nigwekar SU, 2016, J AM SOC NEPHROL, V27, P3421, DOI 10.1681/ASN.2015091065
   Olesen JB, 2012, NEW ENGL J MED, V367, P625, DOI 10.1056/NEJMoa1105594
   Olesen JB, 2011, THROMB HAEMOSTASIS, V106, P739, DOI 10.1160/TH11-05-0364
   Patel MR, 2010, NEW ENGL J MED, V362, P886, DOI 10.1056/NEJMoa0907272
   Perera V, 2009, AGE AGEING, V38, P156, DOI 10.1093/ageing/afn293
   Piccini JP, 2016, CIRCULATION, V133, P352, DOI 10.1161/CIRCULATIONAHA.115.018544
   Piccini JP, 2013, CIRCULATION, V127, P224, DOI 10.1161/CIRCULATIONAHA.112.107128
   Pisters R, 2010, CHEST, V138, P1093, DOI 10.1378/chest.10-0134
   Poli D, 2012, THROMB HAEMOSTASIS, V107, P1100, DOI 10.1160/TH11-10-0721
   Polidoro A, 2013, ARCH GERONTOL GERIAT, V57, P325, DOI 10.1016/j.archger.2013.04.014
   Proietti M, 2016, CLIN RES CARDIOL, V105, P412, DOI 10.1007/s00392-015-0936-y
   Providencia R, 2014, AM J CARDIOL, V114, P646, DOI 10.1016/j.amjcard.2014.05.048
   Rao MP, 2018, AM J MED, V131, P269, DOI 10.1016/j.amjmed.2017.10.036
   Rockwood K, 2005, CAN MED ASSOC J, V173, P489, DOI 10.1503/cmaj.050051
   Rockwood K, 2004, J GERONTOL A-BIOL, V59, P1310, DOI 10.1093/gerona/59.12.1310
   Roldan V, 2013, THROMB HAEMOSTASIS, V109, P956, DOI 10.1160/TH13-01-0054
   Romanelli RJ, 2016, CIRC-CARDIOVASC QUAL, V9, P126, DOI 10.1161/CIRCOUTCOMES.115.002369
   Segal JB, 2017, MED CARE, V55, P716, DOI 10.1097/MLR.0000000000000729
   Seliger SL, 2003, J AM SOC NEPHROL, V14, P2623, DOI 10.1097/01.ASN.0000088722.56342.A8
   Shah M, 2014, CIRCULATION, V129, P1196, DOI 10.1161/CIRCULATIONAHA.113.004777
   Shamliyan T, 2013, AGEING RES REV, V12, P719, DOI 10.1016/j.arr.2012.03.001
   Siontis KC, 2018, CIRCULATION
   Sohal AS, 2006, THROMB RES, V118, P417, DOI 10.1016/j.thromres.2005.03.032
   Soliman EZ, 2010, AM HEART J, V159, P1102, DOI 10.1016/j.ahj.2010.03.027
   Sourial N, 2010, J CLIN EPIDEMIOL, V63, P647, DOI 10.1016/j.jclinepi.2009.08.007
   Stangier J, 2010, CLIN PHARMACOKINET, V49, P259, DOI 10.2165/11318170-000000000-00000
   Steffel J, 2018, EUR HEART J, V39, P1330, DOI 10.1093/eurheartj/ehy136
   Steffel J, 2016, J AM COLL CARDIOL, V68, P1169, DOI 10.1016/j.jacc.2016.06.034
   Wang XL, 2016, J CLIN PHARMACOL, V56, P628, DOI 10.1002/jcph.628
   Wang Yishen, 2016, Pharmacy Pract (Granada), V14, DOI 10.18549/PharmPract.2016.02.706
   Ware K, 2011, J AM SOC NEPHROL, V22, P1856, DOI 10.1681/ASN.2010101110
   Watanabe H, 2009, AM HEART J, V158, P629, DOI 10.1016/j.ahj.2009.06.031
   Yagmur E, 2015, CLIN APPL THROMB-HEM, V21, P132, DOI 10.1177/1076029613490828
   Yang FL, 2017, HEART, V103, P818, DOI 10.1136/heartjnl-2016-309266
   Yao XX, 2017, J AM COLL CARDIOL, V70, P2621, DOI 10.1016/j.jacc.2017.09.1087
   Zimmerman D, 2012, NEPHROL DIAL TRANSPL, V27, P3816, DOI 10.1093/ndt/gfs416
NR 108
TC 5
Z9 5
U1 0
U2 5
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD OCT
PY 2018
VL 48
IS 10
BP 873
EP 889
DI 10.4070/kcj.2018.0261
PG 17
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA HB0VB
UT WOS:000450735300002
PM 30238705
OA Green Published
DA 2021-04-22
ER

PT J
AU Chung, FP
   Lin, CY
   Lin, YJ
   Chang, SL
   Lo, LW
   Hu, YF
   Tuan, TC
   Chao, TF
   Liao, JN
   Chang, TY
   Chen, SA
AF Chung, Fa-Po
   Lin, Chin-Yu
   Lin, Yenn-Jiang
   Chang, Shih-Lin
   Lo, Li-Wei
   Hu, Yu-Feng
   Tuan, Ta-Chuan
   Chao, Tze-Fan
   Liao, Jo-Nan
   Chang, Ting-Yung
   Chen, Shih-Ann
TI Catheter Ablation of Ventricular Tachycardia in Arrhythmogenic Right
   Ventricular Dysplasia/Cardiomyopathy
SO KOREAN CIRCULATION JOURNAL
LA English
DT Review
DE Arrhythmogenic right ventricular dysplasia-cardiomyopathy; Catheter
   ablation; Percutaneous epicardial mapping; Ventricular tachycardia
ID CARDIOVERTER-DEFIBRILLATOR THERAPY; ADIPOSE-TISSUE THICKNESS; LONG-TERM
   SUCCESS; EPICARDIAL ABLATION; SUBSTRATE ABLATION; END-POINT; NONISCHEMIC
   CARDIOMYOPATHY; ELECTROANATOMIC SUBSTRATE; RISK STRATIFICATION;
   DIAGNOSTIC-VALUE
AB Arrhythmogenic right ventricular dysplasia/cardiomyopathy (ARVD/C) is predominantly an inherited cardiomyopathy with typical histopathological characteristics of fibro-fatty infiltration mainly involving the right ventricular (RV) inflow tract, RV outflow tract, and RV apex in the majority of patients. The above pathologic evolution frequently brings patients with ARVD/C to medical attention owing to the manifestation of syncope, sudden cardiac death (SCD), ventricular arrhythmogenesis, or heart failure. To prevent future or recurrent SCD, an implantable cardiac defibrillator (ICD) is highly desirable in patients with ARVD/C who had experienced unexplained syncope, hemodynamically intolerable ventricular tachycardia (VT), ventricular fibrillation, and/or aborted SCD. Notably, the management of frequent ventricular tachyarrhythmias in ARVD/C is challenging, and the use of antiarrhythmic drugs could be unsatisfactory or limited by the unfavorable side effects. Therefore, radiofrequency catheter ablation (RFCA) has been implemented to treat the drug-refractory VT in ARVD/C for decades. However, the initial understanding of the link between fibro-fatty pathogenesis and ventricular arrhythmogenesis in ARVD/C is scarce, the efficacy and prognosis of endocardial RFCA alone were limited and disappointing. The electrophysiologists had broken through this frontier after better illustration of epicardial substrates and broadly application of epicardial approaches in ARVD/C. In recent works of literature, the application of epicardial ablation also successfully results in higher procedural success and decreases VT recurrences in patients with ARVD/C who are refractory to the endocardial approach during long-term follow-up. In this article, we review the important evolution on the delineation of arrhythmogenic substrates, ablation strategies, and ablation outcome of VT in patients with ARVD/C.
C1 [Chung, Fa-Po; Lin, Chin-Yu; Lin, Yenn-Jiang; Chang, Shih-Lin; Lo, Li-Wei; Hu, Yu-Feng; Tuan, Ta-Chuan; Chao, Tze-Fan; Liao, Jo-Nan; Chang, Ting-Yung; Chen, Shih-Ann] Taipei Vet Gen Hosp, Heart Rhythm Ctr, Div Cardiol, Dept Med, 201 Sect 2,Shipai Rd, Taipei 11217, Taiwan.
   [Chung, Fa-Po; Lin, Chin-Yu; Lin, Yenn-Jiang; Chang, Shih-Lin; Lo, Li-Wei; Hu, Yu-Feng; Tuan, Ta-Chuan; Chao, Tze-Fan; Liao, Jo-Nan; Chang, Ting-Yung; Chen, Shih-Ann] Natl Yang Ming Univ, Inst Clin Med, Cardiovasc Res Ctr, Taipei, Taiwan.
   [Lin, Chin-Yu] Taipei Vet Gen Hosp, Dept Internal Med, Yuan Shan Branch, I LAN, Taipei, Taiwan.
RP Chen, SA (corresponding author), Taipei Vet Gen Hosp, Heart Rhythm Ctr, Div Cardiol, Dept Med, 201 Sect 2,Shipai Rd, Taipei 11217, Taiwan.
EM epsachen@ms41.hinet.net
OI Chung, Fa-Po/0000-0001-8960-1301; Lin, Chin-Yu/0000-0003-3282-7523;
   Liao, Jo-Nan/0000-0001-8033-127X
FU Center for Dynamical Biomarkers and Translational Medicine, Ministry of
   Science and Technology [MOST 106-2314-B-075-006-MY3, MOST
   106-2314-B-010-046-MY3, MOST 106-2314-B-075-073-MY3, MOST
   104-2314-B-010-063-MY2, MOST 104-2314-B-075-089-MY3]; Research
   Foundation of Cardiovascular Medicine, TVGH-NTUH Joint Research Program
   [VGHUST105-G7-9-1, VGHUST105-G7-4-1, VGHUST104-G7-3-1]; Szu-Yuan
   Research Foundation of Internal Medicine; Taipei Veterans General
   HospitalTaipei Veterans General Hospital [V104B-018, V104E7-001,
   V104C-121, V104C-109, V105B-014, V105C-122, V105C-116, V106C-158,
   V106B-010, V106C-104, V107B-014, V107C-060, V107C-054]
FX This work was supported by the Center for Dynamical Biomarkers and
   Translational Medicine, Ministry of Science and Technology (Grant No.
   MOST 106-2314-B-075-006-MY3, MOST 106-2314-B-010-046-MY3, MOST
   106-2314-B-075-073-MY3, MOST 104-2314-B-010-063-MY2, MOST
   104-2314-B-075-089-MY3), Research Foundation of Cardiovascular Medicine,
   TVGH-NTUH Joint Research Program (Grant No. VGHUST105-G7-9-1,
   VGHUST105-G7-4-1, VGHUST104-G7-3-1), Szu-Yuan Research Foundation of
   Internal Medicine and Taipei Veterans General Hospital (Grant No.
   V104B-018, V104E7-001, V104C-121, V104C-109, V105B-014, V105C-122,
   V105C-116, V106C-158, V106B-010, V106C-104, V107B-014, V107C-060, and
   V107C-054).
CR Aliot EM, 2009, HEART RHYTHM, V6, P886, DOI 10.1016/j.hrthm.2009.04.030
   Anter E, 2016, CIRCULATION, V134, P314, DOI 10.1161/CIRCULATIONAHA.116.021955
   Arenal A, 2004, CIRCULATION, V110, P2568, DOI 10.1161/01.CIR.0000145544.35565.47
   Avella A, 2008, J CARDIOVASC ELECTR, V19, P1127, DOI 10.1111/j.1540-8167.2008.01228.x
   Aydin E, 2017, ACTA CARDIOL SIN, V33, P266, DOI 10.6515/ACS20161023A
   Aziz Zaid, 2018, Curr Treat Options Cardiovasc Med, V20, P34, DOI 10.1007/s11936-018-0615-1
   Bai R, 2006, J CARDIOVASC ELECTR, V17, P944, DOI 10.1111/j.1540-8167.2006.00536.x
   Bai R, 2011, CIRC-ARRHYTHMIA ELEC, V4, P478, DOI 10.1161/CIRCEP.111.963066
   Basso C, 1996, CIRCULATION, V94, P983, DOI 10.1161/01.CIR.94.5.983
   Bazan V, 2006, HEART RHYTHM, V3, P1132, DOI 10.1016/j.hrthm.2006.06.024
   Berruezo A, 2015, CIRC-ARRHYTHMIA ELEC, V8, P326, DOI 10.1161/CIRCEP.114.002386
   Bhonsale A, 2011, J AM COLL CARDIOL, V58, P1485, DOI 10.1016/j.jacc.2011.06.043
   Campos B, 2015, HEART RHYTHM, V12, P95, DOI 10.1016/j.hrthm.2014.10.002
   Cano O, 2009, J AM COLL CARDIOL, V54, P799, DOI 10.1016/j.jacc.2009.05.032
   Chi PC, 2014, J CARDIOVASC ELECTR, V25, P1343, DOI 10.1111/jce.12495
   Chung FP, 2017, KOREAN CIRC J, V47, P282, DOI 10.4070/kcj.2016.0328
   Chung FP, 2017, HEART RHYTHM, V14, P508, DOI 10.1016/j.hrthm.2017.01.006
   Corrado D, 2003, CIRCULATION, V108, P3084, DOI 10.1161/01.CIR.0000103130.33451.D2
   Corrado D, 2015, CIRCULATION, V132, P441, DOI 10.1161/CIRCULATIONAHA.115.017944
   Corrado D, 2010, CIRCULATION, V122, P1144, DOI 10.1161/CIRCULATIONAHA.109.913871
   d'Avila A, 2004, CIRCULATION, V109, P2363, DOI 10.1161/01.CIR.0000128039.87485.0B
   Dalal D, 2005, CIRCULATION, V112, P3823, DOI 10.1161/CIRCULATIONAHA.105.542266
   Dalal D, 2007, J AM COLL CARDIOL, V50, P432, DOI 10.1016/j.jacc.2007.03.049
   Dalla Volta S, 1965, Arch Mal Coeur Vaiss, V58, P1129
   De Chillou C, 2014, HEART RHYTHM, V11, P175, DOI 10.1016/j.hrthm.2013.10.042
   Della Bella P, 2011, CIRC-ARRHYTHMIA ELEC, V4, P653, DOI 10.1161/CIRCEP.111.962217
   Denis A, 2014, CIRC-ARRHYTHMIA ELEC, V7, P590, DOI 10.1161/CIRCEP.113.001224
   Desjardins B, 2010, J AM COLL CARDIOL, V56, P1320, DOI 10.1016/j.jacc.2010.04.054
   Di Biase L, 2012, J AM COLL CARDIOL, V60, P132, DOI 10.1016/j.jacc.2012.03.044
   Do VBD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140167
   Ellison KE, 1998, J AM COLL CARDIOL, V32, P724, DOI 10.1016/S0735-1097(98)00292-7
   Garcia FC, 2009, CIRCULATION, V120, P366, DOI 10.1161/CIRCULATIONAHA.108.834903
   Groeneweg JA, 2015, CIRC-CARDIOVASC GENE, V8, P437, DOI 10.1161/CIRCGENETICS.114.001003
   Haqqani HM, 2012, CIRC-ARRHYTHMIA ELEC, V5, P796, DOI 10.1161/CIRCEP.111.967935
   Hsieh WH, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182364
   Hulot JS, 2004, CIRCULATION, V110, P1879, DOI 10.1161/01.CIR.0000143375.93288.82
   Irie T, 2015, CIRC-ARRHYTHMIA ELEC, V8, P390, DOI 10.1161/CIRCEP.114.002637
   Jackson N, 2015, CIRC-ARRHYTHMIA ELEC, V8, P1433, DOI 10.1161/CIRCEP.115.003083
   Jais P, 2012, CIRCULATION, V125, P2184, DOI 10.1161/CIRCULATIONAHA.111.043216
   Jamil-Copley S, 2015, CIRC-ARRHYTHMIA ELEC, V8, P76, DOI 10.1161/CIRCEP.114.001827
   Komatsu Y, 2014, J AM COLL CARDIOL, V63, P1416, DOI 10.1016/j.jacc.2013.10.087
   Kubala M, 2018, CIRC-ARRHYTHMIA ELEC, V11, DOI 10.1161/CIRCEP.117.005553
   Lin CY, 2018, EUROPACE, V20, P501, DOI 10.1093/europace/euw393
   Lin CY, 2018, ACTA CARDIOL SIN, V34, P49, DOI [10.6515/ACS.201801_34(1).20170724A, 10.6515/AC5.201801_34(1).20170724A]
   Lin Chin-Yu, 2016, JACC Clin Electrophysiol, V2, P459, DOI 10.1016/j.jacep.2016.01.013
   Lin CY, 2017, INT J CARDIOL, V227, P930, DOI 10.1016/j.ijcard.2016.11.055
   Link MS, 2014, J AM COLL CARDIOL, V64, P119, DOI 10.1016/j.jacc.2014.04.035
   Luther V, 2016, CIRC-ARRHYTHMIA ELEC, V9, DOI 10.1161/CIRCEP.116.004072
   Maagh P, 2017, CARDIOL RES, V8, P293, DOI 10.14740/cr636w
   Maccabelli G, 2014, EUROPACE, V16, P1363, DOI 10.1093/europace/euu017
   Marchlinski FE, 2000, CIRCULATION, V101, P1288, DOI 10.1161/01.CIR.101.11.1288
   Marchlinski FE, 2004, CIRCULATION, V110, P2293, DOI 10.1161/01.CIR.0000145154.02436.90
   MARCUS FI, 1982, CIRCULATION, V65, P384, DOI 10.1161/01.CIR.65.2.384
   Marcus FI, 2010, EUR HEART J, V31, P806, DOI 10.1093/eurheartj/ehq025
   Marcus FI, 2010, CIRCULATION, V121, P1533, DOI 10.1161/CIRCULATIONAHA.108.840827
   Maron BJ, 2015, J AM COLL CARDIOL, V66, P2362, DOI 10.1016/j.jacc.2015.09.035
   MCKENNA WJ, 1994, BRIT HEART J, V71, P215
   Nayyar S, 2014, CIRC-ARRHYTHMIA ELEC, V7, P90, DOI 10.1161/CIRCEP.113.000882
   Nogami A, 2008, J CARDIOVASC ELECTR, V19, P681, DOI 10.1111/j.1540-8167.2008.01104.x
   Oncel CR, 2017, ACTA CARDIOL SIN, V33, P559, DOI 10.6515/ACS20170220C
   Ozturk MT, 2017, ACTA CARDIOL SIN, V33, P74, DOI 10.6515/AC520160418A
   Philips B, 2015, HEART RHYTHM, V12, P716, DOI 10.1016/j.hrthm.2014.12.018
   Philips B, 2014, CIRC-ARRHYTHMIA ELEC, V7, P230, DOI 10.1161/CIRCEP.113.000932
   Philips B, 2012, CIRC-ARRHYTHMIA ELEC, V5, P499, DOI 10.1161/CIRCEP.111.968677
   Polin GM, 2011, HEART RHYTHM, V8, P76, DOI 10.1016/j.hrthm.2010.09.088
   Priori SG, 2015, EUROPACE, V17, P1601, DOI 10.1093/europace/euv319
   Reithmann C, 2003, PACE, V26, P1308, DOI 10.1046/j.1460-9592.2003.t01-1-00188.x
   Roberts-Thomson KC, 2009, CIRCULATION, V120, P1465, DOI 10.1161/CIRCULATIONAHA.109.870790
   Romero J, 2018, JACC-CLIN ELECTROPHY, V4, P374, DOI 10.1016/j.jacep.2017.12.008
   Sacher F, 2010, J AM COLL CARDIOL, V55, P2366, DOI 10.1016/j.jacc.2009.10.084
   Saguner AM, 2013, AM J CARDIOL, V111, P250, DOI 10.1016/j.amjcard.2012.09.025
   Santangeli P, 2015, CIRC-ARRHYTHMIA ELEC, V8, P1413, DOI 10.1161/CIRCEP.115.003562
   Satomi K, 2006, J CARDIOVASC ELECTR, V17, P469, DOI 10.1111/j.1540-8167.2006.00434.x
   Silberbauer J, 2014, CIRC-ARRHYTHMIA ELEC, V7, P424, DOI 10.1161/CIRCEP.113.001239
   Soejima K, 2004, J AM COLL CARDIOL, V43, P1834, DOI 10.1016/j.jacc.2004.01.029
   Sosa E, 2005, J CARDIOVASC ELECTR, V16, P449, DOI 10.1046/j.1540-8167.2005.40710.x
   Sosa E, 1996, J CARDIOVASC ELECTR, V7, P531, DOI 10.1111/j.1540-8167.1996.tb00559.x
   Sosa E, 2000, J AM COLL CARDIOL, V35, P1442, DOI 10.1016/S0735-1097(00)00606-9
   Tanawuttiwat T, 2016, J CARDIOVASC ELECTR, V27, P443, DOI 10.1111/jce.12925
   Tokuda M, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000215
   Tschabrunn Cory M, 2017, JACC Clin Electrophysiol, V3, P654, DOI 10.1016/j.jacep.2017.01.009
   Tschabrunn CM, 2016, CIRC-ARRHYTHMIA ELEC, V9, DOI 10.1161/CIRCEP.115.003841
   Tung R, 2017, CIRC-ARRHYTHMIA ELEC, V10, DOI 10.1161/CIRCEP.116.004560
   Tzou WS, 2015, CIRC-ARRHYTHMIA ELEC, V8, P353, DOI 10.1161/CIRCEP.114.002310
   van Taxis CFV, 2013, JACC-CARDIOVASC IMAG, V6, P42, DOI 10.1016/j.jcmg.2012.05.016
   Venlet J, 2017, CIRC-ARRHYTHMIA ELEC, V10, DOI 10.1161/CIRCEP.117.005175
   Verma A, 2005, CIRCULATION, V111, P3209, DOI 10.1161/CIRCULATIONAHA.104.510503
   Wei W, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169863
   Wichter T, 2004, CIRCULATION, V109, P1503, DOI 10.1161/01.CIR.0000121738.88273.43
   Wijnmaalen AP, 2011, EUR HEART J, V32, P104, DOI 10.1093/eurheartj/ehq345
NR 90
TC 1
Z9 1
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD OCT
PY 2018
VL 48
IS 10
BP 890
EP 905
DI 10.4070/kcj.2018.0268
PG 16
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA HB0VB
UT WOS:000450735300003
PM 30238706
OA Green Published
DA 2021-04-22
ER

PT J
AU Song, YJ
   Ha, SJ
   Lee, DS
   Bang, WD
   Shin, DG
   Woo, Y
   Cheong, S
   Yoo, SY
AF Song, Yeo-Jeong
   Ha, Sang Jin
   Lee, Dong Seok
   Bang, Woo-Dae
   Shin, Dong Geum
   Woo, Yeongmin
   Cheong, Sangsig
   Yoo, Sang-Yong
TI Ergonovine Stress Echocardiography for the Diagnosis of Vasospastic
   Angina and Its Prognostic Implications in 3,094 Consecutive Patients
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Coronary vasospasm; Ergonovine; Echocardiography; Safety; Prognosis
ID LONG-TERM PROGNOSIS; CORONARY-ARTERY SPASM; VARIANT ANGINA; MULTICENTER
   REGISTRY; MYOCARDIAL-ISCHEMIA; SAFETY; PECTORIS; IMPACT
AB Background and Objectives: Ergonovine stress echocardiography (ErgECHO) has been proposed as a noninvasive tool for the diagnosis of coronary vasospasm. However, concern over the safety of ErgECHO remains. This study was undertaken to investigate the safety and prognostic value of ErgECHO in a large population.
   Methods: We studied 3,094 consecutive patients from a single-center registry who underwent ErgECHO from November 2002 to June 2009. Medical records, echocardiographic data, and laboratory findings obtained from follow-up periods were analyzed.
   Results: The overall positive rate of ErgECHO was 8.6%. No procedure-related mortality or myocardial infarction (MI) occurred. Nineteen patients (0.6%) had transient symptomatic complications during ErgECHO including one who was successfully resuscitated. Cumulative major adverse cardiac events (MACEs) occurred in 14.0% and 5.1% of the patients with positive and negative ErgECHO results, respectively (p<0.001) at a median follow-up of 10.5 years. Cox regression survival analyses revealed that male sex, age, presence of diabetes, total cholesterol level of >220 mg/dL, and positive ErgECHO result itself were independent factors associated with MACEs.
   Conclusions: ErgECHO can be performed safely by experienced physicians and its positive result may be an independent risk factor for long-term adverse outcomes. It may also be an alternative tool to invasive ergonovine-provoked coronary angiography for the diagnosis of vasospastic angina.
C1 [Song, Yeo-Jeong] Inje Univ, Coll Med, Div Cardiol, Dept Internal Med,Haeundae Paik Hosp, Busan, South Korea.
   [Ha, Sang Jin; Lee, Dong Seok; Bang, Woo-Dae; Shin, Dong Geum; Woo, Yeongmin; Cheong, Sangsig; Yoo, Sang-Yong] Univ Ulsan, Div Cardiol, Dept Internal Med, Gangneung Asan Hosp,Coll Med, 38 Bangdong Gil, Kangnung 25440, South Korea.
RP Yoo, SY (corresponding author), Univ Ulsan, Div Cardiol, Dept Internal Med, Gangneung Asan Hosp,Coll Med, 38 Bangdong Gil, Kangnung 25440, South Korea.
EM bovio@naver.com
OI Woo, Yeongmin/0000-0002-4390-2915; Lee, Dong Seok/0000-0003-2231-0563;
   Ha, Sang Jin/0000-0003-4275-6538; Song, Yeo-Jeong/0000-0001-9051-3093
CR Akasaka T, 2014, CIRC J, V78, P2779, DOI 10.1253/circj.CJ-66-0098
   Anderson JL, 2007, J AM COLL CARDIOL, V50, P652, DOI 10.1016/j.jacc.2007.02.028
   Cortell A, 2010, WORLD J CARDIOL, V2, P437, DOI 10.4330/wjc.v2.i12.437
   DISTANTE A, 1984, AM HEART J, V107, P465, DOI 10.1016/0002-8703(84)90087-5
   Douglas PS, 2011, J AM COLL CARDIOL, V58, P801, DOI 10.1016/j.jacc.2011.05.019
   Kim MH, 2005, CIRC J, V69, P39, DOI 10.1253/circj.69.39
   Kishida H, 1996, JPN HEART J, V37, P317
   Lang RM, 2015, J AM SOC ECHOCARDIOG, V28, P1, DOI 10.1016/j.echo.2014.10.003
   Lattanzi F, 2000, DRUG SAFETY, V22, P251, DOI 10.2165/00002018-200022040-00001
   MORALES MA, 1995, EUR HEART J, V16, P1361, DOI 10.1093/oxfordjournals.eurheartj.a060743
   NESTO RW, 1987, AM J CARDIOL, V59, pC23, DOI 10.1016/0002-9149(87)90192-5
   Ong P, 2012, J AM COLL CARDIOL, V59, P655, DOI 10.1016/j.jacc.2011.11.015
   Pepine CJ, 1996, J AM COLL CARDIOL, V27, P1162, DOI 10.1016/0735-1097(96)00015-0
   PREVITALI M, 1983, AM J CARDIOL, V52, P19, DOI 10.1016/0002-9149(83)90062-0
   Roffi M, 2016, EUR HEART J, V37, P267, DOI 10.1093/eurheartj/ehv320
   ROVAI D, 1985, AM HEART J, V109, P78, DOI 10.1016/0002-8703(85)90418-1
   Sato K, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000227
   Shimada T, 1999, CLIN CARDIOL, V22, P795, DOI 10.1002/clc.4960221208
   Song JK, 2000, J AM COLL CARDIOL, V35, P1850, DOI 10.1016/S0735-1097(00)00646-X
   Song JK, 1996, J AM COLL CARDIOL, V27, P1156, DOI 10.1016/0735-1097(95)00590-0
   Song JK, 1998, AM J CARDIOL, V82, P1475, DOI 10.1016/S0002-9149(98)00690-0
   Song JK, 2002, J AM SOC ECHOCARDIOG, V15, P1346, DOI 10.1067/mje.2002.125284
   Takagi Y, 2013, J AM COLL CARDIOL, V62, P1144, DOI 10.1016/j.jacc.2013.07.018
   Takagi Y, 2013, EUR HEART J, V34, P258, DOI 10.1093/eurheartj/ehs199
   Takagi Y, 2011, CIRC-ARRHYTHMIA ELEC, V4, P295, DOI 10.1161/CIRCEP.110.959809
   Thygesen K, 2012, GLOB HEART, V7, DOI 10.1016/j.gheart.2012.08.001
   Yamagishi M, 2003, CIRC J, V67, P1029, DOI 10.1253/circj.67.1029
   YASUE H, 1988, CIRCULATION, V78, P1, DOI 10.1161/01.CIR.78.1.1
   Yasue H, 2008, J CARDIOL, V51, P2, DOI 10.1016/j.jjcc.2008.01.001
   Zaya M, 2014, J AM COLL CARDIOL, V63, P103, DOI 10.1016/j.jacc.2013.10.038
NR 30
TC 2
Z9 2
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD OCT
PY 2018
VL 48
IS 10
BP 906
EP 916
DI 10.4070/kcj.2017.0395
PG 11
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA HB0VB
UT WOS:000450735300004
PM 30238707
OA Green Published
DA 2021-04-22
ER

PT J
AU Okar, S
   Kaypakli, O
   Sahin, DY
   Koc, M
AF Okar, Sefa
   Kaypakli, Onur
   Sahin, Durmus Yildiray
   Koc, Mevlut
TI Fibrosis Marker Soluble ST2 Predicts Atrial Fibrillation Recurrence
   after Cryoballoon Catheter Ablation of Nonvalvular Paroxysmal Atria
   Fibrillation
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Soluble ST2; AF recurrence; Cryosurgery
ID HEART-FAILURE; DISEASE
AB Background and Objectives: We aimed to investigate the relationship between the recurrence of atrial fibrillation (AF) and fibrosis marker soluble ST2 (sST2) in patients with nonvalvular paroxysmal AF (PAF).
   Methods: We prospectively included 100 consecutive patients with PAF diagnosis and scheduled for cryoballoon catheter ablation for AF (47 males, 53 females; mean age 55.1 +/- 10.8 years). sST2 plasma levels were determined using the ASPECT-PLUS assay on ASPECT Reader device (Critical Diagnostics). The measurement range of these measurements was 12.5-250 ng/mL. Patients had regular follow-up visits with 12-lead electrocardiogram (ECG), medical history, and clinical evaluation. Twenty-four hours Hotter ECG monitoring had been recorded 12 months after ablation.
   Results: AF recurrence was detected in 22 patients after 1 year. Age, smoking history, diabetes mellitus,hypertension frequency, angiotensin converting enzyme inhibitor-angiotensin receptor blocker use, CHA(2)DS(2)VASc and HAS-BLED scores, serum sST2 level, left atrium (LA) end-diastolic diameter, LA volume and LA volume index were related to AF recurrence. In multivariable logistic regression analysis, sST2 was found to be only independent parameter for predicting AF recurrence (odds ratio, 1.085; p=0.001). Every 10-unit increase in sST2 was found to be associated with 2.103-fold increase in the risk of AF recurrence. The cut-off value of sST2 obtained by receiver operating characteristic curve analysis was 30.6 ng/mL for prediction of AF recurrence (sensitivity: 77.3%, specificity: 79.5%). The area under the curve was 0.831 (p<0.001).
   Conclusions: sST2, which is associated with atrial fibrosis, can be thought to be a useful marker for detection of patients with high-grade fibrosis who will get less benefit from cryoablation.
C1 [Okar, Sefa; Sahin, Durmus Yildiray; Koc, Mevlut] Univ Hlth Sci, Dept Cardiol, Adana Hlth Practices & Res Ctr, Adana, Turkey.
   [Kaypakli, Onur] Mustafa Kemal Univ, Fac Med, Dept Cardiol, TR-31060 Antakya, Turkey.
RP Kaypakli, O (corresponding author), Mustafa Kemal Univ, Fac Med, Dept Cardiol, TR-31060 Antakya, Turkey.
EM onurkaypakli@hotmail.com
RI Okar, Sefa/AAF-2872-2020
OI Okar, Sefa/0000-0003-1413-7393
CR Allessie MA, 2010, CIRC-ARRHYTHMIA ELEC, V3, P606, DOI 10.1161/CIRCEP.109.910125
   Andrade JG, 2011, HEART RHYTHM, V8, P1444, DOI 10.1016/j.hrthm.2011.03.050
   Anne W, 2005, CARDIOVASC RES, V67, P655, DOI 10.1016/j.cardiores.2005.04.016
   Balk EM, 2010, J CARDIOVASC ELECTR, V21, P1208, DOI 10.1111/j.1540-8167.2010.01798.x
   Boos CJ, 2006, EUR HEART J, V27, P136, DOI 10.1093/eurheartj/ehi645
   Chugh SS, 2014, CIRCULATION, V129, P837, DOI 10.1161/CIRCULATIONAHA.113.005119
   D'Ascenzo F, 2013, INT J CARDIOL, V167, P1984, DOI 10.1016/j.ijcard.2012.05.008
   Dieplinger B, 2015, CLIN CHIM ACTA, V451, P310, DOI 10.1016/j.cca.2015.10.015
   Kuhne M, 2010, HEART RHYTHM, V7, P1770, DOI 10.1016/j.hrthm.2010.08.028
   Ky B, 2011, CIRC-HEART FAIL, V4, P180, DOI 10.1161/CIRCHEARTFAILURE.110.958223
   McMurray JJV, 2012, EUR HEART J, V33, P1787, DOI 10.1093/eurheartj/ehs104
   Miller AM, 2011, PHARMACOL THERAPEUT, V131, P179, DOI 10.1016/j.pharmthera.2011.02.005
   Neumann T, 2008, J AM COLL CARDIOL, V52, P273, DOI 10.1016/j.jacc.2008.04.021
   Packer DL, 2013, J AM COLL CARDIOL, V61, P1713, DOI 10.1016/j.jacc.2012.11.064
   Parikh RH, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.115.003188
   Rienstra M, 2014, AM HEART J, V167, P109, DOI 10.1016/j.ahj.2013.10.003
   Shinagawa K, 2002, CIRCULATION, V105, P2672, DOI 10.1161/01.CIR.0000016826.62813.F5
   Sonmez O, 2014, MED SCI MONITOR, V20, P463, DOI 10.12659/MSM.890635
   Weinberg EO, 2009, BIOMARK MED, V3, P495, DOI 10.2217/BMM.09.56
   Youn JY, 2013, J MOL CELL CARDIOL, V62, P72, DOI 10.1016/j.yjmcc.2013.04.019
NR 20
TC 15
Z9 15
U1 4
U2 12
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD OCT
PY 2018
VL 48
IS 10
BP 920
EP 929
DI 10.4070/kcj.2018.0047
PG 10
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA HB0VB
UT WOS:000450735300006
PM 30238709
OA Green Published
DA 2021-04-22
ER

PT J
AU Ji, NN
   Lou, HH
   Gong, XY
   Fu, T
   Ni, SM
AF Ji, Ningning
   Lou, Honghong
   Gong, Xinyan
   Fu, Ting
   Ni, Shimao
TI Treatment with 3-Bromo-4,5-Dihydroxybenzaldehyde Improves Cardiac
   Function by Inhibiting Macrophage Infiltration in Mice
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Myocardial infarction; 3-Bromo-4,5-Dihydroxybenzaldehyde; Macrophages
ID NF-KAPPA-B; RED ALGA; BROMOPHENOLS; HEART; REGENERATION; INFLAMMATION;
   PATHWAYS; MONOCYTE; ALPHA
AB Background and Objectives: Appropriate inflammatory response is necessary for cardiac repairing after acute myocardial infarction (MI). Three-Bromo-4,5-dihydroxybenzaldehyde (BDB) is a potent antioxidant and natural bromophenol compound derived from red algae. Although BDB has been shown to have an anti-inflammatory effect, it remains unclear whether BDB affects cardiac remolding after MI. The aim of this study was to investigate the potential role of BDB on cardiac function recovery after MI in mice.
   Methods: Mice were intraperitoneally injected with BDB (100 mg/kg) or vehicle control respectively 1 hour before MI and then treated every other day. Cardiac function was monitored by transthoracic echocardiography at day 7 after MI. The survival of mice was observed for 2 weeks and hematoxylin and eosin (H&E) staining was used to determine the infarct size. Macrophages infiltration was examined by immunofluorescence staining. Enzyme-linked immunosorbent assay (ELISA) was used to test the production of cytokines associated with macrophages. The phosphorylation status of nuclear factor (NF)-kappa B was determined by western blot.
   Results: BDB administration dramatically improved cardiac function recovery, and decreased mortality and infarcted size after MI. Treatment with BDB reduced CD68' macrophages, M1 and M2 macrophages infiltration post-MI, and suppressed the secretion of pro-inflammatory cytokines, such as tumor necrosis factor (TNF)-alpha, interleukin (IL)-1 beta, monocyte chemoattractant protein (MCP)-1, and IL-6 in the injured hearts. Furthermore, BDB inhibited the phosphorylation of NF-kappa B in the infarcted hearts.
   Conclusions: These data demonstrate, for the first time, that BDB treatment facilitated cardiac healing by suppressing pro-inflammatory cytokine secretion, and indicate that BDB may serve as a therapeutic agent for acute MI.
C1 [Ji, Ningning; Lou, Honghong; Gong, Xinyan; Fu, Ting; Ni, Shimao] Wenzhou Med Univ, Dept Cardiol, Yiwu Hosp, Yiwu Cent Hosp, 699 Jiangdong Rd, Yiwu 322000, Peoples R China.
RP Ni, SM (corresponding author), Wenzhou Med Univ, Dept Cardiol, Yiwu Hosp, Yiwu Cent Hosp, 699 Jiangdong Rd, Yiwu 322000, Peoples R China.
EM 1793870950@qq.com
CR Aurora AB, 2014, J CLIN INVEST, V124, P1382, DOI 10.1172/JCI72181
   Capece D, 2017, SEMIN CELL DEV BIOL
   Catrysse L, 2017, TRENDS CELL BIOL, V27, P417, DOI 10.1016/j.tcb.2017.01.006
   Fan X, 2003, J NAT PROD, V66, P455, DOI 10.1021/np020528c
   Gaffney L, 2017, RESULTS PROBL CELL D, V62, P245, DOI 10.1007/978-3-319-54090-0_10
   Gilmore TD, 2006, ONCOGENE, V25, P6680, DOI 10.1038/sj.onc.1209954
   Han YS, 2005, J PHARMACOL EXP THER, V312, P1097, DOI 10.1124/jpet.104.079707
   Hofmann U, 2015, CIRC RES, V116, P354, DOI 10.1161/CIRCRESAHA.116.304072
   Hyun YJ, 2012, ECOTOX ENVIRON SAFE, V83, P71, DOI 10.1016/j.ecoenv.2012.06.010
   Kang NJ, 2017, TOX RESEARCH, V33, P325, DOI 10.5487/TR.2017.33.4.325
   Kim KC, 2017, MAR DRUGS, V15, DOI 10.3390/md15090291
   Kim SY, 2011, J MICROBIOL, V49, P102, DOI 10.1007/s12275-011-1035-z
   Kong DP, 2016, J EXP MED, V213, P2209, DOI 10.1084/jem.20160459
   Lavine KJ, 2014, P NATL ACAD SCI USA, V111, P16029, DOI 10.1073/pnas.1406508111
   Lee JC, 2013, CANCER CELL INT, V13, DOI 10.1186/1475-2867-13-55
   Li K, 2008, J NAT PROD, V71, P28, DOI 10.1021/np070281p
   Maruotti N, 2013, VASC CELL, V5, DOI 10.1186/2045-824X-5-11
   Nahrendorf M, 2007, J EXP MED, V204, P3037, DOI 10.1084/jem.20070885
   Nahrendorf M, 2013, CIRC RES, V112, P1624, DOI 10.1161/CIRCRESAHA.113.300890
   Perkins ND, 2007, NAT REV MOL CELL BIO, V8, P49, DOI 10.1038/nrm2083
   Piao MJ, 2017, MAR DRUGS, V15, DOI 10.3390/md15090268
   Speranskii A. I., 2016, Biomeditsinskaya Khimiya, V62, P331, DOI 10.18097/PBMC20166203331
   Vlasov I A, 2004, Fiziol Cheloveka, V30, P62
   Zhang JY, 2017, INT IMMUNOPHARMACOL, V48, P187, DOI 10.1016/j.intimp.2017.05.013
NR 24
TC 6
Z9 6
U1 1
U2 6
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD OCT
PY 2018
VL 48
IS 10
BP 933
EP 943
DI 10.4070/kcj.2017.0373
PG 11
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA HB0VB
UT WOS:000450735300008
PM 30238711
OA Green Published
DA 2021-04-22
ER

PT J
AU Park, JH
AF Park, Jae-Hyeong
TI Ergonovine Provocation Echocardiography for Detection and
   Prognostication in Patients with Vasospastic Angina
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
C1 [Park, Jae-Hyeong] Chungnam Natl Univ, Chungnam Natl Univ Hosp, Sch Med, Dept Internal Med,Div Cardiol, 282 Munhwa Ro, Daejeon 35015, South Korea.
RP Park, JH (corresponding author), Chungnam Natl Univ, Chungnam Natl Univ Hosp, Sch Med, Dept Internal Med,Div Cardiol, 282 Munhwa Ro, Daejeon 35015, South Korea.
EM jaehpark@cnu.ac.kr
RI Park, Jae-Hyeong/AAD-9015-2021
OI Park, Jae-Hyeong/0000-0001-7035-286X
CR Ahn JM, 2016, J AM COLL CARDIOL, V68, P137, DOI 10.1016/j.jacc.2016.04.050
   Beltrame JF, 1999, J AM COLL CARDIOL, V33, P1442, DOI 10.1016/S0735-1097(99)00073-X
   Beltrame JF, 2016, CIRC J, V80, P289, DOI 10.1253/circj.CJ-15-1202
   Choi BG, 2016, KOREAN CIRC J, V46, P632, DOI 10.4070/kcj.2016.46.5.632
   Kim Kyung-Hee, 2017, J Cardiovasc Ultrasound, V25, P20, DOI 10.4250/jcu.2017.25.1.20
   Scanlon PJ, 1999, J AM COLL CARDIOL, V33, P1756, DOI 10.1016/S0735-1097(99)00126-6
   Song J K, 1994, J Am Soc Echocardiogr, V7, P607
   Song YJ, 2018, KOREAN CIRC J, V48, P906, DOI 10.4070/kcj.2017.0395
NR 8
TC 0
Z9 0
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD OCT
PY 2018
VL 48
IS 10
BP 917
EP 919
DI 10.4070/kcj.2018.0139
PG 3
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA HB0VB
UT WOS:000450735300005
PM 30238708
OA Green Published
DA 2021-04-22
ER

PT J
AU AlTurki, A
AF AlTurki, Ahmed
TI Soluble ST2 in Paroxysmal Atrial Fibrillation: a New Biomarker that
   Predicts Recurrence?
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
ID HEART-FAILURE; ABLATION; TUMORIGENICITY-2; METAANALYSIS; SUPPRESSION
C1 [AlTurki, Ahmed] McGill Univ, Div Cardiol, Hlth Ctr, 1650 Cedar Ave, Montreal, PQ H3G 1A4, Canada.
RP AlTurki, A (corresponding author), McGill Univ, Div Cardiol, Hlth Ctr, 1650 Cedar Ave, Montreal, PQ H3G 1A4, Canada.
EM ahmedalturkimd@gmail.com
OI AlTurki, Ahmed/0000-0003-0593-9191
CR AbouEzzeddine OF, 2017, J AM HEART ASSOC, V6, DOI 10.1161/JAHA.116.004382
   Aimo A, 2017, JACC-HEART FAIL, V5, P287, DOI 10.1016/j.jchf.2016.12.016
   Aimo A, 2017, JACC-HEART FAIL, V5, P280, DOI 10.1016/j.jchf.2016.09.010
   AlTurki A, 2018, CURR OPIN CARDIOL, V33, P50, DOI 10.1097/HCO.0000000000000469
   Balk EM, 2010, J CARDIOVASC ELECTR, V21, P1208, DOI 10.1111/j.1540-8167.2010.01798.x
   Calkins H, 2017, HEART RHYTHM, V14, pE275, DOI 10.1016/j.hrthm.2017.05.012
   Eggers KM, 2010, AM HEART J, V159, P788, DOI 10.1016/j.ahj.2010.02.022
   Okar S, 2018, KOREAN CIRC J, V48, P920, DOI 10.4070/kcj.2018.0047
   Tang RB, 2014, EUROPACE, V16, P1569, DOI 10.1093/europace/euu013
NR 9
TC 2
Z9 2
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD OCT
PY 2018
VL 48
IS 10
BP 930
EP 932
DI 10.4070/kcj.2018.0183
PG 3
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA HB0VB
UT WOS:000450735300007
PM 30238710
OA Green Published
DA 2021-04-22
ER

PT J
AU Park, MS
   Youn, JC
AF Park, Myung-Soo
   Youn, Jong-Chan
TI A New Era of Targeting Pathogenic Immune Mechanisms in Cardiovascular
   Disease
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
ID ACUTE MYOCARDIAL-INFARCTION; T-CELLS
C1 [Park, Myung-Soo; Youn, Jong-Chan] Hallym Univ, Dongtan Sacred Heart Hosp, Hallym Univ Coll Med, Div Cardiol, 7 Keunjaebong Gil, Hwaseong 18450, South Korea.
RP Youn, JC (corresponding author), Hallym Univ, Dongtan Sacred Heart Hosp, Hallym Univ Coll Med, Div Cardiol, 7 Keunjaebong Gil, Hwaseong 18450, South Korea.
EM jong.chan.youn@gmail.com
RI Youn, Jong-Chan/AAS-1405-2020
OI Youn, Jong-Chan/0000-0003-0998-503X
CR Frangogiannis NG, 2014, NAT REV CARDIOL, V11, P255, DOI 10.1038/nrcardio.2014.28
   Giugliano GR, 2003, AM J CARDIOL, V91, P1055, DOI 10.1016/S0002-9149(03)00148-6
   Huang SB, 2018, BRIT J PHARMACOL, V175, P1377, DOI 10.1111/bph.14155
   Ji NN, 2018, KOREAN CIRC J, V48, P933, DOI 10.4070/kcj.2017.0373
   Kang NJ, 2017, TOX RESEARCH, V33, P325, DOI 10.5487/TR.2017.33.4.325
   Youn Jong-Chan, 2018, Clin Hypertens, V24, P5, DOI 10.1186/s40885-018-0090-8
   Youn JC, 2017, KOREAN CIRC J, V47, P16, DOI 10.4070/kcj.2016.0429
   Youn JC, 2013, HYPERTENSION, V62, P126, DOI 10.1161/HYPERTENSIONAHA.113.00689
   Yu HT, 2016, CLIN EXP MED, V16, P257, DOI 10.1007/s10238-015-0376-z
   Yu HT, 2015, CELL MOL IMMUNOL, V12, P466, DOI 10.1038/cmi.2014.74
NR 10
TC 2
Z9 2
U1 1
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD OCT
PY 2018
VL 48
IS 10
BP 944
EP 946
DI 10.4070/kcj.2018.0158
PG 3
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA HB0VB
UT WOS:000450735300009
PM 30238712
OA Green Published
DA 2021-04-22
ER

PT J
AU Lee, CH
   Son, JW
   Kong, EJ
AF Lee, Chan-Hee
   Son, Jang-Won
   Kong, Eun-Jung
TI Cardiac Sarcoidosis Presenting as Complete Atrioventricular Block:
   Findings on PET/MRI
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
C1 [Lee, Chan-Hee; Son, Jang-Won] Yeungnam Univ, Med Ctr, Dept Internal Med, Div Cardiol, Daegu, South Korea.
   [Kong, Eun-Jung] Yeungnam Univ, Dept Nucl Med, Med Ctr, Daegu, South Korea.
RP Lee, CH (corresponding author), Yeungnam Univ, Coll Med, Yeungnam Univ Med Ctr, Dept Internal Med,Div Cardiol, 170 Hyeonchung Ro, Daegu 42415, South Korea.
EM chanheebox@naver.com
CR Dweck MR, 2018, JACC-CARDIOVASC IMAG, V11, P94, DOI 10.1016/j.jcmg.2017.02.021
   Terasaki F., 2017, ANN NUCL CARDIOL, V3, P42, DOI [DOI 10.17996/anc.17-00042, 10.17996/anc.17-00042, DOI 10.17996/ANC.17-00042]
NR 2
TC 2
Z9 2
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD OCT
PY 2018
VL 48
IS 10
BP 947
EP 948
DI 10.4070/kcj.2018.0045
PG 2
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA HB0VB
UT WOS:000450735300010
PM 30238713
OA Green Published
DA 2021-04-22
ER

PT J
AU Kaneko, U
   Kobayashi, K
   Hachinohe, D
   Sumino, S
   Furugen, A
   Kawamura, T
   Doi, H
   Fujita, T
AF Kaneko, Umihiko
   Kobayashi, Ken
   Hachinohe, Daisuke
   Sumino, Satoshi
   Furugen, Azusa
   Kawamura, Takeshi
   Doi, Hirosato
   Fujita, Tsutomu
TI Successful Direct Iliac Transcatheter Aortic Valve Implantation to
   Overcome Significant Tortuosity of the Thoracic Aorta
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
C1 [Kaneko, Umihiko; Kobayashi, Ken; Hachinohe, Daisuke; Furugen, Azusa; Fujita, Tsutomu] Sapporo Heart Ctr, Dept Cardiovasc Med, Sapporo Cardio Vasc Clin, North 49,East 16,8-1 Higashi Ward, Sapporo, Hokkaido 0070849, Japan.
   [Sumino, Satoshi; Doi, Hirosato] Sapporo Heart Ctr, Dept Cardiovasc Surg, Sapporo Cardio Vasc Clin, Sapporo, Hokkaido, Japan.
   [Kawamura, Takeshi] Sapporo Heart Ctr, Dept Anesthesiol, Sapporo Cardio Vasc Clin, Sapporo, Hokkaido, Japan.
RP Kaneko, U (corresponding author), Sapporo Heart Ctr, Dept Cardiovasc Med, Sapporo Cardio Vasc Clin, North 49,East 16,8-1 Higashi Ward, Sapporo, Hokkaido 0070849, Japan.
EM uk434471@gmail.com
CR de Agustin JA, 2016, CIRCULATION, V133, pE14, DOI 10.1161/CIRCULATIONAHA.115.019824
   Aminian A, 2011, CATHETER CARDIO INTE, V77, P1076, DOI 10.1002/ccd.22960
NR 2
TC 1
Z9 1
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD OCT
PY 2018
VL 48
IS 10
BP 949
EP 950
DI 10.4070/kcj.2018.0129
PG 2
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA HB0VB
UT WOS:000450735300011
PM 30238714
OA Green Published
DA 2021-04-22
ER

PT J
AU Cardoso, R
   Aryana, A
   Singh, SM
   Tandri, H
   d'Avila, A
AF Cardoso, Rhanderson
   Aryana, Arash
   Singh, Sheldon M.
   Tandri, Harikrishna
   d'Avila, Andre
TI Epicardial Ablation of Ventricular Tachycardia: a Review
SO KOREAN CIRCULATION JOURNAL
LA English
DT Review
DE Ventricular tachycardia; Catheter ablation; Epicardial mapping
ID RADIOFREQUENCY CATHETER ABLATION; CORONARY-ARTERY-DISEASE; EHRA/HRS
   EXPERT CONSENSUS; 12-LEAD ECG FEATURES; MYOCARDIAL-INFARCTION;
   NONISCHEMIC CARDIOMYOPATHY; CONTACT FORCE; CARDIAC-ARRHYTHMIAS;
   SUBSTRATE; FAT
AB For over 3 decades, it has been known that reentry circuits for ventricular tachycardia (VT) are not limited to the subendocardial myocardium. Rather, intramural or subepicardial substrates may also give rise to VT, particularly in those with non-ischemic cardiomyopathy. Percutaneous epicardial mapping and ablation has been successfully introduced for the treatment of such subepicardial VT. Herein, we review the indications for epicardial ablation and the identification of epicardial VT by electrocardiographic and imaging modalities. We also discuss the optimal technique for epicardial access and the implications of epicardial fat which has the potential to mimic scar, decreasing the specificity of electrogram morphology and impeding energy delivery to the tissue. Finally, we also report on possible complications of the procedure and strategies to mitigate adverse events.
C1 [Cardoso, Rhanderson; Tandri, Harikrishna] Johns Hopkins Univ, Ctr Excellence ARVC & Complex Ventricular Arrhyth, Baltimore, MD USA.
   [Aryana, Arash] Mercy Gen Hosp, Sacramento, CA USA.
   [Aryana, Arash] Dign Hlth Heart & Vasc Inst, Sacramento, CA USA.
   [Singh, Sheldon M.] Univ Toronto, Fac Med, Sunnybrook Hlth Sci Ctr, Schulich Heart Program, Toronto, ON, Canada.
   [d'Avila, Andre] Hosp Cardiol SOS Cardioflorianopolis, Florianopolis, SC, Brazil.
RP d'Avila, A (corresponding author), Hosp Cardiol, Hosp SOS Cardio, Serv Arritmia Cardiaca Florianopolis, BR-8803000 Florianopolis, SC, Brazil.
EM andredavila@mac.com
RI d'Avila, Andre Luiz Buchele/F-8009-2010
OI d'Avila, Andre Luiz Buchele/0000-0001-8769-1411
CR Abbara S, 2006, EUR J RADIOL, V57, P417, DOI 10.1016/j.ejrad.2005.12.030
   Ahn SG, 2008, HEART, V94, DOI 10.1136/hrt.2007.118471
   Aliot EM, 2009, HEART RHYTHM, V6, P886, DOI 10.1016/j.hrthm.2009.04.030
   Aliot EM, 2009, EUROPACE, V11, P771, DOI 10.1093/europace/eup098
   Andreu D, 2011, CIRC-ARRHYTHMIA ELEC, V4, P674, DOI 10.1161/CIRCEP.111.961946
   Aryana A, 2016, HEART RHYTHM, V13, P1602, DOI 10.1016/j.hrthm.2016.05.008
   Bai R, 2006, J CARDIOVASC ELECTR, V17, P944, DOI 10.1111/j.1540-8167.2006.00536.x
   Bai R, 2011, CIRC-ARRHYTHMIA ELEC, V4, P478, DOI 10.1161/CIRCEP.111.963066
   Bala R, 2011, CIRC-ARRHYTHMIA ELEC, V4, P667, DOI 10.1161/CIRCEP.111.963553
   Basso C, 1996, CIRCULATION, V94, P983, DOI 10.1161/01.CIR.94.5.983
   Bazan V, 2007, HEART RHYTHM, V4, P1403, DOI 10.1016/j.hrthm.2007.07.004
   Bazan V, 2006, HEART RHYTHM, V3, P1132, DOI 10.1016/j.hrthm.2006.06.024
   Berruezo A, 2004, CIRCULATION, V109, P1842, DOI 10.1161/01.CIR.0000125525.04081.4B
   Berruezo A, 2012, CIRC-ARRHYTHMIA ELEC, V5, P111, DOI 10.1161/CIRCEP.110.960740
   BLANCHARD SM, 1994, PACE, V17, P2315, DOI 10.1111/j.1540-8159.1994.tb02382.x
   Bogun FM, 2009, J AM COLL CARDIOL, V53, P1138, DOI 10.1016/j.jacc.2008.11.052
   Boyle NG, 2012, CIRCULATION, V126, P1752, DOI 10.1161/CIRCULATIONAHA.111.060327
   Cano O, 2009, J AM COLL CARDIOL, V54, P799, DOI 10.1016/j.jacc.2009.05.032
   d'Avila A, 2004, CIRCULATION, V109, P2363, DOI 10.1161/01.CIR.0000128039.87485.0B
   D'Avila A, 2002, PACE, V25, P1488, DOI 10.1046/j.1460-9592.2002.01488.x
   D'Avila A, 2008, PACE, V31, P1322, DOI 10.1111/j.1540-8159.2008.01184.x
   D'Avila A, 2007, J CARDIOVASC ELECTR, V18, P1178, DOI 10.1111/j.1540-8167.2007.00945.x
   d'Avita A, 2008, HEART RHYTHM, V5, pS73, DOI 10.1016/j.hrthm.2008.01.035
   Daniels DV, 2006, CIRCULATION, V113, P1659, DOI 10.1161/CIRCULATIONAHA.105.611640
   Della Bella P, 2011, CIRC-ARRHYTHMIA ELEC, V4, P653, DOI 10.1161/CIRCEP.111.962217
   Dello Russo A, 2012, CIRC-ARRHYTHMIA ELEC, V5, P492, DOI 10.1161/CIRCEP.111.965012
   Desjardins B, 2010, J AM COLL CARDIOL, V56, P1320, DOI 10.1016/j.jacc.2010.04.054
   Di Biase L, 2009, HEART RHYTHM, V6, P957, DOI 10.1016/j.hrthm.2009.03.022
   DOWNAR E, 1984, J AM COLL CARDIOL, V4, P703, DOI 10.1016/S0735-1097(84)80396-4
   Fernandes GC, 2018, HEART RHYTHM
   Garcia FC, 2009, CIRCULATION, V120, P366, DOI 10.1161/CIRCULATIONAHA.108.834903
   GONSKA BD, 1994, J AM COLL CARDIOL, V24, P1506, DOI 10.1016/0735-1097(94)90147-3
   Henz BD, 2009, J INTERV CARD ELECTR, V26, P195, DOI 10.1007/s10840-009-9433-4
   Hong KN, 2007, J CARDIAC SURG, V22, P521, DOI 10.1111/j.1540-8191.2007.00454.x
   Javaheri A, 2012, CIRC-HEART FAIL, V5, pE22, DOI 10.1161/CIRCHEARTFAILURE.111.965236
   Jesel L, 2014, CIRC-ARRHYTHMIA ELEC, V7, P1168, DOI 10.1161/CIRCEP.113.001219
   KALTENBRUNNER W, 1991, CIRCULATION, V84, P1058, DOI 10.1161/01.CIR.84.3.1058
   Koplan BA, 2006, HEART RHYTHM, V3, P924, DOI 10.1016/j.hrthm.2006.03.031
   Koruth JS, 2011, CIRC-ARRHYTHMIA ELEC, V4, P882, DOI 10.1161/CIRCEP.111.965731
   Kumar S, 2015, HEART RHYTHM, V12, P1691, DOI 10.1016/j.hrthm.2015.03.045
   LITTMANN L, 1991, CIRCULATION, V83, P1577, DOI 10.1161/01.CIR.83.5.1577
   Lustgarten DL, 2005, HEART RHYTHM, V2, P82, DOI 10.1016/j.hrthm.2004.09.022
   Martinek M, 2012, J CARDIOVASC ELECTR, V23, P188, DOI 10.1111/j.1540-8167.2011.02179.x
   Mathuria N, 2012, CIRC-ARRHYTHMIA ELEC, V5, pE18, DOI 10.1161/CIRCEP.111.968420
   MORADY F, 1993, CIRCULATION, V87, P363, DOI 10.1161/01.CIR.87.2.363
   Papageorgiou N, 2018, EUROPACE, V20, P682, DOI 10.1093/europace/eux077
   Pisani CF, 2014, CURR OPIN CARDIOL, V29, P59, DOI 10.1097/HCO.0000000000000021
   Saba MM, 2009, EUROPACE, V11, P949, DOI 10.1093/europace/eup156
   Sacher F, 2013, CIRC-ARRHYTHMIA ELEC, V6, P144, DOI 10.1161/CIRCEP.111.974501
   Sacher F, 2010, J AM COLL CARDIOL, V55, P2366, DOI 10.1016/j.jacc.2009.10.084
   Sacher F, 2008, CIRC-ARRHYTHMIA ELEC, V1, P153, DOI 10.1161/CIRCEP.108.769471
   Scanavacca M, 2014, ARQ BRAS CARDIOL, V102, P524, DOI 10.5935/abc.20140082
   Silaghi A, 2008, OBESITY, V16, P2424, DOI 10.1038/oby.2008.379
   Soejima K, 2004, CIRCULATION, V110, P1197, DOI 10.1161/01.CIR.0000140725.42845.90
   Soejima K, 2004, J AM COLL CARDIOL, V43, P1834, DOI 10.1016/j.jacc.2004.01.029
   Sosa E, 2005, J CARDIOVASC ELECTR, V16, P449, DOI 10.1046/j.1540-8167.2005.40710.x
   Sosa E, 1996, J CARDIOVASC ELECTR, V7, P531, DOI 10.1111/j.1540-8167.1996.tb00559.x
   Sosa E, 1998, J CARDIOVASC ELECTR, V9, P229, DOI 10.1111/j.1540-8167.1998.tb00907.x
   Stevenson WG, 1998, CIRCULATION, V98, P308, DOI 10.1161/01.CIR.98.4.308
   Stevenson WG, 2008, CIRCULATION, V118, P2773, DOI 10.1161/CIRCULATIONAHA.108.788604
   SVENSON RH, 1990, J AM COLL CARDIOL, V15, P163, DOI 10.1016/0735-1097(90)90194-T
   Tschabrunn CM, 2012, J CARDIOVASC ELECTR, V23, P744, DOI 10.1111/j.1540-8167.2011.02286.x
   Tung R, 2013, HEART RHYTHM, V10, P490, DOI 10.1016/j.hrthm.2012.12.013
   Tung R, 2010, HEART RHYTHM, V7, P389, DOI 10.1016/j.hrthm.2009.11.023
   Valles E, 2010, CIRC-ARRHYTHMIA ELEC, V3, P63, DOI 10.1161/CIRCEP.109.859942
   van Taxis CFV, 2013, JACC-CARDIOVASC IMAG, V6, P42, DOI 10.1016/j.jcmg.2012.05.016
   Viles-Gonzalez JF, 2011, CIRC-ARRHYTHMIA ELEC, V4, P526, DOI 10.1161/CIRCEP.110.961508
   Wichter T, 2005, HERZ, V30, P91, DOI 10.1007/s00059-005-2677-6
   Wijnmaalen AP, 2011, EUR HEART J, V32, P104, DOI 10.1093/eurheartj/ehq345
   Wong MCG, 2013, CIRC-ARRHYTHMIA ELEC, V6, P1222, DOI 10.1161/CIRCEP.113.000184
NR 70
TC 1
Z9 1
U1 0
U2 2
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD SEP
PY 2018
VL 48
IS 9
BP 778
EP 791
DI 10.4070/kcj.2018.0210
PG 14
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA HB0UO
UT WOS:000450733700002
PM 30088360
OA Green Published
DA 2021-04-22
ER

PT J
AU Regitz-Zagrosek, V
AF Regitz-Zagrosek, Vera
TI Unsettled Issues and Future Directions for Research on Cardiovascular
   Diseases in Women
SO KOREAN CIRCULATION JOURNAL
LA English
DT Review
DE Women; CVD; Gender; CAD; HF
ID CORONARY-ARTERY-DISEASE; ISCHEMIC-HEART-DISEASE; ELEVATION
   MYOCARDIAL-INFARCTION; SUPPRESS ADVERSE OUTCOMES; RAPID RISK
   STRATIFICATION; CARDIOLOGY WORKING GROUP; SEX-DIFFERENCES;
   EUROPEAN-SOCIETY; ST-ELEVATION; ISCHEMIA/REPERFUSION INJURY
AB Biological sex (being female or male) significantly influences the course of disease. This simple fact must be considered in all cardiovascular diagnosis and therapy. However, major gaps in knowledge about and awareness of cardiovascular disease in women still impede the implementation of sex-specific strategies. Among the gaps are a lack of understanding of the pathophysiology of women-biased coronary artery disease syndromes (spasms, dissections, Takotsubo syndrome), sex differences in cardiomyopathies and heart failure, a higher prevalence of cardiomyopathies with sarcomeric mutations in men, a higher prevalence of heart failure with preserved ejection fraction in women, and sex-specific disease mechanisms, as well as sex differences in sudden cardiac arrest and long QT syndrome. Basic research strategies must do more to include female-specific aspects of disease such as the genetic imbalance of 2 versus one X chromosome and the effects of sex hormones. Drug therapy in women also needs more attention. Furthermore, pregnancy-associated cardiovascular disease must be considered a potential risk factor in women, including pregnancy-related coronary artery dissection, preeclampsia, and peripartum cardiomyopathy. Finally, the sociocultural dimension of gender should be included in research efforts. The organization of gender medicine must be established as a cross-sectional discipline but also as a centered structure with its own research resources, methods, and questions.
C1 [Regitz-Zagrosek, Vera] CHARITE Univ Med Berlin, Inst Gender Med, Berlin, Germany.
   [Regitz-Zagrosek, Vera] CCR, Berlin, Germany.
   [Regitz-Zagrosek, Vera] DZHK, Partner Site Berlin, Berlin, Germany.
RP Regitz-Zagrosek, V (corresponding author), CHARITE Univ Med Berlin, Inst Gender Med GIM, Hessische Str 3-4, D-10115 Berlin, Germany.
EM vera.regitz-zagrosek@charite.de
OI Regitz-Zagrosek, Vera/0000-0002-3566-3467
FU DZHK (German Centre for Cardiovascular Research); BMBF (German Ministry
   of Education and Research)Federal Ministry of Education & Research
   (BMBF) [FKZ:81Z2100201, FKZ:81Z7100271]
FX This research was supported by the DZHK (German Centre for
   Cardiovascular Research) and by the BMBF (German Ministry of Education
   and Research) - partner site projects BER3.2HF (FKZ:81Z2100201) and BER
   I.1 (FKZ:81Z7100271).
CR Ahmed B, 2013, CIRCULATION, V127, P641, DOI 10.1161/CIRCULATIONAHA.112.108290
   Al-Khatib SM, 2012, CIRCULATION, V125, P1094, DOI 10.1161/CIRCULATIONAHA.111.066605
   [Anonymous], 2015, CLIN INV DIFF MAGN C
   Arola A, 1997, AM J EPIDEMIOL, V146, P385, DOI 10.1093/oxfordjournals.aje.a009291
   BAGGER JP, 1984, BRIT HEART J, V52, P327
   BARRETTCONNOR EL, 1991, JAMA-J AM MED ASSOC, V265, P627, DOI 10.1001/jama.265.5.627
   Berger JS, 2009, JAMA-J AM MED ASSOC, V302, P874, DOI 10.1001/jama.2009.1227
   Bertrand OF, 2012, AM HEART J, V163, P632, DOI 10.1016/j.ahj.2012.01.015
   Bushnell C, 2014, STROKE, V45, P1545, DOI 10.1161/01.str.0000442009.06663.48
   Camici PG, 2015, NAT REV CARDIOL, V12, P48, DOI 10.1038/nrcardio.2014.160
   Champney KP, 2009, HEART, V95, P895, DOI 10.1136/hrt.2008.155804
   COUGHLIN SS, 1993, J CLIN EPIDEMIOL, V46, P1003, DOI 10.1016/0895-4356(93)90167-Y
   Coylewright M, 2008, HYPERTENSION, V51, P952, DOI 10.1161/HYPERTENSIONAHA.107.105742
   De Bruyne B, 2014, NEW ENGL J MED, V371, P1208, DOI 10.1056/NEJMoa1408758
   Diercks DB, 2010, AM HEART J, V160, P80, DOI 10.1016/j.ahj.2010.04.017
   Donahue RP, 2007, DIABETES CARE, V30, P354, DOI 10.2337/dc06-1772
   Douglas PS, 1996, NEW ENGL J MED, V334, P1311, DOI 10.1056/NEJM199605163342007
   Dworatzek E., 2018, CARDIOVASC RES
   Dworatzek E, 2014, CARDIOVASC RES, V102, P418, DOI 10.1093/cvr/cvu065
   Evans CS, 2011, HYPERTENSION, V58, P57, DOI 10.1161/HYPERTENSIONAHA.111.173278
   Ferreira RG, 2015, J CARDIAC SURG, V30, P238, DOI 10.1111/jocs.12506
   Flammer AJ, 2012, CIRCULATION, V126, P753, DOI 10.1161/CIRCULATIONAHA.112.093245
   Fliegner D, 2010, AM J PHYSIOL-REG I, V298, pR1597, DOI 10.1152/ajpregu.00825.2009
   Ford ES, 2007, J AM COLL CARDIOL, V50, P2128, DOI 10.1016/j.jacc.2007.05.056
   Franconi F, 2015, INT J CARDIOL, V179, P514, DOI 10.1016/j.ijcard.2014.11.019
   Gehrie ER, 2009, AM HEART J, V158, P688, DOI 10.1016/j.ahj.2009.08.004
   GILLUM RF, 1986, AM HEART J, V111, P752, DOI 10.1016/0002-8703(86)90111-0
   Gulati M, 2005, NEW ENGL J MED, V353, P468, DOI 10.1056/NEJMoa044154
   Herrmann J, 2012, EUR HEART J, V33, P2771, DOI 10.1093/eurheartj/ehs246
   Hochman JS, 1997, J AM COLL CARDIOL, V30, P141, DOI 10.1016/S0735-1097(97)00107-1
   Hoffmann B, 2007, CIRCULATION, V116, P489, DOI 10.1161/CIRCULATIONAHA.107.693622
   Humphries KH, 2017, FRONT NEUROENDOCRIN, V46, P46, DOI 10.1016/j.yfrne.2017.04.001
   Huynh Karina, 2015, Nat Rev Cardiol, V12, P129, DOI 10.1038/nrcardio.2015.15
   Jespersen L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093170
   Johnston N, 2015, AM J CARDIOL, V115, P1661, DOI 10.1016/j.amjcard.2015.03.006
   Johnston N, 2011, EUR HEART J, V32, P1331, DOI 10.1093/eurheartj/ehr009
   Kalyani RR, 2014, DIABETES CARE, V37, P830, DOI 10.2337/dc13-1755
   Kang SJ, 2013, JACC-CARDIOVASC INTE, V6, P562, DOI 10.1016/j.jcin.2013.02.016
   Kararigas G, 2014, J PROTEOME RES, V13, P5829, DOI 10.1021/pr500749j
   Kararigas G, 2014, EUR J HEART FAIL, V16, P1160, DOI 10.1002/ejhf.171
   Kararigas G, 2014, ENDOCRINOLOGY, V155, P2667, DOI 10.1210/en.2013-2180
   Kararigas G, 2012, J AM COLL CARDIOL, V59, P410, DOI 10.1016/j.jacc.2011.09.054
   Kararigas G, 2011, PHYSIOL GENOMICS, V43, P438, DOI 10.1152/physiolgenomics.00199.2010
   Karlstadt A, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-114
   Kaul P, 2011, AM HEART J, V161, DOI 10.1016/j.ahj.2010.09.016
   Kendel F, 2011, PSYCHOSOM MED, V73, P280, DOI 10.1097/PSY.0b013e3182114d35
   Kendel F, 2010, ARCH INTERN MED, V170, P1717, DOI 10.1001/archinternmed.2010.368
   Knaapen P, 2009, BASIC RES CARDIOL, V104, P485, DOI 10.1007/s00395-009-0037-z
   Komamura K, 2014, WORLD J CARDIOL, V6, P602, DOI 10.4330/wjc.v6.i7.602
   Kothawade K, 2011, CURR PROB CARDIOLOGY, V36, P291, DOI 10.1016/j.cpcardiol.2011.05.002
   Kotseva K, 2009, EUR J CARDIOV PREV R, V16, P121, DOI 10.1097/HJR.0b013e3283294b1d
   Lansky AJ, 2012, JACC-CARDIOVASC IMAG, V5, pS62, DOI 10.1016/j.jcmg.2012.02.003
   Lehmkuhl E, 2012, CLIN RES CARDIOL, V101, P745, DOI 10.1007/s00392-012-0454-0
   Lempereur M, 2016, EUROINTERVENTION, V12, pE216, DOI 10.4244/EIJY14M12_11
   Li J, 2013, CIRC-CARDIOVASC INTE, V6, P662, DOI 10.1161/CIRCINTERVENTIONS.113.000762
   Li JY, 2017, J MOL CELL CARDIOL, V102, P108, DOI 10.1016/j.yjmcc.2016.11.006
   Li JY, 2012, AM J CARDIOVASC DIS, V2, P192
   Li JY, 2012, BASIC RES CARDIOL, V107, DOI 10.1007/s00395-012-0271-7
   Lyon AR, 2016, EUR J HEART FAIL, V18, P8, DOI 10.1002/ejhf.424
   MacFadden DR, 2009, HEART RHYTHM, V6, P1289, DOI 10.1016/j.hrthm.2009.05.017
   Mahmoodzadeh Shokoufeh, 2014, J Cell Sci Ther, V5, P153, DOI 10.4172/2157-7013.1000153
   Mahmoodzadeh S, 2012, CARDIOVASC RES, V96, P411, DOI 10.1093/cvr/cvs281
   Mahmoodzadeh S, 2010, CARDIOVASC RES, V85, P719, DOI 10.1093/cvr/cvp350
   Mahmoodzadeh S, 2009, J BIOL CHEM, V284, P24705, DOI 10.1074/jbc.M109.000463
   Marijon E, 2015, CIRCULATION, V131, P1384, DOI 10.1161/CIRCULATIONAHA.114.011988
   Mega JL, 2010, CIRCULATION, V121, P1809, DOI 10.1161/CIRCULATIONAHA.109.897231
   Mieres JH, 2014, CIRCULATION, V130, P350, DOI 10.1161/CIR.0000000000000061
   Mieres JH, 2005, CIRCULATION, V111, P682, DOI 10.1161/01.CIR.0000155233.67287.60
   Miller VM, 2016, BIOL SEX DIFFER, V7, DOI 10.1186/s13293-016-0093-7
   Montalescot G, 2013, EUR HEART J, V34, P2949, DOI 10.1093/eurheartj/eht296
   Morise AP, 2002, AM HEART J, V144, P818, DOI 10.1067/mhj.2002.125835
   Murthy VL, 2014, CIRCULATION, V129, P2518, DOI 10.1161/CIRCULATIONAHA.113.008507
   Narasimha D, 2015, ARRHYTH ELECTROPHYSI, V4, P129, DOI 10.15420/aer.2015.04.02.129
   Oertelt-Prigione S, 2012, SEX AND GENDER ASPECTS IN CLINICAL MEDICINE, P9, DOI 10.1007/978-0-85729-832-4_3
   Otten AM, 2013, EUR HEART J-ACUTE CA, V2, P334, DOI 10.1177/2048872612475270
   Ouyang P, 2016, BIOL SEX DIFFER, V7, DOI 10.1186/s13293-016-0073-y
   Parashar S, 2009, CIRC-CARDIOVASC QUAL, V2, P33, DOI 10.1161/CIRCOUTCOMES.108.818500
   Park DW, 2013, EUR HEART J, V34, P1662, DOI 10.1093/eurheartj/eht048
   Patten IS, 2012, NATURE, V485, P333, DOI 10.1038/nature11040
   Pelletier R, 2016, J AM COLL CARDIOL, V67, P127, DOI 10.1016/j.jacc.2015.10.067
   Pelletier R, 2015, PSYCHOSOM MED, V77, P517, DOI 10.1097/PSY.0000000000000186
   Pepine CJ, 2010, J AM COLL CARDIOL, V55, P2825, DOI 10.1016/j.jacc.2010.01.054
   Prescott E, 1998, BMJ-BRIT MED J, V316, P1043
   Puymirat E, 2012, JAMA-J AM MED ASSOC, V308, P998, DOI 10.1001/2012.jama.11348
   Queiros AM, 2013, INT J CARDIOL, V169, P331, DOI 10.1016/j.ijcard.2013.09.002
   Regitz-Zagrosek V, 2004, J AM COLL CARDIOL, V44, P2413, DOI 10.1016/j.jacc.2004.09.031
   Regitz-Zagrosek V, 2012, SEX GENDER DIFFERENC
   Regitz-Zagrosek V, 2011, EUR HEART J, V32, P3147, DOI 10.1093/eurheartj/ehr218
   Regitz-Zagrosek V, 2017, PHYSIOL REV, V97, P1, DOI 10.1152/physrev.00021.2015
   Regitz-Zagrosek V, 2016, EUR HEART J, V37, P24, DOI 10.1093/eurheartj/ehv598
   Regitz-Zagrosek V, 2012, EMBO REP, V13, P596, DOI 10.1038/embor.2012.87
   Regitz-Zagrosek V, 2010, TRANSPLANTATION, V89, P236, DOI 10.1097/TP.0b013e3181c35255
   Reynolds HR, 2011, CIRCULATION, V124, P1414, DOI 10.1161/CIRCULATIONAHA.111.026542
   Robinson JG, 2008, AM J CARDIOL, V102, P693, DOI 10.1016/j.amjcard.2007.12.044
   Roth A, 2008, J AM COLL CARDIOL, V52, P171, DOI 10.1016/j.jacc.2008.03.049
   Salama G, 2014, AM J PHYSIOL-HEART C, V307, pH640, DOI 10.1152/ajpheart.00864.2013
   Schubert C, 2016, BIOL SEX DIFFER, V7, DOI 10.1186/s13293-016-0104-8
   Schuster I, 2016, CLIN SCI, V130, P365, DOI 10.1042/CS20150609
   Seeland Ute, 2016, Biol Sex Differ, V7, P39
   Shah ASV, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.g7873
   Sharkey SW, 2014, CIRC J, V78, P2119, DOI 10.1253/circj.CJ-14-0770
   Shaw LJ, 2009, J AM COLL CARDIOL, V54, P1561, DOI 10.1016/j.jacc.2009.04.098
   Silber TC, 2015, J CARDIOPULM REHABIL, V35, P328, DOI 10.1097/HCR.0000000000000111
   Sliwa K, 2017, EUR J HEART FAIL, V19, P1131, DOI 10.1002/ejhf.780
   Sliwa K, 2014, EUR J HEART FAIL, V16, P583, DOI 10.1002/ejhf.68
   Sliwa K, 2010, EUR J HEART FAIL, V12, P767, DOI 10.1093/eurjhf/hfq120
   Staessen JA, 2001, LANCET, V358, P1305, DOI 10.1016/S0140-6736(01)06411-X
   Tamis-Holland JE, 2013, J AM COLL CARDIOL, V61, P1767, DOI 10.1016/j.jacc.2013.01.062
   Templin C, 2015, NEW ENGL J MED, V373, P929, DOI 10.1056/NEJMoa1406761
   Thygesen K, 2012, CIRCULATION, V126, P2020, DOI 10.1161/CIR.0b013e31826e1058
   Unsold B, 2014, CARDIOVASC RES, V101, P97, DOI 10.1093/cvr/cvt235
   Vaccarino V, 2011, CARDIOVASC RES, V90, P9, DOI 10.1093/cvr/cvq394
   Vasan RS, 2001, NEW ENGL J MED, V345, P1291, DOI 10.1056/NEJMoa003417
   Ventura-Clapier R, 2017, CARDIOVASC RES, V113, P711, DOI 10.1093/cvr/cvx066
   Westphal C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073490
   Xu X, 2015, CIRCULATION, V131, P614, DOI 10.1161/CIRCULATIONAHA.114.012826
   Yahagi K, 2015, ATHEROSCLEROSIS, V239, P260, DOI 10.1016/j.atherosclerosis.2015.01.017
   Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9
   Zucker I, 2010, NATURE, V465, P690, DOI 10.1038/465690a
NR 119
TC 4
Z9 4
U1 0
U2 6
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD SEP
PY 2018
VL 48
IS 9
BP 792
EP 812
DI 10.4070/kcj.2018.0249
PG 21
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA HB0UO
UT WOS:000450733700003
PM 30146804
OA Green Published
DA 2021-04-22
ER

PT J
AU Rha, SW
   Choi, SH
   Kim, DI
   Jeon, DW
   Lee, JH
   Hong, KS
   Cha, TJ
   Cho, JH
   Lee, SK
   Park, YH
   Park, WJ
   Kim, HJ
   Kim, YJ
   Lee, J
   Choi, D
AF Rha, Seung-Woon
   Choi, Seung-Hyuk
   Kim, Doo-Il
   Jeon, Dong Woon
   Lee, Jae-Hwan
   Hong, Kyung-Soon
   Cha, Tae-Joon
   Cho, Jang-Hyun
   Lee, Sang Kon
   Park, Yong Hwan
   Park, Woo Jung
   Kim, Hyun-Joo
   Kim, Young-Joo
   Lee, Juneyoung
   Choi, Donghoon
CA PADO Res Investigators
TI Medical Resource Consumption and Quality of Life in Peripheral Arterial
   Disease in Korea: PAD Outcomes PADO Research
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Peripheral arterial disease; Disease burden; Quality of life
ID NATIONAL-HEALTH; RISK-FACTORS; SMOKING; CLASSIFICATION; COMPLEMENTARY;
   EPIDEMIOLOGY; THERAPIES
AB Background and Objectives: We aimed to investigate the history of medical resource consumption and quality of life (QoL) in peripheral arterial disease (PAD) patients in Korea.
   Methods: This was a prospective, multi-center (23 tertiary-hospitals, division of cardiology non-interventional study. Adult patients (age >= 20 years) suffering from PAD for the last 12-month were enrolled in the study if they met with any of following; 1) ankle-brachial index (ABI) <= 0.9, 2) lower-extremity artery stenosis on computed tomography angiography >= 50%, or 3) peak-systolic-velocity-ratio (PSVR) on ultrasound >= 2.0. Medical chart review was used to assess patient characteristics/treatment patterns while the history of medical resource consumption and QoL data were collected using a patient survey. QoL was measured using EuroQoL-5-dimensions-3-level (EQ-5D-3L) score system, and the factors associated with QoL were analyzed using multiple linear regression analysis.
   Results: This study included 1,260 patients (age: 69.8 years, male: 77.0%). The most prevalent comorbidities were hypertension (74.8%), hyperlipidemia (51.0%) and diabetes mellitus (50.2%). The 94.1% of the patients took pharmacotherapy including aspirin (76.2%), clopidogrel (53.3%), and cilostazol (33.6%). The 12.6% of the patients were receiving smoking cessation education/pharmacotherapy. A considerable number of patients 500 patients, 40.0%) had visit history to another hospital before diagnosis/treatment at the current hospital, with visits to orthopedic units (50.4%) being the most common. At the time, 29% (or higher) of the patients were already experiencing symptoms of critical limb ischemia. Baseline EQ-SD index and EQ VAS were 0.64 +/- 0.24 and 67.49 +/- 18.29. Factors significantly associated with QoL were pharmacotherapy (B=0.05053; p=0.044) compared to no pharmacotherapy, and Fontaine stage improvement/maintain stage I (B=0.04448; p<0.001) compared to deterioration/maintain stage II-IV.
   Conclusions: Increase in disease awareness for earlier diagnosis and provision of adequate pharmacotherapy is essential to reduce disease burden and improve QoL of Korean PAD patients.
C1 [Rha, Seung-Woon] Korea Univ, Dept Internal Med, Div Cardiol, Guro Hosp, Seoul, South Korea.
   [Choi, Seung-Hyuk] Samsung Med Ctr, Dept Internal Med, Dept Cardiol, Seoul, South Korea.
   [Kim, Doo-Il] Inje Univ, Dept Internal Med, Div Cardiol, Haeundae Paik Hosp, Busan, South Korea.
   [Jeon, Dong Woon] Natl Hlth Insurance Serv Ilsan Hosp, Dept Internal Med, Div Cardiol, Goyang, South Korea.
   [Lee, Jae-Hwan] Chungnam Natl Univ Hosp, Dept Internal Med, Div Cardiol, Daejeon, South Korea.
   [Hong, Kyung-Soon] Hallym Univ, Dept Internal Med, Div Cardiol, Chuncheon Sacred Heart Hosp, Chunchon, South Korea.
   [Cha, Tae-Joon] Kosin Univ, Gospel Hosp, Dept Internal Med, Div Cardiol, Busan, South Korea.
   [Cho, Jang-Hyun] St Carollo Hosp, Dept Internal Med, Div Cardiol, Sunchon, South Korea.
   [Lee, Sang Kon] Ulsan Univ Hosp, Dept Internal Med, Div Cardiol, Ulsan, South Korea.
   [Park, Yong Hwan] Sungkyunkwan Univ, Samsung Changwon Hosp, Dept Internal Med, Div Cardiol,Sch Med, Chang Won, South Korea.
   [Park, Woo Jung] Hallym Univ, Dept Internal Med, Div Cardiol, Sacred Heart Hosp, Anyang, South Korea.
   [Kim, Hyun-Joo; Kim, Young-Joo] Pfizer Pharmaceut Korea Ltd, Outcomes Res & Real World Data, Seoul, South Korea.
   [Lee, Juneyoung] Korea Univ, Dept Biostat, Coll Med, Seoul, South Korea.
   [Choi, Donghoon] Yonsei Univ Hlth Syst, Severance Cardiovasc Hosp, Dept Internal Med, Div Cardiol, 50-1 Yonsei Ro, Seoul 03722, South Korea.
RP Choi, D (corresponding author), Yonsei Univ Hlth Syst, Severance Cardiovasc Hosp, Dept Internal Med, Div Cardiol, 50-1 Yonsei Ro, Seoul 03722, South Korea.
EM CDHLYJ@yuhs.ac
OI Choi, Donghoon/0000-0002-2009-9760; Lee, Jae-Hwan/0000-0002-6561-7760;
   Lee, Sang-Kon/0000-0003-4901-8132
FU Pfizer Pharmaceuticals Korea Ltd.Pfizer
FX This research was sponsored by Pfizer Pharmaceuticals Korea Ltd.
CR Becker F, 2011, EUR J VASC ENDOVASC, V42, pS4, DOI 10.1016/S1078-5884(11)60009-9
   Becker GJ, 2002, J VASC INTERV RADIOL, V13, P7, DOI 10.1016/S1051-0443(07)60002-5
   Choi SH, 2010, J KOREAN MED ASSOC, V53, P228, DOI 10.5124/jkma.2010.53.3.228
   Coleman T, 2010, HEALTH TECHNOL ASSES, V14, P1, DOI 10.3310/hta14490
   Creager M A, 1998, Vasc Med, V3, P257, DOI 10.1177/1358836X9800300314
   Ferreiro JL, 2014, J AM COLL CARDIOL, V63, P769, DOI 10.1016/j.jacc.2013.10.043
   Fowkes FGR, 2017, NAT REV CARDIOL, V14, DOI 10.1038/nrcardio.2016.179
   Gerhard-Herman MD, 2017, CIRCULATION, V135, pE726, DOI 10.1161/CIR.0000000000000471
   Hankey GJ, 2006, JAMA-J AM MED ASSOC, V295, P547, DOI 10.1001/jama.295.5.547
   Hirsch AT, 2008, VASC MED, V13, P209, DOI 10.1177/1358863X08089277
   Issa SM, 2010, VASC MED, V15, P163, DOI 10.1177/1358863X10364208
   Izquierdo-Porrera AM, 2005, J VASC SURG, V41, P625, DOI 10.1016/j.jvs.2005.01.012
   Kang EJ, 2009, VALUE HEALTH, V12, pS114, DOI 10.1111/j.1524-4733.2009.00642.x
   Kang Eunjeong, 2006, [The Korean Journal of Health Economics and Policy, 보건경제와 정책연구], V12, P19
   Klonizakis M, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4206-y
   Ko YG, 2017, KOREAN CIRC J, V47, P469, DOI 10.4070/kcj.2017.0020
   Lee YH, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-94
   Liles DR, 2006, J SURG RES, V136, P294, DOI 10.1016/j.jss.2006.06.008
   Lu Jeffrey T, 2004, Rev Cardiovasc Med, V5, P189
   Meijer WT, 2000, ARCH INTERN MED, V160, P2934, DOI 10.1001/archinte.160.19.2934
   Nahin RL, 2009, COSTS COMPLEMENTARY
   Novo S, 2002, DIABETES OBES METAB, V4, pS1, DOI 10.1046/j.1463-1326.2002.0040s20s1.x
   Pittler MH, 2005, ATHEROSCLEROSIS, V181, P1, DOI 10.1016/j.atherosclerosis.2005.02.021
   Rhee SY, 2015, DIABETES METAB J, V39, P283, DOI 10.4093/dmj.2015.39.4.283
   Selvin E, 2004, CIRCULATION, V110, P738, DOI 10.1161/01.CIR.0000137913.26087.F0
   Suzuki J, 2016, HYPERTENS RES, V39, P183, DOI 10.1038/hr.2015.134
   Verma A, 2011, J CLIN OUTCOMES MANA, V18, P74
   Wieland LS, 2011, ALTERN THER HEALTH M, V17, P50
NR 28
TC 2
Z9 2
U1 1
U2 4
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD SEP
PY 2018
VL 48
IS 9
BP 813
EP 825
DI 10.4070/kcj.2017.0340
PG 13
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA HB0UO
UT WOS:000450733700004
PM 30088358
OA Green Published
DA 2021-04-22
ER

PT J
AU Kim, KH
   Kim, HK
   Chan, SY
   Kim, YJ
   Sohn, DW
AF Kim, Kyung-Hee
   Kim, Hyung-Kwan
   Chan, Stephen Y.
   Kim, Yong-Jin
   Sohn, Dae-Won
TI Hemodynamic and Histopathologic Benefits of Early Treatment with
   Macitentan in a Rat Model of Pulmonary Arterial Hypertension
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Macitentan; Pulmonary hypertension; Hemodynamics; Pathology
ID ENDOTHELIN RECEPTOR ANTAGONIST; BOSENTAN; SILDENAFIL; THERAPY; ERA
AB Background and Objectives: Macitentan (MAC) reduces morbidity and mortality among advanced-stage pulmonary arterial hypertension (PAH) patients. However, data regarding the histopathologic and hemodynamic benefits of MAC treatment at an early stage of PAH is lacking.
   Methods: One week after monocrotaline (MCT) injection, rats were randomly assigned to MAC (n=16), MAC combined with sildenafil (SIL) (MAC+SIL, n=16), or normal saline (MCT, n=16). Twelve sham rats (Sham) were included for comparison. Right ventricular (RV) systolic function was assessed via echocardiography as the RV fractional area change (RV-FAC). An invasive pressure-volume analysis using a Millar conductance catheter was performed 7 weeks after MCT injection. Rats were subsequently euthanized for histopathologic analysis.
   Results: RV-right atrial pressure gradient on echocardiography was significantly increased 3 weeks after MCT injection, but was maintained in the Sham. RV-FAC was less deteriorated in the MAC, compared to that in the MCT (44 +/- 3% vs. 25 +/- 7%, p<0.05), and the coadministration of SIL showed no additional benefit (45 +/- 8%, p>0.05 vs. the MAC). On invasive hemodynamic analyses, RV end-systolic (196 +/- 78 mu L) and end-diastolic volumes (310 +/- 86 mu L), pulmonary artery systolic pressure (89 +/- 7.2 mmHg), and end-systolic pressurevolume relationship (-254 +/- 25.1) were significantly worse in the MCT vs. in the MAC (101 +/- 45 mu L, 235 +/- 55 mu L, 40 +/- 10.5 mmHg, and -145 +/- 42.1, respectively) and MAC+SIL (109 +/- 47 mu L, 242 +/- 46 mu L, 38 +/- 9.2 mmHg, and -151 +/- 39.2, respectively) (all p<0.05). However, the MAC and MAC+SIL did not differ (all p>0.05). On histopathology, both RV and lung fibrosis were significantly reduced in the MAC and MAC+SIL vs. in the MCT (all p<0.05); the 2 treatment groups did not differ.
   Conclusions: MAC treatment at an earlier stage significantly attenuated experimental PAH progression hemodynamically and histopathologically.
C1 [Kim, Kyung-Hee] Sejong Gen Hosp, Dept Internal Med, Div Cardiol, Bucheon, South Korea.
   [Kim, Kyung-Hee; Kim, Hyung-Kwan; Kim, Yong-Jin; Sohn, Dae-Won] Seoul Natl Univ, Seoul Natl Univ Hosp, Cardiovasc Ctr, Div Cardiol,Dept Internal Med,Coll Med, 101 Daehak Ro, Seoul 03080, South Korea.
   [Chan, Stephen Y.] UPMC, Pittsburgh Heart Lung Blood & Vasc Med Inst, Div Cardiol, Dept Med, Pittsburgh, PA USA.
   [Chan, Stephen Y.] Univ Pittsburgh, Sch Med, Pittsburgh, PA USA.
RP Kim, HK (corresponding author), Seoul Natl Univ, Seoul Natl Univ Hosp, Cardiovasc Ctr, Div Cardiol,Dept Internal Med,Coll Med, 101 Daehak Ro, Seoul 03080, South Korea.
EM cardiman73@gmail.com
RI Kim, Hyung-Kwan/R-8375-2019
OI Chan, Stephen Y./0000-0002-9520-7527; Kim,
   Hyung-Kwan/0000-0001-7950-2131; Sohn, Dae-Won/0000-0002-1092-3285; Kim,
   Kyung-Hee/0000-0003-0708-8685
FU Korea Society of Echocardiography; NATIONAL HEART, LUNG, AND BLOOD
   INSTITUTEUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Heart Lung & Blood
   Institute (NHLBI) [R01HL122596, R01HL122596] Funding Source: NIH
   RePORTER
FX This research was funded by Korea Society of Echocardiography research
   fund (2014).
CR Baber SR, 2007, AM J PHYSIOL-HEART C, V292, pH1120, DOI 10.1152/ajpheart.00173.2006
   Bruderer S, 2012, XENOBIOTICA, V42, P901, DOI 10.3109/00498254.2012.664665
   Clozel M, 2006, EXP BIOL MED, V231, P967
   Condliffe R, 2009, AM J RESP CRIT CARE, V179, P151, DOI 10.1164/rccm.200806-953OC
   Ding MG, 2015, J CARDIOVASC PHARM, V65, P562, DOI 10.1097/FJC.0000000000000224
   Galie N, 2008, LANCET, V371, P2093, DOI 10.1016/S0140-6736(08)60919-8
   Galie N, 2005, J AM COLL CARDIOL, V46, P529, DOI 10.1016/j.jacc.2005.04.050
   Galie N, 2015, NEW ENGL J MED, V373, P834, DOI 10.1056/NEJMoa1413687
   Galie N, 2005, NEW ENGL J MED, V353, P2148, DOI 10.1056/NEJMoa050010
   Galie N, 2016, EUR HEART J, V37, P67, DOI 10.1093/eurheartj/ehv317
   Hessel MHM, 2006, AM J PHYSIOL-HEART C, V291, pH2424, DOI 10.1152/ajpheart.00369.2006
   Humbert M, 2010, CIRCULATION, V122, P156, DOI 10.1161/CIRCULATIONAHA.109.911818
   Iglarz M, 2008, J PHARMACOL EXP THER, V327, P736, DOI 10.1124/jpet.108.142976
   Iglarz M, 2015, J CARDIOVASC PHARM, V66, P457, DOI 10.1097/FJC.0000000000000296
   Iglarz M, 2014, LIFE SCI, V118, P333, DOI 10.1016/j.lfs.2014.02.018
   Kim KH, 2011, KOREAN CIRC J, V41, P603, DOI 10.4070/kcj.2011.41.10.603
   Kim KH, 2012, CIRCULATION, V125, P1390, DOI 10.1161/CIRCULATIONAHA.111.065300
   Nogueira-Ferreira R, 2015, PULM PHARMACOL THER, V35, P8, DOI 10.1016/j.pupt.2015.09.007
   Pulido T, 2013, NEW ENGL J MED, V369, P809, DOI 10.1056/NEJMoa1213917
   Rubin LJ, 2002, NEW ENGL J MED, V346, P896, DOI 10.1056/NEJMoa012212
   Schermuly RT, 2011, NAT REV CARDIOL, V8, P443, DOI 10.1038/nrcardio.2011.87
   Stenmark KR, 2009, AM J PHYSIOL-LUNG C, V297, pL1013, DOI 10.1152/ajplung.00217.2009
   Takimoto E, 2005, NAT MED, V11, P214, DOI 10.1038/nm1175
   Tyndall AJ, 2010, ANN RHEUM DIS, V69, P1809, DOI 10.1136/ard.2009.114264
NR 24
TC 4
Z9 4
U1 1
U2 4
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD SEP
PY 2018
VL 48
IS 9
BP 839
EP 853
DI 10.4070/kcj.2017.0394
PG 15
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA HB0UO
UT WOS:000450733700008
PM 30088353
OA Green Published
DA 2021-04-22
ER

PT J
AU Song, JK
AF Song, Jae-Kwan
TI Coronary Artery Vasospasm
SO KOREAN CIRCULATION JOURNAL
LA English
DT Review
DE Coronary artery vasospasm
ID VARIANT ANGINA; SPASM; ERGONOVINE; DIAGNOSIS; ECHOCARDIOGRAPHY;
   GUIDELINES; MANAGEMENT; INDUCTION; PROGNOSIS; DISEASE
AB Coronary artery vasospasm (CVS) is an important mechanism of myocardial ischemia and produces any of the manifestations of coronary artery disease from silent myocardial ischemia, to effort-induced angina and variant angina, to acute coronary syndrome including myocardial infarction or sudden cardiac death. The pathogenesis, characteristic clinical features, diagnosis, and treatment of CVS are summarized. Emphasis is placed on correct diagnosis of CVS using pharmacological spasm provocation test, either during coronary angiography or with echocardiographic monitoring of ventricular wall motion. Current underutilization of pharmacologic provocative test at the time of coronary angiography cannot be justified, as there is no evidence supporting that the incidence of CVS is declining. Physicians' vigilance for objective documentation of CVS is necessary for appropriate management of patients with various clinical presentations of ischemic heart disease.
C1 [Song, Jae-Kwan] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Cardiol,Heart Inst, Seoul, South Korea.
RP Song, JK (corresponding author), Univ Ulsan, Coll Med, Asan Med Ctr, Heart Inst, 88 Olymp Ro,43 Gil, Seoul 05505, South Korea.
EM jksong@amc.seoul.kr
CR Ahn JM, 2016, J AM COLL CARDIOL, V68, P137, DOI 10.1016/j.jacc.2016.04.050
   Akasaka T, 2014, CIRC J, V78, P2779, DOI 10.1253/circj.CJ-66-0098
   Anderson JL, 2013, J AM COLL CARDIOL, V61, pE179, DOI 10.1016/j.jacc.2013.01.014
   Beltrame JF, 2017, EUR HEART J, V38, P2565, DOI 10.1093/eurheartj/ehv351
   BERTRAND ME, 1982, CIRCULATION, V65, P1299, DOI 10.1161/01.CIR.65.7.1299
   BUXTON A, 1980, AM J CARDIOL, V46, P329, DOI 10.1016/0002-9149(80)90080-6
   Djordjevic-Dikic A, 1999, Cardiologia, V44, P901
   Fihn SD, 2012, J AM COLL CARDIOL, V60, pE44, DOI 10.1016/j.jacc.2012.07.013
   HACKETT D, 1987, CIRCULATION, V75, P577, DOI 10.1161/01.CIR.75.3.577
   HEUPLER FA, 1978, AM J CARDIOL, V41, P631, DOI 10.1016/0002-9149(78)90810-X
   MacAlpin RN, 2015, INT J CARDIOL, V181, P389, DOI 10.1016/j.ijcard.2014.12.047
   MASERI A, 1987, J AM COLL CARDIOL, V9, P249, DOI 10.1016/S0735-1097(87)80372-8
   NESTO RW, 1987, AM J CARDIOL, V59, pC23, DOI 10.1016/0002-9149(87)90192-5
   OLIVA PB, 1973, NEW ENGL J MED, V288, P745, DOI 10.1056/NEJM197304122881501
   Park SW, 1991, KOREAN CIRC J, V21, P842
   PRINZMETAL M, 1959, AM J MED, V27, P375, DOI 10.1016/0002-9343(59)90003-8
   Song J K, 1994, J Am Soc Echocardiogr, V7, P607
   Song JK, 2000, J AM COLL CARDIOL, V35, P1850, DOI 10.1016/S0735-1097(00)00646-X
   Song JK, 1996, J AM COLL CARDIOL, V27, P1156, DOI 10.1016/0735-1097(95)00590-0
   Takagi Y, 2013, EUR HEART J, V34, P258, DOI 10.1093/eurheartj/ehs199
   WATERS DD, 1983, CIRCULATION, V67, P310, DOI 10.1161/01.CIR.67.2.310
   YASUE H, 1988, CIRCULATION, V78, P1, DOI 10.1161/01.CIR.78.1.1
   YASUE H, 1986, CIRCULATION, V74, P955, DOI 10.1161/01.CIR.74.5.955
   YASUE H, 1978, CIRCULATION, V58, P56, DOI 10.1161/01.CIR.58.1.56
   Zaya M, 2014, J AM COLL CARDIOL, V63, P103, DOI 10.1016/j.jacc.2013.10.038
NR 25
TC 5
Z9 6
U1 0
U2 3
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD SEP
PY 2018
VL 48
IS 9
BP 767
EP 777
DI 10.4070/kcj.2018.0251
PG 11
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA HB0UO
UT WOS:000450733700001
PM 30146803
OA Green Published
DA 2021-04-22
ER

PT J
AU Agrawal, A
   Jain, D
   Dias, A
   Jorge, V
   Figueredo, VM
AF Agrawal, Akanksha
   Jain, Deepanshu
   Dias, Andre
   Jorge, Vinicius
   Figueredo, Vincent M.
TI Real World Utility of Dobutamine Stress Echocardiography in Predicting
   Perioperative Cardiovascular Morbidity and Mortality after Othotopic
   Liver Transplantation
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Dobutamine stress echocardiography; Liver transplantation; Major adverse
   cardiac event; Coronary artery disease
ID CARDIAC EVENTS; DISEASE; ASSOCIATION; RISK
AB Background and Objectives: Stress echocardiography is the current standard for cardiac risk stratification of patients undergoing orthotopic liver transplantation (OLT). We aim to evaluate the role of dobutamine stress echocardiography (DSE) in predicting perioperative major adverse cardiac event (MACE) in patients undergoing OLT.
   Methods: This was a single-center retrospective study including 144 OLT patients. Of 144 patients, 118 had DSE. MACE included myocardial infarction (MI), heart failure (HF), cardiovascular and all-cause death 1 year after OLT.
   Results: Our study cohort included 118 patients. The mean age was 57.3 +/- 8.2 years (range, 25-72 years). There were 85 men and 33 women, male to female ratio being 2.6:1. Of 118, 15 (13%) had positive DSE and 103 (87%) had negative DSE. Perioperative MACE incidence was 5.9% (95% confidence interval [CI], 2.6-42.3%). In predicting MACE, DSE had sensitivity of 5.6% (95% CI, 0.2-29.4%), specificity 86% (95% CI, 77.3-91.9%), positive predictive value 6.7% (95% CI, 0.3-33.4%), and negative predictive value (NPV) 83.5% (95% CI, 74.6-89.8%). Eighteen patients had MACE in first year post OLT (15%, 95% CI, 9.5-23.3%). Adverse events included cardiogenic shock (2/18), systolic HF (2/18), non-ST-elevated MI (7/18), cardiac mortality (3/18), and all-cause mortality (7/18). The overall complication rate of DSE was 17% (20/118).
   Conclusions: In our cohort, DSE had a low sensitivity but high NPV in predicting perioperative MACE post OLT. A similar trend was noted for DSE in predicting 1-year MACE post OLT. We reiterate the need of a better screening and risk stratification tool for OLT.
C1 [Agrawal, Akanksha; Jorge, Vinicius] Albert Einstein Med Ctr, Dept Internal Med, 5501 Old York Rd, Philadelphia, PA 19141 USA.
   [Jain, Deepanshu] Albert Einstein Med Ctr, Dept Digest Dis & Transplantat, Philadelphia, PA 19141 USA.
   [Dias, Andre; Figueredo, Vincent M.] Albert Einstein Med Ctr, Div Cardiol, Dept Internal Med, Philadelphia, PA 19141 USA.
RP Agrawal, A (corresponding author), Albert Einstein Med Ctr, Dept Internal Med, 5501 Old York Rd, Philadelphia, PA 19141 USA.
EM akanksha21agr@gmail.com
RI Dias, Andre/W-1500-2019
OI Dias, Andre/0000-0003-0660-5628; Agrawal, Akanksha/0000-0002-0718-7416
CR AFRIDI I, 1994, AM HEART J, V127, P1510, DOI 10.1016/0002-8703(94)90378-6
   Donovan CL, 1996, TRANSPLANTATION, V61, P1180, DOI 10.1097/00007890-199604270-00011
   LAKE JR, 1993, GASTROENTEROL CLIN N, V22, P213
   Lentine KL, 2012, CIRCULATION, V126, P617, DOI 10.1161/CIR.0b013e31823eb07a
   Linhares MM, 2006, TRANSPLANTATION, V81, P1016, DOI 10.1097/01.tp.0000203798.96491.2f
   Martin P, 2014, HEPATOLOGY, V59, P1144, DOI 10.1002/hep.26972
   Mazeika PK, 1991, CIRCULATION, V84
   McAvoy NC, 2008, LIVER TRANSPLANT, V14, P1725, DOI 10.1002/lt.21540
   McCaughan GW, 2012, LIVER TRANSPLANT, V18, pS39, DOI 10.1002/lt.23526
   Nguyen P, 2013, INT J CARDIOVAS IMAG, V29, P1741, DOI 10.1007/s10554-013-0275-x
   Nicolau-Raducu R, 2015, LIVER TRANSPLANT, V21, P13, DOI 10.1002/lt.23997
   PELLIKKA PA, 1992, CIRCULATION, V86, P1429, DOI 10.1161/01.CIR.86.5.1429
   Pisano G, 2016, WORLD J GASTROENTERO, V22, P8869, DOI 10.3748/wjg.v22.i40.8869
   POLDERMANS D, 1993, CIRCULATION, V87, P1506, DOI 10.1161/01.CIR.87.5.1506
   Rosamond TL, 1991, CIRCULATION, V84
   Tsutsui JM, 2006, LIVER TRANSPLANT, V12, P592, DOI 10.1002/lt.20651
NR 16
TC 4
Z9 5
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD SEP
PY 2018
VL 48
IS 9
BP 828
EP 835
DI 10.4070/kcj.2017.0350
PG 8
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA HB0UO
UT WOS:000450733700006
PM 30088354
OA Green Published
DA 2021-04-22
ER

PT J
AU Kim, HO
   Kim, W
AF Kim, Hyung Oh
   Kim, Weon
TI Elucidation of the Diagnosis and Treatment of Peripheral Arterial
   Disease
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
C1 [Kim, Hyung Oh; Kim, Weon] Kyung Hee Univ, Kyung Hee Univ Hosp, Dept Internal Med, Div Cardiovasc, 23 Kyungheedae Ro, Seoul 02447, South Korea.
RP Kim, W (corresponding author), Kyung Hee Univ, Kyung Hee Univ Hosp, Dept Internal Med, Div Cardiovasc, 23 Kyungheedae Ro, Seoul 02447, South Korea.
EM mylovekw@hanmail.net
OI Kim, Hyung Oh/0000-0003-2157-441X
CR Berger JS, 2009, JAMA-J AM MED ASSOC, V301, P1909, DOI 10.1001/jama.2009.623
   Bhatt DL, 2006, JAMA-J AM MED ASSOC, V295, P180, DOI 10.1001/jama.295.2.180
   Gerhard-Herman MD, 2017, VASC MED, V22, pNP1, DOI 10.1177/1358863X17701592
   Hirsch AT, 2001, JAMA-J AM MED ASSOC, V286, P1317, DOI 10.1001/jama.286.11.1317
   Issa SM, 2010, VASC MED, V15, P163, DOI 10.1177/1358863X10364208
   Kim HO, 2018, INT J CARDIOL, V262, P32, DOI 10.1016/j.ijcard.2018.03.108
   Ko YG, 2017, KOREAN CIRC J, V47, P469, DOI 10.4070/kcj.2017.0020
   Muhlestein JB, 2013, J AM COLL CARDIOL, V61, pE1155, DOI 10.1016/S0735-1097(13)61155-9
   Rha SW, 2018, KOREAN CIRC J, V48, P813, DOI 10.4070/kcj.2017.0340
NR 9
TC 0
Z9 0
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD SEP
PY 2018
VL 48
IS 9
BP 826
EP 827
DI 10.4070/kcj.2018.0155
PG 2
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA HB0UO
UT WOS:000450733700005
PM 30088357
OA Green Published
DA 2021-04-22
ER

PT J
AU Chung, H
   Sohn, IS
AF Chung, Hyemoon
   Sohn, Il Suk
TI The Safety and Utility of Dobutamine Stress Echocardiography for
   Pre-operative Risk Stratification in Orthotopic Liver Transplantation
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
C1 [Chung, Hyemoon] Kyung Hee Univ, Med Ctr, Dept Cardiol, Seoul, South Korea.
   [Sohn, Il Suk] Kyung Hee Univ Hosp Gangdong, Dept Cardiol, Seoul, South Korea.
RP Sohn, IS (corresponding author), Kyung Hee Univ, Kyung Hee Univ Hosp Gangdong, Coll Med, Dept Cardiol, 892 Dongnam Ro, Seoul 05278, South Korea.
EM issohn@khu.ac.kr
RI SOHN, ILSUK/AAI-1097-2020
OI SOHN, ILSUK/0000-0001-8004-5185
CR Agrawal A, 2018, KOREAN CIRC J, V48, P828, DOI 10.4070/kcj.2017.0350
   Douglas PS, 2011, J AM COLL CARDIOL, V57, P1126, DOI 10.1016/j.jacc.2010.11.002
   Geleijnse ML, 2010, CIRCULATION, V121, P1756, DOI 10.1161/CIRCULATIONAHA.109.859264
   Glance LG, 2012, ANN SURG, V255, P696, DOI 10.1097/SLA.0b013e31824b45af
   Kristensen SD, 2014, EUR HEART J, V35, P2383, DOI 10.1093/eurheartj/ehu282
   Montalescot G, 2013, EUR HEART J, V34, P2949, DOI 10.1093/eurheartj/eht296
   Nguyen P, 2013, INT J CARDIOVAS IMAG, V29, P1741, DOI 10.1007/s10554-013-0275-x
   Raval Z, 2011, J AM COLL CARDIOL, V58, P223, DOI 10.1016/j.jacc.2011.03.026
   Snipelisky D, 2014, CLIN CARDIOL, V37, P468, DOI 10.1002/clc.22283
   Sohn IS, 2010, INT J CARDIOL, V144, P433, DOI 10.1016/j.ijcard.2009.03.069
NR 10
TC 0
Z9 0
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD SEP
PY 2018
VL 48
IS 9
BP 836
EP 838
DI 10.4070/kcj.2018.0144
PG 3
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA HB0UO
UT WOS:000450733700007
PM 30088356
OA Green Published
DA 2021-04-22
ER

PT J
AU Jung, HO
AF Jung, Hae Ok
TI Benefits from the Early Initiation of Macitentan for Pulmonary Arterial
   Hypertension
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
ID ENDOTHELIN RECEPTOR ANTAGONIST; DIAGNOSIS; SURVIVAL
C1 [Jung, Hae Ok] Catholic Univ Korea, Coll Med, Dept Internal Med, Div Cardiol, 222 Banpo Daero, Seoul 06591, South Korea.
RP Jung, HO (corresponding author), Catholic Univ Korea, Coll Med, Dept Internal Med, Div Cardiol, 222 Banpo Daero, Seoul 06591, South Korea.
EM hojehart@catholic.ac.kr
OI Jung, Hae Ok/0000-0002-5102-9212
CR Benza RL, 2012, CHEST, V142, P448, DOI 10.1378/chest.11-1460
   Chung WJ, 2015, J KOREAN MED SCI, V30, P1429, DOI 10.3346/jkms.2015.30.10.1429
   Hoeper MM, 2013, J AM COLL CARDIOL, V62, pD42, DOI 10.1016/j.jacc.2013.10.032
   Humbert M, 2004, NEW ENGL J MED, V351, P1425, DOI 10.1056/NEJMra040291
   Humbert M, 2010, CIRCULATION, V122, P156, DOI 10.1161/CIRCULATIONAHA.109.911818
   Iglarz M, 2008, J PHARMACOL EXP THER, V327, P736, DOI 10.1124/jpet.108.142976
   Kim KC, 2016, KOREAN CIRC J, V46, P79, DOI 10.4070/kcj.2016.46.1.79
   Kim KH, 2018, KOREAN CIRC J, V48, P839, DOI 10.4070/kcj.2017.0394
   Pulido T, 2013, NEW ENGL J MED, V369, P809, DOI 10.1056/NEJMoa1213917
   Raja SG, 2010, CURR OPIN INVEST DR, V11, P1066
NR 10
TC 0
Z9 1
U1 0
U2 2
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD SEP
PY 2018
VL 48
IS 9
BP 854
EP 856
DI 10.4070/kcj.2018.0156
PG 3
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA HB0UO
UT WOS:000450733700009
PM 30088355
OA Green Published
DA 2021-04-22
ER

PT J
AU Kook, H
   Yu, CW
   Lee, SH
   Danenberg, H
   Park, SM
AF Kook, Hyungdon
   Yu, Cheol Woong
   Lee, Seung Hun
   Danenberg, Haim
   Park, Seong-Mi
TI Successful Transcatheter Aortic Valve Replacement for Severe Aortic
   Regurgitation after CARVAR Operation
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
C1 [Kook, Hyungdon; Yu, Cheol Woong; Lee, Seung Hun; Park, Seong-Mi] Korea Univ, Anam Hosp, Cardiovasc Ctr, Seoul, South Korea.
   [Danenberg, Haim] Hadassah Hebrew Univ, Med Ctr, Cardiovasc Res Ctr, Jerusalem, Israel.
RP Yu, CW (corresponding author), Korea Univ, Anam Hosp, Dept Cardiol, 73 Inchon Ro, Seoul 02841, South Korea.
EM ycw717@naver.com
OI Yu, Cheol Woong/0000-0002-5871-4562; Park, Seong-Mi/0000-0002-6710-685X
CR Bae JM, 2012, KOREAN CIRC J, V42, P769, DOI 10.4070/kcj.2012.42.11.769
   Dvir D, 2012, CIRCULATION, V126, P2335, DOI 10.1161/CIRCULATIONAHA.112.104505
   Hahm SY, 2006, EUR J CARDIO-THORAC, V29, P530, DOI 10.1016/j.ejcts.2006.01.009
   Roy DA, 2013, J AM COLL CARDIOL, V61, P1577, DOI 10.1016/j.jacc.2013.01.018
   Webb JG, 2015, JACC-CARDIOVASC INTE, V8, P1850, DOI 10.1016/j.jcin.2015.10.004
NR 5
TC 0
Z9 0
U1 0
U2 2
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD SEP
PY 2018
VL 48
IS 9
BP 857
EP 860
DI 10.4070/kcj.2018.0108
PG 4
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA HB0UO
UT WOS:000450733700010
PM 30088359
OA Green Published
DA 2021-04-22
ER

PT J
AU Lee, JY
   Lee, SH
   Kim, WH
AF Lee, Ja-Yeon
   Lee, Sun Hwa
   Kim, Won-Ho
TI Three-valve Endocarditis Caused by Corynebacterium striatum
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
C1 [Lee, Ja-Yeon; Lee, Sun Hwa; Kim, Won-Ho] Chonbuk Natl Univ, Med Sch, Dept Internal Med, Div Cardiol, 20 Geonji Ro, Jeonju 54907, South Korea.
   [Lee, Ja-Yeon; Lee, Sun Hwa; Kim, Won-Ho] Chonbuk Natl Univ, Res Inst Clin Med, Jeonju, South Korea.
   [Lee, Ja-Yeon; Lee, Sun Hwa; Kim, Won-Ho] Chonbuk Natl Univ Hosp, Biomed Res Inst, Jeonju, South Korea.
RP Lee, SH (corresponding author), Chonbuk Natl Univ, Med Sch, Dept Internal Med, Div Cardiol, 20 Geonji Ro, Jeonju 54907, South Korea.
EM shleemd@jbnu.ac.kr
RI lee, sun hwa/R-1431-2019
OI Lee, Sun Hwa/0000-0001-9752-9717; Lee, Ja yeon/0000-0002-6055-3964
CR Hahn WO, 2016, EMERG INFECT DIS, V22, P1908, DOI 10.3201/eid2211.160141
   Jagadeeshan Naveena, 2016, Indian Heart J, V68 Suppl 2, pS271, DOI 10.1016/j.ihj.2015.07.026
   McMullen AR, 2017, ANTIMICROB AGENTS CH, V61, DOI [10.1128/AAC.01111-17, 10.1128/aac.01111-17]
NR 3
TC 2
Z9 2
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD SEP
PY 2018
VL 48
IS 9
BP 861
EP 862
DI 10.4070/kcj.2018.0126
PG 2
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA HB0UO
UT WOS:000450733700011
PM 30088361
OA Green Published
DA 2021-04-22
ER

PT J
AU Li, YG
   Lee, SR
   Choi, EK
   Lip, GYH
AF Li, Yan-Guang
   Lee, So-Ryoung
   Choi, Eue-Keun
   Lip, Gregory Y. H.
TI Stroke Prevention in Atrial Fibrillation: Focus on Asian Patients
SO KOREAN CIRCULATION JOURNAL
LA English
DT Review
DE Atrial fibrillation; Stroke; Prevention; Anticoagulant agents; Asian
   continental ancestry group
ID ANTAGONIST ORAL ANTICOAGULANTS; ASSESSING BLEEDING RISK; VITAMIN-K
   ANTAGONISTS; HEART RHYTHM SOCIETY; CHA(2)DS(2)-VASC SCORE; CHINESE
   PATIENTS; APPENDAGE CLOSURE; ISCHEMIC-STROKE; ANTITHROMBOTIC TREATMENT;
   INTRACRANIAL HEMORRHAGE
AB Atrial fibrillation (AF) is the most common arrhythmia conferring a fivefold increased risk of stroke. Stroke prevention is the cornerstone of management of patients with AF. Asians have a generally higher incidence of AF-related risks of stroke and bleeding (particularly intracranial bleeding), compared with non-Asians. Despite the well-documented efficacy and relative safety of oral anticoagulation for stroke prevention among Asians, the suboptimal use of oral anticoagulation remains common. The current narrative review aims to provide a summary of the available evidence on stroke prevention among patients with AF focused on the Asia region, regarding stroke and bleeding risk evaluation, the performance of oral anticoagulation, and current use of thromboprophylaxis.
C1 [Li, Yan-Guang; Lip, Gregory Y. H.] Univ Birmingham, Inst Cardiovasc Sci, Birmingham, W Midlands, England.
   [Li, Yan-Guang; Lip, Gregory Y. H.] Chinese PLA Med Sch, Dept Cardiol, Beijing, Peoples R China.
   [Lee, So-Ryoung] Soon Chun Hyang Univ Hosp Seoul, Div Cardiol, Dept Internal Med, Seoul, South Korea.
   [Choi, Eue-Keun] Seoul Natl Univ Hosp, Dept Internal Med, Seoul, South Korea.
   [Lip, Gregory Y. H.] Aalborg Univ, Dept Clin Med, Aalborg Thrombosis Res Unit, Aalborg, Denmark.
RP Lip, GYH (corresponding author), Univ Birmingham, Inst Cardiovasc Sci, Birmingham, W Midlands, England.
EM g.y.h.lip@bham.ac.uk
RI Choi, Eue-Keun/J-5968-2014
OI Choi, Eue-Keun/0000-0002-0411-6372; Li, Yan-Guang/0000-0002-9121-1887;
   Lee, So-Ryoung/0000-0002-6351-5015
CR Amerena J, 2012, AM J CARDIOL, V109, P378, DOI 10.1016/j.amjcard.2011.08.046
   Apostolakis S, 2013, CHEST, V144, P1555, DOI 10.1378/chest.13-0054
   Esteve-Pastor MA, 2017, THROMB HAEMOSTASIS, V117, P2261, DOI 10.1160/TH17-10-0710
   Bai Y, 2017, EUROPACE
   Bai Y, 2018, AGE AGEING, V47, P9, DOI 10.1093/ageing/afx103
   Bai Y, 2017, CHEST, V152, P810, DOI 10.1016/j.chest.2017.03.048
   Bassand JP, 2016, EUR HEART J, V37, P2882, DOI 10.1093/eurheartj/ehw233
   Bernaitis N, 2017, THROMB RES, V157, P120, DOI 10.1016/j.thromres.2017.07.007
   Bernaitis N, 2017, J STROKE CEREBROVASC, V26, P64, DOI 10.1016/j.jstrokecerebrovasdis.2016.08.030
   Cardoso R, 2018, HEART RHYTHM, V15, P107, DOI 10.1016/j.hrthm.2017.09.011
   Cha MJ, 2017, STROKE, V48, P3040, DOI 10.1161/STROKEAHA.117.018773
   Chan EW, 2016, HEART RHYTHM, V13, P1581, DOI 10.1016/j.hrthm.2016.03.049
   Chan PH, 2016, CAN J CARDIOL, V32, P1381, DOI 10.1016/j.cjca.2016.05.009
   Chang CH, 2014, THROMB RES, V133, P782, DOI 10.1016/j.thromres.2014.02.024
   Chang SS, 2016, STROKE, V47, P1803, DOI 10.1161/STROKEAHA.116.012988
   Chao T-F, 2018, CIRCULATION
   Chao TF, 2018, THROMB HAEMOSTASIS, V118, P768, DOI 10.1055/s-0038-1636534
   Chao TF, 2018, INT J CARDIOL, V254, P157, DOI 10.1016/j.ijcard.2017.11.025
   Chao TF, 2018, CHEST, V153, P453, DOI 10.1016/j.chest.2017.10.001
   Chao TF, 2018, J AM COLL CARDIOL, V71, P122, DOI 10.1016/j.jacc.2017.10.085
   Chao TF, 2016, STROKE, V47, P2462, DOI 10.1161/STROKEAHA.116.013880
   Chao TF, 2016, HEART RHYTHM, V13, P46, DOI 10.1016/j.hrthm.2015.08.017
   Chao TF, 2015, J AM COLL CARDIOL, V66, P1339, DOI 10.1016/j.jacc.2015.07.026
   Chao TF, 2015, J AM COLL CARDIOL, V65, P635, DOI 10.1016/j.jacc.2014.11.046
   Chao TF, 2014, J AM COLL CARDIOL, V64, P1658, DOI 10.1016/j.jacc.2014.06.1203
   Chen YH, 2017, PACE, V40, P607, DOI 10.1111/pace.13020
   Chiang CE, 2017, J ARRYTHM, V33, P345, DOI 10.1016/j.joa.2017.05.004
   Chiang CE, 2016, J FORMOS MED ASSOC, V115, P893, DOI 10.1016/j.jfma.2016.10.005
   Chiang CE, 2014, THROMB HAEMOSTASIS, V111, P789, DOI 10.1160/TH13-11-0948
   Connolly SJ, 2009, NEW ENGL J MED, V361, P1139, DOI 10.1056/NEJMoa0905561
   Dillinger JG, 2018, ARCH CARDIOVASC DIS, V111, P85, DOI 10.1016/j.acvd.2017.04.008
   Eckman MH, 2011, CIRC-CARDIOVASC QUAL, V4, P14, DOI 10.1161/CIRCOUTCOMES.110.958108
   Fang MC, 2011, J AM COLL CARDIOL, V58, P395, DOI 10.1016/j.jacc.2011.03.031
   Fauchier L, 2016, AM J MED, V129, DOI 10.1016/j.amjmed.2016.06.045
   Gamra H, 2014, ARCH CARDIOVASC DIS, V107, P77, DOI 10.1016/j.acvd.2014.01.001
   Giugliano RP, 2013, NEW ENGL J MED, V369, P2093, DOI 10.1056/NEJMoa1310907
   Gladstone DJ, 2009, STROKE, V40, P235, DOI 10.1161/STROKEAHA.108.516344
   Goto S, 2014, AM HEART J, V168, P303, DOI 10.1016/j.ahj.2014.06.005
   Granger CB, 2011, NEW ENGL J MED, V365, P981, DOI 10.1056/NEJMoa1107039
   Guo YT, 2016, SCI REP-UK, V6, DOI 10.1038/srep31755
   Guo YT, 2018, AM J MED, V131, P185, DOI 10.1016/j.amjmed.2017.09.009
   Guo YT, 2015, CHEST, V148, P62, DOI 10.1378/chest.14-2018
   Guo YT, 2013, INT J CARDIOL, V168, P515, DOI 10.1016/j.ijcard.2012.09.187
   Hart RG, 2007, ANN INTERN MED, V147, P590, DOI 10.7326/0003-4819-147-8-200710160-00018
   Henninger N, 2016, STROKE, V47, P1486, DOI 10.1161/STROKEAHA.116.012865
   Hijazi Z, 2016, LANCET, V387, P2302, DOI 10.1016/S0140-6736(16)00741-8
   Holmes DR, 2009, LANCET, V374, P534, DOI 10.1016/S0140-6736(09)61343-X
   Holmes DR, 2014, J AM COLL CARDIOL, V64, P1, DOI 10.1016/j.jacc.2014.04.029
   Hong KS, 2017, JAMA NEUROL, V74, P1206, DOI 10.1001/jamaneurol.2017.2161
   Hong KS, 2017, J CLIN NEUROL, V13, P273, DOI 10.3988/jcn.2017.13.3.273
   Hori M, 2013, STROKE, V44, P1891, DOI 10.1161/STROKEAHA.113.000990
   Hori M, 2012, CIRC J, V76, P2104, DOI 10.1253/circj.CJ-12-0454
   Huisman MV, 2016, EUROPACE, V18, P1308, DOI 10.1093/europace/euw073
   Huisman MV, 2015, AM J MED, V128, P1306, DOI 10.1016/j.amjmed.2015.07.013
   Hung Y, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.116.003839
   Inoue H, 2014, CIRC J, V78, P1997, DOI 10.1253/circj.CJ-66-0092
   January CT, 2014, J AM COLL CARDIOL, V64, pE1, DOI 10.1016/j.jacc.2014.03.022
   Jones C, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g3655
   Jung BC, 2015, KOREAN CIRC J, V45, P9, DOI 10.4070/kcj.2015.45.1.9
   Kang SH, 2017, CIRC J, V81, P1158, DOI 10.1253/circj.CJ-16-1267
   Kim D, 2018, HEART
   Kim H, 2017, KOREAN CIRC J, V47, P877, DOI 10.4070/kcj.2017.0146
   Kim JS, 2016, CIRC J, V80, P1123, DOI 10.1253/circj.CJ-15-1134
   Kim TH, 2017, STROKE, V48, P2984, DOI 10.1161/STROKEAHA.117.018551
   Kirchhof P, 2016, EUR J CARDIO-THORAC, V50, pE1, DOI 10.1093/ejcts/ezw313
   Kohsaka S, 2018, CURR MED RES OPIN, V34, P1627, DOI 10.1080/03007995.2018.1478282
   Lam YY, 2012, CATHETER CARDIO INTE, V79, P794, DOI 10.1002/ccd.23136
   Landmesser U, 2017, EUROINTERVENTION, V13, P867, DOI 10.4244/EIJ-D-17-00493
   Lee JM, 2018, KOREAN J MED, V93, P87, DOI DOI 10.3904/kjm.2018.93.2.87
   Lee KH, 2017, EUROPACE, V19, P1, DOI 10.1093/europace/eux247
   Lee OH, 2018, AM J CARDIOL, V121, P1534, DOI 10.1016/j.amjcard.2018.02.045
   Lee SR, 2018, KOREAN CIRC J, V48, P622, DOI 10.4070/kcj.2017.0362
   Lee SR, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0189495
   Lee SR, 2017, INT J CARDIOL, V236, P226, DOI 10.1016/j.ijcard.2017.02.039
   Li YG, 2018, ANN MED, V50, P288, DOI 10.1080/07853890.2018.1460489
   Lip GYH, 2016, J THROMB HAEMOST, V14, P1711, DOI 10.1111/jth.13386
   Lip GYH, 2017, NAT REV CARDIOL, V14, P627, DOI 10.1038/nrcardio.2017.153
   Lip GYH, 2017, THROMB HAEMOSTASIS, V117, P1230, DOI 10.1160/TH16-11-0876
   Lip GYH, 2015, INT J CARDIOL, V180, P246, DOI 10.1016/j.ijcard.2014.11.182
   Lip GYH, 2010, CHEST, V137, P263, DOI 10.1378/chest.09-1584
   Man-Son-Hing M, 2002, ARCH INTERN MED, V162, P541, DOI 10.1001/archinte.162.5.541
   Martinez C, 2016, THROMB HAEMOSTASIS, V115, P31, DOI 10.1160/TH15-04-0350
   Miyazaki S, 2018, J CARDIOL, V71, P590, DOI 10.1016/j.jjcc.2017.10.021
   Ntaios G, 2017, STROKE, V48, P2494, DOI 10.1161/STROKEAHA.117.017549
   O'Brien EC, 2015, EUR HEART J, V36, P3258, DOI 10.1093/eurheartj/ehv476
   Oh S, 2016, INT J CARDIOL, V223, P543, DOI 10.1016/j.ijcard.2016.08.236
   Okumura Y, 2017, J ARRYTHM, V33, P289, DOI 10.1016/j.joa.2016.11.003
   Park CS, 2017, HEART RHYTHM, V14, P501, DOI 10.1016/j.hrthm.2016.12.036
   Patel MR, 2010, NEW ENGL J MED, V362, P886, DOI 10.1056/NEJMoa0907272
   Perera KS, 2016, STROKE, V47, P2197, DOI 10.1161/STROKEAHA.116.013378
   Phan QT, 2018, CARDIOL J
   Pisters R, 2010, CHEST, V138, P1093, DOI 10.1378/chest.10-0134
   Pokorney SD, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.115.002197
   Reddy VY, 2017, J AM COLL CARDIOL, V70, P2964, DOI 10.1016/j.jacc.2017.10.021
   Rivera-Caravaca JM, 2017, THROMB HAEMOSTASIS, V117, P1448, DOI 10.1160/TH16-12-0961
   Ruff CT, 2014, LANCET, V383, P955, DOI 10.1016/S0140-6736(13)62343-0
   Saokaew S, 2012, INT J CLIN PHARM-NET, V34, P105, DOI 10.1007/s11096-011-9597-8
   Sato H, 2006, STROKE, V37, P447, DOI 10.1161/01.STR.0000198839.61112.ee
   Shimada YJ, 2015, CIRC J, V79, P2560, DOI 10.1253/circj.CJ-15-0574
   Singer DE, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.112.000067
   Siu CW, 2014, HEART RHYTHM, V11, P1401, DOI 10.1016/j.hrthm.2014.04.021
   Siu CW, 2014, CIRC-ARRHYTHMIA ELEC, V7, P300, DOI 10.1161/CIRCEP.113.000858
   Son MK, 2018, J EPIDEMIOL, V28, P81, DOI [10.2188/jea.JE20160149, 10.2188/jea.je20160149]
   Suzuki S, 2016, CIRC J, V80, P639, DOI 10.1253/circj.CJ-15-1237
   Thanimalai S, 2013, INT J CLIN PHARM-NET, V35, P736, DOI 10.1007/s11096-013-9796-6
   Tomita H, 2015, J STROKE CEREBROVASC, V24, P2613, DOI 10.1016/j.jstrokecerebrovasdis.2015.07.016
   Wallentin L, 2010, LANCET, V376, P975, DOI 10.1016/S0140-6736(10)61194-4
   Wang KL, 2016, HEART RHYTHM, V13, P2340, DOI 10.1016/j.hrthm.2016.09.010
   Wang KL, 2015, STROKE, V46, P2555, DOI 10.1161/STROKEAHA.115.009947
   Wilke T, 2017, PATIENT, V10, P17, DOI 10.1007/s40271-016-0185-9
   WOLF PA, 1991, STROKE, V22, P983, DOI 10.1161/01.STR.22.8.983
   Wong KSL, 2014, STROKE, V45, P1739, DOI 10.1161/STROKEAHA.113.002968
   Wu S, 2016, AM J CARDIOL, V117, P926, DOI 10.1016/j.amjcard.2015.12.027
   Xiong QM, 2015, INT J CARDIOL, V195, P237, DOI 10.1016/j.ijcard.2015.05.115
   Yamashita T, 2016, CIRC J, V80, P860, DOI 10.1253/circj.CJ-15-1082
   Yang QD, 2004, CEREBROVASC DIS, V17, P303, DOI 10.1159/000077341
   Yao XX, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.115.003074
   Yasaka M, 2014, CIRC J, V78, P2367, DOI 10.1253/circj.CJ-14-0720
   Yoon M., 2018, THROMB HAEMOST
   Zoppellaro G, 2017, THROMB HAEMOSTASIS, V117, P1828, DOI 10.1160/TH16-11-0846
NR 120
TC 18
Z9 18
U1 2
U2 4
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD AUG
PY 2018
VL 48
IS 8
BP 665
EP 684
DI 10.4070/kcj.2018.0190
PG 20
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA HB0TW
UT WOS:000450731600001
PM 30073805
OA Green Published
DA 2021-04-22
ER

PT J
AU Ko, YG
AF Ko, Young-Guk
TI SFA Intervention: Intraluminal or Subintimal?
SO KOREAN CIRCULATION JOURNAL
LA English
DT Review
DE Peripheral artery disease; Femoral artery; Popliteal artery; Angioplasty
ID SUPERFICIAL FEMORAL-ARTERY; LONG FEMOROPOPLITEAL OCCLUSIONS; MIDTERM
   OUTCOMES; ANGIOPLASTY; RECANALIZATION; SUCCESS; REENTRY; ISCHEMIA;
   PATENCY; STENT
AB Subintimal angioplasty (SA) is an endovascular technique to recanalize an occluded arterial segment through an extraluminal channel between the intima and media. Since its introduction in 1989, the technical success rate has improved with the accumulation of procedural experience and the development of retrograde approaches and re-entry devices. To date, no randomized trial has compared SA with intraluminal angioplasty (IA) for chronic total occlusion (CTO) of the superficial femoral artery (SFA). Based on limited data from several registry studies, SA appears to achieve a higher technical success rate than IA, whereas mid-term primary patency rates are comparable for both endovascular wiring strategies for SFA CTO. Additional clinical data are needed to confirm that SA is as effective as IA. The optimal stenting strategy and role of drug-eluting technologies also need to be defined to improve SA outcomes.
C1 [Ko, Young-Guk] Yonsei Univ, Severance Cardiovasc Hosp, Coll Med, Div Cardiol, 50-1 Yonsei Ro, Seoul 03722, South Korea.
   [Ko, Young-Guk] Yonsei Univ, Severance Cardiovasc Hosp, Coll Med, Cardiovasc Res Inst, 50-1 Yonsei Ro, Seoul 03722, South Korea.
RP Ko, YG (corresponding author), Yonsei Univ, Severance Cardiovasc Hosp, Coll Med, Div Cardiol, 50-1 Yonsei Ro, Seoul 03722, South Korea.; Ko, YG (corresponding author), Yonsei Univ, Severance Cardiovasc Hosp, Coll Med, Cardiovasc Res Inst, 50-1 Yonsei Ro, Seoul 03722, South Korea.
EM ygko@yuhs.ac
OI Ko, Young-Guk/0000-0001-7748-5788
CR Antusevas A, 2008, EUR J VASC ENDOVASC, V36, P101, DOI 10.1016/j.ejvs.2008.02.010
   BOLIA A, 1989, CLIN RADIOL, V40, P325, DOI 10.1016/S0009-9260(89)80231-4
   Boufi M, 2013, EUR J VASC ENDOVASC, V46, P347, DOI 10.1016/j.ejvs.2013.06.003
   Bown MJ, 2009, EUR J VASC ENDOVASC, V38, P323, DOI 10.1016/j.ejvs.2009.05.014
   Gandini R, 2013, CATHETER CARDIO INTE, V82, P485, DOI 10.1002/ccd.24742
   Hong SJ, 2015, JACC-CARDIOVASC INTE, V8, P472, DOI 10.1016/j.jcin.2014.10.016
   Hong SJ, 2013, J ENDOVASC THER, V20, P782, DOI 10.1583/13-4398MR.1
   Ishihara T, 2016, J ENDOVASC THER, V23, P889, DOI 10.1177/1526602816666261
   Kim K, 2018, CIRC J, V82, P1900, DOI 10.1253/circj.CJ-17-1464
   Ko YG, 2007, J ENDOVASC THER, V14, P374, DOI 10.1583/06-1983.1
   Ko YG, 2017, KOREAN CIRC J, V47, P469, DOI 10.4070/kcj.2017.0020
   Kocher M, 2010, EUR J RADIOL, V73, P672, DOI 10.1016/j.ejrad.2008.12.019
   Laxdal E, 2003, EUR J VASC ENDOVASC, V25, P578, DOI 10.1053/ejvs.2002.1899
   LONDON NJM, 1994, EUR J VASCULAR SURG, V8, P148, DOI 10.1016/S0950-821X(05)80450-5
   Marks NA, 2008, J VASC SURG, V47, P109, DOI 10.1016/j.jvs.2007.09.039
   McCarthy RJ, 2000, BRIT J SURG, V87, P1361, DOI 10.1046/j.1365-2168.2000.01633.x
   Palena LM, 2017, CATHETER CARDIO INTE, V89, P910, DOI 10.1002/ccd.26863
   REEKERS JA, 1994, EUR J VASCULAR SURG, V8, P723, DOI 10.1016/S0950-821X(05)80653-X
   Schmieder GC, 2008, J VASC SURG, V48, P1175, DOI 10.1016/j.jvs.2008.05.080
   Setacci C, 2009, EUR J VASC ENDOVASC, V38, P76, DOI 10.1016/j.ejvs.2009.03.020
   Siablis D, 2012, CARDIOVASC INTER RAD, V35, P483, DOI 10.1007/s00270-011-0244-5
   Smith BM, 2005, ANN ROY COLL SURG, V87, P361, DOI 10.1308/1478708051801
   Soga Y, 2013, J VASC SURG, V58, P1547, DOI 10.1016/j.jvs.2013.05.107
   Tatli E, 2015, CARDIOL J, V22, P115, DOI 10.5603/CJ.a2014.0043
   Treiman GS, 2006, J VASC SURG, V43, P513, DOI 10.1016/j.jvs.2005.11.015
   Yilmaz S, 2003, J VASC INTERV RADIOL, V14, P997, DOI 10.1097/01.RVI.000008261.05622.B8
NR 26
TC 2
Z9 2
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD AUG
PY 2018
VL 48
IS 8
BP 685
EP 691
DI 10.4070/kcj.2018.0216
PG 7
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA HB0TW
UT WOS:000450731600002
PM 30073806
OA Green Published
DA 2021-04-22
ER

PT J
AU Sharma, SP
   Park, P
   Lakkireddy, D
AF Sharma, Sharan Prakash
   Park, Peter
   Lakkireddy, Dhanunjaya
TI Left Atrial Appendages Occlusion: Current Status and Prospective
SO KOREAN CIRCULATION JOURNAL
LA English
DT Review
DE Left atrial appendage occlusion; Atrial fibrillation; Watchman; Amulet;
   Lariat
ID PERI-PROCEDURAL OUTCOMES; AMPLATZER CARDIAC PLUG; STROKE PREVENTION;
   PERCUTANEOUS CLOSURE; WATCHMAN DEVICE; ORAL ANTICOAGULANTS;
   INITIAL-EXPERIENCE; COST-EFFECTIVENESS; WARFARIN THERAPY; IMPLANT
   SUCCESS
AB Stroke continues to be a major cause of morbidity and mortality in atrial fibrillation (AF) patients. Oral anticoagulation (OAC) provides protection against stroke and peripheral embolization in AF but significant proportion of patients could not be started on anticoagulation because of bleeding complications. Left atrial appendage harbors clot in about 90% of nonvalvular AF. The advent of left atrial appendage occlusion (LAAO) techniques has provided these patients with alternative to OAC for stroke prophylaxis. Multiple LAAO devices are currently available with Watchman and Amulet being the most commonly used in clinical practice. Randomized studies are available for Watchman device only. Data on Amplatzer Cardiac Plug, Amulet and Lariat devices are limited by the paucity of randomized data. Long-term data on different LAAO techniques are showing promising results. Device related thrombosis continues to be a serious complication associated with LAAO. Future studies should look into comparative effectiveness between different LAAO techniques, optimal patient selection, risk of complications, and anticoagulant treatment after LAAO. This article aims to provide current available evidence on efficacy and safety of different LAAO devices and future prospective.
C1 [Sharma, Sharan Prakash; Park, Peter; Lakkireddy, Dhanunjaya] Kansas City Heart Rhythm Inst, 5701 W 119th St,Suite 430, Overland Pk, KS 66209 USA.
RP Lakkireddy, D (corresponding author), Kansas City Heart Rhythm Inst, 5701 W 119th St,Suite 430, Overland Pk, KS 66209 USA.
EM dlakkireddy@kchrf.org
CR Abualsaud A, 2016, J INVASIVE CARDIOL, V28, P34
   Afzal MR, 2015, HEART RHYTHM, V12, P52, DOI 10.1016/j.hrthm.2014.09.053
   Ailawadi G, 2011, J THORAC CARDIOV SUR, V142, P1002, DOI 10.1016/j.jtcvs.2011.07.052
   Alli O, 2013, J AM COLL CARDIOL, V61, P1790, DOI 10.1016/j.jacc.2013.01.061
   [Anonymous], 2018, ASSESSMENT WATCHMANT
   [Anonymous], 2015, COHEREX WAVECREST I
   [Anonymous], 2018, AMAZE STUDY LAA LIGA
   [Anonymous], 2018, AMPLATZERTM AMULETTM
   [Anonymous], 2016, LEFT ATRIAL APPENDAG
   Badhwar N, 2015, J CARDIOVASC ELECTR, V26, P608, DOI 10.1111/jce.12655
   Bartus K, 2013, J AM COLL CARDIOL, V62, P108, DOI 10.1016/j.jacc.2012.06.046
   Berti S, 2016, HEART, V102, P1969, DOI 10.1136/heartjnl-2015-309150
   Betts TR, 2017, CATHETER CARDIO INTE, V89, P484, DOI 10.1002/ccd.26782
   Blackshear JL, 1996, ANN THORAC SURG, V61, P755, DOI 10.1016/0003-4975(95)00887-X
   Boersma LVA, 2016, EUR HEART J, V37, P2465, DOI 10.1093/eurheartj/ehv730
   Bosche LI, 2015, CLIN CARDIOL, V38, P720, DOI 10.1002/clc.22478
   Cruz-Gonzalez I, 2016, CATHETER CARDIO INTE, V87, pE39, DOI 10.1002/ccd.25985
   Enomoto Y, 2017, HEART RHYTHM, V14, P19, DOI 10.1016/j.hrthm.2016.10.020
   Fauchier L, 2018, J AM COLL CARDIOL, V71, P1528, DOI 10.1016/j.jacc.2018.01.076
   Genovesi S, 2018, INT J CARDIOL, V262, P38, DOI 10.1016/j.ijcard.2018.03.083
   Gloekler S, 2015, CLIN RES CARDIOL, V104, P656, DOI 10.1007/s00392-015-0828-1
   Go AS, 2001, JAMA-J AM MED ASSOC, V285, P2370, DOI 10.1001/jama.285.18.2370
   Hart RG, 2007, ANN INTERN MED, V146, P857, DOI 10.7326/0003-4819-146-12-200706190-00007
   Holmes DR, 2009, LANCET, V374, P534, DOI 10.1016/S0140-6736(09)61343-X
   Holmes DR, 2015, J AM COLL CARDIOL, V65, P2614, DOI 10.1016/j.jacc.2015.04.025
   Holmes DR, 2014, J AM COLL CARDIOL, V64, P1, DOI 10.1016/j.jacc.2014.04.029
   January CT, 2014, CIRCULATION, V130, P2071, DOI [10.1161/CIR.0000000000000041, 10.1161/CIR.0000000000000040]
   Kirchhof P, 2016, EUROPACE, V18, DOI 10.1093/europace/euw295
   Klein AL, 2001, NEW ENGL J MED, V344, P1411, DOI 10.1056/NEJM200105103441901
   Kleinecke C, 2017, CARDIOL J, V24, P131, DOI 10.5603/CJ.a2017.0017
   Koskinas KC, 2016, JACC-CARDIOVASC INTE, V9, P1374, DOI 10.1016/j.jcin.2016.04.019
   Lakkireddy D, 2018, J AM COLL CARDIOL, V71, P135, DOI 10.1016/j.jacc.2017.10.092
   Lakkireddy D, 2016, HEART RHYTHM, V13, P1030, DOI 10.1016/j.hrthm.2016.01.022
   Landmesser U, 2017, EUROINTERVENTION, V13, P867, DOI 10.4244/EIJ-D-17-00493
   Lee OH, 2018, AM J CARDIOL, V121, P1534, DOI 10.1016/j.amjcard.2018.02.045
   Minguez JRL, 2015, HEART, V101, P877, DOI 10.1136/heartjnl-2014-306332
   Lopez-Minguez JR, 2018, REV ESP CARDIOL
   Main ML, 2016, AM J CARDIOL, V117, P1127, DOI 10.1016/j.amjcard.2016.01.039
   Majunke N, 2015, J INVASIVE CARDIOL, V27, P448
   Mant J, 2007, LANCET, V370, P493, DOI 10.1016/S0140-6736(07)61233-1
   Meincke F, 2013, EUROINTERVENTION, V9, P463, DOI 10.4244/EIJV9I4A75
   Miyasaka Y, 2006, CIRCULATION, V114, P119, DOI 10.1161/CIRCULATIONAHA.105.595140
   Nietlispach F, 2013, CATHETER CARDIO INTE, V82, P283, DOI 10.1002/ccd.24872
   Onalan O, 2007, STROKE, V38, P624, DOI 10.1161/01.STR.0000250166.06949.95
   Pillarisetti J, 2015, HEART RHYTHM, V12, P1501, DOI 10.1016/j.hrthm.2015.03.020
   Price MJ, 2014, J AM COLL CARDIOL, V64, P565, DOI 10.1016/j.jacc.2014.03.057
   Reddy VY, 2017, J AM COLL CARDIOL, V70, P2964, DOI 10.1016/j.jacc.2017.10.021
   Reddy VY, 2017, J AM COLL CARDIOL, V69, P253, DOI 10.1016/j.jacc.2016.10.010
   Reddy VY, 2016, EUROPACE, V18, P979, DOI 10.1093/europace/euv412
   Reddy VY, 2015, J AM COLL CARDIOL, V66, P2728, DOI 10.1016/j.jacc.2015.09.084
   Reddy VY, 2013, J AM COLL CARDIOL, V61, P2551, DOI 10.1016/j.jacc.2013.03.035
   Reddy VY, 2011, CIRCULATION, V123, P417, DOI 10.1161/CIRCULATIONAHA.110.976449
   Regueiro A, 2018, J INTERV CARD ELECTR, V52, P53, DOI 10.1007/s10840-018-0356-9
   Regueiro A, 2017, CATHETER CARDIO INTE, V90, P817, DOI 10.1002/ccd.26870
   Santoro G, 2016, EUROINTERVENTION, V11, P1188, DOI [10.4244/EIJY14M10_12, 10.4244/EIJY14M10_13]
   Savelieva I, 2008, CLIN CARDIOL, V31, P55, DOI 10.1002/clc.20138
   Sick PB, 2007, J AM COLL CARDIOL, V49, P1490, DOI 10.1016/j.jacc.2007.02.035
   Starck CT, 2012, INTERACT CARDIOV TH, V15, P416, DOI 10.1093/icvts/ivs136
   Tsai YC, 2015, EUR J CARDIO-THORAC, V47, P847, DOI 10.1093/ejcts/ezu291
   Tzikas A, 2016, EUROINTERVENTION, V11, P1170, DOI 10.4244/EIJY15M01_06
   Urena M, 2013, J AM COLL CARDIOL, V62, P96, DOI 10.1016/j.jacc.2013.02.089
   US Food and Drug Administration, 2015, WATCHM LAA CLOS TECH
NR 62
TC 7
Z9 8
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD AUG
PY 2018
VL 48
IS 8
BP 692
EP 704
DI 10.4070/kcj.2018.0231
PG 13
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA HB0TW
UT WOS:000450731600003
PM 30073807
OA Green Published
DA 2021-04-22
ER

PT J
AU Cho, S
   Lee, W
   Lim, SH
   Kang, TS
AF Cho, Sungsoo
   Lee, Wonkyung
   Lim, Seong-Hoon
   Kang, Tae Soo
TI Relationship between Clinical Outcomes and Cardiopulmonary Resuscitation
   Time in Patients with Acute Myocardial Infarction Treated by
   Extracorporeal Membrane Oxygenation-Assisted Primary Percutaneous
   Coronary Intervention
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Myocardial infarction; Cardiogenic shock; Extracorporeal membrane
   oxygenation; Cardiopulmonary resuscitation
ID PROFOUND CARDIOGENIC-SHOCK; HOSPITAL CARDIAC-ARREST; EARLY
   REVASCULARIZATION; SHORT-TERM; SUPPORT; SURVIVAL; PERSPECTIVE;
   MANAGEMENT; MORTALITY; TRENDS
AB Background and Objectives: Extracorporeal membrane oxygenation (ECMO) support is increasingly used in primary percutaneous coronary intervention (PCI) during cardiopulmonary resuscitation (CPR) to treat acute myocardial infarction (AMI) patients who experienced cardiogenic shock. However, to date, there have been no studies on the relationship between clinical outcomes and CPR time in such patients with AMI treated by ECMO-assisted primary PCI.
   Methods: From July 2008 to March 2016, we analyzed data from 42 AMI with cardiogenic shock patients who underwent CPR and were treated by ECMO-assisted primary PCI. The primary outcome was 30-day in-hospital mortality after primary PCI. The predictors of mortality were determined using a Cox proportional hazards model.
   Results: Thirty-day in-hospital mortality was observed for 33 patients (78.6%). The mean CPR time was 37.0 +/- 37.3 minutes. The best cut-off CPR time value associated with clinical outcome was calculated to be 12.5 minutes using receiver operating characteristic curve analysis. Multivariate analysis revealed that CPR time of >12.5 minutes was an independent predictor of 30-day mortality (adjusted hazard ratio, 4.71; 95% confidence interval, 1.30-17.406; p=0.018).
   Conclusions: Despite ECMO support, the clinical outcomes of AMI patients with a complication of cardiogenic shock remain poor. Prolonged CPR time is associated with a poor prognosis in patients with AMI treated by ECMO-assisted primary PCI.
C1 [Cho, Sungsoo; Lim, Seong-Hoon; Kang, Tae Soo] Dankook Univ, Dankook Univ Hosp, Dept Internal Med, Div Cardiovasc Med,Coll Med, Cheonan, South Korea.
   [Lee, Wonkyung] Good Morning Hosp, Dept Internal Med, Div Cardiol, Pyeongtaek, South Korea.
RP Kang, TS (corresponding author), Dankook Univ, Coll Med, Dankook Univ Hosp, Div Cardiovasc Med,Dept Internal Med, 201 Manghyang Ro, Cheon 31116, South Korea.
EM neosoo70@dankook.ac.kr
OI Kang, Tae Soo/0000-0002-4298-6272; Lee, Wonkyung/0000-0002-5337-129X
CR Babaev A, 2005, JAMA-J AM MED ASSOC, V294, P448, DOI 10.1001/jama.294.4.448
   Chen YS, 2008, LANCET, V372, P554, DOI 10.1016/S0140-6736(08)60958-7
   Chung SY, 2016, INT J CARDIOL, V223, P412, DOI 10.1016/j.ijcard.2016.08.068
   Flaherty MP, 2017, JACC-CARDIOVASC INTE, V10, P1805, DOI 10.1016/j.jcin.2017.06.027
   GOLDBERG RJ, 1991, NEW ENGL J MED, V325, P1117, DOI 10.1056/NEJM199110173251601
   Goldberg RJ, 2009, CIRCULATION, V119, P1211, DOI 10.1161/CIRCULATIONAHA.108.814947
   Hajbaghery MA, 2005, RESUSCITATION, V66, P317, DOI 10.1016/j.resuscitation.2005.04.004
   Hochman JS, 2001, JAMA-J AM MED ASSOC, V285, P190, DOI 10.1001/jama.285.2.190
   Hochman JS, 2006, JAMA-J AM MED ASSOC, V295, P2511, DOI 10.1001/jama.295.21.2511
   Jo IJ, 2011, INT J CARDIOL, V151, P12, DOI 10.1016/j.ijcard.2010.04.050
   Kagawa E, 2012, CIRCULATION, V126, P1605, DOI 10.1161/CIRCULATIONAHA.111.067538
   Kim DS, 2016, CLIN ENDOSC, V49, P273, DOI 10.5946/ce.2015.086
   Na SJ, 2018, REV ESP CARDIOL
   Park TK, 2014, YONSEI MED J, V55, P920, DOI 10.3349/ymj.2014.55.4.920
   Reynolds JC, 2013, CIRCULATION, V128, P2488, DOI 10.1161/CIRCULATIONAHA.113.002408
   Sheu JJ, 2010, CRIT CARE MED, V38, P1810, DOI 10.1097/CCM.0b013e3181e8acf7
   Shin TG, 2011, CRIT CARE MED, V39, P1, DOI 10.1097/CCM.0b013e3181feb339
   Thiele H, 2012, NEW ENGL J MED, V367, P1287, DOI 10.1056/NEJMoa1208410
   Thygesen K, 2012, CIRCULATION, V126, P2020, DOI 10.1161/CIR.0b013e31826e1058
   Tsao NW, 2012, J CRIT CARE, V27, DOI 10.1016/j.jcrc.2012.02.012
   Werdan K, 2014, EUR HEART J, V35, P156, DOI 10.1093/eurheartj/eht248
   Wu MY, 2013, RESUSCITATION, V84, P940, DOI 10.1016/j.resuscitation.2012.12.019
   Yip HK, 2001, AM J CARDIOL, V87, P1184, DOI 10.1016/S0002-9149(01)01491-6
NR 23
TC 4
Z9 5
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD AUG
PY 2018
VL 48
IS 8
BP 705
EP 715
DI 10.4070/kcj.2018.0121
PG 11
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA HB0TW
UT WOS:000450731600004
PM 30073808
OA Green Published
DA 2021-04-22
ER

PT J
AU Xu, Y
   Jin, C
   Qiao, SB
   Wu, YJ
   Yan, HB
   Dou, KF
   Xu, B
   Yang, JG
   Yang, YJ
AF Xu, Yi
   Jin, Chen
   Qiao, Shubin
   Wu, Yongjian
   Yan, Hongbing
   Dou, Kefei
   Xu, Bo
   Yang, Jingang
   Yang, Yuejin
TI A Comparison of Transradial and Transfemoral Percutaneous Coronary
   Intervention in Chinese Women Based on a Propensity Score Analysis
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Coronary artery disease; Percutaneous coronary intervention; Women;
   Radial artery; Femoral artery
ID FEMORAL ACCESS; ARTERY APPROACH; ANGIOGRAPHY; RIVAL; PCI
AB Background and objectives: Over the past decades, transradial approach for percutaneous coronary intervention (PCI) has been increasingly adopted in clinical practice. Women represent a large population who will possibly benefit from PCI, but they are often underrepresented in clinical studies. Therefore, the role of TRI in women remains to be further defined. This study sought to compare safety and efficacy for transradial intervention (TRI) and transfemoral intervention (TFI) in women undergoing PCI in China.
   Methods: The study population consisted of 5,067 women undergoing PCI at Fuwai Hospital, Beijing, China between 2006 and 2011 (TRI: n=4,105, TFI: n=962). Incidence rates of clinical outcomes during hospitalization and at 1-year follow-up were compared between TRI and TFI. In order to minimize potential biases, a 1:1 propensity score matching (PSM) was performed. A total of 899 pairs were matched.
   Results: Baseline and procedural characteristics were well-balanced between TRI and TFI groups after controlling for confounders using PSM. TRI was associated with reduced major post-PCI bleeding (odds ratio [OR], 0.64; 95% confidence interval [CI], 0.54-0.76; p<0.001) and access site complications (OR, 0.67; 95% CI, 0.61-0.74; p<0.001) after PSM. There was no statistical differences in the incidence rates of major adverse cardiac events (a composite of cardiac death, myocardial infarction, and target vessel revascularization) both during hospitalization and at 1-year follow-up (p>0.05).
   Conclusions: In this propensity score-based analysis of TRI versus TFI in Chinese women, TRI showed advantages of safety and feasibility over TFI. A wider adoption of TRI in women has the potential to improve outcomes in treatment of coronary artery diseases.
C1 [Yang, Yuejin] Chinese Acad Med Sci, Fuwai Hosp, Natl Ctr Cardiovasc Dis, State Key Lab Cardiovasc Dis, 167 Beilishi Rd, Beijing 100037, Peoples R China.
   [Yang, Yuejin] Peking Union Med Coll, 167 Beilishi Rd, Beijing 100037, Peoples R China.
RP Yang, YJ (corresponding author), Chinese Acad Med Sci, Fuwai Hosp, Natl Ctr Cardiovasc Dis, State Key Lab Cardiovasc Dis, 167 Beilishi Rd, Beijing 100037, Peoples R China.; Yang, YJ (corresponding author), Peking Union Med Coll, 167 Beilishi Rd, Beijing 100037, Peoples R China.
EM yangyjfw@126.com
RI Xu, Yi/AAH-9171-2021
CR Ball WT, 2011, CIRC-CARDIOVASC INTE, V4, P336, DOI 10.1161/CIRCINTERVENTIONS.110.960864
   Bertrand OF, 2012, AM HEART J, V163, P632, DOI 10.1016/j.ahj.2012.01.015
   Bucholz EM, 2015, CIRC-CARDIOVASC QUAL, V8, pS1, DOI 10.1161/CIRCOUTCOMES.115.001756
   Cooper CJ, 1999, AM HEART J, V138, P430, DOI 10.1016/S0002-8703(99)70143-2
   Dauerman HL, 2011, J AM COLL CARDIOL, V58, P1, DOI 10.1016/j.jacc.2011.02.039
   Doyle BJ, 2009, J AM COLL CARDIOL, V53, P2019, DOI 10.1016/j.jacc.2008.12.073
   Feldman DN, 2013, CIRCULATION, V127, P2295, DOI 10.1161/CIRCULATIONAHA.112.000536
   Hibbert B, 2012, JACC-CARDIOVASC INTE, V5, P819, DOI 10.1016/j.jcin.2012.04.009
   Hochman JS, 1999, NEW ENGL J MED, V341, P226, DOI 10.1056/NEJM199907223410402
   Jin Chen, 2017, Chinese Medical Sciences Journal, V32, P161, DOI 10.24920/J1001-9294.2017.023
   Jin C, 2017, ANGIOLOGY, V68, P799, DOI 10.1177/0003319716685670
   Jin C, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.115.002684
   Jolly SS, 2011, LANCET, V377, P1409, DOI 10.1016/S0140-6736(11)60404-2
   Jolly SS, 2009, AM HEART J, V157, P132, DOI 10.1016/j.ahj.2008.08.023
   Kedev S, 2016, INT J CARDIOL, V217, pS16, DOI 10.1016/j.ijcard.2016.06.222
   KIEMENEIJ F, 1993, CATHETER CARDIO DIAG, V30, P173, DOI 10.1002/ccd.1810300220
   Kiemeneij F, 1997, J AM COLL CARDIOL, V29, P1269, DOI 10.1016/S0735-1097(97)00064-8
   Lansky AJ, 2005, CIRCULATION, V111, P940, DOI 10.1161/01.CIR.0000155337.50423.C9
   Lee HW, 2016, INT J CARDIOL, V202, P419, DOI 10.1016/j.ijcard.2015.09.004
   Mazure CM, 2015, BMC WOMENS HEALTH, V15, DOI 10.1186/s12905-015-0251-9
   Mehran R, 2011, CIRCULATION, V123, P2736, DOI 10.1161/CIRCULATIONAHA.110.009449
   Pandie S, 2015, JACC-CARDIOVASC INTE, V8, P505, DOI 10.1016/j.jcin.2014.11.017
   Rao SV, 2014, JACC-CARDIOVASC INTE, V7, P857, DOI 10.1016/j.jcin.2014.04.007
   Romagnoli E, 2012, J AM COLL CARDIOL, V60, P2481, DOI 10.1016/j.jacc.2012.06.017
   Valgimigli M, 2015, LANCET, V385, P2465, DOI 10.1016/S0140-6736(15)60292-6
   Wang L, 2010, INT J CARDIOL, V145, P246, DOI 10.1016/j.ijcard.2009.08.027
   Yang YJ, 2010, JACC-CARDIOVASC INTE, V3, P1035, DOI 10.1016/j.jcin.2010.09.003
NR 27
TC 1
Z9 1
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD AUG
PY 2018
VL 48
IS 8
BP 719
EP 727
DI 10.4070/kcj.2018.0040
PG 9
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA HB0TW
UT WOS:000450731600006
PM 30073810
OA Green Published
DA 2021-04-22
ER

PT J
AU Jung, KJ
   Hwang, S
   Lee, S
   Kim, HC
   Jee, SH
AF Jung, Keum Ji
   Hwang, Semi
   Lee, Sunmi
   Kim, Hyeon Chang
   Jee, Sun Ha
TI Traditional and Genetic Risk Score and Stroke Risk Prediction in Korea
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Risk factors; Epidemiologic methods; Genetics; Stroke
ID ISCHEMIC-STROKE; PREDISPOSITION; HERITABILITY; DISEASES
AB Background and Objectives: Whether using both traditional risk factors and genetic variants for stroke as opposed to using either of the 2 alone improves the prediction of stroke risk remains unclear. The purpose of this study was to compare the predictability of stroke risk between models using traditional risk score (TRS) and genetic risk score (GRS).
   Methods: We used a case-cohort study from the Korean Cancer Prevention Study-II (KCPS-II) Biobank (n=156,701). We genotyped 72 single nucleotide polymorphisms (SNPs) identified in genome-wide association study (GWAS) on the KCPS-II sub-cohort members and stroke cases. We calculated GRS by summing the number of risk alleles. Prediction models with or without GRS were evaluated in terms of the area under the receiver operating characteristic curve (AUROC).
   Results: Sixteen out of 72 SNPs identified in GWAS showed significant associations with stroke, with an odds ratio greater than 2.0. For participants aged <40 years, AUR005 for incident stroke were 0.58, 0.65, and 0.67 in models using modifiable TRS only, GRS only, and TRS plus GRS, respectively, showing that GRS only model had better prediction than TRS only. For participants aged >= 40 years, however, TRS only model had better prediction than GRS only model. Favorable levels of traditional risk were associated with significantly lower stroke risks within each genetic risk category.
   Conclusions: TRS and GRS were both independently associated with stroke risk. Using genetic variants in addition to traditional risk factors may be the most accurate way of predicting stroke risk, particularly in relatively younger individuals.
C1 [Jung, Keum Ji; Hwang, Semi; Jee, Sun Ha] Yonsei Univ, Grad Sch Publ Hlth, Dept Epidemiol & Hlth Promot, 50-1 Yonsei Ro, Seoul 03722, South Korea.
   [Lee, Sunmi] Natl Hlth Insurance Serv, Hlth Insurance Policy Res Inst, Wonju, South Korea.
   [Kim, Hyeon Chang] Yonsei Univ, Dept Prevent Med & Publ Hlth, Coll Med, Seoul, South Korea.
RP Jee, SH (corresponding author), Yonsei Univ, Grad Sch Publ Hlth, Dept Epidemiol & Hlth Promot, 50-1 Yonsei Ro, Seoul 03722, South Korea.
EM jsunha@yuhs.ac
RI Kim, Hyeon Chang/F-8796-2019
OI Kim, Hyeon Chang/0000-0001-7867-1240; Jee, Sun Ha/0000-0001-9519-3068;
   Jung, Keum Ji/0000-0003-4993-0666; Hwang, Semi/0000-0002-7870-9963
FU Korean Health Technology R&D Project, Ministry of Health & Welfare,
   Republic of Korea [HI13C0715, HI14C2686]
FX This study was funded by a grant of the Korean Health Technology R&D
   Project, Ministry of Health & Welfare, Republic of Korea (HI13C0715,
   HI14C2686).
CR Achterberg S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119203
   [Anonymous], 2014, ANN REP CAUS DEATH S
   Bluher A, 2015, EUR J NEUROL, V22, P1488, DOI 10.1111/ene.12827
   Damen JAAG, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i2416
   Gage SH, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1005765
   Hachiya T, 2017, STROKE, V48, P253, DOI 10.1161/STROKEAHA.116.014506
   Ibrahim-Verbaas CA, 2014, STROKE, V45, P403, DOI 10.1161/STROKEAHA.113.003044
   Janssens ACJW, 2008, HUM MOL GENET, V17, pR166, DOI 10.1093/hmg/ddn250
   Jee SH, 2008, ATHEROSCLEROSIS, V197, P318, DOI 10.1016/j.atherosclerosis.2007.05.014
   Jee Sun Ha, 2014, [Journal of Health Informatics and Statistics, 보건정보통계학회지], V39, P25
   Jee YH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162930
   Kim J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149321
   Kofler T, 2017, CIRC-ARRHYTHMIA ELEC, V10, DOI 10.1161/CIRCEP.116.004735
   Lee SJ, 2017, STROKE, V48, P1154, DOI [10.1161/STROKEAHA.116.015083, 10.1161/strokeaha.116.015083]
   Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494
   Morrison AC, 2007, AM J EPIDEMIOL, V166, P28, DOI 10.1093/aje/kwm060
   Park JK., 2000, KOREAN J PREV MED, V33, P76
   Traylor M, 2015, STROKE, V46, P3042, DOI 10.1161/STROKEAHA.115.009816
   Traylor M, 2012, LANCET NEUROL, V11, P951, DOI 10.1016/S1474-4422(12)70234-X
   Wang D, 2009, BMC P S7, V3, pS109, DOI DOI 10.1186/1753-6561-3-S7-S109
   Williams FMK, 2013, ANN NEUROL, V73, P16, DOI 10.1002/ana.23838
   Zhuo YY, 2017, J STROKE CEREBROVASC, V26, P679, DOI 10.1016/j.jstrokecerebrovasdis.2017.01.020
NR 22
TC 4
Z9 4
U1 0
U2 2
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD AUG
PY 2018
VL 48
IS 8
BP 731
EP 740
DI 10.4070/kcj.2018.0036
PG 10
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA HB0TW
UT WOS:000450731600008
PM 30073812
OA Green Published
DA 2021-04-22
ER

PT J
AU Jang, JY
   Lee, S
   Kim, DH
   Song, JM
   Kang, DH
   Song, JK
AF Jang, Jeong Yoon
   Lee, Sahmin
   Kim, Dae-Hee
   Song, Jong-Min
   Kang, Duk-Hyun
   Song, Jae-Kwan
TI Variable Hemodynamic Responses during Diastolic Stress Echocardiography
   in Patients Who Have Relaxation Abnormality with Possible Elevated
   Filling Pressure
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Diastole; Exercise; Doppler echocardiography
ID VENTRICULAR EJECTION FRACTION; EXERCISE DOPPLER-ECHOCARDIOGRAPHY;
   INDUCED PULMONARY-HYPERTENSION; MITRAL REGURGITATION; HEART-FAILURE;
   EUROPEAN ASSOCIATION; AMERICAN SOCIETY; DYSFUNCTION; RECOMMENDATIONS;
   CAPACITY
AB Background and Objectives: The clinical characteristics of patients with diastolic dysfunction characterized by a relaxation abnormality with possible elevated filling pressure is remain to be determined. We sought to test whether diastolic stress echocardiography (DSE) is useful for characterization of these patients.
   Methods: A total of 120 patients (58 men, mean age of 64 +/- 7 years) with E/A ratio <1.0 (mean +/- SD, 0.7 +/- 0.1) and 10 <= E/e' <15 at rest echocardiography was enrolled prospectively for supine bicycle exercise up to 50 W.
   Results: During exercise, 47 patients (39%) showed high left ventricular filling pressure (E/e' >15, hLVFP) and 40 (30%) developed exercise-induced pulmonary hypertension (systolic pulomary arterial pressure >50 mmHg, EiPH) without hLVFP. The remaining 33 patients did not show hLVFP or EiPH. The incidence of EiPH with hLVFP was 21% (25/120). By multivariate analysis, age (odds ratio [OR), 1.07; 95% confidence interval [CI], 1.00-1.13; p=0.039) and systolic pulmonary artery pressure at rest (OR, 1.14; 95% CI, 1.02-1.27; p=0.02) were associated with EiPH, whereas late diastolic transmitral velocity (OR, 1.04; 95% CI, 1.00-1.08; p=0.03) and diastolic blood pressure (OR, 0.94; 95% CI, 0.90-0.99; p=0.02) were associated with hLVFP during exercise.
   Conclusions: Patients with relaxation abnormality and possibly hLVFP showed markedly heterogeneous hemodynamic changes during low-level exercise and DSE was useful to characterize these patients.
C1 [Jang, Jeong Yoon] Kyung Hee Univ, Grad Sch, Dept Med, Seoul, South Korea.
   [Lee, Sahmin; Kim, Dae-Hee; Song, Jong-Min; Kang, Duk-Hyun; Song, Jae-Kwan] Univ Ulsan, Asan Med Ctr Heart Inst, Coll Med, Heart Inst, 88 Olymp Ro 43 Gil, Seoul 05505, South Korea.
RP Song, JK (corresponding author), Univ Ulsan, Asan Med Ctr Heart Inst, Coll Med, Heart Inst, 88 Olymp Ro 43 Gil, Seoul 05505, South Korea.
EM jksong@amc.seoul.kr
OI Kang, Duk-Hyun/0000-0003-4031-8649; Kim, Dae-Hee/0000-0002-8275-4871;
   Jang, Jeong Yoon/0000-0002-5430-7679
CR Bhatia RS, 2006, NEW ENGL J MED, V355, P260, DOI 10.1056/NEJMoa051530
   Bidart CM, 2007, J AM SOC ECHOCARDIOG, V20, P270, DOI 10.1016/j.echo.2006.08.032
   Bossone E, 1999, J AM COLL CARDIOL, V33, P1662, DOI 10.1016/S0735-1097(99)00055-8
   Burgess MI, 2006, J AM COLL CARDIOL, V47, P1891, DOI 10.1016/j.jacc.2006.02.042
   Davies MK, 2001, LANCET, V358, P439, DOI 10.1016/S0140-6736(01)05620-3
   Fontes-Carvalho R, 2015, JACC-CARDIOVASC IMAG, V8, P229, DOI 10.1016/j.jcmg.2014.09.022
   Ha JW, 2009, HEART, V95, P490, DOI 10.1136/hrt.2007.139295
   Ha JW, 2005, J AM SOC ECHOCARDIOG, V18, P63, DOI 10.1016/j.echo.2004.08.033
   Kane GC, 2012, CURR CARDIOL REP, V14, P359, DOI 10.1007/s11886-012-0269-7
   KULIK TJ, 1983, BRIT HEART J, V50, P59
   Kuwaki H, 2014, JACC-CARDIOVASC IMAG, V7, P749, DOI 10.1016/j.jcmg.2014.05.002
   Lancellotti P, 2016, EUR HEART J-CARD IMG, V17, P1191, DOI 10.1093/ehjci/jew190
   Lester SJ, 2008, J AM COLL CARDIOL, V51, P679, DOI 10.1016/j.jacc.2007.09.061
   Magne J, 2015, HEART, V101, P391, DOI 10.1136/heartjnl-2014-306296
   Magne J, 2010, CIRCULATION, V122, P33, DOI 10.1161/CIRCULATIONAHA.110.938241
   Marchandise S, 2014, AM J CARDIOL, V113, P2036, DOI 10.1016/j.amjcard.2014.03.051
   Nagueh SF, 2016, J AM SOC ECHOCARDIOG, V29, P277, DOI 10.1016/j.echo.2016.01.011
   Nagueh SF, 2009, J AM SOC ECHOCARDIOG, V22, P107, DOI 10.1016/j.echo.2008.11.023
   Pandit A, 2015, ECHOCARDIOGR-J CARD, V32, P56, DOI 10.1111/echo.12600
   Pierard LA, 2004, NEW ENGL J MED, V351, P1627, DOI 10.1056/NEJMoa040532
   Podolec P, 2008, J AM SOC ECHOCARDIOG, V21, P834, DOI 10.1016/j.echo.2007.12.008
   Seo JS, 2012, CIRC J, V76, P2792, DOI 10.1253/circj.CJ-12-0446
   Shim CY, 2011, HEART, V97, P1417, DOI 10.1136/hrt.2010.220467
   Song JK, 1996, AM J CARDIOL, V78, P1060, DOI 10.1016/S0002-9149(96)00539-5
   Unzek S, 2011, JACC-CARDIOVASC IMAG, V4, P460, DOI 10.1016/j.jcmg.2011.01.016
NR 25
TC 2
Z9 2
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD AUG
PY 2018
VL 48
IS 8
BP 744
EP 754
DI 10.4070/kcj.2018.0046
PG 11
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA HB0TW
UT WOS:000450731600010
PM 30073814
OA Green Published
DA 2021-04-22
ER

PT J
AU Yang, JH
AF Yang, Jeong Hoon
TI Clinical Significance of Low-flow Time in Patients Treated with
   Extracorporeal Cardiopulmonary Resuscitation
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
ID HOSPITAL CARDIAC-ARREST; MYOCARDIAL-INFARCTION
C1 [Yang, Jeong Hoon] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Cardiol,Dept Crit Care Med & Med, Seoul, South Korea.
RP Yang, JH (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Crit Care Med, 81 Irwon Ro, Seoul 06351, South Korea.; Yang, JH (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Cardiol,Dept Med, 81 Irwon Ro, Seoul 06351, South Korea.
EM jhysmc@gmail.com
OI Yang, Jeong Hoon/0000-0001-8138-1367
CR Chen YS, 2008, LANCET, V372, P554, DOI 10.1016/S0140-6736(08)60958-7
   Cho S, 2018, KOREAN CIRC J, V48, P705, DOI 10.4070/kcj.2018.0121
   D'Arrigo S, 2017, RESUSCITATION, V121, P62, DOI 10.1016/j.resuscitation.2017.10.005
   Kim KH, 2016, KOREAN CIRC J, V46, P315, DOI 10.4070/kcj.2016.46.3.315
   Lamhaut L, 2017, RESUSCITATION, V117, P109, DOI 10.1016/j.resuscitation.2017.04.014
   Park SB, 2014, INT J CARDIOL, V177, P1031, DOI 10.1016/j.ijcard.2014.09.124
   Ryu JA, 2017, CRIT CARE, V21, DOI 10.1186/s13054-017-1604-6
   Youness H, 2016, CRIT CARE RES PRACT, V2016, DOI 10.1155/2016/7384649
NR 8
TC 2
Z9 2
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD AUG
PY 2018
VL 48
IS 8
BP 716
EP 718
DI 10.4070/kcj.2018.0187
PG 3
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA HB0TW
UT WOS:000450731600005
PM 30073809
OA Green Published
DA 2021-04-22
ER

PT J
AU Lee, CW
   Cho, SC
AF Lee, Cheol Whan
   Cho, Sang-Cheol
TI The Transradial Approach for Coronary Intervention: More Comfort, Better
   Outcome
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
ID FEMORAL ACCESS; CARDIAC-CATHETERIZATION; ARTERY APPROACH; ANGIOGRAPHY;
   TRIAL; RIVAL
C1 [Lee, Cheol Whan; Cho, Sang-Cheol] Univ Ulsan, Asan Med Ctr, Heart Inst, Div Cardiol, 88 Olymp Ro 43 Gil, Seoul 05505, South Korea.
RP Lee, CW (corresponding author), Univ Ulsan, Asan Med Ctr, Heart Inst, Div Cardiol, 88 Olymp Ro 43 Gil, Seoul 05505, South Korea.
EM cheolwlee@amc.seoul.kr
OI Cho, Sang-Cheol/0000-0001-7587-5037
CR CAMPEAU L, 1989, CATHETER CARDIO DIAG, V16, P3, DOI 10.1002/ccd.1810160103
   Feldman DN, 2013, CIRCULATION, V127, P2295, DOI 10.1161/CIRCULATIONAHA.112.000536
   Jang HJ, 2016, KOREAN CIRC J, V46, P161, DOI 10.4070/kcj.2016.46.2.161
   Jolly SS, 2011, LANCET, V377, P1409, DOI 10.1016/S0140-6736(11)60404-2
   Kanei Y, 2011, CATHETER CARDIO INTE, V78, P840, DOI 10.1002/ccd.22978
   KIEMENEIJ F, 1993, CATHETER CARDIO DIAG, V30, P173, DOI 10.1002/ccd.1810300220
   Pandie S, 2015, JACC-CARDIOVASC INTE, V8, P505, DOI 10.1016/j.jcin.2014.11.017
   Romagnoli E, 2012, J AM COLL CARDIOL, V60, P2481, DOI 10.1016/j.jacc.2012.06.017
   Valgimigli M, 2015, LANCET, V385, P2465, DOI 10.1016/S0140-6736(15)60292-6
   Xu Y, 2018, KOREAN CIRC J, V48, P719, DOI 10.4070/kcj.2018.0040
NR 10
TC 2
Z9 3
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD AUG
PY 2018
VL 48
IS 8
BP 728
EP 730
DI 10.4070/kcj.2018.0118
PG 3
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA HB0TW
UT WOS:000450731600007
PM 30073811
OA Green Published
DA 2021-04-22
ER

PT J
AU Bae, JW
AF Bae, Jang-Whan
TI New Prediction Model for Stroke in Korean
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
ID ISCHEMIC-STROKE; HERITABILITY; RISK
C1 [Bae, Jang-Whan] Chungbuk Natl Univ, Dept Internal Med, Coll Med, 1 Chungdae Ro, Cheongju 28644, South Korea.
   [Bae, Jang-Whan] Chungbuk Natl Univ Hosp, Reg Cardiocerebrovasc Ctr, Cheongju, South Korea.
RP Bae, JW (corresponding author), Chungbuk Natl Univ, Dept Internal Med, Coll Med, 1 Chungdae Ro, Cheongju 28644, South Korea.
EM drcorazon@hanamil.net
CR Bevan S, 2012, STROKE, V43, P3161, DOI 10.1161/STROKEAHA.112.665760
   Bluher A, 2015, EUR J NEUROL, V22, P1488, DOI 10.1111/ene.12827
   Damen JAAG, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i2416
   Hachiya T, 2017, STROKE, V48, P253, DOI 10.1161/STROKEAHA.116.014506
   Jung KJ, 2018, KOREAN CIRC J, V48, P731, DOI 10.4070/kcj.2018.0036
   Lindgren A, 2014, J STROKE, V16, P114, DOI 10.5853/jos.2014.16.3.114
   Meschia JF, 2014, STROKE, V45, P3754, DOI 10.1161/STR.0000000000000046
   Seshadri S, 2010, CIRCULATION, V121, P1304, DOI 10.1161/CIRCULATIONAHA.109.854240
   Statistics Korea, 2017, ANN REP CAUS DEATH S
NR 9
TC 0
Z9 0
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD AUG
PY 2018
VL 48
IS 8
BP 741
EP 743
DI 10.4070/kcj.2018.0223
PG 3
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA HB0TW
UT WOS:000450731600009
PM 30073813
OA Green Published
DA 2021-04-22
ER

PT J
AU Ha, JW
AF Ha, Jong-Won
TI Diastolic Stress Echocardiography to Quantify the Response of Diastolic
   Functional Indices to Dynamic Exercise in Abnormal Relaxation: Unmasking
   Diastolic Abnormalities is Getting Ready for Prime Time
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
ID VENTRICULAR EJECTION FRACTION; TISSUE DOPPLER-ECHOCARDIOGRAPHY; INDUCED
   PULMONARY-HYPERTENSION; HEART-FAILURE; EUROPEAN ASSOCIATION; AMERICAN
   SOCIETY; FILLING PRESSURE; DYSFUNCTION; RESERVE; RECOMMENDATIONS
C1 [Ha, Jong-Won] Yonsei Univ, Severance Biomed Sci Inst, Div Cardiol, Coll Med, 50-1 Yonsei Ro, Seoul 03722, South Korea.
RP Ha, JW (corresponding author), Yonsei Univ, Severance Biomed Sci Inst, Div Cardiol, Coll Med, 50-1 Yonsei Ro, Seoul 03722, South Korea.
EM jwha@yuhs.ac
OI Ha, Jong-Won/0000-0002-8260-2958
CR Burgess MI, 2006, J AM COLL CARDIOL, V47, P1891, DOI 10.1016/j.jacc.2006.02.042
   CHENG CP, 1992, CIRC RES, V70, P9, DOI 10.1161/01.RES.70.1.9
   GAASCH WH, 1976, AM J CARDIOL, V38, P645, DOI 10.1016/S0002-9149(76)80015-X
   GROSSMAN W, 1976, ANN INTERN MED, V84, P316, DOI 10.7326/0003-4819-84-3-316
   GROSSMAN W, 1980, FED PROC, V39, P148
   Ha JW, 2009, HEART, V95, P490, DOI 10.1136/hrt.2007.139295
   Ha JW, 2009, HEART, V95, P399, DOI 10.1136/hrt.2008.145441
   Ha JW, 2007, HEART, V93, P1571, DOI 10.1136/hrt.2006.101667
   Ha JW, 2006, J AM SOC ECHOCARDIOG, V19, P1314, DOI 10.1016/j.echo.2006.05.022
   Ha JW, 2005, J AM SOC ECHOCARDIOG, V18, P63, DOI 10.1016/j.echo.2004.08.033
   Hong SJ, 2018, EUR HEART J-CARD IMG, V19, P12, DOI 10.1093/ehjci/jex241
   Jang JY, 2018, KOREAN CIRC J, V48, P744, DOI 10.4070/kcj.2018.0046
   KITZMAN DW, 1991, J AM COLL CARDIOL, V17, P1065, DOI 10.1016/0735-1097(91)90832-T
   Lancellotti P, 2017, J AM SOC ECHOCARDIOG, V30, DOI 10.1016/j.echo.2016.10.016
   Lancellotti P, 2016, EUR HEART J-CARD IMG, V17, P1191, DOI 10.1093/ehjci/jew190
   Marwick TH, 2007, PROG CARDIOVASC DIS, V49, P263, DOI 10.1016/j.pcad.2006.08.006
   Mizushige K, 1996, AM HEART J, V131, P131, DOI 10.1016/S0002-8703(96)90061-7
   Nagueh SF, 2016, J AM SOC ECHOCARDIOG, V29, P277, DOI 10.1016/j.echo.2016.01.011
   Oh JK, 2014, J AM SOC ECHOCARDIOG, V27, P1060, DOI 10.1016/j.echo.2014.08.013
   Redfield MM, 2003, JAMA-J AM MED ASSOC, V289, P194, DOI 10.1001/jama.289.2.194
   Shim CY, 2011, HEART, V97, P1417, DOI 10.1136/hrt.2010.220467
   Smiseth OA, 2018, EUR HEART J-CARD IMG, V19, P20, DOI 10.1093/ehjci/jex307
   Tolle JJ, 2008, CIRCULATION, V118, P2183, DOI 10.1161/CIRCULATIONAHA.108.787101
   Vasan RS, 1999, J AM COLL CARDIOL, V33, P1948, DOI 10.1016/S0735-1097(99)00118-7
NR 24
TC 0
Z9 0
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD AUG
PY 2018
VL 48
IS 8
BP 755
EP 759
DI 10.4070/kcj.2018.0164
PG 5
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA HB0TW
UT WOS:000450731600011
PM 30073815
OA Green Published
DA 2021-04-22
ER

PT J
AU Park, WK
   Kim, DH
   Cho, SH
AF Park, Won Kyoun
   Kim, Dae Hyun
   Cho, Sang-Ho
TI Large Chronic Pseudoaneurysm of Left Ventricle Complicating Anterior
   Myocardial Infarction
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
C1 [Park, Won Kyoun; Kim, Dae Hyun; Cho, Sang-Ho] Kyung Hee Univ, Sch Med, Kyung Hee Univ Hosp Gangdong, Dept Thorac & Cardiovasc Surg, 892 Dongnam Ro, Seoul 05278, South Korea.
RP Cho, SH (corresponding author), Kyung Hee Univ, Sch Med, Kyung Hee Univ Hosp Gangdong, Dept Thorac & Cardiovasc Surg, 892 Dongnam Ro, Seoul 05278, South Korea.
EM sinan75@khnmc.or.kr
OI Cho, Sang-Ho/0000-0001-5590-1904
CR Atik FA, 2007, ANN THORAC SURG, V83, P526, DOI 10.1016/j.athoracsur.2006.06.080
   Bisoyi S, 2016, ANN CARD ANAESTH, V19, P169, DOI 10.4103/0971-9784.173042
   Frances C, 1998, J AM COLL CARDIOL, V32, P557, DOI 10.1016/S0735-1097(98)00290-3
   Garrido JM, 2014, SURG SCI, V5, P138
   Moreno R, 2003, HEART, V89, P1144, DOI 10.1136/heart.89.10.1144
NR 5
TC 0
Z9 0
U1 1
U2 2
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD AUG
PY 2018
VL 48
IS 8
BP 760
EP 762
DI 10.4070/kcj.2018.0112
PG 3
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA HB0TW
UT WOS:000450731600012
PM 30073816
OA Green Published
DA 2021-04-22
ER

PT J
AU Ikidag, MA
AF Ikidag, Mehmet Ali
TI Retroaortic Course and Azygous Continuation of an Aberrant Left
   Brachiocephalic Vein
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
ID INNOMINATE VEIN; EMBRYOLOGY; CT
C1 [Ikidag, Mehmet Ali] Sanko Univ, Dept Radiol, Med Sch, Gaziantep, Turkey.
RP Ikidag, MA (corresponding author), Sanko Univ, Dept Radiol, Sani Konukoglu Hastanesi, Uygulama & Arastirma Merkezi Radyol Bolumu, Ali Fuat Cebesoy Bulvari 45, Gaziantep, Turkey.
EM mikidag@hotmail.com
RI Ikidag, Mehmet Ali/P-5019-2015
OI ikidag, mehmet ali/0000-0003-4004-9645
CR Chen SJ, 2005, AM J ROENTGENOL, V184, P1235, DOI 10.2214/ajr.184.4.01841235
   Konstantinov IE, 2003, ANN THORAC SURG, V75, P1014, DOI 10.1016/S0003-4975(02)04333-3
   Leal SMB, 2002, CARDIOL YOUNG, V12, P159, DOI 10.1017/S104795110200032X
   Topcuoglu OM, 2015, SURG RADIOL ANAT, V37, P315, DOI 10.1007/s00276-014-1345-z
   Yigit AE, 2008, PEDIATR RADIOL, V38, P322, DOI 10.1007/s00247-007-0663-2
NR 5
TC 1
Z9 1
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD AUG
PY 2018
VL 48
IS 8
BP 763
EP 765
DI 10.4070/kcj.2018.0092
PG 3
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA HB0TW
UT WOS:000450731600013
PM 30073817
OA Green Published
DA 2021-04-22
ER

PT J
AU Roh, SY
   Shim, J
   Lee, KN
   Ahn, J
   Kim, DH
   Lee, DI
   Choi, JI
   Kim, YH
AF Roh, Seung-Young
   Shim, Jaemin
   Lee, Kwang-No
   Ahn, Jinhee
   Kim, Dong-Hyeok
   Lee, Dae In
   Choi, Jong Il
   Kim, Young-Hoon
TI Gender-related Difference in Clinical Outcome of the Patient with Atrial
   Fibrillation after Radiofrequency Catheter Ablation
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Atrial fibrillation; Gender; Catheter ablation
ID QUALITY-OF-LIFE; RHYTHM CONTROL; ISCHEMIC-STROKE; SEX-DIFFERENCES; RISK;
   HEART; COMPLICATIONS; MORTALITY; THERAPY; HEALTH
AB Background and Objectives: Previous studies provided controversial result about gender differences in the clinical outcome after radiofrequency catheter ablation (RFCA) for atrial fibrillation (AF). We assessed pure difference after adjustment of referral bias.
   Methods: The clinical outcomes including freedom from AF/atrial tachycardia (AT) recurrence after RFCA were compared between women and men in 1:1 confounding factor matching with age, AF type, periods since diagnosis (+/- 12 months), and procedure era (+/- 12 months). Subgroup analysis was performed in categories defined by AF type and age of 55 (mean menopausal age of Asian women).
   Results: Total 1,875 patients with AF underwent 2,307 RFCA between January 1998 and May 2014 in a single center. Total 367 women (19.6%, 59 +/- 10 years) who had undergone first ablation were included. Women had larger left atrial diameter index (26 +/- 4 vs. 23 +/- 4 mm/m(2); p<0.001) and higher ped-procedural complications (9.2% vs. 4.9%; p=0.030) compared to men. The freedom from AF/AT recurrence after RFCA was not different between both groups (71% vs. 76%; log-rank p=0.131, mean follow-up of 55 months). Women with non-paroxysmal AF (PAF) had significantly worse outcome (54% vs. 69%; p=0.014), especially in subgroup with age <= 55 (48% vs. 71%; p=0.010). In multivariate analysis, female gender was an independent predictor of recurrence in subgroup with non-PAF and age <= 55 (hazard ratio [HR], 2.539; 95% confidence interval (CI), 1.112-5.801; p=0.027).
   Conclusions: The clinical outcome after RFCA was not different between both genders regardless of referral bias. However, the gender difference became evident in patients tinder 55 years with non-PAF.
C1 [Roh, Seung-Young] Dongguk Univ, Coll Med, Div Cardiol, Goyang, South Korea.
   [Roh, Seung-Young] Dongguk Univ, Med Ctr, Goyang, South Korea.
   [Shim, Jaemin; Lee, Kwang-No; Choi, Jong Il; Kim, Young-Hoon] Korea Univ, Coll Med, Div Cardiol, 73 Inchon Ro, Seoul 02841, South Korea.
   [Shim, Jaemin; Lee, Kwang-No; Choi, Jong Il; Kim, Young-Hoon] Korea Univ, Anam Hosp, 73 Inchon Ro, Seoul 02841, South Korea.
   [Ahn, Jinhee] Pusan Natl Univ Hosp, Div Cardiol, Busan, South Korea.
   [Kim, Dong-Hyeok] Sejong Gen Hosp, Div Cardiol, Bucheon, South Korea.
   [Lee, Dae In] Chungbuk Natl Univ Hosp, Div Cardiol, Cheongju, South Korea.
RP Kim, YH (corresponding author), Korea Univ, Coll Med, Div Cardiol, 73 Inchon Ro, Seoul 02841, South Korea.; Kim, YH (corresponding author), Korea Univ, Anam Hosp, 73 Inchon Ro, Seoul 02841, South Korea.
EM yhkmd@unitel.co.kr
RI Kim, Dong-Hyeok/N-7559-2018
OI Shim, Jaemin/0000-0001-8251-1522; Choi, Jong-Il/0000-0001-6617-508X
CR Balk EM, 2010, J CARDIOVASC ELECTR, V21, P1208, DOI 10.1111/j.1540-8167.2010.01798.x
   Benjamin EJ, 1998, CIRCULATION, V98, P946, DOI 10.1161/01.CIR.98.10.946
   Chugh SS, 2014, CIRCULATION, V129, P837, DOI 10.1161/CIRCULATIONAHA.113.005119
   Coutinho T, 2013, J AM COLL CARDIOL, V61, P96, DOI 10.1016/j.jacc.2012.08.997
   Dewland TA, 2013, PACE, V36, P55, DOI 10.1111/pace.12028
   Fang MC, 2005, CIRCULATION, V112, P1687, DOI 10.1161/CIRCULATIONAHA.105.553438
   Forleo GB, 2007, EUROPACE, V9, P613, DOI 10.1093/europace/eum144
   Friberg J, 2004, AM J CARDIOL, V94, P889, DOI 10.1016/j.amjcard.2004.06.023
   Hart RG, 1999, STROKE, V30, P1223, DOI 10.1161/01.STR.30.6.1223
   Humphries KH, 2001, CIRCULATION, V103, P2365
   January CT, 2014, CIRCULATION, V130, P2071, DOI [10.1161/CIR.0000000000000041, 10.1161/CIR.0000000000000040]
   Michowitz Y, 2014, CIRC-ARRHYTHMIA ELEC, V7, P274, DOI 10.1161/CIRCEP.113.000760
   OlivaresReyes A, 1997, J AM SOC ECHOCARDIOG, V10, P644, DOI 10.1016/S0894-7317(97)70027-0
   Ong L, 2006, J PSYCHOSOM RES, V61, P769, DOI 10.1016/j.jpsychores.2006.08.003
   Paquette M, 2000, AM J CARDIOL, V86, P764, DOI 10.1016/S0002-9149(00)01077-8
   Patel D, 2010, HEART RHYTHM, V7, P167, DOI 10.1016/j.hrthm.2009.10.025
   Perez MV, 2012, CIRC-ARRHYTHMIA ELEC, V5, P1108, DOI 10.1161/CIRCEP.112.972224
   Piccini JP, 2012, CIRC-CARDIOVASC QUAL, V5, P85, DOI 10.1161/CIRCOUTCOMES.111.962688
   Potpara TS, 2012, INT J CARDIOL, V161, P39, DOI 10.1016/j.ijcard.2011.04.022
   Rienstra M, 2005, J AM COLL CARDIOL, V46, P1298, DOI 10.1016/j.jacc.2005.05.078
   Saito T, 2009, CIRC RES, V105, P343, DOI 10.1161/CIRCRESAHA.108.190041
   Salam AM, 2013, INT J CARDIOL, V168, P975, DOI 10.1016/j.ijcard.2012.10.041
   Santangeli P, 2011, J CARDIOVASC ELECTR, V22, P605, DOI 10.1111/j.1540-8167.2010.01920.x
   Schoenaker DAJM, 2014, INT J EPIDEMIOL, V43, P1542, DOI 10.1093/ije/dyu094
   Shah RU, 2012, J AM COLL CARDIOL, V59, P143, DOI 10.1016/j.jacc.2011.08.068
   Van Gelder IC, 2002, NEW ENGL J MED, V347, P1834, DOI 10.1056/NEJMoa021375
   Wang TJ, 2003, JAMA-J AM MED ASSOC, V290, P1049, DOI 10.1001/jama.290.8.1049
   Wolf PA, 1998, ARCH INTERN MED, V158, P229, DOI 10.1001/archinte.158.3.229
   Wyse DG, 2002, NEW ENGL J MED, V347, P1825, DOI 10.1056/nejmoa021328
   Zhang YY, 2011, AM J EPIDEMIOL, V174, P403, DOI 10.1093/aje/kwr172
NR 30
TC 3
Z9 3
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JUL
PY 2018
VL 48
IS 7
BP 605
EP 618
DI 10.4070/kcj.2017.0327
PG 14
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA HB0TA
UT WOS:000450729400006
PM 29968433
OA Green Published
DA 2021-04-22
ER

PT J
AU Lee, SR
   Choi, EK
   Han, K
   Cha, MJ
   Oh, S
AF Lee, So-Ryoung
   Choi, Eue-Keun
   Han, Kyungdo
   Cha, Myung-Jin
   Oh, Seil
TI Prevalence of Non-valvular Atrial Fibrillation Based on Geographical
   Distribution and Socioeconomic Status in the Entire Korean Population
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Atrial fibrillation; Prevalence; Income; Social class; Region
ID ORAL ANTICOAGULANTS; STROKE PREVENTION; ISCHEMIC-STROKE; GLOBAL BURDEN;
   RISK-FACTORS; WARFARIN; EPIDEMIOLOGY; METAANALYSIS; MORTALITY; TRENDS
AB Background and Objectives: Prevalence of atrial fibrillation (AF) varies based on geographical location and socioeconomic status. We aimed to evaluate the prevalence of AF and utilization of antithrombotic therapy based on geographical regions and income levels in the entire Korean population.
   Methods: We performed a cross-sectional analysis of Korean adults (aged >= 20 years) using the 2015 National Health Insurance Service database (n=41,505,679). The study population was stratified into 17 geographical regions and 21 income levels.
   Results: We identified 276,842 patients diagnosed with AF. Overall prevalence of AF in suburban/rural regions was significantly higher than that observed in urban regions (0.72% vs. 0.61%, respectively, p<0.001). Elderly patients (age >= 75 years) showed a higher prevalence of AF and comorbidities related to AF development showed a higher prevalence among the population residing in suburban/rural regions. Among AF patients with a CHA(2)DS(2)-VASc score >= 2, oral anticoagulation (OAC) therapy utilization was lower in the suburban/rural regions than that observed in the urban regions (48.2% vs. 51.8%, respectively, p<0.001). The relationship between income levels and AF prevalence showed a J-shaped curve. The OAC prescription rate showed a positive correlation with income levels. Non-vitamin K antagonist oral anticoagulants tended to be more commonly prescribed among the higher income groups.
   Conclusions: Geographical location of residence and income levels were closely associated with the prevalence of AF and antithrombotic therapy utilization. This information may provide further insights for more effective surveillance of AF and stroke prevention for improved clinical outcomes.
C1 [Lee, So-Ryoung] Soonchunhyang Univ, Dept Internal Med, Seoul Hosp, Seoul, South Korea.
   [Choi, Eue-Keun; Cha, Myung-Jin; Oh, Seil] Seoul Natl Univ Hosp, Dept Internal Med, 101 Daeruk Ro, Seoul 03080, South Korea.
   [Han, Kyungdo] Catholic Univ Korea, Coll Med, Dept Biostat, Seoul, South Korea.
RP Choi, EK (corresponding author), Seoul Natl Univ Hosp, Dept Internal Med, 101 Daeruk Ro, Seoul 03080, South Korea.
EM choiek17@snu.ac.kr
RI Oh, Seil/J-5539-2012; Choi, Eue-Keun/J-5968-2014
OI Oh, Seil/0000-0002-2504-9615; Choi, Eue-Keun/0000-0002-0411-6372; Cha,
   Myung-Jin/0000-0001-6180-0157; Lee, So-Ryoung/0000-0002-6351-5015
FU Seoul National University Hospital Research Fund [0620160680]; National
   Research Foundation of Korea - Ministry of Education, Science and
   TechnologyMinistry of Education, Science and Technology, Republic of
   KoreaNational Research Foundation of Korea [2014R1A1A2A16055218]; Korean
   Healthcare Technology R&D project - Ministry of Health Welfare
   [HI15C1200]
FX This study was supported by grant from the Seoul National University
   Hospital Research Fund (No. 0620160680); grant from the National
   Research Foundation of Korea funded by the Ministry of Education,
   Science and Technology (2014R1A1A2A16055218); and the Korean Healthcare
   Technology R&D project, funded by the Ministry of Health & Welfare
   (HI15C1200).
CR Andersen KK, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.113.000762
   Barrett TW, 2013, AM J CARDIOL, V112, P1410, DOI 10.1016/j.amjcard.2013.07.005
   Chao TF, 2015, CIRCULATION, V132, P1604, DOI 10.1161/CIRCULATIONAHA.114.013709
   Choi EJ, 2016, INT J CARDIOL, V220, P647, DOI 10.1016/j.ijcard.2016.06.177
   Chugh SS, 2014, CIRCULATION, V129, P837, DOI 10.1161/CIRCULATIONAHA.113.005119
   Guo YT, 2015, CHEST, V147, P109, DOI 10.1378/chest.14-0321
   Hart RG, 2007, ANN INTERN MED, V146, P857, DOI 10.7326/0003-4819-146-12-200706190-00007
   Huisman MV, 2017, J AM COLL CARDIOL, V69, P777, DOI 10.1016/j.jacc.2016.11.061
   Kang SH, 2017, CIRC J, V81, P1158, DOI 10.1253/circj.CJ-16-1267
   Kang SH, 2016, INT J CARDIOL, V215, P449, DOI 10.1016/j.ijcard.2016.04.036
   Kim MH, 2011, CIRC-CARDIOVASC QUAL, V4, P313, DOI 10.1161/CIRCOUTCOMES.110.958165
   Kimura K, 2005, J NEUROL NEUROSUR PS, V76, P679, DOI 10.1136/jnnp.2004.048827
   Kirchhof P, 2016, EUR J CARDIO-THORAC, V50, pE1, DOI 10.1093/ejcts/ezw313
   Kishore A, 2014, STROKE, V45, P520, DOI 10.1161/STROKEAHA.113.003433
   Lee H, 2017, KOREAN CIRC J, V47, P56, DOI 10.4070/kcj.2016.0045
   Lee IH, 2015, J CARDIOL, V66, P475, DOI 10.1016/j.jjcc.2015.06.013
   Lee SR, 2017, INT J CARDIOL, V236, P226, DOI 10.1016/j.ijcard.2017.02.039
   Lee SR, 2016, INT J CARDIOL, V223, P953, DOI 10.1016/j.ijcard.2016.08.296
   Leyden JM, 2013, STROKE, V44, P1226, DOI 10.1161/STROKEAHA.113.675140
   Misialek JR, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.114.001159
   Modesti PA, 2013, J HUM HYPERTENS, V27, P572, DOI 10.1038/jhh.2013.18
   Nakibuuka J, 2015, NEUROEPIDEMIOLOGY, V44, P156, DOI 10.1159/000381453
   Rahman F, 2014, NAT REV CARDIOL, V11, P639, DOI 10.1038/nrcardio.2014.118
   Ruff CT, 2014, LANCET, V383, P955, DOI 10.1016/S0140-6736(13)62343-0
   Sholzberg M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149142
   Sjolander M, 2015, STROKE, V46, P2220, DOI 10.1161/STROKEAHA.115.009718
   Stewart S, 2004, HEART, V90, P286, DOI 10.1136/hrt.2002.008748
   Tomlin AM, 2017, EUR J PREV CARDIOL, V24, P311, DOI 10.1177/2047487316674830
   Tse HF, 2013, HEART RHYTHM, V10, P1082, DOI 10.1016/j.hrthm.2013.03.017
NR 29
TC 18
Z9 18
U1 0
U2 5
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JUL
PY 2018
VL 48
IS 7
BP 622
EP 634
DI 10.4070/kcj.2017.0362
PG 13
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA HB0TA
UT WOS:000450729400008
PM 29968435
OA Green Published
DA 2021-04-22
ER

PT J
AU Kang, J
   Kim, HS
AF Kang, Jeehoon
   Kim, Hyo-Soo
TI The Evolving Concept of Dual Antiplatelet Therapy after Percutaneous
   Coronary Intervention: Focus on Unique Feature of East Asian and "Asian
   Paradox"
SO KOREAN CIRCULATION JOURNAL
LA English
DT Review
DE Dual antiplatelet therapy; Percutaneous coronary intervention; East
   Asians; Ischemic risk; Bleeding risk
ID ELUTING STENT IMPLANTATION; ACUTE MYOCARDIAL-INFARCTION; TREATMENT
   PLATELET REACTIVITY; TICAGRELOR VS. CLOPIDOGREL; ARTERY-DISEASE;
   DOUBLE-BLIND; CLINICAL-OUTCOMES; ADJUNCTIVE CILOSTAZOL; ACC/AHA
   GUIDELINE; DOSE CLOPIDOGREL
AB Dual antiplatelet therapy (DAPT) with aspirin and a P2Y12 inhibitor is essential after percutaneous coronary intervention (PCI), while many studies have focused on determining the optimal degree of platelet inhibition and optimal DAPT duration to minimize complications after PCI. Current guidelines developed by the American College of Cardiology/American Heart Association and the European Society of Cardiology summarize previous studies and provide recommendations. However, these guidelines are mainly based on Western patients, and their characteristics might differ from those of East Asian patients. Previous data suggested that East Asian patients have unique features with regard to the response to antiplatelet agents. On comparing Western and East Asian patients, it was found that East Asian patients have a lower rate of ischemic events and higher rate of bleeding events after PCI, despite a higher on-treatment platelet reactivity, which is referred to as the "East Asian paradox." As the main purpose of DAPT is to minimize ischemic and bleeding complications after PCI, these differences should be clarified before adopting the guidelines for East Asian patients. Therefore, in this article, we will review various issues regarding DAPT in East Asian patients, with a focus on the unique characteristics of East Asian patients, previous studies regarding antiplatelet agents in East Asian patients, and a guideline from an East Asian perspective.
C1 [Kang, Jeehoon; Kim, Hyo-Soo] Seoul Natl Univ Hosp, Dept Internal Med, Cardiovasc Ctr, 101 Daehak Ro, Seoul 03080, South Korea.
RP Kim, HS (corresponding author), Seoul Natl Univ Hosp, Dept Internal Med, Cardiovasc Ctr, 101 Daehak Ro, Seoul 03080, South Korea.
EM hyosoo@snu.ac.kr
OI Kang, Jeehoon/0000-0002-9078-2231
FU Korea Health Technology R&D Project "Korea Research-Driven Hospital"
   through the Korea Health Industry Development Institute (KHIDI) -
   Ministry of Health & Welfare, Republic of Korea [HI14C1277]
FX This study was supported by a grant of the Korea Health Technology R&D
   Project "Korea Research-Driven Hospital" through the Korea Health
   Industry Development Institute (KHIDI), funded by the Ministry of Health
   & Welfare, Republic of Korea (grant number: HI14C1277).
CR Angiolillo DJ, 2007, CIRCULATION, V115, P708, DOI 10.1161/CIRCULATIONAHA.106.667741
   Bertrand ME, 2000, CIRCULATION, V102, P624, DOI 10.1161/01.CIR.102.6.624
   Bhatt DL, 2006, NEW ENGL J MED, V354, P1706, DOI 10.1056/NEJMoa060989
   Bittl JA, 2016, CIRCULATION, V134, pE156, DOI 10.1161/CIR.0000000000000405
   Bittl JA, 2016, J AM COLL CARDIOL, V68, P1116, DOI 10.1016/j.jacc.2016.03.512
   Bonello L, 2010, J AM COLL CARDIOL, V56, P919, DOI 10.1016/j.jacc.2010.04.047
   Brar SS, 2011, J AM COLL CARDIOL, V58, P1945, DOI 10.1016/j.jacc.2011.06.059
   Cayla G, 2016, LANCET, V388, P2015, DOI 10.1016/S0140-6736(16)31323-X
   Chen ZM, 2005, LANCET, V366, P1607, DOI 10.1016/s0140-6736(05)67660-x
   Collet JP, 2014, LANCET, V384, P1577, DOI 10.1016/S0140-6736(14)60612-7
   Collet JP, 2012, NEW ENGL J MED, V367, P2100, DOI 10.1056/NEJMoa1209979
   Colombo A, 2014, J AM COLL CARDIOL, V64, P2086, DOI 10.1016/j.jacc.2014.09.008
   Faber DR, 2009, OBES REV, V10, P554, DOI 10.1111/j.1467-789X.2009.00593.x
   Feres F, 2013, JAMA-J AM MED ASSOC, V310, P2510, DOI 10.1001/jama.2013.282183
   Gilard M, 2015, J AM COLL CARDIOL, V65, P777, DOI 10.1016/j.jacc.2014.11.008
   Goto S, 2015, CIRC J, V79, P2452, DOI 10.1253/circj.CJ-15-0112
   Gwon HC, 2012, CIRCULATION, V125, P505, DOI 10.1161/CIRCULATIONAHA.111.059022
   Han Y., 2016, CIRC CARDIOVASC INTE, V9, DOI DOI 10.1161/CIRCINTERVENTIONS.115.003145
   Helft G, 2016, EUR HEART J, V37, P365, DOI 10.1093/eurheartj/ehv481
   Hong SJ, 2016, JACC-CARDIOVASC INTE, V9, P1438, DOI 10.1016/j.jcin.2016.04.036
   Hulot JS, 2006, BLOOD, V108, P2244, DOI 10.1182/blood-2006-04-013052
   James S, 2010, EUR HEART J, V31, P3006, DOI 10.1093/eurheartj/ehq325
   James S, 2010, CIRCULATION, V122, P1056, DOI 10.1161/CIRCULATIONAHA.109.933796
   Jeong YH, 2014, CURR CARDIOL REP, V16, DOI 10.1007/s11886-014-0485-4
   Kang HJ, 2015, AM HEART J, V169, P899, DOI 10.1016/j.ahj.2015.03.015
   Kang J, 2018, J AM COLL CARDIOL, V71, P1320, DOI 10.1016/S0735-1097(18)31861-8
   Kang J, 2018, THROMB HAEMOSTASIS, V118, P591, DOI 10.1055/s-0038-1626697
   Kim BK, 2012, J AM COLL CARDIOL, V60, P1340, DOI 10.1016/j.jacc.2012.06.043
   Kim C, 2017, KOREAN CIRC J, V47, P888, DOI 10.4070/kcj.2017.0072
   Lee CW, 2014, CIRCULATION, V129, P304, DOI 10.1161/CIRCULATIONAHA.113.003303
   Lee K, 2015, INT J CARDIOL, V190, P370, DOI 10.1016/j.ijcard.2015.04.180
   Levine GN, 2016, CIRCULATION, V134, pE123, DOI 10.1161/CIR.0000000000000404
   Levine GN, 2014, NAT REV CARDIOL, V11, P597, DOI 10.1038/nrcardio.2014.104
   Mak KH, 2009, AM HEART J, V157, P658, DOI 10.1016/j.ahj.2008.08.031
   Mauri L, 2014, NEW ENGL J MED, V371, P2155, DOI 10.1056/NEJMoa1409312
   Montalescot G, 2009, LANCET, V373, P723, DOI 10.1016/S0140-6736(09)60441-4
   Nakamura M, 2017, JACC-CARDIOVASC INTE, V10, P1189, DOI 10.1016/j.jcin.2017.04.019
   Olier I, 2018, HEART
   Park KW, 2013, JACC-CARDIOVASC INTE, V6, P932, DOI 10.1016/j.jcin.2013.04.022
   Park KW, 2012, CARDIOVASC THER, V30, P5, DOI 10.1111/j.1755-5922.2010.00249.x
   Park KW, 2012, HEART, V98, P1366, DOI 10.1136/heartjnl-2012-301892
   Park KW, 2012, CIRC J, V76, P287, DOI 10.1253/circj.CJ-11-1494
   Park KW, 2011, AM J CARDIOL, V108, P1556, DOI 10.1016/j.amjcard.2011.07.012
   Parodi G, 2011, JAMA-J AM MED ASSOC, V306, P1215, DOI 10.1001/jama.2011.1332
   Patil RK, 2015, CURR ATHEROSCLER REP, V17, DOI 10.1007/s11883-015-0543-4
   Price MJ, 2011, JAMA-J AM MED ASSOC, V305, P1097, DOI 10.1001/jama.2011.290
   Roberts JD, 2012, LANCET, V379, P1705, DOI 10.1016/S0140-6736(12)60161-5
   Sabatine MS, 2005, NEW ENGL J MED, V352, P1179, DOI 10.1056/NEJMoa050522
   Sahlen A, 2016, EUR HEART J, V37, P3335, DOI 10.1093/eurheartj/ehw284
   Saito S, 2014, CIRC J, V78, P1684, DOI 10.1253/circj.CJ-13-1482
   Schomig A, 1996, NEW ENGL J MED, V334, P1084, DOI 10.1056/NEJM199604253341702
   Schulz-Schupke S, 2015, EUR HEART J, V36, P1252, DOI 10.1093/eurheartj/ehu523
   Shen AYJ, 2007, J AM COLL CARDIOL, V50, P309, DOI 10.1016/j.jacc.2007.01.098
   Smith PK, 2012, J AM COLL CARDIOL, V60, P388, DOI 10.1016/j.jacc.2012.03.030
   Steg PG, 2010, CIRCULATION, V122, P2131, DOI 10.1161/CIRCULATIONAHA.109.927582
   Steinhubl SR, 2002, JAMA-J AM MED ASSOC, V288, P2411, DOI 10.1001/jama.288.19.2411
   Suh JW, 2011, J AM COLL CARDIOL, V57, P280, DOI 10.1016/j.jacc.2010.08.631
   Urban P, 2015, NEW ENGL J MED, V373, P2038, DOI 10.1056/NEJMoa1503943
   Valgimigli M, 2018, EUR HEART J, V39, P213, DOI 10.1093/eurheartj/ehx419
   Valgimigli M, 2017, KARDIOL POL, V75, P1217, DOI 10.5603/KP.2017.0224
   Valgimigli M, 2012, CIRCULATION, V125, P2015, DOI 10.1161/CIRCULATIONAHA.111.071589
   Wallentin L, 2009, NEW ENGL J MED, V361, P1045, DOI 10.1056/NEJMoa0904327
   Wiviott SD, 2007, NEW ENGL J MED, V357, P2001, DOI 10.1056/NEJMoa0706482
   Xie X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059344
   Yusuf S, 2001, NEW ENGL J MED, V345, P494
NR 65
TC 20
Z9 20
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JUL
PY 2018
VL 48
IS 7
BP 537
EP 551
DI 10.4070/kcj.2018.0166
PG 15
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA HB0TA
UT WOS:000450729400001
PM 29968428
OA Green Published
DA 2021-04-22
ER

PT J
AU Cuspidi, C
   Tadic, M
   Mancia, G
   Grassi, G
AF Cuspidi, Cesare
   Tadic, Marijana
   Mancia, Giuseppe
   Grassi, Guido
TI White-Coat Hypertension: the Neglected Subgroup in Hypertension
SO KOREAN CIRCULATION JOURNAL
LA English
DT Review
DE White coat hypertension; Cardiovascular prognosis; Anti-hypertensive
   treatment
ID LONG-TERM RISK; ISOLATED SYSTOLIC HYPERTENSION; TARGET ORGAN DAMAGE;
   MASKED HYPERTENSION; PROGNOSTIC VALUE; SUSTAINED HYPERTENSION; METABOLIC
   SYNDROME; EUROPEAN-SOCIETY; OFFICE; HOME
AB The clinical prognostic importance of white coat hypertension (WCH), that is, the clinical condition characterized by an increase of office but a normal ambulatory or home blood pressure (BP) is since a long time matter of considerable debate. WCH accounts for a consistent portion of hypertensive patients (up to 30-40%), particularly when hypertension is mild or age is more advanced. Although scanty and inconsistent information is available on the response of office and out-office BP to antihypertensive treatment and the cardiovascular (CV) protection provided by treatment, an increasing body of evidence focusing on the association of WCH with CV risk factors, subclinical cardiac and extra-cardiac organ damage and, more importantly, with CV events indicates that the risk entailed by this condition is intermediate between true normotension and sustained hypertension. This review will address a number of issues concerning WCH with particular attention to prevalence and clinical correlates, relation with subclinical target organ damage and CV morbidity/mortality, therapeutic perspectives. Several topics covered in this review are based on data acquired over the past 20 years by the Pressioni Arteriose Monitorate E Loro Associazioni (PAMELA) study, a longitudinal survey performed by our group on the general population living in the surroundings of Milan area in the north part of Italy.
C1 [Cuspidi, Cesare; Mancia, Giuseppe; Grassi, Guido] Univ Milano Bicocca, Dept Hlth Sci, Clin Med, Milan, Italy.
   [Cuspidi, Cesare] Ist Auxol Italiano IRCCS, Milan, Italy.
   [Tadic, Marijana] Charite, Campus Virchow Klinikum, Dept Cardiol, Berlin, Germany.
   [Grassi, Guido] IRCCS Multimed, Milan, Italy.
RP Grassi, G (corresponding author), Univ Milano Bicocca, Dept Hlth Sci, Clin Med, Milan, Italy.
EM guido.grassi@unimib.it
OI GRASSI, GUIDO/0000-0003-1922-6547
CR Afsar B, 2013, J CARDIOL, V61, P222, DOI 10.1016/j.jjcc.2012.11.003
   Banegas JR, 2018, NEW ENGL J MED, V378, P1509, DOI 10.1056/NEJMoa1712231
   Bombelli M, 2009, J HYPERTENS, V27, P2458, DOI 10.1097/HJH.0b013e328330b845
   Briasoulis A, 2016, J HYPERTENS, V34, P593, DOI 10.1097/HJH.0000000000000832
   Bulpitt CJ, 2013, HYPERTENSION, V61, P89, DOI 10.1161/HYPERTENSIONAHA.112.191791
   Cuspidi C, 2018, J HYPERTENS
   Cuspidi C, 2007, J HYPERTENS, V25, P315, DOI 10.1097/HJH.0b013e3280119025
   Cuspidi C, 2015, BLOOD PRESS MONIT, V20, P57, DOI 10.1097/MBP.0000000000000094
   Cuspidi C, 2015, J HYPERTENS, V33, P24, DOI 10.1097/HJH.0000000000000416
   de la Sierra A, 2017, J HYPERTENS, V35, P2324, DOI 10.1097/HJH.0000000000001522
   Fagard RH, 2000, CIRCULATION, V102, P1139, DOI 10.1161/01.CIR.102.10.1139
   Franklin SS, 2012, HYPERTENSION, V59, P564, DOI 10.1161/HYPERTENSIONAHA.111.180653
   Grassi G, 2007, HYPERTENSION, V50, P537, DOI 10.1161/HYPERTENSIONAHA.107.092528
   Grassi G, 2015, CIRC RES, V116, P976, DOI 10.1161/CIRCRESAHA.116.303604
   Hermida RC, 2015, CHRONOBIOL INT, V32, P1329, DOI 10.3109/07420528.2015.1113804
   HOEGHOLM A, 1993, AM J HYPERTENS, V6, P282, DOI 10.1093/ajh/6.4.282
   Hoegholm A, 1996, BLOOD PRESS MONIT, V1, P375
   Leung AA, 2017, CAN J CARDIOL, V33, P557, DOI 10.1016/j.cjca.2017.03.005
   Mancia G, 1995, J HYPERTENS, V13, P1377
   Mancia G, 2006, HYPERTENSION, V47, P846, DOI 10.1161/01.HYP.0000215363.69793.bb
   Mancia G, 2016, J AM COLL CARDIOL, V68, P2044, DOI 10.1016/j.jacc.2016.08.043
   Mancia G, 2015, HYPERTENSION, V66, P437, DOI 10.1161/HYPERTENSIONAHA.115.05367
   Mancia G, 2015, CIRC RES, V116, P1034, DOI 10.1161/CIRCRESAHA.116.303755
   Mancia G, 2014, HYPERTENSION, V64, P1388, DOI 10.1161/HYPERTENSIONAHA.114.04278
   Mancia G, 2013, J HYPERTENS, V31, P1281, DOI 10.1097/01.hjh.0000431740.32696.cc
   Mancia G, 2013, HYPERTENSION, V62, P168, DOI 10.1161/HYPERTENSIONAHA.111.00690
   Mancia G, 2009, HYPERTENSION, V54, P226, DOI 10.1161/HYPERTENSIONAHA.109.129882
   Mancia G, 2009, J HYPERTENS, V27, P1672, DOI 10.1097/HJH.0b013e32832be5f9
   Mancusi C, 2017, INT J CARDIOL, V244, P260, DOI 10.1016/j.ijcard.2017.06.045
   Manios E, 2016, J CLIN HYPERTENS, V18, P1095, DOI 10.1111/jch.12888
   Mule G, 2007, J HUM HYPERTENS, V21, P854, DOI 10.1038/sj.jhh.1002238
   National Institute for Health and Clinical Excellence (UK), 2011, HYP AD DIAGN MAN CLI
   O'Brien E, 2013, J HYPERTENS, V31, P1731, DOI 10.1097/HJH.0b013e328363e964
   Palatini P, 1998, J HYPERTENS, V16, P977, DOI 10.1097/00004872-199816070-00011
   PICKERING TG, 1988, JAMA-J AM MED ASSOC, V259, P225, DOI 10.1001/jama.259.2.225
   Pierdomenico SD, 2011, AM J HYPERTENS, V24, P52, DOI 10.1038/ajh.2010.203
   Sega R, 2001, CIRCULATION, V104, P1385, DOI 10.1161/hc3701.096100
   Siven SSE, 2016, J HYPERTENS, V34, P54, DOI 10.1097/HJH.0000000000000750
   Tientcheu D, 2015, J AM COLL CARDIOL, V66, P2159, DOI 10.1016/j.jacc.2015.09.007
   Tocci G, 2018, J CLIN HYPERTENS, V20, P297, DOI 10.1111/jch.13181
   Vyssoulis G, 2008, BLOOD PRESS MONIT, V13, P251, DOI 10.1097/MBP.0b013e32830719c0
   Whelton PK, 2018, HYPERTENSION, V71, pE13, DOI [10.1161/HYP.0000000000000065, 10.1161/HYP.0000000000000066]
NR 42
TC 7
Z9 8
U1 2
U2 4
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JUL
PY 2018
VL 48
IS 7
BP 552
EP 564
DI 10.4070/kcj.2018.0167
PG 13
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA HB0TA
UT WOS:000450729400002
PM 29968429
OA Green Published
DA 2021-04-22
ER

PT J
AU Kim, IC
   Youn, JC
   Kobashigawa, JA
AF Kim, In-Cheol
   Youn, Jong-Chan
   Kobashigawa, Jon A.
TI The Past, Present and Future of Heart Transplantation
SO KOREAN CIRCULATION JOURNAL
LA English
DT Review
DE Heart transplantation; History; Current practice; Forecasting; Heart
   failure
ID ANTIBODY-MEDIATED REJECTION; CARDIAC ALLOGRAFT VASCULOPATHY;
   MYCOPHENOLATE-MOFETIL MMF; 2013 ACCF/AHA GUIDELINE; LUNG
   TRANSPLANTATION; INTERNATIONAL SOCIETY; INTRAVASCULAR ULTRASOUND;
   CONSENSUS CONFERENCE; WORKING FORMULATION; VS. CYCLOSPORINE
AB Heart transplantation (HTx) has become standard treatment for selected patients with end-stage heart failure. Improvements in immunosuppressant, donor procurement, surgical techniques, and post-HTx care have resulted in a substantial decrease in acute allograft rejection, which had previously significantly limited survival of HTx recipients. However, limitations to long-term allograft survival exist, including rejection, infection, coronary allograft vasculopathy, and malignancy. Careful balance of immunosuppressive therapy and vigilant surveillance for complications can further improve long-term outcomes of HTx recipients.
C1 [Kim, In-Cheol] Keimyung Univ, Dongsan Med Ctr, Div Cardiol, Daegu, South Korea.
   [Youn, Jong-Chan] Hallym Univ, Dongtan Sacred Heart Hosp, Div Cardiol, Coll Med, 7 Keunjaebong Gil, Hwaseong 18450, South Korea.
   [Kobashigawa, Jon A.] Cedars Sinai Smidt Heart Inst, Div Cardiol, 127 S San Vicente Blvd,Third Floor Cardiol A3107, Los Angeles, CA 90048 USA.
RP Youn, JC (corresponding author), Hallym Univ, Dongtan Sacred Heart Hosp, Div Cardiol, Coll Med, 7 Keunjaebong Gil, Hwaseong 18450, South Korea.; Kobashigawa, JA (corresponding author), Cedars Sinai Smidt Heart Inst, Div Cardiol, 127 S San Vicente Blvd,Third Floor Cardiol A3107, Los Angeles, CA 90048 USA.
EM Kobashigawaj@cshs.org
RI Youn, Jong-Chan/AAS-1405-2020
OI Kim, In-Cheol/0000-0002-5751-2328; Kobashigawa, Jon/0000-0001-9308-3172;
   Youn, Jong-Chan/0000-0003-0998-503X
FU Korean Society of Cardiology [201703-03]; Basic Science Research Program
   through the National Research Foundation of Korea (NRF) - Ministry of
   Science, ICT & Future Planning [NRF-2018R1C1B6005448]; Korea Health
   Technology R&D Project through the Korea Health Industry Development
   Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea
   [HI18C0575]
FX This study was supported by the fund from the Korean Society of
   Cardiology (201703-03), by Basic Science Research Program through the
   National Research Foundation of Korea (NRF) funded by the Ministry of
   Science, ICT & Future Planning (NRF-2018R1C1B6005448) and by the Korea
   Health Technology R&D Project through the Korea Health Industry
   Development Institute (KHIDI) funded by the Ministry of Health &
   Welfare, Republic of Korea (HI18C0575).
CR Andreassen AK, 2014, AM J TRANSPLANT, V14, P1828, DOI 10.1111/ajt.12809
   Ardehali A, 2015, LANCET, V385, P2577, DOI 10.1016/S0140-6736(15)60261-6
   Awad M, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.116.004070
   Bardy GH, 2005, NEW ENGL J MED, V352, P225, DOI 10.1056/NEJMoa043399
   BARNARD C N, 1967, South African Medical Journal, V41, P1271
   Beck J, 2015, TRANSPL P, V47, P2400, DOI 10.1016/j.transproceed.2015.08.035
   Berry GJ, 2013, J HEART LUNG TRANSPL, V32, P1147, DOI 10.1016/j.healun.2013.08.011
   Bestetti R, 2006, TRANSPLANTATION, V81, P692, DOI 10.1097/01.tp.0000177644.45192.a3
   Briasoulis A, 2018, HEART FAIL REV
   Butler CR, 2015, J HEART LUNG TRANSPL, V34, P643, DOI 10.1016/j.healun.2014.12.020
   Cabezon S, 2005, TRANSPLANT P, V37, P1546, DOI 10.1016/j.transproceed.2005.02.006
   Chawalit O, 1988, Rinsho Kyobu Geka, V8, P480
   Cleland JGF, 2005, NEW ENGL J MED, V352, P1539, DOI 10.1056/NEJMoa050496
   Colvin MM, 2015, CIRCULATION, V131, P1608, DOI 10.1161/CIR.0000000000000093
   Colvin-Adams M, 2012, AM J TRANSPLANT, V12, P3213, DOI 10.1111/j.1600-6143.2012.04258.x
   Costanzo MR, 2010, J HEART LUNG TRANSPL, V29, P914, DOI 10.1016/j.healun.2010.05.034
   Coutance G, 2015, J HEART LUNG TRANSPL, V34, P1050, DOI 10.1016/j.healun.2015.03.002
   Dantal J, 2005, NEW ENGL J MED, V352, P1371, DOI 10.1056/NEJMe058018
   Davies RR, 2017, J HEART LUNG TRANSPL, V36, P595, DOI 10.1016/j.healun.2017.03.010
   De Vlaminck I, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007803
   Deng MC, 2006, AM J TRANSPLANT, V6, P150, DOI 10.1111/j.1600-6143.2005.01175.x
   Dhital KK, 2015, LANCET, V385, P2585, DOI 10.1016/S0140-6736(15)60038-1
   Eisen HJ, 2013, AM J TRANSPLANT, V13, P1203, DOI 10.1111/ajt.12181
   Eisen HJ, 2003, NEW ENGL J MED, V349, P847, DOI 10.1056/NEJMoa022171
   Ekser B, 2017, CURR OPIN ORGAN TRAN, V22, P513, DOI 10.1097/MOT.0000000000000463
   Fan Y, 2009, J HEART LUNG TRANSPL, V28, P58, DOI 10.1016/j.healun.2008.10.004
   Fehr T, 2008, TRANSPL INT, V21, P1118, DOI 10.1111/j.1432-2277.2008.00783.x
   Feld JJ, 2015, NEW ENGL J MED, V373, P2599, DOI 10.1056/NEJMoa1512610
   Fukushima N, 2017, CIRC J, V81, P298, DOI 10.1253/circj.CJ-16-0976
   Goldenberg I, 2014, NEW ENGL J MED, V370, P1694, DOI 10.1056/NEJMoa1401426
   Grimm M, 2006, AM J TRANSPLANT, V6, P1387, DOI 10.1111/j.1600-6143.2006.01300.x
   Huprikar S, 2015, AM J TRANSPLANT, V15, P1162, DOI 10.1111/ajt.13187
   Jung SH, 2011, J KOREAN MED SCI, V26, P599, DOI 10.3346/jkms.2011.26.5.599
   Keogh A, 2004, CIRCULATION, V110, P2694, DOI 10.1161/01.CIR.0000136812.90177.94
   Khush KK, 2015, AM J TRANSPLANT, V15, P642, DOI 10.1111/ajt.13055
   Kim IC, 2017, KOREAN CIRC J, V47, P858, DOI 10.4070/kcj.2017.0330
   Kim IC, 2017, KOREAN CIRC J, V47, P538, DOI 10.4070/kcj.2017.0015
   Kim MS, 2017, KOREAN CIRC J, V47, P555, DOI 10.4070/kcj.2017.0009
   Kim SH, 2015, AM J TRANSPLANT, V15, P833, DOI 10.1111/ajt.13008
   Kittleson MM, 2016, HEART FAIL CLIN, V12, P411, DOI 10.1016/j.hfc.2016.03.004
   Kittleson MM, 2017, HURSTS THE HEART
   Kobashigawa J, 2017, AM J TRANSPLANT, V17, P2559, DOI 10.1111/ajt.14354
   Kobashigawa J, 2013, TRANSPL INFECT DIS, V15, P150, DOI 10.1111/tid.12007
   Kobashigawa J, 1998, TRANSPLANTATION, V66, P507, DOI 10.1097/00007890-199808270-00016
   Kobashigawa J., 2017, CLIN GUIDE HEART TRA
   Kobashigawa JA, 2015, AM J TRANSPLANT, V15, P55, DOI 10.1111/ajt.13033
   Kobashigawa JA, 2012, AM J TRANSPLANT, V12, P2875, DOI 10.1111/j.1600-6143.2012.04223.x
   Kobashigawa JA, 2006, AM J TRANSPLANT, V6, P1377, DOI 10.1111/j.1600-6143.2006.01290.x
   Kobashigawa JA, 2005, J AM COLL CARDIOL, V45, P1532, DOI 10.1016/j.jacc.2005.02.035
   KOBASHIGAWA JA, 1993, J AM COLL CARDIOL, V21, P1142, DOI 10.1016/0735-1097(93)90237-U
   KOBASHIGAWA JA, 1995, NEW ENGL J MED, V333, P621, DOI 10.1056/NEJM199509073331003
   Kobashigawa J, 2015, CIRC-HEART FAIL, V8, P557, DOI 10.1161/CIRCHEARTFAILURE.114.001658
   Kobashigawa J, 2014, J HEART LUNG TRANSPL, V33, P327, DOI 10.1016/j.healun.2014.02.027
   Kobashigawa J, 2011, J HEART LUNG TRANSPL, V30, P252, DOI 10.1016/j.healun.2010.11.003
   Kobashigawa JA, 2006, J HEART LUNG TRANSPL, V25, P935, DOI 10.1016/j.healun.2006.04.005
   Kobashigawa JA, 2013, JACC-HEART FAIL, V1, P389, DOI 10.1016/j.jchf.2013.07.002
   Kobashigawa JA, 2010, J HEART LUNG TRANSPL, V29, P504, DOI 10.1016/j.healun.2009.12.015
   Krittayaphong R, 2015, HEART FAIL CLIN, V11, P563, DOI 10.1016/j.hfc.2015.07.008
   Kuppahally S, 2006, AM J TRANSPLANT, V6, P986, DOI 10.1111/j.1600-6143.2006.01282.x
   Lee HY, 2017, KOREAN CIRC J, V47, P868, DOI 10.4070/kcj.2016.0403
   Lee HY, 2017, CIRC J, V81, P617, DOI 10.1253/circj.CJ-17-0162
   Lee KF, 2014, TRANSPL P, V46, P934, DOI 10.1016/j.transproceed.2013.11.067
   Leventhal JR, 2015, TRANSPLANTATION, V99, P288, DOI 10.1097/TP.0000000000000605
   Lo K, 2009, J HEART LUNG TRANSPL, V28, pS211, DOI 10.1016/j.healun.2008.12.017
   Lo YMD, 1998, LANCET, V351, P1329, DOI 10.1016/S0140-6736(05)79055-3
   Lund LH, 2017, J HEART LUNG TRANSPL, V36, P1037, DOI 10.1016/j.healun.2017.07.019
   Mancini D, 2003, CIRCULATION, V108, P48, DOI 10.1161/01.CIR.0000070421.38604.2B
   Mehra MR, 2016, J HEART LUNG TRANSPL, V35, P1, DOI 10.1016/j.healun.2015.10.023
   Meyer DM, 2015, AM J TRANSPLANT, V15, P44, DOI 10.1111/ajt.13030
   Murthy R, 2016, ANN THORAC SURG, V101, P1605, DOI 10.1016/j.athoracsur.2015.10.017
   Ng AKY, 2016, INT J CARDIOL, V220, P787, DOI 10.1016/j.ijcard.2016.06.319
   Nwakanma LU, 2007, ANN THORAC SURG, V84, P1556, DOI 10.1016/j.athoracsur.2007.05.095
   OPELZ G, 1993, LANCET, V342, P1514, DOI 10.1016/S0140-6736(05)80084-4
   Pham MX, 2010, NEW ENGL J MED, V362, P1890, DOI 10.1056/NEJMoa0912965
   Ponikowski P, 2016, EUR HEART J, V37, P2129, DOI 10.1093/eurheartj/ehw128
   REITZ BA, 1981, TRANSPLANT P, V13, P393
   Russo MJ, 2007, J THORAC CARDIOV SUR, V133, P554, DOI 10.1016/j.jtcvs.2006.09.019
   Russo MJ, 2010, TRANSPLANTATION, V90, P444, DOI 10.1097/TP.0b013e3181e6f1eb
   Salgo R, 2010, AM J TRANSPLANT, V10, P1385, DOI 10.1111/j.1600-6143.2009.02997.x
   Schaffer SA, 2011, AM J TRANSPLANT, V11, P2751, DOI 10.1111/j.1600-6143.2011.03743.x
   Shin HS, 2014, ANN TRANSPL, V19, P1, DOI 10.12659/AOT.889680
   Smits JM, 2013, J HEART LUNG TRANSPL, V32, P873, DOI 10.1016/j.healun.2013.03.015
   Stallone G, 2005, NEW ENGL J MED, V352, P1317, DOI 10.1056/NEJMoa042831
   Stehlik J, 2018, CIRCULATION, V137, P71, DOI 10.1161/CIRCULATIONAHA.117.029753
   Stewart S, 2005, J HEART LUNG TRANSPL, V24, P1710, DOI 10.1016/j.healun.2005.03.019
   SWINNEN LJ, 1990, NEW ENGL J MED, V323, P1723, DOI 10.1056/NEJM199012203232502
   Tambur AR, 2005, TRANSPLANTATION, V80, P1019, DOI 10.1097/01.tp.0000180564.14050.49
   Taylor AJ, 2010, EUR J HEART FAIL, V12, P45, DOI 10.1093/eurjhf/hfp174
   Taylor DO, 1999, J HEART LUNG TRANSPL, V18, P336, DOI 10.1016/S1053-2498(98)00060-6
   Velazquez EJ, 2016, NEW ENGL J MED, V374, P1511, DOI 10.1056/NEJMoa1602001
   Wang SS, 1996, TRANSPLANT P, V28, P1733
   Weber BN, 2017, JACC-HEART FAIL, V5, P869, DOI 10.1016/j.jchf.2017.10.009
   Williams K, 2014, CLIN INFECT DIS, V58, P997, DOI 10.1093/cid/cit940
   Yancy CW, 2017, J AM COLL CARDIOL, V70, P776, DOI 10.1016/j.jacc.2017.04.025
   Yancy CW, 2013, J AM COLL CARDIOL, V62, pE147, DOI 10.1016/j.jacc.2013.05.019
   Youn JC, 2018, J AM COLL CARDIOL, V71, P40, DOI 10.1016/j.jacc.2017.10.077
   Youn JC, 2017, KOREAN CIRC J, V47, P16, DOI 10.4070/kcj.2016.0429
   Youn JC, 2013, HEART, V99, P1304, DOI 10.1136/heartjnl-2013-303983
   Zaroff Jonathan G., 2002, Circulation, V106, P836, DOI 10.1161/01.CIR.0000025587.40373.75
NR 99
TC 25
Z9 26
U1 0
U2 4
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JUL
PY 2018
VL 48
IS 7
BP 565
EP 590
DI 10.4070/kcj.2018.0189
PG 26
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA HB0TA
UT WOS:000450729400003
PM 29968430
OA Green Published
DA 2021-04-22
ER

PT J
AU Choo, EH
   Han, EJ
   Kim, CJ
   Kim, SN
   Joo-Hyun, O
   Chang, K
   Seung, KB
AF Choo, Eun Ho
   Han, Eun-Ji
   Kim, Chan Joon
   Kim, Sung-Noon
   Joo-Hyun, O.
   Chang, Kiyuk
   Seung, Ki-Bae
TI Effect of Pioglitazone in Combination with Moderate Dose Statin on
   Atherosclerotic Inflammation: Randomized Controlled Clinical Trial Using
   Serial FDG-PET/CT
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Atherosclerosis; Positron emission tomography computed tomography;
   Carotid stenosis; PPAR gamma; Hydroxymethylglutaryl-CoA reductase
   inhibitors
ID MYOCARDIAL-INFARCTION; SECONDARY PREVENTION; IN-VIVO; RISK;
   ATORVASTATIN; PLAQUE; THERAPY; EVENTS
AB Background and Objectives: Non-statin therapy plus lower intensity statin might be an alternative in patients with coronary artery disease (CAD). A recent data suggested an anti-inflammatory therapy can reduce recurrent cardiovascular events and pioglitazone is also an intriguing inflammatory-modulating agent. However, limited data exist on whether pioglitazone on top of statins further attenuates plaque inflammation.
   Methods: Statin-naive patients with stable CAD and carotid plaques of >= 3 mm were randomly prescribed moderate dose atorvastatin (20 mg/day), or moderate dose atorvastatin plus pioglitazone (30 mg/day) for 3 months. The primary endpoint was the change in the arterial inflammation of the carotid artery measured by F-18-fluorodeoxyglucose positron emission tomography/computed tomography F-18-FUG-PET/CT) during 3 months.
   Results: Of the 41 randomized patients, 33 underwent an evaluation by fluorodeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT; 17 atorvastatin plus pioglitazone and 16 atorvastatin patients). The addition of pioglitazone significantly improved the insulin sensitivity and increased the high-density lipoprotein cholesterol after 3 months. Although a reduction in the (FDG) uptake by pioglitazone on top ofatorvastatin in carotid arteries with plaque showed marginally statistical significance in the entire patient group (atorvastatin plus pioglitazone; -0.10 +/- 0.07 and atorvastatin -0.06 +/- 0.04, p=0.058), pioglitazone showed a further reduction of the fluorodeoxyglucose (FDG) uptake among patients who had a baseline FUG uptake above the median (atorvastatin plus pioglitazone; -0.14 +/- 0.04 and atorvastatin -0.03 +/- 0.03, p<0.001).
   Conclusions: Pioglitazone demonstrated marginally significant anti-inflammatory effects in addition to moderate dose atorvastatin. This may have been due to the lack of power of the study. However, pioglitazone may have an anti-inflammatory effect in those patients with high plaque inflammation.
C1 [Choo, Eun Ho; Kim, Chan Joon; Seung, Ki-Bae] Catholic Univ Korea, Dept Cardiol, Coll Med, 222 Banpo Daero, Seoul 06951, South Korea.
   [Han, Eun-Ji; Kim, Sung-Noon; Joo-Hyun, O.; Chang, Kiyuk] Catholic Univ Korea, Dept Radiol, Coll Med, Seoul, South Korea.
RP Seung, KB (corresponding author), Catholic Univ Korea, Dept Cardiol, Coll Med, 222 Banpo Daero, Seoul 06951, South Korea.
EM kbseung@catholic.ac.kr
OI HAN, EUN JI/0000-0002-9041-9977; Kim, Chan Joon/0000-0003-2929-8325;
   kim, sunghoon/0000-0002-1570-3230
FU Korean Health Technology RAMP;D Project, Ministry of Health, Welfare
   Family Affairs; Republic of Korea [A070001]
FX This study was supported by a grant of the Korean Health Technology R&D
   Project, Ministry of Health, Welfare & Family Affairs, and the Republic
   of Korea (A070001).
CR Arnold SV, 2014, CIRCULATION, V129, P1303, DOI 10.1161/CIRCULATIONAHA.113.003589
   Catapano AL, 2016, EUR HEART J, V37, P2999, DOI 10.1093/eurheartj/ehw272
   Chang K, 2010, ARTERIOSCL THROM VAS, V30, P1933, DOI 10.1161/ATVBAHA.110.206342
   Cocker MS, 2012, J NUCL CARDIOL, V19, P1211, DOI 10.1007/s12350-012-9631-9
   Dormandy JA, 2005, LANCET, V366, P1279, DOI 10.1016/S0140-6736(05)67528-9
   Erdmann E, 2007, J AM COLL CARDIOL, V49, P1772, DOI 10.1016/j.jacc.2006.12.048
   Fayad ZA, 2011, LANCET, V378, P1547, DOI 10.1016/S0140-6736(11)61383-4
   Forst T, 2008, DIABETES VASC DIS RE, V5, P298, DOI 10.3132/dvdr.2008.043
   Hanefeld M, 2007, J AM COLL CARDIOL, V49, P290, DOI 10.1016/j.jacc.2006.08.054
   Hwang BH, 2011, KOREAN CIRC J, V41, P497, DOI 10.4070/kcj.2011.41.9.497
   Kernan WN, 2016, NEW ENGL J MED, V374, P1321, DOI 10.1056/NEJMoa1506930
   Koh KK, 2017, KOREAN CIRC J, V47, P432, DOI 10.4070/kcj.2016.0406
   LaRosa JC, 2005, NEW ENGL J MED, V352, P1425, DOI 10.1056/NEJMoa050461
   Li AC, 2000, J CLIN INVEST, V106, P523, DOI 10.1172/JCI10370
   Lincoff AM, 2007, JAMA-J AM MED ASSOC, V298, P1180, DOI 10.1001/jama.298.10.1180
   Lloyd-Jones DM, 2016, J AM COLL CARDIOL, V68, P92, DOI 10.1016/j.jacc.2016.03.519
   Mazzone T, 2006, JAMA-J AM MED ASSOC, V296, P2572, DOI 10.1001/jama.296.21.joc60158
   Mizoguchi M, 2011, JACC-CARDIOVASC IMAG, V4, P1110, DOI 10.1016/j.jcmg.2011.08.007
   Pedersen TR, 2005, JAMA-J AM MED ASSOC, V294, P2437, DOI 10.1001/jama.294.19.2437
   Preiss D, 2011, JAMA-J AM MED ASSOC, V305, P2556, DOI 10.1001/jama.2011.860
   Pucci A, 2011, ATHEROSCLEROSIS, V218, P479, DOI 10.1016/j.atherosclerosis.2011.06.009
   Ridker PM, 2017, NEW ENGL J MED, V377, P1119, DOI 10.1056/NEJMoa1707914
   Ridker PM, 2014, EUR HEART J, V35, P1782, DOI 10.1093/eurheartj/ehu203
   Rudd JHF, 2009, CIRC-CARDIOVASC IMAG, V2, P107, DOI 10.1161/CIRCIMAGING.108.811752
   Saremi A, 2013, ARTERIOSCL THROM VAS, V33, P393, DOI 10.1161/ATVBAHA.112.300346
   Tawakol A, 2013, J AM COLL CARDIOL, V62, P909, DOI 10.1016/j.jacc.2013.04.066
   Thorp E, 2007, CIRCULATION, V116, P2182, DOI 10.1161/CIRCULATIONAHA.107.698852
   van der Valk FM, 2016, JACC-CARDIOVASC IMAG, V9, P1198, DOI 10.1016/j.jcmg.2016.04.007
NR 28
TC 4
Z9 4
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JUL
PY 2018
VL 48
IS 7
BP 591
EP 601
DI 10.4070/kcj.2017.0029
PG 11
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA HB0TA
UT WOS:000450729400004
PM 29968431
OA Green Published
DA 2021-04-22
ER

PT J
AU Lee, CJ
   Kim, JY
   Shim, E
   Hong, SH
   Lee, M
   Jeon, JY
   Park, S
AF Lee, Chan Joo
   Kim, Ji Young
   Shim, Eugene
   Hong, Sung Hyun
   Lee, Mikyung
   Jeon, Justin Y.
   Park, Sungha
TI The Effects of Diet Alone or in Combination with Exercise in Patients
   with Prehypertension and Hypertension: a Randomized Controlled Trial
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Diet; Exercise; Hypertension; Lifestyle; Prehypertension
ID BLOOD-PRESSURE CONTROL; PHYSICAL-ACTIVITY; CARDIOVASCULAR RISK; STOP
   HYPERTENSION; PRACTICE GUIDELINES; ARTERIAL STIFFNESS; WAVE REFLECTIONS;
   INTERVENTION; ADULTS; MECHANISMS
AB Background and Objectives: Supervised lifestyle interventions, including dietary and exercise programs, may be infeasible to implement in real-world settings. Therefore, this study aimed to evaluate the effectiveness of a home-based lifestyle modification intervention on blood pressure (BP) management.
   Methods: Eighty-five patients aged over 20 years and diagnosed with prehypertension or mild hypertension were randomly assigned to an advice-only comparison group (C group, n=28), a Dietary Approaches to Stop Hypertension (DASH) diet education group (D group, n=30), or a DASH and home-based exercise group (D+Ex group, n=27). The intervention lasted for 8 weeks. The primary outcome was the difference in office systolic blood pressure (SBP) before and after the study period (Trial registry at ClinicalTrials.gov , NCT01637909).
   Results: Seventy-two participants (87.8%) completed the trial. The degree of change in office SBP did not significantly differ among the intervention groups; however, the D+Ex group demonstrated a tendency toward decreased SBP. Upon analysis of 24-hour ambulatory BP measurements, daytime ambulatory SBP was significantly lower in the D+Ex group (134 mmHg; 95% confidence interval (CI], 131 to 137; p=0.011) than in the C group (139.5 mmHg; 95% CI, 130.9 to 137), and daytime ambulatory SBP was significantly decreased in the D+Ex group (-5.2 mmHg; 95% CI, -8.3 to 2.1; p=0.011) compared to the C group (0.4 mmHg, 95% CI, -2.5 to 3.3).
   Conclusions: In conclusion, lifestyle modification emphasizing both diet and exercise was effective for lowering BP and should be favored over diet-only modifications.
C1 [Lee, Chan Joo] Severance Hosp, Dept Hlth Promot, Seoul, South Korea.
   [Kim, Ji Young; Hong, Sung Hyun; Lee, Mikyung; Jeon, Justin Y.] Yonsei Univ, Dept Sport Ind Studies, Coll Educ, 50-1 Yonsei Ro, Seoul 03722, South Korea.
   [Kim, Ji Young; Hong, Sung Hyun; Lee, Mikyung; Jeon, Justin Y.] Yonsei Univ, Exercise Med Ctr Diabet & Canc Patients, Coll Educ, Seoul, South Korea.
   [Kim, Ji Young; Lee, Mikyung; Jeon, Justin Y.] Yonsei Univ, Canc Prevent Ctr, Yonsei Canc Ctr, Coll Med, Seoul, South Korea.
   [Shim, Eugene] Soongeui Womens Coll, Dept Food & Nutr, Seoul, South Korea.
   [Park, Sungha] Yonsei Univ, Dept Internal Med, Div Cardiol, Coll Med, Seoul, South Korea.
   [Park, Sungha] Yonsei Univ Hlth Syst, Cardiovasc Res Inst, Seoul, South Korea.
   [Park, Sungha] Yonsei Univ Hlth Syst, Cardiovasc Genome Ctr, Seoul, South Korea.
RP Jeon, JY (corresponding author), Yonsei Univ, Dept Sport Ind Studies, Coll Educ, 50-1 Yonsei Ro, Seoul 03722, South Korea.; Park, S (corresponding author), Yonsei Univ, Coll Med, Dept Internal Med, Severance Cardiovasc Hosp, 50-1 Yonsei Ro, Seoul 03722, South Korea.
EM jjeon@yonsei.ac.kr; shpark0530@yuhs.ac
OI Lee, Chan Joo/0000-0002-8756-409X; Park, Sungha/0000-0001-5362-478X;
   Jeon, Justin/0000-0001-7978-4271; EUGENE, SHIM/0000-0001-9930-6349
FU Korean Health Technology R&D Project, Ministry of Health and Welfare,
   Republic of Korea [HI13C0715]; Sanofi-Aventis Korea Company
   [4-2011-0305]
FX This work was supported by a grant from the Korean Health Technology R&D
   Project, Ministry of Health and Welfare, Republic of Korea (HI13C0715)
   and by a research grant from Sanofi-Aventis Korea Company (4-2011-0305).
CR Artinian NT, 2010, CIRCULATION, V122, P406, DOI 10.1161/CIR.0b013e3181e8edf1
   Bassett DR, 2002, PREV MED, V34, P179, DOI 10.1006/pmed.2001.0969
   Cornelissen VA, 2005, HYPERTENSION, V46, P667, DOI 10.1161/01.HYP.0000184225.05629.51
   Couch SC, 2008, J PEDIATR-US, V152, P494, DOI 10.1016/j.jpeds.2007.09.022
   Eckel RH, 2014, CIRCULATION, V129, pS76, DOI 10.1161/01.cir.0000437740.48606.d1
   Elmer PJ, 2006, ANN INTERN MED, V144, P485, DOI 10.7326/0003-4819-144-7-200604040-00007
   Friedberg JP, 2015, HYPERTENSION, V65, P440, DOI 10.1161/HYPERTENSIONAHA.114.03483
   Funk KL, 2008, HEALTH PROMOT PRACT, V9, P271, DOI 10.1177/1524839906289035
   Guagnano MT, 2001, INT J OBESITY, V25, P1360, DOI 10.1038/sj.ijo.0801722
   Kabaroff JL, 2013, WORK, V44, P423, DOI 10.3233/WOR-2012-1379
   Kim H, 2013, J CARDIOVASC NURS, V28, P514, DOI 10.1097/JCN.0b013e318262c0c1
   Kwan MWM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078412
   Mancia G, 2013, J HYPERTENS, V31, P1925, DOI 10.1097/HJH.0b013e328364ca4c
   Mancia G, 2013, J HYPERTENS, V31, P1281, DOI 10.1097/01.hjh.0000431740.32696.cc
   Millar PJ, 2014, SPORTS MED, V44, P345, DOI 10.1007/s40279-013-0118-x
   Moore TJ, 2001, HYPERTENSION, V38, P155, DOI 10.1161/01.HYP.38.2.155
   Nothwehr F, 2007, HEALTH EDUC RES, V22, P532, DOI 10.1093/her/cyl117
   Parikh A, 2009, AM J HYPERTENS, V22, P409, DOI 10.1038/ajh.2009.10
   Petrella RJ, 2010, CAN FAM PHYSICIAN, V56, pE191
   Sacks FM, 2001, NEW ENGL J MED, V344, P3, DOI 10.1056/NEJM200101043440101
   Sharman JE, 2015, AM J HYPERTENS, V28, P147, DOI 10.1093/ajh/hpu191
   Shilts MK, 2004, AM J HEALTH PROMOT, V19, P81, DOI 10.4278/0890-1171-19.2.81
   Son SookMee, 2007, Korean Journal of Community Nutrition, V12, P838
   Son SookMee, 2007, Korean Journal of Community Nutrition, V12, P545
   Weber MA, 2014, J HYPERTENS, V32, P3, DOI 10.1097/HJH.0000000000000065
   Weber T, 2004, CIRCULATION, V109, P184, DOI 10.1161/01.CIR.0000105767.94169.E3
   Weber T, 2008, AM J HYPERTENS, V21, P1194, DOI 10.1038/ajh.2008.277
   Whelton SP, 2002, ANN INTERN MED, V136, P493, DOI 10.7326/0003-4819-136-7-200204020-00006
   World Health Organization, 2008, WAIST CIRCUMFERENCE
NR 29
TC 11
Z9 12
U1 2
U2 13
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JUL
PY 2018
VL 48
IS 7
BP 637
EP 651
DI 10.4070/kcj.2017.0349
PG 15
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA HB0TA
UT WOS:000450729400010
PM 29968437
OA Green Published
DA 2021-04-22
ER

PT J
AU Morrone, D
   Morrone, V
AF Morrone, Doralisa
   Morrone, Vincenzo
TI Acute Pulmonary Embolism Focus on the Clinical Picture (vol 48, pg 365,
   2018)
SO KOREAN CIRCULATION JOURNAL
LA English
DT Correction
C1 [Morrone, Doralisa] Univ Pisa, Dept Surg Med Mol & Crit Area Pathol, Pisa, Italy.
   [Morrone, Vincenzo] SS Annunziata Hosp, Dept Cardiol, Taranto, Italy.
RP Morrone, D (corresponding author), Univ Pisa, Dept Surg Med Mol & Crit Area Pathol, Pisa, Italy.
RI Morrone, Doralisa/AAB-2223-2019
OI Morrone, Doralisa/0000-0002-9667-6931
CR Morrone D, 2018, KOREAN CIRC J, V48, P365, DOI 10.4070/kcj.2017.0314
NR 1
TC 2
Z9 2
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JUL
PY 2018
VL 48
IS 7
BP 661
EP 663
DI 10.4070/kcj.2017.0998
PG 3
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA HB0TA
UT WOS:000450729400014
PM 29968441
OA Green Published
DA 2021-04-22
ER

PT J
AU Lee, JY
   Cha, BS
AF Lee, Ji-Yeon
   Cha, Bong-Soo
TI Effects of Combination Therapy of Statin and Thiazolidinedione on
   Vascular Inflammation
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
ID PIOGLITAZONE; PRAVASTATIN; MECHANISMS
C1 [Lee, Ji-Yeon; Cha, Bong-Soo] Yonsei Univ, Coll Med, Dept Internal Med, Div Endocrinol & Metab, 50-1 Yonsei Ro, Seoul 03722, South Korea.
RP Cha, BS (corresponding author), Yonsei Univ, Coll Med, Dept Internal Med, Div Endocrinol & Metab, 50-1 Yonsei Ro, Seoul 03722, South Korea.
EM bscha@yuhs.ac
OI Cha, Bong-Soo/0000-0003-0542-2854; Lee, Ji-Yeon/0000-0001-7057-9044
CR Antonopoulos AS, 2012, CURR PHARM DESIGN, V18, P1519
   Choo EH, 2018, KOREAN CIRC J, V48, P591, DOI 10.4070/kcj.2017.0029
   Erdmann E, 2010, QJM-INT J MED, V103, P213, DOI 10.1093/qjmed/hcp168
   Hanefeld M, 2007, J AM COLL CARDIOL, V49, P290, DOI 10.1016/j.jacc.2006.08.054
   Lawal I, 2016, BRIT MED BULL, V120, P55, DOI 10.1093/bmb/ldw035
   Lazich I, 2012, DIABETES OBES METAB, V14, P181, DOI 10.1111/j.1463-1326.2011.01510.x
   Nissen SE, 2008, JAMA-J AM MED ASSOC, V299, P1561, DOI 10.1001/jama.299.13.1561
   Sacks FM, 1996, NEW ENGL J MED, V335, P1001, DOI 10.1056/NEJM199610033351401
   SHEPHERD J, 1995, NEW ENGL J MED, V333, P1301, DOI 10.1056/NEJM199511163332001
   THIAZOLIDINEDIO.YJ, 2004, NEW ENGL J MED, V351, P1106
NR 10
TC 1
Z9 1
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JUL
PY 2018
VL 48
IS 7
BP 602
EP 604
DI 10.4070/kcj.2018.0120
PG 3
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA HB0TA
UT WOS:000450729400005
PM 29968432
OA Green Published
DA 2021-04-22
ER

PT J
AU Yu, HT
   Pak, HN
AF Yu, Hee Tae
   Pak, Hui-Nam
TI Gender Difference in Catheter Ablation: Atrial Fibrillations from Mars
   and Venus?
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
ID SEX-DIFFERENCES; TRENDS
C1 [Yu, Hee Tae; Pak, Hui-Nam] Yonsei Univ Hlth Syst, Div Cardiol, Dept Internal Med, Seoul, South Korea.
RP Pak, HN (corresponding author), Yonsei Univ Hlth Syst, 50-1 Yonsei Ro, Seoul 03722, South Korea.
EM hnpak@yuhs.ac
RI Pak, Hui-Nam/C-4266-2015
OI Pak, Hui-Nam/0000-0002-3256-3620
CR Emdin CA, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.h7013
   Kim D, 2018, EUROPACE, V20, pi232
   Lee H, 2017, KOREAN CIRC J, V47, P56, DOI 10.4070/kcj.2016.0045
   Lee JS, 2013, CIRC J, V77, P697, DOI 10.1253/circj.CJ-12-1009
   Michowitz Y, 2014, CIRC-ARRHYTHMIA ELEC, V7, P274, DOI 10.1161/CIRCEP.113.000760
   Roh SY, 2018, KOREAN CIRC J, V48, P605, DOI 10.4070/kcj.2017.0327
   Shim CY, 2011, J AM COLL CARDIOL, V57, P1226, DOI 10.1016/j.jacc.2010.09.067
   Tsadok MA, 2015, HEART RHYTHM, V12, P1979, DOI [10.1016/j.hrthm.20l5.06.029, 10.1016/j.hrthm.2015.06.029]
   Yu HT, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.116.003361
   Yu HT, 2017, EUR HEART J, V38, P2668
NR 10
TC 0
Z9 0
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JUL
PY 2018
VL 48
IS 7
BP 619
EP 621
DI 10.4070/kcj.2018.0094
PG 3
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA HB0TA
UT WOS:000450729400007
PM 29968434
OA Green Published
DA 2021-04-22
ER

PT J
AU Yang, PS
   Joung, B
AF Yang, Pil-Sung
   Joung, Boyoung
TI Regional and Socioeconomic Inequality of Atrial Fibrillation with
   Regular Hospital Visit
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
ID ASIAN PATIENTS; PREVALENCE; MORTALITY; OLDER
C1 [Yang, Pil-Sung] CHA Univ, Dept Cardiol, CHA Bundang Med Ctr, Seongnam, South Korea.
   [Joung, Boyoung] Yonsei Univ Hlth Syst, Div Cardiol, Dept Internal Med, 50-1 Yonsei Ro, Seoul 03722, South Korea.
RP Joung, B (corresponding author), Yonsei Univ Hlth Syst, Div Cardiol, Dept Internal Med, 50-1 Yonsei Ro, Seoul 03722, South Korea.
EM cby6908@yuhs.ac
OI Joung, Boyoung/0000-0001-9036-7225; Yang, Pil-sung/0000-0002-6552-1742
FU Korean Healthcare Technology R&D project - Ministry of Health Welfare
   [HI15C1200]
FX This study was supported by a research grant from the Korean Healthcare
   Technology R&D project funded by the Ministry of Health & Welfare
   (HI15C1200).
CR Chao TF, 2018, CHEST, V153, P453, DOI 10.1016/j.chest.2017.10.001
   Iguchi Y, 2008, CIRC J, V72, P909, DOI 10.1253/circj.72.909
   Kim D, 2018, HEART
   Kim H, 2017, KOREAN CIRC J, V47, P877, DOI 10.4070/kcj.2017.0146
   Kim TH, 2017, STROKE, V48, P1524, DOI 10.1161/STROKEAHA.117.016926
   Lee H, 2017, KOREAN CIRC J, V47, P56, DOI 10.4070/kcj.2016.0045
   Lee SR, 2018, KOREAN CIRC J, V48, P622, DOI 10.4070/kcj.2017.0362
   Li CH, 2016, SCI REP-UK, V6, DOI 10.1038/srep30734
   Yap KB, 2008, J ELECTROCARDIOL, V41, P94, DOI 10.1016/j.jelectrocard.2007.03.012
NR 9
TC 1
Z9 1
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JUL
PY 2018
VL 48
IS 7
BP 635
EP 636
DI 10.4070/kcj.2018.0116
PG 2
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA HB0TA
UT WOS:000450729400009
PM 29968436
OA Green Published
DA 2021-04-22
ER

PT J
AU Pyun, WB
AF Pyun, Wook Bum
TI Lifestyle Modification, the Effective but Neglected Strategy in Lowering
   Blood Pressure
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
ID HYPERTENSION; ADULTS
C1 [Pyun, Wook Bum] Ewha Womans Univ, Div Cardiol, Dept Internal Med, 1071 Anyangcheon Ro, Seoul 07985, South Korea.
RP Pyun, WB (corresponding author), Ewha Womans Univ, Div Cardiol, Dept Internal Med, 1071 Anyangcheon Ro, Seoul 07985, South Korea.
EM pwb423@ewha.ac.kr
OI Pyun, Wook Bum/0000-0002-6377-0411
CR Cornelissen VA, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.112.004473
   Kim H, 2013, J CARDIOVASC NURS, V28, P514, DOI 10.1097/JCN.0b013e318262c0c1
   Kim HJ, 2016, KOREAN CIRC J, V46, P384, DOI 10.4070/kcj.2016.46.3.384
   Lee CJ, 2018, KOREAN CIRC J, V48, P637, DOI 10.4070/kcj.2017.0349
   Noh J, 2016, KOREAN CIRC J, V46, P672, DOI 10.4070/kcj.2016.46.5.672
   Schwingshackl L, 2018, CRIT REV FOOD SCI NU
   Tajeu GS, 2017, CIRCULATION, V136, P798, DOI 10.1161/CIRCULATIONAHA.117.027362
   Whelton PK, 2018, J AM COLL CARDIOL, V71, P2275, DOI 10.1016/j.jacc.2018.03.016
   Yang MH, 2017, KOREAN J FAM MED, V38, P173, DOI 10.4082/kjfm.2017.38.4.173
NR 9
TC 1
Z9 1
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JUL
PY 2018
VL 48
IS 7
BP 652
EP 654
DI 10.4070/kcj.2018.0194
PG 3
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA HB0TA
UT WOS:000450729400011
PM 29968438
OA Green Published
DA 2021-04-22
ER

PT J
AU Gulel, O
   Camlidag, I
   Elmali, M
AF Gulel, Okan
   Camlidag, Ilkay
   Elmali, Muzaffer
TI Successful Medical Management of a Rare Loeffler Endocarditis Case
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
C1 [Gulel, Okan] Ondokuz Mayis Univ, Dept Cardiol, Fac Med, TR-55139 Samsun, Turkey.
   [Camlidag, Ilkay; Elmali, Muzaffer] Ondokuz Mayis Univ, Dept Radiol, Fac Med, Samsun, Turkey.
RP Gulel, O (corresponding author), Ondokuz Mayis Univ, Dept Cardiol, Fac Med, TR-55139 Samsun, Turkey.
EM okangulel@hotmail.com
RI Camlidag, Ilkay/H-9836-2019
OI Camlidag, Ilkay/0000-0001-6151-1312
CR Podjasek JC, 2013, LEUKEMIA RES, V37, P392, DOI 10.1016/j.leukres.2012.12.016
   Priglinger U, 2002, LEUKEMIA LYMPHOMA, V43, P215, DOI 10.1080/10428190210184
   Valent P, 2012, J ALLERGY CLIN IMMUN, V130, P607, DOI 10.1016/j.jaci.2012.02.019
NR 3
TC 1
Z9 1
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JUL
PY 2018
VL 48
IS 7
BP 655
EP 657
DI 10.4070/kcj.2017.0348
PG 3
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA HB0TA
UT WOS:000450729400012
PM 29968439
OA Green Published
DA 2021-04-22
ER

PT J
AU Lee, JY
   Lee, PH
   Lee, SW
   Lee, WJ
   Kang, JW
   Shin, MJ
AF Lee, Joo Yeon
   Lee, Pil Hyung
   Lee, Seung-Whan
   Lee, Woo Je
   Kang, Joon-Won
   Shin, Myung Jin
TI Assessment of Tissue Perfusion with Blood Oxygenation Level-Dependent
   Magnetic Resonance Imaging in Critical Limb Ischemia
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
C1 [Lee, Joo Yeon; Kang, Joon-Won; Shin, Myung Jin] Univ Ulsan, Asan Med Ctr, Coll Med, Dept Radiol, Seoul, South Korea.
   [Lee, Joo Yeon; Kang, Joon-Won; Shin, Myung Jin] Univ Ulsan, Asan Med Ctr, Coll Med, Res Inst Radiol, Seoul, South Korea.
   [Lee, Pil Hyung; Lee, Seung-Whan] Univ Ulsan, Div Cardiol, Dept Internal Med, Asan Med Ctr,Coll Med, 88,Olymp Ro 43 Gil, Seoul 05505, South Korea.
   [Lee, Woo Je] Univ Ulsan, Div Endocrinol, Dept Internal Med, Asan Med Ctr,Coll Med, Seoul, South Korea.
RP Lee, PH (corresponding author), Univ Ulsan, Div Cardiol, Dept Internal Med, Asan Med Ctr,Coll Med, 88,Olymp Ro 43 Gil, Seoul 05505, South Korea.
EM pilmo11@hanmail.net
OI Kang, Joon-Won/0000-0001-6478-0390; LEE, WOO JE/0000-0002-9605-9693
FU Korean Cardiac Research Foundation [201702-01]
FX This work was supported by the Korean Cardiac Research Foundation
   (201702-01).
CR Bajwa A, 2016, J AM COLL CARDIOL, V67, P420, DOI 10.1016/j.jacc.2015.10.085
   Bajwa A, 2014, CIRC-CARDIOVASC IMAG, V7, P836, DOI 10.1161/CIRCIMAGING.114.002123
   Ledermann HP, 2006, RADIOLOGY, V241, P477, DOI 10.1148/radiol.2412050701
   Stacy MR, 2016, EUR J VASC ENDOVASC, V51, P743, DOI 10.1016/j.ejvs.2016.02.008
NR 4
TC 0
Z9 0
U1 0
U2 2
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JUL
PY 2018
VL 48
IS 7
BP 658
EP 660
DI 10.4070/kcj.2018.0019
PG 3
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA HB0TA
UT WOS:000450729400013
PM 29968440
OA Green Published
DA 2021-04-22
ER

PT J
AU Cerlinskaite, K
   Javanainen, T
   Cinotti, R
   Mebazaa, A
AF Cerlinskaite, Kamile
   Javanainen, Tuija
   Cinotti, Raphael
   Mebazaa, Alexandre
CA Global Res Acute Conditions Team
TI Acute Heart Failure Management
SO KOREAN CIRCULATION JOURNAL
LA English
DT Review
DE Heart failure; Cardiogenic shock; Management; Treatment
ID CARDIOGENIC PULMONARY-EDEMA; ACUTE MYOCARDIAL-INFARCTION; 2016 ESC
   GUIDELINES; EUROPEAN-SOCIETY; TASK-FORCE; CONTEMPORARY MANAGEMENT;
   NATRIURETIC PEPTIDE; CARDIAC TROPONIN; CLINICAL PROFILE; OUTCOMES
AB Acute heart failure (AHF) is a life-threatening medical condition, where urgent diagnostic and treatment methods are of key importance. However, there are few evidence-based treatment methods. Interestingly, despite relatively similar ways of management of AHF throughout the globe, mid-term outcome in East Asia, including South Korea is more favorable than in Europe. Yet, most of the treatment methods are symptomatic. The cornerstone of AHF management is identifying precipitating factors and specific phenotype. Multidisciplinary approach is important in AHF, which can be caused or aggravated by both cardiac and non-cardiac causes. The main pathophysiological mechanism in AHF is congestion, both systemic and inside the organs (lung, kidney, or liver). Cardiac output is often preserved in AHF except in a few cases of advanced heart failure. This paper provides guidance on AHF management in a time-based approach. Treatment strategies, criteria for triage, admission to hospital and discharge are described.
C1 [Cerlinskaite, Kamile; Javanainen, Tuija; Cinotti, Raphael; Mebazaa, Alexandre] Hop Lariboisiere, Dept Anesthesiol & Reanimat, Paris, France.
   [Cerlinskaite, Kamile; Javanainen, Tuija; Cinotti, Raphael; Mebazaa, Alexandre] Hop Univ St Louis Lariboisiere, AP HP, Dept Anesthesiol & Crit Care, 2 Rue Ambroise Pare, F-75010 Paris, France.
   [Cerlinskaite, Kamile] Vilnius Univ, Inst Clin Med, Clin Cardiac & Vasc Dis, Fac Med, Vilnius, Lithuania.
   [Javanainen, Tuija] Univ Helsinki, Helsinki Univ Hosp, Dept Cardiol, Heart & Lung Ctr, Helsinki, Finland.
   [Cinotti, Raphael] Univ Hosp Nantes, Dept Anesthesia & Crit Care, Nantes, France.
   [Mebazaa, Alexandre] Univ Paris Diderot, Paris, France.
RP Mebazaa, A (corresponding author), Hop Univ St Louis Lariboisiere, AP HP, Dept Anesthesiol & Crit Care, 2 Rue Ambroise Pare, F-75010 Paris, France.
EM alexandre.mebazaa@aphp.fr
OI Cerlinskaite, Kamile/0000-0002-6753-9356
FU BMSBristol-Myers Squibb; Adrenomed; Neurotronik; RocheRoche Holding;
   Sanofi; Sphyngotec
FX Alexandre Mebazaa (AM) received speaker's honoraria from Abbott, Orion,
   Roche et Servier. AM received fee as member of advisory board and/or
   Steering Committee and/or research grant from BMS, Adrenomed,
   Neurotronik, Roche, Sanofi, and Sphyngotec.
CR Akiyama E, 2018, EUR J HEART FAIL
   Al Deeb M, 2014, ACAD EMERG MED, V21, P843, DOI 10.1111/acem.12435
   Arrigo M, 2016, ESC HEART FAIL, V3, P115, DOI 10.1002/ehf2.12083
   Arrigo M, 2015, INTENS CARE MED, V41, P912, DOI 10.1007/s00134-015-3659-7
   Branson RD, 2013, RESP CARE, V58, P86, DOI 10.4187/respcare.02251
   Brignole M, 2013, EUROPACE, V15, P1070, DOI 10.1093/europace/eut206
   CHAKKO S, 1991, AM J MED, V90, P353, DOI 10.1016/0002-9343(91)90576-J
   Collins SP, 2006, ANN EMERG MED, V47, P13, DOI 10.1016/j.annemergmed.2005.04.003
   Cotter G, 1998, LANCET, V351, P389, DOI 10.1016/S0140-6736(97)08417-1
   Cowie MR, 1997, LANCET, V350, P1349, DOI 10.1016/S0140-6736(97)06031-5
   Cox ZL, 2014, J CARD FAIL, V20, P611, DOI 10.1016/j.cardfail.2014.05.007
   Damman K, 2007, J CARD FAIL, V13, P599, DOI 10.1016/j.cardfail.2007.04.008
   De Backer D, 2010, NEW ENGL J MED, V362, P779, DOI 10.1056/NEJMoa0907118
   Demissei BG, 2016, INT J CARDIOL, V204, P164, DOI 10.1016/j.ijcard.2015.11.141
   Dharmarajan K, 2013, JAMA-J AM MED ASSOC, V309, P355, DOI 10.1001/jama.2012.216476
   Dries DL, 2000, J AM COLL CARDIOL, V35, P681, DOI 10.1016/S0735-1097(99)00608-7
   Faris RF, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003838.pub3
   Felker GM, 2015, EUR J HEART FAIL, V17, P1262, DOI 10.1002/ejhf.341
   Felker GM, 2011, NEW ENGL J MED, V364, P797, DOI 10.1056/NEJMoa1005419
   Flaherty JD, 2009, J AM COLL CARDIOL, V53, P254, DOI 10.1016/j.jacc.2008.08.072
   Follath F, 2011, INTENS CARE MED, V37, P619, DOI 10.1007/s00134-010-2113-0
   Fonarow GC, 2005, JAMA-J AM MED ASSOC, V293, P572, DOI 10.1001/jama.293.5.572
   Fonarow GC, 2008, ARCH INTERN MED, V168, P847, DOI 10.1001/archinte.168.8.847
   Galie N, 2016, EUR HEART J, V37, P67, DOI 10.1093/eurheartj/ehv317
   Gheorghiade M, 2011, JAMA-J AM MED ASSOC, V305, P2456, DOI 10.1001/jama.2011.836
   Harjola VP, 2016, EUR J HEART FAIL, V18, P226, DOI 10.1002/ejhf.478
   Harjola VP, 2015, EUR J HEART FAIL, V17, P501, DOI 10.1002/ejhf.260
   Ibanez B, 2018, EUR HEART J, V39, P119, DOI 10.1093/eurheartj/ehx393
   Khan SS, 2008, AM J MANAG CARE, pS273
   Kirchhof P, 2016, EUR HEART J, V37, P2893, DOI 10.1093/eurheartj/ehw210
   Kociol RD, 2010, J AM COLL CARDIOL, V56, P1071, DOI 10.1016/j.jacc.2010.06.016
   Koelling TM, 2005, CIRCULATION, V111, P179, DOI 10.1161/01.CIR.0000151811.53450.B8
   Konstantinides SV, 2014, EUR HEART J, V35, P3033, DOI 10.1093/eurheartj/ehu283
   Lassus J, 2013, INT J CARDIOL, V168, P2186, DOI 10.1016/j.ijcard.2013.01.228
   Levy B, 2015, ANN INTENSIVE CARE, V5, DOI [10.1186/s13613-015-0052-1, 10.1186/s13613-015-0063-y]
   Levy B, 2011, CRIT CARE MED, V39, P450, DOI 10.1097/CCM.0b013e3181ffe0eb
   Liesching T, 2003, CHEST, V124, P699, DOI 10.1378/chest.124.2.699
   Liteplo AS, 2009, ACAD EMERG MED, V16, P201, DOI 10.1111/j.1553-2712.2008.00347.x
   Maisel A, 2012, EUR J HEART FAIL, V14, P278, DOI 10.1093/eurjhf/hfr177
   Maisel AS, 2008, J AM COLL CARDIOL, V52, P534, DOI 10.1016/j.jacc.2008.05.010
   Masip J, 2005, JAMA-J AM MED ASSOC, V294, P3124, DOI 10.1001/jama.294.24.3124
   Masip J, 2012, EUR HEART J-ACUTE CA, V1, P275, DOI 10.1177/2048872612457087
   McMurray JJV, 2012, EUR HEART J, V33, P1787, DOI 10.1093/eurheartj/ehs104
   Mebazaa A, 2016, INTENS CARE MED, V42, P147, DOI 10.1007/s00134-015-4041-5
   Mebazaa A, 2015, EUR J HEART FAIL, V17, P652, DOI 10.1002/ejhf.294
   Mebazaa A, 2015, EUR J HEART FAIL, V17, P544, DOI 10.1002/ejhf.289
   Mebazaa A, 2011, INTENS CARE MED, V37, P290, DOI 10.1007/s00134-010-2073-4
   Mentz RJ, 2014, EUR J HEART FAIL, V16, P471, DOI 10.1002/ejhf.74
   Mockel M, 2017, ESC HEART FAIL, V4, P203, DOI 10.1002/ehf2.12189
   Mortara A, 2014, J HEART LUNG TRANSPL, V33, P1056, DOI 10.1016/j.healun.2014.05.015
   Nikolaou M, 2013, EUR HEART J, V34, P742, DOI 10.1093/eurheartj/ehs332
   Nohria A, 2003, J AM COLL CARDIOL, V41, P1797, DOI 10.1016/S0735-1097(03)00309-7
   Nohria A, 2002, JAMA-J AM MED ASSOC, V287, P628, DOI 10.1001/jama.287.5.628
   Packer M, 2017, NEW ENGL J MED, V376, P1956, DOI 10.1056/NEJMoa1601895
   Patarroyo M, 2012, J AM COLL CARDIOL, V60, P1906, DOI 10.1016/j.jacc.2012.08.957
   Peacock WF, 2008, EMERG MED J, V25, P205, DOI 10.1136/emj.2007.050419
   Peacock WF, 2008, NEW ENGL J MED, V358, P2117, DOI 10.1056/NEJMoa0706824
   Peacock WF, 2014, AM HEART J, V167, P529, DOI 10.1016/j.ahj.2013.12.023
   Peacock William Frank, 2009, Congest Heart Fail, V15, P256, DOI 10.1111/j.1751-7133.2009.00112.x
   Picano E, 2016, EUR HEART J, V37, P2097, DOI 10.1093/eurheartj/ehw164
   Plaisance P, 2007, EUR HEART J, V28, P2895, DOI 10.1093/eurheartj/ehm502
   Ponikowski P, 2016, EUR HEART J, V37, P2129, DOI 10.1093/eurheartj/ehw128
   Prins KW, 2015, JACC-HEART FAIL, V3, P647, DOI 10.1016/j.jchf.2015.03.008
   PRIORI SG, 2016, J IMMUNOL, V196, P2793, DOI DOI 10.1093/EURHEARTJ/EHV316
   Rochwerg B, 2017, EUR RESPIR J, V50, DOI 10.1183/13993003.02426-2016
   Roffi M, 2016, EUR HEART J, V37, P267, DOI 10.1093/eurheartj/ehv320
   Shaefi S, 2015, J AM HEART ASSOC, V4, DOI 10.1161/JAHA.114.001462
   Stevenson LW, 2005, EUR J HEART FAIL, V7, P323, DOI 10.1016/j.ejheart.2005.01.004
   Stretch R, 2014, J AM COLL CARDIOL, V64, P1407, DOI 10.1016/j.jacc.2014.07.958
   Tarvasmaki T, 2018, EUR J HEART FAIL, V20, P572, DOI 10.1002/ejhf.958
   Teerlink JR, 2017, EUR J HEART FAIL, V19, P800, DOI 10.1002/ejhf.830
   Teerlink JR, 2013, LANCET, V381, P29, DOI 10.1016/S0140-6736(12)61855-8
   Teerlink JR, 2017, HEART FAIL 2017 4 WO
   Thiele H, 2017, NEW ENGL J MED, V377, P2419, DOI 10.1056/NEJMoa1710261
   Thiele H, 2015, EUR HEART J, V36, P1223, DOI 10.1093/eurheartj/ehv051
   Thiele H, 2013, LANCET, V382, P1638, DOI 10.1016/S0140-6736(13)61783-3
   Thiele H, 2012, NEW ENGL J MED, V367, P1287, DOI 10.1056/NEJMoa1208410
   Vieillard-Baron A, 2008, CRIT CARE MED, V36, P1701, DOI 10.1097/CCM.0b013e318174db05
   WUERZ RC, 1992, ANN EMERG MED, V21, P669, DOI 10.1016/S0196-0644(05)82777-5
   Yancy CW, 2013, CIRCULATION, V128, P1810, DOI 10.1161/CIR.0b013e31829e8807
   Zannad F, 2006, EUR J HEART FAIL, V8, P697, DOI 10.1016/j.ejheart.2006.01.001
NR 81
TC 8
Z9 8
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JUN
PY 2018
VL 48
IS 6
BP 463
EP 480
DI 10.4070/kcj.2018.0125
PG 18
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA GJ3BV
UT WOS:000435150900002
PM 29856141
OA Green Published
DA 2021-04-22
ER

PT J
AU Song, PS
   Ryu, DR
   Kim, MJ
   Jeon, KH
   Choi, RK
   Park, JS
   Song, YB
   Hahn, JY
   Gwon, HC
   Ahn, Y
   Jeong, MH
   Choi, SH
AF Song, Pil Sang
   Ryu, Dong Ryeol
   Kim, Min Jeong
   Jeon, Ki-Hyun
   Choi, Rak Kyeong
   Park, Jin Sik
   Song, Young Bin
   Hahn, Joo-Yong
   Gwon, Hyeon-Cheol
   Ahn, Youngkeun
   Jeong, Myung Ho
   Choi, Seung-Hyuk
CA Korea Acute Myocardial Infarction
TI Risk Scoring System to Assess Outcomes in Patients Treated with
   Contemporary Guideline-Adherent Optimal Therapies after Acute Myocardial
   Infarction
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Myocardial Infarction; Angioplasty; Drug Therapy; Risk Risk
   stratification
ID PERCUTANEOUS CORONARY INTERVENTION; HEART-FAILURE; FOLLOW-UP;
   PREDICTION; MORTALITY; REGISTRY; MODEL; TRIAL; DISEASE; SCORES
AB Background and Objectives: A risk prediction is needed even in the contemporary era of acute myocardial infarction (AMI). We sought to develop a risk scoring specific for patients with AMI being treated with guideline-adherent optimal therapies, including percutaneous coronary intervention and all 5 medications (aspirin, thienopyridine, beta-blocker, angiotensin-converting enzyme inhibitor or angiotensin receptor blocker, and statin).
   Methods: From registries, 12,174 AMI patients were evaluated. The primary outcome was 1-year all-cause death or AMI. The Korea Working Group in Myocardial Infarction (KorMI) system was compared with the Assessment of Pexelizumab in Acute Myocardial Infarction (APEX AMI), Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC), and Global Registry of Acute Coronary Events scores (GRACE) models.
   Results: Ten predictors were identified: left ventricular dysfunction (hazard ratio [HR.], 2.3 bare-metal stent (HR, 2.0), Killip class >= II(HR, 1.9), renal insufficiency (HR, 1.8), previous stroke (HR, 1.6), regional wall-motion-score >20 on echocardiography (HR, 1.5), body mass index <= 24 kg/m(2) (HR, 1.4), age >= 70 years (HR, 1.4), prior coronary heart disease (HR, 1.4), and diabetes (HR, 1.4). Compared with the previous models, the KorMI system had good discrimination (time-dependent C statistic, 0.759) and showed reasonable goodnessof-fit by Hosmer-Lemeshow test (p=0.84). Moreover, the continuous-net reclassification improvement varied from -27.3% to -19.1%, the integrated discrimination index varied from -2.1% to -0.9%, and the median improvement in risk score was from -1.0% to -0.4%.
   Conclusions: The KorMI system would be a useful tool for predicting outcomes in survivors treated with guideline-adherent optimal therapies after AMI.
C1 [Song, Pil Sang] Mediplex Sejong Gen Hosp, Heart Stroke Vasc Ctr, Div Cardiol, Incheon, South Korea.
   [Ryu, Dong Ryeol] Kangwon Natl Univ, Kangwon Natl Univ Hosp, Sch Med, Div Cardiol,Dept Internal Med, Chunchon, South Korea.
   [Kim, Min Jeong; Jeon, Ki-Hyun; Choi, Rak Kyeong; Park, Jin Sik] Mediplex Sejong Hosp, Cardiovasc Ctr, Div Cardiol, Incheon, South Korea.
   [Song, Young Bin; Hahn, Joo-Yong; Gwon, Hyeon-Cheol; Choi, Seung-Hyuk] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Cardiol,Dept Internal Med,Heart Vasc Stroke I, Seoul, South Korea.
   [Ahn, Youngkeun; Jeong, Myung Ho] Chonnam Natl Univ, Coll Med, Heart Res Ctr, Gwangju, South Korea.
RP Choi, SH (corresponding author), Sungkyunkwan Univ, Sch Med, Div Cardiol, Dept Internal Med,Heart Vasc & Stroke Inst,Samsun, 81 Irwon Ro, Seoul 06351, South Korea.
EM sh1214.choi@samsung.com
RI Hahn, Joo-Yong/AAU-7250-2020
OI Hahn, Joo-Yong/0000-0002-4412-377X; Jeong, Myung Ho/0000-0003-2424-810X;
   JEON, KI HYUN/0000-0002-6277-7697; Song, Young Bin/0000-0003-3986-9152;
   Ryu, Dong-Ryeol/0000-0002-5309-7606; Kim, Min Jeong/0000-0001-8398-7020
FU Korean Society of Cardiology; Korean Health Technology R&D project,
   Ministry of Health and Welfare, Republic of Korea [HI13C1527]
FX This study was supported by grants of the Korean Society of Cardiology
   and the Korean Health Technology R&D project, Ministry of Health and
   Welfare (HI13C1527), Republic of Korea.
CR [Anonymous], 2013, CIRCULATION, V127, P1052, DOI 10.1161/CIR.0b013e3182831a11
   Antman EM, 2000, JAMA-J AM MED ASSOC, V284, P835, DOI 10.1001/jama.284.7.835
   Arnold SV, 2015, J AM HEART ASSOC, V4, DOI 10.1161/JAHA.114.001352
   Arnold SV, 2013, J AM COLL CARDIOL, V62, P1791, DOI 10.1016/j.jacc.2013.04.102
   Bangalore S, 2013, CIRC-CARDIOVASC INTE, V6, P378, DOI 10.1161/CIRCINTERVENTIONS.113.000415
   Bawamia B, 2013, AM HEART J, V165, P441, DOI 10.1016/j.ahj.2012.12.020
   Blanche P, 2013, STAT MED, V32, P5381, DOI 10.1002/sim.5958
   COCKCROFT DW, 1976, NEPHRON, V16, P31, DOI 10.1159/000180580
   Cook NR, 2007, CIRCULATION, V115, P928, DOI 10.1161/CIRCULATIONAHA.106.672402
   DeFilippis AP, 2015, ANN INTERN MED, V162, P266, DOI 10.7326/M14-1281
   Eagle KA, 2004, JAMA-J AM MED ASSOC, V291, P2727, DOI 10.1001/jama.291.22.2727
   Halkin A, 2005, J AM COLL CARDIOL, V45, P1397, DOI 10.1016/j.jacc.2005.01.041
   Hosmer DW, 1997, STAT MED, V16, P965
   Kaltoft A, 2010, J AM COLL CARDIOL, V56, P641, DOI 10.1016/j.jacc.2010.05.009
   Khot UN, 2003, JAMA-J AM MED ASSOC, V290, P2174, DOI 10.1001/jama.290.16.2174
   Kim HK, 2014, KOREAN J INTERN MED, V29, P703, DOI 10.3904/kjim.2014.29.6.703
   Kueh SH, 2016, HEART LUNG CIRC, V25, P837, DOI 10.1016/j.hlc.2015.10.007
   Loncar G, 2015, ARCH CARDIOVASC DIS, V108, P554, DOI 10.1016/j.acvd.2015.06.001
   Moller JE, 2006, AM HEART J, V151, P419, DOI 10.1016/j.ahj.2005.03.042
   Park KH, 2012, KOREAN J INTERN MED, V27, P180, DOI 10.3904/kjim.2012.27.2.180
   Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929
   Pilgrim T, 2016, AM HEART J, V175, P56, DOI 10.1016/j.ahj.2016.01.021
   Rasmussen JN, 2007, JAMA-J AM MED ASSOC, V297, P177, DOI 10.1001/jama.297.2.177
   ROECKER E, 1991, TECHNOMETRICS, V33, P459, DOI 10.2307/1269417
   Stebbins A, 2010, CIRC-CARDIOVASC INTE, V3, P414, DOI 10.1161/CIRCINTERVENTIONS.109.925180
   Steyerberg EW, 2014, EUR HEART J, V35, P1925, DOI 10.1093/eurheartj/ehu207
   Subherwal S, 2012, CIRC-CARDIOVASC QUAL, V5, P541, DOI 10.1161/CIRCOUTCOMES.111.964379
   Uno H, 2013, STAT MED, V32, P2430, DOI 10.1002/sim.5647
   Wallentin L, 2009, NEW ENGL J MED, V361, P1045, DOI 10.1056/NEJMoa0904327
NR 29
TC 6
Z9 6
U1 0
U2 3
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JUN
PY 2018
VL 48
IS 6
BP 492
EP 504
DI 10.4070/kcj.2017.0128
PG 13
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA GJ3BV
UT WOS:000435150900004
PM 29856143
OA Green Published
DA 2021-04-22
ER

PT J
AU Al-Hijji, M
   El Sabbagh, A
   Holmes, DR
AF Al-Hijji, Mohammed
   El Sabbagh, Abdallah
   Holmes, David R.
TI Revascularization for Left Main and Multivessel Coronary Artery Disease:
   Current Status and Future Prospects after the EXCEL and NOBLE Trials
SO KOREAN CIRCULATION JOURNAL
LA English
DT Review
DE Coronary artery disease; Percutaneous coronary intervention; Coronary
   artery bypass; Coronary disease
ID EVEROLIMUS-ELUTING STENTS; CONTROLLED CLINICAL-TRIAL; 3 THERAPEUTIC
   STRATEGIES; CHRONIC KIDNEY-DISEASE; BYPASS GRAFT-SURGERY; DOUBLE KISSING
   CRUSH; QUALITY-OF-LIFE; FOLLOW-UP; RANDOMIZED-TRIAL; 5-YEAR OUTCOMES
AB Revascularization of severe left main and multivessel coronary artery disease has been shown to improve survival in both stable ischemic heart disease and acute coronary syndrome. While revascularization with coronary artery bypass surgery for these disease entities carries class I recommendation in most current guidelines, recent trials has shown potential comparable survival and cardiovascular outcomes between percutaneous and surgical interventions in patients with less complex coronary anatomy. Despite the conflicting results observed in the most recent left main revascularization trials, Everolimus-Eluting Stents or Bypass Surgery for Left Main Coronary Artery Disease (EXCEL) and Nordic-Baltic-British left main revascularization (NOBLE), both treatment strategies remain important for the management of left main disease (LMD) and multivessel disease (MVD) reflecting on the importance of heart team discussion. This review is focused on revascularization of LMD and MVD in patients who are not presenting with ST-segment elevation myocardial infarction, encompassing the evidence from historic and contemporary trials which shaped up current practices. This review discusses the heart team approach to guide decision making, including special populations that are not represented in clinical trials.
C1 [Al-Hijji, Mohammed; El Sabbagh, Abdallah; Holmes, David R.] Mayo Clin, Dept Cardiovasc Med, 200 First St SW, Rochester, MN 55905 USA.
RP Holmes, DR (corresponding author), Mayo Clin, Dept Cardiovasc Med, 200 First St SW, Rochester, MN 55905 USA.
EM holmes.david@mayo.edu
RI Al-Hijji, Mohammed/AAX-1700-2020
OI Al-Hijji, Mohammed/0000-0002-9572-7688
CR Abdallah MS, 2017, J AM COLL CARDIOL, V69, P2039, DOI 10.1016/j.jacc.2017.02.031
   Ahn JM, 2015, J AM COLL CARDIOL, V65, P2198, DOI 10.1016/j.jacc.2015.03.033
   Alazzoni Ashraf, 2012, Thrombosis, V2012, P126369, DOI 10.1155/2012/126369
   Bangalore S, 2012, CIRCULATION, V125, P2873, DOI 10.1161/CIRCULATIONAHA.112.097014
   Baron SJ, 2017, J AM COLL CARDIOL, V70, P3113, DOI 10.1016/j.jacc.2017.10.036
   Boden WE, 2007, NEW ENGL J MED, V356, P1503, DOI 10.1056/NEJMoa070829
   Booth J, 2008, CIRCULATION, V118, P381, DOI 10.1161/CIRCULATIONAHA.107.739144
   BRUSCHKE AV, 1973, CIRCULATION, V47, P1154, DOI 10.1161/01.CIR.47.6.1154
   Buszman PE, 2016, JACC-CARDIOVASC INTE, V9, P318, DOI 10.1016/j.jcin.2015.10.044
   Cameron A, 1996, NEW ENGL J MED, V334, P216, DOI 10.1056/NEJM199601253340402
   Capodanno D, 2011, J AM COLL CARDIOL, V58, P1426, DOI 10.1016/j.jacc.2011.07.005
   Chang TI, 2012, J AM SOC NEPHROL, V23, P2042, DOI 10.1681/ASN.2012060554
   Chen SL, 2017, J AM COLL CARDIOL, V70, P2605, DOI 10.1016/j.jacc.2017.09.1066
   Chen SL, 2015, JACC-CARDIOVASC INTE, V8, P1335, DOI 10.1016/j.jcin.2015.05.017
   Chen SL, 2013, J AM COLL CARDIOL, V61, P1482, DOI 10.1016/j.jacc.2013.01.023
   Cohen DJ, 2014, CIRCULATION, V130, P1146, DOI 10.1161/CIRCULATIONAHA.114.009985
   De Bruyne B, 2012, NEW ENGL J MED, V367, P991, DOI 10.1056/NEJMoa1205361
   Farkouh ME, 2012, NEW ENGL J MED, V367, P2375, DOI 10.1056/NEJMoa1211585
   FitzGibbon GM, 1996, J AM COLL CARDIOL, V28, P616, DOI 10.1016/0735-1097(96)00206-9
   Gansera B, 2007, THORAC CARDIOV SURG, V55, P412, DOI 10.1055/s-2007-965372
   Giacoppo D, 2017, JAMA CARDIOL, V2, P1079, DOI 10.1001/jamacardio.2017.2895
   GOETZ RH, 1961, J THORAC CARDIOV SUR, V41, P378
   Goldman S, 2011, JAMA-J AM MED ASSOC, V305, P167, DOI 10.1001/jama.2010.1976
   Graham MM, 2002, CIRCULATION, V105, P2378, DOI 10.1161/01.CIR.0000016640.99114.3D
   GRUENTZIG A, 1982, AM HEART J, V103, P779, DOI 10.1016/0002-8703(82)90486-0
   Head SJ, 2014, EUR HEART J, V35, P2821, DOI 10.1093/eurheartj/ehu213
   Hemmelgarn BR, 2004, CIRCULATION, V110, P1890, DOI 10.1161/01.CIR.0000143629.55725.D9
   Hueb W, 2007, CIRCULATION, V115, P1082, DOI 10.1161/CIRCULATIONAHA.106.625475
   Hueb W, 2010, CIRCULATION, V122, P949, DOI 10.1161/CIRCULATIONAHA.109.911669
   KAISER GC, 1985, J THORAC CARDIOV SUR, V89, P513
   Kappetein AP, 2013, EUR J CARDIO-THORAC, V43, P1006, DOI 10.1093/ejcts/ezt017
   Kapur A, 2010, J AM COLL CARDIOL, V55, P432, DOI 10.1016/j.jacc.2009.10.014
   Kim HJ, 2017, EUR J CARDIO-THORAC, V52, P937, DOI 10.1093/ejcts/ezx288
   Kolh P, 2014, EUR J CARDIO-THORAC, V46, P517, DOI [10.1093/eurheartj/ehu278, 10.1093/ejcts/ezu366]
   Levine GN, 2011, CIRCULATION, V124, pE574, DOI 10.1161/CIR.0b013e31823ba622
   Lu RJ, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.116.003990
   Makikallio T, 2016, LANCET, V388, P2743, DOI 10.1016/S0140-6736(16)32052-9
   McKellar SH, 2008, NAT CLIN PRACT CARD, V5, P738, DOI 10.1038/ncpcardio1348
   Morice MC, 2014, CIRCULATION, V129, P2388, DOI 10.1161/CIRCULATIONAHA.113.006689
   Morice MC, 2010, CIRCULATION, V121, P2645, DOI 10.1161/CIRCULATIONAHA.109.899211
   Navarese EP, 2014, OPEN HEART, V1, DOI 10.1136/openhrt-2014-000064
   Osnabrugge RL, 2015, HEART, V101, P1980, DOI 10.1136/heartjnl-2015-307578
   Park SJ, 2011, NEW ENGL J MED, V364, P1718, DOI 10.1056/NEJMoa1100452
   Patel M, 2017, J NUCL CARDIOL, V24, P439, DOI 10.1007/s12350-017-0780-8
   Pfisterer M, 2001, LANCET, V358, P951
   Puskas JD, 2016, J AM COLL CARDIOL, V68, P356, DOI 10.1016/j.jacc.2016.05.032
   Ragosta M, 2006, CATHETER CARDIO INTE, V68, P357, DOI 10.1002/ccd.20709
   Ramanathan KB, 2005, ANN THORAC SURG, V80, P1340, DOI 10.1016/j.athoracsur.2005.03.057
   Sardar P, 2018, CATHETER CARDIO INTE, V91, P203, DOI 10.1002/ccd.27098
   Sarno G, 2010, AM J CARDIOL, V106, P1369, DOI 10.1016/j.amjcard.2010.06.069
   Serruys PW, 2009, NEW ENGL J MED, V360, P961, DOI 10.1056/NEJMoa0804626
   Serruys PW, 2005, J AM COLL CARDIOL, V46, P575, DOI 10.1016/j.jacc.2004.12.082
   Sigwart U, 2002, LANCET, V360, P965
   Sipahi I, 2014, JAMA INTERN MED, V174, P223, DOI 10.1001/jamainternmed.2013.12844
   Stone GW, 2016, NEW ENGL J MED, V375, P2223, DOI 10.1056/NEJMoa1610227
   Taggart DP, 2008, J AM COLL CARDIOL, V51, P885, DOI 10.1016/j.jacc.2007.09.067
   Taggart DP, 2016, NEW ENGL J MED, V375, P2540, DOI 10.1056/NEJMoa1610021
   Varenne O, 2018, LANCET, V391, P41, DOI 10.1016/S0140-6736(17)32713-7
   Velazquez EJ, 2016, NEW ENGL J MED, V374, P1511, DOI 10.1056/NEJMoa1602001
   Velazquez EJ, 2011, NEW ENGL J MED, V364, P1607, DOI 10.1056/NEJMoa1100356
   Vieira RD, 2012, CIRCULATION, V126, pS158, DOI 10.1161/CIRCULATIONAHA.111.084236
   Wang YS, 2018, CLIN EXP NEPHROL, V22, P99, DOI 10.1007/s10157-017-1432-7
   Wolff G, 2017, CIRC-HEART FAIL, V10, DOI 10.1161/CIRCHEARTFAILURE.116.003255
   Yamasaki M, 2016, ANN THORAC SURG, V102, P712, DOI 10.1016/j.athoracsur.2016.02.107
   Ye YC, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179756
   YUSUF S, 1994, LANCET, V344, P563, DOI 10.1016/S0140-6736(94)91963-1
NR 66
TC 2
Z9 3
U1 0
U2 7
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JUN
PY 2018
VL 48
IS 6
BP 447
EP 462
DI 10.4070/kcj.2018.0078
PG 16
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA GJ3BV
UT WOS:000435150900001
PM 29856140
OA Green Published
DA 2021-04-22
ER

PT J
AU Gwon, HC
AF Gwon, Hyeon-Cheol
TI Understanding the Coronary Bifurcation Stenting
SO KOREAN CIRCULATION JOURNAL
LA English
DT Review
DE Bifurcation lesion; Stents; Percutaneous coronary intervention
ID SIROLIMUS-ELUTING STENTS; INTRAVASCULAR ULTRASOUND ANALYSIS; FRACTIONAL
   FLOW RESERVE; SIDE-BRANCH INTERVENTION; KISSING BALLOON; MAIN VESSEL;
   CLINICAL-OUTCOMES; RANDOMIZED-TRIAL; LESIONS; IMPLANTATION
AB Coronary bifurcation stenting is still complex and associated with a high risk of stent thrombosis and restenosis even with contemporary techniques. Although provisional approach has been proved to be the standard strategy of treatment, There is still lack of evidences for multiple steps of the procedure. For so many years we have been focused on the optimization of side branch (SB), but the clinical outcome is mostly dependent on the main vessel (MV) stenting. The optimal expansion of MV stent without the compromise of SB is the ultimate goal to achieve in the coronary bifurcation stenting. Understanding the anatomy and physiology of coronary bifurcation lesion should be the most important step to this goal. The relationship of vessel diameter between branches and the anatomical and functional significance of plaque shift and carina shift are two most important concepts to understand. They are the science behind the predictors of SB occlusion, and the rationale of proximal optimization technique and final kissing ballooning. This specific review will be devoted to review those concepts as well as clinical evidences to support them.
C1 [Gwon, Hyeon-Cheol] Sungkyunkwan Univ, Div Cardiol, Dept Med, Samsung Med Ctr,Sch Med, Seoul, South Korea.
RP Gwon, HC (corresponding author), Sungkyunkwan Univ, Div Cardiol, Dept Med,Heart Vasc Stroke Inst, Samsung Med Ctr,Sch Med, 81 Irwon Ro, Seoul 06351, South Korea.
EM hcgwon@naver.com
CR Behan MW, 2011, CIRC-CARDIOVASC INTE, V4, P57, DOI 10.1161/CIRCINTERVENTIONS.110.958512
   Chen SL, 2013, J AM COLL CARDIOL, V61, P1482, DOI 10.1016/j.jacc.2013.01.023
   Colombo A, 2004, CIRCULATION, V109, P1244, DOI 10.1161/01.CIR.0000118474.71662.E3
   Colombo A, 2016, EUR HEART J, V37, P1929, DOI 10.1093/eurheartj/ehw185
   Colombo A, 2009, CIRCULATION, V119, P71, DOI 10.1161/CIRCULATIONAHA.108.808402
   Cutlip DE, 2007, CIRCULATION, V115, P2344, DOI 10.1161/CIRCULATIONAHA.106.685313
   Darremont O, 2015, EUROINTERVENTION S5, V11, pV86
   Erglis A, 2009, CIRC-CARDIOVASC INTE, V2, P27, DOI 10.1161/CIRCINTERVENTIONS.108.804658
   Ferenc M, 2016, EUR HEART J, V37, P3399, DOI 10.1093/eurheartj/ehw345
   Finet G, 2015, JACC-CARDIOVASC INTE, V8, P1308, DOI 10.1016/j.jcin.2015.05.016
   Finet Gerard, 2008, EuroIntervention, V3, P490, DOI 10.4244/EIJV3I4A87
   Foin N, 2011, EUROINTERVENTION, V7, P597, DOI 10.4244/EIJV7I5A96
   Ge L, 2005, J AM COLL CARDIOL, V46, P613, DOI 10.1016/j.jacc.2005.05.032
   Hahn JY, 2013, J AM COLL CARDIOL, V62, P1654, DOI 10.1016/j.jacc.2013.07.041
   Hahn JY, 2008, ATHEROSCLEROSIS, V201, P326, DOI 10.1016/j.atherosclerosis.2008.02.021
   Kang SJ, 2013, CATHETER CARDIO INTE, V82, P1075, DOI 10.1002/ccd.24956
   Kim JS, 2011, AM HEART J, V161, DOI 10.1016/j.ahj.2010.10.002
   Kim YH, 2015, JACC-CARDIOVASC INTE, V8, P550, DOI 10.1016/j.jcin.2015.01.016
   Koo BK, 2005, J AM COLL CARDIOL, V46, P633, DOI 10.1016/j.jacc.2005.04.054
   Koo BK, 2008, EUR HEART J, V29, P726, DOI 10.1093/eurheartj/ehn045
   Koo BK, 2010, CIRC-CARDIOVASC INTE, V3, P113, DOI 10.1161/CIRCINTERVENTIONS.109.887406
   Lassen JF, 2018, EUROINTERVENTION, V13, P1540, DOI 10.4244/EIJ-D-17-00622
   Lefevre T, 2000, CATHETER CARDIO INTE, V49, P274, DOI 10.1002/(SICI)1522-726X(200003)49:3<274::AID-CCD11>3.0.CO;2-N
   Medina A, 2006, REV ESP CARDIOL, V59, P183, DOI 10.1016/S1885-5857(06)60130-8
   Murray CD, 1926, P NATL ACAD SCI USA, V12, P207, DOI 10.1073/pnas.12.3.207
   Mylotte D, 2013, CATHETER CARDIO INTE, V82, pE437, DOI 10.1002/ccd.24901
   Nairooz R, 2017, HEART, V103, P1427, DOI 10.1136/heartjnl-2016-310929
   NAKAMURA S, 1995, CATHETER CARDIO DIAG, V34, P353, DOI 10.1002/ccd.1810340217
   Nakazawa G, 2010, J AM COLL CARDIOL, V55, P1679, DOI 10.1016/j.jacc.2010.01.021
   Niemela M, 2011, CIRCULATION, V123, P79, DOI 10.1161/CIRCULATIONAHA.110.966879
   Pan M, 2005, REV ESP CARDIOL, V58, P1278, DOI 10.1157/13080956
   Pan M, 2014, AM HEART J, V168, P374, DOI 10.1016/j.ahj.2014.05.014
   Park JJ, 2014, RADIOLOGY, V271, P711, DOI 10.1148/radiol.14131959
   Poerner TC, 2002, AM HEART J, V143, P627, DOI 10.1067/mhj.2002.120411
   Serruys Patrick W, 2015, EuroIntervention, V11 Suppl V, pV7, DOI 10.4244/EIJV11SVA1
   Serruys PW, 2010, J AM COLL CARDIOL, V55, P1093, DOI 10.1016/j.jacc.2009.11.049
   Song PS, 2013, INT J CARDIOL, V167, P1251, DOI 10.1016/j.ijcard.2012.03.146
   Song YB, 2012, JACC-CARDIOVASC INTE, V5, P1133, DOI 10.1016/j.jcin.2012.07.010
   Steigen TK, 2006, CIRCULATION, V114, P1955, DOI 10.1161/CIRCULATIONAHA.106.664920
   Tanabe K, 2004, AM J CARDIOL, V94, P115, DOI 10.1016/j.amjcard.2004.03.040
   Vassilev D, 2008, KARDIOL POL, V66, P371
   Xu JQ, 2013, CHINESE MED J-PEKING, V126, P3505, DOI 10.3760/cma.j.issn.0366-6999.20123434
   Xu JQ, 2012, CIRC-CARDIOVASC INTE, V5, P657, DOI 10.1161/CIRCINTERVENTIONS.112.969089
NR 43
TC 4
Z9 4
U1 1
U2 2
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JUN
PY 2018
VL 48
IS 6
BP 481
EP 491
DI 10.4070/kcj.2018.0088
PG 11
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA GJ3BV
UT WOS:000435150900003
PM 29856142
OA Green Published
DA 2021-04-22
ER

PT J
AU Xiao, L
   Wang, P
   Fang, Q
   Zhao, QH
AF Xiao, Ling
   Wang, Pan
   Fang, Qin
   Zhao, Qinghua
TI Health-promoting Lifestyle in Patients after Percutaneous Coronary
   Intervention
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Cardiovascular diseases; Coronary artery disease; Health promotion;
   Percutaneous coronary intervention
ID PSYCHOSOCIAL RISK-FACTORS; QUALITY-OF-LIFE; HEART-DISEASE;
   PHYSICAL-ACTIVITY; ARTERY-DISEASE; CRUCIAL FACTOR; SPIRITUALITY;
   BEHAVIORS; INDIVIDUALS; PREDICTORS
AB Background and Objectives: The purpose of this study was to determine the status of health-promoting behaviors in patients after percutaneous coronary intervention (PCI) and explore what factors affect healthy lifestyle behaviors.
   Methods: A total of 120 patients with coronary artery disease after PCI was included in this study. The Health Promoting Lifestyle Profile (HPLP) II was used to assess health-promoting lifestyle behavior. Data analysis was performed by t-test, analysis of variance, and multiple linear stepwise regression analyses.
   Results: The average age of the participants was 60.10 +/- 9.84 (range, 37-81) years old. Among the participants, 86.7% were men and 13.3% were women. In all, 24.2% of the patients had an excellent level of health-promoting lifestyle and 74.2% had a moderate level of health-promoting lifestyle. The spiritual growth scores were the highest, while stress management and physical activity scores were the lowest. The level of health-promoting lifestyle was higher for people with higher income and a diagnosis of stable angina.
   Conclusions: Healthcare providers should focus on promoting physical exercise and stress management for patients after PCI. It is also necessary to keep an eye out for patients with low income and severe illness to encourage a health-promoting lifestyle in these subsets of patients.
C1 [Xiao, Ling; Wang, Pan; Zhao, Qinghua] Chongqing Med Univ, Affiliated Hosp 1, Dept Nursing, 1 Youyi Rd, Chongqing 400016, Peoples R China.
   [Fang, Qin] Chongqing Med Univ, Affiliated Hosp 1, Dept Cardiovasc Internal Med, Chongqing, Peoples R China.
RP Zhao, QH (corresponding author), Chongqing Med Univ, Affiliated Hosp 1, Dept Nursing, 1 Youyi Rd, Chongqing 400016, Peoples R China.
EM qh20063@163.com
FU Chongqing Health and Family Planning Commission Scientific Research
   Projects [2015ZDXM009]
FX This work was supported by funding from the Chongqing Health and Family
   Planning Commission Scientific Research Projects (No. 2015ZDXM009).
CR Bekke-Hansen S, 2014, J HEALTH PSYCHOL, V19, P740, DOI 10.1177/1359105313479625
   Blumenthal D, 2016, JAMA INTERN MED, V176, P521, DOI 10.1001/jamainternmed.2016.0198
   Bonnet F, 2005, ATHEROSCLEROSIS, V178, P339, DOI 10.1016/j.atherosclerosis.2004.08.035
   Booth JN, 2014, AM J CARDIOL, V113, P1933, DOI 10.1016/j.amjcard.2014.03.033
   Bunker SJ, 2003, MED J AUSTRALIA, V178, P272, DOI 10.5694/j.1326-5377.2003.tb05193.x
   Chiou AF, 2016, APPL NURS RES, V30, P1, DOI 10.1016/j.apnr.2015.08.008
   Ginting H, 2015, J CARDIOVASC NURS, V30, P537, DOI 10.1097/JCN.0000000000000201
   Glozier N, 2013, MED J AUSTRALIA, V199, P179, DOI 10.5694/mja13.10440
   Gokyildiz S, 2014, INT J NURS PRACT, V20, P390, DOI 10.1111/ijn.12187
   Hajizadeh-Sharafabad F, 2016, INT J NURS PRACT, V22, P486, DOI 10.1111/ijn.12459
   Hamilton JM, 2003, BEHAV MED, V28, P132, DOI 10.1080/08964280309596051
   Kahkonen O, 2017, J CLIN NURS, V26, P1264, DOI 10.1111/jocn.13527
   Kahkonen O, 2015, J ADV NURS, V71, P2364, DOI 10.1111/jan.12708
   Kureshi F, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g5309
   Lee John H, 2012, Mo Med, V109, P79
   Marzolini S, 2015, EUR J PHYS REHAB MED, V51, P291
   Mehri A, 2016, INT J PREVENTIVE MED, V7, DOI 10.4103/2008-7802.180411
   Morris EL, 2001, ALTERN THER HEALTH M, V7, P96
   Nicholson S O, 2000, J Pediatr Nurs, V15, P343
   Pope L, 2011, J AGING PHYS ACTIV, V19, P99, DOI 10.1123/japa.19.2.99
   Rezaei-Adaryani M, 2012, J CLIN NURS, V21, P3587, DOI 10.1111/j.1365-2702.2012.04176.x
   Smith SC, 2011, CIRCULATION, V124, P2458, DOI 10.1161/CIR.0b013e318235eb4d
   Stewart R, 2013, EUR HEART J, V34, P3286, DOI 10.1093/eurheartj/eht258
   Teo K, 2013, JAMA-J AM MED ASSOC, V309, P1613, DOI 10.1001/jama.2013.3519
   Tingstrom Pia R, 2006, J Cardiopulm Rehabil, V26, P32, DOI 10.1097/00008483-200601000-00007
   Wan YF, 2015, EXP THER MED, V10, P1115, DOI 10.3892/etm.2015.2646
   Whittle J, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g5613
   WHO, 2016, CARD DIS CVDS
   World Health Organization, 2011, GLOBAL ATLAS CARDIOV
   Zheng X, 2016, JAMA INTERN MED, V176, P512, DOI 10.1001/jamainternmed.2016.0166
NR 30
TC 5
Z9 6
U1 0
U2 11
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JUN
PY 2018
VL 48
IS 6
BP 507
EP 515
DI 10.4070/kcj.2017.0312
PG 9
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA GJ3BV
UT WOS:000435150900006
PM 29856145
OA Green Published
DA 2021-04-22
ER

PT J
AU Kim, HC
AF Kim, Hyeon Chang
TI A New Prognostic Tool for Korean Patients with Acute Myocardial
   Infarction
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
ID SCORE; RISK
C1 [Kim, Hyeon Chang] Yonsei Univ, Dept Prevent Med, Coll Med, 50-1 Yonsei Ro, Seoul 03722, South Korea.
   [Kim, Hyeon Chang] Yonsei Univ, Div Cardiol, Dept Internal Med, Coll Med, Seoul, South Korea.
RP Kim, HC (corresponding author), Yonsei Univ, Dept Prevent Med, Coll Med, 50-1 Yonsei Ro, Seoul 03722, South Korea.
EM hckim@yuhs.ac
RI Kim, Hyeon Chang/F-8796-2019
OI Kim, Hyeon Chang/0000-0001-7867-1240
CR Bjornson E, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00002
   Cho IJ, 2017, CIRC-CARDIOVASC QUAL, V10, DOI 10.1161/CIRCOUTCOMES.117.004197
   Jee SH, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005025
   Kim HC, 2012, KOREAN CIRC J, V42, P223, DOI 10.4070/kcj.2012.42.4.223
   Kim HK, 2011, AM J CARDIOL, V107, P965, DOI 10.1016/j.amjcard.2010.11.018
   Kim HK, 2010, INT J CARDIOL, V145, P450, DOI 10.1016/j.ijcard.2009.06.001
   Lee JH, 2015, AM J CARDIOL, V115, P1167, DOI 10.1016/j.amjcard.2015.02.001
   Park GM, 2014, CIRC-CARDIOVASC QUAL, V7, P944, DOI 10.1161/CIRCOUTCOMES.114.001305
   Roth GA, 2017, J AM COLL CARDIOL, V70, P1, DOI 10.1016/j.jacc.2017.04.052
   Song PS, 2018, KOREAN CIRC J, V48, P492, DOI 10.4070/kcj.2017.0128
NR 10
TC 0
Z9 0
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JUN
PY 2018
VL 48
IS 6
BP 505
EP 506
DI 10.4070/kcj.2018.0127
PG 2
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA GJ3BV
UT WOS:000435150900005
PM 29856144
OA Green Published
DA 2021-04-22
ER

PT J
AU Ahn, JM
AF Ahn, Jung-Min
TI Health Promoting Life Style after Coronary Stenting: Underuse of Proven
   Therapy
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
ID DISEASE
C1 [Ahn, Jung-Min] Univ Ulsan, Dept Cardiol, Asan Med Ctr, Coll Med, Seoul, South Korea.
RP Ahn, JM (corresponding author), Univ Ulsan, Coll Med, Asan Med Ctr, Dept Cardiol,Cardiac Ctr, 88 Olymp Ro 43 Gil, Seoul 05505, South Korea.
EM drjmahn@gmail.com
CR Chow CK, 2010, CIRCULATION, V121, P750, DOI 10.1161/CIRCULATIONAHA.109.891523
   Dalal HM, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h5000
   Eckel RH, 2014, J AM COLL CARDIOL, V63, P2960, DOI 10.1016/j.jacc.2013.11.003
   Im HW, 2018, ANN REHABIL MED-ARM, V42, P154, DOI 10.5535/arm.2018.42.1.154
   Menzin J, 2008, CURR MED RES OPIN, V24, P461, DOI [10.1185/030079908X261096, 10.1185/030079908X261096 ]
   Nabel EG, 2012, NEW ENGL J MED, V366, P54, DOI 10.1056/NEJMra1112570
   Perk J, 2015, EUROINTERVENTION, V10, DOI 10.4244/EIJV10I11A223
   Piepoli MF, 2016, EUR HEART J, V37, P2315, DOI 10.1093/eurheartj/ehw106
   Xiao L, 2018, KOREAN CIRC J, V48, P507, DOI 10.4070/kcj.2017.0312
NR 9
TC 0
Z9 0
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JUN
PY 2018
VL 48
IS 6
BP 516
EP 518
DI 10.4070/kcj.2018.0133
PG 3
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA GJ3BV
UT WOS:000435150900007
PM 29856146
OA Green Published
DA 2021-04-22
ER

PT J
AU Lee, JM
   Kim, TH
   Cha, MJ
   Park, J
   Park, JK
   Kang, KW
   Shim, J
   Uhm, JS
   Kim, J
   Park, HW
   Lee, YS
   Choi, EK
   Kim, CS
   Joung, B
   Kim, JB
AF Lee, Jung Myung
   Kim, Tae-Hoon
   Cha, Myung-Jin
   Park, Junbeom
   Park, Jin-Kyu
   Kang, Ki-Woon
   Shim, Jaemin
   Uhm, Jae-Sun
   Kim, Jun
   Park, Hyung Wook
   Lee, Young Soo
   Choi, Eue-Keun
   Kim, Chang-Soo
   Joung, Boyoung
   Kim, Jin-Bae
TI Gender-related Differences in Management of Nonvalvular Atrial
   Fibrillation in an Asian Population
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Atrial fibrillation; Registries; Sex characteristics; Asian ceancestry
   group; Anticoagulants
ID STROKE PREVENTION; JAPANESE PATIENTS; ISCHEMIC-STROKE; SEX-DIFFERENCES;
   RISK; OUTCOMES; CHA(2)DS(2)-VASC; WARFARIN; REGISTRY; VALIDATION
AB Background and Objectives: Gender-related differences in health care utilization for atrial fibrillation (AF) are increasingly recognized. However, large cohort data for examining gender-related differences in AF are lacking in Asian populations.
   Methods: The Registry for Comparison Study of Drugs for Symptom Control and Complication Prevention of AF (CODE-AF Registry) is a prospective observational cohort-study that enrolled participants at 10 tertiary hospitals in South Korea. Baseline characteristics retrieved from the CODE-AF Registry were analyzed.
   Results: A total of 6,274 patients were recruited (mean age 67 +/- 11 years, mean CHA(2)DS(2)-VASc score 2.7 +/- 1.7, 63% male, 65% paroxysmal AF) from June 2016 to April 2017. Women underwent less electric cardioversion (12.3% vs. 19.6%, p<0.001), less radiofrequency ablation (12.4% vs. 17.9%, p<0.001), and less antiarrhythmic drug therapy (44.7% vs. 49.5%, p<0.001), despite having more severe symptoms (symptom class III or IV, 45.8% vs. 37.5%, p<0.001). Among patients with a CHA 2 DS 2 -VA score of 2 or more, a slightly higher proportion of women were taking oral anticoagulants than men (85.7% vs. 81.9%, p=0.002), and non-vitamin K antagonist oral anticoagulant (NOAC) use was more prevalent in women than men (70.4% vs. 62.3%, p<0.001). Insufficient NOAC dosing was very common, more so in women than men (61.5% vs. 56.3%, p<0.001).
   Conclusions: Female patients with AF were treated more conservatively and rhythm control strategies were used less frequently than in males, even though the female patients with AF had more severe symptoms. While insufficient NOAC dosing was common in both sex, it was significantly more frequent in women.
C1 [Lee, Jung Myung; Kim, Jin-Bae] Kyung Hee Univ, Div Cardiol, Med Coll, 26-6 Kyungheedae Ro, Seoul 02453, South Korea.
   [Kim, Tae-Hoon; Uhm, Jae-Sun; Joung, Boyoung] Yonsei Univ, Severance Cardiovasc Hosp, Coll Med, Div Cardiol, 50-1 Yonsei Ro, Seoul 03722, South Korea.
   [Cha, Myung-Jin; Choi, Eue-Keun] Seoul Natl Univ Hosp, Dept Internal Med, Seoul, South Korea.
   [Park, Junbeom] Ewha Womans Univ, Coll Med, Dept Cardiol, Seoul, South Korea.
   [Park, Jin-Kyu] Hanyang Univ, Div Cardiol, Med Ctr, Seoul, South Korea.
   [Kang, Ki-Woon] Eulji Univ Hosp, Div Cardiol, Korea, South Korea.
   [Shim, Jaemin] Korea Univ, Div Cardiol, Anam Hosp, Seoul, South Korea.
   [Kim, Jun] Univ Ulsan, Dept Internal Med, Coll Med, Seoul, South Korea.
   [Park, Hyung Wook] Chonnam Natl Univ, Med Sch, Dept Cardiovasc Med, Gwangju, South Korea.
   [Lee, Young Soo] Catholic Univ Daegu, Div Cardiol, Daegu, South Korea.
   [Kim, Chang-Soo] Yonsei Univ, Dept Prevent Med, Coll Med, Seoul, South Korea.
RP Kim, JB (corresponding author), Kyung Hee Univ, Div Cardiol, Med Coll, 26-6 Kyungheedae Ro, Seoul 02453, South Korea.; Joung, B (corresponding author), Yonsei Univ, Severance Cardiovasc Hosp, Coll Med, Div Cardiol, 50-1 Yonsei Ro, Seoul 03722, South Korea.
EM cby6908@yuhs.ac; jinbbai@khu.ac.kr
RI Lee, Jung Myung/S-6184-2019; Choi, Eue-Keun/J-5968-2014; Choi,
   Eue-Keun/K-3752-2019; Park, Junbeom/AAH-6065-2021
OI Lee, Jung Myung/0000-0002-1904-5335; Choi, Eue-Keun/0000-0002-0411-6372;
   Cha, Myung-Jin/0000-0001-6180-0157; Kim, Changsoo/0000-0002-5940-5649;
   Kim, Tae-Hoon/0000-0003-4200-3456; Uhm, Jae-Sun/0000-0002-1611-8172; a,
   gokul/0000-0003-2226-4691; Joung, Boyoung/0000-0001-9036-7225; Kang,
   Ki-Woon/0000-0002-1361-0022; Park, Jin-Kyu/0000-0001-7931-777X; Shim,
   Jaemin/0000-0001-8251-1522
FU Basic Science Research Program through the National Research Foundation
   of Korea (NRF) - Ministry of Science, ICT & Future Planning
   [NRF-2012R1A2A2A02045367, 2010-0021993]; Korean Healthcare Technology R
   & D Project - Ministry of Health Welfare [HI12C1552, HI16C0058,
   HI15C1200]
FX This research was supported by the Basic Science Research Program
   through the National Research Foundation of Korea (NRF), which is funded
   by the Ministry of Science, ICT & Future Planning
   (NRF-2012R1A2A2A02045367, 2010-0021993). This work was also supported by
   grants from the Korean Healthcare Technology R & D Project, which is
   funded by the Ministry of Health & Welfare (HI12C1552, HI16C0058, and
   HI15C1200).
CR Andersson T, 2014, INT J CARDIOL, V177, P91, DOI 10.1016/j.ijcard.2014.09.092
   Connolly SJ, 2009, NEW ENGL J MED, V361, P1139, DOI 10.1056/NEJMoa0905561
   Cooke FL, 2010, INT J HUM RESOUR MAN, V21, P2249, DOI 10.1080/09585192.2010.509627
   Friberg L, 2012, EUR HEART J, V33, P1500, DOI 10.1093/eurheartj/ehr488
   Friberg L, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e3522
   Gillis AM, 2017, CIRCULATION, V135, P593, DOI 10.1161/CIRCULATIONAHA.116.025312
   Giugliano RP, 2013, NEW ENGL J MED, V369, P2093, DOI 10.1056/NEJMoa1310907
   Granger CB, 2011, NEW ENGL J MED, V365, P981, DOI 10.1056/NEJMoa1107039
   Hsu JC, 2016, J AM COLL CARDIOL, V67, P2913, DOI 10.1016/j.jacc.2016.03.581
   January CT, 2014, J AM COLL CARDIOL, V64, pE1, DOI 10.1016/j.jacc.2014.03.022
   Kim H, 2017, KOREAN CIRC J, V47, P877, DOI 10.4070/kcj.2017.0146
   Ko D, 2017, NAT REV CARDIOL, V14, P113, DOI 10.1038/nrcardio.2016.171
   Lee JM, 2017, HEART RHYTHM, V14, P1297, DOI 10.1016/j.hrthm.2017.05.034
   Lip GYH, 2015, CIRC-CARDIOVASC QUAL, V8, pS12, DOI 10.1161/CIRCOUTCOMES.114.001556
   Lip GYH, 2015, EUROPACE, V17, P24, DOI 10.1093/europace/euu155
   Okumura K, 2014, CIRC J, V78, P1593, DOI 10.1253/circj.CJ-14-0144
   Patel MR, 2010, NEW ENGL J MED, V362, P886, DOI 10.1056/NEJMoa0907272
   Patterson L, 2013, ASIA PAC BUS REV, V19, P85, DOI 10.1080/13602381.2012.697774
   Perino AC, 2017, J AM COLL CARDIOL, V70, P78, DOI 10.1016/j.jacc.2017.04.054
   Piccini JP, 2016, JAMA CARDIOL, V1, P282, DOI 10.1001/jamacardio.2016.0529
   Pisters R, 2010, CHEST, V138, P1093, DOI 10.1378/chest.10-0134
   Rienstra M, 2005, J AM COLL CARDIOL, V46, P1298, DOI 10.1016/j.jacc.2005.05.078
   Shantsila E, 2015, INT J CLIN PRACT, V69, P840, DOI 10.1111/ijcp.12625
   Steinberg BA, 2017, AM HEART J, V189, P40, DOI 10.1016/j.ahj.2017.03.024
   Suzuki S, 2015, CIRC J, V79, P432, DOI 10.1253/circj.CJ-14-1131
   Tomita H, 2015, CIRC J, V79, P1719, DOI 10.1253/circj.CJ-15-0095
   Tsadok MA, 2015, CIRC-CARDIOVASC QUAL, V8, P593, DOI 10.1161/CIRCOUTCOMES.114.001398
   Vallakati A, 2015, INT J CARDIOL, V187, P12, DOI 10.1016/j.ijcard.2015.03.341
   WOLF PA, 1991, STROKE, V22, P983, DOI 10.1161/01.STR.22.8.983
NR 29
TC 13
Z9 13
U1 0
U2 2
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JUN
PY 2018
VL 48
IS 6
BP 519
EP 528
DI 10.4070/kcj.2017.0389
PG 10
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA GJ3BV
UT WOS:000435150900008
PM 29856147
OA Green Published
DA 2021-04-22
ER

PT J
AU Nam, GB
AF Nam, Gi-Byoung
TI Gender Issues in Medical Decisions: Implicit Stereotyping and
   Unconscious Bias
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
ID ATRIAL-FIBRILLATION; STROKE; RISK
C1 [Nam, Gi-Byoung] Univ Ulsan, Dept Cardiol, Asan Med Ctr, Coll Med, 88 Olymp Ro 43 Gil, Seoul 05505, South Korea.
RP Nam, GB (corresponding author), Univ Ulsan, Dept Cardiol, Asan Med Ctr, Coll Med, 88 Olymp Ro 43 Gil, Seoul 05505, South Korea.
EM gbnam@amc.seoul.kr
CR Cheng EY, 2016, AM J CARDIOL, V117, P1021, DOI 10.1016/j.amjcard.2015.12.040
   Dagres N, 2007, J AM COLL CARDIOL, V49, P572, DOI 10.1016/j.jacc.2006.10.047
   Kang SH, 2017, CIRC J, V81, P1158, DOI 10.1253/circj.CJ-16-1267
   Kaufman ES, 2009, HEART RHYTHM, V6, pS51, DOI 10.1016/j.hrthm.2009.02.009
   Khamis RY, 2016, HEART, V102, P1142, DOI 10.1136/heartjnl-2014-306463
   Lane DA, 2009, THROMB HAEMOSTASIS, V101, P802, DOI 10.1160/TH09-02-0106
   Lee JM, 2018, KOREAN CIRC J, V48, P519, DOI 10.4070/kcj.2017.0389
   Maas AHEM, 2010, NETH HEART J, V18, P598, DOI 10.1007/s12471-010-0841-y
   Richardson SS, 2010, BIOL PHILOS, V25, P823, DOI 10.1007/s10539-010-9207-5
   Roger VL, 2011, CIRCULATION, V123, pE18, DOI 10.1161/CIR.0b013e3182009701
NR 10
TC 1
Z9 1
U1 0
U2 2
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JUN
PY 2018
VL 48
IS 6
BP 529
EP 531
DI 10.4070/kcj.2018.0151
PG 3
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA GJ3BV
UT WOS:000435150900009
PM 29856148
OA Green Published
DA 2021-04-22
ER

PT J
AU Kim, Y
   Jeong, MH
   Kim, I
   Kim, MC
   Sim, DS
   Hong, YJ
   Kim, JH
   Ahn, Y
AF Kim, Yongcheol
   Jeong, Myung Ho
   Kim, Inna
   Kim, Min Chul
   Sim, Doo Sun
   Hong, Young Joon
   Kim, Ju Han
   Ahn, Youngkeun
TI Intravascular Ultrasound-Guided Percutaneous Coronary Intervention with
   Drug-eluting Stent for Unprotected Left Main Disease via Left Snuffbox
   Approach
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
C1 [Kim, Yongcheol; Jeong, Myung Ho; Kim, Inna; Kim, Min Chul; Sim, Doo Sun; Hong, Young Joon; Kim, Ju Han; Ahn, Youngkeun] Chonnam Natl Univ Hosp, Div Cardiol, Gwangju, South Korea.
RP Jeong, MH (corresponding author), Chonnam Natl Univ Hosp, Cardiovasc Convergence Res Ctr, 42 Jebong Ro, Gwangju 61469, South Korea.
EM myungho@chollian.net
OI Kim, Yongcheol/0000-0001-5568-4161; Kim, Juhan/0000-0002-3186-0770; Kim,
   Ju Han/0000-0003-1522-9038; Kim, Min Chul/0000-0001-6026-1702; Jeong,
   Myung Ho/0000-0003-2424-810X; Lee, Doo Hwan/0000-0001-7069-2047
CR Kiemeneij F, 2017, EUROINTERVENTION, V13, P851, DOI 10.4244/EIJ-D-17-00079
NR 1
TC 25
Z9 25
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JUN
PY 2018
VL 48
IS 6
BP 532
EP 533
DI 10.4070/kcj.2018.0016
PG 2
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA GJ3BV
UT WOS:000435150900010
PM 29856149
OA Green Published
DA 2021-04-22
ER

PT J
AU Shikama, T
   Miura, M
   Shirai, S
   Hayashi, M
   Morita, J
   Nagashima, M
   Ando, K
AF Shikama, Taku
   Miura, Mizuki
   Shirai, Shinichi
   Hayashi, Masaomi
   Morita, Junji
   Nagashima, Michio
   Ando, Kenji
TI Leadless Pacemaker Implantation Following Transcatheter Aortic Valve
   Implantation Using SAPIEN 3
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
C1 [Shikama, Taku; Miura, Mizuki; Shirai, Shinichi; Hayashi, Masaomi; Morita, Junji; Nagashima, Michio; Ando, Kenji] Kokura Mem Hosp, Dept Cardiol, Kitakyushu, Fukuoka, Japan.
RP Miura, M (corresponding author), Kokura Mem Hosp, Dept Cardiol, Kokurakita Ku, 3-2-1 Asano, Kitakyushu, Fukuoka 8028555, Japan.
EM mizumiura-circ@umin.ac.jp
OI Miura, Mizuki/0000-0003-3252-3861
NR 0
TC 3
Z9 3
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JUN
PY 2018
VL 48
IS 6
BP 534
EP 535
DI 10.4070/kcj.2018.0024
PG 2
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA GJ3BV
UT WOS:000435150900011
PM 29856150
OA Green Published
DA 2021-04-22
ER

PT J
AU Yu, CW
   Kim, WJ
   Ahn, JM
   Kook, H
   Kang, SH
   Han, JK
   Ko, YG
   Choi, SH
   Koo, BK
   Chang, K
   Kim, HS
AF Yu, Cheol Woong
   Kim, Won-Jang
   Ahn, Jung-Min
   Kook, Hyungdon
   Kang, Se Hun
   Han, Jung-Kyu
   Ko, Young-Guk
   Choi, Seung-Hyuk
   Koo, Bon-Kwon
   Chang, Kiyuk
   Kim, Hyo-Soo
TI Trends and Outcomes of Transcatheter Aortic Valve Implantation (TAVI) in
   Korea: the Results of the First Cohort of Korean TAVI Registry
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Aortic valve stenosis; Transcatheter aortic valve replacement;
   Mortality; Koreans
ID INTERMEDIATE-RISK PATIENTS; REPLACEMENT; STENOSIS
AB Background and Objectives: There has been no nation-wide data on the outcomes of transcatheter aortic valve implantation (TAVI) after commercialization of TAVI in Korea. We report clinical features and outcomes of the first cohort of TAVI performed from Jun 2015 to Jun 2017 in Korea.
   Methods: The first cohort of Korean-TAVI (K-TAVI) registry includes 576 consecutive patients with severe symptomatic aortic stenosis who underwent TAVI from 17 Korean hospitals for 2 years.
   Results: Most of TAVI procedures were performed for septuagenarians and octogenarians (90.8%) through transfemoral approach (98.3%). The rate of device success was 92.5% and permanent pacemaker was implanted in 5.6%. In successive years, incidences of paravalvular leakage (PVL) and major bleeding declined. Society of Thoracic Surgeons (STS) score was 5.2 (3.0 to 9.0) and 34.7% of patients had high surgical risk (STS >= 8). One-year all-cause death occurred in 8.9% and was significantly lower in low to intermediate risk one than in high risk (5.4% vs. 15.5%, p< 0.001). The independent predictors of 1-year mortality were age (hazard ratio [HR], 1.087; 95% confidence interval [CI], 1.036-1.141; p= 0.001), moderate or severe PVL (HR, 4.631; 95% CI, 1.624-13.203; p= 0.004) and end-stage renal disease (HR, 5.785; 95% CI, 2.717-12.316; p< 0.001).
   Conclusions: K-TAVI registry showed favorable 1-year outcomes with decreasing complication rate over time in real-world Korean patients. Two-thirds of patients were low to intermediate surgical risk and showed a significantly lower mortality than the high-risk patients, suggesting the promising future on the expanded indications of TAVI.
C1 [Yu, Cheol Woong; Kook, Hyungdon] Korea Univ, Coll Med, Anam Hosp, Dept Cardiol,Dept Internal Med, Seoul, South Korea.
   [Kim, Won-Jang; Kang, Se Hun] CHA Univ, Coll Med, CHA Bundang Med Ctr, Dept Cardiol,Dept Internal Med, Seongnam, South Korea.
   [Ahn, Jung-Min] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Cardiol,Dept Internal Med, Seoul, South Korea.
   [Han, Jung-Kyu; Koo, Bon-Kwon; Kim, Hyo-Soo] Seoul Natl Univ, Seoul Natl Univ Hosp, Dept Cardiol, Dept Internal Med,Coll Med, Seoul, South Korea.
   [Ko, Young-Guk] Yonsei Univ, Coll Med, Severance Hosp, Dept Cardiol,Dept Internal Med, Seoul, South Korea.
   [Choi, Seung-Hyuk] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Cardiol,Dept Internal Med, Seoul, South Korea.
   [Chang, Kiyuk] Catholic Univ, Korea Sch Med, Seoul St Marys Hosp, Dept Cardiol,Dept Internal Med, Seoul, South Korea.
RP Kim, HS (corresponding author), Seoul Natl Univ Hosp, Dept Internal iedicine, 101 Daehak Ro, Seoul 03080, South Korea.; Chang, K (corresponding author), Catholic Univ, Korea Sch Med, Seoul St Marys Hosp, 222 Banpo Daero, Seoul, South Korea.
EM kiyuk@catholic.ac.kr; hyosoo@snu.ac.kr
OI Yu, Cheol Woong/0000-0002-5871-4562; Kang, Se Hun/0000-0001-5876-1791
CR Barbash IM, 2015, AM J CARDIOL, V116, P1916, DOI 10.1016/j.amjcard.2015.09.030
   Grube E, 2007, J AM COLL CARDIOL, V50, P69, DOI 10.1016/j.jacc.2007.04.047
   Kappetein AP, 2012, EUR HEART J, V33, P2403, DOI 10.1093/eurheartj/ehs255
   Leon MB, 2016, NEW ENGL J MED, V374, P1609, DOI 10.1056/NEJMoa1514616
   Leon MB, 2010, NEW ENGL J MED, V363, P1597, DOI 10.1056/NEJMoa1008232
   Ludman PF, 2015, CIRCULATION, V131, P1181, DOI 10.1161/CIRCULATIONAHA.114.013947
   Mack MJ, 2013, JAMA-J AM MED ASSOC, V310, P2069, DOI 10.1001/jama.2013.282043
   Reardon MJ, 2017, NEW ENGL J MED, V376, P1321, DOI 10.1056/NEJMoa1700456
   Sawa Y, 2014, CIRC J, V78, P1083, DOI 10.1253/circj.CJ-14-0162
   Sinning JM, 2010, JACC-CARDIOVASC INTE, V3, P1141, DOI 10.1016/j.jcin.2010.09.009
   Smith CR, 2011, NEW ENGL J MED, V364, P2187, DOI 10.1056/NEJMoa1103510
   Takimoto S, 2017, CIRC J, V81, P103, DOI 10.1253/circj.CJ-16-0546
   Van Mieghem NM, 2014, CATHETER CARDIO INTE, V83, pE277, DOI 10.1002/ccd.24597
NR 13
TC 9
Z9 9
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAY
PY 2018
VL 48
IS 5
BP 382
EP 394
DI 10.4070/kcj.2018.0117
PG 13
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA GI3FZ
UT WOS:000434258300004
PM 29671283
OA Green Published
DA 2021-04-22
ER

PT J
AU Her, AY
   Shin, ES
AF Her, Ae-Young
   Shin, Eun-Seok
TI Current Management of In-Stent Restenosis
SO KOREAN CIRCULATION JOURNAL
LA English
DT Review
DE Restenosis; Angioplasty; Balloon; Coronary; Drug-eluting stent
ID DRUG-ELUTING STENT; PACLITAXEL-COATED BALLOON; BARE-METAL STENTS;
   RANDOMIZED CONTROLLED-TRIAL; PERCUTANEOUS CORONARY INTERVENTION; OPTICAL
   COHERENCE TOMOGRAPHY; GAMMA-RADIATION THERAPY; ANGIOGRAPHIC FOLLOW-UP;
   ROTATIONAL ATHERECTOMY; VASCULAR BRACHYTHERAPY
AB Despite the advent of the drug-eluting stents (DES) and improved stent design, in-stent restenosis (ISR) remains a challenging problem. The currently available options for treatment of ISR include angioplasty alone, repeat stenting with DES or drug-coated balloons. Several recent studies have compared the available options for treating ISR in an attempt to identify the preferred therapeutic strategy. In this review, we will discuss the currently available therapeutic strategies for the management of patients with ISR and the evidence supporting their use.
C1 [Her, Ae-Young] Kangwon Natl Univ, Sch Med, Dept Internal Med, Div Cardiol, Chunchon, South Korea.
   [Shin, Eun-Seok] Univ Ulsan, Coll Med, Ulsan Univ Hosp, Div Cardiol,Dept Internal Med, 877 Bangeojinsunhwando Ro, Ulsan 44033, South Korea.
RP Shin, ES (corresponding author), Univ Ulsan, Coll Med, Ulsan Univ Hosp, Div Cardiol,Dept Internal Med, 877 Bangeojinsunhwando Ro, Ulsan 44033, South Korea.
EM sesim1989@gmail.com
CR Adamian M, 2001, J AM COLL CARDIOL, V38, P672, DOI 10.1016/S0735-1097(01)01458-9
   Albiero R, 2004, J AM COLL CARDIOL, V43, P943, DOI 10.1016/j.jacc.2003.09.054
   Alfonso F, 2005, CATHETER CARDIO INTE, V66, P521, DOI 10.1002/ccd.20524
   Alfonso F, 2012, MINERVA MED, V103, P441
   Alfonso F, 2003, J AM COLL CARDIOL, V42, P796, DOI 10.1016/S0735-1097(03)00852-0
   Alfonso F, 2006, AM HEART J, V151, DOI 10.1016/j.ahj.2005.10.014
   Alfonso F, 2005, AM HEART J, V149, DOI 10.1016/j.ahj.2004.06.022
   Alfonso F, 1999, AM J CARDIOL, V83, P1268, DOI 10.1016/S0002-9149(99)00071-5
   Alfonso F, 2008, J AM COLL CARDIOL, V52, P1621, DOI 10.1016/j.jacc.2008.08.025
   Alfonso F, 2006, J AM COLL CARDIOL, V47, P2152, DOI 10.1016/j.jacc.2005.10.078
   Alfonso F, 2015, J AM COLL CARDIOL, V66, P23, DOI 10.1016/j.jacc.2015.04.063
   Alfonso F, 2014, J AM COLL CARDIOL, V63, P2659, DOI 10.1016/j.jacc.2014.02.545
   Alfonso F, 2014, J AM COLL CARDIOL, V63, P1378, DOI 10.1016/j.jacc.2013.12.006
   Alfonso F, 2012, JACC-CARDIOVASC INTE, V5, P728, DOI 10.1016/j.jcin.2012.03.017
   Alfonso F, 2012, CIRC-CARDIOVASC INTE, V5, pE1, DOI 10.1161/CIRCINTERVENTIONS.111.966606
   Alfonso F, 2010, J AM COLL CARDIOL, V55, P2717, DOI 10.1016/j.jacc.2010.03.026
   Alfonso Fernando, 2009, EuroIntervention, V5 Suppl D, pD70
   Alfonso F, 2009, J AM COLL CARDIOL, V54, P1036, DOI 10.1016/j.jacc.2009.04.082
   Angiolillo DJ, 2004, CATHETER CARDIO INTE, V61, P387, DOI 10.1002/ccd.10765
   Aoyama T, 2008, CIRC J, V72, P56, DOI 10.1253/circj.72.56
   Byrne RA, 2012, MINERVA CARDIOANGIOL, V60, P473
   Byrne RA, 2013, EUROINTERVENTION, V9, P797, DOI 10.4244/EIJV9I7A132
   Byrne RA, 2013, LANCET, V381, P461, DOI 10.1016/S0140-6736(12)61964-3
   Byrne RA, 2009, JACC-CARDIOVASC INTE, V2, P291, DOI 10.1016/j.jcin.2008.11.015
   Cassese S, 2014, HEART, V100, P153, DOI 10.1136/heartjnl-2013-304933
   Collet CA, 2011, JACC-CARDIOVASC INTE, V4, P1067, DOI 10.1016/j.jcin.2011.07.010
   Dangas GD, 2010, J AM COLL CARDIOL, V56, P1897, DOI 10.1016/j.jacc.2010.07.028
   Dibra A, 2007, J AM COLL CARDIOL, V49, P616, DOI 10.1016/j.jacc.2006.10.049
   Fujii K, 2004, CIRCULATION, V109, P1085, DOI 10.1161/01.CIR.0000121327.67756.19
   Giacoppo D, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h5392
   Goel SS, 2016, CATHETER CARDIO INTE, V87, P1080, DOI 10.1002/ccd.26151
   Habara S, 2011, JACC-CARDIOVASC INTE, V4, P149, DOI 10.1016/j.jcin.2010.10.012
   Hausleiter J, 2004, CIRCULATION, V110, P790, DOI 10.1161/01.CIR.0000138935.17503.35
   HERNANDEZ RA, 1992, J AM COLL CARDIOL, V19, P1402, DOI 10.1016/0735-1097(92)90594-D
   Holmes DR, 2006, JAMA-J AM MED ASSOC, V295, P1264, DOI 10.1001/jama.295.11.1264
   Ichimoto E, 2018, INT HEART J, V59, P14, DOI 10.1536/ihj.16-638
   Indermuehle A, 2013, HEART, V99, P327, DOI 10.1136/heartjnl-2012-302945
   Jamshidi P, 2016, EUROINTERVENTION, V11, P1479, DOI 10.4244/EIJV11I13A287
   Kang SJ, 2011, CIRCULATION, V123, P2954, DOI 10.1161/CIRCULATIONAHA.110.988436
   Kastrati A, 2005, JAMA-J AM MED ASSOC, V293, P165, DOI 10.1001/jama.293.2.165
   Kastrati A, 2011, JACC-CARDIOVASC INTE, V4, P165, DOI 10.1016/j.jcin.2010.11.008
   Kim YH, 2017, YONSEI MED J, V58, P720, DOI 10.3349/ymj.2017.58.4.720
   Kim YH, 2017, CORONARY ARTERY DIS, V28, P307, DOI 10.1097/MCA.0000000000000479
   Kimura T, 1996, NEW ENGL J MED, V334, P561, DOI 10.1056/NEJM199602293340903
   Kobayashi Y, 2001, CATHETER CARDIO INTE, V52, P208, DOI 10.1002/1522-726X(200102)52:2<208::AID-CCD1049>3.0.CO;2-H
   Kufner S, 2017, JACC-CARDIOVASC INTE, V10, P1332, DOI 10.1016/j.jcin.2017.04.024
   Kufner S, 2009, JACC-CARDIOVASC INTE, V2, P1142, DOI 10.1016/j.jcin.2009.08.015
   KUNTZ RE, 1993, CIRCULATION, V88, P1310, DOI 10.1161/01.CIR.88.3.1310
   Latib A, 2011, JACC-CARDIOVASC INTE, V4, P155, DOI 10.1016/j.jcin.2010.09.027
   Leon MB, 2001, NEW ENGL J MED, V344, P250, DOI 10.1056/NEJM200101253440402
   Lopez-Palop R, 2004, EUR HEART J, V25, P2040, DOI 10.1016/j.ehj.2004.07.016
   MACANDER PJ, 1994, CATHETER CARDIO DIAG, V32, P125, DOI 10.1002/ccd.1810320206
   Mehran R, 2000, CIRCULATION, V101, P2484, DOI 10.1161/01.CIR.101.21.2484
   Mehran R, 1996, AM J CARDIOL, V78, P618, DOI 10.1016/S0002-9149(96)00381-5
   Mehran R, 1999, CIRCULATION, V100, P1872, DOI 10.1161/01.CIR.100.18.1872
   Mintz GS, 1998, AM J CARDIOL, V81, p7E, DOI 10.1016/S0002-9149(98)00190-8
   Montorsi Piero, 2004, Ital Heart J, V5, P271
   Moustapha A, 2002, CATHETER CARDIO INTE, V56, P184, DOI 10.1002/ccd.10166
   Mukherjee D, 2000, J Invasive Cardiol, V12, P540
   Nakazawa G, 2011, J AM COLL CARDIOL, V57, P1314, DOI 10.1016/j.jacc.2011.01.011
   Nam CW, 2011, AM J CARDIOL, V107, P1783, DOI 10.1016/j.amjcard.2011.02.328
   Nicolais C, 2018, CURR CARDIOL REP, V20, DOI 10.1007/s11886-018-0952-4
   Pinto DS, 2006, J AM COLL CARDIOL, V48, P32, DOI 10.1016/j.jacc.2006.02.060
   Rittger H, 2012, J AM COLL CARDIOL, V59, P1377, DOI 10.1016/j.jacc.2012.01.015
   Rivero F, 2015, CAN J CARDIOL, V31, P255, DOI 10.1016/j.cjca.2014.11.017
   Sanchez PL, 2003, CATHETER CARDIO INTE, V58, P155, DOI 10.1002/ccd.10399
   Scheller B, 2006, NEW ENGL J MED, V355, P2113, DOI 10.1056/NEJMoa061254
   Sharma SK, 2004, AM HEART J, V147, P16, DOI 10.1016/j.ahj.2003.07.002
   Siontis GCM, 2015, LANCET, V386, P655, DOI 10.1016/S0140-6736(15)60657-2
   Solinas E, 2008, AM J CARDIOL, V102, P311, DOI 10.1016/j.amjcard.2008.03.060
   Stefanini GG, 2013, NEW ENGL J MED, V368, P254, DOI 10.1056/NEJMra1210816
   Stettler C, 2007, LANCET, V370, P937, DOI 10.1016/S0140-6736(07)61444-5
   Stone GW, 2005, JAMA-J AM MED ASSOC, V294, P1215, DOI 10.1001/jama.294.10.1215
   Stone GW, 2006, JAMA-J AM MED ASSOC, V295, P1253, DOI 10.1001/jama.295.11.1253
   Torguson R, 2006, AM J CARDIOL, V98, P1340, DOI 10.1016/j.amjcard.2006.06.027
   Unverdorben M, 2009, CIRCULATION, V119, P2986, DOI 10.1161/CIRCULATIONAHA.108.839282
   vom Dahl J, 2002, CIRCULATION, V105, P583, DOI 10.1161/hc0502.103347
   Waksman R, 2000, CIRCULATION, V101, P2165, DOI 10.1161/01.CIR.101.18.2165
   Win HK, 2007, JAMA-J AM MED ASSOC, V297, P2001, DOI 10.1001/jama.297.18.2001
   Xu B, 2014, JACC-CARDIOVASC INTE, V7, P204, DOI 10.1016/j.jcin.2013.08.011
NR 80
TC 9
Z9 9
U1 1
U2 5
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAY
PY 2018
VL 48
IS 5
BP 337
EP 349
DI 10.4070/kcj.2018.0103
PG 13
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA GI3FZ
UT WOS:000434258300001
PM 29737639
OA Green Published
DA 2021-04-22
ER

PT J
AU Kenny, D
AF Kenny, Damien
TI Interventional Cardiology for Congenital Heart Disease
SO KOREAN CIRCULATION JOURNAL
LA English
DT Review
DE Transcatheter; Congenital; Stenting; Pulmonary valve replacement
ID TRANSCATHETER PULMONARY VALVE; VENTRICULAR SEPTAL-DEFECTS; HYPOPLASTIC
   LEFT-HEART; SINGLE-CENTER EXPERIENCE; BLALOCK-TAUSSIG SHUNT; BALLOON
   AORTIC VALVULOPLASTY; PATENT DUCTUS-ARTERIOSUS; OUTFLOW TRACT; MELODY
   VALVE; CARDIAC-CATHETERIZATION
AB Congenital heart interventions are now replacing surgical palliation and correction in an evolving number of congenital heart defects. Right ventricular outflow tract and ductus arteriosus stenting have demonstrated favorable outcomes compared to surgical systemic to pulmonary artery shunting, and it is likely surgical pulmonary valve replacement will become an uncommon procedure within the next decade, mirroring current practices in the treatment of atrial septal defects. Challenges remain, including the lack of device design focused on smaller infants and the inevitable consequences of somatic growth. Increasing parental and physician expectancy has inevitably lead to higher risk interventions on smaller infants and appreciation of the consequences of these interventions on departmental outcome data needs to be considered. Registry data evaluating congenital heart interventions remain less robust than surgical registries, leading to a lack of insight into the longer-term consequences of our interventions. Increasing collaboration with surgical colleagues has not been met with necessary development of dedicated equipment for hybrid interventions aimed at minimizing the longer-term consequences of scar to the heart. Therefore, great challenges remain to ensure children and adults with congenital heart disease continue to benefit from an exponential growth in minimally invasive interventions and technology. This can only be achieved through a concerted collaborative approach from physicians, industry, academia and regulatory bodies supporting great innovators to continue the philosophy of thinking beyond the limits that has been the foundation of our specialty for the past 50 years.
C1 [Kenny, Damien] Our Ladys Childrens Hosp, Cooley Rd,D12 V004, Dublin 12, Ireland.
RP Kenny, D (corresponding author), Our Ladys Childrens Hosp, Cooley Rd,D12 V004, Dublin 12, Ireland.
EM damien_kenny@icloud.com
CR Akintuerk H, 2002, CIRCULATION, V105, P1099, DOI 10.1161/hc0902.104709
   Aldoss O, 2016, PEDIATR CARDIOL, V37, P1211, DOI 10.1007/s00246-016-1418-3
   Alsoufi B, 2011, ANN THORAC SURG, V91, P566, DOI 10.1016/j.athoracsur.2010.08.034
   Avolio E, 2015, FRONT CELL DEV BIOL, V3, DOI 10.3389/fcell.2015.00039
   Backes CH, 2013, CATHETER CARDIO INTE, V82, P786, DOI 10.1002/ccd.24726
   Barron DJ, 2013, EUR J CARDIO-THORAC, V44, P656, DOI 10.1093/ejcts/ezt188
   Bentham JR, 2018, CIRCULATION, V137, P581, DOI 10.1161/CIRCULATIONAHA.117.028972
   Bergersen L, 2017, JACC-CARDIOVASC INTE, V10, P1763, DOI 10.1016/j.jcin.2017.05.034
   Bergersen L, 2011, JACC-CARDIOVASC INTE, V4, P1037, DOI 10.1016/j.jcin.2011.05.021
   Boe BA, 2017, JACC-CARDIOVASC INTE, V10, P1717, DOI [10.1016/j.jcin.2017.08.00, 10.1016/j.jcin.2017.08.001]
   Boudjemline Y, 2018, CATHETER CARDIO INTE, V91, P64, DOI 10.1002/ccd.27332
   Brili S, 2005, ATHEROSCLEROSIS, V182, P97, DOI 10.1016/j.atherosclerosis.2005.01.030
   Bruckheimer E, 2016, EUR HEART J-CARD IMG, V17, P845, DOI 10.1093/ehjci/jew087
   Cao QL, 2014, CATHETER CARDIO INTE, V84, P1131, DOI 10.1002/ccd.25544
   Cevallos PC, 2016, PEDIATR CARDIOL, V37, P1436, DOI 10.1007/s00246-016-1454-z
   Cheatham JP, 2015, CIRCULATION, V131, P1960, DOI 10.1161/CIRCULATIONAHA.114.013588
   Chungsomprasong P, 2011, CATHETER CARDIO INTE, V78, P1032, DOI 10.1002/ccd.23084
   Cohen S, 2017, CIRCULATION
   Donofrio MT, 2014, CIRCULATION, V129, P2183, DOI 10.1161/01.cir.0000437597.44550.5d
   Emery SP, 2010, MINIM INVASIVE SURG, V2010, DOI 10.1155/2010/674185
   Esch JJ, 2013, J HEART LUNG TRANSPL, V32, P381, DOI 10.1016/j.healun.2013.01.1049
   Ewert P, 2004, CATHETER CARDIO INTE, V62, P506, DOI 10.1002/ccd.20136
   Feltes TF, 2011, CIRCULATION, V123, P2607, DOI 10.1161/CIR.0b013e31821b1f10
   Forte MNV, 2018, JACC-CARDIOVASC IMAG, V11, P275, DOI 10.1016/j.jcmg.2017.07.010
   Freud LR, 2014, CIRCULATION, V130, P638, DOI 10.1161/CIRCULATIONAHA.114.009032
   Frydrychowicz A, 2007, ROFO-FORTSCHR RONTG, V179, P463, DOI 10.1055/s-2007-962941
   Fu YC, 2006, J AM COLL CARDIOL, V47, P319, DOI 10.1016/j.jacc.2005.09.028
   Glatz AC, 2018, CIRCULATION, V137, P589, DOI 10.1161/CIRCULATIONAHA.117.029987
   Gray RG, 2017, CATHETER CARDIO INTE, V90, P281, DOI 10.1002/ccd.27121
   Haggerty CM, 2012, ANN BIOMED ENG, V40, P2639, DOI 10.1007/s10439-012-0614-4
   Happel CM, 2015, CATHETER CARDIO INTE, V85, P990, DOI 10.1002/ccd.25783
   Hasan BS, 2011, CIRC-CARDIOVASC INTE, V4, P615, DOI 10.1161/CIRCINTERVENTIONS.111.963389
   Holzer RJ, 2009, PEDIATR CARDIOL, V30, P1075, DOI 10.1007/s00246-009-9500-8
   Jameel AA, 2006, PEDIATR CARDIOL, V27, P720, DOI 10.1007/s00246-006-1365-5
   Karamlou T, 2015, J THORAC CARDIOV SUR, V149, P195, DOI 10.1016/j.jtcvs.2014.08.020
   Kim GB, 2017, CATHETER CARDIO INTE, V89, P906, DOI 10.1002/ccd.26910
   KING TD, 1976, JAMA-J AM MED ASSOC, V235, P2506, DOI 10.1001/jama.235.23.2506
   Koneti NR, 2013, CATHETER CARDIO INTE, V82, pE500, DOI 10.1002/ccd.25020
   Levi DS, 2016, CATHETER CARDIO INTE, V88, P434, DOI 10.1002/ccd.26398
   Lin CH, 2013, PEDIATR CARDIOL, V34, P743, DOI 10.1007/s00246-012-0337-1
   Maglione J, 2009, CIRC-CARDIOVASC INTE, V2, P52, DOI 10.1161/CIRCINTERVENTIONS.108.826263
   Marshall AC, 2008, PRENATAL DIAG, V28, P1023, DOI 10.1002/pd.2114
   MAXWELL D, 1991, BRIT HEART J, V65, P256
   McCrossan BA, 2016, CATHETER CARDIO INTE, V87, P324, DOI 10.1002/ccd.25768
   McElhinney DB, 2016, CIRCULATION, V133, P1738, DOI 10.1161/CIRCULATIONAHA.115.019987
   Morray BH, 2017, CIRC-CARDIOVASC INTE, V10, DOI 10.1161/CIRCINTERVENTIONS.116.004914
   Morray BH, 2013, CIRC-CARDIOVASC INTE, V6, P535, DOI 10.1161/CIRCINTERVENTIONS.113.000202
   Mullen MJ, 2006, CIRCULATION, V114, P1962, DOI 10.1161/CIRCULATIONAHA.106.664672
   NEYA K, 1995, CIRCULATION, V91, P2445, DOI 10.1161/01.CIR.91.9.2445
   Nijres BM, 2017, CATHETER CARDIO INTE, V90, P1154, DOI 10.1002/ccd.26996
   Nykanen DG, 2016, CATHETER CARDIO INTE, V87, P302, DOI 10.1002/ccd.26300
   Papa M, 2013, CATHETER CARDIO INTE, V81, P1180, DOI 10.1002/ccd.24633
   Patel S, 2015, CATHETER CARDIO INTE, V86, P821, DOI 10.1002/ccd.26036
   Phillips ABM, 2016, CATHETER CARDIO INTE, V87, P403, DOI 10.1002/ccd.26315
   Porras D, 2014, CONGENIT HEART DIS, V9, P316, DOI 10.1111/chd.12142
   PORSTMANN W, 1967, THORAXCHIRURGIE, V15, P109
   Quandt D, 2017, HEART, V103, P1985, DOI 10.1136/heartjnl-2016-310620
   Quandt D, 2017, JACC-CARDIOVASC INTE, V10, P1774, DOI 10.1016/j.jcin.2017.06.023
   Quinonez LG, 2014, J THORAC CARDIOV SUR, V148, P1443, DOI 10.1016/j.jtcvs.2013.10.059
   Ratnayaka K, 2016, JACC-CARDIOVASC INTE, V9, P959, DOI 10.1016/j.jcin.2016.01.032
   Rogers T, 2015, CURR CARDIOL REP, V17, DOI 10.1007/s11886-015-0580-1
   Ryan A, 2018, PEDIATR CARDIOL, V39, P160, DOI 10.1007/s00246-017-1742-2
   Sathanandam S, 2017, CATHETER CARDIO INTE, V89, P1051, DOI 10.1002/ccd.26878
   Schranz D, 2015, PEDIATR CARDIOL, V36, P365, DOI 10.1007/s00246-014-1015-2
   Shahanavaz S, 2018, CATHETER CARDIO INTE, V91, P81, DOI 10.1002/ccd.27237
   Shibbani K, 2016, PEDIATR CARDIOL, V37, P925, DOI 10.1007/s00246-016-1372-0
   Sizarov A, 2016, ARCH CARDIOVASC DIS, V109, P348, DOI 10.1016/j.acvd.2016.01.005
   Sizarov A, 2016, ARCH CARDIOVASC DIS, V109, P286, DOI 10.1016/j.acvd.2016.01.007
   Sizarov A, 2016, ARCH CARDIOVASC DIS, V109, P278, DOI 10.1016/j.acvd.2015.12.002
   Sosnowski C, 2016, CATHETER CARDIO INTE, V88, P804, DOI 10.1002/ccd.26620
   Szkutnik M, 2007, HEART, V93, P355, DOI 10.1136/hrt.2006.096321
   Takaya Y, 2016, JACC-CARDIOVASC INTE, V9, pE111, DOI 10.1016/j.jcin.2016.03.014
   Torres A, 2015, CATHETER CARDIO INTE, V86, P438, DOI 10.1002/ccd.25897
   Truong UT, 2015, CATHETER CARDIO INTE, V86, P1068, DOI 10.1002/ccd.26004
   Ungerleider RM, 2001, ANN THORAC SURG, V71, P476, DOI 10.1016/S0003-4975(00)01822-1
   Van Dijck I, 2015, HEART, V101, P788, DOI 10.1136/heartjnl-2014-306761
   van Velzen CL, 2016, BJOG-INT J OBSTET GY, V123, P400, DOI 10.1111/1471-0528.13274
   Warnes CA, 2008, CIRCULATION, V118, P2395, DOI 10.1161/CIRCULATIONAHA.108.190811
   Xu Z, 2010, CIRCULATION, V121, P742, DOI 10.1161/CIRCULATIONAHA.109.889071
   Zahn EM, 2016, JACC-CARDIOVASC INTE, V9, P2429, DOI 10.1016/j.jcin.2016.09.019
NR 80
TC 2
Z9 2
U1 0
U2 5
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAY
PY 2018
VL 48
IS 5
BP 350
EP 364
DI 10.4070/kcj.2018.0064
PG 15
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA GI3FZ
UT WOS:000434258300002
PM 29671282
OA Green Published
DA 2021-04-22
ER

PT J
AU Morrone, D
   Morrone, V
AF Morrone, Doralisa
   Morrone, Vincenzo
TI Acute Pulmonary Embolism: Focus on the Clinical Picture
SO KOREAN CIRCULATION JOURNAL
LA English
DT Review
DE Pulmonary embolism; Sudden cardiac death; Syncope; Deep vein thrombosis
ID DEEP-VEIN THROMBOSIS; PATENT FORAMEN OVALE; ACUTE CORONARY SYNDROME;
   ST-SEGMENT-ELEVATION; RIGHT-VENTRICULAR DYSFUNCTION; SUDDEN CARDIAC
   DEATH; VENOUS THROMBOEMBOLISM; PARADOXICAL EMBOLISM; RISK-FACTORS;
   PROGNOSTIC-SIGNIFICANCE
AB Acute pulmonary embolism (APE) is characterized by numerous clinical manifestations which are the result of a complex interplay between different organs; the symptoms are therefore various and part of a complex clinical picture. For this reason, it may not be easy to make an immediate diagnosis. This is a comprehensive review of the literature on all the various clinical pictures in order to help physicians to promptly recognize this clinical condition, remembering that our leading role as cardiologists depends on and is influenced by our knowledge and working methods.
C1 [Morrone, Doralisa] Univ Pisa, Dept Surg Med Mol & Crit Area Pathol, Via Paradisa 2, I-56124 Pisa, Italy.
   [Morrone, Vincenzo] SS Annunziata Hosp, Dept Cardiol, Taranto, Italy.
RP Morrone, D (corresponding author), Univ Pisa, Dept Surg Med Mol & Crit Area Pathol, Via Paradisa 2, I-56124 Pisa, Italy.
EM doralisa.morrone@unipi.it
RI Morrone, Doralisa/AAB-2223-2019
OI Morrone, Doralisa/0000-0002-9667-6931
CR Adabag AS, 2010, NAT REV CARDIOL, V7, P216, DOI 10.1038/nrcardio.2010.3
   Akrawinthawong K, 2016, J AM COLL CARDIOL, V67, P1194, DOI 10.1016/S0735-1097(16)31195-0
   Amini R, 2014, J AM COLL CARDIOL, V63, pA699, DOI 10.1016/S0735-1097(14)60699-9
   Babak S, 2014, BMJ CASE REP, V2014
   Beckman MG, 2010, AM J PREV MED, V38, pS495, DOI 10.1016/j.amepre.2009.12.017
   Bharadwaj RS, 2011, PRIM CARE COMPANION, V13
   Bougouin W, 2016, CIRCULATION, V134, P2125, DOI 10.1161/CIRCULATIONAHA.116.024746
   Boyer NH, 1944, ARCH INTERN MED, V73, P0403, DOI 10.1001/archinte.1944.00210170040006
   Carey HB, 1999, AM J KIDNEY DIS, V34, P752, DOI 10.1016/S0272-6386(99)70403-8
   Carrascosa MF, 2009, MAYO CLIN PROC, V84, P91, DOI 10.1016/S0025-6196(11)60813-6
   Chugh SS, 2001, CARD ELECTROPHYSIOL, V5, P394, DOI DOI 10.1023/A:1013254132689
   Ciliberti P, 2012, J EMERG MED, V43, pE255, DOI 10.1016/j.jemermed.2011.03.037
   Cohen AT, 2007, THROMB HAEMOSTASIS, V98, P756, DOI 10.1160/TH07-03-0212
   Cohen AT, 1996, HAEMOSTASIS, V26, P65
   DITULLIO M, 1993, STROKE, V24, P1020, DOI 10.1161/01.STR.24.7.1020
   Duplyakov D, 2015, EUR HEART J-ACUTE CA, V4, P353, DOI 10.1177/2048872614527837
   Duru S, 2014, ARCH MED SCI, V10, P557, DOI 10.5114/aoms.2013.34325
   Eckart RE, 2011, J AM COLL CARDIOL, V58, P1254, DOI 10.1016/j.jacc.2011.01.049
   Eurostat, 2001, EUR STAT HLTH SAF 20
   Falterman TJ, 2001, J EMERG MED, V21, P255, DOI 10.1016/S0736-4679(01)00381-X
   Fanikos J, 2009, THROMB HAEMOSTASIS, V102, P688, DOI 10.1160/TH09-04-0266
   Fonarow GC, 2008, ARCH INTERN MED, V168, P847, DOI 10.1001/archinte.168.8.847
   Geibel A, 2005, EUR RESPIR J, V25, P843, DOI 10.1183/09031936.05.00119704
   Giorgi-Pierfranceschi M, 2017, BLOOD COAGUL FIBRIN, V28, P107, DOI 10.1097/MBC.0000000000000542
   Goldhaber SZ, 1999, LANCET, V353, P1386, DOI 10.1016/S0140-6736(98)07534-5
   Harjola VP, 2016, EUR J HEART FAIL, V18, P226, DOI 10.1002/ejhf.478
   Heit JA, 2000, ARCH INTERN MED, V160, P809, DOI 10.1001/archinte.160.6.809
   Heit JA, 2006, J THROMB THROMBOLYS, V21, P23, DOI 10.1007/s11239-006-5572-y
   Heit JA, 1999, ARCH INTERN MED, V159, P445, DOI 10.1001/archinte.159.5.445
   Heit JA, 2008, ARTERIOSCL THROM VAS, V28, P370, DOI 10.1161/ATVBAHA.108.162545
   Inouye SK, 2006, NEW ENGL J MED, V354, P1157, DOI 10.1056/NEJMra052321
   Islam M, 2018, RESPIROLOGY
   Jaff MR, 2011, CIRCULATION, V123, P1788, DOI 10.1161/CIR.0b013e318214914f
   Jenab Y, 2015, CLIN APPL THROMB-HEM, V21, P772, DOI 10.1177/1076029614540037
   Jerjes Sanchez Carlos, 1995, Archivos del Instituto de Cardiologia de Mexico, V65, P65
   Jimenez D, 2010, AM J RESP CRIT CARE, V181, P983, DOI 10.1164/rccm.200908-1204OC
   Karabulut N, 2008, DIAGN INTERV RADIOL, V14, P189
   Kearon C, 2003, CIRCULATION, V107, pI22, DOI 10.1161/01.CIR.0000078464.82671.78
   Kleber FX, 2014, J AM COLL CARDIOL, V64
   Klok FA, 2010, CHEST, V138, P1432, DOI 10.1378/chest.09-2482
   Knight B, 1996, FORENSIC PATHOLOGY
   Konstantinides S, 2005, CURR OPIN CARDIOL, V20, P496, DOI 10.1097/01.hco.0000179818.65329.bb
   Konstantinides S, 1998, CIRCULATION, V97, P1946, DOI 10.1161/01.CIR.97.19.1946
   Konstantinides SV, 2014, EUR HEART J, V35, P3033, DOI 10.1093/eurheartj/ehu283
   Kosuge M, 2016, J AM COLL CARDIOL, V67, P528, DOI 10.1016/S0735-1097(16)30529-0
   Kosuge M, 2012, EUR HEART J-ACUTE CA, V1, P349, DOI 10.1177/2048872612466790
   Kurkciyan I, 1998, CIRCULATION, V98, P766, DOI 10.1161/01.CIR.98.8.766
   Laack TA, 2004, EMERG MED CLIN N AM, V22, P961, DOI 10.1016/j.emc.2004.05.011
   Laporte S, 2008, CIRCULATION, V117, P1711, DOI 10.1161/CIRCULATIONAHA.107.726232
   LEWIS GP, 1960, PHYSIOL REV, V40, P647
   Lin JF, 2009, CIRC J, V73, P1157, DOI 10.1253/circj.CJ-08-0474
   LOSCALZO J, 1986, AM HEART J, V112, P141, DOI 10.1016/0002-8703(86)90692-7
   Lucena J, 2009, J FORENSIC LEG MED, V16, P196, DOI 10.1016/j.jflm.2008.08.015
   LUISADA AA, 1956, CIRCULATION, V13, P113, DOI 10.1161/01.CIR.13.1.113
   Manne JRR, 2016, J AM COLL CARDIOL, V67, P1118, DOI 10.1016/S0735-1097(16)31119-6
   Marshall Peter S, 2011, J Intensive Care Med, V26, P275, DOI 10.1177/0885066610392658
   McConnell MV, 1996, AM J CARDIOL, V78, P469, DOI 10.1016/S0002-9149(96)00339-6
   MCINTYRE KM, 1971, AM J CARDIOL, V28, P288, DOI 10.1016/0002-9149(71)90116-0
   MCMICHAEL J, 1948, BRIT HEART J, V10, P80
   Mittal S R, 2001, Indian Heart J, V53, P218
   Mittal S R, 2005, Indian Heart J, V57, P80
   Mittal S R, 1996, Indian Heart J, V48, P704
   OlivaresReyes A, 1997, J AM SOC ECHOCARDIOG, V10, P644, DOI 10.1016/S0894-7317(97)70027-0
   Omar HR, 2016, EUR HEART J-ACUTE CA, V5, P579, DOI 10.1177/2048872615604273
   PAGE IH, 1958, PHYSIOL REV, V38, P277
   Patriquin L, 1998, AM J ROENTGENOL, V171, P347, DOI 10.2214/ajr.171.2.9694449
   Pichereau C, 2015, INTENS CARE MED, V41, P167, DOI 10.1007/s00134-014-3520-4
   Pineda LA, 2001, CHEST, V120, P791, DOI 10.1378/chest.120.3.791
   Pinto FJ, 2005, HEART, V91, P438, DOI 10.1136/hrt.2004.052233
   Pollack CV, 2011, J AM COLL CARDIOL, V57, P700, DOI 10.1016/j.jacc.2010.05.071
   Prandoni P, 2016, NEW ENGL J MED, V375, P1524, DOI 10.1056/NEJMoa1602172
   Rodger MA, 2000, AM J RESP CRIT CARE, V162, P2105, DOI 10.1164/ajrccm.162.6.2004204
   Roger VL, 2012, CIRCULATION, V125, pE2, DOI 10.1161/CIR.0b013e31823ac046
   SANDLER DA, 1989, J ROY SOC MED, V82, P203, DOI 10.1177/014107688908200407
   Sentjens REJH, 2010, NETH J CRIT CARE, V14, P399
   Sogaard KK, 2014, CIRCULATION, V130, P829, DOI 10.1161/CIRCULATIONAHA.114.009107
   Stein PD, 1996, CHEST, V109, P78, DOI 10.1378/chest.109.1.78
   Stein PD, 1997, CHEST, V112, P974, DOI 10.1378/chest.112.4.974
   STEIN PD, 1995, CHEST, V108, P978, DOI 10.1378/chest.108.4.978
   Stein PD, 1998, CHEST, V113, P499, DOI 10.1378/chest.113.2.499
   THAMES MD, 1977, JAMA-J AM MED ASSOC, V238, P2509, DOI 10.1001/jama.238.23.2509
   Tzoran I, 2014, RAMBAM MAIMONIDES ME, V5, DOI 10.5041/RMMJ.10171
   Varkul M, 2001, Can Respir J, V8, P105
   Vicente DC, 1999, CURR OPIN CARDIOL, V14, P453, DOI 10.1097/00001573-199909000-00016
   Wasek WC, 2015, CIRCULATION, V131, P1214, DOI 10.1161/CIRCULATIONAHA.114.009846
   Wei F, 2016, J AM COLL CARDIOL, V68, pC154, DOI 10.1016/j.jacc.2016.07.581
   Windecker S, 2014, J AM COLL CARDIOL, V64, P403, DOI 10.1016/j.jacc.2014.04.063
   WOLFE MW, 1994, AM HEART J, V127, P1371, DOI 10.1016/0002-8703(94)90058-2
   WOLFF L, 1952, CIRCULATION, V6, P768, DOI 10.1161/01.CIR.6.5.768
   Wood KE, 2002, CHEST, V121, P877, DOI 10.1378/chest.121.3.877
   Xu K, 2015, J TRANSL MED EPIDEMI, V3, P1039
   Yamaki T, 2009, EUR J VASC ENDOVASC, V37, P225, DOI 10.1016/j.ejvs.2008.08.018
   Yameogo NV, 2011, ANN CARDIOL ANGEIOL, V60, P169, DOI 10.1016/j.ancard.2010.12.011
   Yildiz A, 2012, AM J EMERG MED, V30, DOI 10.1016/j.ajem.2011.02.006
   Zipes DP, 1998, CIRCULATION, V98, P2334, DOI 10.1161/01.CIR.98.21.2334
NR 95
TC 18
Z9 19
U1 0
U2 2
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAY
PY 2018
VL 48
IS 5
BP 365
EP 381
DI 10.4070/kcj.2017.0314
PG 17
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA GI3FZ
UT WOS:000434258300003
PM 29737640
OA Green Published
DA 2021-04-22
ER

PT J
AU Ha, KH
   Kim, B
   Shin, HS
   Lee, J
   Choi, H
   Kim, HC
   Kim, DJ
AF Ha, Kyoung Hwa
   Kim, Bongseong
   Shin, Hae Sol
   Lee, Jinhee
   Choi, Hansol
   Kim, Hyeon Chang
   Kim, Dae Jung
TI Comparative Cardiovascular Risks of Dipeptidyl Peptidase-4 Inhibitors:
   Analyses of Real-world Data in Korea
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Type 2 diabetes mellitus; Cardiovascular diseases; Dipeptidyl-peptidase
   IV inhibitors
ID HEART-FAILURE; DOUBLE-BLIND; TYPE-2; SAFETY; VILDAGLIPTIN; ASSOCIATION;
   METFORMIN; EVENTS; MANAGEMENT; MORTALITY
AB Background and Objectives: To compare cardiovascular disease (CVD) risk associated with 5 different dipeptidyl peptidase-4 inhibitors (DPP-4is) in people with type 2 diabetes.
   Methods: We identified 534,327 people who were newly prescribed sitagliptin (n= 167,157), vildagliptin (n= 67,412), saxagliptin (n= 29,479), linagliptin (n= 220,672), or gemigliptin (n= 49,607) between January 2013 and June 2015 using the claims database of the Korean National Health Insurance System. A Cox proportional hazards model was used to estimate hazard ratios (HRs) for major CVD events (myocardial infarction, stroke, or death) among users of different DPP-4is. The model was adjusted for sex, age, duration of DPP-4i use, use of other glucose-lowering drugs, use of antiplatelet agents, hypertension, dyslipidemia, atrial fibrillation, chronic kidney disease, microvascular complications of diabetes, Charlson comorbidity index, and the calendar index year as potential confounders.
   Results: Compared to sitagliptin users, the fully adjusted HRs for CVD events were 0.97 (95% confidence interval [CI], 0.94-1.01; p= 0.163) for vildagliptin, 0.76 (95% CI, 0.71-0.81; p< 0.001) for saxagliptin, 0.95 (95% CI, 0.92-0.98; p< 0.001) for linagliptin, and 0.84 (95% CI, 0.80-0.88; p< 0.001) for gemigliptin.
   Conclusions: Compared to sitagliptin therapy, saxagliptin, linagliptin, and gemigliptin therapies were all associated with a lower risk of cardiovascular events.
C1 [Ha, Kyoung Hwa; Lee, Jinhee; Kim, Dae Jung] Ajou Univ, Dept Endocrinol & Metab, Sch Med, 164 World Cup Ro, Suwon 16499, South Korea.
   [Ha, Kyoung Hwa; Kim, Dae Jung] Ajou Univ, Cardiovasc & Metab Dis Etiol Res Ctr, Sch Med, Suwon, South Korea.
   [Kim, Bongseong] Soongsil Univ, Dept Stat & Actuarial Sci, Seoul, South Korea.
   [Shin, Hae Sol] Yonsei Univ, Dept Biostat, Coll Med, Seoul, South Korea.
   [Choi, Hansol; Kim, Hyeon Chang] Yonsei Univ, Dept Prevent Med, Coll Med, Seoul, South Korea.
   [Choi, Hansol; Kim, Hyeon Chang] Yonsei Univ, Cardiovasc & Metab Dis Etiol Res Ctr, Coll Med, Seoul, South Korea.
RP Kim, DJ (corresponding author), Ajou Univ, Dept Endocrinol & Metab, Sch Med, 164 World Cup Ro, Suwon 16499, South Korea.
EM djkim@ajou.ac.kr
RI Kim, Hyeon Chang/F-8796-2019; Kim, Dae Jung/AAJ-7518-2021
OI Kim, Hyeon Chang/0000-0001-7867-1240; Kim, Dae Jung/0000-0003-1025-2044
FU Korea Health Technology R&D project through the Korea Health Industry
   Development Institute (KHIDI) - Ministry of Health and Welfare, Republic
   of Korea [HI13C0715]; LG Chem, Ltd.
FX This study used National Health Insurance Service (NHIS) data
   (NHIS-2017-1-059) made by NHIS. This research was supported by a grant
   of the Korea Health Technology R&D project through the Korea Health
   Industry Development Institute (KHIDI), funded by the Ministry of Health
   and Welfare, Republic of Korea (grant number: HI13C0715).; This research
   was supported by LG Chem, Ltd. The funder did not play any role in the
   study design, data collection and analysis, decisions regarding data
   release, or manuscript preparation.
CR Anagnostis P, 2011, DIABETES OBES METAB, V13, P302, DOI 10.1111/j.1463-1326.2010.01345.x
   Cobble ME, 2012, CARDIOVASC DIABETOL, V11, DOI 10.1186/1475-2840-11-6
   Deacon CF, 2011, DIABETES OBES METAB, V13, P7, DOI 10.1111/j.1463-1326.2010.01306.x
   Engel SS, 2013, CARDIOVASC DIABETOL, V12, DOI 10.1186/1475-2840-12-3
   Eurich DT, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2267
   Ferrannini E, 2015, EUR HEART J, V36, P2288, DOI 10.1093/eurheartj/ehv239
   Fu AZ, 2016, DIABETES CARE, V39, P726, DOI 10.2337/dc15-0764
   Gallwitz B, 2012, LANCET, V380, P475, DOI 10.1016/S0140-6736(12)60691-6
   Green JB, 2015, NEW ENGL J MED, V373, P232, DOI 10.1056/NEJMoa1501352
   Ha KH, 2017, DIABETIC MED, V34, P1235, DOI 10.1111/dme.13384
   Inzucchi SE, 2015, DIABETES CARE, V38, P140, DOI 10.2337/dc14-2441
   Johansen OE, 2012, CARDIOVASC DIABETOL, V11, DOI 10.1186/1475-2840-11-3
   Kim JH, 2016, DIABETES METAB J, V40, P230, DOI 10.4093/dmj.2016.40.3.230
   Kim JH, 2011, DIABETES METAB J, V35, P571, DOI 10.4093/dmj.2011.35.6.571
   Kim SH, 2016, DIABETES METAB J, V40, P339, DOI 10.4093/dmj.2016.40.5.339
   Kimm H, 2012, KOREAN CIRC J, V42, P10, DOI 10.4070/kcj.2012.42.1.10
   Monami M, 2013, DIABETES OBES METAB, V15, P112, DOI 10.1111/dom.12000
   Morgan CL, 2014, DIABETES OBES METAB, V16, P977, DOI 10.1111/dom.12306
   Ou HT, 2017, BRIT J CLIN PHARMACO, V83, P1556, DOI 10.1111/bcp.13241
   Park JK., 2000, KOREAN J PREV MED, V33, P76
   Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83
   Saraiva FK, 2014, CARDIOVASC DIABETOL, V13, DOI 10.1186/s12933-014-0142-7
   Schweizer A, 2010, DIABETES OBES METAB, V12, P485, DOI 10.1111/j.1463-1326.2010.01215.x
   Scirica BM, 2016, JAMA CARDIOL, V1, P123, DOI 10.1001/jamacardio.2016.0184
   Scirica BM, 2013, NEW ENGL J MED, V369, P1317, DOI 10.1056/NEJMoa1307684
   Suh S, 2015, DIABETES METAB J, V39, P247, DOI 10.4093/dmj.2015.39.3.247
   Toh S, 2016, ANN INTERN MED, V164, P705, DOI 10.7326/M15-2568
   Vanderheyden M, 2009, CLIN CHEM LAB MED, V47, P248, DOI 10.1515/CCLM.2009.065
   Williams R, 2017, DIABETES OBES METAB, V19, P1473, DOI 10.1111/dom.12951
   Zannad F, 2015, LANCET, V385, P2067, DOI 10.1016/S0140-6736(14)62225-X
NR 30
TC 7
Z9 7
U1 0
U2 4
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAY
PY 2018
VL 48
IS 5
BP 395
EP 405
DI 10.4070/kcj.2017.0324
PG 11
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA GI3FZ
UT WOS:000434258300005
PM 29671284
OA Green Published
DA 2021-04-22
ER

PT J
AU Oka, H
   Nakau, K
   Kajihama, A
   Azuma, H
AF Oka, Hideharu
   Nakau, Kouichi
   Kajihama, Aya
   Azuma, Hiroshi
TI Assessment of Potential Renal Dysfunction in Patients with Congenital
   Heart Disease after Biventricular Repair
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Kidney; Renal dysfunction; Microalbumin; Congenital heart disease;
   Biventricular repair
ID DEPENDENT DIABETES-MELLITUS; GLOMERULAR-FILTRATION-RATE; NONDIABETIC
   INDIVIDUALS; CARDIOVASCULAR-DISEASE; JAPANESE CHILDREN; FONTAN
   PALLIATION; CYSTATIN C; NEPHROPATHY; FAILURE; ALBUMINURIA
AB Background and Objectives: There are few reports on renal dysfunction in the remote period after biventricular repair, and biomarkers for early detection of renal dysfunction are not well understood. We examined whether early fluctuation of biomarkers of renal function occurs in the remote period after biventricular repair in patients with congenital heart disease (CHD).
   Methods: Fourteen patients with CHD after biventricular repair were included. The examination values obtained by cardiac catheterization test and renal function indices based on blood and urine sampling were compared.
   Results: The median estimated glomerular filtration rate (eGFR) of creatinine was 113 mL/min/1.73 m(2), and the median eGFR of cystatin C was 117 mL/min/1.73 m(2). A urine albuminto-creatinine ratio (UACR) >= 10 mg/gCr was considered a risk factor for cardiovascular disease in 6 (43%) patients. There was a significant difference in right ventricular ejection fraction and deviation in right ventricular end-diastolic volume from the normal value between the 2 groups divided by UACR. Cyanosis before biventricular repair was noted in 2 (25%) patients with UACR < 10 mg/gCr and in 4 (67%) patients with UACR >= 10 mg/gCr.
   Conclusions: Increased UACR was noted in 43% of patients. In patients with UACR >= 10 mg/gCr, right heart system abnormality was observed, and several patients had cyanosis before radical treatment. Measurement for UACR may be able to detect renal dysfunction early in the postoperative remote period.
C1 [Oka, Hideharu; Nakau, Kouichi; Kajihama, Aya; Azuma, Hiroshi] Asahikawa Med Univ, Dept Pediat, 2-1-1-1 Midorigaoka Higashi, Asahikawa, Hokkaido 0788510, Japan.
RP Oka, H (corresponding author), Asahikawa Med Univ, Dept Pediat, 2-1-1-1 Midorigaoka Higashi, Asahikawa, Hokkaido 0788510, Japan.
EM oka5p@asahikawa-med.ac.jp
OI Oka, Hideharu/0000-0001-8701-826X
CR Anne P, 2009, INT J CARDIOL, V132, P244, DOI 10.1016/j.ijcard.2007.11.079
   Arnlov J, 2005, CIRCULATION, V112, P969, DOI 10.1161/CIRCULATIONAHA.105.538132
   Dimopoulos K, 2008, CIRCULATION, V117, P2320, DOI 10.1161/CIRCULATIONAHA.107.734921
   Gerstein HC, 2001, JAMA-J AM MED ASSOC, V286, P421, DOI 10.1001/jama.286.4.421
   Guglin M, 2011, CLIN CARDIOL, V34, P113, DOI 10.1002/clc.20831
   Horio M, 2013, AM J KIDNEY DIS, V61, P197, DOI 10.1053/j.ajkd.2012.07.007
   Inatomi J, 2006, PEDIATR NEPHROL, V21, P1440, DOI 10.1007/s00467-006-0220-5
   Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034
   Mielniczuk Lisa M, 2012, Congest Heart Fail, V18, P151, DOI 10.1111/j.1751-7133.2011.00275.x
   MOGENSEN CE, 1984, NEW ENGL J MED, V311, P89, DOI 10.1056/NEJM198407123110204
   Mullens W, 2009, J AM COLL CARDIOL, V53, P589, DOI 10.1016/j.jacc.2008.05.068
   NAKAZAWA M, 1976, CIRCULATION, V53, P884, DOI 10.1161/01.CIR.53.5.884
   Nelson RG, 1996, NEW ENGL J MED, V335, P1636, DOI 10.1056/NEJM199611283352203
   Perloff JK, 2001, CIRCULATION, V103, P2637
   Sharma S, 2016, CONGENIT HEART DIS, V11, P630, DOI 10.1111/chd.12358
   STEHOUWER CDA, 1992, LANCET, V340, P319, DOI 10.1016/0140-6736(92)91401-S
   Uemura O, 2014, CLIN EXP NEPHROL, V18, P718, DOI 10.1007/s10157-013-0910-9
   Uemura O, 2014, CLIN EXP NEPHROL, V18, P626, DOI 10.1007/s10157-013-0856-y
   Yana A, 2013, CIRC J, V77, P667, DOI 10.1253/circj.CJ-12-0148
NR 19
TC 1
Z9 1
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAY
PY 2018
VL 48
IS 5
BP 418
EP 426
DI 10.4070/kcj.2017.0017
PG 9
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA GI3FZ
UT WOS:000434258300007
PM 29671286
OA Green Published
DA 2021-04-22
ER

PT J
AU Kim, K
   Lee, YJ
   Kim, TH
   Uhm, JS
   Pak, HN
   Lee, MH
   Joung, B
AF Kim, Kyu
   Lee, Yong-Joon
   Kim, Tae-Hoon
   Uhm, Jae-Sun
   Pak, Hui-Nam
   Lee, Moon-Hyoung
   Joung, Boyoung
TI Effect of Non-vitamin K Antagonist Oral Anticoagulants in Atrial
   Fibrillation Patients with Newly Diagnosed Cancer
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Atrial fibrillation; Hemorrhage; Neoplasms; Stroke; Anticoagulants
ID TRANSIENT ISCHEMIC ATTACK; HEALTH-CARE PROFESSIONALS; STROKE PREVENTION;
   HEART-FAILURE; WARFARIN; RISK; GUIDELINES; MANAGEMENT; RIVAROXABAN;
   PREVALENCE
AB Background and Objectives: There are limited data on the use of non-vitamin K antagonist oral anticoagulants (NOACs) in atrial fibrillation (AF) patients with cancer. We aimed to assess the efficacy and safety of NOACs in AF patients with cancer in this study.
   Methods: In 2,568 consecutive non-valvular AF patients with newly diagnosed cancer, we analyzed ischemic stroke/systemic embolism (SE), major bleeding, and all-cause death. Based on propensity score matching, 388 matched pairs were included in the NOAC and warfarin groups.
   Results: Patient baseline characteristics were comparable between the matched groups. During median follow-up of 1.8 years, the NOAC group had significantly lower incidences of ischemic stroke/SE (p< 0.001), major bleeding (p< 0.001), and all-cause death (p< 0.001) than the warfarin group. Moreover, the incidence of major bleeding was significantly lower in the NOAC group than in the warfarin group with optimal international normalized ratio control (p= 0.03). Especially, within 1 year after cancer diagnosis, the incidences of all clinical events were significantly lower in the NOAC group than in the warfarin group.
   Conclusions: In AF patients with newly diagnosed cancer, NOACs showed lower incidences of ischemic stroke/SE, major bleeding, and all-cause death than warfarin, especially within 1 year after cancer diagnosis.
C1 [Kim, Kyu; Lee, Yong-Joon; Kim, Tae-Hoon; Uhm, Jae-Sun; Pak, Hui-Nam; Lee, Moon-Hyoung; Joung, Boyoung] Yonsei Univ, Severance Cardiovasc Hosp, Coll Med, Div Cardiol,Dept Internal Med, 50-1 Yonsei Ro, Seoul 03722, South Korea.
RP Joung, B (corresponding author), Yonsei Univ, Severance Cardiovasc Hosp, Coll Med, Div Cardiol,Dept Internal Med, 50-1 Yonsei Ro, Seoul 03722, South Korea.
EM cby6908@yuhs.ac
RI ; Pak, Hui-Nam/C-4266-2015
OI Kim, Tae-Hoon/0000-0003-4200-3456; Lee, Moon-Hyoung/0000-0002-7268-0741;
   Pak, Hui-Nam/0000-0002-3256-3620; Joung, Boyoung/0000-0001-9036-7225;
   Uhm, Jae-Sun/0000-0002-1611-8172
FU Yonsei University College of Medicine [6-2015-0173]; Basic Science
   Research Program through the National Research Foundation of Korea -
   Ministry of Education, Science and Technology [NRF-2017R1A2B3003303];
   Korean Healthcare Technology R&D project - Ministry of Health and
   Welfare [HI16C0058, HI15C1200]
FX This study was supported by a CMB-Yuhan research grant from Yonsei
   University College of Medicine (6-2015-0173), the research grants from
   the Basic Science Research Program through the National Research
   Foundation of Korea funded by the Ministry of Education, Science and
   Technology (NRF-2017R1A2B3003303), and the Korean Healthcare Technology
   R&D project funded by the Ministry of Health and Welfare (HI16C0058,
   HI15C1200).
CR Akao M, 2014, CIRC J, V78, P2166, DOI 10.1253/circj.CJ-14-0344
   Austin PC, 2009, BIOMETRICAL J, V51, P171, DOI 10.1002/bimj.200810488
   Chan YH, 2016, J AM COLL CARDIOL, V68, P1389, DOI 10.1016/j.jacc.2016.06.062
   COCKCROFT DW, 1976, NEPHRON, V16, P31, DOI 10.1159/000180580
   Connolly SJ, 2009, NEW ENGL J MED, V361, P1139, DOI 10.1056/NEJMoa0905561
   Cowie MR, 1997, LANCET, V350, P1349, DOI 10.1016/S0140-6736(97)06031-5
   Cronin-Fenton DP, 2010, BRIT J CANCER, V103, P947, DOI 10.1038/sj.bjc.6605883
   Dentali F, 2012, CIRCULATION, V126, P2381, DOI 10.1161/CIRCULATIONAHA.112.115410
   Furie KL, 2011, STROKE, V42, P227, DOI 10.1161/STR.0b013e3181f7d043
   Giugliano RP, 2013, NEW ENGL J MED, V369, P2093, DOI 10.1056/NEJMoa1310907
   Go AS, 2001, JAMA-J AM MED ASSOC, V285, P2370, DOI 10.1001/jama.285.18.2370
   Gomez-Outes Antonio, 2013, Thrombosis, V2013, P640723, DOI 10.1155/2013/640723
   Granger CB, 2011, NEW ENGL J MED, V365, P981, DOI 10.1056/NEJMoa1107039
   Guzzetti S, 2008, INTERN EMERG MED, V3, P227, DOI 10.1007/s11739-008-0124-4
   Hori M, 2012, CIRC J, V76, P2104, DOI 10.1253/circj.CJ-12-0454
   Jauch EC, 2013, STROKE, V44, P870, DOI 10.1161/STR.0b013e318284056a
   Kim TH, 2017, STROKE, V48, P1524, DOI 10.1161/STROKEAHA.117.016926
   Kirchhof P, 2016, EUR HEART J, V37, P2893, DOI 10.1093/eurheartj/ehw210
   Lanas A, 2006, GUT, V55, P1731, DOI 10.1136/gut.2005.080754
   Lee SJ, 2015, INT J CARDIOL, V180, P185, DOI 10.1016/j.ijcard.2014.11.183
   Lee YJ, 2016, INT J CARDIOL, V203, P372, DOI 10.1016/j.ijcard.2015.10.166
   Lip GYH, 2006, THROMB RES, V118, P321, DOI 10.1016/j.thromres.2005.08.007
   Mani H, 2014, DRUG DES DEV THER, V8, P789, DOI 10.2147/DDDT.S45644
   O'Neal WT, 2015, AM J CARDIOL, V115, P1090, DOI 10.1016/j.amjcard.2015.01.540
   Ostenfeld EB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102861
   Patel MR, 2010, NEW ENGL J MED, V362, P886, DOI 10.1056/NEJMoa0907272
   Pisters R, 2010, CHEST, V138, P1093, DOI 10.1378/chest.10-0134
   Rose AJ, 2007, J GEN INTERN MED, V22, P997, DOI 10.1007/s11606-007-0228-y
   ROSENDAAL FR, 1993, THROMB HAEMOSTASIS, V69, P236
   Schulman S, 2005, J THROMB HAEMOST, V3, P692, DOI 10.1111/j.1538-7836.2005.01204.x
NR 30
TC 16
Z9 16
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAY
PY 2018
VL 48
IS 5
BP 406
EP 417
DI 10.4070/kcj.2017.0328
PG 12
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA GI3FZ
UT WOS:000434258300006
PM 29671285
OA Green Published
DA 2021-04-22
ER

PT J
AU Kim, C
   Hong, MK
AF Kim, Choongki
   Hong, Myeong-Ki
TI Good Patients Make Favorable Clinical Outcome: K-TAVI Registry Reports
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
ID AORTIC-VALVE-REPLACEMENT; INTERMEDIATE-RISK PATIENTS; TRANSCATHETER
C1 [Kim, Choongki; Hong, Myeong-Ki] Yonsei Univ, Coll Med, Severance Cardiovasc Hosp, Div Cardiol, 50-1 Yonsei Ro, Seoul 03722, South Korea.
   [Hong, Myeong-Ki] Yonsei Univ, Coll Med, Cardiovasc Res Inst, Seoul, South Korea.
RP Hong, MK (corresponding author), Yonsei Univ, Coll Med, Severance Cardiovasc Hosp, Div Cardiol, 50-1 Yonsei Ro, Seoul 03722, South Korea.
EM mkhong61@yuhs.ac
OI Hong, Myeong-Ki/0000-0002-2090-2031
CR Adams DH, 2014, NEW ENGL J MED, V370, P1790, DOI 10.1056/NEJMoa1400590
   Kapadia SR, 2015, LANCET, V385, P2485, DOI 10.1016/S0140-6736(15)60290-2
   Leon MB, 2016, NEW ENGL J MED, V374, P1609, DOI 10.1056/NEJMoa1514616
   Leon MB, 2010, NEW ENGL J MED, V363, P1597, DOI 10.1056/NEJMoa1008232
   Nishimura RA, 2017, CIRCULATION, V135, pE1159, DOI 10.1161/CIR.0000000000000503
   Reardon MJ, 2017, NEW ENGL J MED, V376, P1321, DOI 10.1056/NEJMoa1700456
   Smith CR, 2011, NEW ENGL J MED, V364, P2187, DOI 10.1056/NEJMoa1103510
   Sondergaard L, 2016, CIRC-CARDIOVASC INTE, V9, DOI 10.1161/CIRCINTERVENTIONS.115.003665
   Yu CW, 2018, KOREAN CIRC J, V48, P382, DOI 10.4070/kcj.2018.0117
NR 9
TC 0
Z9 0
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAY
PY 2018
VL 48
IS 5
BP 427
EP 429
DI 10.4070/kcj.2018.0095
PG 3
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA GI3FZ
UT WOS:000434258300008
PM 29737641
OA Green Published
DA 2021-04-22
ER

PT J
AU Kim, KI
AF Kim, Kwang-il
TI Effect of Dipeptidyl Peptidase-4 Inhibitors on Cardiovascular Outcome
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
ID GLUCOSE CONTROL
C1 [Kim, Kwang-il] Seoul Natl Univ, Bundang Hosp, Dept Internal Med, Coll Med, 82 Gumi Ro 173 Beon Gil, Seongnam 13620, South Korea.
RP Kim, KI (corresponding author), Seoul Natl Univ, Bundang Hosp, Dept Internal Med, Coll Med, 82 Gumi Ro 173 Beon Gil, Seongnam 13620, South Korea.
EM kikim907@snu.ac.kr
RI Kim, Kwang-il/D-8024-2012
OI Kim, Kwang-il/0000-0002-6658-047X
CR Duckworth W, 2009, NEW ENGL J MED, V360, P129, DOI 10.1056/NEJMoa0808431
   Ha KH, 2018, KOREAN CIRC J, V48, P395, DOI 10.4070/kcj.2017.0324
   Holman RR, 2008, NEW ENGL J MED, V359, P1577, DOI 10.1056/NEJMoa0806470
   Home PD, 2009, LANCET, V373, P2125, DOI 10.1016/S0140-6736(09)60953-3
   Nissen SE, 2007, NEW ENGL J MED, V356, P2457, DOI 10.1056/NEJMoa072761
   Preis SR, 2009, CIRCULATION, V119, P1728, DOI 10.1161/CIRCULATIONAHA.108.829176
   Scirica BM, 2013, NEW ENGL J MED, V369, P1317, DOI 10.1056/NEJMoa1307684
   Smith RJ, 2016, DIABETES CARE, V39, P738, DOI 10.2337/dc15-2237
   Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6
NR 9
TC 0
Z9 0
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAY
PY 2018
VL 48
IS 5
BP 430
EP 432
DI 10.4070/kcj.2018.0085
PG 3
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA GI3FZ
UT WOS:000434258300009
PM 29671287
OA Green Published
DA 2021-04-22
ER

PT J
AU Kim, DY
   Lim, HE
AF Kim, Do Young
   Lim, Hong Euy
TI Oral Anticoagulants for Atrial Fibrillation Patients with Active Cancer
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
ID BLEEDING RISK
C1 [Kim, Do Young; Lim, Hong Euy] Korea Univ, Guro Hosp, Div Cardiac Electrophysiol, Cardiovasc Ctr, 148 Gurodong Ro, Seoul 08308, South Korea.
RP Lim, HE (corresponding author), Korea Univ, Guro Hosp, Div Cardiac Electrophysiol, Cardiovasc Ctr, 148 Gurodong Ro, Seoul 08308, South Korea.
EM hongeuy@korea.ac.kr
OI Kim, Do Young/0000-0002-5601-9427; Lim, Hong Euy/0000-0001-8102-8352
CR Conen D, 2016, JAMA CARDIOL, V1, P389, DOI 10.1001/jamacardio.2016.0280
   Farmakis D, 2014, J AM COLL CARDIOL, V63, P945, DOI 10.1016/j.jacc.2013.11.026
   Hendrie PC, 2013, J NATL COMPR CANC NE, V11, P1446, DOI 10.6004/jnccn.2013.0165
   Kim K, 2018, KOREAN CIRC J, V48, P406, DOI 10.4070/kcj.2017.0328
   Lee AYY, 2013, BLOOD, V122, P2310, DOI 10.1182/blood-2013-04-460162
   Lee YJ, 2016, INT J CARDIOL, V203, P372, DOI 10.1016/j.ijcard.2015.10.166
   Senoo K, 2014, KOREAN CIRC J, V44, P281, DOI 10.4070/kcj.2014.44.5.281
   Short NJ, 2014, ONCOLOGIST, V19, P82, DOI 10.1634/theoncologist.2013-0239
NR 8
TC 0
Z9 0
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAY
PY 2018
VL 48
IS 5
BP 433
EP 434
DI 10.4070/kcj.2018.0081
PG 2
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA GI3FZ
UT WOS:000434258300010
PM 29671288
OA Green Published
DA 2021-04-22
ER

PT J
AU Kang, SJ
AF Kang, Soo Jung
TI Increased Urine Albumin-to-Creatinine Ratio-a Harbinger of Renal
   Dysfunction after Repair of Congenital Heart Disease?
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
ID MECHANISMS; PREVALENCE; FAILURE; ADULTS
C1 [Kang, Soo Jung] CHA Univ, Sch Med, CHA Bundang Med Ctr, Dept Pediat, 11 Yatap Ro 65 Beon Gil, Seongnam 13496, South Korea.
RP Kang, SJ (corresponding author), CHA Univ, Sch Med, CHA Bundang Med Ctr, Dept Pediat, 11 Yatap Ro 65 Beon Gil, Seongnam 13496, South Korea.
EM kittysooni@chamc.co.kr
CR Collins RT, 2013, CIRCULATION, V127, P2125, DOI 10.1161/CIRCULATIONAHA.112.000064
   Dimopoulos K, 2008, CIRCULATION, V117, P2320, DOI 10.1161/CIRCULATIONAHA.107.734921
   Hongsawong N, 2018, PEDIATR NEPHROL, V33, P493, DOI 10.1007/s00467-017-3804-3
   Inatomi J, 2006, PEDIATR NEPHROL, V21, P1440, DOI 10.1007/s00467-006-0220-5
   Lui GK, 2017, CIRCULATION, V136, pE348, DOI 10.1161/CIR.0000000000000535
   Magri P, 1998, CIRCULATION, V98, P2849, DOI 10.1161/01.CIR.98.25.2849
   Oka H, 2018, KOREAN CIRC J, V48, P418, DOI 10.4070/kcj.2017.0017
   Ronco C, 2010, EUR HEART J, V31, P703, DOI 10.1093/eurheartj/ehp507
   Schrier RW, 1999, NEW ENGL J MED, V341, P577, DOI 10.1056/NEJM199908193410806
   Taylor ML, 2013, J THORAC CARDIOV SUR, V146, P146, DOI 10.1016/j.jtcvs.2012.09.008
NR 10
TC 0
Z9 0
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAY
PY 2018
VL 48
IS 5
BP 435
EP 437
DI 10.4070/kcj.2018.0128
PG 3
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA GI3FZ
UT WOS:000434258300011
PM 29737642
OA Green Published
DA 2021-04-22
ER

PT J
AU Kang, DY
   Ahn, JM
   Lee, CH
   Kang, SH
   Heo, R
   Park, DW
   Song, JM
   Park, SJ
AF Kang, Do-Yoon
   Ahn, Jung-Min
   Lee, Cheol Hyun
   Kang, Se Hun
   Heo, Ran
   Park, Duk-Woo
   Song, Jong-Min
   Park, Seung-Jung
TI Transseptal Transcatheter Mitral Valve-in-valve Replacement for a Failed
   Bioprosthetic Mitral Valve
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
C1 [Kang, Do-Yoon; Ahn, Jung-Min; Lee, Cheol Hyun; Kang, Se Hun; Heo, Ran; Park, Duk-Woo; Song, Jong-Min; Park, Seung-Jung] Univ Ulsan, Coll Med, Heart Inst, Asan Med Ctr, Seoul, South Korea.
RP Ahn, JM (corresponding author), Univ Ulsan, Asan Med Ctr, Heart Inst, 88 Olymp Ro 43 Gil, Seoul 05505, South Korea.
EM drjmahn@gmail.com
RI Heo, Ran/AAJ-8471-2021
OI Heo, Ran/0000-0002-2675-3612; Lee, Cheol Hyun/0000-0003-4203-1457; Park,
   Duk-Woo/0000-0001-6643-0239; Kang, Se Hun/0000-0001-5876-1791
FU CardioVascular Research Foundation
FX This work was supported by the CardioVascular Research Foundation.
CR Bourguignon T, 2014, J THORAC CARDIOV SUR, V148, P2004, DOI 10.1016/j.jtcvs.2014.02.050
   Jones JM, 2001, J THORAC CARDIOV SUR, V122, P913, DOI 10.1067/mtc.2001.116470
   Paradis JM, 2015, J AM COLL CARDIOL, V66, P2019, DOI 10.1016/j.jacc.2015.09.015
   Yoon SH, 2017, J AM COLL CARDIOL, V70, P1121, DOI 10.1016/j.jacc.2017.07.714
NR 4
TC 2
Z9 2
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAY
PY 2018
VL 48
IS 5
BP 438
EP 441
DI 10.4070/kcj.2017.0364
PG 4
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA GI3FZ
UT WOS:000434258300012
PM 29671289
OA Green Published
DA 2021-04-22
ER

PT J
AU Rigatelli, G
AF Rigatelli, Gianluca
TI Symptomatic Anomalous Coronary Artery Origin Diagnosis and Interventions
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
ID ADULTS
C1 [Rigatelli, Gianluca] Rovigo Gen Hosp, Dept Cardiol, Rovigo, Italy.
RP Rigatelli, G (corresponding author), Rovigo Gen Hosp, Cardiovasc Diag & Endoluminal Intervent Unit, Dept Cardiol, Viale Tre Martiri 140, I-45100 Rovigo, Italy.
EM jackyheart@libero.it
OI Rigatelli, Gianluca/0000-0002-7318-3640
CR Angelini P, 2015, CATHETER CARDIO INTE, V86, P199, DOI 10.1002/ccd.26069
   Rigatelli G, 2008, J CARDIOVASC MED, V9, P113, DOI 10.2459/JCM.0b013e32813e3cd1
NR 2
TC 0
Z9 0
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAY
PY 2018
VL 48
IS 5
BP 442
EP 445
DI 10.4070/kcj.2018.0025
PG 4
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA GI3FZ
UT WOS:000434258300013
PM 29671290
OA Green Published
DA 2021-04-22
ER

PT J
AU Niwa, K
AF Niwa, Koichiro
TI Adult Congenital Heart Disease with Pregnancy
SO KOREAN CIRCULATION JOURNAL
LA English
DT Review
DE Pregnancy; Delivery; Congenital heart disease
ID SYSTEMIC RIGHT VENTRICLE; CORRECTED TRANSPOSITION;
   PULMONARY-HYPERTENSION; REPAIRED TETRALOGY; AORTIC DILATATION; CARDIAC
   OUTCOMES; ATRIAL REPAIR; WOMEN; COMPLICATIONS; RISK
AB The number of women with congenital heart disease (CHD) at risk of pregnancy is growing because over 90% of them are grown-up into adulthood. The outcome of pregnancy and delivery is favorable in most of them provided that functional class and systemic ventricular function are good. Women with CHD such as pulmonary hypertension (Eisenmenger syndrome), severe left ventricular outflow stenosis, cyanotic CHD, aortopathy, Fontan procedure and systemic right ventricle (complete transposition of the great arteries [TGA] after atrial switch, congenitally corrected TGA) carry a high-risk. Most frequent complications during pregnancy and delivery are heart failure, arrhythmias, bleeding or thrombosis, and rarely maternal death. Complications of fetus are prematurity, low birth weight, abortion, and stillbirth. Risk stratification of pregnancy and delivery relates to functional status of the patient and is lesion specific. Medication during pregnancy and post-delivery (breast feeding) is a big concern. Especially prescribing medication with teratogenicity should be avoidable. Adequate care during pregnancy, delivery, and the postpartum period requires a multidisciplinary team approach with cardiologists, obstetricians, anesthesiologists, neonatologists, nurses and other related disciplines. Caring for a baby is an important issue due to temporarily pregnancy-induced cardiac dysfunction, and therefore familial support is mandatory especially during peripartum and after delivery. Timely pre-pregnancy counseling should be offered to all women with CHD to prevent avoidable pregnancy-related risks. Successful pregnancy is feasible for most women with CHD at relatively low risk when appropriate counseling and optimal care are provided.
C1 [Niwa, Koichiro] St Lukes Int Hosp, Dept Cardiol, Cardiovasc Ctr, Tokyo, Japan.
RP Niwa, K (corresponding author), St Lukes Int Hosp, Dept Cardiol, Cardiovasc Ctr, Chuo Ku, 9-1 Akashi Cho, Tokyo 1048560, Japan.
EM koniwa@luke.ac.jp
CR Akagi T, 2005, CIRCULATION S2, V108, P682
   Assenza GE, 2013, INT J CARDIOL, V168, P1847, DOI 10.1016/j.ijcard.2012.12.071
   Balint OH, 2010, HEART, V96, P1656, DOI 10.1136/hrt.2010.202838
   Beauchesne LM, 2001, J AM COLL CARDIOL, V38, P1728, DOI 10.1016/S0735-1097(01)01617-5
   Bedard E, 2009, EUR HEART J, V30, P256, DOI 10.1093/eurheartj/ehn597
   Bowater SE, 2013, CONGENIT HEART DIS, V8, P302, DOI 10.1111/chd.12001
   BRODSKY M, 1992, AM HEART J, V123, P933, DOI 10.1016/0002-8703(92)90699-V
   Buttar HS, 1997, MOL CELL BIOCHEM, V176, P61, DOI 10.1023/A:1006822911586
   Canobbio MM, 1996, J AM COLL CARDIOL, V28, P763, DOI 10.1016/0735-1097(96)00234-3
   Child JS, 2009, CONGENITAL HEART DIS, P194
   Child JS, 2009, CONGENITAL HEART DIS, P168
   Colman J M, 2000, Cardiol Rev, V8, P166
   CONNOLLY HM, 1994, J AM COLL CARDIOL, V23, P1194, DOI 10.1016/0735-1097(94)90610-6
   Connolly HM, 1997, AM J CARDIOL, V79, P519, DOI 10.1016/S0002-9149(96)00801-6
   Connolly HM, 1999, J AM COLL CARDIOL, V33, P1692, DOI 10.1016/S0735-1097(99)00046-7
   Cooper WO, 2006, NEW ENGL J MED, V354, P2443, DOI 10.1056/NEJMoa055202
   Curry RA, 2012, BJOG-INT J OBSTET GY, V119, P752, DOI 10.1111/j.1471-0528.2012.03295.x
   Curtis SL, 2016, HEART DIS PREGNANCY, P191
   DALVI BV, 1992, OBSTET GYNECOL, V79, P802
   Dayan N, 2014, J AM COLL CARDIOL, V64, P1862, DOI 10.1016/j.jacc.2014.07.977
   De Wilde JP, 2005, PROG BIOPHYS MOL BIO, V87, P335, DOI 10.1016/j.pbiomolbio.2004.08.010
   Dhanjal MK., 2016, HEART DIS PREGNANCY, P6
   Donnelly RT, 2012, J AM COLL CARDIOL, V60, P224, DOI 10.1016/j.jacc.2012.03.051
   Drenthen W, 2006, HEART, V92, P1290, DOI 10.1136/hrt.2005.085407
   Drenthen W, 2005, EUR HEART J, V26, P2588, DOI 10.1093/eurheartj/ehi472
   Drenthen W, 2005, EUR HEART J, V26, P2581, DOI 10.1093/eurheartj/ehi439
   Drenthen W, 2007, J AM COLL CARDIOL, V49, P2303, DOI 10.1016/j.jacc.2007.03.027
   Drenthen W, 2010, EUR HEART J, V31, P2124, DOI 10.1093/eurheartj/ehq200
   Edlow AG, 2009, AM J OBSTET GYNECOL, V200, pE60, DOI 10.1016/j.ajog.2008.10.012
   Genoni M, 1999, HEART, V81, P276, DOI 10.1136/hrt.81.3.276
   Greutmann M, 2010, EUR HEART J, V31, P1764, DOI 10.1093/eurheartj/ehq157
   Guedes A, 2004, J AM COLL CARDIOL, V44, P433, DOI 10.1016/j.jacc.2004.04.037
   Hameed A, 2001, J AM COLL CARDIOL, V37, P893, DOI 10.1016/S0735-1097(00)01198-0
   JAMIESON WRE, 1995, ANN THORAC SURG, V60, pS282
   Joglar JA, 2001, CURR OPIN CARDIOL, V16, P40, DOI 10.1097/00001573-200101000-00006
   Johnson M, 2016, HEART DIS PREGNANCY, P19
   Kafka H, 2016, HEART DIS PREGNANCY, P227
   Kafka H, 2016, HEART DIS PREGNANCY, P43
   Kamiya C, 2008, J ECHOCARDIOGR, V6, P29
   Kamiya CA, 2012, CIRC J, V76, P957, DOI 10.1253/circj.CJ-11-1239
   Katsuragi S, 2011, CIRC J, V75, P2545, DOI 10.1253/circj.CJ-11-0465
   Khairy P, 2006, CIRCULATION, V113, P517, DOI 10.1161/CIRCULATIONAHA.105.589655
   Kiely DG, 2010, BJOG-INT J OBSTET GY, V117, P565, DOI 10.1111/j.1471-0528.2009.02492.x
   Koerten MA, 2016, INT J CARDIOL, V206, P13, DOI 10.1016/j.ijcard.2015.12.031
   Kovacs AH, 2008, J AM COLL CARDIOL, V52, P577, DOI 10.1016/j.jacc.2008.05.013
   Lui GK, 2011, CIRCULATION, V123, P242, DOI 10.1161/CIRCULATIONAHA.110.953380
   MABIE WC, 1994, AM J OBSTET GYNECOL, V170, P849, DOI 10.1016/S0002-9378(94)70297-7
   Melchiorre K, 2014, CIRCULATION, V130, P703, DOI 10.1161/CIRCULATIONAHA.113.003664
   Melchiorre K, 2011, HYPERTENSION, V58, P709, DOI 10.1161/HYPERTENSIONAHA.111.176537
   Metz TD, 2011, AM J OBSTET GYNECOL, V205, DOI 10.1016/j.ajog.2011.06.042
   Niwa K, 1999, J AM COLL CARDIOL, V34, P223, DOI 10.1016/S0735-1097(99)00153-9
   Niwa K, 2001, CIRCULATION, V103, P393
   Niwa K, 2017, 19 ANN M JAP SOC AD
   Niwa K, 2016, HEART DIS PREGNANCY, P180
   Niwa K, 2007, INT J CARDIOL, V122, P143, DOI 10.1016/j.ijcard.2006.11.045
   Niwa K, 2015, PROG PEDIATR CARDIOL, V39, P139, DOI 10.1016/j.ppedcard.2015.10.015
   Niwa K, 2012, CIRC J, V76, P240, DOI 10.1253/circj.CJ-88-0023
   NORA JJ, 1987, AM J CARDIOL, V59, P459, DOI 10.1016/0002-9149(87)90956-8
   Ohuchi H, 2013, CIRC J, V77, P470, DOI 10.1253/circj.CJ-12-0485
   Parry AJ, 1996, ANN THORAC SURG, V61, P1865, DOI 10.1016/0003-4975(96)00150-6
   Poppas A, 1997, CIRCULATION, V95, P2407, DOI 10.1161/01.CIR.95.10.2407
   PRESBITERO P, 1994, CIRCULATION, V89, P2673, DOI 10.1161/01.CIR.89.6.2673
   Presbitero P, 1996, EUR HEART J, V17, P182
   Regitz-Zagrosek V, 2011, EUR HEART J, V32, P3147, DOI 10.1093/eurheartj/ehr218
   Robertson JE, 2012, J OBSTET GYNAECOL CA, V34, P812, DOI 10.1016/S1701-2163(16)35378-6
   Saidi AS, 1998, AM J CARDIOL, V82, P786, DOI 10.1016/S0002-9149(98)00443-3
   SBAROUNI E, 1994, BRIT HEART J, V71, P196
   Shotan A, 1997, AM J CARDIOL, V79, P1061, DOI 10.1016/S0002-9149(97)00047-7
   Silka MJ, 1998, J AM COLL CARDIOL, V32, P245, DOI 10.1016/S0735-1097(98)00187-9
   Silversides CK, 2010, CAN J CARDIOL, V26, pE80, DOI 10.1016/S0828-282X(10)70355-X
   Silversides CK, 2003, AM J CARDIOL, V91, P1386, DOI 10.1016/S0002-9149(03)00340-0
   Siu SC, 2001, CIRCULATION, V104, P515, DOI 10.1161/hc3001.093437
   Siu SC, 2002, CIRCULATION, V105, P2179, DOI 10.1161/01.CIR.0000015699.48605.08
   Siu SC, 1997, CIRCULATION, V96, P2789
   Steer A C, 2005, ADULT CONGENITAL HEA, P16
   Tamhane P, 2006, INT J OBSTET ANESTH, V15, P332, DOI 10.1016/j.ijoa.2006.04.006
   Tan JL, 2005, CIRCULATION, V112, P961, DOI 10.1161/CIRCULATIONAHA.105.537928
   Tanous D, 2010, J AM COLL CARDIOL, V56, P1247, DOI 10.1016/j.jacc.2010.02.076
   Tateno S, 2003, CIRC J, V67, P992, DOI 10.1253/circj.67.992
   TATSUNO K, 1975, AM HEART J, V89, P171, DOI 10.1016/0002-8703(75)90042-3
   The Japanese Circulation Society, 2010, GUID IND MAN PREGN D
   The Japanese Circulation Society, 2008, GUID PREV TREATM INF
   Therrien J, 1999, AM J CARDIOL, V84, P820, DOI 10.1016/S0002-9149(99)00444-0
   Thorne S, 2006, HEART, V92, P1520, DOI 10.1136/hrt.2006.095240
   Tobler D, 2010, AM J CARDIOL, V106, P417, DOI 10.1016/j.amjcard.2010.03.047
   Uebing A, 2010, INT J CARDIOL, V139, P50, DOI 10.1016/j.ijcard.2008.09.001
   Veldtman GR, 2004, J AM COLL CARDIOL, V44, P174, DOI 10.1016/j.jacc.2003.11.067
   Vigl M, 2010, AM J CARDIOL, V106, P1317, DOI 10.1016/j.amjcard.2010.06.060
   Warnes CA., 2016, HEART DIS PREGNANCY, P234
   Warnes CA, 2008, J AM COLL CARDIOL, V52, pE1, DOI 10.1016/j.jacc.2008.10.001
   Weiss BM, 1998, J AM COLL CARDIOL, V31, P1650, DOI 10.1016/S0735-1097(98)00162-4
   Wloch A, 2004, ACTA CARDIOL, V59, P242
   Zentner D, 2012, HEART LUNG CIRC, V21, P433, DOI 10.1016/j.hlc.2012.04.009
NR 93
TC 7
Z9 9
U1 2
U2 22
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD APR
PY 2018
VL 48
IS 4
BP 251
EP 276
DI 10.4070/kcj.2018.0070
PG 26
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA GC2JY
UT WOS:000429609400002
PM 29625509
OA Green Published
DA 2021-04-22
ER

PT J
AU Ha, KS
   Jang, GY
   Lee, J
   Lee, KC
   Son, CS
AF Ha, Kee-Soo
   Jang, Gi Young
   Lee, JungHwa
   Lee, Kwang Chul
   Son, Chang Sung
TI Laboratory Markers in Incomplete Kawasaki Disease according to Coronary
   Artery Outcome
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Mucocutaneous lymph node syndrome; Coronary artery disease; Biomarkers
ID AMERICAN-HEART-ASSOCIATION; INTRAVENOUS IMMUNOGLOBULIN; PREDICTION;
   RESISTANCE; GLOBULIN; THERAPY
AB Background and Objectives: We defined laboratory marker profiles typical of incomplete Kawasaki disease (iKD) during illness, especially with respect to the presence of a coronary artery abnormality such as coronary artery dilation or aneurysm.
   Methods: This retrospective study examined the clinical and laboratory markers of patients with iKD over time, along with those of patients with complete KD (cKD) and febrile controls.
   Results: Of 795 patients, 178 had iKD, 504 had cKD and 113 were febrile controls. During the transition from the acute to subacute phase, the age-adjusted hemoglobin levels and platelet counts were significantly lower and higher, respectively, in the subacute phase than in the acute phase in both iKD and cKD patients, which differed from those of febrile controls. Lower levels of acute and subacute age-adjusted hemoglobin levels in iKD patients (odds ratio [OR], 0.538 and 0.583; p= 0.006 and 0.018, respectively) and higher subacute platelet counts in cKD patients (OR, 1.004; p= 0.014) were correlated with the risk of coronary dilation. A higher acute neutrophil-to-lymphocyte ratio was associated with aneurysm only in cKD patients (OR, 1.059; p= 0.044).
   Conclusions: The iKD patients share KD-specific laboratory marker profiles in terms of complete blood cell counts and acute phase reactant levels with cKD patients. However, the factors predicting coronary dilation differ according to the phenotype; lower acute and subacute age-adjusted hemoglobin levels predict coronary dilation only in iKD patients.
C1 [Ha, Kee-Soo; Lee, JungHwa] Korea Univ, Guro Hosp, Dept Pediat, 148 Gurodong Ro, Seoul 08308, South Korea.
   [Jang, Gi Young] Korea Univ, Ansan Hosp, Dept Pediat, Seoul, South Korea.
   [Lee, Kwang Chul; Son, Chang Sung] Korea Univ, Anam Hosp, Dept Pediat, Seoul, South Korea.
RP Lee, J (corresponding author), Korea Univ, Guro Hosp, Dept Pediat, 148 Gurodong Ro, Seoul 08308, South Korea.
EM leejmd@chol.com
OI Lee, Kwang Chul/0000-0003-3552-8721; JANG, GI YOUNG/0000-0002-4831-1188
CR Ashouri N, 2008, J PEDIATR-US, V153, P365, DOI 10.1016/j.jpeds.2008.03.014
   Cha Y, 2011, HEMATOLOGY, P49
   COMENZO RL, 1992, J PEDIATR-US, V120, P926, DOI 10.1016/S0022-3476(05)81964-X
   Egami K, 2006, J PEDIATR-US, V149, P237, DOI 10.1016/j.jpeds.2006.03.050
   Ha KS, 2015, AM J CARDIOL, V116, P301, DOI 10.1016/j.amjcard.2015.04.021
   Japan Kawasaki Disease Research Committee, 1984, REP SUBC STAND DIAGN
   Kahwaji J, 2009, CLIN J AM SOC NEPHRO, V4, P1993, DOI 10.2215/CJN.04540709
   Kawasaki T, 1967, Arerugi, V16, P178
   Kobayashi T, 2006, CIRCULATION, V113, P2606, DOI 10.1161/CIRCULATIONAHA.105.592865
   Manlhiot C, 2012, EUR J PEDIATR, V171, P657, DOI 10.1007/s00431-011-1631-2
   Nemeth E, 2014, HEMATOL ONCOL CLIN N, V28, P671, DOI 10.1016/j.hoc.2014.04.005
   Newburger JW, 2004, CIRCULATION, V110, P2747, DOI 10.1161/01.CIR.0000145143.19711.78
   Sabharwal T, 2009, AM J CARDIOL, V104, P1743, DOI 10.1016/j.amjcard.2009.07.062
   Sano T, 2007, EUR J PEDIATR, V166, P131, DOI 10.1007/s00431-006-0223-z
   Song D, 2009, EUR J PEDIATR, V168, P1315, DOI 10.1007/s00431-009-0925-0
   Sudo D, 2012, EUR J PEDIATR, V171, P651, DOI 10.1007/s00431-011-1630-3
   Terai M, 2002, PEDIATR INFECT DIS J, V21, P777, DOI 10.1097/00006454-200208000-00015
   Tremoulet AH, 2008, J PEDIATR-US, V153, P117, DOI 10.1016/j.jpeds.2007.12.021
   Tremoulet AH, 2011, PEDIATR INFECT DIS J, V30, P1022, DOI 10.1097/INF.0b013e31822d4f56
   Witt MT, 1999, PEDIATRICS, V104, DOI 10.1542/peds.104.1.e10
   Yellen ES, 2010, PEDIATRICS, V125, pE234, DOI 10.1542/peds.2009-0606
   Zhang Wei, 2006, Zhonghua Er Ke Za Zhi, V44, P324
NR 22
TC 9
Z9 10
U1 1
U2 4
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD APR
PY 2018
VL 48
IS 4
BP 287
EP 295
DI 10.4070/kcj.2017.0342
PG 9
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA GC2JY
UT WOS:000429609400004
PM 29625511
OA Green Published
DA 2021-04-22
ER

PT J
AU Myers, MG
AF Myers, Martin G.
TI Automated Office Blood Pressure Measurement
SO KOREAN CIRCULATION JOURNAL
LA English
DT Review
DE Blood pressure; Hypertension diagnosis; Measurement; Devices; Office
ID TREATED HYPERTENSIVE PATIENTS; CARDIOVASCULAR RISK; REDUCE; TRIAL
AB Manual blood pressure (BP) recorded in routine clinical practice is relatively inaccurate and associated with higher readings compared to BP measured in research studies in accordance with standardized measurement guidelines. The increase in routine office BP is the result of several factors, especially the presence of office staff, which tends to make patients nervous and also allows for conversation to occur. With the disappearance of the mercury sphygmomanometer because of environmental concerns, there is greater use of oscillometric BP recorders, both in the office setting and elsewhere. Although oscillometric devices may reduce some aspects of observer BP measurement error in the clinical setting, they are still associated with higher BP readings, known as white coat hypertension (for diagnosis) or white coat effect (with treated hypertension). Now that fully automated sphygmomanometers are available which are capable of recording several readings with the patient resting quietly, there is no longer any need to have office staff present when BP is being recorded. Such readings are called automated office blood pressure (AOBP) and they are both more accurate than conventional manual office BP and not associated with the white coat phenomena. AOBP readings are also similar to the awake ambulatory BP and home BP, both of which are relatively good predictors of cardiovascular risk. The available evidence suggests that AOBP should now replace manual or electronic office BP readings when screening patients for hypertension and also after antihypertensive drug therapy is initiated.
C1 [Myers, Martin G.] Univ Toronto, Sunnybrook Hlth Sci Ctr, Schulich Heart Program, Div Cardiol, Toronto, ON, Canada.
   [Myers, Martin G.] Univ Toronto, Dept Med, Toronto, ON, Canada.
RP Myers, MG (corresponding author), Sunnybrook Hlth Sci Ctr, Div Cardiol, 2075 Bayview Ave, Toronto, ON M4N 3M5, Canada.
EM martin.myers@sunnybrook.ca
CR Al-Karkhi I, 2015, BLOOD PRESS MONIT, V20, P98, DOI 10.1097/MBP.0000000000000088
   Andreadis EA, 2011, AM J HYPERTENS, V24, P661, DOI 10.1038/ajh.2011.38
   Armstrong D, 2015, BLOOD PRESS MONIT, V20, P204, DOI 10.1097/MBP.0000000000000133
   Bauer F, 2018, HYPERTENSION, V71, P243, DOI 10.1161/HYPERTENSIONAHA.117.10026
   Beckett Linda, 2005, BMC Cardiovasc Disord, V5, P18, DOI 10.1186/1471-2261-5-18
   Brown MA, 2001, AM J HYPERTENS, V14, P1263, DOI 10.1016/S0895-7061(01)02193-8
   Burgess SE, 2011, J AM SOC HYPERTENS, V5, P484, DOI 10.1016/j.jash.2011.08.007
   Campbell NRC, 2007, J HUM HYPERTENS, V21, P588, DOI 10.1038/sj.jhh.1002190
   Chambers Larry W, 2013, CMAJ Open, V1, pE37, DOI 10.9778/cmajo.20130005
   de la Sierra A, 2016, J AM SOC HYPERTENS, V10, P947, DOI 10.1016/j.jash.2016.10.013
   Godwin M, 2011, FAM PRACT, V28, P110, DOI 10.1093/fampra/cmq067
   Graves JW, 2003, J HUM HYPERTENS, V17, P823, DOI 10.1038/sj.jhh.1001626
   Gustavsen PH, 2003, J HUM HYPERTENS, V17, P811, DOI 10.1038/sj.jhh.1001643
   Head GA, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c1104
   KACZOROWSKI J, 2011, BMJ-BRIT MED J, V342, DOI DOI 10.1136/BMJ.D442
   Kaczorowski J, 2017, CAN FAM PHYSICIAN, V63, pE193
   Leung AA, 2016, CAN J CARDIOL, V32, P569, DOI 10.1016/j.cjca.2016.02.066
   Mancia G, 2013, J HYPERTENS, V31, P1281, DOI 10.1097/01.hjh.0000431740.32696.cc
   Muntner P, 2017, J AM COLL CARDIOL, V69, P2446, DOI 10.1016/j.jacc.2017.02.066
   Myers MG, 2017, J CLIN HYPERTENS, V19, P1210, DOI 10.1111/jch.13090
   Myers MG, 2016, HYPERTENSION, V68, P866, DOI 10.1161/HYPERTENSIONAHA.116.07721
   Myers MG, 2016, J CLIN HYPERTENS, V18, P721, DOI 10.1111/jch.12820
   Myers MG, 2015, HYPERTENSION, V66, P489, DOI 10.1161/HYPERTENSIONAHA.115.05782
   Myers MG, 2012, J HYPERTENS, V30, P1937, DOI 10.1097/HJH.0b013e328356abd3
   Myers MG, 2012, FAM PRACT, V29, P376, DOI 10.1093/fampra/cmr113
   Myers MG, 2010, BLOOD PRESS MONIT, V15, P300, DOI 10.1097/MBP.0b013e328340d128
   Myers MG, 2010, J HYPERTENS, V28, P703, DOI 10.1097/HJH.0b013e328335d091
   Myers MG, 2010, HYPERTENSION, V55, P195, DOI 10.1161/HYPERTENSIONAHA.109.141879
   Myers MG, 2009, BLOOD PRESS MONIT, V14, P108, DOI 10.1097/MBP.0b013e32832c5167
   Myers MG, 2009, J HYPERTENS, V27, P280, DOI 10.1097/HJH.0b013e32831b9e6b
   MYERS MG, 1995, J HUM HYPERTENS, V9, P729
   MYERS MG, 1995, AM J HYPERTENS, V8, P591, DOI 10.1016/0895-7061(95)00049-U
   Myers MG, 2003, AM J HYPERTENS, V16, P494, DOI 10.1016/S0895-7061(03)00058-X
   Myers MG, 1997, J HUM HYPERTENS, V11, P491, DOI 10.1038/sj.jhh.1000483
   Piper MA, 2015, ANN INTERN MED, V162, P192, DOI 10.7326/M14-1539
   Whelton PK, 2017, A Report of the American College of Cardiology/American Heart Association Task
   Wright JT, 2015, NEW ENGL J MED, V373, P2103, DOI 10.1056/NEJMoa1511939
NR 37
TC 8
Z9 8
U1 0
U2 5
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD APR
PY 2018
VL 48
IS 4
BP 241
EP 250
DI 10.4070/kcj.2018.0066
PG 10
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA GC2JY
UT WOS:000429609400001
PM 29625508
OA Green Published
DA 2021-04-22
ER

PT J
AU Dash, D
AF Dash, Debabrata
TI Interventional Management of "Balloon-Uncrossable" Coronary Chronic
   Total Occlusion: Is There Any Way Out?
SO KOREAN CIRCULATION JOURNAL
LA English
DT Review
DE Chronic total occlusion; Percutaneous coronary intervention;
   Balloon-uncrossable
ID PERCUTANEOUS RECANALIZATION; ATHERECTOMY; ARTERIES
AB It has been estimated that coronary chronic total occlusion (CTO) is encountered in 15 to 20% patients referred for coronary angiography (CAG). The success of percutaneous coronary intervention (PCI) of CTO can be attributed to the vast array of hardware that has now become available and also to the vastly enhanced operator expertise. It is however realistic to state that despite the tremendous increase in the rate of success, there then comes a subset of CTO where PCI attempts fail. The reason for such failures given that other variables remain constant is the inability to cross the CTO lesion. This can be due to a failure to cross the lesion with a guide wire (despite guide wire escalation). The second cause of failure is the inability to cross the lesion with a balloon (balloon-uncrossable [BU] CTO). This can occur despite the successful placement of a guidewire in the distal true lumen. The BU lesions contribute 2% to 10% of CTO PCI failure cases. The author attempts to present a creative solution to assist crossing such lesions.
C1 [Dash, Debabrata] Thumbay Hosp, Sheikh Jaber Al Sabah St,POB 4184, Ajman, U Arab Emirates.
   [Dash, Debabrata] Beijing Tiantan Hosp, Beijing, Peoples R China.
RP Dash, D (corresponding author), Thumbay Hosp, Sheikh Jaber Al Sabah St,POB 4184, Ajman, U Arab Emirates.
EM dr_dash2003@yahoo.com
CR Brilakis ES, 2011, CATHETER CARDIO INTE, V78, P363, DOI 10.1002/ccd.23319
   Dash D., 2017, J HEART LUNG CIRC, V1, pe104
   Dash D, 2018, INDIAN HEART J, V70, P132, DOI 10.1016/j.ihj.2017.11.014
   Dash Debabrata, 2016, Indian Heart J, V68, P584, DOI 10.1016/j.ihj.2016.05.008
   Dash D, 2016, J INTERV CARDIOL, V29, P70, DOI 10.1111/joic.12268
   Fang HY, 2011, CATHETER CARDIO INTE, V78, P356, DOI 10.1002/ccd.22862
   Han YL, 2008, CHINESE MED J-PEKING, V121, P518, DOI 10.1097/00029330-200803020-00010
   Li Y, 2014, J INVASIVE CARDIOL, V26, P167
   Liu RF, 2015, TECHNOL HEALTH CARE, V23, pS223, DOI 10.3233/THC-150957
   Luna M, 2012, CATHETER CARDIO INTE, V80, P437, DOI 10.1002/ccd.23232
   Michael TT, 2013, J INVASIVE CARDIOL, V25, P552
   Niccoli G, 2011, INT J CARDIOL, V146, P296, DOI 10.1016/j.ijcard.2010.10.092
   Pagnotta P, 2010, CATHETER CARDIO INTE, V76, P366, DOI 10.1002/ccd.22504
   Patel SM, 2015, J INVASIVE CARDIOL, V27, P78
   Scheinowitz M, 2011, CARDIOVASC REVASCULA, V12, P20, DOI 10.1016/j.carrev.2010.01.005
   Stone GW, 2005, CIRCULATION, V112, P2530, DOI 10.1161/CIRCULATIONAHA.105.583716
   Stone GW, 2005, CATHETER CARDIO INTE, V66, P217, DOI 10.1002/ccd.20489
   Sueta D, 2015, IJC HEART VASC, V9, P70, DOI 10.1016/j.ijcha.2015.08.004
   Von Sohsten R, 1998, J INVASIVE CARDIOL, V10, P198
NR 19
TC 4
Z9 4
U1 0
U2 3
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD APR
PY 2018
VL 48
IS 4
BP 277
EP 286
DI 10.4070/kcj.2017.0345
PG 10
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA GC2JY
UT WOS:000429609400003
PM 29625510
OA Green Published
DA 2021-04-22
ER

PT J
AU Seo, SK
   Kim, N
   Lee, JH
   Kim, SM
   Lee, SY
   Bae, JW
   Hwang, KK
   Kim, DW
   Koch, WJ
   Cho, MC
AF Seo, Seul-ki
   Kim, Nari
   Lee, Ju-Hee
   Kim, Sang Min
   Lee, Sang Yeub
   Bae, Jang-Whan
   Hwang, Kyung-Kuk
   Kim, Dong-Woon
   Koch, Walter J.
   Cho, Myeong-Chan
TI beta-arrestin2 Affects Cardiac Progenitor Cell Survival through Cell
   Mobility and Tube Formation in Severe Hypoxia
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Beta-arrestins; Stem cells; Cell movement; Myocardial ischemia;
   Apoptosis
ID MESENCHYMAL STEM-CELLS; MYOCARDIAL-INFARCTION; BETA-ARRESTINS;
   WNT/BETA-CATENIN; HEART-FAILURE; IN-VITRO; MIGRATION; ACTIVATION; ROLES;
   REGENERATION
AB Background and Objectives: beta-arrestin2 (beta-arr2) basically regulates multiple signaling pathways in mammalian cells by desensitization and internalization of G-protein coupled receptors (GPCRs). We investigated impacts of beta-arr2 on survival, mobility, and tube formation of cardiac progenitor cells (CPCs) obtained from wild-type (WT) mouse (CPC-WT), and beta-arr2 knock-out (KO) mouse (CPC-KO) cultured in presence or absence of serum and oxygen as non-canonical roles in GPCR system.
   Methods: CPCs were cultured in Dulbecco's Modified Eagle Medium/Nutrient Mixture F-12-based media containing fetal bovine serum and growth factors. Survival of 2 types of CPCs in hypoxia and/or serum deprivation was measured by fluorescence-activated cell sorting. Wound healing ability, and tube formation ability on Matrigel of 2 kinds of CPCs were compared in normoxic and hypoxic cultures. Protein expression related to survival and mobility were measured with the Western blot for each culture conditions.
   Results: CPC-KO showed significantly worse mobility in the wound healing assay and in tube formation on Matrigel especially in hypoxic culture than did the CPC-WT. Also, CPC-KO showed significantly higher apoptosis fraction in both normoxic and hypoxic cultures than did the CPC-WT. Expression of proteins associated with cell survival and mobility, e.g., protein kinase B (Akt), beta-catenin, and glycogen synthase kinase-3 beta (GSK-3 beta) was significantly worse in CPC-KO.
   Conclusions: The CPC-KO had significantly worse cell mobility, tube formation ability, and survival than the CPC-WT, especially in the hypoxic cultures. Apparently, beta-arr2 is important on CPC survival by means of mobility and tube formation in myocardial ischemia.
C1 [Seo, Seul-ki; Kim, Nari; Lee, Sang Yeub; Bae, Jang-Whan; Hwang, Kyung-Kuk; Kim, Dong-Woon; Cho, Myeong-Chan] Chungbuk Natl Univ, Coll Med, Dept Internal Med, 1 Chungdae Ro, Cheongju 28644, South Korea.
   [Lee, Ju-Hee; Kim, Sang Min; Lee, Sang Yeub; Bae, Jang-Whan; Hwang, Kyung-Kuk; Kim, Dong-Woon; Cho, Myeong-Chan] Chungbuk Natl Univ Hosp, Chungbuk Reg Cardiocerebrovasc Ctr, Cheongju, South Korea.
   [Koch, Walter J.] Temple Univ, Lewis Katz Sch Med, Dept Pharmacol, Ctr Translat Med, Philadelphia, PA 19122 USA.
RP Bae, JW (corresponding author), Chungbuk Natl Univ, Coll Med, Dept Internal Med, 1 Chungdae Ro, Cheongju 28644, South Korea.
EM drcorazon@hanmail.net
OI Lee, sang yeub/0000-0003-1386-349X; Cho,
   Myeong-Chan/0000-0002-0047-0227; Hwang, Kyung-Kuk/0000-0003-3464-3023
FU Korean Society of Cardiology
FX The work was supported by research grant in 2015 from the Korean Society
   of Cardiology.
CR ATTRAMADAL H, 1992, J BIOL CHEM, V267, P17882
   Beltrami AP, 2003, CELL, V114, P763, DOI 10.1016/S0092-8674(03)00687-1
   Bohn LM, 1999, SCIENCE, V286, P2495, DOI 10.1126/science.286.5449.2495
   Buchanan FG, 2006, CELL CYCLE, V5, P2060, DOI 10.4161/cc.5.18.3212
   Chun WJ, 2015, KOREAN CIRC J, V45, P234, DOI 10.4070/kcj.2015.45.3.234
   DeFea KA, 2013, PROG MOL BIOL TRANSL, V118, P205, DOI 10.1016/B978-0-12-394440-5.00008-5
   Fransioli J, 2008, STEM CELLS, V26, P1315, DOI 10.1634/stemcells.2007-0751
   Ge L, 2003, J BIOL CHEM, V278, P34418, DOI 10.1074/jbc.M300573200
   Krock Bryan L, 2011, Genes Cancer, V2, P1117, DOI 10.1177/1947601911423654
   Kuang D, 2008, BASIC RES CARDIOL, V103, P265, DOI 10.1007/s00395-007-0690-z
   la Cour CM, 2011, MOL PHARMACOL, V79, P91, DOI 10.1124/mol.110.065409
   Lee JH, 2016, KOREAN CIRC J, V46, P658, DOI 10.4070/kcj.2016.46.5.658
   Lefkowitz RJ, 2006, MOL CELL, V24, P643, DOI 10.1016/j.molcel.2006.11.007
   Liang SX, 2013, ANAT REC, V296, P184, DOI 10.1002/ar.22633
   Luttrell LM, 2002, J CELL SCI, V115, P455
   Makkar RR, 2012, LANCET, V379, P895, DOI 10.1016/S0140-6736(12)60195-0
   McCubrey JA, 2014, LEUKEMIA, V28, P15, DOI 10.1038/leu.2013.184
   Naaldijk Y, 2015, EXP CELL RES, V338, P97, DOI 10.1016/j.yexcr.2015.08.019
   Park Keon-Jae, 2010, Korean Circ J, V40, P651, DOI 10.4070/kcj.2010.40.12.651
   Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319
   Takeda K, 2015, ANN PLAS SURG, V74, P728, DOI 10.1097/SAP.0000000000000084
   Takeda N, 2011, INT J INFLAMM, V2011, DOI 10.4061/2011/535241
   Traynham CJ, 2016, J MOL CELL CARDIOL, V92, P196, DOI 10.1016/j.yjmcc.2016.01.027
   van Berlo JH, 2014, NATURE, V509, P337, DOI 10.1038/nature13309
   Walker JKL, 2003, J CLIN INVEST, V112, P566, DOI 10.1172/JCI200317265
   Williams AR, 2013, CIRCULATION, V127, P213, DOI 10.1161/CIRCULATIONAHA.112.131110
   Yang P, 2015, BIOCHEM BIOPH RES CO, V459, P327, DOI 10.1016/j.bbrc.2015.02.112
   Youn JC, 2017, KOREAN CIRC J, V47, P16, DOI 10.4070/kcj.2016.0429
   Zhang T, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt221
   Zou L, 2008, FASEB J, V22, P355, DOI 10.1096/fj.07-9046com
NR 30
TC 5
Z9 5
U1 0
U2 3
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD APR
PY 2018
VL 48
IS 4
BP 296
EP 309
DI 10.4070/kcj.2017.0119
PG 14
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA GC2JY
UT WOS:000429609400005
PM 29625512
OA Green Published
DA 2021-04-22
ER

PT J
AU Han, S
   Park, GM
   Kim, YG
   Park, MW
   Her, SH
   Lee, SW
   Kim, YH
AF Han, Seungbong
   Park, Gyung-Min
   Kim, Yong-Giun
   Park, Mahn-Won
   Her, Sung Ho
   Lee, Seung-Whan
   Kim, Young-Hak
TI Trends, Characteristics, and Clinical Outcomes of Patients Undergoing
   Percutaneous Coronary Intervention in Korea between 2011 and 2015
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Percutaneous coronary intervention; Angina pectoris; Myocardial
   infarction; Coronary artery disease
ID BARE-METAL STENTS; OPTIMAL MEDICAL THERAPY; DRUG-ELUTING STENTS;
   CARDIOVASCULAR-DISEASE; MYOCARDIAL-INFARCTION; ARTERY-DISEASE; RISK;
   PCI; REVASCULARIZATION; THROMBOSIS
AB Background and Objectives: We sought to evaluate nationwide trends, characteristics, and clinical outcomes in patients undergoing percutaneous coronary intervention (PCI) in Korea.
   Methods: From National Health Insurance claims data in Korea, 81,115 patients, who underwent PCI for the first episode of coronary artery disease between 2011 and 2015, were enrolled. Patients were categorized into angina (n= 49,288) or acute myocardial infarction (AMI, n= 31,887) groups and analyzed.
   Results: The mean age of patients was 64.4 +/- 12.2 years and 56,576 (69.7%) were men. Diabetes, hyperlipidemia, and hypertension were observed in 27,086 (33.4%), 30,675 (37.8%), and 45,389 (56.0%) patients, respectively. There was a 10% increase in the number of patients undergoing PCI for angina between 2011-2012 and 2014-2015 (11,105 vs. 13,261; p= 0.021). However, the number of patients undergoing PCI for AMI marginally decreased between 2011-2012 and 2014-2015 (8,068 vs. 7,823; p= 0.052). In procedures, drug-eluting stent was the most frequently used device (93.2%), followed by balloon angioplasty (5.5%) and bare metal stents (1.3%). The mean number of stents per patient was 1.39 +/- 0.64. At discharge, dual-anti platelet therapy, statin, beta-blockers, and angiotensin converting enzyme inhibitor or angiotensin receptor blocker were provided to 76,292 (94.1%), 71,411 (88.0%), 57,429 (70.8%), and 54,418 (67.1%) patients, respectively. The mean in-hospital and 1-year total medical costs were 8,628,768 +/- 4,832,075 and 13,128,158 +/- 9,758,753 Korean Won, respectively. In-hospital mortality occurred in 2,094 patients (2.6%).
   Conclusions: Appropriate healthcare strategies reflecting trends, characteristics, and clinical outcomes of PCI are needed in Korea.
C1 [Han, Seungbong] Gachon Univ, Dept Appl Stat, Seongnam, South Korea.
   [Park, Gyung-Min; Kim, Yong-Giun] Univ Ulsan, Coll Med, Ulsan Univ Hosp, Dept Cardiol, 877 Bangeojinsunhwando Ro, Ulsan 44033, South Korea.
   [Park, Mahn-Won; Her, Sung Ho] Catholic Univ Korea, Daejeon St Marys Hosp, Dept Cardiol, Daejeon, South Korea.
   [Lee, Seung-Whan; Kim, Young-Hak] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Cardiol, Seoul, South Korea.
RP Park, GM (corresponding author), Univ Ulsan, Coll Med, Ulsan Univ Hosp, Dept Cardiol, 877 Bangeojinsunhwando Ro, Ulsan 44033, South Korea.
EM min8684@hanmail.net
OI Lee, Seung-Whan/0000-0002-2662-5952; Park, Mahn-Won/0000-0001-5293-8461;
   Kim, Yong-Giun/0000-0002-0816-9025
FU Korean Circulation Society [201505-03]; Basic Science Research Program
   through the National Research Foundation of Korea - Ministry of Science
   and ICT [2017R1C1B1006717]
FX This study was supported by research grants from Korean Circulation
   Society (201505-03) and Basic Science Research Program through the
   National Research Foundation of Korea funded by the Ministry of Science
   and ICT (2017R1C1B1006717).
CR Bangalore S, 2013, CIRC-CARDIOVASC INTE, V6, P378, DOI 10.1161/CIRCINTERVENTIONS.113.000415
   Boden WE, 2007, NEW ENGL J MED, V356, P1503, DOI 10.1056/NEJMoa070829
   Camenzind E, 2007, CIRCULATION, V115, P1440, DOI 10.1161/CIRCULATIONAHA.106.666800
   Conroy RM, 2003, EUR HEART J, V24, P987, DOI 10.1016/S0195-668X(03)00114-3
   Epstein AJ, 2011, JAMA-J AM MED ASSOC, V305, P1769, DOI 10.1001/jama.2011.551
   Goyal A, 2007, ANN THORAC SURG, V83, P993, DOI 10.1016/j.athoracsur.2006.10.046
   Gwon HC, 2017, KOREAN CIRC J, V47, P320, DOI 10.4070/kcj.2017.0070
   Harnek J, 2013, SCAND CARDIOVASC J, V47, P1, DOI 10.3109/14017431.2013.780389
   Iqbal J, 2015, CIRCULATION, V131, P1269, DOI 10.1161/CIRCULATIONAHA.114.013042
   Jang JS, 2017, KOREAN CIRC J, V47, P328, DOI 10.4070/kcj.2017.0071
   Kolh P, 2014, EUR J CARDIO-THORAC, V46, P517, DOI [10.1093/eurheartj/ehu278, 10.1093/ejcts/ezu366]
   Kook HY, 2014, AM J CARDIOL, V114, P1817, DOI 10.1016/j.amjcard.2014.09.019
   Lagerqvist B, 2007, NEW ENGL J MED, V356, P1009, DOI 10.1056/NEJMoa067722
   Lee PH, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000002971
   Levine GN, 2016, J AM COLL CARDIOL, V68, P1082, DOI 10.1016/j.jacc.2016.03.513
   Lin GA, 2008, JAMA-J AM MED ASSOC, V300, P1765, DOI 10.1001/jama.300.15.1765
   McWilliams JM, 2009, ANN INTERN MED, V150, P505, DOI 10.7326/0003-4819-150-8-200904210-00005
   Nabel EG, 2012, NEW ENGL J MED, V366, P54, DOI 10.1056/NEJMra1112570
   Palmerini T, 2012, LANCET, V379, P1393, DOI 10.1016/S0140-6736(12)60324-9
   Park GM, 2016, J NUCL MED, V57, P1364, DOI 10.2967/jnumed.115.169318
   Park GM, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000000917
   Park GM, 2014, CIRC-CARDIOVASC QUAL, V7, P944, DOI 10.1161/CIRCOUTCOMES.114.001305
   Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83
   Shreibati JB, 2011, JAMA-J AM MED ASSOC, V306, P2128, DOI 10.1001/jama.2011.1652
   Ueshima H, 2008, CIRCULATION, V118, P2702, DOI 10.1161/CIRCULATIONAHA.108.790048
   Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837
NR 26
TC 15
Z9 15
U1 1
U2 4
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD APR
PY 2018
VL 48
IS 4
BP 310
EP 321
DI 10.4070/kcj.2017.0359
PG 12
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA GC2JY
UT WOS:000429609400006
PM 29625513
OA Green Published
DA 2021-04-22
ER

PT J
AU Jeong, HS
   Hong, SJ
AF Jeong, Han Saem
   Hong, Soon Jun
TI Current Practices of Percutaneous Coronary Intervention in Korea between
   2011 and 2015
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
ID GUIDELINES; MANAGEMENT
C1 [Jeong, Han Saem; Hong, Soon Jun] Korea Univ, Anam Hosp, Dept Cardiol, Cardiovasc Ctr, Seoul, South Korea.
RP Hong, SJ (corresponding author), Korea Univ, Anam Hosp, Cardiovasc Ctr, Dept Cardiol, 73 Inchon Ro, Seoul 02841, South Korea.
EM psyche94@gmail.com
OI Jeong, Han Saem/0000-0002-6035-4332
CR Anderson JL, 2013, J AM COLL CARDIOL, V61, pE179, DOI 10.1016/j.jacc.2013.01.014
   Bangalore S, 2015, INT J CARDIOL, V183, P6, DOI 10.1016/j.ijcard.2015.01.053
   Bangalore S, 2013, CIRC-CARDIOVASC INTE, V6, P378, DOI 10.1161/CIRCINTERVENTIONS.113.000415
   Fihn SD, 2014, J AM COLL CARDIOL, V64, P1929, DOI 10.1016/j.jacc.2014.07.017
   Han S, 2018, KOREAN CIRC J, V48, P310, DOI 10.4070/kcj.2017.0359
   Messerli FH, 2006, EUR HEART J, V27, P2902, DOI 10.1093/eurheartj/ehl308
   O'Neill D, 2017, CIRC-CARDIOVASC QUAL, V10, DOI 10.1161/CIRCOUTCOMES.116.003186
   Pursnani S, 2012, CIRC-CARDIOVASC INTE, V5, P476, DOI 10.1161/CIRCINTERVENTIONS.112.970954
   Singh M, 2007, CIRCULATION, V115, P2835, DOI 10.1161/CIRCULATIONAHA.106.632679
   Tsai TT, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.114.001380
NR 10
TC 0
Z9 0
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD APR
PY 2018
VL 48
IS 4
BP 322
EP 324
DI 10.4070/kcj.2018.0058
PG 3
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA GC2JY
UT WOS:000429609400007
PM 29625514
OA Green Published
DA 2021-04-22
ER

PT J
AU Marquez, J
   Han, J
AF Marquez, Jubert
   Han, Jin
TI You're Not under Arrest: Worry-free with beta-arrestin
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
ID INFARCTION HEART-FAILURE
C1 [Marquez, Jubert; Han, Jin] Inje Univ, Grad Sch, Dept Hlth Sci & Technol, Plus Project Team BK21, Busan, South Korea.
   [Han, Jin] Inje Univ, Natl Res Lab Mitochondrial Signaling, Cardiovasc & Metab Dis Ctr, Plus Project Team BK21, 75 Bokji Ro, Busan 47392, South Korea.
RP Han, J (corresponding author), Inje Univ, Natl Res Lab Mitochondrial Signaling, Cardiovasc & Metab Dis Ctr, Plus Project Team BK21, 75 Bokji Ro, Busan 47392, South Korea.
EM phyhanj@inje.ac.kr
OI Marquez, Jubert/0000-0002-8541-4362
FU Priority Research Centers Program through the National Research
   Foundation of Korea (NRF) - Ministry of Education, Science, and
   Technology [2010-0020224]; Basic Science Research Program through the
   National Research Foundation of Korea (NRF) - Ministry of Education,
   Science, and Technology [2015R1A2A1A13001900]
FX This work was supported by the Priority Research Centers Program
   (2010-0020224) and the Basic Science Research Program
   (2015R1A2A1A13001900) through the National Research Foundation of Korea
   (NRF) funded by the Ministry of Education, Science, and Technology.
CR Bathgate-Siryk A, 2014, HYPERTENSION, V63, P404, DOI 10.1161/HYPERTENSIONAHA.113.02043
   Bolli R, 2011, LANCET, V378, P1847, DOI 10.1016/S0140-6736(11)61590-0
   Hu SS, 2013, MOL BIOL REP, V40, P1065, DOI 10.1007/s11033-012-2148-0
   Le TYL, 2016, CELL DEATH DISCOV, V2, DOI 10.1038/cddiscovery.2016.52
   McCrink KA, 2017, HYPERTENSION, V70, P972, DOI 10.1161/HYPERTENSIONAHA.117.09817
   Nakaya M, 2012, J BIOL CHEM, V287, P35669, DOI 10.1074/jbc.M112.357871
   Noor N, 2011, J MOL CELL CARDIOL, V51, P534, DOI 10.1016/j.yjmcc.2010.11.005
   Savarese Gianluigi, 2017, Card Fail Rev, V3, P7, DOI 10.15420/cfr.2016:25:2
   Seo SK, 2018, KOREAN CIRC J, V48, P296, DOI 10.4070/kcj.2017.0119
   Wurth R, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00144
NR 10
TC 0
Z9 0
U1 0
U2 3
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD APR
PY 2018
VL 48
IS 4
BP 325
EP 328
DI 10.4070/kcj.2018.0057
PG 4
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA GC2JY
UT WOS:000429609400008
PM 29625515
OA Green Published
DA 2021-04-22
ER

PT J
AU Kim, SJ
AF Kim, Soo-Jin
TI Risk Factors Related to Coronary Artery Outcome in Kawasaki Disease
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
C1 [Kim, Soo-Jin] Konkuk Univ, Sch Med, Dept Pediat, 120-1 Neungdong Ro, Seoul 05030, South Korea.
RP Kim, SJ (corresponding author), Konkuk Univ, Sch Med, Dept Pediat, 120-1 Neungdong Ro, Seoul 05030, South Korea.
EM ksoojn@naver.com
RI Kim, Soo-Jin/P-2677-2014
OI Kim, Soo-Jin/0000-0001-9671-6019
CR Galeotti C, 2010, AUTOIMMUN REV, V9, P441, DOI 10.1016/j.autrev.2009.12.004
   Ha KS, 2018, KOREAN CIRC J, V48, P287, DOI 10.4070/kcj.2017.0342
   Kawasaki T, 1967, JAP J ALLERG, V16, P178, DOI DOI 10.4070/KCJ.2018.0214
   Manlhiot C, 2012, EUR J PEDIATR, V171, P657, DOI 10.1007/s00431-011-1631-2
   Newburger JW, 2004, CIRCULATION, V110, P2747, DOI 10.1161/01.CIR.0000145143.19711.78
   Tewelde Helen, 2014, Hosp Pediatr, V4, P233, DOI 10.1542/hpeds.2014-0008
   Yu XY, 2004, PEDIATR RES, V55, P688, DOI 10.1203/01.PDR.0000113464.93042.A4
NR 7
TC 2
Z9 2
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD APR
PY 2018
VL 48
IS 4
BP 329
EP 331
DI 10.4070/kcj.2018.0077
PG 3
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA GC2JY
UT WOS:000429609400009
PM 29625516
OA Green Published
DA 2021-04-22
ER

PT J
AU Miura, M
   Shirai, S
   Hayashi, M
   Jinnouchi, H
   Isotani, A
   Kakumoto, S
   Arai, Y
   Ando, K
AF Miura, Mizuki
   Shirai, Shinichi
   Hayashi, Masaomi
   Jinnouchi, Hiroyuki
   Isotani, Akihiro
   Kakumoto, Shinichi
   Arai, Yoshio
   Ando, Kenji
TI Atypical Annulus Rupture after Transcatheter Aortic Valve Implantation
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
C1 [Miura, Mizuki; Shirai, Shinichi; Hayashi, Masaomi; Jinnouchi, Hiroyuki; Isotani, Akihiro; Ando, Kenji] Kokura Mem Hosp, Dept Cardiol, Kitakyushu, Fukuoka, Japan.
   [Kakumoto, Shinichi] Kokura Mem Hosp, Dept Anesthesiol, Kitakyushu, Fukuoka, Japan.
   [Arai, Yoshio] Kokura Mem Hosp, Dept Cardiovasc Surg, Kitakyushu, Fukuoka, Japan.
RP Miura, M (corresponding author), Kokura Mem Hosp, Dept Cardiol, Kokurakita Ku, 3-2-1 Asano, Kitakyushu, Fukuoka 8028555, Japan.
EM mizumiura-circ@umin.ac.jp
OI Miura, Mizuki/0000-0003-3252-3861
CR Hagiwara K, 2017, BMJ CASE REP, V2017
   Hayashida K, 2013, CATHETER CARDIO INTE, V82, pE742, DOI 10.1002/ccd.24524
NR 2
TC 1
Z9 1
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD APR
PY 2018
VL 48
IS 4
BP 332
EP 333
DI 10.4070/kcj.2017.0306
PG 2
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA GC2JY
UT WOS:000429609400010
PM 29625517
OA Green Published
DA 2021-04-22
ER

PT J
AU Han, SK
   Park, SW
   Lee, JW
   Ahn, SG
   Youn, YJ
   Oh, JR
   Park, IH
AF Han, Sul Ki
   Park, Sang Wook
   Lee, Jun-Won
   Ahn, Sung Gyun
   Youn, Young Jin
   Oh, Jin Rok
   Park, Il Hwan
TI Intermittent Claudication due to Cystic Adventitial Disease of the
   Popliteal Artery: Importance of Multiple Imaging Modalities
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
C1 [Han, Sul Ki; Park, Sang Wook; Lee, Jun-Won; Ahn, Sung Gyun; Youn, Young Jin] Yonsei Univ, Wonju Coll Med, Dept Internal Med, Div Cardiol, 20 Ilsan Ro, Wonju 26426, South Korea.
   [Oh, Jin Rok] Yonsei Univ, Wonju Coll Med, Dept Orthoped, Wonju, South Korea.
   [Park, Il Hwan] Yonsei Univ, Wonju Coll Med, Dept Cardiovasc & Thorac Surg, Wonju, South Korea.
RP Youn, YJ (corresponding author), Yonsei Univ, Wonju Coll Med, Dept Internal Med, Div Cardiol, 20 Ilsan Ro, Wonju 26426, South Korea.
EM younyj@yonsei.ac.kr
RI Ahn, Sung Gyun/AAG-5976-2020
OI Ahn, Sung Gyun/0000-0002-1528-2739; Han, Seul Ki/0000-0002-8294-3517;
   Lee, Jun-Won/0000-0001-6206-1704; Youn, Young Jin/0000-0001-7066-7474;
   Oh, Jinrok/0000-0002-1729-9526
CR ATKINS HJB, 1947, BRIT J SURG, V34, P426, DOI 10.1002/bjs.18003413618
   Desy NM, 2014, J VASC SURG, V60, P235, DOI 10.1016/j.jvs.2014.04.014
NR 2
TC 0
Z9 1
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD APR
PY 2018
VL 48
IS 4
BP 334
EP 335
DI 10.4070/kcj.2017.0319
PG 2
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA GC2JY
UT WOS:000429609400011
PM 29625518
OA Green Published
DA 2021-04-22
ER

PT J
AU Lee, JM
   Doh, JH
   Nam, CW
   Shin, ES
   Koo, BK
AF Lee, Joo Myung
   Doh, Joon-Hyung
   Nam, Chang-Wook
   Shin, Eun-Seok
   Koo, Bon-Kwon
TI Functional Approach for Coronary Artery Disease: Filling the Gap Between
   Evidence and Practice
SO KOREAN CIRCULATION JOURNAL
LA English
DT Review
DE Ischemic heart disease; Coronary artery stenosis; Coronary physiology;
   Invasive physiologic assessment
ID FRACTIONAL FLOW RESERVE; WAVE-FREE RATIO; INCREMENTAL PROGNOSTIC VALUE;
   MICROCIRCULATORY RESISTANCE; INTENSITY ANALYSIS; STENOSIS SEVERITY;
   BLOOD-FLOW; FOLLOW-UP; ANGIOGRAPHY; PRESSURE
AB The presence of myocardial ischemia is the most important prognostic factor in patients with coronary artery disease, and ischemia-directed revascularization has been a standard of care. Fractional flow reserve (FFR) is an invasive method used to detect the functionally significant epicardial coronary stenosis, and FFR-guided revascularization strategy has been proven to be superior to angiography-guided strategy. Recently, a hyperemia-free index, instantaneous wave free ratio (iFR), was developed and showed its non-inferiority for clinical outcomes compared with FFR-guided strategy. While evidence supporting the benefit of pressure wire assessment exists, there remain several unresolved issues, such as the mechanism of discordance between resting and hyperemic physiologic indices, clinical outcomes of patient/lesions with discordant results among the physiologic indices, role of physiologic indices beyond per-vessel decision tool, and the role of microvascular dysfunction in patient prognosis. The current article will review the recent studies performed to address these questions.
C1 [Lee, Joo Myung] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Cardiol,Dept Internal Med,Heart Vasc Stroke I, Seoul, South Korea.
   [Doh, Joon-Hyung] Inje Univ, Ilsan Paik Hosp, Dept Med, Goyang, South Korea.
   [Nam, Chang-Wook] Keimyung Univ, Dongsan Med Ctr, Dept Med, Daegu, South Korea.
   [Shin, Eun-Seok] Univ Ulsan, Coll Med, Ulsan Univ Hosp, Dept Cardiol, Ulsan, South Korea.
   [Shin, Eun-Seok] Ernst Moritz Arndt Univ Greifswald, Acad Teaching Hosp, Dietrich Bonhoeffer Hosp, Div Cardiol, Greifswald, Germany.
   [Koo, Bon-Kwon] Seoul Natl Univ Hosp, Dept Internal Med, 103 Daehak Ro, Seoul 03080, South Korea.
   [Koo, Bon-Kwon] Seoul Natl Univ Hosp, Cardiovasc Ctr, 103 Daehak Ro, Seoul 03080, South Korea.
   [Koo, Bon-Kwon] Seoul Natl Univ, Inst Aging, Seoul, South Korea.
RP Koo, BK (corresponding author), Seoul Natl Univ Hosp, Dept Internal Med, 103 Daehak Ro, Seoul 03080, South Korea.; Koo, BK (corresponding author), Seoul Natl Univ Hosp, Cardiovasc Ctr, 103 Daehak Ro, Seoul 03080, South Korea.
EM bkkoo@snu.ac.kr
RI Lee, Jung Myung/S-6184-2019
OI Lee, Jung Myung/0000-0002-1904-5335; Lee, Joo Myung/0000-0002-2178-4014;
   Nam, Chang-Wook/0000-0002-3370-5774; Doh, Joon Hyung/0000-0001-7966-9564
FU St. Jude Medical (Abbott Vascular); Philips Volcano
FX Dr. Bon-Kwon Koo received an Institutional Research Grant from St. Jude
   Medical (Abbott Vascular) and Philips Volcano. Dr. Joo Myung Lee
   received a Research Grant from St. Jude Medical (Abbott Vascular) and
   Philips Volcano.
CR Ahn JM, 2015, AM J CARDIOL, V116, P1163, DOI 10.1016/j.amjcard.2015.07.028
   Berry C, 2013, J AM COLL CARDIOL, V61, P1421, DOI 10.1016/j.jacc.2012.09.065
   Camici PG, 2007, NEW ENGL J MED, V356, P830, DOI 10.1056/NEJMra061889
   Cook CM, 2017, JACC-CARDIOVASC INTE, V10, P2514, DOI 10.1016/j.jcin.2017.09.021
   Curzen N, 2014, CIRC-CARDIOVASC INTE, V7, P248, DOI 10.1161/CIRCINTERVENTIONS.113.000978
   Davies JE, 2017, NEW ENGL J MED, V376, P1824, DOI 10.1056/NEJMoa1700445
   Davies JE, 2006, CIRCULATION, V113, P1768, DOI 10.1161/CIRCULATIONAHA.105.603050
   Escaned J, 2015, JACC-CARDIOVASC INTE, V8, P824, DOI 10.1016/j.jcin.2015.01.029
   Gotberg M, 2017, NEW ENGL J MED, V376, P1813, DOI 10.1056/NEJMoa1616540
   Hachamovitch R, 2002, CIRCULATION, V105, P823, DOI 10.1161/hc0702.103973
   Hennigan B, 2016, CIRC-CARDIOVASC INTE, V9, DOI 10.1161/CIRCINTERVENTIONS.116.004016
   Iskander S, 1998, J AM COLL CARDIOL, V32, P57, DOI 10.1016/S0735-1097(98)00177-6
   ISKANDRIAN AS, 1993, J AM COLL CARDIOL, V22, P665, DOI 10.1016/0735-1097(93)90174-Y
   Jeremias A, 2014, J AM COLL CARDIOL, V63, P1253, DOI 10.1016/j.jacc.2013.09.060
   Johnson NP, 2016, JACC-CARDIOVASC INTE, V9, P757, DOI 10.1016/j.jcin.2015.12.273
   Johnson NP, 2014, J AM COLL CARDIOL, V64, P1641, DOI 10.1016/j.jacc.2014.07.973
   Kobayashi Y, 2017, CIRC-CARDIOVASC INTE, V10, DOI 10.1161/CIRCINTERVENTIONS.117.005445
   Kolh P, 2014, EUR J CARDIO-THORAC, V46, P517, DOI [10.1093/eurheartj/ehu278, 10.1093/ejcts/ezu366]
   Lanza GA, 2010, CIRCULATION, V121, P2317, DOI 10.1161/CIRCULATIONAHA.109.900191
   Lee JM, 2017, EUR HEART J
   Lee JM, 2017, J AM HEART ASSOC, V6, DOI 10.1161/JAHA.117.006071
   Lee JM, 2017, JACC-CARDIOVASC INTE, V10, P2502, DOI 10.1016/j.jcin.2017.07.019
   Lee JM, 2017, CIRCULATION, V136, P1798, DOI 10.1161/CIRCULATIONAHA.117.029911
   Lee JM, 2017, J AM COLL CARDIOL, V70, P2114, DOI 10.1016/j.jacc.2017.09.007
   Lee JM, 2017, INT J CARDIOL, V245, P63, DOI 10.1016/j.ijcard.2017.07.099
   Lee JM, 2017, INT J CARDIOL, V243, P91, DOI 10.1016/j.ijcard.2017.05.114
   Lee JM, 2016, J AM COLL CARDIOL, V67, P1158, DOI 10.1016/j.jacc.2015.12.053
   Lee JM, 2015, CIRC-CARDIOVASC INTE, V8, DOI 10.1161/CIRCINTERVENTIONS.115.002857
   Levine GN, 2011, J AM COLL CARDIOL, V58, pE44, DOI 10.1016/j.jacc.2011.08.007
   Lin GA, 2008, JAMA-J AM MED ASSOC, V300, P1765, DOI 10.1001/jama.300.15.1765
   Meuwissen M, 2008, CATHETER CARDIO INTE, V71, P291, DOI 10.1002/ccd.21331
   Nijjer SS, 2016, EUR HEART J, V37, P2069, DOI 10.1093/eurheartj/ehv626
   Park JJ, 2013, INT J CARDIOL, V168, P4070, DOI 10.1016/j.ijcard.2013.07.030
   Park J, 2017, J AM COLL CARDIOL, V70, pB29
   Park SH, 2015, CIRC-CARDIOVASC INTE, V8, DOI 10.1161/CIRCINTERVENTIONS.115.002442
   Patel MR, 2017, J AM COLL CARDIOL, V69, P2212, DOI 10.1016/j.jacc.2017.02.001
   Patel MR, 2010, NEW ENGL J MED, V362, P886, DOI 10.1056/NEJMoa0907272
   Petraco R, 2014, AM HEART J, V168, P739, DOI 10.1016/j.ahj.2014.06.022
   Petraco R, 2013, EUROINTERVENTION, V9, P91, DOI 10.4244/EIJV9I1A14
   Sen S, 2013, J AM COLL CARDIOL, V61, P1409, DOI 10.1016/j.jacc.2013.01.034
   Sen S, 2012, J AM COLL CARDIOL, V59, P1392, DOI 10.1016/j.jacc.2011.11.003
   Siebes M, 2009, MED BIOL ENG COMPUT, V47, P233, DOI 10.1007/s11517-009-0448-x
   Tonino PAL, 2009, NEW ENGL J MED, V360, P213, DOI 10.1056/NEJMoa0807611
   Toth G, 2014, EUR HEART J, V35, P2831, DOI 10.1093/eurheartj/ehu094
   Van Belle E, 2017, CIRC-CARDIOVASC INTE, V10, DOI 10.1161/CIRCINTERVENTIONS.116.004296
   Van Belle E, 2014, CIRCULATION, V129, P173, DOI 10.1161/CIRCULATIONAHA.113.006646
   van de Hoef TP, 2014, CIRC-CARDIOVASC INTE, V7, P301, DOI 10.1161/CIRCINTERVENTIONS.113.001049
   van Nunen LX, 2015, LANCET, V386, P1853, DOI 10.1016/S0140-6736(15)00057-4
   Wessel TR, 2007, CLIN CARDIOL, V30, P69, DOI 10.1002/clc.19
   Yong ASC, 2012, CIRC-CARDIOVASC INTE, V5, P103, DOI 10.1161/CIRCINTERVENTIONS.111.966556
   Yong AS, 2012, CIRC-CARDIOVASC INTE, V5, pS1, DOI DOI 10.1161/CIRCINTERVENTI0NS.111.966556
   Zimmermann FM, 2015, EUR HEART J, V36, P3182, DOI 10.1093/eurheartj/ehv452
NR 52
TC 12
Z9 12
U1 1
U2 8
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAR
PY 2018
VL 48
IS 3
BP 179
EP 190
DI 10.4070/kcj.2017.0393
PG 12
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA GA2GL
UT WOS:000428135100001
PM 29557104
OA Green Published
DA 2021-04-22
ER

PT J
AU Min, SH
   Kim, SH
   Jeong, IK
   Cho, HC
   Jeong, JO
   Lee, JH
   Kang, HJ
   Kim, HS
   Park, KS
   Lim, S
AF Min, Se Hee
   Kim, Se-Hong
   Jeong, In-Kyung
   Cho, Ho Chan
   Jeong, Jin-Ok
   Lee, Ju-Hee
   Kang, Hyun-Jae
   Kim, Hyo Soo
   Park, Kyong Soo
   Lim, Soo
TI Independent Association of Serum Aldosterone Level with Metabolic
   Syndrome and Insulin Resistance in Korean Adults
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Aldosterone; Metabolic syndrome X; Insulin resistance
ID CONVERTING-ENZYME-INHIBITION; PLASMA-ALDOSTERONE; HYPERTENSION; GLUCOSE;
   INDEX; SENSITIVITY; HOMEOSTASIS; PREVENTION; CAPTOPRIL
AB Background and Objectives: A relationship between renin-angiotensin system (RAS) components and metabolic syndrome (MetS) has been suggested, but not elucidated clearly. We examined the levels of RAS components in patients with and without MetS and their association with MetS in Korean population.
   Methods: This study was approved by the review boards of the participating institutions and endorsed by the Korean Society of Lipid and Atherosclerosis. We screened 892 Koreans aged >= 20 years who underwent evaluation of hypertension, diabetes, or dyslipidemia at 6 tertiary hospitals in 2015-2016. After excluding patients who were taking diuretics, beta-blockers, or RAS blockers, or suspected of primary aldosteronism, 829 individuals were enrolled. Anthropometric and biochemical parameters including aldosterone, plasma renin activity (PRA), and aldosterone-to-PRA ratio were evaluated. The homeostasis model assessment for insulin resistance (HOMA-IR) were used for evaluating insulin resistance.
   Results: The mean age of the participants was 52.8 +/- 12.8 years, 56.3% were male, and their mean systolic and diastolic blood pressures were 133.9 +/- 20.0 and 81.2 +/- 14.6 mmHg, respectively. The levels of serum aldosterone, but not PRA, were significantly higher in subjects with MetS than in those without (20.6 +/- 33.6 vs. 15.3 +/- 12.2 ng/dL, p<0.05), and positively correlated with waist circumference, blood pressure, triglycerides, and glycated hemoglobin. The levels of aldosterone were independently associated with the number of MetS components and HOMA-IR after adjusting for conventional risk factors.
   Conclusion: Serum aldosterone levels were higher in Korean adults with MetS than in those without. This finding suggests that increased aldosterone level might be closely associated with insulin resistance.
C1 [Min, Se Hee; Kang, Hyun-Jae; Kim, Hyo Soo; Park, Kyong Soo] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul, South Korea.
   [Kim, Se-Hong] Catholic Univ Korea, Coll Med, St Vincents Hosp, Dept Family Med, Suwon, South Korea.
   [Jeong, In-Kyung] Kyung Hee Univ, Kyung Hee Univ Hosp Gangdong, Coll Med, Dept Internal Med, Seoul, South Korea.
   [Cho, Ho Chan] Keimyung Univ, Dongsan Med Ctr, Dept Internal Med, Daegu, South Korea.
   [Jeong, Jin-Ok] Chungnam Natl Univ, Chungnam Natl Univ Hosp, Sch Med, Dept Internal Med, Daejeon, South Korea.
   [Lee, Ju-Hee] Chungbuk Natl Univ, Coll Med, Chungbuk Natl Univ Hosp, Dept Internal Med, Cheongju, South Korea.
   [Lim, Soo] Seoul Natl Univ, Coll Med, Bundang Hosp, Dept Internal Med, 82 Gumi Ro, Seongnam 13620, South Korea.
RP Lim, S (corresponding author), Seoul Natl Univ, Coll Med, Bundang Hosp, Dept Internal Med, 82 Gumi Ro, Seongnam 13620, South Korea.
EM limsoo@snu.ac.kr
RI Lim, Soo/AAU-8107-2020; Jeong, In-Kyung/AAI-6488-2020; Park, Kyong
   Soo/C-2265-2008
OI Lim, Soo/0000-0002-4137-1671; Jeong, In-Kyung/0000-0001-7857-546X;
   Jeong, Jin-Ok/0000-0003-0763-4754; Seong, In-Whan/0000-0003-4628-0258;
   Park, Kyong Soo/0000-0003-3597-342X; Min, Se Hee/0000-0001-9423-3937;
   Kim, Se-Hong/0000-0001-6465-8993
FU Korean Society of Lipidology and Atherosclerosis; Seoul National
   University Bundang Hospital
FX This research was supported by the Korean Society of Lipidology and
   Atherosclerosis (2015) and Seoul National University Bundang Hospital.
CR Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644
   American Diabetes Association, 2015, Diabetes Care, V38 Suppl, pS8, DOI 10.2337/dc15-S005
   Bentley-Lewis R, 2007, J CLIN ENDOCR METAB, V92, P4472, DOI 10.1210/jc.2007-1088
   Brenner BM, 2001, NEW ENGL J MED, V345, P861, DOI 10.1056/NEJMoa011161
   Briet M, 2011, CURR HYPERTENS REP, V13, P163, DOI 10.1007/s11906-011-0182-2
   Catena C, 2006, J CLIN ENDOCR METAB, V91, P3457, DOI 10.1210/jc.2006-0736
   Chobanian AV, 2003, JAMA-J AM MED ASSOC, V289, P2560, DOI 10.1001/jama.289.19.2560
   Coliussi G, 2007, DIABETES CARE, V30, P2349, DOI 10.2337/dc07-0525
   Fallo F, 2007, CURR HYPERTENS REP, V9, P106, DOI 10.1007/s11906-007-0019-1
   Garg R, 2010, J CLIN ENDOCR METAB, V95, P1986, DOI 10.1210/jc.2009-2521
   GOODFRIEND TL, 1995, HYPERTENSION, V25, P30, DOI 10.1161/01.HYP.25.1.30
   Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143
   Hansson L, 1999, LANCET, V353, P611, DOI 10.1016/S0140-6736(98)05012-0
   Hong AR, 2015, J DIABETES INVEST, V6, P508, DOI 10.1111/jdi.12313
   Ingelsson E, 2007, CIRCULATION, V116, P984, DOI 10.1161/CIRCULATIONAHA.107.708537
   Jeon JH, 2008, FASEB J, V22, P1502, DOI 10.1096/fj.07-9412com
   Kassi E, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-48
   Kathiresan S, 2005, AM J HYPERTENS, V18, P657, DOI 10.1016/j.amjhyper.2004.12.005
   Katz A, 2000, J CLIN ENDOCR METAB, V85, P2402, DOI 10.1210/jc.85.7.2402
   Kidambi S, 2007, HYPERTENSION, V49, P704, DOI 10.1161/01.HYP.0000253258.36141.c7
   Kim CS, 2014, DIABETES METAB J, V38, P35, DOI 10.4093/dmj.2014.38.1.35
   LEWIS EJ, 1993, NEW ENGL J MED, V329, P1456, DOI 10.1056/NEJM199311113292004
   MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883
   Patel VB, 2014, CLIN SCI, V126, P471, DOI 10.1042/CS20130344
   POLLARE T, 1989, NEW ENGL J MED, V321, P868, DOI 10.1056/NEJM198909283211305
   Putnam K, 2012, AM J PHYSIOL-HEART C, V302, pH1219, DOI 10.1152/ajpheart.00796.2011
   Rossi GP, 2008, J CLIN ENDOCR METAB, V93, P2566, DOI 10.1210/jc.2008-0251
   Stiefel P, 2011, INT J HYPERTENS, V2011, DOI 10.4061/2011/685238
   Vasan RS, 2004, NEW ENGL J MED, V351, P33, DOI 10.1056/NEJMoa033263
   Yusuf S, 2001, JAMA-J AM MED ASSOC, V286, P1882, DOI 10.1001/jama.286.15.1882
NR 30
TC 7
Z9 7
U1 1
U2 2
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAR
PY 2018
VL 48
IS 3
BP 198
EP 208
DI 10.4070/kcj.2017.0200
PG 11
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA GA2GL
UT WOS:000428135100003
PM 29557106
OA Green Published
DA 2021-04-22
ER

PT J
AU Kwon, HJ
   Park, JH
   Lee, JH
   Jeong, HS
   Song, HJ
   Kim, J
   Kim, M
   Kwon, IS
   Seong, IW
AF Kwon, Hee-Jin
   Park, Jae-Hyeong
   Lee, Jae-Hwan
   Jeong, Hye Seon
   Song, Hee-Jung
   Kim, Jei
   Kim, Mijoo
   Kwon, In-Sun
   Seong, In-Whan
TI Low Common Carotid Artery Systolic Occlusion Pressure and Symptomatic
   Carotid Artery Stenosis Are Associated with Development of Neurologic
   Intolerance during Proximal Protected Carotid Artery Stenting
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Carotid stenosis; Stent; Neurologic symptoms; Embolic protection devices
ID CEREBRAL PROTECTION; RANDOMIZED-TRIAL; HIGH-RISK; ENDARTERECTOMY;
   METAANALYSIS; REGISTRY; FILTER
AB Background and Objectives: Neurologic intolerance (NI) is defined as the occurrence of neurological symptoms during carotid artery stenting (CAS). Because NI is inevitable problem, it may be helpful to anticipate its occurrence. So, we studied factors associated with NI during proximal protected CAS.
   Methods: We retrospectively analyzed all consecutive patients underwent proximal protected CAS from August 2012 to January 2017.
   Results: We included total 123 patients (109 males, 72 +/- 8 years old). The total procedure time was 43 +/- 12 minutes, and mean occlusion time was 4.8 +/- 1.2 minutes. We divided CAS patients into 2 groups according to presence of NI; neurologic tolerance (NT; n=74, 60%) and NI (n=49, 40%) groups. After the univariate analysis, symptomatic carotid artery stenosis (p=0.003), absence of anterior communicating artery (p=0.015) and low common carotid artery occlusion pressure (CCAOP, p<0.001) were associated with NI. After the multivariate analysis, NI was significantly associated with symptomatic carotid artery stenosis (odds ratio [OR], 5.549; p=0.014) and systolic CCAOP <= 42 mmHg (OR, 6.461; p<0.001). In NI group, 43 patients (88%) recovered right after the balloon deflation and 2 patients were normalized within 2 hours. However, 1 had major stroke and 3 had minor strokes in 4 patients with persistent NI >= 24 hours.
   Conclusion: About 40% showed NI during the CAS. Most of them (88%, 43 of 49 patients) recovered after the balloon deflation, but stroke incidence was significantly higher in NI group. Symptomatic carotid artery stenosis and systolic CCAOP <= 42 mmHg were significantly associated with the development of NI during proximal protected CAS.
C1 [Kwon, Hee-Jin; Park, Jae-Hyeong; Lee, Jae-Hwan; Kim, Mijoo; Seong, In-Whan] Chungnam Natl Univ, Chungnam Natl Univ Hosp, Sch Med, Div Cardiol,Dept Internal Med, 282 Munhwa Ro, Daejeon 35015, South Korea.
   [Jeong, Hye Seon; Song, Hee-Jung; Kim, Jei] Chungnam Natl Univ, Chungnam Natl Univ Hosp, Sch Med, Dept Neurol, Daejeon, South Korea.
   [Kwon, In-Sun] Chungnam Natl Univ, Sch Med, Chungnam Natl Univ Hosp, Clin Trial Ctr, Daejeon, South Korea.
RP Lee, JH (corresponding author), Chungnam Natl Univ, Chungnam Natl Univ Hosp, Sch Med, Div Cardiol,Dept Internal Med, 282 Munhwa Ro, Daejeon 35015, South Korea.
EM myheart@cnu.ac.kr
RI Park, Jae-Hyeong/AAD-9015-2021
OI Park, Jae-Hyeong/0000-0001-7035-286X; Seong,
   In-Whan/0000-0003-4628-0258; Song, Hee-Jung/0000-0001-9572-4105; Lee,
   Jae-Hwan/0000-0002-6561-7760; Jeong, Jin-Ok/0000-0003-0763-4754; Kwon,
   Hee-Jin/0000-0002-4281-5211; Jeong, Hye Seon/0000-0002-2031-5662
CR Bagan P, 2006, ANN VASC SURG, V20, P747, DOI 10.1007/s10016-006-9126-8
   Bersin RM, 2012, CATHETER CARDIO INTE, V80, P1072, DOI 10.1002/ccd.24433
   Bijuklic K, 2012, J AM COLL CARDIOL, V59, P1383, DOI 10.1016/j.jacc.2011.11.035
   Brott TG, 2011, VASC MED, V16, P317, DOI 10.1177/1358863X11419064
   Cassese S, 2015, EUROINTERVENTION, V11, P238, DOI 10.4244/EIJY15M03_01
   Cremonesi A, 2006, J ENDOVASC THER, V13, P190, DOI 10.1583/05-1702MR.1
   Diederich KW, 2004, EUR J VASC ENDOVASC, V28, P629, DOI 10.1016/j.ejvs.2004.08.012
   Giugliano G, 2014, JACC-CARDIOVASC INTE, V7, P1237, DOI 10.1016/j.jcin.2014.05.021
   Howell M, 2002, J ENDOVASC THER, V9, P810, DOI 10.1583/1545-1550(2002)009<0810:COPSBP>2.0.CO;2
   Montisci R, 2013, EUR J VASC ENDOVASC, V45, P107, DOI 10.1016/j.ejvs.2012.11.012
   Montorsi P, 2011, J AM COLL CARDIOL, V58, P1656, DOI 10.1016/j.jacc.2011.07.015
   Reimers B, 2005, J ENDOVASC THER, V12, P156, DOI 10.1583/04-1400MR.1
   Shahidi S, 2017, J CARDIOVASC SURG, V58, P431, DOI 10.23736/S0021-9509.16.08173-8
   Stabile E, 2010, J AM COLL CARDIOL, V55, P1661, DOI 10.1016/j.jacc.2009.11.079
   White CJ, 2014, J AM COLL CARDIOL, V64, P723, DOI 10.1016/j.jacc.2014.04.069
NR 15
TC 2
Z9 2
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAR
PY 2018
VL 48
IS 3
BP 217
EP 226
DI 10.4070/kcj.2017.0031
PG 10
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA GA2GL
UT WOS:000428135100005
PM 29557108
OA Green Published
DA 2021-04-22
ER

PT J
AU Kim, W
   Choi, D
AF Kim, Wonho
   Choi, Donghoon
TI Treatment of Femoropopliteal Artery In-stent Restenosis
SO KOREAN CIRCULATION JOURNAL
LA English
DT Review
DE Peripheral artery disease
ID SUPERFICIAL FEMORAL-ARTERY; PACLITAXEL-ELUTING BALLOON; DRUG-COATED
   BALLOON; PROXIMAL POPLITEAL ARTERIES; STANDARD ANGIOPLASTY; LASER
   ATHERECTOMY; DIABETIC-PATIENTS; CLINICAL IMPACT; DEBATE-ISR; TRIAL
AB Femoropopliteal (FP) artery-in stent restenosis (ISR) is a daunting management problem that we continue to face. FP artery-ISR rates after primary stent implantation are relatively high. Although repeat FP artery-ISR and the need for additional interventions remain all too common, little consensus exists regarding the best treatment algorithm. In this article, we review the limitations of the currently used devices for the endovascular treatment of FP artery-ISR and discuss which strategies are the most effective and safe.
C1 [Kim, Wonho] Eulji Univ, Sch Med, Eulji Univ Hosp, Div Cardiol, Daejeon, South Korea.
   [Choi, Donghoon] Yonsei Univ, Coll Med, Severance Cardiovasc Hosp, Div Cardiol,Dept Internal Med, 50-1 Yonsei Ro, Seoul 03722, South Korea.
RP Choi, D (corresponding author), Yonsei Univ, Coll Med, Severance Cardiovasc Hosp, Div Cardiol,Dept Internal Med, 50-1 Yonsei Ro, Seoul 03722, South Korea.
EM cdhlyj@yuhs.ac
OI Choi, Donghoon/0000-0002-2009-9760; Kim, Wonho/0000-0003-0704-6901
CR Bosiers M, 2010, J CARDIOVASC SURG, V51, P591
   Brodmann M, 2017, JACC-CARDIOVASC INTE, V10, P2113, DOI 10.1016/j.jcin.2017.06.018
   Byrne RA, 2014, NAT REV CARDIOL, V11, P13, DOI 10.1038/nrcardio.2013.165
   Cassese S, 2012, CIRC-CARDIOVASC INTE, V5, P582, DOI 10.1161/CIRCINTERVENTIONS.112.969972
   Dake MD, 2011, CIRC-CARDIOVASC INTE, V4, P495, DOI 10.1161/CIRCINTERVENTIONS.111.962324
   Dippel EJ, 2015, JACC-CARDIOVASC INTE, V8, P92, DOI 10.1016/j.jcin.2014.09.009
   Gandini R, 2013, J ENDOVASC THER, V20, P805, DOI 10.1583/13-4308MR.1
   Gorgani F, 2013, J INVASIVE CARDIOL, V25, P670
   Grotti S, 2016, J ENDOVASC THER, V23, P52, DOI 10.1177/1526602815614555
   Hoffmann R, 1996, CIRCULATION, V94, P1247, DOI 10.1161/01.CIR.94.6.1247
   Katsanos K, 2017, CARDIOVASC INTER RAD, V40, P964, DOI 10.1007/s00270-017-1649-6
   Kinstner CM, 2016, JACC-CARDIOVASC INTE, V9, P1386, DOI 10.1016/j.jcin.2016.04.012
   Ko YG, 2017, KOREAN CIRC J, V47, P469, DOI 10.4070/kcj.2017.0020
   Krankenberg H, 2015, CIRCULATION, V132, P2230, DOI 10.1161/CIRCULATIONAHA.115.017364
   Laird JR, 2010, CIRC-CARDIOVASC INTE, V3, P267, DOI 10.1161/CIRCINTERVENTIONS.109.903468
   Laird JR, 2012, CATHETER CARDIO INTE, V80, P852, DOI 10.1002/ccd.23475
   Liistro F, 2014, J ENDOVASC THER, V21, P1, DOI 10.1583/13-4420R.1
   Mehran R, 1999, CIRCULATION, V100, P1872, DOI 10.1161/01.CIR.100.18.1872
   Murata N, 2016, J ENDOVASC THER, V23, P642, DOI 10.1177/1526602816642195
   Scheinert D, 2005, J AM COLL CARDIOL, V45, P312, DOI 10.1016/j.jacc.2004.11.026
   Shammas NW, 2016, J ENDOVASC THER, V23, P339, DOI 10.1177/1526602816634028
   Shammas NW, 2013, INT J ANGIOL, V22, P1, DOI [10.1055/s-0032-1331840, 10.1055/s-0032-133184]
   Shishehbor MH, 2015, J AM COLL CARDIOL, V66, P2339, DOI 10.1016/j.jacc.2015.09.062
   Sixt S, 2013, J VASC SURG, V58, P682, DOI 10.1016/j.jvs.2013.02.019
   Stabile E, 2012, J AM COLL CARDIOL, V60, P1739, DOI 10.1016/j.jacc.2012.07.033
   Tomoi Y, 2016, J ENDOVASC THER, V23, P461, DOI 10.1177/1526602816639721
   Tosaka A, 2012, J AM COLL CARDIOL, V59, P16, DOI 10.1016/j.jacc.2011.09.036
   Virga V, 2014, JACC-CARDIOVASC INTE, V7, P411, DOI 10.1016/j.jcin.2013.11.020
   Zeller T, 2013, JACC-CARDIOVASC INTE, V6, P274, DOI 10.1016/j.jcin.2012.12.118
NR 29
TC 4
Z9 5
U1 0
U2 2
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAR
PY 2018
VL 48
IS 3
BP 191
EP 197
DI 10.4070/kcj.2018.0074
PG 7
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA GA2GL
UT WOS:000428135100002
PM 29557105
OA Green Published
DA 2021-04-22
ER

PT J
AU Choi, BG
   Hwang, SK
   Kwon, JE
   Kim, YH
AF Choi, Bo Geum
   Hwang, Su-Kyung
   Kwon, Jung Eun
   Kim, Yeo Hyang
TI Array Comparative Genomic Hybridization as the First-line Investigation
   for Neonates with Congenital Heart Disease: Experience in a Single
   Tertiary Center
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Array comparative genomic hybridization; Heart defects; congenital;
   Neonate
ID NOONAN SYNDROME; ANOMALIES
AB Background and Objectives: The purpose of the present study was to investigate the advantages and disadvantages of verifying genetic abnormalities using array comparative genomic hybridization (a-CGH) immediately after diagnosis of congenital heart disease (CHD).
   Methods: Among neonates under the age of 28 days who underwent echocardiography from January 1, 2014 to April 30, 2016, neonates whose chromosomal and genomic abnormalities were tested using a-CGH in cases of an abnormal finding on echocardiography were enrolled.
   Results: Of the 166 patients diagnosed with CHD, 81 underwent a-CGH and 11 patients (11/81, 13.5%) had abnormal findings on a-CGH. 22q11.2 deletion syndrome was the most common (4/11, 36.4%). On the first a-CGH, 4 patients were negative (4/81, 5%). Three of them were finally diagnosed with Williams syndrome using fluorescent in situ hybridization (FISH), 1 patient was diagnosed with Noonan syndrome through exome sequencing. All of them exhibited diffuse pulmonary artery branch hypoplasia, as well as increased velocity of blood flow, on repeated echocardiography. Five patients started rehabilitation therapy at mean 6 months old age in outpatient clinics and epilepsy was diagnosed in 2 patients. Parents of 2 patients (22q11.2 deletion syndrome and Patau syndrome) refused treatment due to the anticipated prognosis.
   Conclusions: Screening tests for genetic abnormalities using a-CGH in neonates with CHD has the advantage of early diagnosis of genetic abnormality during the neonatal period in which there is no obvious symptom of genetic abnormality. However, there are disadvantages that some genetic abnormalities cannot be identified on a-CGH.
C1 [Choi, Bo Geum; Hwang, Su-Kyung; Kwon, Jung Eun; Kim, Yeo Hyang] Kyungpook Natl Univ, Childrens Hosp, Sch Med, Dept Pediat, Daegu, South Korea.
RP Kim, YH (corresponding author), Kyungpook Natl Univ, Sch Med, Dept Pediat, 130 Dongdeok Ro, Daegu 41944, South Korea.
EM kimyhmd@knu.ac.kr
OI Choi, Bo Geum/0000-0001-6431-3338
FU Biomedical Research Institute grant, Kyungpook National University
   Hospital
FX This work was supported by Biomedical Research Institute grant,
   Kyungpook National University Hospital (2016).
CR Anderlid BM, 2002, AM J MED GENET, V107, P275, DOI 10.1002/ajmg.10029
   Cunniff C, 2001, PEDIATRICS, V107, P1192
   Egbe A, 2014, ANN PEDIAT CARDIOL, V7, P86, DOI 10.4103/0974-2069.132474
   Gelb B, 2013, CIRC RES, V112, P698, DOI 10.1161/CIRCRESAHA.111.300297
   Ko JM, 2008, J HUM GENET, V53, P999, DOI 10.1007/s10038-008-0343-6
   Lee BH, 2011, J PEDIATR-US, V159, P1029, DOI 10.1016/j.jpeds.2011.05.024
   NORA JJ, 1968, CIRCULATION, V38, P604, DOI 10.1161/01.CIR.38.3.604
   Park SJ, 2013, MOL CYTOGENET, V6, DOI 10.1186/1755-8166-6-21
   Pierpont ME, 2007, CIRCULATION, V115, P3015, DOI 10.1161/CIRCULATIONAHA.106.183056
   Roberts AE, 2013, LANCET, V381, P333, DOI 10.1016/S0140-6736(12)61023-X
   van der Burgt I, 2007, ORPHANET J RARE DIS, V2, DOI 10.1186/1750-1172-2-4
   van Trier DC, 2013, EUR J MED GENET, V56, P426, DOI 10.1016/j.ejmg.2013.05.002
NR 12
TC 3
Z9 4
U1 1
U2 3
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAR
PY 2018
VL 48
IS 3
BP 209
EP 216
DI 10.4070/kcj.2017.0166
PG 8
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA GA2GL
UT WOS:000428135100004
PM 29557107
OA Green Published
DA 2021-04-22
ER

PT J
AU Park, S
AF Park, Sungha
TI Emerging Role of Aldosterone in Mediating the Vicious Cycle of Obesity,
   Insulin Resistance and Metabolic Syndrome
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
ID HYPERTENSION; POPULATION
C1 [Park, Sungha] Yonsei Univ, Coll Med, Severance Cardiovasc Hosp, Div Cardiol, 50-1 Yonsei Ro, Seoul 03722, South Korea.
   [Park, Sungha] Yonsei Univ, Coll Med, Cardiovasc Res Inst, 50-1 Yonsei Ro, Seoul 03722, South Korea.
RP Park, S (corresponding author), Yonsei Univ, Coll Med, Severance Cardiovasc Hosp, Div Cardiol, 50-1 Yonsei Ro, Seoul 03722, South Korea.; Park, S (corresponding author), Yonsei Univ, Coll Med, Cardiovasc Res Inst, 50-1 Yonsei Ro, Seoul 03722, South Korea.
EM shpark0530@yuhs.ac
CR Catena C, 2006, J CLIN ENDOCR METAB, V91, P3457, DOI 10.1210/jc.2006-0736
   CONN JW, 1965, NEW ENGL J MED, V273, P1135, DOI 10.1056/NEJM196511182732106
   Goodfriend TL, 2004, HYPERTENSION, V43, P358, DOI 10.1161/01.HYP.0000113294.06704.64
   Kumagai E, 2011, HYPERTENSION, V58, P1043, DOI 10.1161/HYPERTENSIONAHA.111.180521
   Lastra G, 2008, AM J PHYSIOL-ENDOC M, V295, pE110, DOI 10.1152/ajpendo.00258.2007
   Luther JM, 2014, STEROIDS, V91, P54, DOI 10.1016/j.steroids.2014.08.016
   Min SH, 2018, KOREAN CIRC J, V48, P198, DOI 10.4070/kcj.2017.0200
   Selvaraj J, 2013, MOL CELL BIOCHEM, V372, P113, DOI 10.1007/s11010-012-1452-2
   Sowers JR, 2009, ANN INTERN MED, V150, P776, DOI 10.7326/0003-4819-150-11-200906020-00005
   Wu VC, 2017, J HYPERTENS, V35, P1698, DOI 10.1097/HJH.0000000000001361
   Yamashita R, 2004, ENDOCR J, V51, P243, DOI 10.1507/endocrj.51.243
NR 11
TC 1
Z9 1
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAR
PY 2018
VL 48
IS 3
BP 227
EP 229
DI 10.4070/kcj.2018.0003
PG 3
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA GA2GL
UT WOS:000428135100006
PM 29557109
OA Green Published
DA 2021-04-22
ER

PT J
AU Rha, SW
AF Rha, Seung-Woon
TI Proximal Protected Carotid Artery Stenting and Neurologic Intolerance:
   Can We Predict before Stenting?
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
ID REGISTRY
C1 [Rha, Seung-Woon] Korea Univ, Guro Hosp, Cardiovasc Ctr, 148 Gurodong Ro, Seoul 08308, South Korea.
RP Rha, SW (corresponding author), Korea Univ, Guro Hosp, Cardiovasc Ctr, 148 Gurodong Ro, Seoul 08308, South Korea.
EM swrha617@yahoo.co.kr
CR Brott TG, 2011, VASC MED, V16, P317, DOI 10.1177/1358863X11419064
   Cremonesi A, 2009, EUROINTERVENTION, V5, P589, DOI 10.4244/EIJV5I5A95
   Giugliano G, 2014, JACC-CARDIOVASC INTE, V7, P1237, DOI 10.1016/j.jcin.2014.05.021
   Gray WA, 2007, CATHETER CARDIO INTE, V69, P341, DOI 10.1002/ccd.21050
   Gray WA, 2006, J VASC SURG, V44, P258, DOI 10.1016/j.jvs.2006.03.044
   Kwon HJ, 2018, KOREAN CIRC J, V48, P217, DOI 10.4070/kcj.2017.0031
   Pieniazek P, 2008, J ENDOVASC THER, V15, P249, DOI 10.1583/07-2264.1
NR 7
TC 0
Z9 0
U1 1
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAR
PY 2018
VL 48
IS 3
BP 230
EP 232
DI 10.4070/kcj.2018.0017
PG 3
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA GA2GL
UT WOS:000428135100007
PM 29557110
OA Green Published
DA 2021-04-22
ER

PT J
AU Ko, JM
AF Ko, Jung Min
TI Chromosomal Microarray: Application for Congenital Heart Diseases
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
ID CLINICAL DIAGNOSTIC-TEST; DEVELOPMENTAL DELAY; INDIVIDUALS; CGH
C1 [Ko, Jung Min] Seoul Natl Univ, Coll Med, Childrens Hosp, Dept Pediat, 101 Daehak Ro, Seoul 03080, South Korea.
RP Ko, JM (corresponding author), Seoul Natl Univ, Coll Med, Childrens Hosp, Dept Pediat, 101 Daehak Ro, Seoul 03080, South Korea.
EM jmko@snu.ac.kr
OI Ko, Jung Min/0000-0002-0407-7828
CR Barrett MT, 2004, P NATL ACAD SCI USA, V101, P17765, DOI 10.1073/pnas.0407979101
   Battaglia A, 2013, EUR J PAEDIATR NEURO, V17, P589, DOI 10.1016/j.ejpn.2013.04.010
   Bejjani BA, 2005, AM J MED GENET A, V134A, P259, DOI 10.1002/ajmg.a.30621
   Choi BG, 2018, KOREAN CIRC J, V48, P209, DOI 10.4070/kcj.2017.0166
   Coulter ME, 2011, GENET MED, V13, P770, DOI 10.1097/GIM.0b013e31821dd54a
   Keren Boris, 2014, Mol Cytogenet, V7, pI31, DOI 10.1186/1755-8166-7-S1-I31
   Manning M, 2010, GENET MED, V12, P742, DOI 10.1097/GIM.0b013e3181f8baad
   Miller DT, 2010, AM J HUM GENET, V86, P749, DOI 10.1016/j.ajhg.2010.04.006
   Stankiewicz P, 2007, CURR OPIN GENET DEV, V17, P182, DOI 10.1016/j.gde.2007.04.009
NR 9
TC 0
Z9 0
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAR
PY 2018
VL 48
IS 3
BP 233
EP 235
DI 10.4070/kcj.2018.0032
PG 3
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA GA2GL
UT WOS:000428135100008
PM 29557111
OA Green Published
DA 2021-04-22
ER

PT J
AU Kuwabara, M
   Ishimura, RN
   Ishiwata, S
   Ohno, M
AF Kuwabara, Masanari
   Ishimura, Rieko Niitsu
   Ishiwata, Sugao
   Ohno, Minoru
TI Isolated Cardiac Sarcoidosis Presenting with Stroke
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
ID DIAGNOSIS
C1 [Kuwabara, Masanari; Ishimura, Rieko Niitsu; Ishiwata, Sugao; Ohno, Minoru] Toranomon Gen Hosp, Dept Cardiol, Tokyo, Japan.
   [Kuwabara, Masanari] Univ Colorado Denver, Sch Med, Div Renal Dis & Hypertens, Aurora, CO USA.
RP Kuwabara, M (corresponding author), Toranomon Gen Hosp, Dept Cardiol, Minato Ku, 2-2-2 Toranomon, Tokyo 1058470, Japan.
EM kuwamasa728@gmail.com
RI Kuwabara, Masanari/O-9844-2017
OI Kuwabara, Masanari/0000-0002-6601-4347
CR BROWN MM, 1989, STROKE, V20, P400, DOI 10.1161/01.STR.20.3.400
   Isobe M, 2015, INT J CARDIOL, V182, P132, DOI 10.1016/j.ijcard.2014.12.056
   Sadek MM, 2013, CAN J CARDIOL, V29, P1034, DOI 10.1016/j.cjca.2013.02.004
   Takaya Y, 2015, AM J CARDIOL, V115, P1293, DOI 10.1016/j.amjcard.2015.01.562
   White J, 2010, CIRC-HEART FAIL, V3, pE28, DOI 10.1161/CIRCHEARTFAILURE.110.939686
NR 5
TC 0
Z9 0
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAR
PY 2018
VL 48
IS 3
BP 236
EP 239
DI 10.4070/kcj.2017.0133
PG 4
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA GA2GL
UT WOS:000428135100009
PM 29557112
OA Green Published
DA 2021-04-22
ER

PT J
AU Park, JH
   Lee, JH
AF Park, Jae-Hyeong
   Lee, Jae-Hwan
TI Carotid Artery Stenting
SO KOREAN CIRCULATION JOURNAL
LA English
DT Review
DE Carotid artery stenting; Percutaneous coronary intervention; Carotid
   stenosis
ID CEREBRAL HYPERPERFUSION SYNDROME; ISCHEMIC-STROKE; GLOBAL BURDEN;
   HIGH-RISK; ENDARTERECTOMY; STENOSIS; DISEASE; ASPIRIN; ANGIOPLASTY;
   CLOPIDOGREL
AB Carotid artery stenosis is relatively common and is a significant cause of ischemic stroke, but carotid revascularization can reduce the risk of ischemic stroke in patients with significant symptomatic stenosis. Carotid endarterectomy has been and remains the gold standard treatment to reduce the risk of carotid artery stenosis. Carotid artery stenting (CAS) (or carotid artery stent implantation) is another method of carotid revascularization, which has developed rapidly over the last 30 years. To date, the frequency of use of CAS is increasing, and clinical outcomes are improving with technical advancements. However, the value of CAS remains unclear in patients with significant carotid artery stenosis. This review article discusses the basic concepts and procedural techniques involved in CAS.
C1 [Park, Jae-Hyeong; Lee, Jae-Hwan] Chungnam Natl Univ, Sch Med, Dept Cardiol Internal Med, Chungnam Natl Univ Hosp, 282 Munhwa Ro, Daejeon 35015, South Korea.
RP Park, JH (corresponding author), Chungnam Natl Univ, Sch Med, Dept Cardiol Internal Med, Chungnam Natl Univ Hosp, 282 Munhwa Ro, Daejeon 35015, South Korea.
EM myheart@cnu.ac.kr
RI Park, Jae-Hyeong/AAD-9015-2021
OI Lee, Jae-Hwan/0000-0002-6561-7760; Park, Jae-Hyeong/0000-0001-7035-286X
CR Amarenco P, 2017, LANCET NEUROL, V16, P301, DOI 10.1016/S1474-4422(17)30038-8
   Barnett HJM, 2000, JAMA-J AM MED ASSOC, V283, P1429, DOI 10.1001/jama.283.11.1429
   Barnett HJM, 1998, NEW ENGL J MED, V339, P1415, DOI 10.1056/NEJM199811123392002
   Bartlett ES, 2006, AM J NEURORADIOL, V27, P13
   Benavente OR, 2012, NEW ENGL J MED, V367, P817, DOI 10.1056/NEJMoa1204133
   Benjamin EJ, 2017, CIRCULATION, V135, pE146, DOI 10.1161/CIR.0000000000000485
   Bersin RM, 2012, CATHETER CARDIO INTE, V80, P1072, DOI 10.1002/ccd.24433
   Bijuklic K, 2012, J AM COLL CARDIOL, V59, P1383, DOI 10.1016/j.jacc.2011.11.035
   Brott TG, 2016, NEW ENGL J MED, V374, P1021, DOI 10.1056/NEJMoa1505215
   Chiarella F, 1998, AM J CARDIOL, V81, P822, DOI 10.1016/S0002-9149(98)00003-4
   De Rango P, 2011, J AM COLL CARDIOL, V57, P664, DOI 10.1016/j.jacc.2010.09.041
   EASTCOTT HHG, 1954, LANCET, V2, P994
   Eckstein HH, 2016, EUR J VASC ENDOVASC, V51, P761, DOI 10.1016/j.ejvs.2016.02.005
   Eckstein HH, 2008, LANCET NEUROL, V7, P893, DOI 10.1016/S1474-4422(08)70196-0
   Garg N, 2009, J ENDOVASC THER, V16, P412, DOI 10.1583/09-2713.1
   Gent M, 1996, LANCET, V348, P1329, DOI 10.1016/s0140-6736(96)09457-3
   George JC, 2010, JACC-CARDIOVASC INTE, V3, P988, DOI 10.1016/j.jcin.2010.08.001
   Gupta A, 2015, J AM HEART ASSOC, V4, DOI 10.1161/JAHA.115.002012
   Inzitari D, 2000, NEW ENGL J MED, V342, P1693, DOI 10.1056/NEJM200006083422302
   Kernan WN, 2014, STROKE, V45, P2160, DOI 10.1161/STR.0000000000000024
   Kim KH, 2013, J KOREAN NEUROSURG S, V54, P159, DOI 10.3340/jkns.2013.54.3.159
   Komotar RJ, 2010, NEUROSURGERY, V66, pN12, DOI 10.1227/01.neu.0000375271.39513.b2
   Krishnamurthi RV, 2013, LANCET GLOB HEALTH, V1, pE259, DOI 10.1016/S2214-109X(13)70089-5
   Kwon YD, 2012, J KOREAN MED ASSOC, V55, P1014, DOI 10.5124/jkma.2012.55.10.1014
   안계택, 2008, Korean Circulation Journal, V38, P659
   Liu ZJ, 2012, ANN VASC SURG, V26, P576, DOI 10.1016/j.avsg.2011.09.009
   Mancia G, 2013, EUR HEART J, V34, P2159, DOI 10.1093/eurheartj/eht151
   Markus HS, 2005, CIRCULATION, V111, P2233, DOI 10.1161/01.CIR.0000163561.90680.1C
   Mas JL, 2008, LANCET NEUROL, V7, P885, DOI 10.1016/S1474-4422(08)70195-9
   Mazzaccaro D, 2016, J CARDIOVASC SURG, V57, P474
   Meschia JF, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.114.001180
   Mohammed N, 2005, VASC MED, V10, P77, DOI 10.1191/1358863x05vm588xx
   Montorsi P, 2011, J AM COLL CARDIOL, V58, P1656, DOI 10.1016/j.jacc.2011.07.015
   Naghavi M, 2015, LANCET, V385, P117, DOI 10.1016/S0140-6736(14)61682-2
   Nerla R, 2016, EUROINTERVENTION, V12, pE677, DOI 10.4244/EIJV12I5A109
   Ogasawara K, 2007, J NEUROSURG, V107, P1130, DOI 10.3171/JNS-07/12/1130
   Piepoli MF, 2016, EUR HEART J, V37, P2315, DOI 10.1093/eurheartj/ehw106
   Ricco JB, 2017, EUR J VASC ENDOVASC
   Rothwell PM, 2004, LANCET, V363, P915, DOI 10.1016/S0140-6736(04)15785-1
   Rothwell PM, 2003, LANCET, V361, P107, DOI 10.1016/S0140-6736(03)12228-3
   Shin Jinho, 2015, Clin Hypertens, V21, P1, DOI 10.1186/s40885-014-0012-3
   Shin Jinho, 2015, Clin Hypertens, V21, P2, DOI 10.1186/s40885-014-0013-2
   Shin Jinho, 2015, Clin Hypertens, V21, P3, DOI 10.1186/s40885-014-0014-1
   Statistics Korea, 2014, VIT STAT
   Stone NJ, 2014, J AM COLL CARDIOL, V63, P2889, DOI 10.1016/j.jacc.2013.11.002
   Tendera M, 2011, EUR HEART J, V32, P2851, DOI 10.1093/eurheartj/ehr211
   WALKER MD, 1995, JAMA-J AM MED ASSOC, V273, P1421, DOI 10.1001/jama.1995.03520420037035
   Wardlaw JM, 2006, HEALTH TECHNOL ASSES, V10, P1
   WARLOW C, 1991, LANCET, V337, P1235, DOI 10.1016/0140-6736(91)92916-P
   White H, 2005, CIRCULATION, V111, P1327, DOI 10.1161/01.CIR.0000157736.19739.D0
   Yadav JS, 2004, NEW ENGL J MED, V351, P1493, DOI 10.1056/NEJMoa040127
   Zahn R, 2007, EUR HEART J, V28, P370, DOI 10.1093/eurheartj/ehl421
NR 52
TC 7
Z9 7
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD FEB
PY 2018
VL 48
IS 2
BP 97
EP 113
DI 10.4070/kcj.2017.0208
PG 17
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA FX1WF
UT WOS:000425842100001
PM 29171201
OA Green Published
DA 2021-04-22
ER

PT J
AU Park, HW
   Kang, MG
   Kim, K
   Koh, JS
   Park, JR
   Jeong, YH
   Ahn, JH
   Jang, JY
   Kwak, CH
   Park, Y
   Jeong, MH
   Kim, YJ
   Cho, MC
   Kim, CJ
   Hwang, JY
AF Park, Hyun Woong
   Kang, Min Gyu
   Kim, Kyehwan
   Koh, Jin-Sin
   Park, Jeong Rang
   Jeong, Young-Hoon
   Ahn, Jong Hwa
   Jang, Jeong Yoon
   Kwak, Choong Hwan
   Park, Yongwhi
   Jeong, Myung Ho
   Kim, Young Jo
   Cho, Myeong Chan
   Kim, Chong Jin
   Hwang, Jin Yong
CA KAMIR-NIH Registry
TI Long-term Prognosis and Clinical Characteristics of Patients with Newly
   Diagnosed Diabetes Mellitus Detected after First Acute Myocardial
   Infarction: from KAMIR-NIH Registry
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Diabetes mellitus; Myocardial infarction; Cardiac death; Congestive
   heart failure
ID PERCUTANEOUS CORONARY INTERVENTION; ASSOCIATION TASK-FORCE;
   ST-ELEVATION; HOSPITAL MORTALITY; AMERICAN-COLLEGE; HEART-DISEASE;
   RISK-FACTOR; IMPACT; OUTCOMES; PATHOPHYSIOLOGY
AB Background and Objectives: After the first acute myocardial infarction (AMI), a considerable proportion of patients are newly diagnosed with diabetes mellitus (DM). However, in AMI, controversy remains regarding the disparity in prognosis between previously diagnosed DM (known-DM) and newly diagnosed DM (new-DM).
   Methods: The study included 10,455 patients with AMI (non-DM, 6,236; new-DM, 659; known-DM, 3,560) admitted to one of 15 participating centers in Korea between November 2011 and January 2016 (average follow-up, 523 days). We compared the characteristics and clinical course of patients with known-DM and those with new- or non-DM.
   Results: Compared to patients with known-DM, those with new-DM or non-DM were younger, more likely to be male, and less likely to have hypertension, dyslipidemia, prior stroke, angina, or myocardial infarction. Compared to patients with new-DM or non-DM (reference), those with known-DM had higher risks of major adverse cardiac events (hazard ratio [HR], 1.20; 95% confidence interval [CI], 1.06-1.35; p=0.004), cardiac death (HR, 1.26; 95% CI, 1.01-1.57; p=0.042), and congestive heart failure (HR, 1.58; 95% CI, 1.20-2.08). Unlike known-DM, new-DM did not increase the risk of cardiac events (including death).
   Conclusions: Known-DM was associated with a significantly higher risk of cardiovascular events after AMI, while new-DM had a similar risk of cardiac events as that noted for nonDM. There were different cardiovascular outcomes according to diabetes status in patients with AMI.
C1 [Park, Hyun Woong; Kang, Min Gyu; Kim, Kyehwan; Koh, Jin-Sin; Park, Jeong Rang; Hwang, Jin Yong] Gyeongsang Natl Univ, Gyeongsang Natl Univ Hosp, Dept Internal Med, Sch Med, 79 Gangnam Ro, Jinju 52727, South Korea.
   [Jeong, Young-Hoon; Ahn, Jong Hwa; Jang, Jeong Yoon; Kwak, Choong Hwan; Park, Yongwhi] Gyeongsang Natl Univ, Changwon Hosp, Sch Med, Dept Internal Med, Chang Won, South Korea.
   [Jeong, Myung Ho] Chonnam Natl Univ Hosp, Dept Internal Med, Gwangju, South Korea.
   [Kim, Young Jo] Yeungnam Univ Hosp, Dept Internal Med, Daegu, South Korea.
   [Cho, Myeong Chan] Chungbuk Natl Univ Hosp, Dept Internal Med, Cheongju, South Korea.
   [Kim, Chong Jin] Kyung Hee Univ Hosp, Dept Internal Med, Seoul, South Korea.
RP Hwang, JY (corresponding author), Gyeongsang Natl Univ, Gyeongsang Natl Univ Hosp, Dept Internal Med, Sch Med, 79 Gangnam Ro, Jinju 52727, South Korea.
EM jyhwan@gnu.ac.kr
RI Jeong, Young-Hoon/AAO-4401-2020; Jeong, Young-Hoon/F-3476-2015
OI Jeong, Young-Hoon/0000-0003-0403-3726; Jeong, Myung
   Ho/0000-0003-2424-810X
FU Research of Korea Centers for Disease Control and Prevention
   [2016-ER6304-00]
FX This research was supported by a grant (2016-ER6304-00) from the
   Research of Korea Centers for Disease Control and Prevention.
CR Aguilar D, 2004, CIRCULATION, V110, P1572, DOI 10.1161/01.CIR.0000142047.28024.F2
   American Diabetes Association, 2015, Diabetes Care, V38 Suppl, pS8, DOI 10.2337/dc15-S005
   Beckman JA, 2002, JAMA-J AM MED ASSOC, V287, P2570, DOI 10.1001/jama.287.19.2570
   Boudina S, 2006, PHYSIOLOGY, V21, P250, DOI 10.1152/physiol.00008.2006
   Creager MA, 2003, CIRCULATION, V108, P1527, DOI 10.1161/01.CIR.0000091257.27563.32
   Eagle KA, 2004, JAMA-J AM MED ASSOC, V291, P2727, DOI 10.1001/jama.291.22.2727
   Ertelt K, 2017, AM J CARDIOL, V119, P1917, DOI 10.1016/j.amjcard.2017.03.016
   Fox CS, 2004, DIABETES CARE, V27, P704, DOI 10.2337/diacare.27.3.704
   Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143
   Haffner SM, 1998, NEW ENGL J MED, V339, P229, DOI 10.1056/NEJM199807233390404
   Kang SH, 2013, NICOTINE TOB RES, V15, P1230, DOI 10.1093/ntr/nts248
   Kim JH, 2016, CIRC J, V80, P1427, DOI 10.1253/circj.CJ-16-0061
   Knobler H, 1998, THROMB RES, V90, P181, DOI 10.1016/S0049-3848(98)00050-4
   Lindsey JB, 2009, CIRC-CARDIOVASC INTE, V2, P543, DOI 10.1161/CIRCINTERVENTIONS.109.876672
   Moreno PR, 2000, CIRCULATION, V102, P2180
   Mukamal KJ, 2001, DIABETES CARE, V24, P1422, DOI 10.2337/diacare.24.8.1422
   Norhammar A, 2004, J AM COLL CARDIOL, V43, P585, DOI 10.1016/j.jacc.2003.08.050
   Pandey A, 2014, CIRCULATION, V130
   Park HW, 2013, INT J CARDIOL, V169, P254, DOI 10.1016/j.ijcard.2013.08.132
   Park KH, 2012, KOREAN J INTERN MED, V27, P180, DOI 10.3904/kjim.2012.27.2.180
   Rogers WJ, 2008, AM HEART J, V156, P1026, DOI 10.1016/j.ahj.2008.07.030
   SILVA JA, 1995, CIRCULATION, V92, P1731, DOI 10.1161/01.CIR.92.7.1731
   Smith SC, 2006, CIRCULATION, V113, pE166, DOI 10.1161/CIRCULATIONAHA.106.173220
   STAMLER J, 1993, DIABETES CARE, V16, P434, DOI 10.2337/diacare.16.2.434
   Steg PG, 2004, CIRCULATION, V109, P494, DOI 10.1161/01.CIR.0000109691.16944.DA
   Tenerz A, 2001, EUR HEART J, V22, P1102, DOI 10.1053/euhj.2000.2445
   Thygesen K, 2007, EUR HEART J, V28, P2525
   Tian L, 2013, CORONARY ARTERY DIS, V24, P669, DOI 10.1097/MCA.0000000000000036
   Vaccarino V, 2000, AM J CARDIOL, V85, P1486, DOI 10.1016/S0002-9149(00)00800-6
   Wright RS, 2011, J AM COLL CARDIOL, V57, P1920, DOI 10.1016/j.jacc.2011.02.009
NR 30
TC 3
Z9 3
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD FEB
PY 2018
VL 48
IS 2
BP 134
EP 147
DI 10.4070/kcj.2017.0174
PG 14
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA FX1WF
UT WOS:000425842100004
PM 29441746
OA Green Published
DA 2021-04-22
ER

PT J
AU Baek, SM
   Chung, H
   Song, MK
   Bae, EJ
   Kim, GB
   Noh, CI
AF Baek, Seung Min
   Chung, Hyun
   Song, Mi Kyoung
   Bae, Eun Jung
   Kim, Gi Beom
   Noh, Chung Il
TI The Complexity of Pediatric Multifoca Atrial Tachycardia and Its
   Prognostic Factors
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Supraventricular tachycardias; Atrial fibrillation; Atrial flutter
ID CLINICAL COURSE; CHILDREN; INFANTS; RHYTHM; NEUROFIBROMATOSIS;
   MANAGEMENT; HEART
AB Background and Objectives: Multifocal atrial tachycardia (MAT), in general, has a favorable outcome. However, there are insufficient data regarding MAT in a pediatric population. This study sought to determine the clinical course of MAT and identify potential prognostic factors.
   Methods: The medical records of MAT patients from 1997-2015 were reviewed. The arrhythmia control rate and factors for unfavorable outcomes were assessed and compared to those in the literature.
   Results: Of the 33 included patients (19 boys and 14 girls), 27 were infants less than 1 year of age. The median age at diagnosis was 1.7 months (range, 0 day to 14 years). Fourteen (42%) patients had structural heart disease. Eight (24%) patients had lung disease and 6 (18%) had a syndromic diagnosis belonging to RASopathy. Two patients developed polymorphic ventricular tachycardia, in whom genetic analysis confirmed the presence of the RyR2 mutation several years later. MAT was controlled in 26 patients (84%) within 3.9 months (median; range, 16 days-18.4 years) using an average of 2.4 medications. There were 3 cases of cardiopulmonary mortality. The arrhythmia control rate was higher in the infant group (85%) than in the non-infant group (67%), although this trend was not statistically significant. There was a significantly lower rate of unfavorable outcomes in the idiopathic infant group (n=11) than in the other groups (p=0.008). Considering the findings of previous studies, the mortality rate was significantly higher in patients with structural heart disease than in patients without (21% vs. 5%, p=0.01).
   Conclusion: MAT usually affects infants and has a favorable prognosis, particularly in the idiopathic infant group. However, in the presence of other comorbidities, MAT may have a variable clinical course.
C1 [Baek, Seung Min; Chung, Hyun; Song, Mi Kyoung; Bae, Eun Jung; Kim, Gi Beom; Noh, Chung Il] Seoul Natl Univ, Childrens Hosp, Dept Pediat, 101 Daehak Ro, Seoul 03080, South Korea.
RP Song, MK (corresponding author), Seoul Natl Univ, Childrens Hosp, Dept Pediat, 101 Daehak Ro, Seoul 03080, South Korea.
EM mksong52@gmail.com
OI Kim, Gi Beom/0000-0002-7880-280X
CR BEITZKE A, 1979, HELV PAEDIATR ACTA, V34, P319
   BISSET GS, 1981, AM HEART J, V101, P268, DOI 10.1016/0002-8703(81)90189-7
   Bouziri Asma, 2011, Tunis Med, V89, P59
   Bradley DJ, 2001, J AM COLL CARDIOL, V38, P401, DOI 10.1016/S0735-1097(01)01390-0
   Broendberg AK, 2017, HEART, V103, P901, DOI 10.1136/heartjnl-2016-310509
   Cetta F, 1997, PEDIATR EMERG CARE, V13, P120, DOI 10.1097/00006565-199704000-00010
   CHANTEPIE A, 1986, ARCH MAL COEUR VAISS, V79, P1371
   Di Pino A, 2014, HEART RHYTHM, V11, P1480, DOI 10.1016/j.hrthm.2014.04.037
   DODO H, 1995, AM HEART J, V129, P990, DOI 10.1016/0002-8703(95)90121-3
   FAROOKI ZQ, 1977, BRIT HEART J, V39, P872
   Finsterer J, 2013, INT J GEN MED, V6, P743, DOI 10.2147/IJGM.S45825
   Fish FA, 1996, AM J CARDIOL, V78, P1052, DOI 10.1016/S0002-9149(96)00536-X
   HOUYEL L, 1990, INT J CARDIOL, V27, P27, DOI 10.1016/0167-5273(90)90187-A
   Hsieh Ming-Yun, 2006, J Chin Med Assoc, V69, P439
   KASTOR JA, 1990, NEW ENGL J MED, V322, P1713
   Lazaros G, 2014, ANN NONINVAS ELECTRO, V19, P483, DOI 10.1111/anec.12165
   LIBERTHSON RR, 1982, PEDIATR CARDIOL, V2, P179, DOI 10.1007/BF02332108
   Lin AE, 2011, AM J MED GENET A, V155A, P486, DOI 10.1002/ajmg.a.33857
   LIPSON MJ, 1970, CIRCULATION, V42, P397, DOI 10.1161/01.CIR.42.3.397
   PICKOFF AS, 1985, AM J CARDIOL, V55, P1402, DOI 10.1016/0002-9149(85)90513-2
   Prada CE, 2011, AM J MED GENET A, V155A, P1360, DOI 10.1002/ajmg.a.33996
   Pregowska K, 2014, EUR J PEDIATR, V173, P1577, DOI 10.1007/s00431-013-2103-7
   SALIM MA, 1995, AM HEART J, V129, P831, DOI 10.1016/0002-8703(95)90339-9
   Tutar E, 2016, PEDIATR INT, V58, P523, DOI 10.1111/ped.12917
   YEAGER SB, 1984, AM J DIS CHILD, V138, P689, DOI 10.1001/archpedi.1984.02140450071022
   ZEEVI B, 1986, AM J CARDIOL, V57, P344, DOI 10.1016/0002-9149(86)90920-3
NR 26
TC 3
Z9 4
U1 0
U2 2
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD FEB
PY 2018
VL 48
IS 2
BP 148
EP 158
DI 10.4070/kcj.2017.0179
PG 11
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA FX1WF
UT WOS:000425842100005
PM 29441747
OA Green Published
DA 2021-04-22
ER

PT J
AU Lee, KH
   Shin, MH
   Park, HW
   Cho, JG
   Kweon, SS
   Lee, YH
AF Lee, Ki Hong
   Shin, Min-Ho
   Park, Hyung Wook
   Cho, Jeong Gwan
   Kweon, Sun-Seog
   Lee, Young-Hoon
TI Association between Serum Parathyroid Hormone Levels and the Prevalence
   of Atrial Fibrillation: the Dong-gu Study
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Atrial fibrillation; Parathyroid hormone
ID VITAMIN-D; CARDIOVASCULAR EVENTS; BLOOD-PRESSURE; OLDER MEN; RISK;
   INCREASE; DISEASE
AB Background and Objectives: We aimed to investigate the association between serum parathyroid hormone (PTH) levels and the prevalence of atrial fibrillation (AF) in a population based study.
   Methods: This study included a total of 9,007 community-dwelling Koreans aged 50 years and over who were enrolled in the Dong-gu study from 2007 to 2010. Electrocardiograms were recorded from the subjects using the HP-PageWriter 200 M1771A. All potential cases of AF were determined by 2 cardiologists. PTH concentration was measured by a chemiluminescent microparticle immunoassay. Multiple logistic regression analysis was used to evaluate the relationship between the quartiles of PTH and AF, adjusting for potential confounders.
   Results: The prevalence of AF was 2.41% in males and 0.9% in females and increased with advanced age in both genders. The median and interquartile range (IQR) of serum PTH was 39.5 pg/mL (IQR, 30.6-50.8), which was significantly higher in patients with AF than in patients without AF (p<0.001). The prevalence of AF increased with increasing PTH quartile (0.8%, 0.9%,1.6%, and 2.8%in the lowest, second, third, and highest PTH quartiles, respectively; p<0.001). Multivariable logistic analysis adjusted for cardiovascular risk factors showed the highest quartile of serum PTH levels was associated with a higher prevalence of AF than the lowest quartile (odds ratio, 3.34; 95% confidence interval, 1.93-5.78).
   Conclusion: Higher levels of serum PTH were associated with higher prevalence of AF. Further studies are needed to determine whether this association is present in other populations and in a prospective study setting.
C1 [Lee, Ki Hong; Park, Hyung Wook; Cho, Jeong Gwan] Chonnam Natl Univ Hosp, Dept Cardiovasc Med, Gwangju, South Korea.
   [Shin, Min-Ho; Kweon, Sun-Seog] Chonnam Natl Univ, Med Sch, Dept Prevent Med, 264 Seoyang Ro, Hwasun 58128, South Korea.
   [Lee, Young-Hoon] Wonkwang Univ, Sch Med, Dept Prevent Med, Iksan, South Korea.
   [Lee, Young-Hoon] Wonkwang Univ, Sch Med, Inst Wonkwang Med Sci, Iksan, South Korea.
RP Shin, MH (corresponding author), Chonnam Natl Univ, Med Sch, Dept Prevent Med, 264 Seoyang Ro, Hwasun 58128, South Korea.; Park, HW (corresponding author), Chonnam Natl Univ Hosp, Heart Ctr, Dept Cardiovasc Med, 42 Jebong Ro, Gwangju 61469, South Korea.
EM mhshinx@paran.com; mdhwp@chol.com
OI KWEON, SUNSEOG/0000-0003-2378-8550; Shin, Min-Ho/0000-0002-2217-5624;
   Lee, Young-Hoon/0000-0003-1367-025X; Lee, Ki Hong/0000-0002-9938-3464
CR Allay H, 2012, AM J CARDIOL, V109, P252, DOI 10.1016/j.amjcard.2011.08.039
   Anderson JL, 2011, AM HEART J, V162, P331, DOI 10.1016/j.ahj.2011.05.005
   Andersson P, 2004, EUR HEART J, V25, P1776, DOI 10.1016/j.ehj.2004.07.010
   GRANT FD, 1992, J CLIN ENDOCR METAB, V75, P988, DOI 10.1210/jc.75.4.988
   Hara M, 1997, CIRCULATION, V96, P3704
   Jorde R, 2005, J HYPERTENS, V23, P1639, DOI 10.1097/01.hjh.0000179764.40701.36
   Kestenbaum B, 2011, J AM COLL CARDIOL, V58, P1433, DOI 10.1016/j.jacc.2011.03.069
   Kirchhof P, 2016, EUR HEART J, V37, P2893, DOI 10.1093/eurheartj/ehw210
   Kweon SS, 2014, INT J EPIDEMIOL, V43, P558, DOI 10.1093/ije/dys244
   Lopez FL, 2013, AM J CARDIOL, V111, P857, DOI 10.1016/j.amjcard.2012.11.045
   McCarty MF, 2009, MED HYPOTHESES, V72, P581, DOI 10.1016/j.mehy.2008.12.023
   OGINO K, 1995, ENDOCRINOLOGY, V136, P3024, DOI 10.1210/en.136.7.3024
   Pilz S, 2010, EUR HEART J, V31, P1591, DOI 10.1093/eurheartj/ehq109
   Rienstra M, 2011, J AM COLL CARDIOL, V57, P2542, DOI 10.1016/j.jacc.2011.01.041
   Saleh FN, 2003, EUR HEART J, V24, P2054, DOI 10.1016/j.ehj.2003.09.010
   Shor R, 2008, AM J EMERG MED, V26, P361, DOI 10.1016/j.ajem.2007.08.005
   Snijder MB, 2007, J INTERN MED, V261, P558, DOI 10.1111/j.1365-2796.2007.01778.x
   van Ballegooijen AJ, 2013, AM J CARDIOL, V111, P418, DOI 10.1016/j.amjcard.2012.10.021
   Wannamethee SG, 2014, CIRC-HEART FAIL, V7, P732, DOI 10.1161/CIRCHEARTFAILURE.114.001272
   Watson T, 2009, LANCET, V373, P155, DOI 10.1016/S0140-6736(09)60040-4
NR 20
TC 2
Z9 2
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD FEB
PY 2018
VL 48
IS 2
BP 159
EP 167
DI 10.4070/kcj.2017.0187
PG 9
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA FX1WF
UT WOS:000425842100006
PM 29441748
OA Green Published
DA 2021-04-22
ER

PT J
AU Jin, ES
   Wang, PJ
AF Jin, Eun-Sun
   Wang, Paul J.
TI Cryoballoon Ablation for Atrial Fibrillation: a Comprehensive Review and
   Practice Guide
SO KOREAN CIRCULATION JOURNAL
LA English
DT Review
DE Atrial fibrillation; Catheter ablation; Cryosurgery
ID PULMONARY VEIN ISOLATION; RADIOFREQUENCY CATHETER ABLATION;
   2ND-GENERATION CRYOBALLOON; FOLLOW-UP; FORCE; 1ST; CRYOABLATION;
   BIOPHYSICS; PATIENT
AB The cryoballoon was invented to achieve circumferential pulmonary vein isolation more efficiently to compliment the shortcomings of point-by-point ablation by radiofrequency ablation (RFA). Its efficacy and safety were shown to be comparable to those of RFA, and the clinical outcomes have improved with the second-generation cryoballoon. The basic biophysics, implemental techniques, procedural recommendations, clinical outcomes, and complications of the cryoballoon are presented in this practical and systematic review.
C1 [Jin, Eun-Sun] Kyung Hee Univ, Kyung Hee Univ Hosp Gangdong, Cardiovasc Ctr, Seoul, South Korea.
   [Wang, Paul J.] Stanford Univ, Sch Med, Div Cardiovasc Med, Stanford, CA 94305 USA.
RP Wang, PJ (corresponding author), Stanford Univ, 300 Pasteur Dr, Stanford, CA 94305 USA.
EM pjwang@stanford.edu
RI Jin, Eun-Sun/ABF-3500-2020
OI Jin, Eun-Sun/0000-0003-1182-8244
CR Andrade JG, 2012, PACE, V35, P1162, DOI 10.1111/j.1540-8159.2012.03436.x
   Aryana Arash, 2015, J Atr Fibrillation, V8, P1231, DOI 10.4022/jafib.1231
   Calkins H, 2012, HEART RHYTHM, V9, P632, DOI 10.1016/j.hrthm.2011.12.016
   Casado-Arroyo R, 2013, HEART RHYTHM, V10, P1318, DOI 10.1016/j.hrthm.2013.07.005
   Ciconte G, 2015, EUROPACE, V17, P559, DOI 10.1093/europace/euu350
   Di Giovanni G, 2014, J CARDIOVASC ELECTR, V25, P834, DOI 10.1111/jce.12409
   GALLAGHER JJ, 1978, CIRCULATION, V57, P190, DOI 10.1161/01.CIR.57.1.190
   Haissaguerre M, 1998, NEW ENGL J MED, V339, P659, DOI 10.1056/NEJM199809033391003
   Jourda F, 2015, EUROPACE, V17, P225, DOI 10.1093/europace/euu215
   Julia J, 2015, J INTERV CARD ELECTR, V42, P161, DOI 10.1007/s10840-014-9961-4
   Kardos A, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/6495753
   Kaszala K, 2015, CIRC-ARRHYTHMIA ELEC, V8, P15, DOI 10.1161/CIRCEP.115.002675
   Khoueiry Z, 2016, EUROPACE, V18, P1343, DOI 10.1093/europace/euv419
   Kimura M, 2014, HEART RHYTHM, V11, P984, DOI 10.1016/j.hrthm.2014.03.019
   Kuck KH, 2016, NEW ENGL J MED, V374, P2235, DOI 10.1056/NEJMoa1602014
   Lakhani M, 2014, HEART RHYTHM, V11, P369, DOI 10.1016/j.hrthm.2013.11.015
   Metzner A, 2015, ARRHYTH ELECTROPHYSI, V4, P58, DOI 10.15420/aer.2015.4.1.58
   Metzner A, 2014, CIRC-ARRHYTHMIA ELEC, V7, P288, DOI 10.1161/CIRCEP.114.001473
   Metzner A, 2013, CIRC-ARRHYTHMIA ELEC, V6, P769, DOI 10.1161/CIRCEP.113.000228
   Miyazaki S, 2016, J CARDIOVASC ELECTR, V27, P1038, DOI 10.1111/jce.13015
   Miyazaki S, 2016, CIRC J, V80, P346, DOI 10.1253/circj.CJ-15-1051
   Mondesert B, 2014, CIRC-ARRHYTHMIA ELEC, V7, P605, DOI 10.1161/CIRCEP.113.001238
   Nagy Z, 2016, ORVOSI HETILAP, V157, P849, DOI 10.1556/650.2016.30408
   Squara F, 2015, EUROPACE, V17, P718, DOI 10.1093/europace/euv060
   Straube F, 2016, EUROPACE, V18, P368, DOI 10.1093/europace/euv271
   Straube F, 2014, CIRC-ARRHYTHMIA ELEC, V7, P293, DOI 10.1161/CIRCEP.113.000899
   Verma A, 2015, NEW ENGL J MED, V372, P1812, DOI 10.1056/NEJMoa1408288
   Wasserlauf J, 2015, PACE, V38, P483, DOI 10.1111/pace.12582
   WHITTAKER DK, 1984, ANN ROY COLL SURG, V66, P313
NR 29
TC 6
Z9 6
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD FEB
PY 2018
VL 48
IS 2
BP 114
EP 123
DI 10.4070/kcj.2017.0318
PG 10
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA FX1WF
UT WOS:000425842100002
PM 29441744
OA Green Published
DA 2021-04-22
ER

PT J
AU Dwivedi, A
   Al'Aref, SJ
   Lin, FY
   Min, JK
AF Dwivedi, Aeshita
   Al'Aref, Subhi J.
   Lin, Fay Y.
   Min, James K.
TI Evaluation of Atherosclerotic Plaque in Non-invasive Coronary Imaging
SO KOREAN CIRCULATION JOURNAL
LA English
DT Review
DE Atherosclerosis; Coronary artery disease; Atherosclerotic plaque
ID COMPUTED-TOMOGRAPHY ANGIOGRAPHY; ALL-CAUSE MORTALITY; INTERNATIONAL
   MULTICENTER REGISTRY; NAPKIN-RING SIGN; ARTERY-DISEASE; CT ANGIOGRAPHY;
   INTRAVASCULAR ULTRASOUND; CLINICAL-OUTCOMES; PROGNOSTIC VALUE;
   DIAGNOSTIC PERFORMANCE
AB Coronary artery disease (CAD) is the leading cause of morbidity and mortality worldwide. Over the last decade coronary computed tomography angiography (CCTA) has gained wide acceptance as a reliable, cost-effective and non-invasive modality for diagnosis and prognostication of CAD. Use of CCTA is now expanding to characterization of plaque morphology and identification of vulnerable plaque. Additionally, CCTA is developing as a non-invasive modality to monitor plaque progression, which holds future potential in individualizing treatment. In this review, we discuss the role of CCTA in diagnosis and management of CAD. Additionally, we discuss the recent advancements and the potential clinical applications of CCTA in management of CAD.
C1 [Dwivedi, Aeshita; Al'Aref, Subhi J.; Lin, Fay Y.; Min, James K.] NewYork Presbyterian Hosp, Dalio Inst Cardiovasc Imaging, New York, NY USA.
   [Al'Aref, Subhi J.; Min, James K.] Weill Cornell Med, Dept Med, New York, NY USA.
   [Al'Aref, Subhi J.; Lin, Fay Y.; Min, James K.] Weill Cornell Med, Dept Radiol, New York, NY USA.
RP Min, JK (corresponding author), NewYork Presbyterian Hosp, Dept Radiol, 413 E 69th St,Suite 108, New York, NY 10021 USA.; Min, JK (corresponding author), NewYork Presbyterian Hosp, Dept Med, 413 E 69th St,Suite 108, New York, NY 10021 USA.; Min, JK (corresponding author), Weill Cornell Med Coll, 413 E 69th St,Suite 108, New York, NY 10021 USA.
EM jkm2001@med.cornell.edu
RI Lin, Fay/AAJ-9453-2021
CR Achenbach S, 2003, AM J CARDIOL, V92, P1471, DOI 10.1016/j.amjcard.2003.08.064
   AGATSTON AS, 1990, J AM COLL CARDIOL, V15, P827, DOI 10.1016/0735-1097(90)90282-T
   Arad Y, 2005, J AM COLL CARDIOL, V46, P166, DOI 10.1016/j.jacc.2005.02.089
   Bamberg F, 2011, J AM COLL CARDIOL, V57, P2426, DOI 10.1016/j.jacc.2010.12.043
   Barrett JF, 2004, RADIOGRAPHICS, V24, P1679, DOI 10.1148/rg.246045065
   Bittencourt MS, 2014, CIRC-CARDIOVASC IMAG, V7, P282, DOI 10.1161/CIRCIMAGING.113.001047
   BLANKENHORN DH, 1959, AMER J ROENTGENOL RA, V81, P772
   Bruining N, 2007, CATHETER CARDIO INTE, V69, P857, DOI 10.1002/ccd.21067
   Budoff MJ, 2008, J AM COLL CARDIOL, V52, P1724, DOI 10.1016/j.jacc.2008.07.031
   Budoff MJ, 2007, J AM COLL CARDIOL, V49, P1860, DOI 10.1016/j.jacc.2006.10.079
   Budoff MJ, 2010, JACC-CARDIOVASC IMAG, V3, P1229, DOI 10.1016/j.jcmg.2010.08.018
   Budoff MJ, 1996, CIRCULATION, V93, P898, DOI 10.1161/01.CIR.93.5.898
   Chang HJ, J AM COLL CARDIOL
   Criqui MH, 2017, JACC-CARDIOVASC IMAG, V10, P845, DOI 10.1016/j.jcmg.2017.04.018
   Criqui MH, 2014, JAMA-J AM MED ASSOC, V311, P271, DOI 10.1001/jama.2013.282535
   Douglas PS, 2015, NEW ENGL J MED, V372, P1291, DOI 10.1056/NEJMoa1415516
   Galonska M, 2008, ACAD RADIOL, V15, P222, DOI 10.1016/j.acra.2007.09.007
   Greenland P, 2010, CIRCULATION, V122, P2748, DOI 10.1161/CIR.0b013e3182051bab
   Gupta A, 2017, JACC-CARDIOVASC IMAG, V10, P833, DOI 10.1016/j.jcmg.2017.01.030
   Haberl R, 2001, J AM COLL CARDIOL, V37, P451, DOI 10.1016/S0735-1097(00)01119-0
   Hadamitzky M, 2013, J AM COLL CARDIOL, V62, P468, DOI 10.1016/j.jacc.2013.04.064
   Heo R, 2016, EUR RADIOL, V26, P3190, DOI 10.1007/s00330-015-4121-5
   Kajinami K, 1997, J AM COLL CARDIOL, V29, P1549, DOI 10.1016/S0735-1097(97)00090-9
   Lehman SJ, 2009, JACC-CARDIOVASC IMAG, V2, P1262, DOI 10.1016/j.jcmg.2009.07.007
   Lin FY, 2011, J AM COLL CARDIOL, V58, P510, DOI 10.1016/j.jacc.2010.11.078
   Lo J, 2015, LANCET HIV, V2, pE52, DOI 10.1016/S2352-3018(14)00032-0
   Maurovich-Horvat P, 2014, NAT REV CARDIOL, V11, P390, DOI 10.1038/nrcardio.2014.60
   Maurovich-Horvat P, 2010, JACC-CARDIOVASC IMAG, V3, P440, DOI 10.1016/j.jcmg.2010.02.003
   Miller JM, 2008, NEW ENGL J MED, V359, P2324, DOI 10.1056/NEJMoa0806576
   Min JK, 2007, J AM COLL CARDIOL, V50, P1161, DOI 10.1016/j.jacc.2007.03.067
   Min JK, 2012, EUR HEART J, V33, P3088, DOI 10.1093/eurheartj/ehs315
   Min JK, 2010, EUR HEART J, V31, P1212, DOI 10.1093/eurheartj/ehq020
   Motoyama S, 2007, J AM COLL CARDIOL, V50, P319, DOI 10.1016/j.jacc.2007.03.044
   Motoyama S, 2015, J AM COLL CARDIOL, V66, P337, DOI 10.1016/j.jacc.2015.05.069
   Nakazato R, 2013, J AM COLL CARDIOL, V62, P460, DOI 10.1016/j.jacc.2013.04.062
   Nasir K, 2010, CIRC-CARDIOVASC QUAL, V3, P228, DOI 10.1161/CIRCOUTCOMES.109.893396
   Otsuka K, 2014, EUR HEART J-CARD IMG, V15, P332, DOI 10.1093/ehjci/jet232
   Otsuka K, 2013, JACC-CARDIOVASC IMAG, V6, P448, DOI 10.1016/j.jcmg.2012.09.016
   Otsuka M, 2008, INVEST RADIOL, V43, P314, DOI 10.1097/RLI.0b013e31816a88a9
   Papadopoulou SL, 2012, JACC-CARDIOVASC IMAG, V5, pS28, DOI 10.1016/j.jcmg.2012.01.009
   Park HB, 2015, EUR RADIOL, V25, P3073, DOI 10.1007/s00330-015-3698-z
   Park HB, 2015, JACC-CARDIOVASC IMAG, V8, P1, DOI 10.1016/j.jcmg.2014.11.002
   Pletcher MJ, 2004, ARCH INTERN MED, V164, P1285, DOI 10.1001/archinte.164.12.1285
   Pundziute G, 2008, JACC-CARDIOVASC INTE, V1, P176, DOI 10.1016/j.jcin.2008.01.007
   Roijers RB, 2011, AM J PATHOL, V178, P2879, DOI 10.1016/j.ajpath.2011.02.004
   Shaw LJ, 2003, J NUCL MED, V44, P134
   Shin S, 2017, JACC-CARDIOVASC IMAG, V10, P437, DOI 10.1016/j.jcmg.2016.04.013
   Stone GW, 2011, NEW ENGL J MED, V364, P226, DOI 10.1056/NEJMoa1002358
   Thomsen C, 2016, EUR HEART J-CARD IMG, V17, P120, DOI 10.1093/ehjci/jev325
   Tian J, 2014, J AM COLL CARDIOL, V64, P672, DOI 10.1016/j.jacc.2014.05.052
   Villines TC, 2011, J AM COLL CARDIOL, V58, P2533, DOI 10.1016/j.jacc.2011.10.851
   Virmani R, 2000, ARTERIOSCL THROM VAS, V20, P1262, DOI 10.1161/01.ATV.20.5.1262
   Vliegenthart R, 2005, CIRCULATION, V112, P572, DOI 10.1161/CIRCULATIONAHA.104.488916
   Voros S, 2011, JACC-CARDIOVASC INTE, V4, P198, DOI 10.1016/j.jcin.2010.10.008
   Zeb I, 2013, ATHEROSCLEROSIS, V231, P198, DOI 10.1016/j.atherosclerosis.2013.08.019
NR 55
TC 6
Z9 6
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD FEB
PY 2018
VL 48
IS 2
BP 124
EP 133
DI 10.4070/kcj.2017.0392
PG 10
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA FX1WF
UT WOS:000425842100003
PM 29441745
OA Green Published
DA 2021-04-22
ER

PT J
AU Park, HJ
AF Park, Hun-Jun
TI Clinical Significance of Newly Diagnosed Diabetes Mellitus in the Era of
   DES for Acute Myocardial Infarction
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
ID PERCUTANEOUS CORONARY INTERVENTION; PROGNOSIS; OUTCOMES
C1 [Park, Hun-Jun] Catholic Univ Korea, Cardiovasc Ctr, Coll Med, Seoul St Marys Hosp,Div Cardiol, Seoul, South Korea.
RP Park, HJ (corresponding author), Catholic Univ Korea, Div Cardiol, Coll Med, 222 Banpodaero, Seoul 06951, South Korea.
EM cardioman@catholic.ac.kr
CR Aguilar D, 2004, CIRCULATION, V110, P1572, DOI 10.1161/01.CIR.0000142047.28024.F2
   Bangalore S, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e5170
   Chamberlain JJ, 2016, ANN INTERN MED, V164, P542, DOI 10.7326/M15-3016
   Ertelt K, 2017, AM J CARDIOL, V119, P1917, DOI 10.1016/j.amjcard.2017.03.016
   Herman WH, 2016, DIABETES CARE, V39, pS3, DOI 10.2337/dc16-S002
   Levine GN, 2011, J AM COLL CARDIOL, V58, pE44, DOI 10.1016/j.jacc.2011.08.007
   Norhammar A, 2004, J AM COLL CARDIOL, V43, P585, DOI 10.1016/j.jacc.2003.08.050
   Park HW, 2018, KOREAN CIRC J, V48, P134, DOI 10.4070/kcj.2017.0174
   Park HW, 2013, INT J CARDIOL, V169, P254, DOI 10.1016/j.ijcard.2013.08.132
   Stefanini GG, 2013, NEW ENGL J MED, V368, P254, DOI 10.1056/NEJMra1210816
NR 10
TC 0
Z9 0
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD FEB
PY 2018
VL 48
IS 2
BP 168
EP 169
DI 10.4070/kcj.2018.0006
PG 2
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA FX1WF
UT WOS:000425842100007
PM 29441749
OA Green Published
DA 2021-04-22
ER

PT J
AU Cha, MJ
AF Cha, Myung-Jin
TI Current Understanding on Mechanisms Leading to Atrial Fibrillation
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
ID RISK; ASSOCIATION; PREVALENCE
C1 [Cha, Myung-Jin] Seoul Natl Univ Hosp, Dept Internal Med, Seoul, South Korea.
RP Cha, MJ (corresponding author), Seoul Natl Univ, Coll Med, Dept Internal Med, 101 Daehak Ro, Seoul 03080, South Korea.; Cha, MJ (corresponding author), Seoul Natl Univ Hosp, 101 Daehak Ro, Seoul 03080, South Korea.
EM mjcha@snuh.org
OI Cha, Myung-Jin/0000-0001-6180-0157
CR Aviles RJ, 2003, CIRCULATION, V108, P3006, DOI 10.1161/01.CIR.0000103131.70301.4F
   BENJAMIN EJ, 1994, JAMA-J AM MED ASSOC, V271, P840, DOI 10.1001/jama.1994.03510350050036
   Cha MJ, 2017, EUR J INTERN MED, V46, P41, DOI 10.1016/j.ejim.2017.07.028
   Gudbjartsson DF, 2007, NATURE, V448, P353, DOI 10.1038/nature06007
   Kirchhof P, 2016, EUR HEART J, V37, P2893, DOI 10.1093/eurheartj/ehw210
   Lee KH, 2018, KOREAN CIRC J, V48, P159, DOI 10.4070/kcj.2017.0187
   Lee SR, 2017, INT J CARDIOL, V236, P226, DOI 10.1016/j.ijcard.2017.02.039
   Lim WH, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06579-0
   Nguyen BL, 2009, HEART RHYTHM, V6, P454, DOI 10.1016/j.hrthm.2009.01.010
   Schotten U, 2011, PHYSIOL REV, V91, P265, DOI 10.1152/physrev.00031.2009
NR 10
TC 0
Z9 0
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD FEB
PY 2018
VL 48
IS 2
BP 170
EP 172
DI 10.4070/kcj.2018.0008
PG 3
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA FX1WF
UT WOS:000425842100008
PM 29441750
OA Green Published
DA 2021-04-22
ER

PT J
AU Huh, J
AF Huh, June
TI Clinical Implication of Multifocal Atrial Tachycardia in Children for
   Pediatric Cardiologist
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
C1 [Huh, June] Sungkyunkwan Univ, Heart Vasc Stroke Inst, Dept Pediat, Samsung Med Ctr,Sch Med, 81 Irwon Ro, Seoul 06351, South Korea.
RP Huh, J (corresponding author), Sungkyunkwan Univ, Heart Vasc Stroke Inst, Dept Pediat, Samsung Med Ctr,Sch Med, 81 Irwon Ro, Seoul 06351, South Korea.
EM herz.huh@samsung.com
OI Huh, June/0000-0003-4523-9632
FU Direct For Mathematical & Physical ScienNational Science Foundation
   (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)
   [1638352] Funding Source: National Science Foundation
CR Baek SM, 2018, KOREAN CIRC J, V48, P148, DOI 10.4070/kcj.2017.0179
   Bradley DJ, 2001, J AM COLL CARDIOL, V38, P401, DOI 10.1016/S0735-1097(01)01390-0
   Broendberg AK, 2017, HEART, V103, P901, DOI 10.1136/heartjnl-2016-310509
   Fish FA, 1996, AM J CARDIOL, V78, P1052, DOI 10.1016/S0002-9149(96)00536-X
   KASTOR JA, 1990, NEW ENGL J MED, V322, P1713
   Lazaros G, 2014, ANN NONINVAS ELECTRO, V19, P483, DOI 10.1111/anec.12165
   Lin AE, 2011, AM J MED GENET A, V155A, P486, DOI 10.1002/ajmg.a.33857
   PICKOFF AS, 1985, AM J CARDIOL, V55, P1402, DOI 10.1016/0002-9149(85)90513-2
   SHINE KI, 1968, NEW ENGL J MED, V279, P344, DOI 10.1056/NEJM196808152790703
NR 9
TC 0
Z9 0
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD FEB
PY 2018
VL 48
IS 2
BP 173
EP 175
DI 10.4070/kcj.2018.0037
PG 3
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA FX1WF
UT WOS:000425842100009
PM 29441751
OA Green Published
DA 2021-04-22
ER

PT J
AU Jin, U
   Lim, HS
   Tahk, SJ
AF Jin, Uram
   Lim, Hong-Seok
   Tahk, Seung-Jea
TI Longitudinal Stent-Strut Injury at the Distal End of a Newer-generation
   Drug-eluting Stent
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
ID DEFORMATION; COMPRESSION; MECHANISMS; ELEMENT
C1 [Jin, Uram; Lim, Hong-Seok; Tahk, Seung-Jea] Ajou Univ, Sch Med, Dept Cardiol, 164 World Cup Ro, Suwon 16499, South Korea.
RP Lim, HS (corresponding author), Ajou Univ, Sch Med, Dept Cardiol, 164 World Cup Ro, Suwon 16499, South Korea.
EM camdhslim@ajou.ac.kr
OI Jin, Uram/0000-0001-8406-8886; Lim, Hong-Seok/0000-0002-3127-2071
CR Arnous S, 2015, CATHETER CARDIO INTE, V86, P1002, DOI 10.1002/ccd.25790
   Hanratty CG, 2011, EUROINTERVENTION, V7, P872, DOI 10.4244/EIJV7I7A135
   Ormiston JA, 2014, CIRC-CARDIOVASC INTE, V7, P62, DOI 10.1161/CIRCINTERVENTIONS.113.000621
   Shannon J, 2013, CATHETER CARDIO INTE, V81, P810, DOI 10.1002/ccd.24600
   Williams PD, 2012, EUROINTERVENTION, V8, P267, DOI 10.4244/EIJV8I2A41
NR 5
TC 0
Z9 0
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD FEB
PY 2018
VL 48
IS 2
BP 176
EP 178
DI 10.4070/kcj.2017.0180
PG 3
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA FX1WF
UT WOS:000425842100010
PM 29171204
OA Green Published
DA 2021-04-22
ER

PT J
AU Capodanno, D
AF Capodanno, Davide
TI Bioresorbable Scaffolds in Coronary Intervention: Unmet Needs and
   Evolution
SO KOREAN CIRCULATION JOURNAL
LA English
DT Review
DE Bioresorbable scaffolds; ABSORB; Biodegradable stents; Angioplasty;
   Coronary stents
ID ABSORBABLE METAL SCAFFOLD; SIROLIMUS-ELUTING SCAFFOLD; BIOSOLVE-I TRIAL;
   VASCULAR SCAFFOLDS; ARTERY-DISEASE; 1ST-IN-MAN TRIAL; SUSTAINED SAFETY;
   LESIONS; OUTCOMES; MULTICENTER
AB Bioresorbable scaffolds (BRS) represent a novel paradigm in the 40-year history of interventional cardiology. Restoration of cyclic pulsatility and physiologic vasomotion, adaptive vascular remodeling, plaque regression, and removal of the trigger for late adverse events are expected BRS benefits over current metallic drug-eluting stents. However, first-generation BRS devices have significant manufacturing limitations and rely on optimal implantation technique to avoid experiencing an excess of clinical events. There are currently at least 22 BRS devices in different stages of development, including many trials of device iterations with thinner (<150 mu m) struts than first-generation BRS. This article reviews the outcomes of commercially available and potentially upcoming BRS, focusing on the most recent stages of clinical development and future directions for each scaffold type.
C1 [Capodanno, Davide] Univ Catania, Policlin Vittorio Emanuele, Azienda Osped Univ, Div Cardiol,Cardiothorac Vasc Dept, Catania, Italy.
RP Capodanno, D (corresponding author), Univ Catania, Dept Gen Surg & Med Surg Specialties, Via Citelli 6, I-95100 Catania, Italy.; Capodanno, D (corresponding author), Univ Catania, Policlin Vittorio Emanuele, Azienda Osped Univ, Div Cardiol,Ferrarotto Hosp,Cardiothorac Vasc Dep, Via Citelli 6, I-95100 Catania, Italy.
EM dcapodanno@gmail.com
RI Capodanno, Davide/AAP-4949-2020
FU Abbott Vascular, Santa Clara, CA, USAAbbott Laboratories
FX Speaker and consulting fees from Abbott Vascular, Santa Clara, CA, USA.
CR Abizaid A, 2016, JACC-CARDIOVASC INTE, V9, P565, DOI 10.1016/j.jcin.2015.12.004
   Ali ZA, 2017, LANCET, V390, P760, DOI 10.1016/S0140-6736(17)31470-8
   Capodanno Davide, 2016, Interv Cardiol Clin, V5, P357, DOI 10.1016/j.iccl.2016.02.005
   Capodanno D, 2017, JACC-CARDIOVASC INTE, V10, P425, DOI 10.1016/j.jcin.2016.12.279
   Capodanno D, 2015, EUROINTERVENTION, V10, P1144, DOI 10.4244/EIJY14M07_11
   Cassese S, 2016, LANCET, V387, P537, DOI 10.1016/S0140-6736(15)00979-4
   Ellis SG, 2015, NEW ENGL J MED, V373, P1905, DOI 10.1056/NEJMoa1509038
   Fajadet J, 2016, EUROINTERVENTION, V12, P828, DOI 10.4244/EIJV12I7A137
   Gao RL, 2015, J AM COLL CARDIOL, V66, P2298, DOI 10.1016/j.jacc.2015.09.054
   Haude M, 2017, EUROINTERVENTION, V13, P432, DOI [10.4244/EIJ-D-17-00254, 10.4244/EIJ.D.17.00254]
   Haude M, 2016, EUR HEART J, V37, P2701, DOI 10.1093/eurheartj/ehw196
   Haude M, 2016, EUROINTERVENTION, V12, pE160, DOI [10.4244/EIJY16M06_01, 10.4244/EIJ-D-15-00371]
   Haude M, 2016, LANCET, V387, P31, DOI 10.1016/S0140-6736(15)00447-X
   Haude M, 2013, LANCET, V381, P836, DOI 10.1016/S0140-6736(12)61765-6
   Kereiakes DJ, 2016, CIRCULATION, V134, P168, DOI 10.1161/CIRCULATIONAHA.116.021539
   Kimura T, 2015, EUR HEART J, V36, P3332, DOI 10.1093/eurheartj/ehv435
   Nef HM, 2017, INT J CARDIOL, V227, P127, DOI 10.1016/j.ijcard.2016.11.033
   Palmerini T, 2013, J AM COLL CARDIOL, V62, P1915, DOI 10.1016/j.jacc.2013.08.725
   Serruys PW, 2016, LANCET, V388, P2479, DOI 10.1016/S0140-6736(16)32050-5
   Serruys PW, 2015, LANCET, V385, P43, DOI 10.1016/S0140-6736(14)61455-0
   Seth A, 2017, EUROINTERVENTION, V13, P415, DOI 10.4244/EIJ-D-17-00306
   Stone GW, 2016, LANCET, V387, P1277, DOI 10.1016/S0140-6736(15)01039-9
   Tenekecioglu E, 2017, JACC-CARDIOVASC INTE, V10, P1115, DOI 10.1016/j.jcin.2017.03.015
   Verheye S, 2014, JACC-CARDIOVASC INTE, V7, P89, DOI 10.1016/j.jcin.2013.07.007
   Wu YZ, 2016, CATHETER CARDIO INTE, V87, P630, DOI 10.1002/ccd.26404
   Wykrzykowska JJ, 2017, NEW ENGL J MED, V376, P2319, DOI 10.1056/NEJMoa1614954
   Zhang YJ, 2016, EUROINTERVENTION, V12, P1279, DOI 10.4244/EIJV12I10A209
NR 27
TC 9
Z9 9
U1 0
U2 9
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JAN
PY 2018
VL 48
IS 1
BP 24
EP 35
DI 10.4070/kcj.2017.0194
PG 12
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA FX1WE
UT WOS:000425842000003
PM 29322695
OA Green Published
DA 2021-04-22
ER

PT J
AU Sun, BJ
   Jin, X
   Song, JK
   Lee, S
   Lee, JH
   Park, JB
   Lee, SP
   Kim, DH
   Park, SJ
   Kim, YJ
   Cho, GY
   Song, JM
   Kang, DH
   Sohn, DW
AF Sun, Byung Joo
   Jin, Xin
   Song, Jae-Kwan
   Lee, Sahmin
   Lee, Ji Hye
   Park, Jun-Bean
   Lee, Seung-Pyo
   Kim, Dae-Hee
   Park, Sung-Ji
   Kim, Yong-Jin
   Cho, Goo-Yeong
   Song, Jong-Min
   Kang, Duk-Hyun
   Sohn, Dae-Won
TI Clinical Characteristics of Korean Patients with Bicuspid Aortic Valve
   Who Underwent Aortic Valve Surgery
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Bicuspid aortic valve; Heart valve diseases; Phenotype; Cardiac surgical
   procedures
ID WALL SHEAR-STRESS; MORPHOLOGY; DISEASE; AORTOPATHY; ADULTS;
   CLASSIFICATION; COMPLICATIONS; ENDOCARDITIS; REPLACEMENT; DILATATION
AB Background and Objectives: Clinical data for Korean patients with bicuspid aortic valve (BAV) that underwent aortic valve (AV) surgery are currently limited.
   Methods: Data for 1,160 consecutive adult BAV patients who underwent AV surgery from 2000 to 2014 in 4 tertiary referral centers were retrospectively analyzed. A standard case report form was used for clinical and echocardiographic parameters.
   Results: Mean age at the time of AV surgery was 59 +/- 13 years. The most common cause of AV surgery was aortic stenosis (AS, 892 [77 0 /0]), followed by aortic regurgitation (AR, 199 [17%]), and infective endocarditis (69 [6%]). AS showed a skewed peak in the aged population and was the predominant cause of AV surgery (87%) in patients >= 50 years of age, whereas AR (46%) and active infective endocarditis (19 degrees/0) were more common in younger patients (p<0.001). Echocardiographic determination of the BAV phenotype revealed that fusion of the right coronary cusp (RCC) and left coronary cusp (LCC) was most common (622 [53%]), followed by fusion of RCC and non-coronary cusp (NCC) (313 [27%]), and fusion of LCC and NCC (42 [4%]); the BAV phenotype could not be determined in the remaining 183 patients (16%). Fusion of RCC and LCC was more commonly observed in patients with AR than in those with AS (74% vs. 49%; p<0.001).
   Conclusion: BAV patients were characterized by distinct surgical indications according to their age. Possible associations between BAV phenotypes and surgical indications with potential impacts of ethnicity need to be tested in further studies.
C1 [Sun, Byung Joo] Chungnam Natl Univ, Sch Med, Chungnam Natl Univ Hosp, Dept Cardiol,Internal Med, Daejeon, South Korea.
   [Jin, Xin; Song, Jae-Kwan; Lee, Sahmin; Lee, Ji Hye; Kim, Dae-Hee; Song, Jong-Min; Kang, Duk-Hyun] Asan Med Ctr Heart Inst, Valvular Heart Dis Ctr, 88 Olymp Ro 43 Gil, Seoul 05505, South Korea.
   [Jin, Xin; Song, Jae-Kwan; Lee, Sahmin; Lee, Ji Hye; Kim, Dae-Hee; Song, Jong-Min; Kang, Duk-Hyun] Univ Ulsan, Coll Med, Res Inst Valvular Heart Dis, 88 Olymp Ro 43 Gil, Seoul 05505, South Korea.
   [Park, Jun-Bean; Lee, Seung-Pyo; Kim, Yong-Jin; Sohn, Dae-Won] Seoul Natl Univ Hosp, Cardiovasc Ctr, Dept Internal Med, Seoul, South Korea.
   [Park, Sung-Ji] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Cardiol, Seoul, South Korea.
   [Cho, Goo-Yeong] Seoul Natl Univ, Bundang Hosp, Cardiovasc Ctr, Seongnam, South Korea.
RP Song, JK (corresponding author), Asan Med Ctr Heart Inst, Valvular Heart Dis Ctr, 88 Olymp Ro 43 Gil, Seoul 05505, South Korea.; Song, JK (corresponding author), Univ Ulsan, Coll Med, Res Inst Valvular Heart Dis, 88 Olymp Ro 43 Gil, Seoul 05505, South Korea.
EM jksong@amc.seoul.kr
OI Park, Jun-Bean/0000-0003-4053-8713; Park, Sung-Ji/0000-0002-7075-847X;
   Jin, Xin/0000-0002-8250-1444; Sun, Byung Joo/0000-0001-6019-4343
FU Korean Society of Cardiology [201303-5]; KoBAV Research Group of the
   Korean Society of Echocardiography
FX This work was supported in part by the Korean Society of Cardiology
   (grant number 201303-5, 2013) and the KoBAV Research Group of the Korean
   Society of Echocardiography.
CR ANGELINI A, 1989, J THORAC CARDIOV SUR, V98, P362
   Anguera I, 2005, AM J CARDIOL, V96, P976, DOI 10.1016/j.amjcard.2005.05.056
   Bissell MM, 2013, CIRC-CARDIOVASC IMAG, V6, P499, DOI 10.1161/CIRCIMAGING.113.000528
   Boodhwani M, 2010, J THORAC CARDIOV SUR, V140, P276, DOI 10.1016/j.jtcvs.2009.11.058
   Cedars A, 2012, PROG PEDIATR CARDIOL, V34, P91, DOI 10.1016/j.ppedcard.2012.08.006
   Chandra S, 2012, JACC-CARDIOVASC IMAG, V5, P981, DOI 10.1016/j.jcmg.2012.07.008
   Fedak PWM, 2002, CIRCULATION, V106, P900, DOI 10.1161/01.CIR.0000027905.26586.E8
   Fernandes SM, 2004, J AM COLL CARDIOL, V44, P1648, DOI 10.1016/j.jacc.2004.05.063
   Fernandez B, 2009, J AM COLL CARDIOL, V54, P2312, DOI 10.1016/j.jacc.2009.07.044
   Garg V, 2005, NATURE, V437, P270, DOI 10.1038/nature03940
   Guzzardi DG, 2015, J AM COLL CARDIOL, V66, P892, DOI 10.1016/j.jacc.2015.06.1310
   Hoffman JIE, 2002, J AM COLL CARDIOL, V39, P1890, DOI 10.1016/S0735-1097(02)01886-7
   Kang JW, 2013, JACC-CARDIOVASC IMAG, V6, P150, DOI 10.1016/j.jcmg.2012.11.007
   Kinoshita T, 2016, CIRC J, V80, P1356, DOI 10.1253/circj.CJ-15-1378
   Mahadevia R, 2014, CIRCULATION, V129, P673, DOI 10.1161/CIRCULATIONAHA.113.003026
   Michelena HI, 2008, CIRCULATION, V117, P2776, DOI 10.1161/CIRCULATIONAHA.107.740878
   Michelena HI, 2014, CIRCULATION, V129, P2691, DOI 10.1161/CIRCULATIONAHA.113.007851
   Michelena HI, 2011, JAMA-J AM MED ASSOC, V306, P1104, DOI 10.1001/jama.2011.1286
   Otto CM, 2014, NEW ENGL J MED, V371, P744, DOI 10.1056/NEJMra1313875
   Prakash SK, 2014, J AM COLL CARDIOL, V64, P832, DOI 10.1016/j.jacc.2014.04.073
   Roberts WC, 2005, CIRCULATION, V111, P920, DOI 10.1161/01.CIR.0000155623.48408.C5
   ROBERTS WC, 1970, AM J CARDIOL, V26, P72, DOI 10.1016/0002-9149(70)90761-7
   Roger VL, 2011, CIRCULATION, V123, pE18, DOI 10.1161/CIR.0b013e3182009701
   Sabet HY, 1999, MAYO CLIN PROC, V74, P14, DOI 10.4065/74.1.14
   Schaefer BM, 2008, HEART, V94, P1634, DOI 10.1136/hrt.2007.132092
   Sievers HH, 2007, J THORAC CARDIOV SUR, V133, P1226, DOI 10.1016/j.jtcvs.2007.01.039
   Tribouilloy C, 2010, HEART, V96, P1723, DOI 10.1136/hrt.2009.189050
   Tzemos N, 2008, JAMA-J AM MED ASSOC, V300, P1317, DOI 10.1001/jama.300.11.1317
   Verma S, 2014, NEW ENGL J MED, V370, P1920, DOI 10.1056/NEJMra1207059
NR 29
TC 2
Z9 2
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JAN
PY 2018
VL 48
IS 1
BP 48
EP 58
DI 10.4070/kcj.2017.0124
PG 11
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA FX1WE
UT WOS:000425842000005
PM 29171200
OA Green Published
DA 2021-04-22
ER

PT J
AU Kim, MK
   Song, MS
   Kim, GB
AF Kim, Min Kyu
   Song, Min Seob
   Kim, Gi Beom
TI Factors Predicting Resistance to Intravenous Immunoglobulin Treatment
   and Coronary Artery Lesion in Patients with Kawasaki Disease: Analysis
   of the Korean Nationwide Multicenter Survey from 2012 to 2014
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Mucocutaneous lymph node syndrome; Intravenous immunoglobulins; Coronary
   artery disease; Natriuretic peptide; Brain; Neutrophils
ID BRAIN NATRIURETIC PEPTIDE; GAMMA-GLOBULIN TREATMENT; NT-PROBNP;
   TREATMENT FAILURE; RISK-FACTORS; CHILDREN; LYMPHOCYTE; RETREATMENT
AB Background and Objectives: Approximately 10-15% of children with Kawasaki disease (KD)do not respond to initial intravenous immunoglobulin (IVIG) and have higher risk for coronary artery lesion (CAL). The aim of this study was to identify predictive factors from laboratory findings in patients who do not respond to IVIG treatment and develop CAL from KD.& para;& para;Methods: We retrospectively collected nationwide multicenter data from the Korean Society of Kawasaki Disease and included 5,151 patients with KD between 2012 and 2014 from 38 hospitals.& para;& para;Results: Among 5,151 patients with KD, 524 patients belonged to the IVIG-resistant group. The patients in the IVIG-resistant group had a significantly higher serum N-terminal pro-brain natriuretic peptide (NT-proBNP) level (1,573.91 +/- 3,166.46 vs. 940.62 +/- 2,326.10 pg/mL; p<0.001) and a higher percentage of polymorphonuclear neutrophils (PMNs) (70.89 +/- 15.75% vs. 62.38 +/- 32.94%; p<0.001). Multivariate logistic regression analyses revealed that significantly increased PMN, NT-proBNP, C-reactive protein (CRP), aspartate aminotransferase (AST), and alanine aminotransferase (ALT) were the predictors of IVIG resistance (p<0.05). Multivariate logistic regression analyses also showed that only CRP was associated with the risk of CAL (p<0.01), while PMN, NT-proBNP, AST, and ALT were not.& para;& para;Conclusions: Elevated PMN, serum NT-proBNP, CRP, AST, and ALT levels are significantly associated with IVIG resistance in patients with KD. Moreover, serum CRP is significantly increased in patients with KD with CAL.
C1 [Kim, Min Kyu] Good Moonwha Hosp, Dept Pediat, Busan, South Korea.
   [Song, Min Seob] Inje Univ Haeundae Paik Hosp, Dept Pediat, 875 Haeun Daero, Busan 48108, South Korea.
   [Kim, Gi Beom] Seoul Natl Univ, Childrens Hosp, Dept Pediat, Seoul, South Korea.
RP Song, MS (corresponding author), Inje Univ Haeundae Paik Hosp, Dept Pediat, 875 Haeun Daero, Busan 48108, South Korea.
EM msped@hanmail.net
RI Song, Min Seob/R-3075-2019; Kim, Gi Beom/AAK-3377-2021
OI Kim, Gi Beom/0000-0002-7880-280X; Song, Min Seob/0000-0003-3426-6803
CR Ayusawa M, 2005, PEDIATR INT, V47, P232, DOI 10.1111/j.1442-200x.2005.02033.x
   Baek Jin-Young, 2016, Korean J Pediatr, V59, P80, DOI 10.3345/kjp.2016.59.2.80
   Burns JC, 1998, PEDIATR INFECT DIS J, V17, P1144, DOI 10.1097/00006454-199812000-00009
   Cho KH, 2014, KOREAN CIRC J, V44, P328, DOI 10.4070/kcj.2014.44.5.328
   Dahdah N, 2009, PEDIATR CARDIOL, V30, P810, DOI 10.1007/s00246-009-9441-2
   Durongpisitkul K, 2003, PEDIATR CARDIOL, V24, P145, DOI 10.1007/s00246-002-0216-2
   FURUSHO K, 1984, LANCET, V2, P1055
   Giannouli G, 2013, PEDIATR CARDIOL, V34, P1476, DOI 10.1007/s00246-013-0673-9
   Ha KS, 2015, AM J CARDIOL, V116, P301, DOI 10.1016/j.amjcard.2015.04.021
   Kawamura Y, 2016, J PEDIATR-US, V178, P281, DOI 10.1016/j.jpeds.2016.07.035
   Kawasaki T, 1967, Arerugi, V16, P178
   Kim BY, 2016, KOREAN CIRC J, V46, P542, DOI 10.4070/kcj.2016.46.4.542
   Kim SY, 2013, PEDIATR CARDIOL, V34, P1837, DOI 10.1007/s00246-013-0724-2
   Leliefeld PHC, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1250-4
   Ma KK, 2004, J MOL CELL CARDIOL, V36, P505, DOI 10.1016/j.yjmcc.2004.01.001
   Nasser N, 2005, J PEDIATR-US, V147, P248, DOI 10.1016/j.jpeds.2005.03.051
   Newburger JW, 2004, CIRCULATION, V110, P2747, DOI 10.1161/01.CIR.0000145143.19711.78
   NEWBURGER JW, 1991, NEW ENGL J MED, V324, P1633, DOI 10.1056/NEJM199106063242305
   NEWBURGER JW, 1986, NEW ENGL J MED, V315, P341, DOI 10.1056/NEJM198608073150601
   Nir A, 2005, J CARD FAIL, V11, pS76, DOI 10.1016/j.cardfail.2005.04.009
   Research Committee on Kawasaki Disease (JP), 1984, REP SUBC STAND DIAGN
   Rusconi PG, 2010, AM HEART J, V160, P776, DOI 10.1016/j.ahj.2010.07.012
   Sato YZ, 2013, INT J CARDIOL, V164, P58, DOI 10.1016/j.ijcard.2011.06.065
   Shiraishi M, 2013, CIRC J, V77, P2097, DOI 10.1253/circj.CJ-12-1281
   TAKESHITA S, 1990, Acta Paediatrica Japonica, V32, P508
   Uehara R, 2008, PEDIATR INFECT DIS J, V27, P155, DOI 10.1097/INF.0b013e31815922b5
   Wallace CA, 2000, PEDIATRICS, V105, part. no., DOI 10.1542/peds.105.6.e78
   Yoshimura K, 2013, J PEDIATR-US, V162, P1205, DOI 10.1016/j.jpeds.2012.11.026
NR 28
TC 21
Z9 23
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JAN
PY 2018
VL 48
IS 1
BP 71
EP 79
DI 10.4070/kcj.2017.0136
PG 9
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA FX1WE
UT WOS:000425842000007
PM 29171205
OA Green Published
DA 2021-04-22
ER

PT J
AU Yonetsu, T
   Jang, IK
AF Yonetsu, Taishi
   Jang, Ik-Kyung
TI Advances in Intravascular Imaging: New Insights into the Vulnerable
   Plaque from Imaging Studies
SO KOREAN CIRCULATION JOURNAL
LA English
DT Review
DE Acute coronary syndrome; Atherosclerotic plaque; Interventional
   ultrasonography; Optical coherence tomography
ID OPTICAL COHERENCE TOMOGRAPHY; CORONARY-ARTERY-DISEASE; ACUTE
   MYOCARDIAL-INFARCTION; THIN-CAP FIBROATHEROMA; RISK-ASSESSMENT
   STRATEGIES; IN-VIVO; ATHEROSCLEROTIC PLAQUES; CALCIFIED NODULE; TISSUE
   CHARACTERIZATION; ULTRASOUND
AB The term "vulnerable plaque" denotes the plaque characteristics that are susceptible to coronary thrombosis. Previous post-mortem studies proposed 3 major mechanisms of coronary thrombosis: plaque rupture, plaque erosion, and calcified nodules. Of those, characteristics of rupture-prone plaque have been extensively studied. Pathology studies have identified the features of rupture-prone plaque including thin fibrous cap, large necrotic core, expansive vessel remodeling, inflammation, and neovascularization. Intravascular imaging modalities have emerged as adjunctive tools of angiography to identify vulnerable plaques. Multiple devices have been introduced to catheterization laboratories to date, including intravascular ultrasound (IVUS), virtual-histology IVUS, optical coherence tomography (OCT), coronary angioscopy, and near-infrared spectroscopy. With the use of these modalities, our understanding of vulnerable plaque has rapidly grown over the past several decades. One of the goals of intravascular imaging is to better predict and prevent future coronary events, for which prospective observational data is still lacking. OCT delineates microstructures of plaques, whereas IVUS visualizes macroscopic vascular structures. Specifically, plaque erosion, which has been underestimated in clinical practice, is gaining an interest due to the potential of OCT to make an in vivo diagnosis. Another potential future avenue for intravascular imaging is its use to guide treatment. Feasibility of tailored therapy for acute coronary syndromes (ACS) guided by OCT is under investigation. If it is proven to be effective, it may potentially lead to major shift in the management of millions of patients with ACS every year.
C1 [Yonetsu, Taishi] Tsuchiura Kyodo Gen Hosp, Dept Cardiovasc Med, Tsuchiura, Ibaraki, Japan.
   [Jang, Ik-Kyung] Harvard Med Sch, Massachusetts Gen Hosp, Cardiol Div, GRB 800,55 Fruit St, Boston, MA 02114 USA.
   [Jang, Ik-Kyung] Kyung Hee Univ Hosp, Div Cardiol, Seoul, South Korea.
RP Jang, IK (corresponding author), Harvard Med Sch, Massachusetts Gen Hosp, Cardiol Div, GRB 800,55 Fruit St, Boston, MA 02114 USA.
EM ijang@mgh.harvard.edu
OI Yonetsu, Taishi/0000-0002-1798-5008
FU St. Jude Medical / Abbott Vascular
FX Dr. Jang received research grant and lecturer's honoraria from St. Jude
   Medical / Abbott Vascular.
CR Arbustini E, 1999, HEART, V82, P269, DOI 10.1136/hrt.82.3.269
   Brown AJ, 2015, CIRC-CARDIOVASC IMAG, V8, DOI 10.1161/CIRCIMAGING.115.003487
   Burke AP, 1997, NEW ENGL J MED, V336, P1276, DOI 10.1056/NEJM199705013361802
   Burke AP, 2001, CIRCULATION, V103, P934
   DAVIES MJ, 1990, CIRCULATION, V82, P38
   DAVIES MJ, 1993, BRIT HEART J, V69, P377
   DAVIES MJ, 1985, BRIT HEART J, V53, P363
   FALK E, 1983, BRIT HEART J, V50, P127
   FRIEDMAN M, 1966, BRIT J EXP PATHOL, V47, P550
   Garcia-Garcia HM, 2011, INT J CARDIOVAS IMAG, V27, P215, DOI 10.1007/s10554-010-9789-7
   Garcia-Garcia HM, 2009, EUROINTERVENTION, V5, P177, DOI 10.4244/EIJV5I2A29
   Gossl M, 2010, JACC-CARDIOVASC IMAG, V3, P32, DOI 10.1016/j.jcmg.2009.10.009
   Higuma T, 2015, JACC-CARDIOVASC INTE, V8, P1166, DOI 10.1016/j.jcin.2015.02.026
   Hu SN, 2014, J AM COLL CARDIOL, V63, P1336, DOI 10.1016/j.jacc.2013.11.025
   Jaffer FA, 2011, J AM COLL CARDIOL, V57, P2516, DOI 10.1016/j.jacc.2011.02.036
   Jang IK, 2005, CIRCULATION, V111, P1551, DOI 10.1161/01.CIR.0000159354.43778.69
   Jang IK, 2002, J AM COLL CARDIOL, V39, P604, DOI 10.1016/S0735-1097(01)01799-5
   Jia HB, 2017, EUR HEART J, V38, P792, DOI 10.1093/eurheartj/ehw381
   Jia HB, 2013, J AM COLL CARDIOL, V62, P1748, DOI 10.1016/j.jacc.2013.05.071
   Kato K, 2012, CIRC-CARDIOVASC IMAG, V5, P433, DOI 10.1161/CIRCIMAGING.112.973701
   Kini AS, 2017, J AM COLL CARDIOL, V69, P644, DOI 10.1016/j.jacc.2016.10.028
   Kitabata H, 2010, AM J CARDIOL, V105, P1673, DOI 10.1016/j.amjcard.2010.01.346
   Kolodgie FD, 2001, CURR OPIN CARDIOL, V16, P285, DOI 10.1097/00001573-200109000-00006
   Kubo T, 2007, J AM COLL CARDIOL, V50, P933, DOI 10.1016/j.jacc.2007.04.082
   KUMAMOTO M, 1995, HUM PATHOL, V26, P450, DOI 10.1016/0046-8177(95)90148-5
   Kume T, 2006, AM J CARDIOL, V97, P1172, DOI 10.1016/j.amjcard.2005.11.035
   Kume T, 2006, AM J CARDIOL, V97, P1713, DOI 10.1016/j.amjcard.2006.01.031
   Kume T, 2016, J INVASIVE CARDIOL, V28, P17
   Kume T, 2006, AM HEART J, V152, DOI 10.1016/j.ahj.2006.06.030
   Lee JB, 2011, AM J CARDIOL, V108, P1547, DOI 10.1016/j.amjcard.2011.07.014
   Lee T, 2017, JACC-CARDIOVASC IMAG, V10, P883, DOI 10.1016/j.jcmg.2017.05.013
   Li BH, 2013, CATHETER CARDIO INTE, V81, P494, DOI 10.1002/ccd.24295
   Libby P, 2005, CIRCULATION, V111, P3481, DOI 10.1161/CIRCULATIONAHA.105.537878
   MacNeill BD, 2004, J AM COLL CARDIOL, V44, P972, DOI 10.1016/j.jacc.2004.05.066
   Maehara A, 2012, JACC-CARDIOVASC IMAG, V5, pS1, DOI 10.1016/j.jcmg.2011.11.019
   Mintz GS, 2001, J AM COLL CARDIOL, V37, P1478, DOI 10.1016/S0735-1097(01)01175-5
   MIZUNO K, 1992, NEW ENGL J MED, V326, P287, DOI 10.1056/NEJM199201303260502
   MIZUNO K, 1991, LANCET, V337, P809, DOI 10.1016/0140-6736(91)92514-3
   Moreno PR, 2004, CIRCULATION, V110, P2032, DOI 10.1161/01.CIR.0000143233.87854.23
   MULLER JE, 1994, J AM COLL CARDIOL, V23, P809, DOI 10.1016/0735-1097(94)90772-2
   Naghavi M, 2003, CIRCULATION, V108, P1772, DOI 10.1161/01.CIR.0000087481.55887.C9
   Naghavi M, 2003, CIRCULATION, V108, P1664, DOI 10.1161/01.CIR.0000087480.94275.97
   NATHAN CF, 1980, NEW ENGL J MED, V303, P622, DOI 10.1056/NEJM198009113031106
   Nicholls SJ, 2016, JAMA-J AM MED ASSOC, V316, P2373, DOI 10.1001/jama.2016.16951
   Nissen SE, 2006, JAMA-J AM MED ASSOC, V295, P1556, DOI 10.1001/jama.295.13.jpc60002
   Okubo M, 2008, CIRC J, V72, P1631, DOI 10.1253/circj.CJ-07-0936
   Phipps JE, 2016, CIRC-CARDIOVASC INTE, V9, DOI 10.1161/CIRCINTERVENTIONS.115.003163
   Prati F, 2012, EUR HEART J, V33, P2513, DOI 10.1093/eurheartj/ehs095
   Qian D, 2012, J CARDIOVASC MAGN R, V14, DOI 10.1186/1532-429X-14-20
   Rioufol G, 2002, CIRCULATION, V106, P804, DOI 10.1161/01.CIR.0000025609.13806.31
   Sathyanarayana S, 2009, EUROINTERVENTION, V5, P133, DOI 10.4244/EIJV5I1A21
   Stone GW, 2011, NEW ENGL J MED, V364, P226, DOI 10.1056/NEJMoa1002358
   Takano M, 2008, AM J CARDIOL, V101, P471, DOI 10.1016/j.amjcard.2007.09.106
   Takayama T, 2009, CIRC J, V73, P2110, DOI 10.1253/circj.CJ-09-0358
   Taruya A, 2015, J AM COLL CARDIOL, V65, P2469, DOI 10.1016/j.jacc.2015.04.020
   Tearney GJ, 2003, CIRCULATION, V107, P113, DOI 10.1161/01.CIR.0000044384.41037.43
   Tearney GJ, 2012, J AM COLL CARDIOL, V59, P1058, DOI 10.1016/j.jacc.2011.09.079
   Tian JW, 2014, J AM COLL CARDIOL, V63, P2209, DOI 10.1016/j.jacc.2014.01.061
   Uemura S, 2012, EUR HEART J, V33, P78, DOI 10.1093/eurheartj/ehr284
   VANDERWAL AC, 1994, CIRCULATION, V89, P36, DOI 10.1161/01.CIR.89.1.36
   Vergallo R, 2014, CIRC-CARDIOVASC IMAG, V7, P905, DOI 10.1161/CIRCIMAGING.114.001932
   Virmani R, 2006, J AM COLL CARDIOL, V47, pC13, DOI 10.1016/j.jacc.2005.10.065
   Virmani R, 2000, ARTERIOSCL THROM VAS, V20, P1262, DOI 10.1161/01.ATV.20.5.1262
   WILLERSON JT, 1984, AM J CARDIOL, V54, P1349, DOI 10.1016/S0002-9149(84)80095-8
   Xing L, 2017, J AM COLL CARDIOL, V69, P2502, DOI 10.1016/j.jacc.2017.03.556
   Xu YJ, 2012, CIRCULATION, V126, P537, DOI 10.1161/CIRCULATIONAHA.111.055004
   Yabushita H, 2002, CIRCULATION, V106, P1640, DOI 10.1161/01.CIR.0000029927.92825.F6
   Yonetsu T, 2011, EUR HEART J, V32, P1251, DOI 10.1093/eurheartj/ehq518
NR 68
TC 11
Z9 14
U1 1
U2 7
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JAN
PY 2018
VL 48
IS 1
BP 1
EP 15
DI 10.4070/kcj.2017.0182
PG 15
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA FX1WE
UT WOS:000425842000001
PM 29171202
OA Green Published
DA 2021-04-22
ER

PT J
AU Lim, HS
   Seo, KW
   Yoon, MH
   Yang, HM
   Tahk, SJ
AF Lim, Hong-Seok
   Seo, Kyoung-Woo
   Yoon, Myeong-Ho
   Yang, Hyoung-Mo
   Tahk, Seung-Jea
TI Ischemia-based Coronary Revascularization: Beyond Anatomy and Fractional
   Flow Reserve
SO KOREAN CIRCULATION JOURNAL
LA English
DT Review
DE Coronary artery disease; Coronary angiography; Intravascular
   ultrasonography; Fractional flow reserve
ID CARDIOVASCULAR-DISEASE ENTERPRISES; INTRAVASCULAR ULTRASOUND CRITERIA;
   ANTERIOR DESCENDING ARTERY; MYOCARDIAL-INFARCTION; HEART-DISEASE;
   INTERNATIONAL MULTICENTER; FUNCTIONAL-SIGNIFICANCE; INTERMEDIATE
   STENOSIS; COMPUTED-TOMOGRAPHY; MAJOR SHAREHOLDERS
AB Treatment strategies for patients with coronary artery disease (CAD) should be based on objective evidence of inducible ischemia in the subtended myocardium to improve clinical outcomes, symptoms, and cost-effectiveness. Fractional flow reserve (FFR) is the most verified index to-date for invasively evaluating lesion-specific myocardial ischemia. Favorable results from large clinical trials that applied FFR-guided percutaneous coronary intervention (PCI) prompted changes in coronary revascularization guidelines to emphasize the importance of this ischemia-based strategy using invasive coronary physiology. However, the frequency of functional evaluations is lacking in daily practice, and visual assessment still dominates treatment decisions in CAD patients. Despite recent efforts to integrate functional and anatomical assessments for coronary stenosis, there is considerable discordance between the 2 modalities, and the diagnostic accuracy of simple parameters obtained from current imaging tools is not satisfactory to determine functional significance. Although evidence that supports or justifies anatomy-guided PCI is more limited, and FFR-guided PCI is currently recommended, it is important to be aware of conditions and factors that influence FFR for accurate interpretation and application. In this article, we review the limitations of the current anatomy-derived evaluation of the functional significance of coronary stenosis, detail considerations for the clinical utility of FFR, and discuss the importance of an integrated physiologic approach to determine treatment strategies for CAD patients.
C1 [Lim, Hong-Seok; Seo, Kyoung-Woo; Yoon, Myeong-Ho; Yang, Hyoung-Mo; Tahk, Seung-Jea] Ajou Univ, Sch Med, Dept Cardiol, 164 World Cup Ro, Suwon 16499, South Korea.
RP Tahk, SJ (corresponding author), Ajou Univ, Sch Med, Dept Cardiol, 164 World Cup Ro, Suwon 16499, South Korea.
EM sjtahk@ajou.ac.kr
OI Lim, Hong-Seok/0000-0002-3127-2071; Yang, Hyoung-Mo/0000-0003-3602-9772
CR Ahn JM, 2011, JACC-CARDIOVASC INTE, V4, P665, DOI 10.1016/j.jcin.2011.02.013
   Biasco L, 2015, AM J CARDIOL, V115, P1475, DOI 10.1016/j.amjcard.2015.02.047
   Cho HO, 2014, KOREAN CIRC J, V44, P394, DOI 10.4070/kcj.2014.44.6.394
   D'Ascenzo F, 2015, AM HEART J, V169, P663, DOI 10.1016/j.ahj.2015.01.013
   De Bruyne B, 2012, NEW ENGL J MED, V367, P991, DOI 10.1056/NEJMoa1205361
   Echavarria-Pinto M, 2014, CURR OPIN CARDIOL, V29, P564, DOI 10.1097/HCO.0000000000000110
   Fearon WF, 2014, CIRCULATION, V129, P1860, DOI 10.1161/CIRCULATIONAHA.113.004300
   Fearon WF, 2013, CIRCULATION, V128, P2551, DOI 10.1161/CIRCULATIONAHA.113.006095
   Fearon WF, 2010, CIRCULATION, V122, P2545, DOI 10.1161/CIRCULATIONAHA.109.925396
   Fischer JJ, 2002, AM J CARDIOL, V90, P210, DOI 10.1016/S0002-9149(02)02456-6
   Gonzalo N, 2012, J AM COLL CARDIOL, V59, P1080, DOI 10.1016/j.jacc.2011.09.078
   Ha J, 2016, CIRC-CARDIOVASC INTE, V9, DOI 10.1161/CIRCINTERVENTIONS.116.003613
   Hachamovitch R, 1998, CIRCULATION, V97, P535
   Han JK, 2014, CARDIOLOGY, V127, P256, DOI 10.1159/000356480
   Jang JS, 2017, KOREAN CIRC J, V47, P328, DOI 10.4070/kcj.2017.0071
   Jang JS, 2016, KOREAN CIRC J, V46, P622, DOI 10.4070/kcj.2016.46.5.622
   Jin XJ, 2015, INT J CARDIOL, V185, P56, DOI 10.1016/j.ijcard.2015.03.048
   Kang SJ, 2011, CIRC-CARDIOVASC INTE, V4, P65, DOI 10.1161/CIRCINTERVENTIONS.110.959148
   Kim HY, 2016, JACC-CARDIOVASC INTE, V9, P1548, DOI 10.1016/j.jcin.2016.04.008
   Kim YH, 2013, CIRC J, V77, P1967, DOI 10.1253/circj.CJ-13-0376
   Kolh P, 2010, EUR J CARDIO-THORAC, V38, pS1, DOI 10.1016/j.ejcts.2010.08.019
   Koo BK, 2011, JACC-CARDIOVASC INTE, V4, P803, DOI 10.1016/j.jcin.2011.03.013
   Krams R, 1998, CIRCULATION, V97, P230, DOI 10.1161/01.CIR.97.3.230
   Lakatta EG, 2003, CIRCULATION, V107, P139, DOI 10.1161/01.CIR.0000048892.83521.58
   Lee JM, 2016, J AM COLL CARDIOL, V67, P1158, DOI 10.1016/j.jacc.2015.12.053
   Montalescot G, 2013, EUR HEART J, V34, P2949, DOI 10.1093/eurheartj/eht296
   NAHSER PJ, 1995, CIRCULATION, V91, P635, DOI 10.1161/01.CIR.91.3.635
   Nallamothu BK, 2014, J AM COLL CARDIOL, V63, P722, DOI 10.1016/j.jacc.2013.12.003
   Park JB, 2016, HEART, V102, P1655, DOI 10.1136/heartjnl-2016-309299
   Patel Manesh R, 2012, J Am Coll Cardiol, V59, P857, DOI 10.1016/j.jacc.2011.12.001
   Pijls NH, 2000, CORONARY PRESSURE
   PIJLS NHJ, 1993, CIRCULATION, V87, P1354, DOI 10.1161/01.CIR.87.4.1354
   Pijls NHJ, 2007, J AM COLL CARDIOL, V49, P2105, DOI 10.1016/j.jacc.2007.01.087
   Pijls NHJ, 2010, J AM COLL CARDIOL, V56, P177, DOI 10.1016/j.jacc.2010.04.012
   Ragosta M, 2001, AM HEART J, V141, P456, DOI 10.1067/mhj.2001.113074
   Seo KW, 2017, EUROINTERVENTION, V13, pE185, DOI 10.4244/EIJ-D-16-00400
   Shaw LJ, 2008, CIRCULATION, V117, P1283, DOI 10.1161/CIRCULATIONAHA.107.743963
   Spaan JAE, 2006, CIRCULATION, V113, P446, DOI 10.1161/CIRCULATIONAHA.105.587196
   Taylor CA, 2013, J AM COLL CARDIOL, V61, P2233, DOI 10.1016/j.jacc.2012.11.083
   Tonino PAL, 2009, NEW ENGL J MED, V360, P213, DOI 10.1056/NEJMoa0807611
   TOPOL EJ, 1995, CIRCULATION, V92, P2333, DOI 10.1161/01.CIR.92.8.2333
   Toth GG, 2014, CIRC-CARDIOVASC INTE, V7, P751, DOI 10.1161/CIRCINTERVENTIONS.114.001608
   Tu SX, 2016, JACC-CARDIOVASC INTE, V9, P2024, DOI 10.1016/j.jcin.2016.07.013
   UREN NG, 1994, NEW ENGL J MED, V331, P222, DOI 10.1056/NEJM199407283310402
   Yang HM, 2014, CATHETER CARDIO INTE, V83, P386, DOI 10.1002/ccd.25088
   Yoon MH, 2017, CATHETER CARDIOVASC
NR 46
TC 2
Z9 2
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JAN
PY 2018
VL 48
IS 1
BP 16
EP 23
DI 10.4070/kcj.2017.0177
PG 8
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA FX1WE
UT WOS:000425842000002
PM 29171198
OA Green Published
DA 2021-04-22
ER

PT J
AU Kimm, H
   Mok, Y
   Lee, SJ
   Lee, S
   Back, JH
   Jee, SH
AF Kimm, Heejin
   Mok, Yejin
   Lee, Sun Ju
   Lee, Sunmi
   Back, Joung Hwan
   Jee, Sun Ha
TI The J-curve between Diastolic Blood Pressure and Risk of All-cause and
   Cardiovascular Death
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Blood pressure; Diastolic blood pressure; Hypertension; Mortality;
   Myocardial ischemia
ID ISOLATED SYSTOLIC HYPERTENSION; ACUTE MYOCARDIAL-INFARCTION; VASCULAR
   MORTALITY; DISEASE; ADULTS; EVENTS; STROKE; TRENDS; KOREA; AGE
AB Background and objectives: The J-curve phenomenon between diastolic blood pressure (DBP) and mortality has been reported repeatedly in treated patients. However, the baseline risk of low DBP has not been fully explored. This study was to examine the relationship between DBP and risk of mortality from all-cause, atherosclerotic vascular diseases (ASCVD), and ischemic heart disease (IHD) using a prospective cohort of general population.& para;& para;Methods: We analyzed 1,234,435 participants of the Korean Cancer Prevention Study cohort (789,255 men, 30-95 years of age) who had a medical evaluation from 1992 to 1995 using Cox proportional hazards models.& para;& para;Results: A total of 22.5 million person-years were followed up (mean age 46.6 years, deaths 193,903 cases). The hazard ratios of mortality from all-cause and ASCVD, among those with DBP <60 mmHg compared to 70-79 mmHg were 1.23 (95% confidence interval [CI], 1.16-1.30) and 1.37 (95% CI, 1.20-1.57), respectively, after adjustment for multivariable including systolic blood pressure. Increased risks of all-cause death in the lowest DBP category group were maintained in men or women, 30-59 or >= 60 years of age, smoker or non-smoker and diabetes mellitus (DM) or non-DM subgroups. The risk in DBP 60-69 mmHg groups increased in several subgroups. However, the risk for ASCVD death in 30-59 years and DM group, and risk for IHD death in most subgroups except for elderly (>= 60 years) decreased.& para;& para;Conclusion: A J-curve relationship between low DBP and all-cause death was found consistently. The baseline risk in the general population may be considered for risk assessment, particularly in case of interventions that lower DBP below 60 mmHg.
C1 [Kimm, Heejin; Mok, Yejin; Lee, Sun Ju; Jee, Sun Ha] Yonsei Univ, Grad Sch Publ Hlth, Inst Hlth Promot, Dept Epidemiol & Hlth Promot, 50-1 Yonsei Ro, Seoul 03722, South Korea.
   [Mok, Yejin; Jee, Sun Ha] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA.
   [Lee, Sunmi; Back, Joung Hwan] Natl Hlth Insurance Serv, Hlth Insurance Policy Res Inst, Wonju, South Korea.
RP Jee, SH (corresponding author), Yonsei Univ, Grad Sch Publ Hlth, Inst Hlth Promot, Dept Epidemiol & Hlth Promot, 50-1 Yonsei Ro, Seoul 03722, South Korea.
EM jsunha@yuhs.ac
OI Jee, Sun Ha/0000-0001-9519-3068; Kimm, Heejin/0000-0003-4526-0570; Mok,
   Yejin/0000-0002-8511-604X
FU Korean Society of Cardiology [201203-10]
FX This study was supported by a grant from the Korean Society of
   Cardiology (201203-10).
CR Egan BM, 2017, J CLIN HYPERTENS, V19, P241, DOI 10.1111/jch.12904
   FARNETT L, 1991, JAMA-J AM MED ASSOC, V265, P489, DOI 10.1001/jama.265.4.489
   Franklin SS, 2015, HYPERTENSION, V65, P299, DOI 10.1161/HYPERTENSIONAHA.114.04581
   Franklin SS, 2009, CIRCULATION, V119, P243, DOI 10.1161/CIRCULATIONAHA.108.797936
   HESSEL PA, 1986, INT J EPIDEMIOL, V15, P122, DOI 10.1093/ije/15.1.122
   James PA, 2014, JAMA-J AM MED ASSOC, V311, P1809, DOI 10.1001/jama.2013.284427
   Jee SH, 2004, JNCI-J NATL CANCER I, V96, P1851, DOI 10.1093/jnci/djh334
   Jee SH, 2011, EUR HEART J, V32, P2773, DOI 10.1093/eurheartj/ehr229
   Kikuya M, 2005, HYPERTENSION, V45, P240, DOI 10.1161/01.HYP.0000152079.04553.2c
   Kim RB, 2013, J KOREAN MED SCI, V28, P16, DOI 10.3346/jkms.2013.28.1.16
   Lawes CMM, 2003, J HYPERTENS, V21, P707, DOI 10.1097/01.hjh.0000052492.18130.07
   Lee AK, 2016, J AM COLL CARDIOL, V68, P1370, DOI 10.1016/j.jacc.2016.06.049
   Lee J, 2017, INT J EPIDEMIOL, V46, DOI 10.1093/ije/dyv319
   Lewington S, 2002, LANCET, V360, P1903
   Liu XF, 2015, J AM SOC HYPERTENS, V9, P197, DOI 10.1016/j.jash.2015.01.002
   Mancia G, 2014, HYPERTENSION, V63, P29, DOI [10.1161/HYPERTENSIONAHA.113.01922, 10.1161/01.hyp.0000441190.09494.e9]
   Messerli FH, 2006, ANN INTERN MED, V144, P884, DOI 10.7326/0003-4819-144-12-200606200-00005
   National Health Insurance service (KR), 2015, NAT HLTH INS SYST KO
   Ogihara T, 2010, HYPERTENSION, V56, P196, DOI 10.1161/HYPERTENSIONAHA.109.146035
   Park H, 2017, KOREAN CIRC J, V47, P446, DOI 10.4070/kcj.2017.0008
   Solini A, 2016, DIABETES CARE, V39, pS234, DOI 10.2337/dcS15-3027
   Sweeting MJ, 2016, STAT MED
   Vidal-Petiot E, 2016, LANCET, V388, P2142, DOI 10.1016/S0140-6736(16)31326-5
   Vishram JKK, 2012, HYPERTENSION, V60, P1117, DOI 10.1161/HYPERTENSIONAHA.112.201400
   Yi SW, 2016, CIRCULATION, V133, P2381, DOI 10.1161/CIRCULATIONAHA.115.020752
   Yi SW, 2009, STROKE, V40, P3428, DOI 10.1161/STROKEAHA.109.555144
NR 26
TC 10
Z9 11
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JAN
PY 2018
VL 48
IS 1
BP 36
EP 47
DI 10.4070/kcj.2017.0036
PG 12
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA FX1WE
UT WOS:000425842000004
PM 29322696
OA Green Published
DA 2021-04-22
ER

PT J
AU Rencuzogullari, I
   Cagdas, M
   Karakoyun, S
   Karabag, Y
   Yesin, M
   Gursoy, MO
   Artac, I
   Ilis, D
   Efe, SC
   Tural, K
   Tanboga, IH
AF Rencuzogullari, Ibrahim
   Cagdas, Metin
   Karakoyun, Suleyman
   Karabag, Yavuz
   Yesin, Mahmut
   Gursoy, Mustafa Ozan
   Artac, Inanc
   Ilis, Dogan
   Efe, Suleyman Cagan
   Tural, Kevser
   Tanboga, Ibrahim Halil
TI Association of Syntax Score II with Contrast-induced Nephropathy and
   Hemodialysis Requirement in Patients with ST Segment Elevation
   Myocardial Infarction Undergoing Primary Percutaneous Coronary
   Intervention
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Syntax score II; ST segment elevation myocardial infarction; Contrast
   induced nephropathy
ID CHRONIC KIDNEY-DISEASE; ACUTE-RENAL-FAILURE; RISK SCORE; ARTERY;
   PREDICTION
AB Background and Objectives: Contrast-induced nephropathy (CIN) is a common complication of primary percutaneous coronary intervention (pPCI) and is associated with high mortality and morbidity and long hospital stay in patients with ST elevation myocardial infarction (STEMI). The Syntax Score (SS) has previously been studied in STEMI patients, and it was associated with increased CIN development and long-term mortality. This study investigates a possible relationship between CIN development and Syntax Score II (SSII) and compares SS and SSII by assessing CIN risk in STEMI patients treated with pPCI.
   Methods: A total of 1,234 patients who underwent pPCI were divided into 2 groups according to CIN development. Patients with CIN were further divided into 2 groups according to whether or not they required hemodialysis. Reclassification tables, net reclassification improvement, and integrated discriminative improvement methods were used to assess the additive predictive value of SSII for predicting CIN.
   Results: In the present study, 166 patients (13.5%) had CIN. Although both SS and SSII were significantly higher in CIN patients, only SSII was an independent predictor of CIN (odds ratio (OR], 1.031; 95% confidence interval [CI), 1.012-1.051; p<0.001) and hemodialysis requirement (OR, 1.078; 95% CI, 1.046-1.078; p<0.001). When comparing SSII and SS in their ability to determine CIN risk, we found SSII to have a reclassification improvement of 27.59%(p<0.001) and an integrated discrimination improvement of 9.1%(p<0.001).
   Conclusions: The combination of clinical and anatomic variables can more accurately identify patients who are at high risk for CIN after pPCI. While SSII is harder to calculate than SS, it provides better prediction for CIN and hemodialysis requirement than SS.
C1 [Rencuzogullari, Ibrahim; Cagdas, Metin; Karakoyun, Suleyman; Karabag, Yavuz; Artac, Inanc; Ilis, Dogan] Kafkas Univ, Med Fac, Dept Cardiol, TR-36000 Kars, Turkey.
   [Yesin, Mahmut] Kars Harakani State Hosp, Dept Cardiol, Kars, Turkey.
   [Gursoy, Mustafa Ozan] Gaziemir State Hosp, Dept Cardiol, Izmir, Turkey.
   [Efe, Suleyman Cagan] Agri State Hosp, Dept Cardiol, Agri, Turkey.
   [Tural, Kevser] Kafkas Univ, Med Fac, Dept Cardiovasc Surg, Kars, Turkey.
   [Tanboga, Ibrahim Halil] Ataturk Univ, Med Fac, Dept Cardiol, Erzurum, Turkey.
RP Rencuzogullari, I (corresponding author), Kafkas Univ, Med Fac, Dept Cardiol, TR-36000 Kars, Turkey.
EM rencuzog@gmail.com
RI Tanboga, Ibrahim H/E-8886-2010
OI efe, suleyman/0000-0002-6067-6841; Cagdas, Metin/0000-0001-6704-9886
CR Aykan AC, 2013, HEART LUNG CIRC, V22, P836, DOI 10.1016/j.hlc.2013.03.085
   Dangas G, 2005, AM J CARDIOL, V95, P13, DOI 10.1016/j.amjcard.2004.08.056
   DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595
   Elbasan Z, 2014, ANGIOLOGY, V65, P37, DOI 10.1177/0003319712463816
   Farooq V, 2013, LANCET, V381, P639, DOI 10.1016/S0140-6736(13)60108-7
   Fu Nai-kuan, 2012, Zhonghua Yi Xue Za Zhi, V92, P551
   Gibson CM, 1996, CIRCULATION, V93, P879, DOI 10.1161/01.CIR.93.5.879
   Gupta R, 2005, CATHETER CARDIO INTE, V64, P442, DOI 10.1002/ccd.20316
   Harjai KJ, 2008, AM J CARDIOL, V101, P812, DOI 10.1016/j.amjcard.2007.10.051
   John S, 2003, CURR HYPERTENS REP, V5, P199, DOI 10.1007/s11906-003-0021-1
   Kim SM, 2017, KOREAN CIRC J, V47, P222, DOI 10.4070/kcj.2016.0312
   Liss P, 2006, KIDNEY INT, V70, P1811, DOI 10.1038/sj.ki.5001887
   Magro M, 2011, AM HEART J, V161, P771, DOI 10.1016/j.ahj.2011.01.004
   McCullough PA, 1997, AM J MED, V103, P368, DOI 10.1016/S0002-9343(97)00150-2
   McCullough PA, 2008, J AM COLL CARDIOL, V51, P1419, DOI 10.1016/j.jacc.2007.12.035
   Mehran R, 2004, J AM COLL CARDIOL, V44, P1393, DOI 10.1016/j.jacc.2004.06.068
   Oduncu V, 2013, INT J CARDIOL, V168, P3480, DOI 10.1016/j.ijcard.2013.04.166
   Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929
   Rihal CS, 2002, CIRCULATION, V105, P2259, DOI 10.1161/01.CIR.0000016043.87291.33
   Sianos Georgios, 2005, EuroIntervention, V1, P219
   Steg PG, 2012, EUR HEART J, V33, P2569, DOI 10.1093/eurheartj/ehs215
   Subramaniam RM, 2016, ANN INTERN MED, V164, P406, DOI 10.7326/M15-1456
   SYNTAX Working Group, SYNTAX SCOR CALC
   Thomsen HS, 2003, AM J ROENTGENOL, V181, P1463, DOI 10.2214/ajr.181.6.1811463
   Tziakas D, 2013, INT J CARDIOL, V163, P46, DOI 10.1016/j.ijcard.2011.05.079
   Vuruskan E, 2017, ANGIOLOGY, V68, P728, DOI 10.1177/0003319716679340
   Wang G, 2016, CORONARY ARTERY DIS, V27, P483, DOI 10.1097/MCA.0000000000000385
   Xhepa E, 2017, CATHETER CARDIO INTE, V89, P1, DOI 10.1002/ccd.26645
   YOUDEN WJ, 1950, CANCER, V3, P32, DOI 10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3
NR 29
TC 5
Z9 5
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JAN
PY 2018
VL 48
IS 1
BP 59
EP 70
DI 10.4070/kcj.2017.0058
PG 12
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA FX1WE
UT WOS:000425842000006
PM 29171203
OA Green Published
DA 2021-04-22
ER

PT J
AU Aydin, S
AF Aydin, Suna
TI Can Pre-analytical Mistake Bearing Irisin Concentrations Be an Indicator
   of Coronary Artery Disease?
SO KOREAN CIRCULATION JOURNAL
LA English
DT Letter
ID EXERCISE; MYOKINE
C1 [Aydin, Suna] Heath Sci Univ, Elazig Educ & Res Hosp, Cardiovasc Surg Dept, Inonu Caddesi Hastane Cd 74, TR-23100 Elazig, Turkey.
RP Aydin, S (corresponding author), Heath Sci Univ, Elazig Educ & Res Hosp, Cardiovasc Surg Dept, Inonu Caddesi Hastane Cd 74, TR-23100 Elazig, Turkey.
EM cerrah52@hotmail.com
OI Aydin, Suna/0000-0002-5857-0888
CR Albrecht E, 2015, SCI REP-UK, V5, DOI 10.1038/srep08889
   Aydin S, 2015, PEPTIDES, V72, P4, DOI 10.1016/j.peptides.2015.04.012
   Aydin S, 2014, PEPTIDES, V52, P68, DOI 10.1016/j.peptides.2013.11.024
   Bostrom P, 2012, NATURE, V481, P463, DOI 10.1038/nature10777
   Efe TH, 2017, KOREAN CIRC J, V47, P44, DOI 10.4070/kcj.2016.0079
   Jedrychowski MP, 2015, CELL METAB, V22, P734, DOI 10.1016/j.cmet.2015.08.001
   Park SE, 2015, CRIT REV CL LAB SCI, V52, P180, DOI 10.3109/10408363.2015.1023429
NR 7
TC 1
Z9 1
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JAN
PY 2018
VL 48
IS 1
BP 94
EP 95
DI 10.4070/kcj.2017.0060
PG 2
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA FX1WE
UT WOS:000425842000014
PM 29322701
OA Green Published
DA 2021-04-22
ER

PT J
AU Shin, J
AF Shin, Jinho
TI J-curve Phenomenon Might Be Inherent: How to Know If It Is Treatment
   Induced?
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
ID BLOOD-PRESSURE
C1 [Shin, Jinho] Hanyang Univ, Coll Med, Dept Internal Med, Div Cardiol, 222-1 Wangsimni Ro, Seoul 04763, South Korea.
RP Shin, J (corresponding author), Hanyang Univ, Coll Med, Dept Internal Med, Div Cardiol, 222-1 Wangsimni Ro, Seoul 04763, South Korea.
EM jhs2003@hanyang.ac.kr
OI Shin, Jinho/0000-0001-6706-6504
CR BELLAMY RF, 1978, CIRC RES, V43, P92, DOI 10.1161/01.RES.43.1.92
   Boutitie F, 2002, ANN INTERN MED, V136, P438, DOI 10.7326/0003-4819-136-6-200203190-00007
   Kalkman DN, 2017, CIRCULATION, V136, P2220, DOI 10.1161/CIRCULATIONAHA.117.030342
   Kimm H, 2018, KOREAN CIRC J, V48, P36, DOI 10.4070/kcj.2017.0036
   Lee AK, 2016, J AM COLL CARDIOL, V68, P1370, DOI 10.1016/j.jacc.2016.06.049
   Wang JG, 2005, HYPERTENSION, V45, P907, DOI 10.1161/01.HYP.0000165020.14745.79
NR 6
TC 0
Z9 0
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JAN
PY 2018
VL 48
IS 1
BP 80
EP 81
DI 10.4070/kcj.2017.0356
PG 2
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA FX1WE
UT WOS:000425842000008
PM 29322697
OA Green Published
DA 2021-04-22
ER

PT J
AU Shim, CY
   Hong, GR
AF Shim, Chi Young
   Hong, Geu-Ru
TI Timing and Indications for Aortic Valve Surgery in Korean Bicuspid
   Aortic Valve Patients
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
ID ASSOCIATION
C1 [Shim, Chi Young; Hong, Geu-Ru] Yonsei Univ, Coll Med, Severance Cardiovasc Hosp, Div Cardiol, 50-1 Yonsei Ro, Seoul 03722, South Korea.
RP Hong, GR (corresponding author), Yonsei Univ, Coll Med, Severance Cardiovasc Hosp, Div Cardiol, 50-1 Yonsei Ro, Seoul 03722, South Korea.
EM grhong@yuhs.ac
RI Shim, Chi Young/AAK-1057-2021
OI Shim, Chi Young/0000-0002-6136-0136; Hong, Geu-Ru/0000-0003-4981-3304
CR Kim M, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00622
   Lee SY, 2017, AM J CARDIOL, V119, P2049, DOI 10.1016/j.amjcard.2017.03.038
   Lee SY, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169285
   Lee SY, 2015, AM J CARDIOL, V116, P1547, DOI 10.1016/j.amjcard.2015.08.017
   Prakash SK, 2014, J AM COLL CARDIOL, V64, P832, DOI 10.1016/j.jacc.2014.04.073
   Shim CY, 2011, J AM SOC ECHOCARDIOG, V24, P847, DOI 10.1016/j.echo.2011.04.017
   Song Jae-Kwan, 2015, J Cardiovasc Ultrasound, V23, P1, DOI 10.4250/jcu.2015.23.1.1
   Sun BJ, 2018, KOREAN CIRC J, V48, P48, DOI 10.4070/kcj.2017.0124
NR 8
TC 0
Z9 0
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JAN
PY 2018
VL 48
IS 1
BP 82
EP 83
DI 10.4070/kcj.2017.0380
PG 2
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA FX1WE
UT WOS:000425842000009
PM 29322698
OA Green Published
DA 2021-04-22
ER

PT J
AU Yun, KH
AF Yun, Kyeong Ho
TI Contrast-induced Acute Kidney Injury and Inflammation
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
C1 [Yun, Kyeong Ho] Wonkwang Univ Hosp, Reg Cardiovasc Ctr, Dept Cardiovasc Med, 895 Muwang Ro, Iksan 54538, South Korea.
RP Yun, KH (corresponding author), Wonkwang Univ Hosp, Reg Cardiovasc Ctr, Dept Cardiovasc Med, 895 Muwang Ro, Iksan 54538, South Korea.
EM dryunkh@gmail.com
OI Yun, Kyeong Ho/0000-0003-4911-8854
CR Liang M, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000007384
   Maioli M, 2012, CIRCULATION, V125, P3099, DOI 10.1161/CIRCULATIONAHA.111.085290
   Ozkok Sercin, 2017, World J Nephrol, V6, P86, DOI 10.5527/wjn.v6.i3.86
   Rencuzogullari I, 2018, KOREAN CIRC J, V48, P59, DOI 10.4070/kcj.2017.0058
   Yun KH, 2014, KOREAN CIRC J, V44, P301, DOI 10.4070/kcj.2014.44.5.301
NR 5
TC 0
Z9 0
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JAN
PY 2018
VL 48
IS 1
BP 84
EP 85
DI 10.4070/kcj.2017.0357
PG 2
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA FX1WE
UT WOS:000425842000010
PM 29322699
OA Green Published
DA 2021-04-22
ER

PT J
AU Han, JW
AF Han, Ji Whan
TI Factors Predicting Resistance to Intravenous Immunoglobulin and Coronary
   Complications in Kawasaki Disease: IVIG Resistance in Kawasaki Disease
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
C1 [Han, Ji Whan] Catholic Univ Korea, Coll Med, Yeouido St Marys Hosp, Dept Pediat, 10,63 Ro, Seoul 07345, South Korea.
RP Han, JW (corresponding author), Catholic Univ Korea, Coll Med, Yeouido St Marys Hosp, Dept Pediat, 10,63 Ro, Seoul 07345, South Korea.
EM hanji59@gmail.com
CR Chang LS, 2017, ONCOTARGET, V8, P2044, DOI 10.18632/oncotarget.13489
   Cho KH, 2014, KOREAN CIRC J, V44, P328, DOI 10.4070/kcj.2014.44.5.328
   Downie ML, 2016, J PEDIATR-US, V179, P124, DOI 10.1016/j.jpeds.2016.08.060
   Kim MK, 2018, KOREAN CIRC J, V48, P71, DOI 10.4070/kcj.2017.0136
   Lee Hye Young, 2016, Korean J Pediatr, V59, P477, DOI 10.3345/kjp.2016.59.12.477
   Liu L, 2016, INFLAMM RES, V65, P161, DOI 10.1007/s00011-015-0900-3
   Research Committee on Kawasaki disease, 1984, REP SUBC STAND DIAGN
   Shin J, 2017, J KOREAN MED SCI, V32, P1991, DOI 10.3346/jkms.2017.32.12.1991
   Takeshita S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176957
   Takeuchi M, 2017, PEDIATR INFECT DIS J, V36, P821, DOI 10.1097/INF.0000000000001621
NR 10
TC 3
Z9 3
U1 5
U2 6
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JAN
PY 2018
VL 48
IS 1
BP 86
EP 88
DI 10.4070/kcj.2017.0376
PG 3
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA FX1WE
UT WOS:000425842000011
PM 29322700
OA Green Published
DA 2021-04-22
ER

PT J
AU Ozturk, S
   Durmus, G
   Kalyoncuoglu, M
   Sari, M
   Ozbek, O
   Can, M
AF Ozturk, Semi
   Durmus, Gunduz
   Kalyoncuoglu, Muhsin
   Sari, Mustafa
   Ozbek, Ozlem
   Can, Mehmet
TI Unroofed Coronary Sinus Atrial Septal Defect Misdiagnosed as Ostium
   Primum Defect
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
C1 [Ozturk, Semi; Durmus, Gunduz; Kalyoncuoglu, Muhsin; Sari, Mustafa; Ozbek, Ozlem; Can, Mehmet] Haseki Training & Res Hosp, Dept Cardiol, TR-34130 Istanbul, Turkey.
RP Ozturk, S (corresponding author), Haseki Training & Res Hosp, Dept Cardiol, TR-34130 Istanbul, Turkey.
EM semi_ozturk@yahoo.com
RI Karabay, Can Yucel/AAL-8134-2021
OI Can, Mehmet/0000-0003-2602-6594
NR 0
TC 1
Z9 1
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JAN
PY 2018
VL 48
IS 1
BP 89
EP 90
DI 10.4070/kcj.2017.0131
PG 2
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA FX1WE
UT WOS:000425842000012
PM 29171199
OA Green Published
DA 2021-04-22
ER

PT J
AU Shin, JS
   Choi, SY
   Lim, SH
   Jung, JH
   Kang, DK
   Tahk, SJ
AF Shin, Jeoung-Sook
   Choi, So-Yeon
   Lim, Sang Hyun
   Jung, Jun Ho
   Kang, Doo-Kyoung
   Tahk, Seung-Jea
TI Extrinsic Compression of the Left Main Coronary Artery by a Huge Aortic
   Arch Aneurysm Mimicking Acute Coronary Syndrome
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
ID VALSALVA; SINUS
C1 [Shin, Jeoung-Sook; Choi, So-Yeon; Tahk, Seung-Jea] Ajou Univ, Sch Med, Dept Cardiol, 164 World Cup Ro, Suwon 16499, South Korea.
   [Lim, Sang Hyun; Jung, Jun Ho] Ajou Univ, Sch Med, Dept Cardiac Surg, Suwon, South Korea.
   [Kang, Doo-Kyoung] Ajou Univ, Sch Med, Dept Radiol, Suwon, South Korea.
RP Choi, SY (corresponding author), Ajou Univ, Sch Med, Dept Cardiol, 164 World Cup Ro, Suwon 16499, South Korea.
EM sychoimd@outlook.com
CR Borrello Bruno, 2008, Interact Cardiovasc Thorac Surg, V7, P508, DOI 10.1510/icvts.2007.172726
   Dahya VJ, 2015, JACC-CARDIOVASC INTE, V8, pE99, DOI 10.1016/j.jcin.2014.12.243
   Goto K, 2015, JACC-CARDIOVASC INTE, V8, pE87, DOI 10.1016/j.jcin.2014.12.241
   MINTZ GS, 1995, J AM COLL CARDIOL, V25, P1479, DOI 10.1016/0735-1097(95)00088-L
NR 4
TC 1
Z9 1
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JAN
PY 2018
VL 48
IS 1
BP 91
EP 93
DI 10.4070/kcj.2017.0313
PG 3
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA FX1WE
UT WOS:000425842000013
PM 29171206
OA Green Published
DA 2021-04-22
ER

PT J
AU Sim, DS
   Jeong, MH
AF Sim, Doo Sun
   Jeong, Myung Ho
TI Differences in the Korea Acute Myocardial Infarction Registry Compared
   with Western Registries
SO KOREAN CIRCULATION JOURNAL
LA English
DT Review
DE Myocardial infarction; Risk factors; Hydroxymethylglutaryl-CoA reductase
   inhibitors; Percutaneous coronary intervention
ID PERCUTANEOUS CORONARY INTERVENTION; DUAL ANTIPLATELET THERAPY;
   EVEROLIMUS-ELUTING STENTS; ASSOCIATION TASK-FORCE; CHRONIC
   KIDNEY-DISEASE; BARE-METAL STENTS; ST-SEGMENT; CLINICAL-OUTCOMES;
   THROMBUS ASPIRATION; SECONDARY PREVENTION
AB The Korea Acute Myocardial Infarction Registry (KAMIR) is the first nationwide registry that reflects current therapeutic approaches and acute myocardial infarction (AMI) management in Korea. The results of the KAMIR demonstrated different risk factors and responses to medical and interventional treatments. The results indicated that the incidence of ST-elevation myocardial infarction (STEMI) was relatively high, and that the prevalence of dyslipidemia was relatively low with higher triglyceride and lower high-density lipoprotein cholesterol levels. Percutaneous coronary intervention (PCI) rates were high for both STEMI and non-ST-elevation myocardial infarction (NSTEMI) with higher use of drug-eluting stents (DESs). DES were effective and safe without increased risk of stent thrombosis in Korean AMI patients. Triple antiplatelet therapy, consisting of aspirin, clopidogrel, and cilostazol, was effective in preventing adverse clinical outcomes after PCI. Statin therapy was effective in Korean AMI patients, including those with very low levels of low-density lipoprotein cholesterol and those with cardiogenic shock. The KAMIR score had a greater predictive value than Thrombolysis in Myocardial Infarction (TIMI) and Global Registry of Acute Coronary Events (GRACE) scores for long-term mortality in AMI patients. Based on these results, the KAMIR will be instrumental for establishing new therapeutic strategies and effective methods for secondary prevention of AMI and guidelines for Asian patients.
C1 [Sim, Doo Sun; Jeong, Myung Ho] Chonnam Natl Univ Hosp, Heart Ctr, Gwangju, South Korea.
RP Jeong, MH (corresponding author), Chonnam Natl Univ Hosp, KAMIR, Heart Res Ctr, Korea Minist Hlth & Welf, 42 Jebong Ro, Gwangju 61469, South Korea.
EM myungho@chollian.net
OI Jeong, Myung Ho/0000-0003-2424-810X
FU Korean Circulation Society
FX This study was performed with the support of the Korean Circulation
   Society in commemoration of its 50th Anniversary.
CR Ahmed K, 2014, J CARDIOL, V64, P273, DOI 10.1016/j.jjcc.2014.02.002
   Ahmed K, 2011, AM J CARDIOL, V108, P8, DOI 10.1016/j.amjcard.2011.02.339
   Armstrong PW, 2013, NEW ENGL J MED, V368, P1379, DOI 10.1056/NEJMoa1301092
   Cannon CP, 2004, NEW ENGL J MED, V350, P1495, DOI 10.1056/NEJMoa040583
   Chen KY, 2009, CIRCULATION, V119, P3207, DOI 10.1161/CIRCULATIONAHA.108.822791
   Cho JY, 2014, INT J CARDIOL, V172, pE51, DOI 10.1016/j.ijcard.2013.12.063
   Cho KH, 2015, INT J CARDIOL, V187, P478, DOI 10.1016/j.ijcard.2015.03.386
   Danchin N, 2008, CIRCULATION, V118, P268, DOI 10.1161/CIRCULATIONAHA.107.762765
   Frobert O, 2013, NEW ENGL J MED, V369, P1587, DOI 10.1056/NEJMoa1308789
   Hachinohe D, 2012, J CARDIOL, V59, P249, DOI 10.1016/j.jjcc.2011.12.005
   Hachinohe D, 2011, AM J CARDIOL, V108, P206, DOI 10.1016/j.amjcard.2011.03.025
   Hong YJ, 2013, INT J CARDIOL, V163, P1, DOI 10.1016/j.ijcard.2012.02.003
   Jeong HC, 2014, INT J CARDIOL, V170, P291, DOI 10.1016/j.ijcard.2013.07.146
   Jeong YW, 2014, INT J CARDIOL, V174, P777, DOI 10.1016/j.ijcard.2014.04.055
   Jeong YA, 2015, KOREAN CIRC J, V45, P22, DOI 10.4070/kcj.2015.45.1.22
   Ji MS, 2016, INT J CARDIOL, V225, P50, DOI 10.1016/j.ijcard.2016.09.082
   Ji MS, 2015, INT J CARDIOL, V199, P53, DOI 10.1016/j.ijcard.2015.07.010
   Ji MS, 2015, J CARDIOL, V65, P63, DOI 10.1016/j.jjcc.2014.04.002
   Kim HK, 2017, J CARDIOL, V69, P377, DOI 10.1016/j.jjcc.2016.09.002
   Kim HK, 2015, INT J CARDIOL, V193, P20, DOI 10.1016/j.ijcard.2015.05.017
   Kim HK, 2011, AM J CARDIOL, V107, P965, DOI 10.1016/j.amjcard.2010.11.018
   Kim HK, 2010, INT J CARDIOL, V145, P450, DOI 10.1016/j.ijcard.2009.06.001
   Kim JS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165484
   Kim JH, 2016, CIRC J, V80, P1427, DOI 10.1253/circj.CJ-16-0061
   Kim KH, 2016, KOREAN CIRC J, V46, P324, DOI 10.4070/kcj.2016.46.3.324
   Kim MC, 2014, INT J CARDIOL, V176, P505, DOI 10.1016/j.ijcard.2014.07.054
   Kim MC, 2011, INT J CARDIOL, V153, P148, DOI 10.1016/j.ijcard.2010.08.044
   Kook HY, 2014, AM J CARDIOL, V114, P1817, DOI 10.1016/j.amjcard.2014.09.019
   Kushner FG, 2009, J AM COLL CARDIOL, V54, P2205, DOI 10.1016/j.jacc.2009.10.015
   Lagerqvist B, 2014, NEW ENGL J MED, V371, P1111, DOI 10.1056/NEJMoa1405707
   Lee JH, 2015, AM J CARDIOL, V115, P1167, DOI 10.1016/j.amjcard.2015.02.001
   Lee KH, 2011, J AM COLL CARDIOL, V58, P1664, DOI 10.1016/j.jacc.2011.05.057
   Lee SA, 2014, DIABETES CARE, V37, P2366, DOI 10.2337/dc13-2856
   O'Gara PT, 2013, J AM COLL CARDIOL, V61, pE78, DOI 10.1016/j.jacc.2012.11.019
   Park DW, 2014, JAMA-J AM MED ASSOC, V312, P2019, DOI 10.1001/jama.2014.15095
   Park H, 2017, J CARDIOL, V69, P216, DOI 10.1016/j.jjcc.2016.03.012
   Park KH, 2016, INT J CARDIOL, V215, P193, DOI 10.1016/j.ijcard.2016.04.044
   Park KH, 2014, J CARDIOL, V63, P99, DOI 10.1016/j.jjcc.2013.07.004
   Piao ZH, 2016, J CARDIOL, V68, P7, DOI 10.1016/j.jjcc.2015.09.013
   Piao ZH, 2014, INT J CARDIOL, V177, P1081, DOI 10.1016/j.ijcard.2014.10.007
   Piao ZH, 2014, INT J CARDIOL, V172, P462, DOI 10.1016/j.ijcard.2013.12.282
   Riezebos RK, 2013, HEART, V99, P1867, DOI 10.1136/heartjnl-2012-302034
   Schwartz GG, 2001, JAMA-J AM MED ASSOC, V285, P1711, DOI 10.1001/jama.285.13.1711
   Sim DS, 2017, J CARDIOL, V69, P428, DOI 10.1016/j.jjcc.2016.01.003
   Sim DS, 2016, CIRC-CARDIOVASC INTE, V9, DOI 10.1161/CIRCINTERVENTIONS.115.003508
   Sim DS, 2016, INT J CARDIOL, V221, P937, DOI 10.1016/j.ijcard.2016.07.128
   Sim DS, 2013, KOREAN CIRC J, V43, P100, DOI 10.4070/kcj.2013.43.2.100
   Sim DS, 2013, INT HEART J, V54, P185, DOI 10.1536/ihj.54.185
   Sim DS, 2012, AM J CARDIOL, V110, P1275, DOI 10.1016/j.amjcard.2012.06.028
   Sim DS, 2011, J KOREAN MED SCI, V26, P521, DOI 10.3346/jkms.2011.26.4.521
   Sim DS, 2009, AM J CARDIOL, V103, P1333, DOI 10.1016/j.amjcard.2009.01.339
   Steg PG, 2012, EUR HEART J, V33, P2569, DOI 10.1093/eurheartj/ehs215
   Van de Werf F, 2008, EUR HEART J, V29, P2909, DOI 10.1093/eurheartj/ehn416
   Vlaar PJ, 2008, LANCET, V371, P1915, DOI 10.1016/S0140-6736(08)60833-8
   Yang JH, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g6650
   Yang JH, 2014, JACC-CARDIOVASC INTE, V7, P592, DOI 10.1016/j.jcin.2013.12.206
   Yoo SH, 2017, J CARDIOL, V69, P555, DOI 10.1016/j.jjcc.2016.05.009
NR 57
TC 13
Z9 14
U1 1
U2 3
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD NOV
PY 2017
VL 47
IS 6
BP 811
EP 822
DI 10.4070/kcj.2017.0027
PG 12
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA FQ3XR
UT WOS:000418292300002
PM 29035427
OA Green Published
DA 2021-04-22
ER

PT J
AU Ohuchi, H
AF Ohuchi, Hideo
TI Where Is the "Optimal" Fontan Hemodynamics?
SO KOREAN CIRCULATION JOURNAL
LA English
DT Review
DE Fontan procedure; Hemodynamics; Cardiac output; Vascular resistance;
   Mortality
ID PROTEIN-LOSING ENTEROPATHY; CONGENITAL HEART-DISEASE;
   CARDIAC-RESYNCHRONIZATION THERAPY; AEROBIC EXERCISE CAPACITY; LONG-TERM
   OUTCOMES; FAILING FONTAN; HYPERDYNAMIC CIRCULATION; VENTRICULAR
   DYSFUNCTION; PLASTIC BRONCHITIS; ADULT PATIENTS
AB Fontan circulation is generally characterized by high central venous pressure, low cardiac output, and slightly low arterial oxygen saturation, and it is quite different from normal biventricular physiology. Therefore, when a patient with congenital heart disease is selected as a candidate for this type of circulation, the ultimate goals of therapy consist of 2 components. One is a smooth adjustment to the new circulation, and the other is longterm circulatory stabilization after adjustment. When either of these goals is not achieved, the patient is categorized as having "failed" Fontan circulation, and the prognosis is dismal. For the first goal of smooth adjustment, a lot of effort has been made to establish criteria for patient selection and intensive management immediately after the Fontan operation. For the second goal of long-term circulatory stabilization, there is limited evidence of successful strategies for long-term hemodynamic stabilization. Furthermore, there have been no data on optimal hemodynamics in Fontan circulation that could be used as a reference for patient management. Although small clinical trials and case reports are available, the results cannot be generalized to the majority of Fontan survivors. We recently reported the clinical and hemodynamic characteristics of early and late failing Fontan survivors and their association with all-cause mortality. This knowledge could provide insight into the complex Fontan pathophysiology and might help establish a management strategy for long-term hemodynamic stabilization.
C1 [Ohuchi, Hideo] Natl Cerebral & Cardiovasc Ctr, Dept Pediat Cardiol, 5-7-1 Fujishiro Dai, Suita, Osaka 5658565, Japan.
   [Ohuchi, Hideo] Natl Cerebral & Cardiovasc Ctr, Dept Adult Congenital Heart Dis, 5-7-1 Fujishiro Dai, Suita, Osaka 5658565, Japan.
RP Ohuchi, H (corresponding author), Natl Cerebral & Cardiovasc Ctr, Dept Pediat Cardiol, 5-7-1 Fujishiro Dai, Suita, Osaka 5658565, Japan.; Ohuchi, H (corresponding author), Natl Cerebral & Cardiovasc Ctr, Dept Adult Congenital Heart Dis, 5-7-1 Fujishiro Dai, Suita, Osaka 5658565, Japan.
EM hohuchi@hsp.ncvc.go.jp
CR Agnoletti G, 2017, J THORAC CARDIOV SUR, V153, P1468, DOI 10.1016/j.jtcvs.2017.01.051
   Allen KY, 2017, AM J CARDIOL, V119, P1866, DOI 10.1016/j.amjcard.2017.03.004
   Antonio M, 2016, ANN THORAC SURG, V101, P2370, DOI 10.1016/j.athoracsur.2015.08.079
   Apostolopoulou SC, 2005, J HEART LUNG TRANSPL, V24, P1174, DOI 10.1016/j.healun.2004.11.018
   Asrani SK, 2013, NEW ENGL J MED, V368, P1756, DOI 10.1056/NEJMc1214222
   Assenza GE, 2013, HEART, V99, P491, DOI 10.1136/heartjnl-2012-303347
   Avitabile CM, 2015, BONE, V77, P12, DOI 10.1016/j.bone.2015.04.012
   Avitabile CM, 2014, HEART, V100, P1702, DOI 10.1136/heartjnl-2014-305723
   Benedict CR, 1996, CIRCULATION, V94, P690, DOI 10.1161/01.CIR.94.4.690
   Bhagirath KM, 2007, ANN THORAC SURG, V84, P2110, DOI 10.1016/j.athoracsur.2007.06.064
   Book WM, 2016, CONGENIT HEART DIS, V11, P296, DOI 10.1111/chd.12368
   Brassard P, 2006, INT J CARDIOL, V107, P85, DOI 10.1016/j.ijcard.2005.02.038
   Carins TA, 2016, J THORAC CARDIOV SUR, V152, P1355, DOI 10.1016/j.jtcvs.2016.07.073
   Cordina RL, 2013, INT J CARDIOL, V168, P780, DOI 10.1016/j.ijcard.2012.10.012
   d'Udekem Y, 2007, CIRCULATION, V116, pI157, DOI 10.1161/CIRCULATIONAHA.106.676445
   de Mattos AZ, 2016, ANN HEPATOL, V15, P474
   De Rita Fabrizio, 2015, Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu, V18, P2, DOI 10.1053/j.pcsu.2015.01.004
   Deal BJ, 2012, HEART, V98, P1098, DOI 10.1136/heartjnl-2011-301133
   Diller GP, 2015, CIRCULATION, V132, P2118, DOI 10.1161/CIRCULATIONAHA.115.017202
   Dori Y, 2016, CIRCULATION, V133, P1160, DOI 10.1161/CIRCULATIONAHA.115.019710
   DREXLER H, 1991, EUR HEART J, V12, P21, DOI 10.1093/eurheartj/12.suppl_C.21
   Egbe AC, 2017, AM HEART J, V183, P10, DOI 10.1016/j.ahj.2016.09.014
   Enomoto Y, 2012, CIRCULATION, V125, pE655, DOI 10.1161/CIRCULATIONAHA.111.070979
   FONTAN F, 1971, THORAX, V26, P240, DOI 10.1136/thx.26.3.240
   Friedland-Little JM, 2017, PEDIATR TRANSPLANT, V21, DOI 10.1111/petr.12925
   Giardini A, 2008, EUR HEART J, V29, P1681, DOI 10.1093/eurheartj/ehn215
   Goldberg DJ, 2011, CIRCULATION, V123, P1185, DOI 10.1161/CIRCULATIONAHA.110.981746
   Goldenberg I, 2014, NEW ENGL J MED, V370, P1694, DOI 10.1056/NEJMoa1401426
   Heath L, 2011, PEDIATR CARDIOL, V32, P1182, DOI 10.1007/s00246-011-0058-x
   Hebert A, 2014, CIRCULATION, V130, P2021, DOI 10.1161/CIRCULATIONAHA.113.008441
   Hebson CL, 2013, AM J CARDIOL, V112, P1943, DOI 10.1016/j.amjcard.2013.08.023
   Heinemann M, 2001, THORAC CARDIOV SURG, V49, P172, DOI 10.1055/s-2001-14339
   Henaine R, 2013, J THORAC CARDIOV SUR, V146, P522, DOI 10.1016/j.jtcvs.2012.11.031
   Hoashi T, 2009, CONGENIT HEART DIS, V4, P284, DOI 10.1111/j.1747-0803.2009.00274.x
   Honjo O, 2011, J THORAC CARDIOV SUR, V142, P326, DOI 10.1016/j.jtcvs.2010.11.060
   Iwakiri Y, 2006, HEPATOLOGY, V43, pS121, DOI 10.1002/hep.20993
   Iwakiri Y, 2002, AM J PHYSIOL-HEART C, V282, pH2084, DOI 10.1152/ajpheart.00675.2001
   John AS, 2014, J AM COLL CARDIOL, V64, P54, DOI 10.1016/j.jacc.2014.04.025
   John AS, 2011, ANN THORAC SURG, V92, P1451, DOI 10.1016/j.athoracsur.2011.03.103
   Khairy P, 2008, CIRCULATION, V117, P85, DOI 10.1161/CIRCULATIONAHA.107.738559
   King G, 2017, EUR J CARDIO-THORAC, V51, P1037, DOI 10.1093/ejcts/ezx025
   Latus H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081684
   LEVINE TB, 1990, AM HEART J, V120, P1547, DOI 10.1016/0002-8703(90)90057-5
   Li DX, 2017, PEDIATR CARDIOL, V38, P873, DOI 10.1007/s00246-017-1595-8
   Matsuda H, 2017, GEN THORAC CARDIOVAS, V65, P309, DOI 10.1007/s11748-017-0777-x
   Mitchell MB, 2004, J THORAC CARDIOV SUR, V128, P693, DOI 10.1016/j.jtcvs.2004.07.013
   Mizuno M, 2016, PEDIATR INT, V58, P1061, DOI 10.1111/ped.13054
   MOORE JW, 1989, J THORAC CARDIOV SUR, V98, P1045
   Mori M, 2016, CONGENIT HEART DIS, V11, P589, DOI 10.1111/chd.12345
   Mori M, 2014, PEDIATR CARDIOL, V35, P569, DOI 10.1007/s00246-014-0881-y
   Nair AP, 2012, CIRC J, V76, P268, DOI 10.1253/circj.CJ-11-1424
   Ohuchi H, 2004, PEDIATR CARDIOL, V25, P513, DOI 10.1007/s00246-003-0652-7
   Ohuchi H, 2001, J AM COLL CARDIOL, V37, P1967, DOI 10.1016/S0735-1097(01)01266-9
   Ohuchi H, 2017, HEART
   Ohuchi H, 2017, AM HEART J, V189, P9, DOI 10.1016/j.ahj.2017.03.020
   Ohuchi H, 2016, J CARDIOL, V68, P181, DOI 10.1016/j.jjcc.2016.04.001
   Ohuchi H, 2015, EUR J CARDIO-THORAC, V47, P511, DOI 10.1093/ejcts/ezu145
   Ohuchi H, 2014, INT J CARDIOL, V173, P277, DOI 10.1016/j.ijcard.2014.03.001
   Ohuchi H, 2013, EUR J CARDIO-THORAC, V43, pE49, DOI 10.1093/ejcts/ezs714
   Ohuchi H, 2012, CIRC J, V76, P195, DOI 10.1253/circj.CJ-11-0540
   Ohuchi H, 2011, ANN THORAC SURG, V92, P1457, DOI 10.1016/j.athoracsur.2011.05.055
   Ohuchi H, 2009, AM HEART J, V158, P30, DOI 10.1016/j.ahj.2009.04.021
   Okano S, 2016, INTERNAL MED, V55, P1611, DOI 10.2169/internalmedicine.55.6303
   Opocher F, 2005, AM J CARDIOL, V95, P150, DOI 10.1016/j.amjcard.2004.08.085
   Pundi KN, 2017, CONGENIT HEART DIS, V12, P17, DOI 10.1111/chd.12401
   Pundi K, 2016, AM J CARDIOL, V117, P456, DOI 10.1016/j.amjcard.2015.11.014
   Quinton E, 2015, HEART, V101, P1672, DOI 10.1136/heartjnl-2015-307514
   Rhodes J, 2013, INT J CARDIOL, V168, P2435, DOI 10.1016/j.ijcard.2013.03.014
   Ruiz-del-Arbol L, 2015, WORLD J GASTROENTERO, V21, P11502, DOI 10.3748/wjg.v21.i41.11502
   Rychik J, 2012, PEDIATR CARDIOL, V33, P1001, DOI 10.1007/s00246-012-0315-7
   Schuuring MJ, 2013, EUR J HEART FAIL, V15, P690, DOI 10.1093/eurjhf/hft017
   Song DS, 2002, HEPATOLOGY, V35, P159, DOI 10.1053/jhep.2002.30417
   Straver B, 2011, CIRC-CARDIOVASC INTE, V4, P112, DOI 10.1161/CIRCINTERVENTIONS.110.958736
   Tabarsi N, 2017, AM J CARDIOL, V119, P1269, DOI 10.1016/j.amjcard.2017.01.001
   Takeuchi D, 2014, EUR J CARDIO-THORAC, V46, P913, DOI 10.1093/ejcts/ezu084
   Uzun O, 2006, ANN THORAC SURG, V82, pE39, DOI 10.1016/j.athoracsur.2006.08.043
   Van de Bruaene A, 2014, CIRC-CARDIOVASC IMAG, V7, P265, DOI 10.1161/CIRCIMAGING.113.001243
   Wakeham Martin K, 2005, Pediatr Crit Care Med, V6, P76, DOI 10.1097/01.PCC.0000149320.06424.1D
   Waypa GB, 2010, RESP PHYSIOL NEUROBI, V174, P201, DOI 10.1016/j.resp.2010.08.007
   Wojnowich Katherine, 2016, FP Essent, V442, P18
NR 80
TC 13
Z9 16
U1 0
U2 2
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD NOV
PY 2017
VL 47
IS 6
BP 842
EP 857
DI 10.4070/kcj.2017.0105
PG 16
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA FQ3XR
UT WOS:000418292300005
PM 29035429
OA Green Published
DA 2021-04-22
ER

PT J
AU Lee, HY
   Jeon, ES
   Kang, SM
   Kim, JJ
AF Lee, Hae-Young
   Jeon, Eun-Seok
   Kang, Seok-Min
   Kim, Jae-Joong
TI Initial Report of the Korean Organ Transplant Registry (KOTRY): Heart
   Transplantation
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Heart transplantation; Heart failure; Registries
ID INTERNATIONAL SOCIETY; FAILURE
AB Background and Objectives: The Korean Organ Transplant Registry (KOTRY), which was the first national transplant registry in Korea, was founded by the Korean Society for Transplantation and the Korean Center for Disease Control in 2014. Here, we present the initial report of the Korean Heart Transplant Registry.
   Methods: A total of 183 heart transplantation (HTPL) patients performed at 4 nationally representative hospitals were collected from April 2014 to December 2015. We analyzed donor and recipient characteristics, treatment patterns, and immediate post-transplantation outcomes.
   Results: One hundred and eighty-three patients were enrolled. The mean age of the patients was 50.5 +/- 13.5 years. The mean age of the male recipients was 4 years greater than that of the female recipients (51.7 +/- 13.3 years vs. 47.9 +/- 13.7 years, p<0.050). The mean age of donors was more than 12 years younger than that of heart recipients (37.6 +/- 10.1 years). Dilated cardiomyopathy was the predominant cause (69%) of heart failure in recipients, followed by ischemic heart diseases (14%) and valvular heart disease (4%). Rejection episodes were most frequent in the 1-6-month period after transplantation (48%), and rarely required intensive treatment. Infection episodes were most frequent <1 month after transplantation (66%) and bacterial and viral infections were equally reported. The 1-year survival rate was 91.6% and most mortality cases occurred during the perioperative period within 1 month after transplantation.
   Conclusion: With the establishment of the KOTRY in 2014, it is now possible to present nationwide epidemiological data for HTPL in Korea for the first time. The KOTRY is the first national HTPL registry in Korea, and will continue until 2023.
C1 [Lee, Hae-Young] Seoul Natl Univ Hosp, Dept Internal Med, Seoul, South Korea.
   [Jeon, Eun-Seok] Sungkyunkwan Univ, Dept Internal Med, Coll Med, Seoul, South Korea.
   [Kang, Seok-Min] Yonsei Univ, Dept Internal Med, Coll Med, Seoul, South Korea.
   [Kim, Jae-Joong] Univ Ulsan, Dept Internal Med, Asan Med Ctr, Coll Med, 88,Olymp Ro 43 Gil, Seoul 05505, South Korea.
RP Kim, JJ (corresponding author), Univ Ulsan, Dept Internal Med, Asan Med Ctr, Coll Med, 88,Olymp Ro 43 Gil, Seoul 05505, South Korea.
EM jjkim@amc.seoul.kr
OI Lee, Hae-Young/0000-0002-9521-4102
FU Research of Korea Centers for Disease Control and Prevention
   [2014ER630102]
FX This registry was supported by a grant from the Research of Korea
   Centers for Disease Control and Prevention (2014ER630102).
CR Ahn C, 2014, TRANSPL P, V46, P425, DOI 10.1016/j.transproceed.2013.11.083
   Cha MJ, 2013, CIRC J, V77, P2056, DOI 10.1253/circj.CJ-12-1269
   Choi DJ, 2011, KOREAN CIRC J, V41, P363, DOI 10.4070/kcj.2011.41.7.363
   Eisen HJ, 2003, NEW ENGL J MED, V349, P847, DOI 10.1056/NEJMoa022171
   Jung SH, 2011, J KOREAN MED SCI, V26, P599, DOI 10.3346/jkms.2011.26.5.599
   Lee JM, 2013, ANN TRANSPL, V18, P533, DOI 10.12659/AOT.889103
   Lee SE, 2014, EUR J HEART FAIL, V16, P700, DOI 10.1002/ejhf.91
   Lim Jae Hong, 2014, Korean J Thorac Cardiovasc Surg, V47, P100, DOI 10.5090/kjtcs.2014.47.2.100
   Lim JY, 2017, CLIN TRANSPLANT, V31, DOI 10.1111/ctr.12883
   Lund LH, 2016, J HEART LUNG TRANSPL, V35, P1158, DOI 10.1016/j.healun.2016.08.017
   Lund LH, 2014, J HEART LUNG TRANSPL, V33, P996, DOI 10.1016/j.healun.2014.08.003
   Lund LH, 2013, J HEART LUNG TRANSPL, V32, P951, DOI 10.1016/j.healun.2013.08.006
   Mehra MR, 2010, J HEART LUNG TRANSPL, V29, P717, DOI 10.1016/j.healun.2010.05.017
   Ponikowski P, 2016, EUR HEART J, V37, P2129, DOI 10.1093/eurheartj/ehw128
   Shin HS, 2014, ANN TRANSPL, V19, P1, DOI 10.12659/AOT.889680
   Stehlik J, 2012, J HEART LUNG TRANSPL, V31, P1052, DOI 10.1016/j.healun.2012.08.002
   Yeom Sang Yoon, 2013, Korean J Thorac Cardiovasc Surg, V46, P111, DOI 10.5090/kjtcs.2013.46.2.111
   Youn JC, 2014, J KOREAN MED SCI, V29, P544, DOI 10.3346/jkms.2014.29.4.544
NR 18
TC 6
Z9 6
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD NOV
PY 2017
VL 47
IS 6
BP 868
EP 876
DI 10.4070/kcj.2016.0403
PG 9
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA FQ3XR
UT WOS:000418292300009
PM 29035428
OA Green Published
DA 2021-04-22
ER

PT J
AU Cho, IJ
   Chang, HJ
   Lee, SE
   Shim, CY
   Hong, GR
   Chung, N
AF Cho, In-Jeong
   Chang, Hyuk-Jae
   Lee, Sang-Eun
   Shim, Chi Young
   Hong, Geu-Ru
   Chung, Namsik
TI Prognostic Application of Thoracic Aortic Calcium Scoring for Adverse
   Clinical Outcome Risk in Elderly Patients with Left Ventricular
   Hypertrophy
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Left ventricular hypertrophy; Vascular calcification; Prognosis
ID CARDIOVASCULAR-DISEASE EVENTS; PRESERVED EJECTION FRACTION;
   ESSENTIAL-HYPERTENSION; DIASTOLIC DYSFUNCTION; HEART-FAILURE;
   ASSOCIATION; CALCIFICATION; MORTALITY; STIFFNESS; UPDATE
AB Background and Objectives: Left ventricular hypertrophy (LVH) is associated with poor cardiovascular outcomes. Heavy aortic calcification exacerbates arterial stiffness, which consequently heightens left ventricular (LV) afterload. We assessed the usefulness of aortic calcification for predicting adverse cardiovascular outcomes and to determine whether the relationship, if any, differed as a function of LVH.
   Methods: The analytic sample was comprised of a total of 487 individuals 65 years of age or older. Thoracic aortic calcium score (TACS) was measured by coronary computed tomography, and patients were stratified according to the median (TACS, 446 mm(3)). LVH obtained from echocardiography was defined as LV mass index > 115 g/m(2) for men and > 95 g/m(2) for women. Cox regression reporting hazard ratios (HRs) with 95% confidence intervals (CIs) was performed to predict the risk for the composite study endpoint, defined as cardiac death, admission for heart failure, obstructive coronary artery disease (CAD) requiring revascularization, or stroke.
   Results: A total of 39 composite events (8.0%) occurred during a median follow-up of 65 months (interquartile range [IQR], 17-89 months). For those with LVH, the concurrent presence of high TACS appeared to be an independent predictor (HR, 4.51; 95% CI, 1.7111.88; p=0.002) for the composite study endpoint. Other combined LVH and TACS subgroups were not associated with significant factors for predicting the composite study endpoint (p>0.050, all).
   Conclusion: TACS provides robust predictive utility for a composite of cardiovascular events and cardiac death in persons with LVH. This finding was less pronounced in those with a relatively healthy myocardium, defined by the absence of LVH.
C1 [Cho, In-Jeong; Chang, Hyuk-Jae; Lee, Sang-Eun; Shim, Chi Young; Hong, Geu-Ru; Chung, Namsik] Yonsei Univ, Severance Cardiovasc Hosp, Div Cardiol, Coll Med, 50 Yonsei Ro, Seoul 03722, South Korea.
   [Chang, Hyuk-Jae] Yonsei Univ, Severance Biomed Sci Inst, Coll Med, Seoul, South Korea.
RP Chang, HJ (corresponding author), Yonsei Univ, Severance Cardiovasc Hosp, Div Cardiol, Coll Med, 50 Yonsei Ro, Seoul 03722, South Korea.
EM hjchang@yuhs.ac
RI Shim, Chi Young/AAK-1057-2021
OI Shim, Chi Young/0000-0002-6136-0136; Lee, Sang-Eun/0000-0001-6645-4038;
   Chang, Hyuk-Jae/0000-0002-6139-7545; Hong, Geu-Ru/0000-0003-4981-3304
FU Leading Foreign Research Institute Recruitment Program through the
   National Research Foundation of Korea (NRF) - Ministry of Science, ICT &
   Future Planning (MSIP) [2012027176]
FX This research was supported by the Leading Foreign Research Institute
   Recruitment Program through the National Research Foundation of Korea
   (NRF) funded by the Ministry of Science, ICT & Future Planning (MSIP)
   (No. 2012027176).
CR Arnett DK, 2004, CURR HYPERTENS REP, V6, P36, DOI 10.1007/s11906-004-0009-5
   Cacciapuoti F, 2011, J AM SOC HYPERTENS, V5, P449, DOI 10.1016/j.jash.2011.08.006
   Cho IJ, 2015, J HYPERTENS, V33, P1633, DOI 10.1097/HJH.0000000000000607
   Cohn JN, 2000, J AM COLL CARDIOL, V35, P569, DOI 10.1016/S0735-1097(99)00630-0
   de Simone G, 2013, NUTR METAB CARDIOVAS, V23, P905, DOI 10.1016/j.numecd.2013.06.012
   Eisen A, 2008, CIRCULATION, V118, P1328, DOI 10.1161/CIRCULATIONAHA.107.712141
   Eren M, 2004, HEART, V90, P37, DOI 10.1136/heart.90.1.37
   Frohlich ED, 2012, HEART FAIL CLIN, V8, P21, DOI 10.1016/j.hfc.2011.08.005
   Gibbons RJ, 2002, J AM COLL CARDIOL, V40, P1531, DOI 10.1016/S0735-1097(02)02164-2
   Gibbons RJ, 1997, J AM COLL CARDIOL, V30, P260
   Kawaguchi M, 2003, CIRCULATION, V107, P714, DOI 10.1161/01.CIR.0000048123.22359.A0
   Kim HK, 2008, J AM SOC ECHOCARDIOG, V21, P482, DOI 10.1016/j.echo.2007.08.024
   Kim J, 2017, ATHEROSCLEROSIS, V257, P1, DOI 10.1016/j.atherosclerosis.2016.12.012
   Kim TJ, 2010, RADIOLOGY, V255, P369, DOI 10.1148/radiol.10091083
   Lang RM, 2015, EUR HEART J-CARD IMG, V16, P233, DOI 10.1093/ehjci/jev014
   LEVY D, 1990, NEW ENGL J MED, V322, P1561, DOI 10.1056/NEJM199005313222203
   Nadruz W, 2015, J HUM HYPERTENS, V29, P1, DOI 10.1038/jhh.2014.36
   Paulus WJ, 2013, J AM COLL CARDIOL, V62, P263, DOI 10.1016/j.jacc.2013.02.092
   Ruilope LM, 2008, AM J HYPERTENS, V21, P500, DOI 10.1038/ajh.2008.16
   Schillaci G, 2000, HYPERTENSION, V35, P580, DOI 10.1161/01.HYP.35.2.580
   Sundstrom J, 2001, CIRCULATION, V103, P2346
   Tsioufis C, 2005, J HYPERTENS, V23, P1745, DOI 10.1097/01.hjh.0000174394.57644.69
   WEBER KT, 1991, CIRCULATION, V83, P1849, DOI 10.1161/01.CIR.83.6.1849
   Wong ND, 2009, JACC-CARDIOVASC IMAG, V2, P319, DOI 10.1016/j.jcmg.2008.12.010
NR 24
TC 0
Z9 0
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD NOV
PY 2017
VL 47
IS 6
BP 918
EP 928
DI 10.4070/kcj.2016.0443
PG 11
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA FQ3XR
UT WOS:000418292300014
PM 29035431
OA Green Published
DA 2021-04-22
ER

PT J
AU Yildirim, E
   Celik, M
   Yuksel, UC
   Gungor, M
   Bugan, B
   Dogan, D
   Gokoglan, Y
   Kabul, HK
   Gormel, S
   Yasar, S
   Koklu, M
   Barcin, C
AF Yildirim, Erkan
   Celik, Murat
   Yuksel, Uygar Cagdas
   Gungor, Mutlu
   Bugan, Baris
   Dogan, Deniz
   Gokoglan, Yalcin
   Kabul, Hasan Kutsi
   Gormel, Suat
   Yasar, Salim
   Koklu, Mustafa
   Barcin, Cem
TI Relationship between Pulmonary Artery Stiffness and Functional Capacity
   in Patients with Heart Failure with Reduced Ejection Fraction
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Pulmonary artery; Vascular stiffness; Heart failure; Ejection fraction;
   Stroke volume
ID RIGHT-VENTRICULAR FUNCTION; MAGNETIC-RESONANCE; SYSTOLIC FUNCTION;
   HYPERTENSION; EXERCISE; DISTENSIBILITY; INTERVENTION; ASSOCIATION;
   MORTALITY; DISEASE
AB Background and Objectives: Functional capacity varies significantly among patients with heart failure with reduced ejection fraction (HFrEF), and it remains unclear why functional capacity is severely compromised in some patients with HFrEF while it is preserved in others. In this study, we aimed to evaluate the role of pulmonary artery stiffness (PAS) in the functional status of patients with HFrEF.
   Methods: A total of 46 heart failure (HF) patients without overt pulmonary hypertension or right HF and 52 controls were enrolled in the study. PAS was assessed on parasternal shortaxis view using pulsed-wave Doppler recording of pulmonary flow one centimeter distal to the pulmonic valve annulus at a speed of 100 mm/sec. PAS was calculated according to the following formula: the ratio of maximum flow velocity shift of pulmonary flow to pulmonary acceleration time.
   Results: PAS was significantly increased in the HFrEF group compared to the control group (10.53 +/- 2.40 vs. 7.41 +/- 1.32, p<0.001). In sub-group analysis of patients with HFrEF, PAS was significantly associated with the functional class of the patients. HFrEF patients with poor New York Heart Association (NYHA) functional capacity had higher PAS compared those with good functional capacity. In multivariate regression analysis, NYHA class was independently correlated with PAS.
   Conclusion: PAS is associated with functional status and should be taken into consideration as an underlying pathophysiological mechanism of dyspnea in patients with HFrEF.
C1 [Yildirim, Erkan; Celik, Murat; Yuksel, Uygar Cagdas; Gokoglan, Yalcin; Kabul, Hasan Kutsi; Gormel, Suat; Yasar, Salim; Koklu, Mustafa; Barcin, Cem] Gulhane Training & Res Hosp, Dept Cardiol, Gen Dr Tevfik Saglam Cd, TR-06010 Ankara, Turkey.
   [Gungor, Mutlu] Mem Sisli Hosp, Dept Cardiol, Istanbul, Turkey.
   [Bugan, Baris] Corlu State Hosp, Dept Cardiol, Tekirdag, Turkey.
   [Dogan, Deniz] Gulhane Training & Res Hosp, Dept Thorac Med, Ankara, Turkey.
RP Yildirim, E (corresponding author), Gulhane Training & Res Hosp, Dept Cardiol, Gen Dr Tevfik Saglam Cd, TR-06010 Ankara, Turkey.
EM dr_erkanyildirim@yahoo.com.tr
RI yuksel, uygar cagdas/AAA-5958-2021
OI Bugan, Baris/0000-0002-7210-9537; yasar, salim/0000-0003-2290-0184
CR Altiparmak IH, 2016, TURK KARDIYOL DERN A, V44, P289, DOI 10.5543/tkda.2015.67862
   Baykan AO, 2016, CONGENIT HEART DIS, V11, P144, DOI 10.1111/chd.12302
   Butler J, 1999, J AM COLL CARDIOL, V34, P1802, DOI 10.1016/S0735-1097(99)00408-8
   Celik M, 2014, ECHOCARDIOGR-J CARD, V31, P759, DOI 10.1111/echo.12455
   Champion HC, 2009, CIRCULATION, V120, P992, DOI 10.1161/CIRCULATIONAHA.106.674028
   Delgado JF, 2005, EUR J HEART FAIL, V7, P1011, DOI 10.1016/j.ejheart.2004.10.021
   Duman D, 2008, TURK KARDIYOL DERN A, V36, P82
   FRANCIOSA JA, 1981, AM J CARDIOL, V47, P33, DOI 10.1016/0002-9149(81)90286-1
   Gan CTJ, 2007, CHEST, V132, P1906, DOI 10.1378/chest.07-1246
   Ghio S, 2001, J AM COLL CARDIOL, V37, P183, DOI 10.1016/S0735-1097(00)01102-5
   Gorgulu Sevket, 2003, Anadolu Kardiyol Derg, V3, P92
   Gorgulu S, 2006, INT J CARDIOL, V111, P127, DOI 10.1016/j.ijcard.2005.07.037
   Jardim C, 2007, EUR RESPIR J, V29, P476, DOI 10.1183/09031936.00016806
   Jeffery TK, 2001, PHARMACOL THERAPEUT, V92, P1, DOI 10.1016/S0163-7258(01)00157-7
   Kang KW, 2011, CIRC J, V75, P2244, DOI 10.1253/circj.CJ-10-1310
   Kjaergaard J, 2007, AM J CARDIOL, V99, P1146, DOI 10.1016/j.amjcard.2006.11.052
   Lam CSP, 2009, J AM COLL CARDIOL, V53, P1119, DOI 10.1016/j.jacc.2008.11.051
   Lang RM, 2015, EUR HEART J-CARD IMG, V16, P233, DOI 10.1093/ehjci/jev014
   Lloyd-Jones D, 2010, CIRCULATION, V121, pE46, DOI 10.1161/CIRCULATIONAHA.109.192667
   Mahapatra S, 2006, J AM COLL CARDIOL, V47, P799, DOI 10.1016/j.jacc.2005.09.054
   Mahfouz RA, 2012, ECHOCARDIOGR-J CARD, V29, P1157, DOI 10.1111/j.1540-8175.2012.01785.x
   MARANTZ PR, 1988, CIRCULATION, V77, P607, DOI 10.1161/01.CIR.77.3.607
   Sanz J, 2012, HEART, V98, P238, DOI 10.1136/heartjnl-2011-300462
   Saouti N, 2010, EUR RESPIR REV, V19, P197, DOI 10.1183/09059180.00002210
   Sutendra G, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005428
   Thompson PD, 2003, CIRCULATION, V107, P3109, DOI 10.1161/01.CIR.0000075572.40158.77
   Vonk-Noordegraaf A, 2013, J AM COLL CARDIOL, V62, pD22, DOI 10.1016/j.jacc.2013.10.027
   Weir-McCall JR, 2015, RESP MED, V109, P1381, DOI 10.1016/j.rmed.2015.06.005
NR 28
TC 2
Z9 3
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD NOV
PY 2017
VL 47
IS 6
BP 929
EP 938
DI 10.4070/kcj.2017.0081
PG 10
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA FQ3XR
UT WOS:000418292300015
PM 29171209
OA Green Published
DA 2021-04-22
ER

PT J
AU Kim, YS
   Lee, YJ
   Won, KB
   Kim, JW
   Lee, SC
   Park, CR
   Jung, JP
   Choi, W
AF Kim, Yun Seok
   Lee, Yong Jik
   Won, Ki-Bum
   Kim, Jeong Won
   Lee, Sang Cjeol
   Park, Chang-Ryul
   Jung, Jong-Pil
   Choi, Wookjin
TI Extracorporeal Cardiopulmonary Resuscitation with Therapeutic
   Hypothermia for Prolonged Refractory In-hospital Cardiac Arrest
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Extracorporeal membrane oxygenation; Cardiopulmonary resuscitation;
   Hypothermia, induced
ID LIFE-SUPPORT; MEMBRANE-OXYGENATION; ADULTS; EXPERIENCE; OUTCOMES
AB Background and Objectives: We identified the impact of extracorporeal cardiopulmonary resuscitation (ECPR) followed by therapeutic hypothermia on survival and neurologic outcome in patients with prolonged refractory in-hospital cardiac arrest (IHCA).
   Methods: We enrolled 16 adult patients who underwent ECPR followed by therapeutic hypothermia between July 2011 and December 2015, for IHCA. Survival at discharge and cerebral performance category (CPC) scale were evaluated.
   Results: All patients received bystander cardiopulmonary resuscitation (CPR); the mean CPR time was 66.5 +/- 29.9 minutes, and the minimum value was 39 minutes. Eight patients (50%) were discharged alive with favorable neurologic outcomes (CPC 1-2). The mean followup duration was 20.1 +/- 24.3 months, and most deaths occurred within 21 days after ECPR; thereafter, no deaths occurred within one year after the procedure.
   Conclusion: ECPR followed by therapeutic hypothermia could be considered in prolonged refractory IHCA if bystander-initiated conventional CPR is performed.
C1 [Kim, Yun Seok; Lee, Yong Jik; Lee, Sang Cjeol; Park, Chang-Ryul; Jung, Jong-Pil] Univ Ulsan, Ulsan Univ Hosp, Dept Thorac & Cardiovasc Surg, Coll Med, Ulsan, South Korea.
   [Won, Ki-Bum] Univ Ulsan, Ulsan Univ Hosp, Dept Cardiol, Coll Med, Ulsan, South Korea.
   [Kim, Jeong Won] Andong Hosp, Dept Thorac & Cardiovasc Surg, Andong, South Korea.
   [Choi, Wookjin] Univ Ulsan, Coll Med, Ulsan Univ Hosp, Dept Emergency Med, 877 Bangeojinsunhwando Ro, Ulsan 44033, South Korea.
RP Choi, W (corresponding author), Univ Ulsan, Coll Med, Ulsan Univ Hosp, Dept Emergency Med, 877 Bangeojinsunhwando Ro, Ulsan 44033, South Korea.
EM koreanermd@gmail.com
OI Park, Chang-Ryul/0000-0003-2841-7046; Kim, Jeong
   Won/0000-0001-7986-9240; Lee, Yongjik/0000-0002-0837-4336; Won,
   Ki-Bum/0000-0001-5502-9933
CR Anselmi A, 2015, J THORAC CARDIOV SUR, V150, P947, DOI 10.1016/j.jtcvs.2015.05.070
   Badjatia N, 2008, STROKE, V39, P3242, DOI 10.1161/STROKEAHA.108.523654
   Bednarczyk JM, 2014, RESUSCITATION, V85, P1713, DOI 10.1016/j.resuscitation.2014.09.026
   Chen JS, 2006, CRIT CARE MED, V34, P950, DOI 10.1097/01.CCM.0000206103.35460.1F
   Chen YS, 2008, LANCET, V372, P554, DOI 10.1016/S0140-6736(08)60958-7
   Haneya A, 2012, RESUSCITATION, V83, P1331, DOI 10.1016/j.resuscitation.2012.07.009
   Kagawa E, 2010, RESUSCITATION, V81, P968, DOI 10.1016/j.resuscitation.2010.03.037
   Kim DS, 2016, CLIN ENDOSC, V49, P273, DOI 10.5946/ce.2015.086
   Kim SJ, 2014, CRIT CARE, V18, DOI 10.1186/s13054-014-0535-8
   Link MS, 2015, CIRCULATION, V132, pS444, DOI 10.1161/CIR.0000000000000261
   Massetti M, 2005, ANN THORAC SURG, V79, P178, DOI 10.1016/j.athoracsur.2004.06.095
   Ortega-Deballon I, 2016, RESUSCITATION, V101, P12, DOI 10.1016/j.resuscitation.2016.01.018
   Pang PYK, 2016, J CARDIOTHORAC SURG, V11, DOI 10.1186/s13019-016-0437-8
   Patel JK, 2016, J INTENSIVE CARE MED, V31, P359, DOI 10.1177/0885066615583651
   Rittenberger JC, 2015, NEUROCRIT CARE, V23, pS119, DOI 10.1007/s12028-015-0171-4
   Ryu JA, 2015, BMC ANESTHESIOL, V15, DOI 10.1186/s12871-015-0002-3
   Sakamoto S, 2012, ANN THORAC SURG, V94, P1, DOI 10.1016/j.athoracsur.2012.01.032
   Siao FY, 2015, RESUSCITATION, V92, P70, DOI 10.1016/j.resuscitation.2015.04.016
   Stub D, 2015, RESUSCITATION, V86, P88, DOI 10.1016/j.resuscitation.2014.09.010
   Wang CH, 2016, RESUSCITATION, V107, P1, DOI 10.1016/j.resuscitation.2016.07.005
NR 20
TC 4
Z9 5
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD NOV
PY 2017
VL 47
IS 6
BP 939
EP 948
DI 10.4070/kcj.2017.0079
PG 10
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA FQ3XR
UT WOS:000418292300016
PM 29171213
OA Green Published
DA 2021-04-22
ER

PT J
AU Kim, JS
   Jang, Y
   Kim, JH
   Park, YH
   Hwang, SA
   Kim, J
   Lee, SR
   Xu, ZL
   Ban, C
   Ahn, K
   Chun, KJ
AF Kim, Jeong Su
   Jang, Youngho
   Kim, June Hong
   Park, Yong Hyun
   Hwang, Sun Ae
   Kim, Jun
   Lee, Sung-Ryul
   Xu, Zhelong
   Ban, Changill
   Ahn, Kyohan
   Chun, Kook Jin
TI Cardioprotective Effect of the SDF-1 alpha/CXCR4 Axis in Ischemic
   Postconditioning in Isolated Rat Hearts
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Reperfusion injury; Ischemic postconditioning; Stromal cell-derived
   factor-1 alpha; CXCR4 receptors
ID SALVAGE KINASE PATHWAY; REPERFUSION INJURY; INFARCT SIZE;
   ISCHEMIA/REPERFUSION INJURY; MYOCARDIAL-INFARCTION; CELL RECRUITMENT;
   RABBIT HEARTS; RECEPTORS; PROTECTS; CXCR4
AB Background and Objectives: Information about the role of the stromal cell-derived factor1a (SDF-1 alpha)/chemokine receptor type 4 (CXCR4) axis in ischemic postconditioning (IPOC) is currently limited. We hypothesized that the SDF-1 alpha/CXCR4 signaling pathway is directly involved in the cardioprotective effect of IPOC.
   Methods: Isolated rat hearts were divided into four groups. The control group was subjected to 30-min of regional ischemia and 2-hour of reperfusion (n=12). The IPOC group was induced with 6 cycles of 10-second reperfusion and 10-second global ischemia (n=8) in each cycle. The CXCR4 antagonist, AMD3100, was applied before reperfusion in the IPOC group (AMD+IPOC group, n=11) and control group (AMD group, n=9). Hemodynamic changes with electrocardiography were monitored and infarct size was measured. The SDF-1 alpha, lactate dehydrogenase (LDH) and creatine kinase (CK) concentrations in perfusate were measured. We also analyzed extracellular signal-regulated kinase 1/2 (ERK1/2) and Akt phosphorylation state expression.
   Results: IPOC significantly reduced infarct size, but AMD3100 attenuated the infarct reducing effect of IPOC. IPOC significantly decreased LDH and CK, but these effects were reversed by AMD3100. ERK1/2 and Akt phosphorylation increased with IPOC and these effects were blocked by AMD3100.
   Conclusion: Based on the results of this study, SDF-1 alpha/CXCR4 signaling may be involved in IPOC cardioprotection and this signaling pathway couples to the ERK1/2 and Akt pathways.
C1 [Kim, Jeong Su; Jang, Youngho; Kim, June Hong; Park, Yong Hyun; Hwang, Sun Ae; Chun, Kook Jin] Pusan Natl Univ, Cardiovasc Res Inst, Res Inst Convergence Biomed Sci & Technol, Yangsan Hosp, 20 Geumo Ro, Yangsan 50612, South Korea.
   [Kim, Jun] Univ Ulsan, Asan Med Ctr, Coll Med, Seoul, South Korea.
   [Lee, Sung-Ryul] Inje Univ, Dept Physiol, Natl Res Lab Mitochondrial Signaling, Coll Med, Busan, South Korea.
   [Xu, Zhelong] Univ N Carolina, Dept Anesthesiol, Chapel Hill, NC USA.
   [Ban, Changill; Ahn, Kyohan] Pohang Univ Sci & Technol, Dept Chem, Pohang, South Korea.
RP Chun, KJ (corresponding author), Pusan Natl Univ, Cardiovasc Res Inst, Res Inst Convergence Biomed Sci & Technol, Yangsan Hosp, 20 Geumo Ro, Yangsan 50612, South Korea.
EM ptca82@gmail.com
FU Research Institute for Convergence of Biomedical Science and Technology
   Grant, Pusan National University Yangsan Hospital [30-2013-000]
FX This study was supported by the Research Institute for Convergence of
   Biomedical Science and Technology Grant (30-2013-000), Pusan National
   University Yangsan Hospital.
CR Abbott JD, 2004, CIRCULATION, V110, P3300, DOI 10.1161/01.CIR.0000147780.30124.CF
   Askari AT, 2003, LANCET, V362, P697, DOI 10.1016/S0140-6736(03)14232-8
   Chen ZL, 2008, J SURG RES, V145, P287, DOI 10.1016/j.jss.2007.07.020
   Darling CE, 2005, AM J PHYSIOL-HEART C, V289, pH1618, DOI 10.1152/ajpheart.00055.2005
   Hausenloy DJ, 2006, CARDIOVASC RES, V70, P240, DOI 10.1016/j.cardiores.2006.01.017
   Hausenloy DJ, 2005, TRENDS CARDIOVAS MED, V15, P69, DOI 10.1016/j.tcm.2005.03.001
   Hu XF, 2007, CIRCULATION, V116, P654, DOI 10.1161/CIRCULATIONAHA.106.672451
   Huang CY, 2011, AM J PHYSIOL-HEART C, V301, pH1496, DOI 10.1152/ajpheart.00365.2011
   Jang YH, 2012, CARDIOVASC THER, V30, P264, DOI 10.1111/j.1755-5922.2011.00301.x
   Jang YG, 2008, ANESTHESIOLOGY, V108, P243, DOI 10.1097/01.anes.0000299437.93898.4a
   Jujo K, 2010, P NATL ACAD SCI USA, V107, P11008, DOI 10.1073/pnas.0914248107
   Kin H, 2004, CARDIOVASC RES, V62, P74, DOI 10.1016/j.cardiores.2004.01.006
   Methner C, 2010, AM J PHYSIOL-HEART C, V299, pH1262, DOI 10.1152/ajpheart.00181.2010
   Mykytenko J, 2008, BASIC RES CARDIOL, V103, P472, DOI 10.1007/s00395-008-0731-2
   Peart JN, 2003, AM J PHYSIOL-HEART C, V285, pH81, DOI 10.1152/ajpheart.00985.2002
   Segret A, 2007, J HISTOCHEM CYTOCHEM, V55, P141, DOI 10.1369/jhc.6A7050.2006
   Tachibana K, 1998, NATURE, V393, P591, DOI 10.1038/31261
   Tsang A, 2004, CIRC RES, V95, P230, DOI 10.1161/01.RES.0000138303.76488.fe
   Van Vuuren D, 2008, CARDIOVASC DRUG THER, V22, P391, DOI 10.1007/s10557-008-6119-6
   Wei YJ, 2007, CYTOKINE, V40, P52, DOI 10.1016/j.cyto.2007.08.004
   Yang XM, 2004, J AM COLL CARDIOL, V44, P1103, DOI 10.1016/j.jacc.2004.05.060
   Zhu M, 2006, CARDIOVASC RES, V72, P152, DOI 10.1016/j.cardiores.2006.06.027
NR 22
TC 3
Z9 3
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD NOV
PY 2017
VL 47
IS 6
BP 949
EP 959
DI 10.4070/kcj.2016.0353
PG 11
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA FQ3XR
UT WOS:000418292300017
PM 29035436
OA Green Published
DA 2021-04-22
ER

PT J
AU Seo, JM
   Park, JS
   Jeong, SS
AF Seo, Jeong-Min
   Park, Jong Sung
   Jeong, Sang-Seok
TI Pericardial-esophageal Fistula Complicating Atrial Fibrillation Ablation
   Successfully Resolved after Pericardial Drainage with Conservative
   Management
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Atrial fibrillation; Catheter ablation; Complications; Esophagus;
   Fistula
ID RADIOFREQUENCY-CATHETER ABLATION; PREVALENCE; INJURY; DAMAGE; TIME
AB A 40-year-old male patient underwent radiofrequency catheter ablation for symptomatic paroxysmal atrial fibrillation (AF). Although pulmonary vein (PV) isolation was successfully completed without acute complications, the patient began complaining of sustained retrosternal pain. Seventeen days after ablation, the patient visited the emergency room with fever and severe chest pain with pericarditis-like features. Chest computed tomography (CT) revealed clustered air bubbles in the pericardial space. Esophagography confirmed leakage of contrast agent into the pericardial space but not into the left atrium. While performing pericardiostomy, the operator confirmed the absence of active bleeding from the left atrium. Because there were no signs of left atrial-esophageal fistula, such as systemic embolization, conservative management based on strict fasting with fluids and antibiotic therapy was undertaken. Follow-up esophagography performed 2 weeks later showed no more contrast agent leakage, and the patient was discharged without further incident.
C1 [Seo, Jeong-Min; Park, Jong Sung] Dong A Univ Hosp, Dept Cardiol, Cardiocerebrovasc Ctr, 26 Daesingongwon Ro, Busan 49201, South Korea.
   [Jeong, Sang-Seok] Dong A Univ Hosp, Dept Thorac Surg, Cardiocerebrovasc Ctr, Busan, South Korea.
RP Park, JS (corresponding author), Dong A Univ Hosp, Dept Cardiol, Cardiocerebrovasc Ctr, 26 Daesingongwon Ro, Busan 49201, South Korea.
EM thinkmed@dau.ac.kr
CR Bailey CW, 2014, J RADIOL CASE REP, V8, P23, DOI 10.3941/jrcr.v8i10.1804
   Barbhaiya CR, 2015, J AM COLL CARDIOL, V65, P1377, DOI 10.1016/j.jacc.2014.12.053
   Calkins H, 2012, HEART RHYTHM, V9, P632, DOI 10.1016/j.hrthm.2011.12.016
   Cappato R, 2010, CIRC-ARRHYTHMIA ELEC, V3, P32, DOI 10.1161/CIRCEP.109.859116
   Dagres N, 2006, J CARDIOVASC ELECTR, V17, P1213, DOI 10.1111/j.1540-8167.2006.00611.x
   Di Biase L, 2009, CIRC-ARRHYTHMIA ELEC, V2, P108, DOI 10.1161/CIRCEP.108.815266
   Eitel C, 2013, CIRC-ARRHYTHMIA ELEC, V6, P675, DOI 10.1161/CIRCEP.113.000384
   Ghia KK, 2009, J INTERV CARD ELECTR, V24, P33, DOI 10.1007/s10840-008-9307-1
   Hornero F, 2006, J CARDIOVASC ELECTR, V17, P405, DOI 10.1111/j.1540-8167.2006.00404.x
   Pappone C, 2004, CIRCULATION, V109, P2724, DOI 10.1161/01.CIR.0000131866.44650.46
   Queneherve L, 2013, WORLD J GASTROENTERO, V19, P3352, DOI 10.3748/wjg.v19.i21.3352
   Ripley KL, 2007, J CARDIOVASC ELECTR, V18, P642, DOI 10.1111/j.1540-8167.2007.00790.x
   Schmidt M, 2008, EUROPACE, V10, P205, DOI 10.1093/europace/eun001
   Shalaby A, 2011, HEART RHYTHM, V8, P905, DOI 10.1016/j.hrthm.2011.01.035
   Zellerhoff S, 2010, CIRC-ARRHYTHMIA ELEC, V3, P155, DOI 10.1161/CIRCEP.109.915918
NR 15
TC 3
Z9 3
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD NOV
PY 2017
VL 47
IS 6
BP 970
EP 977
DI 10.4070/kcj.2016.0364
PG 8
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA FQ3XR
UT WOS:000418292300019
PM 29171210
OA Green Published
DA 2021-04-22
ER

PT J
AU Ahn, JM
   Park, DW
   Hong, SJ
   Ahn, YK
   Hahn, JY
   Kim, WJ
   Hong, SJ
   Nam, CW
   Kang, DY
   Lee, SY
   Chun, WJ
   Heo, JH
   Cho, DK
   Kim, JW
   Her, SH
   Kim, SW
   Yoo, SY
   Hong, MK
   Tahk, SJ
   Kim, KS
   Kim, MH
   Jang, Y
   Park, SJ
AF Ahn, Jung-Min
   Park, Duk-Woo
   Hong, Sung Jin
   Ahn, Young Keun
   Hahn, Joo-Yong
   Kim, Won-Jang
   Hong, Soon Jun
   Nam, Chang-Wook
   Kang, Do-Yoon
   Lee, Seung-Yul
   Chun, Woo Jung
   Heo, Jung Ho
   Cho, Deok-Kyu
   Kim, Jin Won
   Her, Sung-Ho
   Kim, Sang Wook
   Yoo, Sang-Yong
   Hong, Myeong-Ki
   Tahk, Seung-Jea
   Kim, Kee-Sik
   Kim, Moo Hyun
   Jang, Yangsoo
   Park, Seung-Jung
TI Bioresorbable Vascular Scaffold Korean Expert Panel Report
SO KOREAN CIRCULATION JOURNAL
LA English
DT Review
DE Coronary disease; Bioresorbable vascular scaffold; Stents; Thrombosis
ID ELEVATION MYOCARDIAL-INFARCTION; CORONARY-ARTERY-DISEASE; ABSORB COHORT
   B; OPTICAL COHERENCE TOMOGRAPHY; ELUTING METALLIC STENT; TERM
   CLINICAL-OUTCOMES; APPROPRIATE DEPLOYMENT; ANTIPLATELET THERAPY; LUMINAL
   DIAMETER; FOLLOW-UP
AB Bioresorbable vascular scaffold (BRS) is an innovative device that provides structural support and drug release to prevent early recoil or restenosis, and then degrades into nontoxic compounds to avoid late complications related with metallic drug-eluting stents (DESs). BRS has several putative advantages. However, recent randomized trials and registry studies raised clinical concerns about the safety and efficacy of first generation BRS. In addition, the general guidance for the optimal practice with BRS has not been suggested due to limited long-term clinical data in Korea. To address the safety and efficacy of BRS, we reviewed the clinical evidence of BRS implantation, and suggested the appropriate criteria for patient and lesion selection, scaffold implantation technique, and management.
C1 [Ahn, Jung-Min; Park, Duk-Woo; Kang, Do-Yoon; Park, Seung-Jung] Univ Ulsan, Coll Med, Asan Med Ctr, Heart Inst, 88 Olympicro 43-Gil, Seoul 05505, South Korea.
   [Hong, Sung Jin; Hong, Myeong-Ki; Jang, Yangsoo] Yonsei Univ, Coll Med, Severance Cardiovasc Hosp, Div Cardiol, Seoul, South Korea.
   [Ahn, Young Keun] Chonnam Natl Univ Hosp, Dept Med, Div Cardiol, Gwangju, South Korea.
   [Hahn, Joo-Yong] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Med,Div Cardiol, Seoul, South Korea.
   [Kim, Won-Jang] CHA Univ, CHA Bundang Med Ctr, Dept Cardiol, Seongnam, South Korea.
   [Hong, Soon Jun] Korea Univ, Anam Hosp, Cardiovasc Ctr, Dept Cardiol, Seoul, South Korea.
   [Nam, Chang-Wook] Keimyung Univ, Coll Med, Dept Med, Daegu, South Korea.
   [Lee, Seung-Yul] Wonkwang Univ Sanbon Hosp, Dept Internal Med, Sanbon, South Korea.
   [Chun, Woo Jung] Sungkyunkwan Univ, Samsung Changwon Hosp, Dept Internal Med, Div Cardiol, Chang Won, South Korea.
   [Heo, Jung Ho] Kosin Univ Gospel Hosp, Dept Internal Med, Div Cardiol, Busan, South Korea.
   [Cho, Deok-Kyu] Myongji Hosp, Dept Cardiol, Goyang, South Korea.
   [Kim, Jin Won] Korea Univ, Guro Hosp, Cardiovasc Ctr, Seoul, South Korea.
   [Her, Sung-Ho] Catholic Univ Korea, Daejeon St Marys Hosp, Div Cardiol, Daejeon, South Korea.
   [Kim, Sang Wook] Chung Ang Univ Hosp, Dept Cardiol, Seoul, South Korea.
   [Yoo, Sang-Yong] GangNeung Asan Hosp, Cardiovasc Ctr, Kangnung, South Korea.
   [Tahk, Seung-Jea] Ajou Univ, Med Ctr, Div Cardiol, Suwon, South Korea.
   [Kim, Kee-Sik] Daegu Catholic Univ, Med Ctr, Dept Internal Med, Div Cardiol, Daegu, South Korea.
   [Kim, Moo Hyun] Dong A Univ, Med Ctr, Dept Cardiol, Busan, South Korea.
RP Park, SJ (corresponding author), Univ Ulsan, Coll Med, Asan Med Ctr, Heart Inst, 88 Olympicro 43-Gil, Seoul 05505, South Korea.
EM sjpark@amc.seoul.kr
RI Hahn, Joo-Yong/AAU-7250-2020
OI Hahn, Joo-Yong/0000-0002-4412-377X; Lee, Seung-Yul/0000-0002-9039-9806;
   Kim, Sang-Wook/0000-0002-7208-8596; Hong, Sung-Jin/0000-0003-4893-039X;
   Hong, Myeong-Ki/0000-0002-2090-2031; Nam, Chang-Wook/0000-0002-3370-5774
CR Abizaid A, 2015, EUROINTERVENTION, V10, P1396, DOI 10.4244/EIJV10I12A243
   Alfonso F, 2017, JACC-CARDIOVASC INTE, V10, P1841, DOI 10.1016/j.jcin.2017.06.064
   Ali ZA, 2017, LANCET, V390, P760, DOI 10.1016/S0140-6736(17)31470-8
   Brugaletta S, 2015, JACC-CARDIOVASC INTE, V8, P189, DOI 10.1016/j.jcin.2014.10.005
   Brugaletta S, 2012, ATHEROSCLEROSIS, V221, P106, DOI 10.1016/j.atherosclerosis.2011.12.008
   Campbell PT, 2015, CATHETER CARDIO INTE, V86, P1177, DOI 10.1002/ccd.25780
   Capodanno D, 2017, JACC-CARDIOVASC INTE, V10, P425, DOI 10.1016/j.jcin.2016.12.279
   Capodanno D, 2015, EUROINTERVENTION, V10, P1144, DOI 10.4244/EIJY14M07_11
   Chakraborty R, 2016, CARDIOVASC REVASCULA, V17, P151, DOI 10.1016/j.carrev.2016.01.004
   Cortese B, 2017, AM J CARDIOL, V119, P1924, DOI 10.1016/j.amjcard.2017.03.017
   Cortese B, 2015, AM J CARDIOL, V116, P705, DOI 10.1016/j.amjcard.2015.05.049
   Diletti R, 2014, EUR HEART J, V35, P777, DOI 10.1093/eurheartj/eht546
   Diletti R, 2013, HEART, V99, P98, DOI 10.1136/heartjnl-2012-302598
   Dudek D, 2014, POL ARCH MED WEWN, V124, P669, DOI 10.20452/pamw.2550
   Ellis SG, 2015, NEW ENGL J MED, V373, P1905, DOI 10.1056/NEJMoa1509038
   Elwany M, 2017, CARDIOVASC REVASC ME
   Everaert B, 2017, NETH HEART J, V25, P419, DOI 10.1007/s12471-017-1014-z
   Farooq V, 2012, CATHETER CARDIO INTE, V79, P880, DOI 10.1002/ccd.23177
   Felix Cordula, 2015, EuroIntervention, V11 Suppl V, pV175, DOI 10.4244/EIJV11SVA42
   Felix CM, 2016, JACC-CARDIOVASC INTE, V9, P1652, DOI 10.1016/j.jcin.2016.04.035
   Foin N, 2016, EUROINTERVENTION, V12, P834, DOI 10.4244/EIJV12I7A138
   Gao RL, 2015, J AM COLL CARDIOL, V66, P2298, DOI 10.1016/j.jacc.2015.09.054
   Gomez-Lara J, 2012, EUROINTERVENTION, V8, P214, DOI 10.4244/EIJV8I2A35
   Gori T, 2014, EUROINTERVENTION, V9, P36, DOI [10.4244/EIJV919A176, 10.4244/EIJV9I9A176]
   Goto K, 2016, JACC-CARDIOVASC IMAG, V9, P1011, DOI 10.1016/j.jcmg.2015.07.006
   Hellenkamp K, 2017, INT J CARDIOL, V234, P58, DOI 10.1016/j.ijcard.2017.02.069
   Hibi K, 2015, CIRC J, V79, P24, DOI 10.1253/circj.CJ-14-1044
   Ielasi A, 2016, EUROINTERVENTION, V11, pE1589, DOI 10.4244/EIJV11I14A309
   Ielasi A, 2014, INT J CARDIOL, V173, P513, DOI 10.1016/j.ijcard.2014.03.061
   Indolfi C, 2016, NAT REV CARDIOL, V13, P719, DOI 10.1038/nrcardio.2016.151
   Ishibashi Y, 2015, JACC-CARDIOVASC INTE, V8, P1715, DOI 10.1016/j.jcin.2015.07.026
   Kajiya T, 2013, EUROINTERVENTION, V9, P501, DOI 10.4244/EIJV9I4A80
   Karanasos A, 2014, J AM COLL CARDIOL, V64, P2343, DOI 10.1016/j.jacc.2014.09.029
   Karanasos A, 2014, EUR HEART J, V35, P1781, DOI 10.1093/eurheartj/ehu031
   Kawamoto H, 2016, JACC-CARDIOVASC INTE, V9, P299, DOI 10.1016/j.jcin.2015.11.019
   Kimura T, 2015, EUR HEART J, V36, P3332, DOI 10.1093/eurheartj/ehv435
   Kochman J, 2015, CARDIOL J, V22, P315, DOI 10.5603/CJ.a2014.0090
   Kocka V, 2014, EUR HEART J, V35, P787, DOI 10.1093/eurheartj/eht545
   Kolh P, 2014, EUR J CARDIO-THORAC, V46, P517, DOI [10.1093/eurheartj/ehu278, 10.1093/ejcts/ezu366]
   Kraak RP, 2015, EUROINTERVENTION, V10, P1160, DOI 10.4244/EIJY14M08_08
   Levine GN, 2016, CIRCULATION, V134, pE123, DOI 10.1161/CIR.0000000000000404
   Miyazaki T, 2016, EUROINTERVENTION, V11, pE1580, DOI 10.4244/EIJV11I14A308
   Moscarella E, 2016, CIRC-CARDIOVASC INTE, V9, DOI 10.1161/CIRCINTERVENTIONS.115.003148
   Muramatsu T, 2014, JACC-CARDIOVASC INTE, V7, P482, DOI 10.1016/j.jcin.2014.01.155
   Onuma Y, 2013, JACC-CARDIOVASC INTE, V6, P999, DOI 10.1016/j.jcin.2013.05.017
   Pinton FA, 2015, REV BRAS CARDIOL INV, V23, P58
   Puricel S, 2016, J AM COLL CARDIOL, V67, P921, DOI 10.1016/j.jacc.2015.12.019
   Puricel S, 2015, J AM COLL CARDIOL, V65, P791, DOI 10.1016/j.jacc.2014.12.017
   Rzeszutko L, 2016, POSTEP KARDIOL INTER, V12, P108, DOI 10.5114/aic.2016.59360
   Sabate M, 2016, EUR HEART J, V37, P229, DOI 10.1093/eurheartj/ehv500
   Serruys PW, 2017, J AM COLL CARDIOL, V70, P60, DOI 10.1016/j.jacc.2017.05.028
   Serruys PW, 2016, LANCET, V388, P2479, DOI 10.1016/S0140-6736(16)32050-5
   Serruys PW, 2016, J AM COLL CARDIOL, V67, P766, DOI 10.1016/j.jacc.2015.11.060
   Serruys PW, 2015, LANCET, V385, P43, DOI 10.1016/S0140-6736(14)61455-0
   Simsek C, 2016, EUROINTERVENTION, V11, P996, DOI 10.4244/EIJY14M10_12
   Sorrentino S, 2015, BMC CARDIOVASC DISOR, V15, DOI 10.1186/s12872-015-0163-5
   Souteyrand G, 2016, EUR HEART J, V37, P1208, DOI 10.1093/eurheartj/ehv711
   Tamburino C, 2015, EUROINTERVENTION, V11, P45, DOI [10.4244/EIJY15M01_05, 10.4244/EIJV11SVA41]
   Tanaka A, 2017, JACC-CARDIOVASC INTE, V10, P539, DOI 10.1016/j.jcin.2016.12.285
   Tanaka A, 2016, CATHETER CARDIO INTE, V87, P832, DOI 10.1002/ccd.26171
   Valgimigli M, 2017, EUR HEART J
   Wiebe J, 2017, JACC-CARDIOVASC INTE, V10, P1222, DOI 10.1016/j.jcin.2017.03.029
   Wiebe J, 2014, CLIN RES CARDIOL, V103, P141, DOI 10.1007/s00392-013-0630-x
   Wohrle J, 2015, EUROINTERVENTION, V11, P149, DOI 10.4244/EIJY14M12_10
   Wykrzykowska JJ, 2017, NEW ENGL J MED, V376, P2319, DOI 10.1056/NEJMoa1614954
NR 65
TC 3
Z9 3
U1 0
U2 3
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD NOV
PY 2017
VL 47
IS 6
BP 795
EP 810
DI 10.4070/kcj.2017.0300
PG 16
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA FQ3XR
UT WOS:000418292300001
PM 29171214
OA Green Published
DA 2021-04-22
ER

PT J
AU Lee, SY
   Hong, MK
   Jang, Y
AF Lee, Seung-Yul
   Hong, Myeong-Ki
   Jang, Yangsoo
TI Formation and Transformation of Neointima after Drug-eluting Stent
   Implantation: Insights from Optical Coherence Tomographic Studies
SO KOREAN CIRCULATION JOURNAL
LA English
DT Review
DE Coronary artery disease; Drug-eluting stents; Optical coherence
   tomography
ID EX-VIVO ASSESSMENT; FOLLOW-UP; VASCULAR-RESPONSE; BARE-METAL;
   NEOATHEROSCLEROSIS; PATHOLOGY; TISSUE; FAILURE; HISTOPATHOLOGY;
   HYPERPLASIA
AB After coronary stent implantation, neointima formation resembles the wound healing process as it involves the sequential processes of inflammation, granulation, and remodeling. Because antiproliferative drugs and polymers of drug-eluting stents (DESs) delay vascular healing compared with bare metal stents, fibrin deposition can remain long after stent implantation, or inflammation can be excessive. Delayed vascular healing can be associated with adverse clinical outcomes including DES thrombosis or restenosis, and poor endothelization of DES neointima can accelerate neoatherosclerotic change inside the neointima, further contributing to luminal restenosis or neointimal instability. Despite the lack of correlation between pathologic and optical coherence tomography (OCT) findings, OCT assessments of neointima under various circumstances can reveal vascular responses to stent therapy. Homogeneous, heterogeneous, and layered neointima patterns can be recognized by OCT and can change with time. Homogeneous neointima might be associated with better clinical outcomes after DES implantation, whereas non-homogeneous neointima or neoatherosclerotic change can be associated with poorer clinical outcomes. However, limited data are currently available, and further studies are required to comprehensively address these questions.
C1 [Lee, Seung-Yul] Wonkwang Univ, Sanbon Hosp, Coll Med, Gunpo, South Korea.
   [Hong, Myeong-Ki; Jang, Yangsoo] Yonsei Univ, Coll Med, Severance Cardiovasc Hosp, Div Cardiol, 50-1 Yonsei Ro, Seoul 03722, South Korea.
   [Hong, Myeong-Ki; Jang, Yangsoo] Yonsei Univ, Coll Med, Cardiovasc Res Inst, Seoul, South Korea.
   [Hong, Myeong-Ki; Jang, Yangsoo] Yonsei Univ, Coll Med, Severance Biomed Sci Inst, Seoul, South Korea.
RP Jang, Y (corresponding author), Yonsei Univ, Coll Med, Severance Cardiovasc Hosp, Div Cardiol, 50-1 Yonsei Ro, Seoul 03722, South Korea.
EM jangys1212@yuhs.ac
OI Hong, Myeong-Ki/0000-0002-2090-2031; Lee, Seung-Yul/0000-0002-9039-9806
CR Cho YK, 2015, KOREAN CIRC J, V45, P87, DOI 10.4070/kcj.2015.45.2.87
   Farb A, 1999, CIRCULATION, V99, P44, DOI 10.1161/01.CIR.99.1.44
   Fukuhara K, 2016, J CARDIOL, V67, P437, DOI 10.1016/j.jjcc.2015.07.002
   Gonzalo N, 2009, AM HEART J, V158, P284, DOI 10.1016/j.ahj.2009.06.004
   Habara M, 2013, EUR HEART J-CARD IMG, V14, P276, DOI 10.1093/ehjci/jes183
   Hiltrop N, 2016, INT J CARDIOL, V223, P133, DOI 10.1016/j.ijcard.2016.08.076
   Imanaka T, 2016, INT J CARDIOL, V221, P1043, DOI 10.1016/j.ijcard.2016.07.110
   Itoh T, 2015, CORONARY ARTERY DIS, V26, P201, DOI 10.1097/MCA.0000000000000225
   Joner M, 2008, J AM COLL CARDIOL, V52, P333, DOI 10.1016/j.jacc.2008.04.030
   Joner M, 2006, J AM COLL CARDIOL, V48, P193, DOI 10.1016/j.jacc.2006.03.042
   Kang SJ, 2011, CIRC-CARDIOVASC INTE, V4, P9, DOI 10.1161/CIRCINTERVENTIONS.110.940320
   Kim JS, 2014, JACC-CARDIOVASC IMAG, V7, P788, DOI 10.1016/j.jcmg.2014.05.004
   Kim JS, 2012, JACC-CARDIOVASC IMAG, V5, P1147, DOI 10.1016/j.jcmg.2012.01.024
   Kimura T, 2002, CIRCULATION, V105, P2986, DOI 10.1161/01.CIR.0000019743.11941.3B
   Kimura T, 1996, NEW ENGL J MED, V334, P561, DOI 10.1056/NEJM199602293340903
   Kolandaivelu K, 2011, CIRCULATION, V123, P1400, DOI 10.1161/CIRCULATIONAHA.110.003210
   Lee SP, 2015, JACC-CARDIOVASC IMAG, V8, P50, DOI 10.1016/j.jcmg.2014.09.018
   Lee SY, 2017, J AM HEART ASSOC, V6, DOI 10.1161/JAHA.116.005386
   Lee SY, 2014, INT J CARDIOVAS IMAG, V30, P1003, DOI 10.1007/s10554-014-0437-5
   Lee SY, 2014, YONSEI MED J, V55, P944, DOI 10.3349/ymj.2014.55.4.944
   Lee SY, 2013, EUROINTERVENTION, V9, P945, DOI 10.4244/EIJV9I8A158
   LEE SL, 2014, BJU INT S3, V113, P9
   Lutter C, 2016, JACC-CARDIOVASC INTE, V9, P2511, DOI 10.1016/j.jcin.2016.09.016
   Mangiameli A, 2015, JACC-CARDIOVASC INTE, V8, P633, DOI 10.1016/j.jcin.2014.11.014
   Nakano M, 2015, CARDIOVASC INTERV TH, V30, P1, DOI 10.1007/s12928-014-0281-5
   Nakano M, 2012, JACC-CARDIOVASC IMAG, V5, P71, DOI 10.1016/j.jcmg.2011.09.015
   Nakazawa G, 2011, J AM COLL CARDIOL, V57, P1314, DOI 10.1016/j.jacc.2011.01.011
   Otsuka F, 2014, J AM COLL CARDIOL, V64, pB190, DOI 10.1016/j.jacc.2014.07.724
   Otsuka F, 2015, EUR HEART J, V36, P2147, DOI 10.1093/eurheartj/ehv205
   Otsuka F, 2014, CIRCULATION, V129, P211, DOI 10.1161/CIRCULATIONAHA.113.001790
   Simon C, 2000, J LONG-TERM EFF MED, V10, P143
   Souteyrand G, 2016, EUR HEART J, V37, P1208, DOI 10.1093/eurheartj/ehv711
   Taniwaki M, 2016, CIRCULATION, V133, P650, DOI 10.1161/CIRCULATIONAHA.115.019071
   Tearney GJ, 2012, J AM COLL CARDIOL, V59, P1058, DOI 10.1016/j.jacc.2011.09.079
   Yonetsu T, 2012, CIRC-CARDIOVASC IMAG, V5, P660, DOI 10.1161/CIRCIMAGING.112.976167
NR 35
TC 4
Z9 4
U1 0
U2 2
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD NOV
PY 2017
VL 47
IS 6
BP 823
EP 832
DI 10.4070/kcj.2017.0157
PG 10
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA FQ3XR
UT WOS:000418292300003
PM 29171207
OA Green Published
DA 2021-04-22
ER

PT J
AU Joung, B
AF Joung, Boyoung
TI Real-world Data and Recommended Dosage of Non-vitamin K Oral
   Anticoagulants for Korean Patients
SO KOREAN CIRCULATION JOURNAL
LA English
DT Review
DE Atrial fibrillation; Anticoagulants; Factor Xa inhibitors; Clinical
   trial
ID NONVALVULAR ATRIAL-FIBRILLATION; MAJOR BLEEDING RISK; MORTALITY RISKS;
   STROKE PREVENTION; DABIGATRAN; WARFARIN; RIVAROXABAN; ANTAGONIST;
   APIXABAN; SAFETY
AB Regulatory approvals of non-vitamin K antagonist oral anticoagulants (NOACs) have been based on large randomized phase III trials evaluating dabigatran, rivaroxaban, apixaban, or edoxaban relative to warfarin for atrial fibrillation (AF). The results of the trials showed that all NOACs were at least non-inferior to warfarin in the prevention of stroke/thromboembolism and showed lower rates of intracranial bleeding than those associated with warfarin. However, the trials were designed differently, varied in the inclusion/exclusion criteria, and used either one dose or a low/high dose of the NOAC drug. Some of these differences have challenged the ability to directly compare various NOACs, and comparative data on effectiveness and intracranial bleeding are sparse in "real-world" patients. Real-world data complement data from large randomized phase III trials by providing new aspects of the "real-world" absolute risks of ischemic and hemorrhagic stroke associated with NOACs vs. warfarin. Moreover, "real-world" fragile patients might have been included (e.g., patients with increased risk of bleeding, liver disease, and chronic kidney disease), although these patients would be less represented in trials. This paper introduces recently published real-world data of NOACs and further suggests the recommended dosage of NOACs for Korean patients.
C1 [Joung, Boyoung] Yonsei Univ, Coll Med, Div Cardiol, Dept Internal Med,Severance Cardiovasc Hosp, Seoul, South Korea.
RP Joung, B (corresponding author), Yonsei Univ, Coll Med, Yonsei Cardiovasc Hosp, Div Cardiol,Dept Internal Med, 50-1 Yonsei Ro, Seoul 03722, South Korea.
EM cby6908@yuhs.ac
OI Joung, Boyoung/0000-0001-9036-7225
FU Basic Science Research Program through the National Research Foundation
   of Korea - Ministry of Education, Science, and Technology
   [2017R1A2B3003303]; Korean Healthcare Technology R&D project - Ministry
   of Health and Welfare [HI16C0058, HI15C1200]
FX This study was supported by research grants from the Basic Science
   Research Program through the National Research Foundation of Korea
   funded by the Ministry of Education, Science, and Technology
   (2017R1A2B3003303). In addition, grants were received from the Korean
   Healthcare Technology R&D project funded by the Ministry of Health and
   Welfare (HI16C0058 and HI15C1200).
CR Abraham NS, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h1857
   Avgil-Tsadok M, 2016, THROMB HAEMOSTASIS, V115, P152, DOI 10.1160/TH15-03-0247
   Bai Y, 2017, STROKE, V48, P970, DOI 10.1161/STROKEAHA.116.016275
   Bouillon K, 2015, LANCET HAEMATOL, V2, pE150, DOI 10.1016/S2352-3026(15)00027-7
   Carmo J, 2016, THROMB HAEMOSTASIS, V116, P754, DOI 10.1160/TH16-03-0203
   Chan NC, 2015, J THROMB HAEMOST, V13, P353, DOI 10.1111/jth.12823
   Chan YH, 2016, J AM COLL CARDIOL, V68, P1389, DOI 10.1016/j.jacc.2016.06.062
   Coleman CI, 2016, CURR MED RES OPIN, V32, P2047, DOI 10.1080/03007995.2016.1237937
   Connolly SJ, 2009, NEW ENGL J MED, V361, P1139, DOI 10.1056/NEJMoa0905561
   Deitelzweig S, 2016, CURR MED RES OPIN, V32, P573, DOI 10.1185/03007995.2015.1131676
   Giugliano RP, 2013, NEW ENGL J MED, V369, P2093, DOI 10.1056/NEJMoa1310907
   Gorst-Rasmussen A, 2015, J THROMB HAEMOST, V13, P495, DOI 10.1111/jth.12845
   Gorst-Rasmussen A, 2016, PHARMACOEPIDEM DR S, V25, P1236, DOI 10.1002/pds.4034
   Graham DJ, 2016, JAMA INTERN MED, V176, P1662, DOI 10.1001/jamainternmed.2016.5954
   Graham DJ, 2015, CIRCULATION, V131, P157, DOI 10.1161/CIRCULATIONAHA.114.012061
   Granger CB, 2011, NEW ENGL J MED, V365, P981, DOI 10.1056/NEJMoa1107039
   Halvorsen S, 2017, EUR HEART J-CARD PHA, V3, P28, DOI 10.1093/ehjcvp/pvw031
   Hart RG, 2007, ANN INTERN MED, V147, P590, DOI 10.7326/0003-4819-147-8-200710160-00018
   Heidbuchel H, 2015, EUROPACE, V17, P1467, DOI 10.1093/europace/euv309
   Hernandez I, 2017, AM J CARDIOVASC DRUG, V17, P37, DOI 10.1007/s40256-016-0189-9
   Hohnloser SH, 2017, CLIN RES CARDIOL, V106, P618, DOI 10.1007/s00392-017-1098-x
   Kim TH, 2017, STROKE, V48, P1524, DOI 10.1161/STROKEAHA.117.016926
   Laliberte F, 2014, CURR MED RES OPIN, V30, P1317, DOI 10.1185/03007995.2014.907140
   Lamberts M, 2017, J AM HEART ASSOC, V6, DOI 10.1161/JAHA.116.004517
   Larsen TB, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i3189
   Lee H, 2017, KOREAN CIRC J, V47, P56, DOI 10.4070/kcj.2016.0045
   Lee SR, 2017, INT J CARDIOL, V236, P226, DOI 10.1016/j.ijcard.2017.02.039
   Lip GYH, 2016, THROMB HAEMOSTASIS, V116, P975, DOI 10.1160/TH16-05-0403
   Lip GYH, 2016, INT J CLIN PRACT, V70, P752, DOI 10.1111/ijcp.12863
   Lip GYH, 2014, THROMB HAEMOSTASIS, V111, P933, DOI 10.1160/TH13-09-0734
   Maura G, 2015, CIRCULATION, V132, P1252, DOI 10.1161/CIRCULATIONAHA.115.015710
   Nielsen PB, 2017, BMJ-BRIT MED J, V356, DOI 10.1136/bmj.j510
   Noseworthy PA, 2016, CHEST, V150, P1302, DOI 10.1016/j.chest.2016.07.013
   Olesen JB, 2012, NEW ENGL J MED, V367, P625, DOI 10.1056/NEJMoa1105594
   Patel MR, 2011, NEW ENGL J MED, V365, P883, DOI 10.1056/NEJMoa1009638
   Staerk L, 2017, EUR HEART J, V38, P907, DOI 10.1093/eurheartj/ehw496
   Steinberg BA, 2016, J AM COLL CARDIOL, V68, P2597, DOI 10.1016/j.jacc.2016.09.966
   Tanislav Christian, 2015, BMC Res Notes, V8, P262, DOI 10.1186/s13104-015-1237-2
   Yao XX, 2017, J AM COLL CARDIOL, V69, P2779, DOI 10.1016/j.jacc.2017.03.600
   Yao XX, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.116.003725
NR 40
TC 5
Z9 5
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD NOV
PY 2017
VL 47
IS 6
BP 833
EP 841
DI 10.4070/kcj.2017.0158
PG 9
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA FQ3XR
UT WOS:000418292300004
PM 29171208
OA Green Published
DA 2021-04-22
ER

PT J
AU Kim, IC
   Youn, JC
AF Kim, In-Cheol
   Youn, Jong-Chan
TI Understanding the Current Status of Korean Heart Transplantation Based
   on Initial KOTRY Report
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
ID INTERNATIONAL SOCIETY; ASIA
C1 [Kim, In-Cheol] Keimyung Univ, Div Cardiol, Dongsan Med Ctr, Daegu, South Korea.
   [Youn, Jong-Chan] Hallym Univ, Dongtan Sacred Heart Hosp, Div Cardiol, Coll Med, 7 Keunjaebong Gil, Hwaseong 18450, South Korea.
RP Youn, JC (corresponding author), Hallym Univ, Dongtan Sacred Heart Hosp, Div Cardiol, Coll Med, 7 Keunjaebong Gil, Hwaseong 18450, South Korea.
EM jong.chan.youn@gmail.com
RI Youn, Jong-Chan/AAS-1405-2020
OI Kim, In-Cheol/0000-0002-5751-2328; Youn, Jong-Chan/0000-0003-0998-503X
CR Costanzo MR, 2010, J HEART LUNG TRANSPL, V29, P914, DOI 10.1016/j.healun.2010.05.034
   Kim IC, 2017, KOREAN CIRC J, V47, P538, DOI 10.4070/kcj.2017.0015
   Kim SH, 2015, AM J TRANSPLANT, V15, P833, DOI 10.1111/ajt.13008
   Krittayaphong R, 2015, HEART FAIL CLIN, V11, P563, DOI 10.1016/j.hfc.2015.07.008
   Lee HY, 2017, KOREAN CIRC J, V47, P868, DOI 10.4070/kcj.2016.0403
   Lee HY, 2017, CIRC J, V81, P617, DOI 10.1253/circj.CJ-17-0162
   Lund LH, 2017, J HEART LUNG TRANSPL, V36, P1037, DOI 10.1016/j.healun.2017.07.019
   Nakatani T, 2015, CIRC J, V80, P44, DOI 10.1253/circj.CJ-15-0975
   Sivathasan C, 2017, J HEART LUNG TRANSPL, V36, P13, DOI 10.1016/j.healun.2016.09.006
   Youn JC, 2017, KOREAN CIRC J, V47, P16, DOI 10.4070/kcj.2016.0429
NR 10
TC 4
Z9 4
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD NOV
PY 2017
VL 47
IS 6
BP 858
EP 860
DI 10.4070/kcj.2017.0330
PG 3
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA FQ3XR
UT WOS:000418292300006
PM 29192425
OA Green Published
DA 2021-04-22
ER

PT J
AU Park, HS
   Han, S
AF Park, Hyoung-Seob
   Han, Seongwook
TI Gaps between Real-world Practice and Guidelines in Managing Patients
   with Atrial Fibrillation in Korea
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
ID STROKE PREVENTION; MANAGEMENT
C1 [Park, Hyoung-Seob; Han, Seongwook] Keimyung Univ, Sch Med, Dongsan Med Ctr, Div Cardiol,Dept Internal Med, 56 Dalseong Ro, Daegu 41931, South Korea.
RP Han, S (corresponding author), Keimyung Univ, Sch Med, Dongsan Med Ctr, Div Cardiol,Dept Internal Med, 56 Dalseong Ro, Daegu 41931, South Korea.
EM swhan@dsmc.or.kr
CR Calkins H, 2017, J INTERV CA IN PRESS
   Chiang CE, 2014, THROMB HAEMOSTASIS, V111, P789, DOI 10.1160/TH13-11-0948
   Fuster V, 2006, J AM COLL CARDIOL, V48, P854, DOI 10.1016/j.jacc.2006.07.009
   January CT, 2014, J AM COLL CARDIOL, V64, pE1, DOI 10.1016/j.jacc.2014.03.022
   Kim H, 2017, KOREAN CIRC J, V47, P877, DOI 10.4070/kcj.2017.0146
   Kirchhof P, 2016, EUR HEART J, V37, P2893, DOI 10.1093/eurheartj/ehw210
   Shin HW, 2012, KOREAN CIRC J, V42, P113, DOI 10.4070/kcj.2012.42.2.113
   Tse HF, 2013, HEART RHYTHM, V10, P1082, DOI 10.1016/j.hrthm.2013.03.017
   Van Gelder IC, 2010, NEW ENGL J MED, V362, P1363, DOI 10.1056/NEJMoa1001337
NR 9
TC 0
Z9 0
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD NOV
PY 2017
VL 47
IS 6
BP 861
EP 863
DI 10.4070/kcj.2017.0304
PG 3
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA FQ3XR
UT WOS:000418292300007
PM 29171215
OA Green Published
DA 2021-04-22
ER

PT J
AU Kim, SJ
AF Kim, Soo-Joong
TI The Use Pattern and Clinical Impact of Novel P2Y12 Receptor Antagonists
   for Acute Myocardial Infarction in Korea
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
ID ACUTE CORONARY SYNDROMES; CLOPIDOGREL; TICAGRELOR; PRASUGREL
C1 [Kim, Soo-Joong] Kyung Hee Univ, Coll Med, Med Ctr, Div Cardiol,Dept Internal Med, 23 Kyungheedae Ro, Seoul 02447, South Korea.
RP Kim, SJ (corresponding author), Kyung Hee Univ, Coll Med, Med Ctr, Div Cardiol,Dept Internal Med, 23 Kyungheedae Ro, Seoul 02447, South Korea.
EM soojoong@dreamwiz.com
CR Amsterdam EA, 2014, CIRCULATION, V130, pE344, DOI 10.1161/CIR.0000000000000134
   Angeras O, 2016, SCAND CARDIOVASC J, V50, P99, DOI 10.3109/14017431.2015.1119304
   Green A, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010880
   Kim C, 2017, KOREAN CIRC J KOREAN, V47, P877
   Larmore C, 2016, CATHETER CARDIO INTE, V88, P535, DOI 10.1002/ccd.26279
   Rezaei SS, 2017, INT J CARDIOL, V235, P61, DOI 10.1016/j.ijcard.2017.02.096
   Wallentin L, 2009, NEW ENGL J MED, V361, P1045, DOI 10.1056/NEJMoa0904327
   Wiviott SD, 2007, NEW ENGL J MED, V357, P2001, DOI 10.1056/NEJMoa0706482
   Yudi MB, 2016, INTERN MED J, V46, P559, DOI 10.1111/imj.13041
   Yusuf S, 2001, NEW ENGL J MED, V345, P494
NR 10
TC 0
Z9 0
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD NOV
PY 2017
VL 47
IS 6
BP 864
EP 867
DI 10.4070/kcj.2017.0302
PG 4
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA FQ3XR
UT WOS:000418292300008
PM 29192426
OA Green Published
DA 2021-04-22
ER

PT J
AU Kim, H
   Kim, TH
   Cha, MJ
   Lee, JM
   Park, J
   Park, JK
   Kang, KW
   Shim, J
   Uhm, JS
   Kim, J
   Park, HW
   Choi, EK
   Kim, JB
   Kim, C
   Lee, YS
   Joung, B
AF Kim, Hyeongsoo
   Kim, Tae-Hoon
   Cha, Myung-Jin
   Lee, Jung Myung
   Park, Junbeom
   Park, Jin-Kyu
   Kang, Ki-Woon
   Shim, Jaemin
   Uhm, Jae-Sun
   Kim, Jun
   Park, Hyung Wook
   Choi, Eue-Keun
   Kim, Jin-Bae
   Kim, Changsoo
   Lee, Young Soo
   Joung, Boyoung
TI A Prospective Survey of Atrial Fibrillation Management for Real-world
   Guideline Adherence: Comparison study of Drugs for symptom control and
   complication prEvention of Atrial Fibrillation (CODE-AF) Registry
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Atrial fibrillation; Anticoagulant agent; Guidelines adherence; Registry
ID ANTITHROMBOTIC THERAPY; MEDICARE BENEFICIARIES; WARFARIN; STROKE;
   ANTICOAGULATION; RISK; DABIGATRAN; ABLATION; COHORT
AB Background and Objectives: The aging population is rapidly increasing, and atrial fibrillation (AF) is becoming a significant public health burden in Asia, including Korea. This study evaluated current treatment patterns and guideline adherence of AF treatment.
   Methods: In a prospective observational registry (COmparison study of Drugs for symptom control and complication prEvention of Atrial Fibrillation [CODE-AF] registry), 6,275 patients with nonvalvular AF were consecutively enrolled between June 2016 and April 2017 from 10 tertiary hospitals in Korea.
   Results: The AF type was paroxysmal, persistent, and permanent in 65.3%, 30.0%, and 2.9% of patients, respectively. Underlying structural heart disease was present in 11.9%. Mean CHA(2)DS(2)-VASc was 2.7 +/- 1.7. Oral anticoagulation (OAC), rate control, and rhythm control were used in 70.1%, 53.9%, and 54.4% of patients, respectively. OAC was performed in 82.7% of patients with a high stroke risk. However, antithrombotic therapy was inadequately used in 53.4% of patients with a low stroke risk. For rate control in 192 patients with low ejection fraction (<40%), ss-blocker (65.6%), digoxin (5.2%), or both (19.3%) were adequately used in 90.1% of patients; however, a calcium channel blocker was inadequately used in 9.9%. A rhythm control strategy was chosen in 54.4% of patients. The prescribing rate of class Ic antiarrythmics, dronedarone, and sotalol was 16.9% of patients with low ejection fraction.
   Conclusion: This study shows how successfully guidelines can be applied in the real world. The nonadherence rate was 17.2%, 9.9%, and 22.4% for stroke prevention, rate control, and rhythm control, respectively.
C1 [Kim, Hyeongsoo; Kim, Tae-Hoon; Uhm, Jae-Sun; Joung, Boyoung] Yonsei Univ, Coll Med, Severance Cardiovasc Hosp, Div Cardiol,Dept Internal Med, 50-1 Yonsei Ro, Seoul 03722, South Korea.
   [Cha, Myung-Jin; Choi, Eue-Keun] Seoul Natl Univ Hosp, Dept Internal Med, Seoul, South Korea.
   [Lee, Jung Myung; Kim, Jin-Bae] Kyung Hee Univ, Kyung Hee Univ Hosp, Div Cardiol, Dept Internal Med, Seoul, South Korea.
   [Park, Junbeom] Ewha Womans Univ, Sch Med, Dept Cardiol, Seoul, South Korea.
   [Park, Jin-Kyu] Hanyang Univ, Dept Cardiol, Seoul Hosp, Seoul, South Korea.
   [Kang, Ki-Woon] Eulji Univ Hosp, Div Cardiol, Daejeon, South Korea.
   [Shim, Jaemin] Korea Univ, Div Cardiol, Dept Internal Med, Med Ctr, Seoul, South Korea.
   [Kim, Jun] Univ Ulsan, Inst Heart, Asan Med Ctr, Coll Med, Seoul, South Korea.
   [Park, Hyung Wook] Chonnam Natl Univ, Chonnam Natl Univ Hosp, Dept Cardiol, Sch Med, Gwangju, South Korea.
   [Kim, Changsoo] Yonsei Univ, Inst Human Complex & Syst Sci, Dept Prevent Med, Coll Med, Seoul, South Korea.
   [Lee, Young Soo] Catholic Univ Daegu, Daegu Catholic Univ Med Ctr, Dept Internal Med, Div Cardiol, 33,Duryugongwon Ro 17 Gil, Daegu 42472, South Korea.
RP Joung, B (corresponding author), Yonsei Univ, Coll Med, Severance Cardiovasc Hosp, Div Cardiol,Dept Internal Med, 50-1 Yonsei Ro, Seoul 03722, South Korea.; Lee, YS (corresponding author), Catholic Univ Daegu, Daegu Catholic Univ Med Ctr, Dept Internal Med, Div Cardiol, 33,Duryugongwon Ro 17 Gil, Daegu 42472, South Korea.
EM mdleeys@cu.ac.kr; cby6908@yuhs.ac
RI Choi, Eue-Keun/J-5968-2014; Lee, Jung Myung/S-6184-2019; Choi,
   Eue-Keun/K-3752-2019; Park, Junbeom/AAH-6065-2021
OI Choi, Eue-Keun/0000-0002-0411-6372; Lee, Jung Myung/0000-0002-1904-5335;
   Kim, Tae-Hoon/0000-0003-4200-3456; Cha, Myung-Jin/0000-0001-6180-0157;
   Kim, Changsoo/0000-0002-5940-5649; kim, hyeongsoo/0000-0002-5030-952X;
   a, gokul/0000-0003-2226-4691; Park, Jin-Kyu/0000-0001-7931-777X; Uhm,
   Jae-Sun/0000-0002-1611-8172; Joung, Boyoung/0000-0001-9036-7225; Shim,
   Jaemin/0000-0001-8251-1522; Kang, Ki-Woon/0000-0002-1361-0022
FU Korean Healthcare Technology R & D project - Ministry of Health and
   Welfare [HI15C1200]
FX This study was supported by a grant from the Korean Healthcare
   Technology R & D project funded by the Ministry of Health and Welfare
   (HI15C1200).
CR Al-Khatib SM, 2014, ANN INTERN MED, V160, P760, DOI 10.7326/M13-1467
   Anselmino M, 2014, CIRC-ARRHYTHMIA ELEC, V7, P1011, DOI 10.1161/CIRCEP.114.001938
   Birman-Deych E, 2006, STROKE, V37, P1070, DOI 10.1161/01.STR.0000208294.46968.a4
   Chao TF, 2015, J AM COLL CARDIOL, V66, P1339, DOI 10.1016/j.jacc.2015.07.026
   Connolly SJ, 2009, NEW ENGL J MED, V361, P1139, DOI 10.1056/NEJMoa0905561
   Donze J, 2012, AM J MED, V125, P773, DOI 10.1016/j.amjmed.2012.01.033
   Giugliano RP, 2013, NEW ENGL J MED, V369, P2093, DOI 10.1056/NEJMoa1310907
   Gorst-Rasmussen A, 2015, J THROMB HAEMOST, V13, P495, DOI 10.1111/jth.12845
   Granger CB, 2011, NEW ENGL J MED, V365, P981, DOI 10.1056/NEJMoa1107039
   Hart RG, 2007, ANN INTERN MED, V147, P590, DOI 10.7326/0003-4819-147-8-200710160-00018
   Hart RG, 2007, ANN INTERN MED, V146, P857, DOI 10.7326/0003-4819-146-12-200706190-00007
   Huisman MV, 2017, J AM COLL CARDIOL, V69, P777, DOI 10.1016/j.jacc.2016.11.061
   Huisman MV, 2016, EUROPACE, V18, P1308, DOI 10.1093/europace/euw073
   Indredavik B, 2005, J INTERN MED, V258, P133, DOI 10.1111/j.1365-2796.2005.01512.x
   January CT, 2014, CIRCULATION, V130, P2071, DOI [10.1161/CIR.0000000000000041, 10.1161/CIR.0000000000000040]
   January CT, 2014, J AM COLL CARDIOL, V64, pE1, DOI 10.1016/j.jacc.2014.03.022
   Kim TH, 2017, STROKE, V48, P1524, DOI 10.1161/STROKEAHA.117.016926
   Kirchhof P, 2016, EUR HEART J, V37, P2893, DOI 10.1093/eurheartj/ehw210
   Lafuente-Lafuente C, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005049.pub2
   Le Heuzey JY, 2010, AM J CARDIOL, V105, P687, DOI 10.1016/j.amjcard.2009.10.012
   Lee H, 2017, KOREAN CIRC J, V47, P56, DOI 10.4070/kcj.2016.0045
   Lip GYH, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.114.001179
   Nielsen JC, 2012, NEW ENGL J MED, V367, P1587, DOI 10.1056/NEJMoa1113566
   Nikolaidou T, 2009, POSTGRAD MED J, V85, P303, DOI 10.1136/pgmj.2008.068908
   Park J, 2017, YONSEI MED J, V58, P282, DOI 10.3349/ymj.2017.58.2.282
   Patel MR, 2011, NEW ENGL J MED, V365, P883, DOI 10.1056/NEJMoa1009638
   Piccini JP, 2012, HEART RHYTHM, V9, P1403, DOI 10.1016/j.hrthm.2012.04.031
   Sandhu RK, 2011, HEART, V97, P2046, DOI 10.1136/heartjnl-2011-300901
   Van Gelder IC, 2010, NEW ENGL J MED, V362, P1363, DOI 10.1056/NEJMoa1001337
NR 29
TC 18
Z9 18
U1 0
U2 3
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD NOV
PY 2017
VL 47
IS 6
BP 877
EP 887
DI 10.4070/kcj.2017.0146
PG 11
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA FQ3XR
UT WOS:000418292300010
PM 29171211
OA Green Published
DA 2021-04-22
ER

PT J
AU Kim, C
   Shin, DH
   Ahn, CM
   Kim, JS
   Kim, BK
   Ko, YG
   Choi, D
   Hong, MK
   Park, J
   Lee, H
   Choi, YJ
   Choi, YS
   Oh, SK
   Jang, Y
AF Kim, Choongki
   Shin, Dong-Ho
   Ahn, Chul-Min
   Kim, Jung-Sun
   Kim, Byeong-Keuk
   Ko, Young-Guk
   Choi, Donghoon
   Hong, Myeong-Ki
   Park, Juhee
   Lee, Hyeyeong
   Choi, Yoon Jung
   Choi, Youn Song
   Oh, Sang-Kwon
   Jang, Yangsoo
TI The Use Pattern and Clinical Impact of New Antiplatelet Agents Including
   Prasugrel and Ticagrelor on 30-day Outcomes after Acute Myocardial
   Infarction in Korea: Korean Health Insurance Review and Assessment Data
SO KOREAN CIRCULATION JOURNAL
LA English
DT Review
DE Myocardial infarction; Prasugrel; Ticagrelor; Clopidogrel; Percutaneous
   coronary intervention
ID ACUTE CORONARY SYNDROMES; ASSOCIATION TASK-FORCE; 2013 ACCF/AHA
   GUIDELINE; PLATELET INHIBITION; AMERICAN-COLLEGE; VS. CLOPIDOGREL;
   AHA/ACC GUIDELINE; FOCUSED UPDATE; DOUBLE-BLIND; PLATO
AB Background and Objectives: Despite the favorable efficacy of new antiplatelet agents demonstrated in randomized controlled trials, their clinical implications in Korea are unclear. The purpose of this study was to investigate trends in antiplatelet agent use for acute myocardial infarction (AMI) and their impact on 30-day clinical outcomes.
   Methods: AMI patients undergoing percutaneous coronary intervention between 2010 and 2015 were assessed using claim data from the Health Insurance Review and Assessment Service.
   Results: The use of new antiplatelet agents has rapidly increased since 2013 and has been preferred over clopidogrel (Plavix; Bristol-Myers Squibb/Sanofi Pharmaceuticals) since 2015. Both prasugrel (Effient; Eli Lilly and Company) (odds ratio [OR], 0.45; 95% confidence interval [CI], 0.31-0.67; p<0.001) and ticagrelor (Brilinta; AstraZeneca Pharmaceuticals LP) (OR, 0.84; 95% CI, 0.71-0.98; p=0.032) had an independent effect on lowering 30-day mortality in a weighted multivariable logistic regression model. However, new antiplatelet agents had no significant effect on other clinical outcomes including myocardial infarction, stroke, bleeding, and readmission within 30 days.
   Conclusion: The use of new antiplatelet agents is rapidly increasing, and they have been used more commonly than clopidogrel since 2015. We demonstrated that new antiplatelet agents have a favorable effect on reducing 30-day mortality in AMI patients in Korea.
C1 [Kim, Choongki; Shin, Dong-Ho; Ahn, Chul-Min; Kim, Jung-Sun; Kim, Byeong-Keuk; Ko, Young-Guk; Choi, Donghoon; Hong, Myeong-Ki; Jang, Yangsoo] Yonsei Univ, Coll Med, Severance Cardiovasc Hosp, Div Cardiol,Dept Internal Med, 50-1 Yonsei Ro, Seoul 03722, South Korea.
   [Shin, Dong-Ho; Ahn, Chul-Min; Kim, Jung-Sun; Kim, Byeong-Keuk; Ko, Young-Guk; Choi, Donghoon; Hong, Myeong-Ki; Jang, Yangsoo] Yonsei Univ, Coll Med, Cardiovasc Res Inst, Seoul, South Korea.
   [Hong, Myeong-Ki; Jang, Yangsoo] Yonsei Univ, Coll Med, Severance Biomed Sci Inst, Seoul, South Korea.
   [Park, Juhee; Lee, Hyeyeong; Choi, Yoon Jung; Choi, Youn Song; Oh, Sang-Kwon] Hlth Insurance Review & Assessment Serv, Wonju, South Korea.
RP Jang, Y (corresponding author), Yonsei Univ, Coll Med, Severance Cardiovasc Hosp, Div Cardiol,Dept Internal Med, 50-1 Yonsei Ro, Seoul 03722, South Korea.
EM JANGYS1212@yuhs.ac
OI Hong, Myeong-Ki/0000-0002-2090-2031; Ahn, Chul-Min/0000-0002-7071-4370
CR Amsterdam EA, 2014, CIRCULATION, V130, pE344, DOI 10.1161/CIR.0000000000000134
   Anderson JL, 2013, J AM COLL CARDIOL, V61, pE179, DOI 10.1016/j.jacc.2013.01.014
   Angeras O, 2016, SCAND CARDIOVASC J, V50, P99, DOI 10.3109/14017431.2015.1119304
   Antman EM, 2008, J AM COLL CARDIOL, V51, P2028, DOI [10.1016/j.jacc.2008.04.002, 10.1016/j.jacc.2007.10.001]
   Burgette L, 2017, PROPENSITY SCORES MU
   Cannon CP, 2010, LANCET, V375, P283, DOI 10.1016/S0140-6736(09)62191-7
   Crump RK, 2009, BIOMETRIKA, V96, P187, DOI 10.1093/biomet/asn055
   Harrington RA, 2009, NEW ENGL J MED, V361, P2318, DOI 10.1056/NEJMoa0908628
   James S, 2010, EUR HEART J, V31, P3006, DOI 10.1093/eurheartj/ehq325
   James S, 2010, CIRCULATION, V122, P1056, DOI 10.1161/CIRCULATIONAHA.109.933796
   Kim L, 2014, EPIDEMIOL HEALTH, V36, DOI 10.4178/epih/e2014008
   Kolh P, 2014, EUR J CARDIO-THORAC, V46, P517, DOI [10.1093/eurheartj/ehu278, 10.1093/ejcts/ezu366]
   Levine GN, 2016, CIRCULATION, V134, pE123, DOI 10.1161/CIR.0000000000000404
   Lindholm D, 2014, EUR HEART J, V35, P2083, DOI 10.1093/eurheartj/ehu160
   Montalescot G, 2009, LANCET, V373, P723, DOI 10.1016/S0140-6736(09)60441-4
   O'Gara PT, 2013, CIRCULATION, V127, P529, DOI 10.1161/CIR.0b013e3182742c84
   Roe MT, 2012, NEW ENGL J MED, V367, P1297, DOI 10.1056/NEJMoa1205512
   Roffi M, 2016, EUR HEART J, V37, P267, DOI 10.1093/eurheartj/ehv320
   Sahlen A, 2016, EUR HEART J, V37, P3335, DOI 10.1093/eurheartj/ehw284
   Schulz S, 2014, EUR HEART J, V35, P2285, DOI 10.1093/eurheartj/ehu182
   Serebruany VL, 2015, INT J CARDIOL, V195, P104, DOI 10.1016/j.ijcard.2015.05.062
   Smith PK, 2012, J AM COLL CARDIOL, V60, P388, DOI 10.1016/j.jacc.2012.03.030
   Steg PG, 2010, CIRCULATION, V122, P2131, DOI 10.1161/CIRCULATIONAHA.109.927582
   Wallentin L, 2009, NEW ENGL J MED, V361, P1045, DOI 10.1056/NEJMoa0904327
   Wiviott SD, 2007, NEW ENGL J MED, V357, P2001, DOI 10.1056/NEJMoa0706482
NR 25
TC 14
Z9 14
U1 0
U2 3
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD NOV
PY 2017
VL 47
IS 6
BP 888
EP 897
DI 10.4070/kcj.2017.0072
PG 10
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA FQ3XR
UT WOS:000418292300011
PM 29035430
OA Green Published
DA 2021-04-22
ER

PT J
AU Yang, HM
   Seo, KW
   Yoon, J
   Kim, HS
   Chang, K
   Lim, HS
   Choi, BJ
   Choi, SY
   Yoon, MH
   Lee, SH
   Ahn, SG
   Youn, YJ
   Lee, JW
   Koo, BK
   Park, KW
   Yang, HM
   Han, JK
   Seung, KB
   Chung, WS
   Kim, PJ
   Koh, YS
   Park, HJ
   Tahk, SJ
AF Yang, Hyoung-Mo
   Seo, Kyoung-Woo
   Yoon, Junghan
   Kim, Hyo-Soo
   Chang, Kiyuk
   Lim, Hong-Seok
   Choi, Byoung-Joo
   Choi, So-Yeon
   Yoon, Myeong-Ho
   Lee, Seung-Hwan
   Ahn, Sung Gyun
   Youn, Young Jin
   Lee, Jun-Won
   Koo, Bon-Kwon
   Park, Kyung Woo
   Yang, Han-Mo
   Han, Jung-Kyu
   Seung, Ki-Bae
   Chung, Wook-Sung
   Kim, Pum-Joon
   Koh, Yoon-Seok
   Park, Hun-Jun
   Tahk, Seung-Jea
TI Clinical and Angiographic Outcomes of the First Korean-made
   Sirolimus-Eluting Coronary Stent with Abluminal Bioresorbable Polymer
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Drug-eluting stents; Coronary artery disease; Sirolimus
ID BIODEGRADABLE-POLYMER; INTRAVASCULAR ULTRASOUND; DURABLE-POLYMER;
   THROMBOSIS; TRIAL; REVASCULARIZATION; HYPERSENSITIVITY; MULTICENTER;
   STENOSIS; LEADERS
AB Background and Objectives: This trial evaluated the safety and efficacy of the Genoss drugeluting coronary stent.
   Methods: This study was a prospective, multicenter, randomized trial with a 1:1 ratio of Genoss drug-eluting stent (DES)(TM) and Promus Element (TM). Inclusion criteria were the presence of stable angina, unstable angina, or silent ischemia. Angiographic inclusion criteria were de novo coronary stenotic lesion with diameter stenosis >50%, reference vessel diameter of 2.5-4.0 mm, and lesion length <= 40 mm. The primary endpoint was in-stent late lumen loss at 9-month quantitative coronary angiography follow-up. Secondary endpoints were in-segment late lumen loss, binary restenosis rate, death, myocardial infarction (MI), target lesion revascularization (TLR), target vessel revascularization (TVR), and stent thrombosis during 9 months of follow-up.
   Results: We enrolled 38 patients for the Genoss DES (TM) group and 39 patients for the Promus Element (TM) group. In-stent late lumen loss at 9 months was not significantly different between the 2 groups (0.11 +/- 0.25 vs. 0.16 +/- 0.43 mm, p=0.567). There was no MI or stent thrombosis in either group. The rates of death (2.6% vs. 0%, p=0.494), TLR (2.6% vs. 2.6%, p=1.000), and TVR (7.9% vs. 2.6%, p=0.358) at 9 months were not significantly different.
   Conclusion: This first-in-patient study of the Genoss DES (TM) stent showed excellent angiographic outcomes for in-stent late lumen loss and major adverse cardiac events over a 9-month follow-up.
C1 [Yang, Hyoung-Mo; Seo, Kyoung-Woo; Lim, Hong-Seok; Choi, Byoung-Joo; Choi, So-Yeon; Yoon, Myeong-Ho; Tahk, Seung-Jea] Ajou Univ, Sch Med, Dept Cardiol, 164 World Cup Ro, Suwon 16499, South Korea.
   [Yoon, Junghan; Lee, Seung-Hwan; Ahn, Sung Gyun; Youn, Young Jin; Lee, Jun-Won] Yonsei Univ, Dept Cardiol, Wonju Christian Hosp, Wonju, South Korea.
   [Kim, Hyo-Soo; Koo, Bon-Kwon; Park, Kyung Woo; Yang, Han-Mo; Han, Jung-Kyu] Seoul Natl Univ, Dept Internal Med, Coll Med, Seoul, South Korea.
   [Chang, Kiyuk; Seung, Ki-Bae; Chung, Wook-Sung; Kim, Pum-Joon; Koh, Yoon-Seok; Park, Hun-Jun] Catholic Univ Korea, Seoul St Marys Hosp, Dept Internal Med, Coll Med, Seoul, South Korea.
RP Tahk, SJ (corresponding author), Ajou Univ, Sch Med, Dept Cardiol, 164 World Cup Ro, Suwon 16499, South Korea.
EM sjtahk@ajou.ac.kr
RI Park, Kyung Woo/AAX-3046-2020; Koh, Yoon-Seok/AAE-1749-2019
OI Lee, Jun-Won/0000-0001-6206-1704; Yang, Hyoung-Mo/0000-0003-3602-9772
FU Genoss Company Limited (Suwon, Korea)
FX This study was supported by Genoss Company Limited (Suwon, Korea).
CR Chevalier B, 2009, CIRC-CARDIOVASC INTE, V2, P188, DOI 10.1161/CIRCINTERVENTIONS.108.823443
   Cutlip DE, 2007, CIRCULATION, V115, P2344, DOI 10.1161/CIRCULATIONAHA.106.685313
   Joner M, 2006, J AM COLL CARDIOL, V48, P193, DOI 10.1016/j.jacc.2006.03.042
   Luscher TF, 2007, CIRCULATION, V115, P1051, DOI 10.1161/CIRCULATIONAHA.106.675934
   Meredith IT, 2011, EUROINTERVENTION, V7, P84, DOI 10.4244/EIJV7I1A15
   Meredith IT, 2009, JACC-CARDIOVASC INTE, V2, P977, DOI 10.1016/j.jcin.2009.07.007
   Mintz GS, 2001, J AM COLL CARDIOL, V37, P1478, DOI 10.1016/S0735-1097(01)01175-5
   Morice M, 2002, NEW ENGL J MED, V346, P1773, DOI 10.1056/NEJMoa012843
   Moses JW, 2003, NEW ENGL J MED, V349, P1315, DOI 10.1056/NEJMoa035071
   Nebeker JR, 2006, J AM COLL CARDIOL, V47, P175, DOI 10.1016/j.jacc.2005.07.071
   Serruys Patrick W, 2005, EuroIntervention, V1, P58
   Stefanini GG, 2012, EUR HEART J, V33, P1214, DOI 10.1093/eurheartj/ehs086
   Stone GW, 2007, NEW ENGL J MED, V356, P998, DOI 10.1056/NEJMoa067193
   Stone GW, 2004, NEW ENGL J MED, V350, P221, DOI 10.1056/NEJMoa032441
   Virmani R, 2004, CIRCULATION, V109, P701, DOI 10.1161/01.CIR.0000116202.41966.D4
   Windecker S, 2008, LANCET, V372, P1163, DOI 10.1016/S0140-6736(08)61244-1
   Zhang YJ, 2014, INT J CARDIOL, V174, P151, DOI 10.1016/j.ijcard.2014.03.167
NR 17
TC 2
Z9 2
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD NOV
PY 2017
VL 47
IS 6
BP 898
EP 906
DI 10.4070/kcj.2017.0094
PG 9
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA FQ3XR
UT WOS:000418292300012
PM 29035435
OA Green Published
DA 2021-04-22
ER

PT J
AU Chung, JH
   Lee, JM
   Her, AY
   Cho, H
   Doh, JH
   Nam, CW
   Kim, HI
   Koo, BK
   Shin, ES
AF Chung, Ju-Hyun
   Lee, Joo Myung
   Her, Ae-Young
   Cho, Heeyoun
   Doh, Joon-Hyung
   Nam, Chang-Wook
   Kim, Hyung Il
   Koo, Bon-Kwon
   Shin, Eun-Seok
TI Plaque Characteristics and Ruptured Plaque Location according to Lesion
   Geometry in Culprit Lesions of ST-Segment Elevation Myocardial
   Infarction
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE ST elevation myocardial infarction; Plaque, atherosclerotic; Diagnostic
   imaging; Coronary artery disease
ID ACUTE CORONARY SYNDROME; WALL SHEAR-STRESS; 3-DIMENSIONAL INTRAVASCULAR
   ULTRASOUND; ARTERY-DISEASE; ATHEROSCLEROSIS; ANGIOGRAPHY; ACQUISITION;
   MORPHOLOGY; PATIENT; IVUS
AB Background and Objectives: The correlations between plaque characteristics and plaque rupture location according to segmental lesion analysis have not been well defined. The aim of this study was to assess those characteristics of ST-segment elevation myocardial infarction (STEMI) culprit lesions according to segmental lesion geometry using virtual histology intravascular ultrasound (VH-IVUS).
   Methods: Sixty single discrete lesions found in the left anterior descending (LAD) coronary arteries of 60 patients with STEMI were included. Each lesion was divided into 3 segments based on lumen area (LA) index, calculated by dividing the lesion LA by the reference LA.
   Results: Among the 3 segments, the mid-segment showed the highest proportion of necrotic core (NC;proximal, mid-,and distal segments: 20.9 +/- 11.8%, 22.7 +/- 11.3%, and 17.5 +/- 11.2%, respectively, p=0.044). VH-IVUS-derived thin-cap fibroatheroma (VH-TCFA) was also more frequently found in the mid-segment than in proximal and distal segments (36.7%, 58.3%, and 16.7%, p<0.001). The mid-segment also showed the highest prevalence of plaque rupture (45.0%, 78.3% and 11.7%, p<0.001) and thrombus (61.7%, 95.0%, and 41.7%, p<0.001) compared to proximal or distal segments. When the lesions were divided into 2 groups according to the median value (4.0 mm(2)) of minimum lumen area (MLA), plaque rupture at the distal segment was observed only in high MLA lesions (23.3% vs. 0.0%, p=0.011).
   Conclusion: Analysis of longitudinal lesion geometry using the LA index can be useful in evaluating plaque vulnerability and the incidence of plaque rupture and thrombus in STEMI patients.
C1 [Chung, Ju-Hyun; Cho, Heeyoun; Shin, Eun-Seok] Univ Ulsan, Ulsan Univ Hosp, Dept Cardiol, Coll Med, 877 Bangeojinsunhwando Ro, Ulsan 44033, South Korea.
   [Lee, Joo Myung] Sungkyunkwan Univ, Dept Internal Med, Samsung Med Ctr, Sch Med, Seoul, South Korea.
   [Lee, Joo Myung] Sungkyunkwan Univ, Cardiovasc Ctr, Samsung Med Ctr, Sch Med, Seoul, South Korea.
   [Her, Ae-Young] Kangwon Natl Univ, Dept Cardiol, Sch Med, Chunchon, South Korea.
   [Doh, Joon-Hyung] Inje Univ, Dept Cardiol, Ilsan Paik Hosp, Goyang, South Korea.
   [Nam, Chang-Wook] Keimyung Univ, Dept Internal Med, Dongsan Med Ctr, Daegu, South Korea.
   [Kim, Hyung Il] Suntech Res Ctr, Seoul, South Korea.
   [Koo, Bon-Kwon] Seoul Natl Univ Hosp, Dept Internal Med, Seoul, South Korea.
   [Koo, Bon-Kwon] Seoul Natl Univ Hosp, Cardiovasc Ctr, Seoul, South Korea.
   [Koo, Bon-Kwon] Seoul Natl Univ, Inst Aging, Seoul, South Korea.
RP Shin, ES (corresponding author), Univ Ulsan, Ulsan Univ Hosp, Dept Cardiol, Coll Med, 877 Bangeojinsunhwando Ro, Ulsan 44033, South Korea.
EM sesim1989@gmail.com
OI Nam, Chang-Wook/0000-0002-3370-5774; Doh, Joon
   Hyung/0000-0001-7966-9564; Chung, Ju-Hyun/0000-0003-1435-7265; Lee, Joo
   Myung/0000-0002-2178-4014
CR Choi G, 2015, JACC-CARDIOVASC IMAG, V8, P1156, DOI 10.1016/j.jcmg.2015.04.024
   Dong L, 2015, AM J CARDIOL, V115, P860, DOI 10.1016/j.amjcard.2015.01.008
   Fukumoto Y, 2008, J AM COLL CARDIOL, V51, P645, DOI 10.1016/j.jacc.2007.10.030
   Garcia-Garcia HM, 2009, EUROINTERVENTION, V5, P177, DOI 10.4244/EIJV5I2A29
   Jang HJ, 2013, EUR HEART J, V34, P2055, DOI 10.1093/eurheartj/eht040
   Kwak BR, 2014, EUR HEART J, V35, P3013, DOI 10.1093/eurheartj/ehu353
   Lee JM, 2017, JACC-CARDIOVASC IMAG, V10, P677, DOI 10.1016/j.jcmg.2016.04.012
   Lee KE, 2016, INT J CARDIOL, V222, P799, DOI 10.1016/j.ijcard.2016.07.153
   Maehara A, 2002, J AM COLL CARDIOL, V40, P904, DOI 10.1016/S0735-1097(02)02047-8
   Mintz GS, 2001, J AM COLL CARDIOL, V37, P1478, DOI 10.1016/S0735-1097(01)01175-5
   Naghavi M, 2003, CIRCULATION, V108, P1664, DOI 10.1161/01.CIR.0000087480.94275.97
   Niccoli G, 2015, EUR HEART J, V36, P1377, DOI 10.1093/eurheartj/ehv029
   O'Gara PT, 2013, J AM COLL CARDIOL, V61, pE78, DOI 10.1016/j.jacc.2012.11.019
   Park JB, 2016, HEART, V102, P1655, DOI 10.1136/heartjnl-2016-309299
   Samady H, 2011, CIRCULATION, V124, P779, DOI 10.1161/CIRCULATIONAHA.111.021824
   Slager CJ, 2005, NAT CLIN PRACT CARD, V2, P456, DOI 10.1038/ncpcardio0298
   Stone GW, 2011, NEW ENGL J MED, V364, P226, DOI 10.1056/NEJMoa1002358
   Takaoka N, 2014, INT J CARDIOL, V171, P423, DOI 10.1016/j.ijcard.2013.12.094
   Tanaka A, 2008, EUR HEART J, V29, P38, DOI 10.1093/eurheartj/ehm507
NR 19
TC 0
Z9 0
U1 0
U2 2
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD NOV
PY 2017
VL 47
IS 6
BP 907
EP 917
DI 10.4070/kcj.2017.0108
PG 11
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA FQ3XR
UT WOS:000418292300013
PM 29171212
OA Green Published
DA 2021-04-22
ER

PT J
AU Gu, G
   Na, Y
   Chung, H
   Seok, SH
   Lee, HY
AF Gu, Gyojeong
   Na, Yirang
   Chung, Hyewon
   Seok, Seung Hyeok
   Lee, Hae-Young
TI Zebrafish Larvae Model of Dilated Cardiomyopathy Induced by Terfenadine
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Zebrafish; Heart failure; Cardiomyopathies
ID CHRONIC HEART-FAILURE; CARDIAC DEVELOPMENT; TASK-FORCE; CARDIOTOXICITY;
   TOOL
AB Background and Objectives: Dilated cardiomyopathy can be the end-stage of severe cardiac disorders and directly affects the cardiac muscle, inducing cardiomegaly and heart failure (HF). Although a wide variety of animal models are available to study dilated cardiomyopathy, there is no model to assess dilated cardiomyopathy with non-invasive, simple, and large screening methods.
   Materials and Methods: We developed a dilated cardiomyopathy model in zebrafish larvae using short duration terfenadine, a known cardiotoxic drug that induces ventricular size dilation. Fractional shortening of zebrafish hearts was calculated.
   Results: We treated zebrafish with 5 to 10 mu M terfenadine for 24 hours. In terfenadinetreated zebrafish, blood frequently pooled and clotted in the chamber, and circulation was remarkably reduced. Atria and ventricles were swollen, and fluid was deposited around the heart, mimicking edema. Cardiac contractility was significantly reduced, and ventricular area was significantly enlarged. Heart rate was markedly reduced even after terfenadine withdrawal. Acridine orange staining also showed that terfenadine increased cardiomyocyte apoptosis. A significant increase of natriuretic peptide B (NPPB) mRNA was found in terfenadine-treated zebrafish. A low dose of terfenadine (5-10 mu M) did not show mortality in short-term treatment (24 hours). However, moderate dose (35-45 mu M) terfenadine treatment reduced zebrafish survival within 1 hour.
   Conclusion: With advantages of rapid sample preparation procedure and transparent observation of the live heart, this model can potentially be applied to large-scale drug screening and toxicity assays for non-ischemic HF.
C1 [Gu, Gyojeong; Na, Yirang; Chung, Hyewon; Seok, Seung Hyeok] Seoul Natl Univ, Inst Endem Dis, Dept Microbiol & Immunol, Coll Med, Seoul, South Korea.
   [Lee, Hae-Young] Seoul Natl Univ, Dept Internal Med, Coll Med, 103 Daehak Ro, Seoul 03080, South Korea.
RP Lee, HY (corresponding author), Seoul Natl Univ, Dept Internal Med, Coll Med, 103 Daehak Ro, Seoul 03080, South Korea.; Seok, SH (corresponding author), Inst Endem Dis, Dept Microbiol & Immunol, 103 Daehak Ro, Seoul 03080, South Korea.
EM lamseok@snu.ac.kr; hylee612@snu.ac.kr
RI Seok, Seung Hyeok/J-3279-2012
OI Seok, Seung Hyeok/0000-0002-4315-0688; Lee,
   Hae-Young/0000-0002-9521-4102
FU Korean Society of Cardiology [201403-06]
FX This work was supported by a research grant from the Korean Society of
   Cardiology (201403-06).
CR Asnani A, 2014, DIS MODEL MECH, V7, P763, DOI 10.1242/dmm.016170
   Bakkers J, 2011, CARDIOVASC RES, V91, P279, DOI 10.1093/cvr/cvr098
   BELTRAMI CA, 1994, CIRCULATION, V89, P151, DOI 10.1161/01.CIR.89.1.151
   Buhler A, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17020187
   Cui GZ, 2016, CARDIOVASC TOXICOL, V16, P46, DOI 10.1007/s12012-015-9315-1
   Du CK, 2007, CIRC RES, V101, P185, DOI 10.1161/CIRCRESAHA.106.146670
   Fearnley CJ, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004242
   Gava FN, 2013, RES VET SCI, V94, P115, DOI 10.1016/j.rvsc.2012.07.027
   Hove-Madsen L, 2006, EUR J PHARMACOL, V553, P215, DOI 10.1016/j.ejphar.2006.09.023
   Huang CC, 2013, ASSAY DRUG DEV TECHN, V11, P561, DOI 10.1089/adt.2013.548
   Huang CJ, 2003, DEV DYNAM, V228, P30, DOI 10.1002/dvdy.10356
   Jung DW, 2012, MOL BIOSYST, V8, P1930, DOI 10.1039/c2mb05501e
   Kooij V, 2014, PROTEOM CLIN APPL, V8, P653, DOI 10.1002/prca.201300123
   Lee SE, 2014, EUR J HEART FAIL, V16, P700, DOI 10.1002/ejhf.91
   Mahmoudabady M, 2013, ACTA PHYSIOL HUNG, V100, P435, DOI 10.1556/APhysiol.100.2013.4.8
   Milan DJ, 2003, CIRCULATION, V107, P1355, DOI 10.1161/01.CIR.0000061912.88753.87
   OAKLEY CM, 1980, BRIT HEART J, V44, P672
   Paquet D, 2009, J CLIN INVEST, V119, P1382, DOI 10.1172/JCI37537
   Peterson RT, 2000, P NATL ACAD SCI USA, V97, P12965, DOI 10.1073/pnas.97.24.12965
   Ponikowski P, 2016, EUR HEART J, V37, P2129, DOI 10.1093/eurheartj/ehw128
   Robert J, 2007, CARDIOVASC TOXICOL, V7, P135, DOI 10.1007/s12012-007-0022-4
   Schoenebeck JJ, 2007, SEMIN CELL DEV BIOL, V18, P27, DOI 10.1016/j.semcdb.2006.12.010
   Shih YH, 2015, CIRC-CARDIOVASC GENE, V8, P261, DOI 10.1161/CIRCGENETICS.114.000702
   Tanaka Y, 2016, HEART RHYTHM, V13, P547, DOI 10.1016/j.hrthm.2015.09.025
   Tang CL, 2015, CHEM BIOL DRUG DES, V85, P253, DOI 10.1111/cbdd.12389
   TEERLINK JR, 1994, CIRC RES, V75, P105, DOI 10.1161/01.RES.75.1.105
   Tsang M, 2010, BIRTH DEFECTS RES C, V90, P185, DOI 10.1002/bdrc.20183
   Zunkler BJ, 2000, BRIT J PHARMACOL, V130, P1571, DOI 10.1038/sj.bjp.0703483
NR 28
TC 6
Z9 6
U1 2
U2 7
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD NOV
PY 2017
VL 47
IS 6
BP 960
EP 969
DI 10.4070/kcj.2017.0080
PG 10
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA FQ3XR
UT WOS:000418292300018
PM 29035434
OA Green Published
DA 2021-04-22
ER

PT J
AU Oh, JK
   Park, JH
   Seong, IW
AF Oh, Jin Kyung
   Park, Jae-Hyeong
   Seong, In-Whan
TI Huge Fresh Mobile Thrombus Attached to the Descending Thoracic Aorta
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
ID ARCH
C1 [Oh, Jin Kyung; Park, Jae-Hyeong; Seong, In-Whan] Chungnam Natl Univ, Chungnam Natl Univ Hosp, Dept Cardiol Internal Med, Sch Med, 282 Munhwa Ro, Daejeon 35015, South Korea.
RP Park, JH (corresponding author), Chungnam Natl Univ, Chungnam Natl Univ Hosp, Dept Cardiol Internal Med, Sch Med, 282 Munhwa Ro, Daejeon 35015, South Korea.
EM jaehpark@cnuh.co.kr
RI Park, Jae-Hyeong/AAD-9015-2021
OI /0000-0001-8371-9704; Jeong, Jin-Ok/0000-0003-0763-4754; Park,
   Jae-Hyeong/0000-0001-7035-286X; Seong, In-Whan/0000-0003-4628-0258
CR Amarenco P, 1996, NEW ENGL J MED, V334, P1216
   DEE W, 1993, AM HEART J, V126, P707, DOI 10.1016/0002-8703(93)90424-8
   Laperche T, 1997, CIRCULATION, V96, P288
NR 3
TC 0
Z9 0
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD NOV
PY 2017
VL 47
IS 6
BP 978
EP 980
DI 10.4070/kcj.2017.0115
PG 3
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA FQ3XR
UT WOS:000418292300020
PM 29035433
OA Green Published
DA 2021-04-22
ER

PT J
AU Lin, PY
   Tsai, WC
   Chen, JY
AF Lin, Pao-Yen
   Tsai, Wei-Chuan
   Chen, Ju-Yi
TI Unusual Disc Dislodgement of a Bjork-Shiley Valve after Long-term
   Implantation
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
C1 [Lin, Pao-Yen] Natl Cheng Kung Univ, Dept Surg, Med Coll & Hosp, Tainan, Taiwan.
   [Tsai, Wei-Chuan; Chen, Ju-Yi] Natl Cheng Kung Univ, Div Cardiol, Dept Internal Med, Med Coll & Hosp, 138 Sheng Li Rd, Tainan 70403, Taiwan.
RP Chen, JY (corresponding author), Natl Cheng Kung Univ, Div Cardiol, Dept Internal Med, Med Coll & Hosp, 138 Sheng Li Rd, Tainan 70403, Taiwan.
EM juyi@mail.ncku.edu.tw
NR 0
TC 0
Z9 0
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD NOV
PY 2017
VL 47
IS 6
BP 981
EP 981
DI 10.4070/kcj.2017.0125
PG 1
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA FQ3XR
UT WOS:000418292300021
PM 29035432
OA Green Published
DA 2021-04-22
ER

PT J
AU Berliner, D
   Bauersachs, J
AF Berliner, Dominik
   Bauersachs, Johann
TI Current Drug Therapy in Chronic Heart Failure - the New Guidelines of
   the European Society of Cardiology (ESC)
SO KOREAN CIRCULATION JOURNAL
LA English
DT Review
DE Heart failure; Standards; Drug therapy; Angiotensin receptor-neprilysin
   inhibitor
ID MINERALOCORTICOID RECEPTOR ACTIVATION; CARDIOVASCULAR OUTCOMES;
   HIGH-RISK; MORTALITY; MORBIDITY; SURVIVAL; SPIRONOLACTONE;
   EMPAGLIFLOZIN; EPLERENONE; ENALAPRIL
AB Congestive heart failure (HF) is a morbidity that is increasing worldwide due to the aging population and improvement in (acute) care for patients with cardiovascular diseases. The prognosis for patients with HF is very poor without treatment. Furthermore, (repeated) hospitalizations for cardiac decompensation cause an increasing economic burden.
   Modern drugs and the consequent implementation of therapeutic recommendations have substantially improved the morbidity and mortality of HF patients. This paper provides an overview of the current pharmacological management of HF patients, based on the 2016 guidelines of the European Society of Cardiology (ESC).
C1 [Berliner, Dominik; Bauersachs, Johann] Hannover Med Sch, Dept Cardiol & Angiol, Carl Neuberg Str 1, D-30625 Hannover, Germany.
RP Berliner, D (corresponding author), Hannover Med Sch, Dept Cardiol & Angiol, Carl Neuberg Str 1, D-30625 Hannover, Germany.
EM berliner.dominik@mh-hannover.de; bauersachs.johann@mh-hannover.de
CR Adams KF, 2016, EUR J HEART FAIL, V18, P1072, DOI 10.1002/ejhf.584
   Anker SD, 2009, NEW ENGL J MED, V361, P2436, DOI 10.1056/NEJMoa0908355
   [Anonymous], 2011, HEART FAILURE 150 QU
   Askoxylakis V, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-105
   Bauersachs J, 2015, HYPERTENSION, V65, P257, DOI 10.1161/HYPERTENSIONAHA.114.04488
   Bauersachs J, 2013, EUR HEART J, V34, P2426, DOI 10.1093/eurheartj/eht235
   Bavendiek U, 2017, EUR HEART J
   Berliner D, 2015, KOMPENDIUM HERZ KREI, V11, P23
   Bohm M, 2013, CLIN RES CARDIOL, V102, P11, DOI 10.1007/s00392-012-0467-8
   Bristow M R, 1998, Lancet, V352 Suppl 1, pSI8, DOI 10.1016/S0140-6736(98)90311-7
   Bristow MR, 1997, AM J CARDIOL, V80, pL26, DOI 10.1016/S0002-9149(97)00846-1
   Burnier M, 2000, LANCET, V355, P637, DOI 10.1016/S0140-6736(99)10365-9
   Burnier M, 2001, CIRCULATION, V103, P904, DOI 10.1161/01.CIR.103.6.904
   Chakeabarti S, 2010, J CARD FAIL, V16, pS53, DOI 10.1016/j.cardfail.2010.04.004
   Dec GW, 2015, J AM COLL CARDIOL, V66, P2072, DOI 10.1016/j.jacc.2015.08.877
   Eschalier R, 2013, J AM COLL CARDIOL, V62, P1585, DOI 10.1016/j.jacc.2013.04.086
   Fitchett D, 2016, EUR HEART J, V37, P1526, DOI 10.1093/eurheartj/ehv728
   Flather MD, 2005, EUR HEART J, V26, P215, DOI 10.1093/eurheartj/ehi118
   Gheorghiade M, 2013, EUR J HEART FAIL, V15, P551, DOI 10.1093/eurjhf/hft010
   Hjalmarson A, 2000, JAMA-J AM MED ASSOC, V283, P1295, DOI 10.1001/jama.283.10.1295
   Jankowska EA, 2016, EUR J HEART FAIL, V18, P786, DOI 10.1002/ejhf.473
   Jankowska EA, 2010, EUR HEART J, V31, P1872, DOI 10.1093/eurheartj/ehq158
   Kristensen SL, 2016, CIRC-HEART FAIL, V9, DOI 10.1161/CIRCHEARTFAILURE.115.002560
   Lechat P, 1999, LANCET, V353, P9
   Maggioni AP, 2013, EUR J HEART FAIL, V15, P1173, DOI 10.1093/eurjhf/hft134
   McMurray JJV, 2014, NEW ENGL J MED, V371, P993, DOI 10.1056/NEJMoa1409077
   Metra M, 2000, AM HEART J, V139, P511, DOI 10.1016/S0002-8703(00)90096-6
   Packer M, 2002, CIRCULATION, V106, P2194, DOI 10.1161/01.CIR.0000035653.72855.BF
   Packer M, 1999, CIRCULATION, V100, P2312, DOI 10.1161/01.CIR.100.23.2312
   Perry G, 1997, NEW ENGL J MED, V336, P525
   Pitt B, 2003, NEW ENGL J MED, V348, P1309, DOI 10.1056/NEJMoa030207
   Pitt B, 1999, NEW ENGL J MED, V341, P709, DOI 10.1056/NEJM199909023411001
   Ponikowski P, 2016, EUR HEART J, V37, P2129, DOI 10.1093/eurheartj/ehw128
   Schmieder RE, 2007, LANCET, V369, P1208, DOI 10.1016/S0140-6736(07)60242-6
   Solomon SD, 2016, EUR HEART J, V37, P455, DOI 10.1093/eurheartj/ehv464
   SWEDBERG K, 1987, NEW ENGL J MED, V316, P1429
   Swedberg K, 2010, LANCET, V376, P875, DOI 10.1016/S0140-6736(10)61198-1
   Yancy CW, 2016, J AM COLL CARDIOL, V68, P1476, DOI 10.1016/j.jacc.2016.05.011
   Young MJ, 2007, CLIN SCI, V112, P467, DOI 10.1042/CS20060275
   YUSUF S, 1991, NEW ENGL J MED, V325, P293, DOI 10.1056/NEJM199108013250501
   Zannad F, 2011, NEW ENGL J MED, V364, P11, DOI 10.1056/NEJMoa1009492
   Zinman B, 2015, NEW ENGL J MED, V373, P2117, DOI 10.1056/NEJMoa1504720
NR 42
TC 10
Z9 10
U1 0
U2 4
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD SEP
PY 2017
VL 47
IS 5
BP 543
EP 554
DI 10.4070/kcj.2017.0030
PG 12
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA FK9PB
UT WOS:000413842200001
PM 28955380
OA Green Published
DA 2021-04-22
ER

PT J
AU Kamo, T
   Akazawa, H
   Suzuki, J
   Komuro, I
AF Kamo, Takehiro
   Akazawa, Hiroshi
   Suzuki, Jun-ichi
   Komuro, Issei
TI Novel Concept of a Heart-Gut Axis in the Pathophysiology of Heart
   Failure
SO KOREAN CIRCULATION JOURNAL
LA English
DT Review
DE Gut epithelial barrier; Gastrointestinal microbiome; Dysbiosis;
   Microbe-derived metabolites
ID TRIMETHYLAMINE-N-OXIDE; TUMOR-NECROSIS-FACTOR; MYOCARDIAL HYPERTROPHY;
   CARDIOVASCULAR-DISEASE; DOUBLE-BLIND; FACTOR-ALPHA; PILOT TRIAL;
   MICROBIOTA; THERAPY; PHOSPHATIDYLCHOLINE
AB Patients with heart failure (HF) have structural and functional changes of the gut as a result of microcirculatory disturbances. A disrupted gut epithelial barrier may lead to translocation of microbial products into systemic circulation, possibly aggravating HF by inducing inflammatory responses. Gut microbiota play an essential role in the maintenance of host homeostasis because large quantities of their gene products complement host physiological processes. Emerging evidence has suggested the potential clinical significance of gut microbiota in the pathophysiology of HF. Imbalances of gut microbe-derived metabolites can contribute to cardiac dysfunction and other morbidities in patients with HF. Therapeutic research for HF through targeting microbiota is under way. Thus, the novel concept of a heart-gut axis may lead to breakthroughs in the development of innovative diagnostics and therapeutic approaches for HF.
C1 [Kamo, Takehiro; Akazawa, Hiroshi; Komuro, Issei] Univ Tokyo, Grad Sch Med, Dept Cardiovasc Med, Tokyo, Japan.
   [Suzuki, Jun-ichi] Univ Tokyo, Grad Sch Med, Dept Adv Clin Sci & Therapeut, Tokyo, Japan.
RP Akazawa, H; Komuro, I (corresponding author), Univ Tokyo, Grad Sch Med, Dept Cardiovasc Med, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138654, Japan.
EM akazawah-tky@umin.ac.jp; komuro-tky@umin.ac.jp
OI Akazawa, Hiroshi/0000-0002-3574-9607
FU Japan Society for the Promotion of ScienceMinistry of Education,
   Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for
   the Promotion of Science [KAKENHI 26670395]; Takeda Pharmaceutical Co.,
   Ltd.Takeda Pharmaceutical Company Ltd; Daiichi Sankyo Co., Ltd.Daiichi
   Sankyo Company Limited; Shionogi Co., Ltd.; Nippon Boehringer Ingelheim
   Co., Ltd.Boehringer Ingelheim; Bristol-Myers Squibb K.K.Bristol-Myers
   Squibb; MSD K.K.Merck & Company; Sanofi K.K.; Mitsubishi Tanabe Pharma
   CorporationMitsubishi Tanabe Pharma Corporation; Sumitomo Dainippon
   Pharma Co., Ltd.; Grants-in-Aid for Scientific ResearchMinistry of
   Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan
   Society for the Promotion of ScienceGrants-in-Aid for Scientific
   Research (KAKENHI) [17K15989] Funding Source: KAKEN
FX This work was supported in part by grants from the Japan Society for the
   Promotion of Science (KAKENHI 26670395) to H.A. H.A. has received
   research funding from Takeda Pharmaceutical Co., Ltd., Daiichi Sankyo
   Co., Ltd., Shionogi & Co., Ltd., Nippon Boehringer Ingelheim Co., Ltd.,
   Bristol-Myers Squibb K.K., MSD K.K., Sanofi K.K., Mitsubishi Tanabe
   Pharma Corporation, and Sumitomo Dainippon Pharma Co., Ltd.
CR Arutyunov GP, 2008, INT J CARDIOL, V125, P240, DOI 10.1016/j.ijcard.2007.11.103
   Belkaid Y, 2014, CELL, V157, P121, DOI 10.1016/j.cell.2014.03.011
   Campbell RBP, 2016, AM J PHYSIOL-GASTR L, V311, pG754, DOI 10.1152/ajpgi.00218.2016
   Chung ES, 2003, CIRCULATION, V107, P3133, DOI 10.1161/01.CIR.0000077913.60364.D2
   Costanza AC, 2015, INT J CARDIOL, V179, P348, DOI 10.1016/j.ijcard.2014.11.034
   Deswal A, 2001, CIRCULATION, V103, P2055
   Fischbach MA, 2016, CELL, V164, P1288, DOI 10.1016/j.cell.2016.02.037
   Gan XT, 2014, CIRC-HEART FAIL, V7, P491, DOI 10.1161/CIRCHEARTFAILURE.113.000978
   Kamo T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174099
   Karbach SH, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.116.003698
   Lam V, 2012, FASEB J, V26, P1727, DOI 10.1096/fj.11-197921
   Lekawanvijit S, 2015, CIRC J, V79, P2088, DOI 10.1253/circj.CJ-15-0749
   Lekawanvijit S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041281
   LEVINE B, 1990, NEW ENGL J MED, V323, P236, DOI 10.1056/NEJM199007263230405
   Li JH, 2014, NAT BIOTECHNOL, V32, P834, DOI 10.1038/nbt.2942
   Lynch SV, 2016, NEW ENGL J MED, V375, P2369, DOI 10.1056/NEJMra1600266
   Mann DL, 2004, CIRCULATION, V109, P1594, DOI 10.1161/01.CIR.0000124490.27666.B2
   Marchesi JR, 2016, GUT, V65, P330, DOI 10.1136/gutjnl-2015-309990
   Marques FZ, 2017, CIRCULATION, V135, P964, DOI [10.1161/CIRCULATIONAHA.116.024545, 10.1161/circulationaha.116.024545]
   Milani RV, 1996, CHEST, V110, P992, DOI 10.1378/chest.110.4.992
   Nagatomo Y, 2015, J CARD FAIL, V21, P973, DOI 10.1016/j.cardfail.2015.09.017
   Niebauer J, 1999, LANCET, V353, P1838, DOI 10.1016/S0140-6736(98)09286-1
   Organ CL, 2016, CIRC-HEART FAIL, V9, DOI 10.1161/CIRCHEARTFAILURE.115.002314
   Pasini E, 2016, JACC-HEART FAIL, V4, P220, DOI 10.1016/j.jchf.2015.10.009
   Peschel T, 2003, EUR J HEART FAIL, V5, P609, DOI 10.1016/S1388-9842(03)00104-1
   Rauchhaus M, 2000, CIRCULATION, V102, P3060
   Rogler G, 2014, EUR HEART J, V35, P426, DOI 10.1093/eurheartj/eht271
   Sandek A, 2007, J AM COLL CARDIOL, V50, P1561, DOI 10.1016/j.jacc.2007.07.016
   Sandek A, 2014, J AM COLL CARDIOL, V64, P1092, DOI 10.1016/j.jacc.2014.06.1179
   Schroeder B, 2016, NAT MED, V22, P1079, DOI 10.1038/nm.4185
   Sundaram V, 2016, CIRCULATION, V133, P1696, DOI 10.1161/CIRCULATIONAHA.115.020894
   Suzuki T, 2016, HEART, V102, P841, DOI 10.1136/heartjnl-2015-308826
   Tang WHW, 2015, J CARD FAIL, V21, P91, DOI 10.1016/j.cardfail.2014.11.006
   Tang WHW, 2014, J AM COLL CARDIOL, V64, P1908, DOI 10.1016/j.jacc.2014.02.617
   Tang WHW, 2014, J CLIN INVEST, V124, P4204, DOI 10.1172/JCI72331
   Tang WHW, 2013, NEW ENGL J MED, V368, P1575, DOI 10.1056/NEJMoa1109400
   Troseid M, 2015, J INTERN MED, V277, P717, DOI 10.1111/joim.12328
   van Nood E, 2013, NEW ENGL J MED, V368, P407, DOI 10.1056/NEJMoa1205037
   Verbrugge FH, 2013, J AM COLL CARDIOL, V62, P485, DOI 10.1016/j.jacc.2013.04.070
   Wang F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042027
   Wang ZN, 2015, CELL, V163, P1585, DOI 10.1016/j.cell.2015.11.055
   Wang ZN, 2011, NATURE, V472, P57, DOI 10.1038/nature09922
   Wikoff WR, 2009, P NATL ACAD SCI USA, V106, P3698, DOI 10.1073/pnas.0812874106
   Yang K, 2015, J AM SOC NEPHROL, V26, P2434, DOI 10.1681/ASN.2014060543
   Zmora N, 2016, CELL HOST MICROBE, V19, P12, DOI 10.1016/j.chom.2015.12.016
NR 45
TC 14
Z9 17
U1 3
U2 7
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD SEP
PY 2017
VL 47
IS 5
BP 663
EP 669
DI 10.4070/kcj.2017.0028
PG 7
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA FK9PB
UT WOS:000413842200004
PM 28955383
OA Green Published
DA 2021-04-22
ER

PT J
AU Akoumianakis, I
   Akawi, N
   Antoniades, C
AF Akoumianakis, Ioannis
   Akawi, Nadia
   Antoniades, Charalambos
TI Exploring the Crosstalk between Adipose Tissue and the Cardiovascular
   System
SO KOREAN CIRCULATION JOURNAL
LA English
DT Review
DE Adipose tissue; Obesity; Cardiovascular disease; Oxidative stress
ID ANGIOTENSIN-ALDOSTERONE SYSTEM; BODY-FAT DISTRIBUTION;
   INSULIN-RESISTANCE; INCREASED EXPRESSION; OXIDATIVE STRESS; OBESITY
   PARADOX; ENDOTHELIAL FUNCTION; METABOLIC SYNDROME; HEART-FAILURE;
   RISK-FACTOR
AB Obesity is a clinical entity critically involved in the development and progression of cardiovascular disease (CVD), which is characterised by variable expansion of adipose tissue (AT) mass across the body as well as by phenotypic alterations in AT. AT is able to secrete a diverse spectrum of biologically active substances called adipocytokines, which reach the cardiovascular system via both endocrine and paracrine routes, potentially regulating a variety of physiological and pathophysiological responses in the vasculature and heart. Such responses include regulation of inflammation and oxidative stress as well as cell proliferation, migration and hypertrophy. Furthermore, clinical observations such as the "obesity paradox," namely the fact that moderately obese patients with CVD have favourable clinical outcome, strongly indicate that the biological "quality" of AT may be far more crucial than its overall mass in the regulation of CVD pathogenesis. In this work, we describe the anatomical and biological diversity of AT in health and metabolic disease; we next explore its association with CVD and, importantly, novel evidence for its dynamic crosstalk with the cardiovascular system, which could regulate CVD pathogenesis.
C1 [Akoumianakis, Ioannis; Akawi, Nadia; Antoniades, Charalambos] Univ Oxford, Div Cardiovasc Med, Oxford, England.
RP Antoniades, C (corresponding author), Univ Oxford, Div Cardiovasc Med, John Radcliffe Hosp, CVM L6 West Wing,Headley Way, Oxford OX3 9DU, England.
EM antoniad@well.ox.ac.uk
RI Akawi, Nadia/AAX-2650-2020
OI Akawi, Nadia/0000-0001-6311-7028; Akoumianakis,
   Ioannis/0000-0002-4674-0210; Antoniades, Charalambos/0000-0002-6983-5423
FU British Heart FoundationBritish Heart Foundation [FS/16/15/32047,
   PG/13/56/30383]; National Institute for Health Research Oxford
   Biomedical Research CentreNational Institute for Health Research (NIHR);
   European commission (Initial Training Network [ITN] network RADical
   reduction of OXidative stress in cardiovascular disease [RADOX]);
   NovoNordisk FoundationNovo Nordisk Foundation [NNF15CC0018486];
   Alexandros S. Onassis Public Benefit Foundation; Novo Nordisk FondenNovo
   Nordisk Foundation [NNF15SA0018486] Funding Source: researchfish
FX Charalambos Antoniades acknowledges support by the British Heart
   Foundation (FS/16/15/32047 and PG/13/56/30383), the National Institute
   for Health Research Oxford Biomedical Research Centre, the European
   commission (Initial Training Network [ITN] network RADical reduction of
   OXidative stress in cardiovascular disease [RADOX]) and the NovoNordisk
   Foundation (NNF15CC0018486). Ioannis Akoumianakis acknowledges support
   by the Alexandros S. Onassis Public Benefit Foundation.
CR Abraham TM, 2015, CIRCULATION, V132, P1639, DOI 10.1161/CIRCULATIONAHA.114.015000
   Aghamohammadzadeh R, 2012, BRIT J PHARMACOL, V165, P670, DOI 10.1111/j.1476-5381.2011.01479.x
   Ahima RS, 2000, ANNU REV PHYSIOL, V62, P413, DOI 10.1146/annurev.physiol.62.1.413
   Akoumianakis I, 2016, BR J PHARM
   Antoniades C, 2009, OBES REV, V10, P269, DOI 10.1111/j.1467-789X.2009.00571.x
   Antonopoulos AS, 2016, OBES REV, V17, P989, DOI 10.1111/obr.12440
   Antonopoulos AS, 2016, CIRC RES, V118, P842, DOI 10.1161/CIRCRESAHA.115.307856
   Antonopoulos AS, 2015, DIABETES, V64, P2207, DOI 10.2337/db14-1011
   Antonopoulos AS, 2014, ARTERIOSCL THROM VAS, V34, P2151, DOI 10.1161/ATVBAHA.114.303828
   Bartelt A, 2014, NAT REV ENDOCRINOL, V10, P24, DOI 10.1038/nrendo.2013.204
   Britton KA, 2013, J AM COLL CARDIOL, V62, P921, DOI 10.1016/j.jacc.2013.06.027
   Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003
   Cat AND, 2016, DIABETES, V65, P2392, DOI 10.2337/db15-1627
   Chang YH, 2011, DIABETES-METAB RES, V27, P515, DOI 10.1002/dmrr.1201
   Chemaly ER, 2011, J MOL CELL CARDIOL, V51, P144, DOI 10.1016/j.yjmcc.2011.04.006
   Cooper SA, 2007, AM J PHYSIOL-HEART C, V293, pH2009, DOI 10.1152/ajpheart.00522.2007
   Crewe C, 2017, J CLIN INVEST, V127, P74, DOI 10.1172/JCI88883
   Dahl TB, 2007, CIRCULATION, V115, P972, DOI 10.1161/CIRCULATIONAHA.106.665893
   Ellmers LJ, 2016, J CARD FAIL, V22, P64, DOI 10.1016/j.cardfail.2015.08.341
   Essick EE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068697
   Fitzgibbons TP, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.113.000582
   Formentini L, 2009, BIOCHEM PHARMACOL, V77, P1612, DOI 10.1016/j.bcp.2009.02.017
   Fuster JJ, 2016, CIRC RES, V118, P1786, DOI 10.1161/CIRCRESAHA.115.306885
   Galic S, 2010, MOL CELL ENDOCRINOL, V316, P129, DOI 10.1016/j.mce.2009.08.018
   Gencer B, 2016, ATHEROSCLEROSIS, V245, P181, DOI 10.1016/j.atherosclerosis.2015.12.004
   Greenberg JD, 2012, NAT REV RHEUMATOL, V8, P13, DOI 10.1038/nrrheum.2011.168
   Greif M, 2009, ARTERIOSCL THROM VAS, V29, P781, DOI 10.1161/ATVBAHA.108.180653
   Hamid T, 2011, CARDIOVASC RES, V89, P129, DOI 10.1093/cvr/cvq274
   Harada K, 2016, ATHEROSCLEROSIS, V251, P299, DOI 10.1016/j.atherosclerosis.2016.07.003
   Harms M, 2013, NAT MED, V19, P1252, DOI 10.1038/nm.3361
   Hartman J, 2014, CARDIOL REV, V22, P147, DOI 10.1097/CRD.0000000000000021
   Hassan M, 2012, NAT REV CARDIOL, V9, P689, DOI 10.1038/nrcardio.2012.148
   Hatem SN, 2014, CARDIOVASC RES, V102, P205, DOI 10.1093/cvr/cvu045
   He Y, 2017, BIOMARKERS, V22, P291, DOI 10.1080/1354750X.2016.1252953
   HUBERT HB, 1983, CIRCULATION, V67, P968, DOI 10.1161/01.CIR.67.5.968
   Hung WC, 2015, CLIN INVEST MED, V38, pE100
   Hurlimann D, 2002, CIRCULATION, V106, P2184, DOI 10.1161/01.CIR.0000037521.71373.44
   Iacobellis G, 2011, TRENDS ENDOCRIN MET, V22, P450, DOI 10.1016/j.tem.2011.07.003
   Ibrahim MM, 2010, OBES REV, V11, P11, DOI 10.1111/j.1467-789X.2009.00623.x
   Jo J, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000324
   Joki Y, 2015, BIOCHEM BIOPH RES CO, V459, P124, DOI 10.1016/j.bbrc.2015.02.081
   Jung HS, 2006, CARDIOVASC RES, V69, P76, DOI 10.1016/j.cardiores.2005.09.015
   Kang S, 2011, J BIOL CHEM, V286, P18465, DOI 10.1074/jbc.M110.200022
   Kataoka Y, 2014, J AM COLL CARDIOL, V63, P2722, DOI 10.1016/j.jacc.2014.03.032
   Kazama K, 2015, BIOCHEM BIOPH RES CO, V457, P602, DOI 10.1016/j.bbrc.2015.01.032
   Kazama K, 2014, AM J PHYSIOL-HEART C, V306, pH1714, DOI 10.1152/ajpheart.00048.2014
   Kobashi C, 2005, CIRC RES, V97, P1245, DOI 10.1161/01.RES.0000194328.57164.36
   Kobayashi H, 2004, CIRC RES, V94, pE27, DOI 10.1161/01.RES.0000119921.86460.37
   Koh KK, 2008, CIRCULATION, V117, P3238, DOI 10.1161/CIRCULATIONAHA.107.741645
   Kume K, 2011, J RHEUMATOL, V38, P2169, DOI 10.3899/jrheum.110340
   Laforest S, 2015, CRIT REV CL LAB SCI, V52, P301, DOI 10.3109/10408363.2015.1041582
   Langheim S, 2010, AM J PHYSIOL-HEART C, V298, pH746, DOI 10.1152/ajpheart.00617.2009
   Laurikka A, 2014, EUR J CARDIO-THORAC, V46, P729, DOI 10.1093/ejcts/ezt634
   Lee S, 2014, CELL METAB, V19, P484, DOI 10.1016/j.cmet.2014.01.013
   Li B, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148273
   Lim SY, 2008, J CELL MOL MED, V12, P1395, DOI 10.1111/j.1582-4934.2008.00332.x
   Lovren F, 2009, AM J PHYSIOL-ENDOC M, V296, pE1440, DOI 10.1152/ajpendo.90780.2008
   Marcus Y, 2013, MOL CELL ENDOCRINOL, V378, P1, DOI 10.1016/j.mce.2012.06.021
   Margaritis M, 2013, CIRCULATION, V127, P2209, DOI 10.1161/CIRCULATIONAHA.112.001133
   Marinou K, 2014, DIABETES CARE, V37, P821, DOI 10.2337/dc13-1353
   Martinez-Martinez E, 2014, J HYPERTENS, V32, P1104, DOI 10.1097/HJH.0000000000000149
   Mazurek T, 2003, CIRCULATION, V108, P2460, DOI 10.1161/01.CIR.0000099542.57313.C5
   Mazurek T, 2015, J AM COLL NUTR, V34, P244, DOI 10.1080/07315724.2014.933685
   Mazurek T, 2014, AM J CARDIOL, V113, P1505, DOI 10.1016/j.amjcard.2014.02.005
   McAninch EA, 2015, OBESITY, V23, P1267, DOI 10.1002/oby.21059
   McKellar GE, 2009, NAT REV CARDIOL, V6, P410, DOI 10.1038/nrcardio.2009.57
   McQuaid SE, 2010, DIABETES, V59, P2465, DOI 10.2337/db10-0678
   Molica F, 2015, THROMB HAEMOSTASIS, V113, P553, DOI 10.1160/TH14-06-0513
   Muse ED, 2015, ATHEROSCLEROSIS, V239, P101, DOI 10.1016/j.atherosclerosis.2014.12.044
   Nagarajan V, 2016, ESC HEART FAIL, V3, P227, DOI 10.1002/ehf2.12120
   Narumi T, 2014, CARDIOVASC DIABETOL, V13, DOI 10.1186/1475-2840-13-84
   Nian M, 2004, CIRC RES, V94, P1543, DOI 10.1161/01.RES.0000130526.20854.fa
   Nishida C, 2010, EUR J CLIN NUTR, V64, P2, DOI 10.1038/ejcn.2009.139
   Ntaios G, 2013, ATHEROSCLEROSIS, V227, P216, DOI 10.1016/j.atherosclerosis.2012.12.029
   Ohashi K, 2014, TRENDS ENDOCRIN MET, V25, P348, DOI 10.1016/j.tem.2014.03.009
   Ouedraogo R, 2007, J CLIN INVEST, V117, P1718, DOI 10.1172/JCI29623
   Pacurari M, 2014, INT J INFLAMM, V2014, DOI 10.1155/2014/689360
   Park J, 2014, PROG CARDIOVASC DIS, V56, P415, DOI 10.1016/j.pcad.2013.10.005
   Reilly SN, 2011, CIRCULATION, V124, P1107, DOI 10.1161/CIRCULATIONAHA.111.029223
   Romacho T, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/946427
   Ronti T, 2006, CLIN ENDOCRINOL, V64, P355, DOI 10.1111/j.1365-2265.2006.02474.x
   Rothwell SE, 2006, BIOCHEM BIOPH RES CO, V349, P400, DOI 10.1016/j.bbrc.2006.08.052
   Saely CH, 2016, ATHEROSCLEROSIS, V244, P38, DOI 10.1016/j.atherosclerosis.2015.10.100
   Saely CH, 2012, GERONTOLOGY, V58, P15, DOI 10.1159/000321319
   Shibata R, 2005, NAT MED, V11, P1096, DOI 10.1038/nm1295
   Smith CCT, 2006, BRIT J PHARMACOL, V149, P5, DOI 10.1038/sj.bjp.0706834
   Sowers JR, 2003, AM J MED, V115, P37, DOI 10.1016/j.amjmed.2003.08.012
   Sun M, 2007, CIRCULATION, V115, P1398, DOI 10.1161/CIRCULATIONAHA.106.643585
   Sweeney G, 2010, NAT REV CARDIOL, V7, P22, DOI 10.1038/nrcardio.2009.224
   Takeishi Y, 2007, CIRC J, V71, P460, DOI 10.1253/circj.71.460
   Tam CS, 2012, CIRCULATION, V125, P2782, DOI 10.1161/CIRCULATIONAHA.111.042929
   Tan BK, 2010, TRENDS CARDIOVAS MED, V20, P143, DOI 10.1016/j.tcm.2010.12.002
   Tanaka N, 2015, J BIOL CHEM, V290, P3092, DOI 10.1074/jbc.M114.605980
   Thanassoulis G, 2010, CIRC-ARRHYTHMIA ELEC, V3, P345, DOI 10.1161/CIRCEP.109.912055
   Tumer N, 2007, J HYPERTENS, V25, P2471, DOI 10.1097/HJH.0b013e3282e9a9fd
   Uemura Y, 2015, FASEB J, V29, P141, DOI 10.1096/fj.14-258129
   Vallejo S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027299
   Vanhoutte PM, 2009, CIRC J, V73, P595, DOI 10.1253/circj.CJ-08-1169
   Venteclef N, 2015, EUR HEART J, V36, P795, DOI 10.1093/eurheartj/eht099
   Villarroya J, 2013, AM J PHYSIOL-ENDOC M, V305, pE567, DOI 10.1152/ajpendo.00250.2013
   von Lueder TG, 2013, CARDIOVASC DRUG THER, V27, P171, DOI 10.1007/s10557-012-6424-y
   Wellen KE, 2003, J CLIN INVEST, V112, P1785, DOI 10.1172/JCI20514
   Wong M, 2009, ANN RHEUM DIS, V68, P1277, DOI 10.1136/ard.2007.086157
   Woodward L, 2016, BR J PHARM
   Xiao J, 2013, J CELL PHYSIOL, V228, P495, DOI 10.1002/jcp.24257
   Yamawaki H, 2011, BIOCHEM BIOPH RES CO, V408, P339, DOI 10.1016/j.bbrc.2011.04.039
   Yamawaki H, 2009, BIOCHEM BIOPH RES CO, V383, P503, DOI 10.1016/j.bbrc.2009.04.074
   Yan WJ, 2013, BASIC RES CARDIOL, V108, DOI 10.1007/s00395-013-0329-1
   Yudkin JS, 2005, LANCET, V365, P1817, DOI 10.1016/S0140-6736(05)66585-3
   Zuo GX, 2015, INT J CLIN EXP MED, V8, P5553
NR 110
TC 8
Z9 9
U1 0
U2 3
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD SEP
PY 2017
VL 47
IS 5
BP 670
EP 685
DI 10.4070/kcj.2017.0041
PG 16
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA FK9PB
UT WOS:000413842200005
PM 28955384
OA Green Published
DA 2021-04-22
ER

PT J
AU Yun, KH
   Rhee, SJ
   Ko, JS
AF Yun, Kyeong Ho
   Rhee, Sang Jae
   Ko, Jum Suk
TI Comparison of the Infarct Size between the Loading of Ticagrelor and
   Clopidogrel in Patients with Acute Myocardial Infarction Undergoing
   Primary Percutaneous Coronary Intervention
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Angioplasty; Myocardial infarction; Blood platelets; Receptors,
   purinergic P2Y12
ID ADENOSINE; ENHANCEMENT; REPERFUSION; INJURY; FLOW
AB Background and Objectives: Ticagrelor is considered a potent antiplatelet agent compared to clopidogrel. However, there are no studies regarding the effect of ticagrelor loading on infarct size in patients with ST-segment elevation myocardial infarction (STEMI) in a primary percutaneous coronary intervention (PCI) setting.
   Subjects and Methods: In this single-center, randomized, open-label study, 188 patients who underwent primary PCI for STEMI were enrolled (92 patients in the clopidogrel group and 96 in the ticagrelor group) and compared the infarct size by technetium-99m (Tc-99m) tetrofosmin single-photon emission computed tomography (SPECT) and serial cardiac biomarker levels between the groups. SPECT was performed at a median of 2 days after PCI.
   Results: Baseline clinical and procedural characteristics were similar between the groups. Infarct size on SPECT, was similar between the 2 groups (28.1%+/- 34.5% vs. 32.8%+/- 29.2%; p=0.169). At all time-points after PCI (8, 24, and 48 hours), the peak levels of creatine kinase-myocardial band (CK-MB) and troponin T were lower in the clopidogrel group. The clopidogrel group showed lower cumulative troponin T levels than the ticagrelor group (12.59 +/- 10.66 vs. 17.67 +/- 19.51 ng/mL; p=0.029).
   Conclusion: Ticagrelor loading before primary PCI was not associated with reduced myocardial infarct size during the first 48 hours, compared to clopidogrel loading.
C1 [Yun, Kyeong Ho; Rhee, Sang Jae; Ko, Jum Suk] Wonkwang Univ Hosp, Dept Cardiovasc Med, Reg Cardiocerebrovasc Ctr, 895 Muwang Ro, Iksan 54538, South Korea.
RP Rhee, SJ (corresponding author), Wonkwang Univ Hosp, Dept Cardiovasc Med, Reg Cardiocerebrovasc Ctr, 895 Muwang Ro, Iksan 54538, South Korea.
EM bsjsh@chol.com
OI Yun, Kyeong Ho/0000-0003-4911-8854; ko, jumsuk/0000-0002-8573-0066
CR Alexopoulos D, 2013, CIRC-CARDIOVASC INTE, V6, P277, DOI 10.1161/CIRCINTERVENTIONS.113.000293
   Bonello L, 2014, J AM COLL CARDIOL, V63, P872, DOI 10.1016/j.jacc.2013.09.067
   Gibbons RJ, 2011, J CARDIOVASC PHARM T, V16, P321, DOI 10.1177/1074248411414906
   Gibson CM, 1996, CIRCULATION, V93, P879, DOI 10.1161/01.CIR.93.5.879
   Hadamitzky M, 2014, EUR HEART J-CARD IMG, V15, P216, DOI 10.1093/ehjci/jet176
   Hahn JY, 2011, AM HEART J, V162, P1026, DOI 10.1016/j.ahj.2011.08.011
   Kim JW, 2014, KOREAN CIRC J, V44, P76, DOI 10.4070/kcj.2014.44.2.76
   Lee CW, 2011, AM J CARDIOL, V108, P799, DOI 10.1016/j.amjcard.2011.05.008
   Lund GK, 2004, RADIOLOGY, V232, P49, DOI 10.1148/radiol.2321031127
   Nanhwan MK, 2014, ARTERIOSCL THROM VAS, V34, P2078, DOI 10.1161/ATVBAHA.114.304002
   Park SD, 2016, EUROINTERVENTION, V12, pE964, DOI 10.4244/EIJV12I8A159
   PELLIKKA PA, 1990, J NUCL MED, V31, P1269
   van't Hof AWJ, 1998, CIRCULATION, V97, P2302, DOI 10.1161/01.CIR.97.23.2302
   Vilahur G, 2016, CIRCULATION, V134, P1708, DOI 10.1161/CIRCULATIONAHA.116.024014
   Wallentin L, 2009, NEW ENGL J MED, V361, P1045, DOI 10.1056/NEJMoa0904327
   Wittfeldt A, 2013, J AM COLL CARDIOL, V61, P723, DOI 10.1016/j.jacc.2012.11.032
NR 16
TC 4
Z9 4
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD SEP
PY 2017
VL 47
IS 5
BP 705
EP 713
DI 10.4070/kcj.2017.0044
PG 9
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA FK9PB
UT WOS:000413842200010
PM 28955389
OA Green Published
DA 2021-04-22
ER

PT J
AU Youn, YJ
   Yoo, BS
   Son, JW
   Lee, JW
   Ahn, MS
   Ahn, SG
   Kim, JY
   Lee, SH
   Yoon, J
   Eom, YW
   Oh, JE
   Choi, SK
AF Youn, Young Jin
   Yoo, Byung-Su
   Son, Jung-Woo
   Lee, Jun-Won
   Ahn, Min-Soo
   Ahn, Sung Gyun
   Kim, Jang-Young
   Lee, Seung-Hwan
   Yoon, Junghan
   Eom, Young Woo
   Oh, Ji-Eun
   Choi, Seong-Kyung
TI Remote Ischemic Conditioning by Effluent Collected from a Novel Isolated
   Hindlimb Model Reduces Infarct Size in an Isolated Heart Model
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Models, Animal; ERK 1/2; Rats; Remote ischemic conditioning; STAT-3
ID INJURY SALVAGE KINASE; REPERFUSION INJURY; CORONARY EFFLUENT;
   HUMORAL-FACTORS; RAT HEARTS; CARDIOPROTECTION; PATHWAY; ACTIVATION;
   OCCLUSION; PROTECTS
AB Background and Objectives: Experimental protocols for remote ischemic conditioning (RIC) utilize models in which a tourniquet is placed around the hindlimb or effluent is collected from an isolated heart. In analyzing the humoral factors that act as signal transducers in these models, sampled blood can be influenced by systemic responses, while the effluent from an isolated heart might differ from that of the hindlimb. Thus, we designed a new isolated hindlimb model for RIC and tested whether the effluent from this model could affect ischemia/reperfusion (IR) injury and if the reperfusion injury salvage kinase (RISK) and survivor activating factor enhancement (SAFE) pathways are involved in RIC.
   Materials and Methods: After positioning needles into the right iliac artery and vein of rats, Krebs-Henseleit buffer was perfused using a Langendorff apparatus, and effluent was collected. The RIC protocol consisted of 3 cycles of IR for 5 minutes. In the RIC effluent group, collected effluent was perfused in an isolated heart for 10 minutes before initiating IR injury.
   Results: Compared with the control group, the infarct area in the RIC effluent group was significantly smaller (31.2%+/- 3.8% vs. 20.6%+/- 1.8%, p < 0.050), while phosphorylation of signal transducer and activation of transcription-3 (STAT-3) was significantly increased. However, there was a trend of increased phosphorylation of extracellular signal-regulated kinase (ERK) 1/2 in this group.
   Conclusion: This is the first study to investigate the effect of effluent from a new isolated hindlimb model after RIC on IR injury in an isolated heart model. The RIC effluent was effective in reducing the IR injury, and the cardioprotective effect was associated with activation of the SAFE pathway.
C1 [Youn, Young Jin; Yoo, Byung-Su; Son, Jung-Woo; Lee, Jun-Won; Ahn, Min-Soo; Ahn, Sung Gyun; Kim, Jang-Young; Lee, Seung-Hwan; Yoon, Junghan] Yonsei Univ, Wonju Coll Med, Dept Internal Med, Div Cardiol, 20 Ilsan Ro, Wonju 26426, South Korea.
   [Eom, Young Woo; Oh, Ji-Eun] Yonsei Univ, Wonju Coll Med, Cell Therapy & Tissue Engn Ctr, Wonju, South Korea.
   [Choi, Seong-Kyung] Yonsei Univ, Wonju Coll Med, Cent Res Lab, Anim Core, Wonju, South Korea.
RP Yoo, BS (corresponding author), Yonsei Univ, Wonju Coll Med, Dept Internal Med, Div Cardiol, 20 Ilsan Ro, Wonju 26426, South Korea.
EM yubs@yonsei.ac.kr
RI Ahn, Sung Gyun/AAG-5976-2020
OI Ahn, Sung Gyun/0000-0002-1528-2739; Youn, Young Jin/0000-0001-7066-7474;
   Lee, Jun-Won/0000-0001-6206-1704; Yoon, Junghan/0000-0002-3363-2675;
   Eom, Young Woo/0000-0002-5985-6490; Son, Jung-Woo/0000-0002-1790-3228
FU office of Research Affairs/University Industry Foundation [2014-51-0407]
FX This work was funded by the office of Research Affairs/University
   Industry Foundation (Grant No. 2014-51-0407).
CR Breivik L, 2011, BASIC RES CARDIOL, V106, P135, DOI 10.1007/s00395-010-0133-0
   Dickson EW, 1999, AM J PHYSIOL-HEART C, V277, pH2451
   Ferrera R, 2009, CARDIOVASC DRUG THER, V23, P327, DOI 10.1007/s10557-009-6176-5
   Gross ER, 2013, BASIC RES CARDIOL, V108, DOI 10.1007/s00395-013-0381-x
   Gross GJ, 2011, CARDIOVASC DRUG THER, V25, P517, DOI 10.1007/s10557-011-6321-9
   Hausenloy DJ, 2006, CARDIOVASC RES, V70, P240, DOI 10.1016/j.cardiores.2006.01.017
   Hausenloy DJ, 2004, CARDIOVASC RES, V61, P448, DOI 10.1016/j.cardiores.2003.09.024
   Heidbreder M, 2008, CARDIOVASC RES, V78, P108, DOI 10.1093/cvr/cvm114
   Heinen NM, 2011, SHOCK, V36, P45, DOI 10.1097/SHK.0b013e31821d8e77
   Heusch G, 2015, J AM COLL CARDIOL, V65, P177, DOI 10.1016/j.jacc.2014.10.031
   Huffman LC, 2008, AM J PHYSIOL-HEART C, V294, pH257, DOI 10.1152/ajpheart.00769.2007
   Jones WK, 2009, CIRCULATION, V120, pS1, DOI 10.1161/CIRCULATIONAHA.108.843938
   Lacerda L, 2009, CARDIOVASC RES, V84, P201, DOI 10.1093/cvr/cvp274
   Lecour S, 2009, J MOL CELL CARDIOL, V47, P32, DOI 10.1016/j.yjmcc.2009.03.019
   Li YW, 2017, KOREAN CIRC J, V47, P182, DOI 10.4070/kcj.2015.0295
   MURRY CE, 1986, CIRCULATION, V74, P1124, DOI 10.1161/01.CIR.74.5.1124
   Pickard JMJ, 2016, BASIC RES CARDIOL, V111, DOI 10.1007/s00395-016-0568-z
   PRZYKLENK K, 1993, CIRCULATION, V87, P893, DOI 10.1161/01.CIR.87.3.893
   Sachdeva J, 2014, J CARDIOVASC PHARM T, V19, P567, DOI 10.1177/1074248413518967
   Serejo FC, 2007, J CARDIOVASC PHARM, V49, P214, DOI 10.1097/FJC.0b013e3180325ad9
   Skyschally A, 2015, CIRC RES, V117, P279, DOI 10.1161/CIRCRESAHA.117.306878
   Song BW, 2014, KOREAN CIRC J, V44, P16, DOI 10.4070/kcj.2014.44.1.16
   Tamareille S, 2011, BASIC RES CARDIOL, V106, P1329, DOI 10.1007/s00395-011-0210-z
   Weinbrenner C, 2002, CARDIOVASC RES, V55, P590, DOI 10.1016/S0008-6363(02)00446-7
   Wong GTC, 2012, LIFE SCI, V91, P860, DOI 10.1016/j.lfs.2012.08.037
   Xin P, 2010, AM J PHYSIOL-HEART C, V298, pH1819, DOI 10.1152/ajpheart.01102.2009
   Yellon DM, 2007, NEW ENGL J MED, V357, P1121, DOI 10.1056/NEJMra071667
   Zhao ZQ, 2003, AM J PHYSIOL-HEART C, V285, pH579, DOI 10.1152/ajpheart.01064.2002
NR 28
TC 6
Z9 6
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD SEP
PY 2017
VL 47
IS 5
BP 714
EP 726
DI 10.4070/kcj.2017.0092
PG 13
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA FK9PB
UT WOS:000413842200011
PM 28955390
OA Green Published
DA 2021-04-22
ER

PT J
AU Kim, M
   Kim, MS
   Lim, SJ
   Ahn, JM
   Kim, JJ
   Park, SJ
AF Kim, Minsu
   Kim, Min-Seok
   Lim, Seo-Jin
   Ahn, Jung-Min
   Kim, Jae-Joong
   Park, Seung-Jung
TI Comparison of Supervised Hospital-based versus Educated Home-based
   Exercise Training in Korean Heart Failure Patients
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Heart failure; Exercise; Rehabilitation
ID QUALITY-OF-LIFE; AEROBIC CAPACITY; CONTROLLED-TRIAL; ASSOCIATION
AB Background and Objectives: Although many clinical trials have shown that exercise training (ET) improves functional capacity and clinical outcomes in heart failure (HF) patients, data comparing supervised hospital-based and educated home-based ET in HF patients is lacking.
   Subjects and Methods: This was a single-center, non-randomized, prospective study of 82 HF patients with reduced ejection fraction (<= 40%) who completed ET. The hospital-based group (n=30) underwent supervised ET at 60% of peak oxygen consumption (VO2), while a physiotherapist-educated group (n=52) exercised at home without monitoring. The 2 groups were compared before and after the 3-month ET program with respect to functional capacity, quality of life (QOL), and cardiac events (all-cause mortality or hospitalization with worsening HF).
   Results: After ET, peak VO2 increased in the hospital-based group (19.4 +/- 4.4 to 21.4 +/- 4.3 mL/min/kg, p=0.006) and remained unchanged in the home-based group (18.9 +/- 4.6 to 18.4 +/- 4.6 mL/min/kg, p=0.660). The change in peak VO2 after ET was greater in the hospital-based group compared to the home-based group by 2.5 mL/min/kg (p=0.014). QOL improved in the hospital-based group (43.1 +/- 18.0 to 28.1 +/- 21.6, p=0.003). During one year of follow-up, a comparison of the 2 groups did not reveal a statistical difference in cardiac events (hazard ratio, 0.66; 95% confidence interval, 0.2-2.8; p=0.570).
   Conclusion: Hospital-based ET was beneficial for HF patients, improving functional capacity and QOL. However, no significant advantages were observed in terms of a composite endpoint compared to home-based ET. Further investigations are required to address the effects and roles of the 2 ET programs for HF patients.
C1 [Kim, Minsu; Kim, Min-Seok; Lim, Seo-Jin; Ahn, Jung-Min; Kim, Jae-Joong; Park, Seung-Jung] Univ Ulsan, Coll Med, Heart Inst, Dept Internal Med,Asan Med Ctr, 88 Olymp Ro 43, Seoul 05505, South Korea.
RP Kim, MS (corresponding author), Univ Ulsan, Coll Med, Heart Inst, Dept Internal Med,Asan Med Ctr, 88 Olymp Ro 43, Seoul 05505, South Korea.
EM msk@amc.seoul.kr
CR Belardinelli R, 1999, CIRCULATION, V99, P1173, DOI 10.1161/01.CIR.99.9.1173
   COATS AJS, 1992, CIRCULATION, V85, P2119, DOI 10.1161/01.CIR.85.6.2119
   Demopoulos L, 1997, J AM COLL CARDIOL, V29, P597, DOI 10.1016/S0735-1097(96)00526-8
   Flynn KE, 2009, JAMA-J AM MED ASSOC, V301, P1451, DOI 10.1001/jama.2009.457
   Giannuzzi P, 2003, CIRCULATION, V108, P554, DOI 10.1161/01.CIR.0000081780.38477.FA
   Gianuzzi P, 2001, EUR HEART J, V22, P125
   Hunt Sharon Ann, 2005, J Am Coll Cardiol, V46, pe1, DOI 10.1016/j.jacc.2005.08.022
   Jessup M, 2003, NEW ENGL J MED, V348, P2007, DOI 10.1056/NEJMra021498
   Kim JS, 2015, KOREAN CIRC J, V45, P310, DOI 10.4070/kcj.2015.45.4.310
   Lloyd-Jones D, 2010, CIRCULATION, V121, P948, DOI 10.1161/CIRCULATIONAHA.109.192666
   Lucas C, 1999, AM HEART J, V138, P618, DOI 10.1016/S0002-8703(99)70174-2
   MANCINI DM, 1992, CIRCULATION, V85, P1364, DOI 10.1161/01.CIR.85.4.1364
   Mezzani A, 2013, EUR J PREV CARDIOL, V20, P442, DOI 10.1177/2047487312460484
   O'Connor CM, 2009, JAMA-J AM MED ASSOC, V301, P1439, DOI 10.1001/jama.2009.454
   Oka RK, 2000, AM J CARDIOL, V85, P365, DOI 10.1016/S0002-9149(99)00748-1
   Parnell MM, 2002, CLIN SCI, V102, P1, DOI 10.1042/CS20010107
   Wielenga RP, 1998, J PSYCHOSOM RES, V45, P459, DOI 10.1016/S0022-3999(97)00309-7
   Yancy CW, 2013, J AM COLL CARDIOL, V62, pE147, DOI 10.1016/j.jacc.2013.05.019
   Zwisler ADO, 2005, AM HEART J, V150, DOI 10.1016/j.ahj.2005.06.010
NR 19
TC 1
Z9 1
U1 0
U2 6
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD SEP
PY 2017
VL 47
IS 5
BP 742
EP 751
DI 10.4070/kcj.2017.0061
PG 10
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA FK9PB
UT WOS:000413842200013
PM 28955392
OA Green Published
DA 2021-04-22
ER

PT J
AU Nam, JH
   Park, KH
   Lee, JH
   Lee, CH
   Son, JW
   Kim, U
   Park, JS
   Shin, DG
AF Nam, Jong-Ho
   Park, Kyu-Hwan
   Lee, Jung-Hee
   Lee, Chan-Hee
   Son, Jang-Won
   Kim, Ung
   Park, Jong-Seon
   Shin, Dong-Gu
TI Discordant Relationships between Systemic Inflammatory Markers and
   Burden of Oxidative Stress in Patients with Atrial Fibrillation
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Atrial fibrillation; Inflammation; Oxidative stress
ID C-REACTIVE PROTEIN; CELL DISTRIBUTION WIDTH; CARDIOVASCULAR-DISEASE;
   LYMPHOCYTE RATIO; NEUTROPHIL/LYMPHOCYTE RATIO; NEUTROPHIL;
   CARDIOVERSION; PERPETUATION; PATHOGENESIS; METAANALYSIS
AB Background and Objectives: Oxidative stress (OS) plays an important role in the pathophysiology of atrial fibrillation (AF) by amplifying the inflammatory cascade, wherein augmented inflammation facilitates the atrial electrical remodeling process. Few studies have investigated the possible link between systemic inflammation and OS in AF.
   Subjects and Methods: A total of 220 consecutive patients with AF (117 patients) or healthy controls (103 patients) were enrolled. Among the 117 AF patients, 65 paroxysmal AF (PaAF) and 52 persistent AF (PeAF) patients were included. The level of 8-iso-prostaglandin F2 alpha (8-iso-PGF2 alpha) was measured as a marker of OS burden. We evaluated the correlations between 3 systemic inflammatory markers, high-sensitivity C-reactive protein (hsCRP), neutrophil to lymphocyte ratio (NLR), and red cell distribution width (RDW), and 8-iso-PGF2 alpha.
   Results: The 8-iso-PGF2 alpha concentration in both PaAF and PeAF patients was higher than that of controls (p < 0.001 and p=0.024, respectively). The NLR and RDW of PeAF patients were higher than those of both control and PaAF patients (p=0.041 and p=0.031 for NLR, p=0.057 and p=0.031 for RDW, respectively). There were no correlations between specific inflammatory markers and the 8-iso-PGF2 alpha in AF. The 8-iso-PGF2 alpha level decreased gradually with an increase in AF duration (p=0.008), contrary to the graded increase in hsCRP. Multiple regression analysis indicated that AF duration persisted as a significant determinant of 8-iso-PGF2 alpha (beta=-0.249, p=0.044).
   Conclusion: Systemic inflammatory marker levels were not proportional to the levels of 8-iso-PGF2 alpha, an OS marker, in AF.
C1 [Nam, Jong-Ho; Park, Kyu-Hwan; Lee, Jung-Hee; Lee, Chan-Hee; Son, Jang-Won; Kim, Ung; Park, Jong-Seon; Shin, Dong-Gu] Yeungnam Univ, Med Ctr, Dept Internal Med, Div Cardiol, 170 Hyeonchung Ro, Daegu 42415, South Korea.
RP Shin, DG (corresponding author), Yeungnam Univ, Med Ctr, Dept Internal Med, Div Cardiol, 170 Hyeonchung Ro, Daegu 42415, South Korea.
EM dgshin@med.yu.ac.kr
OI Nam, Jong-Ho/0000-0001-5106-8361
CR Adamsson Eryd S, 2014, J INTERN MED, V275, P84, DOI 10.1111/joim.12143
   Camm AJ, 2012, EUR HEART J, V33, P2719, DOI 10.1093/eurheartj/ehs253
   Cangemi R, 2012, HEART, V98, P1063, DOI 10.1136/heartjnl-2012-301952
   Canpolat U, 2013, AM J CARDIOL, V112, P513, DOI 10.1016/j.amjcard.2013.04.015
   Carnes CA, 2001, CIRC RES, V89, pE32, DOI 10.1161/hh1801.097644
   Engelmann MDM, 2005, EUR HEART J, V26, P2083, DOI 10.1093/eurheartj/ehi350
   Gibson PH, 2010, AM J CARDIOL, V105, P186, DOI 10.1016/j.amjcard.2009.09.007
   Guo YT, 2012, J AM COLL CARDIOL, V60, P2263, DOI 10.1016/j.jacc.2012.04.063
   Halliwell B, 1999, FREE RADICALS BIOL M, P936
   Huang CX, 2009, MED HYPOTHESES, V72, P466, DOI 10.1016/j.mehy.2008.08.031
   IL'Yasova D, 2008, BIOMARKERS, V13, P41, DOI 10.1080/13547500701617708
   Issac TT, 2007, J AM COLL CARDIOL, V50, P2021, DOI 10.1016/j.jacc.2007.06.054
   Karavelioglu Y, 2015, CLIN APPL THROMB-HEM, V21, P5, DOI 10.1177/1076029613518368
   Kim YM, 2005, CIRC RES, V97, P629, DOI 10.1161/01.RES.0000183735.09871.61
   Korantzopoulos P, 2003, INT J CLIN PRACT, V57, P252
   Korantzopoulos P, 2007, INT J CARDIOL, V115, P135, DOI 10.1016/j.ijcard.2006.04.026
   Korantzopoulos Panagiotis, 2003, Med Sci Monit, V9, pRA225
   Kornej J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044165
   Lee KH, 2015, EUROPACE, V17, P83, DOI 10.1093/europace/euv210
   Liu T, 2007, J AM COLL CARDIOL, V49, P1642, DOI 10.1016/j.jacc.2006.12.042
   Liu T, 2014, INT J CARDIOL, V171, pE52, DOI 10.1016/j.ijcard.2013.11.112
   Mihm MJ, 2001, CIRCULATION, V104, P174, DOI 10.1161/01.CIR.104.2.174
   Papa A, 2008, CLIN CHIM ACTA, V395, P27, DOI 10.1016/j.cca.2008.04.019
   Patel P, 2010, J CARDIOVASC ELECTR, V21, P1064, DOI 10.1111/j.1540-8167.2010.01774.x
   Reilly SN, 2011, CIRCULATION, V124, P1107, DOI 10.1161/CIRCULATIONAHA.111.029223
   Roberts LJ, 2000, FREE RADICAL BIO MED, V28, P505, DOI 10.1016/S0891-5849(99)00264-6
   Schwedhelm E, 2003, CLIN CHEM LAB MED, V41, P1552, DOI 10.1515/CCLM.2003.238
   Shao QM, 2015, ARCH MED RES, V46, P199, DOI 10.1016/j.arcmed.2015.03.011
   Uthamalingam S, 2011, AM J CARDIOL, V107, P433, DOI 10.1016/j.amjcard.2010.09.039
   Van Wagoner DR, 2008, J CARDIOVASC PHARM, V52, P306, DOI 10.1097/FJC.0b013e31817f9398
NR 30
TC 4
Z9 4
U1 1
U2 5
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD SEP
PY 2017
VL 47
IS 5
BP 752
EP 761
DI 10.4070/kcj.2017.0024
PG 10
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA FK9PB
UT WOS:000413842200014
PM 28955393
OA Green Published
DA 2021-04-22
ER

PT J
AU Ozturk, S
   Gurbuz, AS
   Efe, SC
   Yilmaz, MF
   Kirma, C
AF Ozturk, Semi
   Gurbuz, Ahmed Seyfettin
   Efe, Suleyman Cagan
   Yilmaz, Mehmet Fatih
   Kirma, Cevat
TI Enlargement Ratio May Predict Device Size in Elderly Patients with
   Atrial Septal Defect
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Heart septal defects, atrial; Heart defects, congenital;
   Echocardiography
ID TRANSCATHETER CLOSURE; OCCLUDER; ECHOCARDIOGRAPHY
AB Background and Objectives: Balloon sizing remains the main technique for determining occluder device size for atrial septal defects (ASDs). New evidence has proposed that accurate estimation of device size could be possible without using the balloon technique. Operators have predicted the amount of possible enlargement depending on their experiences. Thus, selection criteria have mostly relied on personal observations and experiences. The objective of this study was to determine the relationship between age, sex, defect size, and deployed device size based on the balloon technique.
   Subjects and Methods: Sixty-six patients who underwent percutaneous ASD closure with a Cardi-O-Fix occluder between 2011 and 2012 were retrospectively evaluated. Patients whose maximum defect size and device size were available were included. Enlargement amount (EA) (device size-defect size) and enlargement ratio (ER) (EA/defect size) were calculated. The relationship between these 2 calculations and age, sex, and defect size were analyzed.
   Results: EA and ER were 5.2 +/- 3.6 mm (min: 0, max: 15, median: 5) and 39.3%+/- 31.5% (min: 0, max: 125, median: 32), respectively. EA and ER did not differ between genders (p=0.800; p=0.430). EA and ER were not correlated with maximum defect size (p=0.310; p=0.050). EA and ER showed no correlation with age (p=0.970; p=0.640). However when patients were dichomotized based on age 40, ER was significantly lower in older group (p=0.030). Unexpectedly, no difference was observed between the 2 groups in terms of EA (p=0.110). Size of deployed device had a strong correlation with defect size measured with two-dimensional (2D) transesophageal echocardiography (TEE; device size=1.1177xTEE defect size+3.5297; R=0.84; p < 0.010).
   Conclusion: EA and ER did not show a significant correlation with sex and defect size in our study. Patients older than 40 had a significantly lower ER compared to younger patients. Device size was strongly correlated with defect size measured with TEE.
C1 [Ozturk, Semi] Haseki Training & Res Hosp, Dept Cardiol, Millet Caddesi Aksaray Fatih, TR-34130 Istanbul, Turkey.
   [Gurbuz, Ahmed Seyfettin] Yunus Emre State Hosp, Dept Cardiol, Eskisehir, Turkey.
   [Efe, Suleyman Cagan] Agri State Hosp, Dept Cardiol, Agri, Turkey.
   [Yilmaz, Mehmet Fatih; Kirma, Cevat] Kartal Kosuyolu Heart Training & Res Hosp, Dept Cardiol, Istanbul, Turkey.
RP Ozturk, S (corresponding author), Haseki Training & Res Hosp, Dept Cardiol, Millet Caddesi Aksaray Fatih, TR-34130 Istanbul, Turkey.
EM semi_ozturk@yahoo.com
CR Carlson KM, 2005, CATHETER CARDIO INTE, V66, P390, DOI 10.1002/ccd.20443
   Chien JC, 2008, J CHIN MED ASSOC, V71, P399, DOI 10.1016/S1726-4901(08)70090-X
   Du Zhong-Dong, 2002, J Interv Cardiol, V15, P287, DOI 10.1111/j.1540-8183.2002.tb01105.x
   Egred M, 2007, J Interv Cardiol, V20, P395, DOI 10.1111/j.1540-8183.2007.00279.x
   Helgason H, 2005, CARDIOLOGY, V104, P1, DOI 10.1159/000086045
   Kim KH, 2013, KOREAN CIRC J, V43, P681, DOI 10.4070/kcj.2013.43.10.681
   KING TD, 1976, JAMA-J AM MED ASSOC, V235, P2506, DOI 10.1001/jama.235.23.2506
   McElhinney DB, 2016, CIRCULATION, V133, P1738, DOI 10.1161/CIRCULATIONAHA.115.019987
   Song J, 2013, YONSEI MED J, V54, P1104, DOI 10.3349/ymj.2013.54.5.1104
   U. S. Food and Drug Administration, 2013, RAR SER ER EV ASS ST
   van der Linde D, 2011, J AM COLL CARDIOL, V58, P2241, DOI 10.1016/j.jacc.2011.08.025
   Wang JK, 2008, CATHETER CARDIO INTE, V71, P214, DOI 10.1002/ccd.21308
   Zhu W, 2000, PEDIATR CARDIOL, V21, P465, DOI 10.1007/s002460010111
NR 13
TC 1
Z9 1
U1 0
U2 2
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD SEP
PY 2017
VL 47
IS 5
BP 762
EP 768
DI 10.4070/kcj.2017.0073
PG 7
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA FK9PB
UT WOS:000413842200015
PM 28955394
OA Green Published
DA 2021-04-22
ER

PT J
AU Lee, H
   Yang, JH
   Jun, TG
   Kang, IS
   Huh, J
   Park, SW
   Song, JY
   Kim, CS
AF Lee, Heemoon
   Yang, Ji-Hyuk
   Jun, Tae-Gook
   Kang, I-Seok
   Huh, June
   Park, Seung Woo
   Song, Jinyoung
   Kim, Chung Su
TI The Mid-term Results of Thoracoscopic Closure of Atrial Septal Defects
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Atrial septal defect; Video-assisted thoracoscopic surgery; Minimally
   invasive surgical procedures; Thoracoscopes
ID ROBOTIC ASSISTANCE; REPAIR; EXPERIENCE; INCISION; SURGERY
AB Background and Objectives: Recently, minimally invasive surgical (MIS) techniques including robot-assisted operations have been widely applied in cardiac surgery. The thoracoscopic technique is a favorable MIS option for patients with atrial septal defects (ASDs). Accordingly, we report the mid-term results of thoracoscopic ASD closure without robotic assistance.
   Subjects and Methods: We included 66 patients who underwent thoracoscopic ASD closure between June 2006 and July 2014. Mean age was 27 +/- 9 years. The mean size of the ASD was 25.9 +/- 6.3 mm. Eleven patients (16.7%) had greater than mild tricuspid regurgitation (TR). The TR pressure gradient was 32.4 +/- 8.6 mmHg.
   Results: Fifty-two (78.8%) patients underwent closure with a pericardial patch and 14 (21.2%) underwent direct suture closure. Concomitant procedures included tricuspid valve repair in 8 patients (12.1%), mitral valve repair in 4 patients (6.1%), and right isthmus block in 1 patient (1.5%). The mean length of the right thoracotomy incision was 4.5 +/- 0.9 cm. The mean cardiopulmonary bypass time was 159 +/- 43 minutes, and the mean aortic cross clamp time was 79 +/- 29 minutes. The mean hospital stay lasted 6.1 +/- 2.6 days. There were no early deaths. There were 2 reoperations. One was due to ASD patch detachment and the other was due to residual mitral regurgitation after concomitant mitral valve repair. However, there have been no reoperations since July 2010. There were 2 pneumothoraxes requiring chest tube re-insertion. There was one wound dehiscence in an endoscopic port. The mean follow-up duration was 33 +/- 31 months. There were no deaths, residual shunts, or reoperations during follow-up.
   Conclusion: Thoracoscopic ASD closure without robotic assistance is feasible, suggesting that this method is a reliable MIS option for patients with ASDs.
C1 [Lee, Heemoon; Yang, Ji-Hyuk; Jun, Tae-Gook] Sungkyunkwan Univ, Samsung Med Ctr, Dept Thorac & Cardiovasc Surg, Sch Med, 81 Irwon Ro, Seoul 06351, South Korea.
   [Kang, I-Seok; Song, Jinyoung] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Pediat, Seoul, South Korea.
   [Park, Seung Woo] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Cardiol,Dept Med, Seoul, South Korea.
   [Kim, Chung Su] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Anesthesiol & Pain Med, Seoul, South Korea.
RP Yang, JH (corresponding author), Sungkyunkwan Univ, Samsung Med Ctr, Dept Thorac & Cardiovasc Surg, Sch Med, 81 Irwon Ro, Seoul 06351, South Korea.
EM bestsurgeon@gmail.com
OI Jun, Tae-Gook/0000-0002-5161-4665; Lee, Heemoon/0000-0003-0606-4067;
   Kang, I-Seok/0000-0003-4264-0826; Huh, June/0000-0003-4523-9632
CR Argenziano M, 2003, CIRCULATION, V108, P191, DOI 10.1161/01.cir.0000089043.82199.2f
   Bichell DP, 2000, ANN THORAC SURG, V70, P115, DOI 10.1016/S0003-4975(00)01251-0
   Black MD, 1998, ANN THORAC SURG, V65, P765, DOI 10.1016/S0003-4975(97)01241-1
   Butera G, 2008, AM HEART J, V156, P706, DOI 10.1016/j.ahj.2008.06.008
   Dabritz S, 1999, EUR J CARDIO-THORAC, V15, P18, DOI 10.1016/S1010-7940(98)00267-X
   Jun TG, 2002, CARDIOVASC SURG, V10, P595, DOI 10.1016/S0967-2109(02)00065-0
   Khan JH, 1998, ANN THORAC SURG, V66, P1433, DOI 10.1016/S0003-4975(98)00742-5
   Hyuk Kim, 2003, The Korean Journal of Thoracic and Cardiovascular Surgery, V36, P1
   Kim Ji Eon, 2013, Korean J Thorac Cardiovasc Surg, V46, P93, DOI 10.5090/kjtcs.2013.46.2.93
   Kim KH, 2013, KOREAN CIRC J, V43, P681, DOI 10.4070/kcj.2013.43.10.681
   Liu GL, 2013, J CARDIOTHORAC SURG, V8, DOI 10.1186/1749-8090-8-119
   Ma ZS, 2011, J THORAC CARDIOV SUR, V141, P1380, DOI 10.1016/j.jtcvs.2010.10.028
   Masura J, 2005, J AM COLL CARDIOL, V45, P505, DOI 10.1016/j.jacc.2004.10.066
   Menkis AH, 2004, HEART SURG FORUM, V7, pE49
   Morgan JA, 2004, ANN THORAC SURG, V77, P1328, DOI 10.1016/j.athoracsur.2003.09.044
   Poyrazoglu Huseyin Hakan, 2013, Korean J Thorac Cardiovasc Surg, V46, P340, DOI 10.5090/kjtcs.2013.46.5.340
   Ryan WH, 2003, ANN THORAC SURG, V75, P1532, DOI 10.1016/S0003-4975(02)04720-3
   Torracca L, 2001, ANN THORAC SURG, V72, P1354, DOI 10.1016/S0003-4975(01)02990-3
   Vistarini N, 2010, J THORAC CARDIOV SUR, V139, P139, DOI 10.1016/j.jtcvs.2009.07.022
   Wimmer-Greinecker G, 2003, J THORAC CARDIOV SUR, V126, P465, DOI 10.1016/S0022-5223(03)00053-9
   Xiao CS, 2014, INTERACT CARDIOV TH, V19, P933, DOI 10.1093/icvts/ivu263
   Yao DK, 2013, HEART LUNG CIRC, V22, P433, DOI 10.1016/j.hlc.2012.12.019
NR 22
TC 1
Z9 1
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD SEP
PY 2017
VL 47
IS 5
BP 769
EP 775
DI 10.4070/kcj.2017.0059
PG 7
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA FK9PB
UT WOS:000413842200016
PM 28955395
OA Green Published
DA 2021-04-22
ER

PT J
AU Seo, WW
   Kim, SE
   Park, MS
   Lee, JH
   Park, DG
   Han, KR
   Oh, DJ
AF Seo, Won-Woo
   Kim, Sung Eun
   Park, Myung-Soo
   Lee, Jun-Hee
   Park, Dae-Gyun
   Han, Kyoo-Rok
   Oh, Dong-Jin
TI Systematic Review of Treatment for Trapped Thrombus in Patent Foramen
   Ovale
SO KOREAN CIRCULATION JOURNAL
LA English
DT Review
DE Foramen ovale, patent; Pulmonary embolism; Review, systematic
ID IMPENDING PARADOXICAL EMBOLISM; MASSIVE PULMONARY-EMBOLISM; RIGHT HEART;
   EMBOLECTOMY
AB Background and Objectives: Trapped thrombus in patent foramen ovale (PFO) is a rare complication of pulmonary embolism that may lead to tragic clinical events. The aim of this study was to identify the optimal treatment for different clinical situations in patients with trapped thrombus in a PFO by conducting a literature review.
   Subjects and Methods: A PubMed database search was conducted from 1991 through 2015, and 194 patients (185 articles) with trapped thrombus in a PFO were identified. Patient characteristics, paradoxical embolic events, and factors affecting 60-day mortality were analyzed retrospectively.
   Results: Among all patients, 112 (57.7%) were treated with surgery, 28 with thrombolysis, and 54 with anticoagulation alone. Dyspnea (79.4%), chest pain (33.0%), and syncope (17.5%) were the most common presenting symptoms. Pretreatment embolism was found in 37.6% of cases, and stroke (24.7%) was the most common event. Surgery was associated with fewer post-treatment embolic events than were other treatment options (p=0.044). In the multivariate analysis, initial shock or arrest, and thrombolysis were independent predictors of 60-day mortality. Thrombolysis was related with higher 60-day mortality compared with surgery in patients who had no initial shock or arrest.
   Conclusion: This systematic review showed that surgery was associated with a lower overall incidence of post-treatment embolic events and a lower 60-day mortality in patients with trapped thrombus in a PFO. In patients without initial shock or arrest, thrombolysis was related with a higher 60-day mortality compared with surgery.
C1 [Seo, Won-Woo; Kim, Sung Eun; Park, Myung-Soo; Lee, Jun-Hee; Park, Dae-Gyun; Han, Kyoo-Rok; Oh, Dong-Jin] Hallym Univ, Coll Med, Div Cardiol, Kangdong Sacred Heart Hosp, 150 Seongan Ro, Seoul 05355, South Korea.
RP Kim, SE (corresponding author), Hallym Univ, Coll Med, Div Cardiol, Kangdong Sacred Heart Hosp, 150 Seongan Ro, Seoul 05355, South Korea.
EM drhyangii@hallym.or.kr
OI Lee, Junhee/0000-0001-6897-2824
CR Casazza F, 1997, AM J CARDIOL, V79, P1433, DOI 10.1016/S0002-9149(97)00162-8
   Chartier L, 1999, CIRCULATION, V99, P2779, DOI 10.1161/01.CIR.99.21.2779
   Fauveau E, 2008, ARCH CARDIOVASC DIS, V101, P637, DOI 10.1016/j.acvd.2008.08.011
   Giannitsis E, 2005, CIRCULATION, V112, P1520, DOI 10.1161/CIRCULATIONAHA.105.566182
   HAGEN PT, 1984, MAYO CLIN PROC, V59, P17, DOI 10.1016/S0025-6196(12)60336-X
   Kearon C, 2012, CHEST, V141, pE419S, DOI 10.1378/chest.11-2301
   Kent DM, 2013, NEUROLOGY, V81, P619, DOI 10.1212/WNL.0b013e3182a08d59
   Konstantinides S, 1998, CIRCULATION, V97, P1946, DOI 10.1161/01.CIR.97.19.1946
   MATTOX KL, 1982, ANN SURG, V195, P726, DOI 10.1097/00000658-198206000-00008
   Meacham RR, 1998, ARCH INTERN MED, V158, P438, DOI 10.1001/archinte.158.5.438
   Myers PO, 2010, CHEST, V137, P164, DOI 10.1378/chest.09-0961
   Rose PS, 2002, CHEST, V121, P806, DOI 10.1378/chest.121.3.806
   Torbicki A, 2003, J AM COLL CARDIOL, V41, P2245, DOI 10.1016/S0735-1097(03)00479-0
   Yalamanchili K, 2004, ANN THORAC SURG, V77, P819, DOI 10.1016/j.athoracsur.2003.08.008
NR 14
TC 10
Z9 10
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD SEP
PY 2017
VL 47
IS 5
BP 776
EP 785
DI 10.4070/kcj.2016.0295
PG 10
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA FK9PB
UT WOS:000413842200017
PM 28955396
OA Green Published
DA 2021-04-22
ER

PT J
AU Jeong, HI
   Song, J
   Choi, EY
   Kim, SH
   Huh, J
   Kang, IS
   Yang, JH
   Jun, TG
AF Jeong, Hye-In
   Song, Jinyoung
   Choi, Eun Young
   Kim, Sung Ho
   Huh, Jun
   Kang, I-Seok
   Yang, Ji Hyuk
   Jun, Tae Gook
TI How Long Can the Next Intervention Be Delayed after Balloon Dilatation
   of Homograft in the Pulmonary Position?
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Allografts; Angioplasty, balloon; Pulmonary valve stenosis;
   Re-intervention
ID VENTRICULAR OUTFLOW TRACT; BIOPROSTHETIC VALVES; AORTIC HOMOGRAFTS;
   FOLLOW-UP; RECONSTRUCTION; CONDUITS; ANGIOPLASTY; IMPLANTATION;
   EXPERIENCE; PLACEMENT
AB Background and Objectives: We investigated the effectiveness of balloon dilatation of homograft conduits in the pulmonary position in delaying surgical replacement.
   Subjects and Methods: We reviewed the medical records of patients who underwent balloon dilatation of their homograft in the pulmonary position from 2001 to 2015. The pressure gradient and ratio of right ventricular pressure were measured before and after the procedure. The primary goal of this study was to evaluate the parameters associated with the interval to next surgical or catheter intervention.
   Results: Twenty-eight balloon dilations were performed in 26 patients. The median ages of patients with homograft insertion and balloon dilatation were 20.3 months and 4.5 years, respectively. The origins of the homografts were the aorta (53.6%), pulmonary artery (32.1%), and femoral vein (14.3%). The median interval after conduit implantation was 26.7 months. The mean ratio of balloon to graft size was 0.87. The pressure gradient through the homograft and the ratio of right ventricle to aorta pressure were significantly improved after balloon dilatation (p<0.001). There were no adverse events during the procedure with the exception of one case of balloon rupture. The median interval to next intervention was 12.9 months. The median interval of freedom from re-intervention was 16.6 months. Cox proportional hazards analysis revealed that the interval of freedom from re-intervention differed only according to origin of the homograft (p=0.032), with the pulmonary artery having the longest interval of freedom from re-intervention (p=0.043).
   Conclusion: Balloon dilatation of homografts in the pulmonary position can be safely performed, and homografts of the pulmonary artery are associated with a longer interval to re-intervention.
C1 [Jeong, Hye-In; Song, Jinyoung; Huh, Jun; Kang, I-Seok] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Pediat, 81 Irwon Ro, Seoul 06351, South Korea.
   [Choi, Eun Young; Kim, Sung Ho] Sejong Gen Hosp, Dept Pediat, Bucheon, South Korea.
   [Yang, Ji Hyuk; Jun, Tae Gook] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Thorac Surg, Seoul, South Korea.
RP Song, JY (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Pediat, 81 Irwon Ro, Seoul 06351, South Korea.
EM amyjys@naver.com
OI Huh, June/0000-0003-4523-9632; Kang, I-Seok/0000-0003-4264-0826; Jun,
   Tae-Gook/0000-0002-5161-4665
CR Aggarwal S, 2007, J AM COLL CARDIOL, V49, P480, DOI 10.1016/j.jacc.2006.09.037
   ALBERT JD, 1993, J THORAC CARDIOV SUR, V106, P228
   BANDO K, 1995, J THORAC CARDIOV SUR, V109, P509, DOI 10.1016/S0022-5223(95)70282-2
   Bertels RA, 2012, CARDIOL YOUNG, V22, P589, DOI 10.1017/S1047951112000157
   Bohm JO, 2006, ANN THORAC SURG, V82, P940, DOI 10.1016/j.athoracsur.2006.04.086
   Hainstock MR, 2013, CIRC-CARDIOVASC INTE, V6, P671, DOI 10.1161/CIRCINTERVENTIONS.112.000073
   LeBlanc JG, 1998, ANN THORAC SURG, V66, pS174, DOI 10.1016/S0003-4975(98)01032-7
   LLOYD TR, 1987, AM HEART J, V114, P268, DOI 10.1016/0002-8703(87)90489-3
   McElhinney DB, 2010, CIRCULATION, V122, P507, DOI 10.1161/CIRCULATIONAHA.109.921692
   MCGRATH LB, 1988, ANN THORAC SURG, V45, P273, DOI 10.1016/S0003-4975(10)62461-7
   Oosterhof T, 2006, EUR HEART J, V27, P1478, DOI 10.1093/eurheartj/ehl033
   Peng LF, 2006, CIRCULATION, V113, P2598, DOI 10.1161/CIRCULATIONAHA.105.607127
   POWELL AJ, 1995, CIRCULATION, V92, P3282, DOI 10.1161/01.CIR.92.11.3282
   ROSS DN, 1966, LANCET, V2, P1446
   Sanatani S, 2001, PEDIATR CARDIOL, V22, P228, DOI 10.1007/s002460010209
   SARAVALLI OA, 1980, J THORAC CARDIOV SUR, V80, P909
   Sreeram N, 1999, HEART, V81, P162, DOI 10.1136/hrt.81.2.162
   Tatebe S, 2003, CIRC J, V67, P906, DOI 10.1253/circj.67.906
   WALDMAN JD, 1987, CIRCULATION, V76, P109, DOI 10.1161/01.CIR.76.1.109
   YANKAH AC, 1995, ANN THORAC SURG, V60, pS71, DOI 10.1016/0003-4975(95)00289-W
   ZEEVI B, 1989, J AM COLL CARDIOL, V14, P401, DOI 10.1016/0735-1097(89)90193-9
NR 21
TC 0
Z9 2
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD SEP
PY 2017
VL 47
IS 5
BP 786
EP 793
DI 10.4070/kcj.2017.0033
PG 8
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA FK9PB
UT WOS:000413842200018
PM 28955397
OA Green Published
DA 2021-04-22
ER

PT J
AU Jang, JS
   Shin, HC
   Bae, JS
   Jin, HY
   Seo, JS
   Yang, TH
   Kim, DK
   Cho, KI
   Kim, BH
   Park, YH
   Je, HG
   Kim, DS
AF Jang, Jae-Sik
   Shin, Ho-Cheol
   Bae, Jong Seok
   Jin, Han-Young
   Seo, Jeong-Sook
   Yang, Tae-Hyun
   Kim, Dae-Kyeong
   Cho, Kyoung-Im
   Kim, Bo-Hyun
   Park, Yong Hyun
   Je, Hyung-Gon
   Kim, Dong-Soo
TI Diagnostic Performance of Intravascular Ultrasound-Derived Minimal Lumen
   Area to Predict Functionally Significant Non-Left Main Coronary Artery
   Disease: a Meta-Analysis (vol 46, pg 622, 2016)
SO KOREAN CIRCULATION JOURNAL
LA English
DT Correction
CR Jang JS, 2016, KOREAN CIRC J, V46, P622, DOI 10.4070/kcj.2016.46.5.622
NR 1
TC 0
Z9 0
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD SEP
PY 2017
VL 47
IS 5
BP 794
EP 794
DI 10.4070/kcj.2017.0999
PG 1
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA FK9PB
UT WOS:000413842200019
PM 28955398
OA Green Published
DA 2021-04-22
ER

PT J
AU Kim, MS
   Lee, JH
   Kim, EJ
   Park, DG
   Park, SJ
   Park, JJ
   Shin, MS
   Yoo, BS
   Youn, JC
   Lee, SE
   Ihm, SH
   Jang, SY
   Jo, SH
   Cho, JY
   Cho, HJ
   Choi, S
   Choi, JO
   Han, SW
   Hwang, KK
   Jeon, ES
   Cho, MC
   Chae, SC
   Choi, DJ
AF Kim, Min-Seok
   Lee, Ju-Hee
   Kim, Eung Ju
   Park, Dae-Gyun
   Park, Sung-Ji
   Park, Jin Joo
   Shin, Mi-Seung
   Yoo, Byung Su
   Youn, Jong-Chan
   Lee, Sang Eun
   Ihm, Sang Hyun
   Jang, Se Yong
   Jo, Sang-Ho
   Cho, Jae Yeong
   Cho, Hyun-Jai
   Choi, Seonghoon
   Choi, Jin-Oh
   Han, Seong Woo
   Hwang, Kyung Kuk
   Jeon, Eun Seok
   Cho, Myeong-Chan
   Chae, Shung Chull
   Choi, Dong-Ju
TI Korean Guidelines for Diagnosis and Management of Chronic Heart Failure
SO KOREAN CIRCULATION JOURNAL
LA English
DT Review
DE Chronic heart failure; Guideline
ID CORONARY-ARTERY-DISEASE; LEFT-VENTRICULAR DYSFUNCTION; CARDIOVASCULAR
   MAGNETIC-RESONANCE; BRAIN NATRIURETIC PEPTIDE; IMPLANTABLE
   CARDIOVERTER-DEFIBRILLATOR; ACUTE MYOCARDIAL-INFARCTION; POSITIVE AIRWAY
   PRESSURE; NONSTEROIDAL ANTIINFLAMMATORY DRUGS; MECHANICAL CIRCULATORY
   SUPPORT; OBSTRUCTIVE PULMONARY-DISEASE
AB The prevalence of heart failure (HF) is skyrocketing worldwide, and is closely associated with serious morbidity and mortality. In particular, HF is one of the main causes for the hospitalization and mortality in elderly individuals. Korea also has these epidemiological problems, and HF is responsible for huge socioeconomic burden. However, there has been no clinical guideline for HF management in Korea. The present guideline provides the first set of practical guidelines for the management of HF in Korea and was developed using the guideline adaptation process while including as many data from Korean studies as possible. The scope of the present guideline includes the definition, diagnosis, and treatment of chronic HF with reduced/preserved ejection fraction of various etiologies.
C1 [Kim, Min-Seok] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Internal Med, Seoul, South Korea.
   [Lee, Ju-Hee; Hwang, Kyung Kuk; Cho, Myeong-Chan] Chungbuk Natl Univ, Coll Med, Chungbuk Natl Univ Hosp, Dept Internal Med,Div Cardiol, Cheongju, South Korea.
   [Kim, Eung Ju] Korea Univ, Guro Hosp, Cardiovasc Ctr, Dept Cardiol, Seoul, South Korea.
   [Park, Dae-Gyun; Choi, Seonghoon] Hallym Univ, Coll Med, Kangdong Sacred Heart Hosp, Div Cardiol, Seoul, South Korea.
   [Park, Sung-Ji; Choi, Jin-Oh; Jeon, Eun Seok] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Med,Div Cardiol, Seoul, South Korea.
   [Park, Jin Joo; Choi, Dong-Ju] Seoul Natl Univ Bundang Hosp, Dept Internal Med, Cardiovasc Ctr, Seongnam, South Korea.
   [Shin, Mi-Seung] Gachon Univ, Gil Med Ctr, Dept Internal Med, Div Cardiol, Incheon, South Korea.
   [Yoo, Byung Su] Yonsei Univ, Wonju Coll Med, Dept Internal Med, Div Cardiol, Wonju, South Korea.
   [Youn, Jong-Chan; Han, Seong Woo] Hallym Univ, Coll Med, Dongtan Sacred Heart Hosp, Div Cardiol, Hwaseong, South Korea.
   [Cho, Hyun-Jai] Seoul Natl Univ Hosp, Dept Internal Med, Seoul, South Korea.
   [Ihm, Sang Hyun] Catholic Univ Korea, Bucheon St Marys Hosp, Dept Cardiol, Bucheon, South Korea.
   [Jang, Se Yong] Kyungpook Natl Univ Hosp, Dept Internal Med, Div Cardiol, Daegu, South Korea.
   [Jo, Sang-Ho] Hallym Univ, Coll Med, Pyeongchon Sacred Heart Hosp, Div Cardiol, Anyang, South Korea.
   [Cho, Jae Yeong] Chonnam Natl Univ Hosp, Dept Cardiovasc Med, Gwangju, South Korea.
RP Choi, DJ (corresponding author), Seoul Natl Univ, Coll Med, Bundang Hosp, Dept Internal Med,Div Cardiol, 82 Gumi Ro 173 Beon Gil, Seongnam 13620, South Korea.
EM djchoi@snubh.org
RI Youn, Jong-Chan/AAS-1405-2020
OI PARK, DAE-GYUN/0000-0001-5150-9729; Lee, Sang Eun/0000-0002-7290-2463;
   Park, Sung-Ji/0000-0002-7075-847X; Youn, Jong-Chan/0000-0003-0998-503X;
   Shin, Mi-Seung/0000-0002-0273-0109; Kim, Eung Ju/0000-0003-2322-6267
CR Abdulla J, 2008, EUR HEART J, V29, P594, DOI 10.1093/eurheartj/ehn010
   Abraham WT, 2005, J AM COLL CARDIOL, V46, P57, DOI 10.1016/j.jacc.2005.03.051
   Abraham WT, 2002, NEW ENGL J MED, V346, P1845, DOI 10.1056/NEJMoa013168
   Abramson JL, 2001, JAMA-J AM MED ASSOC, V285, P1971, DOI 10.1001/jama.285.15.1971
   Adams KF, 2005, J AM COLL CARDIOL, V46, P497, DOI 10.1016/j.jacc.2005.02.091
   Agha SA, 2009, J CARD FAIL, V15, P586, DOI 10.1016/j.cardfail.2009.03.002
   Agostoni P, 2000, AM J MED, V109, P450, DOI 10.1016/S0002-9343(00)00532-5
   Aguado O, 2010, HEART LUNG, V39, pS14, DOI 10.1016/j.hrtlng.2010.04.010
   Aguilar D, 2011, CIRC-HEART FAIL, V4, P53, DOI 10.1161/CIRCHEARTFAILURE.110.952556
   Aguilar D, 2009, J AM COLL CARDIOL, V54, P422, DOI 10.1016/j.jacc.2009.04.049
   Albini A, 2010, JNCI-J NATL CANCER I, V102, P14, DOI 10.1093/jnci/djp440
   Alfakih K, 2004, EUR RADIOL, V14, P1813, DOI 10.1007/s00330-004-2387-0
   Allman KC, 2002, J AM COLL CARDIOL, V39, P1151, DOI 10.1016/S0735-1097(02)01726-6
   Anand IS, 2003, CIRCULATION, V107, P1278, DOI 10.1161/01.CIR.0000054164.99881.00
   Andreini D, 2007, J AM COLL CARDIOL, V49, P2044, DOI 10.1016/j.jacc.2007.01.086
   Anker SD, 2006, INT J CARDIOL, V112, P234, DOI 10.1016/j.ijcard.2006.03.057
   Anker SD, 2011, LANCET, V378, P731, DOI 10.1016/S0140-6736(11)61229-4
   Anker SD, 2009, NEW ENGL J MED, V361, P2436, DOI 10.1056/NEJMoa0908355
   [Anonymous], 1989, NEW ENGL J MED, V321, P406
   [Anonymous], 2010, Nat Rev Drug Discov, V9, P350, DOI [10.1038/nrd3171, 10.1038/nrd3172]
   [Anonymous], 2012, DIABETES CARE, V35, pS11, DOI [10.2337/dc35-S011, 10.2337/dc12-s011]
   Anter E, 2009, CIRCULATION, V119, P2516, DOI 10.1161/CIRCULATIONAHA.108.821306
   Aranda JM, 2003, AM HEART J, V145, P324, DOI 10.1067/mhj.2003.50
   Arauz-Pacheco Carlos, 2004, Diabetes Care, V27 Suppl 1, pS65
   Arnaudis B, 2012, CLIN RES CARDIOL, V101, P717, DOI 10.1007/s00392-012-0450-4
   Arzt M, 2007, CIRCULATION, V115, P3173, DOI 10.1161/CIRCULATIONAHA.106.683482
   Arzt M, 2006, ARCH INTERN MED, V166, P1716, DOI 10.1001/archinte.166.16.1716
   Assmus B, 2007, CIRC RES, V100, P1234, DOI 10.1161/01.RES.0000264508.47717.6b
   Au DH, 2004, AM HEART J, V148, P915, DOI 10.1016/j.ahj.2004.03.048
   Auerbach MA, 1999, CIRCULATION, V99, P2921, DOI 10.1161/01.CIR.99.22.2921
   Aurigemma GP, 2001, J AM COLL CARDIOL, V37, P1042, DOI 10.1016/S0735-1097(01)01110-X
   Austin J, 2005, EUR J HEART FAIL, V7, P411, DOI 10.1016/j.ejheart.2004.10.004
   Austin J, 2008, EUR J CARDIOV PREV R, V15, P162, DOI 10.1097/HJR.0b013e3282f10e87
   AZUMA J, 1992, JPN CIRC J, V56, P95, DOI 10.1253/jcj.56.95
   Badgett RG, 1997, JAMA-J AM MED ASSOC, V277, P1712, DOI 10.1001/jama.277.21.1712
   Bae BS, 2011, KOREAN CIRC J, V41, P16, DOI 10.4070/kcj.2011.41.1.16
   Bahrami H, 2008, J AM COLL CARDIOL, V51, P1775, DOI 10.1016/j.jacc.2007.12.048
   Baker DW, 2002, J CARD FAIL, V8, P333, DOI 10.1054/jcaf.2002.127769
   BAKER DW, 1994, JAMA-J AM MED ASSOC, V272, P1614, DOI 10.1001/jama.272.20.1614
   Baker WL, 2012, CIRC-CARDIOVASC QUAL, V5, P711, DOI 10.1161/CIRCOUTCOMES.112.966572
   BALL SG, 1993, LANCET, V342, P821
   Bardy GH, 2005, NEW ENGL J MED, V352, P225, DOI 10.1056/NEJMoa043399
   BARNARD C N, 1967, South African Medical Journal, V41, P1271
   Bart BA, 1997, J AM COLL CARDIOL, V30, P1002, DOI 10.1016/S0735-1097(97)00235-0
   Bart BA, 2012, NEW ENGL J MED, V367, P2296, DOI 10.1056/NEJMoa1210357
   Bartunek J, 2013, J AM COLL CARDIOL, V61, P2329, DOI 10.1016/j.jacc.2013.02.071
   Basuray A, 2014, CIRCULATION, V129, P2380, DOI 10.1161/CIRCULATIONAHA.113.006855
   Bayes-Genis A, 2004, EUR J HEART FAIL, V6, P301, DOI 10.1016/j.ejheart.2003.12.013
   Beckett NS, 2008, NEW ENGL J MED, V358, P1887, DOI 10.1056/NEJMoa0801369
   Behfar A, 2014, NAT REV CARDIOL, V11, P232, DOI 10.1038/nrcardio.2014.9
   Bekelman DB, 2007, J CARD FAIL, V13, P643, DOI 10.1016/j.cardfail.2007.05.005
   Belham M, 2007, EUR J HEART FAIL, V9, P409, DOI 10.1016/j.ejheart.2006.09.007
   BELL MR, 1992, CIRCULATION, V86, P446, DOI 10.1161/01.CIR.86.2.446
   Bellenger NG, 2000, J CARDIOV MAGN RESON, V2, P271, DOI 10.3109/10976640009148691
   Bellenger NG, 2000, EUR HEART J, V21, P1387, DOI 10.1053/euhj.2000.2011
   Bello D, 2003, CIRCULATION, V108, P1945, DOI 10.1161/01.CIR.0000095029.57483.60
   Berger R, 2002, CIRCULATION, V105, P2392, DOI 10.1161/01.CIR.0000016642.15031.34
   Berger R, 2010, J AM COLL CARDIOL, V55, P645, DOI 10.1016/j.jacc.2009.08.078
   Bernheim SM, 2010, CIRC-CARDIOVASC QUAL, V3, P459, DOI 10.1161/CIRCOUTCOMES.110.957613
   Bhuiyan T, 2011, CURR CARDIOVASC RISK, V5, P440, DOI 10.1007/s12170-011-0184-2
   Bitter T, 2009, EUR J HEART FAIL, V11, P602, DOI 10.1093/eurjhf/hfp057
   Blue L, 2001, BRIT MED J, V323, P715, DOI 10.1136/bmj.323.7315.715
   Bock JS, 2010, CIRCULATION, V121, P2592, DOI 10.1161/CIRCULATIONAHA.109.886473
   BOHLEN JG, 1984, ARCH INTERN MED, V144, P1745, DOI 10.1001/archinte.144.9.1745
   Bolger AP, 2006, J AM COLL CARDIOL, V48, P1225, DOI 10.1016/j.jacc.2006.07.015
   Bonow RO, 2005, CIRCULATION, V112, P1853, DOI 10.1161/CIRCULATIONAHA.105.170072
   Bonow RO, 2002, J AM COLL CARDIOL, V39, P1159, DOI 10.1016/S0735-1097(02)01732-1
   Boren SA, 2009, INT J EVID-BASED HEA, V7, P159, DOI 10.1111/j.1744-1609.2009.00134.x
   Bowling CB, 2013, INT J CARDIOL, V167, P151, DOI 10.1016/j.ijcard.2011.12.056
   Boyd KJ, 2004, EUR J HEART FAIL, V6, P585, DOI 10.1016/j.ejheart.2003.11.018
   Bradley TD, 2005, NEW ENGL J MED, V353, P2025, DOI 10.1056/NEJMoa051001
   Brater DC, 1998, NEW ENGL J MED, V339, P387, DOI 10.1056/NEJM199808063390607
   Brignole M, 2011, EUR HEART J, V32, P2420, DOI 10.1093/eurheartj/ehr162
   Bristow MR, 2004, NEW ENGL J MED, V350, P2140, DOI 10.1056/NEJMoa032423
   Brozena SC, 2004, J HEART LUNG TRANSPL, V23, P1082, DOI 10.1016/j.healun.2003.08.017
   BULKLEY BH, 1977, CIRCULATION, V55, P753, DOI 10.1161/01.CIR.55.5.753
   Butler J, 2008, CIRC-HEART FAIL, V1, P125, DOI 10.1161/CIRCHEARTFAILURE.108.768457
   BUTMAN SM, 1993, J AM COLL CARDIOL, V22, P968, DOI 10.1016/0735-1097(93)90405-P
   Camm AJ, 2012, EUR HEART J, V33
   Camm AJ, 2010, EUROPACE, V12, P1360, DOI [10.1093/eurheartj/ehq278, 10.1093/europace/euq350]
   Campbell RC, 2009, NEPHROL DIAL TRANSPL, V24, P186, DOI 10.1093/ndt/gfn445
   Cardinale D, 2006, CIRCULATION, V114, P2474, DOI 10.1161/CIRCULATIONAHA.106.635144
   Caroci AD, 2004, HEART LUNG, V33, P102, DOI 10.1016/j.hrtlng.2003.11.004
   Carson P, 1999, J Card Fail, V5, P178, DOI 10.1016/S1071-9164(99)90001-5
   Cha MJ, 2012, J CARDIOVASC ELECTR, V23, P155, DOI 10.1111/j.1540-8167.2011.02181.x
   한성우, 2005, Korean Circulation Journal, V35, P357
   Chakeabarti S, 2010, J CARD FAIL, V16, pS53, DOI 10.1016/j.cardfail.2010.04.004
   CHAKKO S, 1991, AM J MED, V90, P353, DOI 10.1016/0002-9343(91)90576-J
   Challapalli S, 1998, CORONARY ARTERY DIS, V9, P629, DOI 10.1097/00019501-199809100-00003
   Chareonthaitawee P, 2005, J AM COLL CARDIOL, V46, P567, DOI 10.1016/j.jacc.2005.03.072
   Chen AA, 2006, EUR HEART J, V27, P839, DOI 10.1093/eurheartj/ehi811
   CHIKAMORI T, 1992, AM J CARDIOL, V69, P650, DOI 10.1016/0002-9149(92)90158-U
   Choi DJ, 2011, KOREAN CIRC J, V41, P363, DOI 10.4070/kcj.2011.41.7.363
   Choi Jin-Oh, 2015, J Cardiovasc Ultrasound, V23, P158, DOI 10.4250/jcu.2015.23.3.158
   Choi KA, 2001, CIRCULATION, V104, P1101, DOI 10.1161/hc3501.096798
   Choudhury L, 2002, J AM COLL CARDIOL, V40, P2156, DOI 10.1016/S0735-1097(02)02602-5
   Chugh AR, 2012, CIRCULATION, V126, pS54, DOI 10.1161/CIRCULATIONAHA.112.092627
   Cice G, 2003, J AM COLL CARDIOL, V41, P1438, DOI 10.1016/S0735-1097(03)00241-9
   Cioffi G, 1996, EUR HEART J, V17, P1381
   Clark AM, 2005, ANN INTERN MED, V143, P659, DOI 10.7326/0003-4819-143-9-200511010-00010
   Cleland JGF, 2003, LANCET, V362, P14, DOI 10.1016/S0140-6736(03)13801-9
   Cleland JGF, 2005, NEW ENGL J MED, V352, P1539, DOI 10.1056/NEJMoa050496
   Cleland JGF, 2006, EUR HEART J, V27, P2338, DOI 10.1093/eurheartj/ehl250
   COHN JN, 1986, NEW ENGL J MED, V314, P1547, DOI 10.1056/NEJM198606123142404
   Cohn JN, 2001, NEW ENGL J MED, V345, P1667, DOI 10.1056/NEJMoa010713
   Cohn JN, 1998, NEW ENGL J MED, V339, P1810, DOI 10.1056/NEJM199812173392503
   COHN JN, 1991, NEW ENGL J MED, V325, P303, DOI 10.1056/NEJM199108013250502
   Comin-Colet J, 2009, J CARD FAIL, V15, P727, DOI 10.1016/j.cardfail.2009.05.010
   Connolly SJ, 1997, LANCET, V350, P1417
   Connolly SJ, 2009, NEW ENGL J MED, V361, P1139, DOI 10.1056/NEJMoa0905561
   Cooper HA, 1999, CIRCULATION, V100, P1311, DOI 10.1161/01.CIR.100.12.1311
   Cosin J, 2002, EUR J HEART FAIL, V4, P507, DOI 10.1016/S1388-9842(02)00122-8
   Costanzo MR, 2007, J AM COLL CARDIOL, V49, P675, DOI 10.1016/j.jacc.2006.07.073
   Costello-Boerrigter LC, 2006, J AM COLL CARDIOL, V47, P345, DOI 10.1016/j.jacc.2005.09.025
   Cowie MR, 1997, LANCET, V350, P1349, DOI 10.1016/S0140-6736(97)06031-5
   Cuffe MS, 2002, JAMA-J AM MED ASSOC, V287, P1541, DOI 10.1001/jama.287.12.1541
   Curtis JP, 2005, ARCH INTERN MED, V165, P55, DOI 10.1001/archinte.165.1.55
   Daniels LB, 2006, AM HEART J, V151, P999, DOI 10.1016/j.ahj.2005.10.011
   Dao Q, 2001, J AM COLL CARDIOL, V37, P379, DOI 10.1016/S0735-1097(00)01156-6
   Dargie HJ, 2007, J AM COLL CARDIOL, V49, P1696, DOI 10.1016/j.jacc.2006.10.077
   Dargie HJ, 2001, LANCET, V357, P1385, DOI 10.1016/s0140-6736(00)04560-8
   Davie AP, 1996, BRIT MED J, V312, P222
   Davie AP, 1997, QJM-MON J ASSOC PHYS, V90, P335, DOI 10.1093/qjmed/90.5.335
   Davies EJ, 2010, EUR J HEART FAIL, V12, P706, DOI 10.1093/eurjhf/hfq056
   DAVIS M, 1994, LANCET, V343, P440, DOI 10.1016/S0140-6736(94)92690-5
   Davos CH, 2003, J CARD FAIL, V9, P29, DOI 10.1054/jcaf.2003.4
   de Diego C, 2009, EUR HEART J, V30, P209, DOI 10.1093/eurheartj/ehn498
   de Lemos JA, 2009, AM HEART J, V157, P746, DOI 10.1016/j.ahj.2008.12.017
   Deedwania PC, 2005, AM HEART J, V149, P159, DOI 10.1016/j.ahj.2004.05.056
   Deng MC, 2000, BRIT MED J, V321, P540, DOI 10.1136/bmj.321.7260.540
   Desai A, 2010, EUR J HEART FAIL, V12, P936, DOI 10.1093/eurjhf/hfq094
   Deswal A, 2011, J CARD FAIL, V17, P634, DOI 10.1016/j.cardfail.2011.04.007
   Di Donato M, 2001, J THORAC CARDIOV SUR, V121, P91, DOI 10.1067/mtc.2001.111379
   DIBIANCO R, 1989, NEW ENGL J MED, V320, P677, DOI 10.1056/NEJM198903163201101
   Dickstein K, 2002, LANCET, V360, P752, DOI 10.1016/S0140-6736(02)09895-1
   Dickstein K, 2008, EUR J HEART FAIL, V10, P933, DOI 10.1016/j.ejheart.2008.08.005
   Doenst T, 2005, J THORAC CARDIOV SUR, V129, P246, DOI 10.1016/j.jtcvs.2004.07.060
   Dokainish H, 2011, EUR J ECHOCARDIOGR, V12, P857, DOI 10.1093/ejechocard/jer157
   Dor V, 1998, Jpn J Thorac Cardiovasc Surg, V46, P389
   Dor V, 2001, Semin Thorac Cardiovasc Surg, V13, P435
   Doust JA, 2004, ARCH INTERN MED, V164, P1978, DOI 10.1001/archinte.164.18.1978
   DOVAL HC, 1994, LANCET, V344, P493, DOI 10.1016/S0140-6736(94)91895-3
   Drazner MH, 2008, CIRC-HEART FAIL, V1, P170, DOI 10.1161/CIRCHEARTFAILURE.108.769778
   Drazner MH, 2001, NEW ENGL J MED, V345, P574, DOI 10.1056/NEJMoa010641
   Drazner MH, 2003, AM J MED, V114, P431, DOI 10.1016/S0002-9343(03)00058-5
   Dries DL, 2000, J AM COLL CARDIOL, V35, P681, DOI 10.1016/S0735-1097(99)00608-7
   Dunkman W B, 1995, J Cardiovasc Risk, V2, P107, DOI 10.1097/00043798-199504000-00005
   Dunlay SM, 2009, J AM COLL CARDIOL, V54, P1695, DOI 10.1016/j.jacc.2009.08.019
   DUNN RF, 1982, CIRCULATION, V66, P804, DOI 10.1161/01.CIR.66.4.804
   Edelmann F, 2013, JAMA-J AM MED ASSOC, V309, P781, DOI 10.1001/jama.2013.905
   EISENBERG JD, 1987, AM J CARDIOL, V59, P1410, DOI 10.1016/0002-9149(87)90930-1
   Eitel I, 2011, HEART, V97, P2038, DOI 10.1136/heartjnl-2011-300098
   Elhenawy AM, 2011, J CARDIAC SURG, V26, P542, DOI 10.1111/j.1540-8191.2011.01310.x
   Elkayam U, 2007, AM HEART J, V153, P98, DOI 10.1016/j.ahj.2006.09.005
   ELLIS SG, 1991, CIRCULATION, V83, P1905, DOI 10.1161/01.CIR.83.6.1905
   ELLISON DH, 1991, ANN INTERN MED, V114, P886, DOI 10.7326/0003-4819-114-10-886
   Erdmann E, 2001, EUR J HEART FAIL, V3, P469, DOI 10.1016/S1388-9842(01)00174-X
   Eschenhagen T, 2011, EUR J HEART FAIL, V13, P1, DOI 10.1093/eurjhf/hfq213
   Eurich DT, 2007, BMJ-BRIT MED J, V335, P497, DOI 10.1136/bmj.39314.620174.80
   Evangelista LS, 2000, AM J CARDIOL, V86, P1339, DOI 10.1016/S0002-9149(00)01238-8
   Ewald B, 2008, INTERN MED J, V38, P101, DOI 10.1111/j.1445-5994.2007.01454.x
   Ewer MS, 2005, J CLIN ONCOL, V23, P7820, DOI 10.1200/JCO.2005.13.300
   Ezekowitz JA, 2003, CIRCULATION, V107, P223, DOI 10.1161/01.CIR.0000052622.51963.FC
   Fagard RH, 2009, HYPERTENSION, V54, P1084, DOI 10.1161/HYPERTENSIONAHA.109.136655
   Faris R, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003838.pub2
   Faris R, 2002, INT J CARDIOL, V82, P149, DOI 10.1016/S0167-5273(01)00600-3
   Fazio S, 1996, NEW ENGL J MED, V334, P809, DOI 10.1056/NEJM199603283341301
   Feissel M, 2009, J AM SOC ECHOCARDIOG, V22, P1159, DOI 10.1016/j.echo.2009.06.022
   Felker GM, 2011, NEW ENGL J MED, V364, P797, DOI 10.1056/NEJMoa1005419
   Felker GM, 2009, AM HEART J, V158, P422, DOI 10.1016/j.ahj.2009.06.018
   Felker GM, 2000, NEW ENGL J MED, V342, P1077, DOI 10.1056/NEJM200004133421502
   Ferencik M, 2012, J CARDIOVASC COMPUT, V6, P223, DOI 10.1016/j.jcct.2011.11.007
   Ferrari R, 1997, J Card Fail, V3, P217, DOI 10.1016/S1071-9164(97)90018-X
   Fisher SA, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007888.pub2
   Flaherty JD, 2009, J AM COLL CARDIOL, V53, P254, DOI 10.1016/j.jacc.2008.08.072
   Flather MD, 2005, EUR HEART J, V26, P215, DOI 10.1093/eurheartj/ehi118
   Flather MD, 2000, LANCET, V355, P1575, DOI 10.1016/S0140-6736(00)02212-1
   Flynn KE, 2009, JAMA-J AM MED ASSOC, V301, P1451, DOI 10.1001/jama.2009.457
   FOGELMAN AM, 1971, LANCET, V2, P727
   Follath F, 1998, J AM COLL CARDIOL, V32, P1167, DOI 10.1016/S0735-1097(98)00400-8
   Fonarow GC, 2008, ARCH INTERN MED, V168, P847, DOI 10.1001/archinte.168.8.847
   Fonarow GC, 2010, CIRCULATION, V122, P585, DOI 10.1161/CIRCULATIONAHA.109.934471
   Forfia PR, 2005, J AM COLL CARDIOL, V45, P1667, DOI 10.1016/j.jacc.2005.01.046
   FRANCIS CM, 1995, BRIT MED J, V310, P634, DOI 10.1136/bmj.310.6980.634
   Freedland KE, 2003, PSYCHOSOM MED, V65, P119, DOI 10.1097/01.PSY.0000038938.67401.85
   Funck-Brentano C, 2011, EUR J HEART FAIL, V13, P765, DOI 10.1093/eurjhf/hfr051
   Gao P, 2012, CIRC-CARDIOVASC IMAG, V5, P448, DOI 10.1161/CIRCIMAGING.111.971549
   Garbade J, 2013, CLIN CARDIOL, V36, P378, DOI 10.1002/clc.22124
   Gardin JM, 2001, AM J CARDIOL, V87, P1051, DOI 10.1016/S0002-9149(01)01460-6
   GARG R, 1995, JAMA-J AM MED ASSOC, V273, P1450, DOI 10.1001/jama.1995.03520420066040
   Gentlesk PJ, 2007, J CARDIOVASC ELECTR, V18, P9, DOI 10.1111/j.1540-8167.2006.00653.x
   Gerstein HC, 2006, LANCET, V368, P1096, DOI 10.1016/S0140-6736(06)69420-8
   Ghali JK, 2008, CIRCULATION, V117, P526, DOI 10.1161/CIRCULATIONAHA.107.698514
   Ghali JK, 2006, J CLIN ENDOCR METAB, V91, P2145, DOI 10.1210/jc.2005-2287
   Ghali JK, 2009, J CARD FAIL, V15, P310, DOI 10.1016/j.cardfail.2008.11.003
   GHALI JK, 1991, AM J CARDIOL, V67, P1002, DOI 10.1016/0002-9149(91)90174-J
   Ghatak A, 1996, INT J CARDIOL, V57, P119, DOI 10.1016/S0167-5273(96)02787-8
   Gheorghiade M, 2007, EUR HEART J, V28, P980, DOI 10.1093/eurheartj/ehl542
   Gheorghiade M, 2007, JAMA-J AM MED ASSOC, V297, P1332, DOI 10.1001/jama.297.12.1332
   Ghostine S, 2008, EUR HEART J, V29, P2133, DOI 10.1093/eurheartj/ehn072
   Giles Thomas D, 2010, Congest Heart Fail, V16, P111, DOI 10.1111/j.1751-7133.2010.00154.x
   Gislason GH, 2009, ARCH INTERN MED, V169, P141, DOI 10.1001/archinternmed.2008.525
   Go AS, 2006, JAMA-J AM MED ASSOC, V296, P2105, DOI 10.1001/jama.296.17.2105
   Go AS, 2006, CIRCULATION, V113, P2713, DOI 10.1161/CIRCULATIONAHA.105.577577
   Goetze JP, 2006, EUR HEART J, V27, P3004, DOI 10.1093/eurheartj/ehl406
   GOLDSTEIN RE, 1991, CIRCULATION, V83, P52, DOI 10.1161/01.CIR.83.1.52
   Gorcideski EZ, 2009, CIRC-HEART FAIL, V2, P320, DOI 10.1161/CIRCHEARTFAILURE.108.839076
   Grady KL, 2007, J HEART LUNG TRANSPL, V26, P1182, DOI 10.1016/j.healun.2007.08.001
   Grady KL, 1996, J HEART LUNG TRANSPL, V15, P749
   Grady KL, 1999, J HEART LUNG TRANSPL, V18, P202, DOI 10.1016/S1053-2498(98)00048-5
   Graham I, 2007, EUR J CARDIOV PREV R, V14, pE1, DOI 10.1097/01.hjr.0000277984.31558.c4
   Granger CB, 2003, LANCET, V362, P772, DOI 10.1016/S0140-6736(03)14284-5
   Granger CB, 2011, NEW ENGL J MED, V365, P981, DOI 10.1056/NEJMoa1107039
   Grayburn PA, 2005, J AM COLL CARDIOL, V45, P1064, DOI 10.1016/j.jacc.2004.12.069
   Groenveld HF, 2008, J AM COLL CARDIOL, V52, P818, DOI 10.1016/j.jacc.2008.04.061
   Grothues F, 2002, AM J CARDIOL, V90, P29, DOI 10.1016/S0002-9149(02)02381-0
   Grothues F, 2004, AM HEART J, V147, P218, DOI 10.1016/j.ahj.2003.10.005
   Gu J, 2010, J CLIN PHARMACOL, V50, P401, DOI 10.1177/0091270009343932
   Gurfinkel EP, 2004, EUR HEART J, V25, P25, DOI 10.1016/j.ehj.2003.10.018
   GUYATT GH, 1988, AM J CARDIOL, V61, P371, DOI 10.1016/0002-9149(88)90947-2
   Gwadry-Sridhar FH, 2005, AM HEART J, V150, DOI 10.1016/j.ahj.2005.08.016
   Haas SJ, 2003, AM HEART J, V146, P848, DOI 10.1016/S0002-8703(03)00403-4
   Habedank D, 2007, EUR J HEART FAIL, V9, P310, DOI 10.1016/j.ejheart.2006.07.001
   Hamilton MA, 1996, THYROID, V6, P527, DOI 10.1089/thy.1996.6.527
   Hamilton-Craig C, 2012, INT J CARDIOVAS IMAG, V28, P1111, DOI 10.1007/s10554-011-9926-y
   Hampton JR, 1997, LANCET, V349, P971, DOI 10.1016/S0140-6736(96)10488-8
   Hart RG, 2007, ANN INTERN MED, V146, P857, DOI 10.7326/0003-4819-146-12-200706190-00007
   Hawkins NM, 2009, EUR J HEART FAIL, V11, P684, DOI 10.1093/eurjhf/hfp066
   Heidenreich PA, 2013, CIRC-HEART FAIL, V6, P606, DOI 10.1161/HHF.0b013e318291329a
   Hensley ML, 2009, J CLIN ONCOL, V27, P127, DOI 10.1200/JCO.2008.17.2627
   Hernandez AF, 2012, JAMA-J AM MED ASSOC, V308, P2097, DOI 10.1001/jama.2012.14795
   Hernandez AF, 2010, JAMA-J AM MED ASSOC, V303, P1716, DOI 10.1001/jama.2010.533
   Hess R, 2014, MED KLIN-INTENSIVMED, V109, P403, DOI 10.1007/s00063-014-0368-x
   Heyndrickx G, 1996, HEART, V76, P223, DOI 10.1136/hrt.76.3.223
   Hjalmarson A, 1999, LANCET, V353, P2001
   Hobkirk JP, 2013, EUR J HEART FAIL, V15, P505, DOI 10.1093/eurjhf/hft003
   Hohnloser SH, 2004, NEW ENGL J MED, V351, P2481, DOI 10.1056/NEJMoa041489
   Holzapfel N, 2009, HEART LUNG, V38, P392, DOI 10.1016/j.hrtlng.2008.11.001
   Home PD, 2007, NEW ENGL J MED, V357, P28, DOI 10.1056/NEJMoa073394
   Home PD, 2009, LANCET, V373, P2125, DOI 10.1016/S0140-6736(09)60953-3
   Homma S, 2012, NEW ENGL J MED, V366, P1859, DOI 10.1056/NEJMoa1202299
   Hood WB, 2004, J CARD FAIL, V10, P155, DOI 10.1016/j.cardfail.2003.12.005
   Horwich TB, 2004, J AM COLL CARDIOL, V43, P642, DOI 10.1016/j.jacc.2003.07.049
   Horwich TB, 2002, J CARD FAIL, V8, P216, DOI 10.1054/jcaf.2002.126519a
   Hsu LF, 2004, NEW ENGL J MED, V351, P2373, DOI 10.1056/NEJMoa041018
   Hu SS, 2012, BIOMED ENVIRON SCI, V25, P251, DOI 10.3967/0895-3988.2012.03.001
   Hu SS, 2011, J AM COLL CARDIOL, V57, P2409, DOI 10.1016/j.jacc.2011.01.037
   Hudson M, 2005, BMJ-BRIT MED J, V330, P1370, DOI 10.1136/bmj.330.7504.1370
   Huerta C, 2006, HEART, V92, P1610, DOI 10.1136/hrt.2005.082388
   HUNDLEY WG, 1995, CIRCULATION, V91, P2955, DOI 10.1161/01.CIR.91.12.2955
   Hung MJ, 2002, INT J CLIN PRACT, V56, P57
   Hunt SA, 2009, CIRCULATION, V119, pE391, DOI 10.1161/CIRCULATIONAHA.109.192065
   INGELFINGER JA, 1976, NEW ENGL J MED, V294, P867, DOI 10.1056/NEJM197604152941603
   Ingle L, 2012, INT J CARDIOL, V158, P66, DOI 10.1016/j.ijcard.2010.12.101
   Inglis SC, 2011, EUR J HEART FAIL, V13, P1028, DOI 10.1093/eurjhf/hfr039
   Izzo JL, 2004, MED CLIN N AM, V88, P1257, DOI 10.1016/j.mcna.2004.06.002
   Jaarsma T, 1996, HEART LUNG, V25, P262, DOI 10.1016/S0147-9563(96)80061-6
   Jaarsma Tiny, 2002, Eur J Cardiovasc Nurs, V1, P61, DOI 10.1016/S1474-5151(01)00009-3
   Jackson LA, 2002, AM J EPIDEMIOL, V156, P634, DOI 10.1093/aje/kwf073
   January CT, 2014, J AM COLL CARDIOL, V64, pE1, DOI 10.1016/j.jacc.2014.03.022
   Januzzi JL, 2011, J AM COLL CARDIOL, V58, P1881, DOI 10.1016/j.jacc.2011.03.072
   Januzzi JL, 2005, AM J CARDIOL, V95, P948, DOI 10.1016/j.amjcard.2004.12.032
   Jha AK, 2009, NEW ENGL J MED, V361, P2637, DOI 10.1056/NEJMsa0904859
   Jiang W, 2011, AM J CARDIOL, V107, P545, DOI 10.1016/j.amjcard.2010.10.013
   Jin B, 2010, EUR J HEART FAIL, V12, P249, DOI 10.1093/eurjhf/hfp182
   Jones AL, 2009, BRIT J CANCER, V100, P684, DOI 10.1038/sj.bjc.6604909
   Jones RH, 2009, NEW ENGL J MED, V360, P1705, DOI 10.1056/NEJMoa0900559
   Jourdain P, 2007, J AM COLL CARDIOL, V49, P1733, DOI 10.1016/j.jacc.2006.10.081
   Jung SH, 2011, J KOREAN MED SCI, V26, P599, DOI 10.3346/jkms.2011.26.5.599
   Kalay N, 2006, J AM COLL CARDIOL, V48, P2258, DOI 10.1016/j.jacc.2006.07.052
   Kalogeropoulos A, 2009, ARCH INTERN MED, V169, P708, DOI 10.1001/archinternmed.2009.40
   Kalra PR, 2003, AM J CARDIOL, V91, P888, DOI 10.1016/S0002-9149(03)00030-4
   Kaneko Y, 2003, NEW ENGL J MED, V348, P1233, DOI 10.1056/NEJMoa022479
   Kang HJ, 2007, AM HEART J, V153, DOI 10.1016/j.ahj.2006.11.004
   Kasper EK, 2002, J AM COLL CARDIOL, V39, P471, DOI 10.1016/S0735-1097(01)01761-2
   Katz S D, 1995, J Cardiovasc Risk, V2, P97, DOI 10.1097/00043798-199504000-00003
   Kazory A, 2008, CIRCULATION, V117, P975, DOI 10.1161/CIRCULATIONAHA.107.742270
   Kelder JC, 2011, CIRCULATION, V124, P2865, DOI 10.1161/CIRCULATIONAHA.111.019216
   Kelder JC, 2011, J CARD FAIL, V17, P729, DOI 10.1016/j.cardfail.2011.04.013
   Kenchaiah S, 2002, NEW ENGL J MED, V347, P305, DOI 10.1056/NEJMoa020245
   Kenchaiah S, 2007, CIRCULATION, V116, P627, DOI 10.1161/CIRCULATIONAHA.106.679779
   Khan MN, 2008, NEW ENGL J MED, V359, P1778, DOI 10.1056/NEJMoa0708234
   Khand AU, 2003, J AM COLL CARDIOL, V42, P1944, DOI 10.1016/j.jacc.2003.07.020
   Khunti K, 2004, EUR J HEART FAIL, V6, P571, DOI 10.1016/j.ejheart.2004.03.013
   Kim RJ, 2000, NEW ENGL J MED, V343, P1445, DOI 10.1056/NEJM200011163432003
   Kirklin JK, 2011, J HEART LUNG TRANSPL, V30, P115, DOI 10.1016/j.healun.2010.12.001
   Kirkpatrick JN, 2007, J AM COLL CARDIOL, V50, P381, DOI 10.1016/j.jacc.2007.03.048
   Kjekshus J, 2007, NEW ENGL J MED, V357, P2248, DOI 10.1056/NEJMoa0706201
   Klem I, 2012, J AM COLL CARDIOL, V60, P408, DOI 10.1016/j.jacc.2012.02.070
   Klingbeil AU, 2003, AM J MED, V115, P41, DOI 10.1016/S0002-9343(03)00158-X
   Kobashigawa JA, 1999, NEW ENGL J MED, V340, P272, DOI 10.1056/NEJM199901283400404
   KOBER L, 1995, NEW ENGL J MED, V333, P1670, DOI 10.1056/NEJM199512213332503
   Kober L, 2000, LANCET, V356, P2052, DOI 10.1016/S0140-6736(00)03402-4
   Kober L, 2008, NEW ENGL J MED, V358, P2678, DOI 10.1056/NEJMoa0800456
   Koelling TM, 2005, CIRCULATION, V111, P179, DOI 10.1161/01.CIR.0000151811.53450.B8
   Komajda M, 2010, EUR HEART J, V31, P824, DOI 10.1093/eurheartj/ehp604
   Konstam MA, 2009, LANCET, V374, P1840, DOI 10.1016/S0140-6736(09)61913-9
   KORNOWSKI R, 1995, AM HEART J, V129, P762, DOI 10.1016/0002-8703(95)90327-5
   Korperich H, 2004, CIRCULATION, V109, P1987, DOI 10.1161/01.CIR.0000126494.66859.A2
   KOSTIS JB, 1994, CHEST, V106, P996, DOI 10.1378/chest.106.4.996
   Kostis WJ, 2012, J AM COLL CARDIOL, V59, P572, DOI 10.1016/j.jacc.2011.09.067
   Krishnaswamy P, 2001, AM J MED, V111, P274, DOI 10.1016/S0002-9343(01)00841-5
   Krum H, 2004, EUR J HEART FAIL, V6, P937, DOI 10.1016/j.ejheart.2004.09.005
   Krum H, 2007, CARDIOLOGY, V108, P28, DOI 10.1159/000095629
   Krumholz HM, 2009, CIRC-CARDIOVASC QUAL, V2, P407, DOI 10.1161/CIRCOUTCOMES.109.883256
   Krumholz HM, 2002, J AM COLL CARDIOL, V39, P83, DOI 10.1016/S0735-1097(01)01699-0
   Krumholz HM, 2000, AM HEART J, V139, P72, DOI 10.1016/S0002-8703(00)90311-9
   Kwon DH, 2009, J AM COLL CARDIOL, V54, P242, DOI 10.1016/j.jacc.2009.04.026
   Kwong Raymond Y, 2008, Top Magn Reson Imaging, V19, P15, DOI 10.1097/RMR.0B013e31817d550c
   Lago RM, 2007, LANCET, V370, P1129, DOI 10.1016/S0140-6736(07)61514-1
   Lainchbury JG, 2009, J AM COLL CARDIOL, V55, P53, DOI 10.1016/j.jacc.2009.02.095
   Lainscak M, 2007, EUR J HEART FAIL, V9, P1095, DOI 10.1016/j.ejheart.2007.08.001
   Lainscak M, 2011, EUR J HEART FAIL, V13, P115, DOI 10.1093/eurjhf/hfq219
   Lang RM, 2006, EUR J ECHOCARDIOGR, V7, P79, DOI 10.1016/j.euje.2005.12.014
   Lang RM, 2012, J AM SOC ECHOCARDIOG, V25, P3, DOI 10.1016/j.echo.2011.11.010
   Larkin RJ, 2000, NEW ENGL J MED, V342, P132
   Larsen GK, 2011, HEART RHYTHM, V8, P1881, DOI 10.1016/j.hrthm.2011.07.036
   Larsen TB, 2014, LANCET, V383, P931, DOI 10.1016/S0140-6736(13)62376-4
   LAUPACIS A, 1994, ARCH INTERN MED, V154, P1449
   Lechat P, 1999, LANCET, V353, P9
   Ledwidge M, 2003, EUR J HEART FAIL, V5, P381, DOI 10.1016/S1388-9842(02)00235-0
   LEE DCS, 1982, NEW ENGL J MED, V306, P699, DOI 10.1056/NEJM198203253061202
   Lee DS, 2009, CIRCULATION, V119, P3070, DOI 10.1161/CIRCULATIONAHA.108.815944
   Lee HM, 2011, KOREAN CIRC J, V41, P171, DOI 10.4070/kcj.2011.41.4.171
   Lee SE, 2014, EUR J HEART FAIL, V16, P700, DOI 10.1002/ejhf.91
   Lee YS, 2011, KOREAN CIRC J, V41, P61, DOI 10.4070/kcj.2011.41.2.61
   Lega JC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091398
   Leonardi S, 2009, EUR HEART J, V30, P2003, DOI 10.1093/eurheartj/ehp152
   LEWIS RV, 1989, J CARDIOVASC PHARM, V13, P1, DOI 10.1097/00005344-198901000-00002
   Lip GYH, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003336.pub2
   Lip GYH, 2010, CHEST, V137, P263, DOI 10.1378/chest.09-1584
   Liu P, 2001, CAN J CARDIOL SE, V17, p5E
   Lloyd-Jones DM, 2002, CIRCULATION, V106, P3068, DOI 10.1161/01.CIR.0000039105.49749.6F
   Lloyd-Jones D, 2010, CIRCULATION, V121, pE46, DOI 10.1161/CIRCULATIONAHA.109.192667
   Macchia A, 2005, EUR J HEART FAIL, V7, P904, DOI 10.1016/j.ejheart.2005.04.008
   Macdonald M, 2008, J CLIN SLEEP MED, V4, P38
   MacDonald MR, 2011, HEART, V97, P740, DOI 10.1136/hrt.2010.207340
   MacDonald MR, 2010, DIABETES CARE, V33, P1213, DOI 10.2337/dc09-2227
   Maceira AM, 2005, CIRCULATION, V111, P186, DOI 10.1161/01.CIR.0000152819.97857.9D
   Mackey JR, 2008, CURR ONCOL, V15, P24, DOI 10.3747/co.2008.199
   Madhok V, 2008, BMC FAM PRACT, V9, DOI 10.1186/1471-2296-9-56
   Madias JE, 2011, PACE, V34, P963, DOI 10.1111/j.1540-8159.2011.03131.x
   Maeda K, 2000, J AM COLL CARDIOL, V36, P1587, DOI 10.1016/S0735-1097(00)00912-8
   Mahrholdt H, 2004, CIRCULATION, V109, P1250, DOI 10.1161/01.CIR.0000118493.13323.81
   Mahrholdt H, 2005, EUR HEART J, V26, P1461, DOI 10.1093/eurheartj/ehi258
   Maisel A, 2008, EUR J HEART FAIL, V10, P824, DOI 10.1016/j.ejheart.2008.07.014
   Maisel AS, 2002, NEW ENGL J MED, V347, P161, DOI 10.1056/NEJMoa020233
   Maisel AS, 2003, J AM COLL CARDIOL, V41, P2010, DOI 10.1016/S0735-1097(03)00405-4
   Mamdani M, 2004, LANCET, V363, P1751, DOI 10.1016/S0140-6736(04)16299-5
   Mancini DM, 2003, CIRCULATION, V107, P294, DOI 10.1161/01.CIR.0000044914.42696.6A
   MANCINI DM, 1991, CIRCULATION, V83, P778, DOI 10.1161/01.CIR.83.3.778
   Mancini D, 2010, CIRCULATION, V122, P173, DOI 10.1161/CIRCULATIONAHA.109.858076
   Mansfield DR, 2004, AM J RESP CRIT CARE, V169, P361, DOI 10.1164/rccm.200306-752OC
   Mant J, 2009, HEALTH TECHNOL ASSES, V13, pIX, DOI 10.3310/hta13320
   MARANTZ PR, 1988, CIRCULATION, V77, P607, DOI 10.1161/01.CIR.77.3.607
   Martin BJ, 2012, CIRCULATION, V126, P677, DOI 10.1161/CIRCULATIONAHA.111.066738
   Martinez-Selles M, 2004, EUR J HEART FAIL, V6, P219, DOI 10.1016/j.ejheart.2003.09.009
   Massie BM, 2008, NEW ENGL J MED, V359, P2456, DOI 10.1056/NEJMoa0805450
   Massie BM, 2009, CIRCULATION, V119, P1616, DOI 10.1161/CIRCULATIONAHA.108.801753
   McAlister FA, 2004, J AM COLL CARDIOL, V44, P810, DOI 10.1016/j.jacc.2004.05.055
   McCrohon A, 2003, CIRCULATION, V108, P54, DOI 10.1161/01.CIR.0000078641.19365.4C
   McKelvie RS, 2008, HEART FAIL REV, V13, P3, DOI 10.1007/s10741-007-9052-z
   McKelvie RS, 2011, CAN J CARDIOL, V27, P319, DOI 10.1016/j.cjca.2011.03.011
   MCKELVIE RS, 1995, J AM COLL CARDIOL, V25, P789, DOI 10.1016/0735-1097(94)00428-S
   McMurray JJV, 2003, LANCET, V362, P767, DOI 10.1016/S0140-6736(03)14283-3
   McMurray J, 2015, EUR HEART J, V36, P434, DOI 10.1093/eurheartj/ehu455
   McMurray JJ, 2010, NEW ENGL J MED, V362, P1477, DOI 10.1056/NEJMoa1001121
   McMurray JJV, 2014, NEW ENGL J MED, V371, P993, DOI 10.1056/NEJMoa1409077
   McMurray JJV, 2012, EUR HEART J, V33, P1787, DOI 10.1093/eurheartj/ehs104
   Mehra MR, 2004, J AM COLL CARDIOL, V43, P1590, DOI 10.1016/j.jacc.2003.10.066
   Mehra MR, 1997, AM J CARDIOL, V80, P61, DOI 10.1016/S0002-9149(97)00284-1
   Metra M, 2009, EUR HEART J, V30, P3015, DOI 10.1093/eurheartj/ehp338
   Meyer P, 2009, AM J CARDIOL, V103, P839, DOI 10.1016/j.amjcard.2008.11.045
   Mickleborough LL, 2004, J THORAC CARDIOV SUR, V128, P27, DOI 10.1016/j.jtcvs.2003.08.013
   Miller CS, 2012, AM J CARDIOL, V110, P453, DOI 10.1016/j.amjcard.2012.03.049
   Miller LW, 2007, NEW ENGL J MED, V357, P885, DOI 10.1056/NEJMoa067758
   Mills EJ, 2008, J AM COLL CARDIOL, V52, P1769, DOI 10.1016/j.jacc.2008.08.039
   Min JY, 2014, INT J CARDIOL, V176, P487, DOI 10.1016/j.ijcard.2014.06.074
   Mishkin JD, 2009, J AM COLL CARDIOL, V54, P1993, DOI 10.1016/j.jacc.2009.07.039
   Mittal TK, 2013, RADIOLOGY, V268, P374, DOI 10.1148/radiol.13121440
   Moe GW, 2015, CAN J CARDIOL, V31, P3, DOI 10.1016/j.cjca.2014.10.022
   Moon JCC, 2003, EUR HEART J, V24, P2151, DOI 10.1016/j.ehj.2003.09.017
   Morris CD, 2003, ANN INTERN MED, V139, P56, DOI 10.7326/0003-4819-139-1-200307010-00014
   Moser DK, 2010, HEART LUNG, V39, P378, DOI 10.1016/j.hrtlng.2009.10.017
   MOSS AJ, 1988, NEW ENGL J MED, V319, P385
   Moss AJ, 1996, NEW ENGL J MED, V335, P1933, DOI 10.1056/NEJM199612263352601
   Moss AJ, 2002, NEW ENGL J MED, V346, P877, DOI 10.1056/NEJMoa013474
   Moss AJ, 2009, NEW ENGL J MED, V361, P1329, DOI 10.1056/NEJMoa0906431
   Mozaffarian D, 2015, CIRCULATION, V131, pE29, DOI [10.1161/CIR.0000000000000152, 10.1161/01.cir.0000441139.02102.80, 10.1161/CIR.0b013e31828124ad]
   Muller JE, 1999, AM J CARDIOL, V84, p2N
   Murberg TA, 2004, INT J PSYCHIAT MED, V34, P207, DOI 10.2190/GKJ2-P8BD-V59X-MJNQ
   Murray MD, 2001, AM J MED, V111, P513, DOI 10.1016/S0002-9343(01)00903-2
   MYERS WO, 1989, J THORAC CARDIOV SUR, V97, P487
   Nagueh SF, 1997, J AM COLL CARDIOL, V30, P1527, DOI 10.1016/S0735-1097(97)00344-6
   Nagueh SF, 2009, EUR J ECHOCARDIOGR, V10, P165, DOI 10.1093/ejechocard/jep007
   Nasir S, 2012, AM J CARDIOL, V110, p50B, DOI 10.1016/j.amjcard.2012.08.031
   National Kidney Foundation, 2004, AM J KIDNEY DIS, V43, pS1, DOI DOI 10.1053/J.AJKD.2004.03.003
   Naylor MD, 1999, JAMA-J AM MED ASSOC, V281, P613, DOI 10.1001/jama.281.7.613
   Nerheim P, 2004, CIRCULATION, V110, P247, DOI 10.1161/01.CIR.0000135472.28234.CC
   Neuhold S, 2008, J AM COLL CARDIOL, V52, P266, DOI 10.1016/j.jacc.2008.03.050
   Ng LL, 2005, J AM COLL CARDIOL, V45, P1043, DOI 10.1016/j.jacc.2004.12.058
   Ng TMH, 2002, J CARDIOVASC PHARM, V40, P140, DOI 10.1097/00005344-200207000-00017
   Nichol KL, 1998, ARCH INTERN MED, V158, P1769, DOI 10.1001/archinte.158.16.1769
   Nodari S, 2011, J AM COLL CARDIOL, V57, P870, DOI 10.1016/j.jacc.2010.11.017
   O'Connor CM, 2010, J AM COLL CARDIOL, V56, P692, DOI 10.1016/j.jacc.2010.03.068
   O'Connor CM, 2009, JAMA-J AM MED ASSOC, V301, P1439, DOI 10.1001/jama.2009.454
   O'Meara E, 2006, CIRCULATION, V113, P986, DOI 10.1161/CIRCULATIONAHA.105.582577
   Okonko DO, 2008, J AM COLL CARDIOL, V51, P103, DOI 10.1016/j.jacc.2007.09.036
   Okura Y, 2008, CIRC J, V72, P489, DOI 10.1253/circj.72.489
   OLDRIDGE NB, 1988, JAMA-J AM MED ASSOC, V260, P945, DOI 10.1001/jama.260.7.945
   Olesen JB, 2011, THROMB HAEMOSTASIS, V106, P739, DOI 10.1160/TH11-05-0364
   Oliva F, 1999, AM HEART J, V138, P247, DOI 10.1016/S0002-8703(99)70108-0
   Oosterhof T, 2007, CIRCULATION, V116, P545, DOI 10.1161/CIRCULATIONAHA.106.659664
   OSTER JR, 1983, ANN INTERN MED, V99, P405, DOI 10.7326/0003-4819-99-3-405
   Oudejans I, 2011, EUR J HEART FAIL, V13, P518, DOI 10.1093/eurjhf/hfr021
   Owan TE, 2005, PROG CARDIOVASC DIS, V47, P320, DOI 10.1016/j.pcad.2005.02.010
   Owan TE, 2006, NEW ENGL J MED, V355, P251, DOI 10.1056/NEJMoa052256
   Pack QR, 2013, CIRCULATION, V128, P590, DOI 10.1161/CIRCULATIONAHA.112.001365
   Packer M, 2002, CIRCULATION, V106, P2194, DOI 10.1161/01.CIR.0000035653.72855.BF
   Packer M, 1999, CIRCULATION, V100, P2312, DOI 10.1161/01.CIR.100.23.2312
   Packer M, 1996, NEW ENGL J MED, V335, P1107, DOI 10.1056/NEJM199610103351504
   PACKER M, 1993, NEW ENGL J MED, V329, P1, DOI 10.1056/NEJM199307013290101
   Packer M, 2001, NEW ENGL J MED, V344, P1651, DOI 10.1056/NEJM200105313442201
   PACKER M, 1991, NEW ENGL J MED, V325, P1468, DOI 10.1056/NEJM199111213252103
   Packer M, 2015, CIRCULATION, V131, P54, DOI 10.1161/CIRCULATIONAHA.114.013748
   Pagani FD, 2009, J AM COLL CARDIOL, V54, P312, DOI 10.1016/j.jacc.2009.03.055
   Palazzuoli A, 2006, AM HEART J, V152, DOI 10.1016/j.ahj.2006.08.005
   Panza JA, 2013, J AM COLL CARDIOL, V61, P1860, DOI 10.1016/j.jacc.2013.02.014
   Parissis JT, 2008, AM HEART J, V155, DOI 10.1016/j.ahj.2008.01.016
   Patel MR, 2011, NEW ENGL J MED, V365, P883, DOI 10.1056/NEJMoa1009638
   Patel MR, 2009, CIRCULATION, V120, P1969, DOI 10.1161/CIRCULATIONAHA.109.851352
   Paterna S, 2009, AM J CARDIOL, V103, P93, DOI 10.1016/j.amjcard.2008.08.043
   Paulus WJ, 2007, EUR HEART J, V28, P2539, DOI 10.1093/eurheartj/ehm037
   Paulus WJ, 1998, EUR HEART J, V19, P990
   Perin EC, 2012, JAMA-J AM MED ASSOC, V307, P1717, DOI 10.1001/jama.2012.418
   Perry G, 1997, NEW ENGL J MED, V336, P525
   PFEFFER MA, 1992, NEW ENGL J MED, V327, P669, DOI 10.1056/NEJM199209033271001
   Pfeffer MA, 2003, NEW ENGL J MED, V349, P1893, DOI 10.1056/NEJMoa032292
   Pfeffer MA, 2003, LANCET, V362, P759, DOI 10.1016/S0140-6736(03)14282-1
   Pfisterer M, 2009, JAMA-J AM MED ASSOC, V301, P383, DOI 10.1001/jama.2009.2
   Piepoli M, 1998, INT J CARDIOL, V66, P1, DOI 10.1016/S0167-5273(98)00184-3
   Piller LB, 2011, CIRCULATION, V124, P1811, DOI 10.1161/CIRCULATIONAHA.110.012575
   Pisters R, 2010, CHEST, V138, P1093, DOI 10.1378/chest.10-0134
   Pitt B, 1996, AM J CARDIOL, V78, P902
   Pitt B, 2003, NEW ENGL J MED, V348, P1309, DOI 10.1056/NEJMoa030207
   Pitt B, 1999, NEW ENGL J MED, V341, P709, DOI 10.1056/NEJM199909023411001
   Pitt B, 2014, NEW ENGL J MED, V370, P1383, DOI 10.1056/NEJMoa1313731
   Porapakkham P, 2010, ARCH INTERN MED, V170, P507, DOI 10.1001/archinternmed.2010.35
   Powell LH, 2010, JAMA-J AM MED ASSOC, V304, P1331, DOI 10.1001/jama.2010.1362
   Prasad SK, 2004, CIRCULATION, V109, P207, DOI 10.1161/01.CIR.0000107842.29467.C5
   Purek L, 2006, HEART, V92, P598, DOI 10.1136/hrt.2005.066464
   Rathore SS, 2003, JAMA-J AM MED ASSOC, V289, P871, DOI 10.1001/jama.289.7.871
   Rauchhaus M, 2003, J AM COLL CARDIOL, V42, P1933, DOI 10.1016/j.jacc.2003.07.016
   Redfield MM, 2013, JAMA-J AM MED ASSOC, V309, P1268, DOI 10.1001/jama.2013.2024
   Redfield MM, 2002, J AM COLL CARDIOL, V40, P976, DOI 10.1016/S0735-1097(02)02059-4
   Regitz-Zagrosek V, 2011, EUR HEART J, V32, P3147, DOI 10.1093/eurheartj/ehr218
   REMES J, 1991, CARDIOLOGY, V78, P267, DOI 10.1159/000174793
   Renneboog B, 2006, AM J MED, V119, pe1
   RICH MW, 1993, J GEN INTERN MED, V8, P585, DOI 10.1007/BF02599709
   Richards AM, 2001, J AM COLL CARDIOL, V37, P1781, DOI 10.1016/S0735-1097(01)01269-4
   Riegel B, 2002, ARCH INTERN MED, V162, P705, DOI 10.1001/archinte.162.6.705
   Riegel B, 2009, CIRCULATION, V120, P1141, DOI 10.1161/CIRCULATIONAHA.109.192628
   Rodriguez-Roisin Roberto, 2008, Proc Am Thorac Soc, V5, P842, DOI 10.1513/pats.200807-075TH
   Rogers AE, 2000, BMJ-BRIT MED J, V321, P605, DOI 10.1136/bmj.321.7261.605
   Rogers JG, 2007, J AM COLL CARDIOL, V50, P741, DOI 10.1016/j.jacc.2007.03.063
   Romero J, 2013, EUR HEART J-CARD IMG, V14, P1080, DOI 10.1093/ehjci/jet040
   Romero J, 2012, JACC-CARDIOVASC IMAG, V5, P494, DOI 10.1016/j.jcmg.2012.02.009
   Rose EA, 2001, NEW ENGL J MED, V345, P1435, DOI 10.1056/NEJMoa012175
   Rossi JS, 2008, EUR J HEART FAIL, V10, P1215, DOI 10.1016/j.ejheart.2008.09.009
   Roy D, 2008, NEW ENGL J MED, V358, P2667, DOI 10.1056/NEJMoa0708789
   Ruff CT, 2014, LANCET, V383, P955, DOI 10.1016/S0140-6736(13)62343-0
   Rutledge JM, 2002, PEDIATR CARDIOL, V23, P137, DOI 10.1007/s00246-001-0037-8
   Ruttanaumpawan P, 2009, SLEEP, V32, P91
   Rutten FH, 2005, BMJ-BRIT MED J, V331, P1379, DOI 10.1136/bmj.38664.661181.55
   RYDEN L, 1990, LANCET, V336, P1
   Ryden L, 2000, EUR HEART J, V21, P1967, DOI 10.1053/euhj.2000.2311
   Salehian O, 2004, CIRCULATION, V110, P3229, DOI 10.1161/01.CIR.0000147284.54140.73
   Salpeter S, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003566.pub2
   SALTISSI S, 1981, BRIT HEART J, V46, P290
   Schietinger BJ, 2007, INT J CARDIOVAS IMAG, V23, P595, DOI 10.1007/s10554-006-9200-x
   Schrier RW, 2006, AM J MED, V119, pS47, DOI 10.1016/j.amjmed.2006.05.007
   Schrier RW, 2006, NEW ENGL J MED, V355, P2099, DOI 10.1056/NEJMoa065181
   Schwarz ER, 2008, INT J IMPOT RES, V20, P85, DOI 10.1038/sj.ijir.3901613
   Sears SF, 2011, CIRC-ARRHYTHMIA ELEC, V4, P242, DOI 10.1161/CIRCEP.110.957670
   Selvanayagam JB, 2004, CIRCULATION, V110, P1535, DOI 10.1161/01.CIR.0000142045.22628.74
   Sengstock DM, 2002, J CARD FAIL, V8, P232, DOI 10.1054/jcaf.2002.127771
   Senthilkumar Annamalai, 2009, Heart Fail Clin, V5, P349, DOI 10.1016/j.hfc.2009.02.009
   SETARO JF, 1990, AM J CARDIOL, V66, P981, DOI 10.1016/0002-9149(90)90937-V
   Setoguchi S, 2009, CAN MED ASSOC J, V180, P611, DOI 10.1503/cmaj.080769
   Sharma R, 2004, EUR HEART J, V25, P1021, DOI 10.1016/j.ehj.2004.04.023
   Shekelle PG, 2003, J AM COLL CARDIOL, V41, P1529, DOI 10.1016/S0735-1097(03)00262-6
   Sica DA, 1996, CLIN PHARMACOKINET, V30, P229, DOI 10.2165/00003088-199630030-00004
   Silver Marc A, 2004, Congest Heart Fail, V10, P1, DOI 10.1111/j.1527-5299.2004.03271.x
   Silverberg DS, 2000, J AM COLL CARDIOL, V35, P1737, DOI 10.1016/S0735-1097(00)00613-6
   Silverberg DS, 2001, J AM COLL CARDIOL, V37, P1775, DOI 10.1016/S0735-1097(01)01248-7
   Slatton ML, 1997, J AM COLL CARDIOL, V29, P1206, DOI 10.1016/S0735-1097(97)00057-0
   Slaughter MS, 2009, NEW ENGL J MED, V361, P2241, DOI 10.1056/NEJMoa0909938
   Smart N, 2004, AM J MED, V116, P693, DOI 10.1016/j.amjmed.2003.11.033
   Smeeth L, 2004, NEW ENGL J MED, V351, P2611, DOI 10.1056/NEJMoa041747
   정일형, 2006, Korean Circulation Journal, V36, P200
   유병수, 2004, Korean Circulation Journal, V34, P684
   Kiyooka T, 2007, CIRCULATION, V116, P173, DOI 10.1161/CIRCULATIONAHA.106.183095
   NICKLAS JM, 1992, NEW ENGL J MED, V327, P685
   Smith GL, 2006, J AM COLL CARDIOL, V47, P1987, DOI 10.1016/j.jacc.2005.11.084
   Soman P, 2009, J NUCL CARDIOL, V16, P82, DOI 10.1007/s12350-008-9010-8
   Son YJ, 2011, J CLIN NURS, V20, P3029, DOI 10.1111/j.1365-2702.2011.03755.x
   Soriano CJ, 2005, J AM COLL CARDIOL, V45, P743, DOI 10.1016/j.jacc.2004.11.037
   Starling RC, 2011, J AM COLL CARDIOL, V57, P1890, DOI 10.1016/j.jacc.2010.10.062
   Stefan MS, 2012, THORAX, V67, P977, DOI 10.1136/thoraxjnl-2012-201945
   Stehlik J, 2011, J HEART LUNG TRANSPL, V30, P1078, DOI 10.1016/j.healun.2011.08.003
   Stein JH, 1997, AM J CARDIOL, V80, P1615, DOI 10.1016/S0002-9149(97)00776-5
   Steinbeck G, 2009, NEW ENGL J MED, V361, P1427, DOI 10.1056/NEJMoa0901889
   STEVENSON LW, 1989, JAMA-J AM MED ASSOC, V261, P884, DOI 10.1001/jama.261.6.884
   Stewart S, 1999, LANCET, V354, P1077, DOI 10.1016/S0140-6736(99)03428-5
   Stewart S, 1999, ARCH INTERN MED, V159, P257, DOI 10.1001/archinte.159.3.257
   Strauer BE, 2010, EUR J HEART FAIL, V12, P721, DOI 10.1093/eurjhf/hfq095
   Struthers AD, 2000, HEART, V83, P12, DOI 10.1136/heart.83.1.12
   Suskin N, 2001, J AM COLL CARDIOL, V37, P1677, DOI 10.1016/S0735-1097(01)01195-0
   Suter TM, 2007, J CLIN ONCOL, V25, P3859, DOI 10.1200/JCO.2006.09.1611
   Suzuki H, 2008, AM J KIDNEY DIS, V52, P501, DOI 10.1053/j.ajkd.2008.04.031
   SWEDBERG K, 1987, NEW ENGL J MED, V316, P1429
   Swedberg K, 2013, NEW ENGL J MED, V368, P1210, DOI 10.1056/NEJMoa1214865
   Swedberg K, 2012, J AM COLL CARDIOL, V59, P1938, DOI 10.1016/j.jacc.2012.01.020
   Takahashi A, 2006, NEPHROL DIAL TRANSPL, V21, P2507, DOI 10.1093/ndt/gfl293
   Tang WHW, 2003, CIRCULATION, V108, P2964, DOI 10.1161/01.CIR.0000106903.98196.B6
   Tang YD, 2006, CIRCULATION, V113, P2454, DOI 10.1161/CIRCULATIONAHA.105.583666
   Taub Pam R, 2009, Heart Fail Clin, V5, P169, DOI 10.1016/j.hfc.2008.11.009
   TAUBERG SG, 1993, AM J CARDIOL, V71, P674, DOI 10.1016/0002-9149(93)91009-7
   Tavazzi L, 2008, LANCET, V372, P1231, DOI 10.1016/S0140-6736(08)61240-4
   Tavazzi L, 2008, LANCET, V372, P1223, DOI 10.1016/S0140-6736(08)61239-8
   Taylor AL, 2004, NEW ENGL J MED, V351, P2049, DOI 10.1056/NEJMoa042934
   Taylor F, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004816.pub4
   Telli ML, 2007, J CLIN ONCOL, V25, P3525, DOI 10.1200/JCO.2007.11.0106
   ten Kate GJR, 2013, EUR J HEART FAIL, V15, P1028, DOI 10.1093/eurjhf/hft090
   Therrien J, 2005, AM J CARDIOL, V95, P779, DOI 10.1016/j.amjcard.2004.11.037
   Thompson PD, 2003, CIRCULATION, V107, P3109, DOI 10.1161/01.CIR.0000075572.40158.77
   Thompson WW, 2004, JAMA-J AM MED ASSOC, V292, P1333, DOI 10.1001/jama.292.11.1333
   Toblli JE, 2007, J AM COLL CARDIOL, V50, P1657, DOI 10.1016/j.jacc.2007.07.029
   Toma M, 2012, CIRC-HEART FAIL, V5, P315, DOI 10.1161/CIRCHEARTFAILURE.111.965632
   Torp-Pedersen C, 1999, NEW ENGL J MED, V341, P857, DOI 10.1056/NEJM199909163411201
   Torres D, 2009, J CARD FAIL, V15, pS97, DOI 10.1016/j.cardfail.2009.06.002
   Trent RJ, 2000, HEART, V83, P40, DOI 10.1136/heart.83.1.40
   Troughton RW, 2000, LANCET, V355, P1126, DOI 10.1016/S0140-6736(00)02060-2
   UENO M, 1963, Nihon Hoigaku Zasshi, V17, P330
   Upadhyay GA, 2008, J AM COLL CARDIOL, V52, P1239, DOI 10.1016/j.jacc.2008.06.043
   Uretsky BF, 2000, CIRCULATION, V102, P611, DOI 10.1161/01.CIR.102.6.611
   URETSKY BF, 1993, J AM COLL CARDIOL, V22, P955, DOI 10.1016/0735-1097(93)90403-N
   Usmanov RI, 2008, J NEPHROL, V21, P236
   Usui K, 2005, J AM COLL CARDIOL, V45, P2008, DOI 10.1016/j.jacc.2004.12.080
   Valle-Munoz A, 2009, EUR J ECHOCARDIOGR, V10, P968, DOI 10.1093/ejechocard/jep115
   van Dalen EC, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003917.pub3
   van Kimmenade RRJ, 2006, AM J CARDIOL, V98, P386, DOI 10.1016/j.amjcard.2006.02.043
   van Rees JB, 2011, J AM COLL CARDIOL, V57, P556, DOI 10.1016/j.jacc.2010.06.059
   van Veldhuisen DJ, 2007, EUR HEART J, V28, P2208, DOI 10.1093/eurheartj/ehm328
   Vasan RS, 2002, JAMA-J AM MED ASSOC, V288, P1252, DOI 10.1001/jama.288.10.1252
   Velazquez EJ, 2011, NEW ENGL J MED, V364, P1607, DOI 10.1056/NEJMoa1100356
   Vermes E, 2003, CIRCULATION, V107, P1291, DOI 10.1161/01.CIR.0000054611.89228.92
   von Haehling S, 2011, EUR J HEART FAIL, V13, P656, DOI 10.1093/eurjhf/hfr044
   VONOLSHAUSEN KE, 1988, LANCET, V1, P489
   Waldo AL, 1996, LANCET, V348, P7, DOI 10.1016/S0140-6736(96)02149-6
   Wali RK, 2011, CIRC-HEART FAIL, V4, P18, DOI 10.1161/CIRCHEARTFAILURE.109.932558
   Walsh CR, 2002, ANN INTERN MED, V136, P181, DOI 10.7326/0003-4819-136-3-200202050-00005
   Wang CS, 2005, JAMA-J AM MED ASSOC, V294, P1944, DOI 10.1001/jama.294.15.1944
   Wannamethee SG, 2011, J AM COLL CARDIOL, V58, P1870, DOI 10.1016/j.jacc.2011.06.057
   WEBER KT, 1991, CIRCULATION, V83, P1849, DOI 10.1161/01.CIR.83.6.1849
   Webster LJ, 2004, ARCH INTERN MED, V164, P514, DOI 10.1001/archinte.164.5.514
   WEINTRAUB WS, 1990, AM J CARDIOL, V65, P183, DOI 10.1016/0002-9149(90)90082-C
   Wilhelmsen L, 2001, J INTERN MED, V249, P253, DOI 10.1046/j.1365-2796.2001.00801.x
   Yamamoto K, 2000, J CARD FAIL, V6, P194, DOI 10.1054/jcaf.2000.9676
   Yancy CW, 2013, CIRCULATION, V128, P1810, DOI 10.1161/CIR.0b013e31829e8807
   Yancy CW, 2013, J AM COLL CARDIOL, V62, pE147, DOI 10.1016/j.jacc.2013.05.019
   Yeh ETH, 2009, J AM COLL CARDIOL, V53, P2231, DOI 10.1016/j.jacc.2009.02.050
   Yokota Takashi, 2011, Nihon Rinsho, V69, P1691
   York KM, 2009, HEART FAIL REV, V14, P35, DOI 10.1007/s10741-008-9091-0
   Young M, 2001, PHARMACOECONOMICS, V19, P679, DOI 10.2165/00019053-200119060-00006
   YUSUF S, 1991, NEW ENGL J MED, V325, P293, DOI 10.1056/NEJM199108013250501
   Yusuf S, 2003, LANCET, V362, P777, DOI 10.1016/S0140-6736(03)14285-7
   Zannad F, 2011, NEW ENGL J MED, V364, P11, DOI 10.1056/NEJMoa1009492
   Zaphiriou A, 2005, EUR J HEART FAIL, V7, P537, DOI 10.1016/j.ejheart.2005.01.022
   Zile MR, 2001, CIRCULATION, V104, P779, DOI 10.1161/hc3201.094226
NR 580
TC 28
Z9 30
U1 0
U2 4
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD SEP
PY 2017
VL 47
IS 5
BP 555
EP 643
DI 10.4070/kcj.2017.0009
PG 89
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA FK9PB
UT WOS:000413842200002
PM 28955381
OA Green Published
DA 2021-04-22
ER

PT J
AU Batul, SA
   Gopinathannair, R
AF Batul, Syeda Atiqa
   Gopinathannair, Rakesh
TI Atrial Fibrillation in Heart Failure: a Therapeutic Challenge of Our
   Times
SO KOREAN CIRCULATION JOURNAL
LA English
DT Review
DE Atrial fibrillation; Heart failure; Arrhythmias; Cardiomyopathy;
   Catheter ablation
ID LEFT-VENTRICULAR DYSFUNCTION; PRESERVED EJECTION FRACTION;
   PULMONARY-VEIN ISOLATION; CATHETER ABLATION; PROGNOSTIC-SIGNIFICANCE;
   RISK-FACTORS; CARDIAC RESYNCHRONIZATION; SYSTOLIC DYSFUNCTION; RHYTHM
   MANAGEMENT; SINUS RHYTHM
AB Atrial fibrillation (AF) and heart failure (HF) are growing cardiovascular disease epidemics worldwide. There has been an exponential increase in the prevalence of AF and HF correlating with an increased burden of cardiac risk factors and improved survival rates in patients with structural heart disease. AF is associated with adverse prognostic outcomes in HF and is most evident in mild-to-moderate left ventricular (LV) dysfunction where the loss of "atrial kick" translates into poorer quality of life and increased mortality. In the absence of underlying structural heart disease, arrhythmia can independently contribute to the development of cardiomyopathy. Together, these 2 conditions carry a high risk of thromboembolism due to stasis, inflammation and cellular dysfunction. Stroke prevention with oral anticoagulation (OAC) remains a mainstay of treatment. Pharmacologic rate and rhythm control remain limited by variable efficacy, intolerance and adverse reactions. Catheter ablation for AF has resulted in a paradigm shift with evidence indicating superiority over medical therapy. While its therapeutic success is high for paroxysmal AF, it remains suboptimal in persistent AF. A better mechanistic understanding of AF as well as innovations in ablation technology may improve patient outcomes in the future. Refractory cases may benefit from atrioventricular junction ablation and biventricular pacing. The value of risk factor modification, especially with regard to obesity, sleep apnea, hypertension and diabetes, cannot be emphasized enough. Close interdisciplinary collaboration between HF specialists and electrophysiologists is an essential component of good long-term outcomes in this challenging population.
C1 [Batul, Syeda Atiqa] Mt Sinai Hosp, Icahn Sch Med, Div Cardiol, New York, NY 10029 USA.
   [Gopinathannair, Rakesh] Univ Louisville, Div Cardiovasc Med, Louisville, KY 40202 USA.
RP Gopinathannair, R (corresponding author), Univ Louisville, Div Cardiovasc Med, Sch Med, ACB A3L41,550 S Jackson St, Louisville, KY 40202 USA.
EM rakesh.gopinathannair@louisville.edu
CR Al Halabi Shadi, 2015, JACC Clin Electrophysiol, V1, P200
   Anter E, 2009, CIRCULATION, V119, P2516, DOI 10.1161/CIRCULATIONAHA.108.821306
   Bartus K, 2013, J AM COLL CARDIOL, V62, P108, DOI 10.1016/j.jacc.2012.06.046
   Benjamin EJ, 1998, CIRCULATION, V98, P946, DOI 10.1161/01.CIR.98.10.946
   Beyerbach DM, 2004, HEART RHYTHM, V1, pB8, DOI 10.1016/j.hrthm.2004.04.018
   Bhatia S, 2016, AM J CARDIOL, V117, P1468, DOI 10.1016/j.amjcard.2016.02.016
   Boersma LVA, 2012, CIRCULATION, V125, P23, DOI 10.1161/CIRCULATIONAHA.111.074047
   Brown LAE, 2017, INT J CARDIOL, V227, P863, DOI 10.1016/j.ijcard.2016.09.086
   Cadrin-Tourigny J, 2017, JACC-HEART FAIL, V5, P99, DOI 10.1016/j.jchf.2016.10.015
   Cadrin-Tourigny J, 2014, J CARDIOVASC ELECTR, V25, P1306, DOI 10.1111/jce.12535
   CARSON PE, 1993, CIRCULATION, V87, P102
   Chen MS, 2004, J AM COLL CARDIOL, V43, P1004, DOI 10.1016/j.jacc.2003.09.056
   Colilla S, 2013, AM J CARDIOL, V112, P1142, DOI 10.1016/j.amjcard.2013.05.063
   Corley SD, 2004, CIRCULATION, V109, P1509, DOI 10.1161/01.CIR.0000121736.16643.11
   Di Biase L, 2016, CIRCULATION, V133, P1637, DOI 10.1161/CIRCULATIONAHA.115.019406
   Dries DL, 1998, J AM COLL CARDIOL, V32, P695, DOI 10.1016/S0735-1097(98)00297-6
   Dyrda K, 2015, J CARDIOVASC ELECTR, V26, P1327, DOI 10.1111/jce.12828
   Edgerton Z, 2016, J CARDIOVASC ELECTR, V27, P524, DOI 10.1111/jce.12926
   Fung JWH, 2008, HEART RHYTHM, V5, P780, DOI 10.1016/j.hrthm.2008.02.043
   Ganesan AN, 2012, J AM COLL CARDIOL, V59, P719, DOI 10.1016/j.jacc.2011.10.891
   Gasparini M, 2013, JACC-HEART FAIL, V1, P500, DOI 10.1016/j.jchf.2013.06.003
   Gentlesk PJ, 2007, J CARDIOVASC ELECTR, V18, P9, DOI 10.1111/j.1540-8167.2006.00653.x
   Go AS, 2001, JAMA-J AM MED ASSOC, V285, P2370, DOI 10.1001/jama.285.18.2370
   Gong MQ, 2017, HEART RHYTHM, V14, P3, DOI 10.1016/j.hrthm.2016.10.008
   Gopinathannair R, 2015, J AM COLL CARDIOL, V66, P1714, DOI 10.1016/j.jacc.2015.08.038
   Guglin M, 2010, HEART RHYTHM, V7, P596, DOI 10.1016/j.hrthm.2010.01.003
   Gurbel PA, 2014, JACC-HEART FAIL, V2, P1, DOI 10.1016/j.jchf.2013.07.007
   Hagens VE, 2005, AM HEART J, V149, P1106, DOI 10.1016/j.ahj.2004.11.030
   Hu CY, 2016, EUR REV MED PHARMACO, V20, P4593
   Hunter RJ, 2014, CIRC-ARRHYTHMIA ELEC, V7, P31, DOI 10.1161/CIRCEP.113.000806
   January CT, 2014, J AM COLL CARDIOL, V64, pE1, DOI 10.1016/j.jacc.2014.03.022
   Joglar JA, 2001, AM HEART J, V142, P498, DOI 10.1067/mhj.2001.117318
   Jones DG, 2013, J AM COLL CARDIOL, V61, P1894, DOI 10.1016/j.jacc.2013.01.069
   Jons C, 2011, HEART RHYTHM, V8, P342, DOI 10.1016/j.hrthm.2010.09.090
   Kalifa J, 2003, CIRCULATION, V108, P668, DOI 10.1161/01.CIR.0000086979.39843.7B
   Khan MN, 2008, NEW ENGL J MED, V359, P1778, DOI 10.1056/NEJMoa0708234
   Khazanie P, 2014, JACC-HEART FAIL, V2, P41, DOI 10.1016/j.jchf.2013.11.002
   Kirchhof P, 2016, EUR HEART J, V37, P2893, DOI 10.1093/eurheartj/ehw210
   Kober L, 2006, EUR J HEART FAIL, V8, P591, DOI 10.1016/j.ejheart.2005.11.007
   Kotecha D, 2016, INT J CARDIOL, V203, P660, DOI 10.1016/j.ijcard.2015.10.220
   Kotecha D, 2015, EUR HEART J, V36, P3250, DOI 10.1093/eurheartj/ehv513
   Lam CSP, 2017, JACC-HEART FAIL, V5, P92, DOI 10.1016/j.jchf.2016.10.005
   Lehto M, 2005, EUR HEART J, V26, P350, DOI 10.1093/eurheartj/ehi064
   Ling LH, 2016, NAT REV CARDIOL, V13, P131, DOI 10.1038/nrcardio.2015.191
   Lubitz Steven A, 2010, Heart Fail Clin, V6, P187, DOI 10.1016/j.hfc.2009.11.001
   Lugenbiel P, 2017, BASIC RES CARDIOL, V112, DOI 10.1007/s00395-016-0597-7
   MacDonald MR, 2011, HEART, V97, P740, DOI 10.1136/hrt.2010.207340
   Manolis AG, 1998, J INTERV CARD ELECTR, V2, P71
   Marrouche NF, 2009, PACE, V32, P987, DOI 10.1111/j.1540-8159.2009.02428.x
   Melenovsky V, 2014, EUR HEART J, V35, P3452, DOI 10.1093/eurheartj/ehu193
   MIDDLEKAUFF HR, 1991, CIRCULATION, V84, P40, DOI 10.1161/01.CIR.84.1.40
   Miller MA, 2014, HEART RHYTHM, V11, P1853, DOI 10.1016/j.hrthm.2014.07.032
   Miyasaka Y, 2006, CIRCULATION, V114, P119, DOI 10.1161/CIRCULATIONAHA.105.595140
   Mohanty S, 2015, HEART RHYTHM, V12, P1963, DOI 10.1016/j.hrthm.2015.06.007
   Moreno J, 2014, EUR HEART J, V35, P1908
   Mozaffarian D, 2015, CIRCULATION, V131, pE29, DOI [10.1161/CIR.0000000000000152, 10.1161/01.cir.0000441139.02102.80, 10.1161/CIR.0b013e31828124ad]
   Nilsson KR, 2010, HEART, V96, P838, DOI 10.1136/hrt.2009.180182
   O'Neal WT, 2016, PACE, V39, P907, DOI 10.1111/pace.12907
   Olshansky B, 2004, J AM COLL CARDIOL, V43, P1201, DOI 10.1016/j.jacc.2003.11.032
   Olsson LG, 2006, J AM COLL CARDIOL, V47, P1997, DOI 10.1016/j.jacc.2006.01.060
   Pai RG, 2007, CLIN CARDIOL, V30, P349, DOI 10.1002/clc.20107
   Pandey A, 2017, JACC-HEART FAIL, V5, P44, DOI 10.1016/j.jchf.2016.09.016
   Pandit SV, 2016, CLIN MED INSIGHTS-CA, V10, P41, DOI 10.4137/CMC.S39713
   Patel RB, 2016, PHARM THER
   Pedersen OD, 1999, EUR HEART J, V20, P748, DOI 10.1053/euhj.1998.1352
   Pedersen OD, 2001, CIRCULATION, V104, P292
   Piccini JP, 2017, JACC-HEART FAIL, V5, P107, DOI 10.1016/j.jchf.2016.12.003
   Platonov PG, 2009, HEART RHYTHM, V6, P452, DOI 10.1016/j.hrthm.2009.01.014
   Poli D, 2015, INT J WOMENS HEALTH, V7, P605, DOI 10.2147/IJWH.S45925
   Reddy VY, 2014, JAMA-J AM MED ASSOC, V312, P1988, DOI 10.1001/jama.2014.15192
   Redfield MM, 2000, MAYO CLIN PROC, V75, P790, DOI 10.4065/75.8.790
   Rich MW, 2001, J AM COLL CARDIOL, V38, P806, DOI 10.1016/S0735-1097(01)01442-5
   Rivero-Ayerza M, 2008, EUR HEART J, V29, P1618, DOI 10.1093/eurheartj/ehn217
   Rodriguez CJ, 2015, ANN EPIDEMIOL, V25, P71, DOI 10.1016/j.annepidem.2014.11.024
   Rodriguez F, 2016, AM HEART J, V176, P70, DOI 10.1016/j.ahj.2016.03.004
   Roger VL, 2013, CIRC RES, V113, P646, DOI 10.1161/CIRCRESAHA.113.300268
   Sanders P, 2003, CIRCULATION, V108, P1461, DOI 10.1161/01.CIR.0000090688.49283.67
   Santhanakrishnan R, 2016, CIRCULATION, V133, P484, DOI 10.1161/CIRCULATIONAHA.115.018614
   Schmiegelow MD, 2011, BMC CARDIOVASC DISOR, V11, DOI 10.1186/1471-2261-11-19
   Schnabel RB, 2015, LANCET, V386, P154, DOI 10.1016/S0140-6736(14)61774-8
   Shelton RJ, 2009, HEART, V95, P924, DOI 10.1136/hrt.2008.158931
   Stevenson William G, 2008, J Atr Fibrillation, V1, P101, DOI 10.4022/jafib.101
   Sulzgruber P, 2017, THROMB HAEMOSTASIS, V117, P349, DOI 10.1160/TH16-07-0531
   Swedberg K, 2005, EUR HEART J, V26, P1303, DOI 10.1093/eurheartj/ehi166
   Thihalolipavan S, 2015, PROG CARDIOVASC DIS, V58, P126, DOI 10.1016/j.pcad.2015.07.004
   Thomas KL, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000200
   Ullah W, 2016, EUROPACE, V18, P679, DOI 10.1093/europace/euv440
   van Veldhuisen DJ, 2006, EUR J HEART FAIL, V8, P539, DOI 10.1016/j.ejheart.2006.01.015
   Vroomen M, 2016, J INTERV CARD ELECTR, V47, P265, DOI 10.1007/s10840-016-0183-9
   Wang TJ, 2003, CIRCULATION, V107, P2920, DOI 10.1161/01.CIR.0000072767.89944.6E
   Weinfeld MS, 2000, J HEART LUNG TRANSPL, V19, P638, DOI 10.1016/S1053-2498(00)00123-6
   Wilton SB, 2011, HEART RHYTHM, V8, P1088, DOI 10.1016/j.hrthm.2011.02.014
   Witt BJ, 2007, J CARD FAIL, V13, P489, DOI 10.1016/j.cardfail.2007.01.009
   Workman AJ, 2009, HEART RHYTHM, V6, P445, DOI 10.1016/j.hrthm.2008.12.028
   Xiong QM, 2015, EUR J HEART FAIL, V17, P1192, DOI 10.1002/ejhf.343
   Yeh YH, 2008, CIRC-ARRHYTHMIA ELEC, V1, P93, DOI 10.1161/CIRCEP.107.754788
   Zakeri R, 2013, CIRCULATION, V128, P1085, DOI 10.1161/CIRCULATIONAHA.113.001475
   Zhao YH, 2016, HEART RHYTHM, V13, P141, DOI 10.1016/j.hrthm.2015.08.029
NR 98
TC 20
Z9 20
U1 0
U2 5
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD SEP
PY 2017
VL 47
IS 5
BP 644
EP 662
DI 10.4070/kcj.2017.0040
PG 19
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA FK9PB
UT WOS:000413842200003
PM 28955382
OA Green Published
DA 2021-04-22
ER

PT J
AU Kim, MC
   Kim, JH
AF Kim, Min Chul
   Kim, Ju Han
TI Stent Optimization Using Adjunctive Balloon Dilatation in the Era of
   Second-Generation Drug-Eluting Stents
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
ID INTRAVASCULAR ULTRASOUND; RESTENOSIS
C1 [Kim, Min Chul; Kim, Ju Han] Chonnam Natl Univ Hosp, Div Cardiol, Dept Internal Med, Gwangju, South Korea.
RP Kim, JH (corresponding author), Chonnam Natl Univ Hosp, Dept Cardiol, 42 Jebong Ro, Gwangju 61469, South Korea.
EM kim@zuhan.com
OI Kim, Juhan/0000-0002-3186-0770; Kim, Min Chul/0000-0001-6026-1702
CR Bangalore S, 2012, CIRCULATION, V125, P2873, DOI 10.1161/CIRCULATIONAHA.112.097014
   Bermejo J, 1998, CIRCULATION, V98, P112, DOI 10.1161/01.CIR.98.2.112
   Brodie Bruce R, 2006, J Interv Cardiol, V19, P43, DOI 10.1111/j.1540-8183.2006.00103.x
   Byrne RA, 2015, EUR HEART J, V36, P3320, DOI 10.1093/eurheartj/ehv511
   Costa JD, 2007, AM HEART J, V153, P297, DOI 10.1016/j.ahj.2006.08.026
   Dangas GD, 2010, J AM COLL CARDIOL, V56, P1897, DOI 10.1016/j.jacc.2010.07.028
   Frobert O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056348
   Hong SJ, 2017, KOREAN CIRC J, V47, P694, DOI 10.4070/kcj.2017.0016
   Pasceri V, 2014, CATHETER CARDIO INTE, V83, P898, DOI 10.1002/ccd.24999
   Romagnoli E, 2008, JACC-CARDIOVASC INTE, V1, P22, DOI 10.1016/j.jcin.2007.10.005
NR 10
TC 0
Z9 0
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD SEP
PY 2017
VL 47
IS 5
BP 686
EP 688
DI 10.4070/kcj.2017.0160
PG 3
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA FK9PB
UT WOS:000413842200006
PM 28955385
OA Green Published
DA 2021-04-22
ER

EF